FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Grenho, L
   Salgado, CL
   Fernandes, MH
   Monteiro, FJ
   Ferraz, MP
AF Grenho, L.
   Salgado, C. L.
   Fernandes, M. H.
   Monteiro, F. J.
   Ferraz, M. P.
TI Antibacterial activity and biocompatibility of three-dimensional
   nanostructured porous granules of hydroxyapatite and zinc oxide
   nanoparticles-an in vitro and in vivo study
SO NANOTECHNOLOGY
LA English
DT Article
DE nanostructured hydroxyapatite; zinc oxide nanoparticles; porous
   granules; antibacterial activity; biocompatibility
ID OSTEOBLAST ADHESION; STAPHYLOCOCCUS-AUREUS; LIPID-PEROXIDATION;
   NANOPHASE CERAMICS; ZNO NANOPARTICLES; BIOFILM FORMATION; CANCER-CELLS;
   TISSUE; INFECTIONS; SCAFFOLDS
AB Ceramic scaffolds are widely studied in the bone tissue engineering field due to their potential in regenerative medicine. However, adhesion of microorganisms on biomaterials with subsequent formation of antibiotic-resistant biofilms is a critical factor in implant-related infections. Therefore, new strategies are needed to address this problem. In the present study, three-dimensional and interconnected porous granules of nanostructured hydroxyapatite (nanoHA) incorporated with different amounts of zinc oxide (ZnO) nanoparticles were produced using a simple polymer sponge replication method. As in vitro experiments, granules were exposed to Staphylococcus aureus and Staphylococcus epidermidis and, after 24 h, the planktonic and sessile populations were assessed. Cytocompatibility towards osteoblast-like cells (MG63 cell line) was also evaluated for a period of 1 and 3 days, through resazurin assay and imaging flow cytometry analysis. As in vivo experiments, nanoHA porous granules with and without ZnO nanoparticles were implanted into the subcutaneous tissue in rats and their inflammatory response after 3, 7 and 30 days was examined, as well as their antibacterial activity after 1 and 3 days of S. aureus inoculation. The developed composites proved to be especially effective at reducing bacterial activity in vitro and in vivo for a weight percentage of 2% ZnO, with a low cell growth inhibition in vitro and no differences in the connective tissue growth and inflammatory response in vivo. Altogether, these results suggest that nanoHA-ZnO porous granules have a great potential to be used in orthopaedic and dental applications as a template for bone regeneration and, simultaneously, to restrain biomaterial-associated infections.
C1 [Grenho, L.; Salgado, C. L.; Monteiro, F. J.] Univ Porto, Fac Engn, Dept Engn Met & Mat, P-4200465 Oporto, Portugal.
   [Grenho, L.; Salgado, C. L.; Monteiro, F. J.] Univ Porto, Inst Invest & Inovacao Saude i3s, P-4200465 Oporto, Portugal.
   [Grenho, L.; Salgado, C. L.; Monteiro, F. J.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Fernandes, M. H.] Univ Porto, Fac Med Dent, Lab Bone Metab & Regenerat, P-4200392 Oporto, Portugal.
   [Ferraz, M. P.] Univ Fernando Pessoa, Fac Ciencias Saude, FP ENAS CEBIMED, P-4200150 Oporto, Portugal.
RP Grenho, L (reprint author), Univ Porto, Fac Engn, Dept Engn Met & Mat, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
EM liliana.grenho@ineb.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Salgado, Christiane/0000-0002-3844-1667; Monteiro,
   Fernando/0000-0002-1361-4605
FU FEDER funds through the Programa Operacional Factores de Competitividade
   (COMPETE); Portuguese funds through FCT (Fundacao para a Ciencia e a
   Tecnologia) [PTDC/SAU-BMA/111233/2009, SFRH/BD/72866/2010]
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade (COMPETE) and by Portuguese funds through
   FCT (Fundacao para a Ciencia e a Tecnologia) in the framework of the
   NaNO-Biofilm project (PTDC/SAU-BMA/111233/2009) and PhD grant
   (SFRH/BD/72866/2010) whose support is acknowledged. The authors are
   thankful to Fluidinova S.A. for the supply of NanoXIM.
CR Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129
   Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Barros J, 2014, J BIOMATER APPL, V28, P1325, DOI 10.1177/0885328213507300
   Bernhardt A, 2013, J MATER SCI-MATER M, V24, P1755, DOI 10.1007/s10856-013-4933-2
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Dutta RK, 2012, COLLOID SURFACE B, V94, P143, DOI 10.1016/j.colsurfb.2012.01.046
   Fang M, 2006, INT J ANTIMICROB AG, V27, P513, DOI 10.1016/j.ijantimicag.2006.01.008
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Geilich BM, 2013, INT J NANOMED, V8, P1177, DOI 10.2147/IJN.S42010
   Gervaso F, 2012, INT J APPL CERAM TEC, V9, P507, DOI 10.1111/j.1744-7402.2011.02662.x
   Grenho L, 2014, J BIOMED MATER RES A, V102, P3726, DOI 10.1002/jbm.a.35042
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Laranjeira M S, 2010, J BIOMED MATER RES A, P95891
   Lee HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084272
   Maschhoff PM, 2014, INT J NANOMED, V9, P257, DOI 10.2147/IJN.S54897
   MCCARTHY TJ, 1992, J CLIN PHARM THER, V17, P51, DOI 10.1111/j.1365-2710.1992.tb01265.x
   Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Ninan N, 2014, COLLOID SURFACE B, V115, P244, DOI 10.1016/j.colsurfb.2013.11.048
   Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   Romano CL, 2013, J CHEMOTHERAPY, V25, P67, DOI 10.1179/1973947812Y.0000000045
   Seil JT, 2011, ACTA BIOMATER, V7, P2579, DOI 10.1016/j.actbio.2011.03.018
   Sena LA, 2009, J MATER SCI-MATER M, V20, P2395, DOI 10.1007/s10856-009-3813-2
   Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6
   Suarez-Franco JL, 2013, J NANOMATER, DOI 10.1155/2013/361249
   Taccola L, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S16581
   Teixeira S, 2008, J MATER SCI-MATER M, V19, P855, DOI 10.1007/s10856-007-3005-x
   Tommila M, 2008, ACTA BIOMATER, V4, P354, DOI 10.1016/j.actbio.2007.07.005
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Tripathi G, 2012, CERAM INT, V38, P341, DOI 10.1016/j.ceramint.2011.07.012
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
   Zeelie JJ, 1998, ANALYST, V123, P503, DOI 10.1039/a704895e
   Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1
   Zimmerli W, 2014, J INTERN MED, V276, P111, DOI 10.1111/joim.12233
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 51
TC 13
Z9 13
U1 6
U2 80
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD AUG 7
PY 2015
VL 26
IS 31
AR 315101
DI 10.1088/0957-4484/26/31/315101
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA CN8FY
UT WOS:000358676300006
PM 26180062
DA 2018-10-19
ER

PT J
AU Rahemi, H
   Nigam, N
   Wakeling, JM
AF Rahemi, Hadi
   Nigam, Nilima
   Wakeling, James M.
TI The effect of intramuscular fat on skeletal muscle mechanics:
   implications for the elderly and obese
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE ageing; obesity; connective tissue stiffness; fibre pennation; muscle
   model; finite-elements
ID AGE-ASSOCIATED DIFFERENCES; IN-VIVO; TENDON PROPERTIES; ANKLE JOINT;
   STRENGTH; ARCHITECTURE; FORCE; WOMEN; MODEL; GASTROCNEMIUS
AB Skeletal muscle accumulates intramuscular fat through age and obesity. Muscle quality, a measure of muscle strength per unit size, decreases in these conditions. It is not clear how fat influences this loss in performance. Changes to structural parameters (e.g. fibre pennation and connective tissue properties) affect the muscle quality. This study investigated the mechanisms that lead to deterioration in muscle performance due to changes in intramuscular fat, pennation and aponeurosis stiffness. A finite-element model of the human gastrocnemius was developed as a fibre-reinforced composite biomaterial containing contractile fibres within the base material. The base-material properties were modified to include intramuscular fat in five different ways. All these models with fat generated lower fibre stress and muscle quality than their lean counterparts. This effect is due to the higher stiffness of the tissue in the fatty models. The fibre deformations influence their interactions with the aponeuroses, and these change with fatty inclusions. Muscles with more compliant aponeuroses generated lower forces. The muscle quality was further reduced for muscles with lower pennation. This study shows that whole-muscle force is dependent on its base-material properties and changes to the base material due to fatty inclusions result in reductions to force and muscle quality.
C1 [Rahemi, Hadi; Wakeling, James M.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Neuromuscular Mech Lab, Burnaby, BC V5A 1S6, Canada.
   [Nigam, Nilima] Simon Fraser Univ, Dept Math, Burnaby, BC V5A 1S6, Canada.
RP Rahemi, H (reprint author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Neuromuscular Mech Lab, Burnaby, BC V5A 1S6, Canada.
EM hrahemi@sfu.ca
FU Natural Sciences and Engineering Research Council of Canada; Canada
   Research Chairs Program
FX We gratefully acknowledge funding from Natural Sciences and Engineering
   Research Council of Canada (N.N. and J.W.) and the Canada Research
   Chairs Program (N.N.).
CR Bangerth W, 2013, DEAL 11 LIB VERSION
   Blemker SS, 2005, J BIOMECH, V38, P657, DOI 10.1016/j.jbiomech.2004.04.009
   Bol M, 2008, COMPUT METHOD BIOMEC, V11, P489, DOI 10.1080/10255840701771750
   BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369
   Carrasco DI, 1999, MOTOR CONTROL, V3, P436, DOI 10.1123/mcj.3.4.436
   Csapo R, 2014, J APPL PHYSIOL, V116, P961, DOI 10.1152/japplphysiol.01337.2013
   Csapo R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-209
   Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A
   Foran JRH, 2005, DEV MED CHILD NEUROL, V47, P713, DOI 10.1017/S0012162205001465
   FUKASHIRO S, 1993, CLIN BIOMECH, V8, P25, DOI 10.1016/S0268-0033(05)80006-3
   Goodpaster BH, 2004, AM J CLIN NUTR, V79, P748
   Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4
   GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909
   Hasson CJ, 2012, ANN BIOMED ENG, V40, P1088, DOI 10.1007/s10439-011-0481-4
   Hodgson JA, 2012, J MECH BEHAV BIOMED, V9, P163, DOI 10.1016/j.jmbbm.2012.01.010
   HUBBARD RP, 1984, J BIOMECH ENG-T ASME, V106, P144, DOI 10.1115/1.3138471
   JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3
   Kelley DE, 2002, ANN NY ACAD SCI, V967, P135
   Kulmala JP, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0858
   Lerner ZF, 2014, GAIT POSTURE, V39, P978, DOI 10.1016/j.gaitpost.2013.12.020
   Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.3.CO;2-D
   Lynch NA, 1999, J APPL PHYSIOL, V86, P188
   Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2
   Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x
   Maganaris CN, 2001, J APPL PHYSIOL, V90, P865
   Malenfant P, 2001, INT J OBESITY, V25, P1316, DOI 10.1038/sj.ijo.0801733
   Metter EJ, 1999, J GERONTOL A-BIOL, V54, pB207, DOI 10.1093/gerona/54.5.B207
   NARICI MV, 1992, EUR J APPL PHYSIOL O, V65, P438, DOI 10.1007/BF00243511
   Natali AN, 2012, J MECH BEHAV BIOMED, V5, P216, DOI 10.1016/j.jmbbm.2011.08.025
   Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005
   Oomens CWJ, 2003, PHILOS T ROY SOC B, V358, P1453, DOI 10.1098/rstb.2003.1345
   Porter M. M., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P129
   Rahemi H, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00298
   Randhawa A, 2013, EUR J APPL PHYSIOL, V113, P437, DOI 10.1007/s00421-012-2448-z
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   SALE DG, 1987, J APPL PHYSIOL, V62, P1786
   Schwenzer NF, 2009, J MAGN RESON IMAGING, V29, P1346, DOI 10.1002/jmri.21789
   SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033
   Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012
   Tanner C, 2006, MED PHYS, V33, P1758, DOI 10.1118/1.2198315
   Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112
   Tomlinson DJ, 2014, J ANAT, V225, P675, DOI 10.1111/joa.12248
   Tomlinson D J, 2014, Age (Dordr), V36, P9652, DOI 10.1007/s11357-014-9652-1
   Wakeling JM, 2014, INT J BIOMED IMAGING, DOI 10.1155/2014/352910
   Wickiewicz TL, 1983, ORTHOP RELAT RES, V179, P275, DOI [10.1097/00003086-198310000-00042, DOI 10.1097/00003086-198310000-00042]
   Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8
NR 46
TC 30
Z9 30
U1 1
U2 12
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD AUG 6
PY 2015
VL 12
IS 109
AR 20150365
DI 10.1098/rsif.2015.0365
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR1KR
UT WOS:000361084200016
PM 26156300
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Basargan, T
   Nasun-Saygili, G
AF Basargan, Tugba
   Nasun-Saygili, Gulhayat
TI Spray-Dried Mesoporous Hydroxyapatite Chitosan Biocomposites
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Biomaterial; Chitosan; Hydroxyapatite; Inlet temperature; Spray-drying;
   Weight change
ID IN-VIVO TESTS; NANOCRYSTALLINE HYDROXYAPATITE; COMPOSITE MICROSPHERES;
   BIOMEDICAL APPLICATION; NANO-HYDROXYAPATITE; SURFACE-AREA;
   NANOPARTICLES; FABRICATION; SCAFFOLDS; COATINGS
AB In this study, hydroxyapatite-chitosan composites with weight ratio of 1:0.1 were produced by spray-drying technique using two different inlet temperature. Besides, the effect of weight change of hydroxyapatite on composites was investigated on composites which were spray-dried in the selected temperature. Synthesized hydroxyapatite-chitosan samples were characterized using Fourier transform infrared microscopy, scanning electron microscopy, X-ray fluorescence spectroscopy, Brunauer-Emmet-Teller method, and X-ray diffraction. Particle size measurements were also performed in this content. Simulated body fluid studies were conducted on selected samples. According to results, hydroxyapatite-chitosan sample was successfully synthesized. Spray-dried mesoporous microspheres with high surface areas could be suitable for biomedical usage.
C1 [Basargan, Tugba; Nasun-Saygili, Gulhayat] Istanbul Tech Univ, Dept Chem Engn, TR-80626 Istanbul, Turkey.
RP Basargan, T (reprint author), Istanbul Tech Univ, Chem & Met Engn Fac, Dept Chem Engn, TR-34469 Maslak, Turkey.
EM basargant@itu.edu.tr
CR Afshar A, 2003, MATER DESIGN, V24, P197, DOI 10.1016/S0261-3069(03)00003-7
   Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Arca H.C., 2008, FABAD J PHARM SCI, V33, P35
   Bianco A, 2007, J THERM ANAL CALORIM, V88, P237, DOI 10.1007/s10973-006-8011-6
   Brantley SL, 2000, AM MINERAL, V85, P1767
   Bumgardner J.D., 2007, United States Patent Application, Patent No. 20070254007
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Chesnutt BM, 2009, J BIOMED MATER RES A, V88A, P491, DOI 10.1002/jbm.a.31878
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Danilchenko S. N., 2009, Journal of Biological Physics and Chemistry, V9, P119, DOI 10.4024/22DA09A.jbpc.09.03
   Davidenko N, 2010, ACTA BIOMATER, V6, P466, DOI 10.1016/j.actbio.2009.07.029
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Ding CC, 2012, MATER LETT, V79, P72, DOI 10.1016/j.matlet.2012.03.092
   Gecer A, 2009, POLYM COMPOSITE, V30, P288, DOI 10.1002/pc.20635
   Guo YP, 2011, MATER LETT, V65, P2205, DOI 10.1016/j.matlet.2011.04.057
   Huang ZH, 2008, MATER LETT, V62, P3376, DOI 10.1016/j.matlet.2008.03.045
   Im HH, 2005, KEY ENG MAT, V284-286, P729, DOI 10.4028/www.scientific.net/KEM.284-286.729
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kern A.A., 2006, TOPAS 3
   Kim HS, 2007, MACROMOL RES, V15, P65, DOI 10.1007/BF03218754
   Klinkamnarong J, 2009, SOLID STATE SCI, V11, P1023, DOI 10.1016/j.solidstatesciences.2009.02.003
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   Kumar R, 2008, J R SOC INTERFACE, V5, P427, DOI 10.1098/rsif.2007.1141
   Laurencin C., 1998, US Patent, Patent No. [5 766 618, 5766618]
   Li J. F., 2009, J FUNCT MAT, V40, P653
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Li Xiang-nan, 2011, Journal of Central South University (Science and Technology), V42, P1232
   Maachoua H., 2008, TRENDS BIOMATER ARTI, V22, P16
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Mohamed K.R., 2013, J ADVERTISING RES, V1, P1
   Mohamed KR, 2011, CERAM INT, V37, P3265, DOI 10.1016/j.ceramint.2011.05.121
   Mollazadeh S, 2007, ADV APPL CERAM, V106, P165, DOI 10.1179/174367607X168996
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   Peng Q, 2006, KEY ENG MAT, V309-311, P65, DOI 10.4028/www.scientific.net/KEM.309-311.65
   Rajkumar M., 2010, INT J ENG SCI TECHNO, V2, P2437
   Redepenning J, 2003, J BIOMED MATER RES A, V66A, P411, DOI 10.1002/jbm.a.10571
   Shalaby S. W., 2004, ABSORBABLE BIODEGRAD
   Shum HC, 2009, CHEM MATER, V21, P5548, DOI 10.1021/cm9028935
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Sinha A, 2008, J MATER SCI-MATER M, V19, P2009, DOI 10.1007/s10856-007-3286-0
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Sukhodub L, 2009, MATERIALWISS WERKST, V40, P318, DOI 10.1002/mawe.200800449
   Sun RX, 2009, MATER RES BULL, V44, P1939, DOI 10.1016/j.materresbull.2009.06.015
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang AJ, 2007, MAT SCI ENG A-STRUCT, V460, P1, DOI 10.1016/j.msea.2007.02.043
   Wang AJ, 2009, POWDER TECHNOL, V191, P1, DOI 10.1016/j.powtec.2008.10.020
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang Y, 2008, J MATER SCI-MATER M, V19, P623, DOI 10.1007/s10856-006-0047-4
NR 53
TC 3
Z9 3
U1 4
U2 31
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-2559
EI 1525-6111
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PD AUG 5
PY 2015
VL 54
IS 11
BP 1172
EP 1183
DI 10.1080/03602559.2014.1003235
PG 12
WC Polymer Science
SC Polymer Science
GA CR8WE
UT WOS:000361634100004
DA 2018-10-19
ER

PT J
AU Cordoba, A
   Monjo, M
   Hierro-Oliva, M
   Gonazlez-Martin, ML
   Ramis, JM
AF Cordoba, Alba
   Monjo, Marta
   Hierro-Oliva, Margarita
   Luisa Gonzalez-Martin, Maria
   Maria Ramis, Joana
TI Bioinspired Quercitrin Nanocoatings: A Fluorescence-Based Method for
   Their Surface Quantification, and Their Effect on Stem Cell Adhesion and
   Differentiation to the Osteoblastic Lineage
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE flavonoids; polyphenols; biomaterial; DPBA; implant
ID IN-VITRO; FLAVONOIDS; QUERCETIN; FUNCTIONALITIES; BIOMATERIALS;
   SPECIFICITY; FATE
AB Polyphenol-based coatings have several potential applications in medical devices, such as cardiovascular stents, contrast agents, drug delivery systems, or bone implants, due to the multiple bioactive functionalities of these compounds. In a previous study, we fabricated titanium surfaces functionalized with flavonoids through covalent chemistry, and observed their osteogenic, anti-inflammatory, and antifibrotic properties in vitro. In this work, we report a fluorescence-based method for the quantification of the amount of flavonoid grafted onto the surfaces, using 2-aminoethyl diphenylborinate, a boronic ester that spontaneously forms a fluorescent complex with flavonoids. The method is sensitive, simple, rapid, and easy to perform with routine equipment, and could be applied to determine the surface coverage of other plant-derived polyphenol-based coatings. Besides, we evaluated an approach based on reductive amination to covalently graft the flavonoid quercitrin to Ti substrates, and optimized the grafting conditions. Depending on the reaction conditions, the amount of quercitrin grafted was between 64 +/- 10 and 842 +/- 361 nmol on 6.2 mm Ti coins. Finally, we evaluated the in vitro behavior of bone-marrow-derived human mesenchymal stem cells cultured on the quercitrin nanocoated Ti surfaces. The surfaces functionalized with quercitrin showed a faster stem cell adhesion than control surfaces, probably due to the presence of the catechol groups of quercitrin on the surfaces. A rapid cell adhesion is crucial for the successful performance of an implant. Furthermore, quercitrin-nanocoated surfaces enhanced the mineralization of the cells after 21 days of cell culture. These results indicate that quercitrin nanocoatings could promote the rapid osteointegration of bone implants.
C1 [Cordoba, Alba; Monjo, Marta; Maria Ramis, Joana] Univ Balearic Isl, Grp Cell Therapy & Tissue Engn, Res Inst Hlth Sci IUNICS, Palma De Mallorca 07122, Spain.
   [Cordoba, Alba; Monjo, Marta; Maria Ramis, Joana] Inst Invest Sanitaria Palma, Palma De Mallorca 07010, Spain.
   [Hierro-Oliva, Margarita; Luisa Gonzalez-Martin, Maria] Univ Extremadura, Fac Ciencias, Dept Fis Aplicada, E-06071 Badajoz, Spain.
   [Hierro-Oliva, Margarita; Luisa Gonzalez-Martin, Maria] CIBER BBN, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza 50018, Spain.
RP Monjo, M (reprint author), Univ Balearic Isl, Grp Cell Therapy & Tissue Engn, Res Inst Hlth Sci IUNICS, Carretera Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.
EM marta.monjo@uib.es; joana.ramis@uib.es
RI Cordoba, Alba/V-2448-2017
OI Cordoba, Alba/0000-0002-2726-5119; Hierro-Oliva,
   Margarita/0000-0002-9741-4503; Monjo, Marta/0000-0002-2731-9527; Ramis,
   Joana Maria/0000-0001-9109-8362
FU Conselleria d'Educacio, Cultura i Universitats del Govern de les Illes
   Balears; European Social Fund
FX This work was supported by the Conselleria d'Educacio, Cultura i
   Universitats del Govern de les Illes Balears, and the European Social
   Fund (contract to J.M.R.). We acknowledge NANBIOSIS ICTS (CIBER-BBN) and
   SACSS-SAIUEx (UEx) for the use of the XPS facility.
CR Amic D, 2007, CURR MED CHEM, V14, P827, DOI 10.2174/092986707780090954
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Barrett DG, 2014, CHEM COMMUN, V50, P7265, DOI 10.1039/c4cc02961e
   Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824
   Choi JS, 2014, MACROMOL BIOSCI, V14, P270, DOI 10.1002/mabi.201300281
   Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778
   Cordoba A, 2015, ADV HEALTHC MATER, V4, P540, DOI 10.1002/adhm.201400587
   Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dementev N, 2009, LANGMUIR, V25, P7573, DOI 10.1021/la803947q
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ejima H, 2013, SCIENCE, V341, P154, DOI 10.1126/science.1237265
   Ernst IMA, 2010, PHARMACOL RES, V61, P253, DOI 10.1016/j.phrs.2009.10.006
   Gomez-Florit M., 2015, QUERCITRIN PER UNPUB
   Gomez-Florit M, 2014, J PERIODONTOL, V85, P966, DOI 10.1902/jop.2014.130438
   Goto T, 2003, BIOMATERIALS, V24, P3885, DOI 10.1016/S0142-9612(03)00258-8
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hong S, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400113
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim S, 2015, CHEM COMMUN, V51, P5340, DOI 10.1039/c4cc08609k
   Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898
   Lee JH, 2014, FOOD SCI BIOTECHNOL, V23, P75, DOI 10.1007/s10068-014-0010-y
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lu YC, 2014, NANOSCALE, V6, P10297, DOI 10.1039/c4nr00617h
   McArthur EA, 2004, J AM CHEM SOC, V126, P2260, DOI 10.1021/ja038062n
   Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300
   Nifli AP, 2007, J AGR FOOD CHEM, V55, P2873, DOI 10.1021/jf0632637
   Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009
   Razumovitch J, 2009, J PHYS CHEM B, V113, P8383, DOI 10.1021/jp902383m
   Satue M, 2013, ACTA BIOMATER, V9, P5759, DOI 10.1016/j.actbio.2012.11.021
   Satue M, 2013, BIOCHEM PHARMACOL, V86, P1476, DOI 10.1016/j.bcp.2013.09.009
   Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343
   Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   Xiao LS, 2015, ACS APPL MATER INTER, V7, P6530, DOI 10.1021/am508404t
   Xing YJ, 2007, LANGMUIR, V23, P684, DOI 10.1021/la060994s
   Xu JX, 2014, NANOSCALE, V6, P1277, DOI 10.1039/c3nr04528e
   Yang ZL, 2014, ACS APPL MATER INTER, V6, P2647, DOI 10.1021/am405124z
   Yin YQ, 2013, TOXICOL APPL PHARM, V269, P89, DOI 10.1016/j.taap.2013.03.015
NR 39
TC 9
Z9 9
U1 5
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 5
PY 2015
VL 7
IS 30
BP 16857
EP 16864
DI 10.1021/acsami.5b05044
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CO6PY
UT WOS:000359279800086
PM 26167954
DA 2018-10-19
ER

PT J
AU Oliva, N
   Unterman, S
   Zhang, Y
   Conde, J
   Song, HS
   Artzi, N
AF Oliva, Nuria
   Unterman, Shimon
   Zhang, Yi
   Conde, Joao
   Song, Hyun Seok
   Artzi, Natalie
TI Personalizing Biomaterials for Precision Nanomedicine Considering the
   Local Tissue Microenvironment
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
DE hydrogels; nanomaterials; theranostics; precision medicine; tissue
   microenvironment; nanofillers; multifunctional materials
ID CONTROLLED DRUG-DELIVERY; WALLED CARBON NANOTUBES; PH-RESPONSIVE
   HYDROGELS; BAND-GAP FLUORESCENCE; IN-VIVO EVALUATION; GENE DELIVERY;
   SIRNA DELIVERY; GRAPHENE OXIDE; BIOMEDICAL APPLICATIONS; CANCER-THERAPY
AB New advances in (nano)biomaterial design coupled with the detailed study of tissue-biomaterial interactions can open a new chapter in personalized medicine, where biomaterials are chosen and designed to match specific tissue types and disease states. The notion of a one size fits all biomaterial no longer exists, as growing evidence points to the value of customizing material design to enhance (pre)clinical performance. The complex microenvironment in vivo at different tissue sites exhibits diverse cell types, tissue chemistry, tissue morphology, and mechanical stresses that are further altered by local pathology. This complex and dynamic environment may alter the implanted material's properties and in turn affect its in vivo performance. It is crucial, therefore, to carefully study tissue context and optimize biomaterials considering the implantation conditions. This practice would enable attaining predictable material performance and enhance clinical outcomes.
C1 [Oliva, Nuria; Unterman, Shimon; Zhang, Yi; Conde, Joao; Song, Hyun Seok; Artzi, Natalie] MIT, Harvard Mit Div Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Conde, Joao] Queen Mary Univ London, Sch Mat Sci & Engn, London, England.
   [Artzi, Natalie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol, Boston, MA 02115 USA.
RP Artzi, N (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Inst Med Engn & Sci, E25 449, Cambridge, MA 02139 USA.
EM nartzi@mit.edu
RI Conde, Joao/F-2231-2011; Zhang, Yi/K-3340-2016; Oliva, Nuria/P-7825-2016
OI Conde, Joao/0000-0001-8422-6792; Zhang, Yi/0000-0001-8667-7829; Oliva,
   Nuria/0000-0002-6305-0801
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Agarwal P, 2013, BIOCONJUGATE CHEM, V24, P846, DOI 10.1021/bc400042a
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Arias JL, 2011, CURR DRUG TARGETS, V12, P1151
   Arias JL, 2011, EXPERT OPIN DRUG DEL, V8, P1589, DOI 10.1517/17425247.2012.634794
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Artzi N, 2011, ACTA BIOMATER, V7, P67, DOI 10.1016/j.actbio.2010.07.008
   Artzi N, 2009, ADV MATER, V21, P3399, DOI 10.1002/adma.200900340
   Artzi N, 2009, MACROMOL BIOSCI, V9, P754, DOI 10.1002/mabi.200800355
   Arunbabu D, 2013, J PHYS CHEM B, V117, P441, DOI 10.1021/jp3101688
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bae WK, 2013, BIOMATERIALS, V34, P1433, DOI 10.1016/j.biomaterials.2012.10.077
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Bardajee GR, 2014, CARBOHYD POLYM, V101, P741, DOI 10.1016/j.carbpol.2013.10.028
   Barone PW, 2005, ANAL CHEM, V77, P7556, DOI 10.1021/ac0511997
   Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276
   Barrett DG, 2013, ADV HEALTHC MATER, V2, P745, DOI 10.1002/adhm.201200316
   Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006
   Bikram M, 2007, J CONTROL RELEASE, V123, P219, DOI 10.1016/j.jconrel.2007.08.013
   Blackburn WH, 2009, BIOCONJUGATE CHEM, V20, P960, DOI 10.1021/bc800547c
   Brazel CS, 2009, PHARM RES-DORD, V26, P644, DOI 10.1007/s11095-008-9773-2
   Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008
   Chaban VV, 2010, J PHYS CHEM B, V114, P13481, DOI 10.1021/jp104507g
   Chang CY, 2012, BIOMATERIALS, V33, P8026, DOI 10.1016/j.biomaterials.2012.07.058
   Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v
   Cirillo G, 2014, BIOMED RES INT, DOI 10.1155/2014/825017
   Cochran MC, 2011, ACAD RADIOL, V18, P1341, DOI 10.1016/j.acra.2011.06.013
   Conde J., 2014, NANOONCOLOGICALS NEW
   Conde J, 2012, DRUG DELIV, V2012
   Conde J, 2015, P NATL ACAD SCI USA, V112, pE1278, DOI 10.1073/pnas.1421229112
   Conde J, 2015, ADV DRUG DELIVER REV, V81, P169, DOI 10.1016/j.addr.2014.09.003
   Conde J, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00048
   Conde J, 2013, BIOMATERIALS, V34, P7744, DOI 10.1016/j.biomaterials.2013.06.041
   Conde J, 2012, ACS NANO, V6, P8316, DOI 10.1021/nn3030223
   Conde J, 2012, INT J PHOTOENERGY, DOI 10.1155/2012/619530
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Dayani Y, 2013, BIOMACROMOLECULES, V14, P3380, DOI 10.1021/bm401155a
   de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a
   Demarchi CA, 2014, SOFT MATTER, V10, P3441, DOI 10.1039/c3sm53157k
   DeVolder RJ, 2012, TISSUE ENG PT A, V18, P1642, DOI [10.1089/ten.tea.2011.0547, 10.1089/ten.TEA.2011.0547]
   Dickerson E. B., 2010, BMC CANC, V10
   Ding D, 2011, ACS NANO, V5, P2520, DOI 10.1021/nn102138u
   Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111
   Doria G, 2012, SENSORS-BASEL, V12, P1657, DOI 10.3390/s120201657
   Dunn SS, 2012, J AM CHEM SOC, V134, P7423, DOI 10.1021/ja300174v
   El-Fiqi A, 2013, ACTA BIOMATER, V9, P9508, DOI 10.1016/j.actbio.2013.07.036
   Endres S, 2005, Z ORTHOP GRENZGEB, V143, P660, DOI 10.1055/s-2005-918191
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Fullenkamp DE, 2012, BIOMATERIALS, V33, P3783, DOI 10.1016/j.biomaterials.2012.02.027
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gao ZG, 2011, J CONTROL RELEASE, V152, P84, DOI 10.1016/j.jconrel.2011.01.021
   Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934
   Ge B, 2009, SENSOR ACTUAT B-CHEM, V137, P547, DOI 10.1016/j.snb.2009.01.030
   Gefen A, 2007, J BIOMECH ENG-T ASME, V129, P924, DOI 10.1115/1.2800830
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gupta M, 2004, J CONTROL RELEASE, V99, P157, DOI 10.1016/j.jconrel.2004.06.016
   Haase M, 2011, ANGEW CHEM INT EDIT, V50, P5808, DOI 10.1002/anie.201005159
   Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004
   Heffernan MJ, 2005, BIOCONJUGATE CHEM, V16, P1340, DOI 10.1021/bc050176w
   Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m
   Hoffman AS, 2013, ADV DRUG DELIVER REV, V65, P10, DOI 10.1016/j.addr.2012.11.004
   Huang Y, 2014, SOFT MATTER, V10, P6121, DOI 10.1039/c4sm00871e
   Huschka R, 2012, ACS NANO, V6, P7681, DOI 10.1021/nn301135w
   Hyon SH, 2014, J BIOMED MATER RES A, V102, P2511, DOI 10.1002/jbm.a.34923
   Ito K, 2007, POLYM J, V39, P489, DOI 10.1295/polymj.PJ2006239
   Jaiswal MK, 2014, J NANOSCI NANOTECHNO, V14, P4082, DOI 10.1166/jnn.2014.8662
   Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k
   Kai D, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095705
   Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kang XJ, 2013, NANOSCALE, V5, P253, DOI 10.1039/c2nr33130f
   Kazusa H, 2013, J APPL BIOMATER FUNC, V11, P180, DOI 10.5301/JABFM.5000164
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim BJ, 2014, BIOMACROMOLECULES, V15, P1579, DOI 10.1021/bm4017308
   Kim H, 2013, ACS NANO, V7, P6735, DOI 10.1021/nn403096s
   Kim H, 2011, BIOCONJUGATE CHEM, V22, P2558, DOI 10.1021/bc200397j
   Kim JI, 2012, BIOMATERIALS, V33, P2251, DOI 10.1016/j.biomaterials.2011.11.083
   Kim JH, 2011, ACS NANO, V5, P7848, DOI 10.1021/nn201904t
   Kim JH, 2009, NAT CHEM, V1, P473, DOI [10.1038/NCHEM.332, 10.1038/nchem.332]
   Kim YM, 2013, BIOMATERIALS, V34, P4493, DOI 10.1016/j.biomaterials.2013.02.050
   Kim YM, 2012, ACS NANO, V6, P5757, DOI 10.1021/nn300842a
   Kojima C, 2013, NANOMED-NANOTECHNOL, V9, P767, DOI 10.1016/j.nano.2013.01.004
   Komlev VS, 2002, BIOMATERIALS, V23, P3449, DOI 10.1016/S0142-9612(02)00049-2
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Kuppusamy P, 2002, CANCER RES, V62, P307
   Kurapati R, 2013, CHEM COMMUN, V49, P734, DOI 10.1039/c2cc38417e
   Lai PS, 2007, J CONTROL RELEASE, V122, P39, DOI 10.1016/j.jconrel.2007.06.012
   Laroui H, 2014, J CONTROL RELEASE, V186, P41, DOI 10.1016/j.jconrel.2014.04.046
   Larson N, 2012, CHEM MATER, V24, P840, DOI 10.1021/cm2031569
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee MR, 2004, ANGEW CHEM INT EDIT, V43, P1675, DOI 10.1002/anie.200353204
   LeGeros R. Z., 2002, CLIN ORTHOP RELAT RE, V81
   Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049
   Lei YG, 2010, BIOMATERIALS, V31, P9106, DOI 10.1016/j.biomaterials.2010.08.016
   Lin CW, 2013, BIOMATERIALS, V34, P4387, DOI 10.1016/j.biomaterials.2013.02.058
   Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r
   Liu J, 2010, CARBOHYD POLYM, V82, P432, DOI 10.1016/j.carbpol.2010.04.084
   Liu RQ, 2012, J MATER CHEM, V22, P14160, DOI [10.1039/c2jm32541, 10.1039/c2jm32541a]
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   MacLachlan I., 2007, LIPOSOMES DRUG DELIV, P237
   Malvindi MA, 2012, NANOSCALE, V4, P486, DOI 10.1039/c1nr11269d
   Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133
   Mastronardi E, 2014, SENSORS-BASEL, V14, P3156, DOI 10.3390/s140203156
   McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008
   Medeiros SF, 2011, INT J PHARMACEUT, V403, P139, DOI 10.1016/j.ijpharm.2010.10.011
   Medintz IL, 2004, P NATL ACAD SCI USA, V101, P9612, DOI 10.1073/pnas.0403343101
   Meenach SA, 2013, J BIOMAT SCI-POLYM E, V24, P1112, DOI 10.1080/09205063.2012.741321
   Meenach SA, 2010, ACTA BIOMATER, V6, P1039, DOI 10.1016/j.actbio.2009.10.017
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Moon HK, 2009, ACS NANO, V3, P3707, DOI 10.1021/nn900904h
   Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/NMAT3776, 10.1038/nmat3776]
   Mura S, 2012, ADV DRUG DELIVER REV, V64, P1394, DOI 10.1016/j.addr.2012.06.006
   Naficy S, 2011, AUST J CHEM, V64, P1007, DOI 10.1071/CH11156
   Nair L. L. C., 2007, PROG POLYM SCI, V32, P18
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Navath RS, 2011, MOL PHARMACEUT, V8, P1209, DOI 10.1021/mp200027z
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Ning JY, 2013, MACROMOLECULES, V46, P5317, DOI 10.1021/ma4009059
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Oliva N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1616
   Oliva N, 2012, LANGMUIR, V28, P15402, DOI 10.1021/la303155p
   Pan YJ, 2012, BIOMATERIALS, V33, P6570, DOI 10.1016/j.biomaterials.2012.05.062
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Perumal OP, 2008, BIOMATERIALS, V29, P3469, DOI 10.1016/j.biomaterials.2008.04.038
   Qiu L, 2014, ADV MATER, V26, P3333, DOI 10.1002/adma.201305359
   Rapoport N, 2012, INT J HYPERTHER, V28, P374, DOI 10.3109/02656736.2012.665567
   Ratner BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5371
   Ray GJ, 2014, BIOCONJUGATE CHEM, V25, P665, DOI 10.1021/bc400456g
   REBRIN K, 1992, J BIOMED ENG, V14, P33, DOI 10.1016/0141-5425(92)90033-H
   Restani RB, 2012, ANGEW CHEM INT EDIT, V51, P5162, DOI 10.1002/anie.201200362
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Ryu JH, 2010, LANGMUIR, V26, P7086, DOI 10.1021/la904437u
   Sarvestani AS, 2008, J NANOMATER, DOI 10.1155/2008/126803
   Schoener CA, 2013, J BIOMAT SCI-POLYM E, V24, P1027, DOI 10.1080/09205063.2012.731376
   Schoener CA, 2012, POLYM INT, V61, P874, DOI 10.1002/pi.4219
   Schroeder A, 2009, CHEM PHYS LIPIDS, V162, P1, DOI 10.1016/j.chemphyslip.2009.08.003
   Segovia N, 2015, ADV HEALTHC MATER, V4, P271, DOI 10.1002/adhm.201400235
   Sekine Y, 2012, ADV HEALTHC MATER, V1, P722, DOI 10.1002/adhm.201200175
   Seow WY, 2007, BIOMATERIALS, V28, P1730, DOI 10.1016/j.biomaterials.2006.11.039
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Servant A, 2014, ADV HEALTHC MATER, V3, P1334, DOI 10.1002/adhm.201400016
   Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005
   Shazly TM, 2008, BIOMATERIALS, V29, P4584, DOI 10.1016/j.biomatetials.2008.08.032
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Simson J, 2013, J ORTHOP RES, V31, P392, DOI 10.1002/jor.22247
   Simson JA, 2013, TISSUE ENG PT A, V19, P1843, DOI [10.1089/ten.tea.2012.0578, 10.1089/ten.TEA.2012.0578]
   Simson JA, 2013, BIOMACROMOLECULES, V14, P637, DOI 10.1021/bm301585e
   Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f
   Sohier J, 2010, ACTA BIOMATER, V6, P2932, DOI 10.1016/j.actbio.2010.02.013
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Tao Y, 2014, BIOMATERIALS, V35, P9963, DOI 10.1016/j.biomaterials.2014.08.036
   Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037
   Thorp LE, 2006, ARTHRITIS RHEUM, V54, P3842, DOI 10.1002/art.22247
   Togo Y, 2013, STEM CELLS INT, DOI 10.1155/2013/634379
   Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014
   Tsuji H, 2005, MACROMOL BIOSCI, V5, P569, DOI 10.1002/mabi.200500062
   Unterman SA, 2012, TISSUE ENG PT A, V18, P2497, DOI [10.1089/ten.TEA.2011.0711, 10.1089/ten.tea.2011.0711]
   VASHIST A, 2013, ORIENT J CHEM, V29, P861
   Wallace DG, 2001, J BIOMED MATER RES, V58, P545, DOI 10.1002/jbm.1053
   Wang SY, 2012, ACS NANO, V6, P6843, DOI 10.1021/nn301633m
   Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684
   Whitehead KA, 2011, ANNU REV CHEM BIOMOL, V2, P77, DOI 10.1146/annurev-chembioeng-061010-114133
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wiltsey C, 2013, J MATER SCI-MATER M, V24, P837, DOI 10.1007/s10856-013-4857-x
   Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004
   Wu CJ, 2013, MACROMOL BIOSCI, V13, P59, DOI 10.1002/mabi.201200362
   Wu CJ, 2010, MATERIALS, V3, P2986, DOI 10.3390/ma3052986
   Wu W, 2010, BIOMATERIALS, V31, P8371, DOI 10.1016/j.biomaterials.2010.07.061
   Wu WT, 2010, BIOMATERIALS, V31, P3023, DOI 10.1016/j.biomaterials.2010.01.011
   Xuan JJ, 2010, INT J PHARMACEUT, V395, P317, DOI 10.1016/j.ijpharm.2010.05.042
   Yan B, 2012, J AM CHEM SOC, V134, P16558, DOI 10.1021/ja308876j
   Yang J, 2009, ADV MATER, V21, P4339, DOI 10.1002/adma.200900334
   Yang X, 2013, BIOMACROMOLECULES, V14, P4447, DOI 10.1021/bm401364z
   Yildirim ED, 2008, J BIOMED MATER RES B, V87B, P406, DOI 10.1002/jbm.b.31118
   Yin WY, 2014, ACS NANO, V8, P6922, DOI 10.1021/nn501647j
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zayats M, 2002, ANAL CHEM, V74, P4763, DOI 10.1021/ac020312f
   Zhang HB, 2010, BIOMATERIALS, V31, P5445, DOI 10.1016/j.biomaterials.2010.03.034
   Zhang JQ, 2014, ADV HEALTHC MATER, V3, P412, DOI 10.1002/adhm.201300033
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang L, 2012, SOFT MATTER, V8, P10439, DOI 10.1039/c2sm26102b
   Zhang Yi, 2011, Int J Biomater Res Eng, V1, P18, DOI 10.4018/ijbre.2011010102
   Zhang Y, 2013, BIOMATERIALS, V34, P4048, DOI 10.1016/j.biomaterials.2013.02.040
   Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g
   Zheng D, 2012, P NATL ACAD SCI USA, V109, P11975, DOI 10.1073/pnas.1118425109
   Zhou YL, 2013, J MATER SCI-MATER M, V24, P2277, DOI 10.1007/s10856-013-4987-1
   Zubris KAV, 2012, MOL PHARMACEUT, V9, P196, DOI 10.1021/mp200367s
NR 200
TC 17
Z9 17
U1 1
U2 85
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1584
EP 1599
DI 10.1002/adhm.201400778
PG 16
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600001
PM 25963621
OA Bronze
DA 2018-10-19
ER

PT J
AU Kerativitayanan, P
   Carrow, JK
   Gaharwar, AK
AF Kerativitayanan, Punyavee
   Carrow, James K.
   Gaharwar, Akhilesh K.
TI Nanomaterials for Engineering Stem Cell Responses
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
DE nanomaterials; stem cells; tissue engineering; drug delivery;
   nanoparticles
ID BONE MORPHOGENETIC PROTEIN-2; SEQUENTIAL BMP-2/BMP-7 DELIVERY; FOCAL
   ADHESION KINASE; MARROW STROMAL CELLS; IN-VITRO EVALUATION; OSTEOGENIC
   DIFFERENTIATION; SILVER NANOPARTICLES; CARBON NANOTUBES; NANOFIBROUS
   SCAFFOLDS; TIO2 NANOTUBES
AB Recent progress in nanotechnology has stimulated the development of multifunctional biomaterials for tissue engineering applications. Synergistic interactions between nanomaterials and stem cell engineering offer numerous possibilities to address some of the daunting challenges in regenerative medicine, such as controlling trigger differentiation, immune reactions, limited supply of stem cells, and engineering complex tissue structures. Specifically, the interactions between stem cells and their microenvironment play key roles in controlling stem cell fate, which underlines therapeutic success. However, the interactions between nanomaterials and stem cells are not well understood, and the effects of the nanomaterials shape, surface morphology, and chemical functionality on cellular processes need critical evaluation. In this Review, focus is put on recent development in nanomaterial-stem cell interactions, with specific emphasis on their application in regenerative medicine. Further, the emerging technologies based on nanomaterials developed over the past decade for stem cell engineering are reviewed, as well as the potential applications of these nanomaterials in tissue regeneration, stem cell isolation, and drug/gene delivery. It is anticipated that the enhanced understanding of nanomaterial-stem cell interactions will facilitate improved biomaterial design for a range of biomedical and biotechnological applications.
C1 [Kerativitayanan, Punyavee; Carrow, James K.; Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
   [Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.
RP Gaharwar, AK (reprint author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
EM gaharwar@tamu.edu
OI Carrow, James/0000-0002-9123-9222; Gaharwar,
   Akhilesh/0000-0002-0284-0201
CR Agarwal R, 2013, P NATL ACAD SCI USA, V110, P17247, DOI 10.1073/pnas.1305000110
   Akhavan O, 2013, CARBON, V54, P419, DOI 10.1016/j.carbon.2012.11.058
   Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040
   Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Ambre AH, 2013, J BIOMED MATER RES A, V101, P2644, DOI 10.1002/jbm.a.34561
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Bang AG, 2008, SCIENCE, V320, P58, DOI 10.1126/science.1157042
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   Biswas A, 2012, BIOMATERIALS, V33, P5459, DOI 10.1016/j.biomaterials.2012.04.012
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Carrow JK, 2015, MACROMOL CHEM PHYS, V216, P248, DOI 10.1002/macp.201400427
   Cha CY, 2013, ACS NANO, V7, P2891, DOI 10.1021/nn401196a
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chen YC, 2010, TOXICOL APPL PHARM, V245, P272, DOI 10.1016/j.taap.2010.03.011
   Cheng XG, 2014, ACTA BIOMATER, V10, P1360, DOI 10.1016/j.actbio.2013.11.017
   Chiang CY, 2009, DENT MATER, V25, P1022, DOI 10.1016/j.dental.2009.03.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Deng XY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115101
   Dyondi D, 2013, INT J NANOMED, V8, P47, DOI 10.2147/IJN.S37953
   Ferreira L, 2009, J CELL BIOCHEM, V108, P746, DOI 10.1002/jcb.22303
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Florez L, 2012, SMALL, V8, P2222, DOI 10.1002/smll.201102002
   Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001
   Gaharwar AK, 2014, TISSUE ENG PT A, V20, P2088, DOI 10.1089/ten.tea.2013.0281
   Gaharwar AK, 2014, J CONTROL RELEASE, V187, P66, DOI 10.1016/j.jconrel.2014.04.035
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gaharwar AK, 2012, MACROMOL BIOSCI, V12, P779, DOI 10.1002/mabi.201100508
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P568, DOI 10.1016/j.actbio.2010.09.015
   Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665
   Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003
   Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1
   Gu M, 2014, TISSUE ENG PART B-RE, V20, P477, DOI [10.1089/ten.teb.2013.0638, 10.1089/ten.TEB.2013.0638]
   Gul H, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/15/155101
   Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001
   Haidar ZS, 2009, J BIOMED MATER RES A, V91A, P919, DOI 10.1002/jbm.a.32292
   Harush-Frenkel O, 2008, BIOMACROMOLECULES, V9, P435, DOI 10.1021/bm700535p
   Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135
   Hong SJ, 2010, J BIOMATER APPL, V24, P733, DOI 10.1177/0885328209338956
   Hongbin Z., 2013, BIOMACROMOLECULES, V14, P1299
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hu Y, 2012, ACTA BIOMATER, V8, P439, DOI 10.1016/j.actbio.2011.10.021
   Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Ilie I, 2012, INT J NANOMED, V7, P2211, DOI 10.2147/IJN.S29975
   Jiang XE, 2010, BIOMACROMOLECULES, V11, P748, DOI 10.1021/bm901348z
   Jiang X, 2012, ACTA BIOMATER, V8, P1290, DOI 10.1016/j.actbio.2011.11.019
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kam NWS, 2009, NANO LETT, V9, P273, DOI 10.1021/nl802859a
   Kittler S, 2009, MATERIALWISS WERKST, V40, P258, DOI 10.1002/mawe.200800437
   Kolambkar YM, 2010, TISSUE ENG PT A, V16, P3219, DOI [10.1089/ten.tea.2010.0004, 10.1089/ten.TEA.2010.0004]
   Kshitiz, 2011, TRENDS BIOTECHNOL, V29
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Lai M, 2011, BIOMACROMOLECULES, V12, P1097, DOI 10.1021/bm1014365
   Lee JH, 2010, MACROMOL BIOSCI, V10, P173, DOI 10.1002/mabi.200900169
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li D, 2006, J AM CERAM SOC, V89, P1861, DOI 10.1111/j.1551-2916.2006.00989.x
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Lindberg HK, 2009, TOXICOL LETT, V186, P166, DOI 10.1016/j.toxlet.2008.11.019
   Liu D, 2010, BIOCONJUGATE CHEM, V21, P1673, DOI 10.1021/bc100177v
   Liu DD, 2010, ACS NANO, V4, P2185, DOI 10.1021/nn901479w
   Liu HC, 2011, TISSUE ENG PT A, V17, P2417, DOI [10.1089/ten.tea.2010.0620, 10.1089/ten.TEA.2010.0620]
   Liu KK, 2009, BIOMATERIALS, V30, P4249, DOI 10.1016/j.biomaterials.2009.04.056
   Lo H, 1995, Tissue Eng, V1, P15, DOI 10.1089/ten.1995.1.15
   Lorenz S, 2010, MACROMOL BIOSCI, V10, P1034, DOI 10.1002/mabi.201000099
   Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r
   Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Martino S, 2009, TISSUE ENG PT A, V15, P3139, DOI [10.1089/ten.tea.2008.0552, 10.1089/ten.TEA.2008.0552]
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Meng DC, 2011, J BIOMED MATER RES A, V99A, P435, DOI 10.1002/jbm.a.33185
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mihaila SM, 2014, BIOMATERIALS, V35, P9087, DOI 10.1016/j.biomaterials.2014.07.052
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c
   Nitya G, 2012, J MATER SCI-MATER M, V23, P1749, DOI 10.1007/s10856-012-4647-x
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Park MVDZ, 2009, TOXICOL APPL PHARM, V240, P108, DOI 10.1016/j.taap.2009.07.019
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pulavendran S, 2010, IET NANOBIOTECHNOL, V4, P51, DOI 10.1049/iet-nbt.2009.0014
   Pulavendran S, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-15
   Rajam M, 2011, INT J PHARMACEUT, V410, P145, DOI 10.1016/j.ijpharm.2011.02.065
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rippon HJ, 2004, CELL PROLIFERAT, V37, P23, DOI 10.1111/j.1365-2184.2004.00298.x
   Samberg M, 2012, NANOMEDICINE-UK, V7, P1197, DOI [10.2217/NNM.12.18, 10.2217/nnm.12.18]
   Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h
   Sasidharan A, 2011, NANOSCALE, V3, P2461, DOI 10.1039/c1nr10172b
   Schexnailder PJ, 2010, MACROMOL BIOSCI, V10, P1416, DOI 10.1002/mabi.201000053
   Schrand A. M., 2009, SAFETY NANOPARTICLES
   Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Smith LA, 2010, BIOMATERIALS, V31, P5526, DOI 10.1016/j.biomaterials.2010.03.065
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910
   Stout DA, 2012, MATER TODAY, V15, P312, DOI 10.1016/S1369-7021(12)70136-0
   Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002
   Suh WH, 2009, NANO TODAY, V4, P27, DOI 10.1016/j.nantod.2008.10.013
   Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tatavarty R, 2014, CHEM COMMUN, V50, P8484, DOI 10.1039/c4cc02442g
   Tay CY, 2010, CARBON, V48, P1095, DOI 10.1016/j.carbon.2009.11.031
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Tian LL, 2012, J MATER SCI, V47, P3272, DOI 10.1007/s10853-011-6166-4
   Tran LA, 2010, BIOMATERIALS, V31, P9482, DOI 10.1016/j.biomaterials.2010.08.034
   Wan ACA, 2010, ADV DRUG DELIVER REV, V62, P731, DOI 10.1016/j.addr.2010.02.002
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang SG, 2012, J MATER CHEM, V22, P23357, DOI 10.1039/c2jm34249a
   Wang Z, 2009, NANOSCALE RES LETT, V4, P593, DOI 10.1007/s11671-009-9292-z
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xia YN, 2008, NAT MATER, V7, P758, DOI 10.1038/nmat2277
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xing Y, 2011, ACS NANO, V5, P2376, DOI 10.1021/nn200279k
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
   Yang H, 2007, ADV MATER, V19, P3085, DOI 10.1002/adma.200702050
   Yang M, 2013, ANALYST, V138, P72, DOI 10.1039/c2an35744e
   Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535
   Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Zandi M, 2010, J BIOMED MATER RES A, V92A, P1244, DOI 10.1002/jbm.a.32452
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang S., 2009, PHARM RES, V26
   Zhang Y, 2012, ACS APPL MATER INTER, V4, P4099, DOI 10.1021/am300840p
   Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f
   Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001
NR 162
TC 45
Z9 47
U1 6
U2 141
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1600
EP 1627
DI 10.1002/adhm.201500272
PG 28
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600002
PM 26010739
OA Bronze
DA 2018-10-19
ER

PT J
AU Groen, N
   Tahmasebi, N
   Shimizu, F
   Sano, Y
   Kanda, T
   Barbieri, D
   Yuan, HP
   Habibovic, P
   van Blitterswijk, CA
   de Boer, J
AF Groen, Nathalie
   Tahmasebi, Niloofar
   Shimizu, Fumitaka
   Sano, Yasuteru
   Kanda, Takashi
   Barbieri, Davide
   Yuan, Huipin
   Habibovic, Pamela
   van Blitterswijk, Clemens A.
   de Boer, Jan
TI Exploring the Material-Induced Transcriptional Landscape of Osteoblasts
   on Bone Graft Materials
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE bone regeneration; cell-biomaterial interactions; transcriptional
   profiling
ID CALCIUM-PHOSPHATE CERAMICS; MESENCHYMAL STROMAL CELLS; STEM-CELLS;
   OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; INORGANIC-PHOSPHATE;
   IN-VITRO; BIOMATERIALS; OSTEOINDUCTION; SCAFFOLDS
AB During the past decades, there have been major advances in the field of biomaterials, thereby generating a vast variety of materials for a broad range of tissue engineering and regeneration applications. Although gene expression profiling has been used occasionally in biomaterial research, its usefulness for understanding cell-biomaterial interactions should be further explored for it to fulfill its promise as a tool to assess and improve material properties. Here, the transcriptional landscape induced by 23 materials is explored with a variety of properties within the scope of bone regeneration. An osteoblast cell line is used to identify the gene expression profiles that can be adopted in response to biophysical and chemical cues. It is shown that TGF- and WNT signaling may be involved in the cellular response to osteoinductive materials along with differential cell adhesion kinetics via attenuated FAK signaling. The previously reported effect of calcium and phosphate on BMP2 and TGF- signaling is confirmed and the biological effect of the addition of nanohydroxyapatite in poly (d,l-lactic acid) polymer particles is studied. Together with future applications, this approach will help researchers understand cellular responses in relation to material properties, which will promote the development of more effective biomaterials for applications in tissue regeneration.
C1 [Groen, Nathalie; Tahmasebi, Niloofar; Barbieri, Davide; Yuan, Huipin; Habibovic, Pamela; van Blitterswijk, Clemens A.; de Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Shimizu, Fumitaka; Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Dept Neurol & Clin Neurosci, Grad Sch Med, Yamaguchi 7558505, Japan.
   [Barbieri, Davide; Yuan, Huipin] Xpand Biotechnol BV, NL-3723 MB Bilthoven, Netherlands.
   [Habibovic, Pamela; van Blitterswijk, Clemens A.; de Boer, Jan] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
RP de Boer, J (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
EM jan.deboer@maastrichtuniversity.nl
FU Project BONE-IP of the research program of the BioMedical Materials
   Institute [P2.04]; Dutch Ministry of Economic Affairs
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials Institute, cofunded by the Dutch
   Ministry of Economic Affairs.
CR Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203
   Baker BA, 2014, BIOMATERIALS, V35, P6716, DOI 10.1016/j.biomaterials.2014.04.075
   Barbieri D., 2014, FRONTIERS NANOBIOMED, P473
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1
   Chai Y. C., 2011, TISSUE ENG A
   Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Das RK, 2014, BIOMATERIALS, V35, P5278, DOI 10.1016/j.biomaterials.2014.03.044
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059
   Doorn J, 2013, BIOMATERIALS, V34, P3053, DOI 10.1016/j.biomaterials.2012.12.037
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Groen N, 2013, BIOMATERIALS, V34, P5552, DOI 10.1016/j.biomaterials.2013.04.001
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Lovmand J, 2009, BIOMATERIALS, V30, P2015, DOI 10.1016/j.biomaterials.2008.12.081
   McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370
   Moxham JP, 2007, LARYNGOSCOPE, V117, P1790, DOI 10.1097/MLG.0b013e3180ed451b
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Olivares-Navarrete R, 2011, BIOMATERIALS, V32, P6399, DOI 10.1016/j.biomaterials.2011.05.036
   Olivares-Navarrete R, 2011, ACTA BIOMATER, V7, P2740, DOI 10.1016/j.actbio.2011.02.030
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002
   Shih Y.-R. V., 2014, P NAT AC SCI 2014 JA, V2014
   Sieg DJ, 2000, NAT CELL BIOL, V2, P249
   Sims Natalie A, 2014, Bonekey Rep, V3, P527, DOI 10.1038/bonekey.2014.22
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   van der Maaten L. J. P., 2009, P 12 INT C ART INT S, V5, P384
   Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261
   Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094
   Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhang J., 2014, ACTA BIOMATER, P3254
NR 61
TC 4
Z9 4
U1 3
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1691
EP 1700
DI 10.1002/adhm.201500171
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600012
PM 26046651
DA 2018-10-19
ER

PT J
AU Sahu, N
   Baligar, P
   Midha, S
   Kundu, B
   Bhattacharjee, M
   Mukherjee, S
   Mukherjee, S
   Maushart, F
   Das, S
   Loparic, M
   Kundu, SC
   Ghosh, S
   Mukhopadhyay, A
AF Sahu, Neety
   Baligar, Prakash
   Midha, Swati
   Kundu, Banani
   Bhattacharjee, Maumita
   Mukherjee, Snehasish
   Mukherjee, Souhrid
   Maushart, Florian
   Das, Sanskrita
   Loparic, Marko
   Kundu, Subhas C.
   Ghosh, Sourabh
   Mukhopadhyay, Asok
TI Nonmulberry Silk Fibroin Scaffold Shows Superior Osteoconductivity Than
   Mulberry Silk Fibroin in Calvarial Bone Regeneration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biodegradation; bone graft materials; bone regeneration; calvarial bone
   defect; mulberry silk; nonmulberry silk
ID OSTEOBLAST DIFFERENTIATION; ANTHERAEA-MYLITTA; STEM-CELLS; IN-VITRO;
   BIOMATERIALS; DEFECTS; EXPRESSION; SIALOPROTEIN; DEGRADATION;
   FABRICATION
AB Recent years have witnessed the advancement of silk biomaterials in bone tissue engineering, although clinical application of the same is still in its infancy. In this study, the potential of pure nonmulberry Antheraea mylitta (Am) fibroin scaffold, without preloading with bone precursor cells, to repair calvarial bone defect in a rat model is explored and compared with its mulberry counterpart Bombyx mori (Bm) silk fibroin. After 3 months of implantation, Am scaffold culminates in a completely ossified regeneration with a progressive increase in mineralization at the implanted site. On the other hand, the Bm scaffold fails to repair the damaged bone, presumably due to its low osteoconductivity and early degradation. The deposition of bone matrix on scaffolds is evaluated by scanning electron and atomic force microscopy. These results are corroborated by in vitro studies of enzymatic degradation, colony formation, and secondary conformational features of the scaffold materials. The greater biocompatibility and mineralization in pure nonmulberry fibroin scaffolds warrants the use of these scaffolds as an ideal bone graft biomaterial for effective repair of critical size defects.
C1 [Sahu, Neety; Baligar, Prakash; Mukhopadhyay, Asok] Natl Inst Immunol, Stem Cell Biol Lab, New Delhi 110067, India.
   [Midha, Swati; Bhattacharjee, Maumita; Das, Sanskrita; Ghosh, Sourabh] Indian Inst Technol, Dept Textile Technol, New Delhi 110016, India.
   [Kundu, Banani; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Maushart, Florian; Loparic, Marko] Univ Basel, Biozentrum & Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in; sghosh08@textile.iitd.ac.in;
   ashok@nii.ac.in
RI Kundu, Banani/O-9320-2016
OI Kundu, Banani/0000-0003-1251-700X; /0000-0003-0295-5356; Baligar,
   Prakash/0000-0002-0553-4090; Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology, Government of India, New Delhi; Commission
   for Technology and Innovation (CTI) grant [14540.2, 1 PFNM-NM]
FX N.S. and P.B. contributed equally to this work. The work was funded by
   the Department of Biotechnology, Government of India, New Delhi, for
   which S.C.K. and A.M. are grateful. M.L. and F.M. were supported by
   Commission for Technology and Innovation (CTI) grant (Project 14540.2; 1
   PFNM-NM). A.M., S.C.K., and S.G. acknowledge NII, IIT Kharagpur, and IIT
   Delhi for providing infrastructural supports to conduct this study.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Bhattacharjee M, 2013, BIOMATERIALS, V34, P8161, DOI 10.1016/j.biomaterials.2013.07.018
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   Braccini A, 2007, J TISSUE ENG REGEN M, V1, P60, DOI 10.1002/term.11
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cebe P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01130
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Das S., 2015, ACTA BIOMATER, V1, P233
   Das S, 2013, BIOMACROMOLECULES, V14, P311, DOI 10.1021/bm301193t
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191
   Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Hu JG, 2012, J MATER SCI-MATER M, V23, P711, DOI 10.1007/s10856-011-4533-y
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Jolanda R. V., 2015, ACTA BIOMATER, V13, P277
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Kuboyama N, 2013, J BIOMED MATER RES B, V101B, P295, DOI 10.1002/jbm.b.32839
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu KG, 2012, J BIOMAT SCI-POLYM E, V23, P509, DOI 10.1163/092050610X552861
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Naskar D., 2014, SCI REP, V22, P4745
   Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Ye JH, 2011, BIOMATERIALS, V32, P5065, DOI 10.1016/j.biomaterials.2011.03.053
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 46
TC 11
Z9 11
U1 1
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1709
EP 1721
DI 10.1002/adhm.201500283
PG 13
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600014
PM 26084249
DA 2018-10-19
ER

PT J
AU Ullah, MH
   Mahadi, WNL
   Latef, TA
AF Ullah, M. Habib
   Mahadi, W. N. L.
   Latef, T. A.
TI Aerogel Poly(butylene succinate) Biomaterial Substrate for RF and
   Microwave Applications
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SILICA AEROGEL; ANTENNA; BAND; ACID
AB Polybutylene succinate (PBS) has become a potential candidate, similar to polypropylene (PP) and acrylonitrile butadiene styrene (ABS), for use as an organic plastic material due to its outstanding mechanical properties as well as high thermal deformation characteristics. A new composition of silica aerogel nanoparticles extracted from rice waste with PBS is proposed for use as a dielectric (epsilon(r) = 4.5) substrate for microwave applications. A microstrip patch antenna was fabricated on the proposed dielectric substrate for multi-resonant ultra-wideband (UWB) applications. The performance characteristics of the proposed biomaterial-based antenna were investigated in a far-field measurement environment. The results indicate that the proposed biocompatible material-based antenna covered a bandwidth of 9.4 (2.3-11.7) GHz with stop bands from 5.5 GHz to 5.8 GHz and 7.0 GHz to 8.3 GHz. Peak gains of 9.82 dBi, 7.59 dBi, 8.0 dBi and 7.68 dBi were measured at resonant frequencies of 2.7 GHz, 4.6 GHz, 6.3 GHz and 9.5 GHz, respectively.
C1 [Ullah, M. Habib; Mahadi, W. N. L.; Latef, T. A.] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
RP Ullah, MH (reprint author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
EM mhullah@yahoo.com
RI Engineering, Faculty/I-7935-2015; ABDUL LATEF, TARIK/B-9927-2010
OI Engineering, Faculty/0000-0002-4848-7052; 
FU University of Malaya [FP012-2014A]
FX The authors acknowledge the assistance given by University of Malaya
   (Project: FP012-2014A).
CR Bondioli F, 2010, J AM CERAM SOC, V93, P121, DOI 10.1111/j.1551-2916.2009.03337.x
   Cao WQ, 2013, IEEE T ANTENN PROPAG, V61, P2286, DOI 10.1109/TAP.2012.2235400
   DeJean G, 2005, IEEE ANTENN WIREL PR, V4, P22, DOI 10.1109/LAWP.2004.841626
   Gurav JL, 2010, J NANOMATER, V2010, P23
   Habib Ullah M., 2014, SMART MATER STRUCT, V23
   Hall P.S., 2007, PRINTED ANTENNAS WIR
   Islam MT, 2012, PROG ELECTROMAGN RES, V129, P161, DOI 10.2528/PIER12032604
   Kaufmann T, 2012, INT J ANTENN PROPAG, DOI 10.1155/2012/972696
   Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0
   LEVY D, 1989, J NON-CRYST SOLIDS, V113, P137, DOI 10.1016/0022-3093(89)90004-5
   Lu WJ, 2014, IEEE T ANTENN PROPAG, V62, P2860, DOI 10.1109/TAP.2014.2307343
   Mobashsher AT, 2014, IEEE ANTENN WIREL PR, V13, P798, DOI 10.1109/LAWP.2014.2318035
   Oishi A, 2006, POLYM J, V38, P710, DOI 10.1295/polymj.PJ2005206
   PERI JB, 1966, J PHYS CHEM-US, V70, P2937, DOI 10.1021/j100881a037
   POELZ G, 1982, NUCL INSTRUM METHODS, V195, P491, DOI 10.1016/0029-554X(82)90010-6
   Priel A, 2006, BIOPHYS J, V90, P4639, DOI 10.1529/biophysj.105.078915
   Reppe J. W., 1949, ACETYLENE CHEM
   SCHAEFER DW, 1986, PHYS REV LETT, V56, P2199, DOI 10.1103/PhysRevLett.56.2199
   Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043
   Takahashi H, 2000, CHEM LETT, P684, DOI 10.1246/cl.2000.684
   Tserki V, 2006, POLYM DEGRAD STABIL, V91, P367, DOI 10.1016/j.polymdegradstab.2005.04.035
   Ullah MH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4833496
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Xu J, 2010, BIOTECHNOL J, V5, P1149, DOI 10.1002/biot.201000136
   Zeikus JG, 1999, APPL MICROBIOL BIOT, V51, P545, DOI 10.1007/s002530051431
NR 25
TC 4
Z9 4
U1 6
U2 37
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 4
PY 2015
VL 5
AR 12868
DI 10.1038/srep12868
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO4EQ
UT WOS:000359114000001
PM 26238975
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gupta, KA
   Mita, K
   Arunkumar, KP
   Nagaraju, J
AF Gupta, Adarsh K.
   Mita, Kazuei
   Arunkumar, Kallare P.
   Nagaraju, Javaregowda
TI Molecular architecture of silk fibroin of Indian golden silkmoth,
   Antheraea assama
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROTEIN SECONDARY STRUCTURE; BOMBYX-MORI; MECHANICAL-PROPERTIES;
   NEPHILA-CLAVIPES; EXPRESSED GENES; DRAGLINE SILK; CODON USAGE; SEQUENCE;
   DNA; ORGANIZATION
AB The golden silk spun by Indian golden silkmoth Antheraea assama, is regarded for its shimmering golden luster, tenacity and value as biomaterial. This report describes the gene coding for golden silk H-fibroin (AaFhc), its expression, full-length sequence and structurally important motifs discerning the underlying genetic and biochemical factors responsible for its much sought-after properties. The coding region, with biased isocodons, encodes highly repetitious crystalline core, flanked by a pair of 5' and 3' non-repetitious ends. AaFhc mRNA expression is strictly territorial, confined to the posterior silk gland, encoding a protein of size 230 kDa, which makes homodimers making the elementary structural units of the fibrous core of the golden silk. Characteristic polyalanine repeats that make tight beta-sheet crystals alternate with non-polyalanine repeats that make less orderly antiparallel beta-sheets, beta-turns and partial alpha-helices. Phylogenetic analysis of the conserved N-terminal amorphous motif and the comparative analysis of the crystalline region with other saturniid H-fibroins reveal that AaFhc has longer, numerous and relatively uniform repeat motifs with lower serine content that assume tighter beta-crystals and denser packing, which are speculated to be responsible for its acclaimed properties of higher tensile strength and higher refractive index responsible for golden luster.
C1 [Gupta, Adarsh K.; Arunkumar, Kallare P.; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad 500001, Andhra Pradesh, India.
   [Mita, Kazuei] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.
RP Gupta, KA (reprint author), Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad 500001, Andhra Pradesh, India.
EM adarsh@cdfd.org.in; arun@cdfd.org.in
FU Department of Biotechnology, Government of India through Centre of
   Excellence grant for Genetics and Genomics of Silkmoths
   [BT/01/COE/05/12]
FX This work is sincerely dedicated in memory of Dr. J. Nagaraju. This work
   was supported by Department of Biotechnology, Government of India
   through Centre of Excellence grant for Genetics and Genomics of
   Silkmoths (grant number BT/01/COE/05/12) to JN. We are grateful to Dr.
   H. A. Nagarajaram (Laboratory of Computational Biology, CDFD) for his
   valuable inputs during computational analyses and manuscript
   preparation. We thank Dr. Rashna Bhandari (Laboratory of Cell
   Signalling, CDFD) and Dr. R. Harinarayanan (Laboratory of Bacterial
   Genetics, CDFD) for their helpful discussions during few experiments.
CR Amalendu Tikader, 2013, Plant Knowledge Journal, V2, P83
   Arunkumar KP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-338
   Bratzel G, 2012, J MECH BEHAV BIOMED, V7, P30, DOI 10.1016/j.jmbbm.2011.07.012
   Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564
   Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng1011
   Collin MA, 2010, J MOL EVOL, V70, P519, DOI 10.1007/s00239-010-9349-8
   COUBLE P, 1985, NUCLEIC ACIDS RES, V13, P1801, DOI 10.1093/nar/13.5.1801
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Higgins LE, 2007, INT J BIOL MACROMOL, V40, P201, DOI 10.1016/j.ijbiomac.2006.07.007
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Horard B, 1997, MOL CELL BIOL, V17, P1572, DOI 10.1128/MCB.17.3.1572
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Lesperon L., 1937, Archives de Zoologie Experimentale et Generale Paris, V79, P1
   Ling SJ, 2013, BIOMACROMOLECULES, V14, P1885, DOI 10.1021/bm400267m
   Lucas F., 1968, Comprehensive Biochem, V26, P475
   MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9
   MITA K, 1994, J MOL EVOL, V38, P583
   NAKAMURA T, 1991, FEBS LETT, V289, P123, DOI 10.1016/0014-5793(91)80923-Q
   Nation J. L., 2000, INSECT PHYSL BIOCH, P2485
   PAULING L, 1953, P NATL ACAD SCI USA, V39, P253, DOI 10.1073/pnas.39.4.253
   PAULSSON G, 1992, J MOL BIOL, V225, P349, DOI 10.1016/0022-2836(92)90926-B
   PEDRIXGILLOT S, 1979, BIOCHIMIE, V61, P171
   Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097
   Saravanan D. U. V., 2007, AUTEX RES J, V7, P1
   SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H
   Sezutsu H, 2000, J MOL EVOL, V51, P329, DOI 10.1007/s002390010095
   Sezutsu Hideki, 2009, Journal of Insect Biotechnology and Sericology, V78, P1
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shibukawa A., 1959, B SERICULT EXP STN, V15, P383
   SHIMURA K, 1982, Journal of Sericultural Science of Japan, V51, P20
   Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6
   Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01
   Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645
   Talukdar B., 2011, INT J PURE APPL SCI, V7, P81
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T
   Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
NR 53
TC 2
Z9 2
U1 1
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 3
PY 2015
VL 5
AR 12706
DI 10.1038/srep12706
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0MR
UT WOS:000358846300001
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Abdul-Kader, AM
   Radwan, RM
AF Abdul-Kader, A. M.
   Radwan, R. M.
TI Low-energy He-ion beam modifications the surface properties of
   biomaterial
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE surface properties; ultra-high-molecular-weight polyethylene;
   biocompatibility; ion bombardment
ID MOLECULAR-WEIGHT POLYETHYLENE; GAMMA-IRRADIATION; DIELECTRIC-PROPERTIES;
   HYDROGEN RELEASE; POLYMERS; FILMS; BOMBARDMENT; RADIATION; ELECTRON;
   COMPOSITE
AB In the present work, ultra-high-molecular-weight polyethylene (UHMWPE) films were irradiated with 130keV He ions. The fluence of the ion beam was ranged from 1x10(12) to 1x10(16)cm(-2). The chemical, morphological, and crystallite structure changes resulted from the ion bombardment were obtained using different spectroscopic techniques. These techniques were Fourier transform infrared spectrometer, scanning electron microscope, X-ray diffraction, and UV-vis spectrophotometry. The surface free energy for untreated and ion-beam-treated samples was determined by means of contact angle measurements of three different liquids. Our results showed a decrease in the crystallinity of UHMWPE and formation of C=O groups on the polymer surface for modified samples as well. A remarkable shifting in the UV-vis spectra toward lower energy and increase in the optical absorption were observed as the ion fluence increases. Measurements of the contact angle indicate remarkable increase in the surface free energy as a function of ion fluence.
C1 [Abdul-Kader, A. M.] Helwan Univ, Fac Sci, Dept Phys, Cairo, Egypt.
   [Radwan, R. M.] AEA, NCRRT, Radiat Phys Dept, Cairo, Egypt.
   [Radwan, R. M.] Jazan Univ, Dept Diagnost Radiol, Coll Appl Med Sci, Jazan, Saudi Arabia.
RP Abdul-Kader, AM (reprint author), Helwan Univ, Fac Sci, Dept Phys, Cairo, Egypt.
EM atawab2001@yahoo.com
CR Abdel Moez A, 2012, SPECTROCHIM ACTA A, V93, P203
   Abdul-Kader AM, 2009, APPL SURF SCI, V255, P7786, DOI 10.1016/j.apsusc.2009.04.176
   Abdul-Kader AM, 2005, NUCL INSTRUM METH B, V240, P152, DOI 10.1016/j.nimb.2005.06.106
   Abdul-Kader AM, 2005, VACUUM, V78, P281, DOI 10.1016/j.vacuum.2005.01.039
   Al-Qaradawi IY, 2007, RADIAT PHYS CHEM, V76, P123, DOI 10.1016/j.radphyschem.2006.03.016
   Bakshi SR, 2007, COMPOS PART A-APPL S, V38, P2493, DOI 10.1016/j.compositesa.2007.08.004
   Balabanov S, 2002, VACUUM, V69, P107, DOI 10.1016/S0042-207X(02)00316-0
   Balanzat E, 1995, NUCL INSTRUM METH B, V105, P46, DOI 10.1016/0168-583X(95)00521-8
   Balanzat E, 1996, NUCL INSTRUM METH B, V116, P159, DOI 10.1016/0168-583X(96)00121-8
   Chapiro A, 1995, NUCL INSTRUM METH B, V105, P5, DOI 10.1016/0168-583X(95)00861-6
   Clough RL, 2001, NUCL INSTRUM METH B, V185, P8, DOI 10.1016/S0168-583X(01)00966-1
   Costa L, 1997, POLYM DEGRAD STABIL, V55, P329, DOI 10.1016/S0141-3910(96)00170-X
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   Dworecki K, 2001, NUCL INSTRUM METH B, V185, P61, DOI 10.1016/S0168-583X(01)00779-0
   enkiewicz M, 2008, POLYM TEST, V27, P420, DOI [10.1016/j.polymertesting.2008.01.002, DOI 10.1016/J.POLYMERTESTING.2008.01.002]
   FAKES DW, 1987, SURF INTERFACE ANAL, V10, P416, DOI 10.1002/sia.740100807
   Fernando SS, 2007, POLYM DEGRAD STABIL, V92, P2163, DOI 10.1016/j.polymdegradstab.2007.01.032
   Goldman M, 1996, POLYMER, V37, P2909, DOI 10.1016/0032-3861(96)89386-4
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hazarika J, 2012, NUCL INSTRUM METH B, V288, P74, DOI 10.1016/j.nimb.2012.06.026
   Jagielski J, 2007, NUCL INSTRUM METH B, V261, P690, DOI 10.1016/j.nimb.2007.03.021
   Kumar PK, 2011, MATER DESIGN, V32, P1129, DOI 10.1016/j.matdes.2010.11.001
   Kumar R, 2008, NUCL INSTRUM METH B, V266, P1783, DOI 10.1016/j.nimb.2007.11.059
   Kumar V, 2012, RADIAT PHYS CHEM, V81, P652, DOI 10.1016/j.radphyschem.2012.02.027
   Lee E. H., 1996, POLYIMIDES FUNDAMENT
   Mishra R, 2001, RADIAT MEAS, V33, P845, DOI 10.1016/S1350-4487(01)00038-5
   MOTT NF, 1969, PHILOS MAG, V19, P835, DOI 10.1080/14786436908216338
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pelagade SM, 2012, NUCL INSTRUM METH B, V289, P34, DOI 10.1016/j.nimb.2012.08.010
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   Qureshi A, 2009, NUCL INSTRUM METH B, V267, P3456, DOI 10.1016/j.nimb.2009.07.016
   Radwan RM, 2008, RADIAT PHYS CHEM, V77, P179, DOI 10.1016/j.radphyschem.2007.05.011
   RANDALL JN, 1983, APPL PHYS LETT, V42, P457, DOI 10.1063/1.93969
   Rosu L, 2009, POLYM TEST, V28, P296, DOI 10.1016/j.polymertesting.2009.01.004
   Siljegovic M, 2011, RADIAT PHYS CHEM, V80, P1378, DOI 10.1016/j.radphyschem.2011.08.012
   Singh NL, 2007, MAT SCI ENG B-SOLID, V137, P85, DOI 10.1016/j.mseb.2006.10.013
   Stelescu DM, 2013, POLYM TEST, V32, P187, DOI 10.1016/j.polymertesting.2012.10.010
   Suarez JCM, 2002, POLYM DEGRAD STABIL, V75, P143, DOI 10.1016/S0141-3910(01)00213-0
   Toth S, 2006, THIN SOLID FILMS, V497, P279, DOI 10.1016/j.tsf.2005.10.050
   Tretinnikov ON, 1999, J POLYM SCI POL PHYS, V37, P1503, DOI 10.1002/(SICI)1099-0488(19990701)37:13<1503::AID-POLB16>3.0.CO;2-X
   Turos A, 2006, NUCL INSTRUM METH B, V249, P660, DOI 10.1016/j.nimb.2006.03.075
   Verma R, 2012, J PHYS CHEM SOLIDS, V73, P288, DOI 10.1016/j.jpcs.2011.10.026
   Virk HS, 1998, J PHYS D APPL PHYS, V31, P3139, DOI 10.1088/0022-3727/31/21/020
   Wang YQ, 2000, NUCL INSTRUM METH B, V161, P1027, DOI 10.1016/S0168-583X(99)00989-1
   Wielunski LS, 1997, NUCL INSTRUM METH B, V127, P698, DOI 10.1016/S0168-583X(96)01160-3
   WROBEL AM, 1978, POLYMER, V19, P908, DOI 10.1016/0032-3861(78)90197-0
   Zaki MF, 2008, J PHYS D, V41
   Ziegler J. F., 1985, STOPPING RANGES IONS, VI
NR 48
TC 0
Z9 0
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD AUG 3
PY 2015
VL 29
IS 15
BP 1607
EP 1616
DI 10.1080/01694243.2015.1038104
PG 10
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA CI1VJ
UT WOS:000354532700008
DA 2018-10-19
ER

PT J
AU Bohmler, J
   Haidara, H
   Ponche, A
   Ploux, L
AF Boehmler, Judith
   Haidara, Hamidou
   Ponche, Arnaud
   Ploux, Lydie
TI Impact of Chemical Heterogeneities of Surfaces on Colonization by
   Bacteria
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE bacterial adhesion; surface properties; functional group density;
   chemical heterogeneities; real-time confocal microscopy
ID SELF-ASSEMBLED MONOLAYERS; GRAM-POSITIVE BACTERIA; ACID-BASE PROPERTIES;
   ESCHERICHIA-COLI; STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION;
   MICROBIAL ADHESION; INITIAL ADHESION; FLOW CONDITIONS; CELL-SIZE
AB An essential yet never addressed parameter for the control of bacteria on functionalized biomaterial is surely the accessibility and heterogeneity of the functional groups immobilized on the surface. In this context, we investigated the colonization (Escherichia coli K12, Staphylococcus epidermidis RP62A) of precisely engineered surfaces revealing various densities of NH2 and CH3 functional groups. We demonstrated for the first time nonlinear relationships between the NH2/CH3 surface fraction and the quantity of adhered, adhering or detaching bacteria. Plateaus and transition zones were related to the range of NH2/CH3 surface fraction offering stability or sharp variation in bacterium/surface interactions. The nonlinear behavior was attributed to the discrete distribution of positive charges revealed by the bacterial membrane in the continuum of negative charges resulting from the phospholipids, which may correlate with one single specific distribution of positive NH3+ charges on the material surface, because of electrostatic, repulsive interactions occurring at the local, molecular scale.
C1 [Boehmler, Judith; Haidara, Hamidou; Ponche, Arnaud; Ploux, Lydie] Univ Haute Alsace, Univ Strasbourg, Inst Sci Mat Mulhouse, CNRS,UMR7361, Mulhouse, France.
RP Ploux, L (reprint author), Univ Haute Alsace, Univ Strasbourg, Inst Sci Mat Mulhouse, CNRS,UMR7361, Mulhouse, France.
EM Lydie.Ploux@uha.fr
OI Ponche, Arnaud/0000-0002-8993-2896
FU French "Centre National de la Recherche Scientifique" (CNRS); Region
   Alsace (France)
FX The article has been edited and proofread by Proof-Reading-Services.org.
   All works done at Institut de Science des Materiaux de Mulhouse were
   funded by the French "Centre National de la Recherche Scientifique"
   (CNRS). The present project was also especially funded by Region Alsace
   (France). In addition, the authors sincerely thank Jules Valentin and
   Adeline Marguier for their technical help and Prof Jean-Claude Block for
   stimulating discussions.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anguita-Alonso Paloma, 2005, Expert Rev Anti Infect Ther, V3, P797, DOI 10.1586/14787210.3.5.797
   Anselme K, 2011, ACTA BIOMATER, V7, P1936, DOI 10.1016/j.actbio.2010.12.002
   Aswal DK, 2006, ANAL CHIM ACTA, V568, P84, DOI 10.1016/j.aca.2005.10.027
   Bagshaw SM, 2006, CURR OPIN INFECT DIS, V19, P67, DOI 10.1097/01.qco.0000200292.37909.e0
   Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Barth KA, 2008, ADV FUNCT MATER, V18, P1459, DOI 10.1002/adfm.200701246
   Basu S, 1997, J COLLOID INTERF SCI, V190, P253, DOI 10.1006/jcis.1997.4856
   BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6
   Bohmler J, 2013, ACS APPL MATER INTER, V5, P10478, DOI 10.1021/am401976g
   Burton EA, 2009, LANGMUIR, V25, P1547, DOI 10.1021/la803261b
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   Coico R, 2005, CURRENT PROTOCOLS MI
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cottenye N, 2012, ADV FUNCT MATER, V22, P4891, DOI 10.1002/adfm.201200988
   Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r
   Disney MD, 2004, J AM CHEM SOC, V126, P13343, DOI 10.1021/ja047936i
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Fonseca AP, 2001, J MATER SCI-MATER M, V12, P543, DOI 10.1023/A:1011227915575
   Gasol JM, 1995, MAR ECOL PROG SER, V128, P91, DOI 10.3354/meps128091
   Harkes G, 1992, Cell Biophys, V20, P17, DOI 10.1007/BF02782652
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, J MATER SCI-MATER M, V21, P963, DOI 10.1007/s10856-009-3975-y
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   KOCH AL, 1966, J GEN MICROBIOL, V45, P409, DOI 10.1099/00221287-45-3-409
   Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025
   Lee SH, 2010, J PHYS CHEM C, V114, P10512, DOI 10.1021/jp101426h
   Lin JH, 2014, LANGMUIR, V30, P10328, DOI 10.1021/la5020362
   Lin YC, 2009, J COLLOID INTERF SCI, V340, P126, DOI 10.1016/j.jcis.2009.08.014
   Liu Y, 2001, J APPL MICROBIOL, V90, P337, DOI 10.1046/j.1365-2672.2001.01244.x
   Mauclaire L, 2010, COLLOID SURFACE B, V76, P104, DOI 10.1016/j.colsurfb.2009.10.021
   Miao H, 2009, J MICROBIOL METH, V76, P111, DOI 10.1016/j.mimet.2008.09.015
   Mougin K, 2001, LANGMUIR, V17, P5952, DOI 10.1021/la0102399
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174
   Nicolau Korres A. M., 2013, SCI WORLD J, V2013
   Ploux L, 2007, COLLOID SURFACE B, V57, P174, DOI 10.1016/j.colsurfb.2007.01.018
   Ploux L, 2010, J ADHES SCI TECHNOL, V24, P2165, DOI 10.1163/016942410X511079
   Poortinga AT, 2002, SURF SCI REP, V47, P3, DOI 10.1016/S0167-5729(02)00032-8
   Qian XP, 2002, ANAL CHEM, V74, P1805, DOI 10.1021/ac0110420
   Rasband W, 1997, IMAGEJ
   Roberts JA, 2004, CHEM GEOL, V212, P313, DOI 10.1016/j.chemgeo.2004.08.021
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x
   Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002
   Scherrer B., 2007, BIOSTATISTIQUE, V1
   Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018
   SHERMAN PM, 1985, INFECT IMMUN, V49, P797
   Shyue JJ, 2004, LANGMUIR, V20, P8693, DOI 10.1021/la049247q
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Terada A, 2005, COLLOID SURFACE B, V43, P99, DOI 10.1016/j.colsurfb.2005.03.016
   Vidal O, 1998, J BACTERIOL, V180, P2442
   Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u
   Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043
   Wiencek KM, 1997, BIOFOULING, V11, P293, DOI 10.1080/08927019709378338
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Zhang H, 1998, APPL PHYS A-MATER, V66, pS269, DOI 10.1007/s003390051143
NR 64
TC 4
Z9 4
U1 4
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD AUG
PY 2015
VL 1
IS 8
BP 693
EP 704
DI 10.1021/acsbiomaterials.5b00151
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RP
UT WOS:000372214100010
DA 2018-10-19
ER

PT J
AU Zhang, SS
   Burda, JE
   Anderson, MA
   Zhao, ZR
   Ao, Y
   Cheng, Y
   Sun, Y
   Deming, TJ
   Sofroniew, MV
AF Zhang, Shanshan
   Burda, Joshua E.
   Anderson, Mark A.
   Zhao, Ziru
   Ao, Yan
   Cheng, Yin
   Sun, Yi
   Deming, Timothy J.
   Sofroniew, Michael V.
TI Thermoresponsive Copolypeptide Hydrogel Vehicles for Central Nervous
   System Cell Delivery
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biomaterials; hydrogel; brain; spinal cord; drug delivery; neural stem
   cells; transplantation
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; AXONAL REGENERATION;
   LOCAL-DELIVERY; RADIAL GLIA; TRACT AXONS; TISSUE; SCAR; ASTROCYTES;
   GROWTH
AB Biomaterial vehicles have the potential to facilitate cell transplantation in the central nervous system (CNS). We have previously shown that highly tunable ionic diblock copolypeptide hydrogels (DCH) can provide sustained release of hydrophilic and hydrophobic molecules in the CNS. Here, we show that recently developed nonionic and thermoresponsive DCH, called DCHT, exhibit excellent cytocompatibility. Neural stem cell (NSC) suspensions in DCHT were easily injected as liquids at room temperature. DCHT with a viscosity tuned to prevent cell sedimentation and clumping significantly through injection cannulae. At body temperature, DCHT self-assembled into hydrogels with a stiffness tuned to that of CNS tissue. After injection in vivo, DCHT significantly increased by 3-fold the survival of NSC grafted into a healthy CNS. In an injured CNS, NSC injected as suspensions in DCHT distributed well in non-neural lesion cores, integrated with healthy neural cells at lesion perimeters, and supported regrowing host nerve fibers. Our findings show that nonionic DCHT have numerous advantageous properties that make them useful tools for in vivo delivery of cells and molecules in the CNS for experimental investigations and potential therapeutic strategies.
C1 [Zhang, Shanshan; Deming, Timothy J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   [Burda, Joshua E.; Anderson, Mark A.; Zhao, Ziru; Ao, Yan; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.
   [Cheng, Yin; Sun, Yi] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.
   [Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Sofroniew, MV (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.
EM sofroniew@mednet.ucla.edu
OI Burda, Joshua/0000-0001-5139-348X
FU Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research
   Foundation; NIH [R01NS084030]; Microscopy Core Resource of the UCLA
   Broad Stem Cell Research Center-CIRM Laboratory
FX This study was supported by Wings for Life, The Dr. Miriam and Sheldon
   G. Adelson Medical Research Foundation, NIH R01NS084030, and the
   Microscopy Core Resource of the UCLA Broad Stem Cell Research
   Center-CIRM Laboratory.
CR Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957
   Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195
   Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011
   Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f
   Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chu TC, 2014, BRAIN RES BULL, V107, P18, DOI 10.1016/j.brainresbull.2014.05.003
   Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283
   Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682
   Deming TJ, 2005, SOFT MATTER, V1, P28, DOI 10.1039/b500307e
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340
   Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040
   Dunnett SB, 2014, NEUROBIOL DIS, V61, P79, DOI 10.1016/j.nbd.2013.05.004
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Fernandez-Klett F, 2014, BRAIN PATHOL, V24, P404, DOI 10.1111/bpa.12162
   Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024
   Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008
   Hoban DB, 2013, BIOMATERIALS, V34, P9420, DOI 10.1016/j.biomaterials.2013.08.073
   Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2
   Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kramer JR, 2013, SOFT MATTER, V9, P3389, DOI 10.1039/c3sm27559k
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023
   Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723
   Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467
   McCall J, 2012, CELL TISSUE RES, V349, P27, DOI 10.1007/s00441-012-1388-6
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   NORRIS CR, 1991, J NEUROSCI, V11, P3481
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926
   Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006
   Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013
   Williams RR, 2015, CELL TRANSPLANT, V24, P115, DOI 10.3727/096368913X674657
   Yan CQ, 2012, LANGMUIR, V28, P6076, DOI 10.1021/la2041746
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   Zhang SS, 2015, BIOMACROMOLECULES, V16, P1331, DOI 10.1021/acs.biomac.5b00124
   Zhang S, 2014, BIOMATERIALS, V35, P1989, DOI 10.1016/j.biomaterials.2013.11.005
   Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013
NR 49
TC 15
Z9 15
U1 0
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD AUG
PY 2015
VL 1
IS 8
BP 705
EP 717
DI 10.1021/acsbiomaterials.5b00153
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RP
UT WOS:000372214100011
PM 27547820
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Khalili, AA
   Ahmad, MR
AF Khalili, Amelia Ahmad
   Ahmad, Mohd Ridzuan
TI A Review of Cell Adhesion Studies for Biomedical and Biological
   Applications
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE cell adhesion; attachment event; detachment event; adhesion strength
ID QUARTZ-CRYSTAL MICROBALANCE; ATOMIC-FORCE MICROSCOPY; OSTEOBLAST-LIKE
   CELLS; EXTRACELLULAR-MATRIX PROTEINS; BIOMIMETIC PEPTIDE SURFACES;
   RED-BLOOD-CELLS; ENDOTHELIAL-CELL; FLOW CHAMBER; LIVING CELLS;
   SHEAR-STRESS
AB Cell adhesion is essential in cell communication and regulation, and is of fundamental importance in the development and maintenance of tissues. The mechanical interactions between a cell and its extracellular matrix (ECM) can influence and control cell behavior and function. The essential function of cell adhesion has created tremendous interests in developing methods for measuring and studying cell adhesion properties. The study of cell adhesion could be categorized into cell adhesion attachment and detachment events. The study of cell adhesion has been widely explored via both events for many important purposes in cellular biology, biomedical, and engineering fields. Cell adhesion attachment and detachment events could be further grouped into the cell population and single cell approach. Various techniques to measure cell adhesion have been applied to many fields of study in order to gain understanding of cell signaling pathways, biomaterial studies for implantable sensors, artificial bone and tooth replacement, the development of tissue-on-a-chip and organ-on-a-chip in tissue engineering, the effects of biochemical treatments and environmental stimuli to the cell adhesion, the potential of drug treatments, cancer metastasis study, and the determination of the adhesion properties of normal and cancerous cells. This review discussed the overview of the available methods to study cell adhesion through attachment and detachment events.
C1 [Khalili, Amelia Ahmad; Ahmad, Mohd Ridzuan] Univ Teknol Malaysia, Fac Elect Engn, Dept Control & Mechatron Engn, Johor Baharu 81310, Malaysia.
   [Ahmad, Mohd Ridzuan] Univ Teknol Malaysia, Inst Ibnu Sina, Johor Baharu 81310, Malaysia.
RP Ahmad, MR (reprint author), Univ Teknol Malaysia, Fac Elect Engn, Dept Control & Mechatron Engn, Johor Baharu 81310, Malaysia.
EM amelia.ahmadkhalili@gmail.com; ridzuan@fke.utm.my
RI Ahmad, Mohd Ridzuan/M-9037-2016
OI Ahmad, Mohd Ridzuan/0000-0002-1331-9606
FU Ministry of Higher Education Malaysia [4L640, 4F351]; Universiti
   Teknologi Malaysia [02G46, 03H82, 03H80]
FX The research was supported by the Ministry of Higher Education Malaysia
   (grant Nos. 4L640 and 4F351) and Universiti Teknologi Malaysia, (grant
   Nos. 02G46, 03H82 and 03H80). Thanks to them for funding this project
   and for their endless support.
CR Alapan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07173
   An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x
   Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853
   Askenasy N, 2002, STEM CELLS, V20, P501, DOI 10.1634/stemcells.20-6-501
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   Beaussart A, 2014, NAT PROTOC, V9, P1049, DOI 10.1038/nprot.2014.066
   BELLONI PN, 1990, CANCER METAST REV, V8, P353, DOI 10.1007/BF00052608
   Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   Bhat VD, 1998, J BIOMED MATER RES, V41, P377, DOI 10.1002/(SICI)1097-4636(19980905)41:3<377::AID-JBM6>3.3.CO;2-Q
   Bonakdar N., 2012, PLOS ONE, V7
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Brown MA, 2007, BIOMATERIALS, V28, P3928, DOI 10.1016/j.biomaterials.2007.05.009
   Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0
   Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6
   Cao J, 1997, ANN BIOMED ENG, V25, P573, DOI 10.1007/BF02684196
   Capadona JR, 2003, LANGMUIR, V19, P1847, DOI 10.1021/la026244
   Castelain M, 2012, J APPL PHYS, V111, DOI 10.1063/1.4723566
   Castelain M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2772270
   Castelain M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2842078
   Cavic BA, 1999, ANALYST, V124, P1405, DOI 10.1039/a903236c
   Chan BP, 1999, BIOMATERIALS, V20, P2395, DOI 10.1016/S0142-9612(99)00167-2
   Channavajjala LS, 1997, J CELL SCI, V110, P249
   Chaw KC, 2007, LAB CHIP, V7, P1041, DOI 10.1039/b707399m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515
   Cheung LSL, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054033
   Cho Peter, 2006, Implant Dent, V15, P377, DOI 10.1097/01.id.0000247858.37697.d5
   Christ KV, 2010, J ADHES SCI TECHNOL, V24, P2027, DOI 10.1163/016942410X507911
   Christ KV, 2010, BIOMED MICRODEVICES, V12, P443, DOI 10.1007/s10544-010-9401-x
   Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001
   Correlates M., 1985, J CLIN INVEST, V76, p[1605, 1612]
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   Curtis JE, 2004, P SOC PHOTO-OPT INS, V5514, P455, DOI 10.1117/12.560049
   D'Arcangelo E., 2014, BIOTECHNIQUES, V58, P13
   Da-Silva AC, 2013, BIOTECHNOL J, V8, P690, DOI 10.1002/biot.201200320
   Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Deshpande VS, 2008, J MECH PHYS SOLIDS, V56, P1484, DOI 10.1016/j.jmps.2007.08.006
   Detry JG, 2009, BIOTECHNOL AGRON SOC, V13, P427
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698
   EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8
   EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2
   Ferreira GNM, 2009, TRENDS BIOTECHNOL, V27, P689, DOI 10.1016/j.tibtech.2009.09.003
   Fohlerova Z, 2007, BIOSENS BIOELECTRON, V22, P1896, DOI 10.1016/j.bios.2006.08.015
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Fu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030721
   Gallant ND, 2007, J BIOMECH, V40, P1301, DOI 10.1016/j.jbiomech.2006.05.018
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Gao Z, 2008, MAT SCI ENG C-BIO S, V28, P1227, DOI 10.1016/j.msec.2007.11.003
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gerszten RE, 1998, CIRC RES, V82, P871
   Giacomello E., 1999, BIOTECHNIQUES, V26, P764
   Girdhar G, 2007, BIOPHYS J, V93, P4041, DOI 10.1529/biophysj.107.109298
   Goldstein AS, 2003, J BIOMED MATER RES A, V67A, P658, DOI 10.1002/jbm.a.10125
   Goldstein AS, 2002, J BIOMED MATER RES, V59, P665, DOI 10.1002/jbm.1276
   Goldstein AS, 1998, AICHE J, V44, P465, DOI 10.1002/aic.690440222
   Goldstein AS, 1997, BIOTECHNOL BIOENG, V55, P616, DOI 10.1002/(SICI)1097-0290(19970820)55:4<616::AID-BIT4>3.0.CO;2-K
   Gourier C, 2008, CELL MOL BIOENG, V1, P263, DOI 10.1007/s12195-008-0030-x
   Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780
   Gupta VK, 2010, BIOMECH MODEL MECHAN, V9, P613, DOI 10.1007/s10237-010-0201-2
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hansma HG, 2004, CURR OPIN STRUC BIOL, V14, P380, DOI 10.1016/j.sbi.2004.05.005
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Harbers GM, 2005, LANGMUIR, V21, P8374, DOI 10.1021/la050396y
   Hartmann A, 2014, LAB CHIP, V14, P542, DOI 10.1039/c3lc50916h
   HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Heitmann V, 2007, ANAL CHEM, V79, P3392, DOI 10.1021/ac062433b
   Heitmann V, 2007, SPRINGER SER CHEM SE, V5, P303, DOI 10.1007/5346_031
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Hirano Y, 2008, PFLUG ARCH EUR J PHY, V456, P139, DOI 10.1007/s00424-007-0431-z
   Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x
   Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X
   Hodges SR, 2002, J FLUID MECH, V460, P381, DOI 10.1017/S0022112002008340
   Hoffmann SC, 2011, J IMMUNOL, V186, P2757, DOI 10.4049/jimmunol.1002867
   Honarmandi P, 2011, LAB CHIP, V11, P684, DOI 10.1039/c0lc00487a
   Hong S, 2006, BIOMATERIALS, V27, P5813, DOI 10.1016/j.biomaterials.2006.07.031
   HONN KV, 1992, CANCER METAST REV, V11, P353, DOI 10.1007/BF01307187
   Horwitz AF, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0597-68
   Huan W, 2003, J ORTHOPAED RES, V21, P88, DOI 10.1016/S0736-0266(02)00130-4
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Huynh J, 2013, CELL MOL BIOENG, V6, P138, DOI 10.1007/s12195-013-0278-7
   Hwang WC, 1997, BIOPHYS J, V72, P2669, DOI 10.1016/S0006-3495(97)78910-0
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim WS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/24/245605
   Kong D, 2008, BIOPHYS J, V95, P4034, DOI [10.1529/biophysj.108.131342, 10.1529/biophysj.l08.131342]
   Kong D, 2008, J THEOR BIOL, V250, P75, DOI 10.1016/j.jtbi.2007.09.028
   Kong D, 2010, J BIOMECH, V43, P2524, DOI 10.1016/j.jbiomech.2010.05.019
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572
   Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009
   Kreke MR, 2005, BIOMATERIALS, V26, P2975, DOI 10.1016/j.biomaterials.2004.08.013
   Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026
   Kwon KW, 2007, LAB CHIP, V7, P1461, DOI 10.1039/b710054j
   Lane W. O., 2012, JOVE-J VIS EXP, V1, P12
   LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G
   Le Guillou-Buffello D, 2005, BIOMATERIALS, V26, P4197, DOI 10.1016/j.biomaterials.2004.10.024
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Lee C. C., 2004, J MED BIOL ENG, V24, P51
   Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee MH, 2007, J BIOMED MATER RES A, V81A, P150, DOI 10.1002/jbm.a.31065
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Li F, 2007, BIOSENS BIOELECTRON, V23, P42, DOI 10.1016/j.bios.2007.03.018
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Lu H, 2004, ANAL CHEM, V76, P5257, DOI 10.1021/ac049837t
   Lynch L, 2005, MOL BIOL CELL, V16, P51, DOI 10.1091/mbc.E04-05-0399
   Mandal K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037548
   Marx KA, 2005, ANAL BIOCHEM, V343, P23, DOI 10.1016/j.ab.2005.05.013
   Marx KA, 2001, BIOSENS BIOELECTRON, V16, P773, DOI 10.1016/S0956-5663(01)00219-6
   Marx KA, 2007, ANAL BIOCHEM, V361, P77, DOI 10.1016/j.ab.2006.09.023
   McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Meseke M, 2013, J BIOMED MATER RES A, V101, P1726, DOI 10.1002/jbm.a.34477
   Mianabadi M, 2004, AM J CHINESE MED, V32, P369, DOI 10.1142/S0192415X04002028
   Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076
   Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172
   Miller T, 2003, LANGMUIR, V19, P1723, DOI 10.1021/la0261500
   Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022
   Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166
   Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x
   Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0
   Nalayanda DD, 2010, J PEDIATR SURG, V45, P45, DOI 10.1016/j.jpedsurg.2009.10.008
   Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148
   Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399
   Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445
   Palange AL, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00161
   Palmer CP, 2008, EUR BIOPHYS J BIOPHY, V37, P359, DOI 10.1007/s00249-007-0219-2
   Park JY, 2007, J BIOMOL SCREEN, V12, P406, DOI 10.1177/1087057106299162
   Perinpanayagam H, 2001, J ORTHOPAED RES, V19, P993, DOI 10.1016/S0736-0266(01)00045-6
   Pesen D, 2005, BIOPHYS J, V88, P670, DOI 10.1529/biophysj.104.049965
   Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439
   Polio SR, 2012, ACTA BIOMATER, V8, P82, DOI 10.1016/j.actbio.2011.08.013
   Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Renshaw KM, 2005, BIOTECHNOL PROGR, V21, P538, DOI 10.1021/bp049664t
   REUTELINGSPERGER CPM, 1994, J MATER SCI-MATER M, V5, P361, DOI 10.1007/BF00058964
   Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 1997, ANN BIOMED ENG, V25, P190, DOI 10.1007/BF02738550
   Riahi R, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4868301
   Ronan W, 2012, J MECH BEHAV BIOMED, V14, P143, DOI 10.1016/j.jmbbm.2012.05.016
   Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213
   Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921
   Rupprecht P, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3673802
   Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Saif MTA, 2003, ANN BIOMED ENG, V31, P950, DOI 10.1114/1.1591189
   Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005
   Schluter DK, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1080
   Schwingel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054850
   Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276
   Shen YJ, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/11/115802
   Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046
   Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.biomed.7.060804.100423
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756
   Sordel T, 2007, BIOMATERIALS, V28, P1572, DOI 10.1016/j.biomaterials.2006.10.032
   Spangenberg C, 2006, CANCER RES, V66, P3715, DOI 10.1158/0008-5472.CAN-05-2823
   Szekanecz Z, 2000, ARTHRITIS RES, V2, P368, DOI 10.1186/ar114
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tang ZL, 2012, BIOMATERIALS, V33, P7405, DOI 10.1016/j.biomaterials.2012.06.077
   Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Ting LH, 2012, AM J PHYSIOL-HEART C, V302, pH2220, DOI 10.1152/ajpheart.00975.2011
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   Tsai JW, 2000, P SOC PHOTO-OPT INS, V4082, P213, DOI 10.1117/12.390549
   USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Vogel J, 1998, BBA-BIOMEMBRANES, V1372, P205, DOI 10.1016/S0005-2736(98)00058-3
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wang CC, 2009, J BIOMED MATER RES A, V88A, P370, DOI 10.1002/jbm.a.31604
   Warrick JW, 2013, INTEGR BIOL-UK, V5, P720, DOI 10.1039/c3ib20224k
   Weder G, 2009, BIOINTERPHASES, V4, P27, DOI 10.1116/1.3139962
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wu CC, 2005, BIOCHEM BIOPH RES CO, V329, P256, DOI 10.1016/j.bbrc.2005.01.126
   Xi J., 2013, J BIOCHIPS TISSUE CH, VS5, P001, DOI 10.4172/2153-0777.S5-001
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   Yang J, 2003, J BIOMED MATER RES A, V67A, P1139, DOI 10.1002/jbm.a.10034
   Yang SP, 2012, MAT SCI ENG C-MATER, V32, P254, DOI 10.1016/j.msec.2011.10.026
   Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052
   Zhang X, 2008, CHEM ENG J, V135, pS82, DOI 10.1016/j.cej.2007.07.054
   Zhong Y, 2012, INT J COMPUT MAT SCI, V1, DOI 10.1142/S2047684112500327
   Zhou DW, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029210
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
   Zhu Y, 2012, AGING CELL, V11, P741, DOI 10.1111/j.1474-9726.2012.00840.x
   Zou JX, 2002, J BIOL CHEM, V277, P1824, DOI 10.1074/jbc.M103133200
NR 217
TC 96
Z9 96
U1 13
U2 86
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2015
VL 16
IS 8
BP 18149
EP 18184
DI 10.3390/ijms160818149
PG 36
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CZ0WE
UT WOS:000366826100078
PM 26251901
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Khorasani, AM
   Goldberg, M
   Doeven, EH
   Littlefair, G
AF Khorasani, Amir Mahyar
   Goldberg, Moshe
   Doeven, Egan H.
   Littlefair, Guy
TI Titanium in Biomedical Applications-Properties and Fabrication: A Review
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Biocompatibility; Bioimplants Fabrication; Mechanical Properties;
   Osseointegration; Ti-Based Biomaterial
ID COMMERCIALLY PURE TITANIUM; POROUS HYDROXYAPATITE SCAFFOLDS;
   SHAPE-MEMORY ALLOYS; DIAMOND-LIKE CARBON; CELLS IN-VITRO; SOL-GEL
   METHOD; TI-TA ALLOYS; MECHANICAL-PROPERTIES; CORROSION-RESISTANCE;
   IMPLANT MATERIALS
AB Ti and Ti-based alloys have unique properties such as high strength, low density and excellent corrosion resistance. These properties are essential for the manufacture of lightweight and high strength components for biomedical applications. In this paper, Ti properties such as metallurgy, mechanical properties, surface modification, corrosion resistance, biocompatibility and osseointegration in biomedical applications have been discussed. This paper also analyses the advantages and disadvantages of various Ti manufacturing processes for biomedical applications such as casting, powder metallurgy, cold and hot working, machining, laser engineering net shaping (LEN), superplastic forming, forging and ring rolling. The contributions of this research are twofold, firstly scrutinizing the behaviour of Ti and Ti-based alloys in-vivo and in-vitro experiments in biomedical applications to determine the factors leading to failure, and secondly strategies to achieve desired properties essential to improving the quality of patient outcomes after receiving surgical implants. Future research will be directed toward manufacturing of Ti for medical applications by improving the production process, for example using optimal design approaches in additive manufacturing and investigating alloys containing other materials in order to obtain better medical and mechanical characteristics.
C1 [Khorasani, Amir Mahyar; Goldberg, Moshe; Doeven, Egan H.; Littlefair, Guy] Deakin Univ, Sch Engn, Fac Sci Engn & Built Environm, Waurn Ponds, Vic 3216, Australia.
RP Khorasani, AM (reprint author), Deakin Univ, Sch Engn, Fac Sci Engn & Built Environm, Waurn Ponds, Vic 3216, Australia.
RI Littlefair, Guy/N-1614-2017
CR Akahori T, 1998, MAT SCI ENG A-STRUCT, V243, P237, DOI 10.1016/S0921-5093(97)00807-1
   Akahori T, 2000, METALL MATER TRANS A, V31, P1937, DOI 10.1007/s11661-000-0221-0
   Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   Anawati, 2013, CORROS SCI, V70, P212, DOI 10.1016/j.corsci.2013.01.032
   Andresen P., 2000, STRESS CORROSION CRA
   Antunes RA, 2012, ACTA BIOMATER, V8, P937, DOI 10.1016/j.actbio.2011.09.012
   Appel F, 2004, INTERMETALLICS, V12, P791, DOI 10.1016/j.intermet.2004.02.042
   Arifin A, 2014, MATER DESIGN, V55, P165, DOI 10.1016/j.matdes.2013.09.045
   Asadnia M., 2010, INT J APPL ENG RES, P5
   Au AR, 2000, J ORAL REHABIL, V27, P978, DOI 10.1046/j.1365-2842.2000.00576.x
   Bacakova L, 2001, J BIOMED MATER RES, V54, P567
   Bajpai I, 2015, J BIOMATER TISS ENG, V5, P403, DOI 10.1166/jbt.2015.1322
   Balakrishnan A., 2008, TRENDS BIOMATER ARTI, V22, P54
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Benea L, 2014, CORROS SCI, V80, P331, DOI 10.1016/j.corsci.2013.11.059
   Black G H. J., 1998, HDB BIOMATERIAL PROP
   Borgioli F, 2001, SURF COAT TECH, V141, P103, DOI 10.1016/S0257-8972(01)01164-1
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chang C. J., 2003, FUEL, V2014, P10
   Chang C. J., 2003, TECHNOL, V2005, P08
   Cheah CM, 2005, INT J ADV MANUF TECH, V25, P308, DOI 10.1007/s00170-003-1840-6
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Chien CY, 2013, J BIOMED MATER RES A, V101, P740, DOI 10.1002/jbm.a.34376
   Choi M, 2014, J MECH BEHAV BIOMED, V30, P214, DOI 10.1016/j.jmbbm.2013.11.014
   Choudhury P, 2012, WOODH PUBL SER BIOM, V49, P84
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chua CK, 2010, RAPID PROTOTYPING: PRINCIPLES AND APPLICATIONS, 3RD EDITION, P1
   Chudhuri B, 2013, J BIOMATER TISS ENG, V3, P653, DOI 10.1166/jbt.2013.1126
   Chun YB, 2005, MAT SCI ENG A-STRUCT, V398, P209, DOI 10.1016/j.msea.2005.03.019
   Cooper K.G., 2001, RAPID PROTOTYPING TE
   Santos EC, 2006, INT J MACH TOOL MANU, V46, P1459, DOI 10.1016/j.ijmachtools.2005.09.005
   Courant B, 2005, J MATER PROCESS TECH, V160, P374, DOI 10.1016/j.jmatprotec.2004.06.025
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Da Silva L, 2000, J ORAL REHABIL, V27, P131, DOI 10.1046/j.1365-2842.2000.00506.x
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Fleck C, 2010, INT J FATIGUE, V32, P929, DOI 10.1016/j.ijfatigue.2009.09.009
   Froes F., 2005, DEV TITANIUM P M
   Froes FH, 2010, KEY ENG MATER, V436, P1, DOI 10.4028/www.scientific.net/KEM.436.1
   Furuta T, 2005, MATER TRANS, V46, P3001, DOI 10.2320/matertrans.46.3001
   Gale W. F., 2003, MACHINING PROSTHETIC
   Gaspar M, 2013, COMPUT AIDED DESIGN, V45, P1170, DOI 10.1016/j.cad.2013.04.007
   Geetha M, 2004, SURF ENG, V20, P68, DOI 10.1179/026708404225010595
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gibson I, 2006, VIRTUAL PHYS PROTOTY, V1, P31, DOI 10.1080/17452750500271298
   Glavicic MG, 2008, METALL MATER TRANS A, V39A, P887, DOI 10.1007/s11661-007-9376-2
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Guleryuz H, 2005, SURF COAT TECH, V192, P164, DOI 10.1016/j.surfcoat.2004.05.018
   Guttal Satyabodh, 2005, Gerodontology, V22, P242
   Hall P. C., 2005, GOOGLE PATENTS
   Hannula S.-P, 2006, Advances in Science and Technology, V49, P109, DOI 10.4028/www.scientific.net/AST.49.109
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Haslauer CM, 2010, MED ENG PHYS, V32, P645, DOI 10.1016/j.medengphy.2010.04.003
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   Heidloff AJ, 2010, JOM-US, V62, P35, DOI 10.1007/s11837-010-0075-x
   Heimann R. B., 2008, PRINCIPLES APPL
   Hertl C, 2014, MAT SCI ENG C-MATER, V41, P28, DOI 10.1016/j.msec.2014.03.018
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041
   Hoseini J, 2014, J BIOMATER TISS ENG, V4, P138, DOI 10.1166/jbt.2014.1150
   House K, 2008, AM J ORTHOD DENTOFAC, V133, P584, DOI 10.1016/j.ajodo.2007.03.021
   Hsu HC, 2005, J MATER SCI-MATER M, V16, P821, DOI 10.1007/s10856-005-3585-2
   Hsu HC, 2013, MAT SCI ENG A-STRUCT, V568, P1, DOI 10.1016/j.msea.2013.01.002
   Hsu HC, 2010, MATER CHARACT, V61, P851, DOI 10.1016/j.matchar.2010.05.003
   Huang HH, 2002, BIOMATERIALS, V23, P59, DOI 10.1016/S0142-9612(01)00079-5
   Huang Y, 2013, APPL SURF SCI, V271, P299, DOI 10.1016/j.apsusc.2013.01.187
   Huasheng X., 2008, SPECIAL CASTING NO S, VS1, P462
   Iijima D, 2003, BIOMATERIALS, V24, P1519, DOI 10.1016/S0142-9612(02)00533-1
   Iijima M, 2002, BIOMATERIALS, V23, P1769, DOI 10.1016/S0142-9612(01)00303-9
   Ikeda M, 2003, J JPN I MET, V67, P420, DOI 10.2320/jinstmet1952.67.9_420
   Imam MA, 2010, JOM-US, V62, P17, DOI 10.1007/s11837-010-0069-8
   Inci I, 2014, J BIOMATER TISS ENG, V4, P624, DOI 10.1166/jbt.2014.1210
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Jackson M, 2006, MATER SCI TECH-LOND, V22, P881, DOI 10.1179/174328406x111147
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Jebali A, 2014, J BIOMATER TISS ENG, V4, P638, DOI 10.1166/jbt.2014.1209
   Jeffrey G. A., 1997, INTRO HYDROGEN BONDI
   Jiang XP, 2006, MAT SCI ENG A-STRUCT, V429, P30, DOI 10.1016/j.msea.2006.04.024
   KAHVECI AI, 1986, SCRIPTA METALL MATER, V20, P1287, DOI 10.1016/0036-9748(86)90050-5
   Kalpakjian S. R. S., 2003, MANUFACTURING PROCES
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Kazakeviciute-Makovska R, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.432
   Kazemi RB, 1996, ORAL SURG ORAL MED O, V81, P596, DOI 10.1016/S1079-2104(96)80055-2
   Khorasani A. Mahyar, 2012, International Journal of Computational Materials Science and Surface Engineering, V5, P68, DOI 10.1504/IJCMSSE.2012.049055
   Khorasani Amir Mahyar, 2012, International Journal of Machining and Machinability of Materials, V12, P142, DOI 10.1504/IJMMM.2012.048553
   Khorasani A. M., 2012, ARTIF INTELL, P1
   Khorasani A. M., 2014, MACHINABILITY BIOMAT
   Khorasani A. M., 2014, J MACH FORM TECHNOL, V6, P45
   Khorasani AM, 2013, ARAB J SCI ENG, V38, P1565, DOI 10.1007/s13369-013-0600-7
   Khorasani AM, 2011, INT J ADV MANUF TECH, V55, P457, DOI 10.1007/s00170-010-3060-1
   Khorasani E. G. S. A. M., 2010, J MANUFACTURING TECH, V1, P41
   Kim HS, 2007, MAT SCI ENG A-STRUCT, V449, P322, DOI 10.1016/j.msea.2006.02.329
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Kim KM, 2006, ELECTROCHIM ACTA, V51, P5636, DOI 10.1016/j.electacta.2006.02.038
   Kim SK, 2005, J ORAL REHABIL, V32, P346, DOI 10.1111/j.1365-2842.2004.01475.x
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kom M, 2015, J BIOMATER TISS ENG, V5, P396, DOI 10.1166/jbt.2015.1327
   Komotori J, 2001, WEAR, V251, P1239, DOI 10.1016/S0043-1648(01)00753-0
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kurtz S.M, 2004, CROSSLINKED THERMALL
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Faria ACL, 2011, J MECH BEHAV BIOMED, V4, P1873, DOI 10.1016/j.jmbbm.2011.06.004
   Lausmaa J., 2001, TITANIUM MED, P267
   Lee K, 2013, THIN SOLID FILMS, V549, P154, DOI 10.1016/j.tsf.2013.09.002
   Lei MK, 2011, SURF COAT TECH, V205, P4602, DOI 10.1016/j.surfcoat.2011.03.141
   Leinenbach C, 2006, BIOMATERIALS, V27, P1200, DOI 10.1016/j.biomaterials.2005.08.012
   Li SJ, 2008, ACTA BIOMATER, V4, P305, DOI 10.1016/j.actbio.2007.09.009
   Li SJ, 2004, BIOMATERIALS, V25, P2525, DOI 10.1016/j.biomaterials.2003.09.039
   Liu F, 2015, J BIOMATER TISS ENG, V5, P164, DOI 10.1166/jbt.2015.1297
   Lutjering G., 2003, TITANIUM
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Machado A.R., 1990, ARCH P I MECH ENG B, V204, P53
   Maeshima T, 2006, MAT SCI ENG A-STRUCT, V438, P844, DOI 10.1016/j.msea.2006.05.092
   Mareci D, 2013, T NONFERR METAL SOC, V23, P3829, DOI 10.1016/S1003-6326(13)62936-2
   Marin C, 2008, J PERIODONTOL, V79, P1942, DOI [10.1902/jop.2008.080106, 10.1902/jop.2008.080106 ]
   McCracken CG, 2010, INT J POWDER METALL, V46, P19
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Mohan L, 2012, APPL SURF SCI, V258, P6331, DOI 10.1016/j.apsusc.2012.03.032
   Mori M, 2012, PROC CIRP, V1, P22, DOI 10.1016/j.procir.2012.04.004
   Mtao Australia, 2013, KEY FACTS FIGURES 20, P8
   Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004
   Nag S, 2007, ACTA BIOMATER, V3, P369, DOI 10.1016/j.actbio.2006.08.005
   Nagiah N, 2013, J BIOMATER TISS ENG, V3, P624, DOI 10.1166/jbt.2013.1130
   Nan H., 2005, CHINA FOUNDRY, V2, P239
   Nandy AK, 2009, INT J MACH TOOL MANU, V49, P182, DOI 10.1016/j.ijmachtools.2008.08.008
   Nezafati N, 2015, J BIOMATER TISS ENG, V5, P78, DOI 10.1166/jbt.2015.1240
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M., 2005, TITANIUM ITS ALLOYS
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Nolan D, 2006, SURF COAT TECH, V200, P5698, DOI 10.1016/j.surfcoat.2005.08.110
   Nomani J, 2013, WEAR, V304, P20, DOI 10.1016/j.wear.2013.04.008
   Oak JJ, 2008, J NON-CRYST SOLIDS, V354, P1828, DOI 10.1016/j.jnoncrysol.2007.10.025
   Oberg E., 2008, MACHINERYS HDB
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Ozel T, 2010, CIRP ANN-MANUF TECHN, V59, P77, DOI 10.1016/j.cirp.2010.03.055
   Park J. B., 2002, BIOMATERIALS PRINCIP
   Park JW, 2009, ACTA BIOMATER, V5, P3272, DOI 10.1016/j.actbio.2009.04.038
   Park YJ, 2013, J DENT, V41, P1251, DOI 10.1016/j.jdent.2013.09.003
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Polishetty A., 2010, INT J MECH MECHATRON, V10, P1
   Polmear I., 2005, LIGHT ALLOYS TRADITI
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Poon RWY, 2005, BIOMATERIALS, V26, P2265, DOI 10.1016/j.biomaterials.2004.07.056
   Pramanik Alokesh, 2013, Advanced Materials Research, V651, P338, DOI 10.4028/www.scientific.net/AMR.651.338
   Prevey P. S., 2001, EFFECT LOW PLASTICIT, P1
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Qun Z., 2008, TITANIUM IND PROGR, V2, P7
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Raja KS, 2005, ELECTROCHIM ACTA, V51, P154, DOI 10.1016/j.electacta.2005.04.011
   Rajasekaran B, 2008, MATER LETT, V62, P2473, DOI 10.1016/j.matlet.2007.12.025
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Randeniya LK, 2010, DIAM RELAT MATER, V19, P329, DOI 10.1016/j.diamond.2010.01.003
   Rao TS, 2005, CORROS SCI, V47, P1071, DOI 10.1016/j.corsci.2004.07.025
   Rath PC, 2012, CERAM INT, V38, P3209, DOI 10.1016/j.ceramint.2011.12.026
   Ratner B. D., 2013, SURFACE PROPERTIES S, P34
   Ren L., 2014, J MAT SCI TECHNOL
   Rilo B, 2002, J PROSTHET DENT, V87, P407, DOI 10.1067/mpr.2002.123232
   Robin A, 2008, MATER CORROS, V59, P929, DOI 10.1002/maco.200805014
   Rodrigues DC, 2009, J BIOMED MATER RES B, V88B, P206, DOI 10.1002/jbm.b.31171
   Ribeiro ALR, 2009, J MATER SCI-MATER M, V20, P1629, DOI 10.1007/s10856-009-3737-x
   Roshanbinfar K, 2013, J BIOMATER TISS ENG, V3, P284, DOI 10.1166/jbt.2013.1093
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Saari H, 2005, INTERMETALLICS, V13, P937, DOI 10.1016/j.intermet.2004.12.006
   Sadraie SH, 2014, J BIOMATER TISS ENG, V4, P562, DOI 10.1166/jbt.2014.1203
   Saha R., 2014, DEFENCE SCI J, V36, P121
   Sanders DG, 2008, MATERIALWISS WERKST, V39, P353, DOI 10.1002/mawe.200800305
   Sanders DG, 2008, J MATER ENG PERFORM, V17, P187, DOI 10.1007/s11665-007-9186-0
   Saresh N, 2007, J MATER PROCESS TECH, V192, P83, DOI 10.1016/j.jmatprotec.2007.04.048
   Sargent GA, 2008, METALL MATER TRANS A, V39A, P2949, DOI 10.1007/s11661-008-9650-y
   Schey J. A., 2000, INTRO MANUFACTURING
   Semiatin SL, 2002, METALL MATER TRANS A, V33, P2719, DOI 10.1007/s11661-002-0394-9
   Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745
   Shi W, 2002, MAT SCI ENG A-STRUCT, V337, P104, DOI 10.1016/S0921-5093(02)00003-5
   Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Silva Maria Margareth da, 2006, Mat. Res., V9, P97, DOI 10.1590/S1516-14392006000100018
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Stack MM, 2011, TRIBOL INT, V44, P1827, DOI 10.1016/j.triboint.2011.07.009
   Stolyarov VV, 2005, PHYS MET METALLOGR+, V99, P204
   Su B, 2006, J UNIV SCI TECHNOL B, V13, P469, DOI 10.1016/S1005-8850(06)60095-9
   Sung S. Y., 2007, MELTING CASTING TITA
   Swaminathan V, 2012, BIOMATERIALS, V33, P5487, DOI 10.1016/j.biomaterials.2012.04.015
   Tan Philip L, 2008, J Prosthodont, V17, P378, DOI 10.1111/j.1532-849X.2008.00302.x
   Tay CY, 2014, ACS APPL MATER INTER, V6, P6248, DOI 10.1021/am501266a
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thair L, 2003, CORROS SCI, V45, P1951, DOI 10.1016/S0010-938X(03)00027-1
   Tian Q. M., 2014, ELECTROPHORETIC DEPO
   Tian XJ, 2010, MAT SCI ENG A-STRUCT, V527, P1821, DOI 10.1016/j.msea.2009.11.014
   Tredwin CJ, 2013, DENT MATER, V29, P521, DOI 10.1016/j.dental.2013.02.002
   Uchida M, 2005, BIOMATERIALS, V26, P6924, DOI 10.1016/j.biomaterials.2005.04.066
   Uezono M, 2013, J BIOMED MATER RES B, V101B, P1031, DOI 10.1002/jbm.b.32913
   Uta E, 2009, J MICROSC-OXFORD, V233, P451, DOI 10.1111/j.1365-2818.2009.03141.x
   Varadarajan N, 2014, J BIOMATER TISS ENG, V4, P295, DOI 10.1166/jbt.2014.1173
   Venugopal S, 2008, J MATER PROCESS TECH, V202, P201, DOI 10.1016/j.jmatprotec.2007.09.038
   Wang G, 2007, J MATER PROCESS TECH, V192, P555, DOI 10.1016/j.jmatprotec.2007.04.059
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Wang HY, 2013, CHARACTERIZATION OF BIOMATERIALS, P105, DOI 10.1016/B978-0-12-415800-9.00004-8
   Wang JW, 2007, DENT MATER, V23, P133, DOI 10.1016/j.denta1.2006.01.001
   Wang XY, 2014, IEEE T COMP PACK MAN, V4, P4, DOI 10.1109/TCPMT.2013.2280922
   Wang YB, 2009, MATER LETT, V63, P1293, DOI 10.1016/j.matlet.2009.02.062
   Wangfeng Z., 2010, CHINESE J RARE METAL, V1, P001
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wen CE, 2007, ACTA BIOMATER, V3, P403, DOI 10.1016/j.actbio.2006.10.004
   Wise D. L., 2000, HUMAN APPL
   Wu D., 2008, INVESTIGATION COLD R, V10, P016
   Wu G, 2014, J BIOMATER TISS ENG, V4, P1047, DOI 10.1166/jbt.2014.1260
   Xu LJ, 2008, J ALLOY COMPD, V453, P320, DOI 10.1016/j.jallcom.2006.11.144
   Yamazaki K, 1998, ARTIF ORGANS, V22, P466, DOI 10.1046/j.1525-1594.1998.06156.x
   Yan David Ping, 2011, International Journal of Machining and Machinability of Materials, V10, P264, DOI 10.1504/IJMMM.2011.043089
   Yan DP, 2011, TMS2011 SUPPLEMENTAL PROCEEDINGS, VOL 2: MATERIALS FABRICATION, PROPERTIES, CHARACTERIZATION, AND MODELING, P633
   Yazdi MRS, 2011, EXPERT SYST APPL, V38, P12116, DOI 10.1016/j.eswa.2011.03.002
   Yoneyama T, 2008, WOODHEAD PUBL MATER, P1
   Yu GL, 2007, J PROSTHET DENT, V97, P157, DOI 10.1016/j.prosdent.2007.01.005
   Zavanelli RA, 2004, J ORAL REHABIL, V31, P1029, DOI 10.1111/j.1365-2842.2004.01336.x
   Zhang BB, 2011, DENT MATER, V27, P214, DOI 10.1016/j.dental.2010.10.005
   Zhang T, 2014, J BIOMATER TISS ENG, V4, P1030, DOI 10.1166/jbt.2014.1255
   Zhang XP, 2008, MAT SCI ENG A-STRUCT, V481, P170, DOI 10.1016/j.msea.2007.02.147
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   Zhu XJ, 2005, SCRIPTA MATER, V52, P651, DOI 10.1016/j.scriptamat.2004.11.017
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zielinski A, 2008, CORROS REV, V26, P1, DOI 10.1515/corrrev.2008.1
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 235
TC 23
Z9 23
U1 12
U2 122
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD AUG
PY 2015
VL 5
IS 8
BP 593
EP 619
DI 10.1166/JBT.2015.1361
PG 27
WC Cell & Tissue Engineering
SC Cell Biology
GA CX2VL
UT WOS:000365554800001
DA 2018-10-19
ER

PT J
AU Shikha, D
   Shahid, M
   Jha, U
   Sinha, SK
   Reddy, VR
   Ojha, S
   Kumar, P
   Kanjilal, D
AF Shikha, Deep
   Shahid, Md.
   Jha, Ush
   Sinha, Sanjay Kumar
   Reddy, V. Raghavendra
   Ojha, Sunil
   Kumar, P.
   Kanjilal, Dinakar
TI Corrosion, wettability and thrombogenicity investigation of ion beam
   modified HAP/Al2O3
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Coatings; Surface properties; Corrosion
ID GEL-DERIVED HYDROXYAPATITE; BIOMATERIAL ALUMINA; THIN-FILMS;
   IMPLANTATION; COATINGS; SPECTROSCOPY; GENERATION; LAYERS; TESTS; BLOOD
AB Hydroxyapatite Ca-10(PO4)(6)(OH)(2), is a biosensitive ceramic which promotes bone growth in human fluid. However due to its weak mechanical strength it is often coated on chemically inert material such as alumina. In the present work hydroxyapatite (HAP) of thickness 1 mu m is deposited on alumina using sol gel process and the stoichiometric ratio of Ca:P = 1.67 is maintained. Surface property of HAP is further improved by Ar+ ion implantation. The samples were irradiated with 1.4 MeV Ar+ ions with fluence ranging from 5 x 10(14) to 1 x 10(16) ions/cm(2). After irradiation, the surface is characterized using Atomic Force Microscope (AFM), Scanning Electron Microscope (SEM), electron dispersive X-ray spectroscopy (EDX), Glancing incidence X-ray diffraction (GXRD) and Rutherford backscattering Spectroscopy (RBS) techniques. Corrosion resistances and impedance analysis were carried out in Ringer solution. RBS and EDX were used to confirm the stoichiometric ratio of the film. Compound formation before and after ion implantation was studied using GXRD. Nanohardness, wettability and thrombogenicity of all the samples were studied. Correlation among surface morphology, improvement in corrosion resistance, hardness, wetability and thrombogenicity before and after ion implantation are discussed in this paper. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Shikha, Deep; Shahid, Md.; Jha, Ush] BIT Mesra, Dept Chem, Ranchi 835215, Bihar, India.
   [Sinha, Sanjay Kumar] BIT Mesra, Dept Phys, Ranchi 835215, Bihar, India.
   [Reddy, V. Raghavendra] UGC DAE Consortium Sci Res Indore, Indore, India.
   [Ojha, Sunil; Kumar, P.; Kanjilal, Dinakar] IUAC, New Delhi, India.
RP Sinha, SK (reprint author), BIT Mesra, Dept Phys, Ranchi 835215, Bihar, India.
EM sksinha@bitmesra.ac.in
RI Jha, Usha/L-9583-2017
OI Jha, Usha/0000-0001-9033-6517; Kanjilal, Dinakar/0000-0001-9728-3147
FU Department of Science and Technology (DST), New Delhi; DST
FX The authors are grateful for the financial support from the Department
   of Science and Technology (DST), New Delhi. They also acknowledge the
   help rendered by Central Instrumentation Facility (CIF) of the
   Institute, IUAC New Delhi for ion implantation, UGC-DAE Consortium for
   Scientific Research, Indore Centre for characterization. One of the
   authors (M. Shahid) is thankful to DST for his fellowship.
CR Aksakal B, 2010, J MATER ENG PERFORM, V19, P894, DOI 10.1007/s11665-009-9559-7
   Azevedo AF, 2005, SURF COAT TECH, V194, P271, DOI 10.1016/j.surfcoat.2004.10.007
   Baumann H, 2002, NUCL INSTRUM METH B, V196, P286, DOI 10.1016/S0168-583X(02)01298-3
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   Borruto A, 1998, WEAR, V222, P57, DOI 10.1016/S0043-1648(98)00256-7
   Brinker C. J., 1990, SOL GEL SCI
   Delgado-Alvarado C, 2006, ACTA BIOMATER, V2, P701, DOI 10.1016/j.actbio.2006.05.012
   Dou Y, 2012, J SOL-GEL SCI TECHN, V61, P126, DOI 10.1007/s10971-011-2601-x
   Feng W, 2005, MATER LETT, V59, P916, DOI DOI 10.1016/J.MATLET.2004.08.041
   Heimke G., 1986, HDB BIOMATERIALS EVO
   Hsieh MF, 2001, BIOMATERIALS, V22, P2601, DOI 10.1016/S0142-9612(00)00448-8
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hulbert S. F., 1993, INTRO BIOCERAMIOCS
   Hwang K, 2000, SURF COAT TECH, V123, P252, DOI 10.1016/S0257-8972(99)00512-5
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   KANJILAL D, 1993, NUCL INSTRUM METH A, V328, P97, DOI 10.1016/0168-9002(93)90610-T
   Kim W, 2000, J MATER SCI, V35, P5401, DOI 10.1023/A:1004859231795
   Lapatin C.M., 1998, NUCL INSTRUM METH B, V145, P522
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Lo WJ, 1999, J BIOMED MATER RES, V46, P408, DOI 10.1002/(SICI)1097-4636(19990905)46:3<408::AID-JBM14>3.0.CO;2-Z
   Lopatin CM, 1998, NUCL INSTRUM METH B, V145, P522, DOI 10.1016/S0168-583X(98)80557-0
   Man HH, 1996, J MAGN MAGN MATER, V152, P47, DOI 10.1016/0304-8853(95)00454-8
   Mateo MP, 2009, APPL SURF SCI, V255, P5172, DOI 10.1016/j.apsusc.2008.08.040
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nayak K., 2010, INT J CHEM TECH RES, V2, P903
   Park JB, 1992, BIOMATERIALS INTRO
   Rautray TR, 2010, THIN SOLID FILMS, V518, P3160, DOI 10.1016/j.tsf.2009.08.044
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Rompen EH, 1999, CLIN ORAL IMPLAN RES, V10, P85, DOI 10.1034/j.1600-0501.1999.100202.x
   Shikha D, 2008, INT J APPL CERAM TEC, V5, P44, DOI 10.1111/j.1744-7402.2008.02184.x
   Shikha D, 2007, NUCL INSTRUM METH B, V264, P254, DOI 10.1016/j.nimb.2007.08.093
   Shikha D, 2009, SURF COAT TECH, V203, P2541, DOI 10.1016/j.surfcoat.2009.02.071
   Sinha SK, 2000, NUCL INSTRUM METH B, V170, P120, DOI 10.1016/S0168-583X(00)00068-9
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   Vigen K.M., 2002, SURF COAT TECH, V158-159, P609
   Wang MC, 2001, J MATER SCI, V36, P3283, DOI 10.1023/A:1017907024197
   Weng WJ, 1998, J MATER SCI-MATER M, V9, P159, DOI 10.1023/A:1008819703551
NR 40
TC 1
Z9 1
U1 1
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD AUG 1
PY 2015
VL 163
BP 272
EP 278
DI 10.1016/j.matchemphys.2015.07.040
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CX0BI
UT WOS:000365361500030
DA 2018-10-19
ER

PT J
AU Zhang, Q
   Cao, P
AF Zhang, Qian
   Cao, Peng
TI Degradable porous Fe-35wt.%Mn produced via powder sintering from NH4HCO3
   porogen
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Sintering; Corrosion test; Microstructure
ID FE-MN ALLOYS; SPACE-HOLDER; PURE IRON; IN-VITRO; MAGNESIUM ALLOYS; CELL
   VIABILITY; STENTS; BIOMATERIAL; BIOCOMPATIBILITY; METALLURGY
AB In this study, a Fe-35Mn (wt.%) alloy was produced by a simple press-and-sinter process from blended elemental powders with ammonium bicarbonate as porogen (space holding). The addition of NH4HCO3 leads to an open-cell porosity of 25-31% in the sintered compacts. The predominant phases in the sintered porous samples are austenitic y and martensitic e phases. The presence of these two antiferromagnetic phases assures magnetic resonance imaging (MRI) compatibility. The degradation performance was evaluated by static immersion and electrochemical test. The degradation rate determined by potentiodynamic analysis ranges from ca. 2 to 8 mmpy in both 5% NaCl and simulated body fluid (SBF) solutions, depending on porosity in the samples. Static immersion test performed under conditions close to in vivo degradation confirms the findings from potentiodynamic test. The degradation rate decreases over time and gradually levels off after 7 days of immersion. The observed degradation rate meets the requirements for a biodegradable material. However, the mechanical properties have to be improved in order to maintain mechanical integrity for biomedical applications if the porous Fe-35Mn is used. Nevertheless, the promising degradation properties would provoke further development of biodegradable Fe-Mn alloys in the future. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhang, Qian; Cao, Peng] Univ Auckland, Dept Chem & Mat Engn, Auckland 1142, New Zealand.
RP Cao, P (reprint author), Univ Auckland, Dept Chem & Mat Engn, Private Bag 92019, Auckland 1142, New Zealand.
EM p.cao@auckland.ac.nz
OI Cao, Peng/0000-0001-6390-6852
CR Bafti H, 2010, MATER DESIGN, V31, P4122, DOI 10.1016/j.matdes.2010.04.038
   Cu X. N., 2010, FRONT MAT SCI CHINA, V4, P111
   Fontana M.G., 2005, CORROSION ENG, P53
   FONTECAVE M, 1993, BIOCHIMIE, V75, P767, DOI 10.1016/0300-9084(93)90126-D
   Goldhaber SB, 2003, REGUL TOXICOL PHARM, V38, P232, DOI 10.1016/S0273-2300(02)00020-X
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Jha N, 2013, MATER DESIGN, V47, P810, DOI 10.1016/j.matdes.2013.01.005
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li DS, 2009, J ALLOY COMPD, V474, pL1, DOI 10.1016/j.jallcom.2008.06.043
   Manonukul A, 2010, J MATER PROCESS TECH, V210, P529, DOI 10.1016/j.jmatprotec.2009.10.016
   Marinelli P, 2002, MAT SCI ENG A-STRUCT, V335, P137, DOI 10.1016/S0921-5093(01)01908-6
   Martinez J, 2005, MAT SCI ENG A-STRUCT, V408, P26, DOI 10.1016/j.msea.2005.06.019
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Nag S., 2012, ASM HDB MAT MED DEVI, V23, P1
   Nakai M, 2011, J MECH BEHAV BIOMED, V4, P1206, DOI 10.1016/j.jmbbm.2011.04.003
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   RABINKIN A, 1979, CALPHAD, V3, P77, DOI 10.1016/0364-5916(79)90008-7
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Schumann H., 1967, ARCH EISENHUTTENWES, V38, P647
   Sherif EM, 2010, ELECTROCHIM ACTA, V55, P3657, DOI 10.1016/j.electacta.2010.01.117
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witusiewicz VT, 2004, J PHASE EQUILIB DIFF, V25, P346, DOI 10.1361/15477030420115
   Xiang CS, 2012, PROCEDIA ENGINEER, V27, P768, DOI 10.1016/j.proeng.2011.12.518
   Xiong JY, 2008, J MECH BEHAV BIOMED, V1, P269, DOI 10.1016/j.jmbbm.2007.09.003
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 38
TC 6
Z9 7
U1 2
U2 27
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD AUG 1
PY 2015
VL 163
BP 394
EP 401
DI 10.1016/j.matchemphys.2015.07.056
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA CX0BI
UT WOS:000365361500045
DA 2018-10-19
ER

PT J
AU Sharma, A
   McQuillan, AJ
   Sharma, LA
   Waddell, JN
   Shibata, Y
   Duncan, WJ
AF Sharma, Ajay
   McQuillan, A. James
   Sharma, Lavanya A.
   Waddell, John Neil
   Shibata, Yo
   Duncan, Warwick John
TI Spark anodization of titanium-zirconium alloy: surface characterization
   and bioactivity assessment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMPROVED BIOLOGICAL PERFORMANCE; ANODIC OXIDE-FILMS; DENTAL IMPLANTS;
   PURE TITANIUM; OXIDATION; BONE; PROLIFERATION; CA; TI; OSSEOINTEGRATION
AB Titanium (Ti) and its alloys have been popularly used as implant biomaterial for decades. Recently, titanium-zirconium (TiZr) alloy has been developed as an alternative implant material with improved strength in load bearing areas. Surface modification is one of the key factors to alter the surface properties to hasten osseointegration. Spark anodic oxidation (anodization) is one such method that is reported to enhance the bone formation around implants. This study aims to anodize TiZr and study its surface characteristics and cytocompatibility by cell culture experiments using osteoblast-like cells. Titanium (Ti) and TiZr discs were anodized in an electrolyte containing DL-alpha-glycerophosphate and calcium acetate (CA) at 300 V. The surface characteristics were analyzed by scanning electron microscopy, electron dispersive spectroscopy, X-ray diffraction (XRD), atomic force microscopy and goniometry. Using osteoblast-like cells viability, proliferation, differentiation and mineralization was assessed. The anodized surfaces demonstrated increased oxygen, entrapped calcium and phosphorous from the electrolyte used. XRD analysis confirmed the presence of anatase in the oxide layer. Average roughness increased and there was a significant decrease in contact angle (P<0.01) following anodization. The anodized TiZr (aTiZr) surfaces were more nano-porous compared to anodized Ti (aTi). No significant difference was found in the viability of cells, but after 24 h the total number of cells was significantly higher (P<0.01). Proliferation, alkaline phosphatase activity and calcium deposits were significantly higher on anodized surfaces compared to machined surfaces (P<0.05, ANOVA). Anodization of TiZr resulted in a more nanoporous and hydrophilic surface than aTi, and osteoblast biocompatibility appeared comparable to aTi.
C1 [Sharma, Ajay; Duncan, Warwick John] Univ Otago, Sir John Walsh Res Inst, Fac Dent, Dept Oral Sci, Dunedin 9016, New Zealand.
   [McQuillan, A. James] Univ Otago, Dept Chem, Dunedin 9016, New Zealand.
   [Sharma, Lavanya A.] Univ Otago, Otago Sch Med Sci, Dunedin 9016, New Zealand.
   [Waddell, John Neil] Sir John Walsh Res Inst, Fac Dent, Dunedin, New Zealand.
   [Shibata, Yo] Showa Univ, Sch Dent, Dept Conservat Dent, Div Biomat & Engn, Tokyo 142, Japan.
RP Sharma, A (reprint author), Univ Otago, Sir John Walsh Res Inst, Fac Dent, Dept Oral Sci, Walsh Bldg,310 Great King St, Dunedin 9016, New Zealand.
EM ajsharma.perio@gmail.com
RI Duncan, Warwick/S-2126-2016
OI Duncan, Warwick/0000-0002-5412-0089
FU Dentsply, Austarlia; Wishborne trust
FX This study was funded by Dentsply, Austarlia and Wishborne trust. We
   wish to acknowledge the assistance of Liz Girwan, Otago Centre for
   Electron Microscopy, University of Otago, for her assistance in the SEM.
   We wish to acknowledge the assistance of Andrew McNaughton, Otago Centre
   for Confocal Microscopy, University of Otago, for his assistance in the
   confocal microscopy. We acknowledge the assistance of Paul Reynolds,
   Department of Chemistry for his assistance in fabrication of electrical
   set up. We the authors of this manuscript declare that there is no
   potential conflict of interest with respect to the authorship and/or
   publication of this article.
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Anil S, 2011, DENT IMPLANT SURFACE, P83
   Bai Y, 2011, SURF INTERFACE ANAL, V43, P998, DOI 10.1002/sia.3683
   Balshi SF, 2005, INT J ORAL MAX IMPL, V20, P946
   Barter S, 2012, CLIN ORAL IMPLAN RES, V23, P873, DOI 10.1111/j.1600-0501.2011.02231.x
   Bernhard N, 2009, FORUM IMPLANTOLOGICU, V5, P30
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Chen XB, 2008, BIOTECHNOL BIOENG, V101, P378, DOI 10.1002/bit.21900
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   Connor PA, 1999, LANGMUIR, V15, P2916, DOI 10.1021/la980894p
   Duncan Warwick J, 2008, Ann R Australas Coll Dent Surg, V19, P152
   El-wassefy NA, 2014, CLIN ORAL IMPLAN RES, V25, pE1, DOI 10.1111/clr.12031
   Giordano C, 2005, J MATER SCI-MATER M, V16, P1221, DOI 10.1007/s10856-005-4732-5
   Gottlow J, 2012, CLIN IMPLANT DENT R, V14, P538, DOI 10.1111/j.1708-8208.2010.00289.x
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   Ikarashi Y, 2005, MATER TRANS, V46, P2260, DOI 10.2320/matertrans.46.2260
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   KURZE P, 1986, Stomatologie der DDR, V36, P549
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Ostman PO, 2012, CLIN IMPLANT DENT R, V14, P852, DOI 10.1111/j.1708-8208.2012.00453.x
   Pae A, 2011, INT J ORAL MAX IMPL, V26, P475
   Park IS, 2008, J BIOMED MATER RES B, V84B, P422, DOI 10.1002/jbm.b.30887
   Park IS, 2011, SURF INTERFACE ANAL, V43, P1030, DOI 10.1002/sia.3686
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   SHIBUYA Y, 2009, KOBE J MED SCI, V55, pE73
   Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   Sul YT, 2001, J MATER SCI-MATER M, V12, P1025, DOI 10.1023/A:1012837905910
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Teh TH, 2003, CORROS SCI, V45, P2757, DOI 10.1016/S0010-938X(03)00101-X
   Wu J, 2010, J BIOMED MATER RES B, V92B, P298, DOI 10.1002/jbm.b.31515
   Xiropaidis AV, 2005, CLIN ORAL IMPLAN RES, V16, P532, DOI 10.1111/j.1600-0501.2005.01126.x
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 41
TC 7
Z9 7
U1 2
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2015
VL 26
IS 8
AR 221
DI 10.1007/s10856-015-5555-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CR4OE
UT WOS:000361312700006
PM 26260697
DA 2018-10-19
ER

PT J
AU Ballester-Beltran, J
   Lebourg, M
   Salmeron-Sanchez, M
AF Ballester-Beltran, Jose
   Lebourg, Myriam
   Salmeron-Sanchez, Manuel
TI Sandwich-like Microenvironments to Harness Cell/Material Interactions
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 102; Sandwich culture; 3D culture; cell culture;
   physiological; cellular environment; bioengineering
ID CELL-MIGRATION; VENTRAL STIMULI; 3RD-DIMENSION; PROTEOLYSIS; MATRICES;
   DORSAL; ASSAY; FATE
AB Cell culture has been traditionally carried out on bi-dimensional (2D) substrates where cells adhere using ventral receptors to the biomaterial surface. However in vivo, most of the cells are completely surrounded by the extracellular matrix (ECM), resulting in a three-dimensional (3D) distribution of receptors. This may trigger differences in the outside-in signaling pathways and thus in cell behavior.
   This article shows that stimulating the dorsal receptors of cells already adhered to a 2D substrate by overlaying a film of a new material (a sandwich-like culture) triggers important changes with respect to standard 2D cultures. Furthermore, the simultaneous excitation of ventral and dorsal receptors shifts cell behavior closer to that found in 3D environments. Additionally, due to the nature of the system, a sandwich-like culture is a versatile tool that allows the study of different parameters in cell/material interactions, e.g., topography, stiffness and different protein coatings at both the ventral and dorsal sides. Finally, since sandwich-like cultures are based on 2D substrates, several analysis procedures already developed for standard 2D cultures can be used normally, overcoming more complex procedures needed for 3D systems.
C1 [Ballester-Beltran, Jose; Lebourg, Myriam] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia, Spain.
   [Ballester-Beltran, Jose; Salmeron-Sanchez, Manuel] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Salmeron-Sanchez, M (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia, Spain.
EM manuel.salmeron-sanchez@glasgow.ac.uk
RI Salmeron-Sanchez, Manuel/E-4680-2010
OI Salmeron-Sanchez, Manuel/0000-0002-8112-2100; BALLESTER-BELTRAN,
   JOSE/0000-0002-3287-2925
FU ERC through HealInSynergy [306990]; FPU program [AP2009-3626]
FX The support from ERC through HealInSynergy (306990) and the FPU program
   AP2009-3626 are acknowledged.
CR [Anonymous], 2015, J VIS EXP
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Ballester-Beltran J, 2014, BIOMATER SCI-UK, V2, P381, DOI 10.1039/c3bm60248f
   Ballester-Beltran J., 2015, NANOMEDICINE
   Ballester-Beltran J, 2013, BIOTECHNOL BIOENG, V110, P3048, DOI 10.1002/bit.24972
   Ballester-Beltran J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0039-5
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Glass M, 2012, PATTERN RECOGN, V45, P3154, DOI 10.1016/j.patcog.2012.03.001
   Gobel U, 2012, BIOTECHNOL J, V7, P833, DOI 10.1002/biot.201200176
   Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Lee EJ, 2009, IEEE ENG MED BIO, P6034, DOI 10.1109/IEMBS.2009.5333169
   Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566
   Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124
   Schor SL, 2006, CELL MOTIL CYTOSKEL, V63, P287, DOI 10.1002/cm.20123
   WEISS P, 1959, REV MOD PHYS, V31, P11, DOI 10.1103/RevModPhys.31.11
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 18
TC 1
Z9 1
U1 3
U2 6
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2015
IS 102
AR e53090
DI 10.3791/53090
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7NL
UT WOS:000361537100043
PM 26274867
OA Green Published
DA 2018-10-19
ER

PT J
AU Kaplan, J
   Grinstaff, M
AF Kaplan, Jonah
   Grinstaff, Mark
TI Fabricating Superhydrophobic Polymeric Materials for Biomedical
   Applications
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 102; Electrospinning; electrospraying;
   polycaprolactone; poly(lactide-co-glycolide); microfiber; nanofiber;
   microparticles; superhydrophobic; biomaterials; drug delivery;
   biodegradable; surface coatings
ID ELECTROSPUN POLYPHOSPHAZENE NANOFIBERS; TISSUE ENGINEERING SCAFFOLDS;
   IN-VITRO DEGRADATION; SMALL-DIAMETER; CONTROLLED-RELEASE; VASCULAR
   GRAFTS; SURFACE-TENSION; DRAG REDUCTION; DRUG-DELIVERY; PLUS WATER
AB Superhydrophobic materials, with surfaces possessing permanent or metastable non-wetted states, are of interest for a number of biomedical and industrial applications. Here we describe how electrospinning or electrospraying a polymer mixture containing a biodegradable, biocompatible aliphatic polyester (e.g., polycaprolactone and poly(lactide-co-glycolide)), as the major component, doped with a hydrophobic copolymer composed of the polyester and a stearate-modified poly(glycerol carbonate) affords a superhydrophobic biomaterial. The fabrication techniques of electrospinning or electrospraying provide the enhanced surface roughness and porosity on and within the fibers or the particles, respectively. The use of a low surface energy copolymer dopant that blends with the polyester and can be stably electrospun or electrosprayed affords these superhydrophobic materials. Important parameters such as fiber size, copolymer dopant composition and/or concentration, and their effects on wettability are discussed. This combination of polymer chemistry and process engineering affords a versatile approach to develop application-specific materials using scalable techniques, which are likely generalizable to a wider class of polymers for a variety of applications.
C1 [Kaplan, Jonah; Grinstaff, Mark] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Grinstaff, Mark] Boston Univ, Dept Chem, Boston, MA 02215 USA.
   [Grinstaff, Mark] Boston Univ, Dept Med, Boston, MA 02215 USA.
RP Grinstaff, M (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM mgrin@bu.edu
RI Grinstaff, Mark/U-2829-2017
OI Grinstaff, Mark/0000-0002-5453-3668
FU BU; NIH [R01CA149561]
FX Funding was provided in part by BU and the NIH R01CA149561. The authors
   wish to thank the electrospinning/electrospraying team including Stefan
   Yohe, Eric Falde, Joseph Hersey, and Julia Wang for their helpful
   discussions and contributions to the preparation and characterization of
   superhydrophobic biomaterials.
CR Azizian S, 2003, J CHEM ENG DATA, V48, P662, DOI 10.1021/je025639s
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Caracciolo PC, 2009, J MATER SCI-MATER M, V20, P2129, DOI 10.1007/s10856-009-3768-3
   Carampin P, 2007, J BIOMED MATER RES A, V80A, P661, DOI 10.1002/jbm.a.30999
   Correia DM, 2014, POLYM ENG SCI, V54, P1608, DOI 10.1002/pen.23704
   Crick CR, 2010, CHEM-EUR J, V16, P3568, DOI 10.1002/chem.200903335
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Deng D, 2013, ACS APPL MATER INTER, V5, P774, DOI 10.1021/am302338x
   Ebrahimi A, 2013, LAB CHIP, V13, P4248, DOI 10.1039/c3lc50517k
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Grafahrend D, 2008, J MATER SCI-MATER M, V19, P1479, DOI 10.1007/s10856-007-3299-8
   Greenberg James A, 2009, Rev Obstet Gynecol, V2, P146
   Gugerell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090676
   Guix M, 2012, ACS NANO, V6, P4445, DOI 10.1021/nn301175b
   HOKE BC, 1992, J CHEM ENG DATA, V37, P331, DOI 10.1021/je00007a016
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Inai R, 2005, J POLYM SCI POL PHYS, V43, P3205, DOI 10.1002/polb.20457
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jiang HL, 2007, MACROMOL BIOSCI, V7, P517, DOI 10.1002/mabi.200600277
   Jiang HL, 2006, J BIOMED MATER RES B, V79B, P50, DOI 10.1002/jbm.b.30510
   Ju GN, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.44
   Kaplan JA, 2014, BIOMACROMOLECULES, V15, P2548, DOI 10.1021/bm500410h
   Kenawy ER, 2007, MAT SCI ENG A-STRUCT, V459, P390, DOI 10.1016/j.msea.2007.01.039
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Khanam N, 2007, ACTA BIOMATER, V3, P1050, DOI 10.1016/j.actbio.2007.06.005
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kim YB, 2009, J APPL POLYM SCI, V114, P3870, DOI 10.1002/app.31091
   Ko T.-J., 2013, SOFT MATTER
   Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b
   Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815
   Leach M. K., 2011, J VIS EXP
   Lee JS, 2005, EUR J PHARM BIOPHARM, V59, P169, DOI 10.1016/j.ejpb.2004.06.006
   Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f
   Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gnil171
   Lim HS, 2006, J AM CHEM SOC, V128, P14458, DOI 10.1021/ja0655901
   Lin YJ, 2010, J APPL POLYM SCI, V115, P3393, DOI 10.1002/app.30481
   Liu H, 2012, J APPL POLYM SCI, V125, pE468, DOI 10.1002/app.36757
   Lourenco B.N., 2012, BIOINTERPHASES, V7
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Macias-Montero M, 2012, LANGMUIR, V28, P15047, DOI 10.1021/la3028918
   Manna U, 2013, ADV MATER, V25, P6405, DOI 10.1002/adma.201302561
   Marmur A, 2006, BIOFOULING, V22, P107, DOI 10.1080/08927010600562328
   Mun CH, 2012, TISSUE ENG PT A, V18, P1608, DOI [10.1089/ten.tea.2011.0695, 10.1089/ten.TEA.2011.0695]
   Nagiah N, 2012, ADV ENG MATER, V14, pB138, DOI 10.1002/adem.201180041
   Nair PA, 2013, J BIOMED MATER RES A, V101, P1876, DOI 10.1002/jbm.a.34490
   Nayak BK, 2013, APPL SURF SCI, V266, P27, DOI 10.1016/j.apsusc.2012.11.052
   Niu HT, 2014, RSC ADV, V4, P11782, DOI 10.1039/c4ra00232f
   Norton FJ, 1945, US Patent, Patent No. 2386259
   Oh JH, 2012, CURR APPL PHYS, V12, pS144, DOI 10.1016/j.cap.2012.02.047
   Ong BYS, 2009, BIOMATERIALS, V30, P3189, DOI 10.1016/j.biomaterials.2009.02.030
   Ou J, 2004, PHYS FLUIDS, V16, P4635, DOI 10.1063/1.1812011
   Pant HR, 2013, APPL SURF SCI, V285, P538, DOI 10.1016/j.apsusc.2013.08.089
   Pant HR, 2013, POLYM INT, V62, P1008, DOI 10.1002/pi.4380
   Panthi G, 2013, FIBER POLYM, V14, P718, DOI 10.1007/s12221-013-0718-y
   Paun IA, 2012, APPL SURF SCI, V258, P9302, DOI 10.1016/j.apsusc.2011.10.044
   Peesan M, 2006, J BIOMAT SCI-POLYM E, V17, P547, DOI 10.1163/156856206776986251
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Ray WC, 2003, MACROMOLECULES, V36, P3557, DOI 10.1021/ma025872v
   Reneker DH, 2007, ADV APPL MECH, V41, P43, DOI 10.1016/S0065-2156(07)41002-X
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Sakai Shinji, 2006, Biotechnology Journal, V1, P958, DOI 10.1002/biot.200600054
   Sas I, 2012, J POLYM SCI POL PHYS, V50, P824, DOI 10.1002/polb.23070
   Schmitt E. E., 1967, U. S. Patent, Patent No. [3,297,033, 3297033]
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Srinivasan S, 2013, SOFT MATTER, V9, P5691, DOI 10.1039/c3sm50445j
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tong HW, 2011, POLYM ENG SCI, V51, P1325, DOI 10.1002/pen.21937
   Uykun N, 2014, J BIOACT COMPAT POL, V29, P382, DOI 10.1177/0883911514535153
   VAZQUEZ G, 1995, J CHEM ENG DATA, V40, P611, DOI 10.1021/je00019a016
   Verplanck N, 2007, NANOSCALE RES LETT, V2, P577, DOI 10.1007/s11671-007-9102-4
   Wang SG, 2012, COLLOID SURFACE B, V89, P254, DOI 10.1016/j.colsurfb.2011.09.029
   Weldon CB, 2012, J CONTROL RELEASE, V161, P903, DOI 10.1016/j.jconrel.2012.05.021
   Welle A, 2007, BIOMATERIALS, V28, P2211, DOI 10.1016/j.biomaterials.2007.01.024
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
   Wolinsky J. B., 2012, BIOMACROMOLECULES, V13
   Wolinsky JB, 2007, MACROMOLECULES, V40, P7065, DOI 10.1021/ma071276v
   Wright J., 2012, ADV DELIVERY SCI TEC, P11, DOI DOI 10.1007/978-1-4614-0554-2-2
   Wu YW, 2014, NANOSCALE, V6, P9720, DOI 10.1039/c4nr02198c
   Xie JW, 2008, J BIOMED MATER RES A, V85A, P897, DOI 10.1002/jbm.a.31499
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu XM, 2010, BIOMACROMOLECULES, V11, P2283, DOI 10.1021/bm1003509
   Xue CH, 2014, ACS APPL MATER INTER, V6, P10153, DOI 10.1021/am501371b
   Yamaguchi T, 2008, J SOL-GEL SCI TECHN, V48, P350, DOI 10.1007/s10971-008-1822-0
   Yohe ST, 2013, ADV FUNCT MATER, V23, P3628, DOI 10.1002/adfm.201203111
   Yohe ST, 2013, ADV HEALTHC MATER, V2, P1204, DOI 10.1002/adhm.201200381
   Yohe ST, 2013, CHEM COMMUN, V49, P804, DOI 10.1039/c2cc38012a
   Yohe ST, 2012, J CONTROL RELEASE, V162, P92, DOI 10.1016/j.jconrel.2012.05.047
   Yohe ST, 2012, J AM CHEM SOC, V134, P2016, DOI 10.1021/ja211148a
   You Y, 2005, J APPL POLYM SCI, V95, P193, DOI 10.1002/app.21116
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhang J, 2006, ARTIF ORGANS, V30, P898, DOI 10.1111/j.1525-1594.2006.00322.x
   Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
NR 102
TC 0
Z9 0
U1 5
U2 71
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2015
IS 102
AR e53117
DI 10.3791/53117
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7NL
UT WOS:000361537100046
PM 26383018
OA Green Published
DA 2018-10-19
ER

PT J
AU Nitipir, C
   Albu, MG
   Voicu, G
   Ficai, A
   Barbu, MA
   Popa, LG
   Mirea, D
   Lazar, S
   Levai, C
   Ghica, MV
AF Nitipir, Cornelia
   Albu, Madalina Georgiana
   Voicu, Georgeta
   Ficai, Anton
   Barbu, Maria Alexandra
   Popa, Liliana Gabriela
   Mirea, Daniel
   Lazar, Stefan
   Levai, Codrina
   Ghica, Mihaela Violeta
TI Collagen - vinblastine Delivery Systems as a New Treatment for Kaposi's
   Sarcoma
SO REVISTA DE CHIMIE
LA English
DT Article
DE collagen; genipin; vinblastine; drug delivery systems
AB Collagen-vinblastine composites have been prepared by crosslinking with genipin and glutaraldehyde followed by freeze-drying in order to obtain drug delivery systems in spongious form. The resulting composites have been characterized with respect to their swelling capacity, FT-IR spectroscopy, scanning electron microscopy and vinblastine release. It was observed that the composites absorbed a high amount of water depending on the degree of crosslinking and the amount of vinblastine. They have porous structures as SEM images showed and the native collagen structure was kept for all composites. The release of vinblastine was between 67.72% and 84.91%. In the first hour of experiment, vinblastine is released faster inducing the remission of tumor cells, while during the next four hours the drug is released more slowly and gradually to maintain an appropriate concentration for remission consolidation and tumor healing. In conclusion, the obtained drug delivery systems based on collagen and vinblastine are a promising biomaterial for treatment of Kaposi's sarcoma.
C1 [Nitipir, Cornelia; Popa, Liliana Gabriela; Lazar, Stefan] Univ Med & Pharm Carol Davila, Fac Med, Bucharest 050474, Romania.
   [Nitipir, Cornelia; Barbu, Maria Alexandra; Popa, Liliana Gabriela; Mirea, Daniel] Elias Emergency Univ Hosp, Bucharest 011461, Romania.
   [Albu, Madalina Georgiana] INCDTP Leather & Footwear Res Inst, Bucharest 031215, Romania.
   [Voicu, Georgeta; Ficai, Anton] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
   [Lazar, Stefan] Infect & Trop Dis Hosp Dr Victor Babes, Bucharest 030303, Romania.
   [Levai, Codrina] Victor Babes Univ Med & Pharm, Timisoara 300041, Romania.
   [Ghica, Mihaela Violeta] Univ Med & Pharm Carol Davila, Fac Pharm, Bucharest 020956, Romania.
RP Albu, MG (reprint author), INCDTP Leather & Footwear Res Inst, 93 Ion Minulescu Str, Bucharest 031215, Romania.
EM albu_mada@yahoo.com; codrinalevai@umft.ro
OI FICAI, Anton/0000-0002-1777-0525; Nitipir, Cornelia/0000-0002-5985-3759;
   Albu, Madalina Georgiana/0000-0001-9960-2244; Voicu,
   Georgeta/0000-0001-7155-7138
CR ALBU M.G., 2011, BIOMATERIALS APPL NA
   Albu M.G., 2011, COLLAGEN GELS MATRIC
   Albu MG, 2015, FARMACIA, V63, P20
   Albu MG, 2009, REV CHIM-BUCHAREST, V60, P666
   Cassidy J, 2010, OXFORD HDB ONCOLOGY
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   FLAITZ CM, 1995, ORAL ONCOL, V31B, P280
   Ghica MV, 2013, PHARMAZIE, V68, P340, DOI 10.1691/ph.2013.2101
   Ghica MV, 2012, REV CHIM-BUCHAREST, V63, P929
   de Arriba AG, 2007, ACTAS DERMO-SIFILOGR, V98, P50
   GULLATE M.M., 2014, CLIN GUIDE ANTINEOPL
   Jridi M, 2015, INT J BIOL MACROMOL, V77, P369, DOI 10.1016/j.ijbiomac.2015.03.020
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lungu A, 2011, DIG J NANOMATER BIOS, V6, P1897
   McCormick SU, 1996, J ORAL MAXIL SURG, V54, P583, DOI 10.1016/S0278-2391(96)90637-0
   Sato H, 1996, PHARMACEUT RES, V13, P1565, DOI 10.1023/A:1016096016642
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   Trookman NS, 2011, J AM ACAD DERMATOL, V64, pS16, DOI 10.1016/j.jaad.2010.11.008
NR 18
TC 11
Z9 11
U1 3
U2 11
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD AUG
PY 2015
VL 66
IS 8
BP 1169
EP 1172
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CR1ZQ
UT WOS:000361124600019
DA 2018-10-19
ER

PT J
AU Chang, Q
   Li, L
   Yang, DL
   Zhang, MY
   Minh-Tan, TT
   Hu, W
   Lu, S
AF Chang Qing
   Li Li
   Yang Dalei
   Zhang Mingyao
   Minh-Tan, Ton-That
   Hu Wei
   Lue Shuai
TI Synthesis and Characterization of Poly(omega-pentadecalactone) for Its
   Industrial-scale Production
SO CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
LA English
DT Article
DE Poly(omega-pentadecalactone); Polymerization; Characterization
ID RING-OPENING POLYMERIZATION; OMEGA-PENTADECALACTONE; CRYSTALLIZATION
   KINETICS; CATALYZED SYNTHESIS; CRYSTAL-STRUCTURE; MOLECULAR-WEIGHT;
   MACROLACTONES; POLYPENTADECANOLACTONE; MORPHOLOGY; POLYESTERS
AB The synthesis of biomaterial poly(omega-pentadecalactone)(PPDL) with yttrium isopropoxide as initiator in bulk was explored for its industrial-scale production. The weight-average molecular weight((M) over bar (w) ) of PPDL could be controlled by the molar ratio of monomer to initiator(M/I), polymerization temperature(T-p) and period(t(p)). The synthesis conditions were optimized, and a high (M) over bar (w) of 9.2x10(4) of PPDL could be obtained by the reaction at an M/I molar ratio of 1000/1 and 100 degrees C for only 30 min, which presented tough properties with a tensile strength of about 20 MPa and an elongation at break of about 300%. This mechanical property was comparable to that of high density polyethylene(HDPE). The melting point was about 96 degrees C, and 5% of mass loss temperature(T-5%) was as high as 340 degrees C. Thus, the PPDL with good mechanical properties and high thermal stability can be synthesized without solvent at low expenses.
C1 [Chang Qing; Yang Dalei; Zhang Mingyao; Hu Wei; Lue Shuai] Changchun Univ Technol, Inst Chem Engn, Changchun 130012, Peoples R China.
   [Li Li] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China.
   [Minh-Tan, Ton-That] Natl Res Council Canada, Boucherville, PQ J4B 6Y4, Canada.
RP Hu, W (reprint author), Changchun Univ Technol, Inst Chem Engn, Changchun 130012, Peoples R China.
EM huwei@ccut.edu.cn
FU National Natural Science Foundation of China [21404013]; Science and
   Technology Development Plan of Jilin Province, China [20140204039GX];
   Changchun Science and Technology Plan Project, China [14KG105]; College
   Students' Innovation and Entrepreneurship Training Plan of Higher School
   in Jilin Province, China [201410190034]; Research Project of Science and
   Technology of the Education Department of Jilin Province During the 12th
   Five-year Plan Period, China [2015-78]
FX Supported by the National Natural Science Foundation of China(No.
   21404013), the Science and Technology Development Plan of Jilin
   Province, China(No. 20140204039GX), the Changchun Science and Technology
   Plan Project, China(No. 14KG105), the College Students' Innovation and
   Entrepreneurship Training Plan of Higher School in Jilin Province, China
   (No. 201410190034) and the Research Project of Science and Technology of
   the Education Department of Jilin Province During the 12th Five-year
   Plan Period, China(No. 2015-78).
CR Bisht KS, 1997, MACROMOLECULES, V30, P2705, DOI 10.1021/ma961869y
   Bouyahyi M, 2014, MACROMOLECULES, V47, P517, DOI 10.1021/ma402072t
   Cai JL, 2010, POLYMER, V51, P1088, DOI 10.1016/j.polymer.2010.01.007
   Cai JL, 2009, POLYM INT, V58, P944, DOI 10.1002/pi.2624
   Duda A, 2002, MACROMOLECULES, V35, P4266, DOI 10.1021/ma012207y
   Focarete ML, 2001, J POLYM SCI POL PHYS, V39, P1721
   Gazzano M, 2003, J POLYM SCI POL PHYS, V41, P1009, DOI 10.1002/polb.10419
   Hunsen M, 2008, BIOMACROMOLECULES, V9, P518, DOI 10.1021/bm701269p
   Jasinska-Walc L, 2015, MACROMOLECULES, V48, P502, DOI 10.1021/ma502262e
   Jedlinski Z, 1996, MACROMOL CHEM PHYSIC, V197, P2923, DOI 10.1002/macp.1996.021970925
   Kim E, 2005, MACROMOL BIOSCI, V5, P734, DOI 10.1002/mabi.200500038
   Kobayashi S, 2009, MACROMOL RAPID COMM, V30, P237, DOI 10.1002/marc.200800690
   NOMURA R, 1994, MACROMOLECULES, V27, P620, DOI 10.1021/ma00080a046
   Pascual A, 2013, EUR POLYM J, V49, P1601, DOI 10.1016/j.eurpolymj.2013.02.009
   Skoglund P, 1998, POLYMER, V39, P1899, DOI 10.1016/S0032-3861(97)00473-4
   Skoglund P, 1998, POLYMER, V39, P3143, DOI 10.1016/S0032-3861(97)10023-4
   Wilson JA, 2015, MACROMOLECULES, V48, P950, DOI 10.1021/ma5022049
   Yu Y, 2012, PROCESS BIOCHEM, V47, P1027, DOI 10.1016/j.procbio.2012.04.006
   Zhong ZY, 2000, MACROMOL CHEM PHYSIC, V201, P1329, DOI 10.1002/1521-3935(20000801)201:12<1329::AID-MACP1329>3.0.CO;2-8
NR 19
TC 0
Z9 0
U1 2
U2 20
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 1005-9040
EI 2210-3171
J9 CHEM RES CHINESE U
JI Chem. Res. Chin. Univ.
PD AUG
PY 2015
VL 31
IS 4
BP 640
EP 644
DI 10.1007/s40242-015-5092-4
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA CR1FZ
UT WOS:000361071600027
DA 2018-10-19
ER

PT J
AU Firempong, CK
   Zhang, HY
   Zhang, JJ
   Wang, Y
   Cao, X
   Omari-Siaw, E
   Tong, SS
   Yu, JN
   Xu, XM
AF Firempong, Caleb Kesse
   Zhang, Hui-Yun
   Zhang, Jia-Jia
   Wang, Yan
   Cao, Xia
   Omari-Siaw, Emmmanuel
   Tong, Shan-Shan
   Yu, Jiangnan
   Xu, Ximing
TI Lipid raft biomaterial as a mass screening affinity tool for rapid
   identification of potential antitumor Chinese herbal medicine
SO EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE
LA English
DT Article
DE Affinity system; Antitumor; Lipid raft; Mass screening; Natural products
ID ENHANCED ORAL BIOAVAILABILITY; FLAMMULINA-VELUTIPES STEROLS; TYROSINE
   KINASE INHIBITOR; PHASE-I TRIAL; STATIONARY-PHASE; CHROMATOGRAPHIC
   CHARACTERISTICS; SILICA SURFACE; CELLS; CANCER; DISCOVERY
AB Introduction: The quest for novel cancer drugs is one of the most significant studies in natural products, and Chinese herbs with its promising antitumor properties cannot be exempted from this chemotherapeutic bracket. This study was therefore aimed at piloting the use of receptor-rich lipid raft biomaterial as a mass screening tool for rapid isolation of effective antitumor components from some Chinese herbs used in the treatment of diseases consistent with cancer symptoms.
   Method: Aqueous crude extracts from 10 different Chinese herbs (Paeonia suffruticosa, Vaccaria segetalis, Terminalia chebula, Trichosanthes kirilowii, Arisaema erubescens, Morus australis, Centella asiatica, Rhematoxylon campechianum, Trachelospermum jasminoides and Taraxacum officinale) were screened using lipid raft silica beads. The identified bioactive products were separated into various fractions (petroleum ether, ethyl acetate, n-butanol and raffinate extracts) with another affinity screening analysis. Conventional MTT bioassay was employed to authenticate the susceptibility of liver cancer cells to the final bioactive isolates.
   Results: The results showed that only Vaccaria segetalis and Arisaema erubescens significantly interacted with the system. The MTT bioassay further confirmed the cytotoxicity of these plants and the data correlated very well with its reported cancer-related activities.
   Conclusion: These findings support the reliable application of the lipid raft biomaterial as a prospective mass screening technique for antitumor natural products. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Firempong, Caleb Kesse; Zhang, Hui-Yun; Zhang, Jia-Jia; Wang, Yan; Cao, Xia; Omari-Siaw, Emmmanuel; Tong, Shan-Shan; Yu, Jiangnan; Xu, Ximing] Jiangsu Univ, Ctr Nano Drug Gene Delivery & Tissue Engn, Sch Pharm, Dept Pharmaceut, Zhenjiang 212013, Peoples R China.
   [Yu, Jiangnan] China Pharmaceut Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China.
RP Xu, XM (reprint author), 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.
EM calebuse@yahoo.com; 472998291@qq.com; 934193740@qq.com;
   1185546956@qq.com; 841661898@qq.com; omarisiaw@gmail.com;
   877274194@qq.com; yjn@ujs.edu.cn; xmxu@ujs.edu.cn
FU National Natural Science Foundation of China [30973677, 81373371];
   Ministry of Education of China [20113227110012/2014M560410]; Ministry of
   Education of Jiangsu Province [1401023B]; Priority Academic Program
   Development of Jiangsu University [13JDG007];
   Industry-University-Research Institution Cooperation in Jiangsu province
   [GY2012049, GY2013055]; Industry-University-Research Institution
   Cooperation in Zhenjiang [GY2012049, GY2013055]
FX This work was supported by the National Natural Science Foundation of
   China (Grant 30973677, 81373371), the Doctoral Fund of Ministry of
   Education of China (Grant 20113227110012/2014M560410), Doctoral Fund of
   Ministry of Education of Jiangsu Province ((1401023B), Priority Academic
   Program Development of Jiangsu University (13JDG007) and the
   Industry-University-Research Institution Cooperation (Grants GY2012049
   and GY2013055) in Jiangsu province and Zhenjiang.
CR Astafieva AA, 2012, PEPTIDES, V36, P266, DOI 10.1016/j.peptides.2012.05.009
   Bag Anwesa, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P244, DOI 10.1016/S2221-1691(13)60059-3
   Balsevich JJ, 2012, FITOTERAPIA, V83, P170, DOI 10.1016/j.fitote.2011.10.010
   Beigi F, 1999, J CHROMATOGR A, V852, P313, DOI 10.1016/S0021-9673(99)00025-4
   Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815
   Chan E, 2008, INVEST NEW DRUG, V26, P241, DOI 10.1007/s10637-008-9118-3
   Commission CP, 2005, CHINESE PHARMACOPOEI, p[328, 547]
   Feng L, 2012, ASIAN BIOMED, V6, P683, DOI 10.5372/1905-7415.0605.108
   Firempong CK, 2015, RSC ADV, V5, P49330, DOI 10.1039/c5ra08322b
   Habicht KL, 2013, J PHARMACEUT BIOMED, V72, P159, DOI 10.1016/j.jpba.2012.10.001
   Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172
   He LC, 1999, CHINESE SCI BULL, V44, P826, DOI 10.1007/BF02885029
   He LC, 2001, CHROMATOGRAPHIA, V54, P71, DOI 10.1007/BF02491836
   Hou XF, 2009, J CHROMATOGR A, V1216, P7081, DOI 10.1016/j.chroma.2009.08.062
   Huang X, 2004, J CHROMATOGR B, V812, P71
   Idrus RBH, 2012, J ETHNOPHARMACOL, V140, P333, DOI 10.1016/j.jep.2012.01.023
   Kandil FE, 1996, PHYTOCHEMISTRY, V42, P1243, DOI 10.1016/0031-9422(95)00924-8
   Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959
   Ling CQ, 2014, J INTEGR MED-JIM, V12, P331, DOI 10.1016/S2095-4964(14)60038-8
   Marshall JL, 2005, INVEST NEW DRUG, V23, P31, DOI 10.1023/B:DRUG.0000047103.64335.b0
   Moaddel R, 2010, J PHARMACEUT BIOMED, V52, P416, DOI 10.1016/j.jpba.2009.06.035
   Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1
   NOCTOR TAG, 1992, J CHROMATOGR-BIOMED, V577, P305, DOI 10.1016/0378-4347(92)80252-L
   Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002
   Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141
   Sheu MJ, 2009, J ETHNOPHARMACOL, V126, P332, DOI 10.1016/j.jep.2009.08.019
   Su XY, 2007, J CHROMATOGR A, V1154, P132, DOI 10.1016/j.chroma.2007.03.050
   Takahashi N, 2009, INT IMMUNOPHARMACOL, V9, P508, DOI 10.1016/j.intimp.2009.01.006
   Tong S, 2014, BIOMED CHROMATOGR
   Tong SS, 2014, CHROMATOGRAPHIA, V77, P419, DOI 10.1007/s10337-014-2623-y
   Undevia SD, 2004, INVEST NEW DRUG, V22, P449, DOI 10.1023/B:DRUG.0000036687.26604.8c
   Vuignier K, 2013, J PHARMACEUT BIOMED, V74, P205, DOI 10.1016/j.jpba.2012.10.030
   Yi CX, 2013, J AGR FOOD CHEM, V61, P5961, DOI 10.1021/jf3055278
   Yi CX, 2013, INT J PHARMACEUT, V448, P44, DOI 10.1016/j.ijpharm.2013.03.020
   Yi CX, 2012, INT J NANOMED, V7, P5067, DOI 10.2147/IJN.S34612
   Zhang C, 2012, J CHROMATOGR A, V1233, P78, DOI 10.1016/j.chroma.2012.02.013
   Zhang MH, 2014, J ETHNOPHARMACOL, V151, P591, DOI 10.1016/j.jep.2013.11.015
   Zhang YH, 2014, J INTEGR MED-JIM, V12, P483, DOI 10.1016/S2095-4964(14)60057-1
NR 38
TC 1
Z9 1
U1 2
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1876-3820
EI 1876-3839
J9 EUR J INTEGR MED
JI Eur. J. Integr. Med.
PD AUG
PY 2015
VL 7
IS 4
BP 365
EP 371
DI 10.1016/j.eujim.2015.07.026
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CR0KQ
UT WOS:000361007800008
DA 2018-10-19
ER

PT J
AU Della Bona, A
   Pecho, OE
   Alessandretti, R
AF Della Bona, Alvaro
   Pecho, Oscar E.
   Alessandretti, Rodrigo
TI Zirconia as a Dental Biomaterial
SO MATERIALS
LA English
DT Review
DE biomaterials; zirconia; bonding
ID SHEAR BOND STRENGTH; FIXED PARTIAL DENTURES; ALL-CERAMIC RESTORATIONS;
   RESIN CEMENT; Y-TZP; SURFACE-TREATMENT; FLEXURAL STRENGTH; LUTING
   CEMENTS; ADHESIVE RESIN; STABILIZED ZIRCONIA
AB Ceramics are very important in the science of dental biomaterials. Among all dental ceramics, zirconia is in evidence as a dental biomaterial and it is the material of choice in contemporary restorative dentistry. Zirconia has been applied as structural material for dental bridges, crowns, inserts, and implants, mostly because of its biocompatibility, high fracture toughness, and radiopacity. However, the clinical success of restorative dentistry has to consider the adhesion to different substrates, which has offered a great challenge to dental zirconia research and development. This study characterizes zirconia as a dental biomaterial, presenting the current consensus and challenges to its dental applications.
C1 [Della Bona, Alvaro; Pecho, Oscar E.; Alessandretti, Rodrigo] Univ Passo Fundo, Sch Dent, Postgrad Program Dent, BR-99052900 Passo Fundo, RS, Brazil.
RP Della Bona, A (reprint author), Univ Passo Fundo, Sch Dent, Postgrad Program Dent, Campus 1,BR285, BR-99052900 Passo Fundo, RS, Brazil.
EM dbona@upf.br; opey@correo.ugr.es; rodrigo.alle@yahoo.com.br
RI Pecho, Oscar/N-3831-2018
OI Pecho, Oscar/0000-0001-7314-5049; Della Bona, Alvaro/0000-0002-8312-7503
FU CNPq do Brasil [304995/2013-4]; PNPD from CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior) do Brasil [42009014007P4];
   FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)
   [396-2551/14-1]
FX This study was partially supported by CNPq do Brasil grant #
   304995/2013-4, PNPD 42009014007P4 from CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior) do Brasil, and
   396-2551/14-1 from FAPERGS (Fundacao de Amparo a Pesquisa do Estado do
   Rio Grande do Sul) scholarships.
CR Abduo J, 2010, J ORAL REHABIL, V37, P866, DOI 10.1111/j.1365-2842.2010.02113.x
   Abi-Rached FO, 2015, OPER DENT, V40, pE66, DOI 10.2341/14-013-LR1
   Aboushelib MN, 2005, DENT MATER, V21, P984, DOI 10.1016/j.dental.2005.03.013
   Aboushelib Moustafa N, 2008, J Prosthodont, V17, P9
   Aboushelib MN, 2008, J BIOMED MATER RES B, V87B, P139, DOI 10.1002/jbm.b.31083
   Aboushelib MN, 2008, DENT MATER, V24, P1268, DOI 10.1016/j.dental.2008.02.010
   Aboushelib MN, 2008, INT J PROSTHODONT, V21, P237
   Aboushelib MN, 2009, DENT MATER, V25, P989, DOI 10.1016/j.dental.2009.02.011
   Aboushelib Moustafa N, 2008, J Prosthodont, V17, P401, DOI 10.1111/j.1532-849X.2008.00306.x
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   [Anonymous], 2010, 68722010 ISO
   Atsu SS, 2006, J PROSTHET DENT, V95, P430, DOI 10.1016/j.prosdent.2006.03.016
   Attia A, 2011, DENT MATER, V27, P207, DOI 10.1016/j.dental.2010.10.004
   Batson ER, 2014, J PROSTHET DENT, V112, P770, DOI 10.1016/j.prosdent.2014.05.002
   Bavbek NC, 2014, J ADHES DENT, V16, P473, DOI 10.3290/j.jad.a32812
   BECHER PF, 1992, J AM CERAM SOC, V75, P493, DOI 10.1111/j.1151-2916.1992.tb07832.x
   Benetti P, 2010, DENT MATER, V26, P743, DOI 10.1016/j.dental.2010.03.019
   Blatz MB, 2007, QUINTESSENCE INT, V38, P745
   Blatz MB, 2004, J PROSTHET DENT, V91, P356, DOI 10.1016/j.prosdent.2004.02.001
   Boitelle P, 2014, J ORAL REHABIL, V41, P853, DOI 10.1111/joor.12205
   Bona AD, 2004, DENT MATER, V20, P956, DOI 10.1016/j.dental.2004.02.004
   Bona AD, 2007, DENT MATER, V23, P769, DOI 10.1016/j.dental.2006.06.043
   Borba M, 2011, DENT MATER, V27, P1259, DOI 10.1016/j.dental.2011.09.008
   Borba M, 2011, DENT MATER, V27, P710, DOI 10.1016/j.dental.2011.04.003
   Boscato N, 2007, AM J DENT, V20, P103
   Oyagu RC, 2009, DENT MATER, V25, P392, DOI 10.1016/j.dental.2008.09.002
   Cavalcanti AN, 2009, OPER DENT, V34, P280, DOI 10.2341/08-80
   Queiroz JRC, 2012, DENT MATER, V28, P763, DOI 10.1016/j.dental.2012.03.014
   Chen L, 2013, J PROSTHET DENT, V110, P402, DOI 10.1016/j.prosdent.2013.04.005
   Christensen RP, 2010, J AM DENT ASSOC, V141, P1317, DOI 10.14219/jada.archive.2010.0076
   Coli P, 2004, INT J PROSTHODONT, V17, P577
   Corazza PH, 2015, AM J DENT, V28, P95
   da Silva EM, 2014, J PROSTHET DENT, V112, P568, DOI 10.1016/j.prosdent.2013.12.003
   de Castro HL, 2012, DENT MATER, V28, P91, DOI 10.1016/j.dental.2012.09.003
   de Kler M, 2007, J ORAL REHABIL, V34, P841, DOI 10.1111/j.1365-2842.2006.01675.x
   Della Bona A, 2006, J DENT RES, V85, P1037
   Della Bona A, 2004, DENT MATER, V20, P338, DOI 10.1016/S0109-5641(03)00126-X
   Della Bona A, 2003, DENT MATER, V19, P693, DOI 10.1016/S0109-5641(03)00015-0
   Della Bona A, 2002, INT J PROSTHODONT, V15, P248
   Della Bona A, 2000, J Adhes Dent, V2, P305
   Della Bona A, 2002, INT J PROSTHODONT, V15, P159
   Della Bona A., 2014, CURR ORAL HLTH REP, V1, P232, DOI [10.1007/s40496-014-0030-y, DOI 10.1007/S40496-014-0030-Y]
   Della Bona A, 2009, BONDING CERAMICS SCI
   Della Bona A, 2008, J AM DENT ASSOC, V139, p8S
   Della Bona Alvaro, 2010, J Evid Based Dent Pract, V10, P35, DOI 10.1016/j.jebdp.2009.11.014
   Bona Alvaro Della, 2007, Braz. oral res., V21, P10, DOI 10.1590/S1806-83242007000100002
   Della Bona A, 2009, J ADHES SCI TECHNOL, V23, P1163, DOI 10.1163/156856109X440146
   DELLABONA A, 1995, J DENT RES, V74, P1591, DOI 10.1177/00220345950740091401
   Deng Y, 2002, J BIOMED MATER RES, V63, P137, DOI 10.1002/jbm.10091
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Derand T, 2005, DENT MATER, V21, P1158, DOI 10.1016/j.dental.2005.02.005
   de Souza GMD, 2011, J PROSTHET DENT, V105, P296, DOI 10.1016/S0022-3913(11)60055-3
   Druck CC, 2015, J BIOMED MATER RES B, V103, P143, DOI 10.1002/jbm.b.33184
   Fischer J, 2009, DENT MATER, V25, P419, DOI 10.1016/j.dental.2008.09.003
   Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guess PC, 2009, INT J ESTHET DENT, V4, P262
   Heikkinen TT, 2009, J ADHES SCI TECHNOL, V23, P1043, DOI 10.1163/156856109X440155
   Hjerppe J, 2008, ACTA ODONTOL SCAND, V66, P262, DOI 10.1080/00016350802247123
   Janda R, 2003, DENT MATER, V19, P567, DOI 10.1016/S0109-5641(02)00106-9
   Jevnikar P, 2010, DENT MATER, V26, P688, DOI 10.1016/j.dental.2010.03.013
   Karimipour-Saryazdi M, 2014, J PROSTHET DENT, V111, P395, DOI 10.1016/j.prosdent.2013.09.034
   Kawai Y, 2010, NANO BIOMED, V2, P31
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kelly JR, 2012, DENT MATER, V28, P41, DOI 10.1016/j.dental.2011.09.001
   KELLY JR, 2004, DENT CLIN N AM, V48, P513, DOI DOI 10.1016/J.CDEN.2004.01.003
   Kern M, 2015, DENT MATER, V31, P8, DOI 10.1016/j.dental.2014.06.007
   Kim GH, 2015, J PROSTHET DENT, V113, P603, DOI 10.1016/j.prosdent.2014.12.013
   Kim JH, 2015, OPER DENT, V40, P55, DOI 10.2341/13-303-L
   Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kumbuloglu O, 2006, OPER DENT, V31, P248, DOI 10.2341/05-22
   Liu D, 2012, J ADHES SCI TECHNOL, V26, P1249, DOI 10.1163/156856111X593586
   Liu YH, 2010, J EUR CERAM SOC, V30, P1297, DOI 10.1016/j.jeurceramsoc.2009.11.019
   Lung CYK, 2015, MAT SCI ENG C-MATER, V46, P103, DOI 10.1016/j.msec.2014.10.029
   Lung CYK, 2012, DENT MATER, V28, P863, DOI 10.1016/j.dental.2012.04.023
   Lung CYK, 2012, DENT MATER, V28, P467, DOI 10.1016/j.dental.2012.02.009
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Luthy H, 2006, DENT MATER, V22, P195, DOI 10.1016/j.dental.2005.04.016
   Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005
   Matinlinna JP, 2011, DENT MATER, V27, P273, DOI 10.1016/j.dental.2010.11.002
   Nakamura T, 2009, J PROSTHODONT RES, V53, P116, DOI 10.1016/j.jpor.2009.02.007
   Oba Y, 2014, DENT MATER J, V33, P226, DOI 10.4012/dmj.2013-346
   Oliveira-Ogliari A, 2015, DENT MATER, V31, P68, DOI 10.1016/j.dental.2014.11.011
   Pereira LD, 2015, J ADHES DENT, V17, P169, DOI 10.3290/j.jad.a33974
   Piascik JR, 2009, DENT MATER, V25, P1116, DOI 10.1016/j.dental.2009.03.008
   Piascik JR, 2012, DENT MATER, V28, P604, DOI 10.1016/j.dental.2012.01.008
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piwowarczyk A, 2005, OPER DENT, V30, P382
   Qeblawi DM, 2015, J PROSTHET DENT, V113, P122, DOI 10.1016/j.prosdent.2014.08.006
   Qeblawi DM, 2010, J PROSTHET DENT, V103, P210, DOI 10.1016/S0022-3913(10)60033-9
   Quinn GD, 2007, FRACTOGRAPHY CERAMIC
   Rekow ED, 2006, DENT MATER, V22, P125, DOI 10.1016/j.dental.2005.04.010
   Renda JJ, 2015, J PROSTHODONT, V24, P188, DOI 10.1111/jopr.12246
   Sailer I, 2007, INT J PROSTHODONT, V20, P383
   Sailer I, 2007, CLIN ORAL IMPLAN RES, V18, P86, DOI 10.1111/j.1600-0501.2007.01468.x
   Sailer I, 2009, INT J PROSTHODONT, V22, P553
   Saito A, 2010, J PROSTHET DENT, V104, P247, DOI 10.1016/S0022-3913(10)60133-3
   Sanli S, 2015, DENT MATER, V31, P657, DOI 10.1016/j.dental.2015.03.004
   Sciasci P, 2015, J PROSTHET DENT, V113, P212, DOI 10.1016/j.prosdent.2014.09.012
   Sun T, 2014, J MECH BEHAV BIOMED, V35, P93, DOI 10.1016/j.jmbbm.2014.03.014
   Swain MV, 2009, ACTA BIOMATER, V5, P1668, DOI 10.1016/j.actbio.2008.12.016
   Taskonak B, 2005, BIOMATERIALS, V26, P3235, DOI 10.1016/j.biomaterials.2004.08.025
   Taskonak B, 2008, DENT MATER, V24, P1149, DOI 10.1016/j.dental.2008.01.004
   Tinschert J, 2008, INT J PROSTHODONT, V21, P217
   VANNOORT R, 1989, J DENT, V17, P61, DOI 10.1016/0300-5712(89)90131-0
   Von Steyern PV, 2005, J ORAL REHABIL, V32, P180, DOI 10.1111/j.1365-2842.2004.01437.x
   Wolfart M, 2007, DENT MATER, V23, P45, DOI 10.1016/j.dental.2005.11.040
   Yang B, 2008, DENT MATER, V24, P508, DOI 10.1016/j.dental.2007.04.013
   Yi YA, 2015, OPER DENT, V40, P63, DOI 10.2341/13-149-L
NR 111
TC 11
Z9 11
U1 6
U2 69
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD AUG
PY 2015
VL 8
IS 8
BP 4978
EP 4991
DI 10.3390/ma8084978
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA CQ5KX
UT WOS:000360643900025
PM 28793485
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Venkatesan, J
   Lowe, B
   Manivasagan, P
   Kang, KH
   Chalisserry, EP
   Anil, S
   Kim, DG
   Kim, SK
AF Venkatesan, Jayachandran
   Lowe, Baboucarr
   Manivasagan, Panchanathan
   Kang, Kyong-Hwa
   Chalisserry, Elna P.
   Anil, Sukumaran
   Kim, Dong Gyu
   Kim, Se-Kwon
TI Isolation and Characterization of Nano-Hydroxyapatite from Salmon Fish
   Bone
SO MATERIALS
LA English
DT Article
DE hydroxyapatite; salmon; fish; alkaline hydrolysis
ID NATURAL HYDROXYAPATITE; NANOCRYSTALLINE HYDROXYAPATITE; COLLAGEN
   SCAFFOLDS; BOVINE BONE; TISSUE; NANOPARTICLES; WASTE; APATITE;
   EXTRACTION; TEMPERATURE
AB Nano-Hydroxyapatite (nHA) was isolated from salmon bone by alkaline hydrolysis. The resulting nHA was characterized using several analytical tools, including thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction analysis (XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM), to determine the purity of the nHA sample. The removal of organic matter from the raw fish was confirmed by TGA. FT-IR confirmed the presence of a carbonated group and the similarities to synthetic Sigma HA. XRD revealed that the isolated nHA was amorphous. Microscopy demonstrated that the isolated nHA possessed a nanostructure with a size range of 6-37 nm. The obtained nHA interacted with mesenchymal stem cells (MSCs) and was non-toxic. Increased mineralization was observed for nHA treated MSCs compared to the control group. These results suggest that nHA derived from salmon is a promising biomaterial in the field of bone tissue engineering.
C1 [Venkatesan, Jayachandran; Manivasagan, Panchanathan; Kang, Kyong-Hwa; Kim, Se-Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Busan 608737, South Korea.
   [Lowe, Baboucarr] Pukyong Natl Univ, Dept Marine Bio Convergence Sci, Busan 608737, South Korea.
   [Chalisserry, Elna P.] King Saud Univ, Dept Anat, Stem Cell Unit, Riyadh 12372, Saudi Arabia.
   [Anil, Sukumaran] King Saud Univ, Dent Biomat Res Chair, Riyadh 12372, Saudi Arabia.
   [Kim, Dong Gyu] Pukyong Natl Univ, Specialized Grad Sch Sci & Technol Convergence, Busan 608739, South Korea.
RP Kim, DG (reprint author), Pukyong Natl Univ, Specialized Grad Sch Sci & Technol Convergence, Busan 608739, South Korea.
EM venkatjchem@pknu.ac.kr; babolowe@gmail.com; manimaribtech@gmail.com;
   khkang@pknu.ac.kr; paulelna@gmail.com; drsanil@gmail.com;
   dgkim@pknu.ac.kr; sknkim@pknu.ac.kr
OI Kim, Se-Kwon/0000-0001-6507-9539; Manivasagan,
   Panchanathan/0000-0002-9548-0451; /0000-0002-6440-8780
FU Pukyong National University; Marine Bioprocess Research Center of the
   Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea
FX This paper was supported by research funds from Pukyong National
   University in 2015 and a grant from the Marine Bioprocess Research
   Center of the Marine Biotechnology Program, funded by the Ministry of
   Oceans and Fisheries, Korea.
CR Bahrololoom ME, 2009, J CERAM PROCESS RES, V10, P129
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Chattanathan S., 2013, WATER AIR SOIL POLL, V224, P1
   Coelho T.M., 2007, J APPL PHYS, V101
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Guo GS, 2005, CERAM INT, V31, P869, DOI 10.1016/j.ceramint.2004.10.003
   Hoyer B, 2012, BIOMACROMOLECULES, V13, P1059, DOI 10.1021/bm201776r
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Janus AM, 2008, MICROCHIM ACTA, V161, P349, DOI 10.1007/s00604-007-0864-2
   Jarudilokkul S, 2007, COLLOID SURFACE A, V296, P149, DOI 10.1016/j.colsurfa.2006.09.038
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kim B.S., 2014, BIOMED MAT, V9
   Kongsri S, 2013, CHEM ENG J, V215, P522, DOI 10.1016/j.cej.2012.11.054
   Lima WM, 2005, MATER SCI FORUM, V498-499, P600, DOI 10.4028/www.scientific.net/MSF.498-499.600
   Matsuura A, 2009, DENT MATER J, V28, P234, DOI 10.4012/dmj.28.234
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Ozawa M, 2005, J MATER SCI, V40, P1037, DOI 10.1007/s10853-005-6529-9
   Ozawa M, 2003, J MATER SCI LETT, V22, P513, DOI 10.1023/A:1022982218727
   Ozawa M, 2002, J AM CERAM SOC, V85, P1315, DOI 10.1111/j.1151-2916.2002.tb00268.x
   Ozawa M., 2007, P INT S ECOTOPIA SCI, P957
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Panda NN, 2014, BIOPROC BIOSYST ENG, V37, P433, DOI 10.1007/s00449-013-1009-0
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Piccirillo C, 2013, MAT SCI ENG C-MATER, V33, P103, DOI 10.1016/j.msec.2012.08.014
   Prabakaran K., 2006, TRENDS BIOMATER ARTI, V20, P20
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Ruksudjarlt A, 2008, CURR APPL PHYS, V8, P270, DOI 10.1016/j.cap.2007.10.076
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shimizu K, 2007, J BIOMED MATER RES B, V82B, P471, DOI 10.1002/jbm.b.30752
   Sofronia AM, 2014, MAT SCI ENG C-MATER, V43, P153, DOI 10.1016/j.msec.2014.07.023
   Venkatesan J., 2011, BIOMED MAT, V6
   Venkatesan J, 2012, INT J BIOL MACROMOL, V50, P393, DOI 10.1016/j.ijbiomac.2011.12.032
   Venkatesan J, 2010, MATERIALS, V3, P4761, DOI 10.3390/ma3104761
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
   Xu JL, 2004, MAT SCI ENG A-STRUCT, V374, P101, DOI 10.1016/j.msea.2003.12.040
   Yunoki S., 2011, BIOMED MAT, V6
   Zainol I, 2012, ADV MATER RES-SWITZ, V545, P235, DOI 10.4028/www.scientific.net/AMR.545.235
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 46
TC 10
Z9 11
U1 1
U2 20
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD AUG
PY 2015
VL 8
IS 8
BP 5426
EP 5439
DI 10.3390/ma8085253
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA CQ5KX
UT WOS:000360643900056
PM 28793514
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lee, S
   Jeong, MJ
   Kang, KY
AF Lee, Sinah
   Jeong, Myung-Joon
   Kang, Kyu-Young
TI Preparation of cellulose aerogels as a nano-biomaterial from
   lignocellulosic biomass
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article
DE Cellulose; Aerogel; Fiber analysis; Microstructure; Lignocellulosic
   biomass
ID COHERENT EXPANDED AEROGELS; AEROCELLULOSE
AB Cellulose aerogels were prepared from various delignified wood fibers by using a peracetic acid pretreatment. The effect of the treatment conditions was evaluated to find the optimum condition for the production of a functional cellulose aerogel for use as a nano-biomaterial. The morphologies and the physical properties of the delignified wood fibers were analyzed and compared according to the various conditions of pretreatment. The density and the microstructure were studied for cellulose aerogels produced from delignified wood fibers. The results showed that peracetic acid pretreatment did not have a considerable effect on the average fiber length and the surface; however, acid hydrolysis caused a decrease in the viscosity of the wood fibers and an increase in their density and destroyed the microstructure. According to these results minimizing cellulose degradation while wood pulping is an important consideration in the preparation of cellulose aerogels.
C1 [Lee, Sinah; Jeong, Myung-Joon; Kang, Kyu-Young] Dongguk Univ Seoul, Dept Biol & Environm Sci, Seoul 100715, South Korea.
RP Lee, S (reprint author), Dongguk Univ Seoul, Dept Biol & Environm Sci, Seoul 100715, South Korea.
EM kykang@dongguk.edu
OI Kang, Kyu-Young/0000-0002-0457-842X
FU Korea Forest Service [S111314L010130]; Dongguk University
FX This study was carried out with the support of 'Forest Science &
   Technology Project (Project No. S111314L010130)' provided by Korea
   Forest Service. This work was also supported by the research program of
   Dongguk University, 2015.
CR Duchemin B. J. C., 2009, J APPL POLYM SCI, V115, P216
   Gavillon R, 2008, BIOMACROMOLECULES, V9, P269, DOI 10.1021/bm700972k
   Hattori M., 1998, POLYM J, V30, P44
   Hoepfner S, 2008, CELLULOSE, V15, P121, DOI 10.1007/s10570-007-9146-8
   Innerlohinger J, 2006, MACROMOL SYMP, V244, P126, DOI 10.1002/masy.200651212
   Jeong MJ, 2014, CELLULOSE, V21, P4621, DOI 10.1007/s10570-014-0455-4
   Jin H, 2004, COLLOID SURFACE A, V240, P63, DOI 10.1016/j.colsurfa.2004.03.007
   Kistler SS, 1932, J PHYS CHEM-US, V36, P52, DOI 10.1021/j150331a003
   Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0
   Lafontaine R., 1984, SILICA GEL
   Li J, 2011, BIOMACROMOLECULES, V12, P1860, DOI 10.1021/bm200205z
   Liebner F., 2007, HOLZFORSCHUNG, V63, P3
   Staudinger H., 1938, PAPIERFABRIKANT, V36, P373
   Tan CB, 2001, ADV MATER, V13, P644, DOI 10.1002/1521-4095(200105)13:9<644::AID-ADMA644>3.0.CO;2-#
   Wang ZG, 2012, CELLULOSE, V19, P393, DOI 10.1007/s10570-012-9651-2
   Yamamoto M, 2011, BIOMACROMOLECULES, V12, P3982, DOI 10.1021/bm201211z
NR 16
TC 1
Z9 1
U1 4
U2 38
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
EI 1976-8524
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD AUG
PY 2015
VL 67
IS 4
BP 738
EP 741
DI 10.3938/jkps.67.738
PG 4
WC Physics, Multidisciplinary
SC Physics
GA CQ6KE
UT WOS:000360712400024
DA 2018-10-19
ER

PT J
AU Sedaghati, T
   Seifalian, AM
AF Sedaghati, Tina
   Seifalian, Alexander M.
TI Nanotechnology and bio-functionalisation for peripheral nerve
   regeneration
SO NEURAL REGENERATION RESEARCH
LA English
DT Review
DE nanomaterial; regenerative medicine; biomaterial; peptides; nerve
   regeneration; stem cells; nanotechnology
ID PEPTIDE NANOFIBER SCAFFOLD; SPINAL-CORD-INJURY; EXTRACELLULAR-MATRIX;
   SCHWANN-CELLS; SCIATIC-NERVE; BIOMATERIALS APPROACH; NEURITE OUTGROWTH;
   RGD; CONDUITS; SURFACE
AB There is a high clinical demand for new smart biomaterials, which stimulate neuronal cell proliferation, migration and increase cell-material interaction to facilitate nerve regeneration across these critical-sized defects. This article briefly reviews several up-to-date published studies using Arginine-Glycine-Aspartic acid peptide sequence, nanocomposite based on polyhedral oligomeric silsesquioxane nanoparticle and nanofibrous scaffolds as promising strategies to enhance peripheral nerve regeneration by influencing cellular behaviour such as attachment, spreading and proliferation. The aim is to establish the potent manipulations, which are simple and easy to employ in the clinical conditions for nerve regeneration and repair.
C1 [Sedaghati, Tina; Seifalian, Alexander M.] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
   [Seifalian, Alexander M.] Royal Free NHS Trust Fdn Hosp, London, England.
   [Seifalian, Alexander M.] NanoRegMed Ltd, London, England.
RP Seifalian, AM (reprint author), UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
EM a.seifalian@gmail.com
CR Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055
   BARONVANEVERCOOREN A, 1982, J CELL BIOL, V93, P211, DOI 10.1083/jcb.93.1.211
   Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883
   Chawla R, 2014, J SURG RES, V188, P361, DOI 10.1016/j.jss.2014.01.006
   Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Ghanbari H, 2011, MACROMOL RAPID COMM, V32, P1032, DOI 10.1002/marc.201100126
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hong S, 2010, J BIOMED MATER RES B, V94B, P421, DOI 10.1002/jbm.b.31670
   Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4
   Hu JP, 2011, MACROMOL RAPID COMM, V32, P1729, DOI 10.1002/marc.201100343
   Huang JF, 2013, J RECONSTR MICROSURG, V29, P77, DOI 10.1055/s-0032-1328918
   Huang JF, 2010, NEUROL INDIA, V58, P384, DOI 10.4103/0028-3886.65810
   Jell G., 2009, FUNDAMENTALS TISSUE, P469
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Liu WQ, 2009, NEUROBIOL DIS, V34, P11, DOI 10.1016/j.nbd.2008.11.012
   Masaeli E, 2014, NANOMED-NANOTECHNOL, V10, P1559, DOI 10.1016/j.nano.2014.04.008
   Matsumoto K, 2000, ASAIO J, V46, P415, DOI 10.1097/00002480-200007000-00009
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Olakowska E, 2010, FOLIA NEUROPATHOL, V48, P231
   Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Puppi D, 2011, J TISSUE ENG REGEN M, V5, P253, DOI 10.1002/term.310
   Qiu T, 2014, J BIOMED MATER RES A, V102, P3734, DOI 10.1002/jbm.a.35078
   Rafiuddin M, 2003, BRAIN RES, V993, P208, DOI 10.1016/j.brainres.2003.08.057
   Rashid ST, 2004, EUR J VASC ENDOVASC, V27, P608, DOI 10.1016/j.ejvs.2004.01.020
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sedaghati T., 2014, REGEN MED APPL ORGAN, P799
   Sedaghati T, 2014, NEW BIOTECHNOL, V31, P203, DOI 10.1016/j.nbt.2014.01.002
   Sedaghati T, 2011, BIOTECHNOL APPL BIOC, V58, P288, DOI 10.1002/bab.51
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Torabinejad B, 2014, MAT SCI ENG C-MATER, V42, P199, DOI 10.1016/j.msec.2014.05.003
   Tsintou M, 2015, NEURAL REGEN RES, V10, P726, DOI 10.4103/1673-5374.156966
   Tucker BA, 2008, CAN J NEUROL SCI, V35, P551, DOI 10.1017/S0317167100009331
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037
   Xiao W, 2013, INJURY, V44, P941, DOI 10.1016/j.injury.2013.03.029
   Yan QJ, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-36
   Yazdimamaghani M, 2014, J BIOMED NANOTECHNOL, V10, P911, DOI 10.1166/jbn.2014.1783
   Yildirimer L, 2015, TISSUE ENG PART C-ME, V21, P614, DOI [10.1089/ten.tec.2014.0270, 10.1089/ten.TEC.2014.0270]
   Yun DH, 2014, J BIOMAT SCI-POLYM E, V25, P354, DOI 10.1080/09205063.2013.861170
NR 51
TC 5
Z9 5
U1 1
U2 51
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD AUG
PY 2015
VL 10
IS 8
BP 1191
EP 1194
DI 10.4103/1673-5374.162678
PG 4
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CQ5HX
UT WOS:000360635300003
PM 26487832
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Hosseini, SM
   Vasaghi, A
   Nakhlparvar, N
   Roshanravan, R
   Talaei-Khozani, T
   Razi, Z
AF Hosseini, Seyed Mojtaba
   Vasaghi, Attiyeh
   Nakhlparvar, Newsha
   Roshanravan, Reza
   Talaei-Khozani, Tahereh
   Razi, Zahra
TI Differentiation of Wharton's jelly mesenchymal stem cells into neurons
   in alginate scaffold
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; Wharton's jelly mesenchymal stem cells; mesenchymal
   stem cells; neurons; motor neurons; alginate; 3D scaffold; neural
   regeneration
ID UMBILICAL-CORD; STROMAL CELLS; BONE-MARROW; LINEAGE; ADIPOSE
AB Alginate scaffold has been considered as an appropriate biomaterial for promoting the differentiation of embryonic stem cells toward neuronal cell lineage. We hypothesized that alginate scaffold is suitable for culturing Wharton's jelly mesenchymal stem cells (WJMSCs) and can promote the differentiation of WJMSCs into neuron-like cells. In this study, we cultured WJMSCs in a three-dimensional scaffold fabricated by 0.25% alginate and 50 mM CaCl2 in the presence of neurogenic medium containing 10 mu M retinoic acid and 20 ng/mL basic fibroblast growth factor. These cells were also cultured in conventional two-dimensional culture condition in the presence of neurogenic medium as controls. After 10 days, immunofluorescence staining was performed for detecting beta-tubulin (marker for WJMSCs-differentiated neuron) and CD271 (motor neuron marker). beta-Tubulin and CD271 expression levels were significantly greater in the WJMSCs cultured in the three-dimensional alginate scaffold than in the conventional two-dimensional culture condition. These findings suggest that three-dimensional alginate scaffold cell culture system can induce neuronal differentiation of WJMSCs effectively.
C1 [Hosseini, Seyed Mojtaba; Vasaghi, Attiyeh; Nakhlparvar, Newsha] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   [Hosseini, Seyed Mojtaba; Vasaghi, Attiyeh; Nakhlparvar, Newsha; Razi, Zahra] Shiraz Univ Med Sci, Sch Med, Cell & Mol Med Student Res Grp, Shiraz, Iran.
   [Hosseini, Seyed Mojtaba] Shiraz Univ Med Sci, Dept Anat, Stem Cell Lab, Shiraz, Iran.
   [Roshanravan, Reza] Shiraz Univ Med Sci, Colorectal Res Ctr, Dept Surg, Shiraz, Iran.
   [Talaei-Khozani, Tahereh] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Tissue Engn, Tissue Engn Lab, Shiraz, Iran.
   [Talaei-Khozani, Tahereh] Shiraz Univ Med Sci, Sch Med, Dept Anat, Lab Stem Cell Res, Shiraz, Iran.
   [Razi, Zahra] Shiraz Univ Med Sci, Dept Med Phys, Shiraz, Iran.
RP Talaei-Khozani, T (reprint author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Tissue Engn, Tissue Engn Lab, Shiraz, Iran.
EM talaeit@sums.ac.ir
RI Talaei-khozani, Tahereh/N-2344-2015
OI Talaei-khozani, Tahereh/0000-0002-8425-8871
FU Shiraz University of Medical Sciences, Iran [5959]
FX We wish to thank the research deputy of Shiraz University of Medical
   Sciences, Iran for offering student research grant (No. 5959).
CR Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Balasubramanian S, 2013, CELL BIOL INT, V37, P507, DOI 10.1002/cbin.10056
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bozza A, 2014, BIOMATERIALS, V35, P4636, DOI 10.1016/j.biomaterials.2014.02.039
   Candiello J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-9
   Datta I, 2011, CYTOTHERAPY, V13, P918, DOI 10.3109/14653249.2011.579957
   Divya MS, 2012, STEM CELL RES THER, V19, P57
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x
   Frampton JP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015002
   Hosseini SM, 2013, CELL J, V15, P46
   Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604
   Khodabandeh Z, 2015, IRAN J MED IN PRESS
   Kim J, 2013, STEM CELL RES, V11, P978, DOI 10.1016/j.scr.2013.06.005
   La Rocca G, 2009, HISTOCHEM CELL BIOL, V131, P267, DOI 10.1007/s00418-008-0519-3
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   Messerli M, 2013, REPROD SCI, V20, P1455, DOI 10.1177/1933719113488443
   Montanucci P, 2011, TISSUE ENG PT A, V17, P2651, DOI [10.1089/ten.TEA.2010.0587, 10.1089/ten.tea.2010.0587]
   Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Penolazzi L, 2010, TISSUE ENG PART C-ME, V16, P141, DOI [10.1089/ten.tec.2008.0582, 10.1089/ten.TEC.2008.0582]
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Ribeiro J, 2013, INT REV NEUROBIOL, V108, P79, DOI 10.1016/B978-0-12-410499-0.00004-6
   Shakhbazau AV, 2011, B EXP BIOL MED+, V150, P547, DOI 10.1007/s10517-011-1186-2
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Tantrawatpan Chairat, 2013, Journal of the Medical Association of Thailand, V96, P1208
   Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
   Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330
   Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Zhang L, 2009, NEUROCHEM RES, V34, P2030, DOI 10.1007/s11064-009-9992-x
NR 35
TC 5
Z9 5
U1 0
U2 6
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD AUG
PY 2015
VL 10
IS 8
BP 1312
EP 1316
DI 10.4103/1673-5374.162768
PG 5
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CQ5HX
UT WOS:000360635300032
PM 26487861
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ayyub, OB
   Kofinas, P
AF Ayyub, Omar B.
   Kofinas, Peter
TI Enzyme Induced Stiffening of Nanoparticle-Hydrogel Composites with
   Structural Color
SO ACS NANO
LA English
DT Article
DE hydrogel; nanoparticle; photonic crystal; self-assembly; protease
ID PHOTONIC CRYSTALS; IONIC-STRENGTH; DELIVERY; HYDROLYSIS; SENSORS; FILMS;
   PH
AB The passive monitoring of biological environments by soft materials has a variety of nanobiotechnology applications; however, invoking distinct transitions in geometric, mechanical or optical properties remains a prevalent design challenge. We demonstrate here that close-packed nanoparticle hydrogel composites can progress through a substantial shift in such properties by the use of a chemical-to-physical cross-link transition mediated by the catalytic activity of different proteases. Catalytic cleavage of the original hydrogel network structure initiates the self-assembled formation of a secondary, physically cross-linked network, causing a 1200% increase in storage modulus. Furthermore, this unique mechanism can be fabricated as a 3D photonic crystal with broad (similar to 240 nm), visible responses to the targeted enzymes. Moreover, the material provided threshold responses, requiring a certain extent of proteolytic activity before the transition occurred. This allowed for the fabrication of Boolean logic gates (OR and AND), which responded to a specific assortment of proteases. Ultimately, this mechanism enables the design of stimuli-responsive hydrogels, which can proceed through a secondary network formation, after an energetic barrier has been breached. Protease responsive hydrogel nanocomposites, described here, could offer avenues in degradation-stiffening and collapsing materials for a variety of biomaterial applications.
C1 [Ayyub, Omar B.; Kofinas, Peter] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Kofinas, P (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM kofinas@umd.edu
OI Kofinas, Peter/0000-0001-6657-3037
FU NIBIB NIH HHS [R01 EB019963]
CR Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Asher SA, 2003, J AM CHEM SOC, V125, P3322, DOI 10.1021/ja021037h
   Ayyub OB, 2011, BIOSENS BIOELECTRON, V28, P349, DOI 10.1016/j.bios.2011.07.043
   BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Holtz JH, 1997, NATURE, V389, P829
   Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/nchem.1937, 10.1038/NCHEM.1937]
   Kilian KA, 2009, NANO LETT, V9, P2021, DOI 10.1021/nl900283j
   Kimble KW, 2006, ANAL BIOANAL CHEM, V385, P678, DOI 10.1007/s00216-006-0453-y
   Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282
   Lee K, 2000, J AM CHEM SOC, V122, P9534, DOI 10.1021/ja002017n
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacConaghy KI, 2014, J AM CHEM SOC, V136, P6896, DOI 10.1021/ja5031062
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Orosco MM, 2009, NAT NANOTECHNOL, V4, P255, DOI [10.1038/NNANO.2009.11, 10.1038/nnano.2009.11]
   Orosco MM, 2006, ADV MATER, V18, P1393, DOI 10.1002/adma.200502420
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Plunkett KN, 2005, BIOMACROMOLECULES, V6, P632, DOI 10.1021/bm049349v
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Rose S, 2014, NATURE, V505, P382, DOI 10.1038/nature12806
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Thornton PD, 2007, ADV MATER, V19, P1252, DOI 10.1002/adma.200601784
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Xu M, 2008, J AM CHEM SOC, V130, P3113, DOI [10.1021/ja077979, 10.1021/ja077979+]
   Yetisen AK, 2014, SENSOR ACTUAT B-CHEM, V196, P156, DOI 10.1016/j.snb.2014.01.077
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Yoshida T, 2003, J POLYM SCI POL CHEM, V41, P779, DOI 10.1002/pola.10595
NR 31
TC 22
Z9 22
U1 16
U2 204
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD AUG
PY 2015
VL 9
IS 8
BP 8004
EP 8011
DI 10.1021/acsnano.5b01514
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CQ0YA
UT WOS:000360323300028
PM 26196060
DA 2018-10-19
ER

PT J
AU Brennan, MA
   Renaud, A
   Gamblin, AL
   D'Arros, C
   Nedellec, S
   Trichet, V
   Layrolle, P
AF Brennan, Meadhbh A.
   Renaud, Audrey
   Gamblin, Anne-laure
   D'Arros, Cyril
   Nedellec, Steven
   Trichet, Valerie
   Layrolle, Pierre
TI 3D cell culture and osteogenic differentiation of human bone marrow
   stromal cells plated onto jet-sprayed or electrospun micro-fiber
   scaffolds
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE micro-fiber scaffolds; electrospinning; jet-spraying; cell infiltration;
   mesenchymal stromal cells; 3D in vitro bone tissue models
ID MESENCHYMAL STEM-CELLS; IN-VITRO; INFILTRATION; ADHESION; POROSITY;
   MATRIX; MEDICINE; BIOLOGY; SHAPE
AB A major limitation of the 2D culture systems is that they fail to recapitulate the in vivo 3D cellular microenvironment whereby cell-cell and cell-extracellular matrix (ECM) interactions occur. In this paper, a biomaterial scaffold that mimics the structure of collagen fibers was produced by jet-spraying. This micro-fiber polycaprolactone (PCL) scaffold was evaluated for 3D culture of human bone marrow mesenchymal stromal cells (MSCs) in comparison with a commercially available electrospun scaffold. The jet-sprayed scaffolds had larger pore diameters, greater porosity, smaller diameter fibers, and more heterogeneous fiber diameter size distribution compared to the electrospun scaffolds. Cells on jet-sprayed constructs exhibited spread morphology with abundant cytoskeleton staining, whereas MSCs on electrospun scaffolds appeared less extended with fewer actin filaments. MSC proliferation and cell infiltration occurred at a faster rate on jet-sprayed compared to electrospun scaffolds. Osteogenic differentiation of MSCs and ECM production as measured by ALP, collagen and calcium deposition was superior on jet-sprayed compared to electrospun scaffolds. The jet-sprayed scaffold which mimics the native ECM and permits homogeneous cell infiltration is important for 3D in vitro applications such as bone cellular interaction studies or drug testing, as well as bone tissue engineering strategies.
C1 [Brennan, Meadhbh A.; Renaud, Audrey; Gamblin, Anne-laure; Trichet, Valerie; Layrolle, Pierre] Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt & Primary Bone Tumo, INSERM,UMR 957, F-44035 Nantes, France.
   [D'Arros, Cyril] IRTUN, Biomed Tissues SAS, Nantes, France.
   [Nedellec, Steven] CNRS 3556, SFR Sante Francois Bonamy, MicroPICell Platform, INSERM,UMS 016, Nantes, France.
RP Brennan, MA (reprint author), Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt & Primary Bone Tumo, INSERM,UMR 957, F-44035 Nantes, France.
EM pierre.layrolle@inserm.fr
RI Layrolle, Pierre/K-9257-2015; Brennan, Meadhbh/L-2068-2015; Trichet,
   Valerie/L-1553-2015
OI Layrolle, Pierre/0000-0001-9800-5210; Brennan, Meadhbh
   A/0000-0002-1532-9760
FU Region Pays de la Loire: Postdoctoral Fellowship; European Commission
   [241879]
FX The authors would like to acknowledge funding from Region Pays de la
   Loire: Postdoctoral Fellowship and the European Commission under the FP7
   framework, Reborne Project (#241879). We would also like to thank EFS
   Toulouse for kindly providing the MSCs.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abdal-hay A, 2014, MATER LETT, V125, P51, DOI 10.1016/j.matlet.2014.03.138
   Abdal-haya A, 2013, COLLOID SURFACE B, V102, P635, DOI 10.1016/j.colsurfb.2012.09.017
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Arumuganathar S, 2008, BIOMACROMOLECULES, V9, P759, DOI 10.1021/bm701322k
   Arumuganathar S, 2008, J APPL POLYM SCI, V107, P1215, DOI 10.1002/app.27190
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955067402003733
   Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Fong ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/pnas.1221403110
   Ghasemi-Mobarakeh L, 2008, YAKHTEH, V10, P179
   Ghasemi-Mobarakeh L, 2009, INT J ARTIF ORGANS, V32, P150
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144
   Hsu SH, 2013, ACTA BIOMATER, V9, P6915, DOI 10.1016/j.actbio.2013.02.012
   Jayasinghe SN, 2013, ANALYST, V138, P2215, DOI 10.1039/c3an36599a
   Jayasinghe SN, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3328092
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470
   Lavenus S, 2011, EUR CELLS MATER, V22, P84, DOI 10.22203/eCM.v022a07
   Logan N, 2013, STEM CELLS INT
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1095, DOI 10.1089/ten.tec.2009.0753
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Nerurkar NL, 2011, ACTA BIOMATER, V7, P485, DOI 10.1016/j.actbio.2010.08.011
   Norgaard R, 2006, ANN NY ACAD SCI, V1067, P443, DOI 10.1196/annals.1354.063
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Sohier J, 2014, TISSUE ENG PART C-ME, V20, P285, DOI [10.1089/ten.TEC.2013.0147, 10.1089/ten.tec.2013.0147]
   Sohier J, 2014, BIOMATERIALS, V35, P1833, DOI 10.1016/j.biomaterials.2013.10.061
   Townsend-Nicholson A, 2006, BIOMACROMOLECULES, V7, P3364, DOI 10.1021/bm060649h
   Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b
   Wright LD, 2011, MAT SCI ENG C-MATER, V31, P30, DOI 10.1016/j.msec.2010.02.001
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 46
TC 16
Z9 16
U1 3
U2 47
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045019
DI 10.1088/1748-6041/10/4/045019
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600020
PM 26238732
OA Other Gold
DA 2018-10-19
ER

PT J
AU Brown, CFC
   Yan, J
   Han, TTY
   Marecak, DM
   Amsden, BG
   Flynn, LE
AF Brown, Cody F. C.
   Yan, Jing
   Han, Tim Tian Y.
   Marecak, Dale M.
   Amsden, Brian G.
   Flynn, Lauren E.
TI Effect of decellularized adipose tissue particle size and cell density
   on adipose-derived stem cell proliferation and adipogenic
   differentiation in composite methacrylated chondroitin sulphate
   hydrogels
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE adipose tissue engineering; composite scaffolds; particle size;
   extracellular matrix (ECM); chondroitin sulphate; adipose-derived stem
   cells; adipogenic differentiation
ID SCAFFOLDS; MICROENVIRONMENT; ADHESION
AB An injectable composite scaffold incorporating decellularized adipose tissue (DAT) as a bioactive matrix within a hydrogel phase capable of in situ polymerization would be advantageous for adipose-derived stem cell (ASC) delivery in the filling of small or irregular soft tissue defects. Building on previous work, the current study investigates DAT milling methods and the effects of DAT particle size and cell seeding density on the response of human ASCs encapsulated in photo-cross-linkable methacrylated chondroitin sulphate (MCS)-DAT composite hydrogels. DAT particles were generated by milling lyophilized DAT and the particle size was controlled through the processing conditions with the goal of developing composite scaffolds with a tissue-specific 3D microenvironment tuned to enhance adipogenesis. ASC proliferation and adipogenic differentiation were assessed in vitro in scaffolds incorporating small (average diameter of 38 +/- 6 mu m) or large (average diameter of 278 +/- 3 mu m) DAT particles in comparison to MCS controls over a period of up to 21 d. Adipogenic differentiation was enhanced in the composites incorporating the smaller DAT particles and seeded at the higher density of 5 x 10(5) ASCs/scaffold, as measured by glycerol-3-phosphate dehydrogenase (GPDH) enzyme activity, semi-quantitative analysis of perilipin expression and oil red O staining of intracellular lipid accumulation. Overall, this study demonstrates that decellularized tissue particle size can impact stem cell differentiation through cell-cell and cell-matrix interactions, providing relevant insight towards the rational design of composite biomaterial scaffolds for adipose tissue engineering.
C1 [Brown, Cody F. C.; Flynn, Lauren E.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
   [Yan, Jing; Han, Tim Tian Y.; Marecak, Dale M.; Amsden, Brian G.; Flynn, Lauren E.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   [Yan, Jing; Han, Tim Tian Y.; Marecak, Dale M.; Amsden, Brian G.; Flynn, Lauren E.] Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON K7L 2V7, Canada.
   [Flynn, Lauren E.] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Brown, CFC (reprint author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
EM lauren.flynn@uwo.ca
RI Flynn, Lauren/C-9967-2015
OI Flynn, Lauren/0000-0001-6227-0928
FU Canadian Institutes of Health Research (CIHR); Canada Foundation for
   Innovation (CFI); Ontario Ministry of Research and Innovation (MRI)
FX Funding for this study was provided by the Canadian Institutes of Health
   Research (CIHR), with infrastructure support from the Canada Foundation
   for Innovation (CFI) and the Ontario Ministry of Research and Innovation
   (MRI). The authors would like to acknowledge Drs F Watkins, K Meathrel,
   J Davidson, D McKay, and Mrs K Martin for their clinical collaborations.
CR American Society for Aesthetic Plastic Surgery, 2013, TOP 5 PROC SURG NONS
   Ang XM, 2014, TISSUE ENG PT A, V20, P966, DOI [10.1089/ten.tea.2013.0337, 10.1089/ten.TEA.2013.0337]
   Bauer-Kreisel P, 2010, ADV DRUG DELIVER REV, V62, P798, DOI 10.1016/j.addr.2010.04.003
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   DAVIES PF, 1994, J CLIN INVEST, V93, P2031, DOI 10.1172/JCI117197
   Flynn L, 2009, J BIOMED MATER RES A, V89A, P929, DOI 10.1002/jbm.a.32044
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   Flynn Lauren, 2008, Organogenesis, V4, P228
   Gibson M, 2014, BIOMED RES INT, DOI 10.1155/2014/469120
   Hauner H, 2001, ADIPOSE TISSUE PROTO
   Hillel AT, 2011, SCI TRANSL MED, V3, P93
   Kaufman MR, 2007, PLAST RECONSTR SURG, V119, P2287, DOI 10.1097/01.prs.0000260712.44089.e7
   Korhonen H, 1998, TRENDS FOOD SCI TECH, V9, P307, DOI 10.1016/S0924-2244(98)00054-5
   KUHL M, 1994, MAR ECOL PROG SER, V105, P139, DOI 10.3354/meps105139
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   PEER L A, 1956, Plast Reconstr Surg (1946), V18, P233, DOI 10.1097/00006534-195610000-00001
   Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Saylan Ziya, 2003, Aesthet Surg J, V23, P221, DOI 10.1067/maj.2003.45
   Shenaq SM, 2002, CLIN PLAST SURG, V29, P111, DOI 10.1016/S0094-1298(03)00089-0
   SMAHEL J, 1989, BRIT J PLAST SURG, V42, P207, DOI 10.1016/0007-1226(89)90205-1
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Turner AEB, 2012, BIOMATERIALS, V33, P4490, DOI 10.1016/j.biomaterials.2012.03.026
   Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055
   Yeatts AB, 2012, BIOTECHNOL BIOENG, V109, P2381, DOI 10.1002/bit.24497
   Young DA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024104
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
   Yu C, 2013, BIOMATERIALS, V34, P3290, DOI 10.1016/j.biomaterials.2013.01.056
NR 33
TC 15
Z9 15
U1 1
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045010
DI 10.1088/1748-6041/10/4/045010
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600011
PM 26225549
DA 2018-10-19
ER

PT J
AU Foroutan, F
   Walters, NJ
   Owens, GJ
   Mordan, NJ
   Kim, HW
   de Leeuw, NH
   Knowles, JC
AF Foroutan, Farzad
   Walters, Nick J.
   Owens, Gareth J.
   Mordan, Nicola J.
   Kim, Hae-Won
   de Leeuw, Nora H.
   Knowles, Jonathan C.
TI Sol-gel synthesis of quaternary
   (P2O5)(55)-(CaO)(25)-(Na2O)((20-x))-(TiO2)(x) bioresorbable glasses for
   bone tissue engineering applications (x=0, 5, 10, or 15)
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE sol-gel; phosphate-based glass; bioactive glass; titanium; biomaterial;
   tissue engineering
ID PHOSPHATE-BASED GLASSES; STRUCTURAL-CHARACTERIZATION; BIOMEDICAL
   APPLICATIONS; SOLUBLE GLASSES; TITANIUM; SOLUBILITY; BULK
AB In the present study, we report a new and facile sol-gel synthesis of phosphate-based glasses with the general formula of (P2O5)(55)-(CaO)(25)-(Na2O)((20-x))-(TiO2)(x), where x = 0, 5, 10 or 15, for bone tissue engineering applications. The sol-gel synthesis method allows greater control over glass morphology at relatively low processing temperature (200 degrees C) in comparison with phosphate-based melt-derived glasses (similar to 1000 degrees C). The glasses were analyzed using several characterization techniques, including x-ray diffraction (XRD), P-31 magic angle spinning nuclear magnetic resonance (P-31 MAS-NMR), Fourier transform infrared (FTIR) spectroscopy and energy-dispersive x-ray (EDX) spectroscopy, which confirmed the amorphous and glassy nature of the prepared samples. Degradation was assessed by measuring the ion release and pH change of the storage medium. Cytocompatibility was also confirmed by culturing osteoblast-like osteosarcoma cell line MG-63 on the glass microparticles over a seven-day period. Cell attachment to the particles was imaged using scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). The results revealed the potential of phosphate-based sol-gel derived glasses containing 5 or 10 mol% TiO2, with high surface area, ideal dissolution rate for cell attachment and easily metabolized dissolution products, for bone tissue engineering applications.
C1 [Foroutan, Farzad; Owens, Gareth J.; Mordan, Nicola J.; Knowles, Jonathan C.] UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   [Foroutan, Farzad; de Leeuw, Nora H.] UCL, Dept Chem, London WC1H 0AJ, England.
   [Walters, Nick J.] Univ Tampere, Adult Stem Cell Grp, Tampere 33014, Finland.
   [Walters, Nick J.] BioMediTech, Tampere 33520, Finland.
   [Kim, Hae-Won; Knowles, Jonathan C.] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Kim, Hae-Won; Knowles, Jonathan C.] Dankook Univ, Plus NBM Global Res Ctr Regenerat Med BK21, Cheonan 330714, South Korea.
   [Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Cheonan 330714, South Korea.
   [Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Res Ctr Nanobiomed Sci, Chungnam 330714, South Korea.
   [de Leeuw, Nora H.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales.
RP Foroutan, F (reprint author), UCL Eastman Dent Inst, Div Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
EM j.knowles@ucl.ac.uk
OI Walters, Nick/0000-0002-4138-9695
FU UCL Industrial Doctorate Centre in Molecular Modelling & Material
   Science; National Research Centers Program through the National Research
   Foundation (NRF), Republic of Korea [2009-0093829]; Engineering and
   Physical Sciences Research Council [EP/J008095/1, EP/J008095/2]
FX This project was supported by the UCL Industrial Doctorate Centre in
   Molecular Modelling & Material Science and in part (JCK & HWK) by
   National Research Centers Program (2009-0093829) through the National
   Research Foundation (NRF), Republic of Korea. The authors are grateful
   to Dr David Apperley for performing <SUP>31</SUP>P MAS-NMR measurements
   (EPSRC NMR Service, Department of Chemistry, Durham University).
CR Abou Neel EA, 2014, MAT SCI ENG C-MATER, V35, P307, DOI 10.1016/j.msec.2013.10.029
   Abou Neel EA, 2008, ACTA BIOMATER, V4, P523, DOI 10.1016/j.actbio.2007.11.007
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Brauer DS, 2010, J NON-CRYST SOLIDS, V356, P2626, DOI 10.1016/j.jnoncrysol.2010.03.022
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   Dricsscns F C M, 1982, MONOGRAPHS ORAL SCI, P10
   Fluck E, 1978, PHOSPHOR PHOSPHORUS, V26, P386
   Foroutan F, 2015, J SOL-GEL SCI TECHN, V73, P434, DOI 10.1007/s10971-014-3555-6
   Franks K, 2000, J MATER SCI-MATER M, V11, P609, DOI 10.1023/A:1008949527695
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Hu HJ, 2013, COLLOID SURFACE B, V101, P83, DOI 10.1016/j.colsurfb.2012.06.021
   Kiani A, 2012, PHILOS T R SOC A, V370, P1352, DOI 10.1098/rsta.2011.0276
   KIRKPATRICK RJ, 1995, SOLID STATE NUCL MAG, V5, P9, DOI 10.1016/0926-2040(95)00042-O
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Lakhkar NJ, 2012, ACTA BIOMATER, V8, P4181, DOI 10.1016/j.actbio.2012.07.023
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee IH, 2013, PHYS CHEM GLASSES-B, V54, P115
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   Montague L, CHEM MAT, V15, P4709
   Montchamp J.-L., 2015, PHOSPHORUS CHEM
   Navarro M, 2003, J BIOMED MATER RES A, V67A, P1009, DOI 10.1002/jbm.a.20014
   Pickup DM, 2008, J MATER SCI-MATER M, V19, P1681, DOI 10.1007/s10856-007-3342-9
   Pickup DM, 2008, J MATER SCI-MATER M, V19, P1661, DOI 10.1007/s10856-007-3259-3
   Pickup DM, 2007, J MATER CHEM, V17, P4777, DOI 10.1039/b709955j
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Walters NJ, 2015, ACTA BIOMATER, V11, P3, DOI 10.1016/j.actbio.2014.09.038
NR 28
TC 3
Z9 3
U1 1
U2 28
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045025
DI 10.1088/1748-6041/10/4/045025
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600026
PM 26306553
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gumel, AM
   Razaif-Mazinah, MRM
   Anis, SNS
   Annuar, MSM
AF Gumel, Ahmad Mohammed
   Razaif-Mazinah, Mohd Rafais Mohd
   Anis, Siti Nor Syairah
   Annuar, Mohamad Suffian Mohamad
TI Poly (3-hydroxyalkanoates)-co-(6-hydroxyhexanoate) hydrogel promotes
   angiogenesis and collagen deposition during cutaneous wound healing in
   rats
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE biomaterial; biopolymer; cytokines; hydrogel; PHA; PCL; wound
ID GRANULATION-TISSUE FORMATION; RING-OPENING POLYMERIZATION;
   GROWTH-FACTOR; IN-VITRO; CELL-PROLIFERATION; DIABETIC-RATS;
   SMOOTH-MUSCLE; DELIVERY; COPOLYMER; FILMS
AB Wound management and healing in several physiological or pathological conditions, particularly when comorbidities are involved, usually proves to be difficult. This presents complications leading to socio-economic and public health burdens. The accelerative wound healing potential of biocompatible poly(3-hydroxyalkanoates)-co-(6-hydroxyhexanoate) (PHA-PCL) composite hydrogel is reported herein.
   The biosynthesized PHA-PCL macromer was cross-linked with PEGMA to give a hydrogel. Twenty-four rats weighing 200-250 g each were randomly assigned to four groups of six rats. Rats in group I (negative control) were dressed with sterilized gum acacia paste in 10% normal saline while PEGMA-alone hydrogel (PH) was used to dress group II (secondary control) rats. Group III rats were dressed with PHAs-PCL cross-linked PEGMA hydrogel (PPH). For the positive control (group IV), the rats were dressed with Intrasite (R) gel.
   Biochemical, histomorphometric and immunohistomorphometric analyses revealed a significant difference in area closure and re-epithelialization on days 7 and 14 in PPH or Intrasite (R) gel groups compared to gum acacia or PEGMA-alone groups. Furthermore, wounds dressed with PPH or Intrasite (R) gel showed evident collagen deposition, enhanced fibrosis and extensively organized angiogenesis on day 14 compared to the negative control group. While improvement in wound healing of the PH dressed group could be observed, there was no significant difference between the negative control group and the PH dressed group in any of the tests.
   The findings suggested that topical application of PPH accelerated the rats' wound healing process by improving angiogenesis attributed to the increased microvessel density (MVD) and expressions of VEGF-A in tissue samples. Thus, PPH has been demonstrated to be effective in the treatment of cutaneous wounds in rats, and could be a potential novel agent in the management and acceleration of wound healing in humans and animals.
C1 [Gumel, Ahmad Mohammed; Razaif-Mazinah, Mohd Rafais Mohd; Anis, Siti Nor Syairah; Annuar, Mohamad Suffian Mohamad] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
RP Gumel, AM (reprint author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
EM gumel@um.edu.my
RI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/B-9031-2010
OI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/0000-0003-3387-0160
FU University of Malaya [BK014-2014, UM.C/625/1/HIR/MOHE/05]
FX The authors acknowledge the University of Malaya for research grants
   BK014-2014 and UM.C/625/1/HIR/MOHE/05.
CR Abdulla MA, 2010, BIOMED RES-INDIA, V21, P241
   Agarwal PK, 2009, INDIAN J EXP BIOL, V47, P32
   Al-Bayaty F, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/468764
   Bai MY, 2014, J BIOMED MATER RES A, V102, P2324, DOI 10.1002/jbm.a.34912
   Claria J, 2006, RECENT PAT ANTI-CANC, V1, P369, DOI 10.2174/157489206778776961
   Clarke S, 2006, ULTRAVIOLET LIGHT DI
   Collins N, 2001, Adv Skin Wound Care, V14, P288, DOI 10.1097/00129334-200111000-00008
   DAVIDSON JM, 1985, J CELL BIOL, V100, P1219, DOI 10.1083/jcb.100.4.1219
   de Oliveira AP, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/472382
   Debono R, 2000, THESIS DURHAM U
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dong YX, 2014, ACTA BIOMATER, V10, P2076, DOI 10.1016/j.actbio.2013.12.045
   Dong YX, 2012, MACROMOL RAPID COMM, V33, P120, DOI 10.1002/marc.201100534
   Dong YX, 2012, J MATER SCI-MATER M, V23, P25, DOI 10.1007/s10856-011-4496-z
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Ehrlich HP, 2006, WOUND REPAIR REGEN, V14, P625, DOI 10.1111/j.1743-6109.2006.00170.x
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305
   Fournier D, 2007, MACROMOLECULES, V40, P915, DOI 10.1021/ma062199r
   GROTENDORST GR, 1985, J CLIN INVEST, V76, P2323, DOI 10.1172/JCI112243
   Gumel A., 2013, INT J CHEM REACT ENG, V11, P609
   Gumel AM, 2013, J POLYM ENVIRON, V21, P580, DOI 10.1007/s10924-012-0527-1
   Gumel AM, 2013, INT J BIOL MACROMOL, V55, P127, DOI 10.1016/j.ijbiomac.2012.12.028
   Gumel AM, 2013, ULTRASON SONOCHEM, V20, P937, DOI 10.1016/j.ultsonch.2012.09.015
   Gumel AM, 2012, POLYM DEGRAD STABIL, V97, P1224, DOI 10.1016/j.polymdegradstab.2012.05.041
   Gumel AM, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41149
   Gumel AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045214
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   Hajiaghaalipour F, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/386734
   Howdieshell TR, 2001, J SURG RES, V96, P173, DOI 10.1006/jsre.2001.6089
   Kant V, 2015, J SURG RES, V193, P978, DOI 10.1016/j.jss.2014.10.019
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Li G, 2015, J BIOMED NANOTECHNOL, V11, P105, DOI 10.1166/jbn.2015.2053
   Li J, 1999, MACROMOLECULES, V32, P2789, DOI 10.1021/ma981816b
   Ma JT, 2009, J MOL CATAL B-ENZYM, V56, P151, DOI 10.1016/j.molcatb.2008.03.012
   MAJNO G, 1971, SCIENCE, V173, P548, DOI 10.1126/science.173.3996.548
   Murthy S, 2013, BIOMED RES INT, DOI 10.1155/2013/972028
   Nguyen DT, 2009, WOODHEAD PUBL MATER, P25, DOI 10.1533/9781845695545.1.25
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Saad GR, 2012, POLYM-PLAST TECHNOL, V51, P1113, DOI 10.1080/03602559.2012.680568
   Saranya S, 2014, J BIOACT COMPAT POL, V29, P152, DOI 10.1177/0883911513520380
   SARGENT JM, 1989, BRIT J CANCER, V60, P206, DOI 10.1038/bjc.1989.252
   Sellmayer A, 1999, LIPIDS, V34, pS13, DOI 10.1007/BF02562222
   Shukla A, 1999, PHYTOTHER RES, V13, P50, DOI 10.1002/(SICI)1099-1573(199902)13:1<50::AID-PTR368>3.3.CO;2-M
   Slavin J, 1996, J PATHOL, V178, P5
   Souba W, 1999, MODERN NUTR HLTH DIS, P618
   Teramoto N, 2008, MOLECULES, V13, P1773, DOI 10.3390/molecules13081773
   Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1
   Tsou R, 2002, WOUND REPAIR REGEN, V10, P222, DOI 10.1046/j.1524-475X.2002.10405.x
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Nguyen VC, 2013, INT J POLYM SCI, DOI 10.1155/2013/106570
   Wang K, 2010, CARBOHYD POLYM, V79, P755, DOI 10.1016/j.carbpol.2009.10.004
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   Xiong YC, 2010, J BIOMAT SCI-POLYM E, V21, P127, DOI 10.1163/156856209X410283
   Xu Y, 2013, DRUG DEV IND PHARM, V40, P1
   Yao YC, 2008, BIOMATERIALS, V29, P4823, DOI 10.1016/j.biomaterials.2008.09.008
   Zhang XZ, 2005, POLYMER, V46, P9664, DOI 10.1016/j.polymer.2005.08.055
   Zhang Z, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-24
NR 62
TC 2
Z9 2
U1 1
U2 26
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045001
DI 10.1088/1748-6041/10/4/045001
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600002
PM 26154416
DA 2018-10-19
ER

PT J
AU Lorenzetti, M
   Bernardini, G
   Luxbacher, T
   Santucci, A
   Kobe, S
   Novak, S
AF Lorenzetti, M.
   Bernardini, G.
   Luxbacher, T.
   Santucci, A.
   Kobe, S.
   Novak, S.
TI Surface properties of nanocrystalline TiO2 coatings in relation to the
   in vitro plasma protein adsorption
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE anatase nanocrystalline coatings; plasma protein adsorption; UV
   photo-activation; zeta potential; proteomics; 2D-PAGE
ID UV-PHOTOFUNCTIONALIZED TITANIUM; HUMAN SERUM-ALBUMIN; BIOMATERIAL
   SURFACES; ADHESION; BLOOD; MECHANISM; HYDRATION; INSIGHTS; CONTACT;
   RUTILE
AB This study reports on the selective adsorption of whole plasma proteins on hydrothermally (HT) grown TiO2-anatase coatings and its dependence on the three main surface properties: surface charge, wettability and roughness. The influence of the photo-activation of TiO2 by UV irradiation was also evaluated. Even though the protein adhesion onto Ti-based substrates was only moderate, better adsorption of any protein (at pH = 7.4) occurred for the most negatively charged and hydrophobic substrate (Ti non-treated) and for the most nanorough and hydrophilic surface (HT Ti3), indicating that the mutual action of the surface characteristics is responsible for the attraction and adhesion of the proteins. The HT coatings showed a higher adsorption of certain proteins (albumin 'passivation' layer, apolipoproteins, vitamin D-binding protein, ceruloplasmin, alpha-2-HS-glycoprotein) and higher ratios of albumin to fibrinogen and albumin to immunoglobulin gamma-chains. The UV pre-irradiation affected the surface properties and strongly reduced the adsorption of the proteins. These results provide in-depth knowledge about the characterization of nanocrystalline TiO2 coatings for body implants and provide a basis for future studies on the hemocompatibility and biocompatibility of such surfaces.
C1 [Lorenzetti, M.; Kobe, S.; Novak, S.] Jozef Stefan Inst, Dept Nanostruct Mat, Ljubljana 1000, Slovenia.
   [Lorenzetti, M.; Kobe, S.; Novak, S.] Jozef Stefan Int Postgrad Sch, Ljubljana 1000, Slovenia.
   [Bernardini, G.; Santucci, A.] Univ Siena, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy.
   [Luxbacher, T.] Anton Paar GmbH, A-8054 Graz, Austria.
RP Lorenzetti, M (reprint author), Jozef Stefan Inst, Dept Nanostruct Mat, Jamova Cesta 39, Ljubljana 1000, Slovenia.
EM martina.lorenzetti@ijs.si; sasa.novak@ijs.si
RI Santucci, Annalisa/K-1932-2018
OI Santucci, Annalisa/0000-0001-6976-9086; Luxbacher,
   Thomas/0000-0002-5472-8203; Lorenzetti, Martina/0000-0002-2557-7899
FU European Commission [FP7-PEOPLE-2010-ITN-264635]
FX Funding by the European Commission within the framework of the FP7-ITN
   network BioTiNet (FP7-PEOPLE-2010-ITN-264635) is acknowledged.
CR Bernardini G, 2014, MOL BIOSYST, V10, P1305, DOI 10.1039/c3mb70328b
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068086
   Glokler J, 2003, J CHROMATOGR B, V797, P229, DOI 10.1016/j.jchromb.2003.08.034
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hori N, 2010, ACTA BIOMATER, V6, P4175, DOI 10.1016/j.actbio.2010.05.006
   Huang Y, 2010, ACTA BIOMATER, V6, P2083, DOI 10.1016/j.actbio.2009.12.035
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024
   Jachimska B, 2012, BIOELECTROCHEMISTRY, V87, P138, DOI 10.1016/j.bioelechem.2011.09.004
   Jansson E, 2004, COLLOID SURFACE B, V35, P45, DOI 10.1016/j.colsurfb.2004.02.007
   JONES P, 1971, T FARADAY SOC, V67, P2679, DOI 10.1039/tf9716702679
   Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Labarre D, 2012, POLYMERS-BASEL, V4, P986, DOI 10.3390/polym4020986
   Lazzeri M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.155409
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lorenzetti M, 2014, MAT SCI ENG C-MATER, V37, P390, DOI 10.1016/j.msec.2014.01.029
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   MAKINO K, 1987, J COLLOID INTERF SCI, V115, P65, DOI 10.1016/0021-9797(87)90009-9
   Marucco A, 2013, J PHYS CONF SER, V429, DOI 10.1088/1742-6596/429/1/012014
   MUNUERA G, 1971, DISCUSS FARADAY SOC, P205
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P285, DOI 10.1016/0021-9797(78)90306-5
   Oshida Y., 2007, BIOSCIENCE BIOENGINE, P157
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   SAROFF HA, 1963, J PHYS CHEM-US, V67, P1211, DOI 10.1021/j100800a011
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   TENGVALL P, 2001, TITANIUM MED, P457
   Tengvall P., 2011, COMPREHENSIVE BIOMAT, P63
   Textor M., 2001, TITANIUM MED, P171
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zimmermann R, 2010, CURR OPIN COLLOID IN, V15, P196, DOI 10.1016/j.cocis.2010.01.002
NR 44
TC 6
Z9 6
U1 5
U2 36
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045012
DI 10.1088/1748-6041/10/4/045012
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600013
PM 26225819
DA 2018-10-19
ER

PT J
AU Ajioka, I
AF Ajioka, I.
TI Understanding self-repairing potential by biological and biomaterial
   engineering approaches for brain regeneration
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 25th Biennial Meeting of the International-Society-for-Neurochemistry
   Jointly with the 13th Meeting of the
   Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th
   Meeting of the Australasian-Neuroscience-Society
CY AUG 23-27, 2015
CL Cairns, AUSTRALIA
SP Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc
C1 [Ajioka, I.] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2015
VL 134
SU 1
SI SI
MA W03-04
BP 88
EP 88
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA CP9IA
UT WOS:000360206300177
DA 2018-10-19
ER

PT J
AU Castillo-Dali, G
   Velazquez-Cayon, R
   Serrera-Figallo, MA
   Rodriguez-Gonzalez-Elipe, A
   Gutierrez-Perez, JL
   Torres-Lagares, D
AF Castillo-Dali, Gabriel
   Velazquez-Cayon, Rocio
   Angeles Serrera-Figallo, M.
   Rodriguez-Gonzalez-Elipe, Agustin
   Gutierrez-Perez, Jose-Luis
   Torres-Lagares, Daniel
TI Importance of Poly(lactic-co-glycolic acid) in Scaffolds for Guided Bone
   Regeneration: A Focused Review
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Review
DE biopolymers; scaffold; PLGA; GTR; GBR; bone; regeneration; biomaterial
ID TISSUE REGENERATION; FABRICATION; BEHAVIOR; CELLS
AB Total or partial tissue damage and loss of function in an organ are two of the most serious and costly issues in human health. Initially, these problems were approached through organ and allogenic tissue transplantation, but this option is limited by the scarce availability of donors. In this manner, new bone for restoring or replacing lost and damaged bone tissue is an important health and socioeconomic necessity. Tissue engineering has been used as a strategy during the 21st century for mitigating this need through the development of guided bone regeneration scaffold and composites. In this manner, compared with other traditional methods, bone tissue engineering offers a new and interesting approach to bone repair. The poly-alpha-hydroxy acids, which include the copolymers of lactic acid and glycolic acid, have been used commonly in the fabrication of these scaffolds. The objective of our article was to review the characteristics and functions of scaffold with biomedical applications, with special interest in scaffold construction using poly(lactic-co-glycolic acid) polymers, in order to update the current methods used for fabrication and to improve the quality of these scaffolds, integrating this information into the context of advancements made in tissue engineering based on these structures. In the future, research into bone regeneration should be oriented toward a fruitful exchange between disciplines involved in tissue engineering, which is coming very close to filling the gaps in our ability to provide implants and restoration of functionality in bone tissue. Overcoming this challenge will provide benefits to a major portion of the population and facilitate substantial improvements to quality of life.
C1 [Castillo-Dali, Gabriel; Velazquez-Cayon, Rocio; Angeles Serrera-Figallo, M.; Torres-Lagares, Daniel] Univ Seville, Seville, Spain.
   [Rodriguez-Gonzalez-Elipe, Agustin] Inst Sci Mat, Seville, Spain.
   [Gutierrez-Perez, Jose-Luis] Virgen de Rocio Hosp, Andalusian Hlth Serv, Seville, Spain.
RP Torres-Lagares, D (reprint author), Univ Seville, Seville, Spain.
EM danieltl@us.es
OI CASTILLO-DALI, GABRIEL/0000-0001-5795-9958; Gutierrez Perez, Jose
   Luis/0000-0003-2624-1454
CR Aboudzadeh N, 2010, J BIOMED MATER RES A, V94A, P137, DOI 10.1002/jbm.a.32673
   Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   Alvarez-Barreto JF, 2009, REV ESTUDIOS TRANSDI, V1, P98
   Ge ZG, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/021001
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Huang YX, 2010, J BIOMED MATER RES A, V95A, P993, DOI 10.1002/jbm.a.32922
   Hutmacher D, 1996, INT J ORAL MAXILLOF, V11, P668
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim Y, 2006, J APPL POLYM SCI, V101, P1657, DOI 10.1002/app.22196
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lopez-Santos C, 2010, ACS APPL MATER INTER, V2, P980, DOI 10.1021/am100052w
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   MELCHER AH, 1976, J PERIODONTOL, V47, P256, DOI 10.1902/jop.1976.47.5.256
   Molina-Lorenzo MJ, 2009, PLASTICS APPL MED
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   NYMAN S, 1990, International Journal of Oral and Maxillofacial Implants, V5, P9
   Okada K, 2003, KOREA-AUST RHEOL J, V15, P43
   Park JB, 2011, MED ORAL PATOL ORAL, V16, pE115, DOI 10.4317/medoral.16.e115
   PONTORIERO R, 1988, J CLIN PERIODONTOL, V15, P247, DOI 10.1111/j.1600-051X.1988.tb01578.x
   Qi RL, 2013, COLLOID SURFACE B, V110, P148, DOI 10.1016/j.colsurfb.2013.04.036
   Rojas-Cortes MG, 2008, INGENIERIA INVESTIGA, V28, P57
   Shin M, 2008, J BIOMED MATER RES A, V84A, P702, DOI 10.1002/jbm.a.31392
   Spicer PP, 2013, ACTA BIOMATER, V9, P8832, DOI 10.1016/j.actbio.2013.07.018
   Wang YM, 2005, MACROMOL MATER ENG, V290, P792, DOI 10.1002/mame.200500003
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zong C, 2010, EUR CELLS MATER, V20, P109
NR 28
TC 6
Z9 6
U1 5
U2 49
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD AUG
PY 2015
VL 41
IS 4
BP E152
EP E157
DI 10.1563/AAID-JOI-D-13-00225
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP8QK
UT WOS:000360159000010
PM 24552153
DA 2018-10-19
ER

PT J
AU Catros, S
   Molenberg, A
   Freilich, M
   Dard, M
AF Catros, Sylvain
   Molenberg, Aart
   Freilich, Martin
   Dard, Michel
TI Evaluation of a Polyethylene Glycol-Osteogenic Protein-1 System on
   Alveolar Bone Regeneration in the Mini-Pig
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE polyethylene glycol; osteogenic protein-1; minipig histomorphometry;
   alveolar bone regeneration; dose response
ID SINUS FLOOR AUGMENTATION; PLATELET-RICH PLASMA; MORPHOGENETIC PROTEIN-7;
   MANDIBULAR RECONSTRUCTION; PARATHYROID-HORMONE; RIDGE AUGMENTATION;
   MAXILLARY SINUS; DENTAL IMPLANTS; MINIATURE PIGS; DEFECTS
AB Alveolar bone regeneration associated with the local release of osteogenic protein-1 (OP-1) from a polyethylene glycol (PEG) scaffold was evaluated in 14 mini-pigs. Following extraction of mandibular teeth and 26-weeks of healing time, standardized bone defects were created bilaterally in the posterior mandibles (3 sites for each hemimandible) that were randomly assigned to treatment groups. Seven treatments groups were compared: 4 different concentrations of the PEG/OP-1 test system (n = 14 for each), a positive control (collagen/OP-1, n = 14), a negative control (PEG only, n = 7) and nontreated defects (n = 7). Each animal provided all test and control groups. The animals were sacrificed after 3 weeks of healing and samples were processed for histology and histomorphometry. Three weeks after implantation, there were positive clinical responses for all test groups. Earlier bone maturation was observed in the test groups that had higher concentrations of OP-1 (0.25, 0.5, or 1 mg/mL) compared to the negative control group (PEG alone), the low concentration group (0.1 mg/mL), and the positive control group (collagen/OP-1). However, histomorphometric quantitative analyses did not reveal any statistical difference between any of the groups. No residual PEG biomaterial or inflammatory responses to the biomaterial or growth factor were observed. This study confirmed the safe local delivery of OP-1 from PEG hydrogel. Alveolar bone regeneration was not statistically different between tests groups, negative control (PEG alone) or commercial positive control (collagen/OP-1). The semi-quantitative analysis, however, showed a trend in favor of the higher concentrations of OP-1 to induce faster bone maturation.
C1 [Catros, Sylvain] Bordeaux Segalen Univ, INSERM, U1026, BioTis, Bordeaux, France.
   [Catros, Sylvain] CHU Bordeaux, Pole Odontol & Sante Buccale, Bordeaux, France.
   [Molenberg, Aart; Dard, Michel] Inst Straumann AG, Basel, Switzerland.
   [Freilich, Martin] Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, Ctr Biomat, Farmington, CT 06032 USA.
   [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA.
RP Catros, S (reprint author), Bordeaux Segalen Univ, INSERM, U1026, BioTis, Bordeaux, France.
EM sylvaincatros@hotmail.com
CR Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Clokie CML, 2008, J CAN DENT ASSOC, V74, P67
   Corinaldesi G, 2013, BRIT J ORAL MAX SURG, V51, P247, DOI 10.1016/j.bjoms.2012.06.004
   Dahlin C, 2014, CLIN ORAL IMPLAN RES, V25, P16, DOI 10.1111/clr.12076
   Dard M, 2012, WOODH PUBL SER BIOM, V50, P308
   Dard M, 1997, CELL ENG, V2, P1
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Grainger DW, 2012, ADV DRUG DELIVER REV, V64, P1061, DOI 10.1016/j.addr.2012.08.001
   Heliotis M, 2006, INT J ORAL MAX SURG, V35, P265, DOI 10.1016/j.ijom.2005.07.013
   Howell T. H., 1997, INT J PERIODONT REST, V17, P124
   Jensen SS, 2009, J BIOMED MATER RES B, V90B, P171, DOI 10.1002/jbm.b.31271
   Joshi A, 2004, BRIT DENT J, V196, P167, DOI 10.1038/sj.bdj.4810945
   Jung RE, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2008.01270.x
   Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x
   Jung RE, 2007, INT J ORAL MAX IMPL, V22, P258
   Jung RE, 2009, CLIN ORAL IMPLAN RES, V20, P162, DOI 10.1111/j.1600-0501.2008.01634.x
   Kaigler Darnell, 2006, Expert Opin Drug Deliv, V3, P647, DOI 10.1517/17425247.3.5.647
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mardas N, 2014, J INVEST SURG, V27, P32, DOI 10.3109/08941939.2013.817628
   Reid B, 2015, J TISSUE ENG REGEN M, V9, P315, DOI 10.1002/term.1688
   Roldan JC, 2004, CLIN ORAL IMPLAN RES, V15, P716, DOI 10.1111/j.1600-0501.2004.01070.x
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Silva Fabricio Moreira Serrae, 2006, Implant Dent, V15, P420, DOI 10.1097/01.id.0000246225.51298.67
   Susin C, 2010, J CLIN PERIODONTOL, V37, P574, DOI 10.1111/j.1600-051X.2010.01554.x
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Terheyden H, 2004, INT J ORAL MAX SURG, V33, P164, DOI 10.1016/j.ijom.2003.08.009
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P469, DOI 10.1054/ijom.2000.0008
   Thoma DS, 2014, CLIN ORAL IMPLAN RES, V25, P511, DOI 10.1111/clr.12203
   Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P7, DOI 10.1111/j.1600-0501.2008.01604.x
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   Wang HM, 2004, J BIOMED MATER RES A, V68A, P219, DOI 10.1002/jbm.a.10129
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Warnke PH, 2003, PLAST RECONSTR SURG, V111, P2471, DOI 10.1097/01.PRS.0000063110.10932.9B
NR 36
TC 1
Z9 1
U1 1
U2 3
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD AUG
PY 2015
VL 41
IS 4
BP E96
EP E101
DI 10.1563/AAID-JOI-D-13-00307
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP8QK
UT WOS:000360159000002
PM 24673473
DA 2018-10-19
ER

PT J
AU Havlucu, U
   Bolukbasi, N
   Yeniyol, S
   Cetin, S
   Ozdemir, T
AF Havlucu, Ugur
   Bolukbasi, Nilufer
   Yeniyol, Sinem
   Cetin, Sule
   Ozdemir, Tayfun
TI Effects of Light-Emitting Diode Photobiomodulation Therapy and BioOss as
   Single and Combined Treatment in an Experimental Model of Bone Defect
   Healing in Rats
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE light-emitting diode; photobiomodulation; deproteinized bovine bone
   graft; histomorphometry; histopathology
ID LOW-LEVEL LASER; BOVINE BONE; REPAIR; PHOTOTHERAPY; IRRADIATION;
   REGENERATION; PREVENTION; MOVEMENT; NEURONS; CELLS
AB The present study assesses histopathologically and histomorphometrically the effects of light-emitting diode (LED) photobiomodulation therapy (LPT) on bone healing in BioOss-filled femoral defects of rats. It has been reported that LPT modulates cellular metabolic processes, leading to an enhanced regenerative potential for biological tissues. Thirty-six male Wistar rats with femoral bone defects were divided into 4 groups: defect group (empty bone defect, without application of LPT), graft group (bone defect filled with BioOss, without application of LPT), (defect+LPT) group (empty bone defect, with application of LPT), and (graft+LPT) group (bone defect filled with BioOss, with application of LPT). An OsseoPulse LED device (wavelength: 618 nm; output power: 20 mW/cm(2)) was initiated 24 hours postsurgery and performed every 24 hours for 7, 14, and 21 days. The LPT-applied and BioOss-filled defects presented a higher amount of new bone formation with trabeculae formation. These defects showed statistically significant lower values of inflammation severity, and fewer remnants of biomaterial were present. Within the limitations of this study, LPT has positive effects on bone healing histopathologically and histomorphometrically for the defects filled with BioOss 3 weeks after the rats' femora injury.
C1 [Havlucu, Ugur; Bolukbasi, Nilufer; Yeniyol, Sinem; Ozdemir, Tayfun] Istanbul Univ, Fac Dent, Dept Oral Implantol, Istanbul, Turkey.
   [Cetin, Sule] Marmara Univ, Sch Med, Dept Histol & Embryol, Istanbul, Turkey.
RP Bolukbasi, N (reprint author), Istanbul Univ, Fac Dent, Dept Oral Implantol, Istanbul, Turkey.
EM dr.niluferbolukbasi@hotmail.com
CR AboElsaad NS, 2009, LASER MED SCI, V24, P527, DOI 10.1007/s10103-008-0590-y
   Brawn PR, 2007, IMPLANT DENT, V16, P204, DOI 10.1097/ID.0b013e318065a84c
   Brignardello-Petersen R, 2012, J ORAL MAXIL SURG, V70, P1789, DOI 10.1016/j.joms.2012.01.008
   Cafaro A, 2010, PHOTOMED LASER SURG, V28, DOI 10.1089/pho.2009.2655
   Cankaya AB, 2011, INT J MED SCI, V8, P667, DOI 10.7150/ijms.8.667
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Sousa MVD, 2011, PHOTOMED LASER SURG, V29, P191, DOI 10.1089/pho.2009.2652
   de Lima AG, 2012, INT J RADIAT ONCOL, V82, P270, DOI 10.1016/j.ijrobp.2010.10.012
   De Souza Thais Oricchio Fedri, 2010, Photomed Laser Surg, V28 Suppl 2, pS85, DOI 10.1089/pho.2009.2661
   Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549
   Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121
   Dortbudak O, 2002, CLIN ORAL IMPLAN RES, V13, P288, DOI 10.1034/j.1600-0501.2002.130308.x
   Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033
   Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100
   Ekizer A, 2015, LASER MED SCI, V30, P779, DOI 10.1007/s10103-013-1405-3
   Gavish L, 2004, LASER SURG MED, V35, P369, DOI 10.1002/lsm.20108
   Ghahroudi AAR, 2014, LASER MED SCI, V29, P925, DOI 10.1007/s10103-013-1403-5
   Guzzardella GA, 2003, CLIN ORAL IMPLAN RES, V14, P226, DOI 10.1034/j.1600-0501.2003.00872.x
   Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   Kamali F, 2007, J PHOTOCH PHOTOBIO B, V88, P11, DOI 10.1016/j.jphotobiol.2007.04.010
   KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015
   Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x
   Kaya GS, 2011, PHOTOMED LASER SURG, V29, P405, DOI 10.1089/pho.2010.2807
   Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x
   Kim YD, 2007, LASER SURG MED, V39, P441, DOI 10.1002/lsm.20508
   Kim YD, 2009, LASER MED SCI, V24, P577, DOI 10.1007/s10103-008-0614-7
   Kreisner PE, 2010, MED ORAL PATOL ORAL, V15, pE616, DOI 10.4317/medoral.15.e616
   Lavi R, 2003, J BIOL CHEM, V278, P40917, DOI 10.1074/jbc.M303034200
   Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047
   Salmos-Brito JAL, 2013, LASER MED SCI, V28, P57, DOI 10.1007/s10103-012-1065-8
   Makhlouf M, 2012, PHOTOMED LASER SURG, V30, P160, DOI 10.1089/pho.2011.3069
   Maluf AP, 2012, LASER MED SCI, V25, P693
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   Mercer C, 1996, Dent Update, V23, P74
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585
   Raghoebar GM, 2007, INT J ORAL MAX IMPL, V22, P359
   Rochkind S, 2004, PHOTOMED LASER SURG, V22, P249, DOI 10.1089/1549541041438579
   Freire MDS, 2014, CLIN ORAL INVEST, V18, P1005, DOI 10.1007/s00784-013-1058-4
   Shakouri SK, 2010, LASER MED SCI, V25, P73, DOI 10.1007/s10103-009-0670-7
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Uysal T, 2012, EUR J ORTHODONT, V34, P44, DOI 10.1093/ejo/cjq166
   Vescovi P, 2012, PHOTOMED LASER SURG, V30, P5, DOI 10.1089/pho.2010.2955
   Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200
   Yeager RL, 2006, PHOTOMED LASER SURG, V24, P29, DOI 10.1089/pho.2006.24.29
NR 47
TC 2
Z9 2
U1 1
U2 5
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD AUG
PY 2015
VL 41
IS 4
BP E110
EP E117
DI 10.1563/AAID-JOI-D-13-00310
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP8QK
UT WOS:000360159000004
PM 24766197
DA 2018-10-19
ER

PT J
AU Bencherif, SA
   Sands, RW
   Ali, OA
   Li, WA
   Lewin, SA
   Braschler, TM
   Shih, TY
   Verbeke, CS
   Bhatta, D
   Dranoff, G
   Mooney, DJ
AF Bencherif, Sidi A.
   Sands, R. Warren
   Ali, Omar A.
   Li, Weiwei A.
   Lewin, Sarah A.
   Braschler, Thomas M.
   Shih, Ting-Yu
   Verbeke, Catia S.
   Bhatta, Deen
   Dranoff, Glenn
   Mooney, David J.
TI Injectable cryogel-based whole-cell cancer vaccines
SO NATURE COMMUNICATIONS
LA English
DT Article
ID COLONY-STIMULATING FACTOR; DENDRITIC CELLS; TUMOR-IMMUNOTHERAPY;
   IN-VIVO; PHASE-I; GM-CSF; MELANOMA; SAFETY; THERAPY; RESPONSES
AB A biomaterial-based vaccination system that uses minimal extracorporeal manipulation could provide in situ enhancement of dendritic cell (DC) numbers, a physical space where DCs interface with transplanted tumour cells, and an immunogenic context. Here we encapsulate GM-CSF, serving as a DC enhancement factor, and CpG ODN, serving as a DC activating factor, into sponge-like macroporous cryogels. These cryogels are injected subcutaneously into mice to localize transplanted tumour cells and deliver immunomodulatory factors in a controlled spatio-temporal manner. These vaccines elicit local infiltrates composed of conventional and plasmacytoid DCs, with the subsequent induction of potent, durable and specific anti-tumour T-cell responses in a melanoma model. These cryogels can be delivered in a minimally invasive manner, bypass the need for genetic modification of transplanted cancer cells and provide sustained release of immunomodulators. Altogether, these findings indicate the potential for cryogels to serve as a platform for cancer cell vaccinations.
C1 [Bencherif, Sidi A.; Sands, R. Warren; Ali, Omar A.; Li, Weiwei A.; Lewin, Sarah A.; Braschler, Thomas M.; Shih, Ting-Yu; Verbeke, Catia S.; Bhatta, Deen; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Bencherif, Sidi A.; Sands, R. Warren; Ali, Omar A.; Li, Weiwei A.; Lewin, Sarah A.; Braschler, Thomas M.; Shih, Ting-Yu; Verbeke, Catia S.; Bhatta, Deen; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Bencherif, Sidi A.] Univ Technol Compiegne, Univ Sorbonne, UTC CNRS UMR 7338, Biomech & Bioengn BMBI, F-60205 Compiegne, France.
   [Sands, R. Warren] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA 15232 USA.
   [Braschler, Thomas M.] Ecole Polytech Fed Lausanne, Stn 17, LMIS4, Sch Engn, CH-1015 Lausanne, Switzerland.
   [Dranoff, Glenn] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.
   [Dranoff, Glenn] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02215 USA.
   [Dranoff, Glenn] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA.
   [Dranoff, Glenn] Harvard Univ, Sch Med, Boston, MA 02215 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Li, Aileen/0000-0002-1056-5932
FU National Institutes of Health [5R01DE019917-03, F30DK088518-03,
   T32-GM008152, 1UL1 TR001102]; Swiss National Fonds [PBELP3-133350]
FX We thank Mr Thomas Ferrante and Dr James Weaver at the Wyss Institute
   for their technical assistance with confocal microscopy and scanning
   electron microscopy, respectively. This research was financially
   supported by the National Institutes of Health grants 5R01DE019917-03,
   F30DK088518-03 and T32-GM008152, and the Swiss National Fonds (grant
   PBELP3-133350). Dr. Roger B. Davis from the Harvard Catalyst
   Biostatistical Consulting Program funded by the National Institutes of
   Health (grant 1UL1 TR001102) is acknowledged.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Ali A., 2011, BIOMATTER, V1, P66
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Becker JC, 2010, EXP DERMATOL, V19, P157, DOI 10.1111/j.1600-0625.2009.00986.x
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079
   Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694
   Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609
   Buckwalter M., 2007, J IMMUNOL, V178, P16
   Cann SAH, 2003, POSTGRAD MED J, V79, P672
   Caulfield JJ, 1999, IMMUNOLOGY, V98, P104
   Chiang CLL, 2010, SEMIN IMMUNOL, V22, P132, DOI 10.1016/j.smim.2010.02.004
   Copier J, 2010, CURR OPIN MOL THER, V12, P14
   Davis MB, 2011, CLIN CANCER RES, V17, P3984, DOI 10.1158/1078-0432.CCR-10-3262
   Dhodapkar MV, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008068
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539
   Eggermont AM, 2014, J CLIN ONCOL, V32
   Fong L, 2001, P NATL ACAD SCI USA, V98, P8809, DOI 10.1073/pnas.141226398
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P1111, DOI 10.4161/onci.21494
   Gubeli RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02610
   Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133
   Herlyn M, 2010, J INVEST DERMATOL, V130, P911, DOI 10.1038/jid.2009.441
   Hinrichs CS, 2014, AM J CLIN ONCOL-CANC, V32, P3008
   Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495
   Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294
   Kaufman HL, 2012, SEMIN ONCOL, V39, P263, DOI 10.1053/j.seminoncol.2012.02.011
   Keenan BP, 2012, SEMIN ONCOL, V39, P276, DOI 10.1053/j.seminoncol.2012.02.007
   Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817
   Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108
   Li WA, 2013, CURR OPIN IMMUNOL, V25, P238, DOI 10.1016/j.coi.2012.12.008
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Liu YR, 2014, BIOMACROMOLECULES, V15, P3836, DOI 10.1021/bm501166j
   Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X
   Mansoor W, 2005, BRIT J CANCER, V93, P1085, DOI 10.1038/sj.bjc.6602839
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258
   Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394
   Ribas A, 2014, J CLIN ONCOL, V32, P9000, DOI DOI 10.1200/JCO.2013.54.6911
   Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017
   Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x
   SHRAYER D, 1995, CANCER IMMUNOL IMMUN, V40, P277, DOI 10.1007/s002620050174
   Singh A, 2011, J CONTROL RELEASE, V155, P184, DOI 10.1016/j.jconrel.2011.06.008
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122
   Sznol M, 2014, J CLIN ONCOL, V32, pLBA
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130
   Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802
   Westin JR, 2014, LANCET ONCOL, V15, P69, DOI 10.1016/S1470-2045(13)70551-5
   Wu QJ, 2011, GROWTH FACTORS, V29, P290, DOI 10.3109/08977194.2011.624517
   Zacharski LR, 2005, J THROMB HAEMOST, V3, P424, DOI 10.1111/j.1538-7836.2005.01110.x
NR 56
TC 64
Z9 64
U1 5
U2 72
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG
PY 2015
VL 6
AR 7556
DI 10.1038/ncomms8556
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ1EI
UT WOS:000360339700001
PM 26265369
OA DOAJ Gold, Green Accepted
DA 2018-10-19
ER

PT J
AU Assal, Y
   Mizuguchi, Y
   Mie, M
   Kobatake, E
AF Assal, Yasmine
   Mizuguchi, Yoshinori
   Mie, Masayasu
   Kobatake, Eiry
TI Growth Factor Tethering to Protein Nanoparticles via Coiled-Coil
   Formation for Targeted Drug Delivery
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID MOLTEN GLOBULE; POLYMER THERAPEUTICS; FLUORESCENT-PROBE; POLYPEPTIDE;
   PEPTIDES; MATRIX; STATE
AB Protein-based nanoparticles are attractive carriers for drug delivery because they are biodegradable and can be genetically designed. Moreover, modification of protein-based nanoparticles with cell-specific ligands allows for active targeting abilities. Previously, we developed protein nanoparticles comprising genetically engineered elastin-like polypeptides (ELPs) with fused polyaspartic acid tails (ELP-D). Epidermal growth factor (EGF) was displayed on the surface of the ELP-D nanoparticles via genetic design to allow for active cell-targeting abilities. Herein, we focused on the coiled-coil structural motif as a means for noncovalent tethering of growth factor to ELP-D. Specifically, two peptides known to form a heterodimer via a coiled-coil structural motif were fused to ELP-D and single-chain vascular endothelial growth factor (scVEGF(121)), to facilitate noncovalent tethering upon formation of the heterodimer coiled-coil structure. Drug-loaded growth factor-tethered ELP-Ds were found to be effective against cancer cells by provoking cell apoptosis. These results demonstrate that tethering growth factor to protein nanoparticles through coiled-coil formation yields a promising biomaterial candidate for targeted drug delivery.
C1 [Assal, Yasmine; Mizuguchi, Yoshinori; Mie, Masayasu; Kobatake, Eiry] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268052, Japan.
RP Kobatake, E (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268052, Japan.
EM kobatake.e.aa@m.titech.ac.jp
RI Mie, Masayasu/C-5995-2015
OI Mie, Masayasu/0000-0003-2255-3346
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   JSPS Institutional Program for Young Researcher Overseas Visits
FX This work was financially supported by Grants-in-aid for Scientific
   Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan and JSPS Institutional Program for Young Researcher
   Overseas Visits. We are also grateful to Ms. Keiko Ikeda from the
   Technical Department of the Tokyo Institute of Technology for technical
   support with the transmission electron microscope imaging.
CR Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067
   Ban HS, 2010, CANCER LETT, V296, P17, DOI 10.1016/j.canlet.2010.03.010
   Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022
   Boesen TP, 2002, J BIOL CHEM, V277, P40335, DOI 10.1074/jbc.M204107200
   Boucher C, 2010, BIOMATERIALS, V31, P7021, DOI 10.1016/j.biomaterials.2010.05.072
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Fujita Y, 2009, BIOMATERIALS, V30, P3450, DOI 10.1016/j.biomaterials.2009.03.012
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Kobatake E, 2011, BIOCONJUGATE CHEM, V22, P2038, DOI 10.1021/bc200249u
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   Matsumoto R, 2014, J BIOMED MATER RES B, V102, P1792, DOI 10.1002/jbm.b.33162
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Meyer DE, 2001, CANCER RES, V61, P1548
   Mie M, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015004
   Murschel F, 2013, ACTA BIOMATER, V9, P6806, DOI 10.1016/j.actbio.2013.02.032
   OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T
   OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872
   Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016
   Pechar M, 2014, BIOMACROMOLECULES, V15, P2590, DOI 10.1021/bm500436p
   Pechar M, 2011, BIOMACROMOLECULES, V12, P3645, DOI 10.1021/bm200897b
   Pola R, 2013, BIOMACROMOLECULES, V14, P881, DOI 10.1021/bm3019592
   Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X
   SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   Urry DW, 1997, ANN NY ACAD SCI, V831, P32
   VIDAL BD, 1978, J HISTOCHEM CYTOCHEM, V26, P196
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Yui H, 2005, LANGMUIR, V21, P721, DOI 10.1021/la040109a
NR 28
TC 15
Z9 15
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD AUG
PY 2015
VL 26
IS 8
BP 1672
EP 1677
DI 10.1021/acs.bioconjchem.5b00266
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CP5ZA
UT WOS:000359962900033
PM 26079837
DA 2018-10-19
ER

PT J
AU Dursun, E
   Dursun, CK
   Eratalay, K
   Orhan, K
   Celik, HH
   Tozum, TF
AF Dursun, Erhan
   Dursun, Ceyda Kanli
   Eratalay, Kenan
   Orhan, Kaan
   Celik, Hakan Hamdi
   Toezuem, Tolga Fikret
TI Do Porous Titanium Granule Grafts Affect Bone Microarchitecture at
   Augmented Maxillary Sinus Sites? A Pilot Split-Mouth Human Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE sinus; bone substitute; microtomography; human; dental implant
ID RESIDUAL RIDGE RESORPTION; MICROCOMPUTED TOMOGRAPHY; AUTOGENOUS BONE;
   COMPUTED-TOMOGRAPHY; FLOOR AUGMENTATION; BOVINE BONE; DENSITY;
   QUANTIFICATION; OSTEOPOROSIS; BIOMATERIAL
AB Background:The aim of this randomized controlled clinical study was to analyze the bone microarchitecture at augmented maxillary sinus sites by using different materials in patients to compare the effect of porous titanium granules as a sinus augmentation material with bone microstructural features.Materials and Methods:Eight subjects with bilateral atrophic posterior maxilla of residual bone height <4 mm included in this study and each patient was treated with bilateral sinus augmentation procedure using xenograft with equine origin (Apatos, Osteobiol; Tecnoss Dental) and xenograft (1 g) + porous titanium (1 g) granules (Natix; Tigran Technologies AB). Sixteen human bone biopsy samples were taken from patients receiving two-stage sinus augmentation therapy during implant installation and analyzed using microcomputerized tomography. Three-dimensional bone structural parameters were analyzed in details: tissue volume, bone volume, percentage of bone volume, bone surface and bone surface density, bone specific surface, trabecular thickness trabecular separation, trabecular number, trabecular pattern factor, structural model index, fractal dimension, and bone mineral density.Results:No statistically significant differences were found between groups according to bone structural parameters.Conclusions:Porous titanium grafts may ensure a space for new bone formation in the granules, which may be a clinical advantage for long-term success.
C1 [Dursun, Erhan; Eratalay, Kenan] Hacettepe Univ, Dept Periodontol, Fac Dent, Ankara, Turkey.
   [Orhan, Kaan] Ankara Univ, Dept Dentomaxillofacial Radiol, Fac Dent, TR-06100 Ankara, Turkey.
   [Celik, Hakan Hamdi] Hacettepe Univ, Fac Med, Dept Anat, TR-06100 Ankara, Turkey.
   [Toezuem, Tolga Fikret] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60612 USA.
RP Tozum, TF (reprint author), Univ Illinois, Coll Dent, Dept Periodont, 801 South Paulina St Room 469G, Chicago, IL 60612 USA.
EM ttozum@uic.edu
OI Celik, Hakan Hamdi/0000-0002-7909-7604; Orhan, Kaan/0000-0001-6768-0176
FU Hacettepe University, Scientific Research Projects Coordination Unit,
   Ankara, Turkey [011D10201003]
FX This study is supported by Hacettepe University, Scientific Research
   Projects Coordination Unit (Grant Number: 011D10201003), Ankara, Turkey.
CR Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Butz F, 2011, INT J ORAL MAX IMPL, V26, P1317
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Carballido-Gamio Julio, 2006, Curr Osteoporos Rep, V4, P64, DOI 10.1007/s11914-006-0004-7
   Carlsson Gunnar E, 2004, Gerodontology, V21, P65, DOI 10.1111/j.1741-2358.2004.00005.x
   Caubet J, 2011, J ORAL MAXIL SURG, V69, P482, DOI 10.1016/j.joms.2010.10.037
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Davis GR, 1996, PHYSIOL MEAS, V17, P121, DOI 10.1088/0967-3334/17/3/001
   Deluiz D, 2015, CLIN IMPLANT DENT R, V17, P296, DOI 10.1111/cid.12108
   Ekfeldt A, 2001, CLIN ORAL IMPLAN RES, V12, P462, DOI 10.1034/j.1600-0501.2001.120505.x
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Gedrange T, 2005, CLIN ORAL IMPLAN RES, V16, P425, DOI 10.1111/j.1600-0501.2005.01134.x
   HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Homolka P, 2002, RADIOLOGY, V224, P247, DOI 10.1148/radiol.2241010948
   Huang HL, 2012, CLIN ORAL IMPLAN RES, V23, P1098, DOI 10.1111/j.1600-0501.2011.02273.x
   Kim YJ, 2015, CLIN IMPLANT DENT R, V17, P307, DOI 10.1111/cid.12109
   Klemetti E, 1996, J PROSTHET DENT, V75, P512, DOI 10.1016/S0022-3913(96)90455-2
   Kuhl S, 2012, INT J ORAL MAX IMPL, V27, P1541
   Misch C E, 1989, Dent Today, V8, P39
   Misch CM, 2011, ORAL MAXIL SURG CLIN, V23, P229, DOI 10.1016/j.coms.2011.01.003
   Miyamoto S, 2013, CLIN ORAL IMPLAN RES, V24, P134, DOI 10.1111/j.1600-0501.2011.02396.x
   Monje A, 2015, CLIN IMPLANT DENT R, V17, P111, DOI 10.1111/cid.12075
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Ozan O, 2011, J CRANIOFAC SURG, V22, P1755, DOI 10.1097/SCS.0b013e31822e6305
   PARFITT AM, 1988, CALCIFIED TISSUE INT, V42, P284, DOI 10.1007/BF02556360
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P645, DOI 10.1111/j.1600-0501.2012.02439.x
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P523, DOI 10.1111/j.1600-0501.2011.02414.x
   Pietrokovski Jaime, 2007, J Prosthodont, V16, P502, DOI 10.1111/j.1532-849X.2007.00225.x
   Rebaudi A, 2010, INT J ORAL MAX IMPL, V25, P75
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Soardi CM, 2014, CLIN IMPLANT DENT R, V16, P557, DOI 10.1111/cid.12016
   Southard TE, 2000, ORAL SURG ORAL MED O, V89, P244, DOI 10.1067/moe.2000.102223
   Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031
   Tosoni GM, 2006, ORAL SURG ORAL MED O, V102, P235, DOI 10.1016/j.tripleo.2005.08.020
   Turner TM, 2007, UPSALA J MED SCI, V112, P191, DOI 10.3109/2000-1967-193
   Verket A, 2013, INT J ORAL MAX IMPL, V28, P721, DOI 10.11607/jomi.2853
   Villanueva-Alcojol L, 2013, IMPLANT DENT, V22, P380, DOI 10.1097/ID.0b013e31829afa44
   Xie QF, 1997, ACTA ODONTOL SCAND, V55, P299, DOI 10.3109/00016359709114968
NR 42
TC 5
Z9 5
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD AUG
PY 2015
VL 24
IS 4
BP 427
EP 433
DI 10.1097/ID.0000000000000275
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP3WI
UT WOS:000359813000011
PM 26200164
DA 2018-10-19
ER

PT J
AU Zhang, M
   Zou, Y
   Zhang, FJ
   Zhang, XM
   Wang, MM
AF Zhang, Miao
   Zou, Ying
   Zhang, Fengju
   Zhang, Xuemin
   Wang, Mengmeng
TI Efficacy of Blue-Light Cross-linking on Human Scleral Reinforcement
SO OPTOMETRY AND VISION SCIENCE
LA English
DT Article
DE blue light; cross-linking; human; sclera; efficacy
ID BIOMECHANICAL PROPERTIES; ULTRAVIOLET; RIBOFLAVIN; RADIATION; FLAVINS;
   SAFETY; MYOPIA; TIME
AB Purpose To evaluate the biomechanical effects of collagen cross-linking by riboflavin/blue light (460 nm) on human sclera.
   Methods Forty-two sclera samples from donated human eyes were treated with riboflavin at 0.5% on the equatorial sclera for 20 minutes and then randomly divided into seven groups and irradiated, respectively, with blue light at different intensities (14.6, 19.5, 22.5, 26, 32.5, and 40.6 mW/cm(2)) for 20 minutes using a light-emitting diode source with an exposure area of 10 mm in diameter. The untreated samples constituted the control group. During irradiation, continuous riboflavin solution infiltration was carried out for 20 minutes. Stress-strain measurements of scleral strips were performed with a biomaterial tester. Stress data and Young modulus values in different groups were compared by one-way analysis of variance.
   Results Blue-light (460 nm) cross-linking was efficient in stiffening human sclera strips. Interestingly, eyes treated with 22.5 mW/cm(2) exhibited higher Young modulus values (19.12 [4.88] MPa) at 8% strain compared with other groups, representing a 307.68% increase over control eye values (4.69 [+/- 1.26] MPa). Stress and Young modulus increased gradually with irradiation intensity from 19.5 to 22.5 mW/cm(2) before decreasing for higher intensities.
   Conclusions The biomechanical strength of human sclera may be enhanced by collagen cross-linking with riboflavin/460 nm blue-light irradiation; the dose of 22.5 mW/cm(2) might be used for blue-light (460 nm) scleral cross-linking to achieve a higher efficacy.
C1 [Zhang, Miao; Zou, Ying; Zhang, Fengju; Zhang, Xuemin; Wang, Mengmeng] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100000, Peoples R China.
RP Zhang, FJ (reprint author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100000, Peoples R China.
EM fjz269@yahoo.com
FU National Natural Science Foundation of China [81271041]; Beijing
   Scientific Research Key Program of Beijing Municipal Commission of
   Education [KZ201310025027]; High Level Talent Fund of the Beijing
   Healthcare [2013-2-023]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81271041), Beijing Scientific Research Key Program of Beijing
   Municipal Commission of Education (KZ201310025027) and High Level Talent
   Fund of the Beijing Healthcare (2013-2-023).
CR Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8
   Edwards AM, 1999, J PHOTOCH PHOTOBIO B, V48, P36, DOI 10.1016/S1011-1344(99)00006-8
   Geraghty B, 2012, J MECH BEHAV BIOMED, V16, P181, DOI 10.1016/j.jmbbm.2012.10.011
   Goettsch W, 1998, ENVIRON HEALTH PERSP, V106, P71
   HAM WT, 1979, PHOTOCHEM PHOTOBIOL, V29, P735, DOI 10.1111/j.1751-1097.1979.tb07759.x
   HAM WT, 1982, AM J OPHTHALMOL, V93, P299, DOI 10.1016/0002-9394(82)90529-3
   Hammer A, 2014, INVEST OPHTH VIS SCI, V55, P2881, DOI 10.1167/iovs.13-13748
   Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k
   Holden B, 2014, EYE, V28, P142, DOI 10.1038/eye.2013.256
   Iseli HP, 2008, J REFRACT SURG, V24, pS752
   Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092
   Lamb LE, 2001, ARCH BIOCHEM BIOPHYS, V393, P316, DOI 10.1006/abbi.2001.2492
   Lanchares E, 2011, GRAEF ARCH CLIN EXP, V249, P1223, DOI 10.1007/s00417-011-1674-0
   Edwards AM, 2014, METHODS MOL BIOL, V1146, P3, DOI 10.1007/978-1-4939-0452-5_1
   Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P1639
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   Schumacher S, 2012, INVEST OPHTH VIS SCI, V53, P762, DOI 10.1167/iovs.11-8059
   Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410
   Spoerl E, 1999, J REFRACT SURG, V15, P711
   VANNORREN D, 1990, VISION RES, V30, P1517, DOI 10.1016/0042-6989(90)90032-G
   Wang MM, 2015, CLIN EXP OPHTHALMOL, V43, P156, DOI 10.1111/ceo.12392
   Wang MM, 2012, J REFRACT SURG, V28, P723, DOI 10.3928/1081597X-20120921-08
   Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4
   Wernli J, 2013, INVEST OPHTH VIS SCI, V54, P1176, DOI 10.1167/iovs.12-11409
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2009, ACTA OPHTHALMOL, V87, P193, DOI 10.1111/j.1755-3768.2008.01229.x
   Young TL, 2009, OPTOMETRY VISION SCI, V86, P8, DOI 10.1097/OPX.0b013e3181940655
   Zhang Y, 2014, BIOMED RES INT, V2014
NR 28
TC 2
Z9 2
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-5488
EI 1538-9235
J9 OPTOMETRY VISION SCI
JI Optom. Vis. Sci.
PD AUG
PY 2015
VL 92
IS 8
BP 873
EP 878
DI 10.1097/OPX.0000000000000642
PG 6
WC Ophthalmology
SC Ophthalmology
GA CP3YE
UT WOS:000359818100005
PM 26099056
OA Bronze
DA 2018-10-19
ER

PT J
AU Simon, TE
   Johnson, RJ
   Naig, AL
   Brockmeyer, JR
   Prasad, BM
   White, PW
AF Simon, Todd E.
   Johnson, Rebekah J.
   Naig, Anna L.
   Brockmeyer, Joel R.
   Prasad, Balakrishna M.
   White, Paul W.
TI Permacol Interposition Graft as an Alternative to Vein in Contaminated
   Wounds Using a Rabbit Model
SO ANNALS OF VASCULAR SURGERY
LA English
DT Article
ID COMPROMISED SURGICAL FIELD; ACELLULAR DERMAL ALLOGRAFT; EXTREMITY
   VASCULAR INJURY; VENTRAL HERNIA REPAIR; AUTOGENOUS VEIN; WARTIME REPORT;
   INFECTION; DACRON; BIOMATERIAL; MANAGEMENT
AB Background: Vascular injuries are common in trauma and often involve massive soft tissue injury and segmental arterial loss. Current practice uses either autogenous vein or polytetrafluorethylene (PTFE) for interposition grafting in arterial injuries. Decision making between autogenous or synthetic conduit pivots around the physiological state of the trauma patient. Vein is known to increase operative times in an already physiologically depleted patient, whereas synthetic graft can be simply pulled from the shelf. However, when used in contaminated wounds, PTFE is prone to chronic infection and subsequent graft failure. An alternative synthetic conduit resistant to infection would be ideal for such situations. Permacol (Tissue Science Laboratories, Inc, Andover, MA), a biosynthetic material, has demonstrated resistance to bacterial contamination in contaminated hernia repairs. When fashioned into a tubular structure, this material may be useful as an alternative vascular conduit in contaminated trauma wounds.
   Methods: New Zealand white rabbits were randomized to one of 4 groups: Permacol graft (P) without bacterial contamination (n = 9), Permacol graft with bacterial contamination (CP; n = 9), autogenous vein graft without bacterial contamination (V; n = 9), or autogenous vein with bacterial contamination (CV; n = 9). All groups then underwent interposition grafting of the right common carotid artery. Grafts were contaminated by applying Staphylococcus aureus (1 x 10(5) colonies/0.1 mL) directly to the exposed surface of the graft on completion of the arterial repair. Each graft was then excised at day 42, and segments were collected for histologic evaluation, bacterial counts, and real-time polymerase chain reaction.
   Results: Of the 36 rabbits used in this study, 3 animals in the CV group died within 72 hr of surgery. There was no difference in early mortality between P and V (0% vs. 0%; P = 1.0); however, early mortality was higher in the CV compared with the CP group (33% vs. 0%; P = 0.023). At 42 days, histologic evaluation of graft patency demonstrated no difference between P and V (67% vs. 33%; P = 0.157); however, patency was higher in CP than CV (56% vs. 12%; P - 0.040). In addition, no difference was found between the 2 contaminated groups in regard to the number of bacteria present on each graft material.
   Conclusions: Permacol as an interposition graft is a feasible alternative to vein in a contaminated setting and shows resistance to infection in a rabbit model. Future studies are needed to evaluate this material in larger animal models.
C1 [Simon, Todd E.; White, Paul W.] Walter Reed Natl Mil Med Ctr, Div Vasc Surg, Bethesda, MD 20889 USA.
   [Johnson, Rebekah J.; Naig, Anna L.; Brockmeyer, Joel R.] Dwight D Eisenhower Army Med Ctr, Div Vasc Surg, Ft Gordon, GA USA.
   [Prasad, Balakrishna M.] Dwight D Eisenhower Army Med Ctr, Dept Clin Invest, Ft Gordon, GA USA.
RP Simon, TE (reprint author), Walter Reed Natl Mil Med Ctr, Div Vasc Surg, 8901 Rockville Pike, Bethesda, MD 20889 USA.
EM te.simon@yahoo.com
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Ansaloni L, 2009, AM J SURG, V198, P303, DOI 10.1016/j.amjsurg.2008.09.021
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Bellon JM, 2004, BRIT J SURG, V91, P489, DOI 10.1002/bjs.4451
   BRICKER DL, 1970, CHEST, V58, P566, DOI 10.1378/chest.58.6.566
   Campanelli G, 2008, WORLD J EMERG SURG, V3, DOI 10.1186/1749-7922-3-33
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   Cheek R C, 1974, Am Surg, V40, P439
   Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013
   Clouse WD, 2006, ANN VASC SURG, V20, P429, DOI 10.1007/s10016-006-9090-3
   Diaz JJ, 2006, AM SURGEON, V72, P1181
   FOSTER JH, 1959, SURG GYNECOL OBSTET, V108, P141
   Fox CJ, 2007, SURG CLIN N AM, V87, P1193, DOI 10.1016/j.suc.2007.07.015
   Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010
   Fox CJ, 2007, SURG CLIN NORTH AM, V87, pxi
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   HARRISON JH, 1958, ARCH SURG-CHICAGO, V76, P67, DOI 10.1001/archsurg.1958.01280190069013
   KNOTT LH, 1978, J SURG RES, V24, P288, DOI 10.1016/0022-4804(78)90094-X
   Mancini GJ, 2006, AM SURGEON, V72, P1187
   MATTOX KL, 1989, ANN SURG, V209, P698, DOI 10.1097/00000658-198906000-00007
   Mattox KL, 1989, ANN SURG, V209, P706
   Milburn ML, 2008, SURG INFECT, V9, P433, DOI 10.1089/sur.2007.044
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Peck MA, 2007, J VASC SURG, V45, P1197, DOI 10.1016/j.jvs.2007.02.003
   SHAH PM, 1983, J TRAUMA, V23, P1030, DOI 10.1097/00005373-198312000-00002
   Tsai JW, 2009, ANN VASC SURG, V23, P374, DOI 10.1016/j.avsg.2008.10.004
   WILSON SE, 1975, J SURG RES, V18, P221, DOI 10.1016/0022-4804(75)90145-6
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   ZDANOWSKI Z, 1993, APMIS, V101, P926, DOI 10.1111/j.1699-0463.1993.tb00203.x
NR 29
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0890-5096
EI 1615-5947
J9 ANN VASC SURG
JI Ann. Vasc. Surg.
PD AUG
PY 2015
VL 29
IS 6
BP 1307
EP 1314
DI 10.1016/j.avsg.2015.05.001
PG 8
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA CO7BH
UT WOS:000359312000033
PM 26004967
DA 2018-10-19
ER

PT J
AU Mehta, NK
   Moynihan, KD
   Irvine, DJ
AF Mehta, Naveen K.
   Moynihan, Kelly D.
   Irvine, Darrell J.
TI Engineering New Approaches to Cancer Vaccines
SO CANCER IMMUNOLOGY RESEARCH
LA English
DT Review
ID DENDRITIC CELL-POPULATIONS; LYMPH-NODE; T-CELLS; IN-SITU; INTRANASAL
   IMMUNIZATION; ANTITUMOR IMMUNITY; PEPTIDE VACCINES; IMMUNOTHERAPY;
   VACCINATION; NANOPARTICLES
AB Recently, a number of promising approaches have been developed using synthetic chemistry, materials science, and bioengineering-based strategies to address challenges in the design of more effective cancer vaccines. At the stage of initial priming, potency can be improved by maximizing vaccine delivery to lymph nodes. Because lymphatic uptake from peripheral tissues is strongly size dependent, antigens and adjuvants packaged into optimally sized nanoparticles access the lymph node with much greater efficiency than unformulated vaccines. Once primed, T cells must home to the tumor site. Because T cells acquire the necessary surface receptors in the local lymph node draining the tissue of interest, vaccines must be engineered that reach organs, such as the lung and gut, which are common sites of tumor lesions but inaccessible by been designed that entrap or slowly release immunomodulators at the tumor site, reducing systemic exposure and improving therapeutic efficacy. Finally, lessons learned from the design of biomaterial- based scaffolds in regenerative medicine have led to the development of implantable vaccines that recruit and activate antigen-presenting cells to drive antitumor immunity. Overall, these engineering strategies represent an expanding toolkit to create safe and effective cancer vaccines.
C1 [Mehta, Naveen K.; Moynihan, Kelly D.; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Mehta, Naveen K.; Moynihan, Kelly D.; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Moynihan, Kelly D.; Irvine, Darrell J.] MIT, Ragon Inst MGH, Boston, MA USA.
   [Moynihan, Kelly D.; Irvine, Darrell J.] Harvard Univ, Boston, MA 02115 USA.
   [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP Irvine, DJ (reprint author), MIT, MIT Room 76-261,77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM djirvine@mit.edu
OI Moynihan, Kelly/0000-0001-6200-7863
FU NIH [CA174795, CA172164]; V Foundation; Bridge Project of the Koch
   Institute; Dana-Farber/Harvard Cancer Center; Hertz Foundation; NSF
FX This work was supported by grants from the NIH (CA174795 and CA172164),
   the V Foundation, and the Bridge Project of the Koch Institute and the
   Dana-Farber/Harvard Cancer Center. K.D. Moynihan is supported by a
   graduate fellowship from the Hertz Foundation. K.D. Moynihan and N.K.
   Mehta are supported by graduate research fellowships from the NSF.
CR Ali OA, 2011, J CONTROL RELEASE, V154, P249, DOI 10.1016/j.jconrel.2011.06.021
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Anandasabapathy N, 2014, J EXP MED, V211, P1875, DOI 10.1084/jem.20131397
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155
   Chua BY, 2015, BIOMATERIALS, V53, P50, DOI 10.1016/j.biomaterials.2015.02.066
   de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110
   Egilmez NK, 2000, CANCER RES, V60, P3832
   Fang RH, 2014, NANO LETT, V14, P2181, DOI 10.1021/nl500618u
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Fraser CC, 2014, VACCINE, V32, P2896, DOI 10.1016/j.vaccine.2014.02.024
   Fritsch EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29311
   Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8
   Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988
   Hacohen N, 2013, CANCER IMMUNOL RES, V1, P11, DOI 10.1158/2326-6066.CIR-13-0022
   Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105
   Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915
   Hodi SF, 2014, DENDRITIC CELL ACTIV
   Hor Y, 2009, BIOMATERIALS, V30, P6757, DOI 10.1016/j.biomaterials.2009.08.037
   Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4
   Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599
   John ALS, 2012, NAT MATER, V11, P250, DOI 10.1038/NMAT3222
   Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kourtis IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061646
   Krishnamachari Y, 2011, PHARM RES-DORDR, V28, P215, DOI 10.1007/s11095-010-0241-4
   Kumamoto T, 2002, NAT BIOTECHNOL, V20, P64, DOI 10.1038/nbt0102-64
   Kwong B, 2013, CANCER RES, V73, P1547, DOI 10.1158/0008-5472.CAN-12-3343
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Mercier I, 2013, CANCER RES, V73, P4629, DOI 10.1158/0008-5472.CAN-12-3058
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Mackay CR, 2000, NEW ENGL J MED, V343, P15
   Maloy KJ, 2001, P NATL ACAD SCI USA, V98, P3299, DOI 10.1073/pnas.051630798
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859
   Matsuo K, 2011, J CONTROL RELEASE, V152, P310, DOI 10.1016/j.jconrel.2011.03.009
   McLennan Danielle N, 2005, Drug Discov Today Technol, V2, P89, DOI 10.1016/j.ddtec.2005.05.006
   Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111
   Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   MORTON DL, 1974, ANN SURG, V180, P635, DOI 10.1097/00000658-197410000-00029
   Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/nmat2784, 10.1038/NMAT2784]
   Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109
   Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169
   Sandoval F, 2013, SCI TRANSL MED, V5
   Schulze HJ, 2005, BRIT J DERMATOL, V152, P939, DOI 10.1111/j.1365-2133.2005.06486.x
   Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863
   Seung SK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003649
   Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Smirnov D, 2011, VACCINE, V29, P5434, DOI 10.1016/j.vaccine.2011.05.061
   Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373
   Stano A, 2012, VACCINE, V30, P7541, DOI 10.1016/j.vaccine.2012.10.050
   SUPERSAXO A, 1990, PHARMACEUT RES, V7, P167, DOI 10.1023/A:1015880819328
   Swartz MA, 2014, CANCER IMMUNOL RES, V2, P701, DOI 10.1158/2326-6066.CIR-14-0115
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.957994
   van Herpen CM, 2003, CLIN CANCER RES, V9, P2950
   Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237
   Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883
   Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980
   Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001
   Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095
   Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866
NR 75
TC 17
Z9 17
U1 0
U2 37
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 2326-6066
EI 2326-6074
J9 CANCER IMMUNOL RES
JI Cancer Immunol. Res.
PD AUG
PY 2015
VL 3
IS 8
BP 836
EP 843
DI 10.1158/2326-6066.CIR-15-0112
PG 8
WC Oncology; Immunology
SC Oncology; Immunology
GA CO7DH
UT WOS:000359318100002
PM 26156157
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Tong, S
   Xu, DP
   Liu, ZM
   Wang, XK
AF Tong, Shuang
   Xu, Da-Peng
   Liu, Zi-Mei
   Wang, Xu-Kai
TI Construction and in vitro characterization of three-dimensional silk
   fibroin-chitosan scaffolds
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Silk fibroin; Chitosan; Scaffolds; Bone tissue engineering; Osteoblast
   cell
ID BIOMATERIAL SCAFFOLDS; NETWORKS; DESIGN; CELL
AB The objective of this study was to discuss the construction method, characterization, and biocompatibility of three-dimensional silk fibroin-chitosan (SF-CS) scaffolds which met the requirements of bone tissue engineering scaffolds. Silk fibroin (SF) and chitosan (CS) were mixed at different ratios-3 to 7, 5 to 5, and 7 to 3- to fabricate the composite materials. To find out the optimum mixing ratio of SF and CS, parameters such as pore size, porosity, water absorption, and the mechanical properties were evaluated. Osteoblast cells hFOB1.19 were seeded on SF-CS scaffolds and pure CS scaffolds for the first time. Cell adhesion rate, cell proliferation, and cell activity were evaluated, and cell growth and formation of mineralized nodules were observed. Results showed that SF-CS scaffolds are a suitable candidate for bone tissue engineering.
C1 [Tong, Shuang; Xu, Da-Peng; Liu, Zi-Mei; Wang, Xu-Kai] China Med Univ, Liaoning Inst Dent Res, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shenyang 110002, Liaoning Provin, Peoples R China.
RP Wang, XK (reprint author), China Med Univ, Liaoning Inst Dent Res, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shenyang 110002, Liaoning Provin, Peoples R China.
EM wangxukai757892@sina.com
FU Science and Technology Plan Project of Liaoning Province
   [2012-B-00002012225082]
FX This work was supported by the Science and Technology Plan Project of
   Liaoning Province (Grant No. 2012-B-00002012225082).
CR Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   De Santis R, 2011, J APPL POLYM SCI, V122, P3599, DOI 10.1002/app.34771
   Du CH, 2006, POLYM INT, V55, P377, DOI 10.1002/pi.1995
   El Sayed K, 2013, J TISSUE ENG REGEN M, V7, P61, DOI 10.1002/term.496
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   Harris SA, 1997, US Patent, Patent No. [5,681,701, 5681701]
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khang G, 2006, ENCY MED DEVICES INS, P366
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lai BQ, 2013, BIOMATERIALS, V34, P2888, DOI 10.1016/j.biomaterials.2012.12.046
   Lyons Frank, 2008, Technol Health Care, V16, P305
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Neamnark A, 2007, CARBOHYD POLYM, V68, P166, DOI 10.1016/j.carbpol.2006.07.024
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   Park SJ, 1999, J APPL POLYM SCI, V74, P2571, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2571::AID-APP2>3.0.CO;2-A
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Wang YL, 2012, INT J NANOMED, V7, P2315, DOI [10.2147/IJN.S30593, 10.2147/IJN.S31162]
   Woodward S, 1996, PLANT CELL TISS ORG, V44, P31, DOI 10.1007/BF00045910
NR 27
TC 5
Z9 5
U1 1
U2 16
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD AUG
PY 2015
VL 34
IS 4
BP 475
EP 484
DI 10.4012/dmj.2014-251
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA CO8CX
UT WOS:000359393700008
PM 26235712
OA Bronze
DA 2018-10-19
ER

PT J
AU Wu, PL
   Nakamura, N
   Kimura, T
   Nam, K
   Fujisato, T
   Funamoto, S
   Higami, T
   Kishida, A
AF Wu, Pingli
   Nakamura, Naoko
   Kimura, Tsuyoshi
   Nam, Kwangwoo
   Fujisato, Toshiya
   Funamoto, Seiichi
   Higami, Tetsuya
   Kishida, Akio
TI Decellularized porcine aortic intima-media as a potential cardiovascular
   biomaterial
SO INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
LA English
DT Article
DE Decellularized aortic intima-media; Tissue structure; Mechanical
   properties; Cardiovascular biomaterial
ID MECHANICAL-PROPERTIES; HUMAN PERICARDIUM; TISSUE; MATRIX; VALVE
AB OBJECTIVES: The aim of this research is to investigate the histological and mechanical properties of decellularized aortic intima-media, a promising cardiovascular biomaterial.
   METHODS: Porcine aortic intima-media was decellularized using two methods: high hydrostatic pressurization (HHP) and sodium dodecyl sulphate (SDS). The histological properties were characterized using haematoxylin and eosin staining and Elastica van Gieson staining. The mechanical properties were evaluated using a tensile strength test.
   RESULTS: The structure of the HHP-treated samples was unchanged histologically, whereas that of the SDS-treated samples appeared structurally loose. Consequently, with regard to the mechanical properties of SDS-decellularized intima-media, elastic modulus and tensile strength were significantly decreased.
   CONCLUSIONS: The decellularization method affected the structure and the mechanical properties of the biomaterial. The HHP-treated sample was structurally and mechanically similar to the untreated control. Its mechanical properties were similar to those of human heart valves and the iliac artery and vein. Our results imply that porcine aortic intima-media that is decellularized with HHP is a potential cardiovascular biomaterial.
C1 [Wu, Pingli; Nakamura, Naoko; Kimura, Tsuyoshi; Nam, Kwangwoo; Kishida, Akio] Tokyo Med & Dent Univ, Dept Mat Based Med Engn, Inst Biomat & Bioengn, Tokyo, Japan.
   [Fujisato, Toshiya] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan.
   [Funamoto, Seiichi; Higami, Tetsuya] Sapporo Med Univ, Sch Med, Dept Cardiovasc Surg, Sapporo, Hokkaido, Japan.
RP Kishida, A (reprint author), Tokyo Med & Dent Univ, Dept Mat Based Med Engn, Inst Biomat & Bioengn, Tokyo, Japan.
EM kishida.mbme@tmd.ac.jp
OI FUJISATO, Toshia/0000-0002-7206-093X
FU Japan Society for the Promotion of Science (JSPS)
FX This work was partly supported by a Grant-in-Aid from the Japan Society
   for the Promotion of Science (JSPS).
CR Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122
   Kajbafzadeh AM, 2014, PEDIATR SURG INT, V30, P371, DOI 10.1007/s00383-014-3474-1
   Kalejs Martins, 2009, Interact Cardiovasc Thorac Surg, V8, P553, DOI 10.1510/icvts.2008.196220
   Korossis SA, 2005, J HEART VALVE DIS, V14, P408
   LEE JM, 1985, CIRC RES, V57, P475, DOI 10.1161/01.RES.57.3.475
   Negishi J, 2015, J TISSUE ENG REGEN M, V9, pE144, DOI 10.1002/term.1662
   Negishi J, 2011, J ARTIF ORGANS, V14, P223, DOI 10.1007/s10047-011-0570-z
   Prasertsung I, 2008, J BIOMED MATER RES B, V85B, P210, DOI 10.1002/jbm.b.30938
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCOTT M, 1995, ANN THORAC SURG, V60, pS391, DOI 10.1016/0003-4975(95)00263-K
   Venkatraman S, 2008, PROG POLYM SCI, V33, P953
   Vincentelli A, 1998, J HEART VALVE DIS, V7, P24
   White JK, 2005, ANN THORAC SURG, V80, P704, DOI 10.1016/j.athoracsur.2004.08.063
   WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400
NR 19
TC 4
Z9 4
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1569-9293
EI 1569-9285
J9 INTERACT CARDIOV TH
JI Interact Cardiovasc. Thorac. Surg.
PD AUG
PY 2015
VL 21
IS 2
BP 189
EP 194
DI 10.1093/icvts/ivv113
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA CP2HZ
UT WOS:000359699400011
PM 25972596
OA Bronze
DA 2018-10-19
ER

PT J
AU El-Rashidy, AA
   Gad, A
   Abu-Hussein, AG
   Habib, SI
   Badr, NA
   Hashem, AA
AF El-Rashidy, Aiah A.
   Gad, Ahmed
   Abu-Hussein, Abd El-Hay G.
   Habib, Shaymaa I.
   Badr, Nadia A.
   Hashem, Azza A.
TI Chemical and biological evaluation of Egyptian Nile Tilapia (Oreochromis
   niloticas) fish scale collagen
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Nile Tilapia; Fish scale; Type I collagen; Characterization; BHK-21
   (Baby Hamster kidney)
ID ACID-SOLUBLE COLLAGEN; REDFISH SEBASTES-MENTELLA; CROSS-LINKING; SKIN;
   PROTEINS; BONE; DENATURATION; SPECTROSCOPY; FIBROBLASTS; BIOMATERIAL
AB Collagen is considered to be one of the most useful biomaterials with different medical applications. However, collagen properties differ from one source to another. The aim of this study was to extract, purify, characterize and perform preliminary biological evaluation of type I collagen from scales of Egyptian Nile Tilapia. Pepsin-solubilized collagen (PSC) was successfully prepared from Nile Tilapia fish scale waste. Lyophilized collagen was dissolved in dilute HCl to form acidic collagen solutions (ACS) which was neutralized to form gel. To confirm the biocompatibility of the produced gel, baby hamster kidney (BHK-21) fibroblast cells were seeded onto a 3D collagen gel (0.3% and 0.5%, w/v). The results of an SDS-PAGE test showed that the extracted collagens were type I collagen, with alpha chain composition of (alpha 1)2 alpha 2. Thermal analysis showed that the denaturation temperature was 32 degrees C. X-ray diffraction (XRD) analysis and Fourier-transform infrared spectra (FTIR) showed that the extracted collagen had a triple helix structure. Active proliferation of BHK-21 cells with no signs of toxicity was evident with both collagen gel concentrations tested. The results show that Nile Tilapia scales can be an effective source of collagen extraction that could be used as a potential biomaterial in biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [El-Rashidy, Aiah A.; Habib, Shaymaa I.; Hashem, Azza A.] Cairo Univ, Fac Oral & Dent Med, Dept Biomat, Cairo 11562, Egypt.
   [Gad, Ahmed] Cairo Univ, Fac Agr, Dept Anim Prod, Cairo 12613, Egypt.
   [Gad, Ahmed; Abu-Hussein, Abd El-Hay G.] Cairo Univ, Fac Agr, CURP, Cairo 12613, Egypt.
   [Badr, Nadia A.] Umm Al Qura Univ, Fac Dent, Cairo Univ, Dept Biomat,Fac Oral & Dent Med, Mecca, Saudi Arabia.
RP El-Rashidy, AA (reprint author), Cairo Univ, Fac Oral & Dent Med, Dept Biomat, Cairo 11562, Egypt.
EM aiah.abdelwahab@dentistry.cu.edu.eg
RI Gad, Ahmed/M-7273-2013
OI Gad, Ahmed/0000-0001-9741-2105; El-Rashidy, Aiah/0000-0002-4475-0837
CR ABE Y, 1972, BIOPOLYMERS, V11, P1841, DOI 10.1002/bip.1972.360110906
   Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   AOAC, 2012, OFF METH AN AOAC INT
   Artym VV, 2010, CURRENT PROTOCOLS CE, V10, P1, DOI DOI 10.1002/0471143030.CB1018S48
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Fishery and Aquaculture Country Profiles FAO South Africa, 2010, COUNTR PROF FACT SHE
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Guzzi Plepis AMD, 1996, POLYM ENG SCI, V36, P2932, DOI DOI 10.1002/PEN.10694
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   International Agency for Research on Cancer, 2007, IPCC CLIM CHANG 2007, P1
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Jiang HM, 2005, MOL BIOL CELL, V16, P5070, DOI 10.1091/mbc.E05-01-0007
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lanza R., 2013, PRINC TISSUE ENG, P441
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li CM, 2008, EUR FOOD RES TECHNOL, V227, P1467, DOI 10.1007/s00217-008-0869-z
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Lin Wang, 2008, Food Chemistry, V108, P616, DOI 10.1016/j.foodchem.2007.11.017
   Matmaroh K, 2011, FOOD CHEM, V129, P1179, DOI 10.1016/j.foodchem.2011.05.099
   MIAN M, 1992, INT J TISSUE REACT, V14, P1
   Minh-Thuy L. T., 2014, FOOD CHEM, V149, P264, DOI DOI 10.1016/J.F00DCHEM.2013.10.094
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Najafi MF, 2008, IFMBE PROC, V21, P806
   Nalinanon S., 2012, INT P CHEM BIOL ENV, V39, P47
   NWRC (National Water Research Centre)WL/DELFT Hydraulics National Water Resources Plan for Egypt, 2000, NAT WAT RES PLAN EG
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   Rochdi A, 1999, BIOPOLYMERS, V50, P690, DOI 10.1002/(SICI)1097-0282(199912)50:7<690::AID-BIP2>3.0.CO;2-P
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Sugiura H, 2009, J BIOMAT SCI-POLYM E, V20, P1353, DOI 10.1163/092050609X12457418396658
   TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Villas-Boas SG, 2003, ANAL BIOCHEM, V322, P134, DOI 10.1016/j.ab.2003.07.018
   Wang L, 2007, J FOOD SCI, V72, pE450, DOI 10.1111/j.1750-3841.2007.00478.x
   Wang L, 2008, FOOD CHEM, V108, P616, DOI 10.1016/j.foodchem.2007.11.017
   Westgate S., 2012, COLLAGEN DRESSINGS M
   Wong D. W. S., 1989, MECH THEORY FOOD CHE
   Wu C.-H., 2006, Taiwan Invent. Pat. Publ. Number I, Patent No. 263678
   Yacoub AM, 2012, INT J ENV SCI ENG, V3, P1
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
   Zhang FengXiang, 2011, Food and Nutrition Sciences, V2, P818, DOI 10.4236/fns.2011.28112
   Zhou T, 2015, ACS APPL MATER INTER, V7, P3253, DOI 10.1021/am507990m
NR 49
TC 11
Z9 13
U1 0
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2015
VL 79
BP 618
EP 626
DI 10.1016/j.ijbiomac.2015.05.019
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CO4YH
UT WOS:000359166300079
PM 26026980
DA 2018-10-19
ER

PT J
AU Farghali, RA
   Fekry, AM
   Ahmed, RA
   Elhakim, HKA
AF Farghali, R. A.
   Fekry, A. M.
   Ahmed, Rasha A.
   Elhakim, H. K. A.
TI Corrosion resistance of Ti modified by chitosan-gold nanoparticles for
   orthopedic implantation
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Review
DE Chitosan; AuNPs; Titanium
ID MICROBIOLOGICALLY INFLUENCED CORROSION; ELECTROCHEMICAL CORROSION;
   NANOCOMPOSITE FILMS; TITANIUM-ALLOYS; HANKS SOLUTION; BEHAVIOR; NITI;
   DEPOSITION; PREVENTION; MAGNESIUM
AB Highly uniform bionanocomposite film composed of chitosan (CS) and gold nanoparticles (AuNPs) was synthesized successfully by electrodeposition method. The influence of AuNPs/CS bionanocomposite film on corrosion resistance of Ti was investigated. Surface morphology and compositional properties of the bionanocomposite were analyzed by scanning electron microscope (SEM), energy dispersive X-ray analysis (EDX), and X-ray photoelectron spectroscopy (XPS). Moreover, cyclic voltammetry (CV), open-circuit potential measurements (OCP), electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization (R-p) were used to examine the corrosion behavior in Hanks' solution. In comparison with Ti, Nyquist and Bode plots displayed higher impedance values and phase angles for AuNPs/CS biocomposite denoting a more protective passive film on Ti with inhibition efficiency (IE%) of 98%. An electric equivalent circuit with three time constants was modeled for the bionanocomposite. In addition, the antibacterial effect revealed the high efficiencies of the bionanocomposite film for inhibiting bacterial growth. The combination of the high biocompatibility of chitosan and strong adsorption ability of AuNPs make AuNPs/CS bionanocomposite promising candidate for modifying biomaterial surfaces for medical implantation applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Farghali, R. A.; Ahmed, Rasha A.] Taif Univ, Fac Sci, Dept Chem, At Taif, Saudi Arabia.
   [Farghali, R. A.; Fekry, A. M.] Cairo Univ, Dept Chem, Fac Sci, Giza 12613, Egypt.
   [Ahmed, Rasha A.] Minist Justice, Medico Legal Dept, Forens Chem Labs, Cairo, Egypt.
   [Elhakim, H. K. A.] Cairo Univ, Dept Biochem, Fac Sci, Giza 12613, Egypt.
RP Ahmed, RA (reprint author), Taif Univ, Fac Sci, Dept Chem, Hawiya 888, At Taif, Saudi Arabia.
EM rashaauf@yahoo.com
FU Taif University, Kingdom of Saudi Arabia
FX This work was financial support by Taif University, Kingdom of Saudi
   Arabia. This research was also carried out in cooperation with Faculty
   of Science, Cairo University. The authors would like to thank Core labs
   in King Abdullah University of science and technology (KAUST) for
   performing XPS analysis.
CR Ahmed RA, 2014, APPL SURF SCI, V292, P390, DOI 10.1016/j.apsusc.2013.11.150
   Ameer MA, 2011, PROG ORG COAT, V71, P343, DOI 10.1016/j.porgcoat.2011.04.001
   Ameer MA, 2010, INT J HYDROGEN ENERG, V35, P11387, DOI 10.1016/j.ijhydene.2010.07.071
   Casaletto MP, 2006, SURF INTERFACE ANAL, V38, P215, DOI 10.1002/sia.2180
   Chen CH, 2008, SURF COAT TECH, V202, P2709, DOI 10.1016/j.surfcoat.2007.09.052
   Chudasama B., 2010, J NANOPART RES, V10, P1677
   Davies J. E., 1991, BONE BIOMATERIAL I 1
   ENGH CA, 1988, CLIN ORTHOP RELAT R, P7
   Fadlallah S. A., 2014, ALLOYS COMPD, V583, P455
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P7280, DOI 10.1016/j.electacta.2009.07.047
   Fekry A. M., 2010, INT J HYDRPGEN ENERG, V351, P2945
   Fong YY, 2010, J PHYS CHEM C, V114, P15931, DOI 10.1021/jp9118315
   FRIEDMAN RJ, 1995, J APPL BIOMATER, V6, P231, DOI 10.1002/jab.770060403
   Ghoneim AA, 2010, ELECTROCHIM ACTA, V55, P6028, DOI 10.1016/j.electacta.2010.05.062
   Gu YW, 2005, APPL SURF SCI, V252, P2038, DOI 10.1016/j.apsusc.2005.03.207
   Heakal F. El-Taib, 2008, J ELECTROCHEM SOC, V155, P534
   Helsen J.A., 1998, METALS BIOMATERIALS
   Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P99, DOI 10.2106/JBJS.F.00102
   Jaramillo TF, 2003, J AM CHEM SOC, V125, P7148, DOI 10.1021/ja029800v
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kumar K, 2009, LANGMUIR, V25, P7667, DOI 10.1021/la900327v
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Lane RA, 2005, J FAIL ANAL PREV, V5, P33, DOI 10.1361/154770205X65891
   Li Y, 2008, SURF COAT TECH, V202, P3017, DOI 10.1016/j.surfcoat.2007.11.003
   LITTLE B, 1991, INT MATER REV, V36, P253, DOI 10.1179/imr.1991.36.1.253
   LITTLE B, 1992, ELECTROCHIM ACTA, V37, P2185, DOI 10.1016/0013-4686(92)85110-7
   Liu XM, 2007, APPL SURF SCI, V253, P3154, DOI 10.1016/j.apsusc.2006.07.008
   Liu ZM, 2005, SENSOR ACTUAT B-CHEM, V106, P394, DOI 10.1016/j.snb.2004.08.023
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   McKinney R. V., 1985, DENT IMPLANT TISSUE
   McLachlan D. R. C., 1983, BIOL ASPECTS METALS, P209
   Muzzarelli RAA, 1996, CARBOHYD POLYM, V29, P309, DOI 10.1016/S0144-8617(96)00033-1
   Nagarajan N, 2007, MATER CHEM PHYS, V103, P47, DOI 10.1016/j.matchemphys.2007.01.005
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Raffi M, 2008, J MATER SCI TECHNOL, V24, P192
   Rhim JW, 2006, J AGR FOOD CHEM, V54, P5814, DOI 10.1021/jf060658h
   Schrooten J, 2000, BIOMATERIALS, V21, P1461, DOI 10.1016/S0142-9612(00)00027-2
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Sun F, 2008, COLLOID SURFACE B, V67, P132, DOI 10.1016/j.colsurfb.2008.08.008
   Tondo E, 2009, SURF COAT TECH, V203, P3427, DOI 10.1016/j.surfcoat.2009.05.006
   VOGEL W, 1995, LANGMUIR, V11, P401, DOI 10.1021/la00002a005
   Wei H, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295603
   Wong MH, 2007, SCRIPTA MATER, V56, P205, DOI 10.1016/j.scriptamat.2006.10.014
   Xiao Y, 2003, SCIENCE, V299, P1877, DOI 10.1126/science.1080664
   Youssef AM, 2014, INT J BIOL MACROMOL, V69, P185, DOI 10.1016/j.ijbiomac.2014.05.047
   Zhitomirsky I, 2000, MATER LETT, V46, P1, DOI 10.1016/S0167-577X(00)00133-6
   Zhitomirsky I, 2006, J MATER SCI, V41, P8186, DOI 10.1007/s10853-006-0994-7
   Zhitomirsky I, 2004, J APPL ELECTROCHEM, V34, P235, DOI 10.1023/B:JACH.0000009965.74890.d9
NR 52
TC 6
Z9 6
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2015
VL 79
BP 787
EP 799
DI 10.1016/j.ijbiomac.2015.04.078
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CO4YH
UT WOS:000359166300099
PM 25989146
DA 2018-10-19
ER

PT J
AU Valle, J
   Burgui, S
   Langheinrich, D
   Gil, C
   Solano, C
   Toledo-Arana, A
   Helbig, R
   Lasagni, A
   Lasa, I
AF Valle, Jaione
   Burgui, Saioa
   Langheinrich, Denise
   Gil, Carmen
   Solano, Cristina
   Toledo-Arana, Alejandro
   Helbig, Ralf
   Lasagni, Andres
   Lasa, Inigo
TI Evaluation of Surface Microtopography Engineered by Direct Laser
   Interference for Bacterial Anti-Biofouling
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adhesion; biofilm; biomaterial-associated infection; direct laser
   interference patterning; Staphylococcus aureus
ID FIBRONECTIN-BINDING PROTEINS; ATOMIC-FORCE MICROSCOPE;
   STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA;
   ADHESION; ATTACHMENT; TOPOGRAPHY; INFECTIONS; STRATEGIES
AB Modification of the biomaterial surface topography is a promising strategy to prevent bacterial adhesion and biofilm formation. In this study, we use direct laser interference patterning (DLIP) to modify polystyrene surface topography at sub-micrometer scale. The results revealed that three-dimensional micrometer structures have a profound impact on bacterial adhesion. Thus, line-and pillar-like patterns enhanced S. aureus adhesion, whereas complex lamella microtopography reduced S. aureus adhesion in static and continuous flow culture conditions. Interestingly, lamella-like textured surfaces retained the capacity to inhibit S. aureus adhesion both when the surface is coated with human serum proteins and when the material is implanted subcutaneously in a foreign-body associated infection model.
C1 [Valle, Jaione; Burgui, Saioa; Gil, Carmen; Solano, Cristina; Toledo-Arana, Alejandro; Lasa, Inigo] Univ Publ Navarra, CSIC, Gobierno Navarra, Inst Agrobiotecnol,Lab Microbial Biofilms, Pamplona, Spain.
   [Langheinrich, Denise; Lasagni, Andres] Fraunhofer Inst Mat & Beam Technol IWS Dresden, D-01277 Dresden, Germany.
   [Langheinrich, Denise; Lasagni, Andres] Tech Univ Dresden, Inst Mfg Technol, D-01069 Dresden, Germany.
   [Helbig, Ralf] Leibniz Inst Polymer Res IPF Dresden, D-01069 Dresden, Germany.
RP Valle, J (reprint author), Univ Publ Navarra, CSIC, Gobierno Navarra, Inst Agrobiotecnol,Lab Microbial Biofilms, Campus Arrosadia, Pamplona, Spain.
EM jaione.valle@unavarra.es
RI Toledo-Arana, Alejandro/F-9624-2011; Solano, Cristina/F-9607-2011;
   Lasagni, Andres/M-7476-2017; Gil, Carmen/K-3759-2017; jaione,
   valle/G-6213-2011; Lasa, Inigo/F-2947-2011; Umlauf, Ursula/D-3356-2014
OI Toledo-Arana, Alejandro/0000-0001-8148-6281; Solano,
   Cristina/0000-0002-6207-1766; Gil, Carmen/0000-0002-8867-4442; jaione,
   valle/0000-0003-3115-0207; Lasa, Inigo/0000-0002-6625-9221; 
FU Spanish Ministry of Science and Innovation; Spanish Ministry of Economy
   and Competitivity [AGL2011-23954, BIO2011-30503-C02-02]; Innovation
   Department of the Government of Navarra [IIQ14066. RI1]; Deutsche
   Forschungsgemeinschaft (DFG) [LA-2513 4-1]
FX J. Valle was supported by Spanish Ministry of Science and Innovation
   "Ramon y Cajal" contract. This research was supported by grants
   AGL2011-23954 and BIO2011-30503-C02-02 from the Spanish Ministry of
   Economy and Competitivity and IIQ14066. RI1 from Innovation Department
   of the Government of Navarra. A. Lasagni, D. Langhenirich, and R. Helbig
   thank the Deutsche Forschungsgemeinschaft (DFG) for the financial
   support of the project "Mechanically stable anti-adhesive polymer
   surfaces" (LA-2513 4-1).
CR Abban S, 2012, FOOD MICROBIOL, V31, P139, DOI 10.1016/j.fm.2012.04.003
   Basak P, 2009, J MATER SCI-MATER M, V20, P213, DOI 10.1007/s10856-008-3521-3
   Bieda M., 2014, ADV ENG MAT
   Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042
   Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581
   Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014
   Graham MV, 2014, COATINGS, V4, P37, DOI 10.3390/coatings4010037
   Graham MV, 2013, SOFT MATTER, V9, P6235, DOI 10.1039/c3sm50584g
   Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X
   Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kim P, 2012, NANO LETT, V12, P527, DOI 10.1021/nl200426g
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Komaromy A, 2009, MICROELECTRON ENG, V86, P1431, DOI 10.1016/j.mee.2009.01.024
   Komaromy AZ, 2012, MICROELECTRON ENG, V91, P39, DOI 10.1016/j.mee.2011.10.012
   Langheinrich D., 2011, J POLYM SCI B, V50, P415
   Lasagni AF, 2012, PLASTIC RES ONLINE, DOI [10.1002/spepro.004281, DOI 10.1002/SPEPRO.004281]
   Manabe K, 2013, ACS APPL MATER INTER, V5, P11900, DOI 10.1021/am4035762
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Modjarrad K., 2013, HDB POLYM APPL MED D
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744
   Shah SR, 2013, MATER TODAY, V16, P177, DOI 10.1016/j.mattod.2013.05.003
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
NR 43
TC 23
Z9 23
U1 3
U2 56
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG
PY 2015
VL 15
IS 8
BP 1060
EP 1069
DI 10.1002/mabi.201500107
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CP1IN
UT WOS:000359629600004
PM 25914260
DA 2018-10-19
ER

PT J
AU Goldshmid, R
   Mironi-Harpaz, I
   Shachaf, Y
   Seliktar, D
AF Goldshmid, Revital
   Mironi-Harpaz, Iris
   Shachaf, Yonatan
   Seliktar, Dror
TI A method for preparation of hydrogel microcapsules for stem cell
   bioproces sing and stem cell therapy
SO METHODS
LA English
DT Article
DE Biomaterial; Suspension bioreactor; 3D culture; Physical crosslinking;
   Chemical crosslinking; Pluronic-fibrinogen; PEG
ID DYNAMIC-MECHANICAL ANALYSIS; FULLY-SYNTHETIC SUBSTITUTE; CHONDROGENIC
   DIFFERENTIATION; POLYETHYLENE-GLYCOL; CROSS-LINKING; OSTEOGENIC
   DIFFERENTIATION; BIOMEDICAL APPLICATIONS; CLINICAL-APPLICATIONS;
   IN-VITRO; EXPANSION
AB A method for the preparation of suspension culture microcapsules used in the bioprocessing of human mesenchymal stem cells (hMSCs) is reported. The microcapsules are prepared from a semi-synthetic hydrogel comprising Pluronie (R) F127 conjugated to denatured fibrinogen. The Pluronic-fibrinogen adducts display a lower critical solubility temperature (LCST) at similar to 30 degrees C, thus enabling mild, cell-compatible physical crosslinking of the microcapsules in a warm gelation bath. Cell-laden microgels were prepared from a solution of Pluronic-fibrinogen hydrogel precursor and hMSCs; these were cultivated for up to 15 days in laboratory-scale suspension bioreactors and harvested by reducing the temperature of the microcapsules to disassemble the physical polymer network. The viability, proliferation and cell recovery yields of the hMSCs were shown to be better than photo-chemically crosslinked microcapsules made from a similar material. The cell culture yields, which exceeded 300% after 15 days in suspension culture, were comparable to other microcarrier systems used for the mass production of hMSCs. The simplicity of this methodology, both in terms of the cell inoculation and mild recovery conditions, represent distinct advantages for stem cell bioprocessing with suspension culture bioreactors. (C) 2015 Published by Elsevier Inc.
C1 [Goldshmid, Revital; Mironi-Harpaz, Iris; Shachaf, Yonatan; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Goldshmid, Revital] Technion Israel Inst Technol, Interdisciplinary Program Biotechnol, IL-32000 Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
FU Singapore National Research Foundation (NRF)-Technion-NUS Grant for
   Regenerative Medicine Initiative in Cardiac Restoration Therapy; Lorry
   I. Lokey Interdisciplinary Center for Life Sciences and Engineering;
   EC-IP FP7 grant Angioscaff; Russell Berrie Nanotechnology Institute;
   EC-IP FP7 grant Biodesign
FX This work was supported by the Singapore National Research Foundation
   (NRF)-Technion-NUS Grant for Regenerative Medicine Initiative in Cardiac
   Restoration Therapy, the Lorry I. Lokey Interdisciplinary Center for
   Life Sciences and Engineering, Russell Berrie Nanotechnology Institute,
   as well as by EC-IP FP7 grants Angioscaff and Biodesign.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   ALTANKOV G, 1991, Journal of Biomaterials Science Polymer Edition, V2, P81, DOI 10.1163/156856291X00089
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249
   Boo L, 2011, J MATER SCI-MATER M, V22, P1343, DOI 10.1007/s10856-011-4294-7
   Cellesi F, 2004, BIOTECHNOL BIOENG, V88, P740, DOI 10.1002/bit.20264
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Chen A.K., 2010, CURR PROTOC STEM CEL
   Chun KW, 2004, BIOTECHNOL PROGR, V20, P1797, DOI 10.1021/bp0496981
   Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9
   Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X
   Engler AJ, 2007, METHOD CELL BIOL, V83, P521, DOI 10.1016/S0091-679X(07)83022-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fink T, 2004, STEM CELLS, V22, P1346, DOI 10.1634/stemcells.2004-0038
   Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719
   Frisman I, 2011, LANGMUIR, V27, P6977, DOI 10.1021/la104695m
   GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312
   Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Hewitt CJ, 2011, BIOTECHNOL LETT, V33, P2325, DOI 10.1007/s10529-011-0695-4
   Hoch AI, 2014, STEM CELL TRANSL MED, V3, P643, DOI 10.5966/sctm.2013-0196
   Jackson L, 2007, J POSTGRAD MED, V53, P121
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   Kesselman D, 2013, ACTA BIOMATER, V9, P7630, DOI 10.1016/j.actbio.2013.04.030
   KIREMITCI M, 1990, BIOMATER ARTIF CELL, V18, P599, DOI 10.3109/10731199009117327
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee JH, 2005, EXP CELL RES, V307, P174, DOI 10.1016/j.yexcr.2005.03.008
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Lund AW, 2008, J BIOMED MATER RES B, V87B, P213, DOI 10.1002/jbm.b.31098
   MARLCWAY BD, 2010, CELL TRANSPLANT, V19, P29
   McNiece I, 2007, SEMIN CELL DEV BIOL, V18, P839, DOI 10.1016/j.semcdb.2007.09.005
   Meyvis TKL, 2002, INT J PHARM, V244, P163, DOI 10.1016/S0378-5173(02)00328-9
   Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005
   Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309
   Parson AB, 2008, CELL, V132, P511, DOI 10.1016/j.cell.2008.02.004
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8
   Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301
   RODER B, 1993, J BIOMAT SCI-POLYM E, V5, P79
   Sart S, 2013, J TISSUE ENG REGEN M, V7, P537, DOI 10.1002/term.545
   Schipani E., 2008, STEMBOOK
   Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050
   Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007
   SMIT NPM, 1989, J INVEST DERMATOL, V92, P18, DOI 10.1111/1523-1747.ep13070406
   Tae SK, 2006, BIOMED MATER, V1, P63, DOI 10.1088/1748-6041/1/2/003
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Yang HS, 2010, CELL TRANSPLANT, V19, P1123, DOI 10.3727/096368910X516664
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zweigerdt R, 2009, ADV BIOCHEM ENG BIOT, V114, P201, DOI 10.1007/10_2008_27
NR 59
TC 4
Z9 4
U1 1
U2 34
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 35
EP 43
DI 10.1016/j.ymeth.2015.04.027
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100005
PM 25931428
DA 2018-10-19
ER

PT J
AU Ungerleider, JL
   Johnson, TD
   Rao, N
   Christman, KL
AF Ungerleider, J. L.
   Johnson, T. D.
   Rao, N.
   Christman, K. L.
TI Fabrication and characterization of injectable hydrogels derived from
   decellularized skeletal and cardiac muscle
SO METHODS
LA English
DT Article
DE Decellularization; Hydrogel; Extracellular matrix; Myocardial
   infarction; Peripheral artery disease
ID CRITICAL LIMB ISCHEMIA; PERIPHERAL ARTERIAL-DISEASE;
   EXTRACELLULAR-MATRIX; THERAPEUTIC ANGIOGENESIS; INTRAMUSCULAR INJECTION;
   MYOCARDIAL-INFARCTION; TISSUE-REPAIR; GROWTH-FACTOR; DOUBLE-BLIND;
   QUANTIFICATION
AB Biomaterials, which can contain appropriate biomechanical and/or biochemical cues, are increasingly being investigated as potential scaffolds for tissue regeneration and/or repair for treating myocardial infarction, heart failure, and peripheral artery disease. Specifically, injectable hydrogels are touted for their minimally invasive delivery, ability to self-assemble in situ, and capacity to encourage host tissue regeneration. Here we present detailed methods for fabricating and characterizing decellularized injectable cardiac and skeletal muscle extracellular matrix (ECM) hydrogels. The ECM derived hydrogels have low cellular and DNA content, retain sulfated glycosaminoglycans and other extracellular matrix proteins such as collagen, gel at physiologic temperature and pH, and assume a nanofibrous architecture. These injectable hydrogels are amenable to minimally invasive, tissue specific biomaterial therapies for treating myocardial infarction and peripheral artery disease. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ungerleider, J. L.; Johnson, T. D.; Rao, N.; Christman, K. L.] Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU National Institutes of Health (NIH) [R01HL113468]
FX This research was supported in part by National Institutes of Health
   (NIH) through R01HL113468. Dr. Christman is co-founder, board member,
   and holds equity interest in Ventrix, Inc.
CR Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082
   Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774
   DeQuach J.A., 2013, EUR CELLS MATER, V23, P400
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Hill RC, 2015, MOL CELL PROTEOMICS, V14, P961, DOI 10.1074/mcp.M114.045260
   Johnson T. D., 2014, BIOMATER SCI
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Kawamura I, 2011, J CARDIOVASC PHARM, V57, P416, DOI 10.1097/FJC.0b013e31820c9776
   Lin Y.D., 2012, SCI TRANSL MED, V4
   Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x
   Ouma GO, 2012, VASC MED, V17, P174, DOI 10.1177/1358863X12438270
   Powell RJ, 2011, J VASC SURG, V54, P1032, DOI 10.1016/j.jvs.2011.04.006
   Powell RJ, 2010, J VASC SURG, V52, P1525, DOI 10.1016/j.jvs.2010.07.044
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shigematsu H, 2010, GENE THER, V17, P1152, DOI 10.1038/gt.2010.51
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371
   Ungerleider J.L., 2014, STEM CELL TRANSL MED, V3, P1
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   White CJ, 2007, CIRCULATION, V116, P2203, DOI 10.1161/CIRCULATIONAHA.106.621391
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Young DA, 2014, J BIOMED MATER RES A, V102, P1641, DOI 10.1002/jbm.a.35109
NR 38
TC 20
Z9 20
U1 4
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 53
EP 59
DI 10.1016/j.ymeth.2015.03.024
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100007
PM 25843605
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Abbott, RD
   Raja, WK
   Wang, RY
   Stinson, JA
   Glettig, DL
   Burke, KA
   Kaplan, DL
AF Abbott, Rosalyn D.
   Raja, Waseem K.
   Wang, Rebecca Y.
   Stinson, Jordan A.
   Glettig, Dean L.
   Burke, Kelly A.
   Kaplan, David L.
TI Long term perfusion system supporting adipogenesis
SO METHODS
LA English
DT Article
DE Adipose tissue engineering; Three dimensional culture; Silk scaffold;
   Long term culture; Perfusion
ID MESENCHYMAL STEM-CELLS; ADIPOSE-TISSUE; IN-VITRO; ADIPOCYTE/ENDOTHELIAL
   COCULTURES; LIPOLYTIC FUNCTION; DIFFERENTIATION; BIOREACTORS; ADIPOCYTE;
   CULTURE; PREADIPOCYTES
AB Adipose tissue engineered models are needed to enhance our understanding of disease mechanisms and for soft tissue regenerative strategies. Perfusion systems generate more physiologically relevant and sustainable adipose tissue models, however adipocytes have unique properties that make culturing them in a perfusion environment challenging. In this paper we describe the methods involved in the development of two perfusion culture systems (2D and 3D) to test their applicability for long term in vitro adipogenic cultures. It was hypothesized that a silk protein biomaterial scaffold would provide a 3D framework, in combination with perfusion flow, to generate a more physiologically relevant sustainable adipose tissue engineered model than 2D cell culture. Consistent with other studies evaluating 20 and 3D culture systems for adipogenesis we found that both systems successfully model adipogenesis, however 3D culture systems were more robust, providing the mechanical structure required to contain the large, fragile adipocytes that were lost in 2D perfused culture systems. 3D perfusion also stimulated greater lipogenesis and lipolysis and resulted in decreased secretion of LDH compared to 2D perfusion. Regardless of culture configuration (2D or 3D) greater glycerol was secreted with the increased nutritional supply provided by perfusion of fresh media. These results are promising for adipose tissue engineering applications including long term cultures for studying disease mechanisms and regenerative approaches, where both acute (days to weeks) and chronic (weeks to months) cultivation are critical for useful insight. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Abbott, Rosalyn D.; Raja, Waseem K.; Wang, Rebecca Y.; Stinson, Jordan A.; Glettig, Dean L.; Burke, Kelly A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA.
   [Raja, Waseem K.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.
   [Glettig, Dean L.] MIT, Biol Engn, Cambridge, MA 02139 USA.
   [Burke, Kelly A.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Abbott, Rosalyn/0000-0003-3287-3175
FU NIH Tissue Engineering Resource Center [P41 EB002520]; NIH Ruth
   Kirschstein Postdoctoral Fellowship [F32-DK093194]; AFIRM
   [W81XWH-08-2-0032]
FX The authors wish to thank Dr. Sonal Pandya for providing the surgical
   specimens. The authors would also like to thank Dr. Irene Georgakoudi
   for the use of her confocal microscope. Finally, the authors would like
   to thank Francis Borowsky and Elisa Clark for technical assistance and
   Dr. Teresa DesRochers and Kiyatec for providing the 3D Kube culture
   systems. This work was funded by the NIH Tissue Engineering Resource
   Center (P41 EB002520) a NIH Ruth Kirschstein Postdoctoral Fellowship
   awarded to Kelly Burke (F32-DK093194) and AFIRM (W81XWH-08-2-0032).
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bellas E., 2013, TISSUE ENG C
   Bellas E, 2013, BIOMATERIALS, V34, P2960, DOI 10.1016/j.biomaterials.2013.01.058
   Choi JH, 2011, TISSUE ENG PT A, V17, P1437, DOI [10.1089/ten.tea.2010.0527, 10.1089/ten.TEA.2010.0527]
   Choi JH, 2010, TISSUE ENG PART C-ME, V16, P1157, DOI 10.1089/ten.TEC.2009.0760
   Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050
   Clark AM, 2010, ANAL BIOANAL CHEM, V397, P2939, DOI 10.1007/s00216-010-3897-z
   Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Daya S, 2007, DIFFERENTIATION, V75, P360, DOI 10.1111/j.1432-0436.2006.00146.x
   Dubois Severine G., 2008, V449, P69, DOI 10.1007/978-1-60327-169-1_5
   Gaspar Diana Alves, 2012, Biomatter, V2, P167, DOI 10.4161/biom.22170
   Gerlach JC, 2012, TISSUE ENG PART C-ME, V18, P54, DOI [10.1089/ten.tec.2011.0216, 10.1089/ten.TEC.2011.0216]
   Girandon L, 2011, FOLIA BIOL-PRAGUE, V57, P47
   GOERGEN JL, 1993, CYTOTECHNOLOGY, V11, P189, DOI 10.1007/BF00749869
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z
   Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799
   Lai N, 2012, TISSUE ENG PART C-ME, V18, P958, DOI [10.1089/ten.tec.2012.0168, 10.1089/ten.TEC.2012.0168]
   Mabvuure N, 2012, CURR STEM CELL RES T, V7, P287, DOI 10.2174/157488812800793018
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Minteer Danielle M, 2014, J Diabetes Sci Technol, V8, P1227, DOI 10.1177/1932296814548215
   Ni XF, 2008, MICROELECTRON ENG, V85, P1330, DOI 10.1016/j.mee.2008.01.070
   Oragui E, 2011, OPEN ORTHOP J, V2, P267
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Salter E, 2012, TISSUE ENG PART B-RE, V18, P62, DOI [10.1089/ten.teb.2011.0209, 10.1089/ten.TEB.2011.0209]
   Sistino Joseph J, 2003, J Extra Corpor Technol, V35, P200
   Stacey DH, 2009, TISSUE ENG PT A, V15, P3389, DOI [10.1089/ten.tea.2008.0293, 10.1089/ten.TEA.2008.0293]
   Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P590, DOI 10.1021/bp034238d
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Ward A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055696
   Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h
NR 37
TC 11
Z9 11
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 84
EP 89
DI 10.1016/j.ymeth.2015.03.022
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100011
PM 25843606
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Corvelli, M
   Che, B
   Saeui, C
   Singh, A
   Elisseeff, J
AF Corvelli, Michael
   Che, Bernadette
   Saeui, Christopher
   Singh, Anirudha
   Elisseeff, Jennifer
TI Biodynamic performance of hyaluronic acid versus synovial fluid of the
   knee in osteoarthritis
SO METHODS
LA English
DT Article
DE Cartilage; Osteoarthritis; Hyaluronic acid; Lubricin; Synovial fluid
ID ARTICULAR-CARTILAGE; BOUNDARY LUBRICATION; FRICTIONAL RESPONSE;
   STRESS-RELAXATION; LUBRICIN; PRESSURIZATION; REPLACEMENT; DEGRADATION;
   INJURY; JOINTS
AB Hyaluronic acid (HA), a natural biomaterial present in healthy joints but depleted in osteoarthritis (OA), has been employed clinically to provide symptomatic relief of joint pain. Joint movement combined with a reduced joint lubrication in osteoarthritic knees can result in increased wear and tear, chondrocyte apoptosis, and inflammation, leading to cascading cartilage deterioration. Therefore, development of an appropriate cartilage model that can be evaluated for its friction properties with potential lubricants in different conditions is necessary, which can closely resemble a mechanically induced OA cartilage. Additionally, a comparison of different models with and without endogenous lubricating surface zone proteins, such as PRG4 promotes a well-rounded understanding of cartilage lubrication. In this study, we present our findings on the lubricating effects of HA on different articular cartilage model surfaces in comparison to synovial fluid, a physiological lubricating biomaterial. The mechanical testings data demonstrated that HA reduced average static and kinetic friction coefficient values of the cartilage samples by 75% and 70%, respectively. Furthermore, HA mimicked the friction characteristics of freshly harvested natural synovial fluid throughout all tested and modeled OA conditions with no statistically significant difference. These characteristics led us to exclusively identify HA as an effective boundary layer lubricant in the technology that we develop to treat OA (Singh et al., 2014). (C) 2015 Elsevier Inc. All rights reserved.
C1 [Corvelli, Michael; Che, Bernadette; Saeui, Christopher; Singh, Anirudha; Elisseeff, Jennifer] Johns Hopkins Univ, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD USA.
   [Corvelli, Michael; Che, Bernadette; Saeui, Christopher; Singh, Anirudha; Elisseeff, Jennifer] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA.
   [Singh, Anirudha] Johns Hopkins Univ, Sch Med, Dept Urol, Brady Urol Inst, Baltimore, MD 21205 USA.
RP Singh, A (reprint author), Johns Hopkins Univ, Dept Urol, Brady Urol Inst, Baltimore, MD 21218 USA.
EM anirudhasingh@gmail.com; jhe@jhu.edu
FU NIH [R01AR054005]; United States; DoD-PRORP grant; Wallace H. Coulter
   Foundation; Ort Philanthropic Fund; Jules Stein Professorship from the
   Research to Prevent Blindness Foundation
FX We thank F. Guilak (Duke University) for helpful discussions on the
   friction testing, T. Clemens (Johns Hopkins) for use of their
   laboratory, and the Johns Hopkins' Wilmer Eye Institute Microscopy Core
   Facility. Funding sources gratefully acknowledged are NIH R01AR054005,
   United States, DoD-PRORP grant, the Wallace H. Coulter Foundation, the
   Ort Philanthropic Fund for supporting the rheometer and the Jules Stein
   Professorship from the Research to Prevent Blindness Foundation.
CR ANADERE I, 1979, BIORHEOLOGY, V16, P179
   Ateshian G. A., 2005, FRICTION LUBRICATION, P447
   Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040
   Ballard Brooke L, 2012, J Bone Joint Surg Am, V94, pe64, DOI 10.2106/JBJS.K.00046
   Basalo IM, 2005, J BIOMECH, V38, P1343, DOI 10.1016/j.jbiomech.2004.05.045
   BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013
   Caligaris M, 2008, OSTEOARTHR CARTILAGE, V16, P1220, DOI 10.1016/j.joca.2008.02.020
   Chang DP, 2009, SOFT MATTER, V5, P3438, DOI 10.1039/b907155e
   Courtney P, 2014, BRIT J HOSP MED, V75, pC66, DOI 10.12968/hmed.2014.75.Sup5.C66
   Eckstein F, 2000, J BIOMECH, V33, P819, DOI 10.1016/S0021-9290(00)00034-8
   Ehlers EM, 2001, ANN ANAT, V183, P13, DOI 10.1016/S0940-9602(01)80007-8
   Elsaid KA, 2008, ARTHRITIS RHEUM, V58, P1707, DOI 10.1002/art.23495
   Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104
   Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373
   Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325
   Jones ARC, 2009, ARTHRITIS RHEUM-US, V60, P133, DOI 10.1002/art.24143
   Kersting UG, 2005, OSTEOARTHR CARTILAGE, V13, P925, DOI 10.1016/j.joca.2005.06.005
   Krishnan R, 2004, J ORTHOPAED RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002
   Kumar P, 2001, J ANAT, V199, P241, DOI 10.1046/j.1469-7580.2001.19930241.x
   Kuster MS, 1997, J BONE JOINT SURG BR, V79B, P109, DOI 10.1302/0301-620X.79B1.6978
   Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023
   MCCUTCHEN CW, 1966, FED PROC, V25, P1061
   Musumeci G, 2013, OA ANATOMY, V1, P1
   Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017
   Pickard J, 1998, P I MECH ENG H, V212, P177, DOI 10.1243/0954411981533953
   Saarakkala S, 2004, ULTRASOUND MED BIOL, V30, P783, DOI 10.1016/j.ultrasmedbio.2004.03.005
   Schmidt TA, 2007, OSTEOARTHR CARTILAGE, V15, P35, DOI 10.1016/j.joca.2006.06.005
   Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446
   Seror J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7497
   Singh A, 2014, NAT MATER, V13, P988, DOI [10.1038/NMAT4048, 10.1038/nmat4048]
   Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015
   Wong Benjamin L., 2008, Molecular & Cellular Biomechanics, V5, P197
NR 32
TC 5
Z9 5
U1 1
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 90
EP 98
DI 10.1016/j.ymeth.2015.03.019
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100012
PM 25858258
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Sardella, E
   Fisher, ER
   Shearer, JC
   Trulli, MG
   Gristina, R
   Favia, P
AF Sardella, Eloisa
   Fisher, Ellen R.
   Shearer, Jeffrey C.
   Trulli, Marta Garzia
   Gristina, Roberto
   Favia, Pietro
TI N-2/H(2)o Plasma Assisted Functionalization of
   Poly(epsilon-caprolactone) Porous Scaffolds: Acidic/Basic Character
   versus Cell Behavior
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE absorbent polymers; plasma treatment; scaffolds; surface acid-base
   properties
ID SURFACE MODIFICATION; LACTIC-ACID; BIOMEDICAL APPLICATIONS;
   BIODEGRADABLE POLYMERS; CONTACT-ANGLE; OXYGEN PLASMA; ADHESION;
   DEPOSITION; FILMS; BIOMATERIALS
AB A primary research focus in tissue engineering addresses the factors that drive cell growth in scaffolds. Due to the inherent complexity of phenomena at the cell/biomaterial interface in cell-culture media, it is not easy to unambiguously disentangle the effects of different surface properties (e.g., chemical composition, roughness, porosity, etc.) in promoting specific cell behaviors, especially on porous scaffold materials. We have investigated fast low-pressure plasma treatments of porous PCL scaffolds for tissue engineering with neutral, acidic, and basic groups to obtain stable water absorbent materials. An increase of Saos2 cell growth was observed on plasma-treated scaffolds with respect to native samples; amphoteric surfaces were found very suitable for cell proliferation.
C1 [Sardella, Eloisa; Gristina, Roberto] CNR, Inst Inorgan Methodol & Plasmas IMIP, I-70126 Bari, Italy.
   [Fisher, Ellen R.; Shearer, Jeffrey C.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Gristina, Roberto; Favia, Pietro] Univ Bari, Dept Chem, I-70126 Bari, Italy.
RP Sardella, E (reprint author), CNR, Inst Inorgan Methodol & Plasmas IMIP, Via Orabona 4, I-70126 Bari, Italy.
EM eloisa.sardella@cnr.it; pietro.favia@uniba.it
OI Garzia Trulli, Marta/0000-0001-8644-3731; SARDELLA,
   ELOISA/0000-0002-6776-8327
FU MIUR [PON 16 02_00563_3448479]; LIPP (Apulian Industrial Plasma
   Laboratory) from Regione Puglia [51]; U.S. National Science Foundation
   [CHE-1152963]; American Chemical Society Global Research Experiences,
   Exchanges, and Training (GREET) program
FX The projects "RINOVATIS" (PON 16 02_00563_3448479) from MIUR, and LIPP
   (Apulian Industrial Plasma Laboratory, cod. 51) from Regione Puglia are
   gratefully acknowledged for funding. JCS and ERF (Colorado State
   University) acknowledge financial support for this work provided by the
   U.S. National Science Foundation (CHE-1152963) and by the American
   Chemical Society Global Research Experiences, Exchanges, and Training
   (GREET) program. Ms. F. Florio, Mr. S. Cosmai, and Mr. D. Benedetti
   (IMIP-CNR) are acknowledged for their experimental support.
CR Araujo JV, 2014, J BIOMED MATER RES A, V102, P4415, DOI 10.1002/jbm.a.35128
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Beamson G., 1992, HIGH RESOLUTION XPS
   Buttiglione M, 2007, BIOMATERIALS, V28, P2932, DOI 10.1016/j.biomaterials.2007.02.022
   Chen JL, 2006, J BIOMED MATER RES A, V79A, P307, DOI 10.1002/jbm.a.30799
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Da Ponte G, 2011, SURF COAT TECH, V205, pS525, DOI 10.1016/j.surfcoat.2011.03.112
   Da Ponte G, 2014, PLASMA PROCESS POLYM, V11, P345, DOI 10.1002/ppap.201300130
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Detomaso L, 2005, SURF COAT TECH, V200, P1022, DOI 10.1016/j.surfcoat.2005.02.002
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   Di Mundo R, 2010, PLASMA PROCESS POLYM, V7, P212, DOI 10.1002/ppap.200900112
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Eddy G., 2012, AM J BIOMED ENG, V2, P218, DOI DOI 10.5923/J.AJBE.20120206.02
   Favia P, 2006, PLASMA PROCESS POLYM, V3, P66, DOI 10.1002/ppap.200500073
   Favia P., 2006, PLASMA PROCESS POLYM, P271
   Fisher ER, 2013, ACS APPL MATER INTER, V5, P9312, DOI 10.1021/am4025966
   Gao CY, 2003, J BIOMAT SCI-POLYM E, V14, P937, DOI 10.1163/156856203322381429
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Guex AG, 2012, ACTA BIOMATER, V8, P1481, DOI 10.1016/j.actbio.2011.12.033
   Guo C, 2013, MATER LETT, V94, P11, DOI 10.1016/j.matlet.2012.11.092
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hasirci N, 2010, SURF INTERFACE ANAL, V42, P486, DOI 10.1002/sia.3247
   Heang S., 2013, BIOMED MATER, V8, P1
   HOLMESFARLEY SR, 1985, LANGMUIR, V1, P725, DOI 10.1021/la00066a016
   Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   Intranuovo F, 2011, SURF COAT TECH, V205, pS548, DOI 10.1016/j.surfcoat.2011.04.069
   Intranuovo F., 2014, PLASMA PROCESS POLYM, V11, P2
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Kregar Z, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/145201
   Lee HU, 2011, MAT SCI ENG C-MATER, V31, P688, DOI 10.1016/j.msec.2010.12.012
   Lotz A, 2012, J MATER CHEM, V22, P19455, DOI 10.1039/c2jm30344b
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Morelli S, 2007, J MEMBRANE SCI, V302, P27, DOI 10.1016/j.memsci.2007.06.027
   Nagiah N, 2013, MAT SCI ENG C-MATER, V33, P4444, DOI 10.1016/j.msec.2013.06.042
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Park H, 2010, COLLOID SURFACE B, V77, P90, DOI 10.1016/j.colsurfb.2010.01.011
   Pegalajar-Jurado A, 2014, ACS APPL MATER INTER, V6, P12307, DOI 10.1021/am502003z
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Poll HU, 2001, SURF COAT TECH, V142, P489, DOI 10.1016/S0257-8972(01)01055-6
   Rence F., 2012, PLASMA PROCESS POLYM, V9, P491
   Rosenhahn A, 2009, BIOINTERPHASES, V4, P7, DOI 10.1116/1.3110182
   Sardella E, 2005, SURF COAT TECH, V200, P51, DOI 10.1016/j.surfcoat.2005.02.063
   Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Tanaka T, 2011, NUCL INSTRUM METH B, V269, P2130, DOI 10.1016/j.nimb.2011.07.003
   Trevino KJ, 2011, SURF INTERFACE ANAL, V43, P1257, DOI 10.1002/sia.3707
   Vaissiere G, 2000, MED BIOL ENG COMPUT, V38, P205, DOI 10.1007/BF02344778
   Wan YQ, 2006, BIOMATERIALS, V27, P2699, DOI 10.1016/j.biomaterials.2005.12.007
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Wertheimer MR, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PJ04
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272
   Yildirim ED, 2008, NATO SCI PEACE SEC A, P191
   Yildirim E. D., 2007, PLASMA PROCESS POLYM, V4, P58
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zelzer M, 2012, PLASMA PROCESS POLYM, V9, P149, DOI 10.1002/ppap.201100054
   Zelzer M, 2009, J PHYS CHEM B, V113, P8487, DOI 10.1021/jp902137y
NR 65
TC 7
Z9 7
U1 0
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD AUG
PY 2015
VL 12
IS 8
BP 786
EP 798
DI 10.1002/ppap.201400201
PG 13
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA CP1XZ
UT WOS:000359672400010
DA 2018-10-19
ER

PT J
AU Locatelli, E
   Monaco, I
   Franchini, MC
AF Locatelli, Erica
   Monaco, Ilaria
   Franchini, Mauro Comes
TI Hard and soft nanoparticles for image-guided surgery in nanomedicine
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Image-guided surgery; Soft nanoparticles; Hard nanoparticles; Biomedical
   applications
ID CANCER-TARGETED PROBES; SILICA NANOPARTICLES; ONCOLOGIC SURGERY;
   INDOCYANINE GREEN
AB The use of hard and/or soft nanoparticles for therapy, collectively called nanomedicine, has great potential in the battle against cancer. Major research efforts are underway in this area leading to development of new drug delivery approaches and imaging techniques. Despite this progress, the vast majority of patients who are affected by cancer today sadly still need surgical intervention, especially in the case of solid tumors. An important perspective for researchers is therefore to provide even more powerful tools to the surgeon for pre- and post-operative approaches. In this context, image-guided surgery, in combination with nanotechnology, opens a new strategy to win this battle. In this perspective, we will analyze and discuss the recent progress with nanoparticles of both metallic and biomaterial composition, and their use to develop powerful systems to be applied in image-guided surgery.
C1 [Locatelli, Erica; Monaco, Ilaria; Franchini, Mauro Comes] Univ Bologn, Dept Ind Chem, I-40136 Bologna, Italy.
RP Franchini, MC (reprint author), Univ Bologn, Dept Ind Chem, V Risorgimento 4, I-40136 Bologna, Italy.
EM mauro.comesfranchini@unibo.it
RI comes franchini, mauro/G-9727-2012; Locatelli, Erica/K-2632-2012
OI comes franchini, mauro/0000-0001-5765-7263; 
CR [Anonymous], 2007, N AM CONTR MED MARK
   Barone DG, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009685.PUB2
   Benezra M, 2011, J CLIN INVEST, V121, P2768, DOI 10.1172/JCI45600
   Bradbury MS, 2013, INTEGR BIOL-UK, V5, P74, DOI 10.1039/c2ib20174g
   Burns A. A., 2008, NANO LETT, V9, P442
   Cho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089968
   Hill TK, 2015, BIOCONJUGATE CHEM, V26, P294, DOI 10.1021/bc5005679
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2
   Kircher MF, 2003, CANCER RES, V63, P8122
   Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721
   Li Y, 2012, THERANOSTICS, V2, P769, DOI 10.7150/thno.4690
   Noorlander CW, 2015, NANOMEDICINE-UK, V10, P1599, DOI [10.2217/NNM.15.21, 10.2217/nnm.15.21]
   Phillips E., 2014, SCL TRANSL MED, V6, DOI DOI 10.1126/SCITRANSLMED.3009524
   Rizzo LY, 2013, CURR OPIN BIOTECH, V24, P1159, DOI 10.1016/j.copbio.2013.02.020
   Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943
   Tanaka E, 2006, ANN SURG ONCOL, V13, P1671, DOI 10.1245/s10434-006-9194-6
   TechNavio (Infiniti Research Ltd.), 2015, GLOB CONTR MED CONTR
   Xi L, 2014, ANN SURG ONCOL, V21, P1602, DOI 10.1245/s10434-014-3541-9
   Xiong CY, 2011, J MED CHEM, V54, P1825, DOI 10.1021/jm101477d
   Xu XY, 2015, TRENDS MOL MED, V21, P223, DOI 10.1016/j.molmed.2015.01.001
NR 21
TC 5
Z9 5
U1 0
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD AUG 1
PY 2015
VL 17
IS 8
AR 328
DI 10.1007/s11051-015-3135-x
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CO0II
UT WOS:000358833200001
DA 2018-10-19
ER

PT J
AU Wolbank, S
   Pichler, V
   Ferguson, JC
   Meinl, A
   van Griensven, M
   Goppelt, A
   Redl, H
AF Wolbank, Susanne
   Pichler, Valentin
   Ferguson, James Crawford
   Meinl, Alexandra
   van Griensven, Martijn
   Goppelt, Andreas
   Redl, Heinz
TI Non-invasive in vivo tracking of fibrin degradation by fluorescence
   imaging
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterial degradation; fibrin; fluorescence; non-invasive imaging
ID SEALANT
AB Fibrin-based sealants consist of natural coagulation factors involved in the final phase of blood coagulation, during which fibrinogen is enzymatically converted by thrombin to form a solid-phase fibrin clot. For applications in tissue regeneration, a controlled process of matrix degradation within a certain period of time is essential for optimal wound healing. Hence, it is desirable to follow the kinetics of fibrinolysis at the application site. Non-invasive molecular imaging systems enable real-time tracking of processes in the living animal. In this study, a non-invasive fluorescence based imaging system was applied to follow and quantify site-specific degradation of fibrin sealant. To enable non-invasive tracking of fibrin in vivo, fibrin-matrix was labelled by incorporation of a fluorophore-conjugated fibrinogen component. Protein degradation and release of fluorescence were, in a first step, correlated in vitro. In vivo, fluorophore-labelled fibrin was subcutaneously implanted in mice and followed throughout the experiment using a multispectral imaging system. For the fluorescent fibrin, degradation correlated with the release of fluorescence from the clots in vitro. In vivo it was possible to follow and quantify implanted fibrin clots throughout the experiment, demonstrating degradation kinetics of approximately 16days in the subcutaneous compartment, which was further confirmed by histological evaluation of the application site. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Wolbank, Susanne; Pichler, Valentin; Ferguson, James Crawford; van Griensven, Martijn; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, A-1200 Vienna, Austria.
   [Wolbank, Susanne; Pichler, Valentin; Ferguson, James Crawford; Meinl, Alexandra; van Griensven, Martijn; Redl, Heinz] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Meinl, Alexandra] Bernhard Gottlieb Univ, Sch Dent, Vienna, Austria.
   [Goppelt, Andreas] Baxter Innovat GmbH, Vienna, Austria.
RP Wolbank, S (reprint author), Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM susanne.wolbank@trauma.lbg.ac.at
RI van Griensven, Martijn/F-5808-2012
OI van Griensven, Martijn/0000-0001-5104-9881; Goppelt,
   Andreas/0000-0002-0780-1332
FU Baxter Innovations GmbH, Vienna; Lorenz Bohler Fonds; European FP7
   project Angioscaff [NMP LA 2008 214402]
FX The authors thank Baxter Innovations GmbH, Vienna and the Lorenz Bohler
   Fonds and the European FP7 project Angioscaff (NMP LA 2008 214402) for
   supporting this study.
CR Bancrofts JD, 1982, THEORY PRACTICE HIST
   Buchta C, 2005, BIOMATERIALS, V26, P6233, DOI 10.1016/j.biomaterials.2005.04.014
   DINGES HP, 1986, PATHOL RES PRACT, V181, P746, DOI 10.1016/S0344-0338(86)80051-6
   Hara T, 2012, JACC-CARDIOVASC IMAG, V5, P607, DOI 10.1016/j.jcmg.2012.01.017
   Hattori R, 2000, ANN THORAC SURG, V70, P2132, DOI 10.1016/S0003-4975(00)02126-3
   Kroez M, 2005, WOUND REPAIR REGEN, V13, P318, DOI 10.1111/j.1067-1927.2005.130315.x
   Loskutoff DJ, 2000, J CLIN INVEST, V106, P1441, DOI 10.1172/JCI11765
   Macasev D, 2011, J BIOMATER APPL, V26, P129, DOI 10.1177/0885328210369574
   Michlits W, 2007, WOUND REPAIR REGEN, V15, P360, DOI 10.1111/j.1524-475X.2007.00238.x
   Mittermayr R, 2008, WOUND REPAIR REGEN, V16, P542, DOI 10.1111/j.1524-475X.2008.00391.x
   Ntziachristoss V, 2007, TXB VIVO IMAGING VER
   Pans CP, 2010, BIOMED OPT EXPRESS, V1, P285
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Peterbauer-Scherb A, 2012, J TISSUE ENG REGEN M, V6, P434, DOI 10.1002/term.446
   Pfluger H, 1982, Z Urol Nephrol, V75, P25
   Spuentrup E, 2008, EUR RADIOL, V18, P1995, DOI 10.1007/s00330-008-0965-2
   Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030262
NR 17
TC 6
Z9 6
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD AUG
PY 2015
VL 9
IS 8
BP 973
EP 976
DI 10.1002/term.1941
PG 4
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CO6WM
UT WOS:000359297700009
PM 25044309
DA 2018-10-19
ER

PT J
AU Kumar, B
   Kumar, U
AF Kumar, Binod
   Kumar, Upendra
TI Adsorption of malachite green in aqueous solution onto sodium carbonate
   treated rice husk
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Malachite Green; Adsorption Equilibrium; Kinetic; Thermodynamic Studies;
   SEM; FTIR; COD
ID ACTIVATED CARBON; KINETICS; THERMODYNAMICS; DYE; EQUILIBRIUM; ADSORBENT;
   WASTE; SHELL
AB The feasibility of using rice husk for removing malachite green (MG) from aqueous solutions has been investigated as a low cost and an eco-friendly adsorbent. The effect of chemical treatment of rice husk by sodium carbonate was investigated through SEM and FTIR. As well, the effect of various factors like rotational speed, pH value of solution, temperature, initial concentration of dye, dose of adsorbent, contact time on the adsorption of MG was examined in batch experiments. Adsorption isotherms, kinetics, mass transfer and rate limiting steps are studied in detail. Adsorption thermodynamic parameters, activation energy and isosteric heat of adsorption were also studied. The adsorption was a spontaneous, endothermic and followed the pseudo-second-order kinetic model. The mechanism of adsorption and the COD aspect in deciding the effectiveness of the biomaterial as an adsorbent for dyes has also to be taken into account.
C1 [Kumar, Binod; Kumar, Upendra] Natl Inst Technol, Dept Civil Engn, Silchar, Assam, India.
RP Kumar, U (reprint author), Natl Inst Technol, Dept Civil Engn, Silchar, Assam, India.
EM upendra_kumar72@rediffmail.com
FU World Bank TEQIP II fund of MHRD, Govt. of India
FX The authors greatly appreciate the World Bank TEQIP II fund of MHRD,
   Govt. of India for the financial support. The authors are also grateful
   to all the Civil and Environmental Engineering teams of the National
   Institute of Technology, Silchar, Assam, India, for their support and
   encouragement.
CR Ahmad R, 2010, J ENVIRON MANAGE, V91, P1032, DOI 10.1016/j.jenvman.2009.12.016
   Anirudhan TS, 2008, J CHEM THERMODYN, V40, P702, DOI 10.1016/j.jct.2007.10.005
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Chowdhury S, 2011, DESALINATION, V265, P159, DOI 10.1016/j.desal.2010.07.047
   Ciobanu G, 2014, KOREAN J CHEM ENG, V31, P1021, DOI 10.1007/s11814-014-0040-4
   Daintith J., 2008, OXFORD DICT CHEM
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Derbyshire F, 2001, CHEM PHYS CARBON, V27, P1
   Dom&iacute;nguez G., 2010, J MEX CHEM SOC, V54, P1161
   Ghaedi M, 2011, DESALINATION, V281, P226, DOI 10.1016/j.desal.2011.07.068
   Ghoreishi SM, 2003, CHEM ENG J, V95, P163, DOI 10.1016/S1385-8947(03)00100-1
   Han XL, 2012, KOREAN J CHEM ENG, V29, P494, DOI 10.1007/s11814-011-0211-5
   Kumar PS, 2010, DESALINATION, V261, P52, DOI 10.1016/j.desal.2010.05.032
   LASZLO JA, 1994, J APPL POLYM SCI, V52, P531, DOI 10.1002/app.1994.070520408
   Linh L. P., 2012, INT J BIOMASS RENEWA, V1, P32
   Luduena L, 2011, BIORESOURCES, V6, P1440
   Lyubchik SI, 2004, COLLOID SURFACE A, V242, P151, DOI 10.1016/j.colsurfa.2004.04.066
   Naiya TK, 2008, ENVIRON PROG, V27, P313, DOI 10.1002/ep.10280
   Ngah WSW, 2008, BIORESOURCE TECHNOL, V99, P3935, DOI 10.1016/j.biortech.2007.06.011
   Rosa D., 2010, COMPOS SCI TECHNOL, V70, P116
   Sonawane GH, 2009, DESALINATION, V247, P430, DOI 10.1016/j.desal.2009.01.006
   Subbareddy Y., 2012, J ENV RES DEV, V7, p1A
   Tsai WT, 2010, J HAZARD MATER, V175, P844, DOI 10.1016/j.jhazmat.2009.10.087
   Von Oepen, 1991, CHEMOSPHERE, V22, P285
   Xin HA, 2007, J ENVIRON SCI-CHINA, V19, P1287, DOI 10.1016/S1001-0742(07)60210-1
   Yang XQ, 2009, PROCESS BIOCHEM, V44, P1185, DOI 10.1016/j.procbio.2009.06.015
NR 26
TC 8
Z9 8
U1 1
U2 15
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD AUG
PY 2015
VL 32
IS 8
BP 1655
EP 1666
DI 10.1007/s11814-014-0351-5
PG 12
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CN9CT
UT WOS:000358744700024
DA 2018-10-19
ER

PT J
AU Briquez, PS
   Hubbell, JA
   Martino, MM
AF Briquez, Priscilla S.
   Hubbell, Jeffrey A.
   Martino, Mikael M.
TI Extracellular Matrix-Inspired Growth Factor Delivery Systems for Skin
   Wound Healing
SO ADVANCES IN WOUND CARE
LA English
DT Review
ID FACTOR-BINDING DOMAIN; DIABETIC FOOT; MYOCARDIAL-INFARCTION; FACTOR
   RECEPTORS; DRUG-DELIVERY; FIBRONECTIN; INTEGRIN; PATHOPHYSIOLOGY;
   MORPHOGENESIS; BIOMATERIALS
AB Significance: Growth factors are very promising molecules for the treatment of skin wounds. However, their translation to clinical use has been seriously limited, facing issues related to safety and cost-effectiveness. These problems may derive from the fact that growth factors are used at vastly supra-physiological levels without optimized delivery systems.
   Recent Advances: The extracellular matrix (ECM) plays a fundamental role in coordinating growth factor signaling. Therefore, understanding the mechanisms by which the ECM modulates growth factor activity is key for designing efficient growth factor-based therapies. Recently, several growth factor-binding domains have been discovered within various ECM proteins, and growth factor delivery systems integrating these ECM growth factor-binding domains showed promising results in animal models of skin wound healing. Moreover, a novel strategy consisting of engineering growth factors to target endogenous ECM could substantially enhance their efficacy, even when used at low doses.
   Critical Issues: Optimal delivery of growth factors often requires complex engineered biomaterial matrices, which can face regulatory issues for clinical translation. To simplify delivery systems and render strategies more applicable, growth factors can be engineered to optimally function with clinically approved biomaterials or with endogenous ECM present at the delivery site.
   Future Directions: Further development and clinical trials will reveal whether growth factor-based therapies can be used as main therapeutic approaches for skin wound healing. The future impact of these therapies will depend on our capacity to deliver growth factors more precisely, to improve efficacy, safety, and cost-effectiveness.
C1 [Briquez, Priscilla S.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.
   [Briquez, Priscilla S.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland.
   [Hubbell, Jeffrey A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.
   [Hubbell, Jeffrey A.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA.
   [Martino, Mikael M.] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.
RP Martino, MM (reprint author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.
EM jhubbell@uchicago.edu; mmartino@ifrec.osaka-u.ac.jp
RI Martino, Mikael/N-9345-2013
OI Martino, Mikael/0000-0002-5012-4605
FU European Research Council under the Advanced Grant Cytrix; Swiss
   National Science Foundation
FX The authors would like to acknowledge Dr. Hans M. Larsson and Dr.
   Federico Tortelli for careful reading of the article. This work was
   supported in part by the European Research Council under the Advanced
   Grant Cytrix and by the Swiss National Science Foundation.
CR Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394
   Arora NS, 2009, IMPLANT DENT, V18, P303, DOI 10.1097/ID.0b013e31819e8ec6
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019
   Breitbart AS, 2003, ANN PLAS SURG, V51, P409, DOI 10.1097/01.SAP.0000084461.83554.71
   Broderick N, 2009, NURSE PRACT, V34, P16, DOI 10.1097/01.NPR.0000361299.88402.f6
   Buchberger B, 2010, IMPORTANCE GROWTH FA, V6, pDoc12
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Carter K, 2003, BR J COMMUN NURS, V8, p[S15, S18, S22]
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Cugat R, 2010, EUR MUSCULOSKELET RE, V5, P32
   De Laporte L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062076
   Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P349, DOI 10.1097/01.ASW.0000418541.31366.a3
   Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Ferraro B, 2009, MOL THER, V17, P651, DOI 10.1038/mt.2009.12
   Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kumar V., 2009, ROBBINS COTRAN PATHO
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Lin FB, 2011, J INVEST DERMATOL, V131, P84, DOI 10.1038/jid.2010.253
   Liu YC, 2007, WOUND REPAIR REGEN, V15, P245, DOI 10.1111/j.1524-475X.2007.00211.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b
   Achar RAN, 2014, ACTA CIR BRAS, V29, P125, DOI 10.1590/S0102-86502014000200009
   Powers JG, 2013, DERMATOL THER, V26, P197, DOI 10.1111/dth.12055
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   Schultz G. S., 2005, EXTRACELLULAR MATRIX
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Shuttleworth L, 2005, INT J EXP PATHOL, V86, pA68
   Tokunou T, 2008, FASEB J, V22, P1886, DOI 10.1096/fj.07-100925
   Traub S, 2013, BIOMATERIALS, V34, P5958, DOI 10.1016/j.biomaterials.2013.04.050
   Traversa B, 2001, PRIM INTENTION, V9, P161
   Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148
   Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x
   Werdin F, 2009, EPLASTY, V8, P26
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66
   Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75
   Zhu J, 2014, J INVEST DERMATOL, V134, P895, DOI 10.1038/jid.2013.484
NR 61
TC 51
Z9 52
U1 4
U2 32
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2162-1918
EI 2162-1934
J9 ADV WOUND CARE
JI Adv. Wound Care
PD AUG
PY 2015
VL 4
IS 8
BP 479
EP 489
DI 10.1089/wound.2014.0603
PG 11
WC Dermatology
SC Dermatology
GA CL8YW
UT WOS:000357261900005
OA Green Published
DA 2018-10-19
ER

PT J
AU Bishai, M
   De, S
   Adhikari, B
   Banerjee, R
AF Bishai, Moumita
   De, Swarnalok
   Adhikari, Basudam
   Banerjee, Rintu
TI A platform technology of recovery of lactic acid from a fermentation
   broth of novel substrate Zizyphus oenophlia
SO 3 BIOTECH
LA English
DT Article
DE Lactic acid; Purification; Ion exchange resin; Amberlite IRA 96;
   Amberlite IR 120
ID ANION-EXCHANGE RESINS; CIRCULAR-DICHROISM; L(+)-LACTIC ACID;
   PURIFICATION; ADSORPTION
AB Lactic acid, a biologically derived compound, exists ubiquitously in nature. Its existence ranges from human being to microorganisms. Having paramount industrial significance, lactic acid should be highly pure, devoid of any contaminants. Hence, development of minimum steps of platform technologies to purify it needs urgent attention. The article proposed a novel and simple process for separation of lactic acid from a potential substrate Zizyphus oenophlia, based on ion exchange chromatography. The process herein involves two steps of purification; firstly a weak anion exchange resin was used to separate lactic acid from other anions present in the broth. This was followed by use of strong cation exchanger which washes out the target molecule (lactic acid) while trapped other cations present in the solution. The selected ion exchangers were Amberlite IRA 96 and Amberlite IR 120. Amberlite IRA 96 retained the lactic acid from the broth while washing away other anions. Maximum binding capacity of the resin was found to 210.46 mg lactic acid/g bead. After the simple two-step purification process, the purity of lactic acid improves up to 99.17 % with a recovery yield of 98.9 %. Upon characterization, formation of only levo rotatory form of lactic acid confirms its easy metabolism by the human system, thus triggering its application towards biomaterial sector.
C1 [Bishai, Moumita; De, Swarnalok; Banerjee, Rintu] Indian Inst Technol, Microbial Biotechnol & Downstream Proc Lab, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India.
   [Adhikari, Basudam] Indian Inst Technol, Ctr Mat Sci, Kharagpur 721302, W Bengal, India.
RP Banerjee, R (reprint author), Indian Inst Technol, Microbial Biotechnol & Downstream Proc Lab, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India.
EM rb@iitkgp.ac.in
FU Department of Biotechnology, India
FX The authors would like to acknowledge Department of Biotechnology, India
   for providing funds for this research.
CR ANAND RD, 1967, CHEM COMMUN, P421, DOI 10.1039/c19670000421
   Beavers EM, 2005, THESIS EMPORIA STATE
   Bishai M, 2013, BIORESOURCE TECHNOL, V133, P627, DOI 10.1016/j.biortech.2012.12.049
   Bishai M, 2013, FOOD SCI BIOTECHNOL, V22, P73, DOI 10.1007/s10068-013-0051-7
   Caboche JJ, 2000, CHEM ENG PROCESS, Patent No. US6280985
   Cao XJ, 2002, BIOCHEM ENG J, V11, P189, DOI 10.1016/S1369-703X(02)00024-4
   Chendake YJ, 2014, J MEMBRANE SCI, V451, P243, DOI 10.1016/j.memsci.2013.10.014
   Choi JI, 1999, J CHEM ENG JPN, V32, P184, DOI 10.1252/jcej.32.184
   Dechow F J., 1989, SEPARATION PURIFICAT
   Deyl Z, 1984, NEW COMPREHENSIVE BI, V8
   EVANGELISTA RL, 1994, APPL BIOCHEM BIOTECH, V45-6, P131, DOI 10.1007/BF02941793
   Gargely A, 2000, IDENTIFICATION DETER
   Gonzalez MI, 2007, J FOOD ENG, V80, P553, DOI 10.1016/j.jfoodeng.2006.06.021
   Groot W, 2010, POLY LACTIC ACID SYN
   Guo Q, 2012, CHEM-EUR J, V18, P13854, DOI 10.1002/chem.201201319
   John RP, 2008, BRAZ ARCH BIOL TECHN, V51, P1241, DOI 10.1590/S1516-89132008000600020
   KAUFMAN EN, 1995, APPL BIOCHEM BIOTECH, V51-2, P605, DOI 10.1007/BF02933462
   Kimberley AC, 1996, APPL BIOCHEM BIOTECH, V56, P49
   Kulprathipanja S, 1991, US Patent, Patent No. [US5068419 A, 6280985, US6280985]
   Kulprathipanja S., 1991, US Patent, Patent No. 5068419
   Losada M, 2007, PHYS CHEM CHEM PHYS, V9, P3127, DOI 10.1039/b703368k
   Madzingaidzo L, 2002, J BIOTECHNOL, V96, P223, DOI 10.1016/S0168-1656(02)00049-4
   MARIA HJ, 1972, J MOL SPECTROSC, V42, P177, DOI 10.1016/0022-2852(72)90153-1
   Moldes AB, 2003, BIOPROC BIOSYST ENG, V25, P357, DOI 10.1007/s00449-002-0316-7
   Moldes AB, 2001, APPL BIOCHEM BIOTECH, V95, P69, DOI 10.1385/ABAB:95:2:069
   Myhre CEL, 2004, ATMOS CHEM PHYS DISC, V4, P3013
   Negi S, 2011, FOOD TECHNOL BIOTECH, V49, P310
   Quintero J, 2012, REV FAC ING-UNIV ANT, P139
   Raya-Tonetti G, 1998, LAT AM APPL RES, V28, P89
   Rincon J, 2007, SOLVENT EXTR ION EXC, V15, P329
   Sosa AV, 2000, BIOSEPARATION, V9, P283, DOI 10.1023/A:1011165810823
   Subramanian G., 1995, QUALITY ASSURANCE EN
   Tong WY, 2004, BIOCHEM ENG J, V18, P89, DOI 10.1016/S1369-703X(03)00170-0
   Wee YJ, 2006, FOOD TECHNOL BIOTECH, V44, P163
   Zheng YZ, 1996, APPL BIOCHEM BIOTECH, V57-8, P627, DOI 10.1007/BF02941743
NR 35
TC 5
Z9 6
U1 1
U2 19
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5738
EI 2190-572X
J9 3 BIOTECH
JI 3 Biotech
PD AUG
PY 2015
VL 5
IS 4
BP 455
EP 463
DI 10.1007/s13205-014-0240-y
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CN9NL
UT WOS:000358775700010
PM 28324548
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Muanprasat, C
   Wongkrasant, P
   Satitsri, S
   Moonwiriyakit, A
   Pongkorpsakol, P
   Mattaveewong, T
   Pichyangkura, R
   Chatsudthipong, V
AF Muanprasat, Chatchai
   Wongkrasant, Preedajit
   Satitsri, Saravut
   Moonwiriyakit, Aekkacha
   Pongkorpsakol, Pawin
   Mattaveewong, Tharinee
   Pichyangkura, Rath
   Chatsudthipong, Varanuj
TI Activation of AMPK by chitosan oligosaccharide in intestinal epithelial
   cells: Mechanism of action and potential applications in intestinal
   disorders
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE Chitosan oligosaccharide; Intestinal epithelial cells; AMP-activated
   protein kinase; Diarrhea; Colorectal cancer
ID PROTEIN-KINASE; LIFE-SPAN; TIGHT JUNCTIONS; COLON-CANCER; METFORMIN;
   CHITOOLIGOSACCHARIDES; PHOSPHORYLATION; INFLAMMATION; RESVERATROL;
   HEALTHSPAN
AB Chitosan oligosaccharide (COS), a biomaterial derived from chitin, is absorbed by intestinal epithelia without degradation and has diverse biological activities including intestinal epithelial function. However, the mode of action is still unclear. This study aimed to investigate the effect of COS on AMP-activated protein kinase (AMPK) in intestinal epithelial cells (IEC) and its potential applications in the intestinal diseases benefited from AMPK activation. COS with molecular weights (MW) from 5,000 Da to 14,000 Da induced AMPK activation in T84 cells. That with MW of 5,000-Da was the most potent polymer and was used in the subsequent experiments. COS also activated AMPK in other IEC including HT-29 and Caco-2 cells. Mechanism of COS-induced AMPK activation in T84 cells involves calcium-sensing receptor (CaSR)-phospholipase C (PLC)-IP3 receptor channel-mediated calcium release from endoplasmic reticulum (ER). In addition, COS promoted tight junction assembly in T84 cells in an AMPK-dependent manner. COS also inhibited NF-kappa B transcriptional activity and NF-kappa B-mediated inflammatory response and barrier disruption via AMPK-independent mechanisms. Interestingly, luminal exposure to COS suppressed cholera toxin-induced intestinal fluid secretion by similar to 30% concurrent with AMPK activation in a mouse closed loop model. Importantly, oral administration of COS prevented the development of aberrant crypt foci in a mouse model of colitis-associated colorectal cancer (CRC) via a mechanism involving AMPK activation-induced beta-catenin suppression and caspase-3 activation. Collectively, this study reveals a novel action of COS in activating AMPK via CaSR-PLC-IP3 receptor channel-mediated calcium release from ER. COS may be beneficial in the treatment of secretory diarrheas and CRC chemoprevention. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Muanprasat, Chatchai; Wongkrasant, Preedajit; Satitsri, Saravut; Moonwiriyakit, Aekkacha; Pongkorpsakol, Pawin; Mattaveewong, Tharinee; Chatsudthipong, Varanuj] Mahidol Univ, Dept Physiol, Fac Sci, Bangkok 10400, Thailand.
   [Pichyangkura, Rath] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok 10330, Thailand.
RP Muanprasat, C (reprint author), Mahidol Univ, Dept Physiol, Fac Sci, Bangkok 10400, Thailand.
EM chatchai.mua@mahidol.ac.th
RI Satitsri, Saravut/I-6616-2013
OI Satitsri, Saravut/0000-0002-1555-4917
FU Agricultural Research Development Agency (ARDA); Thailand Research Fund
   (TRF); Mahidol University [RSA5680006]; National Research Council of
   Thailand (NRCT); Faculty of Science, Mahidol University; Office of the
   Higher Education Commission; Mahidol University under the National
   Research Universities Initiative; TRF through the Royal Golden Jubilee
   Ph.D. Program [PHD/0105/2556]
FX This work is supported by grants from the Agricultural Research
   Development Agency (ARDA), Thailand Research Fund (TRF) and Mahidol
   University (grant RSA5680006), and National Research Council of Thailand
   (NRCT) (to C.M.). Financial supports from the Faculty of Science,
   Mahidol University, and the Office of the Higher Education Commission
   and Mahidol University under the National Research Universities
   Initiative are also gratefully acknowledged (to C.M.). C.M. is TRF
   Research Scholar. SS is supported by TRF through the Royal Golden
   Jubilee Ph.D. Program (Grant PHD/0105/2556). Authors thank Professor
   Chumpol Prolpramool for critical reading of the manuscript.
CR Almabrouk TAM, 2014, BRIT J PHARMACOL, V171, P595, DOI 10.1111/bph.12479
   Anwar MA, 2014, J CANCER, V5, P736, DOI 10.7150/jca.9726
   Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151
   Caplan MJ, 2008, CURR OPIN NEPHROL HY, V17, P506, DOI 10.1097/MNH.0b013e32830baaae
   Chi Y, 2011, J PHARMACOL EXP THER, V339, P257, DOI 10.1124/jpet.111.183020
   Dai XL, 2013, NEUROSCI LETT, V554, P64, DOI 10.1016/j.neulet.2013.08.046
   Fan XD, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0450-z
   Gama L, 1997, AM J PHYSIOL-CELL PH, V273, pC1168
   Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244
   Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010
   Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013
   Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327
   Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535
   Je JY, 2012, ADV FOOD NUTR RES, V65, P321, DOI 10.1016/B978-0-12-416003-3.00021-4
   Jouret F, 2013, J CELL SCI, V126, P5132, DOI 10.1242/jcs.127555
   Ju CX, 2010, BIOL PHARM BULL, V33, P1511, DOI 10.1248/bpb.33.1511
   Kim JN, 2009, ISLETS, V1, P111, DOI 10.4161/isl.1.2.9143
   King JD, 2009, AM J PHYSIOL-CELL PH, V297, pC94, DOI 10.1152/ajpcell.00677.2008
   Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435
   Lee SH, 2009, BIOORG MED CHEM LETT, V19, P6655, DOI 10.1016/j.bmcl.2009.10.007
   Li W, 2014, MOL CARCINOG
   Lodhi G, 2014, BIOMED RES INT, DOI 10.1155/2014/654913
   Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Muanprasat C, 2013, FUTURE MED CHEM, V5, P781, DOI [10.4155/fmc.13.42, 10.4155/FMC.13.42]
   Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rogers AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069050
   Saidak Z, 2009, MOL PHARMACOL, V76, P1131, DOI 10.1124/mol.109.058784
   Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0
   Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800
   Szkudelski T, 2014, BIOCH BIOPHYS ACTA
   Thadathil N, 2014, FOOD CHEM, V150, P392, DOI 10.1016/j.foodchem.2013.10.083
   Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061
   Yano T, 2013, J CELL BIOL, V203, P605, DOI 10.1083/jcb.201304194
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
   Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103
   Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104
   Zulato E, 2014, BRIT J CANCER, V111, P25, DOI 10.1038/bjc.2014.274
NR 40
TC 23
Z9 27
U1 8
U2 48
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD AUG 1
PY 2015
VL 96
IS 3
BP 225
EP 236
DI 10.1016/j.bcp.2015.05.016
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CN5JJ
UT WOS:000358465300008
PM 26047848
DA 2018-10-19
ER

PT J
AU Chyasnavichyus, M
   Young, SL
   Tsukruk, VV
AF Chyasnavichyus, Marius
   Young, Seth L.
   Tsukruk, Vladimir V.
TI Recent advances in micromechanical characterization of polymer,
   biomaterial, and cell surfaces with atomic force microscopy
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 22nd International Colloquium on Scanning Probe Microscopy (ICSPM22)
CY DEC 11-13, 2014
CL JAPAN
SP Japan Soc Appl Phys
ID SCANNING PROBE MICROSCOPY; ORGANIC THIN-FILMS; MECHANICAL-PROPERTIES;
   VISCOELASTIC PROPERTIES; NANOMECHANICAL PROPERTIES; TAPPING-MODE; SOFT
   MATTER; AFM NANOINDENTATION; ELASTIC PROPERTIES; RELATIVE-HUMIDITY
AB Probing of micro- and nanoscale mechanical properties of soft materials with atomic force microscopy (AFM) gives essential information about the performance of the nanostructured polymer systems, natural nanocomposites, ultrathin coatings, and cell functioning. AFM provides efficient and is some cases the exclusive way to study these properties nondestructively in controlled environment. Precise force control in AFM methods allows its application to variety of soft materials and can be used to go beyond elastic properties and examine temperature and rate dependent materials response. In this review, we discuss experimental AFM methods currently used in the field of soft nanostructured composites and biomaterials. We discuss advantages and disadvantages of common AFM probing techniques, which allow for both qualitative and quantitative mappings of the elastic modulus of soft materials with nanosacle resolution. We also discuss several advanced techniques for more elaborate measurements of viscoelastic properties of soft materials and experiments on single cells. (C) 2015 The Japan Society of Applied Physics
C1 [Chyasnavichyus, Marius; Young, Seth L.; Tsukruk, Vladimir V.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Chyasnavichyus, M (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM vladimir@mse.gatech.edu
RI Chyasnavichyus, Marius/D-8173-2016
OI Chyasnavichyus, Marius/0000-0003-3640-7200
FU National Science Foundation, Division of Materials Research Award
   [DMR-1209332, DMR-1505234, CBET-1402712]; Air Force Office of Scientific
   Research [FA9550-14-1-0269]; Georgia Tech Microanalysis Center
FX The authors would like to acknowledge financial support which funds the
   AFM work in SEMA lab from: National Science Foundation, Division of
   Materials Research Awards DMR-1209332 and DMR-1505234, and CBET-1402712
   project; Air Force Office of Scientific Research, FA9550-14-1-0269, and
   Georgia Tech Microanalysis Center.
CR Arinero R, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432264
   Arnold W., 2012, ENCY NANOTECHNOLOGY
   Beaussart A, 2014, ACS NANO, V8, P10723, DOI 10.1021/nn5044383
   Beaussart A, 2014, NAT PROTOC, V9, P1049, DOI 10.1038/nprot.2014.066
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Braunsmann C, 2014, POLYMER, V55, P219, DOI 10.1016/j.polymer.2013.11.029
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Buzio R., 2013, SCANNING PROBE MICRO, V3
   Campbell SE, 2012, ACTA BIOMATER, V8, P4389, DOI 10.1016/j.actbio.2012.07.042
   Canetta E, 2005, BIORHEOLOGY, V42, P321
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Cappella B, 2011, POLYMERS-BASEL, V3, P1091, DOI 10.3390/polym3031091
   Cartagena A, 2014, BIOPHYS J, V106, P1033, DOI 10.1016/j.bpj.2013.12.037
   Chakraborty I, 2014, POLYMER, V55, P1609, DOI 10.1016/j.polymer.2014.02.027
   Chawla G, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3626847
   Chen YY, 2009, LANGMUIR, V25, P4607, DOI 10.1021/la8036346
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   Choi I, 2013, LANGMUIR, V29, P9761, DOI 10.1021/la401597p
   Choi T, 2006, ADV FUNCT MATER, V16, P1324, DOI 10.1002/adfm.200500693
   Chyasnavichyus M, 2014, POLYMER, V55, P6091, DOI 10.1016/j.polymer.2014.09.053
   Chyasnavichyus M, 2014, LANGMUIR, V30, P10566, DOI 10.1021/la404925h
   Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434
   Clifford CA, 2005, APPL SURF SCI, V252, P1915, DOI 10.1016/j.apsusc.2005.08.090
   Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003
   Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019
   Dinelli F, 1999, SURF INTERFACE ANAL, V27, P562, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<562::AID-SIA538>3.0.CO;2-K
   Dongmo LS, 2000, ULTRAMICROSCOPY, V85, P141, DOI 10.1016/S0304-3991(00)00051-6
   Dufrene YF, 2013, NAT METHODS, V10, P847, DOI [10.1038/NMETH.2602, 10.1038/nmeth.2602]
   Ebeling D, 2013, ACS NANO, V7, P10387, DOI 10.1021/nn404845q
   Enning R, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3575322
   Fichtner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093123
   Fischer H, 2013, J MICROSC-OXFORD, V250, P210, DOI 10.1111/jmi.12036
   Fischer-Cripps AC, 2004, MAT SCI ENG A-STRUCT, V385, P74, DOI 10.1016/j.msea.2004.04.070
   Franz C. M., 2012, ATOMIC FORCE MICROSC, V1st
   Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006
   Fukuma T., 2012, ATOMIC FORCE MICROSC
   Gaboriaud F, 2005, J BACTERIOL, V187, P3864, DOI 10.1128/JB.187.11.3864-3868.2005
   Gadelrab KR, 2013, LANGMUIR, V29, P2200, DOI 10.1021/la3044413
   Ganser C, 2014, HOLZFORSCHUNG, V68, P53, DOI 10.1515/hf-2013-0014
   Garcia R, 2014, NAT NANOTECHNOL, V9, P577, DOI [10.1038/NNANO.2014.157, 10.1038/nnano.2014.157]
   Garcia R, 2013, EUR POLYM J, V49, P1897, DOI 10.1016/j.eurpolymj.2013.03.037
   Garcia R, 2012, NAT NANOTECHNOL, V7, P217, DOI [10.1038/nnano.2012.38, 10.1038/NNANO.2012.38]
   Gorelik J, 2002, BIOPHYS J, V83, P3296, DOI 10.1016/S0006-3495(02)75330-7
   Grant CA, 2013, MICRON, V44, P174, DOI 10.1016/j.micron.2012.06.004
   Griepentrog M, 2013, POLYM TEST, V32, P455, DOI 10.1016/j.polymertesting.2013.01.011
   Guillaume-Gentil O, 2014, TRENDS BIOTECHNOL, V32, P381, DOI 10.1016/j.tibtech.2014.04.008
   HABERLE W, 1991, J VAC SCI TECHNOL B, V9, P1210, DOI 10.1116/1.585206
   Haugstad G., 2013, SCANNING PROBE MICRO
   Hazel JL, 1998, J TRIBOL-T ASME, V120, P814, DOI 10.1115/1.2833784
   Hazel JL, 1999, THIN SOLID FILMS, V339, P249, DOI 10.1016/S0040-6090(98)00961-4
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Herruzo ET, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4126
   Huey BD, 2007, ANNU REV MATER RES, V37, P351, DOI 10.1146/annurev.matsci.37.052506.084331
   Hurley DC, 2006, APPL SURF SCI, V253, P1274, DOI 10.1016/j.apsusc.2006.01.072
   Hurley D. C., 2013, SCANNING PROBE MICRO
   Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n
   Jimenez-Palomar I, 2012, J MECH BEHAV BIOMED, V5, P149, DOI 10.1016/j.jmbbm.2011.08.018
   Karagiannidis PG, 2011, THIN SOLID FILMS, V519, P4105, DOI 10.1016/j.tsf.2011.01.196
   Kasas S, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/13/133001
   Kashef J, 2015, DEV BIOL, V401, P165, DOI 10.1016/j.ydbio.2014.11.002
   Katan AJ, 2011, CELL, V147, P979, DOI 10.1016/j.cell.2011.11.017
   Killgore JP, 2011, LANGMUIR, V27, P13983, DOI 10.1021/la203434w
   Kovalev A, 2004, J MATER RES, V19, P716, DOI 10.1557/jmr.2004.19.3.716
   Liu JX, 2011, COLLOID SURFACE A, V380, P175, DOI 10.1016/j.colsurfa.2011.02.037
   Longo G, 2013, J MICROBIOL METH, V93, P80, DOI 10.1016/j.mimet.2013.01.022
   Luzinov I, 2000, MACROMOLECULES, V33, P1043, DOI 10.1021/ma990926v
   Luzinov I, 2000, MACROMOLECULES, V33, P7629, DOI 10.1021/ma000523r
   Magonov S., 2013, NANOSCALE APPL INFOR
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Maivald P., 1991, Nanotechnology, V2, P103, DOI 10.1088/0957-4484/2/2/004
   Martinez-Martin D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.198101
   Martinez-Tong DE, 2014, COMPOS SCI TECHNOL, V104, P34, DOI 10.1016/j.compscitech.2014.08.030
   Mazeran PE, 1997, TRIBOL LETT, V3, P125, DOI 10.1023/A:1019123525610
   McConney ME, 2010, POLYM REV, V50, P235, DOI 10.1080/15583724.2010.493255
   Medalsy I, 2011, ANGEW CHEM INT EDIT, V50, P12103, DOI 10.1002/anie.201103991
   MEYER E, 1988, J MICROSC-OXFORD, V152, P269, DOI 10.1111/j.1365-2818.1988.tb01388.x
   Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008
   Nguyen HK, 2014, MACROMOLECULES, V47, P7971, DOI 10.1021/ma501562q
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   OVERNEY RM, 1994, LANGMUIR, V10, P1281, DOI 10.1021/la00016a049
   Pakzad A, 2012, COMPOS SCI TECHNOL, V72, P314, DOI 10.1016/j.compscitech.2011.11.020
   Prokhorov VV, 2011, NANOTECHNOL RUSS, V6, P286, DOI 10.1134/S199507801103013X
   Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003
   Rabe U, 2002, SURF INTERFACE ANAL, V33, P65, DOI 10.1002/sia.1163
   RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4
   Raghavan D, 2000, LANGMUIR, V16, P9448, DOI 10.1021/la991694w
   Rebelo LM, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/5/055102
   Rheinlaender J, 2013, SOFT MATTER, V9, P3230, DOI 10.1039/c2sm27412d
   Rheinlaender J, 2010, SCANNING PROBE MICROSCOPY OF FUNCTIONAL MATERIALS: NANOSCALE IMAGING AND SPECTROSCOPY, P433, DOI 10.1007/978-1-4419-7167-8_15
   Rheinlaender J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3122007
   Robert W. S., 2010, HDB NANOPHYSICS
   Rodriguez BJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/47/475504
   Rodriguez TR, 2004, APPL PHYS LETT, V84, P449, DOI 10.1063/1.1642273
   RosaZeiser A, 1997, MEAS SCI TECHNOL, V8, P1333, DOI 10.1088/0957-0233/8/11/020
   Schaffer TE, 2013, ANAL CHEM, V85, P6988, DOI 10.1021/ac400686k
   Schon P, 2011, EUR POLYM J, V47, P692, DOI 10.1016/j.eurpolymj.2010.09.029
   Schwarz UD, 2003, J COLLOID INTERF SCI, V261, P99, DOI 10.1016/S0021-9797(03)00049-3
   SCHWARZL F, 1952, J APPL PHYS, V23, P838, DOI 10.1063/1.1702316
   Silbernagl D, 2010, SCANNING, V32, P282, DOI 10.1002/sca.20196
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Stan G, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245702
   Stan G, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/21/215703
   Tranchida D, 2011, J PHYS CHEM B, V115, P3385, DOI 10.1021/jp112211c
   Tranchida D, 2011, ADV ENG MATER, V13, pB369, DOI 10.1002/adem.201080129
   Tsou AH, 2008, J APPL POLYM SCI, V107, P1362, DOI 10.1002/app.27184
   Tsukruk VV, 2000, POLYMER, V41, P5541, DOI 10.1016/S0032-3861(00)00004-5
   Tsukruk VV, 2012, SCANNING PROBE MICROSCOPY OF SOFT MATTER: FUNDAMENTALS AND PRACTICES, P1
   TSUKRUK VV, 1995, POLYMER, V36, P1791, DOI 10.1016/0032-3861(95)90925-R
   Tsukruk VV, 1998, LANGMUIR, V14, P446, DOI 10.1021/la970367q
   Tsukruk VV, 2000, POLYM INT, V49, P441, DOI 10.1002/(SICI)1097-0126(200005)49:5<441::AID-PI240>3.0.CO;2-U
   Turner JA, 1997, J APPL PHYS, V82, P966, DOI 10.1063/1.365935
   Vadillo-Rodriguez V, 2008, J BACTERIOL, V190, P4225, DOI 10.1128/JB.00132-08
   VANDERWERF KO, 1994, APPL PHYS LETT, V65, P1195, DOI 10.1063/1.112106
   Verdier C, 2003, J POLYM SCI POL PHYS, V41, P3139, DOI 10.1002/polb.10470
   Wang D, 2010, MACROMOLECULES, V43, P5521, DOI 10.1021/ma100799s
   Xu X, 2012, J APPL PHYS, V111, DOI 10.1063/1.3689815
   Yablon DG, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/5/055402
   Young SL, 2014, ACTA BIOMATER, V10, P4832, DOI 10.1016/j.actbio.2014.07.023
   Young SL, 2012, BIOMACROMOLECULES, V13, P3189, DOI 10.1021/bm300964h
   Young TJ, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/12/125703
   Yu M, 2015, BEILSTEIN J NANOTECH, V6, P157, DOI 10.3762/bjnano.6.15
   Yuya PA, 2008, J APPL PHYS, V104, DOI 10.1063/1.2996259
   Zauscher S., 2014, HDB NANOMATERIALS PR
   Zhang J, 2012, BEILSTEIN J NANOTECH, V3, P464, DOI 10.3762/bjnano.3.53
   Zhao J, 2008, APPL SURF SCI, V255, P2295, DOI 10.1016/j.apsusc.2008.07.099
   ZHONG Q, 1993, SURF SCI, V290, pL688, DOI 10.1016/0167-2584(93)90906-Y
NR 128
TC 21
Z9 21
U1 8
U2 123
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD AUG
PY 2015
VL 54
IS 8
SI 2
AR 08LA02
DI 10.7567/JJAP.54.08LA02
PG 13
WC Physics, Applied
SC Physics
GA CN8BX
UT WOS:000358663300003
OA Bronze
DA 2018-10-19
ER

PT J
AU Basu, B
   Sabareeswaran, A
   Shenoy, SJ
AF Basu, Bikramjit
   Sabareeswaran, A.
   Shenoy, S. J.
TI Biocompatibility property of 100% strontium-substituted
   SiO2-Al2O3-P2O5-CaO-CaF2 glass ceramics over 26 weeks implantation in
   rabbit model: Histology and micro-Computed Tomography analysis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE in vivo; micro-CT; orthopedic; strontium; glass ceramics; implant
   stability
ID BIOACTIVE-GLASS; BONE-FORMATION; IONOMER CEMENTS; IN-VITRO;
   HYDROXYAPATITE; INTERFACE; RANELATE; REPLICATION; REACTIVITY; BEHAVIOR
AB One of the desired properties for any new biomaterial composition is its long-term stability in a suitable animal model and such property cannot be appropriately assessed by performing short-term implantation studies. While hydroxyapatite (HA) or bioglass coated metallic biomaterials are being investigated for in vivo biocompatibility properties, such study is not extensively being pursued for bulk glass ceramics. In view of their inherent brittle nature, the implant stability as well as impact of long-term release of metallic ions on bone regeneration have been a major concern. In this perspective, the present article reports the results of the in vivo implantation experiments carried out using 100% strontium (Sr)-substituted glass ceramics with the nominal composition of 4.5 SiO2-3Al(2)O(3)-1.5P(2)O(5)-3SrO-2SrF(2) for 26 weeks in cylindrical bone defects in rabbit model. The combination of histological and micro-computed tomography analysis provided a qualitative and quantitative understanding of the bone regeneration around the glass ceramic implants in comparison to the highly bioactive HA bioglass implants (control). The sequential polychrome labeling of bone during in vivo osseointegration using three fluorochromes followed by fluorescence microscopy observation confirmed homogeneous bone formation around the test implants. The results of the present study unequivocally confirm the long-term implant stability as well as osteoconductive property of 100% Sr-substituted glass ceramics, which is comparable to that of a known bioactive implant, that is, HA-based bioglass. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1168-1179, 2015.
C1 [Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Basu, Bikramjit] Indian Inst Sci, Interdisciplinary Bioengn Program, Bangalore 560012, Karnataka, India.
   [Sabareeswaran, A.] Sree Chitra Tirunal Inst Med Sci & Technol, Histopathol Lab, Trivandrum, Kerala, India.
   [Shenoy, S. J.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Vivo Models & Testing, Trivandrum 695012, Kerala, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
FU Department of Science and Technology, Government of India
FX Contract grant sponsor: Department of Science and Technology, Government
   of India
CR Acharya NK, 2010, J SPINAL DISORD TECH, V23, P266, DOI 10.1097/BSD.0b013e3181a990fc
   Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031
   Barros VMD, 2002, BIOMATERIALS, V23, P2895, DOI 10.1016/S0142-9612(01)00417-3
   BASLE MF, 1993, J MATER SCI-MATER M, V4, P273, DOI 10.1007/BF00122280
   BLENCKE BA, 1978, J BIOMED MATER RES, V12, P307, DOI 10.1002/jbm.820120305
   Boss JH, 1999, J LONG-TERM EFF MED, V9, P1
   Boyd D, 2006, J MATER SCI-MATER M, V17, P397, DOI 10.1007/s10856-006-8465-x
   Brennan TC, 2009, BRIT J PHARMACOL, V157, P1291, DOI 10.1111/j.1476-5381.2009.00305.x
   Brentegani LG, 1997, BIOMATERIALS, V18, P137, DOI 10.1016/S0142-9612(96)00110-X
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   Brook IM, 1998, BIOMATERIALS, V19, P565, DOI 10.1016/S0142-9612(98)00138-0
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Davidson Carel Leon, 2006, J. Appl. Oral Sci., V14, P3, DOI 10.1590/S1678-77572006000700002
   Devi ND, 2012, J AM CERAM SOC, V95, P2700
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Freeman CO, 2006, J MATER SCI-MATER M, V17, P465, DOI 10.1007/s10856-006-8474-9
   FRIEDMAN S, 1995, J ENDODONT, V21, P384, DOI 10.1016/S0099-2399(06)80976-3
   Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Goel A, 2011, ACTA BIOMATER, V7, P4071, DOI [10.1016/Lactbio.2011.06.047, 10.1016/j.actbio.2011.06.047]
   Guida A, 2003, J MATER SCI LETT, V22, P1401, DOI 10.1023/A:1025794927195
   Hill R, 2004, J PHYS CHEM-US, V45, P127
   Hill RG, 2004, J NON-CRYST SOLIDS, V336, P223, DOI 10.1016/j.jnoncrysol.2004.02.005
   Hill R, 2007, J AM CERAM SOC, V90, P763, DOI 10.1111/j.1551-2916.2006.01474.x
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   Nair MB, 2008, ACTA BIOMATER, V4, P173, DOI 10.1016/j.actbio.2007.07.004
   Nair MB, 2010, TISSUE ENG PT A, V16, P385, DOI [10.1089/ten.tea.2009.0207, 10.1089/ten.TEA.2009.0207]
   Ni GX, 2006, BIOMATERIALS, V27, P5127, DOI 10.1016/j.biomaterials.2006.05.030
   O'Donnell MD, 2008, ACTA BIOMATER, V4, P1455, DOI 10.1016/j.actbio.2008.04.018
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008
   Rafferty A, 2000, J AM CERAM SOC, V83, P2833
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Sabareeswaran A, 2013, BIOMATERIALS, V34, P9278, DOI 10.1016/j.biomaterials.2013.08.070
   SASANALUCKIT P, 1993, BIOMATERIALS, V14, P906, DOI 10.1016/0142-9612(93)90132-L
   Vestermark MT, 2011, DAN MED BULL, V58
   Vogel M, 2004, J BIOMED MATER RES A, V70A, P370, DOI 10.1002/jbm.a.30048
   Wheeler DL, 2001, J BIOMED MATER RES, V55, P603, DOI 10.1002/1097-4636(20010615)55:4<603::AID-JBM1054>3.0.CO;2-N
   Zhao YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069339
NR 46
TC 6
Z9 6
U1 0
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2015
VL 103
IS 6
BP 1168
EP 1179
DI 10.1002/jbm.b.33270
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN5QQ
UT WOS:000358484700004
PM 25303146
DA 2018-10-19
ER

PT J
AU Shaked, E
   Shani, Y
   Zilberman, M
   Scheinowitz, M
AF Shaked, Eliav
   Shani, Yoav
   Zilberman, Meital
   Scheinowitz, Mickey
TI Poly(methyl methacrylate) particles for local drug delivery using shock
   wave lithotripsy: In vitro proof of concept experiment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE local drug release; poly(methyl methacrylate) double emulsion; shock
   wave lithotripsy
ID HORSERADISH-PEROXIDASE; POLYMERS; THERAPY; PERMEABILIZATION;
   NANOPARTICLES; MICROSPHERES; PROTEINS; RELEASE
AB To leverage current local drug delivery systems methodology, there is vast use of polymeric particles serving as drug carriers to assure minimal invasive therapy with little systemic distribution of the released drug. There is an increasing interest in poly(methyl methacrylate) (PMMA) serving as carriers in drug delivery. The study aims to develop PMMA carriers for localized drug delivery and release system, combining innovative biomaterial technology and shock wave lithotripsy (SWL), and to study the effect of SWL on various concentrations of PMMA particles. We prepared PMMA particles that contain horseradish peroxidase (HRP) using a double emulsion technique, and investigated the mechanism of in vitro drug release from the carriers following exposure to SWL. We investigated the correlation between production method modifications, concentrations of the carriers subjected to SWL, and shock wave patterns. We successfully produced PMMA particles as drug carriers and stimulated the release of their contents by SWL; their polymeric shell can be shattered externally by SWL treatment, leading to release of the encapsulated drug. HRP enzyme activity was maintained following the encapsulation process and exposure to high dose of SWL pulses. Increased shock wave number results in increased shattering and greater fragmentation of PMMA particles. The results demonstrate a dose-response release of HRP; quantitation of the encapsulated HRP from the carriers rises with the number of SWL. Moreover, increased concentration of particles subjected to the same dose of SWL results in a significant increase of the total HRP release. Our research offers novel technique and insights into new, site-specific drug delivery and release systems. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1228-1237, 2015.
C1 [Shaked, Eliav; Shani, Yoav; Zilberman, Meital; Scheinowitz, Mickey] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.
RP Scheinowitz, M (reprint author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.
EM mickeys@post.tau.ac.il
FU DIP (Deutsch-Israel-Program Project); Ela Kodesz Institute for Medical
   Engineering and Physical Sciences
FX Contract grant sponsor: DIP (Deutsch-Israel-Program Project); Ela Kodesz
   Institute for Medical Engineering and Physical Sciences
CR Bainor A, 2011, ANAL BIOCHEM, V410, P310, DOI 10.1016/j.ab.2010.11.015
   Bettencourt A, 2012, J MICROENCAPSUL, V29, P353, DOI 10.3109/02652048.2011.651500
   Brewer E, 2011, J NANOMATER, DOI 10.1155/2011/408675
   Chen W, 2002, POLYM TEST, V21, P113, DOI 10.1016/S0142-9418(01)00055-1
   Cleveland RO, 2005, J ACOUST SOC AM, V118, P2667, DOI 10.1121/1.2032187
   Deckers R, 2010, J CONTROL RELEASE, V148, P25, DOI 10.1016/j.jconrel.2010.07.117
   Delius M, 1999, CANCER RES, V59, P5227
   Dick A, 1999, CARDIOVASC INTER RAD, V22, P389, DOI 10.1007/s002709900413
   Eisenmenger W, 2001, ULTRASOUND MED BIOL, V27, P683, DOI 10.1016/S0301-5629(01)00345-3
   Esser-Kahn AP, 2011, MACROMOLECULES, V44, P5539, DOI 10.1021/ma201014n
   Foldager CB, 2012, ULTRASOUND MED BIOL, V38, P1673, DOI 10.1016/j.ultrasmedbio.2012.06.004
   GAMBIHLER S, 1994, J MEMBRANE BIOL, V141, P267
   Hu SH, 2008, LANGMUIR, V24, P11811, DOI 10.1021/la801138e
   Khalil W., 2012, CLIN RESULTS CELLWAV, P1
   Khattab AA, 2007, INT J CARDIOL, V121, P84, DOI 10.1016/j.ijcard.2006.08.030
   Klein SM, 2003, COLLOID POLYM SCI, V282, P7, DOI 10.1007/s00396-003-0915-0
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Markovsky E, 2012, J CONTROL RELEASE, V161, P446, DOI 10.1016/j.jconrel.2011.12.021
   McAteer J A, 2012, PHYS SHOCK WAVE LITH, P527
   Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e
   Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033
   Ravi S, 2008, INDIAN J PHARM SCI, V70, P303, DOI 10.4103/0250-474X.42978
   Sagi A, 2008, J AM CHEM SOC, V130, P5434, DOI 10.1021/ja801065d
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Thiel M, 2001, CLIN ORTHOP RELAT R, P18
   Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022
   Vilar G, 2012, CURR DRUG DELIV, V9, P367, DOI 10.2174/156720112801323053
   Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031
   Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003
   Zhou YF, 2004, J UROLOGY, V172, P349, DOI 10.1097/01.ju.0000132356.97888.8b
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
   Zilberman M, 2006, J BIOMED MATER RES A, V79A, P370, DOI 10.1002/jbm.a.30775
NR 33
TC 1
Z9 1
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2015
VL 103
IS 6
BP 1228
EP 1237
DI 10.1002/jbm.b.33301
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN5QQ
UT WOS:000358484700010
PM 25350479
DA 2018-10-19
ER

PT J
AU Subhan, F
   Ikram, M
   Shehzad, A
   Ghafoor, A
AF Subhan, Fazli
   Ikram, Muhammad
   Shehzad, Adeeb
   Ghafoor, Abdul
TI Marine Collagen: An Emerging Player in Biomedical applications
SO JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE
LA English
DT Review
DE Collagen; Extraction; Biomaterial; Marine
ID JELLYFISH COLLAGEN; SCAFFOLDS; SKIN; GEL
AB Mammalian collagen is a multifactorial biomaterial that is widely used for beneficial purposes in the advanced biomedical technologies. Generally, biomedical applicable collagen is extracted from the mammalian body, but it can also be derived from marine species. Recently, mammalian tissues collagen proteins are considered a great pathological risk for transmitted diseases, because purification of such protein is very challenging and needs efficient tool to avoid structure alteration. Thus, difficult extraction process and high cost decreased mammalian collagen demands for beneficial effects compared to marine collagen. In contrast, marine collagen is safe and easy to extract, however this potential source of collagen is hindered by low denaturing temperature, which is considered a main hurdle in the beneficial effects of marine collagen. Characterization and biomedical applications of marine collagen are in transition state and yet to be discovered. Therefore, an attempt was made to summarize the recent knowledge regarding different aspects of marine collagen applications in the biomedical engineering field.
C1 [Subhan, Fazli; Ikram, Muhammad] Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, South Korea.
   [Shehzad, Adeeb] Natl Univ Sci & Technol, Sch Mech & Mfg Engn, Dept Biomed Engn, Islamabad, Pakistan.
   [Ghafoor, Abdul] Natl Agr Res Ctr, Islamabad, Pakistan.
RP Subhan, F (reprint author), Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, South Korea.
EM fazlisubhan93@gmail.com
OI Ikram, Muhammad/0000-0003-0114-7963
CR Addad S, 2011, MAR DRUGS, V9, P967, DOI 10.3390/md9060967
   Bermueller C, 2013, TISSUE ENG PT A, V19, P2201, DOI [10.1089/ten.tea.2012.0650, 10.1089/ten.TEA.2012.0650]
   Braco GE, 1995, FOOD BIOCH, V19, P285, DOI [10.1111/j.1745-4514.1995.tb00535.x, DOI 10.1111/J.1745-4514.1995.TB00535.X]
   Chai HJ, 2010, BIOMED BIOTECHNOL, V2010, DOI [10.1155/2010/757301, DOI 10.1155/2010/757301]
   Cho JK, 2014, FOOD CHEM, V159, P200, DOI 10.1016/j.foodchem.2014.03.012
   Fernandes-Silva S, 2013, MACROMOL BIOSCI, V13, P1621, DOI 10.1002/mabi.201300228
   Ho HO, 1997, J CONTROL RELEASE, V44, P103, DOI 10.1016/S0168-3659(96)01513-1
   Hoyer B, 2014, ACTA BIOMATER, V10, P883, DOI 10.1016/j.actbio.2013.10.022
   Jayathilakan K, 2012, J FOOD SCI TECH MYS, V49, P278, DOI 10.1007/s13197-011-0290-7
   Pallela R, 2012, J BIOMED MATER RES A, V100A, P486, DOI 10.1002/jbm.a.33292
   Phanat Kittiphattanabawon, 2010, European Food Research and Technology, V230, P475
   Potaros R, 2009, NAT SCI, V43, P584
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x
   Sivakumar P, 2000, J FISH BIOL, V56, P999, DOI 10.1006/jfbi.1999.1225
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Tan CC, 2013, FOOD RES, V20, P3013, DOI [10.1093/bioinformatics/bth351, DOI 10.1093/BIOINFORMATICS/BTH351]
   Veeruraj A, 2013, PROCESS BIOCHEM, V48, P1592, DOI 10.1016/j.procbio.2013.07.011
   Yamamoto K., 2014, BIOMED RES INT, V2014, DOI [10. 1155/2014/630757 24809058, DOI 10.1155/2014/63075724809058]
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang ZF, 2011, J SCI FOOD AGR, V91, P2173, DOI 10.1002/jsfa.4435
NR 21
TC 13
Z9 14
U1 3
U2 48
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0022-1155
EI 0975-8402
J9 J FOOD SCI TECH MYS
JI J. Food Sci. Technol.-Mysore
PD AUG
PY 2015
VL 52
IS 8
BP 4703
EP 4707
DI 10.1007/s13197-014-1652-8
PG 5
WC Food Science & Technology
SC Food Science & Technology
GA CN8CR
UT WOS:000358665800004
PM 26243892
OA Green Published
DA 2018-10-19
ER

PT J
AU Magrys, A
   Paluch-Oles, J
   Bogut, A
   Kielbus, M
   Plewik, D
   Koziol-Montewka, M
AF Magrys, Agnieszka
   Paluch-Oles, Jolanta
   Bogut, Agnieszka
   Kielbus, Michal
   Plewik, Dorota
   Koziol-Montewka, Maria
TI The role of programmed death ligand 1 pathway in persistent
   biomaterial-associated infections
SO JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE PD-L1; Staphylococcus epidermidis; small colony variants;
   biomaterial-associated infections
ID SMALL-COLONY VARIANTS; STAPHYLOCOCCUS-EPIDERMIDIS; INTERFERON-GAMMA;
   MACROPHAGES; AUREUS; PD-1
AB Staphylococcus epidermidis is commonly involved in biomaterial-associated infections. Bacterial small colony variants (SCV) seem to be well adapted to persist intracellularly in professional phagocytes evading the host immune response. We studied the expression of PD-L1/L2 on macrophages infected with clinical isolates of S. epidermidis SCV and their parent wild type (WT) strains. The cytokine pattern which is triggered by the examined strains was also analysed. In the study, we infected macrophages with S. epidermidis WT and SCV strains. Persistence and release from macrophages were monitored via lysostaphin protection assays. Moreover, the effect of IFN-gamma pre-treatment on bacterial internalisation was investigated. Expression of PD-L1/L2 molecules was analysed with the use of FACS. Inflammatory reaction was measured by IL-10, TNF-alpha ELISAs, and transcriptional induction of TNF-alpha. Our study revealed that clinical SCV isolates were able to persist and survive in macrophages for at least 3 days with a low cytotoxic effect and a reduced proinflammatory response as compared to WT strains. Bacteria upregulated PD-L1/L2 expression on macrophages as compared to non-stimulated cells. The results demonstrated that the ability of S. epidermidis SCVs to induce elevated levels of anti-inflammatory cytokine, IL-10, and reduced transcriptional induction of TNF-alpha, together with expression of PD-L1 on macrophages and the ability to persist intracellularly without damaging the host cell could be the key factor contributing to chronicity of SCV infections.
C1 [Magrys, Agnieszka; Paluch-Oles, Jolanta; Bogut, Agnieszka; Koziol-Montewka, Maria] Med Univ Lublin, Chair & Dept Med Microbiol, Ul Chodzki 1, PL-20093 Lublin, Poland.
   [Kielbus, Michal] Med Univ Lublin, Chair & Dept Biochem & Mol Biol, PL-20093 Lublin, Poland.
   [Plewik, Dorota] Pope John Paul II State Sch Higher Educ Biala Pod, Res Ctr Innovat, PL-21500 Biala Podlaska, Poland.
RP Magrys, A (reprint author), Med Univ Lublin, Chair & Dept Med Microbiol, Ul Chodzki 1, PL-20093 Lublin, Poland.
EM agnieszka.magrys@umlub.pl
RI Koziol-Montewka, Maria/B-6615-2017
CR Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07
   Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bogut A, 2014, J MED MICROBIOL, V63, P176, DOI 10.1099/jmm.0.066068-0
   Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043
   Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987
   Hofmeyer KA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/451694
   Jones KJ, 2005, J MED MICROBIOL, V54, P315, DOI 10.1099/jmm.0.45872-0
   Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331
   Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210
   Mack D, 2013, BIOMATERIALS ASS INF, P25, DOI 10.1007/9781-46141031-7
   McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421
   Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327
   Rowe JH, 2012, J IMMUNOL, V189, P876, DOI 10.4049/jimmunol.1103227
   Sakai S, 2010, INT IMMUNOL, V22, P915, DOI 10.1093/intimm/dxq446
   Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
   Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004
   Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443
   Shi SF, 2012, EXP THER MED, V3, P367, DOI 10.3892/etm.2011.423
   Singh R, 2009, J MED MICROBIOL, V58, P1067, DOI 10.1099/jmm.0.009720-0
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551
   Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang J., 2012, SCI REP, V2, P10, DOI DOI 10.1038/SREP00606
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zahra M, 2013, J CLIN MICROBIOL, V51, P3228, DOI 10.1128/JCM.01337-13
NR 30
TC 4
Z9 4
U1 0
U2 8
PU MICROBIOLOGICAL  SOCIETY KOREA
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER 803, 635-4 YEOGSAM-DONG, KANGNAM-KU,
   SEOUL 135-703, SOUTH KOREA
SN 1225-8873
EI 1976-3794
J9 J MICROBIOL
JI J. Microbiol.
PD AUG
PY 2015
VL 53
IS 8
BP 544
EP 552
DI 10.1007/s12275-015-5022-7
PG 9
WC Microbiology
SC Microbiology
GA CN9JG
UT WOS:000358762500008
PM 26224457
DA 2018-10-19
ER

PT J
AU Niknejad, H
   Yazdanpanah, G
   Kakavand, M
AF Niknejad, Hassan
   Yazdanpanah, Ghasem
   Kakavand, Mona
TI Extract of fetal membrane would inhibit thrombosis and hemolysis
SO MEDICAL HYPOTHESES
LA English
DT Article
ID AMNIOTIC EPITHELIAL-CELLS; FIBROBLAST-GROWTH-FACTOR; IN-VITRO;
   ENDOTHELIAL-CELLS; EXTRACORPOREAL-CIRCULATION; PRESERVATION PROCEDURES;
   PLATELET ACTIVATION; VASCULAR GRAFTS; INNATE IMMUNITY; OCULAR SURFACE
AB The innermost layer of fetal membranes is amnion which has anti-adhesive, anti-inflammation and vis-coelastic properties, as well as low immunogenicity. Amniotic membrane has been employed in variety of clinical fields as a natural biomaterial. Amniotic epithelial cells possess stem cell characteristics and capability to differentiate into endothelial cells. The basement membrane of amnion is an extracellular matrix enriched scaffold to support adhesion of endothelial cells. The matrix of amniotic membrane contains two kinds of glycosaminoglycans including perlecan (a heparan sulfate proteoglycan) and hyaluronic acid which both inhibit blood coagulation. Moreover, the other ingredients of amniotic membrane such as pigment-epithelium derived factor (PEDF), IL-10, MMP-9 inhibit platelet aggregation. Based on some biochemical and biomechanical evidences, we hypothesized in this paper that amniotic membrane could prevent thrombosis and hemolysis; therefore, has the capability to be applied in blood contacting devices and implants. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Niknejad, Hassan; Yazdanpanah, Ghasem; Kakavand, Mona] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn, Tehran, Iran.
   [Niknejad, Hassan] Shahid Beheshti Univ Med Sci, Nanomed & Tissue Engn Res Ctr, Tehran, Iran.
RP Niknejad, H (reprint author), Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn, POB 1985711151, Tehran, Iran.
EM niknejad@sbmu.ac.ir
RI Yazdanpanah, Ghasem/B-1347-2018
FU Nanomedicine and Tissue Engineering Research Center of Shahid Beheshti
   University of Medical Sciences
FX We would like to thank Prof. H. Peirovi for his critical comments. This
   work was supported by Nanomedicine and Tissue Engineering Research
   Center of Shahid Beheshti University of Medical Sciences.
CR Ahmadi M, 2013, BLOOD PURIFICAT, V35, P305, DOI 10.1159/000350613
   Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11
   AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Bachleda P, 2010, BIOMED PAP, V154, P13, DOI 10.5507/bp.2010.005
   Barbucci R, 1998, J THROMB THROMBOLYS, V6, P109, DOI 10.1023/A:1008841303634
   Ben-Hadj-Khalifa S, 2012, EUR CYTOKINE NETW, V23, P87, DOI 10.1684/ecn.2012.0315
   Ben-Hadj-Khalifa S, 2011, J THROMB THROMBOLYS, V32, P311, DOI 10.1007/s11239-011-0618-1
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/ten.2004.10.1526
   BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2
   Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   Choi G, 2006, SWISS MED WKLY, V136, P139
   Chuang TW, 2009, BIOMATERIALS, V30, P5341, DOI 10.1016/j.biomaterials.2009.06.029
   CLARK RE, 1976, SURG FORUM, V27, P208
   De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Garfias Y, 2011, IMMUNOL INVEST, V40, P183, DOI 10.3109/08820139.2010.532266
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hieber AD, 1997, PLACENTA, V18, P301, DOI 10.1016/S0143-4004(97)80065-3
   Hinds MT, 2006, J BIOMED MATER RES A, V77A, P458, DOI 10.1002/jbm.a.30571
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Jiang A, 2006, CORNEA, V25, pS36, DOI 10.1097/01.ico.0000247211.78391.af
   Keelan JA, 1998, AM J REPROD IMMUNOL, V40, P332
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   Lee PH, 2012, ACTA BIOMATER, V8, P3342, DOI 10.1016/j.actbio.2012.05.012
   Lee YM, 2006, EUR J PHARMACOL, V537, P52, DOI 10.1016/j.ejphar.2006.03.031
   Libera RD, 2008, ARQ BRAS OFTALMOL, V71, P669, DOI 10.1590/S0004-27492008000500011
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Magatti M., 2014, CELL TRANSPLANT
   Mall JW, 2004, NEPHROL DIAL TRANSPL, V19, P61, DOI 10.1093/ndt/gfg319
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Nightingale MJ, 2008, TRANSFUSION MED, V18, P281, DOI 10.1111/j.1365-3148.2008.00888.x
   Niknejad H, 2013, PLACENTA, V34, P340, DOI 10.1016/j.placenta.2013.02.001
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Niknejad H, 2014, CYTOTHERAPY, V16, P33, DOI 10.1016/j.jcyt.2013.07.005
   Niknejad H, 2013, MED HYPOTHESES, V81, P862, DOI 10.1016/j.mehy.2013.08.018
   Niknejad H, 2012, NEUROSCI LETT, V506, P22, DOI 10.1016/j.neulet.2011.10.038
   Niknejad H, 2011, CRYOBIOLOGY, V63, P145, DOI 10.1016/j.cryobiol.2011.08.003
   Niknejad H, 2010, EUR CELLS MATER, V19, P22, DOI 10.22203/eCM.v019a03
   Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006
   Peirovi H, 2012, J VASC SURG, V56, P1098, DOI 10.1016/j.jvs.2012.02.036
   Russo A, 2012, CELL TISSUE BANK, V13, P353, DOI 10.1007/s10561-011-9261-5
   Schulz C, 2013, J THROMB HAEMOST, V11, P233, DOI 10.1111/jth.12261
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Shao CK, 2004, INVEST OPHTH VIS SCI, V45, P1758, DOI 10.1167/iovs.03-0882
   Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804
   Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017
   Tagarakis Georgios I, 2009, Recent Pat Cardiovasc Drug Discov, V4, P177
   Takashima S, 2004, CELL STRUCT FUNCT, V29, P73, DOI 10.1247/csf.29.73
   Tehrani FA, 2013, CRYOBIOLOGY, V67, P293, DOI 10.1016/j.cryobiol.2013.08.010
   TRELFORDSAUDER M, 1978, J MED, V9, P273
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5
   VANDERPUYE OA, 1993, INT ARCH ALLERGY IMM, V101, P376, DOI 10.1159/000236480
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Willett NJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4476
   Xiao Le, 2004, Chin J Traumatol, V7, P312
   Xiao XY, 2013, EXP EYE RES, V115, P31, DOI 10.1016/j.exer.2013.06.005
   Yamagishi SI, 2009, DIABETES-METAB RES, V25, P266, DOI 10.1002/dmrr.906
   Zaga-Clavellina V, 2014, J MATERN-FETAL NEO M, V27, P1320, DOI 10.3109/14767058.2013.857397
   Zelen CM, 2014, INT WOUND J
   Zhang X, 2011, J BIOMED MATER RES A, V97A, P145, DOI 10.1002/jbm.a.33040
   Zimmermann AK, 2004, ASAIO J, V50, P193, DOI 10.1097/01.MAT.0000123638.41808.59
NR 70
TC 6
Z9 6
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD AUG
PY 2015
VL 85
IS 2
BP 197
EP 202
DI 10.1016/j.mehy.2015.04.030
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CN5KQ
UT WOS:000358468600018
PM 25997985
DA 2018-10-19
ER

PT J
AU Heffernan, JM
   Overstreet, DJ
   Le, LD
   Vernon, BL
   Sirianni, RW
AF Heffernan, John M.
   Overstreet, Derek J.
   Le, Long D.
   Vernon, Brent L.
   Sirianni, Rachael W.
TI Bioengineered Scaffolds for 3D Analysis of Glioblastoma Proliferation
   and Invasion
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Tumor microenvironment; Cell tracking; Three-dimensional cell culture;
   Biomaterial hydrogels; Hyaluronic acid; Gelatin; Poly(ethylene glycol)
ID HYALURONAN-GELATIN HYDROGEL; TUMOR-CELL INVASION; EXTRACELLULAR-MATRIX;
   IN-VITRO; GLIOMA INVASION; ACID; BRAIN; MIGRATION; MICROENVIRONMENT;
   CULTURE
AB The invasion of malignant glioblastoma (GBM) cells into healthy brain is a primary cause of tumor recurrence and associated morbidity. Here, we describe a high-throughput method for quantitative measurement of GBM proliferation and invasion in three-dimensional (3D) culture. Optically clear hydrogels composed of thiolated hyaluronic acid and gelatin were chemically crosslinked with thiol-reactive poly(ethylene glycol) polymers to form an artificial 3D tumor microenvironment. Characterization of the viscoelasticity and aqueous stability indicated the hydrogels were mechanically tunable with stiffness ranging from 18 Pa to 18.2 kPa and were resistant to hydrolysis for at least 30 days. The proliferation, dissemination and subsequent invasion of U118 and U87R GBM spheroids cultured on the hydrogels were tracked in situ with repeated fluorescence confocal microscopy. Using custom automated image processing, cells were identified and quantified through 500 A mu m of gel over 14 days. Proliferative and invasive behaviors were observed to be contingent on cell type, gel stiffness, and hepatocyte growth factor availability. These measurements highlight the utility of this platform for performing quantitative, fluorescence imaging analysis of the behavior of malignant cells within an artificial, 3D tumor microenvironment.
C1 [Heffernan, John M.; Overstreet, Derek J.; Sirianni, Rachael W.] Barrow Neurol Inst, Barrow Brain Tumor Res Ctr, Phoenix, AZ 85013 USA.
   [Heffernan, John M.; Le, Long D.; Vernon, Brent L.; Sirianni, Rachael W.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.
RP Sirianni, RW (reprint author), Barrow Neurol Inst, Barrow Brain Tumor Res Ctr, 350 W Thomas Rd, Phoenix, AZ 85013 USA.
EM jmh325@glink.drexel.edu; derek.overstreet@gmail.com; ldle2@asu.edu;
   brent.vernon@asu.edu; rachael.sirianni@dignityhealth.org
OI Sirianni, Rachael/0000-0002-9196-0239
FU Arizona State University; Barrow Neurological Institute
FX <SUP>1</SUP>H NMR experiments were performed at Arizona State University
   at the Magnetic Resonance Research Center. The authors would like to
   acknowledge our colleagues Mike Berens, Nhan Tran, and Harshil Dhruv at
   the Translational Genomic Institute (TGen) in Phoenix, AZ for providing
   cell lines and advice, and Luis Laitano at Arizona State University for
   performing rheological analysis. The authors also acknowledge Arizona
   State University and Barrow Neurological Institute for providing funding
   support during this project.
CR Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047
   Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   ARIZA A, 1995, HUM PATHOL, V26, P1144, DOI 10.1016/0046-8177(95)90278-3
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319
   Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013
   Beucher S., 1992, P 10 PFEFF C SIGN IM, P299
   Bin Kim J, 2004, BREAST CANCER RES TR, V85, P281
   BULLARD DE, 1981, J NEUROPATH EXP NEUR, V40, P410, DOI 10.1097/00005072-198107000-00005
   Cheng K, 2012, BIOMATERIALS, V33, P5317, DOI 10.1016/j.biomaterials.2012.04.006
   Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70
   DELPECH B, 1993, EUR J CANCER, V29A, P1012, DOI 10.1016/S0959-8049(05)80214-X
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034
   Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075
   Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001
   Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063
   Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054
   Guzman A, 2014, BIOMATERIALS, V35, P6954, DOI 10.1016/j.biomaterials.2014.04.086
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jiglaire CJ, 2014, EXP CELL RES, V321, P99, DOI 10.1016/j.yexcr.2013.12.010
   Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212
   Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004
   Lawyer T., 2012, INT J CELL BIOL, V1-9, P2012
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089
   MERZAK A, 1994, CANCER RES, V54, P3988
   Morpurgo M, 1996, BIOCONJUGATE CHEM, V7, P363, DOI 10.1021/bc9600224
   Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5
   Pedron S, 2013, J BIOMED MATER RES A, V101, P3404, DOI 10.1002/jbm.a.34637
   Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024
   Petrecca K, 2013, J NEURO-ONCOL, V111, P19, DOI 10.1007/s11060-012-0983-4
   PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465
   Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039
NR 41
TC 17
Z9 17
U1 1
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2015
VL 43
IS 8
BP 1965
EP 1977
DI 10.1007/s10439-014-1223-1
PG 13
WC Engineering, Biomedical
SC Engineering
GA CN2KM
UT WOS:000358249800022
PM 25515315
DA 2018-10-19
ER

PT J
AU Fang, HW
   Kao, WY
   Lin, PI
   Chang, GW
   Hung, YJ
   Chen, RM
AF Fang, Hsu-Wei
   Kao, Wei-Yu
   Lin, Pei-I
   Chang, Guang-Wei
   Hung, Ya-Jung
   Chen, Ruei-Ming
TI Effects of Polypropylene Carbonate/Poly(D,L-lactic) Acid/Tricalcium
   Phosphate Elastic Composites on Improving Osteoblast Maturation
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE PPC/PLA/TCP elastic composites; Bone regeneration; Osteoblasts; Cell
   proliferation and maturation; Osteopontin
ID INDUCED APOPTOTIC INSULTS; OF-THE-LITERATURE; GENE-EXPRESSION; BONE;
   DIFFERENTIATION; CELLS; MINERALIZATION; OSTEOPONTIN; ACTIVATION;
   MATRICES
AB Bone tissue engineering utilizing biomaterials to improve osteoblast growth has provided de novo consideration for therapy of bone diseases. Polypropylene carbonate (PPC) is a polymer with a low glass transition temperature but high elasticity. In this study, we developed a new PPC-derived composite by mixing poly-lactic acid (PLA) and tricalcium phosphate (TCP), called PPC/PLA/TCP elastic (PPTE) scaffolds. We also evaluated the beneficial effects of PPTE composites on osteoblast growth and maturation and the possible mechanisms. Compared to PPC polymers, PPTE composites had similar pore sizes and porosities but possessed better hydrophilic surface structures. Biological evaluations further revealed that PPTE composites attracted adhesion of mouse osteoblasts, and these bone cells extended along the porous scaffolds to produce accurate fibroblast-like morphologies. In parallel, seeding mouse osteoblasts onto PPTE composites time-dependently increased cell growth. Sequentially, PPTE composites augmented DNA replication and cell proliferation. Consequently, PPTE composites significantly improved osteoblast mineralization. As to the mechanism, treatment with PPTE composites induced osteopontin (OPN) mRNA and protein expression and alkaline phosphatase activity. Taken together, this study showed that PPTE composites with porous and hydrophilic surfaces can stimulate osteoblast adhesion, proliferation, and maturation through an OPN-dependent mechanism. Therefore, the de novo PPTE scaffolds may have biomaterial potential for bone regeneration.
C1 [Fang, Hsu-Wei; Chang, Guang-Wei; Hung, Ya-Jung] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei 106, Taiwan.
   [Fang, Hsu-Wei; Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei 110, Taiwan.
   [Kao, Wei-Yu; Lin, Pei-I; Chen, Ruei-Ming] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan.
   [Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthet & Toxicol Res Ctr, Taipei, Taiwan.
RP Chen, RM (reprint author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan.
EM rmchen@tmu.edu.tw
FU Taipei Medical University; National Taipei University of Technology
   [NTUT-TMU-100-06, NTUT-TMU-101-15]; Wan-Fang Hospital [102-wf-eva-20];
   National Science Council, Taipei, Taiwan [NSC101-2314-B-038-008-MY3,
   NSC101-2314-B-038-003-MY3]
FX This study was supported by Taipei Medical University and National
   Taipei University of Technology (NTUT-TMU-100-06 and NTUT-TMU-101-15),
   Wan-Fang Hospital (102-wf-eva-20), and National Science Council
   (NSC101-2314-B-038-008-MY3; NSC101-2314-B-038-003-MY3), Taipei, Taiwan.
   We wish to confirm that there are no known conflicts of interest
   associated with this publication and there has been no significant
   financial support for this work that could have influenced its outcome.
CR Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Chatakun P, 2014, CELL MOL LIFE SCI, V71, P113, DOI 10.1007/s00018-013-1326-0
   Chen RM, 2013, SURGERY, V154, P58, DOI 10.1016/j.surg.2013.02.003
   Chen RM, 2010, J BONE MINER RES, V25, P2193, DOI 10.1002/jbmr.121
   Cheng YX, 2014, J BIOMED NANOTECHNOL, V10, P287, DOI 10.1166/jbn.2014.1753
   Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8
   COLLINOSDOBY P, 1995, J CELL BIOCHEM, V57, P399, DOI 10.1002/jcb.240570305
   Du LC, 2004, J APPL POLYM SCI, V92, P1840, DOI 10.1002/app.20165
   Feng JQ, 2013, BONE, V54, P213, DOI 10.1016/j.bone.2013.01.046
   Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036
   Gorter EA, 2014, BONE, V64, P288, DOI 10.1016/j.bone.2014.04.026
   Hamlekhan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096213
   Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365.2141.2006.06218.x
   Ho WP, 2009, J CELL BIOCHEM, V108, P1084, DOI 10.1002/jcb.22338
   Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006
   Huang Z, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055005
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0
   Liao MH, 2014, BRIT J NUTR, V111, P55, DOI 10.1017/S0007114513002043
   Lin PL, 2007, MATER LETT, V61, P3009, DOI 10.1016/j.matlet.2006.10.064
   Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783
   Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200
   Nam D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040044
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Patntirapong S, 2015, J BIOMED MATER RES A, V103, P658, DOI 10.1002/jbm.a.35214
   Rani VVD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195101
   Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037
   RUNGBY J, 1993, HISTOCHEM J, V25, P446, DOI 10.1007/BF00157809
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Sheng Matilda H C, 2014, J Bone Metab, V21, P41, DOI 10.11005/jbm.2014.21.1.41
   Shrivats AR, 2014, DRUG DISCOV TODAY, V19, P781, DOI 10.1016/j.drudis.2014.04.010
   Stein GS, 1996, PHYSIOL REV, V76, P593
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   Wei JD, 2012, J ORTHOP RES, V30, P1058, DOI 10.1002/jor.22046
   Wu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072404
   Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398
   ZHOU H, 1994, J BONE MINER RES, V9, P1489
NR 39
TC 4
Z9 4
U1 2
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2015
VL 43
IS 8
BP 1999
EP 2009
DI 10.1007/s10439-014-1236-9
PG 11
WC Engineering, Biomedical
SC Engineering
GA CN2KM
UT WOS:000358249800025
PM 25549776
DA 2018-10-19
ER

PT J
AU Pucciani, F
   Altomare, DF
   Dodi, G
   Falletto, E
   Frasson, A
   Giani, I
   Martelluci, J
   Naldini, G
   Piloni, V
   Sciaudone, G
   Bove, A
   Bocchini, R
   Bellini, M
   Alduini, P
   Battaglia, E
   Galeazzi, F
   Rossitti, P
   Satta, PU
AF Pucciani, Filippo
   Altomare, Donato Francesco
   Dodi, Giuseppe
   Falletto, Ezio
   Frasson, Alvise
   Giani, Iacopo
   Martelluci, Jacopo
   Naldini, Gabriele
   Piloni, Vittorio
   Sciaudone, Guido
   Bove, Antonio
   Bocchini, Renato
   Bellini, Massimo
   Alduini, Pietro
   Battaglia, Edda
   Galeazzi, Francesca
   Rossitti, Piera
   Satta, Paolo Usai
CA Italian Soc Colorectal Surg SICCR
   Italian Assoc Hosp Gastroenterolog
TI Diagnosis and treatment of faecal incontinence: Consensus statement of
   the Italian Society of Colorectal Surgery and the Italian Association of
   Hospital Gastroenterologists
SO DIGESTIVE AND LIVER DISEASE
LA English
DT Article
DE Anorectal manometry; Biofeedback; Endoanal ultrasonography; Faecal
   incontinence; Post anal repair; Rectopexy; Sphincteroplasty
ID SACRAL NERVE-STIMULATION; ANAL-SPHINCTER REPAIR; QUALITY-OF-LIFE;
   RANDOMIZED CONTROLLED-TRIAL; INTERNAL RECTAL PROLAPSE; PELVIC ORGAN
   PROLAPSE; LAPAROSCOPIC VENTRAL RECTOPEXY; GRACILIS MUSCLE TRANSPOSITION;
   DOUBLE-BLIND CROSSOVER; INJECTABLE SILICONE BIOMATERIAL
AB Faecal incontinence is a common and disturbing condition, which leads to impaired quality of life and huge social and economic costs. Although recent studies have identified novel diagnostic modalities and therapeutic options, the best diagnostic and therapeutic approach is not yet completely known and shared among experts in this field.
   The Italian Society of Colorectal Surgery and the Italian Association of Hospital Gastroenterologists selected a pool of experts to constitute a joint committee on the basis of their experience in treating pelvic floor disorders. The aim was to develop a position paper on the diagnostic and therapeutic aspects of faecal incontinence, to provide practical recommendations for a cost-effective diagnostic work-up and a tailored treatment strategy. The recommendations were defined and graded on the basis of levels of evidence in accordance with the criteria of the Oxford Centre for Evidence-Based Medicine, and were based on currently published scientific evidence. Each statement was drafted through constant communication and evaluation conducted both online and during face-to-face working meetings. A brief recommendation at the end of each paragraph allows clinicians to find concise responses to each diagnostic and therapeutic issue. (C) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
C1 [Pucciani, Filippo] Univ Florence, Dept Surg & Translat Med, I-50134 Florence, Italy.
   [Altomare, Donato Francesco] Univ Bari, Dept Emergency & Organ Transplantat, I-70121 Bari, Italy.
   [Dodi, Giuseppe; Frasson, Alvise] Univ Padua, Dept Surg Oncol & Gastroenterol, I-35100 Padua, Italy.
   [Falletto, Ezio] Univ Turin, Citta Salute & Sci Hosp, Div Surg Sci 1, I-10124 Turin, Italy.
   [Giani, Iacopo; Naldini, Gabriele] Univ Hosp Pisa, Proctol & Perineal Surg Unit, Pisa, Italy.
   [Martelluci, Jacopo] Careggi Univ Hosp, Gen Emergency & Minimally Invas Surg, Florence, Italy.
   [Piloni, Vittorio] Villa Igea Clin, Diagnost Imaging Ctr, Ancona, Italy.
   [Sciaudone, Guido] Univ Naples 2, Sch Med, Gen & Geriatr Surg Unit, Naples, Italy.
   [Bove, Antonio] Dept Gastroenterol AORN A Cardarelli, Gastroenterol & Endoscopy Unit, Naples, Italy.
   [Bocchini, Renato] Malatesta Novello Private Hosp, Gastrointestinal Physiopathol Gastroenterol Dept, Cesena, Italy.
   [Bellini, Massimo] Univ Pisa, Dept Gastroenterol, Gastrointestinal Unit, I-56100 Pisa, Italy.
   [Alduini, Pietro] San Luca Hosp, Digest Endoscopy Unit, Lucca, Italy.
   [Battaglia, Edda] Cardinal Massaia Hosp, Gastroenterol & Endoscopy Unit, Asti, Italy.
   [Galeazzi, Francesca] Padua Univ Hosp, Gastroenterol Unit, Padua, Italy.
   [Rossitti, Piera] SM della Misericordia Univ Hospi, Gastroenterol Unit, Udine, Italy.
   [Satta, Paolo Usai] Brotzu Hosp, Gastroenterol Unit, Cagliari, Italy.
RP Pucciani, F (reprint author), Univ Florence, Dept Surg & Translat Med, Piazza Brambilla 3, I-50134 Florence, Italy.
EM pucciani@unifi.it
RI Frasson, Alvise/D-4245-2014
OI Frasson, Alvise/0000-0002-0287-1278; bellini,
   massimo/0000-0002-6387-6443; Altomare, Donato
   Francesco/0000-0001-8980-2752; PUCCIANI, FILIPPO/0000-0002-9890-5558;
   SCIAUDONE, Guido/0000-0003-4221-8502; Usai-Satta,
   Paolo/0000-0003-3344-927X
CR Abbas MA, 2012, DIS COLON RECTUM, V55, P605, DOI 10.1097/DCR.0b013e3182415406
   Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870
   Adams FJ, 2007, MANAGEMENT 3 4 DEGRE, V29, P1
   Adusumilli S, 2013, COLORECTAL DIS, V15, pE680, DOI 10.1111/codi.12367
   Agachan F, 1996, DIS COLON RECTUM, V39, P899, DOI 10.1007/BF02053989
   Ahmad M, 2012, COLORECTAL DIS, V14, P19, DOI 10.1111/codi.12045
   Altomare DF, 2013, COLORECTAL DIS, V15, pE741, DOI 10.1111/codi.12418
   Altomare DF, 2011, COLORECTAL DIS, V13, P198, DOI 10.1111/j.1463-1318.2009.02088.x
   Altomare D F, 2007, Tech Coloproctol, V11, P268, DOI 10.1007/s10151-007-0363-9
   Altomare DF, 2004, DIS COLON RECTUM, V47, P853, DOI 10.1007/s10350-004-0524-0
   Altomare DF, 2004, BRIT J SURG, V91, P1352, DOI 10.1002/bjs.4600
   Altomare DF, 2004, INT J COLORECTAL DIS, V19, P203, DOI 10.1007/s00384-003-0523-y
   Altomare DF, 2007, DIAGNOSIS CLIN MAN A, P53
   Altomare DF, 2007, RECTAL PROLAPSE DIAG, P97
   Altomare Donato F, 2005, Chir Ital, V57, P153
   Altomare DF, 2007, DIS COLON RECTUM, V50, P1023, DOI 10.1007/s10350-006-0863-0
   Altomare DF, 2010, WORLD J GASTROENTERO, V16, P5267, DOI 10.3748/wjg.v16.i42.5267
   Amoroso L, 2005, RADIOL MED, V109, P421
   Andromanakos Nikolaos, 2006, J Gastrointestin Liver Dis, V15, P41
   [Anonymous], 2007, FEC INC 2007
   Appalaneni V, 2010, GASTROINTEST ENDOSC, V72, P1117, DOI 10.1016/j.gie.2010.04.022
   Ausili E, 2010, SPINAL CORD, V48, P560, DOI 10.1038/sc.2009.186
   Ayabaca SM, 2002, DIS COLON RECTUM, V45, P63, DOI 10.1007/s10350-004-6115-2
   Azpiroz F, 2002, AM J GASTROENTEROL, V97, P232
   BAETEN C, 1988, DIS COLON RECTUM, V31, P134, DOI 10.1007/BF02562646
   Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008
   Baig MK, 2000, BRIT J SURG, V87, P1316, DOI 10.1046/j.1365-2168.2000.01592.x
   Bari Ausaf A, 2012, Surg Neurol Int, V3, pS260, DOI 10.4103/2152-7806.103016
   Barisic GI, 2006, INT J COLORECTAL DIS, V21, P52, DOI 10.1007/s00384-004-0737-7
   Bartlett L, 2011, DIS COLON RECTUM, V54, P846, DOI 10.1007/DCR.0b013e3182148fef
   BARTOLO DCC, 1983, J NEUROL NEUROSUR PS, V46, P1115, DOI 10.1136/jnnp.46.12.1115
   Bellini M, 2010, DIGEST LIVER DIS, V42, P99, DOI 10.1016/j.dld.2009.04.008
   Bharucha AE, 2006, AM J GASTROENTEROL, V101, P2679, DOI 10.1111/j.1572-0241.2006.00900.x
   Bharucha AE, 2006, GASTROENTEROLOGY, V130, P1510, DOI 10.1053/j.gastro.2005.11.064
   Bharucha AE, 2015, AM J GASTROENTEROL, V110, P127, DOI 10.1038/ajg.2014.396
   Bharucha AE, 2014, GASTROENTEROLOGY, V146, P37, DOI 10.1053/j.gastro.2013.10.062
   Bharucha AE, 2012, AM J PHYSIOL-GASTR L, V303, pG256, DOI 10.1152/ajpgi.00099.2012
   Bharucha AE, 2012, AM J GASTROENTEROL, V107, P902, DOI 10.1038/ajg.2012.45
   Bharucha AE, 2010, GASTROENTEROLOGY, V139, P1559, DOI 10.1053/j.gastro.2010.07.056
   Bharucha AE, 2010, AM J GASTROENTEROL, V105, P786, DOI 10.1038/ajg.2010.70
   Bharucha AE, 2005, GUT, V54, P546, DOI 10.1136/gut.2004.047696
   Bharucha AE, 2003, GASTROENTEROLOGY, V124, P1672, DOI 10.1016/S0016-5085(03)00329-9
   Birnbaum EH, 1996, DIS COLON RECTUM, V39, P1215, DOI 10.1007/BF02055111
   Boenicke L, 2012, COLORECTAL DIS, V14, P480, DOI 10.1111/j.1463-1318.2011.02648.x
   Bols EM, 2010, ACTA OBSTET GYNECOL, V89, P302
   Bond C, 2007, J CLIN GASTROENTEROL, V41, P45, DOI 10.1097/MCG.0b013e31802dcba5
   Bordeianou L, 2008, DIS COLON RECTUM, V51, P1010, DOI 10.1007/s10350-008-9230-7
   Bordeianou L, 2011, DIS COLON RECTUM, V54, P60, DOI 10.1007/DCR.0b013e3181fd2373
   Bourguignon J, 1998, PRESSE MED, V27, P1702
   Boyle R, 2012, COCHRANE DB SYST REV, V10
   Bresler L, 2002, ANN CHIR, V127, P520, DOI 10.1016/S0003-3944(02)00828-3
   Briel JW, 1998, DIS COLON RECTUM, V41, P209, DOI 10.1007/BF02238250
   BROWNING GGP, 1983, BRIT MED J, V286, P1873, DOI 10.1136/bmj.286.6381.1873
   Cera Susan M, 2005, Clin Colon Rectal Surg, V18, P46, DOI 10.1055/s-2005-864081
   Chan MKY, 2008, DIS COLON RECTUM, V51, P1015, DOI 10.1007/s10350-008-9326-0
   Chassagne P, 2000, AGE AGEING, V29, P159, DOI 10.1093/ageing/29.2.159
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   CHEONG DMO, 1995, MUSCLE NERVE, V18, P612, DOI 10.1002/mus.880180608
   Chermansky CJ, 2012, CURR OPIN UROL, V22, P287, DOI 10.1097/MOU.0b013e32835480b2
   CHIARIONI G, 1993, GUT, V34, P1576, DOI 10.1136/gut.34.11.1576
   Choi JS, 2001, AM J GASTROENTEROL, V96, P740
   Christensen AF, 2005, BRIT J RADIOL, V78, P308, DOI 10.1259/bjr/720389963
   Christensen P, 2006, GASTROENTEROLOGY, V131, P738, DOI 10.1053/j.gastro.2006.06.004
   Christensen P, 2008, J SPINAL CORD MED, V31, P560, DOI 10.1080/10790268.2008.11754571
   Christensen P, 2009, DIS COLON RECTUM, V52, P286, DOI 10.1007/DCR.0b013e3181979341
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   CHRISTIANSEN J, 1990, BRIT J SURG, V77, P1039, DOI 10.1002/bjs.1800770928
   Chung CP, 2013, INT UROGYNECOL J, V24, P349, DOI 10.1007/s00192-012-1816-x
   Cohen BL, 2006, J UROLOGY, V175, P2178, DOI 10.1016/S0022-5347(06)00315-6
   Collins Brigitte, 2013, Br J Nurs, V22, P575
   Collinson R, 2010, GASTROEN CLIN BIOL, V34, P584, DOI 10.1016/j.gcb.2010.09.007
   Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x
   Collinson R, 2009, COLORECTAL DIS, V11, P11, DOI 10.1111/j.1463-1318.2008.01565.x
   Comiter CV, 1999, UROLOGY, V54, P454, DOI 10.1016/S0090-4295(99)00165-X
   Cook, 1999, Colorectal Dis, V1, P263, DOI 10.1046/j.1463-1318.1999.00083.x
   CORMAN ML, 1985, BRIT J SURG, V72, pS21, DOI 10.1002/bjs.1800721314
   CTERCTEKO G C, 1988, Australian and New Zealand Journal of Surgery, V58, P703, DOI 10.1111/j.1445-2197.1988.tb01100.x
   Cundiff GW, 1998, AM J OBSTET GYNECOL, V179, P1451, DOI 10.1016/S0002-9378(98)70009-2
   Curry JI, 1999, J PEDIATR SURG, V34, P338, DOI 10.1016/S0022-3468(99)90204-X
   D'Hoore A, 2006, SURG ENDOSC, V20, P1919, DOI 10.1007/s00464-005-0485-y
   D'Hoore A, 2004, BRIT J SURG, V91, P1500, DOI 10.1002/bjs.4779
   da Silva GM, 2006, AM J OBSTET GYNECOL, V195, P1742, DOI 10.1016/j.ajog.2006.07.034
   Damon H, 2008, INT J COLORECTAL DIS, V23, P845, DOI 10.1007/s00384-008-0489-x
   Damon H, 2013, INT J COLORECTAL DIS, V28, P227, DOI 10.1007/s00384-012-1558-8
   Daube JR, 1996, CLIN NEUROPHYSIOL, V46, P257
   Davis KJ, 2004, ALIMENT PHARM THERAP, V20, P539, DOI 10.1111/j.1365-2036.2004.02119.x
   de Miguel M, 2011, COLORECTAL DIS, V13, P72, DOI 10.1111/j.1463-1318.2009.02066.x
   de Tayrac R, 2013, INT UROGYNECOL J, V24, P1859, DOI 10.1007/s00192-013-2177-9
   DEEN KI, 1994, BRIT J SURG, V81, P302, DOI 10.1002/bjs.1800810253
   Deffieux X, 2012, EUR J OBSTET GYN R B, V165, P170, DOI 10.1016/j.ejogrb.2012.09.001
   Del Popolo G, 2008, SPINAL CORD, V46, P517, DOI 10.1038/sj.sc.3102167
   Deutekom M, 2005, DIS COLON RECTUM, V48, P2294, DOI 10.1007/s10350-005-0162-1
   Deutekom M, 2012, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005086.PUB3
   Deutekom M, 2007, AM J GASTROENTEROL, V102, P351, DOI 10.1111/j.1572-0241.2006.00927.x
   Devesa JM, 2011, TECH COLOPROCTOL, V15, P17, DOI 10.1007/s10151-010-0673-1
   Devesa JM, 1997, DIS COLON RECTUM, V40, P883, DOI 10.1007/BF02051193
   Devroede G, 2012, FEMALE PELVIC MED RE, V18, P103, DOI 10.1097/SPV.0b013e3182486e60
   Diamant NE, 1999, GASTROENTEROLOGY, V116, P735, DOI 10.1016/S0016-5085(99)70195-2
   Dietz HP, 2007, ULTRASOUND OBST GYN, V29, P329, DOI 10.1002/uog.3951
   Dietz HP, 2005, ULTRASOUND OBST GYN, V25, P580, DOI 10.1002/uog.1899
   Dobben AC, 2007, INT J COLORECTAL DIS, V22, P783, DOI 10.1007/s00384-006-0217-3
   Douard R, 2003, DIS COLON RECTUM, V46, P1089, DOI 10.1097/01.DCR.0000080169.97231.A2
   Dudding TC, 2008, COLORECTAL DIS, V10, P249, DOI 10.1111/j.1463-1318.2007.01319.x
   Dudding TC, 2011, COLORECTAL DIS, V13, pE187, DOI 10.1111/j.1463-1318.2011.02650.x
   Dudding TC, 2008, ANN SURG, V247, P224, DOI 10.1097/SLA.0b013e318142cdf4
   Duelund-Jakobsen J, 2012, COLORECTAL DIS, V14, P753, DOI 10.1111/j.1463-1318.2011.02800.x
   Dulucq JL, 2007, SURG ENDOSC, V21, P2226, DOI 10.1007/s00464-007-9350-5
   Dvorkin LS, 2005, DIS COLON RECTUM, V48, P824, DOI 10.1007/s10350-004-0834-2
   Ehrenpreis ED, 2007, DIS COLON RECTUM, V50, P641, DOI 10.1007/s10350-006-0778-9
   El-Gazzaz G, 2009, INT J COLORECTAL DIS, V24, P1377, DOI 10.1007/s00384-009-0745-8
   Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078
   Eltomey MA, 2008, AM J ROENTGENOL, V191, P1469, DOI 10.2214/AJR.07.3773
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, BRIT J SURG, V81, P1231, DOI 10.1002/bjs.1800810853
   EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229
   Faaborg PM, 2009, SPINAL CORD, V47, P545, DOI 10.1038/sc.2008.159
   Falletto E, 2014, TECH COLOPROCTOL, V18, P53, DOI 10.1007/s10151-013-1002-2
   Faltin DL, 2000, OBSTET GYNECOL, V95, P643, DOI 10.1016/S0029-7844(99)00631-6
   Chia B, 2008, REV ASSOC MED BRAS, V54, P142, DOI 10.1590/S0104-42302008000200017
   Farnsworth B, 2010, PELVIPERINEOLOGY, V29, P116
   FAROUK R, 1994, BRIT J SURG, V81, P743, DOI 10.1002/bjs.1800810542
   Farrell SA, 2012, OBSTET GYNECOL, V120, P803, DOI 10.1097/AOG.0b013e31826ac4bb
   Felt-Bersma RJF, 2008, GASTROENTEROL CLIN N, V37, P645, DOI 10.1016/j.gtc.2008.06.001
   Felt-Bersma RJ, 2008, GASTROENTEROL CLIN N, V37, pix
   Felt-Bersma RJF, 2001, GASTROENTEROL CLIN N, V30, P199, DOI 10.1016/S0889-8553(05)70174-6
   FELTBERSMA RJF, 1989, DIS COLON RECTUM, V32, P112, DOI 10.1007/BF02553822
   FELTBERSMA RJF, 1990, DIS COLON RECTUM, V33, P479, DOI 10.1007/BF02052142
   Fernando RJ, 2006, OBSTET GYNECOL, V107, P1261, DOI 10.1097/01.AOG.0000218693.24144.bd
   Fernando RJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002866.pub3
   Fielding JR, 2002, RADIOGRAPHICS, V22, P295, DOI 10.1148/radiographics.22.2.g02mr25295
   Finlay IG, 2004, BRIT J SURG, V91, P1485, DOI 10.1002/bjs.4721
   Fitzpatrick M, 2000, AM J OBSTET GYNECOL, V183, P1220, DOI 10.1067/mob.2000.108880
   FLESHMAN JW, 1991, DIS COLON RECTUM, V34, P739, DOI 10.1007/BF02051061
   FLESHMAN JW, 1991, DIS COLON RECTUM, V34, P1061, DOI 10.1007/BF02050062
   Food and Drug Administration Safety Communication, 2011, UPD SER COMPL UNPUB
   Frascio M, 2014, COLORECTAL DIS, V16, P167, DOI 10.1111/codi.12403
   FRENCKNER B, 1976, GUT, V17, P147, DOI 10.1136/gut.17.2.147
   Fynes MM, 1999, DIS COLON RECTUM, V42, P753, DOI 10.1007/BF02236930
   GABRIEL WB, 1948, P ROY SOC MED, V41, P467
   Galandiuk S, 2009, LANGENBECK ARCH SURG, V394, P425, DOI 10.1007/s00423-008-0332-4
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   George AT, 2013, BRIT J SURG, V100, P330, DOI 10.1002/bjs.9000
   Giamundo P, 2007, Tech Coloproctol, V11, P310, DOI 10.1007/s10151-007-0371-9
   Giamundo P, 2002, AM J GASTROENTEROL, V97, P2328
   Giani I, 2011, ANN SURG, V254, P90, DOI 10.1097/SLA.0b013e3182196ff4
   Gilliland R, 1998, DIS COLON RECTUM, V41, P1516, DOI 10.1007/BF02237299
   Giordano P, 2002, DIS COLON RECTUM, V45, P635, DOI 10.1007/s10350-004-6260-7
   Glasgow SC, 2006, DIS COLON RECTUM, V49, P1052, DOI 10.1007/s10350-006-0538-x
   Glasgow SC, 2012, DIS COLON RECTUM, V55, P482, DOI 10.1097/DCR.0b013e3182468c22
   Gottesman L., 1995, PRACTICAL GUIDE ANOR, P207
   Govaert B, 2009, DIS COLON RECTUM, V52, P1688, DOI 10.1007/DCR.0b013e3181b55595
   Govaert B, 2009, DIS COLON RECTUM, V52, P1423, DOI 10.1007/DCR.0b013e3181a91241
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Grassini M, 2008, GASTROINTEST ENDOSC, V67, P88, DOI 10.1016/j.gie.2007.05.019
   Grassini M, 2007, WORLD J GASTROENTERO, V13, P1816, DOI 10.3748/wjg.v13.i12.1816
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Harmston C, 2011, COLORECTAL DIS, V13, P791, DOI 10.1111/j.1463-1318.2010.02266.x
   Hasegawa H, 2000, DIS COLON RECTUM, V43, P961, DOI 10.1007/BF02237359
   Hassan C, 2011, J GASTROINTEST LIVER, V20, P279
   Haverfield ME, 2007, PELVIPERINEOLOGY, V26, P108
   Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798
   Hetzer F H, 2005, Tech Coloproctol, V9, P25, DOI 10.1007/s10151-005-0188-3
   Hetzer FH, 2007, ARCH SURG-CHICAGO, V142, P8, DOI 10.1001/archsurg.142.1.8
   Heymen S, 2001, DIS COLON RECTUM, V44, P728, DOI 10.1007/BF02234575
   Heymen S, 2009, DIS COLON RECTUM, V52, P1730, DOI 10.1007/DCR.0b013e3181b55455
   Hoekstra LT, 2011, J PEDIATR SURG, V46, P1603, DOI 10.1016/j.jpedsurg.2011.04.050
   Hollingshead JRF, 2009, BRIT J SURG, V96, P1082, DOI 10.1002/bjs.6664
   Holzer B, 2008, J GASTROINTEST SURG, V12, P921, DOI 10.1007/s11605-008-0485-z
   Hosker G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001310.pub2
   Hultman CS, 2006, ANN PLAS SURG, V56, P65, DOI 10.1097/01.sap.0000186513.75052.29
   IHRE T, 1974, SCAND J GASTROENTERO, V9, P1
   Indinnimeo M, 2010, DIS COLON RECTUM, V53, P1661, DOI 10.1007/DCR.0b013e3181f46309
   INFANTINO A, 1995, DIS COLON RECTUM, V38, P27, DOI 10.1007/BF02053853
   Jarrett MED, 2005, INT J COLORECTAL DIS, V20, P446, DOI 10.1007/s00384-004-0729-7
   Jarrett MED, 2004, BRIT J SURG, V91, P755, DOI 10.1002/bjs.4545
   Jelovsek JE, 2005, AM J OBSTET GYNECOL, V193, P2105, DOI 10.1016/j.ajog.2005.07.016
   Jensen LL, 1997, DIS COLON RECTUM, V40, P197, DOI 10.1007/BF02054988
   Johnson E, 2003, EUR J SURG S, V588, P51
   Jones MP, 2007, AM J GASTROENTEROL, V102, P850, DOI 10.1111/j.1572-0241.2007.01069.x
   Jones OM, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7099
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   Keller J, 2009, BEST PRACT RES CL GA, V23, P407, DOI 10.1016/j.bpg.2009.02.012
   Kellokumpu IH, 2000, SURG ENDOSC-ULTRAS, V14, P634, DOI 10.1007/s004640000017
   Kenefick NJ, 2003, BRIT J SURG, V90, P1256, DOI 10.1002/bjs.4196
   KIFF ES, 1984, BRIT J SURG, V71, P614, DOI 10.1002/bjs.1800710817
   Koch SM, 2010, COLORECTAL DIS, V12, P334, DOI 10.1111/j.1463-1318.2009.01792.x
   Konsten J, 2001, DIS COLON RECTUM, V44, P581, DOI 10.1007/BF02234333
   Kouraklis G, 2004, SURG TODAY, V34, P304, DOI 10.1007/s00595-003-2704-2
   KUMAR D, 1995, BRIT J SURG, V82, P1645, DOI 10.1002/bjs.1800821219
   Laforest A, 2012, COLORECTAL DIS, V14, P1231, DOI 10.1111/j.1463-1318.2012.02956.x
   Lam TJ, 2012, COLORECTAL DIS, V14, P214, DOI 10.1111/j.1463-1318.2011.02548.x
   Lau CW, 2000, DIS COLON RECTUM, V43, P478, DOI 10.1007/BF02237190
   LAURBERG S, 1988, ARCH NEUROL-CHICAGO, V45, P1250, DOI 10.1001/archneur.1988.00520350088021
   Lauretta A, 2012, TECH COLOPROCTOL, V16, P477, DOI 10.1007/s10151-012-0918-2
   LAW PJ, 1990, DIS COLON RECTUM, V33, P370, DOI 10.1007/BF02156260
   Lazorthes F, 1998, DIS COLON RECTUM, V41, P602, DOI 10.1007/BF02235267
   Lee Byoung Hwan, 2010, J Neurogastroenterol Motil, V16, P177, DOI 10.5056/jnm.2010.16.2.177
   Lefaucheur JP, 2006, MUSCLE NERVE, V33, P324, DOI 10.1002/mus.20387
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Leroi AM, 2009, COLORECTAL DIS, V11, P572, DOI 10.1111/j.1463-1318.2009.01914.x
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Liberman H, 2000, DIS COLON RECTUM, V43, P188, DOI 10.1007/BF02236980
   Lindsay I, 2006, COLORECTAL DIS, V8, pS2
   Loening-Baucke V, 2002, CURR OPIN PEDIATR, V14, P570, DOI 10.1097/01.MOP.0000028541.37171.EF
   LOENINGBAUCKE V, 1990, DIGEST DIS, V8, P112, DOI 10.1159/000171245
   Lombardi G, 2010, SPINAL CORD, V48, P154, DOI 10.1038/sc.2009.101
   LONDONOSCHIMMER EE, 1994, INT J COLORECTAL DIS, V9, P110, DOI 10.1007/BF00699424
   Loos M, 2013, ANN SURG ONCOL, V20, P1816, DOI 10.1245/s10434-012-2827-z
   Pereira PL, 2010, J PEDIATR UROL, V6, P134, DOI 10.1016/j.jpurol.2009.07.004
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Madoff RD, 2009, INCONTINENCE, P1387
   Madsen Mari A, 2008, Clin Colon Rectal Surg, V21, P100, DOI 10.1055/s-2008-1075858
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2008, DIS COLON RECTUM, V51, P436, DOI 10.1007/s10350-007-9157-4
   Maeda Y, 2010, DIS COLON RECTUM, V53, P995, DOI 10.1007/DCR.0b013e3181d64207
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Maher C, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004014.PUB2, 10.1002/14651858.CD004014.pub2]
   Mahony RT, 2004, AM J OBSTET GYNECOL, V191, P885, DOI 10.1016/j.ajog.2004.07.006
   Malouf AJ, 2000, AM J ROENTGENOL, V175, P741, DOI 10.2214/ajr.175.3.1750741
   Marcello PW, 1998, DIS COLON RECTUM, V41, P336, DOI 10.1007/BF02237488
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Maris A, 2013, COLORECTAL DIS, V15, pE67, DOI 10.1111/codi.12036
   Matzel KE, 2007, ACTA NEUROCHIR SUPPL, V97, P351
   Matzel KE, 2002, INT J COLORECTAL DIS, V17, P430, DOI 10.1007/s00384-002-0412-9
   Matzel KE, 2001, CHIR GASTROENTEROL, V17, P230
   Matzel KE, 2001, DIS COLON RECTUM, V44, P1427, DOI 10.1007/BF02234593
   Mavrantonis C, 1999, DIS COLON RECTUM, V42, P497, DOI 10.1007/BF02234176
   Melenhorst J, 2008, COLORECTAL DIS, V10, P257, DOI 10.1111/j.1463-1318.2007.01375.x
   Melenhorst J, 2007, COLORECTAL DIS, V9, P725, DOI 10.1111/j.1463-1318.2007.01241.x
   MELLGREN A, 1994, DIS COLON RECTUM, V37, P1133, DOI 10.1007/BF02049817
   Mercer-Jones MA, 2014, COLORECTAL DIS, V16, P82, DOI 10.1111/codi.12415
   Meschia M, 2002, OBSTET GYNECOL, V100, P719, DOI 10.1016/S0029-7844(02)02215-9
   Mevik K, 2009, SCAND J SURG, V98, P234, DOI 10.1177/145749690909800408
   Michelsen HB, 2006, DIS COLON RECTUM, V49, P1039, DOI 10.1007/s10350-006-0548-8
   Michot F, 2003, ANN SURG, V237, P52, DOI 10.1097/00000658-200301000-00008
   Milani R, 2003, P 33 ANN M INT CONT, P189
   Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056
   Mitrani C, 1998, J CLIN GASTROENTEROL, V26, P175, DOI 10.1097/00004836-199804000-00005
   Morris OJ, 2013, TECH COLOPROCTOL, V17, P517, DOI 10.1007/s10151-013-1000-4
   Moscovitz I, 2002, COLORECTAL DIS, V4, P275
   Mouritsen L, 2005, BEST PRACT RES CL OB, V19, P895, DOI 10.1016/j.pbobgyn.2005.08.007
   Mouritsen L, 2003, INT UROGYNECOL J PEL, V14, P122, DOI 10.1007/s00192-002-1024-1
   Moya P, 2012, TECH COLOPROCTOL, V16, P263, DOI 10.1007/s10151-012-0823-8
   Nichols CM, 2005, OBSTET GYNECOL, V106, P1266, DOI 10.1097/01.AOG.0000187303.43011.12
   Nikiteas N, 1996, DIS COLON RECTUM, V39, P1164, DOI 10.1007/BF02081420
   Noelting J, 2012, AM J GASTROENTEROL, V107, P1530, DOI 10.1038/ajg.2012.221
   Nordenstam J, 2008, BJOG-INT J OBSTET GY, V115, P857, DOI 10.1111/j.1471-0528.2008.01726.x
   Norton C, 2001, Colorectal Dis, V3, P323, DOI 10.1046/j.1463-1318.2001.00257.x
   Norton C, 2010, NEUROUROL URODYNAM, V29, P199, DOI 10.1002/nau.20803
   Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x
   Norton C, 2012, COCHRANE DB SYST REV, V7
   Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311
   Oliveira L, 1996, BRIT J SURG, V83, P502, DOI 10.1002/bjs.1800830421
   OLIVER GC, 1994, DIS COLON RECTUM, V37, P461, DOI 10.1007/BF02076192
   Omar MI, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD002116.PUB2
   Oom DMJ, 2012, DIS COLON RECTUM, V55, P646, DOI 10.1097/DCR.0b013e318251dca1
   Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862
   PALMER KR, 1980, GASTROENTEROLOGY, V79, P1272
   Palsson OS, 2004, APPL PSYCHOPHYS BIOF, V29, P153, DOI 10.1023/B:APBI.0000039055.18609.64
   Patton V, 2013, BRIT J SURG, V100, P959, DOI 10.1002/bjs.9114
   Pehl C, 2012, DIGESTION, V86, P78, DOI 10.1159/000338954
   PESCATORI M, 1992, DIS COLON RECTUM, V35, P482, DOI 10.1007/BF02049407
   Pescatori M, 1998, INT J COLORECTAL DIS, V13, P223, DOI 10.1007/s003840050165
   Petros P, 2013, TECH COLOPROCTOL, V17, P449, DOI 10.1007/s10151-013-0980-4
   Pfrommer W, 2000, EUR J PEDIATR SURG, V10, P186, DOI 10.1055/s-2008-1072354
   Pilini V, 1988, COLOPROCTOLOGY, V10, P297
   Piloni V, 1999, INT J COLORECTAL DIS, V14, P131, DOI 10.1007/s003840050198
   Piloni V, 2014, FECAL INCONTINENCE C, P71
   Piloni V, 1995, TECHN COLOPROCT, V2, P70
   Piloni VI, 2013, RECONSTRUCTIVE SURG, P13
   Portier G, 2011, COLORECTAL DIS, V13, P914, DOI 10.1111/j.1463-1318.2010.02327.x
   Portier G, 2006, DIS COLON RECTUM, V49, P1136, DOI 10.1007/s10350-006-0616-0
   Pradal-Prat D, 1998, Electromyogr Clin Neurophysiol, V38, P491
   Pucciani F, 2003, Tech Coloproctol, V7, P139, DOI 10.1007/s10151-003-0025-5
   Pucciani F, 2013, COLORECTAL DIS, V15, P987, DOI 10.1111/codi.12236
   Pucciani F, 2013, TECH COLOPROCTOL, V17, P299, DOI 10.1007/s10151-012-0923-5
   Pucciani F., 2007, FECAL INCONTINENCE D, P167
   Pucciani F, 2008, DIS COLON RECTUM, V51, P1552, DOI 10.1007/s10350-008-9312-6
   Quander CR, 2005, AM J GASTROENTEROL, V100, P905, DOI 10.1111/j.1572-0241.2005.30511.x
   Rajindrajith S, 2013, ALIMENT PHARM THER, V37, P37, DOI 10.1111/apt.12103
   Rao SSC, 2010, CLIN GASTROENTEROL H, V8, P910, DOI 10.1016/j.cgh.2010.06.004
   Rao SSC, 2002, NEUROGASTROENT MOTIL, V14, P553, DOI 10.1046/j.1365-2982.2002.00352.x
   Rao SSC, 2004, AM J GASTROENTEROL, V99, P1585, DOI 10.1111/j.1572-0241.2004.40105.x
   Rasmussen OO, 2000, DIS COLON RECTUM, V43, P633, DOI 10.1007/BF02235577
   Ratto C, 2005, DIS COLON RECTUM, V48, P1027, DOI 10.1007/s10350-004-0884-5
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ratto C, 2010, DIS COLON RECTUM, V53, P264, DOI 10.1007/DCR.0b013e3181c7642c
   Retzke F, 2013, PELVIPERINEOLOGY, V32, P59
   REX DK, 1992, DIS COLON RECTUM, V35, P1040, DOI 10.1007/BF02252993
   Ricciardi R, 2006, DIS COLON RECTUM, V49, P852, DOI 10.1007/s10350-006-0529-y
   Rink AD, 2010, COLORECTAL DIS, V12, P342, DOI 10.1111/j.1463-1318.2009.01790.x
   Robert-Yap J, 2010, DIS COLON RECTUM, V53, P428, DOI 10.1007/DCR.0b013e3181ca74b4
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   ROIG JV, 1995, DIS COLON RECTUM, V38, P952, DOI 10.1007/BF02049731
   Romano G, 1996, BRIT J RADIOL, V69, P6, DOI 10.1259/0007-1285-69-817-6
   Romano G, 2000, DIAGNOSIS TREATMENT, P129
   Rongen MJGM, 2003, DIS COLON RECTUM, V46, P716, DOI 10.1097/01.DCR.0000070035.45378.BD
   Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120
   Rothenhoefer S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-155
   Rygh AB, 2010, ACTA OBSTET GYN SCAN, V89, P1256, DOI 10.3109/00016349.2010.512073
   Sander P, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P177, DOI 10.1007/s001920050041
   Sansoni J, 2006, REFINIG CONTINENCE M
   Sansoni J, 2013, DIS COLON RECTUM, V56, P652, DOI 10.1097/DCR.0b013e318279c2ac
   Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848
   Santoro GA, 2012, DIS COLON RECTUM, V55, P797, DOI 10.1097/DCR.0b013e3182538f14
   SATO Y, 1988, RADIOLOGY, V168, P157, DOI 10.1148/radiology.168.1.3380953
   Scarlett Y, 2004, GASTROENTEROLOGY, V126, pS55, DOI 10.1053/j.gastro.2003.10.007
   Schultz I, 2000, DIS COLON RECTUM, V43, P35, DOI 10.1007/BF02237241
   Schwandner T, 2011, DTSCH ARZTEBL INT, V108, P653, DOI 10.3238/arztebl.2011.0653
   Senapati A, 2013, COLORECTAL DIS, V15, P858, DOI 10.1111/codi.12177
   Sentovich SM, 1997, DIS COLON RECTUM, V40, P1430, DOI 10.1007/BF02070707
   Shafik A, 2007, AM SURGEON, V73, P6
   Shah BJ, 2012, AM J GASTROENTEROL, V107, P1635, DOI 10.1038/ajg.2012.284
   Sheldon R, 2005, BRIT J SURG, V92, P1423, DOI 10.1002/bjs.5111
   Sielezneff I, 1999, DIS COLON RECTUM, V42, P367, DOI 10.1007/BF02236355
   Sielezneff I, 1996, INT J COLORECTAL DIS, V11, P15, DOI 10.1007/BF00418849
   Sileri P, 2012, J GASTROINTEST SURG, V16, P622, DOI 10.1007/s11605-011-1793-2
   SIMMANG C, 1994, DIS COLON RECTUM, V37, P1065, DOI 10.1007/BF02049804
   Singh K, 2001, AM J OBSTET GYNECOL, V185, P71, DOI 10.1067/mob.2001.113876
   Sinha CK, 2008, PEDIATR SURG INT, V24, P685, DOI 10.1007/s00383-008-2130-z
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Sitzler PJ, 1996, DIS COLON RECTUM, V39, P1356, DOI 10.1007/BF02054524
   SLADE MS, 1977, DIS COLON RECTUM, V20, P33, DOI 10.1007/BF02587449
   Slawik S, 2008, COLORECTAL DIS, V10, P138, DOI 10.1111/j.1463-1318.2007.01259.x
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Smart NJ, 2013, COLORECTAL DIS, V15, P650, DOI 10.1111/codi.12219
   Soligo M, 2003, AM J OBSTET GYNECOL, V189, P438, DOI 10.1067/S0002-9378(03)00466-6
   SORENSEN M, 1991, GUT, V32, P1031, DOI 10.1136/gut.32.9.1031
   Stabile G, 1994, Minerva Chir, V49, P1187
   SULTAN AH, 1994, BRIT J SURG, V81, P463, DOI 10.1002/bjs.1800810349
   SUN WM, 1992, GUT, V33, P807, DOI 10.1136/gut.33.6.807
   Talley NJ, 2008, AM J GASTROENTEROL, V103, P820, DOI 10.1111/j.1572-0241.2008.01832.x
   Tan E, 2011, INT J COLORECTAL DIS, V26, P275, DOI 10.1007/s00384-010-1119-y
   Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2
   Ternent CA, 1997, DIS COLON RECTUM, V40, P462, DOI 10.1007/BF02258393
   Thiersch C, 1988, Dis Colon Rectum, V31, P154
   Thin NN, 2013, BRIT J SURG, V100, P1430, DOI 10.1002/bjs.9226
   Thomas GP, 2013, COLORECTAL DIS, V15, P519, DOI 10.1111/codi.12093
   Thomas S, 2006, CONTINENCE OUTCOMES
   Tjandra JJ, 2008, COLORECTAL DIS, V10, P681, DOI 10.1111/j.1463-1318.2007.01467.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1497, DOI 10.1007/s10350-007-9001-x
   Tou S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001758.pub2
   Townsend MK, 2013, AM J GASTROENTEROL, V108, P113, DOI 10.1038/ajg.2012.364
   Tsiaoussis J, 2005, DIS COLON RECTUM, V48, P838, DOI 10.1007/s10350-004-0850-2
   Uludag O, 2011, COLORECTAL DIS, V13, P1162, DOI 10.1111/j.1463-1318.2010.02447.x
   Vaizey CJ, 2000, DIS COLON RECTUM, V43, P298, DOI 10.1007/BF02258292
   Vaizey CJ, 2004, DIS COLON RECTUM, V47, P858, DOI 10.1007/s10350-003-0112-8
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   Vaizey CJ, 1998, BRIT J SURG, V85, P596
   van der Hagen SJ, 2012, COLORECTAL DIS, V14, P1398, DOI 10.1111/j.1463-1318.2012.03023.x
   van Geelen JM, 2013, INT UROGYNECOL J, V24, P707, DOI 10.1007/s00192-012-2025-3
   Van Koughnett JAM, 2013, WORLD J GASTROENTERO, V19, P9216, DOI 10.3748/wjg.v19.i48.9216
   Van WM, 2006, J UROLOGY, V176, P342
   Varma M, 2011, DIS COLON RECTUM, V54, P1339, DOI 10.1097/DCR.0b013e3182310f75
   Velluti Farina A, 2013, PELVIPERINEOLOGY, V32, P9
   VENKATESH KS, 1989, DIS COLON RECTUM, V32, P1039, DOI 10.1007/BF02553877
   Vitton V, 2013, COLORECTAL DIS, V15, pE726, DOI 10.1111/codi.12397
   von Papen M, 2007, DIS COLON RECTUM, V50, P50, DOI 10.1007/s10350-006-0781-1
   Wagenlehner FM, 2012, PELVIPERINEOLOGY, V31, P101
   Wald A, 2007, NEW ENGL J MED, V356, P1648, DOI 10.1056/NEJMcp067041
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Weber AM, 1998, AM J OBSTET GYNECOL, V179, P1446, DOI 10.1016/S0002-9378(98)70008-0
   West RL, 2005, INT J COLORECTAL DIS, V20, P328, DOI 10.1007/s00384-004-0693-2
   Wexner SD, 1996, DIS COLON RECTUM, V39, P957, DOI 10.1007/BF02054681
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Whitehead W E, 2001, Dis Colon Rectum, V44, P131, DOI 10.1007/BF02234835
   Wijffels NAT, 2013, COLORECTAL DIS, V15, P368, DOI 10.1111/j.1463-1318.2012.03183.x
   Williams A, 2006, BJOG-INT J OBSTET GY, V113, P201, DOI 10.1111/j.1471-0528.2006.00806.x
   Withagen MI, 2012, BJOG-INT J OBSTET GY, V119, P354, DOI 10.1111/j.1471-0528.2011.03231.x
   Wong RK, 2012, AM J GASTROENTEROL, V107, P1157, DOI 10.1038/ajg.2012.23
   Yakut M, 1998, INT SURG, V83, P53
   Yip B, 2002, DIS COLON RECTUM, V45, P184, DOI 10.1007/s10350-004-6142-z
   Zbar AP, 2003, INT J COLORECTAL DIS, V18, P369, DOI 10.1007/s00384-003-0478-z
   Zutshi M, 2009, DIS COLON RECTUM, V52, P1089, DOI 10.1007/DCR.0b013e3181a0a79c
NR 380
TC 4
Z9 6
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1590-8658
EI 1878-3562
J9 DIGEST LIVER DIS
JI Dig. Liver Dis.
PD AUG
PY 2015
VL 47
IS 8
BP 628
EP 645
DI 10.1016/j.dld.2015.03.028
PG 18
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CN0FA
UT WOS:000358088300004
PM 25937624
DA 2018-10-19
ER

PT J
AU Aguayo, S
   Donos, N
   Spratt, D
   Bozec, L
AF Aguayo, S.
   Donos, N.
   Spratt, D.
   Bozec, L.
TI Nanoadhesion of Staphylococcus aureus onto Titanium Implant Surfaces
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE atomic force microscopy; biophysics; nanomechanics; microbiology; dental
   implants; bacterial adhesion
ID ATOMIC-FORCE MICROSCOPY; FIBRONECTIN-BINDING PROTEINS; ADHESION FORCES;
   STATISTICAL-ANALYSIS; BACTERIAL ADHESION; POISSON ANALYSIS;
   SILICON-NITRIDE; SPECTROSCOPY; EPIDERMIDIS; FIBRINOGEN
AB Adhesion of bacteria to dental implant surfaces is the critical initial step in the process of biofilm colonization; however, the specific nanoadhesive interactions occurring during the first contact between bacterial cells and biomaterial substrates remain poorly understood. In this report, we utilize single-cell force spectroscopy to characterize the dynamics of the initial interaction between living Staphylococcus aureus cells and machined titanium surfaces at the nanoscale. Values for maximum adhesion force were found to increase from 0-s (-0.27 +/- 0.30 nN) to 60-s (-9.15 +/- 0.78 nN) surface delays, with similar results observed for total adhesion work (7.39 +/- 2.38 and 988.06 +/- 117.08 aJ, respectively). Single unbinding events observed at higher surface delays were modeled according to the wormlike chain model, obtaining molecular contour-length predictions of 314.06 +/- 9.27 nm. Average single-bond rupture forces of -0.95 +/- 0.04 nN were observed at increased contact times. Short- and long-range force components of bacterial adhesion were obtained by Poisson analysis of single unbinding event peaks, yielding values of -0.75 +/- 0.04 and -0.58 +/- 0.15 nN, respectively. Addition of 2-mg/mL chlorhexidine to the buffer solution resulted in the inhibition of specific adhesive events but an increased overall adhesion force and work. These results suggest that initial attachment of S. aureus to smooth titanium is mostly mediated by short-range attractive forces observed at higher surface delays.
C1 [Aguayo, S.; Bozec, L.] UCL, Div Biomat & Tissue Engn, UCL Eastman Dent Inst, London WC1X 8LD, England.
   [Donos, N.] UCL, UCL Eastman Dent Inst, Periodontol Unit, London WC1X 8LD, England.
   [Spratt, D.] UCL, Div Microbial Dis, UCL Eastman Dent Inst, London WC1X 8LD, England.
RP Aguayo, S (reprint author), UCL, Div Biomat & Tissue Engn, UCL Eastman Dent Inst, 256 Grays Inn Rd, London WC1X 8LD, England.
EM Sebastian.aguayo.13@ucl.ac.uk
OI Aguayo, Sebastian/0000-0003-0900-1993
FU BecasChile PhD Scholarship Programme
FX We thank the BecasChile PhD Scholarship Programme for funding this
   research. The authors declare no potential conflicts of interest with
   respect to the authorship and/or publication of this article.
CR Abu-Lail NI, 2006, LANGMUIR, V22, P7296, DOI 10.1021/la0533415
   Aguayo S, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062001
   Beaussart A, 2013, NANOSCALE, V5, P10894, DOI 10.1039/c3nr03272h
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Buck AW, 2010, LANGMUIR, V26, P10764, DOI 10.1021/la100549u
   Chan Y, 2010, J THEOR BIOL, V262, P498, DOI 10.1016/j.jtbi.2009.10.009
   Chen Y, 2014, APPL ENVIRON MICROB, V80, P637, DOI 10.1128/AEM.02745-13
   Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11
   Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Esposito M, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003815.PUB3
   Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x
   Gordesli FP, 2012, ENVIRON SCI TECHNOL, V46, P10089, DOI 10.1021/es300653w
   Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x
   Herman P, 2014, MOL MICROBIOL, V93, P356, DOI 10.1111/mmi.12663
   Herman P, 2013, LANGMUIR, V29, P13018, DOI 10.1021/la4029172
   Izquierdo-Barba I, 2015, ACTA BIOMATER, V15, P20, DOI 10.1016/j.actbio.2014.12.023
   Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x
   Kishen A, 2008, J ENDODONT, V34, P850, DOI 10.1016/j.joen.2008.04.006
   Lee A, 2010, IMPLANT DENT, V19, P387, DOI 10.1097/ID.0b013e3181effa53
   Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044
   Logan N, 2015, J BIOMED MATER RES A, V103, P1208, DOI 10.1002/jbm.a.35264
   Mei L, 2009, J DENT RES, V88, P841, DOI 10.1177/0022034509342523
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   Meyer RL, 2010, ULTRAMICROSCOPY, V110, P1349, DOI 10.1016/j.ultramic.2010.06.010
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006
   Setzer FC, 2014, J DENT RES, V93, P19, DOI 10.1177/0022034513504782
   Storm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051906
   Sullan RMA, 2014, NANOSCALE, V6, P1134, DOI 10.1039/c3nr05462d
   Taubenberger A V, 2013, TISSUE ENG PART B-RE, V20, P40
   UHLEN M, 1984, J BIOL CHEM, V259, P1695
   Valderrama P, 2013, INT J DENT, V2013, DOI DOI 10.1155/2013/740680
   Webb HK, 2011, J MICROBIOL METH, V86, P131, DOI 10.1016/j.mimet.2011.05.021
   Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012
   Younes JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036917
   Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001
NR 40
TC 9
Z9 9
U1 1
U2 33
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD AUG
PY 2015
VL 94
IS 8
BP 1078
EP 1084
DI 10.1177/0022034515591485
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CN1LR
UT WOS:000358182000009
PM 26130256
DA 2018-10-19
ER

PT J
AU Shao, K
   Han, BQ
   Gao, JN
   Song, FL
   Yang, Y
   Liu, WS
AF Shao Kai
   Han Baoqin
   Gao Jinning
   Song Fulai
   Yang Yan
   Liu Wanshun
TI Synthesis and characterization of a hydroxyethyl derivative of chitosan
   and evaluation of its biosafety
SO JOURNAL OF OCEAN UNIVERSITY OF CHINA
LA English
DT Article
DE hydroxyethyl chitosan; biomaterial; cytotoxicity; biocompatibility;
   biodegradability
ID IN-VITRO EVALUATION; CHITIN; POLYMERS; VIVO; CYTOTOXICITY; CONJUGATE;
   RELEASE; SAFETY; PH
AB Hydroxyethyl chitosan (HE-chitosan) is a water-soluble derivative of chitosan with many apparent biological properties. For example, it is non-toxic and rapidly biodegradable. Moreover, HE-chitosan has advantages in water-solubility, moisture retention and gelling property due to its hydroxyethyl group. However, the biocompatibility and biodegradability of this multifunctional derivative have rarely been documented although they are critical for its application in biomedical and clinical treatments. The purpose of this work was to evaluate the biosafety of HE-chitosan, and draw important clues for its diverse applications. HE-chitosan was synthesized and characterized its chemical structure with FTIR. Its molecular weight (MW) was determined by gel permeation chromatography (GPC), and its deacetylation degree (DD) was investigated through potentiometric analysis. The cytotoxicity of HE-chitosan on mouse fibroblast cell L929 was tested. The biocompatibility and biodegradability of HE-chitosan in rat and rabbit were evaluated. The FTIR results indicated that the hydroxyethyl groups were linked to C6 of chitosan. The GPC analysis confirmed that its Mw was about 90.01 kDa. It was also demonstrated that HE-chitosan had excellent biocompatibility and biodegradability in vivo and had no cytotoxicity on L929. These findings indicated that HE-chitosan can potentially be applied as a biomaterial in tissue engineering, drug delivery, and other biomedical fields.
C1 [Shao Kai; Han Baoqin; Gao Jinning; Song Fulai; Yang Yan; Liu Wanshun] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
RP Han, BQ (reprint author), Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
EM baoqinh@ouc.edu.cn
FU National Key Technology R&D Program of the Ministry of Science and
   Technology [2013BAB01B02]
FX This work is supported by the National Key Technology R&D Program of the
   Ministry of Science and Technology (2013BAB01B02).
CR Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Carreira AS, 2010, CARBOHYD POLYM, V80, P618, DOI 10.1016/j.carbpol.2009.12.047
   Chen Y, 2010, J APPL POLYM SCI, V117, P2233, DOI 10.1002/app.32141
   Chow KS, 2002, CARBOHYD POLYM, V47, P357, DOI 10.1016/S0144-8617(01)00190-4
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Dong W, 2010, BIOMACROMOLECULES, V11, P1527, DOI 10.1021/bm100158p
   Dong YM, 2001, ACTA POLYM SIN, P172
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   El-Sherbiny IM, 2009, EUR POLYM J, V45, P199, DOI 10.1016/j.eurpolymj.2008.10.042
   Gomaa YA, 2010, CARBOHYD POLYM, V81, P234, DOI 10.1016/j.carbpol.2010.02.024
   He XK, 2012, THERANOSTICS, V2, P1054, DOI 10.7150/thno.3705
   HUANG R, 2003, CARBOHYD POLYM, V51, P431
   Huang RH, 2005, INT J BIOL MACROMOL, V36, P120, DOI 10.1016/j.ijbiomac.2005.05.001
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Li DH, 2007, CARBOHYD POLYM, V67, P40, DOI 10.1016/j.carbpol.2006.04.022
   Li MY, 2011, J MATER SCI-MATER M, V22, P2745, DOI 10.1007/s10856-011-4455-8
   Liang Y, 2011, J MATER SCI-MATER M, V22, P175, DOI 10.1007/s10856-010-4190-6
   Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022
   Liu WG, 2004, J MATER SCI-MATER M, V15, P1199, DOI 10.1007/s10856-004-5672-1
   Liu XF, 2007, J APPL POLYM SCI, V103, P3521, DOI 10.1002/app.25421
   MUZZARELLI RAA, 1984, CARBOHYD RES, V126, P225, DOI 10.1016/0008-6215(84)85380-X
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Nanaki SG, 2012, CARBOHYD POLYM, V87, P1286, DOI 10.1016/j.carbpol.2011.09.013
   Rasad MSBA, 2010, CARBOHYD POLYM, V79, P1094, DOI 10.1016/j.carbpol.2009.10.048
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Takei T, 2012, ACTA BIOMATER, V8, P686, DOI 10.1016/j.actbio.2011.10.005
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wan Y, 2004, J POLYM SCI POL PHYS, V42, P1379, DOI 10.1002/polb.20007
   Xie YJ, 2007, CARBOHYD POLYM, V69, P142, DOI 10.1016/j.carbpol.2006.09.010
   Xu XL, 2010, CARBOHYD POLYM, V81, P541, DOI 10.1016/j.carbpol.2010.03.011
   Yuan ZX, 2011, J DRUG TARGET, V19, P540, DOI 10.3109/1061186X.2010.521158
   Zhang C, 2005, J APPL POLYM SCI, V97, P2161, DOI 10.1002/app.21975
   Zhao YQ, 2008, CARBOHYD POLYM, V74, P828, DOI 10.1016/j.carbpol.2008.04.042
   Zheng ML, 2011, CARBOHYD POLYM, V86, P231, DOI 10.1016/j.carbpol.2011.04.038
NR 40
TC 3
Z9 6
U1 2
U2 31
PU OCEAN UNIV CHINA
PI QINGDAO
PA 5 YUSHAN RD, QINGDAO, 266003, PEOPLES R CHINA
SN 1672-5182
EI 1993-5021
J9 J OCEAN U CHINA
JI J. OCEAN UNIV.
PD AUG
PY 2015
VL 14
IS 4
BP 703
EP 709
DI 10.1007/s11802-015-2544-x
PG 7
WC Oceanography
SC Oceanography
GA CN3OJ
UT WOS:000358335900017
DA 2018-10-19
ER

PT J
AU Chandrasekaran, N
   Dimartino, S
   Janmale, T
   Gieseg, SP
   Fee, CJ
AF Chandrasekaran, Neha
   Dimartino, Simone
   Janmale, Tejraj
   Gieseg, Steven P.
   Fee, Conan J.
TI Adsorption of chemically synthesized mussel adhesive peptide sequences
   containing DOPA on stainless steel
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE adhesive peptides; DOPA; stainless steel; QCM-D; mushroom tyrosinase
ID QUARTZ-CRYSTAL MICROBALANCE; MARINE MUSSEL; CROSS-LINKING;
   INFRARED-SPECTROSCOPY; MYTILUS-EDULIS; QCM-D; PROTEIN;
   3,4-DIHYDROXYPHENYLALANINE; TYROSINASE; INTERFACES
AB The adsorption of proteins at solid-liquid interfaces is important in biosensor and biomaterial applications. Marine mussels affix themselves to surfaces using a highly cross-linked, protein-based adhesive containing a high proportion of L-3,4-dihydroxyphenylalanine (DOPA) residues. In this work, the effect of DOPA residues on protein adhesion on stainless steel surfaces was studied using a quartz crystal microbalance with dissipation system. The adsorption of two repetitive peptide motifs, KGYKYYGGSS and KGYKYY, from the mussel Mytilus edulis foot protein 5 on stainless steel was studied before and after chemo-enzymatic modification of tyrosine residues to DOPA using mushroom tyrosinase. Conversion from tyrosine to DOPA, evaluated by HPLC, was in the range 70-99%. DOPA-modified sequences showed fourfold greater adhesion than unmodified M. edulis foot protein 5 motifs. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.
C1 [Chandrasekaran, Neha; Dimartino, Simone; Fee, Conan J.] Univ Canterbury, Dept Chem & Proc Engn, Christchurch 1, New Zealand.
   [Dimartino, Simone; Fee, Conan J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.
   [Janmale, Tejraj; Gieseg, Steven P.] Univ Canterbury, Free Radical Biochem, Sch Biol Sci, Christchurch 1, New Zealand.
   [Gieseg, Steven P.] Univ Otago Christchurch, Dept Radiol, Christchurch, New Zealand.
RP Fee, CJ (reprint author), Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.
EM conan.fee@canterbury.ac.nz
RI Dimartino, Simone/I-3392-2012
OI Dimartino, Simone/0000-0002-9695-1278
FU University of Canterbury
FX N. Chandrasekaran is grateful to the University of Canterbury for a UC
   Doctoral Scholarship.
CR Anand G, 2010, LANGMUIR, V27, P1830
   ARWIN H, 1990, LANGMUIR, V6, P1551, DOI 10.1021/la00100a005
   Bandara N, 2013, J ADHES SCI TECHNOL, V18-19, P2139
   Baty AM, 1997, LANGMUIR, V13, P5702, DOI 10.1021/la9610720
   BENEDICT CV, 1989, ACS SYM SER, V385, P465, DOI 10.1021/bk-1989-0385.ch033
   BI RC, 1984, BIOPOLYMERS, V23, P391, DOI DOI 10.1002/BIP.360230302
   Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v
   Chandrasekaran N, 2012, P CHEM C WELL NZ, P23
   Chandrasekaran N, 2013, CHEM ENG RES DES, V91, P1674, DOI 10.1016/j.cherd.2013.07.017
   Creton C, 2003, MRS BULL, V28, P419, DOI 10.1557/mrs2003.121
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Dimartino S, 2013, BIOL BIOMIMETIC ADHE, P117
   Fant C, 2000, BIOFOULING, V16, P119, DOI 10.1080/08927010009378437
   Fant C, 2010, J ADHESION, V86, P25, DOI 10.1080/00218460903417768
   Flammang P, 2006, BIOLOGICAL ADHESIVES, P183, DOI 10.1007/978-3-540-31049-5_10
   Gao ZH, 2007, APPL SPECTROSC, V61, P55, DOI 10.1366/000370207779701398
   GIESEG SP, 1993, BIOCHEMISTRY-US, V32, P4780, DOI 10.1021/bi00069a012
   Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Irwin EF, 2005, LANGMUIR, V21, P5529, DOI 10.1021/la0470737
   ITO S, 1984, BIOCHEM J, V222, P407, DOI 10.1042/bj2220407
   Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019
   Lee BP, 2006, BIOLOGICAL ADHESIVES, P257, DOI 10.1007/978-3-540-31049-5_13
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Malmstrom J, 2007, LANGMUIR, V23, P9760, DOI 10.1021/la701233y
   MARUMO K, 1986, BIOCHIM BIOPHYS ACTA, V872, P98, DOI 10.1016/0167-4838(86)90152-4
   Monahan J, 2003, CHEM COMMUN, P1672, DOI 10.1039/b301052j
   OLIVIERI MP, 1992, BIOMATERIALS, V13, P1000, DOI 10.1016/0142-9612(92)90150-M
   Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h
   Rischka K, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P201, DOI 10.1007/978-3-7091-0286-2_13
   Sauerbrey G., 1959, J PHYS, V155, p206~222
   Schreiber L, 2005, PLANTA, V220, P520, DOI 10.1007/s00425-004-1364-9
   Sever MJ, 2004, ANGEW CHEM, V116, P454
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Stengel G, 2005, ANAL CHEM, V77, P3709, DOI 10.1021/ac048302x
   Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256
   Voigt D, 2008, J EXP BIOL, V211, P2647, DOI 10.1242/jeb.019273
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WAITE JH, 1984, ANAL CHEM, V56, P1935, DOI 10.1021/ac00275a040
   Wilke P, 2012, ACS MACRO LETT, V1, P871, DOI 10.1021/mz300258m
NR 43
TC 2
Z9 2
U1 2
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD AUG
PY 2015
VL 21
IS 8
BP 630
EP 635
DI 10.1002/psc.2776
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA CN4AD
UT WOS:000358369300002
PM 25854691
DA 2018-10-19
ER

PT J
AU Magazzu, A
   Spadaro, D
   Donato, MG
   Sayed, R
   Messina, E
   D'Andrea, C
   Foti, A
   Fazio, B
   Iati, MA
   Irrera, A
   Saija, R
   Gucciardi, PG
   Marago, OM
AF Magazzu, A.
   Spadaro, D.
   Donato, M. G.
   Sayed, R.
   Messina, E.
   D'Andrea, C.
   Foti, A.
   Fazio, B.
   Iati, M. A.
   Irrera, A.
   Saija, R.
   Gucciardi, P. G.
   Marago, O. M.
TI Optical tweezers: a non-destructive tool for soft and biomaterial
   investigations
SO RENDICONTI LINCEI-SCIENZE FISICHE E NATURALI
LA English
DT Article
DE Optical trapping; Optofluidics; Nanospectroscopy; Biosensors
ID ULTRA-SENSITIVE SPECTROSCOPY; SINGLE-PARTICLE DYNAMICS; CYLINDRICAL
   VECTOR BEAMS; T-MATRIX FORMALISM; RED-BLOOD-CELLS; NONSPHERICAL
   PARTICLES; RAMAN-SPECTROSCOPY; GOLD NANOPARTICLES; BIOLOGICAL
   APPLICATIONS; SILVER NANOPARTICLES
AB Optical tweezers are a key technique for trapping and contactless manipulation of particles at the micro- and nanoscale that can exert and sense forces from hundreds of piconewton down to few femtonewton. In their simplest implementation, they are based on a single laser beam tightly focused to a high-intensity diffraction-limited spot. Here, after reviewing the general theoretical background on optical forces, we focus on their calibration and show a comparison between frequency and time domain methods. Then, we show novel measurements and calculations of optical forces on gold nanoparticles discussing their size scaling behavior. Finally, we describe recent applications of chiral optical trapping to soft materials, and integration of optical tweezers with Raman spectroscopy for ultra-sensitive spectroscopy of biomolecules in liquids.
C1 [Magazzu, A.; Spadaro, D.; Donato, M. G.; Sayed, R.; Messina, E.; D'Andrea, C.; Foti, A.; Fazio, B.; Iati, M. A.; Irrera, A.; Gucciardi, P. G.; Marago, O. M.] CNR, IPCF Ist Proc Chim Fis, I-98158 Messina, Italy.
   [Magazzu, A.; Foti, A.; Saija, R.] Univ Messina, Dipartimento Fis & Sci Terra, I-98166 Messina, Italy.
RP Marago, OM (reprint author), CNR, IPCF Ist Proc Chim Fis, Vle F Stagno DAlcontres 37, I-98158 Messina, Italy.
EM marago@me.cnr.it
RI Donato, Maria/A-9645-2018; Gucciardi, Pietro Giuseppe/B-8188-2014;
   Magazzo, Alessandro/J-2476-2016; Marago, Onofrio/J-9827-2016; Irrera,
   Alessia/O-2387-2015; D'Andrea, Cristiano/Q-1095-2018; Fazio,
   Barbara/O-2841-2015
OI Donato, Maria/0000-0002-7580-3137; Gucciardi, Pietro
   Giuseppe/0000-0003-1826-9174; Magazzo, Alessandro/0000-0003-1247-2702;
   Marago, Onofrio/0000-0002-7220-8527; Irrera,
   Alessia/0000-0002-3057-1328; D'Andrea, Cristiano/0000-0001-5807-3067;
   Fazio, Barbara/0000-0002-1947-1123; IATI', MARIA
   ANTONIA/0000-0002-3576-8656; IATI', MARIA ANTONIA/0000-0003-0467-8049
FU Programma Operativo Nazionale Ricerca e Competitivita; Project PANREX
   [PON01_01322]; Project SOCIAL-NANO [PAC02L3_00087]; MPNS COST Action
   "Advances in Optofluidics: Integration of Optical Control and Photonics
   with Microfluidics'' [1205]
FX We acknowledge support from "Programma Operativo Nazionale Ricerca e
   Competitivita'' 2007-2013, Project PON01_01322 PANREX, Project
   PAC02L3_00087 SOCIAL-NANO, and the MPNS COST Action 1205 "Advances in
   Optofluidics: Integration of Optical Control and Photonics with
   Microfluidics''.
CR Ajito K, 2002, LAB CHIP, V2, P11, DOI 10.1039/b108744b
   Albaladejo S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.113602
   ASHKIN A, 1992, BIOPHYS J, V61, P569, DOI 10.1016/S0006-3495(92)81860-X
   ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288
   ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0
   ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156
   BarZiv R, 1997, PHYS REV LETT, V78, P154, DOI 10.1103/PhysRevLett.78.154
   Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654
   Borghese F, 2007, PHYS EARTH SPACE ENV, P1, DOI 10.1007/978-3-540-37414-5
   Borghese F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.163903
   Borghese F, 2007, OPT EXPRESS, V15, P11984, DOI 10.1364/OE.15.011984
   Borghese F, 2006, OPT EXPRESS, V14, P9508, DOI 10.1364/OE.14.009508
   Bosanac L, 2008, NANO LETT, V8, P1486, DOI 10.1021/nl080490+
   Buosciolo A, 2004, OPT COMMUN, V230, P357, DOI 10.1016/j.optcom.2003.11.062
   Callegari A, 2014, ARXIV14025439
   Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761
   Chaumet PC, 2000, OPT LETT, V25, P1065, DOI 10.1364/OL.25.001065
   Cipparrone G, 2011, ADV MATER, V23, P5773, DOI 10.1002/adma.201102828
   Coffey WT, 2004, LANGEVIN EQUATION
   Cojoc D, 2005, P SOC PHOTO-OPT INS, V5930, P59300
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   De Luca AC, 2007, HAEMATOL-HEMATOL J, V92, P174
   De Luca AC, 2008, OPT EXPRESS, V16, P7943, DOI 10.1364/OE.16.007943
   Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301
   Dholakia K, 2011, NAT PHOTONICS, V5, P335, DOI [10.1038/nphoton.2011.80, 10.1038/NPHOTON.2011.80]
   Dienerowitz M, 2008, OPT EXPRESS, V16, P4991, DOI 10.1364/OE.16.004991
   Donato MG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4656
   Donato MG, 2012, OPT LETT, V37, P3381, DOI 10.1364/OL.37.003381
   DRAINE BT, 1988, ASTROPHYS J, V333, P848, DOI 10.1086/166795
   Fazal FM, 2011, NAT PHOTONICS, V5, P318, DOI 10.1038/nphoton.2011.100
   Florin EL, 1997, J STRUCT BIOL, V119, P202, DOI 10.1006/jsbi.1997.3880
   Friese MEJ, 1998, NATURE, V394, P348, DOI 10.1038/28566
   Friese MEJ, 1996, PHYS REV A, V54, P1593, DOI 10.1103/PhysRevA.54.1593
   Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258
   GHISLAIN LP, 1993, OPT LETT, V18, P1678, DOI 10.1364/OL.18.001678
   GORDON JP, 1973, PHYS REV A, V8, P14, DOI 10.1103/PhysRevA.8.14
   Hamden KE, 2005, J VIROL METHODS, V129, P145, DOI 10.1016/j.jviromet.2005.05.018
   Hansen PM, 2005, NANO LETT, V5, P1937, DOI 10.1021/nl051289r
   Henderson S, 2001, COLLOID SURFACE A, V190, P81, DOI 10.1016/S0927-7757(01)00667-7
   Hernandez RJ, 2013, LAB CHIP, V13, P459, DOI 10.1039/c2lc40703e
   Irrera A, 2011, NANO LETT, V11, P4879, DOI 10.1021/nl202733j
   Jones PH, 2007, J OPT A-PURE APPL OP, V9, pS278, DOI 10.1088/1464-4258/9/8/S23
   Jones PH, 2009, ACS NANO, V3, P3077, DOI 10.1021/nn900818n
   Jones PH, 2015, OPTICAL TWEEZERS
   Kyrsting A, 2011, NANO LETT, V11, P888, DOI 10.1021/nl104280c
   Lankers M, 1997, CHEM PHYS LETT, V277, P331, DOI 10.1016/S0009-2614(97)00894-4
   Maier S. A., 2007, PLASMONICS FUNDAMENT
   Marago OM, 2008, NANO LETT, V8, P3211, DOI 10.1021/nl8015413
   Marago OM, 2010, NANOSCI TECHNOL, P23, DOI 10.1007/978-3-642-03535-7_2
   Marago OM, 2013, NAT NANOTECHNOL, V8, P807, DOI [10.1038/NNANO.2013.208, 10.1038/nnano.2013.208]
   Marago OM, 2010, ACS NANO, V4, P7515, DOI 10.1021/nn1018126
   Marques MI, 2014, OPT LETT, V39, P5122, DOI 10.1364/OL.39.005122
   Messina E, 2012, J QUANT SPECTROSC RA, V113, P220, DOI 10.1016/j.jqsrt.2012.06.023
   Messina E, 2011, J PHYS CHEM C, V115, P5115, DOI 10.1021/jp109405j
   Messina E, 2011, ACS NANO, V5, P905, DOI 10.1021/nn102101a
   Mishchenko MI, 2001, J QUANT SPECTROSC RA, V70, P811, DOI 10.1016/S0022-4073(01)00047-4
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Nieminen TA, 2001, J QUANT SPECTROSC RA, V70, P627, DOI 10.1016/S0022-4073(01)00034-6
   Nieminen TA, 2014, J QUANT SPECTROSC RA, V146, P59, DOI 10.1016/j.jqsrt.2014.04.003
   Nieminen TA, 2011, J MOD OPTIC, V58, P528, DOI 10.1080/09500340.2010.528565
   Ohlinger A, 2011, NANO LETT, V11, P1770, DOI 10.1021/nl2003544
   Olof SN, 2012, NANO LETT, V12, P6018, DOI 10.1021/nl303585w
   Padgett M, 2011, NAT PHOTONICS, V5, P343, DOI [10.1038/nphoton.2011.81, 10.1038/NPHOTON.2011.81]
   Palima D, 2013, LASER PHOTONICS REV, V7, P478, DOI 10.1002/lpor.201200030
   Pesce G, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/38002
   Petrov DV, 2007, J OPT A-PURE APPL OP, V9, pS139, DOI 10.1088/1464-4258/9/8/S06
   Phillips DB, 2014, NAT PHOTONICS, V8, P400, DOI 10.1038/nphoton.2014.74
   Phillips DB, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285503
   Ploschner M, 2012, NANO LETT, V12, P1923, DOI 10.1021/nl204378r
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Prikulis J, 2004, NANO LETT, V4, P115, DOI 10.1021/nl0349606
   Rao S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431628
   Reece PJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3225148
   Saija R, 2005, J QUANT SPECTROSC RA, V94, P163, DOI 10.1016/j.jqsrt.2004.09.006
   Saija R, 2009, OPT EXPRESS, V17, P10231, DOI 10.1364/OE.17.010231
   Seol Y, 2006, OPT LETT, V31, P2429, DOI 10.1364/OL.31.002429
   Simpson SH, 2014, J QUANT SPECTROSC RA, V146, P81, DOI 10.1016/j.jqsrt.2014.04.012
   Simpson SH, 2007, J OPT SOC AM A, V24, P430, DOI 10.1364/JOSAA.24.000430
   Skelton SE, 2013, OPT LETT, V38, P28, DOI 10.1364/OL.38.000028
   Skelton SE, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/7/075706
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930
   Swartzlander GA, 2011, NAT PHOTONICS, V5, P48, DOI [10.1038/nphoton.2010.266, 10.1038/NPHOTON.2010.266]
   Tan SD, 2004, NANO LETT, V4, P1415, DOI 10.1021/nl049347g
   Tkachenko G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4577
   Wang F, 2013, NANO LETT, V13, P1185, DOI 10.1021/nl304607v
   Wang F, 2011, NANO LETT, V11, P4149, DOI 10.1021/nl2020262
   Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607
   Wood BR, 2001, BBA-MOL CELL RES, V1539, P58, DOI 10.1016/S0167-4889(01)00089-1
   Xie CG, 2002, OPT LETT, V27, P249, DOI 10.1364/OL.27.000249
NR 91
TC 2
Z9 2
U1 5
U2 43
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 2037-4631
EI 1720-0776
J9 REND LINCEI-SCI FIS
JI Rend. Lincei.-Sci. Fis. Nat.
PD AUG
PY 2015
VL 26
SU 2
BP 203
EP 218
DI 10.1007/s12210-015-0395-4
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN3QQ
UT WOS:000358341800008
DA 2018-10-19
ER

PT J
AU de Olyveira, GM
   dos Santos, ML
   Riccardi, CD
   Costa, LMM
   Daltro, PB
   Basmaji, P
   Daltro, GD
   Guastaldi, AC
AF de Olyveira, Gabriel Molina
   dos Santos, Marcio Luiz
   Riccardi, Carla dos Santos
   Manzine Costa, Ligia Maria
   Daltro, Paula Braga
   Basmaji, Pierre
   Daltro, Gildasio de Cerqueira
   Guastaldi, Antonio Carlos
TI Physically Modified Bacterial Cellulose Biocomposites for Guided Tissue
   Regeneration
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Bacterial Cellulose; Nanoskin (R); Nanocomposites; Scaffolds; Dental
   Materials
ID SURFACE MODIFICATION; BIOMEDICAL APPLICATIONS; NANOCOMPOSITES;
   BIOMATERIALS; POLYMERS; COLLAGEN; PLASMA
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process was modified by the addition of chondroitin sulfate to the culture medium before the bacteria was inoculated. Besides, the potential of gamma irradiation treatment for the modification of the BC surface properties, in enhancing its potential for biomedical applications, was also analyzed. For guided tissue regeneration purposes, biomimetic precipitation of calcium phosphate of biological interest from simulated body fluid on bacterial cellulose was studied. The influence of chondroitin sulfate on bacterial cellulose was analyzed by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM) and thermogravimetric analysis (TGA), as well as after CaP coatings produced by a biomimetic route. FTIR analysis showed interaction between bacterial cellulose nanobiocomposites and calcium phosphate. XRD demonstrated formation of amorphous calcium phosphate and sodium chloride on bacterial cellulose nanobiocomposites. SEM images proved faster calcium phosphate deposition in non-irradiated samples. The different samples showed significant variation in thermal properties.
C1 [de Olyveira, Gabriel Molina; dos Santos, Marcio Luiz; Riccardi, Carla dos Santos; Daltro, Paula Braga; Guastaldi, Antonio Carlos] UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
   [Manzine Costa, Ligia Maria] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09210170 Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
   [Daltro, Gildasio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex COM HUPES, BR-40110910 Salvador, BA, Brazil.
RP de Olyveira, GM (reprint author), UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
EM gabriel.ufabc@gmail.com
RI dos Santos, Marcio/D-9905-2014; Guastaldi, Antonio/O-7379-2014; Manzine
   Costa, Ligia Maria/N-1780-2015
OI dos Santos, Marcio/0000-0002-3385-7516; Guastaldi,
   Antonio/0000-0002-6433-3555; Manzine Costa, Ligia
   Maria/0000-0001-6483-7633
CR Alvarez VA, 2006, POLYM DEGRAD STABIL, V91, P3156, DOI 10.1016/j.polymdegradstab.2006.07.011
   Aoki H., 1999, SCI MED APPL HYDROXY
   Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0
   Basmaji P, 2014, J BIOMATER TISS ENG, V4, P59, DOI 10.1166/jbt.2014.1133
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Chan C. M, 1994, POLYM SURFACE MODIFI
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   Deepa B, 2011, BIORESOURCE TECHNOL, V102, P1988, DOI 10.1016/j.biortech.2010.09.030
   DENLINGER JL, 1980, EXP EYE RES, V31, P81, DOI 10.1016/0014-4835(80)90092-5
   Filho L. X., 2013, J NANOSCI NANOTECHNO, V13, P1
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gois P. B. P., 2013, INT REV BIOPHYSICAL, V3, P48
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Kaczmarek H, 2002, SURF SCI, V507, P883, DOI 10.1016/S0039-6028(02)01367-5
   Kondo T., 1998, POLYSACCHARIDES STRU, P131
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Manfredi B.L., 2006, POLYM DEGRAD STABIL, V91, P255
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Olyveira G., 2014, SCI ADV MATER, V6, P1
   Olyveira G. M., 2011, J NANOTECH ENG MED, V2, P34001
   Olyveira G. M., 2014, J BIOMATER TISS ENG, V4, P1
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P1
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P665, DOI 10.1166/jbt.2013.1127
   Ouajai S., 2006, POLYM DEGRAD STABIL, V13, P131
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Salmen L., 2005, POLYSACCHARIDES STRU, P159
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   SINACORE MS, 1989, BIO-TECHNOL, V7, P1275
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun Y, 2008, BIORESOURCES, V3, P297
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Willians D. F., 1991, CONCISE ENCY MED DEN
   Willians D. F., 1981, BIOCOMPATIBILITY CLI
   Acasigua GAX, 2014, CURR STEM CELL RES T, V9, P117, DOI 10.2174/1574888X08666131124135654
NR 43
TC 2
Z9 2
U1 5
U2 44
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD AUG
PY 2015
VL 7
IS 8
BP 1657
EP 1664
DI 10.1166/sam.2015.2283
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA CN2RK
UT WOS:000358269400034
DA 2018-10-19
ER

PT J
AU Gaston, J
   Bartlett, S
   Klemuk, SA
   Thibeault, SL
AF Gaston, J.
   Bartlett, S.
   Klemuk, S. A.
   Thibeault, S. L.
TI Formulation and characterization of a porous, elastomeric biomaterial
   for vocal fold tissue engineering research (vol 123, pg 866, 2014)
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Correction
CR Gaston J, 2014, ANN OTO RHINOL LARYN, V123, P866, DOI 10.1177/0003489414539131
NR 1
TC 0
Z9 0
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-4894
EI 1943-572X
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD AUG
PY 2015
VL 124
IS 8
BP 675
EP 675
DI 10.1177/0003489415593945
PG 1
WC Otorhinolaryngology
SC Otorhinolaryngology
GA CM8NG
UT WOS:000357957900014
OA Bronze
DA 2018-10-19
ER

PT J
AU Sravanthi, V
   Pallavi, MCP
   Bonam, SR
   Sathyabama, S
   Kumar, HMS
AF Sravanthi, Vemireddy
   Pallavi, M. C. Preethi
   Bonam, Srinivasa Reddy
   Sathyabama, Sathyaseelan
   Kumar, Halmuthur M. Sampath
TI Oleic acid nanoemulsion for nasal vaccination: Impact on adjuvanticity
   based immune response
SO JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Oleic acid nanoemulsion; Nasal vaccination; Antibody class switch;
   Dendritic cell activation
ID PROTECTIVE IMMUNITY; CELLS; VACCINES; ANTIGEN; GENERATION;
   IMMUNOGENICITY; FORMULATIONS; ANTIBODIES; MECHANISM; ROUTE
AB Subunit vaccine formulations with enhanced potency are vital to improve immune response against weak antigens and also promote dose sparing of adjuvant and antigens that may cause undesirable side effects. Recently particulate delivery systems are under exploration to enhance antigen specific immunity. Oleic acid a potential biomaterial in terms of penetration is used for formulating nanoemulsion for nasal vaccination. In this study influence of oleic acid nanoemulsion on antigen uptake and role in dendritic cells activation is studied. Formulation conditions were optimized to produce a stable nanoemulsion at lowest surfactant concentration (2%). Penetration enhancement of oleic acid nanoemulsion was evaluated using cell uptake study by Fluorescein isothiocyanate conjugated OVA on A549 cell line. Here, we report strong class switched, high avidity humoral and cellular (cytokine) immune response elicited by vaccine delivery system with antigen and adjuvant. Flowcytometry analysis showed enhanced expression of activated dendritic cells on 45th day compared to soluble antigen. These data suggest that oleic acid formulation enhances penetration, sustain release of antigen and stimulates both cellular and humoral immune response. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Sravanthi, Vemireddy; Pallavi, M. C. Preethi; Bonam, Srinivasa Reddy; Sathyabama, Sathyaseelan; Kumar, Halmuthur M. Sampath] CSIR Indian Inst Chem Technol, NPC Div, Vaccine Immunol Lab, Hyderabad 500007, Andhra Pradesh, India.
RP Kumar, HMS (reprint author), CSIR Indian Inst Chem Technol, NPC Div, Vaccine Immunol Lab, Hyderabad 500007, Andhra Pradesh, India.
EM sampath@iict.res.in
RI BONAM, SRINIVASA REDDY/I-1342-2016
OI BONAM, SRINIVASA REDDY/0000-0002-2888-2418
FU CSIR-New Delhi [CSC0205]
FX Authors thank CSIR-New Delhi for the support under the 12th FYP supra
   institutional project DENOVA (CSC0205).
CR Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912
   Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020
   Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466
   Bernardi DS, 2011, J NANOBIOTECHNOL, V9, P1
   Borrebaeck C.A., 2002, J IMMUNOL, V168, P3165
   Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399
   Copland MJ, 2005, IMMUNOL CELL BIOL, V83, P97, DOI 10.1111/j.1440-1711.2005.01315.x
   Eck SC, 1999, CANCER IMMUNOL IMMUN, V48, P336, DOI 10.1007/s002620050583
   Ejima D, 2005, ANAL BIOCHEM, V345, P250, DOI 10.1016/j.ab.2005.07.004
   Fox CB, 2012, CLIN VACCINE IMMUNOL, V19, P1633, DOI 10.1128/CVI.00235-12
   Gonipeta B., 2013, ISRN ALLERGY, V20, P1
   GRANFORS K, 1979, J CLIN MICROBIOL, V9, P336
   Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111
   Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057
   Jain J, 2010, AAPS PHARMSCITECH, V11, P826, DOI 10.1208/s12249-010-9440-x
   Kaser M. R., 2013, MAKING USE ANTIBODIE
   Kim YU, 2013, ANTIBODIES, V2, P554, DOI 10.3390/antib2040554
   Kobayashi S, 1996, EUR J PHARM SCI, V4, P267, DOI 10.1016/0928-0987(96)00169-8
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Patil HP, 2014, J CONTROL RELEASE, V174, P51, DOI 10.1016/j.jconrel.2013.11.013
   Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485
   Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729
   Slutter B, 2010, J CONTROL RELEASE, V148, P117, DOI 10.1016/j.jconrel.2010.06.009
   Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531
   WANG LY, 1994, PHARMACEUT RES, V11, P513, DOI 10.1023/A:1018906330308
   Welch RJ, 2010, J CLIN LAB ANAL, V24, P160, DOI 10.1002/jcla.20382
   Wilson NS, 2012, IMMUNOL CELL BIOL, V90, P540, DOI 10.1038/icb.2011.71
NR 27
TC 2
Z9 2
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1773-2247
J9 J DRUG DELIV SCI TEC
JI J. Drug Deliv. Sci. Technol.
PD AUG
PY 2015
VL 28
BP 56
EP 63
DI 10.1016/j.jddst.2015.05.007
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CM4AR
UT WOS:000357627100008
DA 2018-10-19
ER

PT J
AU Zhang, S
   Cheng, X
   Yao, Y
   Wei, YH
   Han, CJ
   Shi, YS
   Wei, QS
   Zhang, Z
AF Zhang, Sheng
   Cheng, Xian
   Yao, Yao
   Wei, Yehui
   Han, Changjun
   Shi, Yusheng
   Wei, Qingsong
   Zhang, Zhen
TI Porous niobium coatings fabricated with selective laser melting on
   titanium substrates: Preparation, characterization, and cell behavior
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Niobium; Titanium; Selective laser melting; Coatings; Biocompatibility
ID ORTHOPEDIC APPLICATIONS; MECHANICAL-PROPERTIES; SURFACE; BONE; IMPLANTS;
   METALS; ALLOY; BIOACTIVITY; SCAFFOLDS; ADHESION
AB Nb, an expensive and refractory element with good wear resistance and biocompatibility, is gaining more attention as a new metallic biomaterial. However, the high price of the raw material, as well as the high manufacturing costs because of Nb's strong oxygen affinity and high melting point have limited the widespread use of Nb and its compounds. To overcome these disadvantages, porous Nb coatings of various thicknesses were fabricated on Ti substrate via selective laser melting (SLM), which is a 3D printing technique that uses computer-controlled high-power laser to melt the metal. The morphology and microstructure of the porous Nb coatings, which had pores ranging from 15 to 50 pm in size, were characterized with scanning electron microscopy (SEM). The average hardness of the coating, which was measured with the linear intercept method, was 392 +/- 37 HV. In vitro tests of the porous Nb coating which was monitored with SEM, immunofluorescence, and CCK-8 counts of cells, exhibited excellent cell morphology, attachment, and growth. The simulated body fluid test also proved the bioactivity of the Nb coating. Therefore, these new porous Nb coatings could potentially be used for enhanced early biological fixation to bone tissue. In addition, this study has shown that SLM technique could be used to fabricate coatings with individually tailored shapes and/or porosities from group IVB and VB biomedical metals and their alloys on stainless steel, Co-Cr, and other traditional biomedical materials without wasting raw materials. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhang, Sheng] Beijing Aeronaut Mfg Technol Res Inst, Sci & Technol Power Beam Proc Lab, Beijing 100024, Peoples R China.
   [Zhang, Sheng; Han, Changjun; Shi, Yusheng; Wei, Qingsong; Zhang, Zhen] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
   [Cheng, Xian; Yao, Yao; Wei, Yehui; Zhang, Zhen] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Stomatol, Wuhan 430022, Peoples R China.
RP Wei, QS (reprint author), Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
EM wqs_xn@163.com; zhangzhentitanium@163.com
FU National Key Technology R&D Program of Ministry of Science and
   Technology of China [2012BAF08B03]; National Natural Science Foundation
   of China [81300920, 51375189]
FX This work has been supported by the National Key Technology R&D Program
   of Ministry of Science and Technology of China (Grant No. 2012BAF08B03),
   the National Natural Science Foundation of China (No. 81300920) and the
   National Natural Science Foundation of China (Grant No. 51375189).
CR Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Davenport R. W., 1993, SENSORY ROLE NEURONA
   Eremeev SV, 2008, PHYS SOLID STATE+, V50, P543, DOI 10.1134/S1063783408030256
   Fox P, 2008, SURF COAT TECH, V202, P5001, DOI 10.1016/j.surfcoat.2008.05.003
   Gristina R, 2009, J BIOMED MATER RES B, V88B, P139, DOI 10.1002/jbm.b.31160
   Hoshikawa Y, 2008, KEY ENG MATER, V361-363, P693, DOI 10.4028/www.scientific.net/KEM.361-363.693
   Jang JS, 2000, J MATER SCI, V35, P2297, DOI 10.1023/A:1004791313979
   Jevremovic D, 2012, METALURGIJA, V51, P171
   Johansson CB, 1991, CLIN ORAL IMPLAN RES, V2, P24, DOI 10.1034/j.1600-0501.1991.020103.x
   Kamber BS, 2003, PRECAMBRIAN RES, V126, P289, DOI 10.1016/S0301-9268(03)00100-1
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kruth JP, 2004, J MATER PROCESS TECH, V149, P616, DOI 10.1016/j.jmatprotec.2003.11.051
   Lei SY, 2014, RAPID PROTOTYPING J, V20, P390, DOI 10.1108/RPJ-10-2012-0095
   Lindner M, 2011, J BIOMED MATER RES A, V97A, P466, DOI 10.1002/jbm.a.33058
   Medellin-Castillo H. I., 2009, ASME 2009 INT MECH E, P609
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mumtaz KA, 2007, J MATER SCI, V42, P7647, DOI 10.1007/s10853-007-1661-3
   Pauline SA, 2014, MAT SCI ENG C-MATER, V36, P194, DOI 10.1016/j.msec.2013.12.016
   Podrezov YN, 2009, POWDER METALL MET C+, V48, P201, DOI 10.1007/s11106-009-9111-1
   Qin LG, 2014, J MATER SCI, V49, P2662, DOI 10.1007/s10853-013-7972-7
   Ramirez G, 2011, APPL SURF SCI, V257, P2555, DOI 10.1016/j.apsusc.2010.10.021
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Seifert HJ, 1996, J PHASE EQUILIB, V17, P24, DOI 10.1007/BF02648366
   Sun J., 2012, ADV MECH ENG, V2012
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   van Elsen M, 2008, RAPID PROTOTYPING J, V14, P15, DOI 10.1108/13552540810841526
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   Wang XJ, 2008, ACTA BIOMATER, V4, P1530, DOI 10.1016/j.actbio.2008.04.005
   Yasa E, 2011, PROCEDIA ENGINEER, V19, DOI 10.1016/j.proeng.2011.11.130
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
NR 35
TC 8
Z9 9
U1 3
U2 108
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2015
VL 53
BP 50
EP 59
DI 10.1016/j.msec.2015.04.005
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CN0HB
UT WOS:000358093600009
PM 26042690
DA 2018-10-19
ER

PT J
AU Borkowski, L
   Pawlowska, M
   Radzki, RP
   Bienko, M
   Polkowska, I
   Belcarz, A
   Karpinski, M
   Slowik, T
   Matuszewski, L
   Slosarczyk, A
   Ginalska, G
AF Borkowski, Leszek
   Pawlowska, Marta
   Radzki, Radoslaw P.
   Bienko, Marek
   Polkowska, Izabela
   Belcarz, Anna
   Karpinski, Miroslaw
   Slowik, Tymoteusz
   Matuszewski, Lukasz
   Slosarczyk, Anna
   Ginalska, Grazyna
TI Effect of a carbonated HAP/beta-glucan composite bone substitute on
   healing of drilled bone voids in the proximal tibial metaphysis of
   rabbits
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bone; Composite; Implantation; Rabbit; Osseointegration; Mineralization
ID HYDROXYAPATITE-FIBRIN IMPLANTS; IN-SITU; TISSUE; PHOSPHATE; BIOACTIVITY;
   COLLAGEN; REPAIR; BIOMATERIALS; DEFECTS; CELLS
AB A novel elastic hydroxyapatite-based composite of high surgical handiness has been developed. Its potential application in orthopedics as a filler of bone defects has been studied. The biomaterial was composed of carbonated hydroxyapatite (CHAP) granules and polysaccharide polymer (beta-1,3-glucan). Cylinders of 4 mm in diameter and 6 mm in length were implanted into bone cavities created in the proximal metaphysis of tibiae of 24 New Zealand white rabbits. 18 sham-operated animals were used as controls. After 1, 3 or 6 months, the rabbits were euthanized, the bones were harvested and subjected to analysis. Radiological images and histological sections revealed integration of implants with bone tissue with no signs of graft rejection. Peripheral quantitative computed tomography (pQCT) indicated the stimulating effect of the biomaterial on bone formation and mineralization. Densitometry (DXA) analysis suggested that biomineralization of bones was preceded by bioresorption and gradual disappearance of porous ceramic granules. The findings suggest that the CHAP-glucan composite material enables regeneration of bone tissue and could serve as a bone defect filler. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Borkowski, Leszek; Belcarz, Anna; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, PL-20093 Lublin, Poland.
   [Pawlowska, Marta; Radzki, Radoslaw P.; Bienko, Marek] Univ Life Sci Lublin, Dept Anim Physiol, PL-20033 Lublin, Poland.
   [Polkowska, Izabela] Univ Life Sci Lublin, Dept & Clin Anim Surg, PL-20612 Lublin, Poland.
   [Karpinski, Miroslaw] Univ Life Sci Lublin, Dept Compan & Wildlife Anim, PL-20950 Lublin, Poland.
   [Slowik, Tymoteusz] Lublin Small Anim Med Ctr, Independent Radiol Unit, PL-20151 Lublin, Poland.
   [Matuszewski, Lukasz] Med Univ Lublin, Childrens Orthopaed Clin, PL-20093 Lublin, Poland.
   [Matuszewski, Lukasz] Med Univ Lublin, Rehabil Dept, PL-20093 Lublin, Poland.
   [Slosarczyk, Anna] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
RP Borkowski, L (reprint author), Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1, PL-20093 Lublin, Poland.
EM leszek.borkowski@umlub.pl
RI Bienko, Marek/V-7116-2017
OI Bienko, Marek/0000-0002-9706-6676; Radzki, Radoslaw/0000-0002-5439-2420;
   Belcarz, Anna/0000-0001-9899-5314; Ginalska, Grazyna/0000-0002-9961-4226
FU European Regional Development Fund within the Innovative Economy
   Operational Program [UDA-POIG 01.03.01-00-005/09-01]; Medical University
   in Lublin [DS2/12]; National Science Centre [5824/B/P01/2011/40]
FX The authors would like to acknowledge that the financial assistance for
   this research was provided by the European Regional Development Fund
   within the Innovative Economy Operational Program, grant no. UDA-POIG
   01.03.01-00-005/09-01, the DS2/12 of Medical University in Lublin, and
   by the National Science Centre grant no. 5824/B/P01/2011/40. The
   experiments were conducted using the equipment purchased within the
   agreement no. POWP.01.03.00-06-010/09-00 Operational Program Development
   of Eastern Poland 2007-2013. The authors would especially like to
   express their gratitude to Mgr Tomasz Piersiak for his assistance in
   histological preparations.
CR Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Belcarz A, 2010, European Patent, Patent No. [EP 107266397, 107266397]
   Belcarz A., 2005, ENG BIOMATER, V9, P34
   Belcarz A, 2013, INT J PHARMACEUT, V454, P285, DOI 10.1016/j.ijpharm.2013.06.076
   Belcarz A, 2013, CENT EUR J BIOL, V8, P534, DOI 10.2478/s11535-013-0169-2
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Bonucci E, 1997, EUR J ORAL SCI, V105, P557, DOI 10.1111/j.1600-0722.1997.tb00217.x
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Detsch R, 2010, ACTA BIOMATER, V6, P3223, DOI 10.1016/j.actbio.2010.03.003
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Gonda Y, 2009, BIOMATERIALS, V30, P4390, DOI 10.1016/j.biomaterials.2009.05.002
   Goto T, 2001, J Orthop Sci, V6, P444, DOI 10.1007/s007760170013
   Guo YP, 2012, MICROPOR MESOPOR MAT, V155, P245, DOI 10.1016/j.micromeso.2012.01.037
   Hasegawa S, 2005, J BIOMED MATER RES A, V75A, P567, DOI 10.1002/jbm.a.30460
   Hong ZK, 2007, J BIOMED MATER RES A, V81A, P515, DOI 10.1002/jbm.a.31038
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Iooss P, 2001, BIOMATERIALS, V22, P2785, DOI 10.1016/S0142-9612(01)00022-9
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   Li B, 2012, MAT SCI ENG C-MATER, V32, P929, DOI 10.1016/j.msec.2012.02.014
   Li QL, 2008, J BIOACT COMPAT POL, V23, P520, DOI 10.1177/0883911508097370
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   Liu BS, 2003, J BIOMED MATER RES A, V67A, P1163, DOI 10.1002/jbm.a.20017
   MARINI E, 1994, CELL MATER, V4, P231
   Meskinfam M, 2011, J BIOMED NANOTECHNOL, V7, P455, DOI 10.1166/jbn.2011.1306
   Neumann M, 2006, EUR J TRAUMA, V32, P125, DOI DOI 10.1007/S00068-006-6044-Y
   Paszkiewicz Z., 2011, European Patent, Patent No. [EP 2338531, 2338531]
   Pieters IY, 2010, ACTA BIOMATER, V6, P1561, DOI 10.1016/j.actbio.2009.11.002
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   Sionkowska A, 2010, INT J BIOL MACROMOL, V47, P483, DOI 10.1016/j.ijbiomac.2010.07.002
   SUH H, 1995, ASAIO J, V41, pM652, DOI 10.1097/00002480-199507000-00091
   Trotter JF, 2003, J BONE JOINT SURG AM, V85A, P2215, DOI 10.2106/00004623-200311000-00026
   Ueda H, 2002, BIOMATERIALS, V23, P1003, DOI 10.1016/S0142-9612(01)00211-3
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
   Yaylao lu M.B., 1999, BIOMATERIALS, V20, P711
   Yoshida A, 2006, J BIOMATER APPL, V21, P179, DOI 10.1177/0885328206059796
   Zagury R, 2007, IMPLANT DENT, V16, P290, DOI 10.1097/ID.0b013e3180e9d9ed
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 49
TC 16
Z9 16
U1 2
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2015
VL 53
BP 60
EP 67
DI 10.1016/j.msec.2015.04.009
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CN0HB
UT WOS:000358093600010
PM 26042691
DA 2018-10-19
ER

PT J
AU Wright, B
   Parmar, N
   Bozec, L
   Aguayo, SD
   Day, RM
AF Wright, Bernice
   Parmar, Nina
   Bozec, Laurent
   Aguayo, Sebastian D.
   Day, Richard M.
TI A simple and robust method for pre-wetting poly (lactic-co-glycolic)
   acid microspheres
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Poly (lactic-co-glycolic) acid microspheres; thermally induced phase
   separation; thermally induced phase separation microspheres; serum
   protein adsorption; human skeletal myoblasts and thermally induced phase
   separation microspheres; poly (lactic-co-glycolic) acid microsphere
   surface topography; wetting poly (lactic-co-glycolic) acid microspheres
ID HUMAN-ENDOTHELIAL CELLS; WETTABILITY GRADIENT; PROTEIN ADSORPTION;
   PLASMA TREATMENT; DRUG-DELIVERY; SURFACES; ADHESION; SCAFFOLDS;
   FISTULAS; STRESS
AB Poly (lactic-co-glycolic) acid microspheres are amenable to a number of biomedical procedures that support delivery of cells, drugs, peptides or genes. Hydrophilisation or wetting of poly (lactic-co-glycolic) acid are an important pre-requisites for attachment of cells and can be achieved via exposure to plasma oxygen or nitrogen, surface hydrolysis with NaOH or chloric acid, immersion in ethanol and water, or prolonged incubation in phosphate buffered saline or cell culture medium. The aim of this study is to develop a simple method for wetting poly (lactic-co-glycolic) acid microspheres for cell delivery applications. A one-step ethanol immersion process that involved addition of serum-supplemented medium and ethanol to PLGA microspheres over 30min-24h is described in the present study. This protocol presents a more efficient methodology than conventional two-step wetting procedures. Attachment of human skeletal myoblasts to poly (lactic-co-glycolic) acid microspheres was dependent on extent of wetting, changes in surface topography mediated by ethanol pre-wetting and serum protein adsorption. Ethanol, at 70% (v/v) and 100%, facilitated similar levels of wetting. Wetting with 35% (v/v) ethanol was only achieved after 24h. Pre-wetting (over 3h) with 70% (v/v) ethanol allowed significantly greater (p0.01) serum protein adsorption to microspheres than wetting with 35% (v/v) ethanol. On serum protein-loaded microspheres, greater numbers of myoblasts attached to constructs wetted with 70% ethanol than those partially wetted with 35% (v/v) ethanol. Microspheres treated with 70% (v/v) ethanol presented a more rugose surface than those treated with 35% (v/v) ethanol, indicating that more efficient myoblast adhesion to the former may be at least partially attributed to differences in surface structure. We conclude that our novel protocol for pre-wetting poly (lactic-co-glycolic) acid microspheres that incorporates biochemical and structural features into this biomaterial can facilitate myoblast delivery for use in clinical settings.
C1 [Wright, Bernice; Parmar, Nina; Day, Richard M.] UCL, Div Med, Appl Biomed Engn Grp, London WC1E 6BT, England.
   [Bozec, Laurent; Aguayo, Sebastian D.] UCL, UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1E 6BT, England.
RP Day, RM (reprint author), UCL, Div Med, Appl Biomed Engn Grp, London WC1E 6BT, England.
EM r.m.day@ucl.ac.uk
OI Aguayo, Sebastian/0000-0003-0900-1993
FU UK Medical Research Council [MR/L002752/1]; Sir Halley Stewart Trust;
   Department of Health's NIHR as a Comprehensive Biomedical Research
   Centre; Medical Research Council [MR/L002752/1]
FX This project was supported by grants from the UK Medical Research
   Council (MR/L002752/1) and Sir Halley Stewart Trust. The research was
   undertaken at UCL/UCLH which receives funding from the Department of
   Health's NIHR as a Comprehensive Biomedical Research Centre.
CR Ahmadi R, 2011, ACTA BIOMATER, V7, P1542, DOI 10.1016/j.actbio.2010.12.022
   BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360
   Blaker JJ, 2008, ALIMENT PHARM THER, V28, P614, DOI 10.1111/j.1365-2036.2008.03773.x
   Blaker JJ, 2008, ACTA BIOMATER, V4, P264, DOI 10.1016/j.actbio.2007.09.011
   Chang J, 2012, PHARM RES-DORDR, V29, P1495, DOI 10.1007/s11095-011-0624-1
   Esposito AR, 2013, MATER RES-IBERO-AM J, V16, P695, DOI [10.1590/S1516-14392013000400002, 10.1590/S1516-14392013005000056]
   Foong KS, 2010, TISSUE ENG PART C-ME, V16, P855, DOI [10.1089/ten.tec.2009.0599, 10.1089/ten.TEC.2009.0599]
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Luck M, 1998, J CONTROL RELEASE, V55, P107, DOI 10.1016/S0168-3659(98)00030-3
   Mi FL, 2003, BIOMATERIALS, V24, P5023, DOI 10.1016/S0142-9612(03)00413-7
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Miller Derick C, 2002, IEEE Trans Nanobioscience, V1, P61, DOI 10.1109/TNB.2002.806917
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Safinia L, 2007, MACROMOL BIOSCI, V7, P315, DOI 10.1002/mabi.200600175
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tran VT, 2012, EUR J PHARM SCI, V45, P128, DOI 10.1016/j.ejps.2011.10.030
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vasita R, 2012, INT J NANOMED, V7, P61, DOI 10.2147/IJN.S26453
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wu LB, 2006, J BIOMED MATER RES A, V76A, P264, DOI 10.1002/jbm.a.30544
NR 30
TC 1
Z9 2
U1 2
U2 21
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2015
VL 30
IS 2
BP 147
EP 159
DI 10.1177/0885328215577297
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CM5PH
UT WOS:000357740000002
PM 25791685
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Yang, LL
   Zhang, JM
   He, JS
   Zhang, J
   Gan, ZH
AF Yang, Lili
   Zhang, Jinming
   He, Jiasong
   Zhang, Jun
   Gan, Zhihua
TI Homogeneous synthesis of amino-reserved chitosan-graft-polycaprolactone
   in an ionic liquid and the application in cell cultivation
SO POLYMER INTERNATIONAL
LA English
DT Article
DE chitosan; polycaprolactone; aminosaccharide unit; microsphere; cell
   culture
ID EPSILON-CAPROLACTONE; ORGANIC CATALYST; IN-VITRO; TISSUE; BIOMATERIAL;
   SCAFFOLDS
AB The homogeneous preparation of amino-reserved chitosan-graft-polycaprolactone copolymer (ACS-g-PCL) was achieved in 1-butyl-3-methylimidazolium acetate via a protection - ring-opening graft polymerization - deprotection procedure. The molar substitution of PCL (MSPCL) in ACS-g-PCL copolymers was in the range 17.1 - 45.6 and could be well controlled by altering reaction conditions. The resultant ACS-g-PCL copolymers were soluble in some common organic solvents such as dimethylsulfoxide, ethanol and toluene. As the increment of MSPCL increased, the hydrophilicity of the ACS-g-PCL copolymers decreased. Eventually, ACS-g-PCL microspheres with a diameter of 100-200 mu m were fabricated by an emulsion evaporation method. Among them, the ACS-g-PCL copolymer with an MSPCL of 26.8 formed into porous microspheres. The fluorescence microscopy and cytotoxicity results suggested that all of the microspheres, especially the ACS-g-PCL microspheres with MSPCL of 17.1 and 26.8, showed high cell adhesion and cytocompatibility to the human osteosarcoma cell line (MG-63), indicating their great prospects in tissue engineering. (c) 2015 Society of Chemical Industry
C1 [Yang, Lili; Zhang, Jinming; He, Jiasong; Zhang, Jun] Chinese Acad Sci, Beijing Natl Lab Mol Sci, Inst Chem, Key Lab Engn Plast, Beijing 100190, Peoples R China.
   [Yang, Lili] Univ Chinese Acad Sci, Beijing 100039, Peoples R China.
   [Gan, Zhihua] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Organ Inorgan Composites, Beijing Lab Biomat, Beijing 100029, Peoples R China.
RP Zhang, J (reprint author), Chinese Acad Sci, Beijing Natl Lab Mol Sci, Inst Chem, Key Lab Engn Plast, Beijing 100190, Peoples R China.
EM jzhang@iccas.ac.cn; zhgan@mail.buct.edu.cn
FU National Science Foundation of China [51425307]
FX This work was supported by the National Science Foundation of China (No.
   51425307).
CR Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Changerath R, 2009, J BIOMED MATER RES B, V89B, P65, DOI 10.1002/jbm.b.31188
   Chen MX, 2014, CARBOHYD POLYM, V111, P298, DOI 10.1016/j.carbpol.2014.04.038
   Chen XG, 2006, BIOCHEM ENG J, V27, P269, DOI 10.1016/j.bej.2005.08.021
   Custodio CA, 2014, ADV FUNCT MATER, V24, P1391, DOI 10.1002/adfm.201301516
   Duan KR, 2010, CARBOHYD POLYM, V80, P498, DOI 10.1016/j.carbpol.2009.12.013
   Feng H, 2007, CARBOHYD POLYM, V70, P258, DOI 10.1016/j.carbpol.2007.04.004
   Feng H, 2006, J POLYM SCI POL CHEM, V44, P5353, DOI 10.1002/pola.21625
   Ho STB, 2010, POLYM INT, V59, P808, DOI 10.1002/pi.2792
   Kim S, 2014, J BIOMED MATER RES B, V102, P1393, DOI 10.1002/jbm.b.33118
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Liu L, 2005, BIOPOLYMERS, V78, P163, DOI 10.1002/bip.20261
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Setoguchi T, 2012, POLYMER, V53, P4977, DOI 10.1016/j.polymer.2012.08.060
   She ZD, 2010, POLYM INT, V59, P55, DOI 10.1002/pi.2688
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tsai WB, 2013, J TAIWAN INST CHEM E, V44, P1, DOI 10.1016/j.jtice.2012.09.003
   Wang ZD, 2013, CARBOHYD POLYM, V94, P505, DOI 10.1016/j.carbpol.2013.01.090
NR 21
TC 6
Z9 6
U1 2
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD AUG
PY 2015
VL 64
IS 8
SI SI
BP 1045
EP 1052
DI 10.1002/pi.4912
PG 8
WC Polymer Science
SC Polymer Science
GA CL9YI
UT WOS:000357334600015
DA 2018-10-19
ER

PT J
AU Imhof, T
   Gruenewald, N
   Schwarz, G
   Noack, MJ
   Koch, M
AF Imhof, Thomas
   Gruenewald, Nora
   Schwarz, Guenter
   Noack, Michael J.
   Koch, Manuel
TI Modified amelogenin is a new and versatile nanomaterial for biomedical
   applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE amelogenin; functionalization; fusion protein; RGD tripeptide;
   nanoparticle
ID IN-VITRO
AB Amelogenin self-assembly is crucial for tooth biomineralization and crystallite enamel orientation. Amelogenin forms stable nanoparticles under physiological conditions. Here, we tested whether the surface properties and binding characteristics of these particles could be modified to enhance amelogenin function as a biomaterial. We evaluated different amelogenin fusion proteins for their ability to form hybrid nanoparticles. As a proof-of-concept, the integrin-binding tripeptide Arg-Gly-Asp (RGD) sequence from fibronectin was integrated into mouse amelogenin (rM179) at three different positions. Dynamic light scattering (DLS) measurements revealed that these amelogenin fusion proteins still form nanospheres. Additional DLS and isothermal titration calorimetry measurements showed that the mixtures of RGD-modified amelogenin and wild-type amelogenin form stable particles. We determined that insertion of the RGD-loop at the amelogenin C-terminus converts the nanoparticle into a cell-binding substrate. Calvarial osteoblasts efficiently attached and spread on modified amelogenin, whereas almost no binding was observed on wild-type amelogenin. These results establish amelogenin as a new versatile biomaterial that can be easily modified to add additional functions. Biotechnol. Bioeng. 2015;112: 1708-1713. (c) 2015 Wiley Periodicals, Inc.
C1 [Imhof, Thomas; Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany.
   [Gruenewald, Nora; Schwarz, Guenter] Univ Cologne, Ctr Mol Med, Inst Biochem, Dept Chem, D-50674 Cologne, Germany.
   [Noack, Michael J.] Univ Cologne, Sch Dent, Dept Operat Dent, D-50931 Cologne, Germany.
   [Koch, Manuel] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, P-1749016 Lisbon, Portugal.
RP Koch, M (reprint author), Univ Cologne, Fac Med, Ctr Biochem, Inst Dent Res & Oral Musculoskeletal Biol, Kerpener Str 32, D-50931 Cologne, Germany.
EM Manuel.Koch@uni-koeln.de
CR AICHMAYER B, 2009, BIOMACROMOLECULES, V11, P369
   Almqvist S, 2010, J MATER SCI-MATER M, V21, P947, DOI 10.1007/s10856-009-3952-5
   AOBA T, 1987, CALCIFIED TISSUE INT, V41, P86, DOI 10.1007/BF02555250
   Bonde JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033269
   Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751
   Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108
   Fincham AG, 1995, CONNECT TISSUE RES, V32, P119, DOI 10.3109/03008209509013713
   Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]
   Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713
   MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006
   SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956
   Smith C E, 1996, Adv Dent Res, V10, P159
   Tarasevich BJ, 2009, BIOPOLYMERS, V91, P103, DOI 10.1002/bip.21095
   Veit G, 2011, J BIOL CHEM, V286, P27804, DOI 10.1074/jbc.M111.220046
   Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007
NR 15
TC 2
Z9 2
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG
PY 2015
VL 112
IS 8
BP 1708
EP 1713
DI 10.1002/bit.25576
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CL5AO
UT WOS:000356971500020
PM 25728989
DA 2018-10-19
ER

PT J
AU Borde, B
   Grunert, P
   Hartl, R
   Bonassar, LJ
AF Borde, Brandon
   Grunert, Peter
   Haertl, Roger
   Bonassar, Lawrence J.
TI Injectable, high-density collagen gels for annulus fibrosus repair: An
   in vitro rat tail model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; crosslinking; intervertebral disc; riboflavin; tissue
   engineering
ID INTERVERTEBRAL DISC DEGENERATION; NEEDLE PUNCTURE INJURY; NUCLEUS
   REPLACEMENT; CROSS-LINKING; ANULUS FIBROSUS; ANIMAL-MODELS; LUMBAR DISC;
   SCAFFOLDS; CONSEQUENCES; CHALLENGES
AB A herniated intervertebral disc often causes back pain when disc tissue is displaced through a damaged annulus fibrosus. Currently, the only methods available for annulus fibrosus repair involve mechanical closure of defect, which does little to address biological healing in the damaged tissue. Collagen hydrogels are injectable and have been used to repair annulus defects in vivo. In this study, high-density collagen hydrogels at 5, 10, and 15mg/mL were used to repair defects made to intact rat caudal intervertebral discs in vitro. A group of gels at 15mg/mL were also cross-linked with riboflavin at 0.03mM, 0.07mM, or 0.10mM. These cross-linked, high-density collagen gels maintained their presence in the defect under loading and contributed positively to the mechanical response of damaged discs. Discs exhibited increases to 95% of undamaged effective equilibrium and instantaneous moduli as well as up to fourfold decreases in effective hydraulic permeability from the damaged discs. These data suggest that high-density collagen gels may be effective at restoring mechanical function of injured discs as well as potential vehicles for the delivery of biological agents such as cells or growth factors that may aid in the repair of the annulus fibrosus. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2571-2581, 2015.
C1 [Borde, Brandon; Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.
   [Grunert, Peter; Haertl, Roger] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA.
   [Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
RP Bonassar, LJ (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.
EM lb244@cornell.edu
RI Bonassar, Lawrence/C-2103-2016
OI Bonassar, Lawrence/0000-0003-1094-6433
FU AO Foundation; AO Spine International; NFL Medical Charities; Howard
   Hughes Medical Institute [NIH F31AR064695-02]
FX Contract grant sponsors: The AO Foundation, AO Spine International, NFL
   Medical Charities, and the Howard Hughes Medical Institute; contract
   grant number: NIH F31AR064695-02
CR Ahearne M, 2008, BRIT J OPHTHALMOL, V92, P268, DOI 10.1136/bjo.2007.130104
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0
   Bowles RD, 2011, NATL ACAD SCI US, V108
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Bron JL, 2012, J MATER SCI-MATER M, V23, P813, DOI 10.1007/s10856-011-4545-7
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chiang CJ, 2010, SPINE, V36, P1
   Connor DE, 2012, J CLIN NEUROSCI, V19, P1706, DOI 10.1016/j.jocn.2012.03.026
   Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072
   Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005
   Dai LY, 2005, SURG NEUROL, V64, P226, DOI 10.1016/j.surneu.2004.11.003
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2
   Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Fawzy A, 2012, J DENT RES, V91, P1049, DOI 10.1177/0022034512459053
   Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010
   Gorensek M, 2006, SPINE J, V6, p143S
   Grunert P, 2014, SPINE, V39, P198, DOI 10.1097/BRS.0000000000000103
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Hussain M, 2011, MED ENG PHYS, V33, P438, DOI 10.1016/j.medengphy.2010.11.011
   Iatridis JC, 1998, J BIOMECH, V31, P535, DOI 10.1016/S0021-9290(98)00046-3
   Ibusuki S, 2007, TISSUE ENG, V13, P1995, DOI 10.1089/ten.2006.0153
   Keorochana G, 2010, SPINE J, V10, P1014, DOI 10.1016/j.spinee.2010.08.013
   Kim Y, 1995, J BIOMECH, P28
   Korecki CL, 2008, SPINE, V33, P235, DOI 10.1097/BRS.0b013e3181624504
   LATHAM JM, 1994, CLIN BIOMECH, V9, P211, DOI 10.1016/0268-0033(94)90001-9
   Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9
   Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20
   Michalek AJ, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004915
   Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z
   Michalek AJ, 2009, J BIOMECH, V42, P2279, DOI 10.1016/j.jbiomech.2009.06.047
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Rohlmann A, 2001, ERGONOMICS, V44, P781, DOI 10.1080/00140130110047657
   Roy R, 2010, J BIOMED MATER RES A, V93A, P843, DOI 10.1002/jbm.a.32231
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schroeder Y, 2008, J ORTHOP RES, V26, P1141, DOI 10.1002/jor.20632
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Singh K, 2010, CONT SPINE SURG, V11, P1
   Thompson RE, 2004, CLIN BIOMECH, V19, P448, DOI 10.1016/j.clinbiomech.2004.01.012
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Zhuang Y, 2011, BIOCHEM BIOPH RES CO, V407, P327, DOI 10.1016/j.bbrc.2011.03.015
NR 53
TC 13
Z9 14
U1 4
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2571
EP 2581
DI 10.1002/jbm.a.35388
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500007
PM 25504661
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Taylor, J
   Anyango, JO
   Potgieter, M
   Kallmeyer, K
   Naidoo, V
   Pepper, MS
   Taylor, JRN
AF Taylor, Janet
   Anyango, Joseph O.
   Potgieter, Marnie
   Kallmeyer, Karlien
   Naidoo, Vinny
   Pepper, Michael S.
   Taylor, John R. N.
TI Biocompatibility and biodegradation of protein microparticle and film
   scaffolds made from kafirin (sorghum prolamin protein) subcutaneously
   implanted in rodent models
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE microparticle; kafirin; histology; film; biocompatibility
ID BONE MORPHOGENETIC PROTEIN-2; POROUS ZEIN SCAFFOLDS;
   MECHANICAL-PROPERTIES; IN-VITRO; DIGESTIBILITY; ENCAPSULATION;
   BIOMATERIAL; RELEASE; TISSUE; FOOD
AB Kafirin, the sorghum prolamin protein, like its maize homologue zein, can be made into microparticles and films and potentially used as a biomaterial. Zein has good bio- and cyto-compatibility. Kafirin could be advantageous as it is more hydrophobic, more crosslinked, more slowly digested by mammalian proteases than zein and is non-allergenic. The safety and biocompatibility of kafirin implants in two forms was determined in rodent models. One week post subcutaneous injection of kafirin microparticles (size 5-mu m diameter) in mice, chronic inflammation, abnormal red blood cells, and gross fibrin formation were observed. This chronic inflammatory response was possibly caused by the release of hydrolysis products such as glutamate during the degradation of the kafirin microparticles. In contrast, films made from kafirin microparticles (50-mu m thick, folded into 1 cm(3)) implanted in rats showed no abnormal inflammatory reactions and were only partially degraded by day 28. The slower degradation of the kafirin films was probably due to their far smaller surface area when compared to kafirin microparticles. Thus, kafirin films appear to have potential as a biomaterial. This study also raises awareness that the form of prolamin based biomaterials, (kafirin and zein) should be considered when assessing the safety of such materials. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2582-2590, 2015.
C1 [Taylor, Janet; Anyango, Joseph O.; Taylor, John R. N.] Univ Pretoria, Inst Food Nutr & Well Being, ZA-0028 Hatfield, South Africa.
   [Taylor, Janet; Anyango, Joseph O.; Taylor, John R. N.] Univ Pretoria, Dept Food Sci, ZA-0028 Hatfield, South Africa.
   [Anyango, Joseph O.] Egerton Univ, Dept Dairy & Food Sci & Technol, Nakuru, Kenya.
   [Potgieter, Marnie; Kallmeyer, Karlien; Pepper, Michael S.] Univ Pretoria, Fac Hlth Sci, Dept Immunol, ZA-0002 Pretoria, South Africa.
   [Potgieter, Marnie; Kallmeyer, Karlien; Pepper, Michael S.] Univ Pretoria, Fac Hlth Sci, Inst Cellular & Mol Med, ZA-0002 Pretoria, South Africa.
   [Naidoo, Vinny] Univ Pretoria, Fac Vet Sci, Biomed Res Ctr, ZA-0002 Pretoria, South Africa.
RP Taylor, JRN (reprint author), Univ Pretoria, Inst Food Nutr & Well Being, Private Bag X20, ZA-0028 Hatfield, South Africa.
EM Janet.taylor@up.ac.za
RI Naidoo, Vinny/A-1508-2008
OI Naidoo, Vinny/0000-0003-2740-5983; Taylor, Janet/0000-0001-7148-5437;
   Potgieter, Marnie/0000-0002-2184-2755; Taylor, John/0000-0002-9714-2093
CR Adebowale AA, 2011, J CEREAL SCI, V54, P360
   Anyango JO, 2012, J AGR FOOD CHEM, V60, P8419, DOI 10.1021/jf302533e
   Anyango JO, 2011, J AGR FOOD CHEM, V59, P12674, DOI 10.1021/jf203273y
   Belton PS, 2006, J CEREAL SCI, V44, P272, DOI 10.1016/j.jcs.2006.05.004
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Boonkong W, 2013, J MATER SCI-MATER M, V24, P1581, DOI 10.1007/s10856-013-4864-y
   Brahatheeswaren D, 2012, BIOMED MATER, V7, P04500
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Ciacci C, 2007, CLIN NUTR, V26, P799, DOI 10.1016/j.clnu.2007.05.006
   DEROSE RT, 1989, PLANT MOL BIOL, V12, P245, DOI 10.1007/BF00043202
   DesSousa FO, 2012, J BIOMATER APPL, V27, P187
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Duodu KG, 2003, J CEREAL SCI, V38, P117, DOI 10.1016/S0733-5210(03)00016-X
   Emmambux NM, 2003, J SCI FOOD AGR, V83, P402, DOI 10.1002/jsfa.1379
   Gleneich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Lin T, 2011, AAPS PHARMSCITECH, V12, P172, DOI 10.1208/s12249-010-9565-y
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Nag S., 2012, ASM HDB, V23, P6
   Oberholzer HM, 2009, INT J MORPHOL, V27, P955, DOI 10.4067/S0717-95022009000300049
   Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Pontieri P, 2013, J AGR FOOD CHEM, V61, P2565, DOI 10.1021/jf304882k
   Reddy N, 2011, TRENDS BIOTECHNOL, V29, P490, DOI 10.1016/j.tibtech.2011.05.003
   ROTHENBUHLER E, 1985, J AGR FOOD CHEM, V33, P433, DOI 10.1021/jf00063a027
   Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517
   Taylor J., 2009, J CEREAL SCI, V50, P90
   Taylor J, 2009, J AGR FOOD CHEM, V57, P7523, DOI 10.1021/jf901592q
   TOBARI C, 1988, CANCER RES, V48, P1543
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Weiler A, 1996, J BONE JOINT SURG BR, V78B, P369
   Withold W, 1996, CLIN CHEM, V42, P210
   Xiao D, 2011, J AGR FOOD CHEM, V59, P7393, DOI 10.1021/jf200774v
   Xue AS, 2014, CRANIOMAX TRAUM REC, V7, P27, DOI 10.1055/s-0033-1364199
   Zhang BC, 2011, FOOD CHEM, V124, P210, DOI 10.1016/j.foodchem.2010.06.019
NR 38
TC 4
Z9 4
U1 0
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2582
EP 2590
DI 10.1002/jbm.a.35394
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500008
PM 25524818
DA 2018-10-19
ER

PT J
AU Mohtaram, NK
   Ko, J
   King, C
   Sun, L
   Muller, N
   Jun, MBG
   Willerth, SM
AF Mohtaram, Nima Khadem
   Ko, Junghyuk
   King, Craig
   Sun, Lin
   Muller, Nathan
   Jun, Martin Byung-Guk
   Willerth, Stephanie M.
TI Electrospun biomaterial scaffolds with varied topographies for neuronal
   differentiation of human-induced pluripotent stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE human-induced pluripotent stem cells; melt electrospinning; solution
   electrospinning; scaffold topography; neural tissue engineering
ID SPINAL-CORD-INJURY; POLYMER MELTS; MODEL; TRANSPLANTATION; REGENERATION;
   RECOVERY
AB In this study, we investigated the effect of micro and nanoscale scaffold topography on promoting neuronal differentiation of human induced pluripotent stem cells (iPSCs) and directing the resulting neuronal outgrowth in an organized manner. We used melt electrospinning to fabricate poly (epsilon-caprolactone) (PCL) scaffolds with loop mesh and biaxial aligned microscale topographies. Biaxial aligned microscale scaffolds were further functionalized with retinoic acid releasing PCL nanofibers using solution electrospinning. These scaffolds were then seeded with neural progenitors derived from human iPSCs. We found that smaller diameter loop mesh scaffolds (43.7 +/- 3.9 mu m) induced higher expression of the neural markers Nestin and Pax6 compared to thicker diameter loop mesh scaffolds (85 +/- 4 mu m). The loop mesh and biaxial aligned scaffolds guided the neurite outgrowth of human iPSCs along the topographical features with the maximum neurite length of these cells being longer on the biaxial aligned scaffolds. Finally, our novel bimodal scaffolds also supported the neuronal differentiation of human iPSCs as they presented both physical and chemical cues to these cells, encouraging their differentiation. These results give insight into how physical and chemical cues can be used to engineer neural tissue. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2591-2601, 2015.
C1 [Mohtaram, Nima Khadem; Ko, Junghyuk; Muller, Nathan; Jun, Martin Byung-Guk; Willerth, Stephanie M.] Univ Victoria, Dept Mech Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [King, Craig] Univ Victoria, Dept Biomed Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [Sun, Lin; Willerth, Stephanie M.] Univ Victoria, Div Med Sci, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [Willerth, Stephanie M.] ICORD, Vancouver, BC V5Z 1M9, Canada.
RP Willerth, SM (reprint author), Univ Victoria, Dept Mech Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
EM willerth@uvic.ca
OI Muller, Nathan/0000-0002-5893-7870; Willerth,
   Stephanie/0000-0002-1665-7723
FU Natural Sciences and Engineering Research Council
FX Contract grant sponsor: Natural Sciences and Engineering Research
   Council's Discovery
CR Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Cordie T, 2014, CELL MOL BIOENG, V7, P379, DOI 10.1007/s12195-014-0341-z
   Dalton PD, 2007, POLYMER, V48, P6823, DOI 10.1016/j.polymer.2007.09.037
   Dalton PD, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034109
   Dalton PD, 2006, BIOMACROMOLECULES, V7, P686, DOI 10.1021/bm050777q
   Detta N, 2010, POLYM INT, V59, P1558, DOI 10.1002/pi.2954
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Jiang X, 2012, ACTA BIOMATER, V8, P1290, DOI 10.1016/j.actbio.2011.11.019
   Ko J, 2014, J BIOMAT SCI-POLYM E, V25, P1, DOI 10.1080/09205063.2013.830913
   Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mohtaram N, 2014, J BIOMATER IN PRESS
   Mohtaram NK, 2013, BIOMED MAT, V8
   Nagy ZK, 2013, J PHARM SCI-US, V102, P508, DOI 10.1002/jps.23374
   Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Nutt SE, 2013, EXP NEUROL, V248, P491, DOI 10.1016/j.expneurol.2013.07.010
   Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104
   Pan F, 2013, BIOMATERIALS, V34, P8131, DOI 10.1016/j.biomaterials.2013.07.025
   Qin J, 2013, NEUROSCI LETT, V548, P95, DOI 10.1016/j.neulet.2013.05.007
   Saadai P, 2013, J PEDIATR SURG, V48, P158, DOI 10.1016/j.jpedsurg.2012.10.034
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sun YB, 2013, INTEGR BIOL-UK, V5, P450, DOI 10.1039/c2ib20256e
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Turksen K, 2012, METHOD MOL BIOL, V873
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012
NR 41
TC 22
Z9 23
U1 1
U2 50
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2591
EP 2601
DI 10.1002/jbm.a.35392
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500009
PM 25524598
DA 2018-10-19
ER

PT J
AU Meyer, RA
   Meyer, RS
   Green, JJ
AF Meyer, Randall A.
   Meyer, Randall S.
   Green, Jordan J.
TI An automated multidimensional thin film stretching device for the
   generation of anisotropic polymeric micro- and nanoparticles
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE anisotropic; particle shape; biomimetic; automation; microparticles;
   nanoparticles
ID ANTIGEN-PRESENTING CELLS; NONVIRAL GENE DELIVERY; DRUG-DELIVERY; SHAPE;
   PARTICLES; MICROPARTICLES; MONODISPERSE; TUMOR
AB Anisotropic polymeric particles are of growing interest for biomaterials applications due to their unique properties. These include the ability for these particles to evade nonspecific cellular uptake and to have enhanced targeted cellular uptake and interaction. One of the most widely used methods for generating anisotropic polymeric particles is the thin film stretching procedure. Despite its theoretical simplicity, this procedure, as it has been implemented to date, can be difficult due to the inconsistent nature of the manual operation of machinery used to stretch the film. We have constructed an automated thin film stretcher for control over biomaterials via thin film stretching in 1D and 2D and as a result, have enabled precise generation of anisotropic polymeric particles. We demonstrate that this device can be utilized to produce anisotropic biodegradable particles of different size, shape, and material consistency. Furthermore, we show that this machine has enabled the scaled up and rapid production of anisotropic polymeric particles, including polymeric microparticles that mimic the shape of red blood cells. Further application of this automated thin film stretching device could allow for significant impact to diverse biomaterial and biomedical applications such as biomimetic particles for immunoengineering and long-circulating particles for controlled release of drugs. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2747-2757, 2015.
C1 [Meyer, Randall A.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Meyer, Randall A.; Meyer, Randall S.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Meyer, Randall A.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Inst Nanobiotechnol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Mat Sci & Engn, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU NIH [R01-EB016721]; NIH Cancer Nanotechnology Training Center
   [R25CA153952]; JHU Institute for Nanobiotechnology; Johns Hopkins
   University
FX Contract grant sponsor: NIH; contract grant number: R01-EB016721;
   Contract grant sponsor: NIH Cancer Nanotechnology Training Center;
   contract grant number: R25CA153952; Contract grant sponsors: JHU
   Institute for Nanobiotechnology; Johns Hopkins University
CR Adriani G, 2012, BIOMATERIALS, V33, P5504, DOI 10.1016/j.biomaterials.2012.04.027
   Aryal S, 2013, NANOMEDICINE-UK, V8, P1271, DOI [10.2217/NNM.12.153, 10.2217/nnm.12.153]
   Barreto-Ortiz SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081061
   Barua S, 2013, P NATL ACAD SCI USA, V110, P3270, DOI 10.1073/pnas.1216893110
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104
   Chen K, 2012, BIOMACROMOLECULES, V13, P2748, DOI 10.1021/bm3007242
   Chou LYT, 2014, NAT NANOTECHNOL, V9, P148, DOI [10.1038/nnano.2013.309, 10.1038/NNANO.2013.309]
   Chu KS, 2014, NANO LETT, V14, P1472, DOI 10.1021/nl4046558
   Chu KS, 2013, NANOMED-NANOTECHNOL, V9, P686, DOI 10.1016/j.nano.2012.11.008
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Fields RJ, 2012, J CONTROL RELEASE, V164, P41, DOI 10.1016/j.jconrel.2012.09.020
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Florez L, 2012, SMALL, V8, P2222, DOI 10.1002/smll.201102002
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Guo BL, 2014, SCI CHINA CHEM, V57, P490, DOI 10.1007/s11426-014-5086-y
   Hasan W, 2012, NANO LETT, V12, P287, DOI 10.1021/nl2035354
   HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Jang SG, 2013, J AM CHEM SOC, V135, P6649, DOI 10.1021/ja4019447
   Jiang X, 2013, ADV MATER, V25, P227, DOI 10.1002/adma.201202932
   Jiang X, 2011, PHARM RES-DORDR, V28, P1317, DOI 10.1007/s11095-011-0436-3
   Karagoz B, 2014, POLYM CHEM-UK, V5, P350, DOI 10.1039/c3py01306e
   Kim HN, 2013, ADV DRUG DELIVER REV, V65, P536, DOI 10.1016/j.addr.2012.07.014
   Kolhar P, 2013, P NATL ACAD SCI USA, V110, P10753, DOI 10.1073/pnas.1308345110
   Kozielski KL, 2013, CHEM COMMUN, V49, P5319, DOI 10.1039/c3cc40718g
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Luo GS, 2011, PARTICUOLOGY, V9, P545, DOI 10.1016/j.partic.2011.06.004
   Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108
   Morton SW, 2013, ADV MATER, V25, P4707, DOI 10.1002/adma.201302025
   Petzetakis N, 2011, CHEM SCI, V2, P955, DOI 10.1039/c0sc00596g
   Ping P, 2005, BIOMACROMOLECULES, V6, P587, DOI 10.1021/bm049477j
   Rao JP, 2011, PROG POLYM SCI, V36, P887, DOI 10.1016/j.progpolymsci.2011.01.001
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Sharma G, 2010, J CONTROL RELEASE, V147, P408, DOI 10.1016/j.jconrel.2010.07.116
   Shum HC, 2010, MACROMOL RAPID COMM, V31, P108, DOI 10.1002/marc.200900590
   Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Tao L, 2011, EXP BIOL MED, V236, P20, DOI 10.1258/ebm.2010.010243
   Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Wang YP, 2011, LANGMUIR, V27, P524, DOI 10.1021/la1045095
   Xu J, 2013, MOL PHARMACEUT, V10, P3366, DOI 10.1021/mp400190z
   Yang SK, 2012, LAB CHIP, V12, P2097, DOI 10.1039/c2lc90046g
   Yoo JW, 2010, P NATL ACAD SCI USA, V107, P11205, DOI 10.1073/pnas.1000346107
   Zhou ZM, 2013, ADV MATER, V25, P2723, DOI 10.1002/adma.201300220
NR 50
TC 10
Z9 10
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2747
EP 2757
DI 10.1002/jbm.a.35399
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500025
PM 25641799
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gudmundsdottir, S
   Lieder, R
   Sigurjonsson, OE
   Petersen, PH
AF Gudmundsdottir, Steinunn
   Lieder, Ramona
   Sigurjonsson, Olafur E.
   Petersen, Petur H.
TI Chitosan leads to downregulation of YKL-40 and inflammasome activation
   in human macrophages
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitin; chitosan; inflammation; chitinase; YKL-40
ID HUMAN CARTILAGE GLYCOPROTEIN-39; BINDING PROPERTIES;
   CHITOOLIGOSACCHARIDES; CHITINASE; CELLS; ANGIOGENESIS; ENDOTOXINS;
   THP-1; DIFFERENTIATION; CHITOTRIOSIDASE
AB Chitosan, the deacetylated derivative of chitin, is used as biomaterial in diverse settings. It is also found on pathogens and can be proinflammatory. Shorter derivatives of chitosan can be generated chemically or enzymatically, chitosan oligosaccharides (ChOS). There is variation in the chemical composition of ChOS, including size distribution, but in general, they have been described as inert or anti-inflammatory. Active human chitinases can cleave chitin and chitosan, while inactive chitinases bind both but do not cleave. Both active and inactive chitinases have important roles in the immune response. The inactive chitinase YKL-40 is expressed highly during inflammation and has been proposed as a marker of poor prognosis. YKL-40 acts as a negative regulator of the inflammasome and as a positive regulator of angiogenesis. Levels of YKL-40 can therefore regulate levels of inflammation, the extent of angiogenesis, and the process of inflammation resolution. This study shows that chitosan leads to reduced secretion of YKL-40 by primary human macrophages and that this is concomitant with inflammasome activation. This was most pronounced with a highly deacetylated ChOS. No effect on the secretion of the active chitinase Chit-1 was detected. Smaller and more acetylated ChOS did not affect YKL-40 levels nor inflammasome activation. We conclude that this effect on the levels of YKL-40 is a part of the proinflammatory mechanisms of chitosan and its derivatives. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2778-2785, 2015.
C1 [Gudmundsdottir, Steinunn; Petersen, Petur H.] Univ Iceland, Dept Anat, Biomed Ctr, Fac Med,Sch Hlth Sci, IS-101 Reykjavik, Iceland.
   [Lieder, Ramona; Sigurjonsson, Olafur E.] Landspitali Univ Hosp, Blood Bank, IS-105 Reykjavik, Iceland.
   [Lieder, Ramona; Sigurjonsson, Olafur E.] Reykjavik Univ, Sch Sci & Engn, IS-101 Reykjavik, Iceland.
   [Sigurjonsson, Olafur E.; Petersen, Petur H.] Univ Iceland, Biomed Ctr, IS-101 Reykjavik, Iceland.
RP Petersen, PH (reprint author), Univ Iceland, Dept Anat, Biomed Ctr, Fac Med,Sch Hlth Sci, IS-101 Reykjavik, Iceland.
EM phenry@hi.is
OI Sigurjonsson, Olafur/0000-0002-4968-842X
FU Landspitali University Hospital Research Fund; Icelandic Student
   Innovation Fund [1323410091]
FX Contract grant sponsor: Landspitali University Hospital Research Fund;
   Contract grant sponsor: Icelandic Student Innovation Fund; contract
   grant number: 1323410091
CR Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482
   Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06
   Barone R, 2003, J TROP PEDIATRICS, V49, P63, DOI 10.1093/tropej/49.1.63
   Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x
   Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936
   Cederkvist FH, 2008, CARBOHYD POLYM, V74, P41, DOI 10.1016/j.carbpol.2008.01.020
   Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017
   Di Rosa M, 2013, INFLAMMATION, V36, P482, DOI 10.1007/s10753-012-9569-8
   Einarsson JM, 2013, BIOCHEM BIOPH RES CO, V434, P298, DOI 10.1016/j.bbrc.2013.02.122
   Fernandes JC, 2010, MAR DRUGS, V8, P1763, DOI 10.3390/md8061763
   Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200
   Goldman DL, 2012, CLIN EXP ALLERGY, V42, P523, DOI 10.1111/j.1365-2222.2011.03886.x
   Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   JOHANSEN JS, 1995, EUR J CANCER, V31A, P1437, DOI 10.1016/0959-8049(95)00196-P
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Labadaridis I, 2005, ARCH DIS CHILD-FETAL, V90, pF531, DOI 10.1136/adc.2004.051284
   Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250
   Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271
   Lieder R, 2012, J TISSUE ENG REGEN M, V6, P356
   Lieder R, 2013, TISSUE ENG PART B-RE, V19, P391, DOI [10.1089/ten.teb.2012.0636, 10.1089/ten.TEB.2012.0636]
   Lieder R, 2013, ACTA BIOMATER, V9, P4771, DOI 10.1016/j.actbio.2012.08.043
   Maess MB, 2014, J IMMUNOL METHODS, V402, P76, DOI 10.1016/j.jim.2013.11.006
   Mathieu C, 2013, OSTEOARTHR CARTILAGE, V21, P849, DOI 10.1016/j.joca.2013.03.012
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Porporatto C, 2004, INT IMMUNOL, V16, P433, DOI 10.1093/intimm/dxh051
   Prakash M, 2013, CELL SIGNAL, V25, P1567, DOI 10.1016/j.cellsig.2013.03.016
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075
   Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377
   Schultz Nicolai A, 2010, Cancers (Basel), V2, P1453, DOI 10.3390/cancers2031453
   Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328
   Weecharangsan W, 2008, INT J PHARMACEUT, V348, P161, DOI 10.1016/j.ijpharm.2007.07.011
   Wu HG, 2012, CARBOHYD POLYM, V89, P511, DOI 10.1016/j.carbpol.2012.03.037
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
NR 43
TC 8
Z9 9
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2778
EP 2785
DI 10.1002/jbm.a.35417
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500028
PM 25684555
DA 2018-10-19
ER

PT J
AU Hameed, N
   Glattauer, V
   Ramshaw, JAM
AF Hameed, Nishar
   Glattauer, Veronica
   Ramshaw, John A. M.
TI Evaluation of polyvinyl alcohol composite membranes containing collagen
   and bone particles
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Polyvinyl alcohol; Bone; Demineralised bone; Thermal properties;
   Mechanical properties; Cell culture
ID POLY(VINYL ALCOHOL); ALCOHOL/COLLAGEN HYDROGEL; MORPHOGENETIC PROTEINS;
   GROWTH-FACTORS; IN-VIVO; MATRIX; BIOMATERIALS; BLENDS; FILMS;
   OSTEOINDUCTIVITY
AB Composite biomaterials provide alternative materials that improve on the properties of the individual components and can be used to replace or restore damaged or diseased tissues. Typically, a composite biomaterial consists of a matrix, often a polymer, with one or more fillers that can be made up of particles, sheets or fibres. The polymer matrix can be chosen from a wide range of compositions and can be fabricated easily and rapidly into complex shapes and structures. In the present study we have examined three size fractions of collagen-containing particles embedded at up to 60% w/w in a poly(vinyl alcohol) (PVA) matrix. The particles used were bone particles, which are a mineral-collagen composite and demineralised bone, which gives naturally cross-linked collagen particles. SEM showed well dispersed particles in the PVA matrix for all concentrations and sizes of particles, with FTIR suggesting collagen to PVA hydrogen bonding. T-g of membranes shifted to a slightly lower temperature with increasing collagen content, along with a minor amount of melting point depression. The modulus and tensile strength of membranes were improved with the addition of both particles up to 10 wt%, and were clearly strengthened by the addition, although this effect decreased with higher collagen loadings. Elongation at break decreased with collagen content. Cell adhesion to the membranes was observed associated with the collagen particles, indicating a lack of cytotoxicity. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Hameed, Nishar] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3216, Australia.
   [Glattauer, Veronica; Ramshaw, John A. M.] CSIRO Mfg Flagship, Clayton, Vic 3169, Australia.
RP Hameed, N (reprint author), Deakin Univ, Inst Frontier Mat, Pigdons Rd, Geelong, Vic 3216, Australia.
EM nishar.hameed@deakin.edu.au; veronica.glattauer@csiro.au;
   john.ramshaw@csiro.au
RI Glattauer, veronica/A-9435-2018
FU Alfred Deakin Research Fellowship
FX This work was funded in part by an Alfred Deakin Research Fellowship to
   NH.
CR Alexy P, 2003, POLYM TEST, V22, P801, DOI 10.1016/S0142-9418(03)00016-3
   Bae HW, 2006, SPINE, V31, P1299, DOI 10.1097/01.brs.0000218581.92992.b7
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Blum B, 2004, ORTHOPEDICS, V27, pS161
   Figueiredo A, 2013, MAT SCI ENG C-MATER, V33, P3506, DOI 10.1016/j.msec.2013.04.047
   FISCHER EG, 1990, J IMMUNOL METHODS, V128, P235, DOI 10.1016/0022-1759(90)90215-H
   Glattauer V, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P261
   Glattauer V, 2010, J BIOMED MATER RES A, V92A, P1301, DOI 10.1002/jbm.a.32468
   Gupta A, 2009, J APPL POLYM SCI, V111, P1400, DOI 10.1002/app.28990
   Ivanovic A, 2014, CLIN ORAL INVEST, V18, P1319, DOI 10.1007/s00784-013-1089-x
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Jiang YJ, 2010, J BIOMED MATER RES B, V93B, P275, DOI 10.1002/jbm.b.31585
   Kobayashi M, 2001, J BIOMED MATER RES, V58, P344
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Peng ZY, 2012, J MACROMOL SCI B, V51, P1934, DOI 10.1080/00222348.2012.660060
   Peng ZY, 2011, POLYM-PLAST TECHNOL, V50, P245, DOI 10.1080/03602559.2010.531438
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P645, DOI 10.1111/j.1600-0501.2012.02439.x
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Sailaja GS, 2009, ACTA BIOMATER, V5, P1647, DOI 10.1016/j.actbio.2008.12.005
   SARTI B, 1995, BIOMATERIALS, V16, P785, DOI 10.1016/0142-9612(95)99641-X
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Sharaf F, 1999, POLYM DEGRAD STABIL, V66, P173, DOI 10.1016/S0141-3910(98)00101-3
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sionkowska A, 2009, J MOL LIQ, V144, P71, DOI 10.1016/j.molliq.2008.09.007
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Weis C, 2004, J BIOMED MATER RES B, V70B, P191, DOI 10.1002/jbm.b.30007
   Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
   Yi F, 2006, J BIOMAT SCI-POLYM E, V17, P1015, DOI 10.1163/156856206778365997
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
NR 35
TC 6
Z9 6
U1 0
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2015
VL 48
BP 38
EP 45
DI 10.1016/j.jmbbm.2015.04.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK4QO
UT WOS:000356208500004
PM 25913606
DA 2018-10-19
ER

PT J
AU Arahira, T
   Maruta, M
   Matsuya, S
   Todo, M
AF Arahira, T.
   Maruta, M.
   Matsuya, S.
   Todo, M.
TI Development and characterization of a novel porous beta-TCP scaffold
   with a three-dimensional PLLA network structure for use in bone tissue
   engineering
SO MATERIALS LETTERS
LA English
DT Article
DE Composite scaffold; beta-TCP; PLLA; Biomaterial; Bone regeneration
ID MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLD; DIFFERENTIATION;
   PROLIFERATION; CELLS; FOAM
AB In the field of bone regenerative medicine, the need for artificial bone substitutes has been rapidly increasing, and various porous bioactive ceramics have been developed for use as bone substitutes. While materials such as beta-tricalcium phosphate (beta-TCP) have good oseteoconductivity, poly (L-lactide acid) (PLLA) has been shown to have good mechanical and physical properties. Therefore, the primary aim of this study was to fabricate a porous beta-TCP scaffold with a PLLA network structure (beta-TCP/PLLA) for use in bone tissue engineering. The fabricated beta-TCP/PLLA scaffolds were characterized,by their surface microstructures and compressive moduli. The results demonstrated that the structure of the PLLA membrane, such as pore size and thickness of membrane, could be changed by varying the concentration of PLEA. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Arahira, T.; Maruta, M.; Matsuya, S.] Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, Fukuoka 8140193, Japan.
   [Todo, M.] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan.
RP Arahira, T (reprint author), Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM arahira@college.fdcnet.ac.jp
RI U-ID, Kyushu/C-5291-2016; Kyushu, RIAM/F-4018-2015
OI Kyushu, RIAM/0000-0002-3518-444X
FU Japan Society for the Promotion of Science, Japan [25893284]
FX This work was supported by a Japan Society for the Promotion of Science,
   Japan Grant-in-Aid for Research Activity Start-up Grant number 25893284.
CR Arahira T, 2014, J MECH BEHAV BIOMED, V39, P218, DOI 10.1016/j.jmbbm.2014.07.013
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221
   Gerard C, 2010, J BIOMED MATER RES A, V93A, P615, DOI 10.1002/jbm.a.32568
   He XM, 2010, TISSUE ENG PART C-ME, V16, P329, DOI [10.1089/ten.tec.2008.0703, 10.1089/ten.TEC.2008.0703]
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Munar GM, 2013, DENT MATER J, V32, P608, DOI 10.4012/dmj.2013-031
   Nikaido T, 2013, KEY ENG MATER, V529-530, P15, DOI 10.4028/www.scientific.net/KEM.529-530.15
   Park JE, 2011, J MATER SCI-MATER M, V22, P1171, DOI 10.1007/s10856-011-4289-4
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P302, DOI 10.1016/j.actbio.2011.10.009
   Tiwari Akshay, 2012, J Clin Orthop Trauma, V3, P4, DOI 10.1016/j.jcot.2012.04.004
   Todo M, 2009, J MATER SCI, V44, P4191, DOI 10.1007/s10853-009-3546-0
   Udoh K, 2010, DENT MATER J, V29, P154, DOI 10.4012/dmj.2009-079
   Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457
   Zhang X, 2011, J MATER SCI-MATER M, V22, P371, DOI 10.1007/s10856-010-4198-y
NR 17
TC 6
Z9 7
U1 1
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD AUG 1
PY 2015
VL 152
BP 148
EP 150
DI 10.1016/j.matlet.2015.03.128
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CK4IS
UT WOS:000356188100040
DA 2018-10-19
ER

PT J
AU Rajendran, V
   Prabhu, M
   Suriyaprabha, R
AF Rajendran, V.
   Prabhu, M.
   Suriyaprabha, R.
TI Synthesis of TiO2-doped mesoporous nanobioactive glass particles and
   their cytocompatibility against osteoblast cell line
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID TITANIUM-DOPED BIOGLASS; PHOSPHATE-BASED GLASS; SIMULATED BODY-FLUID;
   IN-VITRO; CRYSTALLIZATION BEHAVIOR; BIOMEDICAL APPLICATIONS; APATITE
   FORMATION; BIOACTIVE GLASS; ION RELEASE; THIN-FILMS
AB To obtain medically important mesoporous biomaterial, we prepared titanium-doped nanobioactive glass (NBG) particles 55SiO(2)-(36 - x) CaO-9P(2)O(5)-xTiO(2) (x = 0, 1, 2, and 3 mol%) were prepared by simple sol-gel method. The physicochemical properties of the prepared nanocomposites were analyzed using different characterization techniques. The developed mesoporous nanocomposites showed amorphous nature with globular morphology, with a particle size of approximately 50 nm. The specific surface area of glass nanocomposites doped with TiO2 at different concentrations, namely SCPT0 (0 %), SCPT1 (1 %), SCPT2 (2 %), and SCPT3 (3 %) samples, was 129, 186, 105, and 129 m(2) g(-1), respectively. In addition, the average pore diameter of the glass series was 33, 18, 27, and 25 nm. The in vitro bioactivity of hydroxyapatite layer formation was confirmed using simulated body fluid. Further, antibacterial property of mesoporous nanocomposites was investigated against Escherichia coli and Staphylococcus aureus. The diameter of the inhibition zone of TiO2-doped nanocomposites against E. coli was found to be 16, 18, and 20 mm. No significant inhibition was found for Ti-free samples against E. coli and S. aureus. The cytotoxicity assay revealed that the prepared NBG particles doped with 1 % TiO2 were nontoxic and showed better cell viability in osteoblast cell line (MG-63) at a concentration of 125 A mu g ml(-1). Therefore, the addition of biomimic metal oxide dopant such as TiO2 in NBGs is an effective approach to develop a highly biocompatible material for bone implant applications.
C1 [Rajendran, V.; Prabhu, M.; Suriyaprabha, R.] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
RP Rajendran, V (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM veerajendran@gmail.com; prabhubpt16@gmail.com; rsuriyaprabha@gmail.com
FU Department of Science and Technology (DST), New Delhi
   [SR/S2/CMP-0054/2009]
FX The authors acknowledge the financial support (SR/S2/CMP-0054/2009 dt.
   27.09.2010) provided by the Department of Science and Technology (DST),
   New Delhi, to carry out this research project.
CR Abou Neel EA, 2009, J NON-CRYST SOLIDS, V355, P991, DOI 10.1016/j.jnoncrysol.2009.04.016
   Asif IM, 2014, J MATER SCI-MATER M, V25, P1865, DOI 10.1007/s10856-014-5230-4
   Barbieri L, 1997, MATER RES BULL, V32, P637, DOI 10.1016/S0025-5408(97)00029-9
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Bielby RC, 2004, TISSUE ENG, V10, P1018, DOI 10.1089/1076327041887664
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Caballero L, 2009, J PHOTOCH PHOTOBIO A, V202, P92, DOI 10.1016/j.jphotochem.2008.11.005
   Chen Q, 1999, BIOMATERIALS, V20, P1127, DOI 10.1016/S0142-9612(99)00015-0
   Dhayal M, 2014, MAT SCI ENG C-MATER, V37, P99, DOI 10.1016/j.msec.2013.12.035
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   FitzGerald V, 2009, J BIOMED MATER RES A, V91A, P76, DOI 10.1002/jbm.a.32206
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Kim YS, 2012, POWDER TECHNOL, V215-16, P195, DOI 10.1016/j.powtec.2011.09.047
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lakhkar NJ, 2012, ACTA BIOMATER, V8, P4181, DOI 10.1016/j.actbio.2012.07.023
   Li ZS, 2009, ACTA BIOMATER, V5, P2189, DOI 10.1016/j.actbio.2009.02.013
   Martin RA, 2012, PHYS CHEM CHEM PHYS, V14, P15807, DOI 10.1039/c2cp43032k
   Mohammadi MS, 2014, COLLOID SURFACE B, V121, P82, DOI 10.1016/j.colsurfb.2014.05.037
   Monem AS, 2008, J MATER SCI-MATER M, V19, P1097, DOI 10.1007/s10856-007-3044-3
   NAN Y, 1992, J AM CERAM SOC, V75, P1641, DOI 10.1111/j.1151-2916.1992.tb04237.x
   Ni SY, 2008, J MATER SCI-MATER M, V19, P359, DOI 10.1007/s10856-007-3186-3
   Pena J, 2006, SOLID STATE SCI, V8, P513, DOI 10.1016/j.solidstatesciences.2005.11.003
   Prabhu M, 2013, J NANOSCI NANOTECHNO, V13, P5327, DOI 10.1166/jnn.2013.7474
   Prabhu M, 2013, CERAM INT, V39, P1683, DOI 10.1016/j.ceramint.2012.08.011
   Rajendran V, 2010, J AM CERAM SOC, V93, P4053, DOI 10.1111/j.1551-2916.2010.04009.x
   Rouquerol F, 1999, GEN CONCLUSIONS RECO, P439
   Saravanakumar B, 2015, INT J APPL CERAM TEC, V12, P95, DOI 10.1111/ijac.12124
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Shahadat M, 2015, COLLOID SURFACE B, V126, P121, DOI 10.1016/j.colsurfb.2014.11.049
   Socrates G., 2004, INFRARED RAMAN CHARA
   Talos F, 2013, CORROS SCI, V72, P41, DOI 10.1016/j.corsci.2013.03.003
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Vasconcelos HC, 2010, J SOL-GEL SCI TECHN, V55, P126, DOI 10.1007/s10971-010-2223-8
   Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202
   Yu BB, 2012, LANGMUIR, V28, P17465, DOI 10.1021/la303768b
   Yun HS, 2010, MATER LETT, V64, P1850, DOI 10.1016/j.matlet.2010.04.053
NR 40
TC 3
Z9 3
U1 3
U2 62
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD AUG
PY 2015
VL 50
IS 15
BP 5145
EP 5156
DI 10.1007/s10853-015-9047-4
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA CI7RH
UT WOS:000354961400004
DA 2018-10-19
ER

PT J
AU Linh, NTB
   Jang, DW
   Lee, BT
AF Nguyen Thuy Ba Linh
   Jang, Dong-Woo
   Lee, Byong-Taek
TI Collagen immobilization of multi-layered BCP-ZrO2 bone substitutes to
   enhance bone formation
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Porous scaffolds; Multi layered BCP-ZrO2; Collagen immobilization;
   Surface modification; Bone substitutes
ID BIPHASIC CALCIUM-PHOSPHATE; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION;
   MARROW-CELLS; IN-VITRO; SCAFFOLDS; BIOMATERIAL; ZIRCONIA; HYDROGELS;
   ADHESION
AB A porous microstructure of multi-layered BCP-ZrO2 bone substitutes was fabricated using the sponge replica method in which the highly interconnected structure was immobilized with collagen via ethyl(dimethylaminopropypcarbodiimide/N-hydroxysuccinimide crosslinking. Their struts are combined with a three-layered BCP/BCP-ZrO2/ZrO2 microstructure. Collagen fibers were firmly attached to the strut surface of the BCP-ZrO2 scaffolds. With control of the three-layered microstructure and collagen immobilization, the compressive strength of the scaffolds increased significantly to 6.8 MPa compared to that of the monolithic BCP scaffolds (1.3 MPa). An in vitro study using MU, confocal observation, and real-time polymer chain reaction analysis demonstrated that the proliferation and differentiation of the pre-osteoblast-like MC3T3-E1 cells was improved due to the collagen incorporation. Remarkable enhancement of bone regeneration was observed without any immunological reaction in the femurs of rabbits during 1 and 5 months of implantation. Furthermore, the interfaces between new bone and the scaffold struts bonded directly without any gaps. (C) 2015 Published by Elsevier B.V.
C1 [Nguyen Thuy Ba Linh; Jang, Dong-Woo; Lee, Byong-Taek] Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan 330090, South Korea.
   [Nguyen Thuy Ba Linh; Lee, Byong-Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Cheonan 330090, South Korea.
RP Lee, BT (reprint author), Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan 330090, South Korea.
EM lbt@sch.ac.kr
FU Business for Academic-industrial Cooperative establishments [C0247339]
FX This work (Grants No. C0247339) was supported by Business for
   Academic-industrial Cooperative establishments funded Korea Small and
   Medium Business Administration in 2014.
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Charles PT, 2009, SENSORS-BASEL, V9, P645, DOI 10.3390/s90100645
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHEVALIER J, 1997, BIOCERAMICS, V10
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   CUDKOWICZ G, 1971, J EXP MED, V134, P83, DOI 10.1084/jem.134.1.83
   Donegan M, 2013, PLASMA PROCESS POLYM, V10, P526, DOI 10.1002/ppap.201200078
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Goldberg M.M., 1992, BONE IMPLANT GRAFTIN, P9
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hamed E, 2012, J R SOC INTERFACE, V9, P1654, DOI 10.1098/rsif.2011.0814
   He J, 2012, J BIOMED MATER RES A, V100A, P1706, DOI 10.1002/jbm.a.34121
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Jager M, 2013, J BIOMED MATER RES A, V101, P2905, DOI 10.1002/jbm.a.34590
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Jun IK, 2006, MATER LETT, V60, P2507, DOI 10.1016/j.matlet.2006.01.031
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim M, 2010, KOREAN J MAT RES, V20, P331
   Kim M, 2011, J EUR CERAM SOC, V31, P1541, DOI 10.1016/j.jeurceramsoc.2011.03.019
   Kim RY, 2014, BIOMATERIALS, V35, P1869, DOI 10.1016/j.biomaterials.2013.11.029
   Kim Y. - H., 2012, SCI TECHNOL ADV MAT, V12
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   McLaren EA, 2005, QDT, V28, P99
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   Nettles Dana L., 2002, TISSUE ENG PART A, V8, P1009
   Linh NTB, 2013, J BIOMED MATER RES A, V101, P2412, DOI 10.1002/jbm.a.34533
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pires MM, 2009, ANGEW CHEM INT EDIT, V48, P7813, DOI 10.1002/anie.200902375
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Richard F., 2008, BIOCHEM SOC T, V36, P241
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122
   SILBERMANN M, 1983, ANAT REC, V206, P373, DOI 10.1002/ar.1092060404
   STEIN GS, 1990, FASEB J, V4, P3111
   STRAUSS PG, 1990, J CELL BIOL, V110, P1369, DOI 10.1083/jcb.110.4.1369
   Taubenberger A. V., 2013, TISSUE ENG B
   VandeVord PJ, 2005, J ORTHOP RES, V23, P1059, DOI 10.1016/j.orthres.2004.12.004
   Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Wang B., 2012, ACCOUNTS CHEM RES, V46, P761
   Weinand C, 2006, BONE, V38, P555, DOI 10.1016/j.bone.2005.10.016
   Yamada K, 1997, J NEUROSURG, V86, P871, DOI 10.3171/jns.1997.86.5.0871
   Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025
NR 50
TC 4
Z9 4
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 1
PY 2015
VL 345
BP 238
EP 248
DI 10.1016/j.apsusc.2015.03.126
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CH1SY
UT WOS:000353803000031
DA 2018-10-19
ER

PT J
AU Kang, BM
   Jeong, WJ
   Park, GC
   Yoon, DJ
   Ahn, HG
   Lim, YS
AF Kang, Byeong-Mo
   Jeong, Woon-Jo
   Park, Gye-Choon
   Yoon, Dong-Joo
   Ahn, Ho-Geun
   Lim, Yeong-Seog
TI The Characteristics of an Antibacterial TiAgN Thin Film Coated by
   Physical Vapor Deposition Technique
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE TiAgN; Nanoconnposite; Nanoparticle; Thin Film; Antibacterial
   Biomaterial; PVD
ID BACTERIAL ADHESION; STAINLESS-STEEL; TITANIUM; INFECTIONS
AB In this work, we found the characteristics of an antibacterial TiAgN thin film coated on the pure titanium specimen via the physical vapor deposition process (PVD). TiAgN thin films were coated using TiAg alloy targets by arc ion plating method. Changing the process parameters, the surface analysis of TiAgN thin film was observed by FE-SEM and the force of adhesion was measured with Scratch Tester. The proliferation of human gingival fibroblast (HGF) cells was examined by XTT test assay and the antibacterial properties were investigated by culturing Streptococus Mutans (KCTC 3065) using paper disk techniques. At the result of experiment, cytotoxic effects were not found and the antibacterial effects against Streptococus Mutans were appeared over 5 wt% TiAgN specimens.
C1 [Kang, Byeong-Mo; Lim, Yeong-Seog] Chonnam Natl Univ, Dept Elect & Comp Engn, Kwangju 500757, South Korea.
   [Jeong, Woon-Jo] OT&T Inc, Kwangju 500706, South Korea.
   [Park, Gye-Choon] Mokpo Natl Univ, Dept Elect Engn, Muan 534729, Jeonnam, South Korea.
   [Yoon, Dong-Joo] Sunchon Natl Univ, Ctr Pract Use Rate Mat, Sunchon 540742, Jeonnam, South Korea.
   [Ahn, Ho-Geun] Sunchon Natl Univ, Dept Chem Engn, Sunchon 540742, Jeonnam, South Korea.
RP Kang, BM (reprint author), Chonnam Natl Univ, Dept Elect & Comp Engn, Kwangju 500757, South Korea.
FU Ministry of Trade, Industry and Energy (MOTIE); Korea Institute for
   Advancement of Technology (KIAT); Honam Institute for Regional Program
   Evaluation through the Leading Industry Development for Economic Region
FX This research was financially supported by the Ministry of Trade,
   Industry and Energy (MOTIE), Korea Institute for Advancement of
   Technology (KIAT) and Honam Institute for Regional Program Evaluation
   through the Leading Industry Development for Economic Region.
CR Bahna P, 2007, INT J ANTIMICROB AG, V29, P593, DOI 10.1016/j.ijantimicag.2006.12.013
   Berry C W, 1992, Implant Dent, V1, P59, DOI 10.1097/00008505-199200110-00006
   Dan ZG, 2005, THIN SOLID FILMS, V492, P93, DOI 10.1016/j.tsf.2005.06
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   ELAGLI K, 1992, BIOMATERIALS, V13, P25, DOI 10.1016/0142-9612(92)90090-B
   Elias C. N., 2008, BIOL MAT SCI JOM, V3, P46
   Hsieh JH, 2008, SURF COAT TECH, V202, P5586, DOI 10.1016/j.surfcoat.2008.06.107
   Jeyachandran YL, 2007, MAT SCI ENG C-BIO S, V27, P35, DOI 10.1016/j.msec.2006.01.004
   Joo YK, 2009, MATERIALS, V2, P699, DOI 10.3390/ma2020699
   JOSHI RI, 1988, J MED MICROBIOL, V27, P105, DOI 10.1099/00222615-27-2-105
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Wang HF, 2011, J MATER SCI TECHNOL, V27, P309, DOI 10.1016/S1005-0302(11)60067-4
   Zhang W, 2008, SURF COAT TECH, V203, P909, DOI 10.1016/j.surfcoat.2008.08.023
   Zhao Q, 2007, APPL SURF SCI, V253, P7254, DOI 10.1016/j.apsusc.2007.03.011
NR 14
TC 3
Z9 3
U1 1
U2 34
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2015
VL 15
IS 8
BP 6020
EP 6023
DI 10.1166/jnn.2015.10417
PG 4
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC3RW
UT WOS:000350268100083
PM 26369190
DA 2018-10-19
ER

PT J
AU Nagasawa, D
   Azuma, T
   Noguchi, H
   Uosaki, K
   Takai, M
AF Nagasawa, Daiki
   Azuma, Tomoyuki
   Noguchi, Hidenori
   Uosaki, Kohei
   Takai, Madoka
TI Role of Interfacial Water in Protein Adsorption onto Polymer Brushes as
   Studied by SFG Spectroscopy and QCM
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; SUM-FREQUENCY GENERATION; QUARTZ-CRYSTAL
   MICROBALANCE; TRANSFER RADICAL POLYMERIZATION; ISOTOPIC DILUTION
   SPECTROSCOPY; MOLECULAR SIMULATION; VIBRATIONAL SPECTROSCOPY;
   ZWITTERIONIC POLYMERS; PHOSPHOLIPID POLYMERS; SURFACE INTERACTIONS
AB The adsorption of large biomolecules such as proteins is of high relevance in medicine; adsorbed proteins can initiate undesirable biOlogice reactions such as blood coagulation or immune responses, which adversely affect the human body and the functioning of medical devices. Thus, the suppression of protein adsorption onto material surfaces is essential for medical and biomedical applications. Interfacial water molecules may play a key role in protein adsorption. In this context, in this study, we prepare various types of surfaces (hydrophobic, hydrophilic, anionic, cationic, and zwitterionic) using polymer brushes with different molecular structures. We analyze the adsorption of negatively and positively charged proteins using a quartz crystal microbalance (QCM) to quantitatively investigate protein adsorption onto the polymer brush surfaces. The structure of the interface between the polymer brushes and water media is investigated using sum frequency generation (SFG) spectroscopy. Our comparison of the protein adsorption characteristics with the properties of the interfacial water molecules of each polymer brush indicates that the interfacial water molecules, which strongly interact with polymer brushes, are important for suppressing protein adsorption. The findings can significantly contribute to the functional biomaterial design.
C1 [Nagasawa, Daiki; Azuma, Tomoyuki; Takai, Madoka] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Noguchi, Hidenori; Uosaki, Kohei] NIMS, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan.
   [Noguchi, Hidenori; Uosaki, Kohei] NIMS, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan.
RP Takai, M (reprint author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM takai@bis.t.u-tokyo.ac.jp
OI Uosaki, Kohei/0000-0001-8886-3270
FU World Premier International Research Center (WPI) Initiative on
   Materials Nanoarchitectonics from the Ministry of Education, Culture,
   Sports, Science and Technology of Japan
FX This work was supported by the Grant-in-Aid for Scientific Research on
   Innovative Areas "Molecular Soft-Interface Science" and World Premier
   International Research Center (WPI) Initiative on Materials
   Nanoarchitectonics from the Ministry of Education, Culture, Sports,
   Science and Technology of Japan. The authors thank K. Kushiro from the
   University of Tokyo for helpful discussions and comments.
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Anderson A, 2009, LANGMUIR, V25, P11549, DOI 10.1021/la901459b
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bednarek M, 2007, J POLYM SCI POL CHEM, V45, P333, DOI 10.1002/pola.21784
   Bharti B, 2011, LANGMUIR, V27, P9823, DOI 10.1021/la201898v
   Bonn M, 2012, BIOINTERPHASES, V7, P1
   Carter D. C., 1994, ADV PROTEIN CHEM
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313
   Feiler AA, 2007, J COLLOID INTERF SCI, V315, P475, DOI 10.1016/j.jcis.2007.07.029
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Ghi PY, 2002, BIOMACROMOLECULES, V3, P991, DOI 10.1021/bm0200332
   Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jin J, 2013, LANGMUIR, V29, P6624, DOI 10.1021/la4017239
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   Kitano H, 2005, MACROMOL BIOSCI, V5, P314, DOI 10.1002/mabi.200400212
   Kitano K, 2009, COLLOID SURFACE B, V74, P350, DOI 10.1016/j.colsurfb.2009.08.004
   Kondo T, 2012, COLLOID SURFACE B, V100, P126, DOI 10.1016/j.colsurfb.2012.05.008
   Kondo T, 2012, COLLOID SURFACE B, V91, P215, DOI 10.1016/j.colsurfb.2011.11.012
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Leng C, 2015, J PHYS CHEM C, V119, P8775, DOI 10.1021/acs.jpcc.5b01649
   Leung BO, 2012, LANGMUIR, V28, P5724, DOI 10.1021/la204805x
   Li GZ, 2008, BIOMATERIALS, V29, P4592, DOI 10.1016/j.biomaterials.2008.08.021
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   McDonald S, 2001, MACROMOLECULES, V34, P8600, DOI 10.1021/ma0115186
   Mondal JA, 2012, J AM CHEM SOC, V134, P7842, DOI 10.1021/ja300658h
   Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025
   Morita S, 2007, LANGMUIR, V23, P3750, DOI 10.1021/la0625998
   Pyun J, 2003, MACROMOL RAPID COMM, V24, P1043, DOI 10.1002/marc.200300078
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodriguez O, 2003, POLYMER, V44, P6323, DOI 10.1016/S0032-3861(03)00654-2
   Shao Q, 2010, J PHYS CHEM B, V114, P16625, DOI 10.1021/jp107272n
   Shen YR, 2006, CHEM REV, V106, P1140, DOI 10.1021/cr040377d
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Sovago M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173901
   Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173
   Tajima N, 2011, ANAL CHEM, V83, P1969, DOI 10.1021/ac1026786
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tian CS, 2009, CHEM PHYS LETT, V470, P1, DOI 10.1016/j.cplett.2009.01.016
   Tsujii Y, 2006, ADV POLYM SCI, V197, P1, DOI 10.1007/12_063
   Tsuruta T, 2010, J BIOMAT SCI-POLYM E, V21, P1831, DOI 10.1163/092050610X488269
   Uosaki K, 2010, J AM CHEM SOC, V132, P17271, DOI 10.1021/ja107265q
   Wu J, 2012, LANGMUIR, V28, P7436, DOI 10.1021/la300394c
   Xie Y, 2012, APPL SURF SCI, V258, P8153, DOI 10.1016/j.apsusc.2012.05.013
   Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242
   Yu GB, 2014, J PHYS CHEM B, V118, P4451, DOI 10.1021/jp409326f
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhao C, 2013, BIOMATERIALS, V34, P4714, DOI 10.1016/j.biomaterials.2013.03.028
   Zheng J, 2004, LANGMUIR, V20, P8931, DOI 10.1021/la036345n
   Zheng J, 2005, BIOPHYS J, V89, P158, DOI 10.1529/biophysj.105.059428
NR 57
TC 28
Z9 28
U1 7
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD JUL 30
PY 2015
VL 119
IS 30
BP 17193
EP 17201
DI 10.1021/acs.jpcc.5b04186
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CO3BP
UT WOS:000359031900018
DA 2018-10-19
ER

PT J
AU Wang, Y
   Zhang, DM
   Wen, CE
   Li, YC
AF Wang, Yu
   Zhang, Dongmei
   Wen, Cuie
   Li, Yuncang
TI Processing and Characterization of SrTiO3-TiO2 Nanoparticle-Nanotube
   Heterostructures on Titanium for Biomedical Applications
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE TiO2 nanotube; SeTiO3-TiO2 nanoparticle-nanotube heterostructure;
   surface energy; biocompatibility; SaOS2 cell
ID SUBSTITUTED HYDROXYAPATITE COATINGS; TIO2 NANOTUBES; HYDROTHERMAL
   SYNTHESIS; STRONTIUM RANELATE; CELL RESPONSE; IN-VITRO; SURFACE;
   OSTEOBLAST; ALLOYS; ARRAYS
AB Surface properties such as physicochemical characteristics and topographical parameters of biomaterials, essentially determining the interaction between the biological cells and the biomaterial, are important considerations in the design of implant materials. In this study, a layer of SrTiO3TiO2 nanoparticlenanotube heterostructures on titanium has been fabricated via anodization combined with a hydrothermal process. Titanium was anodized to create a layer of titania (TiO2) nanotubes (TNTs), which was then decorated with a layer of SrTiO3 nanoparticles via hydrothermal processing. SrTiO3-TiO2 heterostructures with high and low volume fraction of SrTiO3 nanoparticle (denoted by 6.3-Sr/TNTs and 1.4-Sr/TNTs) were achieved by using a hydrothermal processing time of 12 and 3 h, respectively. The in vitro biocompatibility of the SrTiO3-TiO2 heterostructures was assessed by using osteoblast cells (SaOS(2)). Our results indicated that the SrTiO3-TiO2 heterostructures with different volume fractions of SrTiO3 nanoparticles exhibited different Sr ion release in cell culture media and different surface energies. An appropriate volume fraction of SrTiO3 in the heterostructures stimulated the secretion of cell filopodia, leading to enhanced biocompatibility in terms of cell attachment, anchoring, and proliferation on the heterostructure surface.
C1 [Wang, Yu; Zhang, Dongmei] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia.
   [Wen, Cuie; Li, Yuncang] RIMET Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
RP Li, YC (reprint author), RIMET Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
EM yuncang.li@rmit.edu.au
RI Li, Yuncang/I-5832-2012
OI Li, Yuncang/0000-0003-4290-4772
FU NHMRC [GNT1087290]
FX The authors are grateful to Paul Morrison, School of Applied Sciences,
   RMIT University, for his technical support in the ion concentration
   analysis using ICP-MS. C.W. and Y.L. acknowledge the support for this
   research by NHMRC through Grant GNT1087290.
CR Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   Brammer KS, 2010, MAT SCI ENG C-MATER, V30, P518, DOI 10.1016/j.msec.2010.01.013
   Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Carre A, 2007, J ADHES SCI TECHNOL, V21, P961, DOI 10.1163/156856107781393875
   Cheng H, 2014, J BIOMED MATER RES A, V102, P3488, DOI 10.1002/jbm.a.35019
   Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Davies John E, 2003, J Dent Educ, V67, P932
   Eckert JO, 1996, J AM CERAM SOC, V79, P2929, DOI 10.1111/j.1151-2916.1996.tb08728.x
   Fu Y.F., 2005, J ORAL TISSUE ENG, V2, P76
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   Gum D., 2007, J PHYS CHEM C, V111, P13393
   Jiao ZB, 2014, CHEM-EUR J, V20, P2654, DOI 10.1002/chem.201304135
   Kabaso D, 2011, COMPUT METHOD BIOMEC, V14, P469, DOI 10.1080/10255842.2010.534986
   LENCKA MM, 1995, CHEM MATER, V7, P18, DOI 10.1021/cm00049a006
   Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopez MCB, 2000, J EUR CERAM SOC, V20, P107
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Narayanan R, 2011, MATER CHEM PHYS, V125, P510, DOI 10.1016/j.matchemphys.2010.10.024
   Ni GX, 2012, J BIOMED MATER RES B, V100B, P562, DOI 10.1002/jbm.b.31986
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Pors Nielsen S., 2004, BONE, V35, P583, DOI DOI 10.1016/J.B0NE.2004.04.026
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Schmidt-Stein F, 2009, ELECTROCHEM COMMUN, V11, P2077, DOI 10.1016/j.elecom.2009.08.036
   Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027
   Sekine K, 2013, IEEE ENG MED BIO, P858, DOI 10.1109/EMBC.2013.6609636
   Shrestha N. K, 2009, ANGEW CHEM, V121, P987
   Song YY, 2009, J AM CHEM SOC, V131, P4230, DOI 10.1021/ja810130h
   Textor M, 2001, ENG MAT SER, P171
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wang Y, 2014, J BIOMED MATER RES A, V102, P743, DOI 10.1002/jbm.a.34738
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xin YC, 2009, ACS NANO, V3, P3228, DOI 10.1021/nn9007675
   Yin P, 2014, J BIOMED MATER RES A, V102, P621, DOI 10.1002/jbm.a.34723
   Zhang J, 2010, ACS NANO, V4, P387, DOI 10.1021/nn901087c
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041
NR 47
TC 14
Z9 14
U1 7
U2 87
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUL 29
PY 2015
VL 7
IS 29
BP 16018
EP 16026
DI 10.1021/acsami.5b04304
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CO1ES
UT WOS:000358897200039
PM 26136139
DA 2018-10-19
ER

PT J
AU Song, X
   Wang, L
   Niinomi, M
   Nakai, M
   Liu, Y
AF Song, Xiu
   Wang, Lei
   Niinomi, Mitsuo
   Nakai, Masaaki
   Liu, Yang
TI Fatigue characteristics of a biomedical beta-type titanium alloy with
   titanium boride
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Biomaterial; beta-type titanium alloy; Fatigue strength; Titanium boride
ID MECHANICAL-PROPERTIES; TI-29NB-13TA-4.6ZR ALLOY; CORROSION BEHAVIOR;
   TI-6AL-4V ELI; MICROSTRUCTURE; COMPOSITES; FIXATION; DESIGN; FLUID;
   BORON
AB A beta-type Ti-29Nb-13Ta-4.6Zr (TNTZ) alloy containing various amounts of TiB reinforcements has been developed to achieve higher fatigue strength for biomedical applications. Fatigue tests were performed at room temperature, and the effects of TiB on fatigue crack initiation and propagation were investigated. The results indicate that the fatigue limit of the TNTZ alloy was substantially improved by the TiB reinforcements. However, the fatigue strength first increased and subsequently decreased as the B concentration increased. TNTZ alloy with 0.10% B has the largest fatigue limit, which is 67% greater than that of the TNTZ alloy. The effects of TiB on the improvement of the fatigue properties are due to the following two factors. First, sliding of the dislocations can be blocked by TiB particles, which results in resistance to fatigue crack initiation. In addition, the crack deflection and crack bridging by the TiB particles could delay the crack propagation. Conversely, debonding of some larger TiB particles may occur, especially when the B concentration is higher than 0.20%. Therefore, the crack initiates from the debonding of the TiB particles and easily propagates along the voids from the interfacial decohesion, which could exert a deleterious influence on the fatigue strength. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Song, Xiu; Wang, Lei; Liu, Yang] Northeastern Univ, Sch Met & Mat, Minist Educ, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Peoples R China.
   [Niinomi, Mitsuo; Nakai, Masaaki] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Wang, L (reprint author), Northeastern Univ, Sch Met & Mat, Minist Educ, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Peoples R China.
EM wanglei@mail.neu.edu.cn
FU National Natural Science Foundation of China, China [51301037];
   Fundamental Research Funds for the Central Universities [N140204001];
   Doctoral Fund of Liaoning Province, China [20131036]
FX This research work was financially supported by the National Natural
   Science Foundation of China, China (51301037) and the Fundamental
   Research Funds for the Central Universities (N140204001), and the
   Doctoral Fund of Liaoning Province, China (20131036).
CR Akahori T, 1998, MAT SCI ENG A-STRUCT, V243, P237, DOI 10.1016/S0921-5093(97)00807-1
   Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Chen W, 2010, INT J FATIGUE, V32, P799, DOI 10.1016/j.ijfatigue.2009.06.002
   Dai SJ, 2013, T NONFERR METAL SOC, V23, P3027, DOI 10.1016/S1003-6326(13)62829-0
   Diomidis N, 2011, WEAR, V271, P1093, DOI 10.1016/j.wear.2011.05.010
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Huang LJ, 2009, SCRIPTA MATER, V60, P996, DOI 10.1016/j.scriptamat.2009.02.032
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Laheurte P, 2010, J MECH BEHAV BIOMED, V3, P565, DOI 10.1016/j.jmbbm.2010.07.001
   Li SJ, 2008, ACTA BIOMATER, V4, P305, DOI 10.1016/j.actbio.2007.09.009
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Narita K, 2012, J MECH BEHAV BIOMED, V9, P207, DOI 10.1016/j.jmbbm.2012.01.011
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   Quast JP, 2008, MAT SCI ENG A-STRUCT, V497, P1, DOI 10.1016/j.msea.2008.07.045
   Sarkar R, 2011, MAT SCI ENG A-STRUCT, V528, P4819, DOI 10.1016/j.msea.2011.03.014
   Song X, 2011, MAT SCI ENG A-STRUCT, V528, P5600, DOI 10.1016/j.msea.2011.03.108
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002
   Wang LQ, 2010, MAT SCI ENG A-STRUCT, V527, P1058, DOI 10.1016/j.msea.2009.09.022
   Xie LC, 2014, INT J FATIGUE, V66, P127, DOI 10.1016/j.ijfatigue.2014.03.019
   Yilbas BS, 2009, J MATER PROCESS TECH, V209, P1199, DOI 10.1016/j.jmatprotec.2008.03.024
   Zhang XH, 2003, MAT SCI ENG A-STRUCT, V348, P41
NR 25
TC 6
Z9 7
U1 3
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUL 29
PY 2015
VL 640
BP 154
EP 164
DI 10.1016/j.msea.2015.05.078
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA CN7PN
UT WOS:000358626600017
DA 2018-10-19
ER

PT J
AU Raftery, RM
   Tierney, EG
   Curtin, CM
   Cryan, SA
   O'Brien, FJ
AF Raftery, Rosanne M.
   Tierney, Erica G.
   Curtin, Caroline M.
   Cryan, Sally-Ann
   O'Brien, Fergal J.
TI Development of a gene-activated scaffold platformfor tissue engineering
   applications using chitosan-pDNA nanoparticles on collagen-based
   scaffolds
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Chitosan nanoparticles; Gene delivery; Mesenchymal stem cells (MSCs);
   Gene-activated scaffold; Tissue engineering
ID IN-VIVO; TRANSFECTION EFFICIENCY; MOLECULAR-WEIGHT; DNA NANOPARTICLES;
   DELIVERY-SYSTEM; GAG SCAFFOLDS; BONE REGENERATION; NONVIRAL VECTORS;
   PROTON SPONGE; THERAPY
AB Biomaterial scaffolds that support cell infiltration and tissue formation can also function as platforms for the delivery of therapeutics such as drugs, proteins, and genes. As burst release of supraphysiological quantities of recombinant proteins can result in adverse side effects, the objective of this study was to explore the potential of a series of collagen-based scaffolds, developed in our laboratory, as gene-activated scaffold platforms with potential in a range of tissue engineering applications. The potential of chitosan, a biocompatible material derived from the shells of crustaceans, as a gene delivery vector was assessed using mesenchymal stem cells (MSCs). A transfection efficiency of >45% is reported which is similar to what is achieved with polyethyleneimine (PEI), a non-viral gold standard vector, without causing cytotoxic side effects. When the optimised chitosan nanoparticles were incorporated into a series of collagen-based scaffolds, sustained transgene expression from MSCs seeded on the scaffolds was maintained for up to 28 days and interestingly the composition of the scaffold had an effect on transfection efficiency. These results demonstrate that by simply varying the scaffold composition and the gene (or combinations thereof) chosen; the systemhas potential for amyriad of therapeutic applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; Cryan, Sally-Ann; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin 2, Dublin, Ireland.
   [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; Cryan, Sally-Ann; O'Brien, Fergal J.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Dublin, Ireland.
   [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; O'Brien, Fergal J.] RCSI, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland.
   [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; O'Brien, Fergal J.] TCD, Dublin, Ireland.
   [Cryan, Sally-Ann] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Dublin, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Dublin, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Raftery,
   Rosanne/0000-0001-7820-0246; Cryan, Sally-Ann/0000-0002-3941-496X
FU Science Foundation Ireland (SFI) Research Frontiers Programme
   [11/RFP/ENM/3053]; European Research Council under the European
   Community's Seventh Framework Programme (FP7)/ERC [239685]
FX This work was funded by Science Foundation Ireland (SFI) Research
   Frontiers Programme (Grant No. 11/RFP/ENM/3053) and the European
   Research Council under the European Community's Seventh Framework
   Programme (FP7/2007-2013)/ERC grant agreement No. 239685. Collagen
   materials were provided by Integra Life Sciences, Inc. through a
   Material Transfer Agreement. We also thank Dr. M. Sawkins and the Centre
   for Research on Adaptive Nanostructures and Nanodevices (CRANN), Trinity
   College Dublin, for their help with SEM and AFM imaging.
CR Agirre M, 2014, POLYMERS-BASEL, V6, P1727, DOI 10.3390/polym6061727
   Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Behr JP, 1997, CHIMIA, V51, P34
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028
   Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Djurovic S, 2004, MOL BIOTECHNOL, V28, P21, DOI 10.1385/MB:28:1:21
   Garaiova Z, 2012, INT J BIOL MACROMOL, V51, P1043, DOI 10.1016/j.ijbiomac.2012.08.016
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616
   Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Ishii T, 2001, BBA-BIOMEMBRANES, V1514, P51, DOI 10.1016/S0005-2736(01)00362-5
   Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099
   Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Klausner EA, 2010, BIOMATERIALS, V31, P1814, DOI 10.1016/j.biomaterials.2009.10.031
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029
   Lee RJ, 2000, CIRCULATION, V102, P898
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Lundstrom K, 2003, TECHNOL CANCER RES T, V2, P471, DOI 10.1177/153303460300200513
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Malakooty Poor E., 2013, ARTIF CELL NANOMED B, V1, P1
   Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/s0939-641(03)00155-3
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Matsiko A, 2012, J MECH BEHAV BIOMED, V11, P41, DOI 10.1016/j.jmbbm.2011.11.012
   Miyazaki M, 2009, EUR SPINE J, V18, P783, DOI 10.1007/s00586-009-0924-x
   Moreira C, 2009, ACTA BIOMATER, V5, P2995, DOI 10.1016/j.actbio.2009.04.021
   Mumper R.J., 1995, P INT S CONTR REL BI, V22, P178
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Puras G, 2013, EUR J PHARM BIOPHARM, V83, P131, DOI 10.1016/j.ejpb.2012.09.010
   Quinlan E, 2015, J CONTROL RELEASE, V198, P71, DOI 10.1016/j.jconrel.2014.11.021
   Regnstrom K, 2006, PHARM RES, V23, P475, DOI 10.1007/s11095-006-9563-7
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Romoren K, 2003, INT J PHARM, V261, P115, DOI 10.1016/S0378-5173(03)00301-6
   Sambrook J, 1989, MOL CLONING LAB MANU, P6
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Schaffert D, 2008, GENE THER, V15, P1131, DOI 10.1038/gt.2008.105
   Strand SP, 2010, BIOMATERIALS, V31, P975, DOI 10.1016/j.biomaterials.2009.09.102
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Tierney EG, 2012, J CONTROL RELEASE, V158, P304, DOI 10.1016/j.jconrel.2011.11.026
   XIANMIAO C, 2009, MAT SCI ENG C, V29, P29, DOI DOI 10.1016/J.MSEC.2008.05.008
NR 60
TC 26
Z9 26
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 28
PY 2015
VL 210
BP 84
EP 94
DI 10.1016/j.jconrel.2015.05.005
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CK5CC
UT WOS:000356238700010
PM 25982680
DA 2018-10-19
ER

PT J
AU Gammon, JM
   Tostanoski, LH
   Adapa, AR
   Chiu, YC
   Jewell, CM
AF Gammon, Joshua M.
   Tostanoski, Lisa H.
   Adapa, Arjun R.
   Chiu, Yu-Chieh
   Jewell, Christopher M.
TI Controlled delivery of a metabolic modulator promotes regulatory T cells
   and restrains autoimmunity
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Nanoparticle; Tolerance; Biomaterial; Immunotherapy; Metabolism;
   Autoimmunity; Immunology; Vaccine
ID METABOTROPIC GLUTAMATE-RECEPTOR; TOLEROGENIC DENDRITIC CELLS;
   CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ADAPTIVE IMMUNITY; MYELIN;
   ANTIGEN; ENCEPHALOMYELITIS; MICE; NANOPARTICLES
AB Autoimmune disorders occur when the immune system abnormally recognizes and attacks self-molecules. Dendritic cells (DCs) play a powerful role in initiating adaptive immune response, and are therefore a recent target for autoimmune therapies. N-Phenyl-7-(hydroxyimino) cyclopropa[ b] chromen-1a-carboxamide (PHCCC), a small molecule glutamate receptor enhancer, alters how DCs metabolize glutamate, skewing cytokine secretion to bias T cell function. These effects provide protection in mouse models of multiple sclerosis (MS) by polarizing T cells away from inflammatory T(H)17 cells and toward regulatory T cells (T-REG) when mice receive daily systemic injections of PHCCC. However, frequent, continued treatment is required to generate and maintain therapeutic benefits. Thus, the use of PHCCC is limited by poor solubility, the need for frequent dosing, and cell toxicity. We hypothesized that controlled release of PHCCC from degradable nanoparticles (NPs) might address these challenges by altering DC function to maintain efficacy with reduced treatment frequency and toxicity. This idea could serve as a new strategy for harnessing biomaterials to polarize immune function through controlled delivery of metabolic modulators. PHCCC was readily encapsulated in nanoparticles, with controlled release of 89% of drug into media over three days. Culture of primary DCs or DC and T cell co-cultures with PHCCC NPs reduced DC activation and secretion of pro-inflammatory cytokines, while shifting T cells away from T(H)17 and toward T-REG phenotypes. Importantly, PHCCC delivered to cells in NPs was 36-fold less toxic compared with soluble PHCCC. Treatment of mice with PHCCC NPs every three days delayed disease onset and decreased disease severity compared with mice treated with soluble drug at the same dose and frequency. These results highlight the potential to promote tolerance through controlled delivery of metabolic modulators that alter DC signaling to polarize T cells, and suggest future gains that could be realized by engineering materials that provide longer term release. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Gammon, Joshua M.; Tostanoski, Lisa H.; Adapa, Arjun R.; Chiu, Yu-Chieh; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.
RP Jewell, CM (reprint author), Fischell Dept Bioengn, 2212 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
OI Tostanoski, Lisa/0000-0001-9255-5684; Jewell,
   Christopher/0000-0002-6668-6928
FU NSF CAREER Award [1351688]; National Multiple Sclerosis Society
   [PP2103]; Pharmaceutics division of the PhRMA Foundation [13071672];
   Damon Runyon Foundation [DDR3415]; Alliance for Cancer Gene Therapy
   [15051543]; Melanoma Research Alliance [348963];  [DGE1322106]
FX This work was supported in part by NSF CAREER Award # 1351688, the
   National Multiple Sclerosis Society # PP2103, and the Pharmaceutics
   division of the PhRMA Foundation # 13071672. CMJ is a Damon
   Runyon-Rachleff Innovator supported by the Damon Runyon Foundation (#
   DDR3415), a Young Investigator supported by the Alliance for Cancer Gene
   Therapy (# 15051543), and a Young Investigator support by the Melanoma
   Research Alliance (# 348963). LHT is a NSF Graduate Research Fellow
   supported by grant # DGE1322106.
CR Andorko J.I., 2014, AAPS J, V17, P323
   Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603
   Comabella M, 2012, CLIN IMMUNOL, V142, P2, DOI 10.1016/j.clim.2011.03.004
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Fallarino F, 2010, NAT MED, V16, P897, DOI 10.1038/nm.2183
   Fazio F, 2014, NEUROPHARMACOLOGY, V81, P237, DOI 10.1016/j.neuropharm.2014.02.011
   Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011
   Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036
   Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358
   Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168
   Lutterotti A, 2014, EXPERT OPIN INV DRUG, V23, P9, DOI 10.1517/13543784.2014.844788
   Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5
   Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111
   McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507
   MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Niswender CM, 2008, MOL PHARMACOL, V74, P1345, DOI 10.1124/mol.108.049551
   Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163
   Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555
   Samarasinghe R, 2006, J INTERF CYTOK RES, V26, P893, DOI 10.1089/jir.2006.26.893
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Spampinato Simona Federica, 2014, Front Cell Neurosci, V8, P462, DOI 10.3389/fncel.2014.00462
   Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1
   Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
NR 34
TC 15
Z9 17
U1 3
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 28
PY 2015
VL 210
BP 169
EP 178
DI 10.1016/j.jconrel.2015.05.277
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CK5CC
UT WOS:000356238700018
PM 26002150
OA Other Gold
DA 2018-10-19
ER

PT J
AU Yang, WK
   Chang, EJ
   Lee, WK
AF Yang, Won-Kyue
   Chang, Eun-Ju
   Lee, Woo-Kul
TI Alendronate-calcium phosphate hybrid films promoted the osteoblast
   differentiation and inhibited osteoclastogenic activity
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Calcium phosphate; Alendronate; Proliferation; Differentiation;
   Osteoblast; Osteoclast
ID NITROGEN-CONTAINING BISPHOSPHONATES; MESENCHYMAL STEM-CELLS; MARROW
   STROMAL CELLS; IN-VITRO; BONE; PROLIFERATION; HYDROXYAPATITE;
   NANOPARTICLES; OSTEOPOROSIS; MODULATION
AB Surface property of biomaterials is a crucial factor determining the biocompatibility of a biomaterial. In this study, we aimed at evaluating the feasibility of alendronate (ALN) and CP hybrid films (CPAs) to promote bone regeneration. Experimental analysis elucidated that ALN incorporation promoted osteoblast proliferation and differentiation, phenotype gene expression, phase shift from differentiation into mineralization, and bone-like nodule formation. Inhibitory effect on the formation of multinucleated osteoclast was substantial. Therefore, the hybrid films can enhance osteogenic responses while inducing anti-osteoclastic effects. We expect the hybrid films can be potentially utilized for the promotion of bone regeneration. (C) 2015 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Yang, Won-Kyue; Lee, Woo-Kul] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Coll Engn, Dept Chem Engn, Cheonan, South Korea.
   [Chang, Eun-Ju] Univ Ulsan, Coll Med, Dept Biomed Sci, Ulsan 680749, South Korea.
   [Chang, Eun-Ju] Univ Ulsan, Man Med Ctr, Ulsan 680749, South Korea.
RP Lee, WK (reprint author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Coll Engn, Dept Chem Engn, Cheonan, South Korea.
EM leewo@dankook.ac.kr
CR Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310
   Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040
   Boanini E, 2012, BONE, V51, P944, DOI 10.1016/j.bone.2012.07.020
   Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897
   Cenni E, 2008, BIOMATERIALS, V29, P1400, DOI 10.1016/j.biomaterials.2007.12.022
   Chang EJ, 2008, J CELL SCI, V121, P2555, DOI 10.1242/jcs.028217
   Coleman R, 2011, ANN NY ACAD SCI, V1218, P3, DOI 10.1111/j.1749-6632.2010.05766.x
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
   Duque G, 2007, J BONE MINER RES, V22, P1603, DOI 10.1359/JBMR.070701
   Elliott Susan N., 1998, Life Sciences, V62, P77
   Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7
   Haynes DR, 2004, BIOMATERIALS, V25, P4877, DOI 10.1016/j.biomaterials.2004.01.003
   Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024
   Inoue Y, 2010, EXP CLIN ENDOCR DIAB, V118, P719, DOI 10.1055/s-0030-1249084
   Jung JY, 2009, J MATER SCI-MATER M, V20, P2441, DOI 10.1007/s10856-009-3817-y
   Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lourwood DL, 1998, PHARMACOTHERAPY, V18, P779
   Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Monkkonen J., 1998, LIFE SCI, V62, pL95
   Moon HJ, 2011, BIOCHEM BIOPH RES CO, V413, P194, DOI 10.1016/j.bbrc.2011.08.057
   Moreau J.L., 2009, BIOMATERIALS, V30, P675
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800
   Price P.A., 1988, ANNU REV NUTR, V8, P865
   Ringe JD, 2001, J CLIN ENDOCR METAB, V86, P5252, DOI 10.1210/jc.86.11.5252
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640
   Schnitzler V, 2011, ACTA BIOMATER, V7, P759, DOI 10.1016/j.actbio.2010.09.017
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122
   Valta MP, 2006, ENDOCRINOLOGY, V147, P2171, DOI 10.1210/en.2005-1502
   VANBEEK E, 1994, J BONE MINER RES, V9, P1875, DOI 10.1002/jbmr.5650091206
   von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059
   Xiong Y, 2009, J INT MED RES, V37, P407, DOI 10.1177/147323000903700216
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Zhu Y, 2013, BIOMACROMOLECULES, V14, P342, DOI 10.1021/bm301523p
NR 41
TC 5
Z9 5
U1 5
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
EI 1876-794X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD JUL 25
PY 2015
VL 27
BP 391
EP 397
DI 10.1016/j.jiec.2015.01.019
PG 7
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CL8LC
UT WOS:000357225200050
DA 2018-10-19
ER

PT J
AU Matos, AC
   Marques, CF
   Pinto, RV
   Ribeiro, IAC
   Goncalves, LM
   Vaz, MA
   Ferreira, JMF
   Almeida, AJ
   Bettencourt, AF
AF Matos, Ana C.
   Marques, Catarina F.
   Pinto, Rosana V.
   Ribeiro, Isabel A. C.
   Goncalves, Ldia M.
   Vaz, Mario A.
   Ferreira, J. M. F.
   Almeida, Antonio J.
   Bettencourt, Ana F.
TI Novel doped calcium phosphate-PMMA bone cement composites as
   levofloxacin delivery systems
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Poly(methylmethacrylate); Biphasic calcium phosphate; Fluoroquinolone;
   Controlled release; Osteomyelitis; Biocompatibility; Drug delivery
   system
ID DRUG-DELIVERY; ANTIBIOTIC DELIVERY; HYDROXYAPATITE; RELEASE;
   REPLACEMENT; INFECTIONS; SURVIVAL; COATINGS
AB Antibiotic-loaded acrylic bone cements (ALABCs) are well-established and cost-effective materials to control the occurrence of bone and joint infections. However, the inexistence of alternative antibiotics other than those already commercially available and the poor ability to bind to bone tissue hampering its biological function are still major drawbacks of ALABCs clinical application. The concept of this research work is to develop a novel bone cement (BC) drug delivery system composed by Mg- and Sr-doped calcium phosphate (CaP) particles as drug carriers loaded into a lactose-modified acrylic BC, which, to the best of our knowledge, has never been reported. CaP particles are known to promote bone ingrowth and current research is focused on using these carriers as antibiotic delivery systems for the treatment of bone infections, like osteomyelitis. Levofloxacin is a fluoroquinolone with anti-staphylococcal activity and adequate penetration into osteoarticular tissues and increasingly being recommended to manage bone-related infections. Also, the lactose-modified BC matrix, with a more porous structure, has already proved to enhance antibiotic release from the BC inner matrix. This novel BC composite biomaterial has shown improved mechanical integrity, biocompatibility maintenance, and sustained release of levofloxacin, with concentrations over the minimum inhibitory concentration values after a 48 h while maintaining antibacterial activity over an 8-week period against Staphyloccocus aureus and Staphyloccocus epidermidis, common pathogens associated with bone infections. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Matos, Ana C.; Pinto, Rosana V.; Ribeiro, Isabel A. C.; Goncalves, Ldia M.; Almeida, Antonio J.; Bettencourt, Ana F.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, IMed ULisboa, P-1649003 Lisbon, Portugal.
   [Marques, Catarina F.; Ferreira, J. M. F.] Univ Aveiro, CICECO, Dept Mat & Ceram Engn, P-3810193 Aveiro, Portugal.
   [Vaz, Mario A.] Univ Porto, Fac Engn, INEGI, P-4200465 Oporto, Portugal.
RP Bettencourt, AF (reprint author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, IMed ULisboa, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.
EM asimao@ff.ulisboa.pt
RI Bettencourt, Ana/M-4219-2013; Vaz, Mario/I-5613-2015; iMed.ULisboa,
   CBT/B-4215-2014; Almeida, Antonio/I-6590-2012; iMed.ULisboa,
   NanoBB/B-5393-2014; Ribeiro, Isabel/A-6098-2014; iMed.ULisboa,
   iMed.ULisboa/C-6292-2014
OI Bettencourt, Ana/0000-0002-8498-5892; Vaz, Mario/0000-0002-6347-9608;
   Almeida, Antonio/0000-0002-7807-4726; Ribeiro,
   Isabel/0000-0002-7110-6393; Ferreira, Jose/0000-0002-7520-2809; Pinto,
   Flavia/0000-0002-8523-5479; Goncalves, Lidia/0000-0002-6799-2740;
   Marques, Catarina/0000-0002-3650-1830
FU CICECO; Portuguese government through the "Fundacao para a Ciencia e
   Tecnologia (FCT), Portugal" [EXCL/CTM-NAN/0166/2012,
   PEst-OE/SAU/UI4013/2011, SFRH/BD/78355/2011]
FX The authors gratefully acknowledge to Professor Jose Esteves from
   INEGI/FEUP, U. Porto, for the helpful availability throughout all the
   mechanical assays and to Nuno Monge for image on graphical artwork. The
   support of CICECO is also acknowledged. Authors thank the Portuguese
   government through the "Fundacao para a Ciencia e Tecnologia (FCT),
   Portugal" for financial support in the frame of the research project
   EXCL/CTM-NAN/0166/2012 and strategic project PEst-OE/SAU/UI4013/2011 and
   the Ph.D. grant SFRH/BD/78355/2011.
CR [Anonymous], 2009, 109935 ISO
   Bettencourt A, 2002, INT J PHARM, V241, P97, DOI 10.1016/S0378-5173(02)00136-9
   Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8
   Bettencourt AF, 2007, FREE RADICAL BIO MED, V43, pS44
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08
   Canul-Chuil A, 2003, J BIOMED MATER RES B, V64B, P27, DOI 10.1002/jbm.b.10486
   Clinical and Laboratory Standards Institute [CLSI], 2007, M100S17 CLSI
   Clinical Laboratory Standards Institute (CLSI), 2012, M07M09 CLSI, pM07
   Dall'Oca C, 2014, EUR J HISTOCHEM, V58, P95, DOI 10.4081/ejh.2014.2255
   de Lima IR, 2011, J BIOMED MATER RES A, V98A, P351, DOI 10.1002/jbm.a.33126
   Frutos G, 2010, ACTA BIOMATER, V6, P804, DOI 10.1016/j.actbio.2009.08.028
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032
   Hart E, 2010, J ANTIMICROB CHEMOTH, V65, P974, DOI 10.1093/jac/dkq057
   Hosseinzadeh H. R. S., 2013, ACRYLIC BONE CEMENT
   Hurst M, 2002, DRUGS, V62, P2127, DOI 10.2165/00003495-200262140-00013
   *ISO, 2002, 5833 ISO
   Jameson SS, 2015, ACTA ORTHOP, V86, P7, DOI 10.3109/17453674.2014.972256
   Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Lewis G, 2009, J BIOMED MATER RES B, V89B, P558, DOI 10.1002/jbm.b.31220
   Lin Y., 2014, J ANTIBIOT, P1
   Liu S, 2014, CARBOHYD POLYM, V102, P869, DOI 10.1016/j.carbpol.2013.10.076
   Lopez-Heredia MA, 2012, ACTA BIOMATER, V8, P3120, DOI 10.1016/j.actbio.2012.05.007
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI DOI 10.2174/1877610801002010040
   Matos AC, 2015, INT J PHARMACEUT, V485, P317, DOI 10.1016/j.ijpharm.2015.03.035
   Matos AC, 2014, MAT SCI ENG C-MATER, V38, P218, DOI 10.1016/j.msec.2014.02.002
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Pina S, 2010, EUR CELLS MATER, V20, P162
   Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044
   Sa Y, 2015, J BIOMED MATER RES B, V103, P548, DOI 10.1002/jbm.b.33233
   Shi M, 2010, BIOMATERIALS, V31, P4146, DOI 10.1016/j.biomaterials.2010.01.112
   Siepmann J, 2012, ADV DEL SCI TECHNOL, P127, DOI 10.1007/978-1-4614-0881-9_6
   Takechi M, 2002, J MATER SCI-MATER M, V13, P973, DOI 10.1023/A:1019816830793
   Uskokovic V, 2015, CRIT REV THER DRUG, V32, P1
   Uskokovic V, 2014, MAT SCI ENG C-MATER, V37, P210, DOI 10.1016/j.msec.2014.01.008
   WU S, 1971, J POLYM SCI POL SYM, P19
   Zebarjad S. M., 2011, ENGINEERING, V3, P795, DOI DOI 10.4236/ENG.2011.38096
   Zhou Y, 2014, COLLOID SURFACE B, V115, P237, DOI 10.1016/j.colsurfb.2013.11.045
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
   Zimmerli W., 2015, BONE JOINT INFECT MI
NR 45
TC 11
Z9 12
U1 1
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD JUL 25
PY 2015
VL 490
IS 1-2
BP 200
EP 208
DI 10.1016/j.ijpharm.2015.05.038
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CL3FV
UT WOS:000356836700023
PM 26002570
DA 2018-10-19
ER

PT J
AU Neufurth, M
   Wang, XH
   Tolba, E
   Dorweiler, B
   Schroder, HC
   Link, T
   Diehl-Seifert, B
   Muller, WEG
AF Neufurth, Meik
   Wang, Xiaohong
   Tolba, Emad
   Dorweiler, Bernhard
   Schroeder, Heinz C.
   Link, Thorben
   Diehl-Seifert, Baerbel
   Mueller, Werner E. G.
TI Modular Small Diameter Vascular Grafts with Bioactive Functionalities
SO PLOS ONE
LA English
DT Article
ID POLYELECTROLYTE MULTILAYER FILMS; ENDOTHELIAL-CELLS; INORGANIC
   POLYPHOSPHATE; IN-VIVO; CALCIUM POLYPHOSPHATE; ALKALINE-PHOSPHATASE;
   BLOOD-VESSEL; VE-CADHERIN; STEM-CELLS; ALGINATE
AB We report the fabrication of a novel type of artificial small diameter blood vessels, termed biomimetic tissue-engineered blood vessels (bTEBV), with a modular composition. They are composed of a hydrogel scaffold consisting of two negatively charged natural polymers, alginate and a modified chitosan, N,O-carboxymethyl chitosan (N,O-CMC). Into this biologically inert scaffold two biofunctionally active biopolymers are embedded, inorganic polyphosphate (polyP) and silica, as well as gelatin which exposes the cell recognition signal, Arg-Gly-Asp (RGD). These materials can be hardened by exposure to Ca2+ through formation of Ca2+ bridges between the polyanions, alginate, N, O-CMC, and polyP (alginate-Ca2+-N,O-CMC-polyP). The bTEBV are formed by pressing the hydrogel through an extruder into a hardening solution, containing Ca2+. In this universal scaffold of the bTEBV biomaterial, polycations such as poly(L-Lys), poly(D-Lys) or a His/Gly-tagged RGD peptide (three RGD units) were incorporated, which promote the adhesion of endothelial cells to the vessel surface. The mechanical properties of the biopolymer material (alginate-Ca2+-N,O-CMC-polyP-silica) revealed a hardness (elastic modulus) of 475 kPa even after a short incubation period in CaCl2 solution. The material of the artificial vascular grafts (bTEBVs with an outer size 6 mm and 1.8 mm, and an inner diameter 4 mm and 0.8 mm, respectively) turned out to be durable in 4-week pulsatile flow experiments at an alternating pressure between 25 and 100 mbar (18.7 and 75.0 mm Hg). The burst pressure of the larger (smaller) vessels was 850 mbar (145 mbar). Incorporation of polycationic poly(L-Lys), poly(D-Lys), and especially the His/Gly-tagged RGD peptide, markedly increased the adhesion of human, umbilical vein/vascular endothelial cells, EA.HY926 cells, to the surface of the hydrogel. No significant effect of the polyP samples on the clotting of human plasma is measured. We propose that the metabolically degradable polymeric scaffold bTEBV is a promising biomaterial for future prosthetic vascular grafts.
C1 [Neufurth, Meik; Wang, Xiaohong; Tolba, Emad; Schroeder, Heinz C.; Link, Thorben; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, D-55128 Mainz, Germany.
   [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Cardiothorac & Vasc Surg, Div Vasc Surg, D-55131 Mainz, Germany.
   [Diehl-Seifert, Baerbel] NanotecMARIN GmbH, D-55128 Mainz, Germany.
RP Muller, WEG (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
EM wang013@uni-mainz.de; wmueller@uni-mainz.de
RI Neufurth, Meik/N-4297-2015
OI Neufurth, Meik/0000-0002-2383-6412; Tolba, Emad/0000-0002-3422-2344
FU NanotecMARIN GmbH; European Research Council (ERC) Advanced Investigator
   Grant ("BIOSILICA") [268476]; ERC-PoC Grant ("MorphoVES-PoC") [662486];
   Deutsche Forschungsgemeinschaft [Schr 277/10-3]; European Commission
   [604036, 311848]; International Human Frontier Science Program
FX NanotecMARIN GmbH provided support in the form of salaries for the
   author BDS, but did not have any additional role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section. WEGM is a holder of a European Research
   Council (ERC) Advanced Investigator Grant ("BIOSILICA": No. 268476) and
   the ERC-PoC Grant ("MorphoVES-PoC": No. 662486). This work was supported
   by grants from the Deutsche Forschungsgemeinschaft (Schr 277/10-3), the
   European Commission ("Bio-Scaffolds": No. 604036 and "BlueGenics": No.
   311848), and the International Human Frontier Science Program.
CR AHN K, 1995, LIFE SCI, V56, P2331, DOI 10.1016/0024-3205(95)00227-W
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Anitha A., 2011, J BIOMAT SCI-POLYM E, V23, P1381, DOI DOI 10.1163/092050611X581534
   [Anonymous], 2013, REPORT A270
   [Anonymous], 2010, HEART DISEASE AND ST
   BARSTAD RM, 1995, BLOOD, V86, P212
   Bergmeister H, 2013, EUR SURG, V45, P187, DOI 10.1007/s10353-013-0224-x
   Biswas R, 2010, SEMIN DIALYSIS, V23, P105, DOI 10.1111/j.1525-139X.2009.00684.x
   Boura C, 2006, BIO-MED MATER ENG, V16, pS115
   Boura C, 2006, CELL BIOCHEM BIOPHYS, V44, P223, DOI 10.1385/CBB:44:2:223
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   BREWSTER DC, 2000, VASCULAR SURG, P559
   Brini Marisa, 2013, Met Ions Life Sci, V13, P81, DOI 10.1007/978-94-007-7500-8_4
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4
   Campos DFD, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015003
   Catto V, 2014, ISRN VASC MED, V2014, P1, DOI [10.1155/2014/923030, DOI 10.1155/2014/923030]
   Chavan D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766959
   Chavan D, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3579496
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811
   Comeau PA, 2012, J BIOMATER APPL, V27, P267, DOI 10.1177/0885328211401933
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Demirkhanyan L, 2014, BIOPHYS J, V106, p753A, DOI 10.1016/j.bpj.2013.11.4145
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   Do KH, 2009, EXP MOL MED, V41, P569, DOI 10.3858/emm.2009.41.8.062
   Embi A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-51
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870
   Faxalv L, 2013, BLOOD, V122, P3818, DOI 10.1182/blood-2013-05-499384
   Felner JM, 1990, CLINICAL METHODS THE, P57
   Fischer-Cripps AC, 2011, MECH ENG SER, P21, DOI 10.1007/978-1-4419-9872-9_2
   Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100
   Gu ZP, 2014, RSC ADV, V4, P2783, DOI 10.1039/c3ra44323j
   Hanson SR, 2006, ANN NY ACAD SCI, V516, P453
   He W, 2013, CELL BIOCHEM BIOPHYS, V66, P855, DOI 10.1007/s12013-013-9528-5
   Heng BC, 2011, BIOTECHNOL BIOPROC E, V16, P127, DOI 10.1007/s12257-010-0141-9
   Hojo K, 2013, PROTEIN PEPTIDE LETT, V20, P1122
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kader KN, 2000, TISSUE ENG, V6, P241, DOI 10.1089/10763270050044425
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Kulaev IS, 2004, THE BIOCHEMISTRY OF, P1
   KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Lee KY, 1997, J APPL POLYM SCI, V63, P425, DOI 10.1002/(SICI)1097-4628(19970124)63:4<425::AID-APP3>3.0.CO;2-T
   Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803
   Linderman S, 2014, FASEB J SUPPL 546 9, V28, P5469
   Loh SA, 2013, ANN VASC SURG, V27, P208, DOI 10.1016/j.avsg.2012.04.018
   Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5
   MacQuarrie JL, 2011, BLOOD, V117, P4134, DOI 10.1182/blood-2010-07-290551
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823
   Mori K, 2007, ONCOL REP, V18, P1365
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Muller WEG, 2015, J TISSUE ENG REGEN M, V9, pE39, DOI 10.1002/term.1745
   Muller WEG, 2015, J MATER CHEM B, V3, P1722, DOI 10.1039/c4tb01586j
   Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j
   Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007
   Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001
   Muller WEG, 2014, Patent application, Patent No. [1413154. 4, 14131544]
   Neufurth M, 2014, BIOMATERIALS, V35, P8810, DOI 10.1016/j.biomaterials.2014.07.002
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   Nikolova-Krstevski V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-240
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Pradeepa R, 2012, DIABETES TECHNOL THE, V14, pS59, DOI 10.1089/dia.2012.0065
   Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200
   Sachs L., 1984, ANGEW STAT, P242
   Sakairi N, 1998, CARBOHYD POLYM, V37, P409, DOI 10.1016/S0144-8617(97)00226-9
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Santos MF, 1997, AM J PHYSIOL-GASTR L, V273, pG175
   Sarkar S, 2006, J VASC SURG, V44, P846, DOI 10.1016/j.jvs.2006.07.023
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Schroder HC, 2003, PROG MOLEC, V33, P249
   Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108
   Smith PJ, 2004, CURR PROTOC CYTOM, V7, P725, DOI [10.1002/0471142956.cy0725s28, DOI 10.1002/0471142956.CY0725S28]
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Takei Takayuki, 2006, Biotechnology Journal, V1, P1014, DOI 10.1002/biot.200600055
   Tielen P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-159
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7
   VANDERLUGT A, 1995, EUR J VASC ENDOVASC, V9, P394, DOI 10.1016/S1078-5884(05)80006-1
   VANSON JAM, 1990, J THORAC CARDIOV SUR, V99, P703
   Varty K, 1996, BRIT J SURG, V83, P1375, DOI 10.1002/bjs.1800831015
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100
   Wang XH, 2014, MAR DRUGS, V12, P1131, DOI 10.3390/md12021131
   Welschoff J, 2014, FASEB J, V28, P2281, DOI 10.1096/fj.13-246348
   Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6
   YOSHIKI S, 1970, HISTOCHEMISTRY, V21, P249, DOI 10.1007/BF00304216
   Zidi M, 2003, COMPUT BIOL MED, V33, P65, DOI 10.1016/S0010-4825(02)00059-8
   Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29
NR 95
TC 5
Z9 5
U1 2
U2 54
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 23
PY 2015
VL 10
IS 7
AR e0133632
DI 10.1371/journal.pone.0133632
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN7NJ
UT WOS:000358621000034
PM 26204529
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Serpooshan, V
   Mahmoudi, M
   Zhao, MM
   Wei, K
   Sivanesan, S
   Motamedchaboki, K
   Malkovskiy, AV
   Goldstone, AB
   Cohen, JE
   Yang, PC
   Rajadas, J
   Bernstein, D
   Woo, YJ
   Ruiz-Lozano, P
AF Serpooshan, Vahid
   Mahmoudi, Morteza
   Zhao, Mingming
   Wei, Ke
   Sivanesan, Senthilkumar
   Motamedchaboki, Khatereh
   Malkovskiy, Andrey V.
   Goldstone, Andrew B.
   Cohen, Jeffrey E.
   Yang, Phillip C.
   Rajadas, Jayakumar
   Bernstein, Daniel
   Woo, Y. Joseph
   Ruiz-Lozano, Pilar
TI Protein Corona Influences Cell-Biomaterial Interactions in
   Nanostructured Tissue Engineering Scaffolds
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE collagen; in situ biosensors; nanostructures; personalized biomaterials;
   protein corona; tissue engineering; scaffolds
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; POST MYOCARDIAL-INFARCTION;
   NANOPARTICLE INTERACTIONS; HYDRAULIC PERMEABILITY; PLASTIC COMPRESSION;
   STEM-CELLS; BIOMARKERS; SECRETOME; PROMOTES; DISEASE
AB Biomaterials are extensively used to restore damaged tissues, in the forms of implants (e.g., tissue engineered scaffolds) or biomedical devices (e.g., pacemakers). Once in contact with the physiological environment, nanostructured biomaterials undergo modifications as a result of endogenous proteins binding to their surface. The formation of this macromolecular coating complex, known as protein corona, onto the surface of nanoparticles and its effect on cell-particle interactions are currently under intense investigation. In striking contrast, protein corona constructs within nanostructured porous tissue engineering scaffolds remain poorly characterized. As organismal systems are highly dynamic, it is conceivable that the formation of distinct protein corona on implanted scaffolds might itself modulate cell-extracellular matrix interactions. Here, it is reported that corona complexes formed onto the fibrils of engineered collagen scaffolds display specific, distinct, and reproducible compositions that are a signature of the tissue microenvironment as well as being indicative of the subject's health condition. Protein corona formed on collagen matrices modulated cellular secretome in a context-specific manner ex vivo, demonstrating their role in regulating scaffold-cellular interactions. Together, these findings underscore the importance of custom-designing personalized nanostructured biomaterials, according to the biological milieu and disease state. The use of protein corona as in situ biosensor of temporal and local biomarkers is proposed.
C1 [Serpooshan, Vahid; Mahmoudi, Morteza; Yang, Phillip C.; Rajadas, Jayakumar; Bernstein, Daniel; Ruiz-Lozano, Pilar] Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Serpooshan, Vahid; Zhao, Mingming; Bernstein, Daniel; Ruiz-Lozano, Pilar] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.
   [Mahmoudi, Morteza; Yang, Phillip C.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Wei, Ke] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.
   [Sivanesan, Senthilkumar; Malkovskiy, Andrey V.; Rajadas, Jayakumar] Stanford Univ, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.
   [Motamedchaboki, Khatereh] Sanford Burnham Med Res Inst, Prote Facil, La Jolla, CA 92037 USA.
   [Goldstone, Andrew B.; Cohen, Jeffrey E.; Woo, Y. Joseph] Stanford Univ, Med Ctr, Dept Cardiothorac Surg, Stanford, CA 94305 USA.
RP Serpooshan, V (reprint author), Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
EM mahmoudi@stanford.edu; prlozano@stanford.edu
RI Mahmoudi, Morteza/L-5332-2017
OI Mahmoudi, Morteza/0000-0002-2575-9684
FU National Institutes of Health [HL65484, HL086879, NIH R01 HL095571]; NIG
   [HL061535]
FX V.S. and M.M. contributed equally to this work. This work was supported
   by National Institutes of Health grants HL65484 and HL086879 (to
   P.R.-L.) and NIH R01 HL095571 (to Y.J.W.). V.S. was an Oak Foundation
   postdoctoral fellow at Stanford. D.B. was supported by NIG grant
   HL061535. K.W. was a SBMRI California Institute for Regenerative
   Medicine postdoctoral fellow (TG2-01162).
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Artym VV, 2010, CURRENT PROTOCOLS CE, V10, P1, DOI DOI 10.1002/0471143030.CB1018S48
   Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577
   Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001
   Breuls Roel G M, 2008, Open Orthop J, V2, P103, DOI 10.2174/1874325000802010103
   Brill LM, 2009, METHODS, V48, P311, DOI 10.1016/j.ymeth.2009.02.023
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652
   Chen HP, 2014, EXP CELL RES, V323, P346, DOI 10.1016/j.yexcr.2014.02.028
   de la Cuesta Fernando, 2013, Methods Mol Biol, V1005, P237, DOI 10.1007/978-1-62703-386-2_19
   Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Duffy PA, 2007, EJC SUPPL, V5, P143, DOI 10.1016/S1359-6349(07)70034-4
   Ghavami M., 2012, RSC ADV, V3, P1119
   Kelly PM, 2015, NAT NANOTECHNOL, V10, P472, DOI [10.1038/nnano.2015.47, 10.1038/NNANO.2015.47]
   Laurent S, 2013, J COLLOID INTERF SCI, V392, P431, DOI 10.1016/j.jcis.2012.10.005
   Li X, 2014, J PROTEOMICS, V98, P138, DOI 10.1016/j.jprot.2013.12.025
   Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248
   Mahmoudi M, 2014, NANO LETT, V14, P6, DOI 10.1021/nl403419e
   Mahmoudi M, 2013, ACS NANO, V7, P8379, DOI 10.1021/nn403844q
   Mahmoudi M, 2012, NANOSCALE, V4, P5461, DOI 10.1039/c2nr31185b
   Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g
   Mahmoudi M, 2011, NANOSCALE, V3, P1127, DOI 10.1039/c0nr00733a
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h
   Monopoli MP, 2011, NAT NANOTECHNOL, V6, P11, DOI 10.1038/nnano.2011.267
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Panahloo A, 2003, ATHEROSCLEROSIS, V168, P297, DOI 10.1016/S0021-9150(03)00095-9
   Serpooshan V, 2014, BIOENGINEERED, V5, DOI 10.4161/bioe.27751
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Serpooshan V, 2013, ACTA BIOMATER, V9, P4673, DOI 10.1016/j.actbio.2012.08.031
   Serpooshan V, 2011, SOFT MATTER, V7, P2918, DOI 10.1039/c0sm00691b
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028
   Shimano M, 2012, CIRCULATION, V126, pE327, DOI 10.1161/CIRCULATIONAHA.112.150656
   Spector M, 2002, TISSUE ENG, V8, P351, DOI 10.1089/107632702760184628
   Tardif JC, 2006, CIRCULATION, V113, P2936, DOI 10.1161/CIRCULATIONAHA.105.598987
   Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Vivanco F, 2005, J PROTEOME RES, V4, P1181, DOI 10.1021/pr0500197
   Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
NR 42
TC 13
Z9 13
U1 1
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUL 22
PY 2015
VL 25
IS 28
BP 4379
EP 4389
DI 10.1002/adfm.201500875
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CN5WR
UT WOS:000358504000001
PM 27516731
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Schultz, KM
   Kyburz, KA
   Anseth, KS
AF Schultz, Kelly M.
   Kyburz, Kyle A.
   Anseth, Kristi S.
TI Measuring dynamic cell-material interactions and remodeling during 3D
   human mesenchymal stem cell migration in hydrogels
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE PEG-peptide hydrogels; human mesenchymal stem cells; cell migration;
   microrheology
ID PARTICLE TRACKING MICRORHEOLOGY; ENGINEERED PEG HYDROGELS;
   CROSS-LINKING; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; DEGRADATION;
   ANGIOGENESIS; PROTEOLYSIS; TRANSITION; MICROSCOPY
AB Biomaterials that mimic aspects of the extracellular matrix by presenting a 3D microenvironment that cells can locally degrade and remodel are finding increased applications as wound-healing matrices, tissue engineering scaffolds, and even substrates for stem cell expansion. In vivo, cells do not simply reside in a static microenvironment, but instead, they dynamically reengineer their surroundings. For example, cells secrete proteases that degrade extracellular components, attach to the matrix through adhesive sites, and can exert traction forces on the local matrix, causing its spatial reorganization. Although biomaterials scaffolds provide initially well-defined microenvironments for 3D culture of cells, less is known about the changes that occur over time, especially local matrix remodeling that can play an integral role in directing cell behavior. Here, we use microrheology as a quantitative tool to characterize dynamic cellular remodeling of peptide-functionalized poly(ethylene glycol) (PEG) hydrogels that degrade in response to cell-secreted matrix metalloproteinases (MMPs). This technique allows measurement of spatial changes in material properties during migration of encapsulated cells and has a sensitivity that identifies regions where cells simply adhere to the matrix, as well as the extent of local cell remodeling of the material through MMP-mediated degradation. Collectively, these microrheological measurements provide insight into microscopic, cellular manipulation of the pericellular region that gives rise to macroscopic tracks created in scaffolds by migrating cells. This quantitative and predictable information should benefit the design of improved biomaterial scaffolds for medically relevant applications.
C1 [Schultz, Kelly M.] Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA.
   [Kyburz, Kyle A.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Kyburz, Kyle A.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Schultz, KM (reprint author), Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA.
EM kes513@lehigh.com; Kristi.Anseth@colorado.edu
FU Howard Hughes Medical Institute; National Science Foundation [CTS
   1236662]; National Institutes of Health [RO1DE016523]
FX We acknowledge Dr. Jennifer Leight for helpful discussion. Funding for
   this work was provided by Howard Hughes Medical Institute, the National
   Science Foundation (CTS 1236662), and the National Institutes of Health
   (RO1DE016523).
CR ADOLF D, 1990, MACROMOLECULES, V23, P3700, DOI 10.1021/ma00217a026
   Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Alkhouli N, 2013, AM J PHYSIOL-ENDOC M, V305, pE1427, DOI 10.1152/ajpendo.00111.2013
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738
   Crocker J. C., 2011, PARTICLE TRACKING US
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Guvendiren M, 2013, CURR OPIN BIOTECH, V24, P841, DOI 10.1016/j.copbio.2013.03.009
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.3.CO;2-V
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kyburz KA, 2013, ACTA BIOMATER, V9, P6381, DOI 10.1016/j.actbio.2013.01.026
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022
   Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mascall KS, 2012, J CELL SCI, V125, P2267, DOI 10.1242/jcs.099044
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975
   Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Reed MJ, 2003, MICROVASC RES, V65, P9, DOI 10.1016/S0026-2862(02)00026-2
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Schultz KM, 2013, SOFT MATTER, V9, P1570, DOI 10.1039/c2sm27303a
   Schultz KM, 2012, ACS MACRO LETT, V1, P706, DOI 10.1021/mz300106y
   Schultz KM, 2012, SOFT MATTER, V8, P6198, DOI 10.1039/c2sm25187f
   Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/nmat3025, 10.1038/NMAT3025]
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tseng Q, 2014, PIV PARTICLE IMAGE V
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616
   Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152
   Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2
   Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035
NR 48
TC 43
Z9 43
U1 4
U2 97
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 21
PY 2015
VL 112
IS 29
BP E3757
EP E3764
DI 10.1073/pnas.1511304112
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN2BJ
UT WOS:000358225100005
PM 26150508
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Shiwaku, Y
   Neff, L
   Nagano, K
   Takeyama, KI
   de Bruijn, J
   Dard, M
   Gori, F
   Baron, R
AF Shiwaku, Yukari
   Neff, Lynn
   Nagano, Kenichi
   Takeyama, Ken-Ichi
   de Bruijn, Joost
   Dard, Michel
   Gori, Francesca
   Baron, Roland
TI The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the
   Composition and Structure of Biphasic Calcium Phosphates
SO PLOS ONE
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; BONE-FORMATION; SPHINGOSINE 1-PHOSPHATE;
   SEALING ZONE; RESORPTION; HYDROXYAPATITE; DIFFERENTIATION; ACTIVATION;
   TISSUE; CELLS
AB Biphasic calcium phosphates (BCPs), consisting of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), exhibit good biocompatibility and osteoconductivity, maintaining a balance between resorption of the biomaterial and formation of new bone. We tested whether the chemical composition and/or the microstructure of BCPs affect osteoclasts (OCs) differentiation and/or their ability to crosstalk with osteoblasts (OBs). To this aim, OCs were cultured on BCPs with HA content of 5, 20 or 60% and their differentiation and activity were assessed. We found that OC differentiation is partially impaired by increased HA content, but not by the presence of micropores within BCP scaffolds, as indicated by TRAP staining and gene profile expression. We then investigated whether the biomaterial-induced changes in OC differentiation also affect their ability to crosstalk with OBs and regulate OB function. We found that BCPs with low percentage of HA favored the expression of positive coupling factors, including sphingosine-kinase 1 (SPHK1) and collagen triple helix repeat containing 1 (Cthrc1). In turn, the increase of these secreted coupling factors promotes OB differentiation and function. All together our studies suggest that the chemical composition of biomaterials affects not only the differentiation and activity of OCs but also their potential to locally regulate bone formation.
C1 [Shiwaku, Yukari; Neff, Lynn; Nagano, Kenichi; Takeyama, Ken-Ichi; Gori, Francesca; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA.
   [Baron, Roland] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Endocrine Unit, Boston, MA USA.
   [de Bruijn, Joost] Xpand Biotechnol BV, Bilthoven, Netherlands.
   [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY 10003 USA.
RP Baron, R (reprint author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.
EM Roland_Baron@hsdm.harvard.edu
FU Straumann
FX This work was supported by Straumann in the form of research support for
   Dr. Baron's laboratory at Harvard.
CR Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Benahmed MD, 1996, J HISTOCHEM CYTOCHEM, V44, P1131, DOI 10.1177/44.10.8813078
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954
   Ghanaati S, 2012, BIOMEDICAL MAT, V7
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Gonda Y, 2009, BIOMATERIALS, V30, P4390, DOI 10.1016/j.biomaterials.2009.05.002
   Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008
   Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7
   Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008
   Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215
   Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840
   Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187
   Matsuzaki E, 2013, BONE, V55, P315, DOI 10.1016/j.bone.2013.04.008
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621
   Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489
   Okuda T, 2007, BIOMATERIALS, V28, P2612, DOI 10.1016/j.biomaterials.2007.01.040
   Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106
   Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   Ripamonti U, 2010, BIOMATERIALS, V31, P6400, DOI 10.1016/j.biomaterials.2010.04.037
   Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430
   Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522
   Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001
   Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215
   Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493
   Tanaka T, 2010, J BIOMED MATER RES A, V93A, P469, DOI 10.1002/jbm.a.32560
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012
NR 48
TC 12
Z9 12
U1 4
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 20
PY 2015
VL 10
IS 7
AR e0132903
DI 10.1371/journal.pone.0132903
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN6LN
UT WOS:000358546400042
PM 26193362
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Premnath, P
   Tan, B
   Venkatakrishnan, K
AF Premnath, P.
   Tan, B.
   Venkatakrishnan, K.
TI Engineering functionalized multi-phased silicon/silicon oxide
   nano-biomaterials to passivate the aggressive proliferation of cancer
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESOPOROUS SILICA NANOPARTICLES; DRUG-DELIVERY; LASER; CELL;
   NANOSTRUCTURES; FABRICATION; DOXORUBICIN; RELEASE; SURFACE; SIZE
AB Currently, the use of nano silicon in cancer therapy is limited as drug delivery vehicles and markers in imaging, not as manipulative/controlling agents. This is due to limited properties that native states of nano silicon and silicon oxides offers. We introduce nano-functionalized multi-phased silicon/silicon oxide biomaterials synthesized via ultrashort pulsed laser synthesis, with tunable properties that possess inherent cancer controlling properties that can passivate the progression of cancer. This nanostructured biomaterial is composed of individual functionalized nanoparticles made of a homogenous hybrid of multiple phases of silicon and silicon oxide in increasing concentration outwards from the core. The chemical properties of the proposed nanostructure such as number of phases, composition of phases and crystal orientation of each functionalized nanoparticle in the three dimensional nanostructure is defined based on precisely tuned ultrashort pulsed laser-material interaction mechanisms. The amorphous rich phased biomaterial shows a 30 fold (95%) reduction in number of cancer cells compared to bulk silicon in 48 hours. Further, the size of the cancer cells reduces by 76% from 24 to 48 hours. This method exposes untapped properties of combination of multiple phases of silicon oxides and its applications in cancer therapy.
C1 [Premnath, P.; Venkatakrishnan, K.] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
   [Tan, B.] Ryerson Univ, Dept Aerosp Engn, Toronto, ON M5B 2K3, Canada.
RP Venkatakrishnan, K (reprint author), Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
EM venkat@ryerson.ca
OI Venkatakrishnan, Krishnan/0000-0002-6491-3971; Tan,
   Bo/0000-0001-8141-4819
FU NSERC
FX The authors thanks Nabila Abraham and Dhruv Patel for assistance in
   imaging and analysis. This study was supported by NSERC.
CR Biserni E, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2461-8
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Dalby M. J., 2003, EXP CELL RES, V284, P272
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dekker RJ, 2005, BIOMATERIALS, V26, P5231, DOI 10.1016/j.biomaterials.2005.01.057
   Dey PP, 2014, APPL SURF SCI, V307, P77, DOI 10.1016/j.apsusc.2014.03.168
   Erogbogbo F, 2010, ACS NANO, V5, P413, DOI [DOI 10.1021/NN1018945, 10.1021/nn1018945]
   Erogbogbo F, 2008, ACS NANO, V2, P873, DOI 10.1021/nn700319z
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Jin CY, 2008, CHEM RES TOXICOL, V21, P1871, DOI 10.1021/tx800179f
   Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524
   Li L, 2014, BIOSENS BIOELECTRON, V61, P76, DOI 10.1016/j.bios.2014.05.012
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m
   Meseguer-Olmo L, 2006, J ORTHOP RES, V24, P454, DOI 10.1002/jor.20064
   Milleret V, 2012, ACTA BIOMATER, V8, P4349, DOI 10.1016/j.actbio.2012.07.032
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Monem AS, 2014, INT J PHARMACEUT, V470, P1, DOI 10.1016/j.ijpharm.2014.04.067
   Nisbet D. R., 2008, J BIOMATER APPL, V27, P269
   Odachi G, 2013, APPL SURF SCI, V282, P525, DOI 10.1016/j.apsusc.2013.06.005
   Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197
   Ravichandran R, 2013, J BIOMAT SCI-POLYM E, V24, P1988, DOI 10.1080/09205063.2013.816930
   Rosenholm JM, 2008, ACS NANO, V3, P197
   Shi L, 2014, J MATER CHEM B, V2, P2658, DOI 10.1039/c4tb00016a
   Sivayoganathan M, 2012, OPT MATER EXPRESS, V2, P987, DOI 10.1364/OME.2.000987
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   Srinivasan S, 2014, J PHOTOCH PHOTOBIO B, V136, P81, DOI 10.1016/j.jphotobiol.2014.04.012
   Tavangar A, 2013, J APPL PHYS, V113, DOI 10.1063/1.4771667
   Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087
   Ullmann M, 2002, J NANOPART RES, V4, P499, DOI 10.1023/A:1022840924336
   Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333
   Xiao L, 2011, ACS NANO, V5, P3651, DOI 10.1021/nn1035262
   Zhang Q, 2012, ADV FUNCT MATER, V22, P5144, DOI 10.1002/adfm.201201316
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
   Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138
NR 35
TC 5
Z9 5
U1 0
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 20
PY 2015
VL 5
AR 12141
DI 10.1038/srep12141
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1HU
UT WOS:000358170300001
PM 26190009
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Nakajima, K
   Fujita, J
   Matsui, M
   Tohyama, S
   Tamura, N
   Kanazawa, H
   Seki, T
   Kishino, Y
   Hirano, A
   Okada, M
   Tabei, R
   Sano, M
   Goto, S
   Tabata, Y
   Fukuda, K
AF Nakajima, Kazuaki
   Fujita, Jun
   Matsui, Makoto
   Tohyama, Shugo
   Tamura, Noriko
   Kanazawa, Hideaki
   Seki, Tomohisa
   Kishino, Yoshikazu
   Hirano, Akinori
   Okada, Marina
   Tabei, Ryota
   Sano, Motoaki
   Goto, Shinya
   Tabata, Yasuhiko
   Fukuda, Keiichi
TI Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes
   and Angiogenesis to Ameliorate Cardiac Function after Myocardial
   Infarction
SO PLOS ONE
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; HEART;
   THERAPY; INTRACORONARY; BIOMATERIALS; REGENERATION; MYOCYTES; TRIAL
AB Cell transplantation therapy will mean a breakthrough in resolving the donor shortage in cardiac transplantation. Cardiomyocyte (CM) transplantation, however, has been relatively inefficient in restoring cardiac function after myocardial infarction (MI) due to low engraftment of transplanted CM. In order to ameliorate engraftment of CM, the novel transplantation strategy must be invented. Gelatin hydrogel (GH) is a biodegradable water-soluble polymer gel. Gelatin is made of collagen. Although we observed that collagen strongly induced the aggregation of platelets to potentially cause coronary microembolization, GH did not enhance thrombogenicity. Therefore, GH is a suitable biomaterial in the cell therapy after heart failure. To assess the effect of GH on the improvement of cardiac function, fetal rat CM (5x10(6) or 1x10(6) cells) were transplanted with GH (10 mg/ml) to infarcted hearts. We compared this group with sham operated rats, CM in phosphate buffered saline (PBS), only PBS, and only GH-transplanted groups. Three weeks after transplantation, cardiac function was evaluated by echocardiography. The echocardiography confirmed that transplantation of 5x10(6) CM with GH significantly improved cardiac systolic function, compared with the CM+PBS group (fractional area change: 75.1 +/- 3.4% vs. 60.7 +/- 5.9%, p<0.05), only PBS, and only GH groups (60.1 +/- 6.5%, 65.0 +/- 2.8%, p<0.05). Pathological analyses demonstrated that in the CM+GH group, CM were efficiently engrafted in infarcted myocardium (p<0.01) and angiogenesis was significantly enhanced (p<0.05) in both central and peripheral areas of the scar. Moreover, quantitative RT-PCR revealed that angiogenic cytokines, such as basic fibroblast growth factor, vascular endothelial growth factor, and hepatocyte growth factor, were significantly enriched in the CM+GH group (p<0.05). Here, we report that GH confined the CM effectively in infarcted myocardium after transplantation, and that CM transplanted with GH improved cardiac function with a direct contraction effect and enhanced angiogenesis.
C1 [Nakajima, Kazuaki; Fujita, Jun; Tohyama, Shugo; Kanazawa, Hideaki; Seki, Tomohisa; Kishino, Yoshikazu; Okada, Marina; Tabei, Ryota; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.
   [Hirano, Akinori] Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan.
   [Matsui, Makoto; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Inst Frontier Med Sci, Field Tissue Engn,Sakyo Ku, Kyoto, Japan.
   [Tamura, Noriko; Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 25911, Japan.
   [Tohyama, Shugo] Japan Soc Promot Sci, Tokyo, Japan.
RP Fujita, J (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.
EM jfujita@a6.keio.jp
RI Fukuda, Keiichi/L-3777-2013
FU Highway Program for Realization of Regenerative Medicine from Japan
   Science and Technology Agency
FX The present work was supported by the Highway Program for Realization of
   Regenerative Medicine from Japan Science and Technology Agency (to KF,
   http://www.jst.go.jp/saisei-nw/highway/research/b.html).
CR Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Fujita J, 2012, AM J PHYSIOL-HEART C, V303, pH1169, DOI 10.1152/ajpheart.00376.2012
   Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198
   Goto SY, 2002, CIRCULATION, V106, P266, DOI 10.1161/01.CIR.0000021427.87256.7E
   Hato N, 2012, OTOLARYNG HEAD NECK, V146, P641, DOI 10.1177/0194599811431661
   Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   Hemmi N, 2014, STEM CELL TRANSL MED, V3, P1473, DOI 10.5966/sctm.2014-0072
   Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137
   Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552
   Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016
   Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Van Belle E, 1998, CIRCULATION, V97, P381
   van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001
   YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
NR 27
TC 13
Z9 13
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 17
PY 2015
VL 10
IS 7
AR e0133308
DI 10.1371/journal.pone.0133308
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1RV
UT WOS:000358198700123
PM 26186362
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wickham, A
   Sjolander, D
   Bergstrom, G
   Wang, EG
   Rajendran, V
   Hildesjo, C
   Skoglund, K
   Nilsson, KPR
   Aili, D
AF Wickham, Abeni
   Sjolander, Daniel
   Bergstrom, Gunnar
   Wang, Ergang
   Rajendran, Vijayalakshmi
   Hildesjo, Camilla
   Skoglund, Karin
   Nilsson, K. Peter R.
   Aili, Daniel
TI Near-Infrared Emitting and Pro-Angiogenic Electrospun Conjugated Polymer
   Scaffold for Optical Biomaterial Tracking
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; IN-VIVO; STEM-CELLS; CONDUCTING
   POLYMERS; NEURAL INTERFACES; SURFACE-ENERGY; SOLAR-CELLS; MICROSCOPY;
   COLLAGEN; DIFFERENTIATION
AB Noninvasive tracking of biomaterials is vital for determining the fate and degradation of an implant in vivo, and to show its role in tissue regeneration. Current biomaterials have no inherent capacity to enable tracing but require labeling with, for example, fluorescent dyes, or nanoparticles. Here a novel biocompatible fully conjugated electrospun scaffold is described, based on a semiconducting luminescent polymer that can be visualized in situ after implantation using fluorescence imaging. The polymer, poly [2,3-bis-(3-octyloxyphenyl)quinoxaline-5,8-diyl-alt -thiophene-2,5-diyl] (TQ1), is electrospun to form a fibrous mat. The fibers display fluorescence emission in the near-infrared region with lifetimes in the sub-nanosecond range, optimal for in situ imaging. The material shows no cytotoxic behaviors for embryonic chicken cardiomyocytes and mouse myoblasts, and cells migrate onto the TQ1 fibers even in the presence of a collagen substrate. Subcutaneous implantations of the material in rats show incorporation of the TQ1 fibers within the tissue, with limited inflammation and a preponderance of small capillaries around the fibers. The fluorescent properties of the TQ1 fibers are fully retained for up to 90 d following implantation and they can be clearly visualized in tissue using fluorescence and lifetime imaging, thus making it both a pro-angiogenic and traceable biomaterial.
C1 [Wickham, Abeni; Aili, Daniel] Linkoping Univ, Div Mol Phys, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
   [Sjolander, Daniel; Nilsson, K. Peter R.] Linkoping Univ, Div Organ Chem, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
   [Bergstrom, Gunnar] Linkoping Univ, Div Biotechnol, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
   [Wang, Ergang] Chalmers, Dept Chem & Chem Engn Polymer Technol, SE-41296 Gothenburg, Sweden.
   [Rajendran, Vijayalakshmi] Linkoping Univ, Integrat Regenerat Med IGEN Ctr, SE-58183 Linkoping, Sweden.
   [Rajendran, Vijayalakshmi] Linkoping Univ, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden.
   [Hildesjo, Camilla; Skoglund, Karin] Linkoping Univ Hosp, Dept Clin Pathol, Council Ostergotland, SE-58183 Linkoping, Sweden.
RP Wickham, A (reprint author), Linkoping Univ, Div Mol Phys, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
EM daniel.aili@liu.se
RI Aili, Daniel/L-2668-2013; Sjolander, Daniel/B-7813-2011; Wang,
   Ergang/F-8157-2010
OI Aili, Daniel/0000-0002-7001-9415; Sjolander, Daniel/0000-0003-2274-4062;
   Wang, Ergang/0000-0002-4942-3771; Wickham, Abeni/0000-0002-2106-0665
FU Linkoping University; Swedish Foundation for Strategic Research; Swedish
   Research Council
FX Thanks to Prof. Torkel Erhardsson for statistical guidance, to Jonas
   Bergqvist for help with photoluminescent data acquisition, Anders
   Elfwing, Dr. Luigi Petrone, Dr. Koen Vandewal, Dr. Naresh Polsetti,
   Prof. Klas I. Udekwu, and Prof. Olle Inganas for help with initial
   experiments. Also, thanks to Dr. Staffan Danmark for reviewing the
   manuscript. Prof. Jordi Altimiras kindly provided the ECCM (Linkoping
   University, Sweden). D.A. and A.W. gratefully acknowledge financial
   support from Linkoping University and the Swedish Foundation for
   Strategic Research. K.P.R.N. and D.S. acknowledge the support by the
   Swedish Foundation for Strategic Research. E.W. thanks the Swedish
   Research Council for financial support. During this study, A.W. was
   enrolled in the graduate school Forum Scientium.
CR Achelle S, 2013, DYES PIGMENTS, V98, P575, DOI 10.1016/j.dyepig.2013.03.030
   Akins RE, 2010, TISSUE ENG PT A, V16, P629, DOI 10.1089/ten.tea.2009.0458
   Appel A. A., 2021, BIOMATERIALS, V34, P6615
   Arja K, 2013, MACROMOL RAPID COMM, V34, P723, DOI 10.1002/marc.201200817
   Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v
   Bai C, 2013, CELL PROLIFERAT, V46, P232, DOI 10.1111/cpr.12024
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Biswas T, 2010, J MOL BIOL, V397, P495, DOI 10.1016/j.jmb.2010.01.053
   Breukers RD, 2010, J BIOMED MATER RES A, V95A, P256, DOI 10.1002/jbm.a.32822
   Burattini S, 2004, EUR J HISTOCHEM, V48, P223
   Cui MC, 2011, BIOORG MED CHEM LETT, V21, P4193, DOI 10.1016/j.bmcl.2011.05.079
   Ding D, 2011, NANOSCALE, V3, P1997, DOI 10.1039/c0nr00950d
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496
   Fomina N, 2010, J AM CHEM SOC, V132, P9540, DOI 10.1021/ja102595j
   Formigli L, 2005, AM J PHYSIOL-CELL PH, V288, pC795, DOI 10.1152/ajpcell.00345.2004
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Harris JR, 2007, MICRON, V38, P513, DOI 10.1016/j.micron.2006.07.026
   Hedstrom S, 2012, J PHYS CHEM C, V116, P26700, DOI 10.1021/jp308063u
   Heinrich L., 2006, J BIOMED MATER RES P, V81B, P153
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278
   Hou LT, 2011, ADV FUNCT MATER, V21, P3169, DOI 10.1002/adfm.201100566
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI [10.1016/j.biomaterials.2004.01.047, 10.1016/j.biomatcrials.2004.01.047]
   Kim SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014110
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Laforgue A, 2010, MACROMOLECULES, V43, P4194, DOI 10.1021/ma9027678
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009
   Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]
   Nwaneshiudu A, 2012, J INVEST DERMATOL, V132, P1, DOI 10.1038/jid.2012.429
   Ostuni E, 2003, LANGMUIR, V19, P1861, DOI 10.1021/la020649c
   Petrone L, 2011, BIOFOULING, V27, P1043, DOI 10.1080/08927014.2011.625474
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Shen Y., 2014, BIOMED MATER, V9, P1
   Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326
   Stachewicz U, 2011, LANGMUIR, V27, P3024, DOI 10.1021/la1046645
   Toshima K, 2002, CHEM COMMUN, P212, DOI 10.1039/b107829c
   Tromholt T, 2012, J MATER CHEM, V22, P7592, DOI 10.1039/c2jm16340c
   Wang EG, 2010, ADV MATER, V22, P5240, DOI 10.1002/adma.201002225
   Weber K. T., 1989, MOL CELL BIOCHEM, V96, P1
   Wegenast-Braun BM, 2012, AM J PATHOL, V181, P1953, DOI 10.1016/j.ajpath.2012.08.031
   Whatmore Jacqueline L., 2002, Angiogenesis, V5, P45, DOI 10.1023/A:1021528628524
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xie J, 2014, ACTA BIOMATER, V10, P2463, DOI 10.1016/j.actbio.2014.01.031
   Yuan YY, 2014, SMALL, V10, P1967, DOI 10.1002/smll.201302765
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
NR 61
TC 9
Z9 9
U1 4
U2 64
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUL 15
PY 2015
VL 25
IS 27
BP 4274
EP 4281
DI 10.1002/adfm.201500351
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CM9AG
UT WOS:000357996600011
DA 2018-10-19
ER

PT J
AU Mahdis, S
   Youngjae, C
AF Mahdis, Shayan
   Youngjae, Chun
TI An overview of thin film nitinol endovascular devices
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Thin film nitinol; Endovascular device; Sputtering deposition;
   Hemocompatibility; Stent graft
ID SHAPE-MEMORY ALLOY; PULSED-LASER DEPOSITION; GUINIER-PRESTON ZONES;
   SPUTTER-DEPOSITION; HEART-VALVE; MECHANICAL-PROPERTIES; MEDICAL
   APPLICATIONS; FLASH EVAPORATION; PLATELET-ADHESION; SURFACE OXIDATION
AB Thin film nitinol has unique mechanical properties (e.g., superelasticity), excellent biocompatibility, and ultra-smooth surface, as well as shape memory behavior. All these features along with its low-profile physical dimension (i.e., a few micrometers thick) make this material an ideal candidate in developing low-profile medical devices (e.g., endovascular devices). Thin film nitinol-based devices can be collapsed and inserted in remarkably smaller diameter catheters for a wide range of catheter-based procedures; therefore, it can be easily delivered through highly tortuous or narrow vascular system. A high-quality thin film nitinol can be fabricated by vacuum sputter deposition technique. Micromachining techniques were used to create micro patterns on the thin film nitinol to provide fenestrations for nutrition and oxygen transport and to increase the device's flexibility for the devices used as thin film nitinol covered stent. In addition, a new surface treatment method has been developed for improving the hemocompatibility of thin film nitinol when it is used as a graft material in endovascular devices. Both in vitro and in vivo test data demonstrated a superior hemocompatibility of the thin film nitinol when compared with commercially available endovascular graft materials such as ePTFE or Dacron polyester. Promising features like these have motivated the development of thin film nitinol as a novel biomaterial for creating endovascular devices such as stent grafts, neurovascular flow diverters, and heart valves. This review focuses on thin film nitinol fabrication processes, mechanical and biological properties of the material, as well as current and potential thin film nitinol medical applications. (C) 2015 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mahdis, Shayan; Youngjae, Chun] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA.
   [Youngjae, Chun] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
RP Youngjae, C (reprint author), Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA.
EM yjchun@pitt.edu
CR Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   Bourantas CV, 2013, INT J CARDIOL, V168, P11, DOI 10.1016/j.ijcard.2013.03.065
   Brisman JL, 2005, AM J NEURORADIOL, V26, P1237
   Buehler W. J., 1962, T ASM, V55, P269
   BUSCH JD, 1990, J APPL PHYS, V68, P6224, DOI 10.1063/1.346914
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Cha JO, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-37
   Chen P, 2001, THIN SOLID FILMS, V398, P597, DOI 10.1016/S0040-6090(01)01325-6
   Chu JP, 2000, MAT SCI ENG A-STRUCT, V277, P11, DOI 10.1016/S0921-5093(99)00560-2
   Chun Y, 2011, J INTEL MAT SYST STR, V22, P1
   Chun YJ, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/105021
   Chun Y, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/5/055021
   Chun Y, 2009, MAT SCI ENG C-MATER, V29, P2436, DOI 10.1016/j.msec.2009.07.004
   Chun YJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118769
   Ciabattari F, 1997, APPL PHYS A-MATER, V64, P623, DOI 10.1007/s003390050528
   Collen KR, 1991, STRUCTURAL ELECT PRO
   de Miranda RL, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/10/104010
   Dinca VC, 2006, APPL SURF SCI, V252, P4619, DOI 10.1016/j.apsusc.2005.07.093
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2
   Gu HD, 1998, THIN SOLID FILMS, V330, P196, DOI 10.1016/S0040-6090(98)00603-8
   Gupta V, 2003, P INT C SHAP MEM SUP
   Gyobu A, 1996, HEAT TREAT, V139, P340
   Habijan T, 2012, MAT SCI ENG C-MATER, V32, P2523, DOI 10.1016/j.msec.2012.07.035
   He JL, 2000, THIN SOLID FILMS, V359, P46, DOI 10.1016/S0040-6090(99)00720-8
   Ho KK, 2002, THIN SOLID FILMS, V413, P1, DOI 10.1016/S0040-6090(02)00339-5
   Ho KK, 2000, THIN SOLID FILMS, V370, P18, DOI 10.1016/S0040-6090(00)00947-0
   Huang XY, 2003, NAT MATER, V2, P307, DOI 10.1038/nmat884
   Ikuta K., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), P355, DOI 10.1109/MEMSYS.1994.556166
   Ishida A, 1999, MAT SCI ENG A-STRUCT, V273, P754, DOI 10.1016/S0921-5093(99)00410-4
   Ishida A, 1995, MATER T JIM, V36, P1349, DOI 10.2320/matertrans1989.36.1349
   Ishida A, 1997, METALL MATER TRANS A, V28, P1985, DOI 10.1007/s11661-997-0155-x
   Ishida A, 2003, ACTA MATER, V51, P5571, DOI 10.1016/S1359-6454(03)00420-8
   Ishida A, 2001, MATER TRANS, V42, P1060, DOI 10.2320/matertrans.42.1060
   ISHIDA A, 1993, THIN SOLID FILMS, V228, P210, DOI 10.1016/0040-6090(93)90600-T
   JARDINE AP, 1994, MATER CHARACT, V32, P169
   Jarrige I, 2004, THIN SOLID FILMS, V458, P314, DOI 10.1016/j.tsf.2003.12.039
   Kajiwara S, 1996, PHIL MAG LETT, V74, P395, DOI 10.1080/095008396179922
   Kauffman GB, 1997, CHEM ED, V21, P1, DOI DOI 10.1007/S00897970111A]
   Kealey CP, 2010, BIOMATERIALS, V31, P8864, DOI 10.1016/j.biomaterials.2010.08.014
   Kikuchi T, 1998, PHILOS MAG A, V78, P467
   KIM JJ, 1986, SCRIPTA METALL MATER, V20, P243, DOI 10.1016/0036-9748(86)90135-3
   Kuribayashi K, 2006, MAT SCI ENG A-STRUCT, V419, P131, DOI 10.1016/j.msea.2005.12.016
   Lee HJ, 2009, SCRIPTA MATER, V60, P1133, DOI 10.1016/j.scriptamat.2009.02.054
   Lee HJ, 2006, MATER TRANS, V47, P527, DOI 10.2320/matertrans.47.527
   Lee YJ, 2005, NEURORADIOLOGY, V47, P680, DOI 10.1007/s00234-005-1402-8
   Lehnert T, 2002, J MATER SCI, V37, P1523, DOI 10.1023/A:1014904415916
   Lehnert T, 1999, MAT SCI ENG A-STRUCT, V273, P713, DOI 10.1016/S0921-5093(99)00402-5
   Levi DS, 2008, ASAIO J, V54, P221, DOI 10.1097/MAT.0b013e31816b43b0
   Machado LG, 2003, BRAZ J MED BIOL RES, V36, P683, DOI 10.1590/S0100-879X2003000600001
   Makino E, 1999, SENSOR ACTUAT A-PHYS, V75, P156, DOI 10.1016/S0924-4247(99)00003-5
   Makino E, 1998, SENSOR ACTUAT A-PHYS, V71, P187, DOI 10.1016/S0924-4247(98)00180-0
   Malisch TW, 1997, J NEUROSURG, V87, P176, DOI 10.3171/jns.1997.87.2.0176
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   MIYAZAKI S, 1994, MATER T JIM, V35, P14, DOI 10.2320/matertrans1989.35.14
   Mohanchandra KP, 2008, MATER LETT, V62, P3481, DOI 10.1016/j.matlet.2008.03.028
   Mohanchandra KP, 2011, MATER LETT, V65, P1184, DOI 10.1016/j.matlet.2011.01.037
   Nair K, 2003, SADHANA-ACAD P ENG S, V28, P575, DOI 10.1007/BF02706448
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Petrini L, 2011, J METALL, V2011, P41
   Qian LM, 2005, TRIBOL LETT, V18, P463, DOI 10.1007/s11249-005-3606-9
   Quandt E, 1996, SENSOR ACTUAT A-PHYS, V53, P434, DOI 10.1016/0924-4247(96)01147-8
   Rigberg D, 2009, J VASC SURG, V50, P375, DOI 10.1016/j.jvs.2009.03.028
   Saatci I, 2004, AM J NEURORADIOL, V25, P1742
   Samaroo HD, 2008, INT J NANOMED, V3, P75
   Sanjabi S, 2005, THIN SOLID FILMS, V491, P190, DOI 10.1016/j.tsf.2005.06.004
   Sanjabi S, 2009, SCI IRAN TRANS B, V16, P248
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SEKIGUCHI Y, 1983, P 32 M JAP SOC MAT, P65
   Serruys PW, 2002, HDB CORONARY STENTS
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Simka W, 2010, ELECTROCHIM ACTA, V55, P2437, DOI 10.1016/j.electacta.2009.11.097
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SRINIVASAN S, 1970, J COLLOID INTERF SCI, V32, P456, DOI 10.1016/0021-9797(70)90131-1
   Stepan LL, 2007, J BIOMED MATER RES A, V82A, P768, DOI 10.1002/jbm.a.31192
   Stepan LL, 2005, J BIOMECH ENG-T ASME, V127, P915, DOI 10.1115/1.2049311
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
   Stone GW, 2012, J AM COLL CARDIOL, V60, P1975, DOI 10.1016/j.jacc.2012.09.004
   Szold A, 2006, SURG ENDOSC, V20, P1493, DOI 10.1007/s00464-005-0867-1
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   Tulloch AW, 2011, J SURG RES, V171, P317, DOI 10.1016/j.jss.2010.01.014
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   WALKER JA, 1990, SENSOR ACTUAT A-PHYS, V21, P243, DOI 10.1016/0924-4247(90)85047-8
   Wang X, 2006, SCRIPTA MATER, V54, P925, DOI 10.1016/j.scriptamat.2005.10.061
   Zhang JX, 2003, ACTA MATER, V51, P3121, DOI 10.1016/S1359-6454(03)00124-1
   Zhang JX, 2001, ACTA MATER, V49, P3001, DOI 10.1016/S1359-6454(01)00204-X
NR 87
TC 13
Z9 13
U1 4
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 15
PY 2015
VL 21
BP 20
EP 34
DI 10.1016/j.actbio.2015.03.025
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK9FR
UT WOS:000356546500002
DA 2018-10-19
ER

PT J
AU Shi, MC
   Zhou, YH
   Shao, J
   Chen, ZT
   Song, BT
   Chang, J
   Wu, CT
   Xiao, Y
AF Shi, Mengchao
   Zhou, Yinghong
   Shao, Jin
   Chen, Zetao
   Song, Botao
   Chang, Jiang
   Wu, Chengtie
   Xiao, Yin
TI Stimulation of osteogenesis and angiogenesis of hBMSCs by delivering Si
   ions and functional drug from mesoporous silica nanospheres
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mesoporous silica nanospheres; Osteogenesis; Angiogenesis;
   Multifunction; Bone regeneration
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BIOACTIVE GLASS SCAFFOLDS;
   BONE TISSUE REGENERATION; CONTROLLED-RELEASE; IN-VITRO; NANOPARTICLES;
   DIFFERENTIATION; BIOCOMPATIBILITY; PROLIFERATION
AB Multifunctional bioactive materials with the ability to stimulate osteogenesis and angiogenesis of stem cells play an important role in the regeneration of bone defects. However, how to develop such biomaterials remains a significant challenge. In this study, we prepared mesoporous silica nanospheres (MSNs) with uniform sphere size (similar to 90 nm) and mesopores (similar to 2.7 nm), which could release silicon ions (Si) to stimulate the osteogenic differentiation of human bone marrow stromal cells (hBMSCs) via activating their ALP activity, bone-related gene and protein (OCN, RUNX2 and OPN) expression. Hypoxia-inducing therapeutic drug, dimethyloxaloylglycine (DMOG), was effectively loaded in the mesopores of MSNs (D-MSNs). The sustained release of DMOG from D-MSNs could stabilize HIF-la and further stimulated the angiogenic differentiation of hBMSCs as indicated by the enhanced VEGF secretion and protein expression. Our study revealed that D-MSNs could combine the stimulatory effect on both osteogenic and angiogenic activity of hBMSCs. The potential mechanism of D-MSN-stimulated osteogenesis and angiogenesis was further elucidated by the supplementation of cell culture medium with pure Si ions and DMOG. Considering the easy handling characteristics of nanospheres, the prepared D-MSNs may be applied in the forms of injectable spheres for minimally invasive surgery, or MSNs/polymer composite scaffolds for bone defect repair. The concept of delivering both stimulatory ions and functional drugs may offer a new strategy to construct a multifunctional biomaterial system for bone tissue regeneration. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shi, Mengchao; Song, Botao; Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Zhou, Yinghong; Shao, Jin; Chen, Zetao; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn; chengtiewu@mail.sic.ac.cn
OI Zhou, Yinghong/0000-0001-9757-7735; Xiao, Yin/0000-0003-1785-3491; SHAO,
   JIN/0000-0002-3864-0391
FU Recruitment Program of Global Young Talent, China; Natural Science
   Foundation of China [31370963, 81190132]; QCAS Biotechnology Fund
   [GJHZ1505]; Key Research Program of Chinese Academy of Sciences
   [KGZD-EW-T06]; Innovative Project of SIC; CAS; ARC [DP120103697]
FX Funding for this study was provided by the Recruitment Program of Global
   Young Talent, China (C.W.), Natural Science Foundation of China (Grant
   31370963, 81190132), the QCAS Biotechnology Fund (Grant No GJHZ1505),
   Key Research Program of Chinese Academy of Sciences (Grant KGZD-EW-T06),
   Innovative Project of SIC, CAS and ARC (DP120103697).
CR Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944
   Asikainen TM, 2007, AM J PHYSIOL-LUNG C, V293, pL555, DOI 10.1152/ajplung.00251.2007
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292
   Ding H, 2014, STEM CELLS DEV, V23, P990, DOI 10.1089/scd.2013.0486
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Huang DM, 2008, TOXICOL APPL PHARM, V231, P208, DOI 10.1016/j.taap.2008.04.009
   Jensen T, 2011, J BIOMED MATER RES A, V99A, P94, DOI 10.1002/jbm.a.33166
   Kamarudin NHN, 2014, J COLLOID INTERF SCI, V421, P6, DOI 10.1016/j.jcis.2014.01.034
   Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Li XY, 2014, ACS NANO, V8, P1309, DOI 10.1021/nn4046985
   Lindfors NC, 2008, J BIOMED MATER RES B, V87B, P73, DOI 10.1002/jbm.b.31070
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Neumann A, 2013, RSC ADV, V3, P24222, DOI 10.1039/c3ra44734k
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146
   Ravichandran R, 2014, MICROPOR MESOPOR MAT, V187, P53, DOI 10.1016/j.micromeso.2013.12.018
   Ravichandran R, 2013, J BIOMAT SCI-POLYM E, V24, P1988, DOI 10.1080/09205063.2013.816930
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Sears JE, 2008, P NATL ACAD SCI USA, V105, P19898, DOI 10.1073/pnas.0805817105
   Slane J, 2014, J MECH BEHAV BIOMED, V29, P451, DOI 10.1016/j.jmbbm.2013.10.008
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   Song BT, 2012, ACTA BIOMATER, V8, P1901, DOI 10.1016/j.actbio.2012.01.020
   Stucki U, 2001, CLIN ORAL IMPLAN RES, V12, P121, DOI 10.1034/j.1600-0501.2001.012002121.x
   Suzuki O, 2004, MICROSURG, V24, P85, DOI 10.1002/micr.10190
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tomoaia G, 2014, MAT SCI ENG C-MATER, V37, P37, DOI 10.1016/j.msec.2013.12.027
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Wang HA, 2012, TISSUE ENG PART B-RE, V18, P24, DOI [10.1089/ten.teb.2011.0184, 10.1089/ten.TEB.2011.0184]
   Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12
   Wu CT, 2014, J CONTROL RELEASE, V193, P282, DOI 10.1016/j.jconrel.2014.04.026
   Wu CT, 2013, ACTA BIOMATER, V9, P9159, DOI 10.1016/j.actbio.2013.06.026
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022
   Xia LU, 2013, MICROPOR MESOPOR MAT, V173, P155, DOI 10.1016/j.micromeso.2013.02.020
   Zhao YN, 2009, J AM CHEM SOC, V131, P8398, DOI 10.1021/ja901831u
   Zhou YH, 2015, J TISSUE ENG REGEN M, V9, P118, DOI 10.1002/term.1619
   Zhu YF, 2005, NANOTECHNOLOGY, V16, P2633, DOI 10.1088/0957-4484/16/11/027
   Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262
NR 46
TC 46
Z9 47
U1 15
U2 180
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 15
PY 2015
VL 21
BP 178
EP 189
DI 10.1016/j.actbio.2015.04.019
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK9FR
UT WOS:000356546500016
PM 25910640
DA 2018-10-19
ER

PT J
AU Facin, BR
   Moret, B
   Baretta, D
   Belfiore, LA
   Paulino, AT
AF Facin, Bruno R.
   Moret, Bruna
   Baretta, Dilmar
   Belfiore, Laurence A.
   Paulino, Alexandre T.
TI Immobilization and controlled release of beta-galactosidase from
   chitosan-grafted hydrogels
SO FOOD CHEMISTRY
LA English
DT Article
DE beta-Galactosidase; Immobilization; Hydrogel; Chitosan; Lactose; Food
ID LACTOSE-INTOLERANCE; MAGNETIC BIOMATERIAL; POTENTIAL DEVICE; HYDROLYSIS;
   ENTRAPMENT; PROTEIN
AB Chitosan-grafted hydrogels were employed for immobilization and controlled released of beta-galactosidase. These hydrogels containing immobilized enzymes were employed to simulate the production of lactose-free food and controlled release of beta-galactosidase into lactose-intolerant individuals. The degree of swelling, efficiency of immobilization (i.e., fractional uptake of enzyme), and controlled release were studied as a function of pH and temperature. The degrees of swelling decreased in acidic media: 49.4 g absorbed water per g hydrogel at pH 7.0, and 8.4 g absorbed water per g hydrogel at pH 3.5. The immobilization efficiency was 19%, indicating that chitosan-grafted hydrogels are promising matrices for enzyme adsorption and immobilization. Cyclic experiments reveal that chitosan-grafted hydrogels containing immobilized enzymes can be reused several times without introducing additional enzyme prior to each cycle. There is no significant decrease in the activity of the immobilized enzyme during reutilization studies. All results were conducted in triplicate by considering t-tests at a 95% significance level. Analysis of beta-galactosidase activity and controlled release reveals that chitosan-grafted hydrogels containing immobilized enzymes are useful for the production of lactose-free food and controlled enzyme release with high performance. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Facin, Bruno R.; Moret, Bruna; Baretta, Dilmar; Paulino, Alexandre T.] Santa Catarina State Univ, Higher Educ Ctr West, Dept Food Engn, BR-89870000 Chapeco Pinhalzinho, SC, Brazil.
   [Belfiore, Laurence A.; Paulino, Alexandre T.] Colorado State Univ, Dept Chem & Biol Engn, Polymer Phys & Engn Lab, Ft Collins, CO 80523 USA.
RP Paulino, AT (reprint author), Santa Catarina State Univ, Higher Educ Ctr West, Dept Food Engn, BR-89870000 Chapeco Pinhalzinho, SC, Brazil.
EM atpaulino10@gmail.com
RI Paulino, Alexandre/B-8075-2013
OI Paulino, Alexandre/0000-0001-7076-2797; Baretta,
   Dilmar/0000-0001-8219-1362
FU CNPq - Brazil [479402/2013-2]; CAPES - Brazil; UDESC - Brazil; CSU -
   United States
FX ATP acknowledges the CNPq - Brazil (Process No 479402/2013-2) for
   financial support. The authors also gratefully acknowledge the CAPES -
   Brazil, UDESC - Brazil and CSU - United States for research support.
CR Ansari S, 2012, J ROY ASIATIC SOC, V22, P1, DOI 10.1017/S1356186312000090
   Aralijo W. A. G., 2007, NUTRITIME, V4, P395
   Bezerra SS, 2011, LAT AM J PHARM, V30, P1833
   Bortolin A, 2012, POLIMEROS, V22, P311, DOI 10.1590/S0104-14282012005000046
   Brena B. M., 2006, METHODS BIOTECHNOLOG, P15
   Flood MT, 2004, REGUL TOXICOL PHARM, V40, P281, DOI 10.1016/j.yrtph.2004.07.011
   Freitas FF, 2011, BIOCHEM ENG J, V58-59, P33, DOI 10.1016/j.bej.2011.08.011
   Grosova Z, 2009, FOOD CHEM, V116, P96, DOI 10.1016/j.foodchem.2009.02.011
   Grosova Z, 2008, BIOTECHNOL LETT, V30, P763, DOI 10.1007/s10529-007-9606-0
   Ha EJ, 2013, MACROMOL RES, V21, P5, DOI 10.1007/s13233-013-1007-8
   Haider T, 2007, INT J BIOL MACROMOL, V41, P72, DOI 10.1016/j.ijbiomac.2007.01.001
   Horn MM, 2010, POLIMEROS, V20, P201, DOI 10.1590/S0104-14282010005000025
   Jurado E, 2002, ENZYME MICROB TECH, V31, P300, DOI 10.1016/S0141-0229(02)00107-2
   Kim MH, 2012, J MOL CATAL B-ENZYM, V75, P68, DOI 10.1016/j.molcatb.2011.11.011
   Kjeldahl J., 1883, Z ANAL CHEM, V22, P366, DOI [DOI 10.1007/BF01338151, 10.1007/BF01338151]
   Klein M. P., 2010, THESIS FEDERAL U RIO
   Klein MP, 2012, BIOMACROMOLECULES, V13, P2456, DOI 10.1021/bm3006984
   Kronska H., 2009, J FOOD NUTR RES, V48, P87
   Mattar R., 2010, REV ASS MED BRASILEI, V56
   Montalto M, 2006, WORLD J GASTROENTERO, V12, P187, DOI 10.3748/wjg.v12.i2.187
   Moura M. R., 2008, POLIMEROS, V18, P132, DOI DOI 10.1590/S0104-14282008000200010
   Paulino AT, 2012, CARBOHYD POLYM, V90, P1216, DOI 10.1016/j.carbpol.2012.06.051
   Paulino AT, 2011, POLYM INT, V60, P1324, DOI 10.1002/pi.3084
   Paulino AT, 2010, MACROMOL CHEM PHYS, V211, P1196, DOI 10.1002/macp.200900657
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Rebros M, 2007, FOOD CHEM, V102, P784, DOI 10.1016/j.foodchem.2006.06.020
   Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z
   SaloVaananen PP, 1996, FOOD CHEM, V57, P27, DOI 10.1016/0308-8146(96)00157-4
   Santiago P. A., 2004, Ciencia e Tecnologia de Alimentos, V24, P567, DOI 10.1590/S0101-20612004000400015
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stefano M. Di., 2002, GASTROENTEROLOGY, V122, P1793
   Suarez FL, 1995, ALIMENT PHARM THER, V9, P589
   Torres P, 2012, J MOL CATAL B-ENZYM, V83, P57, DOI 10.1016/j.molcatb.2012.07.004
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vesa TH, 2000, J AM COLL NUTR, V19, p165S, DOI 10.1080/07315724.2000.10718086
   Vonk RJ, 2003, EUR J CLIN INVEST, V33, P70, DOI 10.1046/j.1365-2362.2003.01099.x
   White A, 1976, BIOCH PRINCIPLES
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 39
TC 15
Z9 15
U1 3
U2 167
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD JUL 15
PY 2015
VL 179
BP 44
EP 51
DI 10.1016/j.foodchem.2015.01.088
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA CF9ZM
UT WOS:000352926400006
PM 25722137
DA 2018-10-19
ER

PT J
AU Seo, BB
   Choi, H
   Koh, JT
   Song, SC
AF Seo, Bo-Bae
   Choi, Hyuck
   Koh, Jeong-Tae
   Song, Soo-Chang
TI Sustained BMP-2 delivery and injectable bone regeneration using
   thermosensitive polymeric nanoparticle hydrogel bearing dual
   interactions with BMP-2
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Polymeric nanoparticles; Dual interactions; Injectable hydrogel; Bone
   morphogenetic protein-2 (BMP-2); Sustained BMP-2 release
ID RAT ECTOPIC MODEL; MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY; BIOMEDICAL
   APPLICATIONS; BIOMATERIAL CARRIERS; IN-VITRO; POLYPHOSPHAZENES; RHBMP-2;
   PHARMACOKINETICS; SYSTEMS
AB Localized and continuous osteogenic stimulation to defected sites is required for effective bone regeneration. Here, we suggest an injectable and sustained bone morphogenetic protein-2 (BMP-2) release system using thermosensitive polymeric nanoparticles bearing dual interacting forces with BMP-2. For sustained BMP-2 release, hydrophobic and ionic interactions were introduced to thermosensitive poly(phosphazene). Hydrophobic isoleucine ethyl ester and hydrophilic poly-ethylene glycol were mainly substituted to the poly(phosphazene) back bone for amphiphilicity and hydrophobic interaction with BMP-2. Carboxylic acid moiety was additionally substituted to the back bone for ionic interaction with BMP-2. These dual interacting polymeric nanoparticles (D-NPs) formed compact nanocomplexes with BMP-2. The aqueous solution of BMP-2/D-NP nanocomplexes was transformed to hydrogel when the temperature of the solution increased. Loaded BMP-2 was sustain-released for three weeks from the BMP-2/D-NP nanocomplex hydrogel. The extended BMP-2 exposure caused higher osteocalcin secretion in C2C12 cells. Significant bone generations were observed at the target site by single injection of BMP-2/D-NP nanocomplexes in vivo. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Seo, Bo-Bae; Song, Soo-Chang] Korea Inst Sci & Technol, Ctr Biomat, Seoul 130650, South Korea.
   [Seo, Bo-Bae; Song, Soo-Chang] Univ Sci & Technol, Dept Biomol Sci, Seoul 136791, South Korea.
   [Choi, Hyuck; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju 500757, South Korea.
   [Choi, Hyuck; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Res Ctr Biomineralizat Disorders, Gwangju 500757, South Korea.
RP Song, SC (reprint author), Korea Inst Sci & Technol, Ctr Biomat, Seoul 130650, South Korea.
EM scsong@kist.re.kr
OI Song, Soo-Chang/0000-0001-9344-0686
FU Korea Institute of Science and Technology (KIST); National Research
   Foundation of Korea
FX This research is financially supported by Korea Institute of Science and
   Technology (KIST) and National Research Foundation of Korea.
CR Asamura S, 2010, ANN PLAS SURG, V64, P496, DOI 10.1097/SAP.0b013e31819b6c52
   Bergman K., 2009, J BIOMED MATER RES A, V91, P111
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bromberg L, 1999, LANGMUIR, V15, P8633, DOI 10.1021/la990946q
   Chan JM, 2010, METHODS MOL BIOL, V624, P163, DOI 10.1007/978-1-60761-609-2_11
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   CROMMEN J, 1993, J CONTROL RELEASE, V24, P167, DOI 10.1016/0168-3659(93)90176-6
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Greenstein J.D., 1961, CHEM AMINO ACIDS, P925
   Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hernandez A, 2012, ACTA BIOMATER, V8, P781, DOI 10.1016/j.actbio.2011.10.008
   Jill D., 2009, J ENDODONT, V35, P321
   Kang G.D., 2008, INT J PHARMACEUT, V249, P1
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Kim YM, 2012, ACS NANO, V6, P5757, DOI 10.1021/nn300842a
   KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133
   Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lemmouchi Y, 1998, J BIOACT COMPAT POL, V13, P4, DOI 10.1177/088391159801300102
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   SOHN YS, 1995, MACROMOLECULES, V28, P7566, DOI 10.1021/ma00126a039
   Tillmann U., 2011, LANGMUIR, V27, P1314
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
NR 34
TC 40
Z9 40
U1 4
U2 92
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 10
PY 2015
VL 209
BP 67
EP 76
DI 10.1016/j.jconrel.2015.04.023
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CJ7KQ
UT WOS:000355674300008
PM 25910579
DA 2018-10-19
ER

PT J
AU Choi, DJ
   Choi, SM
   Kang, HY
   Min, HJ
   Lee, R
   Ikram, M
   Subhan, F
   Jin, SW
   Jeong, YH
   Kwak, JY
   Yoon, S
AF Choi, Da Jeong
   Choi, Seung Mi
   Kang, Hae Yeong
   Min, Hye-Jin
   Lee, Rira
   Ikram, Muhammad
   Subhan, Fazli
   Jin, Song Wan
   Jeong, Young Hun
   Kwak, Jong-Young
   Yoon, Sik
TI Bioactive fish collagen/polycaprolactone composite nanofibrous scaffolds
   fabricated by electrospinning for 3D cell culture
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Electrospun nanofiber; Composite scaffold; Fish collagen; Thymic
   epithelial cells; 3D cell culture
ID TISSUE ENGINEERING APPLICATIONS; I COLLAGEN; PROLIFERATION; GROWTH;
   BIOCOMPATIBILITY; BIOMATERIAL; FIBROBLASTS; PHENOTYPES; MIGRATION;
   GUIDANCE
AB One of the most challenging objectives of 3D cell culture is the development of scaffolding materials with outstanding biocompatibility and favorable mechanical strength. In this study, we fabricated a novel nanofibrous scaffold composed of fish collagen (FC) and polycaprolactone (PCL) blends by using the electrospinning method. Nanofibrous scaffolds were characterized using a scanning electron microscope (SEM), and it was revealed that the diameter of nanofibers decreased as FC content was increased in the FC/PCL composite nanofibers. The cytocompatibility of the FC/PCL scaffolds was evaluated by SEM, WST-1 assay, confocal microscopy, western blot, and RT-PCR. It was found that the scaffolds not only facilitated the adhesion, spreading, protrusions, and proliferation of thymic epithelial cells (TECs), but also stimulated the expression of genes and proteins involved in cell adhesion and T-cell development. Thus, these results suggest that the FC/PCL composite nanofibrous scaffolds will be a useful model of 3D cell culture for TECs and may have wide applicability in the future for engineering tissues or organs. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Choi, Da Jeong; Choi, Seung Mi; Kang, Hae Yeong; Min, Hye-Jin; Lee, Rira; Ikram, Muhammad; Subhan, Fazli; Yoon, Sik] Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, Gyeongsangnam D, South Korea.
   [Jin, Song Wan] Korea Polytech Univ, Dept Mech Engn, Shihung 429793, South Korea.
   [Jeong, Young Hun] Kyungpook Natl Univ, Dept Mech Engn, Taegu 702701, South Korea.
   [Kwak, Jong-Young] Dong A Univ, Sch Med, Dept Biochem, Busan 602714, South Korea.
   [Choi, Da Jeong; Choi, Seung Mi; Kang, Hae Yeong; Min, Hye-Jin; Lee, Rira; Ikram, Muhammad; Subhan, Fazli; Jin, Song Wan; Jeong, Young Hun; Kwak, Jong-Young; Yoon, Sik] Pioneer Res Ctr, Seoul, South Korea.
RP Yoon, S (reprint author), Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, Gyeongsangnam D, South Korea.
EM sikyoon@pusan.ac.kr
RI Tarsitano, Elisa/D-6611-2015
OI Ikram, Muhammad/0000-0003-0114-7963
FU Pioneer Research Center Program through the National Research Foundation
   of Korea - Ministry of Science, ICT & Future Planning [201210130003]
FX This work was supported by the Pioneer Research Center Program through
   the National Research Foundation of Korea funded by the Ministry of
   Science, ICT & Future Planning (201210130003).
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Bae I, 2008, FOOD CHEM, V108, P49, DOI 10.1016/j.foodchem.2007.10.039
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Chakrapani VY, 2012, J APPL POLYM SCI, V125, P3221, DOI 10.1002/app.36504
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Dufour S, 2013, CELL ADHES MIGR, V7, P345, DOI 10.4161/cam.25139
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Gendron R, 2012, MACROMOL BIOSCI, V12, P360, DOI 10.1002/mabi.201100341
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   Haslauer CM, 2011, J BIOMAT SCI-POLYM E, V22, P1695, DOI 10.1163/092050610X521595
   He SW, 2011, J NANOSCI NANOTECHNO, V11, P1052, DOI 10.1166/jnn.2011.3080
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Ingavle GC, 2014, TISSUE ENG PART B-RE, V20, P277, DOI [10.1089/ten.TEB.2013.0276, 10.1089/ten.teb.2013.0276]
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   KIMURA S, 1983, COMP BIOCHEM PHYS B, V74, P525, DOI 10.1016/0305-0491(83)90222-5
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Laco F, 2013, J BIOMED MATER RES A, V101, P1787, DOI 10.1002/jbm.a.34468
   Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z
   Lei K.F., 2013, IEEE ENG MED BIOL SO, V2013, P180
   Li CL, 2008, ONCOL REP, V20, P1465, DOI 10.3892/or_00000167
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8
   Nagai N, 2008, J BIOMED MATER RES B, V87B, P432, DOI 10.1002/jbm.b.31121
   Papiernik M, 1992, Eur Cytokine Netw, V3, P89
   Pati F, 2012, J BIOMED MATER RES A, V100A, P1068, DOI 10.1002/jbm.a.33280
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Solouk Atefeh, 2011, Iranian Biomedical Journal, V15, P6
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Sugiura H, 2009, J BIOMAT SCI-POLYM E, V20, P1353, DOI 10.1163/092050609X12457418396658
   Venugopal JR, 2006, ARTIF ORGANS, V30, P440, DOI 10.1111/j.1525-1594.2006.00239.x
   Yamada S, 2014, BIOMED RES INT, DOI 10.1155/2014/302932
   Zhang YZ, 2007, INT J NANOMED, V2, P623
NR 41
TC 19
Z9 19
U1 2
U2 93
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JUL 10
PY 2015
VL 205
BP 47
EP 58
DI 10.1016/j.jbiotec.2015.01.017
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CI2BV
UT WOS:000354550600006
PM 25617682
DA 2018-10-19
ER

PT J
AU Tallawi, M
   Rosellini, E
   Barbani, N
   Cascone, MG
   Rai, R
   Saint-Pierre, G
   Boccaccini, AR
AF Tallawi, Marwa
   Rosellini, Elisabetta
   Barbani, Niccoletta
   Cascone, Maria Grazia
   Rai, Ranjana
   Saint-Pierre, Guillaume
   Boccaccini, Aldo R.
TI Strategies for the chemical and biological functionalization of
   scaffolds for cardiac tissue engineering: a review
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE biofunctionalization; cardiac tissue engineering; biomimetic scaffolds;
   chemical modification; biological modification
ID ENDOTHELIAL-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; MOLECULARLY IMPRINTED
   POLYMERS; ASSEMBLING PEPTIDE NANOFIBERS; BIOTIN BINDING SYSTEM;
   RGD-MODIFIED ALGINATE; EXTRACELLULAR-MATRIX COMPONENTS; LEFT-VENTRICULAR
   FUNCTION; RAT INFARCT MODEL; MYOCARDIAL-INFARCTION
AB The development of biomaterials for cardiac tissue engineering (CTE) is challenging, primarily owing to the requirement of achieving a surface with favourable characteristics that enhances cell attachment and maturation. The biomaterial surface plays a crucial role as it forms the interface between the scaffold (or cardiac patch) and the cells. In the field of CTE, synthetic polymers ( polyglycerol sebacate, polyethylene glycol, polyglycolic acid, poly-L-lactide, polyvinyl alcohol, polycaprolactone, polyurethanes and poly(N-isopropyl-acrylamide)) have been proven to exhibit suitable biodegradable and mechanical properties. Despite the fact that they show the required biocompatible behaviour, most synthetic polymers exhibit poor cell attachment capability. These synthetic polymers are mostly hydrophobic and lack cell recognition sites, limiting their application. Therefore, biofunctionalization of these biomaterials to enhance cell attachment and cell material interaction is being widely investigated. There are numerous approaches for functionalizing a material, which can be classified as mechanical, physical, chemical and biological. In this review, recent studies reported in the literature to functionalize scaffolds in the context of CTE, are discussed. Surface, morphological, chemical and biological modifications are introduced and the results of novel promising strategies and techniques are discussed.
C1 [Tallawi, Marwa; Rai, Ranjana; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
   [Rosellini, Elisabetta; Barbani, Niccoletta; Cascone, Maria Grazia] Univ Pisa, Dept Civil & Ind Engn, I-56126 Pisa, Italy.
   [Saint-Pierre, Guillaume] Inspiralia, Mat Lab, Madrid 28049, Spain.
RP Tallawi, M (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
EM marwa.tallawi@ww.uni-erlangen.de; aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013
FU EU FP-7 BIOSCENT project [214539]
FX The authors acknowledge partial funding from the EU FP-7 BIOSCENT
   project (ID 214539).
CR Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120
   AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Amsden BG, 2010, J CONTROL RELEASE, V145, P109, DOI 10.1016/j.jconrel.2010.03.029
   Anamelechi CC, 2005, BIOMATERIALS, V26, P6887, DOI 10.1016/.biomaterials.2005.04.027
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Bai XP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045002
   Bakowsky U, 2002, BIOCHEMISTRY-US, V41, P4704, DOI 10.1021/bi0117596
   Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Bauer SM, 2005, J VASC SURG, V41, P699, DOI 10.1016/j.jvs.2005.01.015
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Bhat VD, 1998, J BIOMED MATER RES, V41, P377, DOI 10.1002/(SICI)1097-4636(19980905)41:3<377::AID-JBM6>3.3.CO;2-Q
   Bhatia SK, 2010, BIOTECHNOL J, V5, P1309, DOI 10.1002/biot.201000230
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Boateng SY, 2005, AM J PHYSIOL-CELL PH, V288, pC30, DOI 10.1152/ajpcell.00199.2004
   BOGDANOV AA, 1991, J CELL PHYSIOL, V147, P182, DOI 10.1002/jcp.1041470123
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069
   Brown DA, 2005, J BIOMED MATER RES A, V74A, P419, DOI 10.1002/jbm.a.30344
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100
   Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127
   Cao Y, 2004, BIOPOLYMER METHODS T, V238, P87
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   Chapanian R, 2010, J CONTROL RELEASE, V143, P53, DOI 10.1016/j.jconrel.2009.11.025
   Charlotte KW., 2007, CHEM SOC REV, V36, P1573, DOI [10.10391b614342n, DOI 10.1039/B614342N]
   Chen JL, 2006, J BIOMED MATER RES A, V79A, P307, DOI 10.1002/jbm.a.30799
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chew SY, 2006, NANOTECHNOLOGY, V17, P3880, DOI 10.1088/0957-4484/17/15/045
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3
   Chiono V, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0045
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi S, 2013, CELLS TISSUES ORGANS, V198, P349, DOI 10.1159/000358755
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chua KN, 2007, EXP HEMATOL, V35, P771, DOI 10.1016/j.exphem.2007.02.002
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Cormack PAG, 1999, REACT FUNCT POLYM, V41, P115, DOI 10.1016/S1381-5148(99)00024-3
   Cristallini C, 2004, MACROMOL BIOSCI, V4, P31, DOI 10.1002/mabi.200300026
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Duan Y, 2007, J BIOMAT SCI-POLYM E, V18, P1153, DOI 10.1163/156856207781554019
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   EPPENBERGEREBERHARDT M, 1990, DEV BIOL, V139, P269, DOI 10.1016/0012-1606(90)90296-U
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   Fukuda K, 2003, BONE MARROW TRANSPL, V32, pS25, DOI 10.1038/sj.bmt.1703940
   Fukuda K, 2002, CR BIOL, V325, P1027, DOI 10.1016/S1631-0691(02)01524-X
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI200113713
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Gandaglia A, 2012, TISSUE ENG PT A, V18, P725, DOI [10.1089/ten.tea.2011.0254, 10.1089/ten.TEA.2011.0254]
   Gao J, 2011, TISSUE ENG PT A, V17, P2739, DOI [10.1089/ten.tea.2011.0105, 10.1089/ten.TEA.2011.0105]
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gerhardt WW, 2006, BIOMACROMOLECULES, V7, P1735, DOI 10.1021/bm060024j
   Giraud M. N., 2012, CARDIOL RES PRACT, V2012, DOI DOI 10.1155/2012/971614
   Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Hakuno D, 2002, CIRCULATION, V105, P380, DOI 10.1161/hc0302.102593
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hart BR, 2001, J AM CHEM SOC, V123, P2072, DOI 10.1021/ja005661
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   Hein S, 2001, J NUCL CARDIOL, V8, P188, DOI 10.1067/mnc.2001.113331
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61
   Hidalgo-Bastida LA, 2007, ACTA BIOMATER, V3, P457, DOI 10.1016/j.actbio.2006.12.006
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   HIRD B, 1993, J POLYM SCI POL CHEM, V31, P1377, DOI 10.1002/pola.1993.080310604
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866
   Improvement P, 2010, ANN INTERN MED, V152, pITC61
   Inagaki N, 2003, J APPL POLYM SCI, V89, P96, DOI [10.1002/app.12160, DOI 10.1002/APP.12160]
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Janorkar AV, 2006, J POLYM SCI POL CHEM, V44, P6534, DOI 10.1002/pola.21700
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jia XL, 2011, J BIOMAT SCI-POLYM E, V22, P1811, DOI 10.1163/092050610X528534
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kanematsu A, 2004, J CONTROL RELEASE, V99, P281, DOI 10.1016/j.jconrel.2004.07.008
   KEMPE M, 1995, J CHROMATOGR A, V691, P317, DOI 10.1016/0021-9673(94)00820-Y
   Khang G, 2001, TISSUE ENG, V7, P236
   Kim D, 2012, ANAL CHEM, V84, P2533, DOI 10.1021/ac3000013
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Kojima N, 2006, BIOMATERIALS, V27, P4904, DOI 10.1016/j.biomaterials.2006.05.026
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kubies D, 2003, J MATER SCI-MATER M, V14, P143, DOI 10.1023/A:1022019813078
   Kutryk MJB, 2003, MICROSC RES TECHNIQ, V60, P138, DOI 10.1002/jemt.10252
   LADOUX A, 1993, BIOCHEM BIOPH RES CO, V195, P1005, DOI 10.1006/bbrc.1993.2144
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   LaNasa SM, 2009, ACTA BIOMATER, V5, P2929, DOI 10.1016/j.actbio.2009.05.011
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lanza R., 2011, PRINCIPLES TISSUE EN
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Lavik E, 2015, APPL MICROBIOL BIOT, V65, P1
   Layman H, 2009, ACTA BIOMATER, V5, P230, DOI 10.1016/j.actbio.2008.07.024
   Lchek M, 1990, METHOD ENZYMOL, V184, P5
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee J, 2009, J CONTROL RELEASE, V137, P196, DOI 10.1016/j.jconrel.2009.04.008
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Lee KB, 2003, J PHARM SCI, V92, P933, DOI 10.1002/jps.10556
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Li RK, 1999, CIRCULATION, V100, P63
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Losi P, 2010, BIOMATERIALS, V31, P5336, DOI 10.1016/j.biomaterials.2010.03.033
   LUNDGREN E, 1985, EXP CELL RES, V158, P371, DOI 10.1016/0014-4827(85)90462-8
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Maitra N, 2000, CARDIOVASC RES, V47, P715, DOI 10.1016/S0008-6363(00)00140-1
   Maretschek S, 2008, J CONTROL RELEASE, V127, P180, DOI 10.1016/j.jconrel.2008.01.011
   Marra KG, 2008, PLAST RECONSTR SURG, V121, P1153, DOI 10.1097/01.prs.0000305517.93747.72
   Maruyama K, 1999, J MOL CELL CARDIOL, V31, P607, DOI 10.1006/jmcc.1998.0895
   Mathieu HJ, 2001, SURF INTERFACE ANAL, V32, P3, DOI 10.1002/sia.995
   Mathur AB, 2003, J BIOMED MATER RES A, V66A, P729, DOI 10.1002/jbm.a.10581
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miskon A, 2009, J ARTIF ORGANS, V12, P111, DOI 10.1007/s10047-009-0449-4
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X
   Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163
   Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Patra C, 2012, BIOMATERIALS, V33, P4327, DOI 10.1016/j.biomaterials.2012.03.021
   Patra C, 2011, DEVELOPMENT, V138, P4499, DOI 10.1242/dev.067454
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pons J, 2009, J GENE MED, V11, P743, DOI 10.1002/jgm.1362
   Porter AM, 2011, BIOMACROMOLECULES, V12, P242, DOI 10.1021/bm101220b
   Rachkov A, 2001, BBA-PROTEIN STRUCT M, V1544, P255, DOI 10.1016/S0167-4838(00)00226-0
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rocher P, 2002, BIOMATERIALIEN, V3, P14, DOI 10.1515/BIOMAT.2002.3.1.14
   Rosellini E, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065007
   Rosellini E, 2010, J APPL POLYM SCI, V118, P3236, DOI 10.1002/app.32622
   Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sanders EH, 2003, MACROMOLECULES, V36, P3803, DOI 10.1021/ma021771l
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182
   Schussler O, 2009, NAT CLIN PRACT CARD, V6, P240, DOI 10.1038/ncpcardio1451
   SELLERGREN B, 1993, J CHROMATOGR A, V654, P17, DOI 10.1016/0021-9673(93)83061-V
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Silvestri A, 2014, J BIOMED MATER RES B, V102, P1002, DOI 10.1002/jbm.b.33081
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   Silvestri D, 2005, ANAL CHIM ACTA, V542, P3, DOI 10.1016/j.aca.2004.12.005
   Simon-Yarza T, 2012, THERANOSTICS, V2, P541, DOI 10.7150/thno.3682
   Singh S, 2011, BIOMATERIALS, V32, P2059, DOI 10.1016/j.biomaterials.2010.11.038
   Sivagnanam V, 2009, ANAL CHEM, V81, P6509, DOI 10.1021/ac9009319
   Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904
   Sondermeijer HP, 2008, CIRCULATION, V118, pS322
   Spadaccio C, 2011, J CELL MOL MED, V15, P1096, DOI 10.1111/j.1582-4934.2010.01100.x
   Steinke J, 1995, ADV POLYM SCI, V123, P80
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Svenson J, 2001, ANAL CHIM ACTA, V435, P19, DOI 10.1016/S0003-2670(00)01396-9
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tabata Yasuhiko, 2000, Pharmaceutical Science and Technology Today, V3, P80, DOI 10.1016/S1461-5347(00)00242-X
   Tae G, 2007, BIOMACROMOLECULES, V8, P1979, DOI 10.1021/bm0701189
   Taguchi T, 2000, J BIOACT COMPAT POL, V15, P309, DOI 10.1106/U857-BGYG-UP8G-C6T3
   Taipale J, 1997, FASEB J, V11, P51
   Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3
   Takano H, 2003, CURR PHARM DESIGN, V9, P1121, DOI 10.2174/1381612033455008
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Tsai WB, 2005, MACROMOL BIOSCI, V5, P214, DOI 10.1002/mabi.200400144
   Tsai WB, 2005, BIOMATERIALS, V26, P3141, DOI 10.1016/j.biomaterials.2004.08.014
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   VANBILSEN M, 1993, CARDIOVASC RES, V27, P1140
   Ventura C, 2000, CIRC RES, V87, P189, DOI 10.1161/01.RES.87.3.189
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   vonSegesser LK, 1996, ANN THORAC SURG, V61, P330, DOI 10.1016/0003-4975(95)01011-4
   Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang HY, 1996, LANGMUIR, V12, P4850, DOI 10.1021/la960243y
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Winn N, 2002, COLD SPRING HARB SYM, V67, P507, DOI 10.1101/sqb.2002.67.507
   Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Wulff G, 2002, BIOSEPARATION, V10, P257, DOI DOI 10.1023/A:1021585518592
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   YAMAGISHI H, 1995, J MEMBRANE SCI, V105, P249, DOI 10.1016/0376-7388(95)00064-J
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhang S, 2009, J BIOMED MATER RES A, V90A, P671, DOI 10.1002/jbm.a.32136
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao WX, 2008, J MOL MED, V86, P1127, DOI 10.1007/s00109-008-0372-9
   Zhong Z, 2005, BIOMACROMOLECULES, V6, P2998, DOI [10.1021/bm050318p, DOI 10.1021/BM050318P]
   Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051
   Zieris A, 2011, J CONTROL RELEASE, V156, P28, DOI 10.1016/j.jconrel.2011.06.042
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zou YZ, 2003, CIRCULATION, V108, P748, DOI 10.1161/01.CIR.0000081773.76337.44
NR 280
TC 52
Z9 52
U1 8
U2 116
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUL 6
PY 2015
VL 12
IS 108
AR 20150254
DI 10.1098/rsif.2015.0254
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0FD
UT WOS:000358824600001
PM 26109634
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Mayer, S
   Decaluwe, H
   Ruol, M
   Manodoro, S
   Kramer, M
   Till, H
   Deprest, J
AF Mayer, Steffi
   Decaluwe, Herbert
   Ruol, Michele
   Manodoro, Stefano
   Kramer, Manuel
   Till, Holger
   Deprest, Jan
TI Diaphragm Repair with a Novel Cross-Linked Collagen Biomaterial in a
   Growing Rabbit Model
SO PLOS ONE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL DEFECTS; HERNIA REPAIR; PATCH
   REPAIR; TRACHEAL OCCLUSION; ANIMAL-MODEL; MESHES; RECONSTRUCTION;
   METAANALYSIS; MANAGEMENT
AB Background
   Neonates with congenital diaphragmatic hernia and large defects often require patch closure. Acellular collagen matrices (ACM) have been suggested as an alternative to synthetic durable patches as they are remodeled by the host or could also be used for tissue engineering purposes.
   Materials and Methods
   2.0x1.0 cm diaphragmatic defects were created in 6-weeks old New-Zealand white rabbits. We compared reconstruction with a purpose-designed cross-linked ACM (Matricel) to 4-layer non-cross-linked small intestinal submucosa (SIS) and a 1-layer synthetic Dual Mesh (Gore-Tex). Unoperated animals or animals undergoing primary closure (4/0 polyglecaprone) served as age-matched controls. 60 (n = 25) resp. 90 (n = 17) days later, animals underwent chest x-ray and obduction for gross examination of explants, scoring of adhesion and inflammatory response. Also, uniaxial tensiometry was done, comparing explants to contralateral native diaphragmatic tissue.
   Results
   Overall weight nearly doubled from 1,554 +/- 242 g at surgery to 2,837 +/- 265 g at obduction (+ 84%). X-rays did show rare elevation of the left diaphragm (SIS = 1, Gore-Tex = 1, unoperated control = 1), but no herniation of abdominal organs. 56% of SIS and 10% of Matricel patches degraded with visceral bulging in four (SIS = 3, Matricel = 1). Adhesion scores were limited: 0.5 (Matricel) to 1 (SIS, Gore-Tex) to the left lung (p = 0.008) and 2.5 (Gore-Tex), 3 (SIS) and 4 (Matricel) to the liver (p<0.0001). Tensiometry revealed a reduced bursting strength but normal compliance for SIS. Compliance was reduced in Matricel and Gore-Tex (p<0.01). Inflammatory response was characterized by a more polymorphonuclear cell (SIS) resp. macrophage (Matricel) type of infiltrate (p<0.05). Fibrosis was similar for all groups, except there was less mature collagen deposited to Gore-Tex implants (p<0.05).
   Conclusions
   Matricel induced a macrophage-dominated inflammatory response, more adhesions, had appropriate strength but a lesser compliance compared to native tissue. The herein investigated ACM is not a viable option for CDH repair.
C1 [Mayer, Steffi; Ruol, Michele; Manodoro, Stefano; Deprest, Jan] Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium.
   [Decaluwe, Herbert] Katholieke Univ Leuven, Dept Thorac Surg, Univ Hosp Gasthuisberg, Leuven, Belgium.
   [Ruol, Michele] Univ Hosp Padua, Dept Pediat Surg, Padua, Italy.
   [Manodoro, Stefano] Univ Hosp Monza, Dept Obstet & Gynecol, Monza, Italy.
   [Kramer, Manuel] Univ Erlangen Nurnberg, Dept Radiol, D-91054 Erlangen, Germany.
   [Till, Holger] Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany.
   [Deprest, Jan] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Obstet & Gynecol, Leuven, Belgium.
RP Deprest, J (reprint author), Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium.
EM jan.deprest@uzleuven.be
RI Decaluwe, Herbert/A-2436-2009
OI Decaluwe, Herbert/0000-0002-0877-7717
FU European Commission (EuroSTEC) [LSHC-CT-2006-037409]; Instituut voor
   Wetenschap en Technologie (I.W.T.); Flanders Research Foundation (FWO
   Vlaanderen) [1801207N]
FX This work was supported by the European Commission in its 6th Framework
   Program (EuroSTEC, LSHC-CT-2006-037409) and the Instituut voor
   Wetenschap en Technologie (I.W.T.). Jan Deprest is a clinical researcher
   for the Flanders Research Foundation (FWO Vlaanderen; 1801207N). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aikawa M, 2013, SURG TODAY, V43, P1298, DOI 10.1007/s00595-012-0414-3
   ATKINSON JB, 1992, J PEDIATR SURG, V27, P754, DOI 10.1016/S0022-3468(05)80109-5
   BAX NMA, 1984, J PEDIATR SURG, V19, P484, DOI 10.1016/S0022-3468(84)80281-X
   Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543
   Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Claerhout F, 2008, AM J OBSTET GYNECOL, V198, pe91
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   De Coppi P, 2012, EUR J PEDIATR SURG, V22, P393, DOI 10.1055/s-0032-1329410
   DeKoninck P, 2011, EARLY HUM DEV, V87, P619, DOI 10.1016/j.earlhumdev.2011.08.001
   Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2
   Deprest J, 2010, J UROLOGY, V183, P2249, DOI 10.1016/j.juro.2010.02.008
   Deprest J, 2009, J UROLOGY, V182, P2362, DOI 10.1016/j.juro.2009.07.043
   Fauza DO, 2014, SEMIN PEDIATR SURG, V23, P135, DOI 10.1053/j.sempedsurg.2014.04.004
   Fauza DO, 2001, J PEDIATR SURG, V36, P146, DOI 10.1053/jpsu.2001.20034
   Feola A, 2015, AM J OBSTET GYNECOL, V212, p[474, e1], DOI [10.1016/j.ajog.2014.11.008, DOI 10.1016/J.AJ0G.2014.11.008]
   Gasior AC, 2012, PEDIATR SURG INT, V28, P327, DOI 10.1007/s00383-012-3059-9
   Gonzalez R, 2011, J LAPAROENDOSC ADV S, V21, P449, DOI 10.1089/lap.2010.0409
   Grethel EJ, 2006, J PEDIATR SURG, V41, P29, DOI 10.1016/j.jpedsurg.2005.10.005
   Gucciardo L, 2014, J PEDIATR SURG, V49, P1458, DOI 10.1016/j.jpedsurg.2014.01.058
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Jones KA, 2009, INT UROGYNECOL J, V20, P847, DOI 10.1007/s00192-008-0781-x
   Laituri CA, 2010, EUR J PEDIATR SURG, V20, P363, DOI 10.1055/s-0030-1261939
   Lally KP, 2007, PEDIATRICS, V120, pE651, DOI 10.1542/peds.2006-3040
   LALLY KP, 1992, ANN SURG, V216, P569, DOI 10.1097/00000658-199211000-00008
   Lammers G, 2010, BIOMATERIALS, V31, P8299, DOI 10.1016/j.biomaterials.2010.07.055
   Lantis JC, 2000, J INVEST SURG, V13, P319
   Loff S, 2005, J PEDIATR SURG, V40, P1701, DOI 10.1016/j.jpedsurg.2005.07.007
   Mayer S, 2011, PRENATAL DIAG, V31, P1086, DOI 10.1002/pd.2839
   Mayer S, 2011, SEMIN PEDIATR SURG, V20, P161, DOI 10.1053/j.sempedsurg.2011.03.006
   Montzka K, 2011, BJU INT, V107, P1974, DOI 10.1111/j.1464-410X.2010.09680.x
   MOVAT HZ, 1955, ARCH PATHOL, V60, P289
   Ozog Y, 2011, INT UROGYNECOL J, V22, P1099, DOI 10.1007/s00192-011-1440-1
   Ozog Y, 2009, INT UROGYNECOL J, V20, P435, DOI 10.1007/s00192-008-0793-6
   Peeters E, 2013, J SURG RES, V180, P274, DOI 10.1016/j.jss.2013.01.025
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Romao RLP, 2012, J PEDIATR SURG, V47, P1496, DOI 10.1016/j.jpedsurg.2012.01.009
   Sandoval JA, 2006, J PEDIATR SURG, V41, P518, DOI 10.1016/j.jpedsurg.2005.11.068
   Sinha CK, 2009, J PEDIATR SURG, V44, P312, DOI 10.1016/j.jpedsurg.2008.10.078
   Slack M, 2012, INT UROGYNECOL J, V23, pS15, DOI 10.1007/s00192-012-1678-2
   St Peter SD, 2007, J SURG RES, V140, P234, DOI 10.1016/j.jss.2007.03.018
   Steinau G, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-5
   Tsai J, 2012, J PEDIATR SURG, V47, P637, DOI 10.1016/j.jpedsurg.2011.11.054
   Tsao K, 2011, FETAL DIAGN THER, V29, P46, DOI 10.1159/000320244
   TSUKADA T, 1986, ARTERIOSCLEROSIS, V6, P601, DOI 10.1161/01.ATV.6.6.601
   Turner CG, 2011, J PEDIATR SURG, V46, P57, DOI 10.1016/j.jpedsurg.2010.09.063
   Verbelen T, 2013, EUR J CARDIO-THORAC, V44, P263, DOI 10.1093/ejcts/ezt001
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
   Zuhlke H V, 1990, Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir, P1009
NR 48
TC 4
Z9 4
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2015
VL 10
IS 7
AR e0132021
DI 10.1371/journal.pone.0132021
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1DQ
UT WOS:000358157600181
PM 26147985
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zhang, J
   Deng, AP
   Zhou, AM
   Yang, Y
   Gao, LH
   Zhong, ZC
   Yang, SL
AF Zhang, Jing
   Deng, Aipeng
   Zhou, Aimei
   Yang, Yang
   Gao, Lihu
   Zhong, Zhaocai
   Yang, Shulin
TI Comparison of two proanthocyanidin cross-linked recombinant human
   collagen-peptide (RHC) - chitosan scaffolds
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE recombinant human collagen; chitosan; proanthocyanidin; hydrogen
   bonding; HUVECs viability
ID BIOMATERIAL SCAFFOLDS; POROUS SCAFFOLDS; DRUG-DELIVERY; SILK FIBROIN;
   IN-VITRO; TISSUE; CARTILAGE; GELATIN; LINKING; MATRIX
AB Cross-linking plays an important role in tissue engineering, which involves the alternative of cross-linker and the way of components interaction. We compared two proanthocyanidin (PA) cross-linked recombinant human collagen-peptide - chitosan scaffolds: immerse cross-linking (I-CLS) and premix cross-linking (P-CLS). Both of the scaffolds presented homogeneous pore structure with mean pore size of 110-115m. The swelling ratio was decreased to 29.6 in I-CLS, but increased to 37.1 in P-CLS while porosity of the two scaffolds was reduced about 8% comparing to 94.3% before cross-linking. The cross-linked scaffolds exhibited enhanced resistance to enzyme degradation and improved compressive modulus (I-CLS>P-CLS). The scaffolds transformed from elastic region to plastic region until the strain reached 60%, and the stress was 40.5, 133.2 and 84.1kPa of uncross-linking scaffold, I-CLS and P-CLS individually. Thermal stability indicated molecular bonding between PA and the scaffold components, simultaneously, Fourier transform infrared spectroscopy mainly presented hydrogen bonding between the protein amide carbonyl and the phenolic hydroxyl with a particular transform due to pyrrolidine rings of proline in P-CLS. Both of the I-CLS and P-CLS could promote human umbilical vein endothelial cells attachment and proliferation. The characterization suggested in situ biodegradable application of P-CLS, while a potential long-term utilization of I-CLS in tissue engineering.
C1 [Zhang, Jing; Deng, Aipeng; Zhou, Aimei; Gao, Lihu; Zhong, Zhaocai; Yang, Shulin] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China.
   [Yang, Yang] Univ Nottingham, Fac Engn, Nottingham NG7 2RD, England.
RP Yang, SL (reprint author), Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China.
EM yshulin@njust.edu.cn
RI 南京理工大学, 环境与生物工程学院/N-7361-2016
FU National High Technology Research and Development Program of China
   [2014AA022107]; Science and Technology Project of Jiangsu province,
   China [BE 2011837]; Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD)
FX This work was financially supported by the National High Technology
   Research and Development Program of China [No: 2014AA022107], Science
   and Technology Project of Jiangsu province, China [No: BE 2011837], as
   well as A Project Funded by the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD).
CR Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Bedran-Russo AKB, 2008, J BIOMED MATER RES B, V86B, P330, DOI 10.1002/jmb.b.31022
   Botta SB, 2012, J BIOMED MATER RES B, V100B, P1009, DOI 10.1002/jbm.b.32666
   Browne S, 2013, TISSUE ENG PT A, V19, P1491, DOI [10.1089/ten.tea.2012.0721, 10.1089/ten.TEA.2012.0721]
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen Y, 2015, ACTA BIOMATER, V11, P435, DOI 10.1016/j.actbio.2014.09.028
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Covington AD, 2005, J AM LEATHER CHEM AS, V100, P325
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Epasinghe DJ, 2012, J DENT, V40, P173, DOI 10.1016/j.jdent.2011.11.013
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Friess W, 2003, ADV DRUG DELIVER REV, V55, P1529, DOI 10.1016/j.addr.2003.08.001
   Geiger M., 2002, PHARM TECH EUROPE, V14, P58
   Geiger M, 2002, PHARM TECHNOL EUR, V14, P48
   Guo R, 2011, BIOMATERIALS, V32, P1019, DOI 10.1016/j.biomaterials.2010.08.087
   HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494
   Han B, 2003, J BIOMED MATER RES A, V65A, P118, DOI 10.1002/jbm.a.10460
   Hartwell R, 2011, ACTA BIOMATER, V7, P3060, DOI 10.1016/j.actbio.2011.04.024
   Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+
   He LR, 2011, INT J BIOL MACROMOL, V48, P354, DOI 10.1016/j.ijbiomac.2010.12.012
   Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073
   Horn MM, 2009, CARBOHYD POLYM, V77, P239, DOI 10.1016/j.carbpol.2008.12.039
   Huang CH, 2012, MAT SCI ENG C-MATER, V32, P2476, DOI 10.1016/j.msec.2012.07.029
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Ku CS, 2007, CHEMOSPHERE, V67, P1618, DOI 10.1016/j.chemosphere.2006.11.037
   LEATRESE DH, 1998, J BIOMED MATER RES, V42, P396
   Liu B., 2012, CHEM SCI T, V1, P347
   Liu BS, 2008, J BIOMED MATER RES A, V87A, P1092, DOI 10.1002/jbm.a.31916
   Liu B, 2011, ADV MATER RES-SWITZ, V236-238, P2905, DOI 10.4028/www.scientific.net/AMR.236-238.2905
   Liu Y, 2013, J DENT, V41, P535, DOI 10.1016/j.jdent.2013.03.007
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   McFadden TM, 2013, ACTA BIOMATER, V9, P9303, DOI 10.1016/j.actbio.2013.08.014
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Sagliyan A, 2012, REV MED VET-TOULOUSE, V163, P11
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shinjiro Takata AS, 2004, J MED INVEST, V51, P133
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tiyaboonchai W, 2011, FIBER POLYM, V12, P324, DOI 10.1007/s12221-011-0324-9
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Zhu YJ, 2014, J MECH BEHAV BIOMED, V36, P32, DOI 10.1016/j.jmbbm.2014.04.003
NR 47
TC 2
Z9 3
U1 1
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUL 3
PY 2015
VL 26
IS 10
BP 585
EP 599
DI 10.1080/09205063.2015.1047667
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA CK9WG
UT WOS:000356589600002
PM 26053645
DA 2018-10-19
ER

PT J
AU Darwis, D
   Abbas, EB
   Nurlidar, F
   Putra, DP
AF Darwis, Darmawan
   Abbas, Erizal B.
   Nurlidar, Farah
   Putra, D. Pribadi
TI Radiation Processing of Polymers for Medical and Pharmaceutical
   Applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Conference on Innovation in Polymer Science and Technology
   (IPST)
CY OCT 07-10, 2013
CL Yogyakarta, INDONESIA
DE biomaterial; crosslinking; degradation; electron beam; gamma
   irradiation; polymer; radiation processing; sterilizationbiomaterial
ID HYDROGELS
AB The use of ionizing radiation for the preparation of polymeric biomaterials is one of the examples of the application of atomic energy for the benefit of humanity. Radiation processing is based on the use of high energy ionizing radiation to induce chemical and biological changes in irradiated systems. High energy electron (EB) under 10 keV and gamma irradiation are the most frequently used of ionizing radiation for synthesis, modification of polymers, and sterilization of medical devices. Potential biomedical and pharmaceutical applications of these polymers are implants, topical dressings, injectable formulations, drug delivery devices, diagnostic assays, and immobilized enzyme. Through radiation crosslinking or degradation processes, polymers with specific characteristics can be prepared. The advantages of radiation processing include the absent of any chemical residues (since no chemical additives are requires to initiate the reactions), can be used at all temperatures, can be limited to the surface only and in certain cases, the synthesis/modification of materials can be combined with sterilization.
C1 [Darwis, Darmawan; Abbas, Erizal B.; Nurlidar, Farah; Putra, D. Pribadi] Natl Nucl Energy Agcy, Ctr Applicat Isotopes & Radiat Technol, Jl Lebak Bulus Raya 49, Jakarta 12070, Indonesia.
RP Darwis, D (reprint author), Natl Nucl Energy Agcy, Ctr Applicat Isotopes & Radiat Technol, Jl Lebak Bulus Raya 49, Jakarta 12070, Indonesia.
EM darmawan_p3tir@batan.go.id
CR Australian Government Department of Agriculture Fisheries and Forestry, 2013, GAMM IRR TREATM ADDR, P16
   Caliceti P, 2001, J CONTROL RELEASE, V75, P173, DOI 10.1016/S0168-3659(01)00380-7
   Chapiro A., 1962, RAD CHEM POLYM SYSTE, P354
   Chmielewski A. G., 2008, TRENDS RAD STERILIZA, P29
   Chmielewski A. G., 2008, TRENDS RAD STERILIZA, P49
   Cleland M. R., 2005, CERN ACC SCH SMALL A
   Council on Ionizing Radiation Measurements and Standards, 2004, 4 REP NEEDS ION RAD, P78
   Aquino KAD, 2012, GAMMA RADIATION, P171
   DARMAWAN D., 1999, P NAT SEM IND CHEM S, P324
   Darmawan D., 2004, P NAT SEM IND MED PL, P539
   Darwis D, 2009, AT INDONES, V35, P85, DOI 10.17146/aij.2009.12
   Dziedzic-Goclawska A., 1997, ADV TISSUE BANKING, V1, P266
   Gueven O., 2004, ADV RAD CHEM POLYM, P33
   Gupta B, 2010, INDIAN J FIBRE TEXT, V35, P174
   Hammad A., 2008, TRENDS RAD STERILIZA, P119
   Hammad A. A., 2008, TRENDS RAD STERILIZA, P120
   Hansen JM, 2001, DISINFECTION STERILI, P729
   Hoffman P., 2004, DISINFECTION HEALTHC, P115
   International Atomic Energy Agency, 2004, IAEATECDOC1384, P1
   International Atomic Energy Agency (IAEA), 2001, GAMM IRR RAD PROC, P3
   International Brotherhood of Teamsters, 2008, TRI COUNC POL STAT E, P1
   Joshi G, 2011, INT J PHARM PHARM SC, V3, P200
   Kashyap N., 2004, DRUG DEV DELIVERY, V4, P32
   Kovac A., 2003, P TECHN M VIENN, P85
   Mehta K, 2008, TRENDS RAD STERILIZA, P5
   Minister of Public Works and Government Services Canada, 2012, INTR RAD, P6
   Nather A., 2007, RAD TISSUE BANKING B, P3
   Nikita T. S., 1963, EFFECT IONIZING RAD, P7
   Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030
   Patel A., 2011, BIOMEDICAL ENG FRONT, P280
   Razzak MT, 2001, RADIAT PHYS CHEM, V62, P107, DOI 10.1016/S0969-806X(01)00427-3
   Rosiak J. M., 2002, IAEATECDOC1324, P5
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   Saha N., 2011, J BIOMATER NANOBIOTE, V2, P85, DOI DOI 10.4236/JBNB.2011.21011
   Sarma K. S. S., 2004, IAEA TECDOC 1386 EME, P74
   Silindir M., 2009, FABAD J PHARM SCI, V34, P43
   Singh A., 1994, ISOTOPE RAD TECHNOLO, P2
   Singh A., 1992, RAD PROCESSING POLYM, P2
   Wayne R., 2005, STERILISATION POLYM, P1
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   Yusof N, 2007, RAD TISSUE BANKING B, P99
   Yusof N., 2001, ADV TISSUE BANKING, V5, P342
   Yusof N., 2007, RAD TISSUE BANKING B, P109
   Yusof N., 2007, RAD TISSUE BANKING, P121
   Zaman K., 2001, ADV TISSUE BANKING, V5, P309
NR 45
TC 3
Z9 3
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2015
VL 353
IS 1
SI SI
BP 15
EP 23
DI 10.1002/masy.201550302
PG 9
WC Polymer Science
SC Polymer Science
GA DN7SV
UT WOS:000377279700003
DA 2018-10-19
ER

PT J
AU Nurlidar, F
   Budianto, E
   Darwis, D
   Sugiarto
AF Nurlidar, Farah
   Budianto, Emil
   Darwis, Darmawan
   Sugiarto
TI Hydroxyapatite Deposition on Modified Bacterial Cellulose Matrix
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Conference on Innovation in Polymer Science and Technology
   (IPST)
CY OCT 07-10, 2013
CL Yogyakarta, INDONESIA
DE bacterial cellulose; biopolymers; citric acid; coconut water;
   hydroxyapatite
ID BONE REGENERATION; COMPOSITES
AB Bacterial cellulose (BC), biosynthesized by bacteria, is an attractive biomaterial for bone regeneration due to its biocompatibility and good mechanical properties. However, BC is devoid of inorganic elements which are necessary for formation of chemical bonds with bone. Incorporation of inorganic phases such as hydroxyapatite (HA) into BC matrix may enhance bone regeneration. The aim of this study was to develop BC as a matrix for HA deposition. Absorption capacity is a key to incorporate calcium ion into BC and induces HA deposition. To enhance its absorption capacity, BC was modified using citric acid. The results showed that the incorporation of carboxylate groups into BC via reaction with citric acid improved its absorption capacity. X-ray diffraction (XRD) patterns of the modified BC after soaking treatments showed HA deposition with diffractions attributed to low crystalline HA at 2 theta = 11.7 degrees; 26.2 degrees; 29.4 degrees; 32.0 degrees; 33.0 degrees; 34.2 degrees; and 46.6 degrees. Furthermore, energy dispersive spectroscopy (EDS) analysis showed that the average Ca/P ratio was 1.12.
C1 [Nurlidar, Farah; Darwis, Darmawan; Sugiarto] Ctr Applicat Isotopes & Radiat Technol, Ps Jumat 12070, Jakarta Selatan, Indonesia.
   [Budianto, Emil] Univ Indonesia, Depok 16421, Jawa Barat, Indonesia.
RP Nurlidar, F (reprint author), Ctr Applicat Isotopes & Radiat Technol, Ps Jumat 12070, Jakarta Selatan, Indonesia.
EM farah@batan.go.id
CR Bielecki S., 2002, BIOPOLYMERS, V5, P37, DOI 10.1002/3527600035.bpol5003
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Darwis D., 2009, J ILMIAH A I R, V5, P83
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Kawai T, 2004, BIOMATERIALS, V25, P4529, DOI 10.1016/j.biomaterials.2003.11.039
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Salam A, 2011, CARBOHYD POLYM, V84, P1221, DOI 10.1016/j.carbpol.2011.01.008
   Salam A, 2010, BIOMACROMOLECULES, V11, P1453, DOI 10.1021/bm1000235
   Strange DGT, 2011, ACTA BIOMATER, V7, P3586, DOI 10.1016/j.actbio.2011.06.025
   Nge TT, 2010, BIOPOLYMERS, P345
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 16
TC 0
Z9 0
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2015
VL 353
IS 1
SI SI
BP 128
EP 132
DI 10.1002/masy.201550317
PG 5
WC Polymer Science
SC Polymer Science
GA DN7SV
UT WOS:000377279700018
DA 2018-10-19
ER

PT J
AU Othman, Z
   Hashim, K
   Sabariah, K
   Abd Nasir, MH
   Hassan, A
AF Othman, Zainon
   Hashim, K.
   Sabariah, K.
   Abd Nasir, M. H.
   Hassan, A.
TI Synthesis and Characterization of Carboxymethyl Derivatives of Sago
   (Metroxylon sagu) Starch
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Conference on Innovation in Polymer Science and Technology
   (IPST)
CY OCT 07-10, 2013
CL Yogyakarta, INDONESIA
DE carboxymethyl sago starch; degree of substitution; sago starch
ID POTATO STARCH
AB Synthesis of carboxymethyl starch (CMSS) from sago (Metroxylon sagu), an important agricultural commodity of Malaysia, was conducted in 30 L reactor vessel using isopropanol as the non-aqueous medium. CMSS of degree of substitution (DS) 0.24, 0.40, 0.54 and 0.80 was prepared by varying the molar ratio of sodium hydroxide and sodium monochloroacetate to anhydroglucose units including reaction time. Substitution of the hydroxyl groups on the native starch with carboxymethyl group was confirmed using Fourier transform infrared. All prepared samples were water-soluble at room temperature, producing high paste clarity. Carboxymethylation markedly reduced viscosity of CMSS compared to native sago. The particle size distribution also displayed increase in the granule size range compared to native sago. However X-ray diffractometry of CMSS revealed loss of crystallinity. Scanning electron microscopy showed that the granular smooth appearance of native starch was mostly distorted after carboxymethylation process at higher DS values. The synthesis of carboxymethyl sago starch with different degrees of substitution will add value to the sago industry as new functional biomaterial with potential application in the food and non-food industry.
C1 [Othman, Zainon; Hashim, K.; Sabariah, K.; Abd Nasir, M. H.; Hassan, A.] Agensi Nuklear Malaysia, Kajang 43000, Selangor, Malaysia.
RP Othman, Z (reprint author), Agensi Nuklear Malaysia, Kajang 43000, Selangor, Malaysia.
EM zainon@nuclearmalaysia.gov.my
CR Ahmad FB, 1999, CARBOHYD POLYM, V38, P361, DOI 10.1016/S0144-8617(98)00123-4
   American Standard of Test Method, 1992, ASTM, V6, P24939
   Kittipongpatana OS, 2006, CARBOHYD POLYM, V63, P105, DOI 10.1016/j.carbpol.2005.08.024
   Liu J, 2012, FOOD CHEM, V133, P1196, DOI 10.1016/j.foodchem.2011.05.061
   Noor Fadzlina Z. A., 2005, J FOOD SCI, V70, P9
   Qiu HY, 1999, POLYM ADVAN TECHNOL, V10, P468, DOI 10.1002/(SICI)1099-1581(199907)10:7<468::AID-PAT898>3.3.CO;2-N
   Singhal RS, 2008, CARBOHYD POLYM, V72, P1, DOI 10.1016/j.carbpol.2007.07.043
   Tijsen CJ, 2001, CARBOHYD POLYM, V45, P219, DOI 10.1016/S0144-8617(00)00243-5
   Wang YL, 2009, CARBOHYD RES, V344, P1764, DOI 10.1016/j.carres.2009.06.014
   Yaacob B, 2011, IRAN POLYM J, V20, P195
NR 10
TC 1
Z9 1
U1 2
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2015
VL 353
IS 1
SI SI
BP 139
EP 146
DI 10.1002/masy.201550319
PG 8
WC Polymer Science
SC Polymer Science
GA DN7SV
UT WOS:000377279700020
DA 2018-10-19
ER

PT J
AU Moloney, TC
   Fhlathartaigh, MN
   Kulkarni, M
   Pandit, A
   Dowd, E
AF Moloney, Teresa C.
   Fhlathartaigh, Mary Ni
   Kulkarni, Mangesh
   Pandit, Abhay
   Dowd, Eilis
TI Fibrin As a Scaffold for Delivery of GDNF Overexpressing Stem Cells to
   the Adult Rat Brain
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biomaterial; neurotrophic factors; stem cells; neurodegeneration; fibrin
ID SPINAL-CORD-INJURY; NIGRAL DOPAMINERGIC-NEURONS; MARROW STROMAL CELLS;
   NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE;
   BONE-MARROW; CONTROLLED-RELEASE; SUBACUTE MODEL; CLOT STRUCTURE
AB Treatment of neurodegenerative disease is entering a new era where direct intracerebral delivery of therapeutic factors aims to restore normality to dysfunctional circuits. Cell-based therapeutic approaches, where virally manipulated mesenchymal stem cells (MSCs) overexpressing glial cell line derived neurotrophic factor (GDNF) are utilized as vehicles to deliver neurotrophic support to the Parkinsonian brain, have shown promising preclinical results at preserving dopaminergic neuron integrity. However, poor cell survival following transplantation will hinder clinical progression. One approach to improve MSCs survival following transplantation is to couple the cell engraftment procedure with a scaffold thereby providing a physical substrate upon which to eventually complex pro-survival factors. Evaluation of commercially available, clinically accepted materials with an established safety profile will expedite clinical translation. Therefore, this study sought to determine if a clinically used fibrin scaffold can be utilized as an adjunct to intracerebral cell transplantation without evoking an adverse host or stem cell response. Sixteen male Sprague Dawley rats received bilateral intrastriatal transplants of 30 000 GDNF-transduced MSCs delivered in either control transplantation medium or a fibrin scaffold. Rats were sacrificed 1, 4, 7, and 14 days post-transplantation. Brains were analyzed to determine in situ polymerization and biodegradability of the fibrin scaffold, GDNF release from transplanted GDNF-MSCs, survival of the GDNF-MSC graft and the host's immune response to the transplant. This study found that fibrin scaffold was adaptable to intracerebral delivery with successful polymerization of the fibrin scaffold in situ. Inclusion of the fibrin scaffold was not detrimental to cell survival nor did it impede neurotrophin release from entrapped cells. Importantly, the inclusion of the fibrin scaffold was associated with a reduced host astroglial and microglial response compared to cells alone indicative of a favorable biocompatibility profile. Overall, fibrin represents an adaptable scaffold for inclusion in a minimally invasive cell-based therapeutic approach for neurodegenerative diseases.
C1 [Moloney, Teresa C.; Fhlathartaigh, Mary Ni; Dowd, Eilis] Natl Univ Ireland, Dept Pharmacol, Galway, Ireland.
   [Moloney, Teresa C.; Fhlathartaigh, Mary Ni; Dowd, Eilis] Natl Univ Ireland, Dept Therapeut, Galway, Ireland.
   [Moloney, Teresa C.; Fhlathartaigh, Mary Ni; Kulkarni, Mangesh; Pandit, Abhay; Dowd, Eilis] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
RP Dowd, E (reprint author), Natl Univ Ireland, Dept Pharmacol, Galway, Ireland.
EM eilis.dowd@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Dowd, Eilis/0000-0002-2668-539X
FU Science Foundation Ireland Strategic Research Cluster grant
   [07/SRC/B1163]
FX We acknowledge BAXTER for their kind gift of the TISSEEL used in this
   project. We thank Doczyk Design for the generation of the schematic.
   This research was funded by a Science Foundation Ireland Strategic
   Research Cluster grant (07/SRC/B1163).
CR Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Bartmann C, 2007, TRANSFUSION, V47, P1426, DOI 10.1111/j.1537-2995.2007.01219.x
   Breen A, 2006, J BIOMED MATER RES A, V78A, P702, DOI 10.1002/jbm.a.30735
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Breen A, 2009, J BIOMED MATER RES A, V89A, P876, DOI 10.1002/jbm.a.32039
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   De Faveri Sara, 2014, Front Neuroeng, V7, P7, DOI 10.3389/fneng.2014.00007
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Hoban DB, 2013, BIOMATERIALS, V34, P9420, DOI 10.1016/j.biomaterials.2013.08.073
   Ito T, 2001, J AM SOC NEPHROL, V12, P2625
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Johnson SJ, 2013, MOVEMENT DISORD, V28, P319, DOI 10.1002/mds.25328
   Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P252
   Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P250
   Kassam Amin, 2004, Ear Nose Throat J, V83, P246
   Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x
   Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292
   Kulkarni M, 2014, BIOMATERIALS, V35, P2001, DOI 10.1016/j.biomaterials.2013.11.003
   Kulkarni M, 2009, BIOMACROMOLECULES, V10, P1650, DOI 10.1021/bm900248n
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737
   LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557
   Liu JB, 2013, CELLS TISSUES ORGANS, V198, P35, DOI 10.1159/000351665
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Love S, 2005, NAT MED, V11, P703, DOI 10.1038/nm0705-703
   Manning CN, 2013, ACTA BIOMATER, V9, P6905, DOI 10.1016/j.actbio.2013.02.008
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Moloney TC, 2010, BRAIN RES, V1359, P33, DOI 10.1016/j.brainres.2010.08.040
   Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745
   Moore AM, 2010, J HAND SURG-AM, V35A, P2008, DOI 10.1016/j.jhsa.2010.08.016
   Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ren ZH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02786
   Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260
   Rooney GE, 2009, TISSUE ENG PT A, V15, P3049, DOI [10.1089/ten.tea.2009.0045, 10.1089/ten.TEA.2009.0045]
   Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x
   Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x
   Sherer TB, 2006, MOVEMENT DISORD, V21, P136, DOI 10.1002/mds.20861
   Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216
   Sullivan AM, 1998, EUR J NEUROSCI, V10, P57
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006
   Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400
   Winkler C, 1996, J NEUROSCI, V16, P7206
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wood MD, 2008, J BIOMED MATER RES A, V84A, P300, DOI 10.1002/jbm.a.31269
   Wood MD, 2013, REGEN MED, V8, P27, DOI [10.2217/RME.12.105, 10.2217/rme.12.105]
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Zhang ZQ, 2008, IN VITRO CELL DEV-AN, V44, P169, DOI 10.1007/s11626-008-9093-1
NR 58
TC 1
Z9 1
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUL
PY 2015
VL 1
IS 7
BP 559
EP 566
DI 10.1021/acsbiomaterials.5b00049
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RN
UT WOS:000372213900009
DA 2018-10-19
ER

PT J
AU Appavu, R
   Chesson, CB
   Koyfman, AY
   Snook, JD
   Kohlhapp, FJ
   Zloza, A
   Rudra, JS
AF Appavu, Rajagopal
   Chesson, Charles B.
   Koyfman, Alexey Y.
   Snook, Joshua D.
   Kohlhapp, Frederick J.
   Zloza, Andrew
   Rudra, Jai S.
TI Enhancing the Magnitude of Antibody Responses through Biomaterial
   Stereochemistry
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE adjuvant; enantiomer; nanofiber; peptide; stereochemistry; self-assembly
ID D-AMINO ACIDS; SELF-ASSEMBLING PEPTIDES; CELL RESPONSES; NALP3
   INFLAMMASOME; IMMUNE-RESPONSES; DENDRITIC CELLS; VACCINE; ADJUVANT;
   BETA; IMMUNOMODULATION
AB D-Amino acid analogs of peptides and proteins are attractive for applications in biotechnology and medicine due to their reduced proteolytic sensitivity. Here, we report that self-assembling peptide nanofibers composed of D-amino acids act as immune adjuvants, and investigate their ability to induce antibody responses in comparison to their L-amino acid counterparts. The model antigenic peptide OVA (chicken egg ovalbumin as 323-339) from chicken egg ovalbumin, known to elicit antibody responses in mice, was linked to an L- or D-amino acid self-assembling peptide domain to generate enantiomeric nanofibers displaying the same epitope. The chiral nature of the fusion peptides was confirmed by circular dichrosim spectroscopy and transmission electron microscopy studies indicated that OVA-bearing enantiomers self-assembled into nanofibers with similar morphologies. In mice, D-amino acid peptide nanofibers displaying OVA elicited stronger antibody responses, equivalent levels of CD4+ T cell responses, and long-term antigen-presentation in vivo compared to L-amino acid nanofibers. Our findings indicate that self-assembling peptides composed of D-amino acids are strong immune adjuvants and that biomaterial stereochemistry can be used as a design tool to program adaptive immune responses for vaccine development.
C1 [Appavu, Rajagopal; Koyfman, Alexey Y.; Snook, Joshua D.; Rudra, Jai S.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Chesson, Charles B.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Chesson, Charles B.; Rudra, Jai S.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Kohlhapp, Frederick J.; Zloza, Andrew] Rush Univ, Med Ctr, Dept Microbiol Immunol, Chicago, IL 60612 USA.
   [Kohlhapp, Frederick J.; Zloza, Andrew] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.
RP Rudra, JS (reprint author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
EM jarudra@utmb.edu
FU Sealy Center for Vaccine Development, and the Department of Pharmacology
   and Toxicology, UTMB
FX This study was supported by funds from the Sealy Center for Vaccine
   Development, and the Department of Pharmacology and Toxicology, UTMB
   (J.S.R/). TEM studies were conducted at the Sealy Center for Structural
   Biology Cryo-electron Microscopy core lab and we thank Dr. Misha Sherman
   and Michael Woodson for assistance with imaging. Flow cytometry was
   conducted at the Flow Cytometry and Cell Sorting Facility at UTMB and we
   thank Mark Griffin for his expertise. SPR studies were conducted at the
   Solution Biophysics Research Core Lab at the Sealy Center for Structural
   Biology and we thank Dr. Luis Marcelo F. Holthauzen for his expertise
   and assistance. We thank Dr. Rebecca Pompano for helpful discussions and
   Heather Lander for assistance with editing the manuscript.
CR Anderson RJ, 2014, NAT CHEM BIOL, V10, P943, DOI [10.1038/NCHEMBIO.1640, 10.1038/nchembio.1640]
   ARMSTRONG DW, 1993, CHIRALITY, V5, P375, DOI 10.1002/chir.530050519
   Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020
   Billard JM, 2012, AMINO ACIDS, V43, P1851, DOI 10.1007/s00726-012-1346-3
   Bowerman CJ, 2012, BIOPOLYMERS, V98, P169, DOI 10.1002/bip.22058
   Chen JJ, 2013, BIOMATERIALS, V34, P8776, DOI 10.1016/j.biomaterials.2013.07.063
   Chesson CB, 2014, VACCINE, V32, P1174, DOI 10.1016/j.vaccine.2013.11.047
   Chichili VPR, 2013, PROTEIN SCI, V22, P153, DOI 10.1002/pro.2206
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   FISHER GH, 1991, BRAIN RES BULL, V26, P983, DOI 10.1016/0361-9230(91)90266-M
   Friedman M, 2012, AMINO ACIDS, V42, P1553, DOI 10.1007/s00726-011-0915-1
   Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225
   Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636
   Huang ZH, 2012, J AM CHEM SOC, V134, P8730, DOI 10.1021/ja211725s
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hudalla GA, 2013, ADV HEALTHC MATER, V2, P1114, DOI 10.1002/adhm.201200435
   Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Khan TA, 2014, ACTA BIOMATER, V10, P1720, DOI 10.1016/j.actbio.2013.12.011
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Lewis JS, 2014, MRS BULL, V39, P25, DOI 10.1557/mrs.2013.310
   Li XM, 2012, LANGMUIR, V28, P13512, DOI 10.1021/la302583a
   Liu YR, 2014, MOL PHARMACEUT, V11, P1651, DOI 10.1021/mp5000373
   Luo ZL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002364
   Luo ZL, 2008, MACROMOL BIOSCI, V8, P785, DOI 10.1002/mabi.200800003
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Malyala P, 2008, J PHARM SCI-US, V97, P2041, DOI 10.1002/jps.21152
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Maude S, 2013, NANOMEDICINE-UK, V8, P823, DOI [10.2217/NNM.13.65, 10.2217/nnm.13.65]
   Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003
   Montero A, 2011, CHEM BIOL, V18, P1453, DOI 10.1016/j.chembiol.2011.08.017
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Nagy KJ, 2011, J AM CHEM SOC, V133, P14975, DOI 10.1021/ja206742m
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/nmat2784, 10.1038/NMAT2784]
   O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009
   Pradhan P, 2014, BIOMATERIALS, V35, P5491, DOI 10.1016/j.biomaterials.2014.03.039
   Purwada A, 2014, ACTA BIOMATER, V10, P1728, DOI 10.1016/j.actbio.2013.12.036
   Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Sun TL, 2007, J AM CHEM SOC, V129, P1496, DOI 10.1021/ja0686155
   Swanekamp RJ, 2012, J AM CHEM SOC, V134, P5556, DOI 10.1021/ja301642c
   Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037
   Tsutsumi H, 2013, MOL BIOSYST, V9, P609, DOI 10.1039/c3mb25442a
   Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523
   ZAGON J, 1994, NUTR RES, V14, P445, DOI 10.1016/S0271-5317(05)80182-4
NR 51
TC 10
Z9 11
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUL
PY 2015
VL 1
IS 7
BP 601
EP 609
DI 10.1021/acsbiomaterials.5b00139
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RN
UT WOS:000372213900014
DA 2018-10-19
ER

PT J
AU Naves, MM
   Menezes, HHM
   Magalhaes, D
   Ferreira, JA
   Ribeiro, SF
   de Mello, JDB
   Costa, HL
AF Naves, Marina Melo
   Machado Menezes, Helder Henrique
   Magalhaes, Denildo
   Ferreira, Jessica Afonso
   Ribeiro, Sara Ferreira
   Biasoli de Mello, Jose Daniel
   Costa, Henara Lillian
TI Effect of Macrogeometry on the Surface Topography of Dental Implants
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE dental implants; implant design; osseointegration; surface texturing;
   surface topography; titanium
ID TITANIUM IMPLANTS; RETROSPECTIVE ANALYSIS; EARLY OSSEOINTEGRATION; BONE
   INTEGRATION; MINIATURE PIGS; ROUGHNESS; PARAMETERS; SURVIVAL; ADHESION;
   CONTACT
AB Purpose: Because the microtopography of titanium implants influences the biomaterial-tissue interaction, surface microtexturing treatments are frequently used for dental implants. However, surface treatment alone may not determine the final microtopography of a dental implant, which can also be influenced by the implant macrogeometry. This work analyzed the effects on surface roughness parameters of the same treatment applied by the same manufacturer to implants with differing macro-designs. Materials and Methods: Three groups of titanium implants with different macro-designs were investigated using laser interferometry and scanning electron microscopy. Relevant surface roughness parameters were calculated for different regions of each implant. Two flat disks (treated and untreated) were also investigated for comparison. Results: The tops of the threads and the nonthreaded regions of all implants had very similar roughness parameters, independent of the geometry of the implant, which were also very similar to those of flat disks treated with the same process. In contrast, the flanks and valleys of the threads presented larger irregularities (Sa) with higher slopes (Sdq) and larger developed surface areas (Sdr) on all implants, particularly for implants with threads with smaller heights. The flanks and valleys displayed stronger textures (Str), particularly on the implants with threads with larger internal angles. Conclusion: Parameters associated with the height of the irregularities (Sa), the slope of the asperities (Sdq), the presence of a surface texture (Str), and the developed surface area of the irregularities (Sdr) were significantly affected by the macrogeometry of the implants. Flat disks subjected to the same surface treatment as dental implants reproduced only the surface topography of the flat regions of the implants.
C1 [Naves, Marina Melo; Magalhaes, Denildo; Ferreira, Jessica Afonso] Univ Fed Uberlandia, Sch Dent, Uberlandia, MG, Brazil.
   [Naves, Marina Melo; Machado Menezes, Helder Henrique; Magalhaes, Denildo] HD Ensinos Odontol, Uberlandia, MG, Brazil.
   [Ribeiro, Sara Ferreira; Biasoli de Mello, Jose Daniel; Costa, Henara Lillian] Univ Fed Uberlandia, Lab Tribol & Mat, Campus Sta Monica,Bl 5K, BR-38400901 Uberlandia, MG, Brazil.
RP Costa, HL (reprint author), Univ Fed Uberlandia, Lab Tribol & Mat, Campus Sta Monica,Bl 5K, BR-38400901 Uberlandia, MG, Brazil.
EM ltm-henara@ufu.br
RI Costa, Henara/H-1746-2014
OI Costa, Henara/0000-0002-0412-4436
FU Fundacao de Apoio a Pesquisa no Estado de Minas Gerais (Fapemig),
   Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), Brazil
FX The authors are grateful to Neodent for providing all the samples used
   in this work and to Fundacao de Apoio a Pesquisa no Estado de Minas
   Gerais (Fapemig), Brazil, and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brazil, for financial support. The
   authors reported no conflicts of interest related to this study.
CR Abron A, 2001, J PROSTHET DENT, V85, P40, DOI 10.1067/mpr.2001.112415
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   [Anonymous], 1993, 11562 ISOIS
   [Anonymous], 1997, 4287 ISO
   Bennett J, 1999, INTRO SURFACE ROUGHN
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cardoso MV, 2013, CLIN IMPLANT DENT RE
   Chuang SK, 2006, J DENT RES, V85, P1147, DOI 10.1177/154405910608501216
   Coelho PG, 2011, J MECH BEHAV BIOMED, V27, P1974
   Degidi Marco, 2005, J Oral Implantol, V31, P25, DOI 10.1563/0-730.1
   Deporter D, 2009, INT J PERIODONT REST, V29, P625
   Dong SP, 1994, 3 DIMENSIONAL SURFAC, P3
   DONG WP, 1994, WEAR, V178, P29, DOI 10.1016/0043-1648(94)90127-9
   DONG WP, 1993, WEAR, V167, P9, DOI 10.1016/0043-1648(93)90050-V
   DUNNETT CW, 1992, STAT MED, V11, P1057, DOI 10.1002/sim.4780110807
   Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010
   Elias CN, 2010, EXPERT REV MED DEVIC, V7, P241, DOI [10.1586/erd.09.74, 10.1586/ERD.09.74]
   Goncalves Jr JL, 2012, P 3 INT C METR 21 23
   Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x
   Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Levine RA, 2002, INT J ORAL MAX IMPL, V17, P550
   Novaes AB, 2002, INT J ORAL MAX IMPL, V17, P377
   Rizzi M, 2014, J PROSTHET DENT, V112, P1103, DOI 10.1016/j.prosdent.2014.04.010
   Rosa MB, 2013, INT J ORAL MAX IMPL, V28, P358, DOI 10.11607/jomi.2791
   Rosa MB, 2012, J APPL ORAL SCI, V20, P550, DOI 10.1590/S1678-77572012000500010
   SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204
   Shibli JA, 2007, J BIOMED MATER RES B, V80B, P377, DOI 10.1002/jbm.b.30608
   Soskolne WA, 2002, CLIN ORAL IMPLAN RES, V13, P86, DOI 10.1034/j.1600-0501.2002.130111.x
   Stout K. J., 1993, DEV METHODS CHARACTE
   Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945
   Valverde GB, 2013, CLIN ORAL IMPLAN RES, V24, P238, DOI 10.1111/j.1600-0501.2011.02392.x
   Vercaigne S, 1998, BIOMATERIALS, V19, P1093, DOI 10.1016/S0142-9612(98)00039-8
   Vroom MG, 2009, CLIN ORAL IMPLAN RES, V20, P1231, DOI 10.1111/j.1600-0501.2009.01768.x
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Zupnik J, 2011, J PERIODONTOL, V82, P1390, DOI 10.1902/jop.2011.100685
NR 40
TC 2
Z9 3
U1 2
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JUL-AUG
PY 2015
VL 30
IS 4
BP 789
EP 799
DI 10.11607/jomi.3934
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DD0SH
UT WOS:000369629200007
PM 26252030
OA Bronze
DA 2018-10-19
ER

PT J
AU Ramos-Murguialday, M
   Caubet, J
   Ramis, JM
   Monjo, M
AF Ramos-Murguialday, Mikel
   Caubet, Jorge
   Maria Ramis, Joana
   Monjo, Marta
TI Evaluation of the Ideal Implant Insertion Time in Human Bone Biopsies
   After Sinus Elevation Using a Combination of Autologous Bone and Graft
   Substitute
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE clinical study; composite graft; dental implant; gene expression;
   microcomputed tomography (microCT); sinus lift (SL)
ID RESONANCE FREQUENCY-ANALYSIS; PROSPECTIVE CLINICAL-TRIAL; AUTOGENOUS
   ILIAC CREST; FLOOR AUGMENTATION; STABILITY MEASUREMENTS;
   HISTOMORPHOMETRIC ANALYSIS; MEMBRANE PERFORATIONS; LIFT PROCEDURES;
   MAXILLARY; SURVIVAL
AB Purpose: To evaluate the ideal implant insertion time in human bone biopsies after sinus elevation with a composite graft consisting of an equal amount of biomaterial and autologous bone, by comparing the bone regeneration obtained 4 to 5 months after surgery with that obtained after 6 to 8 months, and using the adjacent native bone as reference. Materials and Methods: Twenty-six biopsy specimens of 11 patients were analyzed. Two groups were created depending on the time of implant insertion: group t1 at 4 to 5 months (n = 13) and group t2 at 6 to 8 months (n = 13). The same volume of grafted bone and native bone were analyzed for each biopsy with microcomputed tomography (microCT) and gene expression analysis. Results: Statistically significant differences were found in bone mineral density (BMD), bone volume fraction, and trabecular separation (TbSp) between native and grafted bone in both groups, with higher grafted bone values, except for the variable TbSp, which was lower in the grafted bone. This decrease in TbSp in the grafted bone in both groups can be explained by the significant increase in trabecular thickness in group t2 and the trabecular number in group t1, compared with native bone. No significant differences were found between the two groups in the morphometric parameters and BMD of the grafted bone. Also, no significant changes in the messenger RNA (mRNA) levels of bone formation, bone resorption, and inflammatory markers were found between both groups, with the exception that alkaline phosphatase mRNA levels were significantly lower in group t1 relative to native bone. Conclusion: This composite graft showed no differences in three-dimensional microstructure, BMD, or at the molecular level between 4 to 5 months and 6 to 8 months of healing time. Thus, this time can be shortened to 4 months with the security of a grafted area of mature bone.
C1 [Ramos-Murguialday, Mikel] Son Espases Hosp, Dept Oral & Maxillofacial Surg, Palma De Mallorca, Spain.
   [Ramos-Murguialday, Mikel; Caubet, Jorge] Clin GBCOM, Unit Oral & Maxillofacial Surg, Palma De Mallorca, Spain.
   [Maria Ramis, Joana; Monjo, Marta] Univ Illes Balears, Dept Fundamental Biol & Hlth Sci, Res Inst Hlth Sci, Palma De Mallorca, Spain.
   [Maria Ramis, Joana; Monjo, Marta] Inst Invest Sanitaria Palma, Palma De Mallorca, Spain.
   [Monjo, Marta] Univ Oslo, Inst Clin Dent, Dept Biomat, Oslo, Norway.
RP Monjo, M (reprint author), UIB, Dept Fundamental Biol & Hlth Sci, Res Inst Hlth Sci IUNICS, Cra Valldemossa,Km 7-5, E-07122 Palma De Mallorca, Spain.
EM marta.monjo@uib.es
OI Monjo, Marta/0000-0002-2731-9527; Ramis, Joana Maria/0000-0001-9109-8362
FU Ministry of Science and Innovation of Spain (Torres Quevedo contract);
   Conselleria de Salut i Consum from the Balearic government; Mateu Orfila
   Foundation; Ministry of Science and Innovation of Spain (Ramon y Cajal
   contract)
FX This work was supported by the Ministry of Science and Innovation of
   Spain (Torres Quevedo contract to J.M. Ramis, and Ramon y Cajal contract
   to M. Monjo), by the Conselleria de Salut i Consum from the Balearic
   government, and by the Mateu Orfila Foundation. The authors thank the
   Department of Biomaterials (University of Oslo, Norway) for the use of
   the micro-CT scanner and all the patients who participated in this
   study. The authors reported no conflicts of interest related to this
   study.
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Becker W, 2005, J PERIODONTOL, V76, P391, DOI 10.1902/jop.2005.76.3.391
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Caubet J, 2015, CLIN ORAL IMPLAN RES, V26, P727, DOI 10.1111/clr.12380
   Caubet J, 2011, J ORAL MAXIL SURG, V69, P482, DOI 10.1016/j.joms.2010.10.037
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   Consolo U, 2007, CLIN ORAL IMPLAN RES, V18, P252, DOI 10.1111/j.1600-0501.2006.01330.x
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Crespi R, 2007, INT J ORAL MAX IMPL, V22, P527
   Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P7
   Fugazzotto PA, 2003, J PERIODONTOL, V74, P1534, DOI 10.1902/jop.2003.74.10.1534
   Galindo-Moreno P, 2008, CLIN ORAL IMPLAN RES, V19, P755, DOI 10.1111/j.1600-0501.2008.01536.x
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Gerressen M, 2009, CLIN ORAL IMPLAN RES, V20, P109, DOI 10.1111/j.1600-0501.2008.01619.x
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman Mats, 2004, Clin Implant Dent Relat Res, V6, P82, DOI 10.1111/j.1708-8208.2004.tb00030.x
   Hernandez-Alfaro F, 2008, CLIN ORAL IMPLAN RES, V19, P91, DOI 10.1111/j.1600-0501.2007.01372.x
   Hirsch JM, 1991, CLIN ORAL IMPLAN RES, V2, P91, DOI 10.1034/j.1600-0501.1991.020207.x
   Huang HL, 2013, CLIN ORAL INVEST, V17, P535, DOI 10.1007/s00784-012-0725-1
   Hurzeler M B, 1996, Int J Oral Maxillofac Implants, V11, P466
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Kessler-Liechti G, 2008, INT J ORAL MAX IMPL, V23, P353
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Nkenke E, 2002, INT J ORAL MAX IMPL, V17, P557
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Raghoebar GM, 2005, CLIN ORAL IMPLAN RES, V16, P349, DOI 10.1111/j.1600-0501.2005.01115.x
   Rodrigo D, 2010, CLIN ORAL IMPLAN RES, V21, P255, DOI 10.1111/j.1600-0501.2009.01820.x
   Roze J, 2009, CLIN ORAL IMPLAN RES, V20, P1140, DOI 10.1111/j.1600-0501.2009.01745.x
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schwartz-Arad D, 2004, J PERIODONTOL, V75, P511, DOI 10.1902/jop.2004.75.4.511
   Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x
   Shlomi B, 2004, INT J ORAL MAX IMPL, V19, P559
   Sittitavornwong S, 2010, ORAL MAXIL SURG CLIN, V22, P317, DOI 10.1016/j.coms.2010.04.006
   Stricker A, 2003, CLIN ORAL IMPLAN RES, V14, P207, DOI 10.1034/j.1600-0501.2003.140211.x
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   ten Bruggenkate CM, 1998, PERIODONTOL 2000, V17, P176
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   van den Bergh JPA, 1998, CLIN ORAL IMPLAN RES, V9, P429, DOI 10.1034/j.1600-0501.1996.090608.x
   van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P256, DOI 10.1034/j.1600-0501.2000.011003256.x
   Zaffe D, 2007, CLIN ORAL IMPLAN RES, V18, P525, DOI 10.1111/j.1600-0501.2007.01368.x
NR 45
TC 0
Z9 0
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JUL-AUG
PY 2015
VL 30
IS 4
BP 891
EP 899
DI 10.11607/jomi.3945
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DD0SH
UT WOS:000369629200019
PM 26252041
OA Bronze
DA 2018-10-19
ER

PT J
AU Seyyedi, K
   Mahdiyar, A
AF Seyyedi, K.
   Mahdiyar, A.
TI DECOLORIZATION OF CONTAMINATED WATER CONTAINING CI DIRECT BLUE 53 BY
   MACROALGAE CHARA SP AND OPTIMIZATION OF DECOLORIZATION PROCESS
SO LATIN AMERICAN APPLIED RESEARCH
LA English
DT Article
DE Biodegradation; Macroalgae Chara; Direct blue53; Decolorization
ID DYE SOLUTION; BIOLOGICAL DECOLORIZATION; OPERATIONAL PARAMETERS;
   MALACHITE-GREEN; REMOVAL; BIOSORPTION; TIO2
AB Dye wastewater is considered as a major pollutant of surface water. In recent years, biological treatment with the use of micro and macro organisms has been used as a good method for removing various organic and inorganic pollutants. In the present study, the potential of a macroalgae Chara sp., was investigated as a viable biomaterial for the biological treatment of Direct Blue 53 solution. The effects of operational parameters such as temperature, pH, initial dye concentration, the amount of algae, salinity, and light-darkness on the efficiency of biological decolorization were studied. In optimal conditions, with an initial value for live algae of 3.5 g, temperature of 25 degrees C, pH = 2, for a solution containing 15 ppm of Direct blue 53, the dye removal efficiency obtained was of 63%. Dye removal increased with an increase in the amount of biomass. The efficiency of the biological treatment of Direct Blue 53 decreased as the temperature and initial dye concentration increased. The salinity of the solution had an inverse relationship with the decolorization efficiency, and the dye was removed more easily in darkness. The results of FTIR and GC-Mass spectroscopy showed that the decolorization mechanism of the solution in the presence of live algae was biodegradation.
C1 [Seyyedi, K.] Islamic Azad Univ, Tabriz Branch, Dept Appl Chem, Tabriz, Iran.
   [Seyyedi, K.] Islamic Azad Univ, East Azarbaijan Sci & Res Branch, Dept Chem, Tabriz, Iran.
   [Mahdiyar, A.] Islamic Azad Univ, Tabriz Branch, Dept Chem Engn Biotechnol, Tabriz, Iran.
   [Mahdiyar, A.] Islamic Azad Univ, East Azarbaijan Sci & Res Branch, Dept Chem Engn Biotechnol, Tabriz, Iran.
RP Seyyedi, K (reprint author), Islamic Azad Univ, Tabriz Branch, Dept Appl Chem, Tabriz, Iran.
EM ka_seyyedi@yahoo.com
CR Aksu Z, 2005, PROCESS BIOCHEM, V40, P1347, DOI 10.1016/j.procbio.2004.06.007
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aleboyeh A, 2008, DYES PIGMENTS, V77, P288, DOI 10.1016/j.dyepig.2007.05.014
   Bakker N. V. J., 2001, PLANT ECOL, V154, P237
   Celekli A, 2011, CHEM ENG J, V169, P166, DOI 10.1016/j.cej.2011.02.077
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Daneshvar N, 2007, J HAZARD MATER, V143, P214, DOI 10.1016/j.jhazmat.2006.09.016
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Daneshvar N, 2004, J PHOTOCH PHOTOBIO A, V162, P317, DOI 10.1016/s1010-6030(03)00378-2
   Donmez GC, 1999, PROCESS BIOCHEM, V34, P885
   Erden E., 2011, ELECTRON J BIOTECHN, V14, P1
   Khatace A. R., 2009, Chinese Journal of Applied and Environmental Biology, V15, P110, DOI 10.3724/SP.J.1145.2009.00110
   Khataee AR, 2011, CHEM ENG RES DES, V89, P172, DOI 10.1016/j.cherd.2010.05.009
   Khataee AR, 2010, BIORESOURCE TECHNOL, V101, P2252, DOI 10.1016/j.biortech.2009.11.079
   Khataee AR, 2009, ENVIRON TECHNOL, V30, P1155, DOI 10.1080/09593330903133911
   Khataee AR, 2009, J HAZARD MATER, V161, P1225, DOI 10.1016/j.jhazmat.2008.04.075
   Mittal A, 2005, J HAZARD MATER, V117, P171, DOI 10.1016/j.jhazmat.2004.09.016
   Orfao JJM, 2006, J COLLOID INTERF SCI, V296, P480, DOI 10.1016/j.jcis.2005.09.063
   Peta A., 2009, SCI TOTAL ENVIRON, V407, P1164
   Rafatullah M, 2010, J HAZARD MATER, V177, P70, DOI 10.1016/j.jhazmat.2009.12.047
   RAMMEL R.S, 2011, J U CHEM TECHNOL MET, V46, P283
   Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003
   Vashishta B.R., 2005, BOT DEGREE STUDENTS
   Velis CA, 2009, BIORESOURCE TECHNOL, V100, P2747, DOI 10.1016/j.biortech.2008.12.026
   Zarei M, 2009, ELECTROCHIM ACTA, V54, P6651, DOI 10.1016/j.electacta.2009.06.060
NR 25
TC 1
Z9 1
U1 2
U2 3
PU PLAPIQUI(UNS-CONICET)
PI BAHIA BLANCA
PA CAMINO LA CARRINDANGA, KM 7, C C 717, 8000 BAHIA BLANCA, ARGENTINA
SN 0327-0793
EI 1851-8796
J9 LAT AM APPL RES
JI Latin Am. Appl. Res.
PD JUL
PY 2015
VL 45
IS 3
BP 193
EP 198
PG 6
WC Engineering, Chemical
SC Engineering
GA CZ6LW
UT WOS:000367213800008
DA 2018-10-19
ER

PT J
AU Schutgens, EM
   Tryfonidou, MA
   Smit, TH
   Oner, FC
   Krouwels, A
   Ito, K
   Creemers, LB
AF Schutgens, E. M.
   Tryfonidou, M. A.
   Smit, T. H.
   Oner, F. Cumhur
   Krouwels, A.
   Ito, K.
   Creemers, L. B.
TI BIOMATERIALS FOR INTERVERTEBRAL DISC REGENERATION: PAST PERFORMANCE AND
   POSSIBLE FUTURE STRATEGIES
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Intervertebral disc degeneration; nucleus pulposus cells; annulus
   fibrosus cells; regeneration; hydrogels; synthetic polymers; natural
   hydrogels; delivery; cell-biomaterial interactions
ID MESENCHYMAL STEM-CELLS; NUCLEUS PULPOSUS REGENERATION; SMALL-INTESTINAL
   SUBMUCOSA; TISSUE ENGINEERING APPLICATIONS; GELATIN HYDROGEL
   MICROSPHERES; PEPTIDE NANOFIBER HYDROGEL; HYALURONIC-ACID HYDROGELS;
   IN-VITRO CHARACTERIZATION; ANNULUS FIBROSUS CELL; DRUG-DELIVERY SYSTEM
AB Intervertebral disc (IVD) degeneration is associated with most cases of cervical and lumbar spine pathologies, amongst which chronic low back pain has become the number one cause of loss of quality-adjusted life years. In search of alternatives to the current less than optimal and usually highly invasive treatments, regenerative strategies are being devised, none of which has reached clinical practice as yet. Strategies include the use of stem cells, gene therapy, growth factors and biomaterial carriers. Biomaterial carriers are an important component in musculoskeletal regenerative medicine techniques. Several biomaterials, both from natural and synthetic origin, have been used for regeneration of the IVD in vitro and in vivo. Aspects such as ease of use, mechanical properties, regenerative capacity, and their applicability as carriers for regenerative and anti-degenerative factors determine their suitability for IVD regeneration. The current review provides an overview of the biomaterials used with respect to these properties, including their drawbacks. In addition, as biomaterial application until now appears to have been based on a mix of mere availability and intuition, a more rational design is proposed for future use of biomaterials for IVD regeneration. Ideally, high-throughput screening is used to identify optimally effective materials, or alternatively medium content comparative studies should be carried out to determine an appropriate reference material for future studies on novel materials.
C1 [Schutgens, E. M.; Oner, F. Cumhur; Krouwels, A.; Ito, K.; Creemers, L. B.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.
   [Tryfonidou, M. A.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, NL-3508 TC Utrecht, Netherlands.
   [Smit, T. H.] Vrije Univ Amsterdam, Med Ctr, Dept Orthopaed, Amsterdam, Netherlands.
   [Ito, K.] Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, NL-5600 MB Eindhoven, Netherlands.
RP Creemers, LB (reprint author), Dept Orthopaed G05 228, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.
EM l.b.creemers@umcutrecht.nl
RI Ito, Keita/A-8592-2017
OI Ito, Keita/0000-0002-7372-4072
FU Project P2.01 IDiDAS of the research program of the BioMedical Materials
   Institute; Dutch Ministry of Economic Affairs, Agriculture and
   Innovation; Dutch Arthritis Foundation [LLP12, LLP22]; Dutch Government
   [FES0908]
FX Authors gratefully acknowledge funding as part of the Project P2.01
   IDiDAS of the research program of the BioMedical Materials Institute,
   co-funded by the Dutch Ministry of Economic Affairs, Agriculture and
   Innovation. In addition, the financial contribution of the Dutch
   Arthritis Foundation (LLP12 and LLP22) and the Dutch Government to the
   Netherlands Institute for Regenerative Medicine (NIRM, grant no FES0908)
   is acknowledged. We wish to confirm that there are no known conflicts of
   interest associated with this publication and there has been no
   significant financial support for this work that could have influenced
   its outcome.
CR Acosta FL, 2011, TISSUE ENG PT A, V17, P3045, DOI 10.1089/ten.tea.2011.0229
   Adams MA, 2014, CLIN ANAT, V28, P195
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Anderson D Greg, 2005, Spine J, V5, p297S, DOI 10.1016/j.spinee.2005.02.019
   Ashley GW, 2013, P NATL ACAD SCI USA, V110, P2318, DOI 10.1073/pnas.1215498110
   Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Benz K, 2012, EUR SPINE J, V21, P1758, DOI 10.1007/s00586-012-2443-4
   Benz K, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-54
   Bertolo Alessandro, 2012, Eur Spine J, V21 Suppl 6, pS826, DOI 10.1007/s00586-011-1975-3
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354
   Bron JL, 2009, J ORTHOP RES, V27, P620, DOI 10.1002/jor.20789
   Bron JL, 2012, J MATER SCI-MATER M, V23, P813, DOI 10.1007/s10856-011-4545-7
   Bron JL, 2011, J MECH BEHAV BIOMED, V4, P1196, DOI 10.1016/j.jmbbm.2011.04.002
   Buckley CT, 2012, TISSUE ENG PT A, V18, P382, DOI [10.1089/ten.tea.2011.0145, 10.1089/ten.TEA.2011.0145]
   Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   CARTER DR, 2004, CLIN ORTHOP RE S OCT, pS69, DOI DOI 10.1097/01.BLO.0000144970.05107.7E
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chan SCW, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13598
   Chang G, 2010, J BIOMED MATER RES A, V92A, P43, DOI 10.1002/jbm.a.32326
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chee AV, 2014, SPINE J, V14, P491, DOI 10.1016/j.spinee.2013.06.095
   Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008
   Chen YC, 2013, ACTA BIOMATER, V9, P5181, DOI 10.1016/j.actbio.2012.09.039
   Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI 10.1089/ten.TEA.2009.0229
   Cheng YH, 2013, CARBOHYD POLYM, V92, P1512, DOI 10.1016/j.carbpol.2012.10.074
   Cheng YH, 2011, BIOMATERIALS, V32, P6953, DOI 10.1016/j.biomaterials.2011.03.065
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Colombini A, 2014, TISSUE ENG PART B-RE, V20, P713, DOI [10.1089/ten.teb.2014.0158, 10.1089/ten.TEB.2014.0158]
   Cortes DH, 2014, J BIOMECH, V47, P2088, DOI 10.1016/j.jbiomech.2013.12.021
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Dahl MC, 2010, SPINE, V35, P1445, DOI 10.1097/BRS.0b013e3181bef192
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/eri.11.59, 10.1586/ERI.11.59]
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Diederichs S, 2012, TISSUE ENG PT A, V18, P1140, DOI [10.1089/ten.TEA.2011.0426, 10.1089/ten.tea.2011.0426]
   Ding AG, 2008, PHARM RES-DORD, V25, P2041, DOI 10.1007/s11095-008-9594-3
   Dodo CG, 2013, BIOFOULING, V29, P549, DOI 10.1080/08927014.2013.787416
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Drira Z, 2013, J MECH BEHAV BIOMED, V18, P20, DOI 10.1016/j.jmbbm.2012.09.015
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Ella V, 2005, J MATER SCI-MATER M, V16, P655, DOI 10.1007/s10856-005-2537-1
   Endres M, 2010, BIOMATERIALS, V31, P5836, DOI 10.1016/j.biomaterials.2010.03.078
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Etebar S, 1999, J NEUROSURG, V90, P163, DOI 10.3171/spi.1999.90.2.0163
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Feng GJ, 2011, BIOMATERIALS, V32, P8182, DOI 10.1016/j.biomaterials.2011.07.049
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Foss BL, 2014, J MECH BEHAV BIOMED, V29, P56, DOI 10.1016/j.jmbbm.2013.08.020
   Francisco AT, 2014, ACTA BIOMATER, V10, P1102, DOI 10.1016/j.actbio.2013.11.013
   Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072
   Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157
   Ghosh P, 2012, J NEUROSURG-SPINE, V16, P479, DOI 10.3171/2012.1.SPINE11852
   Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343
   Gloria A, 2007, J MATER SCI-MATER M, V18, P2159, DOI 10.1007/s10856-007-3003-z
   Gorth DJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3932
   Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032
   Guillaume O, 2015, J BIOMATER APPL, V29, P1230, DOI 10.1177/0885328214557905
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Gupta A, 2014, TISSUE ENG PT A, V20, P3101, DOI [10.1089/ten.TEA.2013.0702, 10.1089/ten.tea.2013.0702]
   Heathfield SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2468
   Hegewald AA, 2010, J TISSUE ENG REGEN M, V5, P275
   Helgeson MD, 2013, SPINE J, V13, P342, DOI 10.1016/j.spinee.2012.12.009
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Higashino K, 2010, SPINE, V35, pE1144, DOI 10.1097/BRS.0b013e3181e504d3
   Ho STB, 2010, BIOMATERIALS, V31, P38, DOI 10.1016/j.biomaterials.2009.09.021
   Hu JG, 2012, J MATER SCI-MATER M, V23, P711, DOI 10.1007/s10856-011-4533-y
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hung KC, 2014, ADV HEALTHC MATER, V3, P1578, DOI 10.1002/adhm.201400018
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x
   Hutton WC, 2004, J SPINAL DISORD TECH, V17, P53, DOI 10.1097/00024720-200402000-00011
   Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Isaacs JL, 2014, J MECH BEHAV BIOMED, V40, P75, DOI 10.1016/j.jmbbm.2014.08.012
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   Jacobs WCH, 2013, BEST PRACT RES CL RH, V27, P673, DOI 10.1016/j.berh.2013.09.009
   Jeong CG, 2014, ACTA BIOMATER, V10, P3421, DOI 10.1016/j.actbio.2014.05.012
   Jin EJ, 2007, DEV BIOL, V308, P474, DOI 10.1016/j.ydbio.2007.06.003
   Jonsson L, 2011, EUR SURG RES, V46, P169, DOI 10.1159/000324401
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Kenne L, 2013, CARBOHYD POLYM, V91, P410, DOI 10.1016/j.carbpol.2012.08.066
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim HY, 2017, J TISSUE ENG REGEN M, V11, P44, DOI 10.1002/term.1856
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kim JH, 2009, SPINE, V34, P2486, DOI 10.1097/BRS.0b013e3181b26ed1
   Kim SH, 2014, J TISSUE ENG REGEN M, V8, P279, DOI 10.1002/term.1520
   Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397
   Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216
   Koepsell L, 2011, MACROMOL BIOSCI, V11, P391, DOI 10.1002/mabi.201000352
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kota DJ, 2014, INT J BIOCHEM CELL B, V55, P1, DOI 10.1016/j.biocel.2014.07.022
   Lai P, 2014, COLLOID SURFACE B, V118, P154, DOI 10.1016/j.colsurfb.2014.03.017
   LARSEN B, 1971, CARBOHYD RES, V17, P287, DOI 10.1016/S0008-6215(00)82536-7
   Lazebnik M, 2011, J TISSUE ENG REGEN M, V5, pE179, DOI 10.1002/term.412
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Leone G, 2008, J BIOMED MATER RES A, V84A, P391, DOI 10.1002/jbm.a.31334
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li Z, 2014, REGEN MED, V9, P309, DOI [10.2217/RME.14.5, 10.2217/rme.14.5]
   Li ZS, 2008, J BIOMED MATER RES A, V86A, P552, DOI 10.1002/jbm.a.31596
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liang CZ, 2012, J MATER SCI-MATER M, V23, P1097, DOI 10.1007/s10856-012-4563-0
   Liang CZ, 2013, ACTA BIOMATER, V9, P9423, DOI 10.1016/j.actbio.2013.08.019
   Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007
   Loo Y, 2012, BIOTECHNOL ADV, V30, P593, DOI 10.1016/j.biotechadv.2011.10.004
   Lopez A, 2010, J BIOMED MATER RES B, V95B, P75, DOI 10.1002/jbm.b.31685
   Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016
   Ma K, 2012, ACTA BIOMATER, V8, P3754, DOI 10.1016/j.actbio.2012.06.028
   Malhotra NR, 2012, SPINE, V37, pE1099, DOI 10.1097/BRS.0b013e31825cdfb7
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Martin JT, 2014, ACTA BIOMATER, V10, P2473, DOI 10.1016/j.actbio.2014.02.024
   Martin Michael D, 2002, Neurosurg Focus, V13, pE1
   Masuda K, 2008, EUR SPINE J, V17, pS441, DOI 10.1007/s00586-008-0749-z
   Mauth C, 2009, EUR CELLS MATER, V18, P27, DOI 10.22203/eCM.v018a03
   Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128
   Mehlhorn AT, 2009, TISSUE ENG PT A, V15, P1159, DOI 10.1089/ten.tea.2008.0069
   Melrose J, 2001, CELLS TISSUES ORGANS, V168, P137, DOI 10.1159/000047829
   Mercuri J, 2014, J BIOMED MATER RES A, V102, P4380, DOI 10.1002/jbm.a.35104
   MILLER JAA, 1988, SPINE, V13, P173, DOI 10.1097/00007632-198802000-00008
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Nakki A, 2014, EUR SPINE J, V23, pS354, DOI 10.1007/s00586-013-2878-2
   Neidlinger-Wilke C, 2009, SPINE, V34, P663, DOI 10.1097/BRS.0b013e318194e20c
   Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414
   Nguyen QT, 2012, BIOMATERIALS, V33, P6682, DOI 10.1016/j.biomaterials.2012.06.005
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275
   Oliveira MB, 2014, TISSUE ENG PART C-ME, V20, P851, DOI [10.1089/ten.tec.2013.0738, 10.1089/ten.TEC.2013.0738]
   Park HS, 2013, ACTA BIOMATER, V9, P8962, DOI 10.1016/j.actbio.2013.07.013
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Park SH, 2012, J TISSUE ENG REGEN M, V6, ps24, DOI 10.1002/term.541
   Park SH, 2011, TISSUE ENG PT A, V17, P2999, DOI [10.1089/ten.tea.2010.0747, 10.1089/ten.TEA.2010.0747]
   Patel MP, 2010, J PHARM PHARM SCI, V13, P536, DOI 10.18433/J3JC7C
   PEARLSTEIN E, 1980, MOL CELL BIOCHEM, V29, P103
   Pereira CL, 2014, BIOMATERIALS, V35, P8144, DOI 10.1016/j.biomaterials.2014.06.017
   Peroglio M, 2012, EUR SPINE J, V21, P839, DOI DOI 10.1007/S00586-011-1976-2
   Pirvu T, 2015, BIOMATERIALS, V42, P11, DOI 10.1016/j.biomaterials.2014.11.049
   Purmessur D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4302
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Radcliff KE, 2013, SPINE J, V13, P1339, DOI 10.1016/j.spinee.2013.03.020
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Richardson SM, 2008, CURR PAIN HEADACHE R, V12, P83, DOI 10.1007/s11916-008-0016-3
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6
   Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI 10.1089/ten.TEA.2009.0770
   Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sasson A, 2012, J MECH BEHAV BIOMED, V8, P143, DOI 10.1016/j.jmbbm.2011.12.008
   Sawamura K, 2009, TISSUE ENG PT A, V15, P3719, DOI 10.1089/ten.TEA.2008.0697
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Scholz B, 2010, EUR CELLS MATER, V20, P24
   Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sharma MB, 2012, HAEMATOL-HEMATOL J, V97, P651, DOI 10.3324/haematol.2011.050500
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Sillat T, 2013, ACTA ORTHOP, V84, P585, DOI 10.3109/17453674.2013.854666
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P4, DOI 10.1002/term.2
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Smith LJ, 2014, TISSUE ENG PT A, V20, P1841, DOI [10.1089/ten.TEA.2013.0516, 10.1089/ten.tea.2013.0516]
   Stern S, 2000, ACTA ORTHOP SCAND, V71, P496, DOI 10.1080/000164700317381207
   STERN S, 2004, CLIN ORTHOP RELA FEB, P238
   Strange DGT, 2012, J MECH BEHAV BIOMED, V11, P16, DOI 10.1016/j.jmbbm.2011.10.003
   Su WY, 2010, ACTA BIOMATER, V6, P3044, DOI 10.1016/j.actbio.2010.02.037
   Sun W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093570
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   Tan B, 2012, J SURG RES, V182, P40
   Tao H, 2014, TISSUE ENG PT A, V20, P1621, DOI [10.1089/ten.tea.2013.0279, 10.1089/ten.TEA.2013.0279]
   Thavaneswaran P, 2014, ANZ J SURG, V84, P121, DOI 10.1111/ans.12315
   Tilwani Reshma K, 2012, J Funct Biomater, V3, P23, DOI 10.3390/jfb3010023
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403
   Tsuchida AI, 2013, REGEN MED, V8, P583, DOI 10.2217/rme.13.44
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101
   van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018
   van Tienen TG, 2009, CLIN SPORT MED, V28, P143, DOI 10.1016/j.csm.2008.08.003
   Wang BC, 2012, J BIOMED MATER RES A, V100A, P646, DOI 10.1002/jbm.a.33300
   Wang H, 2014, TISSUE ENG PT A, V20, P908, DOI [10.1089/ten.tea.2012.0703, 10.1089/ten.TEA.2012.0703]
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Willems N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0727-x
   Williams FM, 2012, ANN RHEUM DIS, V72, P1141
   Wu SC, 2013, J APPL PHYSIOL, V114, P1610, DOI 10.1152/japplphysiol.01132.2012
   Xu BY, 2014, J BIOSCI BIOENG, V117, P624, DOI 10.1016/j.jbiosc.2013.10.018
   Xu L, 2013, STEM CELLS DEV, V22, P1657, DOI 10.1089/scd.2012.0605
   Xu T, 2012, BIOFABRICATION, V5, P15001
   Yan J, 2013, J BIOMATER APPL, V29, P72
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Yang JJ, 2010, TISSUE ENG PT A, V16, P2529, DOI 10.1089/ten.TEA.2009.0647
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   Yang XL, 2009, EUR SPINE J, V18, P1564, DOI 10.1007/s00586-009-1092-8
   Yeganegi M, 2010, ACTA BIOMATER, V6, P3847, DOI 10.1016/j.actbio.2010.05.003
   Yim RLH, 2014, STEM CELLS DEV, V23, P2553, DOI 10.1089/scd.2014.0203
   Zeng C, 2014, MAT SCI ENG C-MATER, V37, P232, DOI 10.1016/j.msec.2014.01.012
   Zhang LM, 2012, CARBOHYD POLYM, V88, P1445, DOI 10.1016/j.carbpol.2012.02.050
   Zhang ZC, 2014, CHINESE MED J-PEKING, V127, P314, DOI 10.3760/cma.j.issn.0366-6999.20130584
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 231
TC 7
Z9 6
U1 0
U2 29
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2015
VL 30
BP 210
EP 231
DI 10.22203/eCM.v030a15
PG 22
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CY1BM
UT WOS:000366141600015
PM 27227695
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Hakim, JS
   Rad, ME
   Grahn, PJ
   Chen, BK
   Knight, AM
   Schmeichel, AM
   Isaq, NA
   Dadsetan, M
   Yaszemski, MJ
   Windebank, AJ
AF Hakim, Jeffrey S.
   Rad, Melika Esmaeili
   Grahn, Peter J.
   Chen, Bingkun K.
   Knight, Andrew M.
   Schmeichel, Ann M.
   Isaq, Nasro A.
   Dadsetan, Mahrokh
   Yaszemski, Michael J.
   Windebank, Anthony J.
TI Positively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold
   Implantation Results in a Permissive Lesion Environment after Spinal
   Cord Injury in Rat
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MYELIN-ASSOCIATED GLYCOPROTEIN; FOREIGN-BODY REACTION; NEURITE
   OUTGROWTH; IN-VIVO; WALLERIAN DEGENERATION; AXONAL REGENERATION;
   MICROGLIAL RESPONSE; MONOCLONAL-ANTIBODY; REACTIVE ASTROCYTES;
   MULTIPLE-SCLEROSIS
AB Positively charged oligo[poly(ethylene glycol) fumarate] (OPF+) scaffolds loaded with Schwann cells bridge spinal cord injury (SCI) lesions and support axonal regeneration in rat. The regeneration achieved is not sufficient for inducing functional recovery. Attempts to increase regeneration would benefit from understanding the effects of the scaffold and transplanted cells on lesion environment. We conducted morphometric and stereological analysis of lesions in rats implanted with OPF+ scaffolds with or without loaded Schwann cells 1, 2, 3, 4, and 8 weeks after thoracic spinal cord transection. No differences were found in collagen scarring, cyst formation, astrocyte reactivity, myelin debris, or chondroitin sulfate proteoglycan (CSPG) accumulation. However, when scaffold-implanted animals were compared with animals with transection injuries only, these barriers to regeneration were significantly reduced, accompanied by increased activated macrophages/microglia. This distinctive and regeneration permissive tissue reaction to scaffold implantation was independent of Schwann cell transplantation. Although the tissue reaction was beneficial in the short term, we observed a chronic fibrotic host response, resulting in scaffolds surrounded by collagen at 8 weeks. This study demonstrates that an appropriate biomaterial scaffold improves the environment for regeneration. Future targeting of the host fibrotic response may allow increased axonal regeneration and functional recovery.
C1 [Hakim, Jeffrey S.; Dadsetan, Mahrokh; Yaszemski, Michael J.; Windebank, Anthony J.] Mayo Clin, Coll Med, Rochester, MN 55905 USA.
   [Hakim, Jeffrey S.; Rad, Melika Esmaeili; Grahn, Peter J.; Isaq, Nasro A.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA.
   [Chen, Bingkun K.; Knight, Andrew M.; Schmeichel, Ann M.; Windebank, Anthony J.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Dadsetan, Mahrokh; Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
   [Yaszemski, Michael J.; Windebank, Anthony J.] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA.
RP Windebank, AJ (reprint author), Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA.
EM windebank.anthony@mayo.edu
FU NIH [EB02390, UL1TR000135]; Morton Foundation; Kipnis Foundation; Mayo
   Foundation
FX We thank Professor Charles Howe for critical reading of the article. We
   thank James Tarara for his help with imaging and microscopy. We thank
   Jarred Nesbit and Bret Ball for their help with animal care and
   surgeries. We thank Jane Meyer for her administrative role in article
   preparation. This work was supported by grants from the NIH (EB02390,
   UL1TR000135), and the Morton, Kipnis, and Mayo Foundations (AJW).
CR Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3
   Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010
   Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Dadsetan M, 2007, BIOMACROMOLECULES, V8, P1702, DOI 10.1021/bm070052h
   Dadsetan M, 2011, ACTA BIOMATER, V7, P2080, DOI 10.1016/j.actbio.2011.01.012
   Dadsetan M, 2010, BIOMATERIALS, V31, P8051, DOI 10.1016/j.biomaterials.2010.06.054
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   Daly WT, 2013, BIOMATERIALS, V34, P8630, DOI 10.1016/j.biomaterials.2013.07.086
   Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884
   Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110
   Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165
   Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014
   Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190
   Imai M, 2008, J NEUROSURG-SPINE, V8, P58, DOI 10.3171/SPI-08/01/058
   Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim J, 2010, J BIOMED MATER RES A, V95A, P191, DOI 10.1002/jbm.a.32810
   Kinard LA, 2012, NAT PROTOC, V7, P1219, DOI 10.1038/nprot.2012.055
   Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422
   Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021
   Lin SX, 2011, ASN NEURO, V3
   LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395
   Linker RA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0394-8
   Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Pertici V., 2014, BIOMATERIALS
   Petter-Puchner AH, 2007, EXP TOXICOL PATHOL, V58, P237, DOI 10.1016/j.etp.2006.07.004
   Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814
   Ritfeld GJ, 2014, BIOMATERIALS, V35, P1924, DOI 10.1016/j.biomaterials.2013.11.062
   Rooney GE, 2008, SPINE, V33, pE914, DOI 10.1097/BRS.0b013e318186b2b1
   Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260
   Rooney GE, 2011, TISSUE ENG PT A, V17, P1287, DOI [10.1089/ten.tea.2010.0396, 10.1089/ten.TEA.2010.0396]
   Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109
   RUDGE JS, 1990, J NEUROSCI, V10, P3594
   Runge MB, 2010, BIOMACROMOLECULES, V11, P2845, DOI 10.1021/bm100526a
   Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012
   Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113
   Shi Q, 2014, SCI CHINA LIFE SCI, V57, P232, DOI 10.1007/s11427-014-4612-7
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013
   South SA, 2000, GLIA, V29, P81, DOI 10.1002/(SICI)1098-1136(20000101)29:1<81::AID-GLIA8>3.0.CO;2-O
   Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J
   Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523
   Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701
NR 74
TC 10
Z9 10
U1 3
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL 1
PY 2015
VL 21
IS 13-14
BP 2099
EP 2114
DI 10.1089/ten.tea.2015.0019
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CV0ZP
UT WOS:000363982900014
PM 25891264
OA Green Published
DA 2018-10-19
ER

PT J
AU Jung, AR
   Kim, RY
   Kim, HW
   Shrestha, KR
   Jeon, SH
   Cha, KJ
   Park, YH
   Kim, DS
   Lee, JY
AF Jung, Ae Ryang
   Kim, Richard Y.
   Kim, Hyung Woo
   Shrestha, Kshitiz Raj
   Jeon, Seung Hwan
   Cha, Kyoung Je
   Park, Yong Hyun
   Kim, Dong Sung
   Lee, Ji Youl
TI Nanoengineered Polystyrene Surfaces with Nanopore Array Pattern Alters
   Cytoskeleton Organization and Enhances Induction of Neural
   Differentiation of Human Adipose-Derived Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ADULT SKELETAL-MUSCLE; REGENERATIVE MEDICINE; NEURONAL LINEAGE; STROMAL
   CELLS; IN-VITRO; ADHESION; TOPOGRAPHY; SUBSTRATE; NANOSCALE; PROTEIN
AB Human adipose-derived stem cells (hADSCs) can differentiate into various cell types depending on chemical and topographical cues. One topographical cue recently noted to be successful in inducing differentiation is the nanoengineered polystyrene surface containing nanopore array-patterned substrate (NP substrate), which is designed to mimic the nanoscale topographical features of the extracellular matrix. In this study, efficacies of NP and flat substrates in inducing neural differentiation of hADSCs were examined by comparing their substrate-cell adhesion rates, filopodia growth, nuclei elongation, and expression of neural-specific markers. The polystyrene nano Petri dishes containing NP substrates were fabricated by a nano injection molding process using a nickel electroformed nano-mold insert (Diameter: 200nm. Depth of pore: 500nm. Center-to-center distance: 500nm). Cytoskeleton and filopodia structures were observed by scanning electron microscopy and F-actin staining, while cell adhesion was tested by vinculin staining after 24 and 48h of seeding. Expression of neural specific markers was examined by real-time quantitative polymerase chain reaction and immunocytochemistry. Results showed that NP substrates lead to greater substrate-cell adhesion, filopodia growth, nuclei elongation, and expression of neural specific markers compared to flat substrates. These results not only show the advantages of NP substrates, but they also suggest that further study into cell-substrate interactions may yield great benefits for biomaterial engineering.
C1 [Jung, Ae Ryang; Kim, Richard Y.; Shrestha, Kshitiz Raj; Jeon, Seung Hwan; Park, Yong Hyun; Lee, Ji Youl] Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul 137040, South Korea.
   [Kim, Hyung Woo; Cha, Kyoung Je; Kim, Dong Sung] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea.
RP Lee, JY (reprint author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, 505 Banpo Dong, Seoul 137040, South Korea.
EM smkds@postech.ac.kr; uroljy@catholic.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2011-0030075]; National Research Foundation of Korea (NRF) grant
   - Korea goverment (MSIP) [2014R1A2A1A01006527]
FX This work was partially supported by the National Research Foundation of
   Korea (NRF) grant funded by the Korea government (MSIP) (No.
   2011-0030075) and partially supported by the National Research
   Foundation of Korea (NRF) grant funded by the Korea goverment (MSIP)
   (No. 2014R1A2A1A01006527).
CR Ahmadi N, 2012, TISSUE CELL, V44, P87, DOI 10.1016/j.tice.2011.11.006
   Ahn EH, 2014, BIOMATERIALS, V35, P2401, DOI 10.1016/j.biomaterials.2013.11.037
   ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Anghileri E, 2008, STEM CELLS DEV, V17, P909, DOI 10.1089/scd.2007.0197
   Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Cha KJ, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/5/055002
   Cha KJ, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025007
   Cha KJ, 2011, MACROMOL BIOSCI, V11, P1357, DOI 10.1002/mabi.201100134
   Chalut KJ, 2010, SOFT MATTER, V6, P1675, DOI 10.1039/b921206j
   Choi MJ, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045006
   Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Jeon K, 2012, BIOMATERIALS, V33, P5206, DOI 10.1016/j.biomaterials.2012.04.011
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Kshitiz, 2012, INTEGR BIOL-UK, V4, P1008, DOI 10.1039/c2ib20080e
   Kwon EB, 2011, KOREAN J UROL, V52, P852, DOI 10.4111/kju.2011.52.12.852
   Lavenus S, 2011, EUR CELLS MATER, V22, P84, DOI 10.22203/eCM.v022a07
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Ning HX, 2008, DIFFERENTIATION, V76, P488, DOI 10.1111/j.1432-0436.2007.00240.x
   Ning HX, 2006, DIFFERENTIATION, V74, P510, DOI 10.1111/j.1432-0436.2006.00081.x
   Pan F, 2013, BIOMATERIALS, V34, P8131, DOI 10.1016/j.biomaterials.2013.07.025
   Park KS, 2012, MACROMOL BIOSCI, V12, P1480, DOI 10.1002/mabi.201200225
   Piao S, 2012, J SEX MED, V9, P1968, DOI 10.1111/j.1743-6109.2012.02760.x
   Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027
   Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3
   Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022
   Taha MF, 2014, J BIOTECHNOL, V172, P1, DOI 10.1016/j.jbiotec.2013.11.028
   Teo BKK, 2010, METHOD CELL BIOL, V98, P241, DOI 10.1016/S0091-679X(10)98011-4
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121
   Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 49
TC 10
Z9 10
U1 0
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL 1
PY 2015
VL 21
IS 13-14
BP 2115
EP 2124
DI 10.1089/ten.tea.2014.0346
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CV0ZP
UT WOS:000363982900015
PM 25919423
DA 2018-10-19
ER

PT J
AU Branisteanu, DE
   Nichifor, M
   Dorobat, CM
   Branisteanu, DC
   Petrariu, FD
   Molodoi, AD
   Radu, DC
   Boda, D
AF Branisteanu, Daciana Elena
   Nichifor, Marieta
   Dorobat, Carmen Mihaela
   Branisteanu, Daniel Constantin
   Petrariu, Florin Dumitru
   Molodoi, Andreea Dana
   Radu, Doru Cezar
   Boda, Daniel
TI Use of textile biomaterials for the topic treatment of chronic venous
   disease
SO ROMANIAN BIOTECHNOLOGICAL LETTERS
LA English
DT Article
DE biomaterial; biopolymer; elastic compression; chronic venous disease;
   troxerutin
ID LASER-SCANNING MICROSCOPY; WALL; LOCALIZATION; TROXERUTIN
AB This scientific work summarizes and concludes the efforts of three regional research centers having regard to discovering an innovating topic treatment for the chronic venous disease.
   New textile biomaterials have been prepared, by chemical or physical application of biopolymers on the textile material, and the load of the biopolymers and biomaterials with rutin, troxerutin and heparine have been tested using physical or chemical methods. The pharmacologically active substance was then gradually released, in a controlled way, at the level of venous endothelium, as a consequence of the prolonged contact of the biomaterial with the skin. There have been performed in vitro and in vivo animal studies, in order to choose the most efficient biomaterial. The textile material chosen must keep intact both the chemical structure and the shape of the grafted polymer, as well as the structure of the drug included in it.
   Finally the efficiency, tolerance and safety of the applied treatments have been analyzed in a rigorous, scientific manner on the patients in different stages of the chronic venous disease.
C1 [Branisteanu, Daciana Elena] Gr T Popa Univ Med & Pharm, Discipline Dermatol, Iasi, Romania.
   [Nichifor, Marieta] P Poni Inst Macromol Chem, Dept Bioact & Biocompatible Polymers, Iasi, Romania.
   [Dorobat, Carmen Mihaela] Gr T Popa Univ Med & Pharm, Discipline Infect Dis, Iasi, Romania.
   [Branisteanu, Daniel Constantin] Gr T Popa Univ Med & Pharm, Discipline Ophthalmol, Iasi, Romania.
   [Petrariu, Florin Dumitru] Gr T Popa Univ Med & Pharm, Discipline Primary Hlth Care & Epidemiol, Iasi, Romania.
   [Molodoi, Andreea Dana] Municipal Hosp, Dept Dermatol, Roman, Romania.
   [Radu, Doru Cezar] Gh Asachi Tech Univ, Fac Text & Leather Engn, Iasi, Romania.
   [Boda, Daniel] Carol Davila Univ Med & Pharm Bucharest, Dermatol Res Lab, Bucharest, Romania.
RP Radu, DC (reprint author), Gh Asachi Tech Univ, Fac Text & Leather Engn, Iasi, Romania.
EM dradu@tex.tuiasi.ro
OI PETRARIU, FLORIN DUMITRU/0000-0003-4538-9809
CR Allegra C., 2006, PHLEBOLYMPHOLOGY, V2, P48
   Andercou A., 2005, RJ ANN VASC SURG, V7, P2
   Andercou A., 2005, RJ ANN VASC SURG, V7, P3
   Andreozzi G. M., 2006, PHLEBOLYMPHOLOGY, V1, P28
   Branisteanu D. E., 2010, DERMATOVENEROL BUC, V3, P197
   Carlsson K, 1996, J MAL VASCUL, V21, P270
   Garde C, 2005, PHLEBOLYMPHOLOGY, P384
   Knittel D., 2003, EXOGENOUS DERMATOLOG, V2, P11
   Lee MH, 2000, J APPL POLYM SCI, V78, P1986, DOI 10.1002/1097-4628(20001209)78:11<1986::AID-APP190>3.0.CO;2-7
   Lim S. H., REV CHITOSAN ITS DER
   Lim SH, 2003, J MACROMOL SCI-POL R, VC43, P223, DOI 10.1081/MC-120020161
   NEUMANN HAM, 1992, EUR J CLIN PHARMACOL, V43, P423, DOI 10.1007/BF02220620
   Nichifor M, 2009, J MATER SCI-MATER M, V20, P975, DOI 10.1007/s10856-008-3653-5
   PATWARDHAN A, 1995, J CARDIOVASC SURG, V36, P381
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ARS DOCENDI
PI BUCHAREST
PA SOS PANDURI 90, SECT 5, BUCHAREST, RO-050663, ROMANIA
SN 1224-5984
J9 ROM BIOTECH LETT
JI Rom. Biotech. Lett.
PD JUL-AUG
PY 2015
VL 20
IS 4
BP 10618
EP 10625
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CR6TX
UT WOS:000361481700008
DA 2018-10-19
ER

PT J
AU Petrovic, MM
   Radovic, MD
   Kostic, MM
   Mitrovic, JZ
   Bojic, DV
   Zarubica, AR
   Bojic, AL
AF Petrovic, Milica M.
   Radovic, Miljana D.
   Kostic, Milos M.
   Mitrovic, Jelena Z.
   Bojic, Danijela V.
   Zarubica, Aleksandra R.
   Bojic, Aleksandar Lj.
TI A Novel Biosorbent Lagenaria vulgaris Shell - ZrO2 for the Removal of
   Textile Dye From Water
SO WATER ENVIRONMENT RESEARCH
LA English
DT Article
DE biomaterial; modification; ZrO2; removal; dye
ID AQUEOUS-SOLUTION; ADSORPTION
AB A new biosorbent, abbreviated as LVB-ZrO2, was synthesized by chemically modifying Lagenaria vulgaris shell with ZrO2. The removal of textile dye RB19 from aqueous solution by LVB-ZrO2 was studied. Characterization by SEM, FTIR and XRD confirmed the chemical modification of the biomaterial, which showed significant improvement of removal efficiency compared with unmodified Lagenaria vulgaris shell. LVB-ZrO2 point of zero charge is 5.49. The biosorption process is highly pH dependent and the optimal pH is 2.0, at which complete dye removal was attained. The results are the best by a pseudo-second order kinetic model. The optimal adsorbent dosage is 4 mg/dm(3). The RB19 biosorption follows the Langmuir isotherm model (R-2 = 0.9978), with the maximum sorption capacity of 75.12 mg/g. LVB-ZrO2 is a mechanically stable, easy to synthesize, cost-effective, biocompatible and environmentally-friendly biosorbent with the high potential for the removal of RB19 from aqueous solution.
C1 [Petrovic, Milica M.; Radovic, Miljana D.; Kostic, Milos M.; Mitrovic, Jelena Z.; Bojic, Danijela V.; Zarubica, Aleksandra R.; Bojic, Aleksandar Lj.] Univ Nis, Fac Sci & Math, Dept Chem, Nish 18000, Serbia.
RP Petrovic, MM (reprint author), Univ Nis, Fac Sci & Math, Dept Chem, Visegradska 33, Nish 18000, Serbia.
EM milicabor84@gmail.com
FU Ministry of Education, Science and Technological development of the
   Republic of Serbia [TR34008]
FX This work was supported by the Ministry of Education, Science and
   Technological development of the Republic of Serbia, Grant No. TR34008.
CR Akar ST, 2009, DESALINATION, V249, P757, DOI 10.1016/j.desal.2008.09.012
   Aksu Z, 2006, J HAZARD MATER, V137, P418, DOI 10.1016/j.jhazmat.2006.02.019
   Alencar WS, 2012, CHEM ENG J, V209, P577, DOI 10.1016/j.cej.2012.08.053
   Barka N, 2013, J TAIWAN INST CHEM E, V44, P52, DOI 10.1016/j.jtice.2012.09.007
   Cardoso NF, 2011, J ENVIRON MANAGE, V92, P1237, DOI 10.1016/j.jenvman.2010.12.010
   Chen H, 2010, J HAZARD MATER, V177, P228, DOI 10.1016/j.jhazmat.2009.12.022
   Copello GJ, 2011, J HAZARD MATER, V186, P932, DOI 10.1016/j.jhazmat.2010.11.097
   Gupta VK, 2012, CHEM ENG J, V180, P81, DOI 10.1016/j.cej.2011.11.006
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Mahmoodi NM, 2011, DESALINATION, V275, P93, DOI 10.1016/j.desal.2011.02.034
   Mitic-Stojanovic D. L., 2011, WATER SA, V37, P1
   Noh HJ, 2003, MATER LETT, V57, P2425, DOI 10.1016/S0167-577X(02)01248-X
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Sahu HR, 2000, B MATER SCI, V23, P349, DOI 10.1007/BF02708383
   Sarkar D, 2007, CERAM INT, V33, P1275, DOI 10.1016/j.ceramint.2006.05.002
   Shah B. N., 2010, Asian Journal of Plant Sciences, V9, P152
   Shore J., 1995, CELLULOSIC DYEING
   Singanan M., 2003, WATER ENV WASTEWATER
   Stankovic MN, 2013, AUST J CHEM, V66, P227, DOI 10.1071/CH12422
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yang YN, 2004, LANGMUIR, V20, P6736, DOI 10.1021/la049363t
   Zollinger H., 2003, COLOR CHEM
NR 23
TC 1
Z9 1
U1 1
U2 7
PU WATER ENVIRONMENT FEDERATION
PI ALEXANDRIA
PA 601 WYTHE ST, ALEXANDRIA, VA 22314-1994 USA
SN 1061-4303
EI 1554-7531
J9 WATER ENVIRON RES
JI Water Environ. Res.
PD JUL
PY 2015
VL 87
IS 7
BP 635
EP 643
DI 10.2175/106143015X14212658614838
PG 9
WC Engineering, Environmental; Environmental Sciences; Limnology; Water
   Resources
SC Engineering; Environmental Sciences & Ecology; Marine & Freshwater
   Biology; Water Resources
GA CR6YT
UT WOS:000361495200007
PM 26163499
DA 2018-10-19
ER

PT J
AU Mo, XH
   Cen, J
   Gibson, E
   Wang, R
   Percival, SL
AF Mo, Xiaohui
   Cen, John
   Gibson, Elaine
   Wang, Robin
   Percival, Steven L.
TI An open multicenter comparative randomized clinical study on chitosan
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID CHRONIC NONHEALING WOUNDS; AUTOLOGOUS PLATELET GEL; HEALING FACTORS;
   RICH PLASMA; TRIAL; CLASSIFICATION; ULCERS
AB Chitosan, a natural polysaccharide derivate from chitin, offers a promising alternative biomaterial for use in wound dressings. In this work, the safety and efficacy of a next-generation KA01 chitosan wound dressing in facilitating the healing of nonhealing chronic wounds was studied. This open multicenter comparative prospective randomized clinical study was conducted at three medical centers in China. A total of 90 patients (45 in test group and 45 in control group) with unhealed chronic wounds including pressure ulcers, vascular ulcers, diabetic foot ulcers, and wounds with minor infections, or at risk of infection, were treated with the next generation chitosan wound dressing as the test article or traditional vaseline gauze as a control. Baseline assessments were undertaken with the primary end point being wound area reduction. The secondary end points included pain reduction (using the NRS11 pain scale) at dressing change, wound exudate levels, wound depth and duration of the treatment. After 4 weeks treatment, the wound area reduction was significantly greater in the test group (65.97+/-4.48%) than the control group (39.95+/-4.48%). The average pain level in the test group was 1.12+/-0.23 and 2.30+/-0.23 in the control group. The wound depth was also lower in the test group 0.30+/-0.48 cm than the control group 0.54+/-0.86 cm. The level of exudate fell and the dressing could be removed integrally in both the test and control groups. The mean duration of the test group was 27.31+/-5.37 days and control group 27.09+/-6.44 days. No adverse events were reported in either group. In conclusion this open multicenter comparative prospective randomized clinical study has provided compelling evidence that the next generation chitosan wound dressing can enhance wound progression towards healing by facilitating wound reepithelialization and reducing the patients pain level. Furthermore the dressing was shown to be clinically safe and effective in the management of chronic wounds.
C1 [Mo, Xiaohui; Cen, John] Foshan United Med Technol Ltd, Foshan, Guangdong, Peoples R China.
   [Gibson, Elaine] Aspen Med Europe Ltd, Redditch, England.
   [Wang, Robin] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.
   [Percival, Steven L.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.
   [Percival, Steven L.] Univ Liverpool, Surface Sci Res Ctr, Liverpool L69 3BX, Merseyside, England.
RP Percival, SL (reprint author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.
EM steven.percival@liverpool.ac.uk
OI Percival, Steven/0000-0002-7752-5935
CR Autologel Diabetic Foot Ulcer Study Group, 2006, OSTOMY WOUND MANAG, V52, p[68, 72, 74]
   Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824
   Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491
   Caceres M, 2012, CLIN ORAL IMPLAN RES, V23, P1104, DOI 10.1111/j.1600-0501.2011.02274.x
   Chen LH, 2013, J DIABETES RES, DOI 10.1155/2013/269527
   Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004
   Friese G, 2007, 5 INT S DIAB FOOT
   [何利平 He Liping], 2012, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V43, P757
   International Working Group on the Diabetic Foot (IWGDF) Editorial Board, 2008, DIABETES-METAB RES S, V24, pS181
   Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573
   Jiang X, 2008, W CHIN MED J, V01, P114
   KNIGHTON DR, 1986, ANN SURG, V204, P322, DOI 10.1097/00000658-198609000-00011
   KRUPSKI WC, 1991, J VASC SURG, V14, P526, DOI 10.1016/0741-5214(91)90247-R
   Nikolidakis D, 2008, TISSUE ENG PART B-RE, V14, P249, DOI 10.1089/ten.teb.2008.0062
   Pietramaggiori G, 2008, WOUND REPAIR REGEN, V16, P218, DOI 10.1111/j.1524-475X.2008.00362.x
   Saad SH, 2011, INT WOUND J, V8, P307
   Saldalamacchia G, 2004, NUTR METAB CARDIOVAS, V14, P395, DOI 10.1016/S0939-4753(04)80029-2
   Senet P, 2003, J VASC SURG, V38, P1342, DOI 10.1016/S0741-5214(03)00908-X
   Treece KA, 2004, DIABETIC MED, V21, P987, DOI 10.1111/j.1464-5491.2004.01275.x
   Vogrin M, 2010, EUR SURG RES, V45, P77, DOI 10.1159/000318597
   Wang Y, 2008, CHIN J REPARATIVE RE, V05, P563
   Wrotniak Maciej, 2007, Ortop Traumatol Rehabil, V9, P227
   Yang Yanzhi, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P571
   Yuan Nan-bing, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P292
   Yuan Nan-bing, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P900
   Yuan Nanbing, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P468
NR 26
TC 5
Z9 5
U1 1
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
EI 1524-475X
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD JUL-AUG
PY 2015
VL 23
IS 4
BP 518
EP 524
DI 10.1111/wrr.12298
PG 7
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA CQ7EG
UT WOS:000360765100175
PM 25845544
DA 2018-10-19
ER

PT J
AU Ye, F
   Jiang, J
   Chang, HL
   Xie, L
   Deng, JJ
   Ma, ZB
   Yuan, WZ
AF Ye, Fang
   Jiang, Jin
   Chang, Honglong
   Xie, Li
   Deng, Jinjun
   Ma, Zhibo
   Yuan, Weizheng
TI Improved single-cell culture achieved using micromolding in capillaries
   technology coupled with poly (HEMA)
SO BIOMICROFLUIDICS
LA English
DT Article
ID SURFACE; BIOLOGY; PATTERN; GROWTH
AB Cell studies at the single-cell level are becoming more and more critical for understanding the complex biological processes. Here, we present an optimization study investigating the positioning of single cells using micromolding in capillaries technology coupled with the cytophobic biomaterial poly (2-hydroxyethyl methacrylate) (poly (HEMA)). As a cytophobic biomaterial, poly (HEMA) was used to inhibit cells, whereas the glass was used as the substrate to provide a cell adhesive background. The poly (HEMA) chemical barrier was obtained using micromolding in capillaries, and the microchannel networks used for capillarity were easily achieved by reversibly bonding the polydimethylsiloxane mold and the glass. Finally, discrete cell adhesion regions were presented on the glass surface. This method is facile and low cost, and the reagents are commercially available. We validated the cytophobic abilities of the poly (HEMA), optimized the channel parameters for higher quality and more stable poly (HEMA) patterns by investigating the effects of changing the aspect ratio and the width of the microchannel on the poly (HEMA) grid pattern, and improved the single-cell occupancy by optimizing the dimensions of the cell adhesion regions. (C) 2015 AIP Publishing LLC.
C1 [Ye, Fang; Jiang, Jin; Chang, Honglong; Deng, Jinjun; Ma, Zhibo; Yuan, Weizheng] Northwestern Polytech Univ, Minist Educ, Key Lab Micro Nano Syst Aerosp, Xian 710072, Peoples R China.
   [Ye, Fang; Jiang, Jin; Chang, Honglong; Deng, Jinjun; Ma, Zhibo; Yuan, Weizheng] Northwestern Polytech Univ, Sch Mech Engn, Xian 710072, Peoples R China.
   [Xie, Li] Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China.
RP Yuan, WZ (reprint author), Northwestern Polytech Univ, Minist Educ, Key Lab Micro Nano Syst Aerosp, Xian 710072, Peoples R China.
EM yuanwz@nwpu.edu.cn
OI Chang, Honglong/0000-0003-0400-3658
FU National Key Scientific Instrument and Equipment Development Project
   [2013YQ190467]; 111 project [B13044]; National Natural Science
   Foundation of China [51375398, 50775188, 51475384]
FX We thank Mr. Yanpeng Hao for drawing the flowcharts, and Mrs. Jianping
   Bai for directing cell experiments. This work was supported by the
   National Key Scientific Instrument and Equipment Development Project
   (2013YQ190467), 111 project (Grant No. B13044), and the National Natural
   Science Foundation of China (Grant Nos. 51375398, 50775188, and
   51475384). All cell culture experiments were performed at the Fourth
   Military Medical University.
CR Cheng Q, 2009, BIOMATERIALS, V30, P4203, DOI 10.1016/j.biomaterials.2009.04.023
   Chien HW, 2009, BIOMATERIALS, V30, P2209, DOI 10.1016/j.biomaterials.2008.12.060
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318
   Jing GS, 2011, ACTA BIOMATER, V7, P1094, DOI 10.1016/j.actbio.2010.09.040
   Kawashima T, 2010, MICROELECTRON ENG, V87, P704, DOI 10.1016/j.mee.2009.12.066
   Leclair AM, 2011, BIOMATERIALS, V32, P1351, DOI 10.1016/j.biomaterials.2010.10.051
   Lee JH, 2008, COLLOID SURFACE B, V64, P126, DOI 10.1016/j.colsurfb.2008.01.015
   Liu WW, 2009, CHINESE J ANAL CHEM, V37, P943, DOI 10.1016/S1872-2040(08)60113-9
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Nakanishi J, 2008, ANAL SCI, V24, P67, DOI 10.2116/analsci.24.67
   Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e
   Shim HW, 2007, BIOSENS BIOELECTRON, V22, P3188, DOI 10.1016/j.bios.2007.02.016
   Shim HW, 2009, J NANOSCI NANOTECHNO, V9, P1204, DOI 10.1166/jnn.2009.C120
   Situ Z. Q., 2007, CELL CULTURE, P6
   Tabatabaei M, 2013, BIOMATERIALS, V34, P10065, DOI 10.1016/j.biomaterials.2013.09.070
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Thibault C., 2005, J NANOBIOTECHNOL, V3
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Ye F., J BIOMED MA IN PRESS
NR 23
TC 3
Z9 4
U1 2
U2 16
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD JUL
PY 2015
VL 9
IS 4
AR 044106
DI 10.1063/1.4926807
PG 9
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA CQ0UD
UT WOS:000360311900008
PM 26339307
OA Green Published
DA 2018-10-19
ER

PT J
AU Hirata, HH
   Munhoz, MAS
   Plepis, AMG
   Martins, VCA
   Santos, GR
   Galdeano, EA
   Cunha, MR
AF Hirata, H. H.
   Munhoz, M. A. S.
   Plepis, A. M. G.
   Martins, V. C. A.
   Santos, G. R.
   Galdeano, E. A.
   Cunha, M. R.
TI Feasibility study of collagen membranes derived from bovine pericardium
   and intestinal serosa for the repair of cranial defects in
   ovariectomised rats
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Biomaterial; Collagen; Osseointegration; Osteoporosis; Ovariectomy
ID BONE DEFECTS; MATRIX; SCAFFOLDS; BIOMATERIALS; REGENERATION; IMPLANTS
AB The indication of biomaterials has increased substantially in the regenerative therapy of bone defects. However, in addition to evaluating the physicochemical properties of biomaterials, the quality of the recipient tissue is also essential for the osseointegration of implants, as abnormalities in bone metabolism, such as gonadal hormone deficiency, can influence bone healing. This study evaluated the osteoregenerative capacity of collagen membranes derived from bovine pericardium and intestinal serosa in the repair of cranial defects in ovariectomised rats. Thirty female Wistar rats were submitted to surgical creation of a 5-mm cranial bone defect. The rats were divided into a control group (not ovariectomised) and an ovariectomised group. The non-ovariectomised group was divided into three subgroups: control (G1) in which the defect was not filled with the biomaterial, and two subgroups (G2 and G3) that received the bovine pericardium- and serosa-derived collagen membranes, respectively. The ovariectomised group was divided into the same subgroups (G4, G5, and G6). The animals were sacrificed 8 weeks after surgery. The calvaria were removed for macroscopic and radiographic photodocumentation and processed for histomorphometric analysis of bone healing at the surgical site. Macroscopic, radiological, and microscopic analyses demonstrated the biocompatibility of the implanted collagen membranes, as indicated by the absence of infiltration and signs of inflammation at the surgical site. Histologically, discrete immature bone neoformation projecting from the margins of the defect was observed at the surgical site in ovariectomised groups when compared to the non-ovariectomised groups. The volume of newly formed bone was significantly higher in the non-ovariectomised groups (G1: 7.83% +/- 1.32; G2: 21.33% +/- 1.96; and G3: 22.83% +/- 0.98) compared to the respective ovariectomised subgroups (G4: 3.16% +/- 0.75; G5: 16.83% +/- 0.98; and G6: 16.16% +/- 0.75), thus demonstrating the deleterious effects of ovariectomy on bone homeostasis. Higher volumes of newly formed bone were observed in the groups receiving the membrane grafts (G2, G3, G5, and G6) compared to the control groups (G1 and G4). In conclusion, the bilateral ovariectomy compromises the ability to repair bone lesions grafted with osteoconductive biomaterials as in the case of collagen membranes derived from both bovine pericardium and intestinal serosa. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Hirata, H. H.; Munhoz, M. A. S.; Plepis, A. M. G.; Cunha, M. R.] Univ Sao Paulo, Programa Posgrad Interunidades Bioengn, BR-13566590 Sao Carlos, SP, Brazil.
   [Hirata, H. H.; Munhoz, M. A. S.; Santos, G. R.; Galdeano, E. A.; Cunha, M. R.] Fac Med Jundiai, Dept Morphol & Pathol, BR-13202550 Jundiai, SP, Brazil.
   [Plepis, A. M. G.; Martins, V. C. A.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil.
RP Cunha, MR (reprint author), Fac Med Jundiai, Dept Morphol & Pathol, Rua Francisco Telles 250, BR-13202550 Jundiai, SP, Brazil.
EM hiratahh@gmail.com; masmunhoz@me.com; amplepis@iqsc.usp.br;
   virginia@iqsc.usp.br; geovanerib.santos@gmail.com;
   eagaldeano@yahoo.com.br; cunhamr@hotmail.com
RI Plepis, Ana/J-2559-2012; Martins, Virginia/H-5832-2012
OI Plepis, Ana/0000-0002-4360-8433; Martins, Virginia/0000-0001-7565-9641;
   Alexandre Galdeano, Ewerton/0000-0002-1922-8430
CR Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X
   Camilli JA, 2004, ARCH ORAL BIOL, V49, P747, DOI 10.1016/j.archoralbio.2004.02.009
   Cho Peter, 2004, Implant Dent, V13, P79, DOI 10.1097/01.ID.0000116456.76235.BC
   Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y
   de Batista TM, 2009, J THERM ANAL CALORIM, V95, P945, DOI 10.1007/s10973-007-8897-7
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   GOISSIS G., 1999, REV BRASILEIRA ENGEN, V15, P55
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Lacerda C, 1998, QUIM NOVA, V21, P267, DOI 10.1590/S0100-40421998000300006
   Lane NE, 1999, J BONE MINER RES, V14, P206, DOI 10.1359/jbmr.1999.14.2.206
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Mandarim de Lacerda CA, 1999, BRAZ J MORPHOL, V16, P131
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Miguel FB, 2013, J MATER SCI-MATER M, V24, P2567, DOI 10.1007/s10856-013-4980-8
   Moreira PD, 2013, J BIOMED MATER RES B, V101B, P18, DOI 10.1002/jbm.b.32804
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Pereira NT, 2012, MICROSC RES TECHNIQ, V75, P36, DOI 10.1002/jemt.21019
   Ramesh S, 2007, P SOC PHOTO-OPT INS, V6423
   RAMSHAW J. A. M., 2001, BIOMEDICAL ENG APPL, V13, P14
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Shalaby SW, 2003, ADV POLYM MAT
   Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948
   Sun Zhe, 2014, Hua Xi Kou Qiang Yi Xue Za Zhi, V32, P134
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang Jian-wei, 2005, Chin J Traumatol, V8, P111
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 31
TC 7
Z9 7
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUL
PY 2015
VL 46
IS 7
BP 1215
EP 1222
DI 10.1016/j.injury.2015.03.039
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA CP8EK
UT WOS:000360124800005
PM 25920373
DA 2018-10-19
ER

PT J
AU Istrate, B
   Mareci, D
   Munteanu, C
   Stanciu, S
   Luca, D
   Crimu, CI
   Kamel, E
AF Istrate, B.
   Mareci, D.
   Munteanu, C.
   Stanciu, S.
   Luca, D.
   Crimu, C. I.
   Kamel, E.
TI In vitro electrochemical properties of biodegradable ZrO2-CaO coated
   MgCa alloy using atmospheric plasma spraying
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Mg-Ca alloy; ZrO2-CaO-coated; plasma spraying; EIS; SEM
ID LOW-POWER PLASMA; CORROSION BEHAVIOR; MAGNESIUM; ZIRCONIA; COATINGS;
   CALCIUM; BONE
AB ZrO2-CaO 95%-5% as a ceramic biomaterial facilitates the osteoconductivity in new bone formation around implant. Surface characterization before and after electrochemical testing was performed used scanning electron microscopy (SEM). ZrO2-CaO coating was performed using a Sulzer Metco 9MCE Atmospheric Plasma Spraying facility. The electrochemical properties of the calcium oxide stabilized zirconium oxide coated and uncoated MgCa sample at the open circuit potential at different immersion time in Ringer's solution were studied by electrochemical impedance spectroscopy (EIS). Equivalent circuit (EC) was used to modeling EIS data, in order to characterize ZrO2-CaO coated and uncoated MgCa surface.
C1 [Istrate, B.; Munteanu, C.; Crimu, C. I.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Iasi 700050, Romania.
   [Mareci, D.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Stanciu, S.; Luca, D.] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Iasi 700050, Romania.
   [Kamel, E.] Dunarea de Jos Univ Galati, Dept Dent Med, Fac Med, Galati, Romania.
RP Munteanu, C (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Bd D Mangeron 6, Iasi 700050, Romania.
EM cornelmun@gmail.com
RI Bogdan, Istrate/P-5182-2014; Luca, Dorin/Q-3616-2016
OI Bogdan, Istrate/0000-0003-0817-3523; Luca, Dorin/0000-0003-3502-2018;
   Mareci, Daniel/0000-0002-5859-1996
CR Bozzini B, 2011, J MATER SCI-MATER M, V22, P193, DOI 10.1007/s10856-010-4187-1
   Chelariu R, 2014, ELECTROCHIM ACTA, V137, P280, DOI 10.1016/j.electacta.2014.06.021
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Deville S, 2004, KEY ENG MAT, V264-268, P2013, DOI 10.4028/www.scientific.net/KEM.264-268.2013
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Li T, 2015, MATER CORROS, V66, P7, DOI 10.1002/maco.201307528
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Mareci D, 2012, J OPTOELECTRON ADV M, V14, P112
   Mareci D, 2010, J OPTOELECTRON ADV M, V12, P1590
   Mareci D, 2010, J MATER SCI-MATER M, V21, P2907, DOI 10.1007/s10856-010-4147-9
   Morks MF, 2006, MATER LETT, V60, P1049, DOI 10.1016/j.matlet.2005.10.073
   Morks MF, 2005, SURF COAT TECH, V199, P66, DOI 10.1016/j.surfcoat.2005.02.159
   Papatoiu C, 2014, J OPTOELECTRON ADV M, V16, P1093
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Zhang JS, 2015, MATER CORROS, V66, P542, DOI 10.1002/maco.201407696
NR 23
TC 0
Z9 0
U1 0
U2 11
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD JUL-AUG
PY 2015
VL 17
IS 7-8
BP 1186
EP 1192
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA CP6AV
UT WOS:000359967600044
DA 2018-10-19
ER

PT J
AU Johansson, P
   Jimbo, R
   Kozai, Y
   Sakurai, T
   Kjellin, P
   Currie, F
   Wennerberg, A
AF Johansson, Par
   Jimbo, Ryo
   Kozai, Yusuke
   Sakurai, Takashi
   Kjellin, Per
   Currie, Fredrik
   Wennerberg, Ann
TI Nanosized Hydroxyapatite Coating on PEEK Implants Enhances Early Bone
   Formation: A Histological and Three-Dimensional Investigation in Rabbit
   Bone
SO MATERIALS
LA English
DT Article
DE polyether ether ketone; HA; biomaterial; histology
ID IN-VITRO; TENSILE PROPERTIES; REMOVAL TORQUE; POLYETHERETHERKETONE;
   TITANIUM; SURFACE; LUMBAR; FUSION; TIBIA; RESPONSES
AB Polyether ether ketone (PEEK) has been frequently used in spinal surgery with good clinical results. The material has a low elastic modulus and is radiolucent. However, in oral implantology PEEK has displayed inferior ability to osseointegrate compared to titanium materials. One idea to reinforce PEEK would be to coat it with hydroxyapatite (HA), a ceramic material of good biocompatibility. In the present study we analyzed HA-coated PEEK tibial implants via histology and radiography when following up at 3 and 12 weeks. Of the 48 implants, 24 were HA-coated PEEK screws (test) and another 24 implants served as uncoated PEEK controls. HA-coated PEEK implants were always osseointegrated. The total bone area (BA) was higher for test compared to control implants at 3 (p < 0.05) and 12 weeks (p < 0.05). Mean bone implant contact (BIC) percentage was significantly higher (p = 0.024) for the test compared to control implants at 3 weeks and higher without statistical significance at 12 weeks. The effect of HA-coating was concluded to be significant with respect to early bone formation, and HA-coated PEEK implants may represent a good material to serve as bone anchored clinical devices.
C1 [Johansson, Par; Jimbo, Ryo; Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prostodont, S-21421 Malmo, Sweden.
   [Kozai, Yusuke; Sakurai, Takashi] Kanagawa Dent Univ, Dept Radiopraxis Sci, Yokosuka, Kanagawa 2388580, Japan.
   [Kjellin, Per; Currie, Fredrik] Promimic AB, S-41292 Gothenburg, Sweden.
RP Johansson, P (reprint author), Malmo Univ, Fac Odontol, Dept Prostodont, S-21421 Malmo, Sweden.
EM par.johansson@mah.se; ryo.jimbo@mah.se; kozai@kdu.ac.jp;
   sakurait@kdcnet.ac.jp; per@promimic.se; fredrik@promimic.se;
   ann.wennerberg@mah.se
FU Swedish Knowledge Foundation
FX This study was supported by grants received from the Swedish Knowledge
   Foundation.
CR Abrahamsson I, 2013, CLIN ORAL IMPLAN RES, V24, P57, DOI 10.1111/j.1600-0501.2012.02424.x
   Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Ahn YH, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044101
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Anandjiwala J, 2011, EUR SPINE J, V20, P1951, DOI 10.1007/s00586-011-1917-0
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   Branemark P. I., 1977, J PLAST RECONSTR SUR, V16, P1, DOI DOI 10.3109/02844316909036699
   Chou WK, 2015, J SPINAL DISORD TECH, V28, pE121, DOI 10.1097/BSD.0000000000000176
   Converse GL, 2007, BIOMATERIALS, V28, P927, DOI 10.1016/j.biomaterials.2006.10.031
   Eom TG, 2012, OR SURG OR MED OR PA, V114, P411, DOI 10.1016/j.oooo.2011.10.036
   Fan JP, 2004, BIOMATERIALS, V25, P5363, DOI 10.1016/j.biomaterials.2003.12.050
   Fontana F, 2011, CLIN ORAL IMPLAN RES, V22, P760, DOI 10.1111/j.1600-0501.2010.02056.x
   Gobbato L, 2012, IMPLANT DENT, V21, P454, DOI 10.1097/ID.0b013e3182611cd7
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Jimbo R, 2011, J DENT RES, V90, P1422, DOI 10.1177/0022034511422911
   Johansson P, 2014, INT J NANOMED, V9, P3903, DOI 10.2147/IJN.S60387
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kim Dong-Seok, 2009, J Adv Prosthodont, V1, P10, DOI 10.4047/jap.2009.1.1.10
   Kim MC, 2013, J SPINAL DISORD TECH, V26, P87, DOI 10.1097/BSD.0b013e318237b9b1
   Kim PD, 2012, SPINE, V37, pE1155, DOI 10.1097/BRS.0b013e318257f14d
   Kjellin P., 2012, US Pantent, Patent No. [8206813 B2, 8206813, US 8206813 B2]
   Kruger T, 1998, Aktuelle Radiol, V8, P81
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lee JH, 2010, TISSUE ENG REGEN MED, V7, P540
   Lee JH, 2005, BIOMATERIALS, V26, P3249, DOI 10.1016/j.biomaterials.2004.08.033
   Mantripragada VP, 2013, J BIOMED MATER RES A, V101, P3349, DOI 10.1002/jbm.a.34605
   Meirelles L, 2008, J BIOMED MATER RES A, V87A, P299, DOI 10.1002/jbm.a.31744
   Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641
   Nakada H, 2008, J HARD TISSUE BIOL, V17, P99, DOI 10.2485/jhtb.17.99
   Nemoto O, 2014, EUR SPINE J, V23, P2150, DOI 10.1007/s00586-014-3466-9
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Park P, 2004, SPINE, V29, P1938, DOI 10.1097/01.brs.0000137069.88904.03
   Peraire C, 2006, J BIOMED MATER RES A, V77A, P370, DOI 10.1002/jbm.a.30556
   Rabiei A, 2013, J BIOMED MATER RES A, V101, P2621, DOI 10.1002/jbm.a.34557
   Rao PJ, 2014, ORTHOP SURG, V6, P81, DOI 10.1111/os.12098
   Reigstad O, 2011, J BIOMED MATER RES B, V99B, P14, DOI 10.1002/jbm.b.31866
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Stein IC, 2015, EUR SPINE J, V24, pS555, DOI 10.1007/s00586-014-3704-1
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Treves C, 2010, J BIOMED MATER RES A, V92A, P1623, DOI 10.1002/jbm.a.32507
   Voor MJ, 2008, J BIOMECH, V41, P186, DOI 10.1016/j.jbiomech.2007.06.028
   Weiner BK, 1998, SPINE, V23, P634, DOI 10.1097/00007632-199803010-00020
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   Williams D, 2008, MED DEVICE TECHNOL, V19, P10
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Yu SC, 2005, BIOMATERIALS, V26, P2343, DOI 10.1016/j.biomaterials.2004.07.028
NR 47
TC 10
Z9 10
U1 3
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2015
VL 8
IS 7
BP 3815
EP 3830
DI 10.3390/ma8073815
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA CP5CG
UT WOS:000359898300003
PM 28793409
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Capanema, NSV
   Mansur, AAP
   Carvalho, SM
   Silva, ARP
   Ciminelli, VS
   Mansur, HS
AF Capanema, Nadia S. V.
   Mansur, Alexandra A. P.
   Carvalho, Sandhra M.
   Silva, Alexandra R. P.
   Ciminelli, Virginia S.
   Mansur, Herman S.
TI Niobium-Doped Hydroxyapatite Bioceramics: Synthesis, Characterization
   and In Vitro Cytocompatibility
SO MATERIALS
LA English
DT Article
DE biomaterial; bioceramic; bioactive ceramic; calcium phosphate; doped
   hydroxyapatite; bone tissue engineering
ID BONE-GRAFT SUBSTITUTES; CALCIUM-PHOSPHATE; THERMAL-DECOMPOSITION; HYBRID
   SCAFFOLDS; GLASS; ATMOSPHERE; TISSUE; IONS
AB Doping calcium phosphates with ionic species can play an important role in biological responses promoting alkaline phosphatase activity, and, therefore inducing the generation of new bone. Thus, in this study, the synthesis of niobium-doped hydroxyapatite (Nb-HA) nanosize particles obtained by the precipitation process in aqueous media followed by thermal treatment is presented. The bioceramics were extensively characterized by X-ray diffraction, wavelength dispersive X-ray fluorescence spectrometry, Fourier transform infrared spectroscopy, scanning electron microscopy/energy dispersive X-ray spectroscopy analysis, transmission electron microscopy, atomic force microscopy and thermal analysis regarding their chemical composition, structure and morphology. The results showed that the precipitate dried at 110 degrees C was composed of amorphous calcium phosphate and HA, with polidisperse particles ranging from micro to nano dimensions. After the thermal treatment at 900 degrees C, the bioceramic system evolved predominantly to HA crystalline phase, with evident features of particle sintering and reduction of surface area. Moreover, the addition of 10 mol% of niobium salt precursor during the synthesis indicated the complete incorporation of the Nb(V) species in the HA crystals with detectable changes in the original lattice parameters. Furthermore, the incorporation of Nb ions caused a significant refinement on the average particle size of HA. Finally, the preliminary cytocompatibility response of the biomaterials was accessed by human osteoblast cell culture using MTT and resazurin assays, which demonstrated no cytotoxicity of the Nb-alloyed hydroxyapatite. Thus, these findings seem promising for developing innovative Nb-doped calcium phosphates as artificial biomaterials for potential use in bone replacements and repair.
C1 [Capanema, Nadia S. V.; Mansur, Alexandra A. P.; Carvalho, Sandhra M.; Silva, Alexandra R. P.; Ciminelli, Virginia S.; Mansur, Herman S.] Univ Fed Minas Gerais, Ctr Nanosci Nanotechnol & Innovat CeNano2I, Escola Engn, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Ctr Nanosci Nanotechnol & Innovat CeNano2I, Escola Engn, Dept Met & Mat Engn, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM nsvnadia@gmail.com; aapiscitelli@uol.com.br; sandhra.carvalho@gmail.com;
   alebiomat@gmail.com; ciminelli@demet.ufmg.br; hmansur@demet.ufmg.br
RI Capanema, Nadia/C-5888-2018
OI Mansur, Alexandra/0000-0003-1526-2508; Mansur,
   Herman/0000-0002-3032-495X
FU CAPES; FAPEMIG; CNPq; INCT-ACQUA
FX The authors acknowledge the financial support from the CAPES, FAPEMIG,
   CNPq and INCT-ACQUA. The authors express their gratitude to the staff of
   the Microscopy Center/UFMG for TEM analysis, Emilio O. Neto for the EDX
   analysis, Isabel de Sousa Batista Carvalho for XRF analysis, and to
   Dagoberto B. Santos and Patricia Trigueiro for SEM/EDX analysis.
CR Alqap ASF, 2011, IFMBE PROC, V35, P108, DOI 10.1007/978-3-642-21729-6_30
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Compton OC, 2009, J PHYS CHEM C, V113, P479, DOI 10.1021/jp807839b
   Costa HS, 2008, J MATER SCI, V43, P510, DOI 10.1007/s10853-007-1849-6
   Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015
   da Rocha DN, 2013, J MATER RES TECHNOL, V2, P24, DOI 10.1016/j.jmrt.2013.03.007
   Demirtas TT, 2015, MAT SCI ENG C-MATER, V49, P713, DOI 10.1016/j.msec.2015.01.057
   Denry IL, 2005, J BIOMED MATER RES B, V75B, P18, DOI 10.1002/jbm.b.30295
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   ELLIOTT JC, 1994, STUDIES INORGANIC CH, V18, P389
   Etoubleau J, 1999, GEOSTANDARD NEWSLETT, V23, P187, DOI 10.1111/j.1751-908X.1999.tb00573.x
   Farzadi A, 2014, CERAM INT, V40, P6021, DOI 10.1016/j.ceramint.2013.11.051
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JARCHO M, 1977, J BIOENG, V1, P79
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Lafon JP, 2003, J THERM ANAL CALORIM, V72, P1127, DOI 10.1023/A:1025036214044
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   LeGeros R. Z., 1993, INTRO BIOCERAMICS
   Legeros R. Z., 1991, MONOGRAPHS ORAL SCI, V15, P200
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Mansur HS, 2008, CHEM ENG J, V137, P72, DOI 10.1016/j.cej.2007.09.036
   Mansur HS, 2012, MAT SCI ENG C-MATER, V32, P404, DOI 10.1016/j.msec.2011.11.012
   Meejoo S, 2006, THERMOCHIM ACTA, V447, P115, DOI 10.1016/j.tca.2006.04.013
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Oliveira LCA, 2014, APPL CATAL B-ENVIRON, V152, P403, DOI 10.1016/j.apcatb.2014.01.025
   Ramesh S, 2013, CERAM INT, V39, P111, DOI 10.1016/j.ceramint.2012.05.103
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   Rueger JM, 1998, ORTHOPADE, V27, P72
   RUYS AJ, 1995, J MATER SCI-MATER M, V6, P297, DOI 10.1007/BF00120274
   Santos MH, 2007, BIOMED MATER, V2, P135, DOI 10.1088/1748-6041/2/2/012
   Santos MH, 2008, MAT SCI ENG C-BIO S, V28, P563, DOI 10.1016/j.msec.2007.07.002
   Santos Maria Helena, 2004, Mat. Res., V7, P625, DOI 10.1590/S1516-14392004000400017
   Tamai M, 2007, J ARTIF ORGANS, V10, P22, DOI 10.1007/s10047-006-0363-y
   Uysal I, 2014, PROG NAT SCI-MATER, V24, P340, DOI 10.1016/j.pnsc.2014.06.004
NR 44
TC 16
Z9 16
U1 4
U2 31
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2015
VL 8
IS 7
BP 4191
EP 4209
DI 10.3390/ma8074191
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA CP5CG
UT WOS:000359898300028
PM 28793433
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gray, A
   Maguire, T
   Schloss, R
   Yarmush, ML
AF Gray, Andrea
   Maguire, Timothy
   Schloss, Rene
   Yarmush, Martin L.
TI Identification of IL-1 and LPS as optimal activators of monolayer and
   alginate-encapsulated mesenchymal stromal cell immunomodulation using
   design of experiments and statistical methods
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE mesenchymal stromal cells; fractional factorial design; alginate
   encapsulation; immunomodulation
ID MOLECULAR-WEIGHT CUTOFF; FACTOR-KAPPA-B; STEM-CELLS; TNF-ALPHA; IN-VIVO;
   INTERFERON-GAMMA; POLYLYSINE MICROCAPSULES; BINDING-PROTEIN; SOLUBLE
   CD14; NITRIC-OXIDE
AB Induction of therapeutic mesenchymal stromal cell (MSC) function is dependent upon activating factors present in diseased or injured tissue microenvironments. These functions include modulation of macrophage phenotype via secreted molecules including prostaglandin E2 (PGE2). Many approaches aim to optimize MSC-based therapies, including preconditioning using soluble factors and cell immobilization in biomaterials. However, optimization of MSC function is usually inefficient as only a few factors are manipulated in parallel. We utilized fractional factorial design of experiments to screen a panel of 6 molecules (lipopolysaccharide [LPS], polyinosinic-polycytidylic acid [poly(I:C)], interleukin [IL]-6, IL-1, interferon [IFN]-, and IFN-), individually and in combinations, for the upregulation of MSC PGE2 secretion and attenuation of macrophage secretion of tumor necrosis factor (TNF)-, a pro-inflammatory molecule, by activated-MSC conditioned medium (CM). We used multivariable linear regression (MLR) and analysis of covariance to determine differences in functions of optimal factors on monolayer MSCs and alginate-encapsulated MSCs (eMSCs). The screen revealed that LPS and IL-1 potently activated monolayer MSCs to enhance PGE2 production and attenuate macrophage TNF-. Activation by LPS and IL-1 together synergistically increased MSC PGE2, but did not synergistically reduce macrophage TNF-. MLR and covariate analysis revealed that macrophage TNF- was strongly dependent on the MSC activation factor, PGE2 level, and macrophage donor but not MSC culture format (monolayer versus encapsulated). The results demonstrate the feasibility and utility of using statistical approaches for higher throughput cell analysis. This approach can be extended to develop activation schemes to maximize MSC and MSC-biomaterial functions prior to transplantation to improve MSC therapies. (c) 2015 American Institute of Chemical Engineers Biotechnol. Prog., 31:1058-1070, 2015
C1 [Gray, Andrea; Maguire, Timothy; Schloss, Rene; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
RP Yarmush, ML (reprint author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
EM yarmush@rci.rutgers.edu
FU New Jersey Commission for Spinal Cord Injury [10-2947-SCR-R-0]; New
   Jersey Commission for Brain Injury Research [CBIR12IRG019]; National
   Institutes of Health (Ruth L. Kirschstein National Research Service
   Award from the National Institute of General Medical Sciences) [T32
   GM8339]; National Science Foundation [0801620]; United States Department
   of Education [P200A100096]
FX The authors thank Dr. Serom Lee and Dr. Mehdi Ghodbane for critical
   review and comments on the manuscript. Support for this work came from
   grants from the New Jersey Commission for Spinal Cord Injury
   (10-2947-SCR-R-0), the New Jersey Commission for Brain Injury Research
   (CBIR12IRG019), the National Institutes of Health (Ruth L. Kirschstein
   National Research Service Award T32 GM8339 from the National Institute
   of General Medical Sciences), the National Science Foundation
   (Integrative Graduate Education and Research Traineeship Award 0801620),
   and the United States Department of Education (Graduate Assistance in
   Areas of National Need Award P200A100096). The authors report no
   conflicts of interest.
CR Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627
   Babiarz J, NANO LIFE
   Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631
   Barminko J, 2011, BIOTECHNOL BIOENG, V108, P2747, DOI 10.1002/bit.23233
   Barminko JA, 2014, BIOTECHNOL BIOENG, V111, P2239, DOI 10.1002/bit.25282
   Bartosh TJ, 2013, STEM CELLS, V31, P2443, DOI 10.1002/stem.1499
   Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247
   Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9
   Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135
   COROMILI V, 1993, BIOMAT ARTIF CELL IM, V21, P427, DOI 10.3109/10731199309117382
   Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007
   Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2007.0037
   de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6
   Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352
   Dong J, 2008, CYTOTECHNOLOGY, V57, P251, DOI 10.1007/s10616-008-9168-6
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698
   Dumitru CA, 2014, FASEB J, V28, P3855
   English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   Gazdic M., 2015, STEM CELL REV
   GOOSEN MFA, 1989, J MEMBRANE SCI, V41, P323, DOI 10.1016/S0376-7388(00)82412-6
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Herrmann JL, 2011, SHOCK, V35, P512, DOI 10.1097/SHK.0b013e31820b2fb9
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Jakobsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096615
   Jaynes J, 2013, STAT MED, V32, P307, DOI 10.1002/sim.5526
   Jiang YF, 2011, NEUROL RES, V33, P331, DOI 10.1179/016164110X12816242542571
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x
   Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108
   Kurachi Maki, 2005, Journal of Infection and Chemotherapy, V11, P199, DOI 10.1007/s10156-005-0392-0
   Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.013909.105812
   Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209
   Lei JX, 2011, CELL IMMUNOL, V271, P147, DOI 10.1016/j.cellimm.2011.06.014
   Li Q, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt213
   Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197
   Luo Y, 2012, SURGERY, V151, P353, DOI 10.1016/j.surg.2011.09.033
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748
   Mandenius CF, 2008, BIOTECHNOL PROGR, V24, P1191, DOI [10.1002/btpr.67, 10.1021/bp.67]
   Matsuura H, 1999, J BIOL CHEM, V274, P29138, DOI 10.1074/jbc.274.41.29138
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   MONTGOMERY D. C., 2008, DESIGN ANAL EXPT
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Mundra V, 2012, MOL PHARM, V10, P77
   Nakamoto N, 2006, INT J ONCOL, V29, P625
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105
   Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7
   Orive G, 2014, ADV DRUG DELIVER REV, V67-68, P3, DOI 10.1016/j.addr.2013.07.009
   OTTERLEI M, 1993, INFECT IMMUN, V61, P1917
   Perdana Arif, 2014, International Journal of Business Information Systems, V16, P247, DOI 10.1504/IJBIS.2014.063767
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Roldan-Valadez E, 2013, ANAT REC, V296, P1913, DOI 10.1002/ar.22817
   Roldan-Valadez E, 2013, EUR J RADIOL, V82, pE697, DOI 10.1016/j.ejrad.2013.07.012
   Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864
   Sarrafzadegan N, 2011, J RES MED SCI, V16, P254
   Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004
   Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3
   Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682
   Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563
   Treffkorn L, 2004, PROSTAG OTH LIPID M, V74, P113, DOI 10.1016/j.prostaglandins.2004.07.005
   Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52
   van den Berk LCJ, 2010, J LEUKOCYTE BIOL, V87, P283, DOI 10.1189/jlb.0709467
   VANDENBOSSCHE GMR, 1991, J PHARM PHARMACOL, V43, P275, DOI 10.1111/j.2042-7158.1991.tb06683.x
   VANDENBOSSCHE GMR, 1993, BIOTECHNOL BIOENG, V42, P381, DOI 10.1002/bit.260420316
   Waterman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045590
   Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
   Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096
   Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191
   Ylostalo JH, 2014, CYTOTHERAPY, V16, P1486, DOI 10.1016/j.jcyt.2014.07.010
   Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x
   Yu B, 1996, J BIOL CHEM, V271, P4100
   Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008
   Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588
   Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004
NR 83
TC 8
Z9 8
U1 1
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
EI 1520-6033
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JUL-AUG
PY 2015
VL 31
IS 4
BP 1058
EP 1070
DI 10.1002/btpr.2103
PG 13
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA CP0YM
UT WOS:000359602900022
PM 25958832
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Yang, J
   Wang, S
   Lee, JH
AF Yang, Jaechang
   Wang, Semyung
   Lee, Jong Hyun
TI Photovoltaic Detection of Hydrogen Peroxide over a Wide Range of
   Concentrations for Agricultural Applications
SO JOURNAL OF CHEMICAL ENGINEERING OF JAPAN
LA English
DT Article
DE Hydrogen Peroxide; Photovoltaic Detection; Chemiluminescence; Capacitor
   Filter; Reflective Plate
ID CARBON-PASTE; ELECTRODE; SENSOR; NANOPARTICLES; HEMOGLOBIN; BIOSENSOR;
   MEMBRANE
AB Detection methods to broaden the measurable range of hydrogen peroxide (H2O2) concentrations are suggested for agricultural applications. Photovoltaic detection is based on the chemiluminescence (CL) of luminol with potassium ferricyanide as a catalyst. The use of potassium ferricyanide (non-biomaterial) enables the sensor to be stored for a long period at room temperature and can lower the manufacturing cost. In this study, the measurement range was broadened down to 3x10(-5)% by improving the stability and enhancing the sensitivity of the sensor. To improve the stability in the time domain, a low pass filter (LPF) was connected, reducing noise caused by ambient light. To enhance sensitivity, a reflective plate was employed to redirect diverging emitted light toward the photodiode. The highest possible detection level was also elevated up to 0.5% by preparing the mixture of luminol and catalysts (MLC) at high concentration. As a result, the performance index, IMR (Index of Measurable Range=maximum/minimum ratio of detectable concentration) of the system grew to over 16,000, which is about 16 times larger than previous results. All of the experimental results were confirmed to be in good agreement with calculated theoretical output voltages from chemiluminescence. The proposed device is intended to replace hazardous pesticides or antibiotics which have been used for agricultural applications.
C1 [Yang, Jaechang; Wang, Semyung; Lee, Jong Hyun] Gwangju Inst Sci & Technol, Chool Mechatron, Gwangju 500712, South Korea.
   [Lee, Jong Hyun] Gwangju Inst Sci & Technol, Dept Med Syst Engn, Gwangju 500712, South Korea.
RP Lee, JH (reprint author), Gwangju Inst Sci & Technol, Chool Mechatron, Gwangju 500712, South Korea.
EM jonghyun@gist.ac.kr
FU Institute of Medical System Engineering (iMSE) in the GIST, Korea
FX This research was supported by a Grant from the Institute of Medical
   System Engineering (iMSE) in the GIST, Korea.
CR AIZAWA M, 1984, ANAL LETT PT B, V17, P555, DOI 10.1080/00032718408066489
   Bruno D. W., 1994, Aquaculture International, V2, P10, DOI 10.1007/BF00118529
   Byun HongJu, 2003, Journal of the Korean Society for Horticultural Science, V44, P859
   Choi I., 2009, J BIOENVIRON CONTROL, V18, P297
   FORZANI ES, 1995, J ELECTROANAL CHEM, V382, P33, DOI 10.1016/0022-0728(94)03640-O
   Kim HJ, 2008, SENSORS-BASEL, V8, P4110, DOI 10.3390/s8074110
   Kim Hyung-Il, 2003, Journal of the Korean Physical Society, V42, P336
   KULYS J, 1994, J ELECTROANAL CHEM, V372, P49, DOI 10.1016/0022-0728(93)03262-N
   KULYS J, 1993, ANAL CHIM ACTA, V274, P53, DOI 10.1016/0003-2670(93)80604-J
   Li JJ, 2010, MICROCHIM ACTA, V171, P125, DOI 10.1007/s00604-010-0383-4
   Luo FB, 2009, MICROCHIM ACTA, V165, P23, DOI 10.1007/s00604-008-0091-5
   Miyasaka T, 1998, J CHEM ENG JPN, V31, P29, DOI 10.1252/jcej.31.29
   Ozaki K, 2009, J PLANT PHYSIOL, V166, P569, DOI 10.1016/j.jplph.2008.08.007
   Rach JJ, 2000, J AQUAT ANIM HEALTH, V12, P267, DOI 10.1577/1548-8667(2000)012<0267:EOHPTC>2.0.CO;2
   Rameshkumar P, 2013, J APPL ELECTROCHEM, V43, P1005, DOI 10.1007/s10800-013-0589-3
   Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003
   Tan XC, 2009, SENSORS-BASEL, V9, P6185, DOI 10.3390/s90806185
   Tensha K., 2006, B YAMAGUCHI PREF FIS, V4, P167
   Tian L, 2012, MICROCHIM ACTA, V177, P39, DOI 10.1007/s00604-011-0746-5
   Uchida A, 2009, J AGR SCI, V64, P415
   Vanninen I, 1998, CROP PROT, V17, P547, DOI 10.1016/S0261-2194(98)00060-X
   Wang Q, 2009, MICROCHIM ACTA, V167, P153, DOI 10.1007/s00604-009-0236-1
   Wolfbeis OS, 2003, MICROCHIM ACTA, V143, P221, DOI 10.1007/s00604-003-0090-5
   Yan ZK, 2013, MICROCHIM ACTA, V180, P145, DOI 10.1007/s00604-012-0916-0
   Yang JC, 2008, JPN J APPL PHYS, V47, P6943, DOI 10.1143/JJAP.47.6943
   Zhang KY, 2010, MICROCHIM ACTA, V171, P139, DOI 10.1007/s00604-010-0409-y
   Zhang Y, 2011, BIOPROC BIOSYST ENG, V34, P215, DOI 10.1007/s00449-010-0463-1
   Zheng J., 2012, ADV OPTICAL MAT, V24, P194
NR 28
TC 0
Z9 1
U1 1
U2 6
PU SOC CHEMICAL ENG JAPAN
PI BUNKYO KU TOKYO
PA KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN
SN 0021-9592
J9 J CHEM ENG JPN
JI J. Chem. Eng. Jpn.
PD JUL
PY 2015
VL 48
IS 7
BP 575
EP 583
DI 10.1252/jcej.14we276
PG 9
WC Engineering, Chemical
SC Engineering
GA CP4EH
UT WOS:000359834300010
DA 2018-10-19
ER

PT J
AU Levin, BP
AF Levin, Barry P.
TI The Dual Function of a Dermal Allograft in Immediate Implant Therapy
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID BEAM COMPUTED-TOMOGRAPHY; ANTERIOR SINGLE IMPLANTS; FACIAL BONE WALL;
   BIOLOGIC WIDTH; AESTHETIC OUTCOMES; TITANIUM IMPLANTS; TISSUE STABILITY;
   PLACEMENT; DIMENSION; DOGS
AB Immediate implant placement often requires tissue augmentation simultaneously. Both hard and soft tissue grafting can improve long-term physiologic and esthetic outcomes. Bone replacement grafts are frequently combined with barrier membranes (guided bone regeneration [GBR]). When these materials are resorbable, they are often composed of collagen or synthetic polymers. These techniques do not address the need for soft tissue augmentation, and harvesting of autogenous soft tissue grafts is required. The use of a dermal allograft composed of natural, non-cross-linked collagen eliminates the need for the second surgical site to harvest autogenous soft tissue. This article demonstrates the dual functionality of a dermal allograft serving as both a GBR membrane and a biologically incorporated soft tissue biomaterial in immediate implant therapy.
C1 [Levin, Barry P.] Univ Penn, Dept Grad Periodontol & Implant Surg, Philadelphia, PA 19104 USA.
RP Levin, BP (reprint author), 509 York Rd, Jenkintown, PA 19046 USA.
EM aperiodoc@verizon.net
CR Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Braut V, 2011, INT J PERIODONT REST, V31, P125
   Caneva M, 2012, CLIN ORAL IMPLAN RES, V00, P1
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P891, DOI 10.1111/j.1600-0501.2010.01946.x
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P186
   Chen ST, 2009, J PERIODONTOL, V80, P163, DOI [10.1902/jop.2009.080243, 10.1902/jop.2009.080243 ]
   Cochran DL, 1997, J PERIODONTOL, V68, P186, DOI 10.1902/jop.1997.68.2.186
   Covani U, 2010, INT J PERIODONT REST, V30, P601
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   Fernandez-Botran R, 2002, TRANSPLANTATION, V74, P623, DOI 10.1097/00007890-200209150-00007
   GARGIULO AW, 1961, J PERIODONTOL, V32, P261, DOI 10.1902/jop.1961.32.3.261
   Grunder U, 2011, INT J PERIODONT REST, V31, P9
   Hermann JS, 2000, CLIN ORAL IMPLAN RES, V11, P1, DOI 10.1034/j.1600-0501.2000.011001001.x
   Huynh-Ba G, 2010, CLIN ORAL IMPLAN RES, V21, P37, DOI 10.1111/j.1600-0501.2009.01870.x
   Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x
   Kan JYK, 2011, INT J ORAL MAX IMPL, V26, P179
   Linkevicius T, 2010, J ORAL MAXIL SURG, V68, P2272, DOI 10.1016/j.joms.2009.08.018
   Martins MC, 2004, INT J ORAL MAX IMPL, V19, P839
   Nisapakultorn K, 2010, CLIN ORAL IMPLAN RES, V21, P662, DOI 10.1111/j.1600-0501.2009.01887.x
   Roe P, 2012, INT J ORAL MAX IMPL, V27, P393
   Romanos GE, 2010, J PERIODONTOL, V81, P70, DOI 10.1902/jop.2009.090364
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Spray J R, 2000, Ann Periodontol, V5, P119, DOI 10.1902/annals.2000.5.1.119
   Vervaeke S, 2014, CLIN IMPLANT DENT R, V16, P1
   Wennstrom JL, 2012, CLIN ORAL IMPLAN RES, V23, P136, DOI 10.1111/j.1600-0501.2012.02540.x
NR 27
TC 0
Z9 0
U1 0
U2 1
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JUL-AUG
PY 2015
VL 35
IS 4
BP 507
EP 513
DI 10.11607/prd.2095
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CN5IE
UT WOS:000358462200008
PM 26133140
OA Bronze
DA 2018-10-19
ER

PT J
AU Ntounis, A
   Pitman, LM
   Pollini, A
   Vidal, R
   Lin, WS
   Madigan, MP
   Greenwell, H
AF Ntounis, Athanasios
   Pitman, Lillie M.
   Pollini, Adrien
   Vidal, Ricardo
   Lin, Wei-Shao
   Madigan, Michael P.
   Greenwell, Henry
TI The ABC Protocol in the Esthetic Zone: A Comprehensive Surgical and
   Prosthetic Approach
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID SOFT-TISSUE AUGMENTATION; SINGLE TOOTH EXTRACTION; IMPLANT PLACEMENT;
   SINUS AUGMENTATION; FOLLOW-UP; BONE; STABILITY; ABUTMENT; CONTOUR
AB The purpose of this article is to present a surgical and restorative protocol for the replacement of missing teeth in the esthetic zone. The ABC protocol consists of digitally guided implantation, autogenous bone graft (A), followed by bovine bone xenograft (B) and connective tissue graft (C). Autogenous bone is placed in contact with the implant surface to induce osseointegration; bovine bone xenograft is then applied to augment the ridge dimension and provide long-term stability. Connective tissue is used to provide additional volume. The ABC biomaterial sequence offers favorable hard and soft tissue dimensions and immediate provisional restoration predictably leads to an esthetically pleasing definitive prosthesis.
C1 [Ntounis, Athanasios; Pollini, Adrien; Vidal, Ricardo; Lin, Wei-Shao; Greenwell, Henry] Univ Louisville, Sch Dent, Dept Oral Hlth & Rehabil, Louisville, KY 40202 USA.
RP Ntounis, A (reprint author), Univ Louisville, Sch Dent, Dept Oral Hlth & Rehabil, 501 South Preston,Room 312, Louisville, KY 40202 USA.
EM perio.ntounis@louisville.edu
CR Arte S, 2001, J DENT RES, V80, P1445, DOI 10.1177/00220345010800051201
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Buser D, 2013, J PERIODONTOL, V84, P1517, DOI 10.1902/jop.2013.120635
   Buser D, 2011, J PERIODONTOL, V82, P342, DOI 10.1902/jop.2010.100408
   Covani U, 2011, CLIN ORAL IMPLAN RES, V22, P820, DOI 10.1111/j.1600-0501.2010.02060.x
   Degidi M, 2013, INT J PERIODONT REST, V33, P559, DOI 10.11607/prd.1795
   Fu JH, 2014, CLIN ORAL IMPLAN RES, V25, P458, DOI 10.1111/clr.12171
   Grunder U, 2011, INT J PERIODONT REST, V31, P9
   Hultin M, 2012, CLIN ORAL IMPLAN RES, V23, P124, DOI 10.1111/j.1600-0501.2012.02545.x
   Jemt T, 1999, Int J Periodontics Restorative Dent, V19, P20
   Jung RE, 2007, INT J PERIODONT REST, V27, P251
   Linkevicius T., 2013, CLIN IMPLANT DENT RE
   Ntounis A, 2012, CLIN ADV PERIODONTIC, V2, P200, DOI 10.1902/cap.2012.110093
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schneider D, 2011, CLIN ORAL IMPLAN RES, V22, P28, DOI 10.1111/j.1600-0501.2010.01987.x
   SEIBERT JS, 1987, DENT CLIN N AM, V31, P529
   Su HA, 2010, INT J PERIODONT REST, V30, P335
   Vastardis H, 2000, AM J ORTHOD DENTOFAC, V117, P650, DOI 10.1016/S0889-5406(00)70173-9
NR 19
TC 0
Z9 0
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JUL-AUG
PY 2015
VL 35
IS 4
BP 561
EP 569
DI 10.11607/prd.2170
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CN5IE
UT WOS:000358462200014
PM 26133146
OA Bronze
DA 2018-10-19
ER

PT J
AU Kulkarni, M
   Mrak-Poljsak, K
   Flasker, A
   Mazare, A
   Schmuki, P
   Kos, A
   Cucnik, S
   Sodin-Semrl, S
   Iglic, A
AF Kulkarni, Mukta
   Mrak-Poljsak, Katjusa
   Flasker, Ajda
   Mazare, Anca
   Schmuki, Patrik
   Kos, Andrej
   Cucnik, Sasa
   Sodin-Semrl, Snezna
   Iglic, Ales
TI FABRICATION OF TiO2 NANOTUBES FOR BIOAPPLICATIONS
SO MATERIALI IN TEHNOLOGIJE
LA English
DT Article
DE TiO2; nanotubes; electrochemical anodization; protein binding
ID TITANIUM; SURFACE; OSTEOBLASTS; ADHESION; ALLOYS; LAYERS
AB Titanium (Ti), due its most promising biomaterial properties, can be used in the medical devices that interact with the body tissue, specifically to evaluate, treat, augment or replace any tissue, organ or function of the body. In the present work, we prepared titanium dioxide (TiO2) nanotubes with different diameters in the same electrolyte by tailoring different parameters of electrochemical anodization. These structures have more nanorough regions and more surface area that can promote protein binding and cell adhesion in order to increase the lifetime of implants and other medical devices. As an example, we showed the differences in the protein binding of human acute-phase serum amyloid A (SAA) to the TiO2 nanotubes of different diameters, specifically of 50 nm and 15 nm, as well as comparing it with the binding to the foil alone. We found that SAA binds most prevalently to the nanotubes 50 nm, as opposed to the nanotubes 15 nm or the foil.
C1 [Kulkarni, Mukta; Flasker, Ajda; Kos, Andrej; Iglic, Ales] Univ Ljubljana, Fac Elect Engn, Ljubljana 1000, Slovenia.
   [Mrak-Poljsak, Katjusa; Cucnik, Sasa; Sodin-Semrl, Snezna] Univ Med Ctr, Dept Rheumatol, Ljubljana, Slovenia.
   [Mazare, Anca; Schmuki, Patrik] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, D-91054 Erlangen, Germany.
   [Cucnik, Sasa; Sodin-Semrl, Snezna] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.
   [Sodin-Semrl, Snezna] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.
RP Kulkarni, M (reprint author), Univ Ljubljana, Fac Elect Engn, Trzaska Cesta 25, Ljubljana 1000, Slovenia.
EM mukta.kulkarni@fe.uni-lj.si
OI Mazare, Anca/0000-0002-4836-946X
CR Awitor KO, 2008, J PHOTOCH PHOTOBIO A, V199, P250, DOI 10.1016/j.jphotochem.2008.05.023
   Bakir M, 2012, J BIOMATER APPL, V27, P3, DOI 10.1177/0885328212439615
   Bauer S., 2010, EUROP CELLS MAT, V20, P16
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   D F, 2009, BIOMATERIALS, V30, P5897, DOI DOI 10.1016/J.BIOMATERIALS.2009.07.027
   D F, 2008, BIOMATERIALS, V20, P2941, DOI DOI 10.1016/J.BIOMATERIALS.2008.04.023
   Dale GR, 2009, J NANOSCI NANOTECHNO, V9, P4215, DOI 10.1166/jnn.2009.M35
   Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607
   Gongadze E, 2013, MINI-REV MED CHEM, V13, P194
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   Kowalski D, 2013, NANO TODAY, V8, P235, DOI 10.1016/j.nantod.2013.04.010
   Lakota K, 2010, RECENT PATENTS ENDOC, V4, P89, DOI DOI 10.4155/PPA.12.26
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Macak JM, 2007, SMALL, V3, P300, DOI 10.1002/smll.200600426
   Mihov D, 2010, TRAKIA J SCI, V8, P119
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Ross AP, 2013, INT J NANOMED, V8, P109, DOI 10.2147/IJN.S36203
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Sasaki K, 2006, ANN ANAT, V188, P137, DOI 10.1016/j.aanat.2005.10.003
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
NR 21
TC 0
Z9 0
U1 1
U2 14
PU INST ZA KOVINSKE MATERIALE I IN TEHNOLOGIE
PI LJUBJANA
PA LEPI POT 11, LJUBJANA, 10000, SLOVENIA
SN 1580-2949
EI 1580-3414
J9 MATER TEHNOL
JI Mater. Tehnol.
PD JUL-AUG
PY 2015
VL 49
IS 4
BP 635
EP 637
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA CN6RB
UT WOS:000358560800026
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Tay, CY
   Wu, YL
   Cai, PQ
   Tan, NS
   Venkatraman, SS
   Chen, XD
   Tan, LP
AF Tay, Chor Yong
   Wu, Yun-Long
   Cai, Pingqiang
   Tan, Nguan Soon
   Venkatraman, Subbu S.
   Chen, Xiaodong
   Tan, Lay Poh
TI Bio-inspired micropatterned hydrogel to direct and deconstruct
   hierarchical processing of geometry-force signals by human mesenchymal
   stem cells during smooth muscle cell differentiation
SO NPG ASIA MATERIALS
LA English
DT Article
ID GROWTH-FACTOR-BETA; STRESS FIBERS; ADIPOSE-TISSUE; ACTIN; TENSION;
   EXPRESSION; MATRIX; SHAPE; FATE; MIGRATION
AB Micropatterned biomaterial-based hydrogel platforms allow the recapitulation of in vivo-like microstructural and biochemical features that are critical physiological regulators of stem cell development. Herein, we report the use of muscle mimicking geometries patterned on polyacrylamide hydrogels as an effective strategy to induce smooth muscle cell (SMC) differentiation of human mesenchymal stem cells (hMSCs). hMSCs were systemically coerced to elongate with varying aspect ratios (AR) (that is, 1:1, 5:1, 10:1 and 15:1) at a fixed projection area of similar to 7000 mu m(2). The results showed engineered cellular anisotropy with an intermediate AR 5: 1 and AR 10: 1, promoting the expression of alpha smooth muscle actin (alpha-SMA) and enhancement of contractile output. Further mechanistic studies indicated that a threshold cell traction force of similar to 3.5 mu N was required for SMC differentiation. Beyond the critical cytoskeleton tension, hMSCs respond to higher intracellular architectural cues such as the stress fiber (SF) alignment, SF subtype expression and diphosphorylated myosin regulatory light-chain activity to promote the expression and incorporation of a-SMA to the SF scaffold. These findings underscore the importance of exploiting biomimetic geometrical cues as an effective strategy to guide hMSC differentiation and are expected to guide the rational design of advanced tissue-engineered vascular grafts.
C1 [Tay, Chor Yong] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117585, Singapore.
   [Wu, Yun-Long] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China.
   [Cai, Pingqiang; Venkatraman, Subbu S.; Chen, Xiaodong; Tan, Lay Poh] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.
   [Tan, Nguan Soon] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore.
RP Tay, CY (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117585, Singapore.
EM chetcy@nus.edu.sg; lptan@ntu.edu.sg
RI ASTAR, IMCB/E-2320-2012; Chen, Xiaodong/A-4537-2009; Tan,
   LP/A-2229-2011; Venkatraman, Subramanian/A-2228-2011; Tay, Chor
   Yong/C-1999-2016
OI Chen, Xiaodong/0000-0002-3312-1664; Tan, LP/0000-0002-0172-1569;
   Venkatraman, Subramanian/0000-0002-8693-1070; Wu,
   Yun-Long/0000-0001-6426-6340; Tan, Nguan Soon/0000-0003-0136-7341
FU Ministry of Education Academic Research [R-279-000-376-112]; Nanyang
   Technological University Tier 1 grant [RGT24/13]; Lee Kuan Yew
   Postdoctoral Fellowship
FX The authors gratefully acknowledge financial support from the Ministry
   of Education Academic Research Grants (R-279-000-376-112 to CYT) and
   Nanyang Technological University Tier 1 grant (RGT24/13). CYT thankfully
   acknowledges support from the Lee Kuan Yew Postdoctoral Fellowship.
CR Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81
   Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Harris LJ, 2011, J SURG RES, V168, P306, DOI 10.1016/j.jss.2009.08.001
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319
   Lam CRI, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.339
   Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978
   Leong David Tai, 2008, Curr Drug Discov Technol, V5, P319, DOI 10.2174/157016308786733537
   Leong DT, 2006, CELLS TISSUES ORGANS, V182, P1, DOI 10.1159/000091713
   Leong WS, 2012, J TISSUE ENG REGEN M, V6, ps68, DOI 10.1002/term.1548
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mizutani T, 2006, J CELL PHYSIOL, V209, P726, DOI 10.1002/jcp.20773
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   ROMAN J, 1992, AM J RESP CELL MOL, V6, P472, DOI 10.1165/ajrcmb/6.5.472
   Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445
   Tay CY, 2014, NANO LETT, V14, P83, DOI 10.1021/nl4032549
   Tay CY, 2013, NANOMEDICINE-UK, V8, P623, DOI [10.2217/NNM.13.31, 10.2217/nnm.13.31]
   Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001
   Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786
   Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.TEA.2011.0172, 10.1089/ten.tea.2011.0172]
   Yang Y, 1999, DEVELOPMENT, V126, P3027
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103
NR 38
TC 19
Z9 19
U1 10
U2 45
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1884-4049
EI 1884-4057
J9 NPG ASIA MATER
JI NPG Asia Mater.
PD JUL
PY 2015
VL 7
AR e199
DI 10.1038/am.2015.66
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA CN9PS
UT WOS:000358781900004
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Coburn, JM
   Kaplan, DL
AF Coburn, Jeannine M.
   Kaplan, David L.
TI Engineering Biomaterial-Drug Conjugates for Local and Sustained
   Chemotherapeutic Delivery
SO BIOCONJUGATE CHEMISTRY
LA English
DT Review
ID PERCUTANEOUS ETHANOL INJECTION; ENHANCED ANTITUMOR EFFICACY; SOLID LIPID
   NANOPARTICLES; BREAST-CANCER CELLS; IN-VIVO; HEPATOCELLULAR-CARCINOMA;
   TRANSARTERIAL CHEMOEMBOLIZATION; COMBINATION CHEMOTHERAPY;
   MULTIDRUG-RESISTANCE; LAPONITE NANODISKS
AB The standard of care for cancer patients includes surgical resection, radiation, and chemotherapy with cytotoxic chemotherapy drugs usually part of the treatment. However, these drugs are commonly associated with cardiotoxicity, ototoxicity, nephrotoxicity, peripheral neuropathy, and myelosuppression. Strategies to deliver cytotoxic chemotherapy drugs while reducing secondary toxicity and increasing tumor dosing would therefore be desirable. This goal can be achieved through the use of controlled release drug carrier systems. The aim of this review is to provide an overview of clinically used drug carrier systems and recently developed approaches for drug biomaterial conjugation.
C1 [Coburn, Jeannine M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Coburn, Jeannine M./0000-0001-6354-5436
FU NIH [P41 EB002520]
FX We thank the NIH (P41 EB002520) for support of various aspects of this
   work.
CR Aboutaleb E, 2014, J BIOMED MATER RES A, V102, P2125, DOI 10.1002/jbm.a.34890
   Albert M, 2011, CANCER-AM CANCER SOC, V117, P343, DOI 10.1002/cncr.25387
   Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745
   Aryal S, 2009, ACS NANO, V4, P251, DOI DOI 10.1021/NN9014032
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Berghammer P, 1998, CARDIOVASC INTER RAD, V21, P214, DOI 10.1007/s002709900247
   Boyette-Davis JA, 2013, CANCER CHEMOTH PHARM, V71, P619, DOI 10.1007/s00280-012-2047-z
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Chitkara D, 2013, BIOCONJUGATE CHEM, V24, P1161, DOI 10.1021/bc400032x
   Chiu B, 2014, BRIT J CANCER, V111, P708, DOI 10.1038/bjc.2014.324
   CSERHATI T, 1994, INT J PHARM, V108, P69, DOI 10.1016/0378-5173(94)90417-0
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025
   Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036
   DEUTSCH JC, 1989, ARCH BIOCHEM BIOPHYS, V274, P327, DOI 10.1016/0003-9861(89)90446-3
   DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611
   Dinarvand R., 2012, P WORLD ACAD SCI ENG, V6, P611
   Dong L, 2010, BIOMATERIALS, V31, P6309, DOI 10.1016/j.biomaterials.2010.04.049
   El-Dakdouki MH, 2014, ACS APPL MATER INTER, V6, P697, DOI 10.1021/am404946v
   El-Dakdouki MH, 2012, BIOMACROMOLECULES, V13, P1144, DOI 10.1021/bm300046h
   Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093
   Feng Z, 2010, CANCER SCI, V101, P2476, DOI 10.1111/j.1349-7006.2010.01708.x
   Gale R., 1984, EXP HEMATOL, V13, P3
   Goncalves M, 2014, ACTA BIOMATER, V10, P300, DOI 10.1016/j.actbio.2013.09.013
   Gooch JL, 1998, CANCER RES, V58, P4199
   Goszcz-yfiski T. M., 2014, PHARM RES PERSPECT, V2
   Hanigan Marie H, 2003, Cancer Ther, V1, P47
   Haxton KJ, 2008, DALTON T, P5872, DOI 10.1039/b809949a
   Haxton KJ, 2009, J PHARM SCI-US, V98, P2299, DOI 10.1002/jps.21611
   Hellmers F, 2013, BIOCHEM ENG J, V75, P72, DOI 10.1016/j.bej.2013.03.019
   Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI [10.1111/j.1582-4934.2007.00189.x, 10.1111/j.1582-4934.2008.00189.x]
   Huynh NT, 2009, INT J PHARMACEUT, V379, P201, DOI 10.1016/j.ijpharm.2009.04.026
   Jager E, 2013, J CONTROL RELEASE, V165, P153, DOI 10.1016/j.jconrel.2012.11.009
   Janknegt R, 1996, SUPPORT CARE CANCER, V4, P298, DOI 10.1007/BF01358884
   John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002
   Kaminskas LM, 2012, MOL PHARMACEUT, V9, P422, DOI 10.1021/mp200522d
   Kaminskas LM, 2012, NANOMED-NANOTECHNOL, V8, P103, DOI 10.1016/j.nano.2011.05.013
   Kaminskas LM, 2011, J CONTROL RELEASE, V152, P241, DOI 10.1016/j.jconrel.2011.02.005
   Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712
   Khdair A, 2010, J CONTROL RELEASE, V141, P137, DOI 10.1016/j.jconrel.2009.09.004
   Khdair A, 2009, EUR J PHARM BIOPHARM, V71, P214, DOI 10.1016/j.ejpb.2008.08.017
   Kim GO, 2012, MOLECULES, V17, P13704, DOI 10.3390/molecules171213704
   Kim H, 2014, MACROMOL RES, V22, P805, DOI 10.1007/s13233-014-2118-6
   Kintzel PE, 2001, ANN PHARMACOTHER, V35, P1114
   Kirchhoff T, 1998, EUR J GASTROEN HEPAT, V10, P907, DOI 10.1097/00042737-199811000-00001
   Kirikoshi H, 2009, HEPATOL RES, V39, P553, DOI 10.1111/j.1872-034X.2009.00490.x
   Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7
   Laurent A, 2007, TECH VASC INTERV RAD, V10, P248, DOI 10.1053/j.tvir.2008.03.010
   Lee CC, 2006, BIOCONJUGATE CHEM, V17, P1364, DOI 10.1021/bc060117y
   Lee E, 2008, J MED CHEM, V51, P6442, DOI 10.1021/jm800767c
   Lencioni R, 2012, CARDIOVASC INTER RAD, V35, P980, DOI 10.1007/s00270-011-0287-7
   Li K, 2014, ACS APPL MATER INTER, V6, P12328, DOI 10.1021/am502094a
   Li S.-D., 2009, MOL PHARM, V7, P280
   Ling GX, 2010, J CONTROL RELEASE, V148, P241, DOI 10.1016/j.jconrel.2010.08.010
   Luo F., 2014, NANOSCALE RES LETT, V9, P1
   Flores ML, 2012, BREAST CANCER RES TR, V133, P917, DOI 10.1007/s10549-011-1864-9
   Ma P, 2009, J BIOMED NANOTECHNOL, V5, P151, DOI 10.1166/jbn.2009.1021
   Maciel D, 2013, BIOMACROMOLECULES, V14, P3140, DOI 10.1021/bm400768m
   MACKA M, 1991, J CHROMATOGR, V586, P291, DOI 10.1016/0021-9673(91)85135-3
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   Malagari K, 2014, CARDIOVASC INTER RAD, V37, P165, DOI 10.1007/s00270-013-0777-x
   Manju S, 2011, J COLLOID INTERF SCI, V359, P318, DOI 10.1016/j.jcis.2011.03.071
   Manocha B, 2010, J NANOMATER, DOI 10.1155/2010/780171
   Miele E, 2009, INT J NANOMED, V4, P99
   Mirakabad FST, 2014, ASIAN PAC J CANCER P, V15, P517, DOI 10.7314/APJCP.2014.15.2.517
   MORSTYN G, 1984, J NATL CANCER I, V73, P801
   Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759
   Namgung R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4702
   OBIRI NI, 1994, CLIN EXP IMMUNOL, V95, P148
   Paraskar AS, 2010, P NATL ACAD SCI USA, V107, P12435, DOI 10.1073/pnas.1007026107
   Perez-Arnaiz C, 2014, J PHYS CHEM B, V118, P1288, DOI 10.1021/jp411429g
   RIZZO V, 1989, BIOCHEMISTRY-US, V28, P274, DOI 10.1021/bi00427a038
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda
   Sampath, 1998, Cancer Control, V5, P130
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Seib FP, 2013, ADV FUNCT MATER, V23, P58, DOI 10.1002/adfm.201201238
   Seib FP, 2012, BIOMATERIALS, V33, P8442, DOI 10.1016/j.biomaterials.2012.08.004
   Sengupta P, 2012, P NATL ACAD SCI USA, V109, P11294, DOI 10.1073/pnas.1203129109
   Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794
   Silverman JA, 2013, CANCER CHEMOTH PHARM, V71, P555, DOI 10.1007/s00280-012-2042-4
   Strickley RG, 2004, PHARM RES, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23
   Sui BW, 2014, MOLECULES, V19, P11915, DOI 10.3390/molecules190811915
   TADAVARTHY SM, 1975, AM J ROENTGENOL, V125, P609, DOI 10.2214/ajr.125.3.609
   Tauro JR, 2005, BIOCONJUGATE CHEM, V16, P1133, DOI 10.1021/bc0501303
   Tiwari G, 2010, J PHARM BIOALLIED SC, V2, P72, DOI 10.4103/0975-7406.67003
   TOI M, 1992, CANCER RES, V52, P275
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Upadhyay KK, 2010, BIOMATERIALS, V31, P2882, DOI 10.1016/j.biomaterials.2009.12.043
   Van Ha Thuong G, 2009, Semin Intervent Radiol, V26, P270, DOI 10.1055/s-0029-1225672
   Vogel SM, 2001, AM J PHYSIOL-LUNG C, V281, pL1512
   Wang F, 2011, ACS NANO, V5, P3679, DOI 10.1021/nn200007z
   Wang SG, 2013, LANGMUIR, V29, P5030, DOI 10.1021/la4001363
   Wei X, 2013, BIOCONJUGATE CHEM, V24, P658, DOI 10.1021/bc300632w
   Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283
   Yan XD, 2005, J LIPOSOME RES, V15, P109, DOI 10.1081/LPR-200064971
   Ye HF, 2006, BIOMATERIALS, V27, P5958, DOI 10.1016/j.biomaterials.2006.08.016
   Yousefpour P, 2011, INT J NANOMED, V6, P1487, DOI 10.2147/IJN.S18535
   Zhang P, 2012, NANOMED-NANOTECHNOL, V8, P185, DOI 10.1016/j.nano.2011.06.007
   Zhang T, 2013, INT J NANOMED, V8, P1185, DOI 10.2147/IJN.S41775
   Zhu Q, 2014, MOL PHARMACEUT, V11, P3269, DOI 10.1021/mp4007776
NR 104
TC 12
Z9 12
U1 4
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1212
EP 1223
DI 10.1021/acs.bioconjchem.5b00046
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500007
PM 25689115
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ryan, CNM
   Sorushanova, A
   Lomas, AJ
   Mullen, AM
   Pandit, A
   Zeugolis, DI
AF Ryan, Christina N. M.
   Sorushanova, Anna
   Lomas, Alex J.
   Mullen, Anne Maria
   Pandit, Abhay
   Zeugolis, Dimitrios I.
TI Glycosaminoglycans in Tendon Physiology, Pathophysiology, and Therapy
SO BIOCONJUGATE CHEMISTRY
LA English
DT Review
ID COLLAGEN-GAG SCAFFOLDS; MESENCHYMAL STEM-CELLS; THERMORESPONSIVE
   HYALURONAN HYDROGELS; THERMALLY RESPONSIVE POLYMERS; HEPARAN-SULFATE
   PROTEOGLYCANS; DIGITAL FLEXOR TENDON; ROTATOR CUFF TENDONS; MODEL
   IN-VITRO; CHONDROITIN SULFATE; EXTRACELLULAR-MATRIX
AB Although glycosaminoglycans constitute a minor portion of native tissues, they play a crucial role in various physiological processes, while their abnormal expression is associated with numerous pathophysiologies. Glycosaminoglycans have become increasingly prevalent in biomaterial design for tendon repair, given their low immunogenicity and their inherent capacity to stimulate the regenerative processes, while maintaining resident cell phenotype and function. Further, their incorporation into three-dimensional scaffold conformations significantly improves their mechanical properties, while reducing the formation of peritendinous adhesions. Herein, we discuss the role of glycosaminoglycans in tendon physiology and pathophysiology and the advancements achieved to date using glycosaminoglycan-functionalized scaffolds for tendon repair and regeneration. It is evidenced that glycosaminoglycan functionalization has led to many improvements in tendon tissue engineering and it is anticipated to play a pivotal role in future reparative therapies.
C1 [Ryan, Christina N. M.; Sorushanova, Anna; Lomas, Alex J.; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway NUI Galway, Regenerat Modular & Dev Engn Lab REMODEL, Galway, Ireland.
   [Ryan, Christina N. M.; Sorushanova, Anna; Lomas, Alex J.; Pandit, Abhay; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway NUI Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Ryan, Christina N. M.; Sorushanova, Anna; Lomas, Alex J.; Pandit, Abhay; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway NUI Galway, Ctr Res Med Devices CURAM, Galway, Ireland.
   [Mullen, Anne Maria] Teagasc Food Res Ctr, Ashtown, Ireland.
RP Zeugolis, DI (reprint author), Natl Univ Ireland Galway NUI Galway, Regenerat Modular & Dev Engn Lab REMODEL, Biosci Res Bldg, Galway, Ireland.
EM dimitrios.zeugolis@nuigalway.ie
RI Mullen, Anne M/E-5779-2016; Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; zeugolis,
   dimitrios/0000-0002-7599-5191
FU EU [251385, 263289]; Health Research Board [HRA_POR/2011/84]; Teagasc
   Walsh Fellowship [2014045]; ReValueProtein Research Project [11/F/043];
   Department of Agriculture, Food and the Marine (DAFM) under the National
   Development Plan - Irish Government
FX The authors would like to thank Maciek Doczyk for the preparation of
   Figure 2. This work is supported by the: EU FP7/2007-2013, Marie Curie,
   IAPP award, part of the People programme, Tendon Regeneration Project
   (Grant Agreement Number: 251385) to D.Z.; EU FP7/2007-2013, NMP award,
   Green Nano Mesh Project (Grant Agreement Number: 263289) to D.Z.; Health
   Research Board, Health Research Awards Programme, under the grant
   agreement number HRA_POR/2011/84 to D.Z. This work forms part of the
   Teagasc Walsh Fellowship (Grant Award No: ref 2014045) and the
   ReValueProtein Research Project (Grant Award No. 11/F/043) supported by
   the Department of Agriculture, Food and the Marine (DAFM) under the
   National Development Plan2007-2013 funded by the Irish Government to
   A.M.M. and D.Z. We thank NW Tex Net for hosting CNMR and Vornia
   Biomaterials for hosting D.Z.
CR Abate M, 2014, BIOMED RES INT, DOI 10.1155/2014/783632
   Abbah SA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt426
   Ahmadzadeh H, 2013, J BIOMECH, V46, P2497, DOI 10.1016/j.jbiomech.2013.07.008
   Akasaka T, 2006, CLIN BIOMECH, V21, P810, DOI 10.1016/j.clinbiomech.2006.04.007
   AMADIO PC, 1988, J HAND SURG-AM, V13A, P559, DOI 10.1016/S0363-5023(88)80095-9
   AMIEL D, 1989, J HAND SURG-AM, V14A, P837, DOI 10.1016/S0363-5023(89)80085-1
   ANDERSON JC, 1972, BIOCHEM J, V127, P179, DOI 10.1042/bj1270179
   Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1
   Angulo J, 2005, GLYCOBIOLOGY, V15, P1008, DOI 10.1093/glycob/cwi091
   Attia M, 2014, BRIT J SPORT MED, V48, P469, DOI 10.1136/bjsports-2013-092633
   Attia M, 2012, J ORTHOP RES, V30, P61, DOI 10.1002/jor.21479
   Baeurle SA, 2009, POLYMER, V50, P1805, DOI 10.1016/j.polymer.2009.01.066
   BALAZS EA, 1986, BIOCHEM J, V235, P903, DOI 10.1042/bj2350903
   Barbosa I, 2005, J CELL SCI, V118, P253, DOI 10.1242/jcs.01607
   Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082
   Barritault D., 2006, Annales Pharmaceutiques Francaises, V64, P135
   Baymurat AC, 2015, J BIOMED MATER RES A, V103, P84, DOI 10.1002/jbm.a.35151
   Berenson MC, 1996, J ORTHOP RES, V14, P518, DOI 10.1002/jor.1100140404
   Bhavsar D, 2010, J SURG RES, V159, P765, DOI 10.1016/j.jss.2009.10.010
   Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x
   Blanquaert F, 1995, BONE, V17, P499, DOI 10.1016/8756-3282(95)00402-5
   Bonnaffe D, 2011, CR CHIM, V14, P59, DOI 10.1016/j.crci.2010.06.002
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Buchanan CI, 2001, J APPL PHYSIOL, V90, P164
   BURD DAR, 1991, BRIT J PLAST SURG, V44, P579, DOI 10.1016/0007-1226(91)90093-Y
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   BURG MA, 1994, J NEUROBIOL, V25, P1, DOI 10.1002/neu.480250102
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277
   Chaubet F, 1999, POLYM INT, V48, P313, DOI 10.1002/(SICI)1097-0126(199904)48:4<313::AID-PI151>3.0.CO;2-H
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436
   Chen SH, 2014, INT J NANOMED, V9, P4079, DOI 10.2147/IJN.S67931
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Chevalier F, 2014, STEM CELL RES, V12, P703, DOI 10.1016/j.scr.2014.03.001
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chou WY, 2010, J SHOULDER ELB SURG, V19, P557, DOI 10.1016/j.jse.2009.08.006
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Comerford EJ, 2004, AM J VET RES, V65, P1136, DOI 10.2460/ajvr.2004.65.1136
   Costantino Cosimo, 2009, Acta Biomed, V80, P225
   CRIBB AM, 1995, J ANAT, V187, P423
   CURWIN SL, 1988, J APPL PHYSIOL, V65, P2297
   D'Este M, 2012, CARBOHYD POLYM, V90, P1378, DOI 10.1016/j.carbpol.2012.07.007
   DANIELSEN CC, 1981, MECH AGEING DEV, V15, P269, DOI 10.1016/0047-6374(81)90135-4
   de Wit T, 2009, J ORTHOP RES, V27, P408, DOI 10.1002/jor.20730
   Desgranges P, 1999, FASEB J, V13, P761
   Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764
   Dvash R, 2013, J CONTROL RELEASE, V170, P295, DOI 10.1016/j.jconrel.2013.05.042
   EGG D, 1983, PHARMACOL RES COMMUN, V15, P709
   ELLIOTT DH, 1965, BIOL REV, V40, P392, DOI 10.1111/j.1469-185X.1965.tb00808.x
   Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Ericsson YB, 2009, OSTEOARTHR CARTILAGE, V17, P565, DOI 10.1016/j.joca.2008.10.009
   Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011
   Fakhari A, 2013, ACTA BIOMATER, V9, P7081, DOI 10.1016/j.actbio.2013.03.005
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Feitosa Vera Lucia Correa, 2005, Brazilian Journal of Morphological Sciences, V22, P113
   Fessel G, 2011, J THEOR BIOL, V268, P77, DOI 10.1016/j.jtbi.2010.10.007
   Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002
   Foldager CB, 2012, INT ORTHOP, V36, P1507, DOI 10.1007/s00264-011-1479-0
   Franchi M, 2010, THESCIENTIFICWORLDJO, V10, P1932, DOI [10.1100/tsw.2010.192, 1100/tsw.2010.192]
   Frazier Sarah B, 2008, Open Glycosci, V1, P31, DOI 10.2174/1875398100801010031
   Frescaline G, 2013, TISSUE ENG PT A, V19, P1641, DOI [10.1089/ten.tea.2012.0377, 10.1089/ten.TEA.2012.0377]
   Frescaline G, 2012, STEM CELL RES, V8, P180, DOI 10.1016/j.scr.2011.09.005
   Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f
   Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951
   FUNDERBURGH JL, 1987, J BIOL CHEM, V262, P11634
   Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Garcia-Filipe S, 2007, J BIOMED MATER RES A, V80A, P75, DOI 10.1002/jbm.a.30874
   Gaspar D, 2015, ADV DRUG DELIVER REV, V84, P240, DOI 10.1016/j.addr.2014.11.023
   GILLARD GC, 1977, BIOCHEM J, V163, P145, DOI 10.1042/bj1630145
   Gudemez E, 2002, J HAND SURG-AM, V27A, P293, DOI 10.1053/jhsu.2002.31161
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Ha DI, 2006, MACROMOL RES, V14, P87, DOI 10.1007/BF03219073
   HAGBERG L, 1992, J HAND SURG-BRIT EUR, V17B, P167, DOI 10.1016/0266-7681(92)90081-C
   HAMM D, 1984, VET MED SM ANIM CLIN, V79, P811
   HARDINGHAM TE, 1992, FASEB J, V6, P861
   Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013
   HOOK M, 1984, ANNU REV BIOCHEM, V53, P847
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hu S, 2009, PROTEOM CLIN APPL, V3, P148, DOI 10.1002/prca.200800153
   Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Ikeda Y, 2011, BIOMATERIALS, V32, P769, DOI 10.1016/j.biomaterials.2010.09.043
   Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019
   Ishikawa M, 2014, OSTEOARTHR CARTILAGE, V22, P1902, DOI 10.1016/j.joca.2014.08.002
   Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540290114478
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JARVINEN M, 1991, EXP MOL PATHOL, V55, P230, DOI 10.1016/0014-4800(91)90003-G
   Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Kang HJ, 2015, CELL TISSUE BANK, V16, P123, DOI 10.1007/s10561-014-9448-7
   Kappler J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3514639
   KATO Y, 1995, J RHEUMATOL, V22, P158
   Katrana F, 2008, J HAND SURG-EUR VOL, V33E, P800, DOI 10.1177/1753193408096021
   Katta J, 2009, OSTEOARTHR CARTILAGE, V17, P1001, DOI 10.1016/j.joca.2009.02.010
   Kershaw-Young CM, 2009, THERIOGENOLOGY, V72, P251, DOI 10.1016/j.theriogenology.2009.02.018
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kinneberg KRC, 2010, J ORTHOP RES, V28, P1092, DOI 10.1002/jor.21095
   KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303
   Kobayashi A, 1999, J COMP PATHOL, V120, P403, DOI 10.1053/jcpa.1998.0288
   Konig U, 2014, J MATER SCI-MATER M, V25, P607, DOI 10.1007/s10856-013-5098-8
   Kolodzinskyi MN, 2013, J HAND SURG-AM, V38A, P231, DOI 10.1016/j.jhsa.2012.11.012
   Kremer M, 2001, LANGENBECK ARCH SURG, V386, P357, DOI 10.1007/s004230100227
   Kumai T, 2014, J ORTHOP SCI, V19, P603, DOI 10.1007/s00776-014-0579-2
   Kumar P., 2015, TISSUE ENG C
   Kumar P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08729
   Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002
   KVIST M, 1987, PATHOLOGY, V19, P1
   Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004
   Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007
   LAM R, 1978, BIOPHYS J, V24, P613, DOI 10.1016/S0006-3495(78)85408-3
   Li Z, 2014, REGEN MED, V9, P309, DOI [10.2217/RME.14.5, 10.2217/rme.14.5]
   Liang JI, 2014, J MATER SCI-MATER M, V25, P217, DOI 10.1007/s10856-013-5036-9
   Liao J, 2007, J BIOMECH, V40, P390, DOI 10.1016/j.jbiomech.2005.12.011
   LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551
   LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8
   Lippiello L, 2007, EVID-BASED COMPL ALT, V4, P219, DOI 10.1093/ecam/nel081
   Liu S, 2012, BIOMACROMOLECULES, V13, P3611, DOI 10.1021/bm301022p
   Liu YC, 2008, J ORTHOP RES, V26, P562, DOI 10.1002/jor.20499
   Loebel C, 2015, CARBOHYD POLYM, V115, P325, DOI 10.1016/j.carbpol.2014.08.097
   Lomas AJ, 2015, ADV DRUG DELIVER REV, V84, P257, DOI 10.1016/j.addr.2014.11.022
   LONGAKER MT, 1991, PLAST RECONSTR SURG, V87, P788, DOI 10.1097/00006534-199104000-00032
   LONGAKER MT, 1989, ANN SURG, V210, P667, DOI 10.1097/00000658-198911000-00016
   Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351
   Lujan TJ, 2009, J APPL PHYSIOL, V106, P423, DOI 10.1152/japplphysiol.90748.2008
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09
   Maffulli N, 2000, AM J SPORT MED, V28, P857, DOI 10.1177/03635465000280061401
   Malcarney HL, 2003, SPORTS MED, V33, P993, DOI 10.2165/00007256-200333130-00004
   Malda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057683
   Manning CN, 2013, ACTA BIOMATER, V9, P6905, DOI 10.1016/j.actbio.2013.02.008
   Marxen S, 2004, ARQ BRAS MED VET ZOO, V56, P701, DOI 10.1590/S0102-09352004000600002
   Meddahi A, 1996, INT J BIOL MACROMOL, V18, P141, DOI 10.1016/0141-8130(95)01074-2
   Meloni F, 2008, EUR J RADIOL, V68, P170, DOI 10.1016/j.ejrad.2007.11.001
   Melrose J, 2012, HISTOCHEM CELL BIOL, V138, P461, DOI 10.1007/s00418-012-0968-6
   Menderes A, 2004, ANN PLAS SURG, V53, P560, DOI 10.1097/01.sap.0000134507.00053.1a
   MERKEL KHH, 1982, PATHOL RES PRACT, V173, P303, DOI 10.1016/S0344-0338(82)80092-7
   Merolla G, 2013, Musculoskelet Surg, V97 Suppl 1, P49, DOI 10.1007/s12306-013-0259-y
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   MEYERS SA, 1989, J ORTHOP RES, V7, P683, DOI 10.1002/jor.1100070508
   Muneta T, 2012, J ORTHOP SCI, V17, P425, DOI 10.1007/s00776-012-0225-9
   Necas J, 2008, VET MED-CZECH, V53, P397
   Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353
   Nishida J, 2004, J BONE JOINT SURG BR, V86B, P918, DOI 10.1302/0301-620x.86b6.14329
   NYSKA M, 1987, ARCH ORTHOP TRAUM SU, V106, P192, DOI 10.1007/BF00452209
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ohya S, 2005, BIOMATERIALS, V26, P655, DOI 10.1016/j.biomaterials.2004.03.002
   Olsson L, 1996, PIGM CELL RES, V9, P5, DOI 10.1111/j.1600-0749.1996.tb00081.x
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   Oryan A, 2008, CONNECT TISSUE RES, V49, P351, DOI 10.1080/03008200802325169
   Ozgen M, 2012, RHEUMATOL INT, V32, P137, DOI 10.1007/s00296-010-1577-0
   Ozgenel GY, 2012, ULUS TRAVMA ACIL CER, V18, P11, DOI [10.5505/tjtes.2012.95530, 10.5505/tjtes.2011.95530]
   Ozgenel GY, 2001, J HAND SURG-AM, V26A, P332, DOI 10.1053/jhsu.2001.22524
   Papy-Garcia D, 2005, MACROMOLECULES, V38, P4647, DOI 10.1021/ma048485p
   PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Petrella Robert J, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P4, DOI 10.1186/1758-2555-2-4
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   RADHAKRISHNAMUR.B, 1964, ARCH BIOCHEM BIOPHYS, V104, P19, DOI 10.1016/S0003-9861(64)80029-1
   Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7
   Redding WR, 1999, VET COMP ORTHOPAED, V12, P48
   Riccio M, 2010, J HAND SURG-EUR VOL, V35E, P130, DOI 10.1177/1753193409342044
   RICKETTS CR, 1952, BIOCHEM J, V51, P129, DOI 10.1042/bj0510129
   Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448
   RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367
   Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363
   RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369
   RYDELL N, 1970, ACTA ORTHOP SCAND, V41, P307, DOI 10.3109/17453677008991516
   Sakamoto K, 2011, TRENDS GLYCOSCI GLYC, V23, P212, DOI 10.4052/tigg.23.212
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Sames K, 2001, J HISTOCHEM CYTOCHEM, V49, P19, DOI 10.1177/002215540104900103
   Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001
   Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745
   Satyam A, 2014, J TISSUE ENG REGEN M, V8, P233, DOI 10.1002/term.1522
   Satyam A, 2014, ADV MATER, V26, P3024, DOI 10.1002/adma.201304428
   Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026
   Schnabelrauch M, 2013, CURR MED CHEM, V20, P2501, DOI 10.2174/0929867311320200001
   SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573
   Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179
   SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313
   SCOTT JE, 1984, BIOCHEM J, V218, P229, DOI 10.1042/bj2180229
   Scott JE, 2001, PATHOL BIOL, V49, P284, DOI 10.1016/S0369-8114(01)00152-3
   Screen HRC, 2005, ANN BIOMED ENG, V33, P1090, DOI 10.1007/s10439-005-5777-9
   Seelbach RJ, 2014, ACTA BIOMATER, V10, P4340, DOI 10.1016/j.actbio.2014.06.028
   Serfozo Z, 2009, BRAIN STRUCT FUNCT, V214, P67, DOI 10.1007/s00429-009-0229-1
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   Shabafrooz V, 2014, J BIOMED MATER RES A, V102, P3130, DOI 10.1002/jbm.a.34984
   Shepherd JH, 2013, J BIOMED MATER RES A, V101, P176, DOI 10.1002/jbm.a.34317
   Shibita Y, 2001, J SHOULDER ELB SURG, V10, P209, DOI 10.1067/mse.2001.113501
   Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540290114450
   SMALL JO, 1989, J HAND SURG-BRIT EUR, V14B, P383, DOI 10.1016/0266-7681(89)90152-6
   Spanoudes K, 2014, TRENDS BIOTECHNOL, V32, P474, DOI 10.1016/j.tibtech.2014.06.009
   Spilker MH, 2001, BIOMATERIALS, V22, P1085, DOI 10.1016/S0142-9612(00)00345-8
   Spirig R, 2008, MOL IMMUNOL, V45, P4084, DOI 10.1016/j.molimm.2008.07.024
   Stamov D, 2008, BIOMATERIALS, V29, P1, DOI 10.1016/j.biomaterials.2007.09.009
   STONGE R, 1980, CLIN ORTHOP RELAT R, P269
   Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451
   Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024
   Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540290114441
   Svensson RB, 2011, CONNECT TISSUE RES, V52, P415, DOI 10.3109/03008207.2010.551569
   SWANN DA, 1974, ANN RHEUM DIS, V33, P318, DOI 10.1136/ard.33.4.318
   Taguchi M, 2009, J HAND SURG-AM, V34A, P1276, DOI 10.1016/j.jhsa.2009.04.011
   Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tanaka T, 2006, J ORTHOP RES, V24, P1555, DOI 10.1002/jor.20205
   Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935
   Tatati H, 2004, ARCH PHYS MED REHAB, V85, P1470, DOI 10.1016/j.apmr.2003.09.022
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   VAILAS AC, 1985, J APPL PHYSIOL, V58, P1572
   VAILAS AC, 1985, COMP BIOCHEM PHYS B, V82, P283, DOI 10.1016/0305-0491(85)90242-1
   Verolino P, 2008, BURNS, V34, P284, DOI 10.1016/j.burns.2006.11.016
   Villanueva I, 2010, MATRIX BIOL, V29, P51, DOI 10.1016/j.matbio.2009.08.004
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   VOGEL KG, 1988, J ORTHOPAED RES, V6, P434, DOI 10.1002/jor.1100060315
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   WEBBON PM, 1977, EQUINE VET J, V9, P61, DOI 10.1111/j.2042-3306.1977.tb03981.x
   Wennink JWH, 2011, MACROMOL SYMP, V309-310, P213, DOI 10.1002/masy.201100032
   Whitelock J, 2008, J CHEM TECHNOL BIOT, V83, P496, DOI 10.1002/jctb.1835
   Wilder RP, 2004, CLIN SPORT MED, V23, P55, DOI 10.1016/S0278-5919(03)00085-1
   Wodewotzky TI, 2012, BRAZ J MED BIOL RES, V45, P1157, DOI 10.1590/S0100-879X2012007500149
   WOO SLY, 1981, ACTA ORTHOP SCAND, V52, P615, DOI 10.3109/17453678108992156
   Wu QJ, 2014, INT J NANOMED, V9, P727, DOI 10.2147/IJN.S55497
   Wuillemin WA, 1997, J IMMUNOL, V159, P1953
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Yang C, 2004, J BIOMED MATER RES B, V68B, P15, DOI 10.1002/jbm.b.10074
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Yannas IV, 1975, POLYM PREPR AM CH PC, V16, P209
   Yokota A, 2005, J SHOULDER ELB SURG, V14, p72S, DOI 10.1016/j.jse.2004.09.021
   Yokoyama M, 2002, DRUG DISCOV TODAY, V7, P426, DOI 10.1016/S1359-6446(02)02216-X
   Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22
   Yoshihara Y, 2001, J ORTHOP RES, V19, P573, DOI 10.1016/S0736-0266(00)00063-2
   Zaia J, 2008, CHEM BIOL, V15, P881, DOI 10.1016/j.chembiol.2008.07.016
   Zhao CF, 2013, J ORTHOP RES, V31, P969, DOI 10.1002/jor.22305
   Zhao CF, 2012, J ORTHOP RES, V30, P1940, DOI 10.1002/jor.22177
   Zhu CH, 2014, MAT SCI ENG C-MATER, V34, P393, DOI 10.1016/j.msec.2013.09.044
   Ziebell MR, 2001, CHEM BIOL, V8, P1081, DOI 10.1016/S1074-5521(01)00078-3
NR 255
TC 7
Z9 7
U1 1
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1237
EP 1251
DI 10.1021/acs.bioconjchem.5b00091
PG 15
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500009
PM 25970130
DA 2018-10-19
ER

PT J
AU Cahill, EM
   O'Cearbhaill, ED
AF Cahill, Ellen M.
   O'Cearbhaill, Eoin D.
TI Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery
SO BIOCONJUGATE CHEMISTRY
LA English
DT Review
ID POLYMER MICRONEEDLES; DISSOLVING MICRONEEDLES; PERCUTANEOUS-ABSORPTION;
   TRANSDERMAL DELIVERY; INSULIN DELIVERY; FLUID EXTRACTION; VACCINE
   DELIVERY; ELECTRODE ARRAY; SYSTEMS; FABRICATION
AB Microneedles have recently been adopted for use as a painless and safe method of transdermal therapeutic delivery through physically permeating the stratum corneum. While microneedles create pathways to introduce drugs, they can also act as conduits for biosignal sensing. Here, we explore the development of microneedles as both biosensing and drug delivery platforms. Microneedle sensors are being developed for continuous monitoring of biopotentials and bioanalytes through the use of conductive and electrochemically reactive biomaterials. The range of therapeutics being delivered through microneedle devices has diversified, while novel bioabsorbable microneedles are undergoing first-in-human clinical studies. We foresee that future microneedle platform development will focus on the incorporation of biofunctional materials, designed to deliver therapeutics in a stimulus responsive fashion. Biofunctional microneedle patches will require improved methods of attaching to and conforming to epithelial tissues in dynamic environments for longer periods of time and thus present an assortment of new design challenges. Through the evolution of biomaterial development and microneedle design, biofunctional microneedles are proposed as a next generation of stimulus responsive drug delivery systems.
C1 [Cahill, Ellen M.; O'Cearbhaill, Eoin D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.
   [Cahill, Ellen M.; O'Cearbhaill, Eoin D.] Univ Coll Dublin, UCD Ctr Biomed Engn, Dublin 4, Ireland.
   [O'Cearbhaill, Eoin D.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
RP O'Cearbhaill, ED (reprint author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.
EM eoin.ocearbhaill@ucd.ie
OI O'Cearbhaill, Eoin/0000-0002-4666-5863
FU Naughton Foundation; Marie Sklodowska-Curie Individual Fellowship
FX The authors would like to thank the Naughton Foundation (E.M.C.) and a
   Marie Sklodowska-Curie Individual Fellowship (E.D.O) for their financial
   support. Illustrations provided by Glen Oomen Medical Scientific
   Graphics.
CR ABI Research, 2012, WEAR DEV MARK SHAR F
   Aggarwal P, 2004, SENSOR ACTUAT B-CHEM, V102, P226, DOI 10.1016/j.snb.2004.04.024
   Akhtar N., 2014, INT J PHARM PHARM SC, V6, P18
   Ameri M, 2010, J PHARM SCI-US, V99, P2123, DOI 10.1002/jps.21985
   Aoyagi S, 2008, SENSOR ACTUAT A-PHYS, V143, P20, DOI 10.1016/j.sna.2007.06.007
   Bediz B., 2013, PHARM RES, V31, P117
   Binkley PF, 2003, IEEE ENG MED BIOL, V22, P23, DOI 10.1109/MEMB.2003.1213623
   Bystrova S, 2011, MICROELECTRON ENG, V88, P1681, DOI 10.1016/j.mee.2010.12.067
   Chang H. C., 2013, BIOMICROFLUIDICS, V7, P1
   Chu LY, 2011, J CONTROL RELEASE, V149, P242, DOI 10.1016/j.jconrel.2010.10.033
   Chua B, 2014, IEEE SENS J, V14, P333, DOI 10.1109/JSEN.2013.2283301
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Damiano ER, 2013, DIABETES CARE, V36, P251, DOI 10.2337/dc12-0070
   Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010
   Demir Y. K., 2013, PLOS ONE, V10, P1
   Donnelly R F., 2014, PLOS ONE, V9
   Donnelly RF, 2014, PHOTOCHEM PHOTOBIOL, V90, P641, DOI 10.1111/php.12209
   Donnelly RF, 2012, ADV FUNCT MATER, V22, P4879, DOI 10.1002/adfm.201200864
   Donnelly RF, 2010, DRUG DELIV, V17, P187, DOI 10.3109/10717541003667798
   El-Laboudi A, 2013, DIABETES TECHNOL THE, V15, P101, DOI 10.1089/dia.2012.0188
   Fernandez L. J., 2009, J MICROMECH MICROENG, V19
   Food and Drug Administration, 2013, GUID IND FDA STAFF T
   Forvi E, 2012, SENSOR ACTUAT A-PHYS, V180, P177, DOI 10.1016/j.sna.2012.04.019
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gestel M. S., 1976, U. S. patent, Patent No. [3,964,482, 3964482, US3,964,482]
   Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017
   Ginsberg B H, 1999, Diabetes Technol Ther, V1, P203, DOI 10.1089/152091599317431
   Guo L, 2013, IEEE T BIOMED CIRC S, V7, P1, DOI 10.1109/TBCAS.2012.2192932
   Guo L, 2011, I IEEE EMBS C NEUR E, P562, DOI 10.1109/NER.2011.5910610
   Hench L. L., 2010, J R SOC INTERFACE, V7, pS379
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Hong XY, 2014, NANO-MICRO LETT, V6, P191, DOI 10.5101/nml140021r
   Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401
   Hsu LS, 2014, SENSORS-BASEL, V14, P12370, DOI 10.3390/s140712370
   Huang CJ, 2007, SENSOR ACTUAT B-CHEM, V122, P461, DOI 10.1016/j.snb.2006.06.015
   Ikeno F, 2004, CATHETER CARDIO INTE, V63, P222, DOI 10.1002/ccd.20167
   Ito Y, 2007, J DRUG TARGET, V15, P323, DOI 10.1080/10611860701349794
   Ito Y, 2006, EUR J PHARM SCI, V29, P82, DOI 10.1016/j.ejps.2006.05.011
   Jiang J., 2007, INVEST OPHTH VIS SCI, V48, P4038
   Jin CY, 2009, BIOMED MICRODEVICES, V11, P1195, DOI 10.1007/s10544-009-9337-1
   Jung PG, 2008, SENSOR MATER, V20, P45
   Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005
   Kudva YC, 2014, DIABETES CARE, V37, P1184, DOI 10.2337/dc13-2066
   Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048
   Lee JH, 2007, ENVIRON SCI TECHNOL, V41, P7857, DOI 10.1021/es070969o
   Lee S, 2003, FOOD CHEM, V82, P521, DOI 10.1016/S0308-8146(02)00592-7
   Li GH, 2009, INT J PHARM, V368, P109, DOI 10.1016/j.ijpharm.2008.10.008
   Martanto W., 2004, PHARM RES, V21, P947
   McCrudden MTC, 2015, DRUG DELIV TRANSL RE, V5, P3, DOI 10.1007/s13346-014-0211-1
   Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4
   Miller PR, 2012, TALANTA, V88, P739, DOI 10.1016/j.talanta.2011.11.046
   Moon SJ, 2005, MICROSYST TECHNOL, V11, P311, DOI [10.1007/s00542-004-0446-8, 10.1007/S00542-004-0446-8]
   Morales JO, 2014, DRUG DEV IND PHARM, V40, P579, DOI 10.3109/03639045.2014.892960
   Mukerjee E, 2004, SENSOR ACTUAT A-PHYS, V114, P267, DOI 10.1016/j.sna.2003.11.008
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P1831, DOI 10.1098/rsta.2010.0001
   Nordquist L, 2007, PHARM RES, V24, P1381, DOI 10.1007/s11095-007-9256-x
   Norman JJ, 2013, PEDIATR DIABETES, V14, P459, DOI 10.1111/pedi.12031
   O'Mahony C, 2012, SENSOR ACTUAT A-PHYS, V186, P130, DOI 10.1016/j.sna.2012.04.037
   Omatsu T, 2010, OPT EXPRESS, V18, P17967, DOI 10.1364/OE.18.017967
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Park JH, 2007, IEEE T BIO-MED ENG, V54, P903, DOI 10.1109/TBME.2006.889173
   Park JH, 2010, J KOREAN PHYS SOC, V56, P1223, DOI 10.3938/jkps.56.1223
   Patel SR, 2011, PHARM RES-DORDR, V28, P166, DOI 10.1007/s11095-010-0271-y
   Peng Q, 2013, ACTA BIOMATER, V9, P5063, DOI 10.1016/j.actbio.2012.09.034
   PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225
   Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18
   Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023
   Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024
   Reed ML, 1998, J PHARM SCI-US, V87, P1387, DOI 10.1021/js980085q
   Rynd F., 1845, DUBLIN MED PRESS, V13, P167
   Sakaguchi K, 2012, DIABETES TECHNOL THE, V14, P485, DOI 10.1089/dia.2011.0255
   Senapati S, 2011, TOP CURR CHEM, V304, P153, DOI 10.1007/128_2011_142
   Suh H, 2014, CLIN EXP VACCINE RES, V3, P42, DOI 10.7774/cevr.2014.3.1.42
   Traverso G, 2015, J PHARM SCI-US, V104, P362, DOI 10.1002/jps.24182
   Tuan-Mahmood TM, 2013, EUR J PHARM SCI, V50, P623, DOI 10.1016/j.ejps.2013.05.005
   Valdes-Ramirez G, 2014, ELECTROCHEM COMMUN, V47, P58, DOI 10.1016/j.elecom.2014.07.014
   Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077
   van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042
   Vrdoljak A, 2013, VACCINE DEV THERAPY, V3, P47, DOI DOI 10.2147/VDT.S34682
   Wang Ping M, 2005, Diabetes Technol Ther, V7, P131, DOI 10.1089/dia.2005.7.131
   Wilke N, 2005, SENSOR ACTUAT A-PHYS, V123-24, P319, DOI 10.1016/j.sna.2005.05.017
   Windmiller JR, 2011, ELECTROANAL, V23, P2302, DOI 10.1002/elan.201100361
   Windmiller JR, 2011, ANALYST, V136, P1846, DOI 10.1039/c1an00012h
   World Health Organization, 2015, WHO GUID US SAF ENG
   Yan K, 2010, INT J PHARMACEUT, V397, P77, DOI 10.1016/j.ijpharm.2010.06.052
   Yang SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2715
NR 86
TC 12
Z9 12
U1 2
U2 98
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1289
EP 1296
DI 10.1021/acs.bioconjchem.5b00211
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500013
PM 26020359
DA 2018-10-19
ER

PT J
AU Samorezov, JE
   Morlock, CM
   Alsberg, E
AF Samorezov, Julia E.
   Morlock, Colin M.
   Alsberg, Eben
TI Dual Ionic and Photo-Crosslinked Alginate Hydrogels for Micropatterned
   Spatial Control of Material Properties and Cell Behavior
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID HYALURONIC-ACID HYDROGELS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   INTERPENETRATING NETWORKS; SUBSTRATE FLEXIBILITY; MECHANICAL-PROPERTIES;
   PROLIFERATION; GROWTH; LINKING; FATE
AB Biomaterial properties such as mechanics, degradation rate, and cell adhesivity affect cell behaviors including spreading, proliferation, and differentiation. To engineer complex tissues, it is often desirable to achieve precise spatial control over these properties. Here, methacrylated alginate (MA-ALG) was used to create hydrogels comprising a single base material with regions of different types and levels of crosslinking and subsequently different material properties. Ionic and ultraviolet light crosslinking mechanisms were combined to create dual-crosslinked hydrogels with significantly increased stiffness and decreased swelling compared to calcium-crosslinked or UV-crosslinked hydrogels. MC3T3 cells showed significantly enhanced proliferation on the surface of dual-crosslinked hydrogels compared with calcium-crosslinked hydrogels. Photomasks were then used to create patterned hydrogels with precise spatial control over regions that were only calcium-crosslinked versus dual-crosslinked. This spatial variation in crosslinking mechanism permitted local regulation of the hydrogel physical properties and alignment of cells seeded on their surface. Photomasks were also used to create hydrogels with patterned presentation of cell adhesion ligands, leading to spatial control over cell attachment and proliferation. This biomaterial system can be useful for providing patterned, instructive cues to guide cell behavior for engineering complex tissues.
C1 [Samorezov, Julia E.; Morlock, Colin M.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Div Gen Med Sci, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Div Gen Med Sci, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Natl Ctr Regenerat Med, Div Gen Med Sci, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Div Gen Med Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU National Institutes of Health [R01AR063194, R21AR061265, R56DE022376];
   NDSEG; NSF Graduate Fellowships
FX The authors thank Michael Hill for providing the acrylated RGD and Oju
   Jeon for creating the crosslinking chemistry schematic, and gratefully
   acknowledge funding support from the National Institutes of Health
   (R01AR063194, R21AR061265, and R56DE022376; EA) and NDSEG and NSF
   Graduate Fellowships (JES).
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Alsberg E, 2006, EXPERT OPIN BIOL TH, V6, P847, DOI 10.1517/14712598.6.9.847
   Bajpai SK, 2004, REACT FUNCT POLYM, V59, P129, DOI 10.1016/j.reactfunctpolym.2004.01.002
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Cha C, 2012, BIOTECHNOL BIOENG, V109, P63, DOI 10.1002/bit.23258
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chueh BH, 2010, BIOMED MICRODEVICES, V12, P145, DOI 10.1007/s10544-009-9369-6
   CORY AH, 1991, CANCER COMMUN, V3, P207
   Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Jeon O, 2013, ADV FUNCT MATER, V23, P4765, DOI 10.1002/adfm.201300529
   Jeon O, 2014, ACTA BIOMATER, V10, P47, DOI 10.1016/j.actbio.2013.09.004
   Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.tea.2012.0581, 10.1089/ten.TEA.2012.0581]
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mihaila SM, 2013, ADV HEALTHC MATER, V2, P895, DOI 10.1002/adhm.201200317
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Rouillard AD, 2010, BIOMACROMOLECULES, V11, P2184, DOI 10.1021/bm1001312
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schade R, 2010, INT J ARTIF ORGANS, V33, P219
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Shilpa A, 2003, J MACROMOL SCI-POL R, VC43, P187, DOI 10.1081/MC-120020160
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Tan HP, 2011, J TISSUE ENG REGEN M, V5, P790, DOI 10.1002/term.378
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Thorpe SD, 2008, BIOCHEM BIOPH RES CO, V377, P458, DOI 10.1016/j.bbrc.2008.09.154
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209
   Zawko SA, 2009, ACTA BIOMATER, V5, P14, DOI 10.1016/j.actbio.2008.09.012
   Zhang XZ, 2004, BIOMATERIALS, V25, P4719, DOI 10.1016/j.biomaterials.2003.11.040
   Zhao XH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3343265
NR 54
TC 9
Z9 9
U1 8
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1339
EP 1347
DI 10.1021/acs.bioconjchem.5b00117
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500018
PM 25799217
DA 2018-10-19
ER

PT J
AU Yu, H
   Yang, JL
   Sun, YX
AF Yu, Hui
   Yang, Jialing
   Sun, Yuxin
TI Energy Absorption of Spider Orb Webs During Prey Capture: A Mechanical
   Analysis
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE silk; spider webs; energy dissipation; finite element
ID NATURALLY COMPLIANT STRUCTURES; DRAGLINE SILK; PERFORMANCE; BIOMATERIAL;
   DESIGN; BIOMECHANICS; EVOLUTION; ROLES
AB When the spider orb web stops a prey, the web dissipates impact energy by three routes: internal dissipation within the radial silk, internal dissipation within the spiral silk and aerodynamic dissipation. This paper investigates the energy dissipation mechanism of spider orb webs from the mechanics point of view. Firstly, the dynamic response and energy dissipation of a single spider silk under transverse impact are studied analytically and numerically. The congruence of dynamic response curve validates the accuracy of finite element analysis. Then the whole web is modeled using the finite element method and the respective contribution of each route to total energy dissipation during the simulated prey impact is obtained, which agrees with published experimental results. Finally, the influence of initial impact kinetic energy on the fraction distribution of three routes is demonstrated based on the finite element model. The mechanical mechanism of energy dissipation of spider orb webs is discussed and the reason for the differences among the existing opinions is speculated.
C1 [Yu, Hui; Yang, Jialing; Sun, Yuxin] Beihang Univ, Inst Solid Mech, Beijing 100191, Peoples R China.
RP Sun, YX (reprint author), Beihang Univ, Inst Solid Mech, Beijing 100191, Peoples R China.
EM yxsun@buaa.edu.cn
FU National Natural Science Foundation of China [11032001]
FX The work described in this paper is fmancially supported by the National
   Natural Science Foundation of China (No. 11032001).
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005
   Alam MS, 2005, INT J DAMAGE MECH, V14, P365, DOI [10.1177/1056789505054313, 10.1177/105678950504313]
   Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Bratzel G, 2012, BIOPOLYMERS, V97, P408, DOI 10.1002/bip.21729
   DENNY M, 1976, J EXP BIOL, V65, P483
   Elices M., 2000, STRUCTURAL BIOL MAT
   FOELIX RF, 1996, BIOL SPIDERS
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Harmer AMT, 2011, J R SOC INTERFACE, V8, P457, DOI 10.1098/rsif.2010.0454
   Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341
   Hesselberg T, 2012, J EXP BIOL, V215, P3362, DOI 10.1242/jeb.068890
   Kelly SP, 2011, ZOOLOGY, V114, P233, DOI 10.1016/j.zool.2011.02.001
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lin L, 1998, STRUCTURAL ENG, V76, P59
   LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0
   Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013
   Tarakanova A, 2012, J R SOC INTERFACE, V9, P3240, DOI 10.1098/rsif.2012.0473
   Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309
   Vollrath F, 2010, NATURE, V466, P319, DOI 10.1038/466319a
   Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068
   Wise D. H., 1993, SPIDERS ECOLOGICAL W
   Yang Y, 2005, ADV MATER, V17, P84, DOI 10.1002/adma.200400344
NR 38
TC 2
Z9 2
U1 2
U2 36
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD JUL
PY 2015
VL 12
IS 3
BP 453
EP 463
DI 10.1016/S1672-6529(14)60136-0
PG 11
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA CN2RN
UT WOS:000358269700012
DA 2018-10-19
ER

PT J
AU Yang, YW
   Wu, JY
   Liu, CT
   Liao, GC
   Cheng, KY
   Chiang, MH
   Wu, JS
AF Yang, Yi-Wei
   Wu, Jane-Yii
   Liu, Chih-Tung
   Liao, Guo-Chun
   Cheng, Kuang-Yao
   Chiang, Ming-Hung
   Wu, Jong-Shinn
TI An Optimized Two-Step Nitrogen-Based Plasma Treatment Procedure under
   Atmospheric-Pressure Condition and its Surface Amination Mechanism
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE amide; amine; atmospheric-pressure plasma; biomedical; biomaterial;
   carbamate; DBD; nitrogen-containing group; PLA
ID MESENCHYMAL STEM-CELLS; POLYMER FILMS; DEPOSITION; DISCHARGE; ADHESION;
   IMMOBILIZATION; ADSORPTION; ALLYLAMINE; COATINGS; BEHAVIOR
AB Atmospheric pressure nitrogen-based dielectric barrier discharge (DBD) jet with two-step plasma treatment procedure has been verified to be very effective in facilitating nitrogen-containing group incorporation on Polylactide (PLA) surface. It includes: 1) pretreatment plasma treatment by a nitrogen discharge with a trace amount of oxygen, and 2) ammonia plasma treatment by a nitrogen discharge with a small amount of ammonia. In this study, the optimized operation condition of two-step plasma procedure is investigated under different concentrations of added gases (0-1% oxygen; 0-10% ammonia). XPS analysis shows that approximate to 0.19 of N/C ratio can be achieved by means of the optimized two-step plasma procedures. Furthermore, a surface amination mechanism is proposed based on the observations of Optical Emission Spectra (OES), Atomic Force Microscope (AFM), and X-ray Photoelectron Spectra (XPS) analyses.
C1 [Yang, Yi-Wei; Liu, Chih-Tung; Liao, Guo-Chun; Cheng, Kuang-Yao; Chiang, Ming-Hung; Wu, Jong-Shinn] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan.
   [Wu, Jane-Yii] Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan.
RP Wu, JS (reprint author), Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan.
EM chongsin@faculty.nctu.edu.tw
FU Ministry of Science and Technology of Taiwan [NSC-01-2221-E-009-041-MY3]
FX The authors would like to express their sincere gratitude to the
   financial support of Ministry of Science and Technology of Taiwan
   through the grant, NSC-01-2221-E-009-041-MY3.
CR Bullett NA, 2004, APPL SURF SCI, V235, P395, DOI 10.1016/j.apsusc.2004.02.058
   Chen Q, 2004, CHEM MATER, V16, P614, DOI 10.1021/cm034529h
   Cheng K. -W., 2012, THESIS NATL CHIAO TU, p[16, 1]
   Chiang MH, 2010, SURF COAT TECH, V204, P3729, DOI 10.1016/j.surfcoat.2010.04.057
   Crespin M, 2011, J MATER SCI-MATER M, V22, P671, DOI 10.1007/s10856-011-4245-3
   Dilecce G, 2010, PURE APPL CHEM, V82, P1201, DOI 10.1351/PAC-CON-09-08-19
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   Forch R, 2005, PLASMA PROCESS POLYM, V2, P351, DOI 10.1002/ppap.200400083
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hiratsuka A, 1999, ELECTROANAL, V11, P1098, DOI 10.1002/(SICI)1521-4109(199911)11:15<1098::AID-ELAN1098>3.0.CO;2-N
   Hu WJ, 2009, THIN SOLID FILMS, V517, P4268, DOI 10.1016/j.tsf.2009.02.043
   Kim KS, 2010, APPL SURF SCI, V257, P398, DOI 10.1016/j.apsusc.2010.06.092
   Klages CP, 2008, PLASMA PROCESS POLYM, V5, P368, DOI 10.1002/ppap.200700142
   Lerouge S, 2007, BIOMATERIALS, V28, P1209, DOI 10.1016/j.biomaterials.2006.10.033
   Mangindaan D, 2011, SURF COAT TECH, V206, P1299, DOI 10.1016/j.surfcoat.2011.08.046
   Meyer-Plath AA, 2003, VACUUM, V71, P391, DOI 10.1016/S0042-207X(02)00766-2
   Mortensen H, 2006, JPN J APPL PHYS 1, V45, P8506, DOI 10.1143/JJAP.45.8506
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Mwale F, 2006, TISSUE ENG, V12, P2639, DOI 10.1089/ten.2006.12.2639
   Nakamura R, 1997, ANAL CHEM, V69, P4649, DOI 10.1021/ac970571i
   Nakanishi K, 1996, ANAL CHEM, V68, P1695, DOI 10.1021/ac950756u
   Nardulli M, 2010, J BIOMED MATER RES B, V94B, P97, DOI 10.1002/jbm.b.31629
   Ogino A, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JF06
   Panousis E, 2006, J PHYS D APPL PHYS, V39, P2140, DOI 10.1088/0022-3727/39/10/026
   Panousis E, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/205201
   Pintassilgo CD, 2005, J PHYS D APPL PHYS, V38, P417, DOI 10.1088/0022-3727/38/3/011
   PIPER LG, 1988, J CHEM PHYS, V88, P231, DOI 10.1063/1.454649
   Pointu A. -M., 2005, J PHYS APPL PHYS, P38
   Ruelle B, 2012, POLYMERS-BASEL, V4, P296, DOI 10.3390/polym4010296
   Sharma H, 2012, SENSOR ACTUAT B-CHEM, V173, P569, DOI 10.1016/j.snb.2012.07.040
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Song H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08HE01
   Thomaz JC, 1999, J PHYS D APPL PHYS, V32, P3208, DOI 10.1088/0022-3727/32/24/317
   Truica-Marasescu F, 2008, PLASMA PROCESS POLYM, V5, P44, DOI 10.1002/ppap.200700077
   Volcke C, 2010, BIOSENS BIOELECTRON, V25, P1875, DOI 10.1016/j.bios.2009.12.034
   Yang LZ, 2010, SURF COAT TECH, V205, pS345, DOI 10.1016/j.surfcoat.2010.08.008
   Yang YW, 2014, J BIOMED MATER RES A, V102, P160, DOI 10.1002/jbm.a.34681
NR 38
TC 3
Z9 3
U1 2
U2 28
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JUL
PY 2015
VL 12
IS 7
BP 678
EP 690
DI 10.1002/ppap.201400095
PG 13
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA CN2ML
UT WOS:000358255500006
DA 2018-10-19
ER

PT J
AU Hsu, CW
   Poche, RA
   Saik, JE
   Ali, S
   Wang, S
   Yosef, N
   Calderon, GA
   Scott, L
   Vadakkan, TJ
   Larina, IV
   West, JL
   Dickinson, ME
AF Hsu, Chih-Wei
   Poche, Ross A.
   Saik, Jennifer E.
   Ali, Saniya
   Wang, Shang
   Yosef, Nejla
   Calderon, Gisele A.
   Scott, Larry, Jr.
   Vadakkan, Tegy J.
   Larina, Irina V.
   West, Jennifer L.
   Dickinson, Mary E.
TI Improved Angiogenesis in Response to Localized Delivery of
   Macrophage-Recruiting Molecules
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; OPTICAL COHERENCE TOMOGRAPHY;
   COLONY-STIMULATING FACTOR; THERAPEUTIC ANGIOGENESIS;
   MYOCARDIAL-ISCHEMIA; CARDIAC-FUNCTION; PROTEIN THERAPY; MYELOID CELLS;
   PDGFR-BETA; VEGF-A
AB Successful engineering of complex organs requires improved methods to promote rapid and stable vascularization of artificial tissue scaffolds. Toward this goal, tissue engineering strategies utilize the release of pro-angiogenic growth factors, alone or in combination, from biomaterials to induce angiogenesis. In this study we have used intravital microscopy to define key, dynamic cellular changes induced by the release of pro-angiogenic factors from polyethylene glycol diacrylate hydrogels transplanted in vivo. Our data show robust macrophage recruitment when the potent and synergistic angiogenic factors, PDGFBB and FGF2 were used as compared with VEGF alone and intravital imaging suggested roles for macrophages in endothelial tip cell migration and anastomosis, as well as pericyte-like behavior. Further data from in vivo experiments show that delivery of CSF1 with VEGF can dramatically improve the poor angiogenic response seen with VEGF alone. These studies show that incorporating macrophage-recruiting factors into the design of pro-angiogenic biomaterial scaffolds is a key strategy likely to be necessary for stable vascularization and survival of implanted artificial tissues.
C1 [Hsu, Chih-Wei; Poche, Ross A.; Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA.
   [Hsu, Chih-Wei; Poche, Ross A.; Wang, Shang; Yosef, Nejla; Calderon, Gisele A.; Scott, Larry, Jr.; Vadakkan, Tegy J.; Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.
   [Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA.
   [Saik, Jennifer E.; Ali, Saniya; West, Jennifer L.; Dickinson, Mary E.] Rice Univ, Dept Bioengn, Houston, TX USA.
   [Ali, Saniya; West, Jennifer L.] Duke Univ, Dept Biomed Engn, Durham, NC USA.
RP Dickinson, ME (reprint author), Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA.
EM mdickins@bcm.edu
FU National Institute of Health [R01HL097520-01A1, R21EY020632,
   F32EY019436, R01HL120140]; Cancer Prevention Research Institute of Texas
   [RP120713-P3]; American Heart Association Predoctoral Fellowship
   [12PRE12030410]
FX This work was supported by: 1. National Institute of Health
   (http://www.nih.gov) R01HL097520-01A1 (MED, JLW); 2. National Institute
   of Health (http://www.nih.gov) R21EY020632 (MED); 3. Cancer Prevention
   Research Institute of Texas (http://www.cprit.state.tx.us) RP120713-P3
   (MED); 4. American Heart Association Predoctoral Fellowship
   (http://www.heart.org) 12PRE12030410 (CWH); 5. National Institute of
   Health (http://www.nih.gov) F32EY019436 (RAP); 6. National Institute of
   Health (http://www.nih.gov) R01HL120140 (IVL). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241
   Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Andres G, 2009, J CELL MOL MED, V13, P2083, DOI 10.1111/j.1582-4934.2008.00415.x
   Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255
   Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB
   Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chu HH, 2012, THER DELIV, V3, P693, DOI 10.4155/TDE.12.50
   des Rieux A, 2011, J CONTROL RELEASE, V150, P272, DOI 10.1016/j.jconrel.2010.11.028
   Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3
   DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   FLEMING TJ, 1993, J IMMUNOL, V151, P2399
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Fung E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00353
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Gould DJ, 2011, MICROCIRCULATION, V18, P136, DOI 10.1111/j.1549-8719.2010.00075.x
   Hedman M, 2003, CIRCULATION, V107, P2677, DOI 10.1161/01.CIR.0000070540.80780.92
   Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A
   Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721
   Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593
   Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483
   Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI [10.1016/S0076-6879(08)021105-3, 10.1016/S0076-6879(08)02005-3]
   LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I
   Larina IV, 2009, ANAT REC, V292, P333, DOI 10.1002/ar.20821
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928
   Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104
   Mahmud MS, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050901
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530
   Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Moldovan NI, 2000, CIRC RES, V87, P378
   Molin D, 2007, CURR OPIN PHARMACOL, V7, P158, DOI 10.1016/j.coph.2006.10.006
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016
   Poche R. A., 2010, COLD SPRING HARB PRO
   Poche RA, 2015, DEV BIOL
   Poche RA, 2009, DEV DYNAM, V238, P2318, DOI 10.1002/dvdy.21886
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripa RS, 2006, EUR HEART J, V27, P1785, DOI 10.1093/eurheartj/ehl117
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-1569
   SIEGBAHN A, 1990, J CLIN INVEST, V85, P916, DOI 10.1172/JCI114519
   Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085
   Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107
   Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445
   Sudheendran N, 2011, LASER PHYS LETT, V8, P247, DOI 10.1002/lapl.201010120
   Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091
   Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Wang RKK, 2010, IEEE J SEL TOP QUANT, V16, P545, DOI 10.1109/JSTQE.2009.2033609
   Wang S, 2014, BIOMED OPT EXPRESS, V5, P1980, DOI 10.1364/BOE.5.001980
   Wang Y, 2011, NEUROINFORMATICS, V9, P193, DOI 10.1007/s12021-011-9110-5
   Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jeb.21116
   Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860
   Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479
NR 77
TC 17
Z9 17
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2015
VL 10
IS 7
AR e0131643
DI 10.1371/journal.pone.0131643
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1CG
UT WOS:000358153000132
PM 26132702
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Tsou, CH
   Lee, HT
   De Guzman, M
   Tsai, HA
   Wang, PN
   Cheng, HJ
   Suen, MC
AF Tsou, Chi-Hui
   Lee, Hsun-Tsing
   De Guzman, Manuel
   Tsai, Hui-An
   Wang, Pin-Ning
   Cheng, Hsiang-Jung
   Suen, Maw-Cherng
TI Synthesis of biodegradable polycaprolactone/polyurethane by curing with
   H2O
SO POLYMER BULLETIN
LA English
DT Article
DE Biodegradable; Polycaprolactone diol; Hydrolytic degradation;
   Polyurethane
ID TYROSINE-BASED POLYURETHANES; BIOMATERIAL APPLICATIONS; ELASTOMERS;
   CURE; COMPOSITES; BEHAVIOR
AB To prepare a pre-polymer in this study, the following materials were used: 4,4'-diphenylmethane diisocyanate, poly(e-caprolactone) diol (PCL), and polytetramethylene ether glycol. The pre-polymer was then cured using H2O to form a new type of polyurethane (PU), PCL/H2O-PU. Fourier transform infrared analysis confirmed the successful synthesis of PCL/H2O-PU. Results from thermal gravimetric analysis, differential scanning calorimetry, and dynamic mechanical analysis showed that the thermal resistance and glass transition temperature of PCL/H2O-PU increased with the H2O and the hard segment content. Stress-strain curves for the PCL/H2O-PU specimens showed that with increasing H2O content, the tensile strength and Young's modulus increased, but the elongation at break decreased. WAXD patterns indicated that with a higher H2O content, the polymer chains were in a more ordered arrangement, although the morphology was still amorphous. The degree of swelling in an aqueous ethanol solution and the hydrolytic degradation rate increased with the PCL content. Scanning electron microscopic images showed that during the degradation period, the original wrinkled surface of PCL/H2O-PU became smooth, and then cracks were formed. The cracks became more severe when the degradation was at a higher temperature.
C1 [Tsou, Chi-Hui] Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei 10607, Taiwan.
   [Tsou, Chi-Hui; De Guzman, Manuel] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Dept Chem Engn, Taoyuan 32023, Taiwan.
   [Lee, Hsun-Tsing] Vanung Univ, Nanomat Applicat R&D Ctr, Taoyuan 32091, Taiwan.
   [Tsai, Hui-An; Wang, Pin-Ning; Suen, Maw-Cherng] Taoyuan Innovat Inst Technol, Dept Creat Fash Design, Taoyuan 32091, Taiwan.
   [Cheng, Hsiang-Jung] Taoyuan Innovat Inst Technol, Grad Sch Mat Appl Technol, Taoyuan 32091, Taiwan.
RP Suen, MC (reprint author), Taoyuan Innovat Inst Technol, Dept Creat Fash Design, Taoyuan 32091, Taiwan.
EM sun@tiit.edu.tw
FU Everlight Chemical Industrial Corporation; Far Eastern New Century
   Corporation; Apex Nanotek Corporation; Grabio Greentech Corporation;
   Ching-Yung Trading Co. Ltd.; Fabric King Textile Co. Ltd.; Ministry of
   Economic Affairs [100-EC-17-A-10-S1-186]; National Science Council [NSC
   102-2221-E-161-011, NSC 100-3113-E-033-001, NSC 102-2221-E-003-065]
FX The authors express their appreciation to Everlight Chemical Industrial
   Corporation, Far Eastern New Century Corporation, Apex Nanotek
   Corporation, Grabio Greentech Corporation, Ching-Yung Trading Co. Ltd.,
   Fabric King Textile Co. Ltd., the Ministry of Economic Affairs
   (100-EC-17-A-10-S1-186), and the National Science Council (NSC
   102-2221-E-161-011, NSC 100-3113-E-033-001, and NSC 102-2221-E-003-065)
   for supporting this work.
CR Chattopadhyay DK, 2006, POLYMER, V47, P3814, DOI 10.1016/j.polymer.2006.03.092
   Chattopadhyay DK, 2005, PROG ORG COAT, V54, P296, DOI 10.1016/j.porgcoat.2005.07.004
   Datta J, 2008, J THERM ANAL CALORIM, V93, P753, DOI 10.1007/s10973-008-9140-x
   Datta J, 2007, PRZEM CHEM, V86, P624
   Datta J, 2010, J ELASTOM PLAST, V42, P117, DOI 10.1177/0095244309354368
   Datta J, 2008, POLIMERY-W, V53, P871
   GARDNER G, 1996, J PROT COAT LININGS, V13, P81
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Hatakeyama T, 2002, POLYMER, V43, P1177, DOI 10.1016/S0032-3861(01)00714-5
   Heijkants GJC, 2005, BIOMATERIALS, V26, P4219
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee HT, 2014, POLYM BULL, V71, P2749, DOI 10.1007/s00289-014-1222-2
   Lee SI, 2001, POLYM DEGRAD STABIL, V72, P1
   Modesti M, 2002, POLYM DEGRAD STABIL, V78, P341, DOI 10.1016/S0141-3910(02)00184-2
   Moore T, 2005, BIOMATERIALS, V26, P3771, DOI 10.1016/j.biomaterials.2004.10.002
   Ni H, 2000, PROG ORG COAT, V40, P175, DOI 10.1016/S0300-9440(00)00116-8
   Ren DK, 2012, INT J ADHES ADHES, V34, P55, DOI 10.1016/j.ijadhadh.2011.12.009
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Shah PN, 2009, POLYMER, V50, P2281, DOI 10.1016/j.polymer.2009.02.048
   Shah PN, 2012, J BIO APPL, P1
   Tsou CH, 2014, MATER RES INNOV, V18, P372, DOI 10.1179/1432891714Z.000000000435
   Tsou CH, 2014, MATER SCI-MEDZG, V20, P446
   Tsou CH, 2014, MATERIALS, V7, P5617, DOI 10.3390/ma7085617
   Tsou CH, 2013, POLYM DEGRAD STABIL, V98, P643, DOI 10.1016/j.polymdegradstab.2012.11.010
   Wang WS, 2006, EUR POLYM J, V42, P1240, DOI 10.1016/j.eurpolymj.2005.11.029
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   Yeganeh H, 2007, POLYM INT, V56, P41, DOI 10.1002/pi.2107
   Yukihiro N, 2007, J POLYM SCI A, V45, P2689
NR 29
TC 8
Z9 8
U1 3
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD JUL
PY 2015
VL 72
IS 7
BP 1545
EP 1561
DI 10.1007/s00289-015-1356-x
PG 17
WC Polymer Science
SC Polymer Science
GA CN4PZ
UT WOS:000358413700001
DA 2018-10-19
ER

PT J
AU Wang, M
   Abbah, SA
   Hu, T
   Lam, RWM
   Toh, SY
   Liu, T
   Cool, SM
   Bhakoo, K
   Li, J
   Goh, JCH
   Wong, HK
AF Wang, Ming
   Abbah, Sunny Akogwu
   Hu, Tao
   Lam, Raymond Wing Moon
   Toh, Soo Yein
   Liu, Tong
   Cool, Simon M.
   Bhakoo, Kishore
   Li, Jun
   Goh, James Cho Hong
   Wong, Hee-Kit
TI Polyelectrolyte Complex Carrier Enhances Therapeutic Efficiency and
   Safety Profile of Bone Morphogenetic Protein-2 in Porcine Lumbar
   Interbody Fusion Model
SO SPINE
LA English
DT Article
DE BMP-2; interbody fusion; heterotopic ossification; polyelectrolyte
   complexes; alginate microbeads; heparin; porcine model; biomaterial
ID SPINAL RECONSTRUCTIVE SURGERY; HEPARIN-CONJUGATED FIBRIN;
   LARGE-ANIMAL-MODEL; IN-VIVO; HETEROTOPIC OSSIFICATION; RETROGRADE
   EJACULATION; POSTEROLATERAL FUSION; INCORPORATING HEPARIN; CANCELLOUS
   BONE; STROMAL CELLS
AB Study Design. Porcine lumbar interbody fusion model.
   Objective. This study evaluates the effect of polyelectrolyte complex (PEC) carrier in enhancing the therapeutic efficiency and safety profile of bone morphogenetic protein-2 (BMP-2) in a large animal model.
   Summary of Background Data. Extremely large amounts of BMP-2 are administered to achieve consistent spinal fusion, which has led to complications. Heparin-modified PEC carrying reduced BMP-2 doses of 0.5 g was demonstrated to achieve consistent spinal fusion with reduction of complications in rodent model. The purpose of this study was to evaluate whether PEC could improve the therapeutic efficiency of BMP-2 in porcine model.
   Methods. Three-segment (L3-L6) anterior lumbar interbody fusions with instrumentation were performed on 6 pigs using 3 different doses of BMP-2, namely, (1) 50 g, (2) 150 g, and (3) 300 g. The BMP-2 was delivered using heparin-modified alginate microbeads loaded into biodegradable cage. Fusion performance was evaluated after 3 months.
   Results. Manual palpation and micro-computed tomography showed consistent fusion in all experimental groups. Heterotopic bone formation beyond the cage implant area was more evident in group 2 and group 3 than in group 1. Similarly, superior bone microstructure was observed in the new bone with the lowered BMP-2 dose. Biomechanical evaluation revealed enhanced stiffness of the operated segments compared with nonoperated segments (P < 0.05). Mechanical stability was maintained despite dose reduction of BMP-2. Although the mineral apposition rate was higher in group 3, unsatisfactory bony microstructure with decreased trabecular number was observed in group 3 compared with group 1.
   Conclusion. PEC carrying low doses of BMP-2 achieved consistent interbody fusion. We observed dose-related reduction in heterotopic ossification without compromising the stability of the fused segments. PEC carrier reduces the efficacious doses of BMP-2. This could enhance the safety profile of BMP-2 and reduce dose- and carrier-related complications. Level of Evidence: N/A
C1 [Wang, Ming; Abbah, Sunny Akogwu; Hu, Tao; Lam, Raymond Wing Moon; Toh, Soo Yein; Cool, Simon M.; Goh, James Cho Hong; Wong, Hee-Kit] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117595, Singapore.
   [Liu, Tong] ASTAR, Singapore Inst Mfg Technol, Singapore, Singapore.
   [Cool, Simon M.] ASTAR, Inst Med Biol, Singapore, Singapore.
   [Bhakoo, Kishore] ASTAR, Singapore Bioimaging Consortium, Singapore, Singapore.
   [Li, Jun] ASTAR, Inst Mat Res & Engn, Singapore, Singapore.
   [Li, Jun; Goh, James Cho Hong] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Singapore 117548, Singapore.
RP Wong, HK (reprint author), Univ Orthopaed Hand & Reconstruct Microsurg Clust, Level 11,NUHS Tower Block,1E Kent Ridge Rd, Singapore 119228, Singapore.
EM heekit_wong@nuhs.edu.sg
RI Li, Jun/B-5308-2008
OI Li, Jun/0000-0003-2982-7960; Abbah, Sunny/0000-0001-6053-6673
FU A*STAR BMRC [09/1/21/19/601]
FX A*STAR BMRC grant 09/1/21/19/601 funds were received to support this
   work.
CR Abbah SA, 2011, TISSUE ENG PT A, V17, P809, DOI [10.1089/ten.tea.2010.0255, 10.1089/ten.TEA.2010.0255]
   Abbah SA, 2011, SPINE, V36, P1752, DOI 10.1097/BRS.0b013e31822576a4
   Abbah SA, 2009, BIOMATERIALS, V30, P5086, DOI 10.1016/j.biomaterials.2009.05.067
   Abbah SA, 2013, TISSUE ENG PT A, V19, P350, DOI [10.1089/ten.TEA.2012.0274, 10.1089/ten.tea.2012.0274]
   Abbah SA, 2014, TISSUE ENG PT A, V20, P1679, DOI [10.1089/ten.tea.2013.0593, 10.1089/ten.TEA.2013.0593]
   Abbah SA, 2012, J CONTROL RELEASE, V162, P364, DOI 10.1016/j.jconrel.2012.07.027
   Anderson CL, 2012, SPINE, V37, pE502, DOI 10.1097/BRS.0b013e318238870b
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   Bitton R, 2014, SMALL, V10, P500, DOI 10.1002/smll.201300254
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   Brower RS, 2008, SPINE, V33, pE653, DOI 10.1097/BRS.0b013e31817c4f1c
   Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Carragee EJ, 2011, SPINE J, V11, P511, DOI 10.1016/j.spinee.2011.02.013
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carragee EJ, 2009, SPINE J, V9, P873, DOI 10.1016/j.spinee.2009.09.001
   Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876
   Deyo RA, 2012, SPINE, V37, P222, DOI 10.1097/BRS.0b013e31821bfa3a
   Dougherty R, 2007, MICROSC MICROANAL S2, V13, P1678, DOI DOI 10.1017/S1431927607074430
   Fluhr H, 2011, MOL HUM REPROD, V17, P354, DOI 10.1093/molehr/gar001
   Foldager C, 2009, BONE, V45, P267, DOI 10.1016/j.bone.2009.04.240
   Foldager C, 2008, SPINE, V33, P2683, DOI 10.1097/BRS.0b013e31817fce91
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Haid Jr RW, 2004, SPINE J, V4, P38
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   Helgeson MD, 2011, SPINE J, V11, P507, DOI 10.1016/j.spinee.2011.01.017
   Joseph V, 2007, SPINE, V32, P2885, DOI 10.1097/BRS.0b013e31815b7596
   King Gaston N., 2001, Current Pharmaceutical Biotechnology, V2, P131, DOI 10.2174/1389201013378716
   Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078551
   Knox JB, 2011, SPINE, V36, P672, DOI 10.1097/BRS.0b013e3181e030e0
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Koo KH, 2012, ARTIF ORGANS, V36, P629, DOI 10.1111/j.1525-1594.2012.01444.x
   Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x
   Li HS, 2004, EUR SPINE J, V13, P354, DOI 10.1007/s00586-003-0647-3
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730
   Mok JM, 2008, SPINE, V33, P1668, DOI 10.1097/BRS.0b013e31817b6229
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Pollari S, 2012, MOL CANCER RES, V10, P597, DOI 10.1158/1541-7786.MCR-11-0482
   Reid JJ, 2011, J BIOMECH, V44, P213, DOI 10.1016/j.jbiomech.2010.10.021
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9
   Shen HX, 2010, SPINE, V35, P747, DOI 10.1097/BRS.0b013e3181bc3420
   Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Singh K, 2006, J SPINAL DISORD TECH, V19, P416, DOI 10.1097/00024720-200608000-00008
   Singh K, 2013, SPINE J, V13, P1118, DOI 10.1016/j.spinee.2013.07.028
   Smoljanovic T, 2008, SPINE, V33, P224, DOI 10.1097/BRS.0b013e31816068e2
   Smoljanovic T, 2010, SPINE, V35, pE622, DOI 10.1097/BRS.0b013e3181e15edf
   Tannoury CA, 2014, SPINE J, V14, P552, DOI 10.1016/j.spinee.2013.08.060
   Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534
   Wang M, 2013, SPINE, V38, P1452, DOI 10.1097/BRS.0b013e31828a3504
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
NR 61
TC 6
Z9 6
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD JUL 1
PY 2015
VL 40
IS 13
BP 964
EP 973
DI 10.1097/BRS.0000000000000935
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA CM8JJ
UT WOS:000357946000002
PM 25893351
DA 2018-10-19
ER

PT J
AU Hulsart-Billstrom, G
   Bergman, K
   Andersson, B
   Hilborn, J
   Larsson, S
   Jonsson, KB
AF Hulsart-Billstrom, Gry
   Bergman, Kristoffer
   Andersson, Brittmarie
   Hilborn, Jons
   Larsson, Sune
   Jonsson, Kenneth B.
TI A uni-cortical femoral defect model in the rat: evaluation using
   injectable hyaluronan hydrogel as a carrier for bone morphogenetic
   protein-2
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE large femoral bone defect; rat model; hydrogel; in vivo; osteogenesis;
   bone regeneration; 3R
ID CELL-SURFACE RECEPTOR; COLLAGEN SPONGES; BOVINE COLLAGEN; CLINICAL USE;
   IN-VIVO; ACID; REGENERATION; POLYSACCHARIDE; DELIVERY; REPAIR
AB The development of biomaterial for bone regeneration requires animal models that are reliable and designed to mimic clinically relevant situations. We have previously investigated hydrogels comprised of modified hyaluronic acid and polyvinyl alcohol in models of ectopic bone formation. This hydrogel induces bone regeneration when loaded with bone morphogenetic proteins (BMPs). To allow further optimization of hydrogels, we developed a new, femoral, non-critical-sized cortical defect model. In the rat femur, we drilled standardized, elongated unilateral cortical defects that did not require stabilization and that could be created bilaterally to allow paired comparisons of biomaterials. After optimizing the defect size, subsequent stress fractures occurred in only 8% and the defect healed partially over the 40 day study period. In a time-course experiment, we treated bone defects with the previously studied hyaluronan hydrogel loaded with 10 mu g hydroxyapatite and 6 mu g BMP-2. The shape of the defect allowed controlled containment of the material within the defect. The defect in the right leg was left untreated, while the left defect was filled with 40 mu l of the BMP hydrogel. As determined by pQCT analysis, the treated defects had a higher bone mineral content, bone area and bone density than control defects. The relative difference was greatest between the groups at 10 and 20 days and diminished as the defect healed in the untreated legs. We conclude that this animal model allows facile and rapid screening of biomaterials for bone regeneration in cortical femoral defects without requiring external fixation. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Hulsart-Billstrom, Gry; Andersson, Brittmarie; Larsson, Sune; Jonsson, Kenneth B.] Uppsala Univ, Dept Surg Sci, Unit Orthopaed, SE-75185 Uppsala, Sweden.
   [Bergman, Kristoffer; Hilborn, Jons] Uppsala Univ, Angstrom Lab, Dept Mat Chem, SE-75185 Uppsala, Sweden.
RP Jonsson, KB (reprint author), Uppsala Univ, Dept Surg Sci, Unit Orthopaed, SE-75185 Uppsala, Sweden.
EM kenneth.jonsson@surgsci.uu.se
OI Hilborn, Jons/0000-0001-6947-9601
FU Biodesign
FX Biodesign is gratefully acknowledged for financial support.
CR An YH, 2003, HDB HIST METHODS BON
   Arosarena O, 2005, Orthod Craniofac Res, V8, P267, DOI 10.1111/j.1601-6343.2005.00349.x
   Arosarena OA, 2005, OTOLARYNG HEAD NECK, V132, P592, DOI 10.1016/j.otohns.2004.09.137
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   BAY BK, 1993, BONE, V14, P225, DOI 10.1016/8756-3282(93)90145-Z
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   DELMAGE JM, 1986, ANN CLIN LAB SCI, V16, P303
   Dimitriou R, 2011, INJURY, V42, pS3, DOI 10.1016/j.injury.2011.06.015
   Docherty-Skogh AC, 2010, PLAST RECONSTR SURG, V125, P1383, DOI 10.1097/PRS.0b013e3181d629dc
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Hilborn J., 2011, WILEY INTERDISCIP RE, V11, P471
   Hulsart-Billstrom G, 2011, ACTA BIOMATER, V7, P3042, DOI 10.1016/j.actbio.2011.04.021
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   LAURENT TC, 1992, FASEB J, V6, P2397
   Leibold RA, 2002, AM J ROENTGENOL, V179, P198, DOI 10.2214/ajr.179.1.1790198
   Manes S, 2000, IUBMB LIFE, V49, P89
   MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   MELCHER AH, 1962, J BONE JOINT SURG BR, V44, P928
   Meyer K, 1934, J BIOL CHEM, V107, P629
   Ossipov DA, 2007, J APPL POLYM SCI, V106, P60, DOI 10.1002/app.26455
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   RAY RD, 1957, J BONE JOINT SURG AM, V39, P1119, DOI 10.2106/00004623-195739050-00012
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   TRAUTINGER F, 1991, ARCH DERMATOL RES, V283, P395, DOI 10.1007/BF00371822
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   Wang YL, 2011, ARCH ORTHOP TRAUM SU, V131, P991, DOI 10.1007/s00402-011-1269-6
   Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   ZHENG SX, 2004, BIOMATERIALS, V25, P1339, DOI DOI 10.1016/J.BIOMATERIALS.2003.08.014
NR 42
TC 6
Z9 7
U1 2
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUL
PY 2015
VL 9
IS 7
BP 799
EP 807
DI 10.1002/term.1655
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CM7NV
UT WOS:000357881900006
PM 23225778
DA 2018-10-19
ER

PT J
AU Secker, C
   Brosnan, SM
   Luxenhofer, R
   Schlaad, H
AF Secker, Christian
   Brosnan, Sarah M.
   Luxenhofer, Robert
   Schlaad, Helmut
TI Poly(alpha-Peptoid)s Revisited: Synthesis, Properties, and Use as
   Biomaterial
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE amino acid N-carboxyanhydride (NCA); biomaterials; peptides; properties;
   ring-opening polymerization
ID ALPHA-AMINO-ACIDS; RING-OPENING POLYMERIZATION; PHOSGENE-FREE SYNTHESIS;
   MEDIATED ZWITTERIONIC POLYMERIZATION; ACTIVATED URETHANE DERIVATIVES;
   SEQUENCE-SPECIFIC POLYPEPTOIDS; GLYCINE N-CARBOXYANHYDRIDES;
   POLY-BETA-PEPTOIDS; INITIATED POLYMERIZATION; DIBLOCK COPOLYPEPTOIDS
AB Polypeptoids have been of great interest in the polymer science community since the early half of the last century; however, they had been basically forgotten materials until the last decades in which they have enjoyed an exciting revival. In this mini-review, we focus on the recent developments in polypeptoid chemistry, with particular focus on polymers synthesized by the ring-opening polymerization (ROP) of amino acid N-carboxyanhydrides (NCAs). Specifically, we will review traditional monomer synthesis (such as Leuchs, Katchalski, and Kricheldorf) and recent advances in polymerization methods to yield both linear, cyclic, and functional polymers, solution and bulk thermal properties, and preliminary results on the use of polypeptoids as biomaterials (i.e immunogenicity, biodistribution, degradability, and drug delivery).
C1 [Secker, Christian; Brosnan, Sarah M.] Max Planck Inst Colloids & Interfaces, Dept Colloid Chem, D-14424 Potsdam, Germany.
   [Luxenhofer, Robert] Univ Wurzburg, Chair Chem Technol Mat Synth, Dept Chem & Pharm, D-97070 Wurzburg, Germany.
   [Schlaad, Helmut] Univ Potsdam, Inst Chem, D-14476 Potsdam, Germany.
RP Schlaad, H (reprint author), Univ Potsdam, Inst Chem, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany.
EM schlaad@uni-potsdam.de
RI Luxenhofer, Robert/C-2825-2008
OI Luxenhofer, Robert/0000-0001-5567-7404; Brosnan, Sarah
   M./0000-0002-0881-889X
FU Max Planck Society; National Science Foundation Postdoctoral Research
   Fellowship in Biology [DBI-1308104]
FX Financial support was given by the Max Planck Society and National
   Science Foundation Postdoctoral Research Fellowship in Biology under
   grant no. DBI-1308104.
CR Aseyev V, 2011, ADV POLYM SCI, V242, P29, DOI 10.1007/12_2010_57
   BALLARD DGH, 1958, J CHEM SOC, P355, DOI 10.1039/jr9580000355
   Bamford C. H., 1976, COMPREHENSIVE CHEM K, V15, P583
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Becer CR, 2009, ANGEW CHEM INT EDIT, V48, P4900, DOI 10.1002/anie.200900755
   Birke A, 2014, BIOMACROMOLECULES, V15, P548, DOI 10.1021/bm401542z
   Brosnan SM, 2014, POLYMER, V55, P5511, DOI 10.1016/j.polymer.2014.08.067
   Chen XP, 2011, J POLYM SCI POL CHEM, V49, P3030, DOI 10.1002/pola.24739
   Chen XP, 2010, MACROMOLECULES, V43, P1341, DOI 10.1021/ma902427m
   Connor EF, 2002, J AM CHEM SOC, V124, P914, DOI 10.1021/ja0173324
   Darensbourg DJ, 2004, J AM CHEM SOC, V126, P13808, DOI 10.1021/ja046225h
   Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g
   Diehl C, 2010, SOFT MATTER, V6, P3784, DOI 10.1039/c0sm00114g
   Dimitrov I, 2007, PROG POLYM SCI, V32, P1275, DOI 10.1016/j.progpolymsci.2007.07.001
   DOUY A, 1986, MAKROMOL CHEM, V187, P465
   EHLER KW, 1976, BIOCHIM BIOPHYS ACTA, V434, P233, DOI 10.1016/0005-2795(76)90055-6
   Fetsch C, 2015, MACROMOL CHEM PHYS, V216, P547, DOI 10.1002/macp.201400534
   Fetsch C, 2013, POLYMERS-BASEL, V5, P112, DOI 10.3390/polym5010112
   Fetsch C, 2012, MACROMOL RAPID COMM, V33, P1708, DOI 10.1002/marc.201200189
   Fetsch C, 2011, MACROMOLECULES, V44, P6746, DOI 10.1021/ma201015y
   Fuchs F., 1922, CHEM BER, V55, P2943
   Fujita Y, 2007, J POLYM SCI POL CHEM, V45, P5365, DOI 10.1002/pola.22281
   Gangloff N, 2013, MACROMOL RAPID COMM, V34, P997, DOI 10.1002/marc.201300269
   Grossmann A., 2014, THESIS TU DRESDEN
   Grossmann A, 2012, MACROMOL RAPID COMM, V33, P1714, DOI 10.1002/marc.201200263
   Guo L, 2012, J AM CHEM SOC, V134, P9163, DOI 10.1021/ja210842b
   Guo L, 2011, BIOPOLYMERS, V96, P596, DOI 10.1002/bip.21597
   Guo L, 2009, J AM CHEM SOC, V131, P18072, DOI 10.1021/ja907380d
   Hadjichristidis N, 2009, CHEM REV, V109, P5528, DOI 10.1021/cr900049t
   Hara E, 2014, J PEPT SCI, V20, P570, DOI 10.1002/psc.2655
   Hara E, 2012, INT IMMUNOPHARMACOL, V14, P261, DOI 10.1016/j.intimp.2012.07.011
   Heller P, 2015, MACROMOL BIOSCI, V15, P63, DOI 10.1002/mabi.201400417
   Heller P, 2015, MACROMOL RAPID COMM, V36, P38, DOI 10.1002/marc.201400466
   Heller P, 2014, MACROMOL BIOSCI, V14, P1380, DOI 10.1002/mabi.201400167
   HENDERSON DC, 1987, INT ARCH ALLER A IMM, V82, P208, DOI 10.1159/000234188
   Ishida T, 2008, INT J PHARM, V354, P56, DOI 10.1016/j.ijpharm.2007.11.005
   Jia L, 2002, J AM CHEM SOC, V124, P7282, DOI 10.1021/ja0263691
   Kamei Y, 2008, MACROMOLECULES, V41, P7913, DOI 10.1021/ma801315r
   Kamei Y, 2008, J POLYM SCI POL CHEM, V46, P2525, DOI 10.1002/pola.22584
   KATCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243, DOI 10.1016/S0065-3233(08)60600-2
   Kidchob T, 1996, J CONTROL RELEASE, V40, P285, DOI 10.1016/0168-3659(95)00196-4
   Kidchob T, 1998, J CONTROL RELEASE, V51, P241, DOI 10.1016/S0168-3659(97)00176-4
   Kidchob T, 1998, J CONTROL RELEASE, V50, P205, DOI 10.1016/S0168-3659(97)00135-1
   Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303
   Koga K, 2010, J POLYM SCI POL CHEM, V48, P4351, DOI 10.1002/pola.24213
   Koga K, 2009, J POLYM SCI POL CHEM, V47, P3839, DOI 10.1002/pola.23450
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Kricheldorf HR, 2006, ANGEW CHEM INT EDIT, V45, P5752, DOI 10.1002/anie.200600693
   KRICHELDORF HR, 1976, MAKROMOL CHEM, V177, P1243
   Lahasky SH, 2014, POLYM CHEM-UK, V5, P1418, DOI 10.1039/c3py01356a
   Lahasky SH, 2011, MACROMOLECULES, V44, P9063, DOI 10.1021/ma201948u
   Lau KHA, 2012, LANGMUIR, V28, P2288, DOI 10.1021/la203905g
   Lau KHA, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201400225
   Lau KHA, 2012, LANGMUIR, V28, P16099, DOI 10.1021/la302131n
   Laufer B, 2009, J PEPT SCI, V15, P141, DOI 10.1002/psc.1076
   Lee CU, 2013, MACROMOLECULES, V46, P8213, DOI 10.1021/ma401067f
   Lee CU, 2013, ACS MACRO LETT, V2, P436, DOI 10.1021/mz300667n
   Lee CU, 2011, MACROMOLECULES, V44, P9574, DOI 10.1021/ma2020936
   Leuchs H, 1906, BER DTSCH CHEM GES, V39, P857, DOI 10.1002/cber.190603901133
   LEVY AL, 1950, NATURE, V165, P152, DOI 10.1038/165152a0
   Luxenhofer R, 2013, J POLYM SCI POL CHEM, V51, P2731, DOI 10.1002/pola.26687
   Luxenhofer R, 2012, MACROMOL RAPID COMM, V33, P1613, DOI 10.1002/marc.201200354
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   Makino A, 2009, BIOMATERIALS, V30, P5156, DOI 10.1016/j.biomaterials.2009.05.046
   MOBASHERY S, 1985, J ORG CHEM, V50, P2200, DOI 10.1021/jo00212a042
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Patch J.A., 2004, PSEUDOPEPTIDES DRUG, P1
   Robinson JW, 2013, MACROMOLECULES, V46, P580, DOI 10.1021/ma302412v
   Robinson JW, 2012, CHEM COMMUN, V48, P7835, DOI 10.1039/c2cc33881e
   Rosales AM, 2010, MACROMOLECULES, V43, P5627, DOI 10.1021/ma1002563
   SARID S, 1959, J BIOL CHEM, V234, P1740
   Schlaad H, 2010, MACROMOL RAPID COMM, V31, P511, DOI 10.1002/marc.200900683
   Schneider M, 2013, LANGMUIR, V29, P6983, DOI 10.1021/la4009174
   Schulz A, 2014, ACS NANO, V8, P2686, DOI 10.1021/nn406388t
   Secker C., 2015, THESIS U POTSDAM
   Secker C, 2015, EUR POLYM J, V62, P394, DOI 10.1016/j.eurpolymj.2014.08.028
   SELA M, 1959, ADV PROTEIN CHEM, V14, P391, DOI 10.1016/S0065-3233(08)60614-2
   SELA MICHAEL, 1966, ADVANCE IMMUNOL, V5, P29, DOI 10.1016/S0065-2776(08)60272-2
   Sigmund F, 1926, H-S Z PHYSIOL CHEM, V157, P91, DOI 10.1515/bchm2.1926.157.1-3.91
   SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367
   SISIDO M, 1977, MAKROMOL CHEM, V178, P3107
   Statz AR, 2008, SOFT MATTER, V4, P131, DOI 10.1039/b711944e
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Sun J, 2013, ACS NANO, V7, P4715, DOI 10.1021/nn4015714
   Surman F, 2015, MACROMOL BIOSCI, V15, P636, DOI 10.1002/mabi.201400470
   Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96
   Szwarc M., 1965, ADV POLYM SCI, V4, P1
   Tanisaka H, 2008, BIOCONJUGATE CHEM, V19, P109, DOI 10.1021/bc7001665
   Tao XF, 2014, MACROMOLECULES, V47, P6173, DOI 10.1021/ma501131t
   Tao XF, 2014, MACROMOL RAPID COMM, V35, P875, DOI 10.1002/marc.201400066
   Tischer T, 2014, ADV MATER, V26, P4087, DOI 10.1002/adma.201401006
   TONELLI AE, 1976, BIOPOLYMERS, V15, P1615, DOI 10.1002/bip.1976.360150814
   Ulbricht J, 2014, BIOMATERIALS, V35, P4848, DOI 10.1016/j.biomaterials.2014.02.029
   WALEY SG, 1949, PROC R SOC LON SER-A, V199, P499, DOI 10.1098/rspa.1949.0151
   WESSELY F, 1950, MONATSH CHEM, V81, P861, DOI 10.1007/BF00899328
   Wessely F., 1926, Z PHYSL CHEM, V159, P102
   Wong S, 2015, J POLYM SCI POL CHEM, V53, P280, DOI 10.1002/pola.27320
   Yamada S, 2014, RSC ADV, V4, P29890, DOI 10.1039/c4ra03315a
   Yamada S, 2013, J POLYM SCI POL CHEM, V51, P3726, DOI 10.1002/pola.26775
   Yamada S, 2012, J POLYM SCI POL CHEM, V50, P2527, DOI 10.1002/pola.26052
   Zhang DH, 2012, MACROMOLECULES, V45, P5833, DOI 10.1021/ma202319g
   Zhou MY, 2011, J MATER CHEM, V21, P693, DOI 10.1039/c0jm01266a
   Zuckermann RN, 2011, BIOPOLYMERS, V96, P545, DOI 10.1002/bip.21573
NR 103
TC 25
Z9 25
U1 5
U2 107
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL
PY 2015
VL 15
IS 7
BP 881
EP 891
DI 10.1002/mabi.201500023
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CM9GN
UT WOS:000358015600001
PM 25851782
DA 2018-10-19
ER

PT J
AU Zhang, SQ
   Karaca, BT
   VanOosten, SK
   Yuca, E
   Mahalingam, S
   Edirisinghe, M
   Tamerler, C
AF Zhang, Siqi
   Karaca, Banu Taktak
   VanOosten, Sarah Kay
   Yuca, Esra
   Mahalingam, Suntharavathanan
   Edirisinghe, Mohan
   Tamerler, Candan
TI Coupling Infusion and Gyration for the Nanoscale Assembly of Functional
   Polymer Nanofibers Integrated with Genetically Engineered Proteins
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE genetically engineered proteins; gyration; infusion; nanofibers;
   peptides
ID PRESSURIZED GYRATION; BINDING PEPTIDE; FIBERS; IMMOBILIZATION;
   MORPHOLOGY; BIOSENSORS; BEHAVIOR
AB Nanofibers featuring functional nanoassemblies show great promise as enabling constituents for a diverse range of applications in areas such as tissue engineering, sensing, optoelectronics, and nanophotonics due to their controlled organization and architecture. An infusion gyration method is reported that enables the production of nanofibers with inherent biological functions by simply adjusting the flow rate of a polymer solution. Sufficient polymer chain entanglement is obtained at Berry number > 1.6 to make bead-free fibers integrated with gold nanoparticles and proteins, in the diameter range of 117-216 nm. Integration of gold nanoparticles into the nanofiber assembly is followed using a gold-binding peptide tag genetically conjugated to red fluorescence protein (DsRed). Fluorescence microscopy analysis corroborated with Fourier transform infrared spectroscopy (FTIR) data confirms the integration of the engineered red fluorescence protein with the nanofibers. The gold nanoparticle decorated nanofibers having red fluorescence protein as an integral part keep their biological functionality including copper-induced fluorescence quenching of the DsRed protein due to its selective Cu+2 binding. Thus, coupling the infusion gyration method in this way offers a simple nanoscale assembly approach to integrate a diverse repertoire of protein functionalities into nanofibers to generate biohybrid materials for imaging, sensing, and biomaterial applications.
C1 [Zhang, Siqi; Mahalingam, Suntharavathanan; Edirisinghe, Mohan] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Karaca, Banu Taktak; VanOosten, Sarah Kay; Yuca, Esra; Tamerler, Candan] Univ Kansas, Bioengn Res Ctr BERC, Dept Mech Engn, Lawrence, KS 66045 USA.
RP Edirisinghe, M (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk; ctamerler@ku.edu
OI Mahalingam, Dr Suntharavathanan/0000-0002-9617-8449; Tamerler,
   Candan/0000-0002-1960-2218
FU Engineering and Physical Science Research Council (EPSRC, UK)-University
   College London (UCL); EPSRC [EP/L023059/1]; University of Kansas; NFRFG;
   TUBITAK-2214-International Doctoral Research Fellowship; Engineering and
   Physical Sciences Research Council [EP/L023059/1]
FX UK authors are grateful for an Engineering and Physical Science Research
   Council (EPSRC, UK)-University College London (UCL) Knowledge Exchange
   Programme Award, which initiated this work and helped to attract
   privately funded researcher S.Z.; S.M. is supported by EPSRC grant
   EP/L023059/1. USA authors greatly appreciate University of Kansas Start
   Up and NFRFG Funds, also a TUBITAK-2214-International Doctoral Research
   Fellowship for Banu Taktak Karaca.
CR Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328
   Fan JZ, 2014, RSC ADV, V4, P27683, DOI 10.1039/c4ra03669g
   Hattori T, 2012, BIOCONJUGATE CHEM, V23, P1934, DOI 10.1021/bc300316p
   He JH, 2008, FIBER POLYM, V9, P140, DOI 10.1007/s12221-008-0023-3
   Hnilova M, 2008, LANGMUIR, V24, P12440, DOI 10.1021/la801468c
   Hnilova M, 2012, J COLLOID INTERF SCI, V365, P97, DOI 10.1016/j.jcis.2011.09.006
   Hsieh YT, 2011, POLYM J, V43, P762, DOI 10.1038/pj.2011.63
   Kacar T, 2009, BIOTECHNOL BIOENG, V103, P696, DOI 10.1002/bit.22282
   Karaca B. T., 2014, MRS ONLINE P LIB, V1621, P155
   Krauland EM, 2007, BIOTECHNOL BIOENG, V97, P1009, DOI 10.1002/bit.21341
   Liu JZ, 2014, MACROMOL RAPID COMM, V35, P1503, DOI 10.1002/marc.201400274
   Mahalingam S, 2015, LANGMUIR, V31, P659, DOI 10.1021/la502181g
   Mahalingam S, 2013, MACROMOL RAPID COMM, V34, P1134, DOI 10.1002/marc.201300339
   Mellado P, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662015
   Nochomovitz R, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145305
   Padron S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4769886
   Park TJ, 2006, ANAL CHEM, V78, P7197, DOI 10.1021/ac060976f
   Saquing CD, 2009, SMALL, V5, P944, DOI 10.1002/smll.200801273
   Tamerler C, 2006, SMALL, V2, P1372, DOI 10.1002/smll.200600070
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Uzun SD, 2014, ACS APPL MATER INTER, V6, P5235, DOI 10.1021/am5005927
   Wang HX, 2009, CHEMBIOCHEM, V10, P2560, DOI 10.1002/cbic.200900249
   Wannatong L, 2004, POLYM INT, V53, P1851, DOI 10.1002/pi.1599
   Wongsasulak S, 2007, POLYMER, V48, P448, DOI 10.1016/j.polymer.2006.11.025
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yuan XY, 2004, POLYM INT, V53, P1704, DOI 10.1002/pi.1538
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zhong H, 1999, J PHYS CHEM B, V103, P3947, DOI 10.1021/jp984518p
NR 29
TC 30
Z9 30
U1 7
U2 70
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD JUL
PY 2015
VL 36
IS 14
BP 1322
EP 1328
DI 10.1002/marc.201500174
PG 7
WC Polymer Science
SC Polymer Science
GA CN0DT
UT WOS:000358084300002
PM 26033345
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Crimu, C
   Bolat, G
   Munteanu, C
   Mareci, D
AF Crimu, C.
   Bolat, G.
   Munteanu, C.
   Mareci, D.
TI Degradation characteristics of Mg0.8Ca in saline solution with and
   without albumin protein investigated by electrochemical impedance
   spectroscopy
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; CORROSION BEHAVIOR; MAGNESIUM ALLOY; IMPLANT
   ALLOYS; TITANIUM-ALLOY; BONE; MICROSTRUCTURE
AB Biodegradable magnesium-calcium (MgCa) alloy is a very attractive biomaterial. Binary Mg0.8Ca alloy was fabricated. X-ray diffraction (XRD) analysis and optical microscopy observed showed that Mg0.8Ca alloy was composed of alpha(Mg) phase. The electrochemical impedance spectroscopy (EIS) technique was used for the study on the degradation characteristics of Mg0.8Ca alloy. Because the proteins have a role on the passivation of metals, the effect of albumin protein addition in NaCl solution on the electrochemical behaviour of Mg0.8Ca alloy was studied. It has been shown that in 0.9wt% NaCl solution the impedance was mainly characterised by one capacitive and one inductive effect, which related to the alloy charge transfer reaction and the relaxation of the absorbed corrosion compounds. The addition of 37.5 mg/mL albumin protein to 0.9wt% NaCl solution increased the impedance compared to that without albumin protein. The equivalent circuits simulating the electrochemical behaviour of Mg0.8Ca alloy in 0.9wt% NaCl solution with and without albumin protein were proposed. The surface morphology of the Mg0.8Ca samples after 1-week immersion in Mg0.8Ca alloy in 0.9wt% NaCl solution with albumin protein was studied using scanning electron microscopy (SEM). The electrochemical mechanism for degradation of Mg0.8Ca alloy in 0.9wt% NaCl solution is related to the albumin protein addition.
C1 [Crimu, C.; Munteanu, C.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Iasi 700050, Romania.
   [Bolat, G.; Mareci, D.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
RP Mareci, D (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, 73 Prof Dr Doc Mangeron St, Iasi 700050, Romania.
EM danmareci@yahoo.com
OI Mareci, Daniel/0000-0002-5859-1996
FU Romanian National Authority for Scientific Research, CNCS-UEFISCDI
   [PN-II-ID-PCE-2011-3-0218]
FX This work was supported by a grant from the Romanian National Authority
   for Scientific Research, CNCS-UEFISCDI, project number
   PN-II-ID-PCE-2011-3-0218.
CR [Anonymous], 1999, G190 ASTM
   Barbinta AC, 2014, MATER CORROS, V65, P1017, DOI 10.1002/maco.201307294
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Dilea M, 2013, MATER CORROS, V64, P493, DOI 10.1002/maco.201206526
   Dragan-Raileanu LA, 2014, MATER CORROS, V65, P828, DOI 10.1002/maco.201307126
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Li T, 2015, MATER CORROS, V66, P7, DOI 10.1002/maco.201307528
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Mareci D, 2010, MATER CORROS, V61, P768, DOI 10.1002/maco.200905527
   Mindroiu M, 2013, MATER CORROS, V64, P926, DOI 10.1002/maco.201106480
   Moreno JMC, 2014, MATER CORROS, V65, P703, DOI 10.1002/maco.201307053
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M., 1998, J JPN SOC MECH ENG A, V64, P312
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Rad HRB, 2012, MATER DESIGN, V33, P88, DOI 10.1016/j.matdes.2011.06.057
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Shaw B.A., 2003, CORROSION RESISTANCE
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Vasilescu C, 2014, MATER CORROS, V65, P715, DOI 10.1002/maco.201206952
   Von Der Hoh N., 2007, ADV ENG MATER, V11, pB47
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Yang S, 2013, MATER CORROS, V64, P402, DOI 10.1002/maco.201106478
   Zhang JS, 2015, MATER CORROS, V66, P542, DOI 10.1002/maco.201407696
NR 30
TC 3
Z9 3
U1 2
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-5117
EI 1521-4176
J9 MATER CORROS
JI Mater. Corros.
PD JUL
PY 2015
VL 66
IS 7
BP 649
EP 655
DI 10.1002/maco.201407980
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CL9XR
UT WOS:000357332900005
DA 2018-10-19
ER

PT J
AU Barrioni, BR
   de Carvalho, SM
   Orefice, RL
   de Oliveira, AAR
   Pereira, MD
AF Barrioni, Breno Rocha
   de Carvalho, Sandhra Maria
   Orefice, Rodrigo Lambert
   Rocha de Oliveira, Agda Aline
   Pereira, Marivalda de Magalhaes
TI Synthesis and characterization of biodegradable polyurethane films based
   on HDI with hydrolyzable crosslinked bonds and a homogeneous structure
   for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biodegradable polyurethane; Films; Crosslinked polyurethane;
   Biomaterial; Biodegradable polymer; Mechanical tests
ID TISSUE ENGINEERING APPLICATIONS; IN-VITRO DEGRADATION; SEGMENTED
   POLYURETHANES; CHAIN EXTENDERS; POLY(ETHYLENE GLYCOL); POLY(ESTER
   URETHANE)S; MECHANICAL-PROPERTIES; THERMAL-PROPERTIES; HARD SEGMENT;
   ELASTOMERS
AB Synthetic biodegradable polymers are considered strategic in the biomaterials field and are used in various applications. Among the polymers used as biomaterials, polyurethanes (Pus) feature prominently due to their versatility and the ability to obtain products with a wide range of physical and mechanical properties. In this work, new biodegradable polyurethane films were developed based on hexamethylene diisocyanate (HDI) and glycerol as the hard segment (HS), and poly(caprolactone) trial (PCL triol) and low-molecular-weight poly( ethylene glycol) PEG as the soft segment (SS) without the use of a catalyst. The films obtained were characterized by structural, mechanical and biological testing. A highly connected network with a homogeneous PU structure was obtained due to crosslinked bonds. The films showed amorphous structures, high water uptake, hydrogel behavior, and susceptibility to hydrolytic degradation. Mechanical tests indicated that the films reached a high deformation at break of up to 425.4%, an elastic modulus of 1.6 MPa and a tensile strength of 3.6 MPa. The materials presented a moderate toxic effect on MTT assay and can be considered potential materials for biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Barrioni, Breno Rocha; de Carvalho, Sandhra Maria; Orefice, Rodrigo Lambert; Rocha de Oliveira, Agda Aline; Pereira, Marivalda de Magalhaes] Univ Fed Minas Gerais, Dept Met Engn & Mat, Sch Engn, BR-31270901 Belo Horizonte, MG, Brazil.
RP Barrioni, BR (reprint author), Univ Fed Minas Gerais, Dept Met Engn & Mat, Sch Engn, Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM brenobarrionibh@hotmail.com; sandhra_carvalho@yahoo.com.br;
   rorefice@demet.ufmg.br; agdalinero@yahoo.com; mpereira@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018; Barrioni, Breno/H-4769-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Barrioni,
   Breno/0000-0002-8681-6451
FU CNPq; CAPES; FAPEMIG/Brazil
FX The authors gratefully acknowledge financial support from CNPq, CAPES
   and FAPEMIG/Brazil.
CR Allan D, 2013, POLYM DEGRAD STABIL, V98, P535, DOI 10.1016/j.polymdegradstab.2012.12.002
   Bil M, 2010, ACTA BIOMATER, V6, P2501, DOI 10.1016/j.actbio.2009.08.037
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Caridade SG, 2013, J MECH BEHAV BIOMED, V20, P173, DOI 10.1016/j.jmbbm.2012.11.012
   Cauich-rodriguez J. V., 2012, DEGRADATION POLYURET
   Chan-Chan LH, 2010, ACTA BIOMATER, V6, P2035, DOI 10.1016/j.actbio.2009.12.010
   Chattopadhyay DK, 2007, PROG POLYM SCI, V32, P352, DOI 10.1016/j.progpolymsci.2006.05.003
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Chiou BS, 2002, J APPL POLYM SCI, V83, P212, DOI 10.1002/app.10056
   da Silva GR, 2011, MAT SCI ENG C-MATER, V31, P414, DOI 10.1016/j.msec.2010.10.019
   da Silva GR, 2010, POLYM DEGRAD STABIL, V95, P491, DOI 10.1016/j.polymdegradstab.2010.01.001
   Fu HG, 2011, SOFT MATTER, V7, P3546, DOI 10.1039/c0sm01350a
   Guelcher SA, 2005, ACTA BIOMATER, V1, P471, DOI 10.1016/j.actbio.2005.02.007
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gupta T, 2003, THERMOCHIM ACTA, V402, P169, DOI 10.1016/S0040-6031(02)00571-3
   Hood MA, 2010, POLYMER, V51, P2191, DOI 10.1016/j.polymer.2010.03.027
   Jia WJ, 2006, MATER LETT, V60, P3686, DOI 10.1016/j.matlet.2006.03.089
   Kim HI, 2011, BIOMATERIALS, V32, P2241, DOI 10.1016/j.biomaterials.2010.11.067
   Krol P, 2007, J APPL POLYM SCI, V104, P1464, DOI 10.1002/app.25011
   Krol P, 2007, PROG MATER SCI, V52, P915, DOI 10.1016/j.pmatsci.2006.11.001
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lee JW, 2001, MACROMOLECULES, V34, P3928, DOI 10.1021/ma0022351
   Liu QY, 2012, PROG POLYM SCI, V37, P715, DOI 10.1016/j.progpolymsci.2011.11.001
   Loh XJ, 2008, BIOMATERIALS, V29, P3185, DOI 10.1016/j.biomaterials.2008.04.015
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   Lonnroth EC, 2003, ACTA ODONTOL SCAND, V61, P52
   Lonnroth Emma Christin, 2005, Int J Occup Saf Ergon, V11, P131
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   Mondal S, 2012, POLYM DEGRAD STABIL, V97, P1553, DOI 10.1016/j.polymdegradstab.2012.04.008
   Oprea S, 2012, J APPL POLYM SCI, V124, P1059, DOI 10.1002/app.35196
   Oprea S, 2010, POLYM BULL, V65, P753, DOI 10.1007/s00289-009-0242-9
   Orefice RL, 2005, MACROMOLECULES, V38, P4058, DOI 10.1021/ma050213e
   Patel A, 2007, MACROMOL BIOSCI, V7, P727, DOI 10.1002/mabi.200600272
   Perez-Liminana MA, 2005, INT J ADHES ADHES, V25, P507, DOI 10.1016/j.ijadhadh.2005.02.002
   Piao LH, 2003, POLYMER, V44, P2025, DOI 10.1016/S0032-3861(03)00087-9
   Qu ZH, 2008, ACTA BIOMATER, V4, P1360, DOI 10.1016/j.actbio.2008.03.006
   Reddy TT, 2008, BIOMACROMOLECULES, V9, P1313, DOI 10.1021/bm701390f
   de Oliveira AAR, 2012, J BIOMED MATER RES B, V100B, P1387, DOI 10.1002/jbm.b.32710
   Rogulska M, 2013, J THERM ANAL CALORIM, V114, P903, DOI 10.1007/s10973-013-3007-5
   Rychly J, 2011, POLYM DEGRAD STABIL, V96, P462, DOI 10.1016/j.polymdegradstab.2011.01.012
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Spirkova M, 2011, EUR POLYM J, V47, P959, DOI 10.1016/j.eurpolymj.2011.01.001
   Talakesh MM, 2012, J MEMBRANE SCI, V415, P469, DOI 10.1016/j.memsci.2012.05.033
   Tatai L, 2007, BIOMATERIALS, V28, P5407, DOI 10.1016/j.biomaterials.2007.08.035
   Teramoto N, 2010, J APPL POLYM SCI, V115, P3199, DOI 10.1002/app.30019
   Trovati G., 2009, CHARACTERIZATION POL, P1
   van der Schuur M, 2006, POLYMER, V47, P1091, DOI 10.1016/j.polymer.2005.11.074
   Wang J, 2013, J APPL POLYM SCI, V128, P4047, DOI 10.1002/app.38613
   Wessler K, 2006, MACROMOL SYMP, V245, P161, DOI 10.1002/masy.200651322
   Yao DG, 2006, J BIOMED MATER RES B, V77B, P287, DOI 10.1002/jbm.b.30419
   Yu TL, 1999, J POLYM SCI POL PHYS, V37, P2673, DOI 10.1002/(SICI)1099-0488(19990915)37:18<2673::AID-POLB11>3.0.CO;2-N
   Yuan Y., 2013, SURFACE SCI TECHNIQU, V51
   Zhang Q, 2013, COLLOID SURFACE B, V102, P354, DOI 10.1016/j.colsurfb.2012.07.037
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 58
TC 54
Z9 56
U1 2
U2 111
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 22
EP 30
DI 10.1016/j.msec.2015.03.027
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100004
PM 25953536
DA 2018-10-19
ER

PT J
AU Siqueira, L
   Passador, FR
   Costa, MM
   Lobo, AO
   Sousa, E
AF Siqueira, L.
   Passador, F. R.
   Costa, M. M.
   Lobo, A. O.
   Sousa, E.
TI Influence of the addition of beta-TCP on the morphology, thermal
   properties and cell viability of poly (lactic acid) fibers obtained by
   electrospinning
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Scaffolds; Electrospinning; Polylactic acid; Tricalcium phosphate
ID POLY(L-LACTIC ACID); BEHAVIOR; FABRICATION; SCAFFOLDS; NANOFIBERS;
   MAGNESIUM; STRENGTH
AB Electrospinning is a simple and low-cost way to fabricate fibers. Among the various polymers used in electrospinning process, the poly (lactic acid) (PLA) stands out due to its excellent biodegradability and biocompatibility. Calcium phosphate ceramics has been recognized as an attractive biomaterial because their chemical composition is similar to the mineral component of the hard tissue in the body. Furthermore, they are bioactive and osteoinductive and some are even quite biodegradable. The beta-tricalcium phosphate (beta-TCP) particles were synthesized by solid state reaction. Different contents of beta-TCP particles were incorporated in polymer matrices to form fibers of PLA/beta-TCP composites by electrospinning aiming a possible application as a scaffold for tissue engineering. The fibers were characterized by scanning electron microscopy (SEM), infrared (FTIR), differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA). The average diameter of the fibers varied in the range of 260-519.6 +/- 50 nm. The presence of beta-TCP particles promoted changes on thermal properties of the fibers. The composite with B wt-% of beta-TCP showed a low degree of crystallinity and can be used for application in tissue engineering. The cell viability was analyzed by reduction of the methyl tetrazolium salt by the pyruvate dehydrogenase enzymatic complex present in the matrix of mitochondria (MTT test). All PLA fiber groups, with different contents of beta-TCP, showed cytocompatibility ability with non-cytotoxicity effect and bioactive properties using SBF assay. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Siqueira, L.; Sousa, E.] UNIFESP, Inst Sci & Technol, Lab Bioceram, Sao Jose Dos Campos, SP, Brazil.
   [Passador, F. R.] UNIFESP, Inst Sci & Technol, Lab Polymer Proc, Sao Jose Dos Campos, SP, Brazil.
   [Costa, M. M.; Lobo, A. O.] UNIVAP, Dev Res Inst IP&D, Lab Biomed Nanotechnol, Sao Jose Dos Campos, SP, Brazil.
RP Lobo, AO (reprint author), 2911 Ave Shishima Hifumi,2911 Urbanova, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
EM aolobo@pq.cnpq.br; eliandra.sousa@unifesp.br
RI Lobo, Anderson/B-2893-2011
OI Lobo, Anderson/0000-0002-2544-0438
FU Sao Paulo Research Foundation (FAPESP) [2011/17877-7]; Brazilian
   Innovation Agency (FINEP) [01.13.0428.00]; National Counsel of
   Technological and Scientific Development (CNPq) [474090/2013-2];
   Coordination for the Improvement of Higher Education Personnel (CAPES)
FX The authors would like to thank The Sao Paulo Research Foundation
   (FAPESP) (grant number 2011/17877-7), Brazilian Innovation Agency
   (FINEP) (grant number 01.13.0428.00) National Counsel of Technological
   and Scientific Development (CNPq) (grant number: 474090/2013-2) and
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   for the financial support, Joao Paulo Barros Machado, PhD from the
   Laboratory of Sensors and Materials (LAS) of the National Institute of
   Space Research (INPE) for permitting XRD analysis and Ana Paula Lemes,
   PhD from University Federal of Sao Paulo (UNIFESP) for thermal analyses.
CR Auras R., 2004, MACROMOL BIOSCI, V4, P835
   Barbanti Samuel H., 2005, Polímeros, V15, P13, DOI 10.1590/S0104-14282005000100006
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Branciforti MC, 2009, J MACROMOL SCI B, V48, P1222, DOI 10.1080/10408390903060970
   Cardoso H. A. I., 2012, Cerâmica, V58, P225, DOI 10.1590/S0366-69132012000200013
   Favaro MM, 2009, POLYM ADVAN TECHNOL, V20, P940, DOI 10.1002/pat.1343
   FISHER EW, 1973, KOLLOID Z Z POLYM, V251, P980
   Garkhal K, 2007, J POLYM SCI POL CHEM, V45, P2755, DOI 10.1002/pola.22031
   Geneva S.H., 1992, TEST CYTOTOXICITY 5
   Haroosh HJ, 2012, J APPL POLYM SCI, V124, P3930, DOI 10.1002/app.35448
   Hoveizi E, 2014, CELL BIOL INT, V38, P41, DOI 10.1002/cbin.10178
   Jiang L, 2006, BIOMACROMOLECULES, V7, P199, DOI 10.1021/bm050581q
   Kawachi EY, 2000, QUIM NOVA, V23, P518, DOI 10.1590/S0100-40422000000400015
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mackle JN, 2011, MACROMOL BIOSCI, V11, P1272, DOI 10.1002/mabi.201100029
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pan PJ, 2008, MACROMOLECULES, V41, P4296, DOI 10.1021/ma800343g
   Pereira C.S., 1998, EMULS CELL MAT, P193
   Pereira RB, 2014, POLIMEROS, V24, P198, DOI 10.4322/polimeros.2014.042
   Pirani S, 2013, J APPL POLYM SCI, V130, P3345, DOI 10.1002/app.39576
   Neto WAR, 2012, POLYM DEGRAD STABIL, V97, P2037, DOI 10.1016/j.polymdegradstab.2012.03.048
   Sparatu M., 2008, REV ROUM CHIM, V53, P955
   Sun B., 2013, PROG POLYM SCI, V29
   Tammaro L, 2014, BIONANOMATERIALS, V15, P9
   Torres-Giner S, 2011, J APPL POLYM SCI, V122, P914, DOI 10.1002/app.34208
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Wang FM, 2006, INT ENDOD J, V39, P477, DOI 10.1111/j.1365-2591.2006.01114.x
   Yasuniwa M, 2004, J POLYM SCI POL PHYS, V42, P25, DOI 10.1002/polb.10674
   Zhang JM, 2005, MACROMOLECULES, V38, P8012, DOI 10.1021/ma051232r
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhou H, 2013, MAT SCI ENG C-MATER, V33, P2302, DOI 10.1016/j.msec.2013.01.058
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 34
TC 12
Z9 13
U1 2
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 135
EP 143
DI 10.1016/j.msec.2015.03.055
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100018
PM 25953550
DA 2018-10-19
ER

PT J
AU Grzesiak, J
   Marycz, K
   Szarek, D
   Bednarz, P
   Laska, J
AF Grzesiak, Jakub
   Marycz, Krzysztof
   Szarek, Dariusz
   Bednarz, Paulina
   Laska, Jadwiga
TI Polyurethane/polylactide-based biomaterials combined with rat olfactory
   bulb-derived glial cells and adipose-derived mesenchymal stromal cells
   for neural regenerative medicine applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Polyurethane; Polylactide; Glial cells; Mesenchymal stem
   cells
ID PERIPHERAL-NERVE REGENERATION; BIODEGRADABLE SYNTHETIC-POLYMERS;
   STEM-CELLS; ENSHEATHING CELLS; IN-VITRO; SCHWANN-CELLS; SILK FIBROIN;
   ADHESION; BEHAVIOR; POLYLACTIDE
AB Research concerning the elaboration and application of biomaterial which may support the nerve tissue regeneration is currently one of the most promising directions. Biocompatible polymer devices are noteworthy group among the numerous types of potentially attractive biomaterials for regenerative medicine application. Polylactides and polyurethanes may be utilized for developing devices for supporting the nerve regeneration, like nerve guide conduits or bridges connecting the endings of broken nerve tracts. Moreover, the combination of these biomaterial-devices with regenerative-cell populations, like stem or precursor cells should significantly improve the final therapeutic effect. Therefore, the composition and structure of final device should support the proper adhesion and growth of cells destined for clinical application. In current research, the three polymer mats elaborated for connecting the broken nerve tracts, made from polylactide, polyurethane and their blend were evaluated both for physical properties and in vitro, using the olfactory-bulb glial cells and mesenchymal stem cells. The evaluation of Young's modulus, wettability and roughness of obtained materials showed the differences between analyzed samples. The analysis of cell adhesion, proliferation and morphology showed that the polyurethane-polylactide blend was the most neutral for cells in culture, while in the pure polymer samples there were significant alterations observed. Our results indicated that polyurethane-polylactide blend is an optimal composition for culturing and delivery of glial and mesenchymal stem cells. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Grzesiak, Jakub; Marycz, Krzysztof] Univ Environm & Life Sci, Electron Microscopy Lab, PL-51631 Wroclaw, Poland.
   [Szarek, Dariusz] Lower Silesia Specialist Hosp T Marciniak, Ctr Emergency Med, Dept Neurosurg, PL-50420 Wroclaw, Poland.
   [Bednarz, Paulina] State Higher Vocat Sch Tarnow, PL-33100 Tarnow, Poland.
   [Laska, Jadwiga] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
RP Grzesiak, J (reprint author), Univ Environm & Life Sci, Electron Microscopy Lab, Kozuchowska 5b, PL-51631 Wroclaw, Poland.
EM grzesiak.kuba@gmail.com
RI Marycz, Krzysztof/A-2249-2017
OI Bednarz, Paulina/0000-0002-8286-9556
FU National Center of Science, Poland [2011/01/B/STB8/07795]
FX This research was financially supported by the National Center of
   Science, Poland (grant no. 2011/01/B/STB8/07795). Authors declare no
   conflict of interest in this manuscript.
CR Benavente JJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090189
   Boyle CC, 1997, CANCER RES, V57, P2404
   Burke A, 2004, ADV EXP MED BIOL, V553, P83
   Czarnecki J.S., 2014, TISSUE ENG A
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Davies Jeannette E, 2006, J Biol, V5, P7, DOI 10.1186/jbiol35
   de Guzman RC, 2008, J BIOMED MATER RES A, V85A, P14, DOI 10.1002/jbm.a.31516
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Feng F, 2011, J MACROMOL SCI B, V50, P1500, DOI 10.1080/00222348.2010.518889
   Feng F, 2011, J APPL POLYM SCI, V119, P2778, DOI 10.1002/app.32863
   Gajowy J., 2009, ENG BIOMATER, V13, P89
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Grzesiak J, 2011, INT J MORPHOL, V29, P1012, DOI 10.4067/S0717-95022011000300059
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gurunathan T, 2014, J MATER SCI, V49, P8016, DOI 10.1007/s10853-014-8509-4
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Han JJ, 2011, J APPL POLYM SCI, V120, P3217, DOI 10.1002/app.33338
   Hausner T, 2007, ACTA NEUROCHIR SUPPL, V100, P69
   Hilmer K., US Patent, Patent No. [US 8633283 B2, 8633283]
   Honore A, 2012, GLIA, V60, P404, DOI 10.1002/glia.22274
   Keatch RP, 2012, CURR OPIN BIOTECH, V23, P579, DOI 10.1016/j.copbio.2012.01.017
   Khaidoyanidi S, 2008, CELL STEM CELL, V2, P198, DOI 10.1016/j.stem.2008.02.012
   Kueh JL, 2012, NANOMEDICINE-UK, V7, P1211, DOI 10.2217/nnm.11.180
   Lakard S., 2004, BIOELECTROCHEMISTRY, V23, P579
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee OJ, 2014, J BIOMED NANOTECHNOL, V10, P1294, DOI 10.1166/jbn.2014.1818
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li XN, 1997, NEUROSURGERY, V40, P1250, DOI 10.1097/00006123-199706000-00027
   Liu GC, 2014, POLYM CHEM-UK, V5, P2530, DOI 10.1039/c3py01649h
   Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400
   Marycz K, 2014, BIO-MED MATER ENG, V24, P1625, DOI 10.3233/BME-140966
   Marycz K, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065004
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Mi HY, 2013, MAT SCI ENG C-MATER, V33, P4767, DOI 10.1016/j.msec.2013.07.037
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Szarek D, 2013, SCANNING, V35, P232, DOI 10.1002/sca.21056
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Thesleff T, 2011, NEUROSURGERY, V68, P1535, DOI 10.1227/NEU.0b013e31820ee24e
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Walsh MF, 2003, CELL PHYSIOL BIOCHEM, V13, P135, DOI 10.1159/000071864
   Wang WS, 2006, EUR POLYM J, V42, P1240, DOI 10.1016/j.eurpolymj.2005.11.029
   Willerth SM, 2008, COMBINING STEM CELLS
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zhu YL, 2010, GLIA, V58, P716, DOI 10.1002/glia.20957
NR 58
TC 24
Z9 24
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 163
EP 170
DI 10.1016/j.msec.2015.03.050
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100022
PM 25953554
OA Other Gold
DA 2018-10-19
ER

PT J
AU Cecchinato, F
   Karlsson, J
   Ferroni, L
   Gardin, C
   Galli, S
   Wennerberg, A
   Zavan, B
   Andersson, M
   Jimbo, R
AF Cecchinato, Francesca
   Karlsson, Johan
   Ferroni, Letizia
   Gardin, Chiara
   Galli, Silvia
   Wennerberg, Ann
   Zavan, Barbara
   Andersson, Martin
   Jimbo, Ryo
TI Osteogenic potential of human adipose-derived stromal cells on
   3-dimensional mesoporous TiO2 coating with magnesium impregnation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE 3-D nanostructure; Magnesium; Osteogenesis; Osteogenic markers;
   Osteopontin
ID MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; IUPAC RECOMMENDATIONS
   2001; OSTEOBLAST-LIKE CELLS; HUMAN BONE-MARROW; GENE-EXPRESSION;
   COMPOSITIONAL CHARACTERISTICS; INORGANIC HOSTS; TITANIUM-ALLOY; IN-VITRO
AB The aim of this study was to evaluate the osteogenic response of human adipose-derived stromal cells (ADScs) to mesoporous titania (TiO2) coatings produced with evaporation-induced self-assembly method (EISA) and loaded with magnesium. Our emphasis with the magnesium release functionality was to modulate progenitor cell osteogenic differentiation under standard culture conditions. Osteogenic properties of the coatings were assessed for stromal cells by means of scanning electron microscopy (SEM) imaging, colorimetric mitochondrial viability assay (MTT), colorimetric alkaline phosphates activity (ALP) assay and real time RT-polymerase chain reaction (PCR). Using atomic force microscopy (AFM) it was shown that the surface expansion area (S-dr) was strongly enhanced by the presence of magnesium. From MTT results it was shown that ADSc viability was significantly increased on mesoporous surfaces compared to the non-porous one at a longer cell culture time. However, no differences were observed between the magnesium impregnated and non-impregnated surfaces. The alkaline phosphatase activity confirmed that ADSc started to differentiate into the osteogenic phenotype after 2 weeks of culturing. The gene expression profile at 2 weeks of cell growth showed that such coatings were capable to incorporate specific osteogenic markers inside their interconnected nano-pores and, at 3 weeks, ADSc differentiated into osteoblasts. Interestingly, magnesium significantly promoted the osteopontin gene expression, which is an essential gene for the early biomaterial-cell osteogenic interaction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Cecchinato, Francesca; Galli, Silvia; Wennerberg, Ann; Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
   [Karlsson, Johan; Andersson, Martin] Chalmers Univ Technol, Dept Chem & Biol Engn Appl Surface Chem, S-41296 Gothenburg, Sweden.
   [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy.
   [Jimbo, Ryo] Nagasaki Univ, Dept Appl Prosthodont, Grad Sch Biomed Sci, Nagasaki 852, Japan.
RP Cecchinato, F (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
EM francesca.cecchinato@mah.se
OI , Martin/0000-0003-1523-4697; Gardin, Chiara/0000-0003-3817-0032
FU People Programme (Marie Curie Actions) of the European Union's under REA
   [n289163]
FX The research leading to these results has received funding from the
   People Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme FP7/2007-2013/under REA grant agreement no. n289163.
CR [Anonymous], 2012, NANOMEDICINE-UK, V7, P20
   [Anonymous], 2009, J DENT IMPLANTOL, P250
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Bressan E, 2013, INT J MOL SCI, V14, P1918, DOI 10.3390/ijms14011918
   CARPENTER TO, 1992, AM J PHYSIOL, V263, pE107
   Cecchinato F., 2013, J BIOMEDICAL MAT R A, V102, P3862
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Flammang BE, 2011, INTEGR COMP BIOL, V51, P128, DOI 10.1093/icb/icr014
   Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3
   Galli S., 2013, CLIN IMPLANT DENT RE
   Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Grosso D, 2004, ADV FUNCT MATER, V14, P309, DOI 10.1002/adfm.200305036
   Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986
   Karlsson J, 2012, ACTA BIOMATER, V8, P4438, DOI 10.1016/j.actbio.2012.07.035
   Katagiri YU, 1999, CANCER RES, V59, P219
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Lin Z, 2011, J PERIODONTOL, V82, P1007, DOI 10.1902/jop.2010.100577
   McCusker LB, 2003, MICROPOR MESOPOR MAT, V58, P3, DOI 10.1016/S1387-1811(02)00545-0
   McCusker LB, 2001, PURE APPL CHEM, V73, P381, DOI 10.1351/pac200173020381
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   MERRY K, 1993, J CELL SCI, V104, P1013
   Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058
   OWEN M, 1988, J CELL SCI, P63
   OWEN M, 1988, CIBA F SYMP, V136, P42
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ryu HH, 2012, J VET MED SCI, V74, P1617, DOI 10.1292/jvms.12-0065
   SODEK J, 1977, ARCH ORAL BIOL, V22, P647, DOI 10.1016/0003-9969(77)90094-2
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
   Wu CW, 2006, J AM CHEM SOC, V128, P4544, DOI 10.1021/ja060453p
   Xia W, 2012, J BIOMED MATER RES B, V100B, P82, DOI 10.1002/jbm.b.31925
   Zhang Y., 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/793823
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 45
TC 6
Z9 7
U1 4
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 225
EP 234
DI 10.1016/j.msec.2015.03.026
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100030
PM 25953562
DA 2018-10-19
ER

PT J
AU Ferroni, L
   Della Puppa, A
   D'Avella, D
   Isola, M
   Scienza, R
   Gardin, C
   Zavan, B
AF Ferroni, Letizia
   Della Puppa, Alessandro
   D'Avella, Domenico
   Isola, Maurizio
   Scienza, Renato
   Gardin, Chiara
   Zavan, Barbara
TI Tissue Engineering Strategies as Tools for Personalized Meningioma
   Treatment
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Tissue engineering; Solid cancer; Drug screening; Personalized medicine;
   Biomaterial
ID COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; SKIN-CANCER;
   STEM-CELLS; PHARMACOGENOMICS; TUMOR; HYALURONAN; GENES; ABNORMALITIES;
   EXPRESSION
AB Pharmacogenomics, the science of how genetic makeup influences an individual's reaction to drugs, is an innovative tool for providing critical insights into how a patient will respond to a particular treatment. In the present work, we constructed cancer-like tissues to be used as tools for determining the most effective drug for an individual patient. Using tissue engineering strategies, we generated two different solid tumor-like tissues in vitro, a neuronal tumor (meningioma) and a nonmelanoma skin cancer. Samples were tested by both histological and genetic approaches (using a comparative genomic hybridization array, and the relative World Health Organization classification of the samples was compared with the results obtained by the molecular analyses. Our data confirmed the ability of the cells to maintain their phenotype in three-dimensional scaffolds as well as the strong relationship between chromosomal alterations and histological malignancy grades. We then validated the in vitro construction of tumor-like tissues as a potential tool for developing personalized drug treatments.
C1 [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy.
   [Della Puppa, Alessandro; D'Avella, Domenico; Scienza, Renato] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
   [Isola, Maurizio] Univ Padua, Dept Anim Med Prod & Hlth MAPS, I-35100 Padua, Italy.
RP Zavan, B (reprint author), Univ Padua, Dept Biomed Sci, Via G Colombo 3, I-35100 Padua, Italy.
EM barbara.zavan@unipd.it
OI Gardin, Chiara/0000-0003-3817-0032; Della Puppa,
   Alessandro/0000-0001-8058-092X
FU University of Padova, Progetto di Ateneo
FX This research was supported by funds from University of Padova, Progetto
   di Ateneo to Barbara Zavan.
CR Aarhus M, 2008, J NEURO-ONCOL, V88, P251, DOI 10.1007/s11060-008-9569-6
   Ahmad A, 2012, CURR MED CHEM, V19, P3739, DOI 10.2174/092986712801661121
   Angstadt AY, 2013, CANCER-AM CANCER SOC, V119, P2477, DOI 10.1002/cncr.28009
   Espinosa AB, 2008, EUR J HUM GENET, V16, P1450, DOI 10.1038/ejhg.2008.128
   Brady PD, 2012, PRENATAL DIAG, V32, P336, DOI 10.1002/pd.2933
   Braude I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-138
   Chen AC, 2013, PATHOLOGY, V45, P331, DOI 10.1097/PAT.0b013e32835f515c
   de Clare M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-24
   Della Puppa A, 2011, J NEURO-ONCOL, V102, P167, DOI 10.1007/s11060-010-0300-z
   Dickschen K, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00092
   Tabernero MD, 2012, GENE CHROMOSOME CANC, V51, P606, DOI 10.1002/gcc.21948
   Tabernero MD, 2009, BRAIN PATHOL, V19, P409, DOI 10.1111/j.1750-3639.2008.00191.x
   Fan YJ, 2014, TISSUE ENG PT A, V20, P588, DOI 10.1089/ten.TEA.2013.0219
   Fathi AR, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0337-4
   Gardin C, 2011, INT J MOL SCI, V12, P6749, DOI 10.3390/ijms12106749
   Greinert R, 2009, PATHOBIOLOGY, V76, P64, DOI 10.1159/000201675
   Karyadi DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003409
   Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002
   Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239
   Laika B, 2010, PHARMACOGENOMICS J, V10, P20, DOI 10.1038/tpj.2009.32
   Maillo A, 2007, NEURO-ONCOLOGY, V9, P438, DOI 10.1215/15228517-2007-026
   Matsuura Tomokazu, 2006, Hum Cell, V19, P11, DOI 10.1111/j.1749-0774.2005.00002.x
   McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139
   Oliveria SA, 2013, PSYCHO-ONCOLOGY, V22, P106, DOI 10.1002/pon.2059
   Pachow D, 2013, CLIN CANCER RES, V19, P1180, DOI 10.1158/1078-0432.CCR-12-1904
   Pandis L, 2010, J BIOMED MATER RES A, V93A, P1289, DOI 10.1002/jbm.a.32626
   Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704
   Preskorn SH, 2013, J PSYCHIATR PRACT, V19, P142, DOI 10.1097/01.pra.0000428559.01953.73
   Rassekh SR, 2013, PEDIATR DRUGS, V15, P71, DOI 10.1007/s40272-013-0021-9
   Ruano Y, 2010, METHODS MOL BIOL, V653, P35, DOI 10.1007/978-1-60761-759-4_3
   Sanoudou D, 2012, PHARMACOGENOMICS J, V12, P185, DOI 10.1038/tpj.2011.53
   Santelli L, 2010, ACTA NEUROCHIR, V152, P1315, DOI 10.1007/s00701-010-0657-y
   Serna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067291
   Stamoulis C, 2009, IEEE ENG MED BIO, P6973, DOI 10.1109/IEMBS.2009.5333851
   Todorovic-Rakovic N, 2011, J BIOSCIENCES, V36, P719, DOI 10.1007/s12038-011-9099-9
   Ueno T, 2012, EXPERT OPIN THER TAR, V16, pS31, DOI 10.1517/14728222.2011.636739
   Van Haren R, 2009, BRIT J DERMATOL, V161, P1278, DOI 10.1111/j.1365-2133.2009.09338.x
   Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972
   Woo KS, 2008, CANCER GENET CYTOGEN, V180, P56, DOI 10.1016/j.cancergencyto.2007.09.012
   Yadav Dinesh, 2012, Recent Pat DNA Gene Seq, V6, P127
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Zhou KY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0458-2
   Zhou PZ, 2013, NEUROL INDIA, V61, P40, DOI 10.4103/0028-3886.107928
NR 43
TC 3
Z9 3
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD JUL
PY 2015
VL 39
IS 7
BP E114
EP E126
DI 10.1111/aor.12483
PG 13
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA CM0XH
UT WOS:000357402300003
PM 25894852
DA 2018-10-19
ER

PT J
AU Paquette, IM
   Varma, MG
   Kaiser, AM
   Steele, SR
   Rafferty, JF
AF Paquette, Ian M.
   Varma, Madhulika G.
   Kaiser, Andreas M.
   Steele, Scott R.
   Rafferty, Janice F.
CA Amer Soc Colon Rectal Surg
TI The American Society of Colon and Rectal Surgeons' Clinical Practice
   Guideline for the Treatment of Fecal Incontinence
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
ID ARTIFICIAL BOWEL SPHINCTER; SACRAL NERVE-STIMULATION; QUALITY-OF-LIFE;
   INJECTABLE SILICONE BIOMATERIAL; LONG-TERM OUTCOMES; MAGNETIC
   ANAL-SPHINCTER; UNILATERAL PUDENDAL NEUROPATHY; RANDOMIZED
   CONTROLLED-TRIAL; PELVIC FLOOR INJURY; DYNAMIC GRACILOPLASTY
CR Abbas SM, 2005, ANZ J SURG, V75, P783, DOI 10.1111/j.1445-2197.2005.03520.x
   Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Altomare DF, 2010, WORLD J GASTROENTERO, V16, P5267, DOI 10.3748/wjg.v16.i42.5267
   [Anonymous], 2014, COLORECTAL DIS, DOI DOI 10.1111/C0DI.12874
   BAETEN CGMI, 1991, LANCET, V338, P1163, DOI 10.1016/0140-6736(91)92030-6
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Becmeur F, 2008, J PEDIATR SURG, V43, P1853, DOI 10.1016/j.jpedsurg.2008.03.043
   Beco J, 2004, BMC SURG, V4, P15
   Beggs AD, 2010, COLORECTAL DIS, V12, P935, DOI 10.1111/j.1463-1318.2009.01927.x
   Bharucha AE, 2010, ALIMENT PHARM THER, V32, P681, DOI 10.1111/j.1365-2036.2010.04391.x
   Bharucha AE, 2006, AM J GASTROENTEROL, V101, P2679, DOI 10.1111/j.1572-0241.2006.00900.x
   Bharucha AE, 2014, CLIN GASTROENTEROL H, V12, P843, DOI 10.1016/j.cgh.2013.06.035
   Bharucha AE, 2012, AM J GASTROENTEROL, V107, P902, DOI 10.1038/ajg.2012.45
   Bharucha AE, 2010, GASTROENTEROLOGY, V139, P1559, DOI 10.1053/j.gastro.2010.07.056
   Bharucha AE, 2006, J CLIN GASTROENTEROL, V40, P96, DOI 10.1097/01.mcg.0000196190.42296.a9
   Bharucha AE, 2004, GASTROENTEROLOGY, V126, pS90, DOI 10.1053/j.gastro.2003.10.014
   Bliss DZ, 2011, NURS RES, V60, pS58, DOI 10.1097/NNR.0b013e3182186d8c
   Bliss DZ, 2010, AM J NURS, V110, P30, DOI 10.1097/01.NAJ.0000388262.72298.f5
   Bliss DZ, 2001, NURS RES, V50, P203, DOI 10.1097/00006199-200107000-00004
   Bock S, 2010, TECH COLOPROCTOL, V14, P41, DOI 10.1007/s10151-009-0554-7
   Bordeianou L, 2008, DIS COLON RECTUM, V51, P1010, DOI 10.1007/s10350-008-9230-7
   Brouwer R, 2010, DIS COLON RECTUM, V53, P273, DOI 10.1007/DCR.0b013e3181ceeb22
   Brown HW, 2012, INT J CLIN PRACT, V66, P1101, DOI 10.1111/ijcp.12018
   Buie WD, 2001, DIS COLON RECTUM, V44, P1255
   Byrne CM, 2005, DIS COLON RECTUM, V48, P2281, DOI 10.1007/s10350-005-0198-2
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   Chen ASH, 1998, DIS COLON RECTUM, V41, P1005, DOI 10.1007/BF02237391
   Chereau N, 2011, COLORECTAL DIS, V13, pE238, DOI 10.1111/j.1463-1318.2011.02651.x
   Chiarioni G, 2002, AM J GASTROENTEROL, V97, P109
   Choe JH, 2008, J UROLOGY, V179, P214, DOI 10.1016/j.juro.2007.08.151
   Colquhoun P, 2006, OSTOMY WOUND MANAG, V52, P68
   Cotterill N, 2011, DIS COLON RECTUM, V54, P1235, DOI 10.1097/DCR.0b013e3182272128
   Croswell E, 2010, J WOUND OSTOMY CONT, V37, P677, DOI 10.1097/WON.0b013e3181feb017
   Damon H, 2014, DIGEST LIVER DIS, V46, P237, DOI 10.1016/j.dld.2013.11.002
   Danielson J, 2013, TECH COLOPROCTOL, V17, P389, DOI 10.1007/s10151-012-0949-8
   Davis KJ, 2004, ALIMENT PHARM THERAP, V20, P539, DOI 10.1111/j.1365-2036.2004.02119.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Deutekom M, 2007, AM J GASTROENTEROL, V102, P351, DOI 10.1111/j.1572-0241.2006.00927.x
   Devesa JM, 2002, DIS COLON RECTUM, V45, P1154, DOI 10.1007/s10350-004-6382-y
   Ditah I, 2014, CLIN GASTROENTEROL H, V12, P636, DOI 10.1016/j.cgh.2013.07.020
   Edden Y, 2009, EXPERT REV MED DEVIC, V6, P307, DOI [10.1586/erd.09.10, 10.1586/ERD.09.10]
   Efron Jonathan E, 2004, Surg Technol Int, V13, P107
   Felt-Bersma RJ, 2007, EUR J GASTROEN HEPAT, V19, P575, DOI 10.1097/MEG.0b013e32811ec010
   Fitzpatrick M, 2003, AM J OBSTET GYNECOL, V189, P730, DOI 10.1067/S0002-9378(03)00817-2
   Frascio M, 2014, COLORECTAL DIS, V16, P167, DOI 10.1111/codi.12403
   George AT, 2012, COLORECTAL DIS, V14, P98, DOI 10.1111/j.1463-1318.2010.02485.x
   George AT, 2012, DIS COLON RECTUM, V55, P302, DOI 10.1097/DCR.0b013e3182401ecd
   Gilliland R, 1998, DIS COLON RECTUM, V41, P1516, DOI 10.1007/BF02237299
   Giordano P, 2002, DIS COLON RECTUM, V45, P635, DOI 10.1007/s10350-004-6260-7
   Glasgow SC, 2012, DIS COLON RECTUM, V55, P482, DOI 10.1097/DCR.0b013e3182468c22
   Goode PS, 2005, J AM GERIATR SOC, V53, P629, DOI 10.1111/j.1532-5415.2005.53211.x
   Gooneratne ML, 2007, DIS COLON RECTUM, V50, P449, DOI 10.1007/510350-006-0839-0
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174
   Hachiro Y, 2007, DIS COLON RECTUM, V50, P1996, DOI 10.1007/s10350-007-9060-z
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Heymen S, 2009, DIS COLON RECTUM, V52, P1730, DOI 10.1007/DCR.0b013e3181b55455
   Holbrook C, 2012, SURG LAPARO ENDO PER, V22, pE58, DOI 10.1097/SLE.0b013e318244eb42
   Hollingshead JRF, 2011, COLORECTAL DIS, V13, P1030, DOI 10.1111/j.1463-1318.2010.02383.x
   Hong KD, 2013, J AM COLL SURGEONS, V217, P718, DOI 10.1016/j.jamcollsurg.2013.04.028
   Hull T, 2013, DIS COLON RECTUM, V56, P234, DOI 10.1097/DCR.0b013e318276b24c
   Hussain ZI, 2012, UPDATES SURG-ITALY, V64, P289, DOI 10.1007/s13304-012-0176-x
   Jensen LL, 1997, DIS COLON RECTUM, V40, P197, DOI 10.1007/BF02054988
   Johnson BL, 2015, J GASTROINTEST SURG, V19, P15, DOI 10.1007/s11605-014-2611-4
   Johnson E, 2010, ACTA OBSTET GYN SCAN, V89, P1466, DOI 10.3109/00016349.2010.519019
   Johnson JK, 2007, J MATERN-FETAL NEO M, V20, P547, DOI 10.1080/14767050701412917
   Kaiser AM, 2014, SURG ENDOSC, V28, P2277, DOI 10.1007/s00464-014-3464-3
   Kang SB, 2013, J KOREAN SURG SOC, V84, P216, DOI 10.4174/jkss.2013.84.4.216
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kim DW, 2009, AM J SURG, V197, P14, DOI 10.1016/j.amjsurg.2007.11.023
   Kwon S, 2005, DIS COLON RECTUM, V48, P323, DOI 10.1007/s10350-004-0899-y
   Lacima G, 2010, COLORECTAL DIS, V12, P742, DOI 10.1111/j.1463-1318.2009.01881.x
   Lam TJ, 2012, COLORECTAL DIS, V14, P214, DOI 10.1111/j.1463-1318.2011.02548.x
   Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x
   Lefebure B, 2008, INT J COLORECTAL DIS, V23, P993, DOI 10.1007/s00384-008-0514-0
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   LEITE Fernando Rocha, 2013, Arq. Gastroenterol., V50, P163, DOI 10.1590/S0004-28032013000200029
   Liberman H, 2001, DIS COLON RECTUM, V44, P1567, DOI 10.1007/BF02234373
   Lundby L, 2011, DIS COLON RECTUM, V54, P318, DOI 10.1007/DCR.0b013e31820348ac
   Mackey P, 2010, COLORECTAL DIS, V12, P367, DOI 10.1111/j.1463-1318.2009.01800.x
   Macmillan AK, 2008, DIS COLON RECTUM, V51, P1502, DOI 10.1007/s10350-008-9301-9
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Maeda Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub3
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Malouf AJ, 2001, ABDOM IMAGING, V26, P76, DOI 10.1007/s002610000100
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Markland AD, 2010, J AM GERIATR SOC, V58, P1341, DOI 10.1111/j.1532-5415.2010.02908.x
   Maslekar S, 2013, DIS COLON RECTUM, V56, P354, DOI 10.1097/DCR.0b013e3182805276
   Matsuoka H, 2000, DIS COLON RECTUM, V43, P1561, DOI 10.1007/BF02236739
   Matzel KE, 2009, COLORECTAL DIS, V11, P636, DOI 10.1111/j.1463-1318.2008.01673.x
   Melenhorst J, 2008, INT J COLORECTAL DIS, V23, P107, DOI 10.1007/s00384-007-0357-0
   Mellgren A, 2010, SURG CLIN N AM, V90, P185, DOI 10.1016/j.suc.2009.10.006
   Meurette G, 2009, COLORECTAL DIS, V11, P631, DOI 10.1111/j.1463-1318.2008.01633.x
   Michelsen HB, 2010, DIS COLON RECTUM, V53, P414, DOI 10.1007/DCR.0b013e3181ca7dc2
   Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056
   Mundy L, 2004, BRIT J SURG, V91, P665, DOI 10.1002/bjs.4587
   Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010
   Norton C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub2
   Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x
   Norton C, 2005, DIS COLON RECTUM, V48, P1062, DOI 10.1007/s10350-004-0868-5
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   Norton C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub3
   Omar MI, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD002116.PUB2
   Ommer A, 2008, INT J COLORECTAL DIS, V23, P1023, DOI 10.1007/s00384-008-0524-y
   Onishi K, 1989, Acta Chir Plast, V31, P56
   Oom DMJ, 2010, DIS COLON RECTUM, V53, P150, DOI 10.1007/DCR.0b013e3181bb059f
   Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862
   Ortiz H, 2003, INT J COLORECTAL DIS, V18, P349, DOI 10.1007/s00384-002-0472-x
   Ortiz H, 2001, REV ESP ENFERM DIG, V93, P130
   Osterberg A, 2000, DIS COLON RECTUM, V43, P1256, DOI 10.1007/BF02237432
   Pager CK, 2002, DIS COLON RECTUM, V45, P997, DOI 10.1097/01.DCR.0000019495.92696.34
   Pares D, 2010, COLORECTAL DIS, V12, P605, DOI 10.1111/j.1463-1318.2010.02202.x
   Pinsk I, 2009, COLORECTAL DIS, V11, P933, DOI 10.1111/j.1463-1318.2008.01730.x
   Qureshi MS, 2011, INT J COLORECTAL DIS, V26, P1589, DOI 10.1007/s00384-011-1273-x
   Rao SSC, 2004, AM J GASTROENTEROL, V99, P1585, DOI 10.1111/j.1572-0241.2004.40105.x
   Rasmussen OO, 2000, DIS COLON RECTUM, V43, P633, DOI 10.1007/BF02235577
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ratto C, 2010, DIS COLON RECTUM, V53, P264, DOI 10.1007/DCR.0b013e3181c7642c
   Raza N, 2009, DIGEST DIS SCI, V54, P2503, DOI 10.1007/s10620-008-0631-1
   Remes-Troche JM, 2008, INT J COLORECTAL DIS, V23, P189, DOI 10.1007/s00384-007-0391-y
   Ricciardi R, 2006, DIS COLON RECTUM, V49, P852, DOI 10.1007/s10350-006-0529-y
   Rieger NA, 1997, AUST NZ J SURG, V67, P566, DOI 10.1111/j.1445-2197.1997.tb02040.x
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199
   Rosen HR, 1998, AM J SURG, V175, P187, DOI 10.1016/S0002-9610(97)00289-4
   Rosen HR, 1999, CHIRURG, V70, P469, DOI 10.1007/s001040050674
   Rosier PFWM, 2010, NEUROUROL URODYNAM, V29, P146, DOI 10.1002/nau.20763
   Rothbarth J, 2000, DIGEST SURG, V17, P390, DOI 10.1159/000018883
   Carmona MDR, 2009, COLORECTAL DIS, V11, P831, DOI 10.1111/j.1463-1318.2008.01652.x
   Ruiz D, 2010, DIS COLON RECTUM, V53, P1041, DOI 10.1007/DCR.0b013e3181defff8
   Ruthmann O, 2006, CHIRURG, V77, P926, DOI 10.1007/s00104-006-1217-0
   Sangwan YP, 1996, DIS COLON RECTUM, V39, P686, DOI 10.1007/BF02056951
   Sansoni J, 2013, DIS COLON RECTUM, V56, P652, DOI 10.1097/DCR.0b013e318279c2ac
   SHAFIK A, 1993, INT SURG, V78, P159
   Shatari T, 2004, SURG TODAY, V34, P463, DOI 10.1007/s00595-003-2700-6
   Siddiqui AA, 2011, J PEDIATR GASTR NUTR, V52, P574, DOI 10.1097/MPG.0b013e3181ff6042
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Smith S, 2007, BRIT J SURG, V94
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Soffer EE, 2000, AM J GASTROENTEROL, V95, P1873
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Stone Anthony R, 2004, ScientificWorldJournal, V4 Suppl 1, P330
   Suilleabhain CBO, 2001, DIS COLON RECTUM, V44, P666
   Takahashi-Monroy T, 2008, DIS COLON RECTUM, V51, P355, DOI 10.1007/s10350-007-9169-0
   Tan EK, 2008, COLORECTAL DIS, V10, P577, DOI 10.1111/j.1463-1318.2007.01418.x
   Terra MP, 2006, DIS COLON RECTUM, V49, P1149, DOI 10.1007/s10350-006-0569-3
   Thekkinkattil DK, 2008, BRIT J SURG, V95, P222, DOI 10.1002/bjs.5933
   Thin NN, 2013, BRIT J SURG, V100, P1430, DOI 10.1002/bjs.9226
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tillin T, 2006, BRIT J SURG, V93, P1402, DOI 10.1002/bjs.5393
   Titi MA, 2008, COLORECTAL DIS, V10, P131, DOI 10.1111/j.1463-1318.2007.01312.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1497, DOI 10.1007/s10350-007-9001-x
   Townsend MK, 2013, AM J GASTROENTEROL, V108, P113, DOI 10.1038/ajg.2012.364
   Tries J, 2004, GASTROENTEROLOGY, V126, pS152, DOI 10.1053/j.gastro.2003.10.039
   Trudinger A, 2008, OBSTET GYNECOL, V111, P1058, DOI 10.1097/AOG.0b013e31816c4433
   Ullah S, 2011, JCPSP-J COLL PHYSICI, V21, P227, DOI 04.2011/JCPSP.227229
   Vaizey CJ, 2004, DIS COLON RECTUM, V47, P858, DOI 10.1007/s10350-003-0112-8
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   Vande Velde S, 2013, SPINAL CORD, V51, P873, DOI 10.1038/sc.2013.123
   Vergara-Fernandez O, 2011, Rev Gastroenterol Mex, V76, P384
   Vonthein R, 2013, INT J COLORECTAL DIS, V28, P1567, DOI 10.1007/s00384-013-1739-0
   Wald A, 2007, NEW ENGL J MED, V356, P1648, DOI 10.1056/NEJMcp067041
   Wald A, 2006, AM J GASTROENTEROL, V101, P2681, DOI 10.1111/j.1572-0241.2006.00900_2.x
   WALKER J, 1989, Z KINDERCHIR, V44, P44
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wasserberg N, 2011, COLORECTAL DIS, V13, P449, DOI 10.1111/j.1463-1318.2010.02208.x
   Watson NFS, 2012, COLORECTAL DIS, V14, P29, DOI 10.1111/codi.12047
   Wexner SD, 2009, DIS COLON RECTUM, V52, P1550, DOI 10.1007/DCR.0b013e3181af62f8
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
   Wong MTC, 2012, COLORECTAL DIS, V14, pE323, DOI 10.1111/j.1463-1318.2012.02995.x
   Wong MTC, 2011, ANN SURG, V254, P951, DOI 10.1097/SLA.0b013e31823ac2bc
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
   Yamana T, 2004, DIS COLON RECTUM, V47, P1982, DOI 10.1007/s10350-004-0675-z
   Yamout SZ, 2009, PEDIATR SURG INT, V25, P1081, DOI 10.1007/s00383-009-2496-6
   Zutshi M, 2010, INT J COLORECTAL DIS, V25, P277, DOI 10.1007/s00384-009-0830-z
NR 186
TC 28
Z9 30
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0012-3706
EI 1530-0358
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD JUL
PY 2015
VL 58
IS 7
BP 623
EP 636
DI 10.1097/DCR.0000000000000397
PG 14
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA CL7YN
UT WOS:000357189000002
PM 26200676
OA Bronze
DA 2018-10-19
ER

PT J
AU Roman, A
   Cioban, C
   Stratul, SI
   Schwarz, F
   Muste, A
   Petrutiu, SA
   Zaganescu, R
   Mihatovic, I
AF Roman, Alexandra
   Cioban, Cosmin
   Stratul, Stefan-Ioan
   Schwarz, Frank
   Muste, Aurel
   Petrutiu, Stefan-Adrian
   Zaganescu, Raluca
   Mihatovic, Ilja
TI Ridge preservation using a new 3D collagen matrix: a preclinical study
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Bone; Collagen membrane; Socket preservation; Wound healing; Animal
ID GUIDED BONE REGENERATION; CORONALLY ADVANCED FLAP; GINGIVAL RECESSION
   DEFECTS; CONTROLLED CLINICAL-TRIAL; MILLER CLASS-I; TOOTH EXTRACTION;
   ALVEOLAR RIDGE; SOCKET PRESERVATION; KERATINIZED MUCOSA;
   CONNECTIVE-TISSUE
AB Objectives The success of ridge preservation techniques in reducing bone resorption is well documented, but no clear guidelines have been provided regarding the type of the biomaterial or technique to be used. This experimental animal study aimed at comparing the effectiveness of two ridge preservation techniques.
   Materials and methods Following the extraction of the distal roots of the mandibular second and fourth premolars of four dogs, the sockets were preserved using a combination of a collagen membrane intimately covering the socket plus a collagen matrix or a collagen membrane alone. The mandibular quadrants were randomly assigned to one of the treatment groups. Histomorphometrical analyses as well as microscopic observations were performed.
   Results After 5 months of healing, the histological analysis revealed a similar picture of bone formation in both groups. No significant differences between the buccal and lingual dimensions were calculated between the two treatment groups. The mucosa covering the alveolar ridges is significantly more abundant in post-extraction sockets preserved with the double-layered approach.
   Conclusions The double-layered approach used to treat post-extraction sockets may result in a better preservation of the mucosal seal than the single-layered approach.
   Clinical relevance The use of the new collagen matrix associated with a collagen membrane could be a clinical option to preserve post-extraction ridges, especially when an improvement in soft tissue dimension and quality is desired. However, the cost-benefit ratio of this approach should be thoroughly evaluated in further studies.
C1 [Roman, Alexandra; Cioban, Cosmin; Petrutiu, Stefan-Adrian] Iuliu Hatieganu Univ Med & Pharm, Dept Periodontol, Cluj Napoca 400012, Romania.
   [Stratul, Stefan-Ioan] Victor Babes Univ Med & Pharm, Dept Periodontol, Timisoara 300014, Romania.
   [Schwarz, Frank; Mihatovic, Ilja] Univ Dusseldorf, Westdeutsche Kieferklin, Dept Oral Surg, D-40225 Dusseldorf, Germany.
   [Muste, Aurel] Univ Vet Med & Agr Sci, Dept Surg, Cluj Napoca 400372, Romania.
   [Zaganescu, Raluca] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca 400012, Romania.
RP Stratul, SI (reprint author), Victor Babes Univ Med & Pharm, Dept Periodontol, Bv Revolutiei 9, Timisoara 300014, Romania.
EM sbs@online.ro
OI Stratul, Stefan-Ioan/0000-0002-9154-9511; Roman,
   Alexandra/0000-0002-0649-9426
CR Al-Asfour A, 2013, INT J PERIODONT REST, V33, P177, DOI 10.11607/prd.1552
   Al-Hezaimi K, 2013, J ORAL IMPLANTOL
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2011, OSTEOLOGY GUIDELINES, P123
   Artzi Z, 2006, CLIN ORAL IMPLAN RES, V17, P85, DOI 10.1111/j.1600-0501.2005.01178.x
   Barone A, 2014, J PERIODONTOL, V85, P14, DOI 10.1902/jop.2013.120711
   Bashara H, 2012, CLIN ORAL IMPLAN RES, V23, P911, DOI 10.1111/j.1600-0501.2011.02240.x
   Bornstein MM, 2007, J PERIODONTOL, V78, P1943, DOI 10.1902/jop.2007.070102
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Bragger U, 1997, CLIN ORAL IMPLAN RES, V8, P412, DOI 10.1034/j.1600-0501.1997.080508.x
   Brownfield LA, 2012, J PERIODONTOL, V83, P581, DOI 10.1902/jop.2011.110365
   Camelo M, 2012, INT J PERIODONT REST, V32, P167
   Cardaropoli D, 2012, J PERIODONTOL, V83, P321, DOI 10.1902/jop.2011.110215
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Cioban C, 2013, ROM J MORPHOL EMBRYO, V54, P125
   COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103
   Cook DC, 2013, J PERIODONTOL, V84, P585, DOI 10.1902/jop.2012.120219
   Darby I, INT J ORAL MAXIL S24, P260
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630
   Faggion CM, 2011, J CLIN PERIODONTOL, V38, P1154, DOI 10.1111/j.1600-051X.2011.01783.x
   Horowitz Robert, 2012, J Evid Based Dent Pract, V12, P149, DOI 10.1016/S1532-3382(12)70029-5
   Ivanovic A, 2013, CLIN ORAL INVESTIG
   Jung RE, 2013, J CLIN PERIODONTOL, V40, P90, DOI 10.1111/jcpe.12027
   Jung RE, 2011, J CLIN PERIODONTOL, V38, P173, DOI 10.1111/j.1600-051X.2010.01640.x
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kim SH, 2009, CLIN ORAL IMPLAN RES, V20, P1124, DOI 10.1111/j.1600-0501.2009.01744.x
   Lambert F, 2012, J CLIN PERIODONTOL, V39, P887, DOI 10.1111/j.1600-051X.2012.01900.x
   Leblebicioglu B, 2013, J CLIN PERIODONTOL, V40, P387, DOI 10.1111/jcpe.12065
   Lekovic V, 1998, J PERIODONTOL, V69, P1044, DOI 10.1902/jop.1998.69.9.1044
   Lin GH, 2013, J PERIODONTOL, V84, P1755, DOI 10.1902/jop.2013.120688
   McGuire MK, 2010, J PERIODONTOL, V81, P1108, DOI 10.1902/jop.2010.090698
   Molnar B, 2013, QUINTESSENCE INT, V44, P17, DOI 10.3290/j.qi.a28739
   Moses O, 2008, J PERIODONTOL, V79, P905, DOI [10.1902/jop.2008.070361, 10.1902/jop.2008.070361 ]
   Nevins M, 2010, INT J PERIODONT REST, V30, P151
   Orgeas GV, 2013, INT J ORAL MAX IMPL, V28, P1049, DOI 10.11607/jomi.2670
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Poulias E, 2013, J PERIODONTOL, V84, P1567, DOI 10.1902/jop.2013.120585
   Reichert C, 2011, J OROFAC ORTHOP, V72, P45, DOI 10.1007/s00056-010-0006-z
   Rothamel D, 2008, INT J ORAL MAX SURG, V37, P741, DOI 10.1016/j.ijom.2008.04.017
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   Schmitt CM, 2013, J PERIODONTOL, V84, P914, DOI 10.1902/jop.2012.120084
   Schwarz F, 2012, CLIN ORAL IMPLAN RES, V23, P83, DOI 10.1111/j.1600-0501.2011.02187.x
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Tarnow D P, 1996, J Esthet Dent, V8, P12, DOI 10.1111/j.1708-8240.1996.tb00904.x
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Thoma DS, 2012, CLIN ORAL IMPLAN RES, V23, P1333, DOI 10.1111/j.1600-0501.2011.02356.x
   Thoma DS, 2012, J CLIN PERIODONTOL, V39, P157, DOI 10.1111/j.1600-051X.2011.01823.x
   Thoma DS, 2011, J CLIN PERIODONTOL, V38, P1063, DOI 10.1111/j.1600-051X.2011.01786.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Vignoletti F, 2011, J CLIN PERIODONTOL, V38, P847, DOI 10.1111/j.1600-051X.2011.01767.x
   Zigdon H, 2008, CLIN ORAL IMPLAN RES, V19, P387, DOI 10.1111/j.1600-0501.2007.01492.x
NR 56
TC 6
Z9 6
U1 0
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD JUL
PY 2015
VL 19
IS 6
BP 1527
EP 1536
DI 10.1007/s00784-014-1368-1
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CL2LA
UT WOS:000356774100040
PM 25418353
DA 2018-10-19
ER

PT J
AU D'Mello, S
   Elangovan, S
   Hong, L
   Ross, RD
   Sumner, DR
   Salem, AK
AF D'Mello, Sheetal
   Elangovan, Satheesh
   Hong, Liu
   Ross, Ryan D.
   Sumner, D. Rick
   Salem, Aliasger K.
TI Incorporation of copper into chitosan scaffolds promotes bone
   regeneration in rat calvarial defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE chitosan; copper; biodegradable scaffolds; tissue engineering; bone
   regeneration
ID GROWTH-FACTOR; METAL-IONS; RABBITS; BIODEGRADATION; PROLIFERATION;
   ANGIOGENESIS; BIOMATERIAL; MEMBRANE; CHITIN
AB The objective of this study was to investigate the effects of a copper loaded chitosan scaffold on bone regeneration in critical-sized calvarial defects in rats. Chitosan scaffolds and copper-chitosan scaffolds were fabricated and characterized by scanning electron microscopy (SEM). Chitosan and copper-chitosan scaffolds were implanted into 5 mm diameter critical-sized calvarial defects in Fisher 344 male rats. Empty defects (no scaffolds) were included as a control. After 4 weeks, the rats were sacrificed for microcomputed tomography (micro-CT) and histological analysis of new bone tissue development. Microscopy images revealed the uniformly porous structure of chitosan and copper-chitosan scaffolds. Significant bone regeneration was noted in the defects treated with copper-chitosan scaffolds when evaluated using micro-CT and histological analysis, when compared with other groups tested. On analysis of the micro-CT scans, an eleven-fold and a two-fold increase in the new bone volume/total volume (BV/TV) % was found in defects treated with the copper-chitosan scaffolds, when compared to empty defects and chitosan scaffolds, respectively. This study demonstrated the suitability of copper-crosslinked chitosan scaffolds for bone tissue engineering and provides the first evidence that inclusion of copper ions in scaffolds can enhance tissue regeneration. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1044-1049, 2015.
C1 [D'Mello, Sheetal; Salem, Aliasger K.] Univ Iowa, Coll Pharm, Div Pharmaceut & Translat Therapeut, Iowa City, IA 52242 USA.
   [Elangovan, Satheesh; Salem, Aliasger K.] Univ Iowa, Dept Periodont, Coll Dent, Iowa City, IA 52242 USA.
   [Hong, Liu] Univ Iowa, Dept Prosthodont, Coll Dent, Iowa City, IA 52242 USA.
   [Ross, Ryan D.; Sumner, D. Rick] Rush Med Coll, Dept Anat & Cell Biol, Chicago, IL 60612 USA.
RP Salem, AK (reprint author), Univ Iowa, Coll Pharm, Div Pharmaceut & Translat Therapeut, Iowa City, IA 52242 USA.
EM satheesh-elangovan@uiowa.edu; aliasger-salem@uiowa.edu
OI Salem, Aliasger/0000-0002-1923-6633
FU ITI Foundation for the Promotion of Implantology, Switzerland [855
   2012]; American Cancer Society [RSG-09-015-01-CDD]; National Cancer
   Institute, National Institutes of Health
   [1R21CA13345-01/R21CA128414-01A2/UI]; Mayo Clinic Lymphoma SPORE;
   University of Iowa Start-up Grant; Osteology Foundation, Switzerland;
   Osseointegration Foundation, USA; Lyle and Sharon Bighley Professorship
FX Contract grant sponsor: ITI Foundation for the Promotion of
   Implantology, Switzerland; contract grant number: 855 2012; Contract
   grant sponsor: American Cancer Society; contract grant number:
   RSG-09-015-01-CDD; Contract grant sponsor: National Cancer Institute,
   National Institutes of Health; contract grant number:
   1R21CA13345-01/R21CA128414-01A2/UI Mayo Clinic Lymphoma SPORE; Contract
   grant sponsors: University of Iowa Start-up Grant, the Osteology
   Foundation, Switzerland, the Osseointegration Foundation, USA, the Lyle
   and Sharon Bighley Professorship
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917
   Borkow G., 2004, COPPERS ROLE WOUND H
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang PC, 2010, GENE THER, V17, P95, DOI 10.1038/gt.2009.117
   Connolly J F, 1989, J Orthop Trauma, V3, P276, DOI 10.1097/00005131-198912000-00002
   Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021
   Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035
   HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x
   Hermann J, 1995, CURR OPIN PERIODONT, V3, P168
   Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
   Jegoux F, 2009, J BIOMED MATER RES A, V91A, P1160, DOI 10.1002/jbm.a.32274
   Kofuji K, 2005, INT J PHARM, V303, P95, DOI 10.1016/j.ijpharm.2005.07.011
   Kojima K, 2004, J VET MED SCI, V66, P1595, DOI 10.1292/jvms.66.1595
   LANE JM, 1999, CLIN ORTHOP S, V367, pS107
   Lim HC, 2010, J BIOMED MATER RES B, V95B, P47, DOI 10.1002/jbm.b.31681
   MCAUSLAN BR, 1980, EXP CELL RES, V130, P147, DOI 10.1016/0014-4827(80)90051-8
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   RAJU KS, 1982, J NATL CANCER I, V69, P1183
   Rhazi M, 2002, EUR POLYM J, V38, P1523, DOI 10.1016/S0014-3057(02)00026-5
   SCHLICK S, 1986, MACROMOLECULES, V19, P192, DOI 10.1021/ma00155a030
   Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wongrakpanich A, 2014, MOL PHARMACEUT, V11, P1022, DOI 10.1021/mp400689r
   Worthington KLS, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/39/395101
   Yang C, 2014, J BIOMED MATER RES B, V102, P80, DOI 10.1002/jbm.b.32984
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 33
TC 15
Z9 15
U1 3
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2015
VL 103
IS 5
BP 1044
EP 1049
DI 10.1002/jbm.b.33290
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL0ZO
UT WOS:000356671800011
PM 25230382
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kim, JE
   Kim, SH
   Jung, Y
AF Kim, Ji Eun
   Kim, Soo Hyun
   Jung, Youngmee
TI In situ chondrogenic differentiation of bone marrow stromal cells in
   bioactive self-assembled peptide gels
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Collagen mimetic peptide; Self-assembled peptide; In situ chondrogenic
   differentiation; Bioactive; Bone marrow stromal cells
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING SCAFFOLDS; CARTILAGE TISSUE;
   NANOFIBER SCAFFOLDS; CONTROLLED-RELEASE; PROGENITOR CELLS; HYDROGELS;
   REGENERATION; CULTURES; DESIGN
AB Articular cartilage is a specific tissue that lacks nerves and blood vessels and has limited self-repair abilities. Accordingly, it is necessary to develop new technology for the regeneration of cartilage to overcome therapeutic limitations. Recently, there have been several studies investigating the use of peptide hydrogel scaffolds, which are biocompatible and have low immunogenicity, for cartilage tissue engineering. In this study, we used self-assembled peptide hydrogels with repeating peptide sequences and bioactive motifs at the end of repeating sequences, which are collagen mimetic peptides (CMPs). CMPs that have a unique collagen-like triple helical conformation have been shown to associate with collagen molecules and fibers via a strand invasion process. In order to confirm the biological activities of the modified bioactive peptide hydrogels, the role of functional motifs in in situ chondrogenic differentiation of rabbit bone marrow stromal cells (rBMSCs) was examined. To compensate for the weaker mechanical properties of peptide hydrogels, we used poly (L-lactide-co-caprolactone) (PLCL) scaffolds, which were loaded with the self-assembled peptides into which the bioactive motifs had been incorporated. Then, we performed in vitro and in vivo analyses with the rBMSC/PLCL-peptide hydrogel complexes. The results indicated that the secretion of a cartilage-specific extracellular matrix and gene expression concerned with chondrogenic differentiation were increased by CMP motifs. In conclusion, it was confirmed that CMP-modified self-assembled peptide hydrogels could effectively enhance chondrogenic differentiation in situ, and, consequently, they could be a good biomaterial for cartilage tissue engineering. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.
C1 [Kim, Ji Eun; Kim, Soo Hyun; Jung, Youngmee] Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 136791, South Korea.
   [Kim, Ji Eun; Kim, Soo Hyun] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 136705, South Korea.
   [Kim, Soo Hyun; Jung, Youngmee] Univ Sci & Technol, Dept Biomed Engn, Seoul 136791, South Korea.
RP Jung, Y (reprint author), Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 136791, South Korea.
EM cantata7@gmail.com; soohkim@kist.re.kr; winnie97@kist.re.kr
OI Kim, Soo Hyun/0000-0002-8391-3686; Jung, Youngmee/0000-0002-4778-4629
FU Korea Institute of Science and Technology Institutional Program
   [2E25119, 2E24680]
FX This study was supported by the Korea Institute of Science and
   Technology Institutional Program (2E25119 and 2E24680).
CR Appleton CTG, 2007, ANN NY ACAD SCI, V1117, P165, DOI 10.1196/annals.1402.022
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Cassiede P, 1996, J BONE MINER RES, V11, P1264
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsu L, 2008, J AM CHEM SOC, V130, P3892, DOI 10.1021/ja076553s
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498
   Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034
   Jung Y, 2008, BIOMATERIALS, V29, P4630, DOI 10.1016/j.biomaterials.2008.08.031
   Kim HJ, 2009, TISSUE ENG PT A, V15, P1543, DOI 10.1089/ten.tea.2008.0368
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Koga H, 2009, KNEE SURG SPORT TR A, V17, P1289, DOI 10.1007/s00167-009-0782-4
   Kopesky PW, 2010, TISSUE ENG PT A, V16, P465, DOI [10.1089/ten.tea.2009.0158, 10.1089/ten.TEA.2009.0158]
   Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Martin Y, 2005, BIOMATERIALS, V26, P7481, DOI 10.1016/j.biomaterials.2005.05.057
   Merceron C, 2008, JOINT BONE SPINE, V75, P672, DOI 10.1016/j.jbspin.2008.07.007
   Miller RE, 2010, OSTEOARTHR CARTILAGE, V18, P1608, DOI 10.1016/j.joca.2010.09.004
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Roberts S, 2011, REGEN MED, V6, P351, DOI [10.2217/RME.11.21, 10.2217/rme.11.21]
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
   Xie J, 2006, TISSUE ENG, V12, P449, DOI 10.1089/ten.2006.12.449
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
NR 42
TC 11
Z9 11
U1 1
U2 46
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUL
PY 2015
VL 120
IS 1
BP 91
EP 98
DI 10.1016/j.jbiosc.2014.11.012
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA CL2ES
UT WOS:000356757000016
PM 25540912
DA 2018-10-19
ER

PT J
AU Park, HJ
   Lee, OJ
   Lee, MC
   Moon, BM
   Ju, HW
   Lee, JM
   Kim, JH
   Kim, DW
   Park, CH
AF Park, Hyun Jung
   Lee, Ok Joo
   Lee, Min Chae
   Moon, Bo Mi
   Ju, Hyung Woo
   Lee, Jung Min
   Kim, Jung-Ho
   Kim, Dong Wook
   Park, Chan Hum
TI Fabrication of 3D porous silk scaffolds by particulate (salt/sucrose)
   leaching for bone tissue reconstruction
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Silk fibroin; Hydroxyapatite; Particulate leaching; Bone reconstruction
ID MESENCHYMAL STEM-CELLS; IN-VITRO; FIBROIN; SALT; BIOCOMPATIBILITY;
   BIOMATERIALS; CARTILAGE; POLYMER; VIVO
AB Silk fibroin is a biomaterial being actively studied in the field of bone tissue engineering. In this study, we aimed to select the best strategy for bone reconstruction on scaffolds by changing various conditions. We compared the characteristics of each scaffold via structural analysis using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), the swelling ratio, water uptake, porosity, compressive strength, cell infiltration and cell viability (CCK-8). The scaffolds had high porosity with good inter pore connectivity and showed high compressive strength and modulus. In addition, to confirm bone reconstruction, animal studies were conducted in which samples were implanted in rat calvaria and investigated by micro-CT scans. In conclusion, the presented study indicates that using sucrose produces scaffolds showing better pore interconnectivity and cell infiltration than scaffolds made by using a salt process. In addition, in vivo experiments showed that hydroxyapatite accelerates bone reconstruction on implanted scaffolds. Accordingly, our scaffold will be expected to have a useful application in bone reconstruction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Park, Hyun Jung; Lee, Ok Joo; Lee, Min Chae; Moon, Bo Mi; Ju, Hyung Woo; Lee, Jung Min; Kim, Jung-Ho; Kim, Dong Wook; Park, Chan Hum] Hallym Univ, Nanobio Regenerat Med Inst, Chunchon 200702, Gangwon, South Korea.
   [Park, Chan Hum] Hallym Univ Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon 200704, Gangwon, South Korea.
RP Park, CH (reprint author), Hallym Univ Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 153 Kyo Dong, Chunchon 200704, Gangwon, South Korea.
EM hlpch@paran.com
RI 이, 옥주/B-8523-2016; Park, Chan Hum/C-6848-2016
FU Hallym University Research Fund; Technology Commercialization Support
   Program, Ministry for Food, Agriculture, Forestry and Fisheries,
   Republic of Korea [814005-03-1-HD030]
FX This work was supported by a grant from Hallym University Research Fund
   and Technology Commercialization Support Program (814005-03-1-HD030),
   Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
   Korea.
CR Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   El Mhammedi M.A., 2007, J PRACT TECHNOL, V6, P1
   Fosso F., 2004, J CELL PHYSL, V199, P174
   Fukasawa T, 2001, J AM CERAM SOC, V84, P230, DOI 10.1111/j.1151-2916.2001.tb00638.x
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO;2-7
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Park HJ, 2014, MACROMOL RES, V22, P592, DOI 10.1007/s13233-014-2083-0
   Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3
   PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110
   Purohit K.M., 2011, BIOPROCES BIOTECHNIQ, V1, P1
   Reignier J, 2006, POLYMER, V47, P4703, DOI 10.1016/j.polymer.2006.04.029
   Sheikh F. A., 2015, J TISSUE ENG REGEN M
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Soliman S, 2011, J BIOMED MATER RES A, V96A, P566, DOI 10.1002/jbm.a.33010
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang XH, 2012, J MATER SCI-MATER M, V23, P315, DOI 10.1007/s10856-011-4476-3
   Zhao Y., 2011, J BIOMED SCI ENG, V4, P397, DOI [10.4236/jbise.2011.45050, DOI 10.4236/JBISE.2011.45050]
NR 29
TC 24
Z9 24
U1 2
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL
PY 2015
VL 78
BP 215
EP 223
DI 10.1016/j.ijbiomac.2015.03.064
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CK4LN
UT WOS:000356195400029
PM 25849999
DA 2018-10-19
ER

PT J
AU Linh, NTB
   Padalhin, AR
   Lee, BY
   Lee, BT
AF Nguyen Thuy Ba Linh
   Padalhin, Andrew R.
   Lee, Byung-Yeol
   Lee, Byong-Taek
TI Bilayer electrospun poly(vinyl alcohol)-gelatin mat and biphasic calcium
   phosphate-pectin-gelatin hydrogel for application in bone hemorrhage
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Bilayer hemostatic scaffold; biphasic calcium phosphate-pectin-gelatin;
   electrospun poly(vinyl alcohol)-gelatin; bone hemorrhage application;
   hemostatic agent
ID TOPICAL HEMOSTATIC AGENTS; ANIMAL-MODEL; LOCAL AGENTS; FABRICATION;
   MORTALITY; SURGICEL; COLLAGEN; POLYMER; SKIN; WAX
AB A bilayer composite scaffold consisting of a biphasic calcium phosphate-pectin-gelatin hydrogel and an electrospun poly(vinyl alcohol)-gelatin matrix was developed and investigated for application in bone hemorrhage. The aim of this research is to develop a new biomaterial system that provides a hemostatic effect on bone hemorrhage and does not interfere with native bone regeneration. The role of electrospun poly(vinyl alcohol)-gelatin in scaffolds is to provide the covering of the wound, while encapsulation and absorption of red blood cells are attributed to the biphasic calcium phosphate-pectin-gelatin hydrogel. Cell viability and cell proliferation were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, Live/Dead assay, and immunofluorescence assay using pre-osteoblast MC3T3-E1 cells. The effects with and without hemostatic bilayer scaffolds on rat calvaria were compared at 1 and 3weeks. The hemostatic bilayer agent showed good blood absorption behavior and efficient bone healing properties after 3weeks, as observed by micro-computed tomography and hematoxylin and eosin staining.
C1 [Nguyen Thuy Ba Linh; Padalhin, Andrew R.; Lee, Byong-Taek] Soonchunhyang Univ, Dept Regenerat Med, Coll Med, Cheonan 330721, South Korea.
   [Nguyen Thuy Ba Linh; Lee, Byong-Taek] Soonchunhyang Univ, Inst Tissue Regenerat, Coll Med, Cheonan 330721, South Korea.
   [Lee, Byung-Yeol] Soonchunhyang Univ, InoBone Corp R&D Ctr, Asan, South Korea.
RP Lee, BT (reprint author), Soonchunhyang Univ, Dept Regenerat Med, Coll Med, Cheonan 330721, South Korea.
EM lbt@sch.ac.kr
FU Business for Academic-industrial Cooperative establishments [C0247339]
FX This work (Grants No. C0247339) was supported by Business for
   Academic-industrial Cooperative establishments funded Korea Small and
   Medium Business Administration in 2014.
CR Armstrong JK, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-37
   Brightmore T G, 1975, Langenbecks Arch Chir, VSuppl, P39
   Byong-Taek Lee, 2007, Materials Chemistry & Physics, V104, P249, DOI 10.1016/j.matchemphys.2007.02.009
   CARSON JL, 1988, LANCET, V1, P727
   Cheng CM, 2009, CLIN THER, V31, P32, DOI 10.1016/j.clinthera.2009.01.005
   COBDEN RH, 1976, J BONE JOINT SURG AM, V58, P70, DOI 10.2106/00004623-197658010-00012
   Groenewold MD, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-15
   Hattori H, 2010, ANN BIOMED ENG, V38, P3724, DOI 10.1007/s10439-010-0121-4
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x
   Linh NTB, 2010, J BIOMED MATER RES B, V95B, P184, DOI 10.1002/jbm.b.31701
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Magyar CE, 2008, NEUROSURGERY, V63, P373, DOI 10.1227/01.NEU.0000316859.03788.44
   Murat FJL, 2004, J UROLOGY, V172, P1119, DOI 10.1097/01.ju.0000136001.99920.97
   NAPPI JF, 1980, CLEFT PALATE J, V17, P291
   Linh NTB, 2013, J MATER SCI, V48, P4233, DOI 10.1007/s10853-013-7236-6
   Linh NTB, 2013, J BIOMAT SCI-POLYM E, V24, P520, DOI 10.1080/09205063.2012.697696
   Nguyen TBL, 2012, J BIOMATER APPL, V27, P255, DOI 10.1177/0885328211401932
   Ostomel TA, 2007, LANGMUIR, V23, P11233, DOI 10.1021/la701281t
   Pal K, 2007, AAPS PHARMSCITECH, V8
   Palm MD, 2008, DERMATOL SURG, V34, P431, DOI 10.1111/j.1524-4725.2007.34090.x
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Peng Tao, 2010, TRENDS BIOMATER ARTI, V24, P27
   Sabel M, 2004, EUR SPINE J, V13, pS97, DOI 10.1007/s00586-004-0735-z
   Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z
   So-Ra S, 2013, SCI TECHNOL ADV MAT, V14
   SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9
   Tadeusz W, 2006, J CRANIOFAC SURG, V17, P420, DOI 10.1097/00001665-200605000-00006
   Nguyen TBL, 2015, TISSUE ENG PT A, V21, P1376, DOI [10.1089/ten.TEA.2014.0313, 10.1089/ten.tea.2014.0313]
   Wellisz T, 2008, ANN THORAC SURG, V85, P1776, DOI 10.1016/j.athoracsur.2007.11.042
NR 31
TC 1
Z9 1
U1 5
U2 36
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2015
VL 30
IS 4
BP 424
EP 435
DI 10.1177/0883911515578762
PG 12
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA CK7NO
UT WOS:000356419400006
DA 2018-10-19
ER

PT J
AU Laffleur, F
   Psenner, J
   Suchaoin, W
AF Laffleur, Flavia
   Psenner, Julia
   Suchaoin, Wongsakorn
TI Permeation Enhancement via Thiolation: In Vitro and Ex Vivo Evaluation
   of Hyaluronic Acid-Cysteine Ethyl Ester
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE biomaterial; Caco-2 cells; mucosal drug delivery; oral drug delivery;
   permeation enhancers
ID DRUG-DELIVERY; MUCOADHESIVE POLYMERS; ENHANCING PROPERTIES; NONINVASIVE
   PEPTIDE; THIOMERS; POLYCARBOPHIL; SYSTEMS; PROTEIN
AB It was the aim of this study to evaluate the permeation-enhancing effect of synthesized thiolated hyaluronic acid (HA). HA, a naturally found polysaccharide, was chemically modified with l-cysteine ethyl ether (C) via amide bond formation. In vitro permeation enhancement was tested on Caco-2 cells with two compounds, sulforhodamine (SR) and fluorescein isothiocyanate-dextran (FD4). Cytotoxicity assays as lactate dehydrogenase and thiazolyl blue tetrazolium bromide (MTT) were performed on colon carcinoma cell line. Transepithelial electrical resistance (TEER) measurements were conducted. Ex vivo evaluation was accomplished on rat intestinal mucosa in order to predict the permeation enhancing effect with SR, sodium fluorescein (SF), and FD4, respectively. The MTT as well as lactate dehydrogenase revealed no toxicity over time periods of 3 and 12 h, respectively. The bioconjugate is biocompatible and safe to use. Furthermore, TEER measurements showed the integrity of tight junctions. The in vitro permeation studies on cell studies exhibit 1.28-fold enhancement for SR and 1.47-fold enhancement for FD4 with hyaluronic acid-cysteine ethyl ester (HAC) in comparison to unmodified one. The ex vivo transport studies exhibit 1.9-fold enhancement for SF, 1.31-fold enhancement for Rhodamine123, and 1.3-fold enhancement for FD4 with HAC in comparison to unmodified one, respectively. Thus, the promising results encourage further investigations and exploitation of this versatile polysaccharide. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2153-2160, 2015
C1 [Laffleur, Flavia; Psenner, Julia; Suchaoin, Wongsakorn] Univ Innsbruck, Ctr Mol Biosci Innsbruck, Inst Pharm, Dept Pharmaceut Technol, A-6020 Innsbruck, Austria.
RP Laffleur, F (reprint author), Univ Innsbruck, Ctr Mol Biosci Innsbruck, Inst Pharm, Dept Pharmaceut Technol, A-6020 Innsbruck, Austria.
EM Flavia.Laffleur@uibk.ac.at
FU FWF (Fonds zur Forderung der wissenschaftlichen Forschung) [ZFP 235150]
FX The authors wish to thank the slaughterhouse Josef Mayr in Natters for
   providing the porcine mucosa. This work was supported by the FWF (Fonds
   zur Forderung der wissenschaftlichen Forschung) project No. ZFP 235150.
CR Aungst BJ, 2000, J PHARM SCI, V89, P429, DOI 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J
   Bernkop-Schnurch A, 2003, J CONTROL RELEASE, V93, P95, DOI 10.1016/j.jconrel.2003.05.001
   Bernkop-Schnurch A, 2004, EUR J PHARM BIOPHARM, V58, P253, DOI 10.1016/j.ejpb.2004.03.032
   Bernkop-Schnurch A, 2000, EXPERT OPIN THER PAT, V10, P1357, DOI 10.1517/13543776.10.9.1357
   Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8
   Clausen AE, 2002, PHARMACEUT RES, V19, P602, DOI 10.1023/A:1015345827091
   Clausen AE, 2000, J PHARM SCI, V89, P1253, DOI 10.1002/1520-6017(200010)89:10<1253::AID-JPS3>3.0.CO;2-8
   Guggi D, 2005, INT J PHARM, V288, P141, DOI 10.1016/j.ijpharm.2004.09.023
   Kafedjiiski K, 2007, INT J PHARMACEUT, V343, P48, DOI 10.1016/j.ijpharm.2007.04.019
   Laffleur F, 2012, DRUG DEV IND PHARM, V39, P1531
   Laffleur F, 2014, J PHARM SCI-US, V103, P2414, DOI 10.1002/jps.24060
   Laffleur F, 2014, DRUG DEV IND PHARM, V40, P591, DOI 10.3109/03639045.2014.892959
   Laffleur F, 2013, NANOMEDICINE-UK, V8, P2061, DOI 10.2217/nnm.13.178
   Laffleur F, 2012, FUTURE MED CHEM, V4, P2205, DOI [10.4155/FMC.12.165, 10.4155/fmc.12.165]
   Leitner VM, 2004, J PHARM SCI-US, V93, P1682, DOI 10.1002/jps.20069
   Mero A, 2014, POLYMERS-BASEL, V6, P346, DOI 10.3390/polym6020346
   Necas J, 2008, VET MED-CZECH, V53, P397
   Nowak J, 2014, INT J PHARMACEUT, V478, P383
   Rahmat D, 2012, INT J PHARMACEUT, V422, P40, DOI 10.1016/j.ijpharm.2011.10.024
   Sarti F, 2012, EUR J PHARM BIOPHARM, V84, P132
   Schmitz T, 2008, DRUG DELIV, V15, P245, DOI 10.1080/10717540802006708 
   Shahnaz G, 2013, EUR J PHARM BIOPHARM, V85, P346, DOI 10.1016/j.ejpb.2013.02.010
   Siissalo S, 2009, EUR J PHARM BIOPHARM, V71, P332, DOI 10.1016/j.ejpb.2008.08.010
   Wang XQ, 2012, INT J PHARMACEUT, V438, P217, DOI 10.1016/j.ijpharm.2012.08.045
   Werle M, 2009, J PHARM SCI-US, V98, P1643, DOI 10.1002/jps.21550
NR 25
TC 10
Z9 11
U1 3
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD JUL
PY 2015
VL 104
IS 7
BP 2153
EP 2160
DI 10.1002/jps.24456
PG 8
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA CL1LT
UT WOS:000356705500005
PM 25900642
DA 2018-10-19
ER

PT J
AU Gonzalez, LM
   Moeser, AJ
   Blikslager, AT
AF Gonzalez, Liara M.
   Moeser, Adam J.
   Blikslager, Anthony T.
TI Porcine models of digestive disease: the future of large animal
   translational research
SO TRANSLATIONAL RESEARCH
LA English
DT Review
ID ISCHEMIA-REPERFUSION INJURY; ACUTE MESENTERIC ISCHEMIA; SMALL-BOWEL
   RESECTION; PROSTAGLANDIN-INDUCED RECOVERY; MUCOSAL BARRIER FUNCTION;
   HUMANIZED MOUSE MODELS; NECROTIZING ENTEROCOLITIS; INTESTINAL ISCHEMIA;
   PRETERM PIGS; PANETH CELLS
AB There is increasing interest in nonrodent translational models for the study of human disease. The pig, in particular, serves as a useful animal model for the study of pathophysiological conditions relevant to the human intestine. This review assesses currently used porcine models of gastrointestinal physiology and disease and provides a rationale for the use of these models for future translational studies. The pig has proven its utility for the study of fundamental disease conditions such as ischemia-reperfuion injury, stress-induced intestinal dysfunction, and short bowel syndrome. Pigs have also shown great promise for the study of intestinal barrier function, surgical tissue manipulation and intervention, as well as biomaterial implantation and tissue transplantation. Advantages of pig models highlighted by these studies include the physiological similarity to human intestine and mechanisms of human disease. Emerging future directions for porcine models of human disease include the fields of transgenics and stem cell biology, with exciting implications for regenerative medicine.
C1 N Carolina State Univ, Ctr Comparat Med & Translat Res, Dept Clin Sci, Raleigh, NC 27695 USA.
   N Carolina State Univ, Ctr Comparat Med & Translat Res, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.
RP Gonzalez, LM (reprint author), Coll Vet Med, 1060 William Moore Dr, Raleigh, NC 27607 USA.
EM Lmgonza4@ncsu.edu
OI Blikslager, Anthony/0000-0002-0867-7310; Moeser,
   Adam/0000-0003-3068-627X
FU NICHD NIH HHS [R01 HD072968]; NIH HHS [T35 OD011070, T32 OD011130];
   NIDDK NIH HHS [P30 DK034987]
CR Abu-Elmagd KM, 2012, ANN SURG, V256, P494, DOI 10.1097/SLA.0b013e318265f310
   Acosta S, 2007, J SURG RES, V143, P320, DOI 10.1016/j.jss.2007.02.003
   Acosta S, 2012, J EMERG MED, V42, P635, DOI 10.1016/j.jemermed.2011.03.036
   Ahdieh N, 1998, PEDIATR RES, V43, P227, DOI 10.1203/00006450-199802000-00012
   Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9
   [Anonymous], 2007, SWINE LAB SURG ANEST
   ARGENZIO RA, 1990, GASTROENTEROLOGY, V98, P1129, DOI 10.1016/0016-5085(90)90325-U
   Avansino JR, 2006, J SURG RES, V132, P74, DOI 10.1016/j.jss.2005.09.009
   Azcarate-Peril M Andrea, 2011, Gut Microbes, V2, P234, DOI 10.4161/gmic.2.4.16332
   Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009
   BELLAMY JEC, 1973, CAN J COMP MED, V37, P56
   Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004
   Benhamou PH, 1997, J PEDIATR SURG, V32, P1332, DOI 10.1016/S0022-3468(97)90315-8
   Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953
   Bicakci Unal, 2013, Afr J Paediatr Surg, V10, P91, DOI 10.4103/0189-6725.115030
   BIJLSMA PB, 1995, GASTROENTEROLOGY, V108, P687, DOI 10.1016/0016-5085(95)90440-9
   Bines JE, 2002, J GASTROEN HEPATOL, V17, P1170, DOI 10.1046/j.1440-1746.2002.02872.x
   Bitar KN, 2012, NEUROGASTROENT MOTIL, V24, P7, DOI 10.1111/j.1365-2982.2011.01843.x
   Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006
   Blikslager AT, 1997, SURGERY, V121, P526, DOI 10.1016/S0039-6060(97)90107-0
   Blikslager AT, 1999, SURGERY, V125, P186, DOI 10.1016/S0039-6060(99)70264-3
   Blikslager AT, 1999, AM J PHYSIOL-GASTR L, V276, pG28, DOI 10.1152/ajpgi.1999.276.1.G28
   Block T, 2011, EUR J VASC ENDOVASC, V41, P281, DOI 10.1016/j.ejvs.2010.09.012
   Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094
   BOROS M, 1995, J SURG RES, V59, P311, DOI 10.1006/jsre.1995.1170
   Brehm MA, 2010, CURR OPIN ENDOCRINOL, V17, P120, DOI 10.1097/MED.0b013e328337282f
   Brown DR, 1997, COMP BIOCHEM PHYS A, V118, P309, DOI 10.1016/S0300-9629(96)00311-8
   Brown DR, 2004, NEUROGASTROENT MOTIL, V16, P50, DOI 10.1111/j.1743-3150.2004.00475.x
   Bruhn RS, 2013, INVEST RADIOL, V48, P231, DOI 10.1097/RLI.0b013e3182809143
   Burrin DG, 2000, AM J PHYSIOL-GASTR L, V279, pG1249
   Burton J, 2014, VET CLIN N AM-SMALL, V44, P977, DOI 10.1016/j.cvsm.2014.05.006
   Butler JE, 2013, J LEUKOCYTE BIOL, V94, P259, DOI 10.1189/jlb.0313120
   Casley-Smith JR, 1984, PHYSL INTESTINAL CIR, P9
   Chen CS, 2006, EUR J PHARMACOL, V539, P116, DOI 10.1016/j.ejphar.2006.03.081
   Chen DC, 2006, J SURG RES, V134, P52, DOI 10.1016/j.jss.2006.03.029
   Chen YM, 2003, WORLD J GASTROENTERO, V9, P795, DOI 10.3748/wjg.v9.i4.795
   Chung S. K., 1997, Hong Kong Medical Journal, V3, P201
   Cilieborg MS, 2011, BRIT J NUTR, V106, P852, DOI 10.1017/S000711451100047X
   Cilieborg MS, 2011, J NUTR, V141, P223, DOI 10.3945/jn.110.128561
   CRISSINGER KD, 1989, PEDIATR RES, V25, P612, DOI 10.1203/00006450-198906000-00012
   Deglaire A, 2012, BRIT J NUTR, V108, pS273, DOI 10.1017/S0007114512002346
   Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008
   Dekaney CM, 1997, ANAT REC, V249, P517
   DELAHUNTY T, 1987, COMP BIOCHEM PHYS A, V86, P565, DOI 10.1016/0300-9629(87)90542-1
   Derikx JPM, 2011, J SURG RES, V166, P222, DOI 10.1016/j.jss.2009.09.046
   Deshmukh DR, 1997, AM J PHYSIOL-CELL PH, V273, pC1130
   DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167
   Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014
   Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031
   Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110
   FLORES CA, 1992, NUTRITION, V8, P418
   Foster DM, 2012, GASTROENTEROLOGY, V143, P133, DOI 10.1053/j.gastro.2012.03.030
   Gayle J, 2002, SURGERY, V132, P461, DOI 10.1067/msy.2002.125320
   Gonzalez LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066465
   Gookin JL, 2006, AM J PHYSIOL-GASTR L, V290, pG164, DOI 10.1152/ajpgi.00460.2004
   Gookin JL, 2003, AM J PHYSIOL-GASTR L, V285, pG967, DOI 10.1152/ajpgi.00532.2002
   Gootenberg DB, 2011, J ANIM SCI, V89, P1531, DOI 10.2527/jas.2010-3371
   Gotthardt DN, 2013, CLIN TRANSPLANT, V27, P49, DOI 10.1111/ctr.12161
   Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039
   GRAHAM H, 1987, SCAND J GASTROENTERO, V22, P55, DOI 10.3109/00365528709095851
   GRANGER DN, 1986, GASTROENTEROLOGY, V90, P80, DOI 10.1016/0016-5085(86)90078-8
   GRANGER DN, 1989, AM J PHYSIOL, V257, pG683
   GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47
   Gregory Katherine E, 2011, Adv Neonatal Care, V11, P155, DOI 10.1097/ANC.0b013e31821baaf4
   GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567
   Guan XF, 2006, GASTROENTEROLOGY, V130, P150, DOI 10.1053/j.gastro.2005.11.005
   Guan XF, 2003, GASTROENTEROLOGY, V125, P136, DOI 10.1016/S0016-5085(03)00667-X
   Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR
   HAGLIND E, 1985, ACTA CHIR SCAND, V151, P147
   HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0
   Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x
   Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152
   HERNANDEZ LA, 1987, AM J PHYSIOL, V253, pH699
   Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3
   Humphray SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r139
   Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x
   Jacobi SK, 2012, J NUTR, V142, P1266, DOI 10.3945/jn.111.150995
   Jeppesen PB, 2011, GUT, V60, P902, DOI 10.1136/gut.2010.218271
   Jeppesen PB, 2012, GASTROENTEROLOGY, V143, P1473, DOI 10.1053/j.gastro.2012.09.007
   Jeppesen PB, 2001, GASTROENTEROLOGY, V120, P806, DOI 10.1053/gast.2001.22555
   Jung Camille, 2010, Int J Inflam, V2010, P823710, DOI 10.4061/2010/823710
   KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502
   Kirk AD, 2003, IMMUNOL REV, V196, P176, DOI 10.1046/j.1600-065X.2003.00081.x
   Klein HM, 1996, J COMPUT ASSIST TOMO, V20, P254, DOI 10.1097/00004728-199603000-00016
   Klymiuk N, 2010, MOL REPROD DEV, V77, P209, DOI 10.1002/mrd.21127
   Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8
   KUBES P, 1992, GASTROENTEROLOGY, V103, P807, DOI 10.1016/0016-5085(92)90010-V
   Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103
   Le Bas-Bernardet S, 2008, GENE THER, V15, P1247, DOI 10.1038/gt.2008.119
   Lee HT, 2013, AM J PHYSIOL-GASTR L, V304, pG12, DOI 10.1152/ajpgi.00201.2012
   Lee H, 2014, MOL IMMUNOL, V58, P151, DOI 10.1016/j.molimm.2013.11.012
   LEHR HA, 1994, CIRCULATION, V90, P1580, DOI 10.1161/circ.90.3.8087970
   Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb
   Lennon D, 2011, LAB ANIMAL, V40, P253, DOI 10.1038/laban0811-253
   Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002
   Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463
   Little D, 2003, AM J PHYSIOL-GASTR L, V284, pG46, DOI 10.1152/ajpgi.00121.2002
   Low MJ, 2012, GASTROENTEROLOGY, V143, P1410, DOI 10.1053/j.gastro.2012.10.011
   Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91
   Meyers SN, 2005, GENOMICS, V86, P739, DOI 10.1016/j.ygeno.2005.04.010
   MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045
   Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006
   Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006
   Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006
   Moeser AJ, 2006, GASTROENTEROLOGY, V130, pA89
   Moeser AJ, 2006, AM J PHYSIOL-GASTR L, V291, pG885, DOI 10.1152/ajpgi.00380.2005
   Moeser AJ, 2004, GASTROENTEROLOGY, V127, P802, DOI 10.1053/j.gastro.2004.06.004
   Montgomery RK, 1999, GASTROENTEROLOGY, V116, P702, DOI 10.1016/S0016-5085(99)70193-9
   Moughan P J, 1992, World Rev Nutr Diet, V67, P40
   Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387
   MYER MS, 1982, J S AFR VET ASSOC, V53, P69
   MYER MS, 1982, ONDERSTEPOORT J VET, V49, P131
   Nagy ES, 2004, J PEDIATR GASTR NUTR, V39, P487, DOI 10.1097/00005176-200411000-00008
   Nankervis CA, 2008, SEMIN PERINATOL, V32, P83, DOI 10.1053/j.semperi.2008.01.003
   National Institute of Diabetes and Digestive and Kidney Diseases, 2009, OPP CHALL DIG DIS RE
   National Institute of Health, 2012, NIH S IMPR AN MOD RE
   Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769
   Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408
   Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935
   Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23
   Paral J, 2007, SURG LAPARO ENDO PER, V17, P291, DOI 10.1097/SLE.0b013e3180dc9376
   Paris MC, 2004, DIGEST DIS SCI, V49, P1688, DOI 10.1023/B:DDAS.0000043388.52260.2f
   PARK PO, 1992, CRIT CARE MED, V20, P135, DOI 10.1097/00003246-199201000-00026
   PARKS DA, 1982, GASTROENTEROLOGY, V82, P9
   PARKS DA, 1986, AM J PHYSIOL, V250, pG749
   Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262
   Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002
   Pereira-Fantini PM, 2008, JPEN-PARENTER ENTER, V32, P266, DOI 10.1177/0148607108316197
   Pereira-Fantini PM, 2008, J PEDIATR GASTR NUTR, V46, P20, DOI 10.1097/01.mpg.0000304449.46434.06
   Pereira-Fantini PM, 2011, HISTOCHEM CELL BIOL, V135, P195, DOI 10.1007/s00418-011-0778-2
   Petersen YM, 2003, J NUTR, V133, P1781
   Petersen YM, 2002, PEDIATR RES, V52, P498, DOI 10.1203/01.0000030884.86822.E4
   Phillips KA, 2006, NAT REV DRUG DISCOV, V5, P463, DOI 10.1038/nrd2033
   Pierson RN, 2009, XENOTRANSPLANTATION, V16, P263, DOI 10.1111/j.1399-3089.2009.00534.x
   Pizarro TT, 2011, INFLAMM BOWEL DIS, V17, P2566, DOI 10.1002/ibd.21638
   Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653
   Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871
   Reginelli A, 2013, CRIT ULTRASOUND J, V5, DOI 10.1186/2036-7902-5-S1-S7
   Rhoads JM, 1997, AM J PHYSIOL-GASTR L, V272, pG943
   Rizk P, 2012, WIRES SYST BIOL MED, V4, P475, DOI 10.1002/wsbm.1176
   Rogan MP, 2010, P NATL ACAD SCI USA, V107, P20571, DOI 10.1073/pnas.1015281107
   Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773
   Rosow DE, 2005, J GASTROINTEST SURG, V9, P1262, DOI 10.1016/j.gassur.2005.07.034
   Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016
   Ruiz P, 2004, TRANSPLANT P, V36, P335, DOI 10.1016/j.transproceed.2004.01.079
   Sala FG, 2009, J SURG RES, V156, P205, DOI 10.1016/j.jss.2009.03.062
   Sangild PT, 2006, J PEDIATR GASTR NUTR, V43, P160, DOI 10.1097/01.mpg.0000228122.82723.1b
   Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359
   Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026
   Sangild PT, 2002, J NUTR, V132, P3785, DOI 10.1093/jn/132.9.2673
   Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391
   Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637
   SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109
   Scheer N, 2013, DRUG DISCOV TODAY, V18, P1200, DOI 10.1016/j.drudis.2013.07.007
   Schmidt LD, 2007, J NEUROIMMUNOL, V185, P20, DOI 10.1016/j.jneuroim.2006.10.028
   Schreiber KL, 2005, STRESS, V8, P185, DOI 10.1080/10253890500188732
   Schwartz CA, 2012, ROFO-FORTSCHR RONTG, V184, P520, DOI 10.1055/s-0031-1299414
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Siggers RH, 2008, J NUTR, V138, P1437
   Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002
   Sinkora M, 2011, J IMMUNOL, V187, P5150, DOI 10.4049/jimmunol.1101879
   Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009
   SMITH SM, 1987, GASTROENTEROLOGY, V92, P950, DOI 10.1016/0016-5085(87)90969-3
   Spurrier RG, 2013, CLIN GASTROENTEROL H, V11, P354, DOI 10.1016/j.cgh.2013.01.028
   STEVENS CE, 1986, CLIN GASTROENTEROL, V15, P763
   Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867
   SUZUKI M, 1989, AM J PHYSIOL, V257, pH1740
   Swindle MM, 1998, SCAND J LAB ANIM SCI, V25, P11
   Tang ZH, 2010, ACAD RADIOL, V17, P1146, DOI 10.1016/j.acra.2010.04.014
   Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858
   Thompson JS, 1996, DIGEST DIS SCI, V41, P1760, DOI 10.1007/BF02088742
   Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009
   Trautmann A, 1884, FUNDAMENTALS HISTOLO
   Trompeter M, 2002, EUR RADIOL, V12, P1179, DOI 10.1007/00330-001-1220-2
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   UDASSIN R, 1994, J SURG RES, V56, P221, DOI 10.1006/jsre.1994.1035
   Van Haver ER, 2009, J PEDIATR GASTR NUTR, V49, P90, DOI 10.1097/MPG.0b013e31818de393
   Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011
   Vegge A, 2013, AM J PHYSIOL-GASTR L, V305, pG277, DOI 10.1152/ajpgi.00064.2013
   Wagner SJ, 2013, INFLAMM BOWEL DIS, V19, P1285, DOI 10.1097/MIB.0b013e318281f573
   Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Weih S, 2011, J SURG RES, V171, P709, DOI 10.1016/j.jss.2011.07.052
   Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149
   Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333
   Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320
   Wolvekamp MCJ, 1996, DIGEST DIS, V14, P59, DOI 10.1159/000171539
   Yandza T, 2012, J SURG RES, V178, P807, DOI 10.1016/j.jss.2012.07.025
   Yasuhara H, 2005, SURG TODAY, V35, P185, DOI 10.1007/s00595-004-2924-0
   Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695
   Zabielski R, 1999, REPROD NUTR DEV, V39, P5, DOI 10.1051/rnd:19990101
   ZIMMERMAN BJ, 1990, AM J PHYSIOL, V258, pG185
NR 192
TC 30
Z9 29
U1 2
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1931-5244
EI 1878-1810
J9 TRANSL RES
JI Transl. Res.
PD JUL
PY 2015
VL 166
IS 1
BP 12
EP 27
DI 10.1016/j.trsl.2015.01.004
PG 16
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA CK6DC
UT WOS:000356317700002
PM 25655839
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Jones, CH
   Gollakota, A
   Chen, MF
   Chung, TC
   Ravikrishnan, A
   Zhang, GJ
   Pfeifer, BA
AF Jones, Charles H.
   Gollakota, Akhila
   Chen, Mingfu
   Chung, Tai-Chun
   Ravikrishnan, Anitha
   Zhang, Guojian
   Pfeifer, Blaine A.
TI Influence of molecular weight upon mannosylated bio-synthetic hybrids
   for targeted antigen presenting cell gene delivery
SO BIOMATERIALS
LA English
DT Article
DE Gene therapy; Nonviral vector; Cationic polymers; Antigen presenting
   cells; Bactofection
ID MANNOSE RECEPTOR; POLYANHYDRIDE NANOPARTICLES; POLY(BETA-AMINO ESTERS);
   MICROBIAL ADHESION; LECTIN RECEPTORS; IMMUNE-RESPONSE; RICIN TOXIN;
   MACROPHAGES; CAVEOLAE; LIBRARY
AB Given the rise of antibiotic resistant microbes, genetic vaccination is a promising prophylactic strategy that enables rapid design and manufacture. Facilitating this process is the choice of vector, which is often situationally-specific and limited in engineering capacity. Furthermore, these shortcomings are usually tied to an incomplete understanding of the structure function relationships driving vector-mediated gene delivery. Building upon our initial report of a hybrid bacterial-biomaterial gene delivery vector, a comprehensive structure function assessment was completed using a class of mannosylated poly(beta-amino esters). Through a top-down screening methodology, an ideal polymer was selected on the basis of gene delivery efficacy and then used for the synthesis of a stratified molecular weight polymer library. By eliminating contributions of polymer chemical background, we were able to complete an in-depth assessment of gene delivery as a function of (1) polymer molecular weight, (2) relative mannose content, (3) polymer-membrane biophysical properties, (4) APC uptake specificity, and (5) serum inhibition. In summary, the flexibility and potential of the hybrid design featured in this work highlights the ability to systematically probe vector-associated properties for the development of translational gene delivery candidates. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Jones, Charles H.; Gollakota, Akhila; Chen, Mingfu; Chung, Tai-Chun; Ravikrishnan, Anitha; Zhang, Guojian; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
RP Pfeifer, BA (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM blainepf@buffalo.edu
OI Chen, Mingfu/0000-0002-0169-613X
FU NIH [AI088485]; SUNY-Buffalo Schomburg fellowship
FX The authors recognize support from NIH award AI088485 (BAP) and a
   SUNY-Buffalo Schomburg fellowship (CHJ).
CR Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Canine BF, 2010, ADV DRUG DELIVER REV, V62, P1524, DOI 10.1016/j.addr.2010.04.001
   Carrillo-Conde B, 2011, MOL PHARMACEUT, V8, P1877, DOI 10.1021/mp200213r
   Chavez-Santoscoy AV, 2012, BIOMATERIALS, V33, P4762, DOI 10.1016/j.biomaterials.2012.03.027
   Chung TC, 2015, MOL PHARM
   Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131
   GEERTSEMADOORNBUSCH GI, 1993, J MICROBIOL METH, V18, P61, DOI 10.1016/0167-7012(93)90072-P
   Jones CH, 2015, BIOMACROMOLECULES
   Jones CH, 2015, MOL PHARMACEUT, V12, P846, DOI 10.1021/mp500683c
   Jones CH, 2015, BIOMATERIALS, V37, P333, DOI 10.1016/j.biomaterials.2014.10.037
   Jones CH, 2014, J MATER CHEM B, V2, P8053, DOI [10.1039/C4TB01058B, 10.1039/c4tb01058b]
   Jones CH, 2014, P NATL ACAD SCI USA, V111, P12360, DOI 10.1073/pnas.1411355111
   Jones CH, 2013, MOL PHARMACEUT, V10, P4301, DOI 10.1021/mp4003927
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Mena MA, 2006, NAT BIOTECHNOL, V24, P1569, DOI 10.1038/nbt1264
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Parsa S, 2008, J BIOTECHNOL, V137, P59, DOI 10.1016/j.jbiotec.2008.07.1815
   Parsa S, 2008, PHARM RES, V25, P1202, DOI 10.1007/s11095-008-9563-x
   Parsa S, 2007, MOL PHARMACEUT, V4, P4, DOI 10.1021/mp0600889
   Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122
   Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x
   Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2
   Rehman ZU, 2013, J CONTROL RELEASE, V166, P46, DOI 10.1016/j.jconrel.2012.12.014
   Rosenberg M, 2006, FEMS MICROBIOL LETT, V262, P129, DOI 10.1111/j.1574-6968.2006.00291.x
   Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614
   Shin JS, 2001, SCIENCE, V293, P1447, DOI 10.1126/science.1061079
   SIMMONS BM, 1986, J BIOL CHEM, V261, P7912
   STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X
   Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9
   STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543
   Zhu CL, 2013, ADV MATER, V25, P1203, DOI 10.1002/adma.201204550
NR 37
TC 4
Z9 4
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 58
BP 103
EP 111
DI 10.1016/j.biomaterials.2015.04.033
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK3ND
UT WOS:000356121900011
PM 25941787
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Nunome, S
   Kanetaka, H
   Kudo, T
   Endoh, K
   Hosoda, H
   Igarashi, K
AF Nunome, Shoko
   Kanetaka, Hiroyasu
   Kudo, Tada-aki
   Endoh, Kazuki
   Hosoda, Hideki
   Igarashi, Kaoru
TI Invitro evaluation of biocompatibility of Ti-Mo-Sn-Zr superelastic alloy
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Biocompatibility; Ti-Mo-Sn-Zr alloy; shape memory alloy;
   superelasticity; invitro evaluation
ID SHAPE-MEMORY ALLOY; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   ORTHODONTIC WIRES; STAINLESS-STEEL; ACTIVE CATHETER; TITANIUM-ALLOYS;
   NICKEL-TITANIUM; CELLS; BEHAVIOR
AB Shape memory alloys (SMAs) including superelastic alloys have unique properties such as shape memory and superelasticity, thus they are recognized as very useful biomaterials. These properties are very advantageous for medical use, and actually the SMA wires have been widely used in medical field. However, biocompatibility of nickel-titanium (Ni-Ti) alloy, which is the only practical SMA at present, has been questioned because of its high nickel content. The aim of this study was to evaluate the biocompatibility of a newly developed Ni-free Ti-based SMA for medical use. The newly developed SMA made of Ti-Mo-Sn-Zr system was processed into a disk of 15.1mm in diameter. Pure titanium of the same shape was prepared as control. All the disk surfaces were polished using emery papers, #120, #400, and #600. Scanning electron microscopy and a 3D optics profiler were used to evaluate the surface of the materials. Invitro evaluations included colony examination for evaluation of the cell cytotoxicity, DNA quantification for the cell proliferation, Alamar blue assay for metabolic activity, FDA staining for the live cell imaging, and cell cycle analysis, using Chinese hamster fibroblastic V-79 cells and mouse osteoblastic MC3T3-E1 cells. In colony examination and DNA quantification, there was no significant difference between the Ti-Mo-Sn-Zr and the pure titanium. In FDA staining, cultured cells on the Ti-Mo-Sn-Zr alloy showed the same biocompatibility as those on the pure titanium. The present results suggest that the newly developed Ti-Mo-Sn-Zr alloy showed the high biocompatibility comparable to pure titanium and can be used as efficient biomaterial for medical use.
C1 [Nunome, Shoko; Igarashi, Kaoru] Tohoku Univ, Grad Sch Dens, Div Oral Dysfunct Sci, Sendai, Miyagi 9808575, Japan.
   [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Dens, Liaison Ctr Innovat Dent, Sendai, Miyagi 9808575, Japan.
   [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Diag & Treatment, Sendai, Miyagi 9808575, Japan.
   [Kudo, Tada-aki] Tohoku Univ, Grad Sch Dens, Div Oral Physiol, Sendai, Miyagi 9808575, Japan.
   [Endoh, Kazuki; Hosoda, Hideki] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.
RP Kanetaka, H (reprint author), Tohoku Univ, Grad Sch Dens, Liaison Ctr Innovat Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM kanetaka@dent.tohoku.ac.jp
FU Funding Program for Next Generation World-Leading Researchers [LR015];
   Japan Society for the Promotion of Science [26220907]
FX Authors would like to thank the financial support for the material
   development by Funding Program for Next Generation World-Leading
   Researchers (No. LR015) and Grant-in-Aid for Scientific Research (S)
   (No.26220907) from Japan Society for the Promotion of Science.
CR Abou Neel EA, 2010, J TISSUE ENG, V1, P1
   Acerbi F, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181faaa86
   Arciniegas M, 2013, J BIOMED MATER RES B, V101B, P709, DOI 10.1002/jbm.b.32873
   Arciniegas M, 2008, PHILOS MAG, V88, P2529, DOI 10.1080/14786430802375667
   BAGOT M, 1995, EUR J DERMATOL, V5, P614
   Barrera JM, 2013, MED ORAL PATOL ORAL, V18, pE547, DOI 10.4317/medoral.18291
   Camelia S, 2010, WSEAS T BIOL BIOMED, V3, P277
   Chen Y, 2012, J NANOMATER, V2012, P1
   Coen N, 2003, BRIT J CANCER, V88, P548, DOI 10.1038/sj.bjc.6600758
   Darel EH, 1990, ASM HDB, P897
   Diego M, 2010, JOM, V52, P36
   Endoh Kazuki, 2014, Advanced Materials Research, V922, P137, DOI 10.4028/www.scientific.net/AMR.922.137
   Espinar E, 2011, J MATER SCI-MATER M, V22, P1119, DOI 10.1007/s10856-011-4292-9
   Franklin NM, 2001, ENVIRON TOXICOL CHEM, V20, P160, DOI 10.1897/1551-5028(2001)020<0160:DOFCBA>2.0.CO;2
   Gonzalez M, 2014, MAT SCI ENG C-MATER, V42, P691, DOI 10.1016/j.msec.2014.06.010
   Gonzalez M, 2011, J MATER ENG PERFORM, V20, P653, DOI 10.1007/s11665-011-9917-0
   Gonzalez M, 2009, J MATER ENG PERFORM, V18, P506, DOI 10.1007/s11665-009-9393-y
   Haga Y, 2001, INTERV NEURORADIOL, V7, P125, DOI 10.1177/15910199010070S118
   Horev-Azaria L, 2011, TOXICOL SCI, V122, P489, DOI 10.1093/toxsci/kfr124
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Hosoda H, 2010, MATER SCI FORUM, V654-656, P2150, DOI 10.4028/www.scientific.net/MSF.654-656.2150
   Hosoda N, 2001, PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS AND PROCESSING, VOLS I AND II, P1623
   Iijima M, 2010, DENT MATER J, V29, P53, DOI 10.4012/dmj.2009-069
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Isama K, 2002, MATER TRANS, V43, P3155, DOI 10.2320/matertrans.43.3155
   Ishigaki T, 2007, INT C SHAP MEM SUP T, P559
   Jia-can S, 2009, INT ORTHOP, V34, P369
   Kanetaka H, 2010, MATER TRANS, V51, P1944, DOI 10.2320/matertrans.M2010038
   Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021
   Kassab EJ, 2013, ANGLE ORTHOD, V83, P864, DOI 10.2319/091712-740.1
   Kawakita Eiji, 2012, Open Orthop J, V6, P239, DOI 10.2174/1874325001206010239
   Kawashita M, 2014, J BIOMED MATER RES A, V102, P1880, DOI 10.1002/jbm.a.34861
   Kim H, 1999, ANGLE ORTHOD, V69, P39
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kodama C, 1998, B RES I MINERAL DRES, V43, P179
   Li HF, 2014, J MATER SCI-MATER M, V25, P1249, DOI 10.1007/s10856-014-5158-8
   Liu YX, 2011, J NANOPART RES, V13, P199, DOI 10.1007/s11051-010-0019-y
   Maeshima T, 2006, MAT SCI ENG A-STRUCT, V438, P844, DOI 10.1016/j.msea.2006.05.092
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Marcin M, 2010, BIOL TRACE ELEM RES, V146, P272
   Miaolei Z., 2013, APPL MATH, V2013, P1
   Michiardi A, 2006, J BIOMED MATER RES B, V77B, P249, DOI 10.1002/jbm.b.30441
   Mineta T, 2001, SENSOR ACTUAT A-PHYS, V88, P112, DOI 10.1016/S0924-4247(00)00510-0
   Moharamzadeh K, 2009, MATERIALS, V2, P514, DOI 10.3390/ma2020514
   Nakagawa M, 2001, Dent Mater J, V20, P305
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627
   Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347
   Robin KP, 2009, ANN CLIN MICROB ANTI, V8, P1
   Saito H, 2007, INT C SHAP MEM SUP T, P565
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Sasano H, 1984, 5 INT C TIT FRANKF G, P1667
   Schiff N, 2006, EUR J ORTHODONT, V28, P298, DOI 10.1093/ejo/cji102
   Sfondrini MF, 2010, AM J ORTHOD DENTOFAC, V137, P809, DOI 10.1016/j.ajodo.2008.07.021
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Sivaraj Aravind, 2013, J Int Oral Health, V5, P1
   Taniguchi M, 2014, FEBS OPEN BIO, V4, P328, DOI 10.1016/j.fob.2014.03.004
   Tripuraneni SC, 2011, TRENDS BIOMATER, V25, P51
   Verstrynge A, 2006, AM J ORTHOD DENTOFAC, V130, P460, DOI 10.1016/j.ajodo.2004.12.030
   Villa R, 2002, MATER TRANS, V43, P2991, DOI 10.2320/matertrans.43.2991
   Xiaohua Y, 2013, BIOMED RES INT, V2013, P1
   Xinwei L, 2013, INT ORTHOP, V34, P1033
   Zhang Y, 2009, BIOMED MATER, V4, DOI [10.1088/1748-6041/25/1/012001, 10.1088/1748-6041/4/1/012001]
NR 69
TC 1
Z9 1
U1 1
U2 32
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2015
VL 30
IS 1
BP 119
EP 130
DI 10.1177/0885328215569892
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK5CL
UT WOS:000356239600011
PM 25659946
DA 2018-10-19
ER

PT J
AU Cardwell, RD
   Kluge, JA
   Thayer, PS
   Guelcher, SA
   Dahlgren, LA
   Kaplan, DL
   Goldstein, AS
AF Cardwell, Robyn D.
   Kluge, Jonathan A.
   Thayer, Patrick S.
   Guelcher, Scott A.
   Dahlgren, Linda A.
   Kaplan, David L.
   Goldstein, Aaron S.
TI Static and Cyclic Mechanical Loading of Mesenchymal Stem Cells on
   Elastomeric, Electrospun Polyurethane Meshes
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE bioreactor; confocal microscopy; polyurethane; mechanical properties;
   C3H10T1/2; electrospinning; cell morphology; cyclic stretch
ID ANTERIOR CRUCIATE LIGAMENT; GENE-EXPRESSION; FIBER DIAMETER; IN-VITRO;
   TENDON; FIBROBLAST; ALIGNMENT; SCAFFOLD; RECONSTRUCTION; MATRIX
AB Biomaterial substrates composed of semi-aligned electrospun fibers are attractive supports for the regeneration of connective tissues because the fibers are durable under cyclic tensile loads and can guide cell adhesion, orientation, and gene expression. Previous studies on supported electrospun substrates have shown that both fiber diameter and mechanical deformation can independently influence cell morphology and gene expression. However, no studies have examined the effect of mechanical deformation and fiber diameter on unsupported meshes. Semi-aligned large (1.75 mu m) and small (0.60 mu m) diameter fiber meshes were prepared from degradable elastomeric poly(esterurethane urea) (PEUUR) meshes and characterized by tensile testing and scanning electron microscopy (SEM). Next, unsupported meshes were aligned between custom grips (with the stretch axis oriented parallel to axis of fiber alignment), seeded with C3H10T1/2 cells, and subjected to a static load (50 mN, adjusted daily), a cyclic load (4% strain at 0.25 Hz for 30 min, followed by a static tensile loading of 50 mN, daily), or no load. After 3 days of mechanical stimulation, confocal imaging was used to characterize cell shape, while measurements of deoxyribonucleic acid (DNA) content and messenger ribonucleic acid (mRNA) expression were used to characterize cell retention on unsupported meshes and expression of the connective tissue phenotype. Mechanical testing confirmed that these materials deform elastically to at least 10%. Cells adhered to unsupported meshes under all conditions and aligned with the direction of fiber orientation. Application of static and cyclic loads increased cell alignment. Cell density and mRNA expression of connective tissue proteins were not statistically different between experimental groups. However, on large diameter fiber meshes, static loading slightly elevated tenomodulin expression relative to the no load group, and tenascin-C and tenomodulin expression relative to the cyclic load group. These results demonstrate the feasibility of maintaining cell adhesion and alignment on semi-aligned fibrous elastomeric substrates under different mechanical conditions. The study confirms that cell morphology is sensitive to the mechanical environment and suggests that expression of select connective tissue genes may be enhanced on large diameter fiber meshes under static tensile loads.
C1 [Cardwell, Robyn D.; Thayer, Patrick S.; Goldstein, Aaron S.] Virginia Tech, Dept Biomed Engn, Blacksburg, VA 24061 USA.
   [Kluge, Jonathan A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Guelcher, Scott A.] Vanderbilt Univ, Chem & Biomol Engn, Nashville, TN 37235 USA.
   [Dahlgren, Linda A.] Virginia Maryland Reg Coll Vet Med, Large Anim Clin Sci, Blacksburg, VA 24061 USA.
   [Goldstein, Aaron S.] Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA.
RP Goldstein, AS (reprint author), Virginia Tech, Dept Biomed Engn, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
FU National Institutes of Health [AR 055872]
FX The authors would like to thank the Tissue Engineering Resource Center
   (P41 EB002520) at Tufts University for providing equipment and
   facilities to perform this work. This publication was made possible by
   Grant No. AR 055872 to R.D.C. from the National Institutes of Health.
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arnoczky SP, 2007, INT J EXP PATHOL, V88, P217, DOI 10.1111/j.1365-2613.2007.00548.x
   Balestrini JL, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049527
   Barber J, 2011, TISSUE ENG PART A, V19, P1265
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Cardwell RD, 2014, J TISSUE ENG REGEN M, V8, P937, DOI 10.1002/term.1589
   Chaurey V, 2012, ACTA BIOMATER, V8, P3982, DOI 10.1016/j.actbio.2012.06.041
   Chen JS, 2006, TISSUE ENG, V12, P3085, DOI 10.1089/ten.2006.12.3085
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072
   Freeman JW, 2011, J BIOMECH, V44, P694, DOI 10.1016/j.jbiomech.2010.10.043
   Freeman JW, 2009, J BIOMAT SCI-POLYM E, V20, P1709, DOI 10.1163/156856208X386282
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Guo L, 2012, ARTHROSCOPY, V28, P211, DOI 10.1016/j.arthro.2011.08.314
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Iatridis JC, 2005, J BIOMECH, V38, P557, DOI 10.1016/j.jbiomech.2004.03.038
   Kahn CJF, 2013, J BIOMAT SCI-POLYM E, V24, P899, DOI 10.1080/09205063.2012.727265
   Kaneko D, 2009, CONNECT TISSUE RES, V50, P263, DOI 10.1080/03008200902846270
   Kidoaki S, 2006, J BIOMED MATER RES B, V76B, P219, DOI 10.1002/jbm.b.30336
   Kluge JA, 2011, ANN BIOMED ENG, V39, P1390, DOI 10.1007/s10439-010-0243-8
   KWON K, 2005, BIOMATERIALS, V26, P3929
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Liljensten E, 2002, J MATER SCI-MATER M, V13, P351, DOI 10.1023/A:1014380332762
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Teh TKH, 2013, TISSUE ENG PT A, V19, P1360, DOI [10.1089/ten.tea.2012.0279, 10.1089/ten.TEA.2012.0279]
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026
   West RV, 2005, J AM ACAD ORTHOP SUR, V13, P197, DOI 10.5435/00124635-200505000-00006
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
NR 29
TC 4
Z9 4
U1 2
U2 28
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JUL
PY 2015
VL 137
IS 7
AR 071010
DI 10.1115/1.4030404
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA CK2VX
UT WOS:000356073400011
PM 25902471
OA Green Published
DA 2018-10-19
ER

PT J
AU Meyer, M
   Prade, I
   Leppchen-Frohlich, K
   Felix, A
   Herdegen, V
   Haseneder, R
   Repke, JU
AF Meyer, Michael
   Prade, Ina
   Leppchen-Froehlich, Kathrin
   Felix, Alexander
   Herdegen, Volker
   Haseneder, Roland
   Repke, Jens-Uwe
TI Sterilisation of collagen materials using hydrogen peroxide doted
   supercritical carbon dioxide and its effects on the materials properties
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE Supercritical carbondioxide; Hydrogen peroxide; Collagen; Sterilisation
ID BIOMATERIAL; INACTIVATION; OXIDATION; DEVICES; SPORES
AB Collagen sponges and membranes which are used as medical device and in tissue engineering (TE) were sterilised by using supercritical carbon dioxide (CO2sc) which was doted with hydrogen peroxide (300 mg/L). Sterilisation was achieved by pressure change treatment (20.5-10 MPa). Neither physical nor structural and biological parameters of the materials were negatively affected. In contrast, sterilisation by gamma-irradiation led to increased solubility and decreased physical stability. As H2O2 is a common chemical used in collagen processing in industrial scale this could become a sterilisation technique for medical devices and TE materials on collagen basis. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Meyer, Michael; Prade, Ina; Leppchen-Froehlich, Kathrin] Forschungsinst Leder & Kunststoffbahnen, Freiberg, Germany.
   [Felix, Alexander; Herdegen, Volker; Haseneder, Roland; Repke, Jens-Uwe] Tech Univ Bergakad Freiberg, ITUN, D-09596 Freiberg, Germany.
RP Meyer, M (reprint author), Forschungsinst Leder & Kunststoffbahnen, Freiberg, Germany.
EM michael.meyer@filkfreiberg.de
RI Meyer, Michael/A-6227-2016
OI Meyer, Michael/0000-0003-2934-9962
FU DFG [PAK 731]; German Ministry of Economy and Technology [VF110002]
FX We thank Ines Zenker for performing the microbiological tests, Sascha
   Adler for the amino acid analyses and Sabine Kleinwechter for the DSC
   measurements. The investigation was funded by the DFG (PAK 731) and the
   German Ministry of Economy and Technology (VF110002). We thank for the
   financial support.
CR Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca
   Berg A., 1982, Patent, Patent No. [US 4320201 A, 4320201]
   Bladier C, 1997, CELL GROWTH DIFFER, V8, P589
   Bloch A., 1961, Purification of Collagen, Patent No. [US 2973302, 2973302]
   BOWES JH, 1962, RADIAT RES, V16, P211, DOI 10.2307/3571153
   Chvapil M, 1972, INT REV CONNECTIVE T, V6, P1
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   COURTS A, 1961, BIOCHEM J, V81, P356, DOI 10.1042/bj0810356
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   FRASER D, 1951, NATURE, V167, P33, DOI 10.1038/167033b0
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GRANT RA, 1973, J ANAT, V115, P29
   Heimann L., Process for the production of collagen material, Patent No. [EP 2098255 A2, 2098255]
   Hemmer JD, 2007, J BIOMED MATER RES B, V80B, P511, DOI 10.1002/jbm.b.30625
   Herdegen V, 2014, CHEM ENG TECHNOL, V37, P1891, DOI 10.1002/ceat.201300679
   Hood L.L., 1987, ADV MEAT RES, V4, P109
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   Kramer A, 2008, WALLHAUSSERS PRAXIS, P719
   Matthews I. P., 1994, Clinical Materials, V15, P191, DOI 10.1016/0267-6605(94)90082-5
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Perrut M, 2012, J SUPERCRIT FLUID, V66, P359, DOI 10.1016/j.supflu.2011.07.007
   RUDAKOVA TE, 1987, POLYM DEGRAD STABIL, V18, P271, DOI 10.1016/0141-3910(87)90015-2
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Schmidt T, 2011, TISSUE ENG PART C-ME, V17, P1161, DOI [10.1089/ten.tec.2011.0201, 10.1089/ten.TEC.2011.0201]
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G
   White A, 2006, J BIOTECHNOL, V123, P504, DOI 10.1016/j.jbiotec.2005.12.033
   Zhang J, 2006, J SUPERCRIT FLUID, V38, P354, DOI 10.1016/j.supflu.2005.05.005
   Zhang J, 2006, J SUPERCRIT FLUID, V38, P268, DOI 10.1016/j.supflu.2006.02.015
NR 36
TC 7
Z9 7
U1 4
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
EI 1872-8162
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JUL
PY 2015
VL 102
BP 32
EP 39
DI 10.1016/j.supflu.2015.04.006
PG 8
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA CK3LJ
UT WOS:000356117300005
DA 2018-10-19
ER

PT J
AU Kwon, MS
   Oh, SY
   Cho, SA
AF Kwon, Min-Seok
   Oh, Sang-Yeob
   Cho, Sung-Am
TI Two-body wear comparison of zirconia crown, gold crown, and enamel
   against zirconia
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Zirconia; Wear; Enamel; Fixed partial dentures
ID FIXED PARTIAL DENTURES; BITE FORCE; IN-VITRO; FRACTURE-RESISTANCE;
   CERAMIC MATERIALS; DENTAL CERAMICS; PORCELAIN; BIOMATERIAL; DENTITION;
   SURFACES
AB Problem statement: Full zirconia crowns have recently been used for dental restorations because of their mechanical properties. However, there is little information about their wear characteristics against enamel, gold, and full zirconia crowns.
   Purpose: The purpose of this study was to compare the wear rate of enamel, gold crowns, and zirconia crowns against zirconia blocks using an in vitro wear test.
   Materials and methods: Upper specimens were divided into three groups: 10 enamels (group 1), 10 gold crowns (group 2, Type III gold), and 10 zirconia crowns (group 3, Prettau (R) Zirkon 9H, Zirkonzahn, Italy). Each of these specimens was wear tested against a zirconia block (40 x 30 x 3 mm(3)) as a lower specimen (30 total zirconia blocks). Each specimen of the groups was abraded against the zirconia block for 600 cycles at 1 Hz with 15 mm front-toback movement on an abrading machine. Moreover, the load applied during the abrading test was 50 N, and the test was performed in a normal saline emulsion for 10 min. Threedimensional images were taken before and after the test, and the statistical analysis was performed using the Krushal Wallis test and Mann Whitney test (p=0.05).
   Results: The mean volume loss of group 1 was 0.47 mm(3), while that of group 2 and group 3 was 0.01 mm(3).
   Conclusion: The wear volume loss of enamels against zirconia was higher than that of gold and zirconia crowns. Moreover, according to this result, zirconia crowns are not recommended for heavy bruxers. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Kwon, Min-Seok; Cho, Sung-Am] Kyungpook Natl Univ, Sch Dent, Dept Prosthodont, Sangju 742711, Gyung Buk, South Korea.
   [Oh, Sang-Yeob] Kyungpook Natl Univ, Sch Automot Engn, Sangju 742711, Gyung Buk, South Korea.
RP Oh, SY (reprint author), Kyungpook Natl Univ, Sch Automot Engn, 2559 Gyeongsang Daero, Sangju 742711, Gyung Buk, South Korea.
EM syoh@knu.ac.kr; sungamcho@gmail.com
FU Kyung-Pook National University ResearchFund [2013]
FX This research was supported by the Kyung-Pook National University
   ResearchFund, (Grant no. 2013).
CR Albashaireh ZSM, 2010, J PROSTHET DENT, V104, P105, DOI 10.1016/S0022-3913(10)60102-3
   ANDERSON D. J., 1956, I JOUR DENTAL RES, V35, P664
   Ashkanani HM, 2008, J PROSTHET DENT, V100, P274, DOI 10.1016/S0022-3913(08)60206-1
   Att W, 2007, ACTA ODONTOL SCAND, V65, P14, DOI 10.1080/00016350600856232
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Christensen G, 2008, CLIN REPORT, V1, P1
   Christensen GJ, 2009, J AM DENT ASSOC, V140, P1036, DOI 10.14219/jada.archive.2009.0316
   Christensen RP, 2010, J AM DENT ASSOC, V141, P1317, DOI 10.14219/jada.archive.2010.0076
   Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3
   Elmaria A, 2006, J PROSTHET DENT, V96, P345, DOI 10.1016/j.prosdent.2006.09.002
   GIBBS CH, 1981, J PROSTHET DENT, V46, P443, DOI 10.1016/0022-3913(81)90455-8
   Heintze SD, 2008, DENT MATER, V24, P433, DOI 10.1016/j.dental.2007.06.016
   HELKIMO E, 1977, ACTA ODONTOL SCAND, V35, P297, DOI 10.3109/00016357709064128
   HUDSON JD, 1995, J PROSTHET DENT, V74, P647, DOI 10.1016/S0022-3913(05)80319-1
   JACOBI R, 1991, J PROSTHET DENT, V66, P303, DOI 10.1016/0022-3913(91)90254-T
   JAGGER DC, 1994, J PROSTHET DENT, V72, P320, DOI 10.1016/0022-3913(94)90347-6
   Jang GW, 2011, PROCEDIA ENGINEER, V10, P1556, DOI 10.1016/j.proeng.2011.04.260
   Janyavula S, 2013, J PROSTHET DENT, V109, P22, DOI 10.1016/S0022-3913(13)60005-0
   Jung YS, 2010, J ADV PROSTHODONT, V2, P111, DOI 10.4047/jap.2010.2.3.111
   Kadokawa A, 2006, J PROSTHET DENT, V96, P258, DOI 10.1016/j.prosdent.2006.08.016
   Kim MJ, 2012, J DENT, V40, P979, DOI 10.1016/j.jdent.2012.08.004
   KREJCI I, 1993, J PROSTHET DENT, V69, P425, DOI 10.1016/0022-3913(93)90192-Q
   KREJCI I, 1994, J DENT RES, V73, P1228, DOI 10.1177/00220345940730061501
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Mitov G, 2012, DENT MATER, V28, P909, DOI 10.1016/j.dental.2012.04.010
   de Abreu RAM, 2014, ARCH ORAL BIOL, V59, P1065, DOI 10.1016/j.archoralbio.2014.05.005
   Morneburg TR, 2002, INT J PROSTHODONT, V15, P20
   Oh WS, 2002, J PROSTHET DENT, V87, P451, DOI 10.1067/mpr.2002.123851
   Owais AI, 2013, EUR J ORTHODONT, V35, P427, DOI 10.1093/ejo/cjs021
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Raigrodski AJ, 2004, J PROSTHET DENT, V92, P557, DOI 10.1016/j.prosdent.2004.09.015
   Sabrah AHA, 2013, DENT MATER, V29, P666, DOI 10.1016/j.dental.2013.03.008
   SEGHI RR, 1991, J DENT RES, V70, P221, DOI 10.1177/00220345910700031301
   Serra CM, 2013, J ORAL REHABIL, V40, P563, DOI 10.1111/joor.12068
   Stober T, 2014, J ORAL REHABIL, V41, P314, DOI 10.1111/joor.12139
   Tinschert J, 2001, INT J PROSTHODONT, V14, P231
   van der Bilt A, 2008, EUR J ORAL SCI, V116, P217, DOI 10.1111/j.1600-0722.2008.00531.x
   Wang L, 2012, J EUR CERAM SOC, V32, P2599, DOI 10.1016/j.jeurceramsoc.2012.03.021
NR 39
TC 5
Z9 5
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUL
PY 2015
VL 47
BP 21
EP 28
DI 10.1016/j.jmbbm.2014.11.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK0IB
UT WOS:000355887800003
PM 25837341
DA 2018-10-19
ER

PT J
AU Brennan, O
   Stenson, B
   Widaaa, A
   O'Gorman, DM
   O'Brien, FJ
AF Brennan, Orlaith
   Stenson, Barry
   Widaaa, Amro
   O'Gorman, Denise M.
   O'Brien, Fergal J.
TI Incorporation of the natural marine multi-mineral dietary supplement
   Aquamin enhances osteogenesis and improves the mechanical properties of
   a collagen-based bone graft substitute
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Bone regeneration; Calcium; Collagen; Osteogenesis; Scaffold
ID GLYCOSAMINOGLYCAN SCAFFOLDS; PORE-SIZE; KNEE OSTEOARTHRITIS; GAG
   SCAFFOLDS; PROLIFERATION; FORMULA; CELLS
AB Aquamin is a commercially-available supplement derived from the algae species Lithothamnion, which has proven osteogenic potential. By harnessing this potential and combining Aquamin with a collagen scaffold, with architecture and composition optimised for bone repair, the aim of this study was to develop a natural osteo-stimulative bone graft substitute. A fabrication process was developed to incorporate Aquamin into scaffolds to produce collagen Aquamin (CollAqua) scaffolds at two different Aquamin concentrations, 100 F or 500 F (equivalent weight% of collagen or five times the weight of collagen respectively). CollAqua constructs had improved mechanical properties which were achieved without reducing the scaffold's permeability or porosity below the minimum level required for successful bone tissue engineering. The fabrication process produced a homogenous Aquamin distribution throughout the scaffold. Release kinetics revealed that in the first 12 h, the entire Aquamin content was released from the 100 F however, less than half of Aquamin in the 500 F was released with the remainder released approximately 21 days later giving an initial burst release followed by a delayed release. Osteoblasts cultured on the CollAqua scaffolds showed improved osteogenesis as measured by alkaline phosphatase, osteopontin and osteocalcin expression. This was confirmed by increased mineralisation as determined by von Kossa and Alizarin red staining.
   In conclusion, a cell and growth factor free collagen-based bone graft substitute with enhanced mechanical properties has been developed. The addition of Aquamin to the collagen biomaterial significantly improved mineralisation by osteoblasts and results in a new product which may be capable of enhancing osteogenesis to facilitate bone repair in vivo. (C) 2015 Elsevier Ltd. An rights reserved.
C1 [Brennan, Orlaith; Stenson, Barry; Widaaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, TERG, Dublin 2, Ireland.
   [Brennan, Orlaith; Stenson, Barry; O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Brennan, Orlaith; Widaaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dublin 2, Ireland.
   [Brennan, Orlaith; Widaaa, Amro; O'Brien, Fergal J.] Trinity Coll Dublin, Adv Mat & Bioengn Res Ctr AMBER, Dublin 2, Ireland.
RP Brennan, O (reprint author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.
EM obrennan1@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Brennan,
   Orlaith/0000-0001-6271-7590
FU Science Foundation Ireland [08/RFP/ENMF487 TIDA]
FX The authors thank Marigot Ltd. for providing Aquamin. This study was
   funded by Science Foundation Ireland, Grant no. 08/RFP/ENMF487 TIDA.
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Alhag M, 2011, ORAL MAXILLOFAC SURG, V15, P31, DOI 10.1007/s10006-010-0241-x
   Aslam MN, 2010, CALCIFIED TISSUE INT, V86, P313, DOI 10.1007/s00223-010-9340-9
   Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Frestedt JL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-9
   Frestedt JL, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-7
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Nielsen BD, 2010, J EQUINE VET SCI, V30, P419, DOI 10.1016/j.jevs.2010.07.003
   O'Brien F.J., 2011, MATER TODAY, V14, P3
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   O'Gorman DM, 2012, PHYTOTHER RES, V26, P375, DOI 10.1002/ptr.3561
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Widaa A, 2014, PHYTOTHER RES, V28, P678, DOI 10.1002/ptr.5038
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
NR 29
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUL
PY 2015
VL 47
BP 114
EP 123
DI 10.1016/j.jmbbm.2015.03.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK0IB
UT WOS:000355887800013
PM 25884141
DA 2018-10-19
ER

PT J
AU Sridharan, R
   Cameron, AR
   Kelly, DJ
   Kearney, CJ
   O'Brien, FJ
AF Sridharan, Rukmani
   Cameron, Andrew R.
   Kelly, Daniel J.
   Kearney, Cathal J.
   O'Brien, Fergal J.
TI Biomaterial based modulation of macrophage polarization: a review and
   suggested design principles
SO MATERIALS TODAY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; FOREIGN-BODY REACTION; IN-VIVO; ALTERNATIVE
   ACTIVATION; TOPOGRAPHICAL CONTROL; MECHANICAL-PROPERTIES; SURFACE;
   PHENOTYPE; SCAFFOLDS; SUBSTRATE
AB Macrophages have long been known for their phagocytic capabilities and immune defence; however, their role in healing is being increasingly recognized in recent years due to their ability to polarize into pro-inflammatory and anti-inflammatory phenotypes. Historically, biomaterials were designed to be inert to minimize the host response. More recently, the emergence of tissue engineering and regenerative medicine has led to the design of biomaterials that interact with the host through tailored mechanical, chemical and temporal characteristics. Due to such advances in biomaterial functionality and an improved understanding of macrophage responses to implanted materials, it is now possible to identify biomaterial design characteristics that dictate the host response and contribute to successful tissue integration. Herein, we begin by briefly reviewing macrophage cell origin and the key cytokine/chemokine markers of macrophage polarization and then describe which responses are favorable for both replacement and regenerative biomaterials. The body of the review focuses on macrophage polarization in response to inherent cues directly provided by biomaterials and the consequent cues that result from events related to biomaterial implantation. To conclude, a section on potential design principles for both replacement and regenerative biomaterials is presented. An in depth understanding of biomaterial cues to selectively polarize macrophages may prove beneficial in the design of a new generation of immuno-informed' biomaterials that can positively interact with the immune system to dictate a favorable macrophage response following implantation.
C1 [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; Kearney, Cathal J.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin 2, Ireland.
   [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; O'Brien, Fergal J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; Kearney, Cathal J.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res Ctr AMBER, Dublin 2, Ireland.
   [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; Kearney, Cathal J.; O'Brien, Fergal J.] Univ Dublin Trinity Coll, Dublin 2, Ireland.
   [Kelly, Daniel J.] Univ Dublin Trinity Coll, Sch Engn, Dept Mech & Mfg Engn, Dublin 2, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin 2, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Cameron,
   Andrew/0000-0002-6341-0379; Sridharan, Rukmani/0000-0001-6368-396X;
   Kelly, Daniel/0000-0003-4091-0992
FU Science Foundation Ireland (SFI) [SFI/12/RC/2278]; European Research
   Council (ERC) [239685]; Enterprise Ireland (EI) [CF20144003]; Irish
   Research Council Postdoctoral Fellowship (Government of Ireland)
   [GOIPD/2013/269]
FX This review has emanated from research supported in part by a research
   grant from Science Foundation Ireland (SFI) under Grant number
   SFI/12/RC/2278, European Research Council (ERC) under Grant number
   239685 (FP7/2007-2013), Enterprise Ireland (EI) under Project Code
   CF20144003 and an Irish Research Council Postdoctoral Fellowship
   (Government of Ireland), Grant Number GOIPD/2013/269.
CR Adutler-Lieber S, 2014, J AUTOIMMUN, V54, P100, DOI 10.1016/j.jaut.2014.05.003
   ALBINA JE, 1995, J IMMUNOL, V155, P4391
   Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002
   Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014
   Beningo KA, 2002, J CELL SCI, V115, P849
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9
   Cameron AR, 2011, BIOMATERIALS, V32, P5979, DOI 10.1016/j.biomaterials.2011.04.003
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537
   De Miguel MP, 2012, CURR MOL MED, V12, P574
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gardner A.B., 2013, BIOMED RES INT, V2013, P82
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Hoogduijn MJ, 2010, INT IMMUNOPHARMACOL, V10, P1496, DOI 10.1016/j.intimp.2010.06.019
   Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jones GE, 1998, CELL ADHES COMMUN, V6, P237, DOI 10.3109/15419069809004479
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McEvoy A, 2002, BONE, V30, P171
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pixley F.J., 2012, INT J CELL BIOL, V2012, P5019
   Prockop DJ, 2013, STEM CELLS, V31, P2042, DOI 10.1002/stem.1400
   Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889
   Rees AJ, 2010, SEMIN NEPHROL, V30, P216, DOI [10.1016/j.semnephrol.2010.03.002, 10.1016/j.seminephrol.2010.03.002]
   Rungsiyakull C, 2010, BIOMATERIALS, V31, P7196, DOI 10.1016/j.biomaterials.2010.05.077
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Steward AJ, 2012, ACTA BIOMATER, V8, P2153, DOI 10.1016/j.actbio.2012.03.016
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001
   Waterfield JD, 2010, J BIOMED MATER RES A, V95A, P837, DOI 10.1002/jbm.a.32857
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Zaveri TD, 2014, BIOMATERIALS, V35, P3504, DOI 10.1016/j.biomaterials.2014.01.007
NR 96
TC 106
Z9 107
U1 6
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD JUL-AUG
PY 2015
VL 18
IS 6
BP 313
EP 325
DI 10.1016/j.mattod.2015.01.019
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA CK4HK
UT WOS:000356184700013
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bai, SM
   Han, HY
   Huang, XW
   Xu, WA
   Kaplan, DL
   Zhu, HS
   Lu, Q
AF Bai, Shumeng
   Han, Hongyan
   Huang, Xiaowei
   Xu, Weian
   Kaplan, David L.
   Zhu, Hesun
   Lu, Qiang
TI Silk scaffolds with tunable mechanical capability for cell
   differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin; Nanofibrous scaffolds; Cell differentiation; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; SELF-ASSEMBLY PROCESS; BETA-SHEET CONTENT;
   IN-VITRO; FIBROIN SCAFFOLDS; OSTEOGENIC-DIFFERENTIATION; NANOFIBROUS
   SCAFFOLDS; COLLAGEN SCAFFOLDS; MATRIX; ELASTICITY
AB Bombyx mori silk fibroin is a promising biomaterial for tissue regeneration and is usually considered an "inert" material with respect to actively regulating cell differentiation due to few specific cell signaling peptide domains in the primary sequence and the generally stiffer mechanical properties due to crystalline content formed in processing. In the present study, silk fibroin porous 3D scaffolds with nanostructures and tunable stiffness were generated via a silk fibroin nanofiber-assisted lyophilization process. The silk fibroin nanofibers with high beta-sheet content were added into the silk fibroin solutions to modulate the self-assembly, and to directly induce water-insoluble scaffold formation after lyophilization. Unlike previously reported silk fibroin scaffold formation processes, these new scaffolds had lower overall beta-sheet content and softer mechanical properties for improved cell compatibility. The scaffold stiffness could be further tuned to match soft tissue mechanical properties, which resulted in different differentiation outcomes with rat bone marrow-derived mesenchymal stem cells toward myogenic and endothelial cells, respectively. Therefore, these silk fibroin scaffolds regulate cell differentiation outcomes due to their mechanical features. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bai, Shumeng; Huang, Xiaowei; Kaplan, David L.; Lu, Qiang] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Bai, Shumeng; Huang, Xiaowei; Kaplan, David L.; Lu, Qiang] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China.
   [Bai, Shumeng; Huang, Xiaowei; Lu, Qiang] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215123, Peoples R China.
   [Han, Hongyan; Xu, Weian] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn
FU National Basic Research Program of China (973 Program) [2013CB934400];
   NSFC [21174097, 81272106]; NIH [R01 DE017207, P41 EB002520]; Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD); Excellent Youth Foundation of Jiangsu Province [BK2012009];
   Natural Science Foundation of Jiangsu Province [BK20140397]; Key Natural
   Science Foundation of the Jiangsu Higher Education Institutions of China
   [11KGA430002]
FX We thank the National Basic Research Program of China (973 Program
   2013CB934400), NSFC (21174097, 81272106) and the NIH (R01 DE017207, P41
   EB002520) for support of this work. We also thank the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD), the
   Excellent Youth Foundation of Jiangsu Province (BK2012009), the Natural
   Science Foundation of Jiangsu Province (Grants No BK20140397), and the
   Key Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China (11KGA430002) for support of this work.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bai S, 2013, ACTA BIOMATER, V9, P7806, DOI 10.1016/j.actbio.2013.04.033
   Bai SM, 2014, J MATER CHEM B, V2, P6590, DOI 10.1039/c4tb00878b
   Bai SM, 2014, BIOMACROMOLECULES, V15, P3044, DOI 10.1021/bm500662z
   Bardouille C, 2001, APPL MICROBIOL BIOT, V55, P556, DOI 10.1007/s002530100595
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cristallini C, 2014, BIOMATERIALS, V35, P92, DOI 10.1016/j.biomaterials.2013.09.058
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dunne LW, 2014, ACTA BIOMATER, V10, P3630, DOI 10.1016/j.actbio.2014.05.005
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Florczyk SJ, 2011, J BIOMED MATER RES A, V98A, P614, DOI 10.1002/jbm.a.33153
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gong PY, 2013, ADV FUNCT MATER, V23, P42, DOI 10.1002/adfm.201201275
   Han F, 2014, ACTA BIOMATER, V10, P921, DOI 10.1016/j.actbio.2013.09.026
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Huang CC, 2014, BIOMATERIALS, V35, P5316, DOI 10.1016/j.biomaterials.2014.03.035
   Huang NF, 2013, BIOMATERIALS, V34, P4038, DOI 10.1016/j.biomaterials.2013.02.036
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HN, 2013, ADV DRUG DELIVER REV, V65, P536, DOI 10.1016/j.addr.2012.07.014
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Li A, 2014, BIOMATERIALS, V35, P8780, DOI 10.1016/j.biomaterials.2014.06.049
   Lin SS, 2014, J MATER CHEM B, V2, P2622, DOI 10.1039/c4tb00019f
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X
   McNamara SL, 2014, BIOMATERIALS, V35, P6941, DOI 10.1016/j.biomaterials.2014.05.013
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Peloquin J, 2011, J BIOMECH, V44, P815, DOI 10.1016/j.jbiomech.2010.12.018
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Solanki A, 2013, ADV MATER, V25, P5477, DOI 10.1002/adma.201302219
   Song YH, 2013, INT J NANOMED, V8, P2745, DOI 10.2147/IJN.S44885
   Sun J, 2014, BIOMATERIALS, V35, P4759, DOI 10.1016/j.biomaterials.2014.02.041
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Valarmathi MT, 2009, BIOMATERIALS, V30, P1098, DOI 10.1016/j.biomaterials.2008.10.044
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012
NR 58
TC 29
Z9 29
U1 7
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2015
VL 20
BP 22
EP 31
DI 10.1016/j.actbio.2015.04.004
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ7VJ
UT WOS:000355708200003
PM 25858557
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Oh, DX
   Kim, S
   Lee, D
   Hwang, DS
AF Oh, Dongyeop X.
   Kim, Sangsik
   Lee, Dohoon
   Hwang, Dong Soo
TI Tunicate-mimetic nanofibrous hydrogel adhesive with improved wet
   adhesion
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tunicates; Underwater adhesives; Chitin nanofibers; Pyrogallol;
   Nanofibrous hydrogels
ID GALLIC ACID; IONIC-LIQUID; MUSSEL; CHITOSAN; PROTEIN; CHITIN; PH;
   TUNICHROMES; ANTIOXIDANT; MECHANICS
AB The main impediment to medical application of biomaterial-based adhesives is their poor wet adhesion strength due to hydration-induced softening and dissolution. To solve this problem, we mimicked the wound healing process found in tunicates, which use a nanofiber structure and pyrogallol group to heal any damage on its tunic under sea water. We fabricated a tunicate-mimetic hydrogel adhesive based on a chitin nanofiber/gallic acid (a pyrogallol acid) composite. The pyrogallol group-mediated cross-linking and the nanofibrous structures improved the dissolution resistance and cohesion strength of the hydrogel compared to the amorphous polymeric hydrogels in wet condition. The tunicate-mimetic adhesives showed higher adhesion strength between fully hydrated skin tissues than did fibrin glue and mussel-mimetic adhesives. The tunicate mimetic hydrogels were produced at low cost from recyclable and abundant raw materials. This tunicate-mimetic adhesive system is an example of how natural materials can be engineered for biomedical applications. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Oh, Dongyeop X.; Lee, Dohoon; Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Ocean Sci & Technol Inst, Pohang 790784, South Korea.
   [Kim, Sangsik; Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Sch Environm Sci, Pohang 790784, South Korea.
   [Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.
RP Hwang, DS (reprint author), Pohang Univ Sci & Technol POSTECH, Sch Environm Sci, Pohang 790784, South Korea.
EM dshwang@postech.ac.kr
RI Hwang, Dong Soo/C-7291-2011
OI Hwang, Dong Soo/0000-0002-2487-2255; Oh, Dongyeop/0000-0003-3665-405X
FU Marine Biomaterials Research Center under Marine Biotechnology Program,
   Ministry of Oceans and Fisheries Affairs, Korea; National Research
   Foundation of Korea - Ministry of Science, ICT and Future Planning
   (MSIP) [NRF-2014R1A2A2A01006724, NRF-C1ABA001-2011-0029960]
FX This work was supported by the Marine Biomaterials Research Center under
   Marine Biotechnology Program, Ministry of Oceans and Fisheries Affairs,
   Korea. We also acknowledge the National Research Foundation of Korea
   Grant funded by the Ministry of Science, ICT and Future Planning (MSIP)
   (NRF-2014R1A2A2A01006724 & NRF-C1ABA001-2011-0029960, NRF-2013-Fostering
   Core Leaders of the Future Basic Science Program).
CR Arnow LE, 1937, J BIOL CHEM, V118, P531
   Barrett DG, 2014, CHEM COMMUN, V50, P7265, DOI 10.1039/c4cc02961e
   BAYER E, 1992, ANGEW CHEM INT EDIT, V31, P52, DOI 10.1002/anie.199200521
   Bicchieri M, 2013, ANAL BIOANAL CHEM, V405, P2713, DOI 10.1007/s00216-012-6681-4
   Burke SA, 2007, BIOMED MATER, V2, P203, DOI 10.1088/1748-6041/2/4/001
   Byun E, 2014, CHEM COMMUN, V50, P2869, DOI 10.1039/c3cc49043b
   Cai MM, 2008, COMP BIOCHEM PHYS B, V151, P110, DOI 10.1016/j.cbpb.2008.06.004
   Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307
   Cha HJ, 2009, BIOFOULING, V25, P99, DOI 10.1080/08927010802563108
   Claudio AFM, 2014, GREEN CHEM, V16, P259, DOI 10.1039/c3gc41999a
   Clay FSH, 2011, AM J OBSTET GYNECOL, V204, P378, DOI 10.1016/j.ajog.2010.11.018
   Das P, 2012, BIOMACROMOLECULES, V13, P4205, DOI 10.1021/bm3014796
   Ejima H, 2013, SCIENCE, V341, P154, DOI 10.1126/science.1237265
   Fichman G, 2014, ACS NANO, V8, P7220, DOI 10.1021/nn502240r
   Giano MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5095
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Holten-Andersen N, 2014, J MATER CHEM B, V2, P2467, DOI 10.1039/c3tb21374a
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d
   Je JY, 2006, BIOMACROMOLECULES, V7, P3448, DOI 10.1021/bm060373d
   Kamata H, 2014, SCIENCE, V343, P873, DOI 10.1126/science.1247811
   Kim BJ, 2015, J MATER CHEM B, V3, P112, DOI 10.1039/c4tb01496k
   Kim BJ, 2014, BIOMACROMOLECULES, V15, P1579, DOI 10.1021/bm4017308
   KIMEHUNT E, 1991, J INORG BIOCHEM, V41, P125, DOI 10.1016/0162-0134(91)80006-4
   Kimura S, 2001, PROTOPLASMA, V216, P71, DOI 10.1007/BF02680133
   Krogsgaard M, 2013, BIOMACROMOLECULES, V14, P297, DOI 10.1021/bm301844u
   Kumamoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P126, DOI 10.1271/bbb.65.126
   Kumari H, 2012, ANGEW CHEM INT EDIT, V51, P9263, DOI 10.1002/anie.201204776
   KUSTIN K, 1974, J AM CHEM SOC, V96, P7410, DOI 10.1021/ja00831a600
   Lee AS, 2006, VIB SPECTROSC, V41, P170, DOI 10.1016/j.vibspec.2005.11.006
   Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lim S, 2010, BIOMATERIALS, V31, P3715, DOI 10.1016/j.biomaterials.2010.01.063
   Lu Q., 2013, ANGEW CHEM INT EDIT, V125, P4036
   Lu Q., 2013, J R SOC INTERFACE, V10
   Lu QY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0759
   MCMANUS JP, 1985, J CHEM SOC PERK T 2, P1429, DOI 10.1039/p29850001429
   Meng H, 2015, ACTA BIOMATER, V17, P160, DOI 10.1016/j.actbio.2015.02.002
   Moses DN, 2006, J BIOL CHEM, V281, P34826, DOI 10.1074/jbc.M603429200
   Oh DX, 2013, MATERIALS, V6, P3826, DOI 10.3390/ma6093826
   Oh DX, 2013, BIOTECHNOL PROGR, V29, P505, DOI 10.1002/btpr.1691
   Ohkawa K, 2004, BIOFOULING, V20, P101, DOI 10.1080/08927010410001681246
   PAPATHEOFANIS FJ, 1989, J BIOMED MATER RES, V23, P661, DOI 10.1002/jbm.820230609
   Pasanphan W, 2008, J APPL POLYM SCI, V109, P38, DOI 10.1002/app.27953
   Pasanphan W, 2008, CARBOHYD POLYM, V72, P169, DOI 10.1016/j.carbpol.2007.08.002
   Ryu JH, 2011, J CONTROL RELEASE, V152, P236
   Shafiq Z., 2012, ANGEW CHEM, V124, P4408, DOI DOI 10.1021/JA9074562
   Shao H, 2010, ADV MATER, V22, P729, DOI 10.1002/adma.200902380
   Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922
   Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x
   Tajiri R, 2014, RSC ADV, V4, P5542, DOI 10.1039/c3ra46285d
   Tamura H, 2006, CELLULOSE, V13, P357, DOI 10.1007/s10570-006-9058-z
   Taylor SW, 1995, ARCH BIOCHEM BIOPHYS, V324, P228, DOI 10.1006/abbi.1995.0035
   Taylor SW, 1997, CHEM REV, V97, P333, DOI 10.1021/cr940467q
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   White JD, 2011, MACROMOLECULES, V44, P5085, DOI 10.1021/ma201044x
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   WILSON TC, 1990, J AGR FOOD CHEM, V38, P1678, DOI 10.1021/jf00098a011
   Yu SH, 2011, CARBOHYD POLYM, V84, P794, DOI 10.1016/j.carbpol.2010.04.035
   Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107
NR 60
TC 29
Z9 29
U1 14
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2015
VL 20
BP 104
EP 112
DI 10.1016/j.actbio.2015.03.031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ7VJ
UT WOS:000355708200011
PM 25841348
DA 2018-10-19
ER

PT J
AU Andrukhov, O
   Gemperli, AC
   Tang, Y
   Howald, N
   Dard, M
   Falkensammer, F
   Moritz, A
   Rausch-Fan, X
AF Andrukhov, Oleh
   Gemperli, Anja C.
   Tang, Yan
   Howald, Nadia
   Dard, Michel
   Falkensammer, Frank
   Moritz, Andreas
   Rausch-Fan, Xiaohui
TI Effect of different enamel matrix derivative proteins on behavior and
   differentiation of endothelial cells
SO DENTAL MATERIALS
LA English
DT Article
DE Endothelial cells; EMD; Cell culture; Migration; Differentiation
ID PERIODONTAL-LIGAMENT CELLS; HUMAN GINGIVAL FIBROBLASTS; IN-VITRO;
   GROWTH-FACTOR; ADHESION MOLECULES; ANGIOGENIC ACTIVITY; VEGF RECEPTOR;
   EXPRESSION; REGENERATION; MODEL
AB Objectives. Enamel matrix derivative (EMD) is an effective biomaterial for periodontal tissue regeneration and might stimulate angiogenesis. In order to clarify mechanisms underlying its biological activity, we separated two EMD fractions with different molecular weight protein components and investigated their effects on human umbilical vein endothelial cells (HUVECs) in vitro.
   Methods. Fraction Low-Molecular Weight (LMW) included proteins with a molecular weight (M.W.) <8 kDa. Fraction LMW-depleted included proteins with M.W. >8 kDa and lower than approximately 55 kDa. The effect of EMD fractions on proliferation/viability, apoptosis, migration and expression of angiopoetin-2 (ang-2), von Willebrand factor (vWF), E-selectin, intracellular adhesion molecules 1 (ICAM-1), vascular endothelial growth factor (VEGF) receptors Flt-1 and KDR was investigated.
   Results. The proliferation/viability of HUVECs was inhibited by both LMW and LMW-depleted at concentrations 100 mu g/ml, whereas EMD slightly increased cell proliferation/viability. The expression of all investigated proteins was up-regulated by EMD. However, differences in the effect of EMD fractions on the protein expression were observed. The effect of LMW-depleted on the expression of ICAM-1 and E-selectin was markedly higher compared to LMW. In contrast, the expression of vWF and VEGF receptors Flt-1 and KDR was primarily affected LMW than by LMW depleted. The expression of ang-2 was not influenced by LMW and LMW-depleted. HUVECs migration was stimulated more strongly by LMW than by EMD and LMW-depleted.
   Conclusion. Our in vitro study shows that the proteins composing EMD have different and specific biological activities and consequently have the ability to cover different aspects of EMD's biological and clinical effects. (C) 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Andrukhov, Oleh; Tang, Yan; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Competence Ctr Periodontal Res, A-1090 Vienna, Austria.
   [Gemperli, Anja C.; Howald, Nadia; Dard, Michel] Inst Straumann AG, Basel, Switzerland.
   [Tang, Yan] Capital Med Univ, Xuanwu Hosp, Dept Stomatol, Beijing, Peoples R China.
   [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA.
   [Falkensammer, Frank] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Orthodont, A-1090 Vienna, Austria.
   [Andrukhov, Oleh; Moritz, Andreas; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Conservat Dent Periodontol & Prophylaxis, A-1090 Vienna, Austria.
RP Andrukhov, O (reprint author), Med Univ Vienna, Bernhard Gottlieb Sch Dent, Sensengasse 2a, A-1090 Vienna, Austria.
EM oleh.andrukhov@meduniwien.ac.at; xiaohui.rausch-fan@meduniwien.ac.at
OI Rausch-Fan, Xiaohui/0000-0002-8010-1914; Andrukhov,
   Oleh/0000-0002-0485-2142
FU ITI Foundation [781_2011]
FX The study was supported by the ITI Foundation (Research Grant No.
   781_2011). The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   authors acknowledge the help of Mrs. Phuong Quynh Nguyen and Mrs. Hedwig
   Rutschek for excellent technical assistance.
CR ALBELDA SM, 1994, FASEB J, V8, P504
   Amin HD, 2014, ACTA BIOMATER, V10, P1930, DOI 10.1016/j.actbio.2013.11.027
   Amin HD, 2013, ACTA BIOMATER, V9, P4796, DOI 10.1016/j.actbio.2012.09.008
   An N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096942
   Andrukhov O, 2015, ODONTOLOGY, V103, P19, DOI 10.1007/s10266-013-0146-x
   Andrukhov O, 2014, ACTA ODONTOL SCAND, V72, P337, DOI 10.3109/00016357.2013.834535
   Andrukhov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090301
   Aspriello SD, 2011, J PERIODONTOL, V82, P606, DOI 10.1902/jop.2010.100180
   Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Bertl K, 2009, J PERIODONTOL, V80, P1622, DOI 10.1902/jop.2009.090157
   Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001
   Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P247
   Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351
   Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x
   Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]
   Johnson DL, 2009, J PERIODONTOL, V80, P648, DOI 10.1902/jop.2009.070420
   Kasaj A, 2012, J PERIODONTAL RES, V47, P479, DOI 10.1111/j.1600-0765.2011.01456.x
   Kauvar AS, 2010, J PERIODONTOL, V81, P1196, DOI 10.1902/jop.2010.090441
   Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Maycock J, 2002, CONNECT TISSUE RES, V43, P472, DOI 10.1080/03008200290000880
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mumulidu A, 2007, J CHROMATOGR B, V857, P210, DOI 10.1016/j.jchromb.2007.07.017
   Murota SI, 2000, ANN NY ACAD SCI, V902, P208
   Murota SI, 2000, ANN NY ACAD SCI, V902, P12
   Nokhbehsaim M, 2011, J PERIODONTOL, V82, P1725, DOI 10.1902/jop.2011.100678
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Pasceri V, 2000, CIRCULATION, V102, P2165
   PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Qu Z, 2010, ORAL SURG ORAL MED O, V109, P924, DOI 10.1016/j.tripleo.2010.01.007
   Riss T. L, 2004, ASSAY GUIDANCE MANUA
   Sakoda K, 2012, EUR J ORAL SCI, V120, P513, DOI 10.1111/j.1600-0722.2012.00999.x
   Schlueter SR, 2007, J PERIODONTOL, V78, P141, DOI 10.1902/jop.2007.060111
   Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9
   Stockert JC, 2012, ACTA HISTOCHEM, V114, P785, DOI 10.1016/j.acthis.2012.01.006
   Thoma DS, 2011, J CLIN PERIODONTOL, V38, P253, DOI 10.1111/j.1600-051X.2010.01656.x
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Venezia E, 2004, CRIT REV ORAL BIOL M, V15, P382, DOI 10.1177/154411130401500605
   Yao NH, 2011, MOL CELL BIOCHEM, V355, P91, DOI 10.1007/s11010-011-0842-1
   Yau TM, 2005, ANN THORAC SURG, V79, P2056, DOI 10.1016/j.athorascur.2004.10.06
   Yuan K, 2003, J CLIN PERIODONTOL, V30, P732, DOI 10.1034/j.1600-051X.2003.00413.x
NR 48
TC 2
Z9 2
U1 2
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 2015
VL 31
IS 7
BP 822
EP 832
DI 10.1016/j.dental.2015.04.004
PG 11
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA CJ9HA
UT WOS:000355811900009
PM 25982018
DA 2018-10-19
ER

PT J
AU Bakhsh, TA
   Sadr, A
   Mandurah, MM
   Shimada, Y
   Zakaria, O
   Tagami, J
AF Bakhsh, Turki A.
   Sadr, Alireza
   Mandurah, Mona M.
   Shimada, Yasushi
   Zakaria, Osama
   Tagami, Junji
TI In situ characterization of resin-dentin interfaces using conventional
   vs. cryofocused ion-beam milling
SO DENTAL MATERIALS
LA English
DT Article
DE FIB; TEM; Resin composite; Collagen; Dental adhesive; Teeth, dentin,
   nano-interaction zone; Cryo; Hybrid layer
ID TEM SPECIMEN PREPARATION; TRANSMISSION ELECTRON-MICROSCOPY;
   ULTRASTRUCTURAL EXAMINATION; COMPARATIVE SEM; TOMOGRAPHY; SAMPLES; TOOL
AB Objective. The introduction of focused ion beam (FIB) milling has facilitated preparation of hard tissue samples for transmission electron microscope (TEM). However, this technique generates high temperature that may alter or damage morphological features in biological tissue. Therefore, the aim of this study was to determine the effects of cryogenic cooling on the morphological features of dentin interfaces with dental restorative materials in samples prepared by FIB for TEM examination.
   Methods. After preparation of a cylindrical-shaped cavities in extracted, non-carious premolar teeth, the specimens were restored with dental adhesive/composite and categorized into two restorative materials groups; (PB) a combination of Clearfil Protect Bond (Kuraray Noritake Dental, Japan)/Estelite Sigma Quick composite (Tokuyama Dental, Japan), and (SB) Filtek Silorane restorative system (3M ESPE, USA). The specimens were subjected to interfacial cross-sectioning, followed by observation and area selection using confocal laser microscopy. Later, ultrathin sections were prepared using FIB with cryogenic cooling (PB-C) and (SB-C), or without cooling (PB-NC) and (SB-NC) that all were examined under TEM.
   Results. Resulting TEM images of the ultra-morphological features at the resin-dentin nano-interaction zone were improved when FIB preparation was conducted in the cryogenic condition and no sign of artifacts were detected.
   Significance. Conducting ion beam milling with cryogenic cooling was advantageous in minimizing the elevation in specimen temperature. This led to preservation of dentin microstructures that revealed additional information about substrates that are necessary for advanced characterization of tooth-biomaterial interactions. (C) 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Bakhsh, Turki A.] King Abdulaziz Univ, Fac Dent, Dept Operat Dent, Jeddah 21589, Saudi Arabia.
   [Sadr, Alireza; Mandurah, Mona M.; Shimada, Yasushi; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Cardiol & Operat Dent Dept, Bunkyo Ku, Tokyo 1138549, Japan.
   [Sadr, Alireza] Univ Washington, Sch Dent, Seattle, WA 98195 USA.
   [Zakaria, Osama] Pharos Univ, Fac Dent, Oral Surg, Alexandria, Egypt.
RP Bakhsh, TA (reprint author), King Abdulaziz Univ, Fac Dent, Dept Operat Dent, POB 80209, Jeddah 21589, Saudi Arabia.
EM taabakhsh@kau.edu.sa
OI Bakhsh, Turki/0000-0002-5953-4109; Sadr, Alireza/0000-0001-7658-0572
FU Deanship of Scientific Research (DSR), King Abdulaziz University,
   Jeddah, Saudi Arabia
FX This work was funded by the Deanship of Scientific Research (DSR), King
   Abdulaziz University, Jeddah, Saudi Arabia. The authors, therefore,
   acknowledge with thanks DSR technical and financial support.
CR Bakhsh TA, 2013, J DENT, V41, P60, DOI 10.1016/j.jdent.2012.10.003
   Bakhsh TA, 2011, DENT MATER, V27, P915, DOI 10.1016/j.dental.2011.05.003
   Breschi L, 2003, AM J DENT, V16, P267
   Coutinho E, 2009, DENT MATER, V25, P1325, DOI 10.1016/j.dental.2009.06.002
   CROWELL CD, 1934, J DENT RES, V14, P251
   Desbois G, 2008, GEOFLUIDS, V8, P60, DOI 10.1111/j.1468-8123.2007.00205.x
   Desbois G, 2013, J MICROSC-OXFORD, V249, P215, DOI 10.1111/jmi.12011
   Dolph MC, 2014, NUCL INSTRUM METH B, V328, P33, DOI 10.1016/j.nimb.2014.02.126
   Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024
   Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0
   Giannuzzi LA, 1998, MICROSC RES TECHNIQ, V41, P285, DOI 10.1002/(SICI)1097-0029(19980515)41:4<285::AID-JEMT1>3.0.CO;2-Q
   Grandfield K, 2012, ADV MATER SCI ENG, V2012, P6
   Hauert R, 2012, ACTA BIOMATER, V8, P3170, DOI 10.1016/j.actbio.2012.04.016
   Kalin C, 1998, J DENT, V26, P511, DOI 10.1016/S0300-5712(98)00005-0
   Li J, 2006, MATER CHARACT, V57, P64, DOI 10.1016/j.matchar.2005.12.007
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   Nalla RK, 2005, MICRON, V36, P672, DOI 10.1016/j.micron.2005.05.011
   Nishimura Kozo, 2005, Journal of Medical and Dental Sciences, V52, P9
   Nomoto R, 1994, Dent Mater J, V13, P198
   Nurrohman H, 2012, DENT MATER, V28, pE89, DOI 10.1016/j.dental.2012.04.025
   Phaneuf MW, 1999, MICRON, V30, P277, DOI 10.1016/S0968-4328(99)00012-8
   Rykaczewski K, 2012, ACS NANO, V6, P9326, DOI 10.1021/nn304250e
   SANO H, 1995, OPER DENT, V20, P160
   Tay F R, 1999, J Adhes Dent, V1, P103
   Thompson GB, 2004, ULTRAMICROSCOPY, V100, P25, DOI 10.1016/j.ultramic.2004.01.010
   Thompson LE, 2006, MICROSC MICROANAL, V12, P156, DOI 10.1017/S1431927606060041
   VANMEERBEEK B, 1995, DENT MATER, V11, P87, DOI 10.1016/0109-5641(95)80039-5
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   YU JE, 1991, J ELECTRON MICR TECH, V18, P315, DOI 10.1002/jemt.1060180314
NR 30
TC 4
Z9 4
U1 2
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 2015
VL 31
IS 7
BP 833
EP 844
DI 10.1016/j.dental.2015.04.010
PG 12
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA CJ9HA
UT WOS:000355811900010
PM 25986333
DA 2018-10-19
ER

PT J
AU Grecchi, F
   Perale, G
   Candotto, V
   Busato, A
   Pascali, M
   Carinci, F
AF Grecchi, F.
   Perale, G.
   Candotto, V.
   Busato, A.
   Pascali, M.
   Carinci, F.
TI RECONSTRUCTION OF THE ZYGOMATIC BONE WITH SMARTBONE (R): CASE REPORT
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE alloplastic implants; bone reconstruction; injury; SmartBone (R)
ID MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; SUBSTITUTES;
   SCAFFOLDS; CERAMICS
AB The repair of complex craniofacial bone defects is challenging and a successful result depends on the defect size, the quality of the soft tissue covering the defect and the choice of reconstructive method. Autologous bone grafts are the gold standard for bone replacement. Tissue engineered constructs are temporary substitutes developed to treat damaged or lost tissue. Recent advances in materials science have provided an abundance of innovations, underlining the increasing importance of polymer in this field. The Galeazzi Orthopedical institute of Milan received a Serbian soldier who reported a deep wound, due to the explosion of a grenade, during former-Yugoslavia's war. His left cheekbone was completely lost, together with the floor of the left eye. SmartBone (R) technology allowed the realization of custom-made grafts which perfectly fitted the bone defect thanks to mechanical strength, also at small thicknesses, and the ability to be shaped without powder formation or unpredicted fractures. Tissue engineering approaches to regeneration utilize 3-dimensional (3D) biomaterial matrices that interact favorably with cells. The potential benefits of using a tissue engineering approach include reduced donor site morbidity, shortened operative time, decreased technical difficulty of the repair, ability to closely mimic the in vivo microenvironment in an attempt to recapitulate normal craniofacial development: this 36-month case study allowed to prove that SmartBone (R) custom-made bone grafts are an effective solution, gathering such benefits and being available now for daily routine.
C1 [Grecchi, F.] Galeazzi Hosp, Dept Maxillofacial Surg, Milan, Italy.
   [Perale, G.] Ind Biomed Insubri SA, Mezzovico Vira, Switzerland.
   [Perale, G.] Univ Appl Sci & Art Southern Switzerland, Dept Innovat Technol, Manno, Switzerland.
   [Candotto, V.; Carinci, F.] Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
   [Pascali, M.] Univ Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
EM crc@unife.it
CR ADAMS SS, 1981, AGENTS ACTIONS, V11, P471
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Arosarena Oneida A, 2006, Oral Maxillofac Surg Clin North Am, V18, P521, DOI 10.1016/j.coms.2006.06.005
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Cordonnier T, 2011, TISSUE ENG PART C-ME, V17, P249, DOI [10.1089/ten.tec.2010.0387, 10.1089/ten.TEC.2010.0387]
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Gronthos S, 2004, LANCET, V364, P735, DOI 10.1016/S0140-6736(04)16948-1
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   Kumar A, 1996, AM J HEMATOL, V53, P92, DOI 10.1002/(SICI)1096-8652(199610)53:2<92::AID-AJH6>3.0.CO;2-Z
   Louis PJ, 2011, ORAL MAXIL SURG CLIN, V23, P209, DOI 10.1016/j.coms.2011.01.002
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Van Lieshout EMM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-34
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 19
TC 2
Z9 2
U1 0
U2 1
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD JUL-SEP
PY 2015
VL 29
IS 3
SU S
BP 42
EP 47
PG 6
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA DS4EG
UT WOS:000380733600010
PM 26511180
DA 2018-10-19
ER

PT J
AU Lopez, MA
   Bassi, MA
   Confalone, L
   Lico, S
   Carinci, F
AF Lopez, M. A.
   Bassi, M. Andreasi
   Confalone, L.
   Lico, S.
   Carinci, F.
TI CRESTAL SINUS LIFT USING A FLUIDO-DYNAMIC COMPUTER GUIDED PRECISE AND
   ATRAUMATIC TECHNIQUE
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE computer guided surgery; graft; maxillary; Schneiderian; sinus
ID MAXILLARY MOLAR EXTRACTION; FLOOR AUGMENTATION; IMPLANTS; SUCCESS;
   PLACEMENT; ELEVATION; RATES; TIME
AB One of the most frequent reasons for failure during the maxillary sinus floor lift operation is connected to the possibility of a rupture of the Schneiderian membrane which, if lacerated, cannot perform the function of graft containment. In order to reduce the incidence of complications it is necessary to cut the hard tissue with extreme accuracy and as little trauma as possible, while saving the soft tissue. The precision of pre-operation measures obtained through endoral x-rays, dental-scans and cone-beam CT allows us to approach and cut with delicacy the sinus cortical floor. The recent development of computer guided surgery gives the possibility of planning the operation, which reduces the risk of failure. The cortical of the maxillary sinus is reduced through the use of calibrated burs and a profiler to obtain a hole that enables both access to the maxillary sinus and, subsequently, the lifting of the Schneiderian membrane. Each stage of the operation is monitored and all the devices used pass through a custom-made template, which acts as a surgical guide. The sinus was filled using fluid biomaterial distributed through a dispenser, which had been created specifically for this technique. Due to the reduction in trauma and the fact that the process is much less invasive, this technique could be a valid alternative to the techniques known and carried out to date. Work time is reduced to less than 3 minutes in the cortical thinning operation and percussive trauma is avoided.
C1 [Carinci, F.] Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
EM crc@unife.it
CR Andreasi Bassi M, 2010, J OSTEOL BIOMAT, V1, P93
   Chen L, 2005, J PERIODONTOL, V76, P482, DOI 10.1902/jop.2005.76.3.482
   Chiapasco M, 2003, IMPLANT PROSTHESIS R
   Cosci F, 2000, Implant Dent, V9, P363, DOI 10.1097/00008505-200009040-00014
   Danza Matteo, 2010, Stomatologija, V12, P35
   Danza M, 2009, J ORAL MAXIL SURG, V67, P2460, DOI 10.1016/j.joms.2009.04.041
   Engelke W, 2005, INT J ORAL MAX IMPL, V20, P891
   Favero GA, 1994, STOMATOL ORTHOGNATOD
   Fugazzotto P A, 2001, Implant Dent, V10, P259
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P52
   Fugazzotto PA, 2002, INT J ORAL MAX IMPL, V17, P113
   Fugazzotto PA, 2002, J PERIODONTOL, V73, P39, DOI 10.1902/jop.2002.73.1.39
   Fugazzotto PA, 1999, INT J ORAL MAX IMPL, V14, P536
   Grecchi F, 2009, J OSSEOINTEGRATION
   Guarnieri R, 2014, VALUTAZIONE VITRO AC, P11
   HORTON JE, 1981, ORAL SURG ORAL MED O, V51, P236, DOI 10.1016/0030-4220(81)90051-7
   Lopez MA, 2014, J CRANIOFAC SURG, V25, pE127, DOI 10.1097/SCS.0000000000000457
   Malchiodi L, 2003, IMPLANT SURG, P219
   Marchetti E, 2010, J OSSEOINTEGRATION
   McFALL T. A., 1961, JOUR ORAL SURG, V19, P200
   Pozzi A, 2011, Oral Implantol (Rome), V4, P4
   Summers R B, 1994, Compendium, V15, P702
   Summers R B, 1994, Compendium, V15, P154
   Summers R B, 1995, Compend Contin Educ Dent, V16, P1094
   Summers R. B., 1994, COMPENDIUM, V15, P158
   Summers R. B., 1994, COMPENDIUM, V15, P162
   SUMMERS RB, 1994, COMPENDIUM, V15, P710
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1098
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1099
   Summers RB, 1995, COMPEND CONTIN ED DE, V16, P1092
   Summers RB, 1994, COMPENDIUM, V15, P154
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1094
   SUMMERS RB, 1994, COMPENDIUM, V15, P700
   Vercellotti T, 2004, Minerva Stomatol, V53, P207
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
   Vercellotti T., 2003, MODERN DENT, V5, P21
   Vercellotti T., 2004, ODONTOIATRY J
   Winter AA, 2002, INT J ORAL MAX IMPL, V17, P687
   Zaninari A, 1987, Dent Cadmos, V55, P63
NR 39
TC 2
Z9 2
U1 3
U2 4
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD JUL-SEP
PY 2015
VL 29
IS 3
SU S
BP 67
EP 73
PG 7
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA DS4EG
UT WOS:000380733600014
PM 26511183
DA 2018-10-19
ER

PT J
AU Li, Y
   Chen, SK
   Li, L
   Qin, L
   Wang, XL
   Lai, YX
AF Li, Ye
   Chen, Shu-Kui
   Li, Long
   Qin, Ling
   Wang, Xin-Luan
   Lai, Yu-Xiao
TI Bone defect animal models for testing efficacy of bone substitute
   biomaterials
SO JOURNAL OF ORTHOPAEDIC TRANSLATION
LA English
DT Review
DE animal models; bone defect; bone regeneration; bone substitutes
ID BETA-TRICALCIUM PHOSPHATE; TOTAL KNEE ARTHROPLASTY; MESENCHYMAL
   STEM-CELLS; CRITICAL SIZE DEFECT; CALCIUM-PHOSPHATE; CALVARIAL DEFECT;
   SEGMENTAL DEFECT; MORPHOGENETIC PROTEIN-2; GRAFT SUBSTITUTES; TRABECULAR
   BONE
AB Large bone defects are serious complications that are most commonly caused by extensive trauma, tumour, infection, or congenital musculoskeletal disorders. If nonunion occurs, implantation for repairing bone defects with biomaterials developed as a defect filler, which can promote bone regeneration, is essential. In order to evaluate biomaterials to be developed as bone substitutes for bone defect repair, it is essential to establish clinically relevant in vitro and in vivo testing models for investigating their biocompatibility, mechanical properties, degradation, and interactional with culture medium or host tissues. The results of the in vitro experiment contribute significantly to the evaluation of direct cell response to the substitute biomaterial, and the in vivo tests constitute a stepmidway between in vitro tests and human clinical trials. Therefore, it is essential to develop or adopt a suitable in vivo bone defect animal model for testing bone substitutes for defect repair. This review aimed at introducing and discussing the most available and commonly used bone defect animal models for testing specific substitute biomaterials. Additionally, we reviewed surgical protocols for establishing relevant preclinical bone defect models with various animal species and the evaluation methodologies of the bone regeneration process after the implantation of bone substitute biomaterials. This review provides an important reference for preclinical studies in translational orthopaedics. Copyright (C) 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Li, Ye; Chen, Shu-Kui; Li, Long; Qin, Ling; Wang, Xin-Luan; Lai, Yu-Xiao] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Translat Med Res & Dev, 1068 Xueyuan Ave,Shenzhen Univ Town, Shenzhen 518055, Peoples R China.
   [Li, Ye] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Peoples R China.
   [Qin, Ling; Wang, Xin-Luan] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.
   [Lai, Yu-Xiao] Fudan Univ, State Key Lab Mol Engn Polymers, Shanghai, Peoples R China.
RP Wang, XL (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Translat Med Res & Dev, 1068 Xueyuan Ave,Shenzhen Univ Town, Shenzhen 518055, Peoples R China.
EM xl.wang@siat.ac.cn; yx.lai@siat.ac.cn
RI Qin, Ling/J-9047-2018
OI Qin, Ling/0000-0001-6173-6167
FU NSFC-DG-RTD Joint Scheme [51361130034]; European Union's
   [NMP3-SL-2013-604517]; NSFC [51203178]; Shenzhen Fundamental Research
   Foundation [JCYJ20120617114912864]
FX The authors are grateful for the financial support from NSFC-DG-RTD
   Joint Scheme (Project No. 51361130034), the European Union's 7th
   Framework Program under grant agreement No. NMP3-SL-2013-604517, NSFC
   grant (Project No. 51203178), and Shenzhen Fundamental Research
   Foundation (Project No. JCYJ20120617114912864).
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   An YH, 1998, ANIMAL MODELS ORTHOP
   Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x
   Blumenfeld I, 2002, EXP GERONTOL, V37, P553, DOI 10.1016/S0531-5565(01)00215-7
   Calvo-Guirado JL, 2012, CLIN ORAL IMPLAN RES, V23, P667, DOI 10.1111/j.1600-0501.2011.02193.x
   CAMPANACCI M, 1979, J BONE JOINT SURG BR, V61, P455
   Carstens MH, 2005, J CRANIOFAC SURG, V16, P1033, DOI 10.1097/01.scs.0000186307.09171.20
   Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z
   Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   Chavassieux P, 1987, J BONE MINER RES  S1, V2, P359
   Chen SH, 2013, ACTA BIOMATER, V9, P6711, DOI 10.1016/j.actbio.2013.01.024
   Chen SH, 2014, J ORTHOP TRANSL, V2, P91, DOI 10.1016/j.jot.2014.01.002
   Cheng CX, 2013, MOL IMAGING BIOL, V15, P336, DOI 10.1007/s11307-012-0592-9
   Clements JR, 2008, J FOOT ANKLE SURG, V47, P350, DOI 10.1053/j.jfas.2008.04.006
   Dai CL, 2011, BIOMATERIALS, V32, P8506, DOI 10.1016/j.biomaterials.2011.07.090
   Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779
   DEKLEER V, 2006, BONE CLIN ORTHOPEDIC, P1
   Delgado-Ruiz RA, 2014, INT J ORAL SCI, V6, P105, DOI 10.1038/ijos.2014.6
   den Boer FC, 1999, J ORTHOPAED RES, V17, P654, DOI 10.1002/jor.1100170506
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   EITEL F, 1981, ARCH ORTHOP TRAUM SU, V99, P59, DOI 10.1007/BF00400911
   Engh GA, 1997, J BONE JOINT SURG AM, V79A, P1030, DOI 10.2106/00004623-199707000-00009
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Ghazavi MT, 1997, J BONE JOINT SURG AM, V79A, P17, DOI 10.2106/00004623-199701000-00002
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Gugala Z, 2007, MACROMOL SYMP, V253, P147, DOI 10.1002/masy.200750722
   Han S, 2000, MOL THER, V2, P302, DOI 10.1006/mthe.2000.0142
   He DW, 2014, J MATER SCI-MATER M, V25, P1415, DOI 10.1007/s10856-014-5183-7
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hussain I., 2012, INT J DENT, V2012
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Jang BJ, 2008, J VET SCI, V9, P387, DOI 10.4142/jvs.2008.9.4.387
   Kim A, 2012, CYTOTHERAPY, V14, P296, DOI 10.3109/14653249.2011.627915
   Kim HW, 2008, J BIOMATER APPL, V22, P485, DOI 10.1177/0885328207078075
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kobayashi H, 2010, J BIOMED MATER RES A, V92A, P596, DOI 10.1002/jbm.a.32397
   Koeter S, 2009, J BIOMED MATER RES B, V90B, P116, DOI 10.1002/jbm.b.31260
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Kraay M J, 1992, J Arthroplasty, V7, P7, DOI 10.1016/0883-5403(92)90025-L
   Kropil P, 2012, ACAD RADIOL, V19, P320, DOI 10.1016/j.acra.2011.10.022
   Kumar S, 2012, BONE, V50, P1012, DOI 10.1016/j.bone.2012.01.027
   Lee EH, 2010, ORAL SURG ORAL MED O, V109, pE33, DOI 10.1016/j.tripleo.2009.12.043
   Lee J, 2009, J CLIN PERIODONTOL, V36, P1067, DOI 10.1111/j.1600-051X.2009.01487.x
   Li R, 2012, J ORTHOP TRAUMA, V26, P689, DOI 10.1097/BOT.0b013e318266eb7e
   Li X, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/07/C07010
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Lim HP, 2013, J MATER SCI-MATER M, V24, P1895, DOI 10.1007/s10856-013-4939-9
   Lindsey RW, 2006, J ORTHOP RES, V24, P1438, DOI 10.1002/jor.20154
   Lippens E, 2010, TISSUE ENG PT A, V16, P617, DOI [10.1089/ten.tea.2009.0418, 10.1089/ten.TEA.2009.0418]
   Liu GP, 2008, J MATER SCI-MATER M, V19, P2367, DOI 10.1007/s10856-007-3348-3
   Liu YJ, 2014, BRAZ J MED BIOL RES, V47, P715, DOI 10.1590/1414-431X20144009
   Maissen O, 2006, J ORTHOP RES, V24, P1670, DOI 10.1002/jor.20231
   Mohan BG, 2013, J BIOMED MATER RES A, V101, P261, DOI 10.1002/jbm.a.34324
   MOSEKILDE L, 1993, BONE, V14, P379, DOI 10.1016/8756-3282(93)90167-9
   MOSEKILDE L, 1987, CALCIFIED TISSUE INT, V40, P318, DOI 10.1007/BF02556693
   Muscolo DL, 2006, ORTHOP CLIN N AM, V37, P65, DOI 10.1016/j.ocl.2005.08.003
   Nafei A, 2000, J BONE JOINT SURG BR, V82B, P910, DOI 10.1302/0301-620X.82B6.9836
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Neyt J G, 1998, Iowa Orthop J, V18, P118
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Pastoureau P, 1989, J BONE MINER RES  S1, V4, P477
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018
   RAAB DM, 1991, J BONE MINER RES, V6, P741
   Rahman CV, 2014, J TISSUE ENG REGEN M, V8, P59, DOI 10.1002/term.1497
   Reichert JC, 2010, TISSUE ENG PART B-RE, V16, P93, DOI [10.1089/ten.teb.2009.0455, 10.1089/ten.TEB.2009.0455]
   Richards RG, 2013, J ORTHOP TRANSL, V1, P11, DOI 10.1016/j.jot.2013.07.009
   Riegger C, 2012, SKELETAL RADIOL, V41, P531, DOI 10.1007/s00256-011-1203-6
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Schlegel KA, 2006, ORAL SURG ORAL MED O, V102, P7, DOI 10.1016/j.tripleo.2005.09.011
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schneider G, 2010, J MATER SCI-MATER M, V21, P2853, DOI 10.1007/s10856-010-4143-0
   Skaliczki G, 2012, ACTA PHYSIOL HUNG, V99, P223, DOI 10.1556/APhysiol.99.2012.2.16
   Smith MR, 2012, J BIOMED MATER RES B, V100B, P206, DOI 10.1002/jbm.b.31940
   Springer ING, 2005, BONE, V37, P563, DOI 10.1016/j.bone.2005.05.010
   STOCKLEY I, 1992, J BONE JOINT SURG BR, V74, P393
   Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077
   Takigami H, 2007, J ORTHOP RES, V25, P1333, DOI 10.1002/jor.20411
   Theos C, 2008, ARCH ORTHOP TRAUM SU, V128, P179, DOI 10.1007/s00402-007-0301-3
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Tielinen L, 2001, ARCH ORTHOP TRAUM SU, V121, P191, DOI 10.1007/s004020000206
   Upman PJ, 2006, BONEZONE, V5, P50
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wang XD, 1998, BIO-MED MATER ENG, V8, P1
   Wang XL, 2013, J ORTHOP RES, V31, P164, DOI 10.1002/jor.22188
   Wehrhan F, 2012, CLIN ORAL IMPLAN RES, V23, P805, DOI 10.1111/j.1600-0501.2011.02223.x
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Willie BM, 2004, J BIOMED MATER RES A, V69A, P567, DOI 10.1002/jbm.a.30038
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Yang HL, 2012, J BIOMED MATER RES B, V100B, P1911, DOI 10.1002/jbm.b.32758
   Yano K, 2012, J ORTHOP SCI, V17, P484, DOI 10.1007/s00776-012-0235-7
   Ye JH, 2011, BIOMATERIALS, V32, P5065, DOI 10.1016/j.biomaterials.2011.03.053
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Yoshii T, 2014, J TISSUE ENG REGEN M, V8, P589, DOI 10.1002/term.1547
   Young S, 2008, J BIOMED MATER RES A, V86A, P182, DOI 10.1002/jbm.a.31639
   Yu D, 2008, INT J ORAL MAX SURG, V37, P929, DOI 10.1016/j.ijom.2008.07.012
   Zanchetta P, 2012, J CRANIO MAXILL SURG, V40, P783, DOI 10.1016/j.jcms.2012.02.011
   Zhang G, 2008, PRACT MAN MUSCULOSKE, V30, P495
   Zhang W, 2012, ASIAN PAC J TROP MED, V5, P310, DOI 10.1016/S1995-7645(12)60045-5
   Zhang X, 2012, INT J ORAL MAX SURG, V41, P1330, DOI 10.1016/j.ijom.2012.05.014
   Zhu XS, 2011, J MATER SCI-MATER M, V22, P159, DOI 10.1007/s10856-010-4191-5
   Zwingenberger S, 2013, J SURG RES, V181, pE7, DOI 10.1016/j.jss.2012.06.039
NR 108
TC 37
Z9 39
U1 4
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-031X
J9 J ORTHOP TRANSL
JI J. Orthop. Transl.
PD JUL
PY 2015
VL 3
IS 3
BP 95
EP 104
DI 10.1016/j.jot.2015.05.002
PG 10
WC Orthopedics
SC Orthopedics
GA V35EA
UT WOS:000215882700001
PM 30035046
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kumar, A
   Young, C
   Farina, J
   Witzl, A
   Marks, ED
AF Kumar, Arun
   Young, Chelsea
   Farina, Juliana
   Witzl, Ashley
   Marks, Edward D.
TI Novel nanocomposite biomaterial to differentiate bone marrow mesenchymal
   stem cells to the osteogenic lineage for bone restorationz
SO JOURNAL OF ORTHOPAEDIC TRANSLATION
LA English
DT Article
DE chitosan; crosslinking; mineralization; nanocomposite; three-point
   analysis
ID IN-VITRO; CHITOSAN; SCAFFOLD; LEADS
AB Background/Objective: As the bone engineering field moves away from nonviable implants to more biocompatible and natural structures, nanomedicine has emerged as a superior tool for developing implantable materials.
   Methods: Here, we describe the fabrication and testing of a nanocomposite structure composed of chitosan and a biocompatible thermoplastic (PMMA).
   Results: Our nanocomposite material displayed morphologically similar characteristics to an extracted murine femur during microscopic and spectroscopic analysis as seen through SEM and FTIR. Crosslinking our nanocomposite enhanced structural and strength characteristics significantly above the noncrosslinked sample, mimicking the strength of an extracted mammalian bone. When cocultured with bone marrow mesenchymal stem cells, the composite material proved to be osteoinductive and osteogenic via DAPI and actin staining, differentiating BMSCs into the osteogenic lineage and promoting mineral deposition. Nodule formation, indicative of mineralization during BMSC differentiation, was confirmed spectroscopically via FTIR and autofluorescence of the nodule.
   Conclusion: These encouraging results show promise for in vivo implantation of our novel scaffold that is both biocompatible and biomimetic in strength and composition. Copyright (C) 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Kumar, Arun; Marks, Edward D.] Univ Delaware, Coll Hlth Sci, Dept Med Lab Sci, Nanomed Res Lab, 305C Willard Hall,16 West Main St, Newark, DE 19716 USA.
   [Young, Chelsea] Univ Delaware, Coll Engn, Dept Chem Engn, Newark, DE 19716 USA.
   [Farina, Juliana; Witzl, Ashley] Univ Delaware, Coll Hlth Sci, Dept Biol Sci, Newark, DE 19716 USA.
RP Kumar, A (reprint author), Univ Delaware, Coll Hlth Sci, Dept Med Lab Sci, Nanomed Res Lab, 305C Willard Hall,16 West Main St, Newark, DE 19716 USA.
EM arunk@udel.edu
FU University of Delaware
FX Dr. Kumar would like to acknowledge the startup funding and UDRF
   (University of Delaware Research Foundation) Award he received from the
   University of Delaware.
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Ashori A, 2013, INT J BIOL MACROMOL, V58, P343, DOI 10.1016/j.ijbiomac.2013.04.056
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Boskey AL, 2010, J DENT RES, V89, P1333, DOI 10.1177/0022034510377791
   Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/eri.11.59, 10.1586/ERI.11.59]
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Evans CH, 2012, ADV DRUG DELIVER REV, V64, P1331, DOI 10.1016/j.addr.2012.03.013
   Flores-Ramirez N, 2008, J BIOMAT SCI-POLYM E, V19, P259, DOI 10.1163/156856208783432525
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717
   Lee JW, 1999, J APPL POLYM SCI, V73, P113
   Lee MJ, 2010, CLIN ORTHOP SURG, V2, P90, DOI 10.4055/cios.2010.2.2.90
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Messora MR, 2013, CLIN ORAL IMPLAN RES, V24, P1347, DOI 10.1111/clr.12008
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   Morgado J, 2013, EXPRESS POLYM LETT, V7, P960, DOI 10.3144/expresspolymlett.2013.94
   Rosa AL, 2014, J CELL BIOCHEM, V115, P540, DOI 10.1002/jcb.24688
   Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/JBMR.090316, 10.1359/jbmr.090316]
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Struszczyk H, 1991, ADV CHITIN CHITOSAN
   Su N, 2013, J BONE MINER RES, V28, P660, DOI 10.1002/jbmr.1778
   Towler Dwight A, 2008, Curr Osteoporos Rep, V6, P67, DOI 10.1007/s11914-008-0012-x
   Tsao CW, 2007, LAB CHIP, V7, P499, DOI 10.1039/b618901f
   Wang TJ, 2012, MOL VIS, V18, P255
NR 29
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-031X
J9 J ORTHOP TRANSL
JI J. Orthop. Transl.
PD JUL
PY 2015
VL 3
IS 3
BP 105
EP 113
DI 10.1016/j.jot.2015.03.002
PG 9
WC Orthopedics
SC Orthopedics
GA V35EA
UT WOS:000215882700002
PM 30035047
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Yang, WX
   Both, SK
   Zuo, Y
   Birgani, ZT
   Habibovic, P
   Li, YB
   Jansen, JA
   Yang, F
AF Yang, Wanxun
   Both, Sanne K.
   Zuo, Yi
   Birgani, Zeinab Tahmasebi
   Habibovic, Pamela
   Li, Yubao
   Jansen, John A.
   Yang, Fang
TI Biological evaluation of porous aliphatic polyurethane/hydroxyapatite
   composite scaffolds for bone tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone regeneration; biomaterial; polyurethane; hydroxyapatite; ectopic
   bone formation
ID OF-THE-ART; CELL-CULTURE; HYDROXYAPATITE; POLYURETHANES; BIOMATERIALS;
   MECHANISMS; IMPLANTS; TITANIUM
AB Biomaterial scaffolds meant to function as supporting structures to osteogenic cells play a pivotal role in bone tissue engineering. Recently, we synthesized an aliphatic polyurethane (PU) scaffold via a foaming method using non-toxic components. Through this procedure a uniform interconnected porous structure was created. Furthermore, hydroxyapatite (HA) particles were introduced into this process to increase the bioactivity of the PU matrix. To evaluate the biological performances of these PU-based scaffolds, their influence on in vitro cellular behavior and in vivo bone forming capacity of the engineered cell-scaffold constructs was investigated in this study. A simulated body fluid test demonstrated that the incorporation of 40 wt % HA particles significantly promoted the biomineralization ability of the PU scaffolds. Enhanced in vitro proliferation and osteogenic differentiation of the seeded mesenchymal stem cells were also observed on the PU/HA composite. Next, the cell-scaffold constructs were implanted subcutaneously in a nude mice model. After 8 weeks, a considerable amount of vascularized bone tissue with initial marrow stroma development was generated in both PU and PU/HA40 scaffold. In conclusion, the PU/HA composite is a potential scaffold for bone regeneration applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103: 2251-2259, 2015.
C1 [Yang, Wanxun; Both, Sanne K.; Jansen, John A.; Yang, Fang] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, Dent 309, NL-6525 ED Nijmegen, Netherlands.
   [Yang, Wanxun] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Peoples R China.
   [Yang, Wanxun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Peoples R China.
   [Zuo, Yi; Li, Yubao] Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
   [Birgani, Zeinab Tahmasebi; Habibovic, Pamela] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
RP Yang, F (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, Dent 309, NL-6525 ED Nijmegen, Netherlands.
EM fang.yang@radboudumc.nl
RI Jansen, John/H-8055-2014; Yang, Fang/E-1937-2011
OI Yang, Fang/0000-0002-4022-7643
FU Royal Netherlands Academy of Arts and Sciences (KNAW) [PSA 08-PSA-M-02];
   China Scholarship Council [2010627030]
FX Contract grant sponsor: Royal Netherlands Academy of Arts and Sciences
   (KNAW); contract grant number: PSA 08-PSA-M-02; Contract grant sponsor:
   China Scholarship Council; contract grant number: 2010627030
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Correia RN, 1996, J MATER SCI-MATER M, V7, P501, DOI 10.1007/BF00705432
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Huang M. N., 2009, J BIOMED SCI ENG, V2, P36
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kavlock KD, 2007, ACTA BIOMATER, V3, P475, DOI 10.1016/j.actbio.2007.02.001
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laschke MW, 2010, ACTA BIOMATER, V6, P2020, DOI 10.1016/j.actbio.2009.12.004
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Liu HH, 2009, J APPL POLYM SCI, V112, P2968, DOI 10.1002/app.29862
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schweitzer P. A., 2004, CORROSION RESISTANCE
   Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517
   Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vaquette C, 2013, BIOMATERIALS, V34, P5538, DOI 10.1016/j.biomaterials.2013.03.088
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Wang L, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025003
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
NR 30
TC 17
Z9 18
U1 7
U2 86
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2015
VL 103
IS 7
BP 2251
EP 2259
DI 10.1002/jbm.a.35365
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ1LZ
UT WOS:000355246400005
PM 25370308
DA 2018-10-19
ER

PT J
AU Santhanam, S
   Liang, J
   Baid, R
   Ravi, N
AF Santhanam, Sruthi
   Liang, Jue
   Baid, Rinku
   Ravi, Nathan
TI Investigating thiol-modification on hyaluronan via carbodiimide
   chemistry using response surface methodology
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyaluronan; thiol; carbodiimide crosslinking; response surface
   methodology; side reaction
ID IN-VITRO EVALUATION; CHEMICAL-MODIFICATION; GOLD NANOPARTICLES; ACID
   HYDROGELS; DRUG-DELIVERY; OPTIMIZATION; DESIGN; SCAFFOLDS; PROTEINS;
   COMPLEX
AB Hyaluronan (HA) is a naturally occurring glycosaminoglycan widely researched for its use as a biomaterial in tissue engineering, drug delivery, angiogenesis, and ophthalmic surgeries. The mechanical properties of this biomaterial can be altered to a required extent by chemically modifying the pendant reactive groups. However, derivatizing these polymers to a predetermined extent has been the Achilles heel for this process. In this study, we have investigated the factors controlling the derivatization of the carboxyl moieties of HA with amine containing thiol, cystamine dihydrochloride (Cys), via carbodiimide crosslinking chemistry. We used fractional factorial design to screen and identify the significant factor(s) affecting the reaction, and response surface methodology (RSM) to develop a model equation for predicting the degree of thiolation of HA. Also, we analyzed the reaction mechanism for potential side reactions. We observed that N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) (mole ratio with repeat unit of HA) is the significant factor controlling the degree of amidation. The quadratic equations developed from RSM predict the formulation for a desired degree of amidation of HA and percentage of potential side product. Hence, derivatizing HA to a predetermined extent with minimal side product can be achieved using the statistical design of experiments. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103: 2300-2308, 2015.
C1 [Santhanam, Sruthi; Ravi, Nathan] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA.
   [Liang, Jue; Baid, Rinku; Ravi, Nathan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.
   [Ravi, Nathan] Vet Affairs Healthcare Syst, Dept Res, St Louis, MO USA.
RP Ravi, N (reprint author), Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA.
EM ravi@vision.wustl.edu
FU Department of Veterans Affairs Rehab Merit Review [RX000657-01]; NIH
   [EY021620, P30 EY02687]; Research to Prevent Blindness, Inc.
FX Contract grant sponsor: Department of Veterans Affairs Rehab Merit
   Review; contract grant number: RX000657-01; Contract grant sponsor: NIH;
   contract grant number: EY021620; Contract grant sponsor: NIH Core Grant;
   contract grant number: P30 EY02687; Contract grant sponsor: Research to
   Prevent Blindness, Inc.
CR Abul Kalam M, 2013, J BIOMED MATER RES A, V101, P1813, DOI 10.1002/jbm.a.34453
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cao H, 2008, J MATER SCI-MATER M, V19, P567, DOI [10.1007/s10856-007-3281-5, 10.1007/S10856-007-3281-5]
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Elia R, 2010, BIOMATERIALS, V31, P4630, DOI 10.1016/j.biomaterials.2010.02.043
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Eng D, 2010, ACTA BIOMATER, V6, P2407, DOI 10.1016/j.actbio.2009.12.049
   Everaerts F, 2007, J BIOMED MATER RES A, V83A, P1176, DOI 10.1002/jbm.a.31398
   Kafedjiiski K, 2007, INT J PHARMACEUT, V343, P48, DOI 10.1016/j.ijpharm.2007.04.019
   Kim WJ, 2003, NAT MATER, V2, P815, DOI 10.1038/nmat1021
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187
   Lee H, 2014, ACS NANO, V8, P4790, DOI 10.1021/nn500685h
   Lee MY, 2012, ACS NANO, V6, P9522, DOI 10.1021/nn302538y
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma Y, 2012, J BIOMED MATER RES A, V100A, P989, DOI 10.1002/jbm.a.34032
   Motealleh B, 2014, J BIOMED MATER RES B, V102, P977, DOI 10.1002/jbm.b.33078
   Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Narayan PM, 2001, J BIOMED MATER RES, V56, P333, DOI 10.1002/1097-4636(20010905)56:3<333::AID-JBM1101>3.0.CO;2-K
   Nottelet B, 2009, J BIOMED MATER RES A, V89A, P865, DOI 10.1002/jbm.a.32023
   Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010
   Palazon F, 2014, LANGMUIR, V30, P4545, DOI 10.1021/la5004269
   Papasani MR, 2012, NANOMED-NANOTECHNOL, V8, P804, DOI 10.1016/j.nano.2012.01.008
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Peng HT, 2009, J BIOMED MATER RES B, V89B, P199, DOI 10.1002/jbm.b.31206
   SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144
   Taguchi T, 2002, J BIOMED MATER RES, V61, P330, DOI 10.1002/jbm.10147
   THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115
   Valencia P, 2013, FOOD BIOPROCESS TECH, V6, P290, DOI 10.1007/s11947-011-0628-1
   Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
NR 35
TC 7
Z9 7
U1 3
U2 74
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2015
VL 103
IS 7
BP 2300
EP 2308
DI 10.1002/jbm.a.35366
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ1LZ
UT WOS:000355246400010
PM 25369214
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ghavimi, SAA
   Ebrahimzadeh, MH
   Solati-Hashjin, M
   Abu Osman, NA
AF Ghavimi, Soheila Ali Akbari
   Ebrahimzadeh, Mohammad H.
   Solati-Hashjin, Mehran
   Abu Osman, Noor Azuan
TI Polycaprolactone/starch composite: Fabrication, structure, properties,
   and applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polycaprolactone; starch; polymeric composite; tissue engineering;
   degradation
ID POLY-EPSILON-CAPROLACTONE; TISSUE ENGINEERING APPLICATIONS; STARCH-BASED
   BIOMATERIALS; RING-OPENING POLYMERIZATION; FIBER-MESH SCAFFOLDS; MARROW
   STROMAL CELLS; DRUG-DELIVERY SYSTEMS; FOOD-PACKAGING APPLICATIONS; FLOW
   PERFUSION BIOREACTOR; NATURAL ORIGIN SCAFFOLDS
AB Interests in the use of biodegradable polymers as biomaterials have grown. Among the different polymeric composites currently available, the blend of starch and polycaprolactone (PCL) has received the most attention since the 1980s. Novamont is the first company that manufactured a PCL/starch (SPCL) composite under the trademark Mater-Bi (R). The properties of PCL (a synthetic, hydrophobic, flexible, expensive polymer with a low degradation rate) and starch (a natural, hydrophilic, stiff, abundant polymer with a high degradation rate) blends are interesting because of the composite components have completely different structures and characteristics. PCL can adjust humidity sensitivity of starch as a biomaterial; while starch can enhance the low biodegradation rate of PCL. Thus, by appropriate blending, SPCL can overcome important limitations of both PCL and starch components and promote controllable behavior in terms of mechanical properties and degradation which make it suitable for many biomedical applications. This article reviewed the different fabrication and modification methods of the SPCL composite; different properties such as structural, physical, and chemical as well as degradation behavior; and different applications as biomaterials. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103: 2482-2498, 2015.
C1 [Ghavimi, Soheila Ali Akbari; Solati-Hashjin, Mehran; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Ebrahimzadeh, Mohammad H.] Mashhad Univ Med Sci, Orthoped Res Ctr, Mashhad, Iran.
   [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Dept Biomed Engn, Tehran 15914, Iran.
RP Ghavimi, SAA (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM ghavimi@aut.ac.ir
RI Engineering, Faculty/I-7935-2015; ABU OSMAN, NOOR AZUAN/B-9265-2010
OI Engineering, Faculty/0000-0002-4848-7052; ABU OSMAN, NOOR
   AZUAN/0000-0002-2853-4421; Solati-Hashjin, Mehran/0000-0002-1187-1237
FU High Impact Research Grant from the University of Malaya
   [UM.C/HIR/MOHE/ENG/10 D000010-16001]
FX Contract grant sponsor: High Impact Research Grant from the University
   of Malaya; contract grant number: UM.C/HIR/MOHE/ENG/10 D000010-16001
CR Abbasi Z, 2014, INT J NANO DIMENS, V5, P549, DOI 10.7508/ijnd.2014.06.006
   Aee LH, 1998, THERMOCHIM ACTA, V322, P39
   Ajili SH, 2009, ACTA BIOMATER, V5, P1519, DOI 10.1016/j.actbio.2008.12.014
   Ali SFA, 2014, J POLYM ENVIRON, V22, P359, DOI 10.1007/s10924-014-0675-6
   AliAkbari Ghavimi S, 2012, J TISSUE ENG REGE S1, P12
   Aliakbari Ghavimi S., 2012, MODARES J MED SCI PA, V15, P37
   Alix S, 2013, EUR POLYM J, V49, P1234, DOI 10.1016/j.eurpolymj.2013.03.016
   Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Arvanitoyannis I, 1997, STARCH-STARKE, V49, P306, DOI 10.1002/star.19970490712
   Avella M, 2000, POLYMER, V41, P3875, DOI 10.1016/S0032-3861(99)00663-1
   Averous L, 2004, J MACROMOL SCI-POL R, VC44, P231, DOI 10.1081/mc-200029326
   Averous L, 2001, POLYM ENG SCI, V41, P727, DOI 10.1002/pen.10768
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Azevedo HS, 2009, ACTA BIOMATER, V5, P3021, DOI 10.1016/j.actbio.2009.04.039
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Balmayor ER, 2009, ACTA BIOMATER, V5, P1035, DOI 10.1016/j.actbio.2008.11.006
   BASTIOLI C, 1995, J ENVIRON POLYM DEGR, V3, P81, DOI 10.1007/BF02067484
   Bastioli C, 1998, MACROMOLECULAR S
   Belard L, 2009, POLYM ENG SCI, V49, P1177, DOI 10.1002/pen.21342
   Beneke CE, 2009, MOLECULES, V14, P2602, DOI 10.3390/molecules14072602
   Cai J, 2014, CARBOHYD POLYM, V102, P746, DOI 10.1016/j.carbpol.2013.10.095
   Campos A, 2012, POLYM DEGRAD STABIL, V97, P1948, DOI 10.1016/j.polymdegradstab.2011.11.010
   Campos A, 2012, J REINF PLAST COMP, V31, P573, DOI 10.1177/0731684412441092
   Carmona VB, 2014, J THERM ANAL CALORIM, V115, P153, DOI 10.1007/s10973-013-3259-0
   Carvalho PP, 2014, J BIOMED MATER RES A, V102, P3102, DOI 10.1002/jbm.a.34983
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chang PR, 2009, J APPL POLYM SCI, V113, P2973, DOI 10.1002/app.30369
   Chen L, 2005, CARBOHYD POLYM, V60, P103, DOI 10.1016/j.carbpol.2004.11.028
   Chivrac F, 2009, MAT SCI ENG R, V67, P1, DOI 10.1016/j.mser.2009.09.002
   Cho HS, 2011, WASTE MANAGE, V31, P475, DOI 10.1016/j.wasman.2010.10.029
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Choi EJ, 1999, J POLYM SCI POL PHYS, V37, P2430, DOI 10.1002/(SICI)1099-0488(19990901)37:17<2430::AID-POLB14>3.0.CO;2-4
   Costa SA, 2004, J MATER SCI-MATER M, V15, P335, DOI 10.1023/B:JMSM.0000021098.75103.3a
   Cyras VP, 2002, J THERMOPLAST COMPOS, V15, P253, DOI [10.1106/089270502021454, 10.1006/089270502021454]
   Cyras VP, 2001, POLYM ENG SCI, V41, P1521, DOI 10.1002/pen.10851
   da Silva M. A., 2008, TISSUE ENG PART A, V15, P377
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Desevaux C, 2002, J BIOMED MATER RES, V63, P772, DOI 10.1002/jbm.10451
   Dhanaraju MD, 2006, J BIOMED MATER RES A, V76A, P63, DOI 10.1002/jbm.a.30458
   di Franco CR, 2004, POLYM DEGRAD STABIL, V86, P95, DOI 10.1016/j.polymdegradstab.2004.02.009
   Dole P, 2004, CARBOHYD POLYM, V58, P335, DOI 10.1016/j.carbpol.2004.08.002
   Duarte ARC, 2010, POLYM DEGRAD STABIL, V10, P2110
   Dubois P, 1999, POLYMER, V40, P3091, DOI 10.1016/S0032-3861(98)00110-4
   Ebrahimzadeh MH, 2011, IRAN J ORTHOPED SURG, V4, P185
   Ebrahimzadeh MH, 2011, INT BON TISS ENG C B
   Eisenberg A, 2002, DIBLOCK COPOLYMER US
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Fei P, 2013, J APPL POLYM SCI, V130, P4129, DOI 10.1002/app.39695
   Fu X, 2012, J BIOMED MATER RES B, V100B, P314, DOI 10.1002/jbm.b.31916
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Gan ZH, 1997, POLYM DEGRAD STABIL, V56, P209, DOI 10.1016/S0141-3910(96)00208-X
   Gaspar M, 2005, POLYM DEGRAD STABIL, V90, P563, DOI 10.1016/j.polymdegradstab.2005.03.012
   Ghanaati S, 2011, J TISSUE ENG REGEN M, V5, pE136, DOI 10.1002/term.373
   Giavaresi G, 2004, BIOMED PHARMACOTHER, V58, P411, DOI 10.1016/j.biopha.2004.08.001
   Gibson JW, 2012, ZERO ORDER PROLONGED
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Grignard B, 2008, BIOMACROMOLECULES, V9, P3141, DOI 10.1021/bm800730m
   Habibi Y, 2008, BIOMACROMOLECULES, V9, P1974, DOI 10.1021/bm8001717
   Hermanova S, 2013, J APPL POLYM SCI, V127, P4726, DOI 10.1002/app.38078
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369
   Janecek S, 2014, CELL MOL LIFE SCI, V71, P1149, DOI 10.1007/s00018-013-1388-z
   Jones I, 2000, BIOMATERIALS UK, V7, P713
   Jukola H, 2008, J BIOMED MATER RES B, V87B, P197, DOI 10.1002/jbm.b.31093
   Kalambur S, 2006, POLYM ENG SCI, V46, P650, DOI 10.1002/pen.20508
   Kalambur S, 2006, J PLAST FILM SHEET, V22, P39, DOI 10.1177/8756087906062729
   Kaur Lovedeep, 2007, P83, DOI 10.1007/978-1-4020-6289-6_5
   Kazimoglu C, 2003, INT J ARTIF ORGANS, V26, P804
   Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122
   Kim EG, 2007, J APPL POLYM SCI, V103, P928, DOI 10.1002/app.25239
   Kim JJ, 2014, J BIOMATER APPL, V28, P1069, DOI 10.1177/0885328213495903
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kweon DK, 2004, J APPL POLYM SCI, V92, P1716, DOI 10.1002/app.20130
   Kweon DK, 2001, J APPL POLYM SCI, V81, P2197, DOI 10.1002/app.1656
   Kweon DK, 2000, J APPL POLYM SCI, V78, P986, DOI 10.1002/1097-4628(20001031)78:5<986::AID-APP70>3.0.CO;2-T
   Labet M, 2007, BIOMACROMOLECULES, V8, P2916, DOI 10.1021/brn700468f
   Lam CXF, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034108
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Liao JJ, 2014, NEW J CHEM, V38, P2522, DOI 10.1039/c3nj01647a
   Lim SW, 1999, EUR POLYM J, V35, P1875, DOI 10.1016/S0014-3057(98)00273-0
   Lima MJ, 2014, BIOMED MICRODEVICES, V16, P69, DOI 10.1007/s10544-013-9806-4
   Link DP, 2013, J BIOMED MATER RES A, V101, P3059, DOI 10.1002/jbm.a.34614
   Liu FJ, 2009, CARBOHYD POLYM, V78, P146, DOI 10.1016/j.carbpol.2009.03.021
   Liu HS, 2009, PROG POLYM SCI, V34, P1348, DOI 10.1016/j.progpolymsci.2009.07.001
   Liu L, 2008, J BIOMED MATER RES B, V87B, P244, DOI 10.1002/jbm.b.31103
   Liu MX, 2012, COLLOID SURFACE A, V395, P131, DOI 10.1016/j.colsurfa.2011.12.017
   Loercks J., 1998, POLYM DEGRAD STABIL, V59, P245
   Mahkam M, 2010, J BIOMED MATER RES A, V92A, P1392, DOI 10.1002/jbm.a.32490
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170
   Mariani PDSC, 2009, POLYM TEST, V28, P824, DOI 10.1016/j.polymertesting.2009.07.004
   Marques AP, 2005, J MATER SCI-MATER M, V16, P1029, DOI 10.1007/s10856-005-4757-9
   Marques AP, 2005, MACROMOL BIOSCI, V5, P775, DOI 10.1002/mabi.200500010
   Marques AP, 2005, J MATER SCI-MATER M, V16, P833, DOI 10.1007/s10856-005-3580-7
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Martins A, 2009, J TISSUE ENG REGEN M, V3, P37, DOI 10.1002/term.132
   Martins AM, 2012, J BIOMED MATER RES A, V100A, P599, DOI 10.1002/jbm.a.33261
   Martins AM, 2010, J BIOMED MATER RES A, V94A, P1061, DOI 10.1002/jbm.a.32785
   Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004
   Massardier-Nageotte V, 2006, POLYM DEGRAD STABIL, V91, P620, DOI 10.1016/j.polymdegradstab.2005.02.029
   Matzinos P, 2002, POLYM DEGRAD STABIL, V77, P17, DOI 10.1016/S0141-3910(02)00072-1
   Matzinos P, 2002, EUR POLYM J, V38, P1713, DOI 10.1016/S0014-3057(02)00061-7
   Mauricio MR, 2015, CARBOHYD POLYM, V115, P715, DOI 10.1016/j.carbpol.2014.07.063
   Mendes S, 2003, TISSUE ENG S1, V4, P91
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Meneguin AB, 2014, CARBOHYD POLYM, V99, P140, DOI 10.1016/j.carbpol.2013.07.077
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Miner MR, 2006, J ENDODONT, V32, P683, DOI 10.1016/j.joen.2006.01.008
   Myllymaki O., 1998, PACKAG TECHNOL SCI, V11, P265
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ng KW, 2007, J BIOMAT SCI-POLYM E, V18, P925, DOI 10.1163/156856207781367693
   Odusanya OS, 2003, J APPL POLYM SCI, V87, P877, DOI 10.1002/app.11295
   Oliveira JT, 2007, J MATER SCI-MATER M, V18, P295, DOI 10.1007/s10856-006-0692-7
   Pashkuleva I, 2008, MACROMOL BIOSCI, V8, P210, DOI 10.1002/mabi.200700076
   Pavlov MP, 2004, MACROMOL BIOSCI, V4, P776, DOI 10.1002/mabi.200400002
   Pena J, 2006, POLYM DEGRAD STABIL, V91, P1424, DOI 10.1016/j.polymdegradstab.2005.10.016
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Pereira JDAS, 2014, MAT SCI ENG C-MATER, V36, P226, DOI 10.1016/j.msec.2013.12.008
   Perez CJ, 2008, MAT SCI ENG A-STRUCT, V480, P259, DOI 10.1016/j.msea.2007.07.031
   Perez E, 2013, CARBOHYD POLYM, V97, P269, DOI 10.1016/j.carbpol.2013.04.099
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   Pranamuda H, 1996, J ENVIRON POLYM DEGR, V4, P1, DOI 10.1007/BF02083877
   Ratto JA, 1999, POLYMER, V40, P6777, DOI 10.1016/S0032-3861(99)00014-2
   Reed CR, 2009, ANN PLAS SURG, V62, P505, DOI 10.1097/SAP.0b013e31818e48bf
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Remya KR, 2013, J BIOMED NANOTECHNOL, V9, P1483, DOI 10.1166/jbn.2013.1640
   Requicha JF, 2014, J ORTHOP RES, V32, P904, DOI 10.1002/jor.22609
   Rodrigues AI, 2012, ACTA BIOMATER, V8, P3765, DOI 10.1016/j.actbio.2012.05.025
   Rodrigues AI, 2011, BIOENG ENBENG IEEE 1
   Rodrigues A, 2012, CARBOHYD POLYM, V87, P987, DOI 10.1016/j.carbpol.2011.09.044
   Rodrigues MT, 2012, BIOMATERIALS, V33, P6069, DOI 10.1016/j.biomaterials.2012.05.016
   Rodrigues MT, 2011, J TISSUE ENG REGEN M, V5, P41, DOI 10.1002/term.287
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Rosa DS, 2007, J MATER SCI, V42, P2323, DOI 10.1007/s10853-006-1105-5
   Rosa DD, 2003, J APPL POLYM SCI, V89, P3539, DOI 10.1002/app.12537
   Rosa DS, 2004, MAT SCI ENG C-BIO S, V24, P663, DOI 10.1016/j.msec.2004.08.045
   Rosa DS, 2005, POLYM TEST, V24, P756, DOI 10.1016/j.polymertesting.2005.03.014
   Ruseckaite RA, 2001, J APPL POLYM SCI, V82, P3275, DOI 10.1002/app.2186.abs
   Rutot D, 2000, COMPOS INTERFACE, V7, P215, DOI 10.1163/156855400300185324
   Saez A, 2000, EUR J PHARM BIOPHARM, V50, P379, DOI 10.1016/S0939-6411(00)00125-9
   Salgado AJ, 2007, J BIOMED MATER RES A, V80A, P983, DOI 10.1002/jbm.a.30946
   Salgado AJ, 2009, J BIOACT COMPAT POL, V24, P235, DOI 10.1177/0883911509104081
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Santos TC, 2010, ACTA BIOMATER, V6, P4314, DOI 10.1016/j.actbio.2010.06.020
   Sarazin P, 2008, POLYMER, V49, P599, DOI 10.1016/j.polymer.2007.11.029
   Sarka E, 2011, CZECH J FOOD SCI, V29, P232, DOI 10.17221/292/2010-CJFS
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Schantz J-T, 2003, TISSUE ENG, V9, P127
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shen Z, 2014, DESALIN WATER TREAT, V52, P1
   Shen ZQ, 2011, BIORESOURCE TECHNOL, V102, P8835, DOI 10.1016/j.biortech.2011.06.090
   Shenoy DB, 2005, INT J PHARM, V293, P261, DOI 10.1016/j.ijpharm.2004.12.010
   Shin BY, 2004, POLYM ENG SCI, V44, P1429, DOI 10.1002/pen.20139
   Silva GA, 2005, J BIOMED MATER RES A, V73A, P234, DOI 10.1002/jbm.a.30287
   Silva NA, 2009, TISSUE ENG PART A, V1, P45
   Silva NA, 2012, J BIOMED MATER RES A, V100A, P470, DOI 10.1002/jbm.a.33289
   Singh RP, 2003, CARBOHYD RES, V338, P1759, DOI 10.1016/S0008-6215(03)00236-2
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   Slattery CJ, 2000, TRENDS PLANT SCI, V5, P291, DOI 10.1016/S1360-1385(00)01657-5
   Solati-Hashjin M, 2013, ARTIF ORGANS, V7, pA27
   Solati-Hashjin M, 2012, 10 INT SEM POL SCI T
   Song SS, 1996, BIODEGRADABLE HYDROG
   Spevacek J, 2007, EUR POLYM J, V43, P1866, DOI 10.1016/j.eurpolymj.2007.02.021
   Su J, 2012, AFR J BIOTECHNOL, V11, P694
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Tabassi SAS, 2014, J SOL-GEL SCI TECHN, V69, P166, DOI 10.1007/s10971-013-3200-9
   Taghizadeh A, 2013, CARBOHYD POLYM, V98, P189, DOI 10.1016/j.carbpol.2013.05.024
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Tuzlakoglu K, 2010, J BIOMED MATER RES A, V92A, P369, DOI 10.1002/jbm.a.32358
   VAIDYA UR, 1994, J APPL POLYM SCI, V52, P617, DOI 10.1002/app.1994.070520505
   Van Natta FJ, 1934, J AM CHEM SOC, V56, P455, DOI 10.1021/ja01317a053
   Vertuccio L, 2009, CARBOHYD POLYM, V75, P172, DOI 10.1016/j.carbpol.2008.07.020
   Vikman M, 1999, J APPL POLYM SCI, V74, P2594, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2594::AID-APP5>3.0.CO;2-R
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Wang XL, 2003, J MACROMOL SCI-POL R, VC43, P385, DOI 10.1081/MC-120023911
   Wang YM, 2005, MACROMOL MATER ENG, V290, P792, DOI 10.1002/mame.200500003
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Wu C, 2011, INT J PHARMACEUT, V403, P162, DOI 10.1016/j.ijpharm.2010.09.040
   Wu CS, 2003, POLYM DEGRAD STABIL, V80, P127, DOI 10.1016/S0141-3910(02)00393-2
   Wu CS, 2003, J APPL POLYM SCI, V89, P2888, DOI 10.1002/app.12475
   Wu KJ, 2007, PROCESS BIOCHEM, V42, P669, DOI 10.1016/j.procbio.2006.12.009
   Xie FW, 2013, PROG POLYM SCI, V38, P1590, DOI 10.1016/j.progpolymsci.2013.05.002
   Xue JX, 2013, BIOMATERIALS, V34, P2624, DOI 10.1016/j.biomaterials.2012.12.011
   Yang CH, 2009, LAB CHIP, V9, P961, DOI 10.1039/b814952f
   Yao DG, 2006, J BIOMED MATER RES B, V77B, P287, DOI 10.1002/jbm.b.30419
   Yavuz H, 2003, J POLYM ENVIRON, V11, P107, DOI 10.1023/A:1024635130991
   Zeleznak K, 1987, CEREAL CHEM, V2, P121
   Zeng JB, 2011, CARBOHYD POLYM, V83, P762, DOI 10.1016/j.carbpol.2010.08.051
   Zhang Y, 2012, CARBOHYD POLYM, V88, P1208, DOI 10.1016/j.carbpol.2012.01.092
   Zhou N, 2013, CARBOHYD POLYM, V94, P420, DOI 10.1016/j.carbpol.2013.01.014
NR 206
TC 18
Z9 18
U1 5
U2 108
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2015
VL 103
IS 7
BP 2482
EP 2498
DI 10.1002/jbm.a.35371
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ1LZ
UT WOS:000355246400026
PM 25407786
DA 2018-10-19
ER

PT J
AU Won, JE
   Yun, YR
   Jang, JH
   Yang, SH
   Kim, JH
   Chrzanowski, W
   Wall, IB
   Knowles, JC
   Kim, HW
AF Won, Jong-Eun
   Yun, Ye-Rang
   Jang, Jun-Hyeog
   Yang, Sung-Hee
   Kim, Joong-Hyun
   Chrzanowski, Wojciech
   Wall, Ivan B.
   Knowles, Jonathan C.
   Kim, Hae-Won
TI Multifunctional and stable bone mimic proteinaceous matrix for bone
   tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Bone mimetic; Protein engineering; Cell adhesion; Osteogenic
   differentiation; Multi-functional
ID COLLAGEN TYPE-I; CELL-ADHESION; HUMAN FIBRONECTIN; STEM-CELLS;
   DIFFERENTIATION; SCAFFOLDS; LAMELLIPODIA; FILOPODIA; RESPONSES; TITANIUM
AB Biomaterial surface design with biomimetic proteins holds great promise for successful regeneration of tissues including bone. Here we report a novel proteinaceous hybrid matrix mimicking bone extracellular matrix that has multifunctional capacity to promote stem cell adhesion and osteogenesis with excellent stability. Osteocalcin-fibronectin fusion protein holding collagen binding domain was networked with fibrillar collagen, featuring bone extracellular matrix mimic, to provide multifunctional and structurallys-table biomatrices. The hybrid protein, integrated homogeneously with collagen fibrillar networks, preserved structural stability over a month. Biological efficacy of the hybrid matrix was proven onto tethered surface of biopolymer porous scaffolds. Mesenchymal stem cells quickly anchored to the hybrid matrix, forming focal adhesions, and substantially conformed to cytoskeletal extensions, benefited from the fibronectin adhesive domains. Cells achieved high proliferative capacity to reach confluence rapidly and switched to a mature and osteogenic phenotype more effectively, resulting in greater osteogenic matrix syntheses and mineralization, driven by the engineered osteocalcin. The hybrid biomimetic matrix significantly improved in vivo bone formation in calvarial defects over 6 weeks. Based on the series of stimulated biological responses in vitro and in vivo the novel hybrid proteinaceous composition will be potentially useful as stem cell interfacing matrices for osteogenesis and bone regeneration. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Won, Jong-Eun; Yun, Ye-Rang; Yang, Sung-Hee; Kim, Joong-Hyun; Chrzanowski, Wojciech; Wall, Ivan B.; Knowles, Jonathan C.; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Won, Jong-Eun; Yun, Ye-Rang; Yang, Sung-Hee; Kim, Joong-Hyun; Chrzanowski, Wojciech; Wall, Ivan B.; Knowles, Jonathan C.; Kim, Hae-Won] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan 330714, South Korea.
   [Won, Jong-Eun; Yun, Ye-Rang; Yang, Sung-Hee; Kim, Joong-Hyun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330714, South Korea.
   [Jang, Jun-Hyeog] Inha Univ, Coll Med, Dept Biochem, Inchon, South Korea.
   [Chrzanowski, Wojciech] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.
   [Wall, Ivan B.] UCL, Dept Biochem Engn, London WC1H 0AH, England.
   [Knowles, Jonathan C.] UCL, Div Biomat & Tissue Engn, UCL Eastman Dent Inst, London WC1X 8LD, England.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan 330714, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330714, South Korea.
EM kimhw@dku.edu
FU Priority Research Centers Program, National Research Foundation, South
   Korea [2009-0093829]
FX This study was supported by grants from the Priority Research Centers
   Program (grant no. 2009-0093829), National Research Foundation, South
   Korea.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Chrzanowski W, 2015, ADV FUNCT MATER, V25, P193, DOI 10.1002/adfm.201401696
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   Dorj B, 2014, ACTA BIOMATER, V10, P1238, DOI 10.1016/j.actbio.2013.11.002
   Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026
   Harris JR, 2007, MICRON, V38, P513, DOI 10.1016/j.micron.2006.07.026
   HEINEGARD D, 1989, FASEB J, V3, P2042
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   INGRAM RT, 1993, J BONE MINER RES, V8, P1019
   Jeon E, 2014, J BIOMED MATER RES A, V102, P1, DOI 10.1002/jbm.a.34689
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Krawetz RJ, 2012, TISSUE ENG PT A, V18, P1014, DOI [10.1089/ten.tea.2011.0174, 10.1089/ten.TEA.2011.0174]
   Kruger TE, 2013, SCI WORLD J, DOI 10.1155/2013/812718
   Lee JH, 2012, ACTA BIOMATER, V23, P2203
   Lee JH, 2013, J MATER CHEM B, V1, P11
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Oh SA, 2011, J TISSUE ENG, V2010
   OLDBERG A, 1983, J BIOL CHEM, V258, P193
   Pitt C G, 1981, NIDA Res Monogr, V28, P232
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sun WJ, 2007, GROWTH FACTORS, V25, P309, DOI 10.1080/08977190701803885
   Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.32445
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   You RC, 2014, J BIOMED MATER RES A, V102, P4206, DOI 10.1002/jbm.a.35097
NR 30
TC 14
Z9 14
U1 1
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 56
BP 46
EP 57
DI 10.1016/j.biomaterials.2015.03.022
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI8SI
UT WOS:000355041600006
PM 25934278
DA 2018-10-19
ER

PT J
AU Mitchell, MJ
   Castellanos, CA
   King, MR
AF Mitchell, Michael J.
   Castellanos, Carlos A.
   King, Michael R.
TI Surfactant functionalization induces robust, differential adhesion of
   tumor cells and blood cells to charged nanotube-coated biomaterials
   under flow
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Halloysite; Surfactant; Circulating tumor cell; Leukocyte;
   Metastasis
ID CANCER-CELLS; E-SELECTIN; NEUTROPHIL ACTIVATION; CLAY NANOTUBES;
   SHEAR-STRESS; METASTASIS; NANOPARTICLES; INFLAMMATION; RECEPTOR; BIOLOGY
AB The metastatic spread of cancer cells from the primary tumor to distant sites leads to a poor prognosis in cancers originating from multiple organs. Increasing evidence has linked selectin-based adhesion between circulating tumor cells (CTCs) and endothelial cells of the microvasculature to metastatic dissemination, in a manner similar to leukocyte adhesion during inflammation. Functionalized biomaterial surfaces hold promise as a diagnostic tool to separate CTCs and potentially treat metastasis, utilizing antibody and selectin-mediated interactions for cell capture under flow. However, capture at high purity levels is challenged by the fact that CTCs and leukocytes both possess selectin ligands. Here, a straightforward technique to functionalize and alter the charge of naturally occurring halloysite nanotubes using surfactants is reported to induce robust, differential adhesion of tumor cells and blood cells to nanotube-coated surfaces under flow. Negatively charged sodium dodecanoate-functionalized nanotubes simultaneously enhanced tumor cell capture while negating leukocyte adhesion, both in the presence and absence of adhesion proteins, and can be utilized to isolate circulating tumor cells regardless of biomarker expression. Conversely, diminishing nanotube charge via functionalization with decyltrimethylammonium bromide both abolished tumor cell capture while promoting leukocyte adhesion. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Mitchell, Michael J.; Castellanos, Carlos A.; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   [Mitchell, Michael J.] MIT, Dept Chem Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
RP King, MR (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
EM mike.king@cornell.edu
RI Mitchell, Michael/K-8420-2014
OI Mitchell, Michael/0000-0002-3628-2244; Castellanos,
   Carlos/0000-0001-7337-487X
FU Cornell Center on the Microenvironment and Metastasis through National
   Cancer Institute [U54CA143876]
FX The authors gratefully acknowledge Jeff Mattison for work with blood
   sample collection and donor recruitment. The work described was
   supported by the Cornell Center on the Microenvironment and Metastasis
   through Award Number U54CA143876 from the National Cancer Institute. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Cancer
   Institute or the National Institutes of Health.
CR Abdullayev E, 2012, ACS NANO, V6, P7216, DOI 10.1021/nn302328x
   Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378
   Bajpai S, 2014, TECHNOLOGY, V2, P101, DOI 10.1142/S2339547814200015
   Ball CJ, 2011, BLOOD CELL MOL DIS, V46, P246, DOI 10.1016/j.bcmd.2010.12.010
   BUTLER TP, 1975, CANCER RES, V35, P512
   Cao TM, 2013, SENSORS-BASEL, V13, P12516, DOI 10.3390/s130912516
   Cavallaro G, 2012, J PHYS CHEM C, V116, P21932, DOI 10.1021/jp307961q
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608
   Chen WQ, 2013, ACS NANO, V7, P566, DOI 10.1021/nn304719q
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824
   Gassmann P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-177
   Greene BT, 2012, FRONT ONCOL, V2, P1
   HOPWOOD JJ, 1977, J BIOL CHEM, V252, P4777
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Hughes AD, 2013, CANC LETT, V352, P28
   Hughes AD, 2012, CLIN CHEM, V58, P846, DOI 10.1373/clinchem.2011.176669
   Hughes AD, 2010, LANGMUIR, V26, P12155, DOI 10.1021/la101179y
   Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006
   Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139
   Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267
   Kim MB, 2003, MICROCIRCULATION, V10, P167, DOI 10.1038/sj.mn.7800182
   Lawrence MB, 1993, J IMMUNOL, V151, P6339
   Liu MX, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455703
   Luo X, 2014, CELL REP, V7, P645, DOI 10.1016/j.celrep.2014.03.039
   Lvov YM, 2008, ACS NANO, V2, P814, DOI 10.1021/nn800259q
   Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002
   Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283
   McDonald B, 2009, INT J CANCER, V125, P1298, DOI 10.1002/ijc.24409
   Miller MC, 2010, J ONCOL, V2010, DOI DOI 10.1155/2010/617421
   Mitchell MB, 2012, J AGING RES, V2012, DOI DOI 10.1155/2012/461592
   Mitchell MJ, 2014, EXPERT REV ANTICANC, V14, P641, DOI 10.1586/14737140.2014.916619
   Mitchell MJ, 2014, BIOPHYS J, V106, P2243, DOI 10.1016/j.bpj.2014.04.001
   Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111
   Mitchell MJ, 2014, AM J PHYSIOL-CELL PH, V306, pC89, DOI 10.1152/ajpcell.00285.2013
   Mitchell MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015008
   Mitchell MJ, 2012, J CONTROL RELEASE, V160, P609, DOI 10.1016/j.jconrel.2012.02.018
   Mitchell MJ, 2012, BIOPHYS J, V102, P1804, DOI 10.1016/j.bpj.2012.03.053
   Mitchell MJ, 2013, FRONT ONCOL, V3, P1
   Mitchell MJ, 2014, EXPERT OPIN DRUG DEL, P1
   Myung JH, 2011, ANAL CHEM, V83, P1078, DOI 10.1021/ac102901e
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Parodi A, 2012, NAT NANOTECHNOL, V8, P61
   Rahn JJ, 2005, CLIN EXP METASTAS, V22, P475, DOI 10.1007/s10585-005-3098-x
   Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825
   SHAFIE SM, 1980, CANCER LETT, V11, P81, DOI 10.1016/0304-3835(80)90097-X
   Silberberg MS., 2008, CHEM MOL NATURE MATT
   Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192
   van Ginhoven TM, 2010, J SURG ONCOL, V102, P348, DOI 10.1002/jso.21649
   Veerabadran NG, 2007, NANO, V2, P115, DOI 10.1142/S1793292007000441
   Vorobyov I, 2010, BIOPHYS J, V98, P2904, DOI 10.1016/j.bpj.2010.03.046
   Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028
   Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021
   Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2
   Zhang Y, 2009, SMALL, V5, P1990, DOI 10.1002/smll.200900520
NR 56
TC 18
Z9 20
U1 1
U2 66
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 56
BP 179
EP 186
DI 10.1016/j.biomaterials.2015.03.045
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI8SI
UT WOS:000355041600018
PM 25934290
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bygd, HC
   Forsmark, KD
   Bratlie, KM
AF Bygd, Hannah C.
   Forsmark, Kiva D.
   Bratlie, Kaitlin M.
TI Altering in vivo macrophage responses with modified polymer properties
SO BIOMATERIALS
LA English
DT Article
DE Macrophage phenotype; In vivo test; Surface modification; Polymer
   properties; Biocompatibility; Biomedical applications
ID TUMOR-ASSOCIATED MACROPHAGES; PROTEIN ADSORPTION; ALTERNATIVE
   ACTIVATION; INFLAMMATORY RESPONSES; IMPLANTED BIOMATERIALS; NEUTROPHIL
   GRANULES; NECROSIS-FACTOR; CATHEPSIN-D; POLARIZATION; CANCER
AB Macrophage reprogramming has long been the focus of research in disease therapeutics and biomaterial implantation. With different chemical and physical properties of materials playing a role in macrophage polarization, it is important to investigate and categorize the activation effects of material parameters both in vitro and in vivo. In this study, we have investigated the effects of material surface chemistry on in vivo polarization of macrophages. The library of materials used here include poly(N-iso-propylacrylamide-co-acrylic acid) (p(NIPAm-co-AAc)) nanoparticles (similar to 600 nm) modified with various functional groups. This study also focuses on the development of a quantitative structure activity relationship method (QSAR) as a predictive tool for determining the macrophage polarization in response to particular biomaterial surface chemistries. Here, we successfully use in vivo imaging and histological analysis to identify the macrophage response and activation. We demonstrate the ability to induce a spectrum of macrophage phenotypes with a change in material functionality as well as identify certain material parameters that seem to correlate with each phenotype. This suggests the potential to develop materials for a variety of applications and predict the outcome of macrophage activation in response to new surface chemistries. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Bygd, Hannah C.; Bratlie, Kaitlin M.] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   [Forsmark, Kiva D.; Bratlie, Kaitlin M.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
   [Bratlie, Kaitlin M.] Ames Natl Lab, Ames, IA 50011 USA.
RP Bratlie, KM (reprint author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
EM kbratlie@iastate.edu
FU National Science Foundation [CBET 1227867]; Roy J. Carver Charitable
   Trust [13-4265]; NSF ARI-R2 [CMMI-0963224]
FX The authors thank Rebecca Steinlage and Samuel Spar land for their
   assistance in imaging H&E sections. This work was supported by the
   National Science Foundation under Grant No. CBET 1227867 and the Roy J.
   Carver Charitable Trust Grant No. 13-4265. The authors also acknowledge
   support from NSF ARI-R2 (CMMI-0963224) for funding the renovation of the
   research laboratories used for these studies.
CR Akilbekova D, 2015, J BIOMED MATER RES A, V103, P262, DOI 10.1002/jbm.a.35169
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Bartneck M, 2013, MAT SCI ENG C-MATER, V33, P5109, DOI 10.1016/j.msec.2013.08.028
   Beningo KA, 2002, J CELL SCI, V115, P849
   Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745
   Bicerano J., 2002, PREDICTION POLYM PRO
   Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Bridges AW, 2008, BIOMATERIALS, V29, P4605, DOI 10.1016/j.biomaterials.2008.08.015
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bygd HC, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0041-2
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   De Vos P, 2006, J BIOMED MATER RES A, P813
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   DIMENT S, 1988, J BIOL CHEM, V263, P6901
   Dimitrijevic M, 2014, AGE OMAHA, V36
   Doshi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010051
   DUNN WJ, 1989, CHEMOMETR INTELL LAB, V6, P181, DOI 10.1016/0169-7439(89)80083-8
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gonzalez-Leal IJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003194
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Guo X, 2008, MUCOSAL IMMUNOL, V1, P139, DOI 10.1038/mi.2007.18
   Hansch C, 2003, J CHEM INF COMP SCI, V43, P120, DOI 10.1021/ci020378b
   Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hollinger J. O., 2011, INTRO BIOMATERIALS
   Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kubinyi H, 1997, DRUG DISCOV TODAY, V2, P457, DOI 10.1016/S1359-6446(97)01079-9
   Kubinyi H, 1993, METHODS PRINCIPLES M
   Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001
   LEVINSON SS, 1978, CLIN CHEM, V24, P2199
   Li X, 2011, ACS COMB SCI, V13, P50, DOI 10.1021/co100019d
   Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409
   Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371
   Petersen LK, 2011, BIOMATERIALS, V32, P6815, DOI 10.1016/j.biomaterials.2011.05.063
   Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069
   Quatromoni JG, 2012, AM J TRANSL RES, V4, P376
   Ramanathan S, 2014, IRAN J CANCER PREV, V7, P1
   Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010
   Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177
   Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111
   Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385
   Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073
   Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   VANOSS CJ, 1978, ANNU REV MICROBIOL, V32, P19, DOI 10.1146/annurev.mi.32.100178.000315
   Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463
   Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338
   Wang D, 2014, BIOMACROMOLECULES
   Wang D, 2015, ACS BIOMATER SCI ENG, V1, P166, DOI 10.1021/ab5001063
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644
   Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x
   Wynn TA, 2011, CURR PROTOC ESSENT L, V2011, P1
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75
NR 91
TC 18
Z9 18
U1 4
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 56
BP 187
EP 197
DI 10.1016/j.biomaterials.2015.03.042
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI8SI
UT WOS:000355041600019
PM 25934291
DA 2018-10-19
ER

PT J
AU Oechsle, AM
   Haupler, M
   Gibis, M
   Kohlus, R
   Weiss, J
AF Oechsle, Anja Maria
   Haeupler, Michaela
   Gibis, Monika
   Kohlus, Reinhard
   Weiss, Jochen
TI Modulation of the rheological properties and microstructure of collagen
   by addition of co-gelling proteins
SO FOOD HYDROCOLLOIDS
LA English
DT Article
DE Filled collagen type I gel; Soy protein isolate; Whey protein isolate;
   Gluten; Blood plasma protein
ID THERMAL-PROPERTIES; GELS; PARTICLES; BIOMATERIAL; STABILITY; DELIVERY;
   ISOLATE; CASINGS; PLASMA; BONDS
AB Collagen gels were modified by addition of co-gelling proteins to obtain gels with new functionalities. Microstructure and rheology of these mixed telopeptide-poor collagen gels were assessed. It was assumed that proteins with a low molecular weight strengthen the collagen structure by embedding themselves in the matrix, while high molecular weight proteins weaken the structure by interfering with the assembly of the network.
   Different combinations of collagen (2.8-5.19% (w/w)) and co-gelling protein concentrations (0.36-2.14% (w/w)) were applied. Blood plasma protein, soy protein isolate, whey protein isolate, and gluten were used as co-gelling proteins. The storage modulus was measured as an indicator of the gel strength. Frequency sweeps (0.1-10 Hz) at 1% strain were conducted in the linear viscoelastic region. The position of the co-gelling proteins in the collagen matrix was examined via both confocal laser scanning and scanning electron microscopy.
   The results showed weakening effects for whey protein isolate. The addition of blood plasma protein did not affect the rheology, but the microstructure was influenced, featuring more fibrillar structures in the pores compared to the reference gels. Gluten seemed to lead to phase separation, forming a separate layer without interacting with the collagen matrix. The greatest impact was found for soy protein isolate, with a strengthening effect indicated by increased storage moduli and well distributed and embedded soy protein isolate in the collagen network.
   In conclusion, co-gelling proteins display a suitable approach to modify collagen strength in order to create matrices with new functionalities, such as co-extruded sausage casings with modified knack or snap. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Oechsle, Anja Maria; Haeupler, Michaela; Gibis, Monika; Weiss, Jochen] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Phys & Meat Sci, D-70599 Stuttgart, Germany.
   [Haeupler, Michaela] Tech Univ Berlin, Chair Food Proc Engn, Dept Food Technol & Food Chem, D-14195 Berlin, Germany.
   [Kohlus, Reinhard] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Proc Engn & Food Powders, D-70599 Stuttgart, Germany.
RP Weiss, J (reprint author), Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Phys & Meat Sci, Garbenstr 21-25, D-70599 Stuttgart, Germany.
EM j.weiss@uni-hohenheim.de
OI Oechsle, Anja/0000-0003-2500-9063
FU German Ministry of Economics and Energy (via AiF); FEI (Forschungskreis
   der Ernahrungsindustrie e.V., Bonn) [AiF 17478 N]
FX This research project was supported by the German Ministry of Economics
   and Energy (via AiF) and the FEI (Forschungskreis der
   Ernahrungsindustrie e.V., Bonn): Project AiF 17478 N.
CR Almdal K., 1993, POLYM GELS NETW, V1, P5, DOI DOI 10.1016/0966-7822(93)90020-I
   Banerjee S, 2012, CRIT REV FOOD SCI, V52, P334, DOI 10.1080/10408398.2010.500234
   Barbut S, 2010, ITAL J FOOD SCI, V22, P126
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   Bueker M., 2009, COLLAGEN CONCENTRATE
   Chen JS, 1999, COLLOID SURFACE B, V12, P373, DOI 10.1016/S0927-7765(98)00091-5
   Davila E, 2007, MEAT SCI, V76, P216, DOI 10.1016/j.meatsci.2006.11.002
   Dekker M., 1997, FOOD PROTEINS THEIR, P341
   Denavi GA, 2009, FOOD HYDROCOLLOID, V23, P2094, DOI 10.1016/j.foodhyd.2009.03.007
   Foegeding EA, 2011, FOOD HYDROCOLLOID, V25, P1853, DOI 10.1016/j.foodhyd.2011.05.008
   Freudenberg U, 2007, BIOPHYS J, V92, P2108, DOI 10.1529/biophysj.106.094284
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Harper BA, 2012, FOOD RES INT, V49, P494, DOI 10.1016/j.foodres.2012.07.043
   Haurowitz F., 2014, PROTEINS BLOOD SERUM
   Highberger J. H., 1939, J AM CHEM SOC, V61, P2302
   Hurtado S, 2012, MEAT SCI, V90, P624, DOI 10.1016/j.meatsci.2011.10.004
   Jaramillo DP, 2011, FOOD RES INT, V44, P911, DOI 10.1016/j.foodres.2011.01.057
   Klein M, 2010, COLLOID SURFACE B, V79, P377, DOI 10.1016/j.colsurfb.2010.04.021
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205
   Montero P, 2000, FOOD HYDROCOLLOID, V14, P455, DOI 10.1016/S0268-005X(00)00025-4
   Nicoleti JF, 2009, FOOD BIOPHYS, V4, P135, DOI 10.1007/s11483-009-9110-2
   Nordqvist P, 2010, INT J ADHES ADHES, V30, P72, DOI 10.1016/j.ijadhadh.2009.09.002
   Oechsle AM, 2014, EUR POLYM J, V58, P144, DOI 10.1016/j.eurpolymj.2014.06.015
   Pang ZH, 2014, FOOD HYDROCOLLOID, V35, P484, DOI 10.1016/j.foodhyd.2013.07.007
   PETRUCCELLI S, 1995, J AGR FOOD CHEM, V43, P1762, DOI 10.1021/jf00055a004
   REISER K, 1992, FASEB J, V6, P2439
   Saglam D, 2014, FOOD HYDROCOLLOID, V38, P163, DOI 10.1016/j.foodhyd.2013.11.015
   Sarbon NM, 2015, FOOD HYDROCOLLOID, V45, P83, DOI 10.1016/j.foodhyd.2014.10.008
   Shewry PR, 1997, J CEREAL SCI, V25, P207, DOI 10.1006/jcrs.1996.0100
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Sun XD, 2011, COMPR REV FOOD SCI F, V10, P33, DOI 10.1111/j.1541-4337.2010.00137.x
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   Phan-Xuan T, 2013, BIOMACROMOLECULES, V14, P1980, DOI 10.1021/bm400347d
   VANVLIET T, 1988, COLLOID POLYM SCI, V266, P518, DOI 10.1007/BF01420762
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang P, 2014, FOOD HYDROCOLLOID, V35, P324, DOI 10.1016/j.foodhyd.2013.06.015
   Zanaboni G, 2000, MATRIX BIOL, V19, P511, DOI 10.1016/S0945-053X(00)00096-2
NR 42
TC 12
Z9 12
U1 3
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-005X
EI 1873-7137
J9 FOOD HYDROCOLLOID
JI Food Hydrocolloids
PD JUL
PY 2015
VL 49
BP 118
EP 126
DI 10.1016/j.foodhyd.2015.03.013
PG 9
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA CH1QR
UT WOS:000353796900014
DA 2018-10-19
ER

PT J
AU Celen, S
AF Celen, Serap
TI A novel strain energy density algorithm for laser-induced micro-hollows
SO OPTICS AND LASERS IN ENGINEERING
LA English
DT Article
DE Lotus effect; Laser-induced 3D frozen melted droplets shaping; Surface
   skin micro-machining
ID BONE ADAPTATION; INTENSITY; TITANIUM; IMPLANTS; PROPOSAL
AB Mechanical adaptation and stability of implants are dependent on strain energy density algorithms of their surfaces. These applications are in their early stage, but theoretical predictions show us that we can manufacture very strong, flexible biomaterial surface which has a shock absorbing ability. Laser micro-machining is a clean tool for biomedical industry. The purpose of this manuscript is to consolidate a laser micro-machining method for imitating lotus effect on commercially pure titanium specimen surfaces and to develop a novel strain energy density algorithm. Novel 3D nelumbo leafs were prepared using a fiber laser (lambda=1060 nm) with 200-250 ns pulse durations and optimum operation parameters were suggested. (C) 2015 Elsevier Ltd. All rights reserved.
C1 Ege Univ, Fac Engn, Dept Mech Engn, TR-35100 Izmir, Turkey.
RP Celen, S (reprint author), Ege Univ, Fac Engn, Dept Mech Engn, TR-35100 Izmir, Turkey.
EM seracelen@hotmail.com
CR ALBREKTSSON T, 1987, ACTA ORTHOP SCAND, V58, P567, DOI 10.3109/17453678709146401
   Alexander H, 2009, J BIOMED MATER RES B, V88B, P306, DOI 10.1002/jbm.b.30845
   Anisimov SI, 1995, INSTABILITIES LASER
   Bachmann F., 2007, P SOC PHOTO-OPT INS, V6735, P1
   Bachmann F, 2005, NOV MAT PROC ADV EL
   Barthlott W, 2004, BOLOGIE UNSERER Z, V34, P290
   Barthlott W, 1990, SYSTEMATICS ASS, V41, P69
   Barthlott W., 1977, TROPISCHE SUBTROPISC, V19, P367
   Breme J, 2008, METALLIC BIOMATERIAL, P271
   Burger EH, 1999, FASEB J, V13, P101
   Burger EH, 2001, BONE MECH HDB, V28, P1
   CARTER DR, 1991, J BIOMECH, V24, P3, DOI 10.1016/0021-9290(91)90373-U
   Celen S, 2011, THESIS EGE U IZMIR
   Celen S., 2009, P 19 INT C PHOT EUR, P459
   Celen S., 2013, P SURF MOD MAT ION B, P138
   Celen S, 2012, APPL SURF SCI, V263, P579, DOI 10.1016/j.apsusc.2012.09.112
   Celen S, 2011, PHYSCS PROC, V12, P245, DOI 10.1016/j.phpro.2011.03.130
   COWIN SC, 1995, J BIOMECH, V28, P1281, DOI 10.1016/0021-9290(95)00058-P
   Dahotre NB, 2008, LASER FABRICATION MA, P558
   DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304
   Doblare M., ADV FRACTURE DAMAGE, VIV, P471
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Gyorgy E, 2002, SURF COAT TECH, V154, P63, DOI 10.1016/S0257-8972(01)01699-1
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Karacs A, 2003, MAT SCI ENG C-BIO S, V23, P431, DOI 10.1016/S0928-4931(02)00316-8
   Lane WC, 1970, SCANNING ELECT MICRO, V1, P43
   Lawrence J, 2006, SURF COAT TECH, V200, P5581, DOI 10.1016/j.surfcoat.2005.07.107
   MARTIN RB, 1972, J BIOMECH, V5, P447, DOI 10.1016/0021-9290(72)90003-6
   McNamara LM, 2007, J BIOMECH, V40, P1381, DOI 10.1016/j.jbiomech.2006.05.007
   Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6
   MULLENDER MG, 1995, J ORTHOPAED RES, V13, P503, DOI 10.1002/jor.1100130405
   Oers RFM, 2008, BONE, V43, P476
   Oshida Y., 2007, BIOSCIENCE BIOENGINE
   Prendergast P J, 1995, BONE STRUCTURE REMOD, P213
   PRENDERGAST PJ, 1994, J BIOMECH, V27, P1067, DOI 10.1016/0021-9290(94)90223-2
   Schulte FA, 2013, BONE, V52, P485, DOI 10.1016/j.bone.2012.09.008
   Smit TH, 2000, J BONE MINER RES, V15, P301, DOI 10.1359/jbmr.2000.15.2.301
   Stratakis E, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3553235
   Turner CH, 1999, CALCIFIED TISSUE INT, V65, P466, DOI 10.1007/s002239900734
   Voisey KT, 2003, MAT SCI ENG A-STRUCT, V356, P414, DOI 10.1016/S0921-5093(03)00155-2
NR 40
TC 5
Z9 5
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-8166
EI 1873-0302
J9 OPT LASER ENG
JI Opt. Lasers Eng.
PD JUL
PY 2015
VL 70
BP 45
EP 50
DI 10.1016/j.optlaseng.2015.02.002
PG 6
WC Optics
SC Optics
GA CG3KB
UT WOS:000353178000007
DA 2018-10-19
ER

PT J
AU Duhring, S
   Germerodt, S
   Skerka, C
   Zipfel, PF
   Dandekar, T
   Schuster, S
AF Duehring, Sybille
   Germerodt, Sebastian
   Skerka, Christine
   Zipfel, Peter F.
   Dandekar, Thomas
   Schuster, Stefan
TI Host-pathogen interactions between the human innate immune system and
   Candida albicans - understanding and modeling defense and evasion
   strategies
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Candida albicans; human immune system; host-pathogen interaction;
   computational systems biology; defense and evasion strategies;
   immunological cross-talk
ID AGENT-BASED MODEL; BETA-LACTAMASE INHIBITION; IN-VITRO; ANTIMICROBIAL
   PEPTIDES; BIOMATERIAL SURFACES; BIOFILM FORMATION; FUNGAL PATHOGENS;
   DENDRITIC CELLS; INFECTION; RESISTANCE
AB The diploid, polymorphic yeast Candida albicans is one of the most important human pathogenic fungi. C. albicans can grow, proliferate and coexist as a commensal on or within the human host for a long time. However, alterations in the host environment can render C. albicans virulent. In this review, we describe the immunological cross-talk between C. albicans and the human innate immune system. We give an overview in form of pairs of human defense strategies including immunological mechanisms as well as general stressors such as nutrient limitation, pH, fever etc. and the corresponding fungal response and evasion mechanisms. Furthermore, Computational Systems Biology approaches to model and investigate these complex interactions are highlighted with a special focus on game-theoretical methods and agent-based models. An outlook on interesting questions to be tackled by Systems Biology regarding entangled defense and evasion mechanisms is given.
C1 [Duehring, Sybille; Germerodt, Sebastian; Schuster, Stefan] Univ Jena, Dept Bioinformat, D-07743 Jena, Germany.
   [Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, Dept Infect Biol, Jena, Germany.
   [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany.
   [Dandekar, Thomas] Univ Wurzburg, Biozentrum, Dept Bioinformat, D-97070 Wurzburg, Germany.
RP Schuster, S (reprint author), Univ Jena, Dept Bioinformat, Ernst Abbe Pl 2, D-07743 Jena, Germany.
EM stefan.schu@uni-jena.de
RI Dandekar, Thomas/A-4431-2017
OI Dandekar, Thomas/0000-0003-1886-7625
FU Deutsche Forschungsgemeinschaft (DFG) [CRC/Transregio 124]
FX Deutsche Forschungsgemeinschaft (DFG) CRC/Transregio 124 "Pathogenic
   fungi and their human host: Networks of interaction" subproject B1 (SD,
   TD, and SS), subproject C4 (CS), and subproject C6 (PFZ).
CR Abt C. C, 1987, SERIOUS GAMES
   Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019
   Audretsch C, 2013, MOL BIOSYST, V9, P2665, DOI 10.1039/c3mb70117d
   AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396
   Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900
   Bain JM, 2012, FUNGAL GENET BIOL, V49, P677, DOI 10.1016/j.fgb.2012.01.008
   Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006
   Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012
   Borkowski M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S14
   Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6
   Broom M, 2011, B MATH BIOL, V73, P683, DOI 10.1007/s11538-010-9546-z
   Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091
   Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110
   Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064
   Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chavali AK, 2008, TRENDS IMMUNOL, V29, P589, DOI 10.1016/j.it.2008.08.006
   Chen B.-S., 2014, METHOD MOL BIOL, P403
   Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11
   Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702
   Cheng SC, 2010, J IMMUNOL, V185, P2450, DOI 10.4049/jimmunol.1000756
   Chin VK, 2014, BIOMED REP, V2, P869, DOI 10.3892/br.2014.365
   Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007
   Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x
   d'Enfert C, 2009, CURR OPIN MICROBIOL, V12, P358, DOI 10.1016/j.mib.2009.05.008
   d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661
   Dancik GM, 2010, J THEOR BIOL, V262, P398, DOI 10.1016/j.jtbi.2009.10.007
   de Figueiredo LF, 2008, BIOINFORMATICS, V24, P2615, DOI 10.1093/bioinformatics/btn500
   de Lima TM, 2014, MOL IMMUNOL, V60, P8, DOI 10.1016/j.molimm.2014.03.010
   De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22
   DeAngelis Donald L, 2014, F1000Prime Rep, V6, P39, DOI 10.12703/P6-39
   Dementhon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032621
   den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099
   Eyerich S, 2011, EUR J IMMUNOL, V41, P1894, DOI 10.1002/eji.201041197
   Faro-Trindade I, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P437
   Filler SG, 2013, TRENDS MICROBIOL, V21, P389, DOI 10.1016/j.tim.2013.05.006
   Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475
   Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39
   Forrest S, 2007, IMMUNOL REV, V216, P176
   Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x
   Ganguly S, 2011, CURR OPIN MICROBIOL, V14, P380, DOI 10.1016/j.mib.2011.06.001
   Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711
   Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023
   Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019
   Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019
   Hahn S, 2013, SEMIN IMMUNOPATHOL, V35, P439, DOI 10.1007/s00281-013-0380-x
   Hamad M, 2012, MYCOSES, V55, P205, DOI 10.1111/j.1439-0507.2011.02078.x
   Havas KA, 2014, ZOONOSES PUBLIC HLTH, V61, P260, DOI 10.1111/zph.12066
   Heinrich R., 1996, REGULATION CELLULAR
   Hofbauer J., 1998, EVOLUTIONARY GAMES P
   Horn H, 2014, ADV BIOCHEM ENG BIOT, V146, P53, DOI 10.1007/10_2014_275
   Hummert S, 2010, J THEOR BIOL, V264, P312, DOI 10.1016/j.jtbi.2010.01.022
   Hummert S, 2014, MOL BIOSYST, V10, P3044, DOI 10.1039/c3mb70602h
   Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/ERI.11.152, 10.1586/eri.11.152]
   Jimenez-Lopez C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003741
   Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153
   Klipp E., 2011, SYSTEMS BIOL TXB
   KNOWLES JR, 1985, ACCOUNTS CHEM RES, V18, P97, DOI 10.1021/ar00112a001
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Kreft JU, 2013, P NATL ACAD SCI USA, V110, P18027, DOI 10.1073/pnas.1317472110
   Krysan DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004139
   Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012
   Kwak MK, 2014, FEBS LETT, V588, P1144, DOI 10.1016/j.febslet.2014.02.042
   Laskowski M, 2011, IEEE T INF TECHNOL B, V15, P877, DOI 10.1109/TITB.2011.2163414
   Leach MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032467
   Li R, 2013, ANTIMICROB AGENTS CH, V57, P1832, DOI 10.1128/AAC.02295-12
   Li YJ, 2008, INT J ANTIMICROB AG, V31, P369, DOI 10.1016/j.ijantimicag.2007.11.015
   Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090042
   Liu YP, 2015, GENOME RES, V25, P679, DOI 10.1101/gr.187427.114
   Lopez C. M., 2013, THESIS FRIEDRICH SCH
   Lu Y, 2014, P NATL ACAD SCI USA, V111, P1975, DOI 10.1073/pnas.1318690111
   Luo SS, 2013, MOL IMMUNOL, V56, P161, DOI 10.1016/j.molimm.2013.05.218
   Macal CM, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-124
   Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127
   Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913
   Mech F, 2014, CYTOM PART A, V85, P126, DOI 10.1002/cyto.a.22418
   Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591
   Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6
   Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005
   Miramon P, 2013, MED MICROBIOL IMMUN, V202, P183, DOI 10.1007/s00430-013-0288-z
   Moyes D. L., 2011, CLIN DEV IMMUNOL, V2011, DOI DOI 10.1155/2011/346307
   Naseem M, 2012, PLANT CELL, V24, P1793, DOI 10.1105/tpc.112.098335
   Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815
   Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007
   Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x
   Peer X, 2014, J PHARMACOKINET PHAR, V41, P493, DOI 10.1007/s10928-014-9381-1
   Pollmacher J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111630
   Pruchniak MP, 2012, CENT EUR J IMMUNOL, V37, P81
   Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120
   Qiao YL, 2013, NAT GENET, V45, P330, DOI 10.1038/ng.2525
   Quintin J, 2014, EUR J IMMUNOL, V44, P2405, DOI 10.1002/eji.201343828
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Ramirez-Ortiz ZG, 2012, VIRULENCE, V3, P635, DOI 10.4161/viru.22295
   READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852
   RENAUD F, 1991, J THEOR BIOL, V152, P319, DOI 10.1016/S0022-5193(05)80197-3
   Sansregret R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003435
   Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217
   Schlatter R, 2012, BRIEF BIOINFORM, V13, P365, DOI 10.1093/bib/bbr065
   SCHUSTER S, 2006, DISCOVERING BIOMOLEC, P95
   Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33
   Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x
   Shankar J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08131
   Siegismund D, 2014, BIOFOULING, V30, P1023, DOI 10.1080/08927014.2014.958999
   Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016
   Singh A, 2013, OMICS, V17, P84, DOI 10.1089/omi.2012.0075
   Smith LM, 2013, BIOCHEM SOC T, V41, P475, DOI 10.1042/BST20130014
   Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025
   Stark HU, 2010, EVOLUTION, V64, P2458, DOI 10.1111/j.1558-5646.2010.00986.x
   Stavrum AK, 2013, J BIOL CHEM, V288, P34555, DOI 10.1074/jbc.M113.474908
   Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Swidergall M, 2013, ANTIMICROB AGENTS CH, V57, P3917, DOI 10.1128/AAC.00862-13
   Szafranski-Schneider E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002501
   Tavanti A, 2006, MICROBES INFECT, V8, P791, DOI 10.1016/j.micinf.2005.09.016
   Tian Y, 2013, HEALTH EDUC BEHAV, V40, p98S, DOI 10.1177/1090198113493910
   Tierney L., 2014, HUMAN FUNGAL PATHOGE, P45
   Tierney Lanay, 2012, Front Microbiol, V3, P85, DOI 10.3389/fmicb.2012.00085
   Tokarski C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00129
   Tyc K. M., 2011, J COMPUT SCI SYST S, VS1, DOI [10.4172/jcsb.s1-001, DOI 10.4172/JCSB.S1-001]
   Tyc KM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00041
   Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639
   Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14
   Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934
   van de Veerdonk FL, 2015, IMMUNOL REV, V265, P172, DOI 10.1111/imr.12280
   VazquezTorres A, 1996, INFECT IMMUN, V64, P3127
   Vialas V, 2014, J PROTEOMICS, V97, P62, DOI 10.1016/j.jprot.2013.06.020
   Voigt J., 2013, THESIS FRIEDRICH SCH
   Vylkova S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003995
   Wellington M, 2014, EUKARYOT CELL, V13, P329, DOI 10.1128/EC.00336-13
   Westerhoff HV, 2000, EUR J BIOCHEM, V267, P5355, DOI 10.1046/j.1432-1327.2000.01559.x
   Whittington A., 2014, HUMAN FUNGAL PATHOGE, V2nd, P3
   Williams JD, 1997, CLIN INFECT DIS, V24, P494, DOI 10.1093/clinids/24.3.494
   Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x
   Yan L, 2013, MICROBIOL RES, V168, P389, DOI 10.1016/j.micres.2013.02.008
   Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636
   Zelante T, 2011, EUR J IMMUNOL, V41, P270, DOI 10.1002/eji.201041246
   Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001
   Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222
   Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010
NR 140
TC 26
Z9 27
U1 2
U2 29
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 30
PY 2015
VL 6
AR 625
DI 10.3389/fmicb.2015.00625
PG 18
WC Microbiology
SC Microbiology
GA CL9ME
UT WOS:000357302000001
PM 26175718
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Alvarez, LM
   Rivera, JJ
   Stockdale, L
   Saini, S
   Lee, RT
   Griffith, LG
AF Alvarez, Luis M.
   Rivera, Jaime J.
   Stockdale, Linda
   Saini, Sunil
   Lee, Richard T.
   Griffith, Linda G.
TI Tethering of Epidermal Growth Factor (EGF) to Beta Tricalcium Phosphate
   (beta TCP) via Fusion to a High Affinity, Multimeric beta TCP-Binding
   Peptide: Effects on Human Multipotent Stromal Cells/Connective Tissue
   Progenitors
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; ACID-RICH SEQUENCES; IN-VIVO;
   FACTOR RECEPTOR; FILAMENTOUS BACTERIOPHAGE; HYDROXYAPATITE CRYSTALS;
   ADSORPTION PROTEIN; TITANIUM SURFACES; COLONY FORMATION
AB Transplantation of freshly-aspirated autologous bone marrow, together with a scaffold, is a promising clinical alternative to harvest and transplantation of autologous bone for treatment of large defects. However, survival proliferation, and osteogenic differentiation of the marrow-resident stem and progenitor cells with osteogenic potential can be limited in large defects by the inflammatory microenvironment. Previous studies using EGF tethered to synthetic polymer substrates have demonstrated that surface-tethered EGF can protect human bone marrow-derived osteogenic stem and progenitor cells from pro-death inflammatory cues and enhance their proliferation without detriment to subsequent osteogenic differentiation. The objective of this study was to identify a facile means of tethering EGF to clinically-relevant beta TCP scaffolds and to demonstrate the bioactivity of EGF tethered to beta TCP using stimulation of the proliferative response of human bone-marrow derived mesenchymal stem cells (hBMSC) as a phenotypic metric. We used a phage display library and panned against beta TCP and composites of beta TCP with a degradable polyester biomaterial, together with orthogonal blocking schemes, to identify a 12-amino acid consensus binding peptide sequence, LLADTTHHRPWT, with high affinity for beta TCP. When a single copy of this beta TCP-binding peptide sequence was fused to EGF via a flexible peptide tether domain and expressed recombinantly in E. coli together with a maltose-binding domain to aid purification, the resulting fusion protein exhibited modest affinity for beta TCP. However, a fusion protein containing a linear concatamer containing 10 repeats of the binding motif the resulting fusion protein showed high affinity stable binding to beta TCP, with only 25% of the protein released after 7 days at 37 degrees C. The fusion protein was bioactive, as assessed by its abilities to activate kinase signaling pathways downstream of the EGF receptor when presented in soluble form, and to enhance the proliferation of hBMSC when presented in tethered form on commercial beta TCP bone regeneration scaffolds.
C1 [Alvarez, Luis M.; Rivera, Jaime J.; Stockdale, Linda; Griffith, Linda G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Saini, Sunil] Integra Life Sci, Plainsboro, NJ USA.
   [Lee, Richard T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Alvarez, Luis M.] US Mil Acad, Dept Chem & Life Sci, West Point, NY 10996 USA.
   [Alvarez, Luis M.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA.
RP Griffith, LG (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM griff@mit.edu
FU NIH [R01DE019523, 1R01HL117986]; Armed Forces Institute for Regenerative
   Medicine (AFIRM); NIH Biotechnology Training Program [T32 GM008334];
   Hertz Foundation
FX Funding: Funding for this work was provided by NIH R01DE019523 (LGG),
   the Armed Forces Institute for Regenerative Medicine (AFIRM) (LGG), NIH
   Biotechnology Training Program T32 GM008334 fellowship (JR), NIH
   1R01HL117986 (RTL), and a Hertz Foundation Pre-doctoral Fellowship
   (LMA).
CR Achille V, 2011, J CELL BIOCHEM, V112, P1817, DOI 10.1002/jcb.23100
   Arap MA, 2005, GENET MOL BIOL, V28, P1, DOI 10.1590/S1415-47572005000100001
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P11
   Brodke D, 2006, J ORTHOP RES, V24, P857, DOI 10.1002/jor.20094
   Brounts SH, 2013, MOL PHARMACEUT, V10, P2086, DOI 10.1021/mp300662r
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Caralla T, 2013, TISSUE ENG PT A, V19, P125, DOI 10.1089/ten.tea.2011.0622
   CARMONA P, 1987, BIOPHYS CHEM, V28, P161, DOI 10.1016/0301-4622(87)80085-6
   Clackson T, 2004, PHAGE DISPLAY A PRAC
   COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129
   Damron TA, 2007, NANOMEDICINE-UK, V2, P763, DOI 10.2217/17435889.2.6.763
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Giannoni P, 2010, TISSUE ENG PT A, V16, P489, DOI [10.1089/ten.tea.2009.0041, 10.1089/ten.TEA.2009.0041]
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GOLDSMITH ME, 1977, BIOCHEMISTRY-US, V16, P2686, DOI 10.1021/bi00631a016
   Greenwald S, 77TH ANUAL MEETING
   GRONTHOS S, 1995, BLOOD, V85, P929
   Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32
   Heylman Christopher M, 2013, J Regen Med Tissue Eng, V2, DOI 10.7243/2050-1218-2-7
   Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071
   HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Hunter GK, 1996, NUCLEATION AND INHIB
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Jay SM, 2011, J BIOL CHEM, V286, P27729, DOI 10.1074/jbc.M111.221093
   Kai T, 2003, SPINE, V28, P1653, DOI 10.1097/00007632-200308010-00005
   Kang J, 2013, BIOMATERIALS, V34, P9747, DOI 10.1016/j.biomaterials.2013.09.004
   Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936
   Kitajima T, 2009, ACTA BIOMATER, V5, P2623, DOI 10.1016/j.actbio.2009.03.022
   KOZLOWSKI H, 1981, ACTA BIOCHIM POL, V28, P1
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kriplani U, 2005, CURR OPIN BIOTECH, V16, P470, DOI 10.1016/j.copbio.2005.07.001
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x
   Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970
   LIN TC, 1980, J BIOL CHEM, V255, P331
   Liu Bin, 2012, Orthop Surg, V4, P139, DOI 10.1111/j.1757-7861.2012.00189.x
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Luangphakdy V, 2013, TISSUE ENG PT A, V19, P634, DOI [10.1089/ten.tea.2012.0289, 10.1089/ten.TEA.2012.0289]
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Malik P, 1996, GENE, V171, P49, DOI 10.1016/0378-1119(96)00070-4
   Marcantonio NA, 2009, BIOMATERIALS, V30, P4629, DOI 10.1016/j.biomaterials.2009.05.061
   MARTINEAUDOIZE B, 1988, ENDOCRINOLOGY, V123, P841, DOI 10.1210/endo-123-2-841
   Meyers SR, 2007, ADV MATER, V19, P2492, DOI 10.1002/adma.200700029
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Muschler GF, 2003, J BIOMED BIOTECHNOL, P170
   Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012
   Muschler GF, 2002, CLIN ORTHOP RELAT R, P66, DOI 10.1097/00003086-200202000-00008
   Muschler GF, 2005, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000149812.32857.8b
   Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758
   Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716
   Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428
   Orii Hisaya, 2005, Journal of Medical and Dental Sciences, V52, P51
   Patterson TE, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.G.01572
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Platt MO, 2009, STEM CELLS, V27, P2804, DOI 10.1002/stem.215
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Roberts TT, 2012, ORGANOGENESIS, V8, P114, DOI 10.4161/org.23306
   Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215
   Roh JD, 2007, TISSUE ENG, V13, P2743, DOI 10.1089/ten.2007.0171
   Roy MD, 2008, ADV MATER, V20, P1830, DOI 10.1002/adma.200702322
   Saini S, 2006, THE EFFECT OF BONE G
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Santana H, 2013, INT J PHARMACEUT, V452, P52, DOI 10.1016/j.ijpharm.2013.04.054
   Satomura K, 1998, J CELL PHYSIOL, V177, P426, DOI 10.1002/(SICI)1097-4652(199812)177:3<426::AID-JCP6>3.0.CO;2-F
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028
   Seker UOS, 2009, BIOMACROMOLECULES, V10, P250, DOI 10.1021/bm8009895
   Seker UOS, 2007, LANGMUIR, V23, P7895, DOI 10.1021/la700446g
   Seker UOS, 2011, MOLECULES, V16, P1426, DOI 10.3390/molecules16021426
   Smith G P, 1991, Curr Opin Biotechnol, V2, P668, DOI 10.1016/0958-1669(91)90032-Z
   Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176
   Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385
   Urresti S, 2012, J BIOL CHEM, V287, P24649, DOI 10.1074/jbc.M112.368191
   Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591
   Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200
   Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833
   Webster MPJ, 2012, NUCLEIC ACIDS RES, V40, P8743, DOI 10.1093/nar/gks633
   Weiger MC, 2010, BIOMATERIALS
   WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263
   Whaley SR, 2000, NATURE, V405, P665
   WOOLFORD JL, 1977, BIOCHEMISTRY-US, V16, P2694, DOI 10.1021/bi00631a017
   Wu S, 2011, BIOMATERIALS, V32, P7524, DOI 10.1016/j.biomaterials.2011.06.050
   Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295
   Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]
NR 94
TC 4
Z9 4
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2015
VL 10
IS 6
AR e0129600
DI 10.1371/journal.pone.0129600
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1BL
UT WOS:000358150400023
PM 26121597
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sambu, S
AF Sambu, Sammy
TI A Bayesian approach to optimizing cryopreservation protocols
SO PEERJ
LA English
DT Article
DE Decision-tree learning (DTL); Sugars; Meta-data; Naive Bayes Classifier
   (NBC); 3D cryopreservation; Mouse embryonic stem cells; Cell attachment;
   Modified alginates; Encapsulation; CPA loading
ID EMBRYONIC STEM-CELLS; SURVIVAL RATE; ALGINATE; CRYOPROTECTANTS;
   STABILIZATION; RECOVERY
AB Cryopreservation is beset with the challenge of protocol alignment across a wide range of cell types and process variables. By taking a cross-sectional assessment of previously published cryopreservation data (sample means and standard errors) as preliminary meta-data, a decision tree learning analysis (DTLA) was performed to develop an understanding of target survival using optimized pruning methods based on different approaches. Briefly, a clear direction on the decision process for selection of methods was developed with key choices being the cooling rate, plunge temperature on the one hand and biomaterial choice, use of composites (sugars and proteins as additional constituents), loading procedure and cell location in 3D scaffolding on the other. Secondly, using machine learning and generalized approaches via the Naive Bayes Classification (NBC) method, these metadata were used to develop posterior probabilities for combinatorial approaches that were implicitly recorded in the metadata. These latter results showed that newer protocol choices developed using probability elicitation techniques can unearth improved protocols consistent with multiple unidimensionally-optimized physical protocols. In conclusion, this article proposes the use of DTLA models and subsequently NBC for the improvement of modern cryopreservation techniques through an integrative approach.
EM Sambu@post.harvard.edu
CR Ahmad HF, 2013, ACTA BIOMATER, V9, P6814, DOI 10.1016/j.actbio.2013.03.002
   ANCHORDOGUY TJ, 1987, CRYOBIOLOGY, V24, P324, DOI 10.1016/0011-2240(87)90036-8
   ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033
   ARAKAWA T, 1990, CRYOBIOLOGY, V27, P401, DOI 10.1016/0011-2240(90)90017-X
   Benson CMK, 2008, CRYOBIOLOGY, V56, P120, DOI 10.1016/j.cryobiol.2007.12.002
   Cui ZF, 2002, BIOTECHNOL PROGR, V18, P354, DOI 10.1021/bp0101886
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Furnkranz J, 1997, MACH LEARN, V27, P139, DOI 10.1023/A:1007329424533
   Gibson MI, 2009, BIOMACROMOLECULES, V10, P328, DOI 10.1021/bm801069x
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Heng BC, 2004, J MICROENCAPSUL, V21, P455, DOI 10.1080/02652040410001729250
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Li N, 2015, BIOTECHNOL APPL BIOC, V62, P530, DOI 10.1002/bab.1295
   Liu Y, 2007, THESIS OXFORD U
   MACGREGO.WS, 1967, ANN NY ACAD SCI, V141, P3, DOI 10.1111/j.1749-6632.1967.tb34860.x
   MARTINSEN A, 1992, BIOTECHNOL BIOENG, V39, P186, DOI 10.1002/bit.260390210
   Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x
   Miszta-Lane H, 2007, CELL PRESERV TECHNOL, V5, P16, DOI 10.1089/cpt.2006.9990
   Mitchell T.M., 1997, MACHINE LEARNING, V45
   Muldrew K, 2000, CRYOBIOLOGY, V40, P102, DOI 10.1006/cryo.2000.2236
   Pongsawatmanit R, 1999, FOOD SCI TECHNOLOGY, V5, P183, DOI 10.3136/fstr.5.183
   PRESTRELSKI SJ, 1993, ARCH BIOCHEM BIOPHYS, V303, P465, DOI 10.1006/abbi.1993.1310
   ROOS YH, 1991, INT J FOOD SCI TECH, V26, P553
   Rubinstein YD, 1997, KDD, V5, P49
   RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1
   Sambu S, 2011, P I MECH ENG H, V225, P1092, DOI 10.1177/0954411911418568
   Sambu S, 2011, CRYOLETTERS, V32, P389
   Santis LD, 2007, HUMAN REPROD, V22, P2776, DOI [10.1093/humrep/dem240, DOI 10.1093/HUMREP/DEM240]
   Sato Y, 2004, FOOD HYDROCOLLOID, V18, P527, DOI 10.1016/j.foodhyd.2003.09.001
   Selmer-Olsen E, 1999, J IND MICROBIOL BIOT, V23, P79, DOI 10.1038/sj.jim.2900693
   Serra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023212
   Shirakashi R., 2003, Heat Transfer-Asian Research, V32, P511, DOI 10.1002/htj.10105
   Terry C, 2007, CELL TRANSPLANT, V16, P639, DOI 10.3727/000000007783465000
   Therneau T, 2015, PORT BR AUTHOR INITI
   Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021
NR 35
TC 2
Z9 2
U1 0
U2 2
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JUN 25
PY 2015
VL 3
AR e1039
DI 10.7717/peerj.1039
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL9TF
UT WOS:000357320300003
PM 26131379
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Chen, W
   Wu, YX
   Li, L
   Yang, MC
   Shen, L
   Liu, G
   Tan, J
   Zeng, W
   Zhu, CH
AF Chen, Wen
   Wu, Yangxiao
   Li, Li
   Yang, Mingcan
   Shen, Lei
   Liu, Ge
   Tan, Ju
   Zeng, Wen
   Zhu, Chuhong
TI Adenosine accelerates the healing of diabetic ischemic ulcers by
   improving autophagy of endothelial progenitor cells grown on a
   biomaterial
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FOOT ULCERS; ANGIOGENESIS; COMPLICATIONS; RECEPTORS; PROMOTE; MICE
AB Endothelial progenitor cells (EPCs) seeded on biomaterials can effectively promote diabetic ischemic wound healing. However, the function of transplanted EPCs is negatively affected by a high-glucose and ischemic microenvironment. Our experiments showed that EPC autophagy was inhibited and mitochondrial membrane potential (MMP) was increased in diabetic patients, while adenosine treatment decreased the energy requirements and increased the autophagy levels of EPCs. In animal experiments, we transplanted a biomaterial seeded with EPCs onto the surface of diabetic wounds and found that adenosine-stimulated EPCs effectively promoted wound healing. Increased microvascular genesis and survival of the transplanted cells were also observed in the adenosine-stimulated groups. Interestingly, our study showed that adenosine increased the autophagy of the transplanted EPCs seeded onto the biomaterial and maintained EPC survival at 48 and 96 hours. Moreover, we observed that adenosine induced EPC differentiation through increasing the level of autophagy. In conclusion, our study indicated that adenosine-stimulated EPCs seeded onto a biomaterial significantly improved wound healing in diabetic mice; mechanistically, adenosine might maintain EPC survival and differentiation by increasing high glucose-inhibited EPC autophagy and maintaining cellular energy metabolism.
C1 [Chen, Wen; Wu, Yangxiao; Li, Li; Yang, Mingcan; Liu, Ge; Tan, Ju; Zeng, Wen; Zhu, Chuhong] Third Mil Med Univ, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Key Lab Biomech & Tissue Engn Chongqing, Chongqing 400038, Peoples R China.
   [Shen, Lei] Qiqihar Med Univ, Dept Anat, Qiqihar, Peoples R China.
RP Zhu, CH (reprint author), Third Mil Med Univ, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Key Lab Biomech & Tissue Engn Chongqing, Chongqing 400038, Peoples R China.
EM 302507008@qq.com; zhuch99@yahoo.com
OI zhu, chuhong/0000-0003-4146-5405
FU Training Program of the Major Research Plan of the National Natural
   Science Foundation of China [91439116]; National Science Foundation of
   China [31470928]; Natural Science Foundation Project of CQ CSTC
   [cstc2011jjjq0016]; Military Twelfth Five-year Key Project [BWS11C056];
   National High Technology Research and Development Program 863
   [2012AA020504]; research project of the Ministry of Education and
   Guangdong Province [2012B091000043]
FX This work was supported by the Training Program of the Major Research
   Plan of the National Natural Science Foundation of China (No. 91439116),
   the National Science Foundation of China (No: 31470928), the Natural
   Science Foundation Project of CQ CSTC (cstc2011jjjq0016), the Military
   Twelfth Five-year Key Project (BWS11C056), the National High Technology
   Research and Development Program 863 (2012AA020504) and the research
   project of the Ministry of Education and Guangdong Province
   (2012B091000043).
CR Altavilla D, 2011, SURGERY, V149, P253, DOI 10.1016/j.surg.2010.04.024
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138
   Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Elsharawy MA, 2012, INTERACT CARDIOV TH, V14, P288, DOI 10.1093/icvts/ivr068
   Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285
   Gershater MA, 2009, DIABETOLOGIA, V52, P398, DOI 10.1007/s00125-008-1226-2
   Hou CL, 2013, BIOMATERIALS, V34, P112, DOI 10.1016/j.biomaterials.2012.09.022
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823
   Montesinos MC, 2002, AM J PATHOL, V160, P2009, DOI 10.1016/S0002-9440(10)61151-0
   Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005
   SCHRADER J, 1990, CIRCULATION, V81, P389, DOI 10.1161/01.CIR.81.1.389
   Shen L, 2013, CELL TRANSPLANT, V22, P1011, DOI 10.3727/096368912X657495
   Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217
   Ulicna M, 2010, BRATISL MED J, V111, P138
   Valls MD, 2009, BIOCHEM PHARMACOL, V77, P1117, DOI 10.1016/j.bcp.2008.11.002
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Zhu CH, 2008, BIOMATERIALS, V29, P2628, DOI 10.1016/j.biomaterials.2008.03.005
NR 26
TC 7
Z9 10
U1 0
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 25
PY 2015
VL 5
AR 11594
DI 10.1038/srep11594
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL3OS
UT WOS:000356860200001
PM 26108983
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Cha, YJ
   Gim, MJ
   Oh, K
   Yoon, DK
AF Cha, Yun Jeong
   Gim, Min-Jun
   Oh, Kyunghwan
   Yoon, Dong Ki
TI In-Plane Switching Mode for Liquid Crystal Displays Using a DNA
   Alignment Layer
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE DNA; biomaterial; liquid crystal; alignment layer; IPS LCD
ID PHASE; FILM; NANO
AB We successfully fabricated the in-plane switching mode (IPS) LC display (LCD) based on a double stranded DNA (dsDNA) alignment layer. As widely known, the DNA has the right-handed double helical structure that has naturally grown grooves with a very regular period, which can be used as an alignment layer to control the orientation of liquid crystal (LC) molecules. The LC molecules on this topographical layer of DNA material align obliquely at a specific angle with respect to the direction of DNA chains, providing an instant and convenient tool for the fabrication of the IPS display compared to the conventional ways such as rubbing and mechanical shearing methods. The electro-optical performance and response time of this device were also investigated. Our result will be of great use in further exploration of the electro-optical properties of the other biomaterials.
C1 [Cha, Yun Jeong; Gim, Min-Jun; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.
   [Cha, Yun Jeong; Gim, Min-Jun; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, KINC, Taejon 305701, South Korea.
   [Oh, Kyunghwan] Yonsei Univ, Inst Phys & Appl Phys, Photon Device Phys Lab, Seoul 120749, South Korea.
RP Yoon, DK (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, 291 Daehak Ro, Taejon 305701, South Korea.
EM nandk@kaist.ac.kr
RI Yoon, Dong Ki/C-9670-2011
OI Yoon, Dong Ki/0000-0002-9383-8958
FU National Research Foundation (NRF); Korean Government (MSIP)
   [2012M3A7B4049802, 2014M3C1A3052537]
FX This was supported by a grant from the National Research Foundation
   (NRF) and funded by the Korean Government (MSIP) (2012M3A7B4049802 and
   2014M3C1A3052537).
CR Becerril HA, 2009, CHEM SOC REV, V38, P329, DOI 10.1039/b718440a
   BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347
   Chen J., 2011, HDB VISUAL DISPLAY T
   Grote J., 2008, SPIE NEWSROOM, V1082
   Hwang SJ, 2007, J DISP TECHNOL, V3, P259, DOI 10.1109/JDT.2007.900920
   Katarzyna M., 2012, J NANOPHOTONICS, V6
   Kim SJ, 2013, ACS APPL MATER INTER, V5, P10715, DOI 10.1021/am402857w
   Kung H. C., 1995, J MAGN RESON SER B, V109, P323
   Lagerwall JPF, 2012, CURR APPL PHYS, V12, P1387, DOI 10.1016/j.cap.2012.03.019
   Lee Y.-J., 2013, J PHYS D, V46, P1
   Livolant F, 1996, PROG POLYM SCI, V21, P1115, DOI 10.1016/S0079-6700(96)00016-0
   Lowe AM, 2012, CHEM MATER, V24, P746, DOI 10.1021/cm202632m
   Malone SM, 2011, LANGMUIR, V27, P11767, DOI 10.1021/la202640a
   Masahito Oh-E., 1997, LIQ CRYST, V22, P391
   Nakao H, 2003, NANO LETT, V3, P1391, DOI 10.1021/nl034620k
   Nakata M, 2008, LANGMUIR, V24, P10390, DOI 10.1021/la800639x
   Ohe M, 1996, APPL PHYS LETT, V69, P623, DOI 10.1063/1.117927
   Ohe M, 1995, APPL PHYS LETT, V67, P3895, DOI 10.1063/1.115309
   Ohzono T., 2014, NAT COMMUN, V5, P1
   Smalyukh II, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177801
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Wang YJ, 2002, J MATER SCI-MATER EL, V13, P173, DOI 10.1023/A:1014337518120
   Xu H, 2014, J PHYS CHEM B, V118, P4151, DOI 10.1021/jp501175h
   Yoon DK, 2012, LIQ CRYST, V39, P571, DOI 10.1080/02678292.2012.666809
NR 26
TC 15
Z9 15
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 24
PY 2015
VL 7
IS 24
BP 13627
EP 13632
DI 10.1021/acsami.5b03321
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CL6FO
UT WOS:000357063200061
PM 26066312
DA 2018-10-19
ER

PT J
AU Weaver, CL
   Cui, XT
AF Weaver, Cassandra L.
   Cui, Xinyan Tracy
TI Directed Neural Stem Cell Differentiation with a Functionalized Graphene
   Oxide Nanocomposite
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE graphene oxide; conducting polymer; neural stem cell; surface
   functionalization; neural biomaterial
ID GROWTH-FACTOR-AA; IN-VITRO; POLY(3,4-ETHYLENEDIOXYTHIOPHENE) PEDOT;
   NEURONAL DIFFERENTIATION; CONDUCTING POLYMERS; ELECTROCHEMICAL
   DEPOSITION; ENHANCED DIFFERENTIATION; LINEAGE DIFFERENTIATION;
   ELECTRICAL-ACTIVITY; ADULT HIPPOCAMPUS
AB Neural stem cell (NSC) transplantation has the potential to restore function to diseased or damaged nervous tissue, but poor control over cell survival, differentiation, and maturation limits therapeutic prospects. Engineered scaffolds that have the ability to drive neural stem cell behavior can address these limitations facing cell transplantation. Conducting polymers, which have the ability to electrically interface with cells, are attractive scaffolding candidates, but they lack the capacity for simple covalent modification, which would enable surface patterning of biomolecules. In this work, the NSC scaffolding performance of a nanocomposite composed of conducting polymer poly(3,4-ethylenedioxythiophene) (PEDOT) and graphene oxide (GO) nanosheets (GO/PEDOT) is investigated. The GO/PEDOT material is nontoxic and improves NSC differentiation toward the neuronal lineage. Biomolecules interferon- (IFN) and platelet-derived growth factor (PDGF) that selectively promote neuronal or oligodendrocyte lineage differentiation, respectively, are covalently cross-linked to the surface of the GO/PEDOT nanocomposite via carboxylic acid functional groups provided by GO using carbodiimide chemistry. The surfaces support a larger population of neurons when modified with IFN and a larger population of oligodendrocytes when modified by PDGF. This work demonstrates the customizability of GO/PEDOT for cell scaffolding applications and underlines its potential for controlling NSC behavior to improve therapeutic potential.
C1 [Weaver, Cassandra L.; Cui, Xinyan Tracy] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.
   [Weaver, Cassandra L.; Cui, Xinyan Tracy] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA.
   [Weaver, Cassandra L.; Cui, Xinyan Tracy] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.
RP Cui, XT (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.
EM xic11@pitt.edu
OI Cui, Xinyan/0000-0002-0470-2005
FU NSF [0748001, DGE-0549352]; University of Pittsburgh Provost's
   Development Fund
FX This work was supported by NSF Grant Nos. 0748001 and DGE-0549352 and
   the University of Pittsburgh Provost's Development Fund. Special thanks
   are given to the Nanoscale Fabrication and Characterization Facility at
   the University of Pittsburgh for access to material characterization
   instrumentation, the Center for Biological Imaging at the University of
   Pittsburgh for access to the scanning electron microscope, Lacey
   Cirinelli for assistance with cortical tissue dissection, and Jonathan
   Callan and Jaclyn LaRosa for assistance with cell culture.
CR Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Akhavan O, 2014, CARBON, V66, P395, DOI 10.1016/j.carbon.2013.09.015
   Alvarez-Buylla A., 2002, NEUROSCIENCE, V22, P629
   Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   Andressen C, 2013, CURR PHARM BIOTECHNO, V14, P20
   Asplund M, 2008, BIOINTERPHASES, V3, P83, DOI 10.1116/1.2998407
   BARRES BA, 1993, DEVELOPMENT, V118, P283
   Barreto JA, 2011, ADV MATER, V23, pH18, DOI 10.1002/adma.201100140
   Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009
   Bianco A, 2013, ANGEW CHEM INT EDIT, V52, P4986, DOI 10.1002/anie.201209099
   BREDAS JL, 1985, ACCOUNTS CHEM RES, V18, P309, DOI 10.1021/ar00118a005
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Cul XT, 2007, IEEE T NEUR SYS REH, V15, P502, DOI 10.1109/TNSRE.2007.909811
   Deng M, 2011, SENSOR ACTUAT B-CHEM, V158, P176, DOI 10.1016/j.snb.2011.05.062
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002
   Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Han DH, 2005, ELECTROCHIM ACTA, V50, P3085, DOI 10.1016/j.electacta.2004.10.085
   Heo C, 2011, BIOMATERIALS, V32, P19, DOI 10.1016/j.biomaterials.2010.08.095
   Hong S. W., 2014, BIOMED RES INT, V2014
   Hu JG, 2008, NEUROSCIENCE, V151, P138, DOI 10.1016/j.neuroscience.2007.10.050
   Ibrahim M, 2005, INDIAN J PURE AP PHY, V43, P911
   Kandel E. R., 2013, PRINCIPLES NEURAL SC, P11709
   Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203
   Kennedy HJ, 2012, JARO-J ASSOC RES OTO, V13, P437, DOI 10.1007/s10162-012-0325-4
   Keung AJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01817
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007
   Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x
   Kim SM, 2013, J BIOMED NANOTECHNOL, V9, P403, DOI 10.1166/jbn.2013.1511
   King ZA, 2011, POLYMER, V52, P1302, DOI 10.1016/j.polymer.2011.01.042
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Li N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01604
   Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065
   Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064
   Liu Y., 2013, SCI REP, V3, P3469
   Lu CH, 2013, BBA-GEN SUBJECTS, V1830, P4321, DOI 10.1016/j.bbagen.2012.08.028
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Luo XL, 2013, J MATER CHEM B, V1, P1340, DOI 10.1039/c3tb00006k
   Murugan AV, 2005, J MATER CHEM, V15, P902, DOI 10.1039/b414922j
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Niu L, 2001, SYNTHETIC MET, V122, P425, DOI 10.1016/S0379-6779(00)00562-2
   Osterholm A, 2012, ELECTROCHIM ACTA, V83, P463, DOI 10.1016/j.electacta.2012.07.121
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211
   Ravichandran R, 2010, J R SOC INTERFACE, V7, pS559, DOI 10.1098/rsif.2010.0120.focus
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Salto C, 2008, LANGMUIR, V24, P14133, DOI 10.1021/la8028337
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Shah S, 2014, ADV MATER, V26, P3673, DOI 10.1002/adma.201400523
   Sharifi S, 2012, CHEM SOC REV, V41, P2323, DOI 10.1039/c1cs15188f
   Solanki A, 2013, ADV MATER, V25, P5477, DOI 10.1002/adma.201302219
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Song SH, 2002, NATURE, V417, P39
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tang ML, 2013, BIOMATERIALS, V34, P6402, DOI 10.1016/j.biomaterials.2013.05.024
   Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378
   Tian HC, 2014, BIOMATERIALS, V35, P2120, DOI 10.1016/j.biomaterials.2013.11.058
   Tu Q, 2013, ACS APPL MATER INTER, V5, P13188, DOI 10.1021/am4042004
   Tu Q, 2014, ANALYST, V139, P105, DOI 10.1039/c3an01796f
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   Vishwakarma SK, 2014, J ADV RES, V5, P277, DOI 10.1016/j.jare.2013.04.005
   Wade A, 2014, BBA-GEN SUBJECTS, V1840, P2520, DOI 10.1016/j.bbagen.2014.01.017
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008
   WARREN LF, 1989, J ELECTROCHEM SOC, V136, P2286, DOI 10.1149/1.2097303
   Weaver CL, 2014, ACS NANO, V8, P1834, DOI 10.1021/nn406223e
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009
   Yamamoto N, 2012, EUR J NEUROSCI, V35, P1595, DOI 10.1111/j.1460-9568.2012.08101.x
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zanden C, 2014, NANOMED-NANOTECHNOL, V10, P949, DOI 10.1016/j.nano.2014.01.010
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
   Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176
   Zhou K, 2012, ACS APPL MATER INTER, V4, P4524, DOI 10.1021/am3007565
   Zhu CZ, 2012, J MATER CHEM, V22, P6300, DOI 10.1039/c2jm16699b
NR 86
TC 27
Z9 28
U1 4
U2 101
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 24
PY 2015
VL 4
IS 9
BP 1408
EP 1416
DI 10.1002/adhm.201500056
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CL3EV
UT WOS:000356834000016
PM 25943251
OA Bronze
DA 2018-10-19
ER

PT J
AU Teodorescu, M
   Bercea, M
AF Teodorescu, Mirela
   Bercea, Maria
TI Poly(vinylpyrrolidone) - A Versatile Polymer for Biomedical and Beyond
   Medical Applications
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Drug-delivery; Membrane; Hydrogel; Poly(vinylpyrrolidone); Biomaterial;
   Film
ID ELECTRON-BEAM LITHOGRAPHY; LINKED POLYVINYLPYRROLIDONE NANOPARTICLES;
   LAYERED SILICATE NANOCOMPOSITES; GAS SEPARATION PROPERTIES;
   POVIDONE-IODINE; DRUG-DELIVERY; POLY(VINYL PYRROLIDONE); THIN-FILMS;
   SILVER NANOPARTICLES; NICKEL NANOPARTICLES
AB The high versatility of poly(vinylpyrrolidone) (PVP) can be explained by its diverse properties including its solubility in water and in a broad range of liquid media, high chemical and thermal resistance, and unique wetting, binding, and film-forming properties. Thanks to biocompatibility, absence of toxicity and high capacity to form interpolymer complexes, PVP is widely used for designing materials for different applications, such as biomaterials for medical and nonmedical uses. This review summarizes a vast diversity of applicative examples showing the tremendous opportunities for future research and developments of PVP based biomaterials.
C1 [Teodorescu, Mirela; Bercea, Maria] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
RP Teodorescu, M (reprint author), Petru Poni Inst Macromol Chem, 41-A Grigore Ghica Voda Alley, Iasi 700487, Romania.
EM teodorescu.mirela@icmpp.ro
RI Bercea, Maria/C-8378-2011
OI Bercea, Maria/0000-0003-0962-0372; Teodorescu,
   Mirela/0000-0002-6748-4789
FU Romanian National Authority for Scientific Research, CNCS-UEFISCDI
   [PN-II-ID-PCE-2011-3-0199, 300/2011]; European Union [264115 - STREAM]
FX This work was supported by a grant of the Romanian National Authority
   for Scientific Research, CNCS-UEFISCDI, Project Number
   PN-II-ID-PCE-2011-3-0199 (contract 300/2011), European Union's Seventh
   Framework Program (FP7/2007-2013) under grant agreement No. 264115 -
   STREAM.
CR Abbaszadeh F, 2014, J IND ENG CHEM, V20, P2895, DOI 10.1016/j.jiec.2013.11.025
   Abd El-Rehim HA, 2013, EUR POLYM J, V49, P601, DOI 10.1016/j.eurpolymj.2012.12.002
   ABDELAZIM AAA, 1993, POLYM J, V25, P671, DOI 10.1295/polymj.25.671
   Ahmed MA, 2013, J ALLOY COMPD, V578, P121, DOI 10.1016/j.jallcom.2013.04.182
   Al Malek SA, 2012, DESALINATION, V288, P31, DOI 10.1016/j.desal.2011.12.006
   Albrecht W, 2007, J MEMBRANE SCI, V291, P10, DOI 10.1016/j.memsci.2006.12.014
   Ali MS, 2010, COLLOID SURFACE B, V75, P590, DOI 10.1016/j.colsurfb.2009.10.002
   Alpatova A, 2013, J MEMBRANE SCI, V444, P449, DOI 10.1016/j.memsci.2013.05.034
   Altecor A, 2014, CERAM INT, V40, P5073, DOI 10.1016/j.ceramint.2013.09.067
   ANDERSON CC, 1979, J APPL POLYM SCI, V23, P2453, DOI 10.1002/app.1979.070230823
   APT L, 1984, ARCH OPHTHALMOL-CHIC, V102, P728, DOI 10.1001/archopht.1984.01040030584025
   APT L, 1989, OPHTHALMOLOGY, V96, P289, DOI 10.1016/S0161-6420(89)32897-1
   Ashot M, 1967, U.S. Patent, Patent No. [3350366 A, 3350366]
   Aytimur A, 2013, POLYM-PLAST TECHNOL, V52, P661, DOI 10.1080/03602559.2012.762662
   Babcock DE, 2013, BIOMATERIALS, V34, P3196, DOI 10.1016/j.biomaterials.2013.01.040
   Bailly N, 2012, BIOMACROMOLECULES, V13, P4109, DOI 10.1021/bm301410d
   Banerjee S, 2014, INT J ADHES ADHES, V50, P70, DOI 10.1016/j.ijadhadh.2014.01.001
   Barzin J, 2004, J APPL POLYM SCI, V92, P3804, DOI 10.1002/app.20395
   BENEVENTO WJ, 1990, AM J OPHTHALMOL, V109, P329, DOI 10.1016/S0002-9394(14)74560-X
   Bharali DJ, 2003, J COLLOID INTERF SCI, V258, P415, DOI 10.1016/S0021-9797(02)00099-1
   Bian FL, 2009, CARBOHYD POLYM, V76, P454, DOI 10.1016/j.carbpol.2008.11.008
   Blosi M, 2012, DYES PIGMENTS, V94, P355, DOI 10.1016/j.dyepig.2012.01.006
   Bolong N, 2009, J MEMBRANE SCI, V331, P40, DOI 10.1016/j.memsci.2009.01.008
   Brandrup J., 1999, POLYM HDB
   Buhler V., 2008, KOLLIDON POLYVINYLPY
   Burkert S, 2007, J APPL POLYM SCI, V106, P534, DOI 10.1002/app.26592
   Burks RI, 1998, PHYS THER, V78, P212, DOI 10.1093/ptj/78.2.212
   Buttini F, 2008, J PHARM SCI-US, V97, P1257, DOI 10.1002/jps.21126
   Chakrabarty B, 2008, J MEMBRANE SCI, V315, P36, DOI 10.1016/j.memsci.2008.02.027
   Chan K, 2006, POLYMER, V47, P6941, DOI 10.1016/j.polymer.2006.07.068
   Chao S, 2012, MATER RES BULL, V47, P907, DOI 10.1016/j.materresbull.2011.09.012
   Chaudhary U, 1998, J Indian Med Assoc, V96, P202
   Chen MJ, 2012, POLYMER, V53, P4501, DOI 10.1016/j.polymer.2012.07.046
   Cheng YT, 2011, MICROELECTRON ENG, V88, P929, DOI 10.1016/j.mee.2010.12.020
   Choi S, 2013, CARBON, V60, P254, DOI 10.1016/j.carbon.2013.04.034
   Choi S, 2013, MATER LETT, V90, P87, DOI 10.1016/j.matlet.2012.09.035
   Chun MK, 2005, INT J PHARM, V288, P295, DOI 10.1016/j.ijpharm.2004.10.016
   Chun MK, 2004, J APPL POLYM SCI, V94, P2390, DOI 10.1002/app.21176
   Chun MK, 2002, J CONTROL RELEASE, V81, P327, DOI 10.1016/S0168-3659(02)00078-0
   Ciulla TA, 2002, OPHTHALMOLOGY, V109, P13, DOI 10.1016/S0161-6420(01)00899-5
   Couto GG, 2007, J COLLOID INTERF SCI, V311, P461, DOI 10.1016/j.jcis.2007.03.045
   Covaliu CI, 2013, POWDER TECHNOL, V237, P415, DOI 10.1016/j.powtec.2012.12.037
   Dafader NC, 2005, POLYM-PLAST TECHNOL, V44, P1339, DOI 10.1080/03602550500208202
   Dafader NC, 2005, POLYM-PLAST TECHNOL, V44, P243, DOI 10.1081/PTE-200048678
   Dai XY, 2012, J MATER SCI-MATER M, V23, P2709, DOI 10.1007/s10856-012-4728-x
   Das S. K., 2008, J INDIAN MED ASSOC, V106, P592
   Das Sibes Kumar, 2008, J Indian Med Assoc, V106, P589
   del Consuelo ID, 2007, J CONTROL RELEASE, V122, P135, DOI 10.1016/j.jconrel.2007.05.017
   Du ZH, 2009, J SOLID STATE CHEM, V182, P1780, DOI 10.1016/j.jssc.2009.04.021
   ELIAS HG, 1961, MAKROMOLEKUL CHEM, V50, P1
   Farm E, 2010, J ELECTROCHEM SOC, V157, pK10, DOI 10.1149/1.3250936
   Fechine GJM, 2004, POLYMER, V45, P4705, DOI 10.1016/j.polymer.2004.05.006
   Feng XM, 2010, CHINESE J CHEM, V28, P1359, DOI 10.1002/cjoc.201090232
   Feng Y, 2013, CERAM INT, V39, P7551, DOI 10.1016/j.ceramint.2013.03.007
   FLORY PJ, 1951, J AM CHEM SOC, V73, P1904, DOI 10.1021/ja01149a002
   Folttmann B.H., 2008, DRUG DELIV TECHNOL, V8, P22
   FOSTER A, 1995, NEW ENGL J MED, V332, P600, DOI 10.1056/NEJM199503023320911
   FRANK HP, 1953, J POLYM SCI, V10, P371, DOI 10.1002/pol.1953.120100402
   Frank Y.X., 2011, US Patent, Patent No. [WO2011094672 A2, 2011094672]
   Furukawa Kiyonori, 2004, Journal of Nippon Medical School, V71, P190, DOI 10.1272/jnms.71.190
   Ganesan S, 2003, MODERN PATHOL, V16, P286, DOI 10.1097/01.MP.0000062653.65441.DA
   Gatti S, 1998, ANTIMICROB AGENTS CH, V42, P2232, DOI 10.1128/AAC.42.9.2232
   Gokmese F, 2013, POLYM-PLAST TECHNOL, V52, P1259, DOI 10.1080/03602559.2013.814144
   Gong K, 2005, J PHARM SCI-US, V94, P2583, DOI 10.1002/jps.20474
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   HAAF F, 1985, POLYM J, V17, P143, DOI 10.1295/polymj.17.143
   Halake K., 2014, J IND ENG CHEM, V1843, P1
   Han MJ, 2002, J MEMBRANE SCI, V202, P55, DOI 10.1016/S0376-7388(01)00718-9
   HARPER BG, 1972, Patent No. 3669103
   Hayama M, 2004, BIOMATERIALS, V25, P1019, DOI 10.1016/S0142-9612(03)00629-X
   He TC, 2009, PHYS LETT A, V373, P592, DOI 10.1016/j.physleta.2008.12.002
   HENGLEIN A, 1959, J PHYS CHEM-US, V63, P1852, DOI 10.1021/j150581a016
   Hida Y, 2005, THIN SOLID FILMS, V476, P264, DOI 10.1016/j.tsf.2004.09.063
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Hita-Iglesias P, 2006, INT J ORAL MAX SURG, V35, P514, DOI 10.1016/j.ijom.2005.12.004
   Hosono H, 2006, NANOMATERIALS RES AP
   Hossen MK, 2008, POLYM-PLAST TECHNOL, V47, P662, DOI 10.1080/03602550802129528
   Howe KS, 2013, INT J HYDROGEN ENERG, V38, P1731, DOI 10.1016/j.ijhydene.2012.08.105
   Huang CC, 2011, BIOMATERIALS, V32, P556, DOI 10.1016/j.biomaterials.2010.08.114
   Huang JH, 2006, CRYST GROWTH DES, V6, P1528, DOI 10.1021/cg050310z
   Huang Z, 2008, TECHNOL CANCER RES T, V7, P309, DOI 10.1177/153303460800700405
   Ibrahim NA, 2013, CARBOHYD POLYM, V94, P612, DOI 10.1016/j.carbpol.2013.01.040
   ILIOPOULOS I, 1991, MACROMOLECULES, V24, P2566, DOI 10.1021/ma00009a066
   Ishiduki K, 1997, LANGMUIR, V13, P1587, DOI 10.1021/la960804l
   Ismail AF, 2007, SEP PURIF TECHNOL, V55, P98, DOI 10.1016/j.seppur.2006.11.002
   Jain P, 2010, INT J PHARMACEUT, V394, P68, DOI 10.1016/j.ijpharm.2010.04.042
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Jin WJ, 2005, MACROMOL RAPID COMM, V26, P1903, DOI 10.1002/marc.200500569
   Jing CB, 2007, J NON-CRYST SOLIDS, V353, P4128, DOI 10.1016/j.jnoncrysol.2007.06.040
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 2005, BIOMATERIALS, V26, P2013, DOI 10.1016/j.biomaterials.2004.06.001
   Jones SA, 2006, J PHARM SCI-US, V95, P1060, DOI 10.1002/jps.20608
   Jung YJ, 2011, SYNTHETIC MET, V161, P1991, DOI 10.1016/j.synthmet.2011.07.009
   Kadlubowski S, 2007, POLYMER, V48, P4974, DOI 10.1016/j.polymer.2007.06.033
   Kadlubowski S, 2014, RADIAT PHYS CHEM, V102, P29, DOI 10.1016/j.radphyschem.2014.04.016
   Kalimuthan Ramanujam, 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P1989
   Kamada H, 2003, NAT BIOTECHNOL, V21, P399, DOI 10.1038/nbt798
   Kaneda Y, 2004, BIOMATERIALS, V25, P3259, DOI 10.1016/j.biomaterials.2003.10.003
   Kang JS, 2002, J APPL POLYM SCI, V85, P57, DOI 10.1002/app.10569
   Kang K, 2011, TOXICOL LETT, V205, P227, DOI 10.1016/j.toxlet.2011.05.1033
   Kang N, 2004, POLYMER, V45, P8967, DOI 10.1016/j.polymer.2004.10.081
   Kariduraganavar MY, 2014, NATURAL AND SYNTHETIC BIOMEDICAL POLYMERS, P1
   Kaynar MB, 2013, POWDER TECHNOL, V233, P331, DOI 10.1016/j.powtec.2012.09.009
   Khan WS, 2013, INT J THERM SCI, V71, P74, DOI 10.1016/j.ijthermalsci.2013.03.006
   Kim JW, 2011, MICROELECTRON ENG, V88, P797, DOI 10.1016/j.mee.2010.07.002
   Kim YK, 2005, J MEMBRANE SCI, V251, P159, DOI 10.1016/j.memsci.2004.11.011
   Kim YK, 2004, J MEMBRANE SCI, V243, P9, DOI 10.1016/j.memsci.2004.05.001
   KIRSH YE, 1979, EUR POLYM J, V15, P223, DOI 10.1016/0014-3057(79)90166-6
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kodaira H, 2004, BIOMATERIALS, V25, P4309, DOI 10.1016/j.biomaterials.2003.01.097
   Koga S, 2010, J MEMBRANE SCI, V355, P208, DOI 10.1016/j.memsci.2010.03.032
   Koo CM, 2003, POLYMER, V44, P681, DOI 10.1016/S0032-3861(02)00803-0
   Kopolow L.S., 2003, US Patent, Patent No. [US6641259, 66412592003]
   Koseoglu-Imer DY, 2013, DESALINATION, V316, P110, DOI 10.1016/j.desal.2013.02.011
   Kozuka H, 2004, J EUR CERAM SOC, V24, P1585, DOI 10.1016/S0955-2219(03)00402-3
   Kubin A, 2008, PHARMAZIE, V63, P263, DOI 10.1691/ph.2008.7292
   Kubota S, 2014, J SUPERCRIT FLUID, V86, P33, DOI 10.1016/j.supflu.2013.11.013
   Kudaibergenov SE, 2000, POLYM ADVAN TECHNOL, V11, P506
   Lachapelle JM, 2005, CONTACT DERMATITIS, V52, P9, DOI 10.1111/j.0105-1873.2005.00479.x
   Laforgue A, 2011, J POWER SOURCES, V196, P559, DOI 10.1016/j.jpowsour.2010.07.007
   LAFRENIERE LY, 1987, IND ENG CHEM RES, V26, P2385, DOI 10.1021/ie00071a035
   Lee BM, 2011, J NANOSCI NANOTECHNO, V11, P7390, DOI 10.1166/jnn.2011.4803
   Lee HJ, 2007, J MEMBRANE SCI, V296, P139, DOI 10.1016/j.memsci.2007.03.025
   Leiva A, 2007, J COLLOID INTERF SCI, V310, P136, DOI 10.1016/j.jcis.2007.01.013
   Lele BS, 2002, MACROMOLECULES, V35, P6714, DOI 10.1021/ma020433h
   Lin H, 2013, J SOLID STATE CHEM, V204, P266, DOI 10.1016/j.jssc.2013.06.020
   Liu C, 2012, INT J ELECTROCHEM SC, V7, P7152
   LOFTSSON T, 1994, INT J PHARM, V110, P169, DOI 10.1016/0378-5173(94)90155-4
   Lopes CMA, 2003, BIOMATERIALS, V24, P1279, DOI 10.1016/S0142-9612(02)00448-9
   Lu CM, 2007, POLYM ENG SCI, V47, P830, DOI 10.1002/pen.20763
   Lu XF, 2005, MACROMOL RAPID COMM, V26, P1325, DOI 10.1002/marc.200500300
   Luo YL, 2010, J BIOACT COMPAT POL, V25, P292, DOI 10.1177/0883911510362459
   Luo YP, 2013, FORENSIC SCI INT, V229, P75, DOI 10.1016/j.forsciint.2013.03.045
   Madaeni SS, 2011, DESALINATION, V280, P305, DOI 10.1016/j.desal.2011.07.020
   Matatagui D, 2014, TALANTA, V120, P408, DOI 10.1016/j.talanta.2013.12.027
   Matsuda M, 2008, J MEMBRANE SCI, V310, P219, DOI 10.1016/j.memsci.2007.10.054
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Messager S, 2004, J HOSP INFECT, V58, P115, DOI 10.1016/j.jhin.2004.06.001
   Mestre S, 2012, J EUR CERAM SOC, V32, P2825, DOI 10.1016/j.jeurceramsoc.2011.12.006
   MEZA R, 1977, EUR POLYM J, V13, P235, DOI 10.1016/0014-3057(77)90119-7
   Misra N., 2013, ADV MAT LETT, V4, P458
   Moga KA, 2013, ADV MATER, V25, P5060, DOI 10.1002/adma.201300526
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Momesso RGRAP, 2010, RADIAT PHYS CHEM, V79, P283, DOI 10.1016/j.radphyschem.2009.08.039
   Montazer M, 2012, PROG ORG COAT, V75, P379, DOI 10.1016/j.porgcoat.2012.07.011
   Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036
   Morozov VN, 2012, J MEMBRANE SCI, V403, P110, DOI 10.1016/j.memsci.2012.02.028
   Narayanan M, 2010, MATER LETT, V64, P22, DOI 10.1016/j.matlet.2009.09.059
   Neiva EGC, 2014, SENSOR ACTUAT B-CHEM, V196, P574, DOI 10.1016/j.snb.2014.02.041
   Ng SL, 2011, BIOMATERIALS, V32, P6277, DOI 10.1016/j.biomaterials.2011.05.011
   Nischala K, 2011, COLLOID SURFACE B, V82, P203, DOI 10.1016/j.colsurfb.2010.08.039
   Noh H, 2012, POLYM-KOREA, V36, P190, DOI 10.7317/pk.2012.36.2.190
   NPCS Board of Consultants & Engineers, 2009, COMPL BOOK WAT SOL P
   Oechsner M, 1999, EUR J PHARM BIOPHARM, V47, P113, DOI 10.1016/S0939-6411(98)00070-8
   Ohm A, 2000, EUR J PHARM BIOPHARM, V49, P183, DOI 10.1016/S0939-6411(99)00080-6
   Omastova M, 2014, ELECTROCHIM ACTA, V122, P296, DOI 10.1016/j.electacta.2013.11.037
   Onlaor K., 2014, ORG ELECTRON, V15, P1
   Park JY, 2012, COLOR TECHNOL, V128, P184, DOI 10.1111/j.1478-4408.2012.00370.x
   Park JG, 2012, ELECTROCHIM ACTA, V85, P600, DOI 10.1016/j.electacta.2012.07.110
   Park O., 2003, FUNCTION FOUNTAIN SO
   Park SH, 2014, THIN SOLID FILMS, V550, P575, DOI 10.1016/j.tsf.2013.11.075
   Patel HA, 2011, APPL CLAY SCI, V51, P126, DOI 10.1016/j.clay.2010.11.013
   Pawar IA, 2014, ULTRASON SONOCHEM, V21, P1108, DOI 10.1016/j.ultsonch.2013.12.013
   Penjweini R, 2014, BBA-MOL CELL RES, V1843, P855, DOI 10.1016/j.bbamcr.2014.01.016
   Penjweini R, 2013, J PHOTOCH PHOTOBIO B, V120, P120, DOI 10.1016/j.jphotobiol.2012.12.013
   Pinteala M, 2005, POLYMER, V46, P7047, DOI 10.1016/j.polymer.2005.05.099
   Qiao JL, 2010, POLYMER, V51, P4850, DOI 10.1016/j.polymer.2010.08.018
   Quan J, 2011, COLLOID SURFACE B, V88, P304, DOI 10.1016/j.colsurfb.2011.07.006
   Raghavan SL, 2001, INT J PHARM, V212, P213, DOI 10.1016/S0378-5173(00)00610-4
   Raimi-Abraham BT, 2014, MAT SCI ENG C-MATER, V39, P168, DOI 10.1016/j.msec.2014.02.016
   Rajeswari N, 2011, J NON-CRYST SOLIDS, V357, P3751, DOI 10.1016/j.jnoncrysol.2011.07.037
   RAO VVRN, 1987, POLYMER, V28, P648, DOI 10.1016/0032-3861(87)90482-4
   Ravi M, 2011, MATER CHEM PHYS, V130, P442, DOI 10.1016/j.matchemphys.2011.07.006
   Reddy CVS, 2006, MICROELECTRON ENG, V83, P281, DOI 10.1016/j.mee.2005.08.010
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Rodriguez J, 2013, J POWER SOURCES, V237, P270, DOI 10.1016/j.jpowsour.2013.03.043
   Ruecha N, 2014, BIOSENS BIOELECTRON, V52, P13, DOI 10.1016/j.bios.2013.08.018
   Saxena A, 2006, BIOMATERIALS, V27, P5596, DOI 10.1016/j.biomaterials.2006.06.029
   Schildknecht C. E., 1953, U. S. Patent, Patent No. [2658045A, 2658045]
   Schmidt T, 2006, MACROMOL MATER ENG, V291, P755, DOI 10.1002/mame.200600057
   Schulz M, 2010, EUR J PHARM SCI, V41, P675, DOI 10.1016/j.ejps.2010.09.011
   Schwartz J.A., 2004, DEKKER ENCY NANOSCIE, V2
   Schwarz W., 1990, PVP CRITICAL REV KIN
   Scoutaris N, 2011, J CONTROL RELEASE, V156, P179, DOI 10.1016/j.jconrel.2011.07.033
   Seabra AB, 2004, BIOMATERIALS, V25, P3773, DOI 10.1016/j.biomaterials.2003.10.035
   Sebe I, 2013, INT J PHARMACEUT, V458, P99, DOI 10.1016/j.ijpharm.2013.10.011
   Sequaris JM, 2000, J COLLOID INTERF SCI, V230, P73, DOI 10.1006/jcis.2000.7046
   Immich APS, 2011, J APPL POLYM SCI, V119, P2560, DOI 10.1002/app.32980
   Immich APS, 2011, POLYM ENG SCI, V51, P445, DOI 10.1002/pen.21845
   Sheng LF, 2011, BIOSENS BIOELECTRON, V26, P3494, DOI 10.1016/j.bios.2011.01.032
   Shi ZQ, 2010, SYNTHETIC MET, V160, P2121, DOI 10.1016/j.synthmet.2010.07.042
   Shuping J., 2005, EUR POLYM J, V41, P2406
   Singh R, 2012, J MATER SCI-MATER M, V23, P2649, DOI 10.1007/s10856-012-4730-3
   Slistan-Grijalva A, 2008, MATER RES BULL, V43, P90, DOI 10.1016/j.materresbull.2007.02.013
   Smith LE, 2006, BIOMATERIALS, V27, P2806, DOI 10.1016/j.biomaterials.2005.12.018
   Sneader W, 2005, DRUG DISCOVERY: A HISTORY, P1, DOI 10.1002/0470015535
   Song JF, 2011, MAT SCI ENG A-STRUCT, V528, P5421, DOI 10.1016/j.msea.2011.03.078
   Svanholm E., 2007, THESIS KARLSTAD U KA
   Szczerba M, 2010, APPL CLAY SCI, V47, P235, DOI 10.1016/j.clay.2009.10.015
   Tan CKI, 2012, CERAM INT, V38, P2513, DOI 10.1016/j.ceramint.2011.11.021
   Tan HB, 2011, T NONFERR METAL SOC, V21, P1563, DOI 10.1016/S1003-6326(11)60897-2
   Traini D, 2012, INT J PHARMACEUT, V438, P150, DOI 10.1016/j.ijpharm.2012.08.036
   Traynor MJ, 2011, INT J PHARMACEUT, V410, P9, DOI 10.1016/j.ijpharm.2011.02.053
   Tseng TT, 2009, CERAM INT, V35, P2837, DOI 10.1016/j.ceramint.2009.03.028
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Ummartyotin S, 2012, CR PHYS, V13, P994, DOI 10.1016/j.crhy.2012.09.008
   Uslu I, 2012, J APPL POLYM SCI, V124, P3520, DOI 10.1002/app.35525
   Vakalopoulos KA, 2013, J SURG RES, V180, P290, DOI 10.1016/j.jss.2012.12.043
   Vatsha B, 2014, PHYS CHEM EARTH, V67-69, P125, DOI 10.1016/j.pce.2013.09.021
   Veeren A, 2013, EUR POLYM J, V49, P3034, DOI 10.1016/j.eurpolymj.2013.06.020
   Venkatathri N, 2007, SOLID STATE COMMUN, V143, P493, DOI 10.1016/j.ssc.2007.06.017
   Verma RK, 2003, INT J PHARMACEUT, V263, P9, DOI 10.1016/S0378-5173(03)00360-0
   Vigh T, 2013, EUR J PHARM SCI, V49, P595, DOI 10.1016/j.ejps.2013.04.034
   Wahyudiono, 2014, CHEM ENG PROCESS, V77, P1, DOI 10.1016/j.cep.2013.12.007
   Wang BL, 2012, CARBOHYD POLYM, V90, P8, DOI 10.1016/j.carbpol.2012.03.080
   Wang GR, 2013, INT J ADHES ADHES, V41, P198, DOI 10.1016/j.ijadhadh.2012.11.010
   Wang HT, 2009, FIBER POLYM, V10, P1, DOI 10.1007/s12221-009-0001-4
   Wang L, 2009, COLLOID SURFACE B, V74, P284, DOI 10.1016/j.colsurfb.2009.07.032
   Wang MC, 2014, POLYMER, V55, P2188, DOI 10.1016/j.polymer.2014.02.035
   Wang SB, 2007, MATER CHEM PHYS, V102, P255, DOI 10.1016/j.matchemphys.2006.12.014
   Wei SF, 2009, APPL SURF SCI, V255, P6978, DOI 10.1016/j.apsusc.2009.03.023
   Wiesner VL, 2014, J EUR CERAM SOC, V34, P453, DOI 10.1016/j.jeurceramsoc.2013.08.017
   Yadav PS, 2013, SAUDI PHARM J, V21, P77, DOI 10.1016/j.jsps.2011.12.007
   Yamazaki K, 2012, J MEMBRANE SCI, V396, P38, DOI 10.1016/j.memsci.2011.12.016
   Yan E, 2006, MATER LETT, V60, P2969, DOI 10.1016/j.matlet.2006.02.045
   Yanai Ryoji, 2006, Cont Lens Anterior Eye, V29, P85, DOI 10.1016/j.clae.2006.02.006
   Yanez F, 2008, EUR J PHARM BIOPHARM, V69, P1094, DOI 10.1016/j.ejpb.2008.01.023
   Yang MY, 2014, INT J PHARMACEUT, V465, P187, DOI [10.1016/i.ijpharm.2014.02.021, 10.1016/j.ijpharm.2014.02.021]
   Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904
   Zabska M, 2011, RADIAT PHYS CHEM, V80, P1125, DOI 10.1016/j.radphyschem.2011.02.019
   Zhai DD, 2013, COLLOID SURFACE A, V424, P1, DOI 10.1016/j.colsurfa.2013.01.055
   Zhang H, 2007, J CRYST GROWTH, V304, P206, DOI 10.1016/j.jcrysgro.2007.01.043
   Zhang JY, 2014, J SOLID STATE CHEM, V213, P210, DOI 10.1016/j.jssc.2014.03.004
   Zhang L, 2008, OPT LASER TECHNOL, V40, P282, DOI 10.1016/j.optlastec.2007.05.002
   Zhang YF, 2007, SCRIPTA MATER, V56, P409, DOI 10.1016/j.scriptamat.2006.10.032
   Zhang ZH, 2011, DESALINATION, V269, P239, DOI 10.1016/j.desal.2010.10.066
   Zhi X, 2013, BIOMATERIALS, V34, P5254, DOI 10.1016/j.biomaterials.2013.03.024
   Zhu YF, 2005, MICROPOR MESOPOR MAT, V84, P218, DOI 10.1016/j.micromeso.2005.05.001
   Zhu ZS, 2010, J CONTROL RELEASE, V142, P438, DOI 10.1016/j.jconrel.2009.11.002
NR 239
TC 20
Z9 21
U1 6
U2 65
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-2559
EI 1525-6111
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PD JUN 23
PY 2015
VL 54
IS 9
BP 923
EP 943
DI 10.1080/03602559.2014.979506
PG 21
WC Polymer Science
SC Polymer Science
GA CJ5AW
UT WOS:000355500800001
DA 2018-10-19
ER

PT J
AU Da Silva, GR
   Lima, TH
   Orefice, RL
   Fernandes-Cunha, GM
   Silva-Cunha, A
   Zhao, M
   Behar-Cohen, F
AF Da Silva, Gisele Rodrigues
   Lima, Tadeu Henrique
   Orefice, Rodrigo Lambert
   Fernandes-Cunha, Gabriella Maria
   Silva-Cunha, Armando
   Zhao, Min
   Behar-Cohen, Francine
TI In vitro and in vivo ocular biocompatibility of electrospun
   poly(epsilon-caprolactone) nanofibers
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Poly(epsilon-caprolactone) nanofibers; Electrospinning; In vitro and in
   vivo ocular biocompatibility; Retinal pigment epithelial cells (ARPE-19
   cells); Muller glial cells (MIO-M1 cells)
ID POLY-EPSILON-CAPROLACTONE; STEM-CELLS; SCAFFOLDS; FABRICATION;
   DIFFERENTIATION; EXPRESSION; GROWTH
AB Biocompatibility is a requirement for the development of nanofibers for ophthalmic applications. In this study, nanofibers were elaborated using poly(epsilon-caprolactone) via electrospinning. The ocular biocompatibility of this material was investigated. MIO-M1 and ARPE-19 cell cultures were incubated with nanofibers and cellular responses were monitored by viability and morphology. The in vitro biocompatibility revealed that the nanofibers were not cytotoxic to the ocular cells. These cells exposed to the nanofibers proliferated and formed an organized monolayer. ARPE-19 and MIO-M1 cells were capable of expressing GFAP, respectively, demonstrating their functionality. Nanofibers were inserted into the vitreous cavity of the rat's eye for 10 days and the in vivo biocompatibility was investigated using Optical Coherence Tomography (OCT), histology and measuring the expression of pro-inflammatory genes (IL-1 beta, TNF-alpha, VEGF and iNOS) (real-time PCR). The OCT and the histological analyzes exhibited the preserved architecture of the tissues of the eye. The biomaterial did not elicit an inflammatory reaction and pro-inflammatory cytokines were not expressed by the retinal cells, and the other posterior tissues of the eye. Results from the biocompatibility studies indicated that the nanofibers exhibited a high degree of cellular biocompatibility and short-term intraocular tolerance, indicating that they might be applied as drug carrier for ophthalmic use. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Da Silva, Gisele Rodrigues] Fed Univ Sao Joao del Rey, Sch Pharm, BR-35501296 Divinopolis, MG, Brazil.
   [Lima, Tadeu Henrique; Orefice, Rodrigo Lambert] Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
   [Fernandes-Cunha, Gabriella Maria; Silva-Cunha, Armando] Univ Fed Minas Gerais, Fac Pharm, BR-31270901 Belo Horizonte, MG, Brazil.
   [Zhao, Min; Behar-Cohen, Francine] INSERM, Ctr Rech Cordeliers, Team 17, U872, F-75006 Paris, France.
   [Zhao, Min; Behar-Cohen, Francine] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France.
   [Behar-Cohen, Francine] Hotel Dieu Paris, AP HP, F-75004 Paris, France.
RP Da Silva, GR (reprint author), Ave Sebastiao Goncalves Coelho 400, BR-35500296 Divinopolis, MG, Brazil.
EM giselersilva@ufsj.edu.br; thenriquel@yahoo.com; rorefice@demet.ufmg.br;
   gabriellafcunha@gmail.com; armando@farmacia.ufmg.br; elodiecn@gmail.com;
   francine.behar@gmail.com
RI Cunha, Armando/G-1157-2012; Orefice, Rodrigo/N-8055-2018
OI Cunha, Armando/0000-0002-1161-8936; Orefice, Rodrigo/0000-0002-6046-4056
FU UFSJ (Brazil); CNPq/MCT (Brazil); Fapemig (Brazil); CAPES (Bolsistas da
   CAPES-Brasilia/Brazil)
FX The authors wish to thank the UFSJ (Brazil), CNPq/MCT (Brazil), Fapemig
   (Brazil) and CAPES (Bolsistas da CAPES-Brasilia/Brazil) for the
   financial support.
CR Bakhshandeh H, 2011, INT J NANOMED, V6, P1509, DOI 10.2147/IJN.S19011
   Bernards DA, 2013, J OCUL PHARMACOL TH, V29, P249, DOI 10.1089/jop.2012.0152
   Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001
   Buchtova N, 2013, J MATER SCI-MATER M, V24, P1875, DOI 10.1007/s10856-013-4951-0
   Chaturvedi T.P., 2013, METHOD MOL BIOL, V1014, P187
   Ding XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007410
   Du J, 2014, CARBOHYD POLYM, V99, P483, DOI 10.1016/j.carbpol.2013.08.050
   Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507
   Ford KM, 2012, MOL VIS, V18, P519
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   He XM, 2013, REGEN MED, V8, P425, DOI 10.2217/rme.13.29
   Holan Vladimir, 2013, Methods Mol Biol, V1014, P187, DOI 10.1007/978-1-62703-432-6_13
   Huang NF, 2013, BIOMATERIALS, V34, P4038, DOI 10.1016/j.biomaterials.2013.02.036
   Hwang Y.S., 2013, PLOS ONE, V1-8
   Ishii D, 2009, MATERIALS, V2, P1520, DOI 10.3390/ma2041520
   Kim JY, 2009, MICROELECTRON ENG, V86, P1447, DOI 10.1016/j.mee.2008.11.026
   Kocabey S, 2013, ACTA BIOMATER, V9, P9075, DOI 10.1016/j.actbio.2013.07.007
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864
   Liu JF, 2014, INT J NANOMED, V9, P197, DOI 10.2147/IJN.S55875
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003
   Moriarty P, 2001, REP PROG PHYS, V64, P297, DOI 10.1088/0034-4885/64/3/201
   Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1016/CIRCULATIONAHA.104.503706
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shabani I, 2014, ACS APPL MATER INTER, V6, P72, DOI 10.1021/am404500c
   Shao-Fen L, 2013, INT J OPHTHALMOL, V6, P559
   Sharma S, 2011, MOL VIS, V17, P2898
   Silva G.R., 2011, INT J ARTIF ORGANS, V34, P198
   Sohrabi A, 2013, POLYMER, V54, P2699, DOI 10.1016/j.polymer.2013.03.046
   Son YJ, 2014, ARCH PHARM RES, V37, P69, DOI 10.1007/s12272-013-0284-2
   Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002
   Subramanian A, 2012, J MATER SCI-MATER M, V23, P1797, DOI 10.1007/s10856-012-4654-y
   Touseef A., 2013, MAT SCI ENG C, V33, P707
   TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867
   Wang F, 2013, J BIOMAT SCI-POLYM E, V24, P769, DOI 10.1080/09205063.2012.712029
NR 38
TC 15
Z9 15
U1 2
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD JUN 20
PY 2015
VL 73
BP 9
EP 19
DI 10.1016/j.ejps.2015.03.003
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CI8NT
UT WOS:000355029700002
PM 25797289
DA 2018-10-19
ER

PT J
AU Silva, MBR
   Gallego, J
   Cabrera, JM
   Balancin, O
   Jorge, AM
AF Silva, M. B. R.
   Gallego, J.
   Cabrera, J. M.
   Balancin, O.
   Jorge, A. M., Jr.
TI Interaction between recrystallization and strain-induced precipitation
   in a high Nb- and N-bearing austenitic stainless steel: Influence of the
   interpass time
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Hot mechanical behavior; Recrystallization; Grain refinement; Niobium;
   Precipitation; Stainless steel
ID NIOBIUM MICROALLOYED STEEL; DYNAMIC RECRYSTALLIZATION; HIGH-NITROGEN;
   DEFORMATION CONDITIONS; HOT; TEMPERATURE; BIOMATERIAL; COLD
AB In this work, we studied the influence of the interpass time (20 and 5 s) on the interaction between recrystallization and strain-induced precipitation occurring during multiple passes' deformations under continuous cooling conditions in a high niobium- and nitrogen-bearing austenitic stainless steel (ISO 5832-9). The correlation between microstructure evolution and hot mechanical properties was performed by physical simulation using hot torsion tests. The microstructure evolution was analyzed by optical microscopy, transmission electron microscopy and electron back scattered diffraction (EBSD). This technique indicated that dynamic recrystallization occurred at the first passes promoting an excellent grain refinement. On the other hand, shorter interpass time (5 s) allowed higher volume fraction of smallest precipitates than larger interpass time (20 s). After soaking, only TiNbN precipitates were found, whereas, Z-phase (CrNbN) and NbN were formed during thermomechanical processing. Particles with sizes between 20 and 50 nm were effective to pin grain boundaries and dislocations. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Silva, M. B. R.; Balancin, O.; Jorge, A. M., Jr.] Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
   [Gallego, J.] UNESP, Dept Mech Engn, BR-15385000 Ilha Solteira, SP, Brazil.
   [Cabrera, J. M.] Univ Politecn Cataluna, Dept Mat Sci & Met Engn, E-08028 Barcelona, Spain.
   [Cabrera, J. M.] Fundacio CTM Ctr Tecnol, Manresa 08243, Spain.
RP Silva, MBR (reprint author), Univ Fed Sao Carlos, Dept Mat Engn, Via Washington Luis,Km 235, BR-13565905 Sao Carlos, SP, Brazil.
EM marianabdrs@gmail.com; moreira@dema.ufscar.br
RI Gallego, Juno/G-1908-2012; Jorge Junior, Alberto/B-2566-2012
OI Gallego, Juno/0000-0002-5477-8139; Jorge Junior,
   Alberto/0000-0002-8121-9834
FU CNPq, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
   [506440/2013-3]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior) [179/09]; CNPq (Brazil) [179/09]; Ministerio de Educacion
   (Spain) [179/09]
FX The authors are grateful to CNPq, (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) under the grant CNPq# 506440/2013-3, FAPESP
   (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), under the
   grant CAPES#179/09 for the financial support received in involved
   projects and Villares Metals, Sao Paulo-Brazil, that supplied the steel.
   As well authors are grateful to CNPq (Brazil) and Ministerio de
   Educacion (Spain) for funding a bilateral cooperation, under the
   cooperation project CAPES#179/09.
CR Abad R, 2001, ISIJ INT, V41, P1373, DOI 10.2355/isijinternational.41.1373
   Boratto F., 1988, INT C PHYS MET THERM, P383
   Chilukuru H, 2009, MAT SCI ENG A-STRUCT, V510-11, P81, DOI 10.1016/j.msea.2008.04.088
   DeArdo AJ, 2001, IRONMAK STEELMAK, V28, P138, DOI 10.1179/030192301678055
   Giordani EJ, 2005, MATER SCI FORUM, V500-501, P179, DOI 10.4028/www.scientific.net/MSF.500-501.179
   GLADMAN T, 1966, PROC R SOC LON SER-A, V294, P298, DOI 10.1098/rspa.1966.0208
   Gomez M, 2005, ISIJ INT, V45, P1711, DOI 10.2355/isijinternational.45.1711
   Hanninen H, 2001, J MATER PROCESS TECH, V117, P424, DOI 10.1016/S0924-0136(01)00804-4
   Hellman P., 1975, SCAND J METALL, V4, P211
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Manohar PA, 1998, ISIJ INT, V38, P913, DOI 10.2355/isijinternational.38.913
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Miao CL, 2010, MAT SCI ENG A-STRUCT, V527, P4985, DOI 10.1016/j.msea.2010.04.039
   Morales EV, 2003, PHIL MAG LETT, V83, P79, DOI 10.1080/0950083021000056632
   Oh YJ, 2000, J NUCL MATER, V278, P242, DOI 10.1016/S0022-3115(99)00255-X
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   SAKAI T, 1995, J MATER PROCESS TECH, V53, P349, DOI 10.1016/0924-0136(95)01992-N
   Sakai T, 2014, PROG MATER SCI, V60, P130, DOI 10.1016/j.pmatsci.2013.09.002
   Seher R. J., 1971, S AM SOC TEST MAT, P119
   Simmons JW, 1996, MAT SCI ENG A-STRUCT, V207, P159, DOI 10.1016/0921-5093(95)09991-3
   Souza RC, 2013, MAT SCI ENG A-STRUCT, V582, P96, DOI 10.1016/j.msea.2013.06.037
   SUN WP, 1993, ACTA METALL MATER, V41, P3595, DOI 10.1016/0956-7151(93)90240-S
   Vervynckt S, 2012, INT MATER REV, V57, P187, DOI 10.1179/1743280411Y.0000000013
NR 23
TC 5
Z9 5
U1 3
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 18
PY 2015
VL 637
BP 189
EP 200
DI 10.1016/j.msea.2015.04.049
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA CK4QF
UT WOS:000356207600023
DA 2018-10-19
ER

PT J
AU Corno, M
   Delle Piane, M
   Monti, S
   Moreno-Couranjou, M
   Choquet, P
   Ugliengo, P
AF Corno, Marta
   Delle Piane, Massimo
   Monti, Susanna
   Moreno-Couranjou, Maryline
   Choquet, Patrick
   Ugliengo, Piero
TI Computational Study of Acidic and Basic Functionalized Crystalline
   Silica Surfaces as a Model for Biomaterial Interfaces
SO LANGMUIR
LA English
DT Article
ID PERIODIC AB-INITIO; DRUG-DELIVERY; MOLECULAR SIMULATION; AMORPHOUS
   SILICA; MESOPOROUS MATERIALS; PROTEIN ADSORPTION; ALKYL MONOLAYERS;
   CHEMISTRY; DYNAMICS; MCM-41
AB In silico modeling of acidic (CH2COOH) or basic (CH2NH2) functionalized silica surfaces has been carried out by means of a density functional approach based on a gradient-corrected functional to provide insight into the characterization of experimentally functionalized surfaces via a plasma method. Hydroxylated surfaces of crystalline cristobalite (sporting 4.8 OH/nm(2)) mimic an amorphous silica interface as unsubstituted material. To functionalize the silica surface we transformed the surface Si OH groups into Si CH2COOH and Si CH2NH2 moieties to represent acidic/basic chemical character for the substitution. Structures, energetics, electronic, and vibrational properties were computed and compared as a function of the increasing loading of the functional groups (from 1 to 4 per surface unit cell). Classical molecular dynamics simulations of selected cases have been performed through a Rear-FE reactive force field to assess the mobility of the surface added chains. Both DFT and force field calculations identify the CH2NH2 moderate surface loading (1 group per unit cell) as the most stable functionalization, at variance with the case of the CH2COOH group, where higher loadings are preferred (2 groups per unit cell). The vibrational fingerprints of the surface functionalities, which are the v(C=O) stretching and delta(NH2) bending modes for acidic/basic cases, have been characterized as a function of substitution percentage in order to guide the assignment of the experimental data. The final results highlighted the different behavior of the two types of functionalization. On the one hand, the frequency associated with the v(C=O) mode shifts to lower wavenumbers as a function of the H-bond strength between the surface functionalities (both COOH and SiOH groups), and on the other hand, the 5(NH2) frequency shift seems to be caused by a subtle balance between the H-bond donor and acceptor abilities of the NH2 moiety. Both sets of data are in general agreement with experimental measurements on the corresponding silica-functionalized materials and provide finer details for a deeper interpretation of experimental spectra.
C1 [Corno, Marta; Delle Piane, Massimo; Ugliengo, Piero] Univ Turin, Dipartimento Chim, I-10125 Turin, Italy.
   [Corno, Marta; Delle Piane, Massimo; Ugliengo, Piero] Univ Turin, NIS Nanostruct Interfaces & Surfaces Ctr, I-10125 Turin, Italy.
   [Monti, Susanna] CNR Inst Chem Organometall Cpds, I-56124 Pisa, Italy.
   [Moreno-Couranjou, Maryline; Choquet, Patrick] Luxembourg Inst Sci & Technol LIST, Mat Res & Technol Dept MRT, L-4362 Esch Sur Alzette, Luxembourg.
RP Corno, M (reprint author), Univ Turin, Dipartimento Chim, Via P Giuria 7, I-10125 Turin, Italy.
EM marta.corno@unito.it
RI Delle Piane, Massimo/K-5153-2012; Corno, Marta/I-4310-2012; ugliengo,
   piero/H-6373-2015
OI Delle Piane, Massimo/0000-0001-8522-9047; Corno,
   Marta/0000-0001-7248-2705; ugliengo, piero/0000-0001-8886-9832; choquet,
   patrick/0000-0001-8696-5812; Monti, Susanna/0000-0002-3419-7118
FU Luxembourgish agency "Fonds National de la Recherche"
   [FNR-INER/MAT/11/01]; Progetti di Ricerca di Ateneo-Compagnia di San
   Paolo-Linea 1A [ORTO11RRT5]
FX This research was carried out in the framework of the European M-ERA.NET
   BioADBD project funded by the Luxembourgish agency "Fonds National de la
   Recherche" (FNR-INER/MAT/11/01). M.C. and P.U. acknowledge Progetti di
   Ricerca di Ateneo-Compagnia di San Paolo-2011-Linea 1A, progetto
   ORTO11RRT5 for funding. S.M. is grateful to Adri C. T. van Duin for the
   serial version of the reactive dynamics program (ReaxFF) and for his
   useful comments and suggestions. A fruitful discussion with Barbara
   Onida (Politecnico of Torino) is also acknowledged.
CR Allen MP, 1989, COMPUTER SIMULATIONS
   Baerends E. J., 2012, ADF2012 01A SCM THEO
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Brunel D, 2002, STUD SURF SCI CATAL, V142, P1395
   Builes S, 2012, J PHYS CHEM C, V116, P10150, DOI 10.1021/jp301947v
   Builes S, 2013, LANGMUIR, V29, P199, DOI 10.1021/la3038507
   Builes S, 2012, J PHYS CHEM C, V116, P3017, DOI 10.1021/jp210494f
   Calvo A, 2008, CHEM MATER, V20, P4661, DOI 10.1021/cm800597k
   CATTI M, 1993, PHYS REV B, V47, P9189, DOI 10.1103/PhysRevB.47.9189
   Civalleri B, 1998, CHEM PHYS LETT, V292, P394, DOI 10.1016/S0009-2614(98)00749-0
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Csogor Z, 2003, MAT SCI ENG C-BIO S, V23, P93
   Datt A, 2012, J PHYS CHEM C, V116, P18358, DOI 10.1021/jp3063959
   Dkhissi A, 2005, J AM CHEM SOC, V127, P9776, DOI 10.1021/ja040246u
   Doadrio JC, 2006, J MATER CHEM, V16, P462, DOI 10.1039/b510101h
   Dovesi R, 2005, REV COMP CH, V21, P1, DOI 10.1002/0471720895.ch1
   Dovesi R, 2005, Z KRISTALLOGR, V220, P571, DOI 10.1524/zkri.220.5.571.65065
   Dovesi R., 2009, CRYSTAL09 USERS MANU
   Ewing CS, 2014, LANGMUIR, V30, P5133, DOI 10.1021/la500422p
   Fiorilli S, 2011, PHYS CHEM CHEM PHYS, V13, P1201, DOI 10.1039/c0cp01260b
   GATTI C, 1994, J CHEM PHYS, V101, P10686, DOI 10.1063/1.467882
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075
   Iler R.K., 1979, CHEM SILICA SOLUBILI
   Jang YH, 2005, J AM CHEM SOC, V127, P4959, DOI 10.1021/ja0444762w
   Kasemo B, 1999, Adv Dent Res, V13, P8
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lecoq E., 2014, 14 INT C PLASM SURF
   Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t
   Mauchauffe R, 2014, J MATER CHEM B, V2, P5168, DOI 10.1039/c4tb00503a
   Meder F, 2013, LANGMUIR, V29, P12502, DOI 10.1021/la402093j
   Musso F, 2009, J PHYS CHEM C, V113, P17876, DOI 10.1021/jp905325m
   Noel Y., 2001, PHYS REV B, V65
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Pei Y, 2003, LANGMUIR, V19, P7652, DOI 10.1021/la0341198
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Puddu V, 2014, LANGMUIR, V30, P227, DOI 10.1021/la403242f
   Pujari SP, 2014, ANGEW CHEM INT EDIT, V53, P2
   Rimola A, 2013, CHEM REV, V113, P4216, DOI 10.1021/cr3003054
   Rosenholm JM, 2008, J CONTROL RELEASE, V128, P157, DOI 10.1016/j.jconrel.2008.02.013
   SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096
   Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943
   Soto-Cantu E, 2012, LANGMUIR, V28, P5562, DOI 10.1021/la204981b
   Tielens F, 2008, CHEM MATER, V20, P3336, DOI 10.1021/cm8001173
   Tsai HHG, 2008, J AM CHEM SOC, V130, P11566, DOI 10.1021/ja802051a
   UGLIENGO P, 1993, Z KRISTALLOGR, V208, P383, DOI 10.1524/zkri.1993.208.Part-2.383
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Williams JJ, 2011, J PHYS CHEM C, V115, P10651, DOI 10.1021/jp112073z
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhang LZ, 2001, LANGMUIR, V17, P6275, DOI 10.1021/la0106337
   Zhu YJ, 2012, CATAL TODAY, V194, P53, DOI 10.1016/j.cattod.2012.02.022
   Zhuravlev LT, 2000, COLLOID SURFACE A, V173, P1, DOI 10.1016/S0927-7757(00)00556-2
   ZHURAVLEV LT, 1987, LANGMUIR, V3, P316, DOI 10.1021/la00075a004
NR 53
TC 5
Z9 5
U1 0
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 16
PY 2015
VL 31
IS 23
BP 6321
EP 6331
DI 10.1021/acs.langmuir.5b01828
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA CL2EB
UT WOS:000356755300008
PM 26010674
DA 2018-10-19
ER

PT J
AU Layer, R
   Aimetti, A
   Podell, P
   Moore, S
   Ulich, T
AF Layer, Richard
   Aimetti, Alex
   Podell, Pamela
   Moore, Simon
   Ulich, Thomas
TI BIODEGRADABLE NEURO-SPINAL SCAFFOLD PRESERVES SPINAL CORD ARCHITECTURE
   FOLLOWING SPINAL CONTUSION INJURY IN RATS
SO JOURNAL OF NEUROTRAUMA
LA English
DT Meeting Abstract
CT 33rd Annual National Neurotrauma Symposium
CY JUN 28-JUL 01, 2015
CL Santa Fe, NM
DE biomaterial; tissue engineering; scaffold; implantation; biodegradable
C1 [Layer, Richard; Aimetti, Alex; Podell, Pamela; Moore, Simon; Ulich, Thomas] InVivo Therapeut, Res, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
EI 1557-9042
J9 J NEUROTRAUM
JI J. Neurotrauma
PD JUN 15
PY 2015
VL 32
IS 12
MA D8-06
BP A115
EP A115
PG 1
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA CV0OB
UT WOS:000363949000313
DA 2018-10-19
ER

PT J
AU Mina, A
   Castano, A
   Caicedo, JC
   Caicedo, HH
   Aguilar, Y
AF Mina, A.
   Castano, A.
   Caicedo, J. C.
   Caicedo, H. H.
   Aguilar, Y.
TI Determination of physical properties for beta-TCP plus chitosan
   biomaterial obtained on metallic 316L substrates
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Composite materials; Chemical synthesis; Mechanical testing; Elastic
   properties; Wear
ID WO3 THIN-FILMS; MECHANICAL-PROPERTIES; TRIBOLOGICAL PROPERTIES;
   MULTILAYER COATINGS; SCRATCH ADHESION; TUNGSTEN-OXIDE; HYDROXYAPATITE;
   SURFACES; BIOCOMPATIBILITY; ELECTROCHROMISM
AB Material surface modification, particularly the deposition of special coatings on the surface of surgical implants, is extensively used in bone tissue engineering applications. beta-Tricalcium phosphate/Chitosan (beta-TCP/Ch) coatings were deposited on 316L stainless steel (316L SS) substrates by a cathodic electro-deposition technique at different coating compositions. The crystal lattice arrangements were analyzed by X-Ray diffraction (XRD), and the results indicated that the crystallographic structure of beta-TCP was affected by the inclusion of the chitosan content. The changes in the surface morphology as a function of increasing chitosan in the coatings via scanning electron microscopy (SEM) and atomic force microscopy (AFM) showed that root-mean square values of the beta-TCP/Ch coatings decreased by further increasing chitosan percentage. The elastic plastic characteristics of the coatings were determined by conducting nanoindentation test, indicating that increase of chitosan percentage is directly related to increase of hardness and elastic modulus of the beta-TCP/Ch coatings. Tribological characterization was performed by scratch test and pin-on-disk test to analyze the changes in the surface wear of beta-TCP/Ch coatings. Finally, the results indicated an improvement in the mechanical and tribological properties of the beta-TCP/Ch coatings as a function of increasing of the chitosan percentage. This new class of coatings, comprising the bioactive components, is expected not only to enhance the bioactivity and biocompatibility, but also to protect the surface of metallic implants against wear and corrosion. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mina, A.; Castano, A.; Caicedo, J. C.; Aguilar, Y.] Univ Valle, Tribol Powder Met & Proc Solid Recycled Res Grp, Cali, Colombia.
   [Caicedo, H. H.] Johnson & Johnson, Pharmaceut Co, Janssen R&D LLC, Biol Res,Biotechnol Ctr Excellence, Spring House, PA 19477 USA.
   [Caicedo, H. H.] Natl Biotechnol & Pharmaceut Assoc, Chicago, IL 60606 USA.
   [Mina, A.] Tecnoacad ASTIN SENA Reginal Valle, Bogota, Colombia.
RP Caicedo, JC (reprint author), Univ Valle, Tribol Powder Met & Proc Solid Recycled Res Grp, Cali, Colombia.
EM julio.cesar.caicedo@correo.univalle.edu.co
FU Universidad Militar Nueva Granada, Bogota-Colombia; Excellence Center
   for Novel Materials (CENM) at Universidad del valle in Colombia [RC-
   043-2005]; Colciencias
FX This research was supported by Universidad Militar Nueva Granada,
   Bogota-Colombia and the Excellence Center for Novel Materials (CENM) at
   Universidad del valle in Colombia under Contract RC- 043-2005 with
   Colciencias.
CR ABE Y, 1990, MAT MED, V1, P233
   [Anonymous], 2010, 59905 ASTM
   [Anonymous], G17103 ASTM
   [Anonymous], G19513A ASTM
   [Anonymous], C162405 ASTM
   ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448
   Bamwenda GR, 1999, J PHOTOCH PHOTOBIO A, V122, P175, DOI 10.1016/S1010-6030(99)00026-X
   Banerjee SS, 2010, ACTA BIOMATER, V6, P4167, DOI 10.1016/j.actbio.2010.05.012
   BOHNKE O, 1982, SOLID STATE IONICS, V6, P121, DOI 10.1016/0167-2738(82)90076-5
   Brunski J. B., 2004, BIOMATERIALS SCI INT, P137
   BULL SJ, 1988, SURF COAT TECH, V36, P503, DOI 10.1016/0257-8972(88)90178-8
   BURNETT PJ, 1987, THIN SOLID FILMS, V154, P403, DOI 10.1016/0040-6090(87)90382-8
   Cabrera G, 2011, MATER CHEM PHYS, V125, P576, DOI 10.1016/j.matchemphys.2010.10.014
   Caicedo JC, 2010, APPL SURF SCI, V256, P5898, DOI 10.1016/j.apsusc.2010.03.071
   Caicedo JC, 2007, PHYS STATUS SOLIDI C, V4, P4127, DOI 10.1002/pssc.200675912
   Castro EM, 2007, SCI TECHNICA, V13, P36
   Cross MJ, 2005, J BONE JOINT SURG BR, V87B, P1073, DOI 10.1302/0301-620X.87B8.15772
   DAVAZOGLOU D, 1988, SOL ENERG MATER, V17, P379, DOI 10.1016/0165-1633(88)90020-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Ding SJ, 2006, DENT MATER J, V25, P706, DOI 10.4012/dmj.25.706
   Gangopadhyay S, 2010, TRIBOL LETT, V37, P487, DOI 10.1007/s11249-009-9544-1
   Guo X, 2002, J ORTHOPAED RES, V20, P740, DOI 10.1016/S0736-0266(01)00167-X
   Hajek V, 1997, WEAR, V213, P80, DOI 10.1016/S0043-1648(97)00176-2
   HURDITCH R, 1975, ELECTRON LETT, V11, P142, DOI 10.1049/el:19750109
   Inamdar AI, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/32/325706
   Ipaz L, 2012, APPL SURF SCI, V258, P3805, DOI 10.1016/j.apsusc.2011.12.033
   Jinno T, 2002, J ARTHROPLASTY, V17, P902, DOI 10.1054/arth.2002.34821
   Karim B, 1996, BIOMATERIALS, V17, P491
   Kim GS, 2003, SURF COAT TECH, V171, P91, DOI 10.1016/S0257-8972(03)00244-5
   Kucharska M, 2003, PROGR CHEM APPL CHIT, V3, P69
   Lackner JM, 2011, B POL ACAD SCI-TECH, V59, P343, DOI 10.2478/v10175-011-0042-x
   Lee KD, 1997, THIN SOLID FILMS, V302, P84, DOI 10.1016/S0040-6090(96)09556-9
   Martinez R, 2007, SCI TECHNICA, V36, P36
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   MONK PMS, 1993, ELECTROCHIM ACTA, V38, P1521, DOI 10.1016/0013-4686(93)80284-7
   Mozafari M, 2013, INT J NANOMED, V8, P1665, DOI 10.2147/IJN.S42659
   Naghib SM, 2012, INT J ELECTROCHEM SC, V7, P2890
   Nledengvist P., 1997, TRIBOL INT, V30, P507
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PANG X, 2009, COLLOID INTERFACE SC, V330, P323, DOI DOI 10.1016/J.JCIS.2008.10.070
   Pena D. Y. Ballesteros, 2010, REV FAC ING-UNIV ANT, V54, P15
   Pighinelli L, 2013, J BIOMATER NANOBIOTE, V4, P20
   Romero J., 2003, APPL PHYS A, V77, P419
   Salahinejad E, 2013, J BIOMED NANOTECHNOL, V9, P1327, DOI 10.1166/jbn.2013.1619
   Salahinejad E, 2012, MATER LETT, V88, P5, DOI 10.1016/j.matlet.2012.08.013
   Salahinejad E., 2013, PLOS ONE, V8, P1
   Tejada A., 2004, REV MEX FIS, V5, P187
   Tomoaia G, 2014, MAT SCI ENG C-MATER, V37, P37, DOI 10.1016/j.msec.2013.12.027
   Wang JW, 2006, J BIOMED MATER RES A, V76A, P503, DOI 10.1002/jbm.a.30542
   Zhang JT, 2014, ACTA BIOMATER, V10, P1035, DOI 10.1016/j.actbio.2013.11.001
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 51
TC 4
Z9 4
U1 0
U2 28
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JUN 15
PY 2015
VL 160
BP 296
EP 307
DI 10.1016/j.matchemphys.2015.04.041
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA CK4RF
UT WOS:000356210200038
DA 2018-10-19
ER

PT J
AU Le, M
   Choi, H
   Choi, MK
   Cho, H
   Kim, JH
   Seo, HG
   Cha, SY
   Seo, K
   Dadi, H
   Park, C
AF MinhThong Le
   Choi, Hojun
   Choi, Min-Kyeung
   Cho, Hyesun
   Kim, Jin-Hoi
   Seo, Han Geuk
   Cha, Se-Yeon
   Seo, Kunho
   Dadi, Hailu
   Park, Chankyu
TI Development of a simultaneous high resolution typing method for three
   SLA class II genes, SLA-DQA, SLA-DQB1, and SLA-DRB1 and the analysis of
   SLA class II haplotypes
SO GENE
LA English
DT Article
DE SLA; DQA; DQB1 and DRB1; Swine
ID MAJOR HISTOCOMPATIBILITY COMPLEX; SEXUAL SELECTION; ANIMAL-MODEL;
   GENOMIC DNA; SWINE; MHC; PIG; AMPLIFICATION; ALLELES; SYSTEM
AB The characterization of the genetic variations of major histocompatibility complex (MHC) is essential to understand the relationship between the genetic diversity of MHC molecules and disease resistance and susceptibility in adaptive immunity. We previously reported the development of high-resolution individual locus typing methods for three of the most polymorphic swine leukocyte antigens (SEA) class Mod, namely, SLA-DQA, SLA-DQB1, and SLA-DRB1. In this study, we extensively modified our previous protocols and developed a method for the simultaneous amplification of the three SLA class II genes and subsequent analysis of individual loci using direct sequencing. The unbiased and simultaneous amplification of alleles from the all three hyper-polymorphic and pseudogene containing genes such as MHC genes is extremely challenging. However, using this method, we demonstrated the successful typing of SLA-DQA, SLA-DQB1, and SLA-DRB1 for 31 selected individuals comprising 26 different SLA class II haplotypes which were identified from 700 animals using the single locus typing methods. The results were identical to the known genotypes from the individual locus typing. The new method has significant benefits over the individual locus typing, including lower typing cost, use of less biomaterial, less effort and fewer errors in handling large samples for multiple loci. We also extensively characterized the haplotypes of SLA class II genes and reported three new haplotypes. Our results should serve as a basis to investigate the possible association between polymorphisms of MHC class II and differences in immune responses to exogenous antigens. (C) 2015 Elsevier B.V. All rights reserved.
C1 [MinhThong Le; Choi, Hojun; Choi, Min-Kyeung; Cho, Hyesun; Kim, Jin-Hoi; Seo, Han Geuk; Dadi, Hailu; Park, Chankyu] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea.
   [Cha, Se-Yeon] Chonbuk Natl Univ, Coll Vet Med, Jeonju, South Korea.
   [Seo, Kunho] Konkuk Univ, Coll Vet Med, Seoul 143701, South Korea.
RP Dadi, H (reprint author), Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea.
EM edenhailu@yahoo.com; chankyu@konkuk.ac.kr
FU Next-Generation BioGreen 21 Program [PJ011130]; Cooperative Research
   Program for Agriculture Science & Technology Development of the Rural
   Development Administration, Republic of Korea [PJ009103]
FX This work was supported by grants from the Next-Generation BioGreen 21
   Program (No. PJ011130) and the "Cooperative Research Program for
   Agriculture Science & Technology Development (PJ009103)" of the Rural
   Development Administration, Republic of Korea.
CR Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x
   Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x
   CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141
   GAUTSCHI C, 1990, ANIM GENET, V21, P161, DOI 10.1111/j.1365-2052.1990.tb03221.x
   Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622
   HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643
   Ho CS, 2009, TISSUE ANTIGENS, V73, P307, DOI 10.1111/j.1399-0039.2009.01213.x
   HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958
   Hwang IT, 2003, BIOTECHNIQUES, V35, P1180, DOI 10.2144/03356st03
   Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x
   Le MT, 2012, TISSUE ANTIGENS, V80, P528, DOI 10.1111/tan.12017
   LECHLER R, 1991, IMMUNOL LETT, V29, P41, DOI 10.1016/0165-2478(91)90197-I
   Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111
   LUMSDEN JS, 1993, CAN J VET RES, V57, P14
   Lunney JK, 2009, DEV COMP IMMUNOL, V33, P362, DOI 10.1016/j.dci.2008.07.002
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Mezrich JD, 2003, TRANSPLANTATION, V75, P904, DOI 10.1097/01.TP.0000054839.43852.BF
   Middelton Derek, 2005, Iran J Allergy Asthma Immunol, V4, P53
   MUTTER GL, 1995, NUCLEIC ACIDS RES, V23, P1411
   Park K, 2010, TISSUE ANTIGENS, V76, P301, DOI 10.1111/j.1399-0039.2010.01522.x
   Park K, 2009, J ANIM BREED GENET, V126, P127, DOI 10.1111/j.1439-0388.2008.00765.x
   Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x
   POTTS WK, 1993, TRENDS GENET, V9, P408, DOI 10.1016/0168-9525(93)90103-O
   Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547
   SETCAVAGE TM, 1976, INFECT IMMUN, V13, P600
   Smith DM, 2005, TISSUE ANTIGENS, V66, P623, DOI 10.1111/j.1399-0039.2005.00492.x
   TAKAHATA N, 1990, GENETICS, V124, P967
   Thong LM, 2011, TISSUE ANTIGENS, V77, P572, DOI 10.1111/j.1399-0039.2011.01662.x
   Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/j.annals.1334.015
   Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293
NR 30
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JUN 15
PY 2015
VL 564
IS 2
BP 228
EP 232
DI 10.1016/j.gene.2015.03.049
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA CI8SX
UT WOS:000355043100016
PM 25824383
DA 2018-10-19
ER

PT J
AU Shi, XJ
   Zhan, WJ
   Chen, GJ
   Yu, Q
   Liu, Q
   Du, H
   Cao, LM
   Liu, XL
   Yuan, L
   Chen, H
AF Shi, Xiujuan
   Zhan, Wenjun
   Chen, Gaojian
   Yu, Qian
   Liu, Qi
   Du, Hui
   Cao, Limin
   Liu, Xiaoli
   Yuan, Lin
   Chen, Hong
TI Regulation of Protein Binding Capability of Surfaces via Host-Guest
   Interactions: Effects of Localized and Average Ligand Density
SO LANGMUIR
LA English
DT Article
ID FUNCTIONALIZED POLYMER BRUSHES; BIOMEDICAL APPLICATIONS; PLASMON
   RESONANCE; GRAFTING DENSITY; PLASMINOGEN; IMPACT; IMMOBILIZATION;
   ADSORPTION; INTERFACES; MOLECULES
AB The protein binding capability of biomaterial surfaces can significantly affect subsequent biological responses, and appropriate ligand presentation is often required to guarantee the best functions. Herein, a new facile method for regulating this capability by varying the localized and average ligand density is presented. Binding between lysine and plasminogen relevant to a fibrinolysis system was chosen as a model. We integrated different lysine-modified beta-cydodextrin (beta-CD) derivatives Onto bioinert copolymer brushes via host-guest interactions. The localized and average lysine density can be conveniently modulated by changing the lysine valency on beta-CD scaffolds and by diluting lysine-perSubstituted beta-CD with pure beta-CD, respectively. Both the plasminogen adsorption and the plasminogen binding affinity were enhanced by lysine-persubstituted beta-CD compared with those of lysine-monosubstituted beta-CD, which is possibly due to the higher localized lysine density and the multivalent binding of plasminogen on lysine-persubstituted beta-CD surfaces. With a change in the ratio of lysine-persubstituted beta-CD to beta-CD, the average lysine density can be tuned, leading to the linear regulation of the adsorption of plasminogen on surfaces.
C1 [Shi, Xiujuan; Zhan, Wenjun; Chen, Gaojian; Yu, Qian; Liu, Qi; Du, Hui; Cao, Limin; Liu, Xiaoli; Yuan, Lin; Chen, Hong] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
   [Chen, Gaojian] Soochow Univ, Ctr Soft Condensed Matter Phys & Interdisciplinar, Suzhou 215006, Peoples R China.
RP Chen, GJ (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
EM gchen@suda.edu.cn; chenh@suda.edu.cn
RI Chen, Gaojian/C-2802-2008
OI Chen, Gaojian/0000-0002-5877-3159; , Lin/0000-0001-6966-8584; Liu,
   Xiaoli/0000-0003-1686-3292
FU National Natural Science Foundation of China [21125418, 21374069,
   21334004, 21304062]; Natural Science Foundation of the Jiangsu Higher
   Education Institutions of China [13KJA430006]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This work was supported by the National Natural Science Foundation of
   China (21125418, 21374069, 21334004, and 21304062), the Natural Science
   Foundation of the Jiangsu Higher Education Institutions of China
   (13KJA430006), and the Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD).
CR Costa P, 2014, ACTA BIOMATER, V10, P2415, DOI 10.1016/j.actbio.2014.01.029
   Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919
   Elias DR, 2013, NANOMED-NANOTECHNOL, V9, P194, DOI 10.1016/j.nano.2012.05.015
   Enrico D. C., 1995, THERMODYNAMIC THEORY, P57
   FLEURY V, 1991, BIOCHEMISTRY-US, V30, P7630, DOI 10.1021/bi00244a035
   Harris DC, 2011, J AM CHEM SOC, V133, P7676, DOI 10.1021/ja2017366
   Hu WH, 2010, ADV FUNCT MATER, V20, P3497, DOI 10.1002/adfm.201001159
   Ishida N, 2010, MACROMOLECULES, V43, P7269, DOI 10.1021/ma101113g
   Jiang H, 2013, CHEM SOC REV, V42, P3394, DOI 10.1039/c2cs35453e
   Jung HS, 2008, BIOPHYS J, V94, P3094, DOI 10.1529/biophysj.107.115519
   Katrlik J, 2011, COLLOID SURFACE A, V382, P198, DOI 10.1016/j.colsurfa.2011.01.020
   Krishnamoorthy M, 2014, CHEM REV, V114, P10976, DOI 10.1021/cr500252u
   Lee EJ, 2014, RSC ADV, V4, P31581, DOI 10.1039/c4ra03795b
   Li D, 2011, ACTA BIOMATER, V7, P954, DOI 10.1016/j.actbio.2010.10.021
   Li DD, 2013, LANGMUIR, V29, P14101, DOI 10.1021/la4033332
   Li HQ, 2014, BIOMACROMOLECULES, V15, P43, DOI 10.1021/bm4012562
   Li X, 2013, LANGMUIR, V29, P1122, DOI 10.1021/la3044472
   Liu T, 2014, ACTA BIOMATER, V10, P1940, DOI 10.1016/j.actbio.2013.12.013
   Loh XJ, 2014, MATER HORIZ, V1, P185, DOI 10.1039/c3mh00057e
   Ma X, 2015, CHEM REV, V115, P7794, DOI 10.1021/cr500392w
   MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500
   MARKUS G, 1978, J BIOL CHEM, V253, P727
   Martinez A, 2013, CHEM SOC REV, V42, P4746, DOI 10.1039/c2cs35424a
   McClung WG, 2003, J BIOMED MATER RES A, V66A, P795, DOI 10.1002/jdm.a.10017
   Meng XL, 2012, LANGMUIR, V28, P13616, DOI 10.1021/la302389e
   Nicholl Suzanne M., 2006, Current Vascular Pharmacology, V4, P101, DOI 10.2174/157016106776359880
   Rodda AE, 2014, PROG POLYM SCI, V39, P1312, DOI 10.1016/j.progpolymsci.2013.11.006
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Sato Y, 2012, LANGMUIR, V28, P1846, DOI 10.1021/la2030044
   Shi JJ, 2007, J AM CHEM SOC, V129, P5954, DOI 10.1021/ja069375w
   Shi XJ, 2013, LANGMUIR, V29, P14188, DOI 10.1021/la4037748
   Shi XJ, 2014, MATER HORIZONS, V1, P540, DOI 10.1039/c4mh00081a
   Trmcic-Cvitas J, 2009, BIOMACROMOLECULES, V10, P2885, DOI 10.1021/bm900706r
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   Wang LS, 2013, ANAL CHEM, V85, P6505, DOI 10.1021/ac401105p
   Wang X, 2010, ANAL CHEM, V82, P9082, DOI 10.1021/ac102114z
   Wei KC, 2013, ACS MACRO LETT, V2, P278, DOI 10.1021/mz400036t
   Wu ZQ, 2009, LANGMUIR, V25, P2900, DOI 10.1021/la8037523
   Yang H, 2014, ACCOUNTS CHEM RES, V47, P2106, DOI 10.1021/ar500105t
   Yu K, 2013, ANAL CHEM, V85, P7786, DOI 10.1021/ac401306b
   Yu QA, 2011, ACTA BIOMATER, V7, P1550, DOI 10.1016/j.actbio.2010.12.021
   Yu Q, 2010, COLLOID SURFACE B, V76, P468, DOI 10.1016/j.colsurfb.2009.12.006
   Zhang YR, 2011, ANAL CHEM, V83, P9651, DOI 10.1021/ac202517x
   Zhang YX, 2013, ANAL CHEM, V85, P1106, DOI 10.1021/ac302874s
NR 44
TC 13
Z9 14
U1 1
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 9
PY 2015
VL 31
IS 22
BP 6172
EP 6178
DI 10.1021/acs.langmuir.5b01380
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA CK4OE
UT WOS:000356202300025
PM 25986051
DA 2018-10-19
ER

PT J
AU Nikkola, L
   Morton, T
   Balmayor, ER
   Jukola, H
   Harlin, A
   Redl, H
   van Griensven, M
   Ashammakhi, N
AF Nikkola, Lila
   Morton, Tatjana
   Balmayor, Elizabeth R.
   Jukola, Hanna
   Harlin, Ali
   Redl, Heinz
   van Griensven, Martijn
   Ashammakhi, Nureddin
TI Fabrication of electrospun poly(D,L lactide-co-glycolide)80/20 scaffolds
   loaded with diclofenac sodium for tissue engineering
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE Electrospinning; Poly(D,L lactide-co-glycolide); Scaffold; Drug release;
   Diclofenac sodium; Biodegradable
ID ULTRAFINE FIBERS; ACID); DEXAMETHASONE; EFFICACY; DELIVERY; NANOMATS;
   RELEASE; MATS
AB Background: Adaptation of nanotechnology into materials science has also advanced tissue engineering research. Tissues are basically composed of nanoscale structures hence making nanofibrous materials closely resemble natural fibers. Adding a drug release function to such material may further advance their use in tissue repair.
   Methods: In the current study, bioabsorbable poly(D,L lactide-co-glycolide) 80/20 (PDLGA80/20) was dissolved in a mixture of acetone/dimethylformamide. Twenty percent of diclofenac sodium was added to the solution. Nanofibers were manufactured using electrospinning. The morphology of the obtained scaffolds was analyzed by scanning electron microscopy (SEM). The release of the diclofenac sodium was assessed by UV/Vis spectroscopy. Mouse fibroblasts (MC3T3) were seeded on the scaffolds, and the cell attachment was evaluated with fluorescent microscopy.
   Results: The thickness of electrospun nanomats was about 1 mm. SEM analysis showed that polymeric nanofibers containing drug particles formed very interconnected porous nanostructures. The average diameter of the nanofibers was 500 nm. Drug release was measured by means of UV/Vis spectroscopy. After a high start peak, the release rate decreased considerably during 11 days and lasted about 60 days. During the evaluation of the release kinetics, a material degradation process was observed. MC3T3 cells attached to the diclofenac sodium-loaded scaffold.
   Conclusions: The nanofibrous porous structure made of PDLGA polymer loaded with diclofenac sodium is feasible to develop, and it may help to improve biomaterial properties for controlled tissue repair and regeneration.
C1 [Nikkola, Lila; Jukola, Hanna; Ashammakhi, Nureddin] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Morton, Tatjana; Redl, Heinz; van Griensven, Martijn] Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Balmayor, Elizabeth R.; van Griensven, Martijn] Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Trauma Surg, D-81675 Munich, Germany.
   [Harlin, Ali] Tampere Univ Technol, Inst Fiber Mat Sci, FIN-33101 Tampere, Finland.
   [Ashammakhi, Nureddin] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England.
RP Balmayor, ER (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Trauma Surg, Ismaninger Str 22, D-81675 Munich, Germany.
EM Elizabeth.Rosado-Balmayor@tum.de
RI Rosado Balmayor, Elizabeth/N-9283-2015; van Griensven,
   Martijn/F-5808-2012
OI Rosado Balmayor, Elizabeth/0000-0002-0484-4847; van Griensven,
   Martijn/0000-0001-5104-9881
FU scope of the EU project EXPERTISSUES [NMP3-CT-2004-500283]
FX This study was performed under the scope of the EU project EXPERTISSUES
   (NMP3-CT-2004-500283). The authors would like to thank Fritz Seidl, M.A.
   for English linguistic corrections.
CR Ashammakhi N, 2006, J NANOSCI NANOTECHNO, V6, P2693, DOI 10.1166/jnn.2006.485
   Ashammakhi N, 2007, J CRANIOFAC SURG, V18, P3, DOI 10.1097/01.scs.0000236444.05345.53
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Choi JS, 2004, INT J BIOL MACROMOL, V34, P249, DOI 10.1016/j.ijbiomac.2004.06.001
   Chua KN, 2007, ACTA BIOMATER, V3, P643, DOI 10.1016/j.actbio.2007.03.012
   da Silva MA, 2009, TISSUE ENG PT A, V15, P377, DOI 10.1089/ten.tea.2007.0327
   Esposito A.R., 2013, BIORES OPEN ACCESS, V2, P138, DOI DOI 10.1089/BIORES.2012.0293
   FDA U.S.F.D.U.S., IN INGR SEARCH APPR
   Fiorani A, 2014, J MATER SCI-MATER M, V25, P2313, DOI 10.1007/s10856-014-5196-2
   Hassanzadeh-Khayyat M, 2011, J WATER RESOURCE PRO, V3, P643, DOI DOI 10.4236/JWARP.2011.39074
   Ignatova M, 2013, MACROMOL BIOSCI, V13, P860, DOI 10.1002/mabi.201300058
   Jahani H, 2012, CELL J, V14, P31
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kong LY, 2013, CARBOHYD POLYM, V92, P1416, DOI 10.1016/j.carbpol.2012.09.026
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Li JR, 2014, PHARM RES-DORDR, V31, P1632, DOI 10.1007/s11095-013-1266-2
   Nakano A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011801
   Ndreu A, 2008, NANOMEDICINE-UK, V3, P45, DOI 10.2217/17435889.3.1.45
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Nikkola L, 2006, J NANOSCI NANOTECHNO, V6, P3290, DOI 10.1166/jnn.2006.467
   Parwe SP, 2014, INT J NANOMED, V9, P1463, DOI 10.2147/IJN.S54971
   Perumcherry SR, 2011, TISSUE ENG PART C-ME, V17, P1121, DOI [10.1089/ten.tec.2010.0734, 10.1089/ten.TEC.2010.0734]
   Piras AM, 2006, J NANOSCI NANOTECHNO, V6, P3310, DOI 10.1166/jnn.2006.486
   Sekiya N, 2013, J PLAST SURG HAND SU, V47, P498, DOI 10.3109/2000656X.2013.788507
   Sequeira SJ, 2012, BIOMATERIALS, V33, P3175, DOI 10.1016/j.biomaterials.2012.01.010
   Shen XB, 2014, J NANOSCI NANOTECHNO, V14, P5258, DOI 10.1166/jnn.2014.8706
   Sun R, 1999, OPHTHALMIC SURG LAS, V30, P382
   TODD PA, 1988, DRUGS, V35, P244, DOI 10.2165/00003495-198835030-00004
   Viitanen P, 2006, J MATER SCI-MATER M, V17, P1267, DOI 10.1007/s10856-006-0601-0
   Xu XL, 2006, J CONTROL RELEASE, V114, P307, DOI 10.1016/j.jconrel.2006.05.031
   Zupanc M, 2013, ULTRASON SONOCHEM, V20, P1104, DOI 10.1016/j.ultsonch.2012.12.003
NR 31
TC 4
Z9 4
U1 1
U2 26
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 0949-2321
EI 2047-783X
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD JUN 5
PY 2015
VL 20
AR 54
DI 10.1186/s40001-015-0145-1
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CK2JT
UT WOS:000356037300001
PM 26044589
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Izumi, R
   Komada, S
   Ochi, K
   Karasawa, L
   Osaki, T
   Murahata, Y
   Tsuka, T
   Imagawa, T
   Itoh, N
   Okamoto, Y
   Izawa, H
   Morimoto, M
   Saimoto, H
   Azuma, K
   Ifuku, S
AF Izumi, Ryotaro
   Komada, Shuntaro
   Ochi, Kosuke
   Karasawa, Lisa
   Osaki, Tomohiro
   Murahata, Yusuke
   Tsuka, Takeshi
   Imagawa, Tomohiro
   Itoh, Norihiko
   Okamoto, Yoshiharu
   Izawa, Hironori
   Morimoto, Minoru
   Saimoto, Hiroyuki
   Azuma, Kazuo
   Ifuku, Shinsuke
TI Favorable effects of superficially deacetylated chitin nanofibrils on
   the wound healing process
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Superficially deacetylated chitin nanofibrils; Chitin nanofibrils; Wound
   healing; Re-epithelium; Biomaterials
ID CHITOSAN NANOFIBERS; ALPHA-CHITIN; BIOMEDICAL APPLICATIONS; DRESSING
   APPLICATIONS; IN-VITRO; SKIN; FIBROBLASTS; DERIVATIVES; SURFACE;
   CHITIN/CHITOSAN
AB Previous reports indicate that the beneficial effect of chitin nanofibrils (CNFs), and chitosan nanofibrils (CSNFs) for wound healing. In this study, the wound healing effects of superficially deacetylated chitin nanofibrils (SDACNFs) were evaluated using an experimental model. In the experiments using circular excision wound model, SDACNFs induced re-epithelium and proliferation of the fibroblasts and collagen tissue. In the chitin, CNFs, and CSNFs, on the other hand, the e-epithelium and proliferation of the fibroblasts and collagen tissue were not induced perfectly compared with the SDACNFs group. In particular, re-epithelization was observed on day 4 in the only SDACNF group. Moreover, SDACNFs did not induce severe systemic inflammation in the linear incision wound model. The data indicated that SDACNFs effectively induced the proliferation and re-modeling phases compared with chitin, CNFs, and CSNFs in the wound. These data indicate that SDACNFs can be beneficial as a new biomaterial for wound healing. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Izumi, Ryotaro; Izawa, Hironori; Saimoto, Hiroyuki; Ifuku, Shinsuke] Tottori Univ, Grad Sch Engn, Tottori 6808533, Japan.
   [Komada, Shuntaro; Ochi, Kosuke; Karasawa, Lisa; Osaki, Tomohiro; Murahata, Yusuke; Tsuka, Takeshi; Imagawa, Tomohiro; Itoh, Norihiko; Okamoto, Yoshiharu; Azuma, Kazuo] Tottori Univ, Dept Vet Clin Med, Tottori 6808533, Japan.
   [Morimoto, Minoru] Tottori Univ, Res Ctr Biosci & Technol, Div Instrumental Anal, Tottori 6808550, Japan.
RP Azuma, K (reprint author), Tottori Univ, Dept Vet Clin Med, 4-101 Koyama Minami, Tottori 6808533, Japan.
EM kazu-azuma@muses.tottori-u.ac.jp; sifuku@chem.tottori-u.ac.jp
RI Izawa, Hironori/M-7037-2014
OI Izawa, Hironori/0000-0002-8715-8462
FU Creating STart-ups from Advanced Research and Technology (START) project
   of JST; KAKENHI of JSPS [26708026]
FX This work was financially supported by the Creating STart-ups from
   Advanced Research and Technology (START) project of JST and KAKENHI
   (26708026) of JSPS.
CR Azuma K, 2015, BIOMATERIALS, V42, P20, DOI 10.1016/j.biomaterials.2014.11.043
   Azuma K, 2013, J CHITIN CHITOSAN SC, V1, P144, DOI 10.1166/jcc.2013.1020
   Azuma K, 2014, J BIOMED NANOTECHNOL, V10, P2891, DOI 10.1166/jbn.2014.1882
   Azuma K, 2012, CARBOHYD POLYM, V90, P197, DOI 10.1016/j.carbpol.2012.05.023
   Azuma K, 2012, CARBOHYD POLYM, V87, P1399, DOI 10.1016/j.carbpol.2011.09.036
   Bean DB, 2003, EMERG MED PRACT, V5, P1
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/eri.11.59, 10.1586/ERI.11.59]
   Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g
   Dutta AK, 2013, J CHITIN CHITOSAN SC, V1, P192, DOI 10.1166/jcc.2013.1024
   Dutta AK, 2013, CARBOHYD POLYM, V97, P363, DOI 10.1016/j.carbpol.2013.05.010
   Erba P, 2011, J TRAUMA, V71, pS187, DOI 10.1097/TA.0b013e318225583c
   Fan YM, 2010, CARBOHYD POLYM, V79, P1046, DOI 10.1016/j.carbpol.2009.10.044
   Getie M, 2002, PHARMAZIE, V57, P320
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Ifuku S, 2014, RSC ADV, V4, P19246, DOI 10.1039/c4ra01975j
   Ifuku S, 2014, MOLECULES, V19, P18367, DOI 10.3390/molecules191118367
   Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c
   Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d
   Ito I, 2014, CARBOHYD POLYM, V101, P464, DOI 10.1016/j.carbpol.2013.09.074
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kelechi TJ, 2012, J AM ACAD DERMATOL, V66, pE209, DOI 10.1016/j.jaad.2011.01.031
   Kondo Toshikazu, 2007, Legal Medicine, V9, P109, DOI 10.1016/j.legalmed.2006.11.009
   Lindner HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018996
   Minagawa T, 2007, CARBOHYD POLYM, V67, P640, DOI 10.1016/j.carbpol.2006.07.007
   Minanni S, 2014, J CHITIN CHITOSAN SC, V2, P163, DOI 10.1166/jcc.2014.1073
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Muzzarelli R. A. A., 2012, POLYM SCI COMPREHENS, V10, P153, DOI DOI 10.1016/B978-
   Muzzarelli RAA, 2014, MAR DRUGS, V12, P5468, DOI 10.3390/md12115468
   Muzzarelli RAA, 2011, TOP GEOBIOL, V34, P1, DOI 10.1007/978-90-481-9684-5_1
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   NISHIMURA S, 1985, INT J BIOL MACROMOL, V7, P100, DOI 10.1016/0141-8130(85)90038-8
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Shetty S, 2008, EVID-BASED COMPL ALT, V5, P95, DOI 10.1093/ecam/nem004
   Suntar I, 2011, J ETHNOPHARMACOL, V135, P63, DOI 10.1016/j.jep.2011.02.023
   Suntar IP, 2010, J ETHNOPHARMACOL, V127, P468, DOI 10.1016/j.jep.2009.10.011
   Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x
NR 39
TC 18
Z9 18
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 5
PY 2015
VL 123
BP 461
EP 467
DI 10.1016/j.carbpol.2015.02.005
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CH1AR
UT WOS:000353754000053
PM 25843880
OA Other Gold
DA 2018-10-19
ER

PT J
AU Trofimov, BA
   Zhuravleva, IY
   Oparina, LA
   Sukhikh, AS
   Vysotskaya, OV
   Borisov, VV
   Gusarova, NK
AF Trofimov, B. A.
   Zhuravleva, I. Yu.
   Oparina, L. A.
   Sukhikh, A. S.
   Vysotskaya, O. V.
   Borisov, V. V.
   Gusarova, N. K.
TI Penta-O-{1-[2-(glycidyloxy)ethoxy]ethyl}-D-glucopyranose: synthesis and
   application for the preservation of cardiovascular bioprostheses
SO RUSSIAN CHEMICAL BULLETIN
LA English
DT Article
DE xenogenic biomaterials; preservation; epoxy compounds; IR spectroscopy;
   scanning electron microscopy
ID GLUTARALDEHYDE
AB Conditions for the atom-economical synthesis of penta-O-{1-[2-(glycidyloxy)ethoxy]ethyl}-d-glucopyranose by the reaction of exhaustive electrophilic addition of alpha-d-glucose to 2-vinyloxyethyl glycidyl ether were elaborated. Scanning electron microscopy and IR spectroscopy were used to study the effect of penta-O-{1-[2-(glycidyloxy)ethoxy]ethyl}-d-glucopyranose on the surface of the biological tissue under conditions of the base preservation of xenogenic biomaterial. The results obtained indicate an improvement of morphological characteristics of the biomaterial surface and a high density of intermolecular bonds of the collagen fibres.
C1 [Trofimov, B. A.; Oparina, L. A.; Vysotskaya, O. V.; Gusarova, N. K.] Russian Acad Sci, Siberian Branch, AE Favorsky Irkutsk Inst Chem, 1 Ul Favorskogo, Irkutsk 664033, Russia.
   [Zhuravleva, I. Yu.] EN Meshalkin Novosibirsk Res Inst Circulat Patol, Novosibirsk 630055, Russia.
   [Sukhikh, A. S.] Hlth Minist Russian Federat, Kemerovo State Med Acad, Kemerovo 650029, Russia.
   [Borisov, V. V.] Res Inst Complex Problems Cardiovasc Dis, Kemerovo 650002, Russia.
RP Trofimov, BA (reprint author), Russian Acad Sci, Siberian Branch, AE Favorsky Irkutsk Inst Chem, 1 Ul Favorskogo, Irkutsk 664033, Russia.
EM boris_trofimov@irioch.irk.ru; juravl_irina@mail.ru
FU Russian Federation Council for Grants (Program for State Support of
   Leading Scientific Schools of the Russian Federation) [NSh-156.2014.3]
FX This work was financially supported by the President of the Russian
   Federation Council for Grants (Program for State Support of Leading
   Scientific Schools of the Russian Federation, Grant NSh-156.2014.3).
CR [Anonymous], 1994, [Byul. isobret., Invention Bull.], Patent No. [RF 2008767, 2008767]
   [Anonymous], 1984, [Byul. isobret., Invention Bull.], Patent No. [A.c. USSR 1074881, 1074881]
   Barbarash L.S., 2012, COMPLEX PROBLEMS CAR, V1, P4
   Barbarash L. S., 2002, VESTN TRANSPLANTOLOG, V2, P42
   Barbarash L. S., 1996, BIOL PROTEZY ARTERII
   Barbarash L. S., 2013, GRUDNAYA SERD SOSUD, V6, P25
   Barbarash L. S., 2012, GRUDNAYA SERD SOSUD, V2, P12
   Bockeriya L. A., 2014, SERDECHNO SOSUDISTAY
   Brodsky-Doyle B, 1975, BIOPOLYMERS, V14, P937
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   HASLAM E, 1979, COMPREHENSIVE ORGANI, V5
   Herrebout W, 2003, SPECTROCHIM ACTA A, V59, P47, DOI 10.1016/S1386-1425(02)00112-9
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Kudryavtseva Yu. A., 2008, PATOLOGIYA KROVOOBRA, V1, P79
   Stankevich V. K., 2004, NAUKA PROIZVODSTVU, V1, P19
   TROFIMOV BA, 1993, REV HETEROATOM CHEM, V9, P205
   WOODROOF EA, 1978, J BIOENG, V2, P1
   Zhuravleva I. Yu., 1994, BIOSOVMESTIMOST, V1, P13
NR 19
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1066-5285
EI 1573-9171
J9 RUSS CHEM B+
JI Russ. Chem. Bull.
PD JUN
PY 2015
VL 64
IS 6
BP 1451
EP 1457
DI 10.1007/s11172-015-1031-2
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA DF4JN
UT WOS:000371313900028
DA 2018-10-19
ER

PT J
AU Colletta, A
   Wu, JF
   Wo, YQ
   Kappler, M
   Chen, H
   Xi, CW
   Meyerhoff, ME
AF Colletta, Alessandro
   Wu, Jianfeng
   Wo, Yaqi
   Kappler, Michael
   Chen, Hao
   Xi, Chuanwu
   Meyerhoff, Mark E.
TI S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley
   Catheters: A Potential Biomaterial/Device To Prevent Catheter-Associated
   Urinary Tract Infections
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE nitric oxide; SNAP-impregnated Foley catheters; long-term NO release;
   antibiofilm; biocompatibility
ID BACTERIAL BIOFILM FORMATION; NITRIC-OXIDE RELEASE; PROTEUS-MIRABILIS;
   STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; URETHRAL CATHETERS;
   ESCHERICHIA-COLI; RESISTANCE; PENETRATION; DEVICES
AB Urinary Foley catheters are utilized for management of hospitalized patients and are associated with high rates of urinary tract infections (UTIs). Nitric oxide (NO) potently inhibits microbial biofilm formation, which is the primary cause of catheter associated UTIs (CAUTIs). Herein, commercial silicone Foley catheters are impregnated via a solvent swelling method with S-nitroso-N-acetyl-D-penicillamine (SNAP), a synthetic NO donor that exhibits long-term NO release and stability when incorporated into low water-uptake polymers. The proposed catheters generate NO surface-fluxes >0.7 x 10(-10) mol min(-1) cm(-2) for over one month under physiological conditions, with minimal SNAP leaching. These biomedical devices are demonstrated to significantly decrease formation of biofilm on the surface of the catheter tubings over 3, 7, and 14 day periods by microbial species (Staphylococcus epidermidis and Proteus mirabilis) commonly causing CAUTIs. Toxicity assessment demonstrates that the SNAP-impregnated catheters are fully biocompatible, as extracts of the catheter tubings score 0 on a 3-point grading scale using an accepted mouse fibroblast cell-line toxicity model. Consequently, SNAP-impregnated silicone Foley catheters can likely provide an efficient strategy to greatly reduce the occurrence of nosocomial CAUTIs.
C1 [Colletta, Alessandro; Wo, Yaqi; Meyerhoff, Mark E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   [Wu, Jianfeng; Xi, Chuanwu] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   [Kappler, Michael; Chen, Hao] Biocrede Inc, Plymouth, MI 48170 USA.
RP Xi, CW (reprint author), Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
EM cxi@umich.edu; mmeryho@umich.edu
OI Colletta, Alessandro/0000-0002-3865-1015
FU National Institutes of Health [NIH-R42-DK100161-02]
FX We thank the National Institutes of Health for supporting these studies
   via grant # NIH-R42-DK100161-02.
CR Aiassa V, 2010, BIOCHEM BIOPH RES CO, V393, P84, DOI 10.1016/j.bbrc.2010.01.083
   Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06
   Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09
   Brisbois EJ, 2013, BIOMATERIALS, V34, P6957, DOI 10.1016/j.biomaterials.2013.05.063
   Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   Cabrera-Contreras R., 2013, ISRN MICROBIOL, V2013
   Cai WY, 2012, BIOMATERIALS, V33, P7933, DOI 10.1016/j.biomaterials.2012.07.027
   Cai WY, 2011, BIOMATERIALS, V32, P7774, DOI 10.1016/j.biomaterials.2011.06.075
   Carpenter AW, 2011, ACS NANO, V5, P7235, DOI 10.1021/nn202054f
   Darouiche RO, 1999, UROLOGY, V54, P976, DOI 10.1016/S0090-4295(99)00288-5
   Davenport K, 2005, J HOSP INFECT, V60, P298, DOI 10.1016/j.jhin.2005.01.026
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   Elliott TSJ, 1999, J ANTIMICROB CHEMOTH, V43, P441, DOI 10.1093/jac/43.4.441
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Gilmore BF, 2010, J BIOMED MATER RES B, V93B, P128, DOI 10.1002/jbm.b.31567
   Hachem R, 2009, ANTIMICROB AGENTS CH, V53, P5145, DOI 10.1128/AAC.00718-09
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hofler L, 2012, RSC ADV, V2, P6765, DOI 10.1039/c2ra20853a
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1118/AAC.49.6.2467-2473.2005
   Jones BV, 2005, J MED MICROBIOL, V54, P807, DOI 10.1099/JMM.0.46123-0
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   Lu Y, 2013, SMALL, V9, P2189, DOI 10.1002/smll.201201798
   Mack D, 2013, BIOMATERIALS ASS INF, P25, DOI 10.1007/9781-46141031-7
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Nicolle LE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-23
   Oman KS, 2012, AM J INFECT CONTROL, V40, P548, DOI 10.1016/j.ajic.2011.07.018
   Pickard R, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI [10.3310/jta16470, 10.3310/hta16470]
   Privett BJ, 2010, MOL PHARMACEUT, V7, P2289, DOI 10.1021/mp100248e
   Ren H, 2014, ACS APPL MATER INTER, V6, P3779, DOI 10.1021/am406066a
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Rocha SPD, 2007, FEMS IMMUNOL MED MIC, V51, P1, DOI 10.1111/j.1574-695X.2007.00284.x
   SEXTON DJ, 1994, PHOTOCHEM PHOTOBIOL, V59, P463, DOI 10.1111/j.1751-1097.1994.tb05065.x
   Shishido SM, 2000, PHOTOCHEM PHOTOBIOL, V71, P273, DOI 10.1562/0031-8655(2000)071<0273:PGMRTR>2.0.CO;2
   STEPHENS AD, 1971, Q J MED, V40, P355
   Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231
   Stickler DJ, 2006, J MED MICROBIOL, V55, P489, DOI 10.1099/jmm.0.46404-0
   Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964
   Tapiainen T, 2014, EUR J CLIN MICROBIOL, V33, P111, DOI 10.1007/s10096-013-1935-4
   Tenke P, 2014, CURR OPIN INFECT DIS, V27, P102, DOI 10.1097/QCO.0000000000000031
   Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003
   Wang HZ, 2011, ANTIMICROB AGENTS CH, V55, P4469, DOI 10.1128/AAC.00126-11
   Wojtyczka RD, 2014, INT J ENV RES PUB HE, V11, P4619, DOI 10.3390/ijerph110504619
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
   Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012
   Zunino P, 2007, FEMS IMMUNOL MED MIC, V51, P125, DOI 10.1111/j.1574-695X.2007.00285.x
NR 56
TC 19
Z9 19
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUN
PY 2015
VL 1
IS 6
BP 416
EP 424
DI 10.1021/acsbiomaterials.5b00032
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RO
UT WOS:000369347500008
PM 26462294
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Marchioli, G
   van Gurp, L
   van Krieken, PP
   Stamatialis, D
   Engelse, M
   van Blitterswijk, CA
   Karperien, MBJ
   de Koning, E
   Alblas, J
   Moroni, L
   van Apeldoorn, AA
AF Marchioli, G.
   van Gurp, L.
   van Krieken, P. P.
   Stamatialis, D.
   Engelse, M.
   van Blitterswijk, C. A.
   Karperien, M. B. J.
   de Koning, E.
   Alblas, J.
   Moroni, L.
   van Apeldoorn, A. A.
TI Fabrication of three-dimensional bioplotted hydrogel scaffolds for
   islets of Langerhans transplantation
SO BIOFABRICATION
LA English
DT Article
DE type 1 diabetes; beta cells; bioplotting; tissue engineering; islets of
   Langerhans
ID ALGINATE-BASED MICROCAPSULES; PANCREATIC BETA-CELLS;
   EXTRACELLULAR-MATRIX; INSULIN-SECRETION; TISSUE; APOPTOSIS; CULTURE;
   GLUCOSE; CONSTRUCTS; METABOLISM
AB In clinical islet transplantation, allogeneic islets of Langerhans are transplanted into the portal vein of patients with type 1 diabetes, enabling the restoration of normoglycemia. After intra-hepatic transplantation several factors are involved in the decay in islet mass and function mainly caused by an immediate blood mediated inflammatory response, lack of vascularization, and allo-and autoimmunity. Bioengineered scaffolds can potentially provide an alternative extra-hepatic transplantation site for islets by improving nutrient diffusion and blood supply to the scaffold. This would ultimately result in enhanced islet viability and functionality compared to conventional intra portal transplantation. In this regard, the biomaterial choice, the three-dimensional (3D) shape and scaffold porosity are key parameters for an optimal construct design and, ultimately, transplantation outcome. We used 3D bioplotting for the fabrication of a 3D alginate-based porous scaffold as an extra-hepatic islet delivery system. In 3D-plotted alginate scaffolds the surface to volume ratio, and thus oxygen and nutrient transport, is increased compared to conventional bulk hydrogels. Several alginate mixtures have been tested for INS1E beta-cell viability. Alginate/gelatin mixtures resulted in high plotting performances, and satisfactory handling properties. INS1E beta-cells, human and mouse islets were successfully embedded in 3D-plotted constructs without affecting their morphology and viability, while preventing their aggregation. 3D plotted scaffolds could help in creating an alternative extra-hepatic transplantation site. In contrast to microcapsule embedding, in 3D plotted scaffold islets are confined in one location and blood vessels can grow into the pores of the construct, in closer contact to the embedded tissue. Once revascularization has occurred, the functionality is fully restored upon degradation of the scaffold.
C1 [Marchioli, G.; Karperien, M. B. J.; van Apeldoorn, A. A.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands.
   [van Gurp, L.; van Krieken, P. P.; de Koning, E.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.
   [van Gurp, L.; van Krieken, P. P.; de Koning, E.] Univ Med Ctr Utrecht, Utrecht, Netherlands.
   [Engelse, M.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
   [Alblas, J.] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.
   [Marchioli, G.; Karperien, M. B. J.; Moroni, L.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Stamatialis, D.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
RP Moroni, L (reprint author), Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
EM a.a.vanapeldoorn@utwente.nl
RI van Gurp, Leon/M-1218-2016; Moroni, Lorenzo/D-2826-2014
OI van Gurp, Leon/0000-0002-6281-5964; Moroni, Lorenzo/0000-0003-1298-6025;
   Alblas, Jacqueline/0000-0002-2996-9697
FU Dutch Diabetes research foundation; Ministry of economical affairs (FES
   program) of the Netherlands
FX This research is part of the Diabetes Cell Therapy Initiative (DCTI) and
   funded by the Dutch Diabetes research foundation and the Ministry of
   economical affairs (FES program) of the Netherlands. The authors
   acknowledge Dr Paul the Vos for kindly providing the ultrapure alginate.
CR Benhamou PY, 2001, DIABETOLOGIA, V44, P859
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   BILLAUDEL B, 1982, J ENDOCRINOL, V95, P315, DOI 10.1677/joe.0.0950315
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Buitinga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064772
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.TEA.2011.0543, 10.1089/ten.tea.2011.0543]
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Daoud JT, 2011, BIOMATERIALS, V32, P1536, DOI 10.1016/j.biomaterials.2010.10.036
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2473, DOI [10.1089/ten.tea.2011.0001, 10.1089/ten.TEA.2011.0001]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Fraga DW, 1998, TRANSPLANTATION, V65, P1060, DOI 10.1097/00007890-199804270-00009
   HALES CN, 1968, J PHYSIOL-LONDON, V199, P177, DOI 10.1113/jphysiol.1968.sp008647
   HANNOUN BJM, 1986, BIOTECHNOL BIOENG, V28, P829, DOI 10.1002/bit.260280609
   Hockaday L A, 2012, BIOFABRICATION, V4, P1758
   Hunt NC, 2009, BIOMATERIALS, V30, P6435, DOI 10.1016/j.biomaterials.2009.08.014
   Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65
   Lee W, 2009, NEUROREPORT, V20, P798, DOI 10.1097/WNR.0b013e32832b8be4
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108
   Lin CC, 2009, BIOMACROMOLECULES, V10, P2460, DOI 10.1021/bm900420f
   LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065
   Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110
   Mallett AG, 2009, TISSUE ENG PT A, V15, P1301, DOI 10.1089/ten.tea.2008.0118
   Mao GH, 2009, BIOMATERIALS, V30, P1706, DOI 10.1016/j.biomaterials.2008.12.030
   Masuda K, 2003, J ORTHOPAED RES, V21, P922, DOI 10.1016/S0736-0266(03)00037-8
   Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099
   Nyqvist D, 2011, DIABETES, V60, P2571
   Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008
   Park SA, 2011, BIOPROC BIOSYST ENG, V34, P505, DOI 10.1007/s00449-010-0499-2
   Pedraza E, 2013, CELL TRANSPLANT, V22, P1123, DOI 10.3727/096368912X657440
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   PROKS P, 1995, J PHYSIOL-LONDON, V487, P465, DOI 10.1113/jphysiol.1995.sp020893
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rutherford SW, 1997, ADSORPTION, V3, P283, DOI 10.1007/BF01653631
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomatei-ials.2007.09.032
   Seyednejad H, 2011, ACTA BIOMATER, V7, P1999, DOI 10.1016/j.actbio.2011.01.018
   Shapiro AMJ, 2005, THER DRUG MONIT, V27, P35, DOI 10.1097/00007691-200502000-00008
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Simpson NE, 2006, BIOMATERIALS, V27, P2577, DOI 10.1016/j.biomaterials.2005.11.042
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118
   Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1016/S0039-6060(99)70169-8
   Turco G, 2001, BIOMACROMOLECULES, V12, P1272
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   Xu T, 2009, TISSUE ENG PT A, V15, P95, DOI 10.1089/ten.tea.2008.0095
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 61
TC 37
Z9 40
U1 2
U2 42
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2015
VL 7
IS 2
AR 025009
DI 10.1088/1758-5090/7/2/025009
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CZ1WJ
UT WOS:000366896300009
PM 26019140
DA 2018-10-19
ER

PT J
AU Othman, R
   Morris, GE
   Shah, DA
   Hall, S
   Hall, G
   Wells, K
   Shakesheff, KM
   Dixon, JE
AF Othman, Rebeen
   Morris, Gavin E.
   Shah, Disheet A.
   Hall, Stephen
   Hall, Graham
   Wells, Keith
   Shakesheff, Kevin M.
   Dixon, James E.
TI An automated fabrication strategy to create patterned tubular
   architectures at cell and tissue scales
SO BIOFABRICATION
LA English
DT Article
DE vessel; fabrication; multilayer; tissue; patterning; PNIPAAM
ID ARTIFICIAL BLOOD-VESSEL; PLURIPOTENT STEM-CELLS; AIRWAY SMOOTH-MUSCLE;
   IN-VITRO; MECHANICAL-PROPERTIES; VASCULAR-SURGERY; TIGHT JUNCTION;
   SHEETS; ARTERIES; DISEASE
AB The use of materials to impose tissue-like architecture at cell resolution will be important if engineered functional replacements for damaged cardiovascular, pulmonary, renal or digestive tissues are to be authentically engineered. Here, we demonstrate a coordinated system for the fabrication and subsequent culture of tubular tissues composed of multiple layers, cell-types and materials with physiological dimensions and defined architectures at cell resolution. We developed an automated tube fabricator that rolls 2D-matrices into 3D-tubular constructs directly from cells, hydrogels and scaffold biomaterials. Coordinated use of surface modification strategies allows 2D cell sheets and cell/biomaterial composites (i.e. hydrogels or electrospun scaffolds) to be fabricated which may be transferred into a perfusion bioreactor in a rapid and standardized procedure. To exemplify our strategy we fabricated structures resembling human mammary artery and gut; these can be imaged in situ and real-time electrical resistance measurements performed of the vessel walls, allowing non-invasive assessment of viability and functionality. Our system allows patterning at cellular resolution with variable tissue thickness, length, luminal diameter, and constituent biomaterial. This inherent flexibility will allow the recapitulation of the complex hierarchical biological architectures and generate functionality found natively in vivo.
C1 [Othman, Rebeen; Morris, Gavin E.; Shah, Disheet A.; Shakesheff, Kevin M.; Dixon, James E.] Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling ST, Sch Pharm, Nottingham NG7 2RD, England.
   [Hall, Stephen] Univ Nottingham, Sch Med, Med Engn Unit, Nottingham NG7 2RD, England.
   [Hall, Graham] Tannlin Ltd, Irvine KA1 2DJ, Scotland.
   [Wells, Keith] Trent Thermal Technol, Nottingham NG7 2QP, England.
RP Othman, R (reprint author), Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling ST, Sch Pharm, Nottingham NG7 2RD, England.
EM kevin.shakesheff@nottingham.ac.uk
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Shah, Disheet/0000-0002-8229-0835
FU ERC; UKRMP; Biotechnology and Biological Sciences Research Council
   [BB/F020619/1]
FX This work was funded by the ERC and UKRMP. We thank Tannlin Ltd for
   stencil manufacture and the University of Nottingham Medical Engineering
   Unit (MEU) in the design and manufacture of the ATF and accessories. We
   thank WPI Ltd for helpful discussions to develop real-time tube
   resistance measurements.
CR Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC
   CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   Dixon JE, 2014, P NATL ACAD SCI USA, V111, P5580, DOI 10.1073/pnas.1319685111
   Dixon JE, 2011, MOL THER, V19, P1695, DOI 10.1038/mt.2011.125
   DOBRIN PB, 1978, PHYSIOL REV, V58, P397
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163
   Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319
   Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Karaman B, 2012, DIAGN INTERV RADIOL, V18, P215, DOI 10.4261/1305-3825.DIR.4788-11.1
   Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC
   Kheirabadi BS, 2006, J INVEST SURG, V19, P387, DOI 10.1080/08941930600985744
   Kim MJ, 2008, MACROMOL RES, V16, P345, DOI 10.1007/BF03218527
   Kubo H, 2007, BIOMATERIALS, V28, P3508, DOI 10.1016/j.biomaterials.2007.04.016
   Kwak YK, 2012, INFECT IMMUN, V80, P1670, DOI 10.1128/IAI.00001-12
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   McAllister TN, 2006, USPatent, Patent No. [7744526 B2, 7744526]
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Morris GE, 2014, AM J PHYSIOL-LUNG C, V307, pL38, DOI 10.1152/ajplung.00318.2013
   Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Paik I, 2012, BIOTECHNOL BIOENG, V109, P2630, DOI 10.1002/bit.24529
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Patterson JT, 2012, REGEN MED, V7, P409, DOI [10.2217/RME.12.12, 10.2217/rme.12.12]
   Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406
   Rhodin R A J, 1980, HDB PHYSL CARDIOVASC, P1
   Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Shum- Tim D, 1999, ANN THORAC SURG, V68, P2305
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7
   Wang S, 2013, INT J NANOMED, V8, P2131, DOI 10.2147/IJN.S44956
   Williams C, 2011, BIOMATERIALS, V32, P5625, DOI 10.1016/j.biomaterials.2011.04.050
   Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027
   Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524
   Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589
NR 49
TC 2
Z9 3
U1 5
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2015
VL 7
IS 2
AR 025003
DI 10.1088/1758-5090/7/2/025003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CZ1WJ
UT WOS:000366896300003
PM 25869447
DA 2018-10-19
ER

PT J
AU Hazra, S
   Chowdhury, S
   Guha, R
   Naskar, D
   Pradhan, N
   Kundu, S
   Konar, A
AF Hazra, Sarbani
   Chowdhury, Sushovan
   Guha, Rajdeep
   Naskar, Deboki
   Pradhan, Nirparaj
   Kundu, Subhas
   Konar, Aditya
TI Antheraea mylitta silk films with natural RGD sequence supports corneal
   cell proliferation: A promising new biomaterial for corneal regeneration
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Hazra, Sarbani; Pradhan, Nirparaj] West Bengal Univ Anim & Fishery Sci, Vet Surg & Radiol, Kolkata, India.
   [Chowdhury, Sushovan; Guha, Rajdeep; Konar, Aditya] CSIR IICB, Kolkata, India.
   [Naskar, Deboki; Kundu, Subhas] IIT Kharagpur, Kharagpur, W Bengal, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 3470
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5ZY
UT WOS:000362891101109
DA 2018-10-19
ER

PT J
AU Griffith, GL
   Wirostko, BM
   Lee, HK
   Zamora, DO
   Johnson, AJ
AF Griffith, Gina L.
   Wirostko, Barbara M.
   Lee, Hee-Kyoung
   Zamora, David O.
   Johnson, Anthony James
TI Model development: Use of a biocompatible thiolated hyaluronic acid
   biomaterial for the treatment of corneal epithelial wounds
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Griffith, Gina L.; Zamora, David O.; Johnson, Anthony James] US Army Inst Surg Res, Ocular Trauma, Ft Sam Houston, TX USA.
   [Wirostko, Barbara M.; Lee, Hee-Kyoung] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA.
   [Wirostko, Barbara M.; Lee, Hee-Kyoung] Jade Therapeut Inc, Salt Lake City, UT USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 3089
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882207252
DA 2018-10-19
ER

PT J
AU Mehta, JS
   Thompson, B
   Konstantopoulos, A
   Goh, G
   Setiawan, M
   Tan, D
   Khor, K
AF Mehta, Jodhbir S.
   Thompson, Brianna
   Konstantopoulos, Aris
   Goh, Gwen
   Setiawan, Melina
   Tan, Donald
   Khor, K.
TI Biocompatibility of Graphene as Candidate Biomaterial for Synthetic
   Keratoprosthesis Skirt
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 1124
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882203033
DA 2018-10-19
ER

PT J
AU Tse, HM
   Padgett, LE
   Kozlovskaya, V
   Kharlampieva, E
   Burg, AR
AF Tse, Hubert M.
   Padgett, Lindsey E.
   Kozlovskaya, Veronika
   Kharlampieva, Eugenia
   Burg, Ashley R.
TI Islet Encapsulation with Immunomodulatory Nanothin Biomaterial Coatings
SO DIABETES
LA English
DT Meeting Abstract
CT 75th Scientific Sessions of the American-Diabetes-Association
CY JUN 05-09, 2015
CL Boston, MA
SP Amer Diabet Assoc
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD JUN
PY 2015
VL 64
SU 1
MA 1844-P
BP A476
EP A477
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CO9GN
UT WOS:000359482702367
DA 2018-10-19
ER

PT J
AU Mehdikhani, B
   Borhani, GH
AF Mehdikhani, Behzad
   Borhani, Gholam Hossein
TI Synthesis nano bio-ceramic powder beta-Ca2P2O7
SO JOURNAL OF CERAMIC PROCESSING RESEARCH
LA English
DT Article
DE biomaterial; nano powder; beta-pyro calcium phosphate; Sol gel; FTIR
   spectroscopy
ID BETA-TRICALCIUM PHOSPHATE; CALCIUM-PHOSPHATE; PROSTHETIC APPLICATIONS;
   HYDROXYAPATITE; BONE; NANOPARTICLES; BEHAVIOR; TCP
AB Nano-size beta calcium pyrophosphate(beta-Ca2P2O7) powders with average grain size of 80 nm were prepared by sol gel method with calcium nitrate 4-hydrateCa(NO3)(2)center dot 4H(2)O and different amount of diammonium hydrogen phosphate (NH4)(2)HPO4(0.4 and 0.6 molar) as calcium and phosphorus precursors. The pH of the system was maintained up to (pH = 10) by the adding of sodium hydroxide. The white precipitate stirred for 2 hour and washed with distilled water and filtered. Filtered cake was dried at 80 degrees C and calcined at 600 degrees C. The dried and calcined powders were characterized for phase composition using X-ray diffractrometry (XRD) and Fourier transform-infrared spectroscopy (FTIR). The particle size and morphology was studied using scanning electron microscopy (SEM).
C1 [Mehdikhani, Behzad; Borhani, Gholam Hossein] Malek Ashtar Ind Univ, Dept Mat, Tehran, Iran.
   [Mehdikhani, Behzad] Standard Res Inst, Bldg & Construct Dept, Tehran, Iran.
RP Mehdikhani, B (reprint author), Malek Ashtar Ind Univ, Dept Mat, Tehran, Iran.
EM mehdikhani@standard.ac.ir
FU ceramic department (International University of Iran)
FX The authors are indebted to ceramic laboratory in institute of standard
   and industrial research of Iran, that supplied the raw materials for the
   development of this research and to ceramic department (International
   University of Iran) for its financial support.
CR Aili W., 2007, J MAT SC ENG, P865
   AKAO M, 1982, J MATER SCI, V17, P343, DOI 10.1007/BF00591468
   Albee FH, 1920, ANN SURG, V71, P32
   Amjad Z, 1998, CALCIUM PHOSPHATES B, P145
   Azaroff L. A., 1968, ELEMENTS XRAY CRYSTA, P38
   Bigi A, 1997, J INORG BIOCHEM, V66, P259, DOI 10.1016/S0162-0134(96)00219-X
   Dasgupta S., 2008, NANOSTRUCTURE HYDROX
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   Deepak K., 2007, J MAT SCI ENG C, P684
   DEPTULA A, 1992, J NON-CRYST SOLIDS, V147, P537, DOI 10.1016/S0022-3093(05)80672-6
   Elliot J. C., 1998, MATERIAUX PHOSPHATE, V5, P25
   Elliott J.C., 1994, STUDIES INORGANIC CH, V18, P112
   FAMERY R, 1994, CERAM INT, V20, P327, DOI 10.1016/0272-8842(94)90050-7
   Gbureck U, 2008, J MATER SCI-MATER M, V19, P1559, DOI 10.1007/s10856-008-3373-x
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   ITATANI K, 1994, J AM CERAM SOC, V77, P801, DOI 10.1111/j.1151-2916.1994.tb05368.x
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   KITSUGI T, 1993, BIOMATERIALS, V14, P216, DOI 10.1016/0142-9612(93)90026-X
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Legeros R.Z., 1991, CLACIUM PHOSPHATES O, P85
   Lemos A. F., 2005, J KEY ENG MAT, P284
   Levitt G. W., 1969, J BIOMEDICAL MAT RES, P683
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li W., 2009, J NANOPART RES, P691
   Liou SC, 2002, BIOMATERIALS, V23, P4541, DOI 10.1016/S0142-9612(02)00198-9
   Martin CL, 2006, J AM CERAM SOC, V89, P3379, DOI 10.1111/j.1551-2916.2006.01249.x
   MARTIN RI, 1994, J MATER SCI-MATER M, V5, P96, DOI 10.1007/BF00121697
   Mehdikhani B, 2012, J CERAM PROCESS RES, V13, P486
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Pan Y, 2003, J MATER SCI, V38, P1049, DOI 10.1023/A:1022354015226
   RADIN SR, 1994, J BIOMED MATER RES, V28, P1303, DOI 10.1002/jbm.820281108
   Ratner B. D, 1996, BIOMATERIALS SCI INT, P81
   Rautaray D, 2005, LANGMUIR, V21, P5185, DOI 10.1021/la048541f
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Uota M, 2005, LANGMUIR, V21, P4724, DOI 10.1021/la050029m
   Vallet-Regy M., 2004, J SOLID STATE IONICS, P445
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Yokogawa Y., 1991, J CERAM SOC JPN, P28
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zyman Z, 2001, J BIOMED MATER RES, V54, P256, DOI 10.1002/1097-4636(200102)54:2<256::AID-JBM13>3.3.CO;2-2
   ZYMAN Z, 1994, BIOMATERIALS, V15, P151, DOI 10.1016/0142-9612(94)90265-8
NR 43
TC 4
Z9 4
U1 0
U2 6
PU KOREAN ASSOC CRYSTAL GROWTH, INC
PI SEOUL
PA SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA
SN 1229-9162
J9 J CERAM PROCESS RES
JI J. Ceram. Process. Res.
PD JUN
PY 2015
VL 16
IS 3
BP 308
EP 312
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA CQ8BV
UT WOS:000360832100006
DA 2018-10-19
ER

PT J
AU Wetie, AGN
   Wormwood, KL
   Russell, S
   Ryan, JP
   Darie, CC
   Woods, AG
AF Wetie, Armand G. Ngounou
   Wormwood, Kelly L.
   Russell, Stefanie
   Ryan, Jeanne P.
   Darie, Costel C.
   Woods, Alisa G.
TI A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum
   Disorder
SO AUTISM RESEARCH
LA English
DT Article
DE ASD; proteomics; biomarker signature; early detection; diagnosis
ID INTENSIVE BEHAVIORAL INTERVENTION; PROTEIN-PROTEIN INTERACTIONS;
   MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; CLINICAL-IMPLICATIONS;
   INTERACTION NETWORKS; CHILDREN; IDENTIFICATION; RECEPTOR; MARKERS
AB Autism spectrum disorder (ASD) prevalence is increasing, with current estimates at 1/68-1/50 individuals diagnosed with an ASD. Diagnosis is based on behavioral assessments. Early diagnosis and intervention is known to greatly improve functional outcomes in people with ASD. Diagnosis, treatment monitoring and prognosis of ASD symptoms could be facilitated with biomarkers to complement behavioral assessments. Mass spectrometry (MS) based proteomics may help reveal biomarkers for ASD. In this pilot study, we have analyzed the salivary proteome in individuals with ASD compared to neurotypical control subjects, using MS-based proteomics. Our goal is to optimize methods for salivary proteomic biomarker discovery and to identify initial putative biomarkers in people with ASDs. The salivary proteome is virtually unstudied in ASD, and saliva could provide an easily accessible biomaterial for analysis. Using nano liquid chromatography-tandem mass spectrometry, we found statistically significant differences in several salivary proteins, including elevated prolactin-inducible protein, lactotransferrin, Ig kappa chain C region, Ig gamma-1 chain C region, Ig lambda-2 chain C regions, neutrophil elastase, polymeric immunoglobulin receptor and deleted in malignant brain tumors 1. Our results indicate that this is an effective method for identification of salivary protein biomarkers, support the concept that immune system and gastrointestinal disturbances may be present in individuals with ASDs and point toward the need for larger studies in behaviorally-characterized individuals. (C) 2015 International Society for Autism Research, Wiley Periodicals, Inc.
C1 [Wetie, Armand G. Ngounou; Wormwood, Kelly L.; Darie, Costel C.; Woods, Alisa G.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA.
   [Russell, Stefanie; Ryan, Jeanne P.; Woods, Alisa G.] SUNY Coll Plattsburgh, Neuropsychol Clin, Plattsburgh, NY 12901 USA.
   [Russell, Stefanie; Ryan, Jeanne P.; Woods, Alisa G.] SUNY Coll Plattsburgh, Psychoeduc Serv, Plattsburgh, NY 12901 USA.
RP Woods, AG (reprint author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, 8 Clarkson Ave, Potsdam, NY 13699 USA.
EM awoods@clarkson.edu
FU Shire Development, LLC; Redcay Foundation; David A. Walsh fellowship;
   U.S. Army research office [W911NF-11-1-0304]; Sci-Fund Challenge 3
   Donors
FX This study was supported by a grant from Shire Development, LLC, the
   Redcay Foundation, the David A. Walsh fellowship, the U.S. Army research
   office (DURIP grant #W911NF-11-1-0304) and the generosity of Sci-Fund
   Challenge 3 Donors. Special thanks to ICare4Autism, Chris McDonough,
   PhD, BCBA, Douglas Barnaby, MD, and Jonathan Rubin, MD for their
   continued support. The authors appreciate the assistance of Patricia
   Egan, PhD, BCBA-D, of the SUNY Plattburgh Autism Intervention Programs.
   The authors would like to give special thanks to the families and
   individuals who participated in this study. All authors declare that
   they have no conflicts of interest related to this work.
CR Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22
   Andreescu S, 2011, ACS SYM SER, V1083, P1, DOI 10.1021/bk-2011-1083
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Aubert Y, 2013, J SEX MED, V10, P1461, DOI 10.1111/jsm.12131
   Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017
   Blumberg S. J., 2013, NATL HLTH STAT REPOR, V65, P1
   Braunschweig D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.50
   Broek JAC, 2014, INT J NEUROPSYCHOPH, V17, P651, DOI 10.1017/S146114571300117X
   Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088
   Chen CL, 2013, J PROTEOMICS, V85, P28, DOI 10.1016/j.jprot.2013.04.024
   Conciatori M, 2004, BIOL PSYCHIAT, V55, P413, DOI 10.1016/j.biopsych.2003.10.005
   Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943
   Darie CC, 2011, PROTEOMICS, V11, P4514, DOI 10.1002/pmic.201000819
   Dawson G, 2010, CURR OPIN NEUROL, V23, P95, DOI 10.1097/WCO.0b013e3283377644
   Dereu M, 2012, EUR CHILD ADOLES PSY, V21, P541, DOI 10.1007/s00787-012-0280-y
   Donadio E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071874
   DORING G, 1994, AM J RESP CRIT CARE, V150, pS114
   Eikeseth S, 2012, RES AUTISM SPECT DIS, V6, P829, DOI 10.1016/j.rasd.2011.09.002
   Eldevik S, 2009, J CLIN CHILD ADOLESC, V38, P439, DOI 10.1080/15374410902851739
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P169, DOI 10.1007/s00787-009-0076-x
   Gesundheit B, 2013, J AUTOIMMUN, V44, P1, DOI 10.1016/j.jaut.2013.05.005
   Hassan MI, 2009, CELL MOL LIFE SCI, V66, P447, DOI 10.1007/s00018-008-8463-x
   Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775
   Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37
   Katz R., 2004, J AM SOC EXPT NEUROT, V1, P189, DOI DOI 10.1602/NEURORX.1.2.189
   Loo JA, 2010, J DENT RES, V89, P1016, DOI 10.1177/0022034510380414
   LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3
   Martirosian G, 2011, ANAEROBE, V17, P43, DOI 10.1016/j.anaerobe.2010.12.003
   Momeni N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.19
   Momeni N., 2012, AUTISM RES TREAT, V2012
   Mu YB, 2013, ELECTROPHORESIS, V34, P1679, DOI 10.1002/elps.201200596
   Muller H, 2012, ARTERIOSCL THROM VAS, V32, P442, DOI 10.1161/ATVBAHA.111.239830
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Noriega DB, 2014, EUR J PEDIATR, V173, P33, DOI 10.1007/s00431-013-2183-4
   O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989
   Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102
   Sokolowska I, 2013, J MOL PSYCHIAT, V1, P8, DOI DOI 10.1186/2049-9256-1-8
   Sokolowska I., J NEURAL TRANSMISSIO
   Sokolowska I, 2013, CELL MOL LIFE SCI, V70, P2835, DOI 10.1007/s00018-012-1185-0
   Sokolowska I, 2012, FEBS J, V279, P2579, DOI 10.1111/j.1742-4658.2012.08641.x
   State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924
   Steeb H, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-4
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Talkowski ME, 2014, HARVARD REV PSYCHIAT, V22, P65, DOI 10.1097/HRP.0000000000000002
   Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199
   Theoharides TC, 2013, CLIN THER, V35, P584, DOI 10.1016/j.clinthera.2013.04.009
   Van Schalkwyk G. I., J AUTISM DEV DISORDE
   Walker EF, 2013, BIOL PSYCHIAT, V74, P410, DOI 10.1016/j.biopsych.2013.02.016
   Wetie AGN, 2014, ELECTROPHORESIS, V35, P2046, DOI 10.1002/elps.201300370
   Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1
   Wetie AGN, 2013, JALA-J LAB AUTOM, V18, P19, DOI 10.1177/2211068212454738
   Wetie AGN, 2013, PROTEOMICS, V13, P538, DOI 10.1002/pmic.201200328
   Wilcken B, 2012, PATHOLOGY, V44, P73, DOI 10.1097/PAT.0b013e32834e843f
   Wingate M, 2014, MMWR SURVEILL SUMM, V63, P1
   Woods Alisa G, 2013, J Mol Psychiatry, V1, P6, DOI 10.1186/2049-9256-1-6
   Woods AG, 2012, J CELL MOL MED, V16, P1184, DOI 10.1111/j.1582-4934.2012.01543.x
   Woods AG, 2012, BIOCHEM BIOPH RES CO, V419, P305, DOI 10.1016/j.bbrc.2012.02.016
   Wu S, 2014, PROTEOMICS, V14, P1211, DOI 10.1002/pmic.201300378
   Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024
   Zwaigenbaum L, 2010, CURR OPIN NEUROL, V23, P97, DOI 10.1097/WCO.0b013e3283372430
NR 61
TC 26
Z9 26
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-3792
EI 1939-3806
J9 AUTISM RES
JI Autism Res.
PD JUN
PY 2015
VL 8
IS 3
BP 338
EP 350
DI 10.1002/aur.1450
PG 13
WC Behavioral Sciences; Psychology, Developmental
SC Behavioral Sciences; Psychology
GA CQ2QQ
UT WOS:000360446600010
PM 25626423
DA 2018-10-19
ER

PT J
AU Aperador, W
   Delgado, A
   Vera, E
AF Aperador, W.
   Delgado, A.
   Vera, E.
TI Tribological and Corrosion Behaviors of Titanium Carbonitride Coatings
   in Simulated Biological Fluid
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE titanium carbonitride; wear; corrosion; biomaterial
ID NITRIDE; WEAR; EROSION; ALLOY; FILMS
AB This article contributes to the study of the behavior of the hard coating titanium carbonitride (TiCN) obtained by the technique physical vapor deposition (PVD), using as substrate Bio-medical grade stainless steel 316LVM. The evaluation was conducted using a tribometer, subsequently the electrochemical properties were evaluated by techniques of electrochemical impedance spectroscopy and polarization curves, Finally, a test is made tribocorrosion, by combining these two trials and in a simulated biological fluid. Techniques of scanning electron microscopy and XRD were used to characterize the coatings. TiCN coatings, showed improved performance against corrosion phenomena and abrasive wear than steel 316LVM.
C1 [Aperador, W.; Delgado, A.] Univ Militar Nueva Granada, Sch Engn, Bogota, Colombia.
   [Vera, E.] Univ Pedagog & Tecnol Colombia, Tunja, Colombia.
RP Aperador, W (reprint author), Univ Militar Nueva Granada, Sch Engn, Bogota, Colombia.
EM g.ing.materiales@gmail.com
OI Vera Lopez, Enrique/0000-0003-4150-9308
FU Universidad Militar Nueva Granada [ING-1775-2015]
FX Thanks the financial support from the Universidad Militar Nueva Granada,
   contract number ING-1775-2015.
CR Abd El-Rahman AM, 2014, SURF COAT TECH, V258, P320, DOI 10.1016/j.surfcoat.2014.09.006
   Ajikumar PK, 2014, CERAM INT, V40, P10523, DOI 10.1016/j.ceramint.2014.03.027
   Ajikumar PK, 2012, CERAM INT, V38, P2253, DOI 10.1016/j.ceramint.2011.10.075
   Aperador William, 2014, Advanced Materials Research, V1016, P320, DOI 10.4028/www.scientific.net/AMR.1016.320
   Bansal DG, 2011, WEAR, V271, P2006, DOI 10.1016/j.wear.2010.11.021
   Borkar T, 2014, J ALLOY COMPD, V617, P933, DOI 10.1016/j.jallcom.2014.08.049
   Buchholz S, 2012, INT J REFRACT MET H, V33, P44, DOI 10.1016/j.ijrmhm.2012.02.008
   Cai F, 2015, WEAR, V324, P27, DOI 10.1016/j.wear.2014.11.008
   Caicedo JC, 2011, THIN SOLID FILMS, V519, P6362, DOI 10.1016/j.tsf.2011.04.035
   Calderon V. S., 2015, J MECH BEHAV BIOMED, V41, P83
   Forn A, 2001, INT J REFRACT MET H, V19, P507, DOI 10.1016/S0263-4368(01)00027-0
   Guu YY, 1996, SURF COAT TECH, V85, P146, DOI 10.1016/0257-8972(95)02737-8
   Guu YY, 1996, THIN SOLID FILMS, V287, P16, DOI 10.1016/S0040-6090(95)08496-7
   Hassani S, 2010, SURF COAT TECH, V205, P1426, DOI 10.1016/j.surfcoat.2010.07.098
   Hogmark S, 2000, WEAR, V246, P20, DOI 10.1016/S0043-1648(00)00505-6
   Munteanu D, 2011, TRIBOL INT, V44, P820, DOI 10.1016/j.triboint.2011.02.004
   Wei CH, 2001, THIN SOLID FILMS, V381, P104, DOI 10.1016/S0040-6090(00)01541-8
   Zhang J, 2013, APPL SURF SCI, V280, P626, DOI 10.1016/j.apsusc.2013.05.037
   Zhang XH, 2014, J ALLOY COMPD, V617, P81, DOI 10.1016/j.jallcom.2014.08.009
NR 19
TC 1
Z9 1
U1 0
U2 37
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JUN
PY 2015
VL 10
IS 6
BP 4473
EP 4481
PG 9
WC Electrochemistry
SC Electrochemistry
GA CN5OF
UT WOS:000358477900001
DA 2018-10-19
ER

PT J
AU Nitta, S
   Kaketani, S
   Iwamoto, H
AF Nitta, Sachiko
   Kaketani, Shinobu
   Iwamoto, Hiroyuki
TI Development of chitosan-nanofiber-based hydrogels exhibiting high
   mechanical strength and pH-responsive controlled release
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Chitosan; Nanofiber; Hydrogel; pH-responsive controlled release
ID CONTROLLED DRUG-DELIVERY; BIOMATERIAL; ELASTICITY; CELLULOSE; SYSTEM;
   POLYSACCHARIDE; COPOLYMER; MATRIX; CELLS
AB Developing naturally derived polymer-based hydrogels with high mechanical strength and a controlled release of loaded bioactive substances is essential in biomedicine and tissue engineering. Here, we report the fabrication of chitosan nanofiber (CNF)-based hydrogels (CNF-poly(ethylene glycol) (PEG) hydrogel) with a semi-penetrating network structure comprising CNF and chemically-crosslinkable PEG diacrylate (PEGDA). Scanning electron microscopy revealed a micro-porous structure, resulting from PEGDA gelation aligned with the bundles of CNF. CNF addition enhanced compressive rupture stress and Young's modulus, indicating that it strengthened the PEGDA hydrogels. Bovine serum albumin (BSA) was encapsulated in CNF-PEG hydrogels probably via the hydrophobic interaction between CNF and BSA. A pH decrease from 7.4 to 5.6 caused accelerated BSA release from the hydrogels due to the difference in their swelling degrees. These results indicated that CNF-PEG hydrogels could be utilized as a carrier for bioactive substances that demonstrates controlled release behavior and improved mechanical properties. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Nitta, Sachiko; Kaketani, Shinobu; Iwamoto, Hiroyuki] Fukuyama Univ, Dept Biotechnol, Fukuyama, Hiroshima 7290292, Japan.
RP Nitta, S (reprint author), Fukuyama Univ, Dept Biotechnol, 1 Sanzo,Gakuen Cho, Fukuyama, Hiroshima 7290292, Japan.
EM nitta@fubac.fukuyama-u.ac.jp
FU MEXT-Supported Program for the Strategic Research Foundation; Japan
   Society for the Promotion of Science Research Fellowships for Young
   Scientist
FX This work was supported by MEXT-Supported Program for the Strategic
   Research Foundation at Private Universities. S.N. was supported by a
   Japan Society for the Promotion of Science Research Fellowships for
   Young Scientist.
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Aouada FA, 2011, J AGR FOOD CHEM, V59, P9433, DOI 10.1021/jf202347h
   Banquy X, 2009, SOFT MATTER, V5, P3984, DOI 10.1039/b821583a
   Bekale L, 2015, COLLOID SURFACE B, V125, P309, DOI 10.1016/j.colsurfb.2014.11.037
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chu XH, 2009, BIOTECHNOL LETT, V31, P347, DOI 10.1007/s10529-008-9892-1
   Dan K., 2012, NANOTECHNOLOGY, V23
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dutta AK, 2013, CARBOHYD POLYM, V97, P363, DOI 10.1016/j.carbpol.2013.05.010
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Hoven VP, 2007, CARBOHYD POLYM, V68, P44, DOI 10.1016/j.carbpol.2006.07.008
   Iwamoto S, 2014, COMPOS PART A-APPL S, V59, P26, DOI 10.1016/j.compositesa.2013.12.011
   Li W, 2008, EUR POLYM J, V44, P3688, DOI 10.1016/j.eurpolymj.2008.08.020
   Li XM, 2012, COLLOID SURFACE B, V92, P136, DOI 10.1016/j.colsurfb.2011.11.030
   Ohkawa K, 2006, BIOMACROMOLECULES, V7, P3291, DOI 10.1021/bm0604395
   Okay O, 2000, PROG POLYM SCI, V25, P711, DOI 10.1016/S0079-6700(00)00015-0
   Omidian H, 2005, J CONTROL RELEASE, V102, P3, DOI 10.1016/j.jconrel.2004.09.028
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Qiu B, 2003, BIOMATERIALS, V24, P11, DOI 10.1016/S0142-9612(02)00227-2
   Rajam M, 2011, INT J PHARMACEUT, V410, P145, DOI 10.1016/j.ijpharm.2011.02.065
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Roldo M, 2004, EUR J PHARM BIOPHARM, V57, P115, DOI 10.1016/S0939-6411(03)00157-7
   Sehaqui H, 1824, SOFT MATTER, V2010, P6
   Shi JF, 2011, LANGMUIR, V27, P14425, DOI 10.1021/la2033862
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Watanabe Y, 2011, BIOPOLYMERS, V95, P833, DOI 10.1002/bip.21686
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Yang JJ, 2010, J BIOMED MATER RES A, V95A, P531, DOI 10.1002/jbm.a.32875
NR 33
TC 11
Z9 13
U1 4
U2 58
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD JUN
PY 2015
VL 67
BP 50
EP 56
DI 10.1016/j.eurpolymj.2015.03.053
PG 7
WC Polymer Science
SC Polymer Science
GA CM5TF
UT WOS:000357750900006
DA 2018-10-19
ER

PT J
AU Takamura, T
   Ko, PJ
   Sharma, J
   Yukino, R
   Ishizawa, S
   Sandhu, A
AF Takamura, Tsukasa
   Ko, Pil Ju
   Sharma, Jaiyam
   Yukino, Ryoji
   Ishizawa, Shunji
   Sandhu, Adarsh
TI Magnetic-Particle-Sensing Based Diagnostic Protocols and Applications
SO SENSORS
LA English
DT Review
DE magnetic particles; medical diagnosis; magnetic sensor; self-assembly;
   porous silicon
ID BEADS; PLATFORM
AB Magnetic particle-labeled biomaterial detection has attracted much attention in recent years for a number of reasons; easy manipulation by external magnetic fields, easy functionalization of the surface, and large surface-to-volume ratio, to name but a few. In this review, we report on our recent investigations into the detection of nano-sized magnetic particles. First, the detection by Hall magnetic sensor with lock-in amplifier and alternative magnetic field is summarized. Then, our approach to detect sub-200 nm diameter target magnetic particles via relatively large micoro-sized "columnar particles" by optical microscopy is described. Subsequently, we summarize magnetic particle detection based on optical techniques; one method is based on the scattering of the magnetically-assembled nano-sized magnetic bead chain in rotating magnetic fields and the other one is based on the reflection of magnetic target particles and porous silicon. Finally, we report recent works with reference to more familiar industrial products (such as smartphone-based medical diagnosis systems and magnetic removal of unspecific-binded nano-sized particles, or "magnetic washing").
C1 [Takamura, Tsukasa; Sandhu, Adarsh] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Tempa Ku, Toyohashi, Aichi 4418580, Japan.
   [Ko, Pil Ju; Sandhu, Adarsh] Univ Electrocommun, Res Promot Ctr, Chofu, Tokyo 1828585, Japan.
   [Sharma, Jaiyam; Yukino, Ryoji; Ishizawa, Shunji] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Tempa Ku, Toyohashi, Aichi 4418580, Japan.
   [Sandhu, Adarsh] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan.
RP Takamura, T (reprint author), Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Tempa Ku, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM takamura@eiiris.tut.ac.jp; pjko77@uec.ac.jp; jaiyam@eiiris.tut.ac.jp;
   yukino@eiiris.tut.ac.jp; ishizawa@eiiris.tut.ac.jp; sandhu@uec.ac.jp
FU A-STEP from Japan Science and Technology Agency
FX This research was partly funded by the A-STEP grant from Japan Science
   and Technology Agency.
CR Bando M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074513
   Ko PJ, 2011, NANOSCI NANOTECH LET, V3, P612, DOI 10.1166/nnl.2011.1236
   Kumagai Y, 2006, IEEE T MAGN, V42, P3893, DOI 10.1109/TMAG.2006.879613
   Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/NMAT2815, 10.1038/nmat2815]
   Morimoto Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556957
   Morimoto Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3352584
   Morimoto Y, 2009, IEEE T MAGN, V45, P2871, DOI 10.1109/TMAG.2009.2018861
   Morimoto Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DL07
   Nishio K, 2008, COLLOID SURFACE B, V64, P162, DOI 10.1016/j.colsurfb.2008.01.013
   Ohashi T, 2008, IEEE T MAGN, V44, P3252, DOI 10.1109/TMAG.2008.2001621
   Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001
   Park SY, 2010, NANO LETT, V10, P446, DOI 10.1021/nl9030488
   Primadani Z, 2007, J APPL PHYS, V101, DOI 10.1063/1.2712962
   Sandhu A, 2004, JPN J APPL PHYS 2, V43, pL868, DOI 10.1143/JJAP.43.L868
   Togawa K, 2006, J APPL PHYS, V99, DOI 10.1063/1.2162041
   van Reenen A, 2014, LAB CHIP, V14, P1966, DOI 10.1039/c3lc51454d
NR 16
TC 4
Z9 4
U1 8
U2 40
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD JUN
PY 2015
VL 15
IS 6
BP 12983
EP 12998
DI 10.3390/s150612983
PG 16
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA CM7JX
UT WOS:000357869200048
PM 26053747
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Huyer, LD
   Montgomery, M
   Zhao, YM
   Xiao, Y
   Conant, G
   Korolj, A
   Radisic, M
AF Huyer, Locke Davenport
   Montgomery, Miles
   Zhao, Yimu
   Xiao, Yun
   Conant, Genevieve
   Korolj, Anastasia
   Radisic, Milica
TI Biomaterial based cardiac tissue engineering and its applications
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE cardiac tissue engineering; biomaterials; host response; in vitro drug
   screening
ID PLURIPOTENT STEM-CELL; LONG-QT SYNDROME; LEFT-VENTRICULAR FUNCTION;
   ELECTRICAL-STIMULATION; EXTRACELLULAR-MATRIX; IN-VITRO; HEART-FAILURE;
   CARDIOMYOCYTE DIFFERENTIATION; DEGRADATION CHARACTERISTICS;
   MYOCARDIAL-INFARCTION
AB Cardiovascular disease is a leading cause of death worldwide, necessitating the development of effective treatment strategies. A myocardial infarction involves the blockage of a coronary artery leading to depletion of nutrient and oxygen supply to cardiomyocytes and massive cell death in a region of the myocardium. Cardiac tissue engineering is the growth of functional cardiac tissue in vitro on biomaterial scaffolds for regenerative medicine application. This strategy relies on the optimization of the complex relationship between cell networks and biomaterial properties. In this review, we discuss important biomaterial properties for cardiac tissue engineering applications, such as elasticity, degradation, and induced host response, and their relationship to engineered cardiac cell environments. With these properties in mind, we also emphasize in vitro use of cardiac tissues for high-throughput drug screening and disease modelling.
C1 [Huyer, Locke Davenport; Montgomery, Miles; Zhao, Yimu; Xiao, Yun; Conant, Genevieve; Korolj, Anastasia; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Huyer, Locke Davenport; Montgomery, Miles; Zhao, Yimu; Xiao, Yun; Conant, Genevieve; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Radisic, Milica] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada.
   [Radisic, Milica] Univ Toronto, IBBME, Toronto, ON, Canada.
RP Huyer, LD (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
EM m.radisic@utoronto.ca
RI Xiao, Yun/N-9949-2015
FU Heart and Stoke Foundation [GIA T6946]; Canadian Institutes of Health
   Research (CIHR) Operating Grant [MOP-126027]; NSERC Discovery Grant
   [RGPIN 326982-10]; National Institutes of Health [2R01 HL076485]; Canada
   Research Chair (Tier 2); Steacie Fellowship
FX This work is funded by the Heart and Stoke Foundation GIA T6946, the
   Canadian Institutes of Health Research (CIHR) Operating Grant
   (MOP-126027), NSERC Discovery Grant (RGPIN 326982-10), and National
   Institutes of Health grant 2R01 HL076485. MR is supported by Canada
   Research Chair (Tier 2) and Steacie Fellowship.
CR Ahadian S, 2013, ORGANOGENESIS, V9, P87, DOI 10.4161/org.25121
   Badie N, 2009, BIOPHYS J, V96, P3873, DOI 10.1016/j.bpj.2009.02.019
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Barrett DG, 2010, SOFT MATTER, V6, P5026, DOI 10.1039/c0sm00476f
   Barrett DG, 2010, POLYM CHEM-UK, V1, P296, DOI 10.1039/b9py00226j
   Bellis AD, 2013, BIOTECHNOL BIOENG, V110, P563, DOI 10.1002/bit.24718
   Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.tea.2011.0341, 10.1089/ten.TEA.2011.0341]
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004
   Brutsaert DL, 1998, CARDIOVASC RES, V38, P281, DOI 10.1016/S0008-6363(98)00044-3
   Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005
   Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chan YC, 2013, J CARDIOVASC TRANSL, V6, P989, DOI 10.1007/s12265-013-9510-z
   Chen A, 2014, BIOMATERIALS, V35, P675, DOI 10.1016/j.biomaterials.2013.10.007
   Chen MX, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-93
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chitcholtan K, 2013, EXP CELL RES, V319, P75, DOI 10.1016/j.yexcr.2012.09.012
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chiu LLY, 2011, J CONTROL RELEASE, V155, P376, DOI 10.1016/j.jconrel.2011.05.026
   Chiu LLY, 2011, TISSUE ENG PT A, V17, P1465, DOI 10.1089/ten.tea.2007.0244
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   CHUONG CJ, 1991, AM J PHYSIOL, V260, pH1224
   Clements M, 2014, TOXICOL SCI, V140, P445, DOI 10.1093/toxsci/kfu084
   Clifford DM, 2012, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD006536.pub3, DOI 10.1002/14651858.CD006536.PUB3]
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   Domansky K, 2013, LAB CHIP, V13, P3956, DOI 10.1039/c3lc50558h
   Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/nnano.2011.160, 10.1038/NNANO.2011.160]
   Dykens JA, 2007, EXPERT REV MOL DIAGN, V7, P161, DOI 10.1586/14737159.7.2.161
   Eschenhagen T, 2006, CIRC RES, V98, P573, DOI 10.1161/01.RES.0000215627.13049.5d
   Fleischer S, 2014, NANOSCALE, V6, P9410, DOI 10.1039/c4nr00300d
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Frobel J, 2014, STEM CELL REP, V3, P414, DOI 10.1016/j.stemcr.2014.07.003
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531
   Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a
   Guo L, 2013, TOXICOL SCI, V136, P581, DOI 10.1093/toxsci/kft205
   Guo L, 2013, IEEE T BIOMED CIRC S, V7, P1, DOI 10.1109/TBCAS.2012.2192932
   Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hoshi RA, 2009, ADV MATER, V21, P188, DOI 10.1002/adma.200801132
   Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747
   Iyer RK, 2012, TISSUE ENG PT A, V18, P1771, DOI [10.1089/ten.tea.2011.0468, 10.1089/ten.TEA.2011.0468]
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Johnston ID, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035017
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04670
   Karp JM, 2006, BIOMATERIALS, V27, P4755, DOI 10.1016/j.biomaterials.2006.04.028
   Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799
   Kimura T, 1985, Kokubyo Gakkai Zasshi, V52, P558
   Lamore SD, 2013, TOXICOL SCI, V135, P402, DOI 10.1093/toxsci/kft167
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lasher R. A., 2012, J TISSUE ENG, V3
   Lee J H, 2012, J DRUG DELIV, V2012
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Levine E, 2008, CLEV CLIN J MED, V75, P591, DOI 10.3949/ccjm.75.8.591
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883
   Liau B, 2012, REGEN MED, V7, P187, DOI [10.2217/RME.11.122, 10.2217/rme.11.122]
   Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041
   Lovitt Carrie J, 2014, Biology (Basel), V3, P345, DOI 10.3390/biology3020345
   Ma DR, 2013, INT J CARDIOL, V168, P5277, DOI 10.1016/j.ijcard.2013.08.015
   Ma Z, 2014, BIOMATERIALS, V35, P1367, DOI 10.1016/j.biomaterials.2013.10.052
   MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4
   Maeda H, 2003, J CONTROL RELEASE, V90, P59, DOI 10.1016/S0168-3659(03)00158-5
   Maltman DJ, 2010, BIOCHEM SOC T, V38, P1072, DOI 10.1042/BST0381072
   Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378
   Mendias CL, 2005, FASEB J, V19, pA1118
   Mooney E, 2012, BIOMATERIALS, V33, P6132, DOI 10.1016/j.biomaterials.2012.05.032
   Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679
   Mukherjee S, 2011, J MATER SCI-MATER M, V22, P1689, DOI 10.1007/s10856-011-4351-2
   Mullard A, 2014, NAT REV DRUG DISCOV, V13, P873, DOI 10.1038/nrd4487
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Natarajan A, 2011, BIOMATERIALS, V32, P4267, DOI 10.1016/j.biomaterials.2010.12.022
   Nelson DM, 2014, BIOMACROMOLECULES, V15, P1, DOI 10.1021/bm4010639
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/nmeth.2524, 10.1038/NMETH.2524]
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pahnke A., 2015, BIOMATERIALS CARDIAC, P71
   Piccini JP, 2009, AM HEART J, V158, P317, DOI 10.1016/j.ahj.2009.06.007
   Prabhakaran MP, 2011, MAT SCI ENG C-MATER, V31, P503, DOI 10.1016/j.msec.2010.12.017
   Qian L, 2013, NAT PROTOC, V8, P1204, DOI 10.1038/nprot.2013.067
   Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1
   Ramade A, 2014, METHOD CELL BIOL, V121, P191, DOI 10.1016/B978-0-12-800281-0.00013-0
   Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005
   Reis LA, 2016, J TISSUE ENG REGEN M, V10, P11, DOI 10.1002/term.1944
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Riegler J, 2014, CIRCULATION, V130, pS77, DOI 10.1161/CIRCULATIONAHA.113.007920
   Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sniadecki NJ, 2007, METHOD CELL BIOL, V83, P313, DOI 10.1016/S0091-679X(07)83013-5
   Song HN, 2011, TISSUE ENG PT A, V17, P1869, DOI [10.1089/ten.tea.2010.0617, 10.1089/ten.TEA.2010.0617]
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197
   Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tandon N, 2010, LAB CHIP, V10, P692, DOI 10.1039/b917743d
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   TUNG L, 1992, BIOPHYS J, V63, P371, DOI 10.1016/S0006-3495(92)81632-6
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vieira AC, 2009, J BIOMECH, V42, P2421, DOI 10.1016/j.jbiomech.2009.07.019
   Vyner MC, 2014, BIOMATERIALS, V35, P9041, DOI 10.1016/j.biomaterials.2014.07.023
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   Wang JX, 2013, BIOMATERIALS, V34, P8878, DOI 10.1016/j.biomaterials.2013.07.039
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157
   Xiao Y, 2014, LAB CHIP, V14, P869, DOI 10.1039/c3lc51123e
   Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855
   Yulin X, 2012, FOLIA BIOL-PRAGUE, V58, P221
   Zhang BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494003
   Zhao YM, 2014, CAN J CARDIOL, V30, P1307, DOI 10.1016/j.cjca.2014.08.027
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zwi-Dantsis L, 2013, EUR HEART J, V34, P1575, DOI 10.1093/eurheartj/ehs096
NR 151
TC 19
Z9 19
U1 5
U2 70
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034004
DI 10.1088/1748-6041/10/3/034004
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000006
PM 25989939
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ledda, M
   De Bonis, A
   Bertani, FR
   Cacciotti, I
   Teghil, R
   Lolli, MG
   Ravaglioli, A
   Lisi, A
   Rau, JV
AF Ledda, Mario
   De Bonis, Angela
   Bertani, Francesca Romana
   Cacciotti, Ilaria
   Teghil, Roberto
   Lolli, Maria Grazia
   Ravaglioli, Antonio
   Lisi, Antonella
   Rau, Julietta V.
TI Interdisciplinary approach to cell-biomaterial interactions:
   biocompatibility and cell friendly characteristics of RKKP glass-ceramic
   coatings on titanium
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE glass-ceramics; RKKP films; CaCo-2 cell line; pulsed laser deposition;
   regenerative medicine; tissue engineering
ID INTESTINAL ALKALINE-PHOSPHATASE; BIOACTIVE GLASSES; CACO-2; MODEL; LINE;
   DIFFERENTIATION; ABSORPTION; PROTEINS; GENE
AB In this work, titanium (Ti) supports have been coated with glass-ceramic films for possible applications as biomedical implant materials in regenerative medicine. For the film preparation, a pulsed laser deposition (PLD) technique has been applied. The RKKP glass-ceramic material, used for coating deposition, was a sol-gel derived target of the following composition: Ca-19.4, P-4.6, Si-17.2, O-43.5, Na-1.7, Mg-1.3, F-7.2, K-0.2, La-0.8, Ta-4.1 (all in wt%). The prepared coatings were compact and uniform, characterised by a nanometric average surface roughness. The biocompatibility and cell-friendly properties of the RKKP glass-ceramic material have been tested. Cell metabolic activity and proliferation of human colon carcinoma CaCo-2 cells seeded on RKKP films showed the same exponential trend found in the control plastic substrates. By the phalloidin fluorescence analysis, no significant modifications in the actin distribution were revealed in cells grown on RKKP films. Moreover, in these cells a high mRNA expression of markers involved in protein synthesis, proliferation and differentiation, such as villin (VIL1), alkaline phosphatase (ALP1), beta-actin (beta-ACT), Ki67 and RPL34, was recorded. In conclusion, the findings, for the first time, demonstrated that the RKKP glass-ceramic material allows the adhesion, growth and differentiation of the CaCo-2 cell line.
C1 [Ledda, Mario; Lolli, Maria Grazia; Lisi, Antonella] Inst Translat Pharmacol IFT CNR, I-00133 Rome, Italy.
   [De Bonis, Angela; Teghil, Roberto] Univ Basilicata, Dipartimento Sci, I-85100 Potenza, Italy.
   [Bertani, Francesca Romana] ISC CNR, I-00133 Rome, Italy.
   [Cacciotti, Ilaria] Univ Roma Niccolo Cusano, I-00166 Rome, Italy.
   [Cacciotti, Ilaria] Univ Roma Tor Vergata, Dipartimento Ingn Impresa, I-00133 Rome, Italy.
   [Cacciotti, Ilaria] UdR INSTM Roma Tor Vergata, I-00133 Rome, Italy.
   [Ravaglioli, Antonio] Ceram Sci & Technol, I-48018 Faenza, Italy.
   [Rau, Julietta V.] ISM CNR, I-00133 Rome, Italy.
RP Ledda, M (reprint author), Inst Translat Pharmacol IFT CNR, Via Fosso Cavaliere 100, I-00133 Rome, Italy.
EM antonella.lisi@ift.cnr.it; giulietta.rau@ism.cnr.it
RI Rau, Julietta/E-6598-2017; Ledda, Mario/B-5656-2015; Cacciotti,
   Ilaria/K-9941-2016; Bertani, Francesca/I-5968-2016; Lisi,
   Antonella/C-7024-2015
OI Rau, Julietta/0000-0002-7953-1853; Ledda, Mario/0000-0002-0349-8938;
   Bertani, Francesca/0000-0001-6529-8993; Lisi,
   Antonella/0000-0002-5465-9500; De Bonis, Angela/0000-0002-1177-2896;
   TEGHIL, ROBERTO/0000-0002-8528-8669; Cacciotti,
   Ilaria/0000-0002-3478-6510
CR Basson MD, 1996, EXP CELL RES, V225, P301, DOI 10.1006/excr.1996.0180
   Bellucci D, 2010, SCI SINTER, V42, P307, DOI 10.2298/SOS1003307B
   BRETSCHER A, 1979, P NATL ACAD SCI USA, V76, P2321, DOI 10.1073/pnas.76.5.2321
   Cacciotti I, 2012, J MATER SCI-MATER M, V23, P1849, DOI 10.1007/s10856-012-4667-6
   Delie F, 1997, CRIT REV THER DRUG, V14, P221
   Farooq I., 2012, WORLD J DENT, V3, P199, DOI DOI 10.5005/JP-JOURNALS-10015-1156
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2013, NEW J GLASS CERAM, V3, P67, DOI DOI 10.4236/NJGC.2013.32011
   HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234
   HENTHORN PS, 1988, J BIOL CHEM, V263, P12011
   HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jones J. R, 2012, BIOGLASSES INTRO
   Krajewski A, 2005, J MATER SCI-MATER M, V16, P119, DOI 10.1007/s10856-005-5913-y
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   Ledda M, 2011, EUR REV MED PHARMACO, V15, P61
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lombardi M, 2014, CERAM INT, V41, P3371
   Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003
   Pelton AD, 1999, J NON-CRYST SOLIDS, V253, P178, DOI 10.1016/S0022-3093(99)00352-X
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rau JV, 2012, MATER RES BULL, V47, P1130, DOI 10.1016/j.materresbull.2012.02.011
   Ravaglioli A, 2008, ADV APPL CERAM, V107, P268, DOI 10.1179/174367608X341488
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Turck N, 2005, EXP CELL RES, V303, P494, DOI 10.1016/j.yexcr.2004.10.025
   Zhang XH, 2003, SURGERY, V133, P429, DOI 10.1067/msy.2003.107
NR 26
TC 6
Z9 7
U1 0
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 035005
DI 10.1088/1748-6041/10/3/035005
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000019
PM 26040849
DA 2018-10-19
ER

PT J
AU Shevach, M
   Zax, R
   Abrahamov, A
   Fleischer, S
   Shapira, A
   Dvir, T
AF Shevach, Michal
   Zax, Rotem
   Abrahamov, Alona
   Fleischer, Sharon
   Shapira, Assaf
   Dvir, Tal
TI Omentum ECM-based hydrogel as a platform for cardiac cell delivery
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; COLLAGEN; DISEASE; FIBROBLASTS; CLEARANCE;
   SCAFFOLDS; HEALTH
AB Cardiovascular diseases remain the number one killer in Western countries. Despite recent advances and promising results in cardiac cell-based therapy, one of the remaining challenges is poor cell retention in the desired site. As a solution, cell delivery systems are developed to ensure that a sufficient number of viable cells reach the infarct area. These delivery systems are based on biomaterials that provide a surrogate microenvironment for the encapsulated cells, retaining them in the desired location post-delivery. Injectable thermoresponsive ECM-based hydrogels have been developed to achieve this goal. Unfortunately, the use of allogeneic or xenogeneic ECM may hamper the treatment due to an immune response to residual cellular content from the host. In this work, we have developed an omentum-based hydrogel capable of self-assembly under physiological conditions. Although in this study the omentum was obtained from porcine sources, it can be easily and safely extracted from the patient, serving as an autologous protective vehicle for the transported cells. We have characterized the biochemical composition, mechanical properties, and gelation and degradation kinetics of the processed biomaterial. Furthermore, the ability of the hydrogel to encapsulate cardiac cells and support their culture was evaluated. We envision that the newly developed platform may open new opportunities for personalized cell delivery to the heart and other tissues.
C1 [Shevach, Michal; Zax, Rotem; Abrahamov, Alona; Fleischer, Sharon; Shapira, Assaf; Dvir, Tal] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Lab Tissue Engn & Regenerat Med, IL-69978 Tel Aviv, Israel.
   [Shevach, Michal; Fleischer, Sharon; Dvir, Tal] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel.
   [Dvir, Tal] Tel Aviv Univ, Dept Mat Sci & Engn, IL-69978 Tel Aviv, Israel.
RP Shevach, M (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Lab Tissue Engn & Regenerat Med, IL-69978 Tel Aviv, Israel.
EM tdvir@post.tau.ac.il
FU Moxie Foundation; European Union; Alon Fellowship; Israel Science
   Foundation; Nicholas and Elizabeth Slezak Super Center for Cardiac
   Research and Biomedical Engineering at Tel Aviv University; NA'AMAT
   women's organization, Israel
FX T D acknowledges support from the Moxie Foundation, European Union FP7
   program (Marie Curie, CIG), Alon Fellowship, Israel Science Foundation
   and the Nicholas and Elizabeth Slezak Super Center for Cardiac Research
   and Biomedical Engineering at Tel Aviv University. M S thanks the
   NA'AMAT women's organization, Israel, for the NA'AMAT women's
   organization scholarship. This work is part of the doctoral thesis of M
   S. We would like to thank Dr Boaz Mizrahi and Ms Regina Kelmansky for
   their initial help with the rheology experiments.
CR Abe T, 2012, INT J SURG CASE REP, V3, P100, DOI 10.1016/j.ijscr.2011.11.004
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Benedicto HG, 2011, MICROSC RES TECHNIQ, V74, P1018, DOI 10.1002/jemt.20988
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Chan RW, 1998, LARYNGOSCOPE, V108, P725, DOI 10.1097/00005537-199805000-00019
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   Graham HK, 2008, ACTA PHYSIOL, V194, P3, DOI 10.1111/j.1748-1716.2008.01881.x
   Holloway JL, 2014, J CONTROL RELEASE, V191, P63, DOI 10.1016/j.jconrel.2014.05.053
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Johnston N, 2007, LARYNGOSCOPE, V117, P1036, DOI 10.1097/M1LG.0b013e31804154c3
   Keane T J, 2014, J TISSUE ENG REGEN M, V9, P504
   Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096
   Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Merenda Marcin, 2013, Pol Przegl Chir, V85, P323, DOI 10.2478/pjs-2013-0048
   Radic M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00365
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Shevach M, 2014, NANO LETT, V14, P5792, DOI 10.1021/nl502673m
   Shevach M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024101
   Shevach M, 2013, J MATER CHEM B, V1, P5210, DOI 10.1039/c3tb20584c
   Soffer-Tsur N, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035023
   Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871
   WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
NR 34
TC 11
Z9 11
U1 1
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034106
DI 10.1088/1748-6041/10/3/034106
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000014
PM 25970726
DA 2018-10-19
ER

PT J
AU Stoppel, WL
   Hu, DJ
   Domian, IJ
   Kaplan, DL
   Black, LD
AF Stoppel, Whitney L.
   Hu, Dongjian
   Domian, Ibrahim J.
   Kaplan, David L.
   Black, Lauren D., III
TI Anisotropic silk biomaterials containing cardiac extracellular matrix
   for cardiac tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE cardiomyocytes; integrins; cell infiltration; acellular scaffold
ID AMERICAN-HEART-ASSOCIATION; MESENCHYMAL STEM-CELLS; RANDOMIZED PHASE-1
   TRIAL; MYOCARDIAL-INFARCTION; SKELETAL MYOBLASTS; IN-VITRO;
   CARDIOMYOCYTES; REPAIR; REGENERATION; SCAFFOLDS
AB Cardiac malformations and disease are the leading causes of death in the United States in live-born infants and adults, respectively. In both of these cases, a decrease in the number of functional cardiomyocytes often results in improper growth of heart tissue, wound healing complications, and poor tissue repair. The field of cardiac tissue engineering seeks to address these concerns by developing cardiac patches created from a variety of biomaterial scaffolds to be used in surgical repair of the heart. These scaffolds should be fully degradable biomaterial systems with tunable properties such that the materials can be altered to meet the needs of both in vitro culture (e.g. disease modeling) and in vivo application (e.g. cardiac patch). Current platforms do not utilize both structural anisotropy and proper cell-matrix contacts to promote functional cardiac phenotypes and thus there is still a need for critically sized scaffolds that mimic both the structural and adhesive properties of native tissue. To address this need, we have developed a silk-based scaffold platform containing cardiac tissue-derived extracellular matrix (cECM). These silk-cECM composite scaffolds have tunable architectures, degradation rates, and mechanical properties. Subcutaneous implantation in rats demonstrated that addition of the cECM to aligned silk scaffold led to 99% endogenous cell infiltration and promoted vascularization of a critically sized scaffold (10 x 5 x 2.5 mm) after 4 weeks in vivo. In vitro, silk-cECM scaffolds maintained the HL-1 atrial cardiomyocytes and human embryonic stem cell-derived cardiomyocytes and promoted a more functional phenotype in both cell types. This class of hybrid silk-cECM anisotropic scaffolds offers new opportunities for developing more physiologically relevant tissues for cardiac repair and disease modeling.
C1 [Stoppel, Whitney L.; Kaplan, David L.; Black, Lauren D., III] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Hu, Dongjian; Domian, Ibrahim J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.
   [Domian, Ibrahim J.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.
   [Black, Lauren D., III] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Cellular Mol & Dev Biol Program, Boston, MA 02111 USA.
RP Stoppel, WL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM lauren.black@tufts.edu
OI Black, Lauren/0000-0002-7486-5811
FU National Institutes of Health Institutional Research and Academic Career
   Development Awards program at Tufts University [K12GM074869]; NIH
   [EB002520]
FX The authors would like to acknowledge Dr William Claycomb, professor in
   the Department of Biochemistry and Molecular Biology at the Louisiana
   State University School of Medicine for his kind donation of HL-1 cells
   for use in this work. In addition, WLS would like to acknowledge funding
   from the National Institutes of Health Institutional Research and
   Academic Career Development Awards program at Tufts University
   (K12GM074869, Training in Education and Critical Research Skills
   (TEACRS)). We also thank the NIH P41 (EB002520) for support of this
   work.
CR Atmanli A, 2014, ADV HEALTHC MATER, V3, P1759, DOI 10.1002/adhm.201400010
   Black LD, 2009, TISSUE ENG PT A, V15, P3099, DOI [10.1089/ten.tea.2008.0502, 10.1089/ten.TEA.2008.0502]
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Brown JW, 2007, J THORAC CARDIOV SUR, V133, P1336, DOI 10.1016/j.jtcvs.2006.12.045
   Buckberg G, 2008, CIRCULATION, V118, P2571, DOI 10.1161/CIRCULATIONAHA.107.754424
   Buikema JW, 2013, DEVELOPMENT, V140, P4165, DOI 10.1242/dev.099325
   Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979
   Durrani S, 2010, REGEN MED, V5, P919, DOI [10.2217/rme.10.65, 10.2217/RME.10.65]
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Fink C, 2000, FASEB J, V14, P669
   Formigli L, 2010, CURR PHARM DESIGN, V16, P915, DOI 10.2174/138161210790883390
   French K M, 2012, FASEB J S, V26
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Gershlaka JR, 2015, EXP CELL RES, V330, P311, DOI 10.1016/j.yexcr.2014.09.007
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Hauser M, 2013, HEART ASIA, V5, P106, DOI 10.1136/heartasia-2013-010319
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Johnson Todd D, 2014, Methods Mol Biol, V1181, P109, DOI 10.1007/978-1-4939-1047-2_10
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kreutziger KL, 2011, PEDIATR CARDIOL, V32, P334, DOI 10.1007/s00246-011-9888-9
   Lan JY, 2014, CELL MOL BIOENG, V7, P432, DOI 10.1007/s12195-014-0346-7
   Lee WY, 2011, BIOMATERIALS, V32, P5558, DOI 10.1016/j.biomaterials.2011.04.031
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Morgan KY, 2014, TISSUE ENG PT A, V20, P1654, DOI [10.1089/ten.tea.2013.0355, 10.1089/ten.TEA.2013.0355]
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/nmeth.2524, 10.1038/NMETH.2524]
   Osterziel KJ, 2007, EUR HEART J, V28, P638, DOI 10.1093/eurheartj/ehl515
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Pok S, 2014, TISSUE ENG PT A, V20, P1877, DOI [10.1089/ten.tea.2013.0620, 10.1089/ten.TEA.2013.0620]
   Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seif-Naraghi S, 2010, JOVE-J VIS EXP, P2109
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sullivan KE, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt403
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tran N, 2006, CELL TRANSPLANT, V15, P351, DOI 10.3727/000000006783981918
   Turnbull IC, 2014, FASEB J, V28, P644, DOI 10.1096/fj.13-228007
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003
   Williams C, 2014, ACTA BIOMATER, V10, P194, DOI 10.1016/j.actbio.2013.08.037
   Williams C, 2015, ACTA BIOMATER, V14, P84, DOI 10.1016/j.actbio.2014.11.035
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Ye K Y, 2011, JOVE-J VIS EXP, P3251
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 57
TC 18
Z9 19
U1 0
U2 58
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034105
DI 10.1088/1748-6041/10/3/034105
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000013
PM 25826196
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wang, Q
   Wang, MH
   Wang, KF
   Liu, YL
   Zhang, HP
   Lu, X
   Zhang, XD
AF Wang, Qun
   Wang, Meng-hao
   Wang, Ke-feng
   Liu, Yaling
   Zhang, Hong-ping
   Lu, Xiong
   Zhang, Xing-dong
TI Computer simulation of biomolecule-biomaterial interactions at surfaces
   and interfaces
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE biomaterials; biomolecules; computer simulation; hydroxyapatite;
   titanium oxide; graphene and graphene oxide
ID DENSITY-FUNCTIONAL THEORY; MOLECULAR-DYNAMICS SIMULATION; HYDROXYAPATITE
   001 SURFACE; TITANIUM-OXIDE SURFACES; METAL-DOPED GRAPHENE; AB-INITIO;
   PEPTIDE ADSORPTION; CARBON NANOTUBES; CITRIC-ACID; CHEMICAL
   FUNCTIONALIZATION
AB Biomaterial surfaces and interfaces are intrinsically complicated systems because they involve biomolecules, implanted biomaterials, and complex biological environments. It is difficult to understand the interaction mechanism between biomaterials and biomolecules through conventional experimental methods. Computer simulation is an effective way to study the interaction mechanism at the atomic and molecular levels. In this review, we summarized the recent studies on the interaction behaviors of biomolecules with three types of the most widely used biomaterials: hydroxyapatite (HA), titanium oxide (TiO2), and graphene(G)/graphene oxide(GO). The effects of crystal forms, crystallographic planes, surface defects, doping atoms, and water environments on biomolecules adsorption are discussed in detail. This review provides valuable theoretical guidance for biomaterial designing and surface modification.
C1 [Wang, Qun; Wang, Meng-hao; Lu, Xiong] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ, Chengdu 610031, Sichuan, Peoples R China.
   [Wang, Qun] MianYang Normal Univ, Coll Life Sci & Technol, Mianyang 621000, Sichuan, Peoples R China.
   [Wang, Ke-feng; Zhang, Xing-dong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610065, Sichuan, Peoples R China.
   [Liu, Yaling] Lehigh Univ, Dept Mech Engn & Mech, Bioengn Program, Bethlehem, PA USA.
   [Zhang, Hong-ping] Southwest Univ Sci & Technol, Sch Mat Sci & Engn, Engn Res Ctr Biomass Mat, Minist Educ, Mianyang 621010, Sichuan, Peoples R China.
RP Wang, Q (reprint author), Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ, Chengdu 610031, Sichuan, Peoples R China.
EM carlcili@163.com; wangmenghao@gmail.com; fencal@163.com;
   zhp1006@126.com; luxiong_2004@163.com; zhangxd@scu.edu.cn
RI LU, xiong/B-3092-2010
OI LU, xiong/0000-0001-6367-430X
FU 863 Program [2015AA034202]; NSFC [51202152]; Sichuan Youth
   Science-Technology Foundation [2011JQ0010]; Construction Program for
   Innovative Research Team of University in Sichuan Province [14TD0050]
FX This project was financially supported by 863 Program (2015AA034202),
   NSFC (51202152), Sichuan Youth Science-Technology Foundation
   (2011JQ0010), Construction Program for Innovative Research Team of
   University in Sichuan Province (14TD0050).
CR Abergel DSL, 2010, ADV PHYS, V59, P261, DOI 10.1080/00018732.2010.487978
   Akdim B, 2013, ACS APPL MATER INTER, V5, P7470, DOI 10.1021/am401731c
   Al-Aqtash N, 2009, J PHYS CHEM C, V113, P12970, DOI 10.1021/jp902280f
   Almora-Barrios N, 2010, LANGMUIR, V26, P14535, DOI 10.1021/la101151e
   Almora-Barrios N, 2010, CRYSTENGCOMM, V12, P960, DOI 10.1039/b917179g
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Azzopardi PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009330
   Barinov A, 2009, J PHYS CHEM C, V113, P9009, DOI 10.1021/jp902051d
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Baweja L, 2013, LANGMUIR, V29, P14230, DOI 10.1021/la4033805
   Becton M, 2013, CHEM PHYS LETT, V584, P135, DOI 10.1016/j.cplett.2013.08.027
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Biswas S, 2013, J BIOMATER NANOBIOTE, V4, P351
   Boukhvalov DW, 2008, NANO LETT, V8, P4373, DOI 10.1021/nl802098g
   Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j
   Cazorla C, 2010, THIN SOLID FILMS, V518, P6951, DOI 10.1016/j.tsf.2010.06.068
   Chen X, 2008, BIOMATERIALS, V29, P2423, DOI 10.1016/j.biomaterials.2008.02.002
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Cortes-Arriagada D, 2013, J MOL MODEL, V19, P3569, DOI 10.1007/s00894-013-1872-2
   Costa D, 2011, LANGMUIR, V27, P2747, DOI 10.1021/la104317j
   Costa D, 2013, J BIOMED MATER RES A, V101, P1210, DOI 10.1002/jbm.a.34416
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   de Pablo JJ, 2014, CURR OPIN SOLID ST M, V18, P99, DOI 10.1016/j.cossms.2014.02.003
   Denis PA, 2013, J PHYS CHEM C, V117, P19048, DOI 10.1021/jp4061945
   Diebold U, 2003, APPL PHYS A-MATER, V76, P681, DOI 10.1007/s00339-002-2004-5
   Ding N, 2012, COMP MATER SCI, V51, P141, DOI 10.1016/j.commatsci.2011.07.045
   Dong XL, 2011, MOL SIMULAT, V37, P1097, DOI 10.1080/08927022.2011.582108
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   Friesner RA, 2005, P NATL ACAD SCI USA, V102, P6648, DOI 10.1073/pnas.0408036102
   [傅强 FU Qiang], 2009, [科学通报, Chinese Science Bulletin], V54, P2657, DOI 10.1360/972009-1537
   Ghaderi N, 2010, J PHYS CHEM C, V114, P21625, DOI 10.1021/jp108688m
   Guo TL, 2014, MOLECULES, V19, P149, DOI 10.3390/molecules19010149
   Guo YN, 2013, J PHYS CHEM C, V117, P5708, DOI 10.1021/jp310088e
   Guo YN, 2011, J PHYS CHEM C, V115, P18572, DOI 10.1021/jp200598t
   Hartree DR, 1928, P CAMB PHILOS SOC, V24, P89
   He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Ingolfsson HI, 2014, WIRES COMPUT MOL SCI, V4, P225, DOI 10.1002/wcms.1169
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Kang HS, 2005, J AM CHEM SOC, V127, P9839, DOI 10.1021/ja0509681
   Kang Y, 2010, J PHYS CHEM C, V114, P14496, DOI 10.1021/jp1037156
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kavathekar RS, 2011, MOL PHYS, V109, P1649, DOI 10.1080/00268976.2011.582051
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim SN, 2011, J AM CHEM SOC, V133, P14480, DOI 10.1021/ja2042832
   Lai ZB, 2014, J MECH BEHAV BIOMED, V36, P12, DOI 10.1016/j.jmbbm.2014.04.002
   Landis WJ, 2009, CELLS TISSUES ORGANS, V189, P20, DOI 10.1159/000151454
   Larson RG, 2004, MOL PHYS, V102, P341, DOI 10.1080/00268970310001640102
   Li DC, 2009, INT J APPL MECH, V1, P113, DOI 10.1142/S1758825109000034
   Li M, 2014, ADV FUNCT MATER, V24, P1631, DOI 10.1002/adfm.201302242
   Liao CY, 2014, RSC ADV, V4, P15759, DOI 10.1039/c3ra47381c
   Liu J, 2013, J PHYS CHEM C, V117, P13037, DOI 10.1021/jp4001972
   Liu XY, 2014, APPL SURF SCI, V293, P216, DOI 10.1016/j.apsusc.2013.12.137
   Liu Y, 2013, BIOMACROMOLECULES, V14, P3321, DOI 10.1021/bm400930k
   Lou ZY, 2012, APPL SURF SCI, V258, P4911, DOI 10.1016/j.apsusc.2012.01.116
   Lu X, 2011, CRYSTENGCOMM, V13, P3741, DOI 10.1039/c0ce00971g
   Ma XY, 2008, BIOMATERIALS, V29, P257, DOI 10.1016/j.biomaterials.2007.10.001
   Miao W, 2013, BIOMATERIALS, V34, P9638, DOI 10.1016/j.biomaterials.2013.08.058
   Monti S, 2011, J PHYS CHEM C, V115, P24238, DOI 10.1021/jp207950p
   Muir JMR, 2014, SURF SCI, V624, P8, DOI 10.1016/j.susc.2014.01.005
   Muir JMR, 2013, SURF SCI, V617, P60, DOI 10.1016/j.susc.2013.07.009
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Ogiso M, 1998, J BIOMED MATER RES, V43, P318, DOI 10.1002/(SICI)1097-4636(199823)43:3<318::AID-JBM13>3.0.CO;2-B
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rajesh C, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3079096
   Ramachandran A, 2011, J PHYS CHEM B, V115, P6138, DOI 10.1021/jp101052x
   Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044
   Rhee SH, 1999, BIOMATERIALS, V20, P2155, DOI 10.1016/S0142-9612(99)00118-0
   Rimola A, 2012, PHILOS T R SOC A, V370, P1478, DOI 10.1098/rsta.2011.0236
   Saikia N, 2013, J COMPUT AID MOL DES, V27, P807, DOI 10.1007/s10822-013-9681-3
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sayyar S, 2013, CARBON, V52, P296, DOI 10.1016/j.carbon.2012.09.031
   Seitz R, 2005, APPL SURF SCI, V252, P154, DOI 10.1016/j.apsusc.2005.02.012
   SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X
   Streeter I, 2011, P ROY SOC A-MATH PHY, V467, P2084, DOI 10.1098/rspa.2010.0559
   Szieberth D, 2010, PHYS CHEM CHEM PHYS, V12, P11033, DOI 10.1039/c004155f
   Taylor WR, 2010, J MOL GRAPH MODEL, V29, P266, DOI 10.1016/j.jmgm.2010.06.004
   Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w
   Vovusha H, 2013, J PHYS CHEM LETT, V4, P3710, DOI 10.1021/jz401929h
   Wang CC, 2006, J PHYS CHEM B, V110, P10266, DOI 10.1021/jp060412f
   Wang KF, 2012, J MATER SCI-MATER M, V23, P1045, DOI 10.1007/s10856-012-4570-1
   Wang MH, 2014, CHEM PHYS LETT, V599, P86, DOI 10.1016/j.cplett.2014.03.024
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   Wu CY, 2010, LANGMUIR, V26, P15972, DOI 10.1021/la103010c
   Xu H, 2013, BIOSENS BIOELECTRON, V50, P251, DOI 10.1016/j.bios.2013.06.039
   Xu LY, 2014, J COLLOID INTERF SCI, V418, P66, DOI 10.1016/j.jcis.2013.12.005
   Yang J, 2013, BIOSENS BIOELECTRON, V47, P530, DOI 10.1016/j.bios.2013.03.051
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Zaib Q, 2012, WATER AIR SOIL POLL, V223, P3281, DOI 10.1007/s11270-012-1109-5
   Zhang HP, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044110
   Zhang HP, 2008, J MATER SCI-MATER M, V19, P3437, DOI 10.1007/s10856-008-3498-y
   Zhang HP, 2014, PHYSICA E, V61, P83, DOI 10.1016/j.physe.2014.03.017
   Zhang HP, 2013, APPL SURF SCI, V283, P559, DOI 10.1016/j.apsusc.2013.06.145
   Zhang HP, 2011, J BIOMED MATER RES A, V96A, P466, DOI 10.1002/jbm.a.33003
   Zhang HP, 2009, ACTA BIOMATER, V5, P1169, DOI 10.1016/j.actbio.2008.11.014
   Zhang T, 2012, NANO TODAY, V7, P180, DOI 10.1016/j.nantod.2012.04.006
   Zhang ZX, 2011, J MOL MODEL, V17, P649, DOI 10.1007/s00894-010-0760-2
   Zhou H, 2007, BIOCHEM BIOPH RES CO, V361, P91, DOI 10.1016/j.bbrc.2007.06.169
NR 104
TC 8
Z9 8
U1 11
U2 107
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 032001
DI 10.1088/1748-6041/10/3/032001
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000002
PM 26065541
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Kuraitis, D
   Burgon, PG
   Crowe, S
   Vulesevic, B
   Beanlands, RS
   Dekemp, RA
   DaSilva, JN
   Ruel, M
   Suuronen, EJ
AF Zhang, Yan
   Kuraitis, Drew
   Burgon, Patrick G.
   Crowe, Suzanne
   Vulesevic, Branka
   Beanlands, Rob S.
   Dekemp, Robert A.
   DaSilva, Jean N.
   Ruel, Marc
   Suuronen, Erik J.
TI Development of reporter gene imaging techniques for long-term assessment
   of human circulating angiogenic cells
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE circulating angiogenic cells; reporter gene imaging; lentiviral vectors;
   cell function; biomatrix
ID MYOCARDIAL-INFARCTION; COLLAGEN MATRIX; LIVING SUBJECTS; THERAPY;
   DELIVERY; SYSTEMS; REGENERATION; SURVIVAL; VECTORS; HEART
AB The use of biomaterials and tracking the long-term fate of the transplanted cells is expected to help improve the clinical translation of cell therapies for cardiac regeneration. To this end, reporter gene strategies are promising for monitoring the fate of cells transplanted with or without a delivery biomaterial; however, their application with primary adult progenitor cells (such as human circulating angiogenic cells (CACs)) has not been extensively evaluated. In this study, human CACs were transduced with reporter genes via one of two lentiviral (LV) vectors: LV-GFP-iresTK or LV-Fluc-RFP-tTK. The mean transduction efficiency was 15% (LV-GFP-iresTK) and 13% (LV-Fluc-RFP-tTK) at multiplicities of infection (MOI) of 10 and 50, respectively. Western blot analysis confirmed HSV1-tk protein expression in transduced CACs. There was no significant difference in viability between the transduced CACs and the untreated controls at a MOI of 50 or below. However, a reduction was observed in cell viability of CACs transduced with LV-Fluc-RFP-tTK at an MOI of 100. Cell migration and angiogenic potential were not affected by transduction protocol. After 4 weeks, 80.3 +/- 8.4% of the labeled cells continued to express the reporters and could be visualized when embedded within a collagen matrix scaffold. Therefore, quiescent human CACs can be stably transduced to express reporter genes without affecting their function. This reporter gene technique is a promising approach to be further tested for tracking transplanted CACs (+/- delivery matrix) noninvasively and longitudinally.
C1 [Zhang, Yan; Kuraitis, Drew; Crowe, Suzanne; Vulesevic, Branka; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Beanlands, Rob S.; Dekemp, Robert A.; DaSilva, Jean N.] Univ Ottawa, Inst Heart, Natl Cardiac PET Ctr, Ottawa, ON K1Y 4W7, Canada.
   [Burgon, Patrick G.; Beanlands, Rob S.; Dekemp, Robert A.; DaSilva, Jean N.] Univ Ottawa, Inst Heart, Dept Med, Div Cardiol, Ottawa, ON K1Y 4W7, Canada.
   [Zhang, Yan; Kuraitis, Drew; Burgon, Patrick G.; Vulesevic, Branka; Beanlands, Rob S.; DaSilva, Jean N.; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
   [DaSilva, Jean N.] Univ Montreal Hosp, Res Ctr, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ H2X 0A9, Canada.
   [Zhang, Yan] Cent Hosp, Shenyang Med Coll, Dept Med, Div Cardiol, Shenyang 110024, Peoples R China.
RP Zhang, Y (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
EM mruel@ottawaheart.ca; esuuronen@ottawaheart.ca
RI Beanlands, Rob/M-2105-2017
OI Beanlands, Rob/0000-0001-7857-8169; Burgon, Patrick/0000-0003-4771-023X;
   RUEL, MARC/0000-0002-0487-1319
FU Canadian Institutes of Health Research [MOP-77536]; Heart and Stroke
   Foundation of Ontario [PRG 6242, NA6121]; Heart and Stroke Foundation of
   Canada; Canadian Institutes of Health Research Canadian Graduate
   Scholarships
FX The authors would like to thank Dr Joseph Wu, Stanford University, for
   kindly providing the plasmid vector for pUb-Fluc-RFP-tTK. This work was
   supported by the Canadian Institutes of Health Research (to Drs Ruel and
   Suuronen, grant MOP-77536), and the Heart and Stroke Foundation of
   Ontario (to Dr Beanlands, program grant PRG 6242; to Dr Suuronen,
   grant-in-aid NA6121). Dr Beanlands is a Career Investigator of the Heart
   and Stroke Foundation of Ontario; Dr Zhang was supported by a Heart and
   Stroke Foundation of Canada Doctoral Research Award, and Drs Kuraitis
   and Vulesevic by Canadian Institutes of Health Research Canadian
   Graduate Scholarships.
CR Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Ahmadi A, 2015, BIOMATERIALS, V49, P18, DOI 10.1016/j.biomaterials.2015.01.016
   Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028
   Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONHA.105.588954
   Choi HS, 2013, NAT BIOTECHNOL, V31, P148, DOI 10.1038/nbt.2468
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Furukawa T, 2006, NUCL MED BIOL, V33, P145, DOI 10.1016/j.nucmedbio.2005.07.013
   Gil JS, 2013, MOL IMAGING BIOL, V15, P273, DOI 10.1007/s11307-012-0596-5
   Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Katz MG, 2013, HUM GENE THER, V24, P914, DOI 10.1089/hum.2013.2517
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y
   Leyva FJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-13
   McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53
   McNeill B, 2014, FASEB J
   Niu G, 2012, THERANOSTICS, V2, P413, DOI 10.7150/thno.3940
   Ponomarev V, 2007, J NUCL MED, V48, P819, DOI 10.2967/jnumed.106.036962
   Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003
   Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816
   Ray P, 2011, J BIOSCIENCES, V36, P499, DOI 10.1007/s12038-011-9079-0
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Sheikh Ahmad Y, 2006, Curr Cardiol Rep, V8, P147, DOI 10.1007/s11886-006-0026-x
   Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291
   Zhang Ya-Ping, 2010, Zoological Research, V31, P1
NR 26
TC 0
Z9 0
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034104
DI 10.1088/1748-6041/10/3/034104
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000012
PM 25782444
DA 2018-10-19
ER

PT J
AU Jimenez, RA
   Millan, D
   Suesca, E
   Sosnik, A
   Fontanilla, MR
AF Jimenez, Ronald A.
   Millan, Diana
   Suesca, Edward
   Sosnik, Alejandro
   Fontanilla, Marta R.
TI Controlled release of an extract of Calendula officinalis flowers from a
   system based on the incorporation of gelatin-collagen microparticles
   into collagen I scaffolds: design and in vitro performance
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Wound healing; Collagen I scaffolds; Calendula officinalis L. flowers
   extract; Polyphenols; Gelatin-collagen microparticle-loaded skin
   dressings
ID ARTIFICIAL CONNECTIVE-TISSUE; FIBROBLAST-GROWTH-FACTOR; CONTROLLED
   DRUG-RELEASE; ENGINEERING APPLICATIONS; OXIDATIVE STRESS; MICROSPHERES;
   REGENERATION; DEXAMETHASONE; BIOMATERIAL; HYDROGELS
AB Aiming to develop biological skin dresses with improved performance in the treatment of skin wounds, acellular collagen I scaffolds were modified with polymeric microparticles and the subsequent loading of a hydroglycolic extract of Calendula officinalis flowers. Microparticles made of gelatin-collagen were produced by a water-in-oil emulsion/crosslinking method. Thereafter, these microparticles were mixed with collagen suspensions at three increasing concentrations and the resulting mixtures lyophilized to make microparticle-loaded porous collagen scaffolds. Resistance to enzymatic degradation, ability to associate with the C. officinalis extract, and the extract release profile of the three gelatin-collagen microparticle-scaffold prototypes were assessed in vitro and compared to collagen scaffolds without microparticles used as control. Data indicated that the incorporation of gelatin-collagen microparticles increased the resistance of the scaffolds to in vitro enzymatic degradation, as well as their association with the C. officinalis flower extract. In addition, a sharp decrease in cytotoxicity, as well as more prolonged release of the extract, was attained. Overall results support the potential of these systems to develop innovative dermal substitutes with improved features. Furthermore, the gelatin-collagen mixture represents a low-cost and scalable alternative with high clinical transferability, especially appealing in developing countries.
C1 [Jimenez, Ronald A.; Millan, Diana; Suesca, Edward; Fontanilla, Marta R.] Univ Nacl Colombia, Dept Pharm, Tissue Engn Grp, Bogota, Colombia.
   [Millan, Diana] Univ El Bosque, Fac Med, Bogota, Colombia.
   [Sosnik, Alejandro] Technion Israel Inst Technol, Dept Mat Sci & Engn, Haifa, Israel.
RP Fontanilla, MR (reprint author), Univ Nacl Colombia, Dept Pharm, Tissue Engn Grp, AveCarrera 30 45-10, Bogota, Colombia.
EM mrfontanillad@unal.edu.co
FU Universidad Nacional de Colombia; Colombian Department of Science,
   Technology and Innovation (COLCIENCIAS) [1101-521-28661,
   1101-452-21387]; Faculty of Science at Universidad Nacional de Colombia
FX This work was supported by Universidad Nacional de Colombia and the
   Colombian Department of Science, Technology and Innovation (COLCIENCIAS)
   (grants 1101-521-28661 and 1101-452-21387). We would like to thank
   Gabriel Zea Jimenez for his contribution to the preliminary experiments
   and "Fundacion Instituto de Inmunologia de Colombia" for lending us
   facilities to make the microparticles. Ronald Jimenez was financed by
   the Faculty of Science at Universidad Nacional de Colombia (teaching
   assistant scholarship) and by COLCIENCIAS (grant 1101-521-28661). Edward
   Suesca and Diana Millan were also supported by COLCIENCIAS (grants
   1101-452-21387 and 1101-521-28661).
CR Basch Ethan, 2006, Journal of Herbal Pharmacotherapy, V6, P135, DOI 10.1300/J157v06n03_08
   Brown DJ, 1998, ARCH DERMATOL, V134, P1401, DOI 10.1001/archderm.134.11.1401
   DeFail AJ, 2006, J BIOMED MATER RES A, V79A, P954, DOI 10.1002/jbm.a.30865
   Espinosa L, 2010, TISSUE ENG PT A, V16, P1667, DOI [10.1089/ten.tea.2008.0571, 10.1089/ten.TEA.2008.0571]
   Fonseca YM, 2010, J ETHNOPHARMACOL, V127, P596, DOI 10.1016/j.jep.2009.12.019
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Galeska I, 2005, AAPS J, V7, pE231, DOI 10.1208/aapsj070122
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Bustos RH, 2014, ANAL CHEM, V86, P2421, DOI 10.1021/ac4033164
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   International Organization for Standardization, 2009, 109935 ISO, P1
   Ju YM, 2010, J BIOMED MATER RES A, V93A, P200, DOI 10.1002/jbm.a.32512
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kikkinides ES, 1998, J CONTROL RELEASE, V51, P313, DOI 10.1016/S0168-3659(97)00182-X
   Kimura Y, 2010, J TISSUE ENG REGEN M, V4, P55, DOI 10.1002/term.218
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   MURPHY GF, 1990, LAB INVEST, V62, P305
   Preethi KC, 2009, INDIAN J EXP BIOL, V47, P113
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Fontanilla MR, 2012, TISSUE ENG PT A, V18, P1857, DOI [10.1089/ten.TEA.2011.0421, 10.1089/ten.tea.2011.0421]
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004
   Shah VP, 1998, PHARMACEUT RES, V15, P889, DOI 10.1023/A:1011976615750
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   USP, 2013, BIOL REACT TESTS IN, V87, P36
   USP, 2013, BIOL REACT TESTS IN, P1832
   Tran VT, 2011, INT J PHARMACEUT, V407, P1, DOI 10.1016/j.ijpharm.2011.01.027
   Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
NR 34
TC 5
Z9 5
U1 0
U2 18
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD JUN
PY 2015
VL 5
IS 3
BP 209
EP 218
DI 10.1007/s13346-015-0217-3
PG 10
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA CM0MG
UT WOS:000357371500002
PM 25787728
DA 2018-10-19
ER

PT J
AU Suzawa, Y
   Kubo, N
   Iwai, S
   Yura, Y
   Ohgushi, H
   Akashi, M
AF Suzawa, Yoshika
   Kubo, Norihiko
   Iwai, Soichi
   Yura, Yoshiaki
   Ohgushi, Hajime
   Akashi, Mitsuru
TI Biomineral/Agarose Composite Gels Enhance Proliferation of Mesenchymal
   Stem Cells with Osteogenic Capability
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
ID ALTERNATE SOAKING PROCESS; ALCOHOL) HYDROGEL MATRICES; IMPROVES
   CARDIAC-FUNCTION; BONE-GRAFTING MATERIAL; ON/IN AGAROSE-GEL;
   CALCIUM-CARBONATE; APATITE FORMATION; STROMAL CELLS; GLA PROTEIN;
   HYDROXYAPATITE
AB Hydroxyapatite (HA) or calcium carbonate (CaCO3) formed on an organic polymer of agarose gel is a biomaterial that can be used for bone tissue regeneration. However, in critical bone defects, the regeneration capability of these materials is limited. Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into bone forming osteoblasts. In this study, we loaded MSCs on HA- or CaCO3-formed agarose gel and cultured them with dexamethasone, which triggers the osteogenic differentiation of MSCs. High alkaline phosphatase activity was detected on both the HA- and CaCO3-formed agarose gels; however, basal activity was only detected on bare agarose gel. Bone-specific osteocalcin content was detected on CaCO3-formed agarose gel on Day 14 of culture, and levels subsequently increased over time. Similar osteocalcin content was detected on HA-formed agarose on Day 21 and levels increased on Day 28. In contrast, only small amounts of osteocalcin were found on bare agarose gel. Consequently, osteogenic capability of MSCs was enhanced on CaCO3-formed agarose at an early stage, and both HA- and CaCO3-formed agarose gels well supported the capability at a later stage. Therefore, MSCs loaded on either HA- or CaCO3-formed agarose could potentially be employed for the repair of critical bone defects.
C1 [Suzawa, Yoshika; Iwai, Soichi; Yura, Yoshiaki] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofcial Surg 2, Suita, Osaka 5650871, Japan.
   [Kubo, Norihiko] Miyata Dent Clin, Miyazaki 8800902, Japan.
   [Ohgushi, Hajime] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Amagasaki, Hyogo 6610974, Japan.
   [Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Div Appl Chem, Osaka 5620871, Japan.
RP Ohgushi, H (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Amagasaki, Hyogo 6610974, Japan.
EM suzawa@dent.osaka-u.ac.jp; Norihiko0409@ybb.ne.jp;
   s-iwai@dent.osaka-u.ac.jp; yura@dent.osaka-u.ac.jp;
   hajime-ohgushi@aist.go.jp; akashi@chem.eng.osaka-u.ac.jp
CR Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Hamadouche M, 2001, J BONE JOINT SURG BR, V83B, P979, DOI 10.1302/0301-620X.83B7.11478
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hirose M, 2004, MAT SCI ENG C-BIO S, V24, P355, DOI 10.1016/j.msec.2003.12.011
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Matsumoto T, 2011, TISSUE ENG PT A, V17, P171, DOI [10.1089/ten.tea.2010.0077, 10.1089/ten.TEA.2010.0077]
   Matsushima A, 2009, ARTIF ORGANS, V33, P474, DOI 10.1111/j.1525-1594.2009.00749.x
   Mizuta N, 2013, J TISSUE ENG REGEN M, V7, P51, DOI 10.1002/term.495
   Muraki K, 2006, TISSUE ENG, V12, P1711, DOI 10.1089/ten.2006.12.1711
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Ogomi D, 2005, J CONTROL RELEASE, V103, P315, DOI 10.1016/j.jconrel.2004.11.032
   Ogomi D, 2003, J BIOMED MATER RES A, V67A, P1360, DOI 10.1002/jbm.a.20053
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   Ohgushi H, 2014, EXPERT OPIN BIOL TH, V14, P197, DOI 10.1517/14712598.2014.866086
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Overgaard S, 1997, CLIN ORTHOP RELAT R, P286
   Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   PRICE PA, 1985, VITAM HORM, V42, P65
   Suzawa Y, 2010, J BIOMED MATER RES A, V93A, P965, DOI 10.1002/jbm.a.32518
   Tabata M, 2005, J BIOMED MATER RES B, V75B, P378, DOI 10.1002/jbm.b.30316
   Tabata M, 2003, J BIOMED MATER RES B, V67B, P680, DOI 10.1002/jbm.b.10063
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P331, DOI 10.1163/156856299X00397
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P795, DOI 10.1163/156856299X00883
   TAGUCHI T, 1998, CHEM LETT, V8, P711
   Watanabe J, 2007, J BIOMED MATER RES A, V83A, P845, DOI 10.1002/jbm.a.31435
NR 32
TC 8
Z9 8
U1 0
U2 22
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2015
VL 16
IS 6
BP 14245
EP 14258
DI 10.3390/ijms160614245
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CM2EO
UT WOS:000357492800134
PM 26110392
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zhou, ZH
   Huang, HH
   Huang, TL
   Peng, C
   Zhou, H
   Liu, QQ
   Zeng, WN
   Liu, LH
   Cao, DF
   He, SL
   Xiang, LJ
   Yan, H
AF Zhou, Zhihua
   Huang, Huihua
   Huang, Tianlong
   Peng, Cheng
   Zhou, Hu
   Liu, Qingquan
   Zeng, Wennan
   Liu, Lihua
   Cao, Dafu
   He, Siliang
   Xiang, Liujiao
   Yan, Hua
TI Synthesis and characterization of novel maleated
   poly(D,L-lactide-co-glycolide) by direct melt copolymerization
SO POLYMER BULLETIN
LA English
DT Article
DE D,L-Lactide; Glycolide; Maleic anhydride;
   Poly(D,L-lactide-co-glycolide); Modification
ID MALEIC-ANHYDRIDE; REACTIVE EXTRUSION; MECHANICAL-PROPERTIES;
   PHYSICAL-PROPERTIES; POLYLACTIDE PLA; POLYPROPYLENE; COMPOSITES;
   POLYMERS; FILMS; ACID)
AB Novel maleated poly(D,L-lactide-co-glycolide) (MPLGA) was melt copolymerized directly from maleic anhydride, D, L-lactide and glycolide monomers with stannous octoate as catalyst and benzoyl peroxide as initiator. FTIR, H-1 NMR, GPC and maleation content were employed to qualitatively characterize the synthesized MPLGA. The effects of the catalyst dosage, reaction time and reaction temperature on weight average molecular mass, polydispersity index and maleation content of MPLGA were also investigated. The results indicated that the novel MPLGA was successfully obtained using melting-copolymerization method. MPLGA, with a weight average molecular mass of about 5.39 x 10(4) Da, a polydispersity index of 1.51 and a maleation content of 7.1 wt%, was obtained when polymerization was conducted with catalyst dosage of 0.03 wt% for 36 h at 140 degrees C. The results indicated that the introduction of maleic anhydride into PLGA may offer new and important options for biomaterial applications.
C1 [Zhou, Zhihua; Huang, Huihua; Zhou, Hu; Liu, Qingquan; Zeng, Wennan; Liu, Lihua; Cao, Dafu; He, Siliang; Xiang, Liujiao; Yan, Hua] Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Xiangtan, Peoples R China.
   [Zhou, Zhihua] Hunan Univ Sci & Technol, Minist Educ, Key Lab Theoret Chem & Mol Simulat, Xiangtan, Peoples R China.
   [Zhou, Zhihua] Hunan Univ Sci & Technol, Hunan Prov Coll Key Lab QSAR QSPR, Xiangtan, Peoples R China.
   [Huang, Tianlong] Cent S Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China.
   [Peng, Cheng] Cent S Univ, Xiangya Hosp 3, Dept Burns & Plast Surg, Changsha, Hunan, Peoples R China.
RP Zhou, ZH (reprint author), Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Xiangtan, Peoples R China.
EM zhou7381@126.com
FU National Natural Science Fund of China [51273062, 51443002]; Hunan
   Provincial Natural Science Fund of China [12JJA003]; Aid Program for
   Science and Technology Innovative Research Team in Higher Educational
   Institutions of Hunan Province
FX This work was financially supported by the National Natural Science Fund
   of China (No. 51273062 and No. 51443002), the Hunan Provincial Natural
   Science Fund of China (No. 12JJA003) and the Aid Program for Science and
   Technology Innovative Research Team in Higher Educational Institutions
   of Hunan Province.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P41
   Carlson D, 1999, J APPL POLYM SCI, V72, P477, DOI 10.1002/(SICI)1097-4628(19990425)72:4<477::AID-APP3>3.0.CO;2-Q
   Chen C, 2003, J APPL POLYM SCI, V88, P659, DOI 10.1002/app11771
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E
   GAYLORD NG, 1983, J POLYM SCI POL LETT, V21, P23, DOI 10.1002/pol.1983.130210104
   GAYLORD NG, 1988, J POLYM SCI POL CHEM, V26, P1903, DOI 10.1002/pola.1988.080260716
   Hassouna F, 2012, EUR POLYM J, V48, P404, DOI 10.1016/j.eurpolymj.2011.12.001
   He ZQ, 2011, J MACROMOL SCI B, V50, P1154, DOI 10.1080/00222348.2010.503106
   Hwang SW, 2012, POLYM TEST, V31, P333, DOI 10.1016/j.polymertesting.2011.12.005
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Kortaberria G, 2006, J NON-CRYST SOLIDS, V352, P5087, DOI 10.1016/j.jnoncrysol.2006.01.153
   Luo YF, 2004, CHINESE CHEM LETT, V15, P521
   Ma GL, 2011, J CONTROL RELEASE, V152, pe133
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Niu XF, 2008, J BIOMED MATER RES A, V84A, P908, DOI 10.1002/jbm.a.31360
   Pamula E, 2008, J MATER SCI-MATER M, V19, P2063, DOI 10.1007/s10856-007-3292-2
   Raquez JM, 2008, MACROMOL MATER ENG, V293, P447, DOI 10.1002/mame.200700395
   Rozman HD, 2000, EUR POLYM J, V36, P1483, DOI 10.1016/S0014-3057(99)00200-1
   Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Todo M, 2007, ENG FRACT MECH, V74, P1872, DOI 10.1016/j.engfracmech.2006.05.021
   Wu L, 2004, BIOMATERIALS, V25, P821
   Zhang JF, 2004, BIOMACROMOLECULES, V5, P1446, DOI 10.1021/bm0400022
   Zhou ZH, 2008, INT J POLYM MATER, V57, P532, DOI 10.1080/00914030701816110
NR 26
TC 4
Z9 4
U1 2
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD JUN
PY 2015
VL 72
IS 6
BP 1531
EP 1543
DI 10.1007/s00289-015-1354-z
PG 13
WC Polymer Science
SC Polymer Science
GA CM2UP
UT WOS:000357538100019
DA 2018-10-19
ER

PT J
AU Song, JR
   Fan, CC
   Ma, HS
   Wei, YG
AF Song, Jingru
   Fan, Cuncai
   Ma, Hansong
   Wei, Yueguang
TI Hierarchical structure observation and nanoindentation size effect
   characterization for a limnetic shell
SO ACTA MECHANICA SINICA
LA English
DT Article
DE Biomaterial; Hierarchical structure; Mechanical property;
   Nanoindentation size effect; Trans-scale mechanics
ID DYNAMIC-MECHANICAL RESPONSE; BIOLOGICAL-MATERIALS; FRACTURE-TOUGHNESS;
   ELASTIC-MODULUS; STROMBUS-GIGAS; NACRE; BONE; INDENTATION; STRENGTH;
   BEHAVIOR
AB In the present research, hierarchical structure observation and mechanical property characterization for a type of biomaterial are carried out. The investigated biomaterial is Hyriopsis cumingii, a typical limnetic shell, which consists of two different structural layers, a prismatic "pillar" structure and a nacreous "brick and mortar" structure. The prismatic layer looks like a "pillar forest" with variation-section pillars sized on the order of several tens of microns. The nacreous material looks like a "brick wall" with bricks sized on the order of several microns. Both pillars and bricks are composed of nanoparticles. The mechanical properties of the hierarchical biomaterial are measured by using the nanoindentation test. Hardness and modulus are measured for both the nacre layer and the prismatic layer, respectively. The nanoindentation size effects for the hierarchical structural materials are investigated experimentally. The results show that the prismatic nanostructured material has a higher stiffness and hardness than the nacre nanostructured material. In addition, the nanoindentation size effects for the hierarchical structural materials are described theoretically, by using the trans-scalemechanics theory considering both strain gradient effect and the surface/interface effect. The modeling results are consistent with experimental ones.
C1 [Song, Jingru; Fan, Cuncai; Ma, Hansong; Wei, Yueguang] Chinese Acad Sci, Inst Mech, LNM, Beijing 100190, Peoples R China.
RP Wei, YG (reprint author), Chinese Acad Sci, Inst Mech, LNM, Beijing 100190, Peoples R China.
EM Songjingru@LNM.imech.ac.cn; Ywei@LNM.imech.ac.cn
CR Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1
   Barthelata F., 2006, J MECH PHYS SOLIDS, V55, P306
   Bechtle S, 2010, BIOMATERIALS, V31, P6378, DOI 10.1016/j.biomaterials.2010.05.044
   Brandt K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02322
   Bruet BJF, 2005, J MATER RES, V20, P2400, DOI 10.1557/JMR.2005.0273
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   CURREY JD, 1974, J ZOOL, V173, P395
   Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339
   Fleischli FD, 2008, ACTA BIOMATER, V4, P1694, DOI 10.1016/j.actbio.2008.05.029
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670
   Ji BH, 2010, ANNU REV MATER RES, V40, P77, DOI 10.1146/annurev-matsci-070909-104424
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Kamat S, 2000, NATURE, V405, P1036
   Katti KS, 2006, J MATER RES, V21, P1237, DOI 10.1557/JMR.2006.0147
   Katti KS, 2005, J MATER RES, V20, P1097, DOI 10.1557/JMR.2005.0171
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k
   Menig R, 2001, MAT SCI ENG A-STRUCT, V297, P203, DOI 10.1016/S0921-5093(00)01228-4
   Menig R, 2000, ACTA MATER, V48, P2383, DOI 10.1016/S1359-6454(99)00443-7
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Shao Y, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1016
   Song F, 2003, J MATER RES, V18, P1741, DOI 10.1557/JMR.2003.0239
   Song F., 2003, BIOMATERIALS, V24, P3621
   Song JR, 2014, CR MECANIQUE, V342, P315, DOI 10.1016/j.crme.2014.03.004
   Sun JY, 2007, J BIONIC ENG, V4, P11, DOI 10.1016/S1672-6529(07)60007-9
   TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73
   Tesch W, 2001, CALCIFIED TISSUE INT, V69, P147, DOI 10.1007/s00223-001-2012-z
   WANG RZ, 1995, J MATER SCI, V30, P2299, DOI 10.1007/BF01184577
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   Wei YG, 2005, INT J PLASTICITY, V21, P2123, DOI 10.1016/j.ijplas.2005.04.003
   Wei YG, 1997, J MECH PHYS SOLIDS, V45, P1253, DOI 10.1016/S0022-5096(97)00018-5
   Wei YG, 2001, SCI CHINA SER A, V44, P74, DOI 10.1007/BF02872285
   Wei YG, 2006, EUR J MECH A-SOLID, V25, P897, DOI 10.1016/j.euromechsol.2006.03.001
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P27, DOI 10.1006/jsbi.1999.4096
   Wu B, 2012, COMP MATER SCI, V57, P2, DOI 10.1016/j.commatsci.2011.03.045
   Xie ZQ, 2014, INT J APPL MECH, V6, DOI 10.1142/S1758825114500173
   Xu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04239
   Zuo SC, 2008, ACTA MECH SINICA, V24, P83, DOI 10.1007/s10409-007-0125-y
   Zuo SC, 2007, ACTA MECH SOLIDA SIN, V20, P198, DOI 10.1007/s10338-007-0723-z
NR 43
TC 2
Z9 3
U1 1
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0567-7718
EI 1614-3116
J9 ACTA MECH SINICA-PRC
JI Acta Mech. Sin.
PD JUN
PY 2015
VL 31
IS 3
SI SI
BP 364
EP 372
DI 10.1007/s10409-015-0405-x
PG 9
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA CM1NV
UT WOS:000357448500007
OA Green Published
DA 2018-10-19
ER

PT J
AU Aziz, G
   Cools, P
   De Geyter, N
   Declercq, H
   Cornelissen, R
   Morent, R
AF Aziz, Gaelle
   Cools, Pieter
   De Geyter, Nathalie
   Declercq, Heidi
   Cornelissen, Ria
   Morent, Rino
TI Dielectric barrier discharge plasma treatment of ultrahigh molecular
   weight polyethylene in different discharge atmospheres at medium
   pressure: A cell-biomaterial interface study
SO BIOINTERPHASES
LA English
DT Article
ID DIAMOND-LIKE CARBON; SURFACE MODIFICATION; ADHESION IMPROVEMENT; POLYMER
   SURFACES; ARGON-PLASMA; WETTABILITY; SPECTROSCOPY; ADSORPTION; MEMBRANE;
   HELIUM
AB Nonthermal plasma activation of ultrahigh molecular weight polyethylene (UHMWPE) is performed in different discharge atmospheres (helium, nitrogen, argon, and air) using a parallel-plate dielectric barrier discharge reactor at medium pressure. Obtained samples are characterized via water contact angle, x-ray photoelectron spectroscopy (XPS), and atomic force microscopy. Plasma treatments were found to significantly alter the samples' surface chemical and physical characteristics. Before conducting a biocompatibility study, the influence of postplasma sterilization processes (ethanol rinsing/UV exposure) on the plasma treatment effects were studied. XPS studies showed that samples' surface chemical composition is least affected by UV exposure, thus making this process the most adequate for sterilization. In-vitro evaluation of biocompatibility was carried out by studying human foreskin fibroblast interaction with untreated and plasma treated surfaces. Cell attachment and viability on all plasma treated UHMWPE were found to be significantly higher in comparison to plain UHMWPE; this was further confirmed by the overall cell morphology. This increased cell viability on treated samples can be explained by the increased wettability on these samples. In this study, a somewhat higher cell proliferation was observed on argon plasma treated surface (water contact angle - 52 degrees) after 7 days culture. (C) 2015 American Vacuum Society.
C1 [Aziz, Gaelle; Cools, Pieter; De Geyter, Nathalie; Declercq, Heidi; Morent, Rino] Univ Ghent, Res Unit Plasma Technol RUPT, Dept Appl Phys, Fac Engn & Architecture, B-9000 Ghent, Belgium.
   [Declercq, Heidi; Cornelissen, Ria] Univ Ghent, Dept Basic Med Sci, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.
RP Aziz, G (reprint author), Univ Ghent, Res Unit Plasma Technol RUPT, Dept Appl Phys, Fac Engn & Architecture, St Pietersnieuwstr 41 B4, B-9000 Ghent, Belgium.
EM Gaelle.Aziz@Ugent.be
RI Morent, Rino/K-7435-2015
OI Morent, Rino/0000-0001-6336-1485; Cools, Pieter/0000-0003-1649-284X
FU Research Foundation Flanders (FWO) [G.0516.13N]; European Research
   Council (ERC) under the European Union's Seventh Framework Program
   (FP)/ERC [279022]
FX This research was supported by a grant (G.0516.13N) from the Research
   Foundation Flanders (FWO) and has also received funding from the
   European Research Council (ERC) under the European Union's Seventh
   Framework Program (FP/2007-2013)/ERC Grant Agreement No. 279022
   (PLASMAPOR).
CR Agraharam S, 2001, J ELECTROCHEM SOC, V148, pF102, DOI 10.1149/1.1366629
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bhoj A. N., 2005, IEEE T PLASMA SCI, V33, P205
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chiper AS, 2011, ROM J PHYS, V56, P126
   Choi DM, 1997, POLYMER, V38, P6243, DOI 10.1016/S0032-3861(97)00175-4
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   De Geyter N, 2008, SURF INTERFACE ANAL, V40, P608, DOI 10.1002/sia.2611
   De Geyter N, 2007, SURF COAT TECH, V201, P7066, DOI 10.1016/j.surfcoat.2007.01.008
   De Geyter N, 2010, SURF COAT TECH, V204, P3272, DOI 10.1016/j.surfcoat.2010.03.037
   De Geyter N., 2008, THESIS U GHENT
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Duca MD, 1998, POLYM DEGRAD STABIL, V61, P65, DOI 10.1016/S0141-3910(97)00130-4
   Fozza A. C., 1999, Plasmas and Polymers, V4, P183, DOI 10.1023/A:1021853026619
   Hegemann D, 2003, NUCL INSTRUM METH B, V208, P281, DOI 10.1016/S0168-583X(03)00644-X
   Idage SB, 1998, LANGMUIR, V14, P2780, DOI 10.1021/la9711286
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Jacobs T, 2011, SURF COAT TECH, V205, pS543, DOI 10.1016/j.surfcoat.2011.02.012
   Jacobs T, 2011, SURF COAT TECH, V205, pS511, DOI 10.1016/j.surfcoat.2011.01.029
   Junkar I., 2010, VACUUM, V84, P83
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Kim KS, 2002, J MEMBRANE SCI, V199, P135, DOI 10.1016/S0376-7388(01)00686-X
   Kurtz SM, 2016, PDL HANDB SER, P1, DOI 10.1016/B978-0-12-374721-1.00001-8
   Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Liu HJ, 2010, APPL SURF SCI, V256, P3941, DOI 10.1016/j.apsusc.2010.01.054
   Loh FC, 1996, SURF INTERFACE ANAL, V24, P597, DOI 10.1002/(SICI)1096-9918(19960916)24:9<597::AID-SIA163>3.0.CO;2-2
   Lotfi M., 2013, ADV BIOMATERIALS SCI, P207
   Ozeki K, 2007, BIO-MED MATER ENG, V17, P175
   Puertolas JA, 2010, WEAR, V269, P458, DOI 10.1016/j.wear.2010.04.033
   Rhodes NP, 2007, BIOMATERIALS, V28, P4561, DOI 10.1016/j.biomaterials.2007.07.008
   Riekerink M. O., 2001, THESIS U TWENTE
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   Vesel A., 2008, VACUUM, V82, P248
   Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zeng H., 2013, POLYM ADHESION FRICT, P210
   Zhu X, 2005, J BIOMED MATER RES A, V73A, P264, DOI 10.1002/jbm.a.30211
NR 41
TC 6
Z9 6
U1 2
U2 61
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2015
VL 10
IS 2
AR 029502
DI 10.1116/1.4907755
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA CL8AY
UT WOS:000357195600020
DA 2018-10-19
ER

PT J
AU Buxadera-Palomero, J
   Canal, C
   Torrent-Camarero, S
   Garrido, B
   Gil, FJ
   Rodriguez, D
AF Buxadera-Palomero, Judit
   Canal, Cristina
   Torrent-Camarero, Sergi
   Garrido, Beatriz
   Javier Gil, Francisco
   Rodriguez, Daniel
TI Antifouling coatings for dental implants: Polyethylene glycol-like
   coatings on titanium by plasma polymerization
SO BIOINTERPHASES
LA English
DT Article
ID DIELECTRIC BARRIER DISCHARGES; BACTERIAL ADHESION; ANTIBACTERIAL
   ACTIVITY; POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION; COVALENT
   IMMOBILIZATION; PERI-IMPLANTITIS; SURFACE-ANALYSIS; ETHYLENE-OXIDE;
   LOW-PRESSURE
AB Titanium dental implants are commonly used for the replacement of lost teeth, but they present a considerable number of failures due to the infection on surrounding tissues. The aim of this paper is the development of a polyethylene glycol-like (PEG-like) coating on the titanium surface by plasma polymerization to obtain a novel improved surface with suitable low bacterial adhesion and adequate cell response. Surface analysis data of these coatings are presented, in particular, water contact angle, surface roughness, and film chemistry, demonstrating the presence of a PEG-like coating. Streptococcus sanguinis and Lactobacillus salivarius bacterial adhesion assays showed a decreased adhesion on the plasma polymerized samples, while cell adhesion of fibroblasts and osteoblasts on the treated surfaces was similar to control surfaces. Thus, the PEG-like antifouling coating obtained by plasma polymerization on Ti confers this biomaterial's highly suitable properties for dental applications, as they reduce the possibility of infection while allowing the tissue integration around the implant. (C) 2015 American Vacuum Society.
C1 [Buxadera-Palomero, Judit; Rodriguez, Daniel] Tech Univ Catalonia UPC, Biomat Biomech & Tissue Engn Grp, EU Engn Tecn Ind Barcelona, Barcelona 08036, Spain.
   [Buxadera-Palomero, Judit; Canal, Cristina; Javier Gil, Francisco; Rodriguez, Daniel] CIBER Bioingn Biomat & Nanomed CIBER BBN, Zaragoza 50118, Spain.
   [Buxadera-Palomero, Judit; Canal, Cristina; Torrent-Camarero, Sergi; Garrido, Beatriz; Javier Gil, Francisco; Rodriguez, Daniel] Ctr Res NanoEngn CRNE UPC, Barcelona 08028, Spain.
   [Canal, Cristina; Torrent-Camarero, Sergi; Garrido, Beatriz; Javier Gil, Francisco] Tech Univ Catalonia UPC, Biomat Biomech & Tissue Engn Grp, ETS Engn Ind Barcelona, Dept Mat Sci & Met, Barcelona 08028, Spain.
RP Rodriguez, D (reprint author), Tech Univ Catalonia UPC, Biomat Biomech & Tissue Engn Grp, EU Engn Tecn Ind Barcelona, C Comte Urgell 187, Barcelona 08036, Spain.
EM daniel.rodriguez.rius@upc.edu
OI Torrent Camarero, Sergi/0000-0002-1399-066X
FU Technical University of Catalonia; Fundacion Ramon Areces; Fundacion
   Ramon Areces through project "Biosellado"; Spanish Government through
   Ramon y Cajal fellowship of CC; EU through European Regional Development
   Funds; European Cooperation in Science and Technology, COST action
   [MP1101];  [MAT2012-2012-30706]
FX The authors acknowledge financial support of Technical University of
   Catalonia and Fundacion Ramon Areces through the fellowship of J.B.-P.
   Financial support for the project is acknowledged to Fundacion Ramon
   Areces through project "Biosellado," the Spanish Government through
   Ramon y Cajal fellowship of CC and Project MAT2012-2012-30706, cofunded
   by the EU through European Regional Development Funds, and the European
   Cooperation in Science and Technology, COST action MP1101. The authors
   also wish to express their gratitude to Montserrat Dominguez, for her
   useful comments and advices regarding the XPS analysis.
CR Abou Neel EA, 2005, BIOMATERIALS, V26, P2247, DOI 10.1016/j.biomaterials.2004.07.024
   Al-Bataineh SA, 2009, LANGMUIR, V25, P7432, DOI 10.1021/la900334w
   Algraffee H, 2012, BRIT J ORAL MAX SURG, V50, P689, DOI 10.1016/j.bjoms.2011.11.020
   Almstahl A, 2008, ORAL DIS, V14, P541, DOI 10.1111/j.1601-0825.2007.01416.x
   Aparicio C, 2011, J MECH BEHAV BIOMED, V4, P1672, DOI 10.1016/j.jmbbm.2011.05.005
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Bretagnol F, 2006, ACTA BIOMATER, V2, P165, DOI 10.1016/j.actbio.2005.11.002
   Burm KTAL, 2007, CONTRIB PLASM PHYS, V47, P177, DOI 10.1002/ctpp.200710025
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Chaid B. T., 2013, INT J RECENT RES REV, VV, P17
   Cools P, 2014, PLASMA CHEM PLASMA P, V34, P917, DOI 10.1007/s11090-014-9552-2
   Cumpson PJ, 2000, SURF INTERFACE ANAL, V29, P403, DOI 10.1002/1096-9918(200006)29:6<403::AID-SIA884>3.0.CO;2-8
   Da Ponte G, 2011, SURF COAT TECH, V205, pS525, DOI 10.1016/j.surfcoat.2011.03.112
   Da Ponte G, 2012, PLASMA PROCESS POLYM, V9, P1176, DOI 10.1002/ppap.201100201
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Dufour D, 2010, ENDOD TOPICS, V22, P2, DOI DOI 10.1111/J.1601-1546.2012.00277.X
   Favia P, 2001, SURF COAT TECH, V142, P1, DOI 10.1016/S0257-8972(01)01191-4
   Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x
   Godoy-Gallardo M., CLIN ORAL IMPL UNPUB
   Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026
   Gour N, 2014, MACROMOL MATER ENG, V299, P648, DOI 10.1002/mame.201300285
   Hadjesfandiari N, 2014, J MATER CHEM B, V2, P4968, DOI 10.1039/c4tb00550c
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Harder S, 2013, CLIN ORAL INVEST, V17, P1135, DOI 10.1007/s00784-012-0805-2
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Hu XF, 2010, BIOMATERIALS, V31, P8854, DOI 10.1016/j.biomaterials.2010.08.006
   Johnston EE, 2005, LANGMUIR, V21, P870, DOI 10.1021/la036274s
   Kane SR, 2010, J MATER SCI-MATER M, V21, P1037, DOI 10.1007/s10856-009-3935-6
   Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   KOLENBRANDER PE, 1990, APPL ENVIRON MICROB, V56, P3890
   KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993
   Kumar DS, 2007, J MATER SCI-MATER M, V18, P1831, DOI 10.1007/s10856-007-3033-6
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Li YL, 2014, APPL SURF SCI, V288, P288, DOI 10.1016/j.apsusc.2013.10.022
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   Manso M, 2005, ACTA BIOMATER, V1, P431, DOI 10.1016/j.actbio.2005.03.003
   Mayanagi G, 2005, INT C SER, V1284, P195
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Michelmore A, 2013, LANGMUIR, V29, P2595, DOI 10.1021/la304713b
   Morris H F, 2001, J Oral Implantol, V27, P180, DOI 10.1563/1548-1336(2001)027<0180:AMCIID>2.3.CO;2
   Mouhyi J, 2012, CLIN IMPLANT DENT R, V14, P170, DOI 10.1111/j.1708-8208.2009.00244.x
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Mutlu S, 2007, J FOOD ENG, V78, P494, DOI 10.1016/j.jfoodeng.2005.10.028
   Nie LH, 2007, PLASMA PROCESS POLYM, V4, P574, DOI 10.1002/ppap.200600212
   Nisol B, 2014, SURF COAT TECH, V252, P126, DOI 10.1016/j.surfcoat.2014.04.056
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   PACE JD, 1973, J PHYS D APPL PHYS, V6, P1525, DOI 10.1088/0022-3727/6/12/315
   Petasch W, 1997, SURF COAT TECH, V97, P176, DOI 10.1016/S0257-8972(97)00143-6
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Pham LC, 2009, ARCH ORAL BIOL, V54, P132, DOI 10.1016/j.archoralbio.2008.09.007
   Pier-Francesco A, 2006, CLIN ORAL IMPLAN RES, V17, P633, DOI 10.1111/j.1600-0501.2006.01274.x
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Radin S, 2007, BIOMATERIALS, V28, P1721, DOI 10.1016/j.biomaterials.2006.11.035
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schlapak R, 2006, LANGMUIR, V22, P277, DOI 10.1021/la0521793
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Smentkowski VS, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4822516
   Smith HB, 2003, PHYS PLASMAS, V10, P875, DOI 10.1063/1.1531615
   Song DH, 2011, THIN SOLID FILMS, V519, P7079, DOI 10.1016/j.tsf.2011.01.385
   Tanaka Y, 2010, J BIOMED MATER RES A, V95A, P1105, DOI 10.1002/jbm.a.32932
   Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wells GP, 2013, PLASMA PROCESS POLYM, V10, P119, DOI 10.1002/ppap.201200066
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zoulalian V, 2010, LANGMUIR, V26, P74, DOI 10.1021/la902110j
NR 78
TC 14
Z9 14
U1 3
U2 59
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2015
VL 10
IS 2
AR 029505
DI 10.1116/1.4913376
PG 11
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA CL8AY
UT WOS:000357195600023
PM 25766480
DA 2018-10-19
ER

PT J
AU Annich, GM
AF Annich, G. M.
TI Extracorporeal life support: the precarious balance of hemostasis
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Review
DE blood coagulation; blood coagulation tests; extracorporeal membrane
   oxygenation; platelets; thrombosis
ID NITRIC-OXIDE RELEASE; MEMBRANE-OXYGENATION; CARDIOPULMONARY BYPASS;
   COAGULATION; ANTICOAGULATION; ACTIVATION; CIRCUITS; SYSTEM; MODEL;
   BIVALIRUDIN
AB Extracorporeal life support is by far the most extraordinary and complex form of extracorporeal technology used in the practice of critical care medicine. It is used to support critically ill patient who suffer acute respiratory or cardiac failure unresponsive to conventional support. As extracorporeal technologies have refined the pathophysiologic reaction that occurs at the blood/biomaterial interface has not been conquered; a new set of physiologic responses/derangements occur with the patient's exposure to the artificial circuit. Without this support mortality is near certain and with support if management is not precise and judicious the complications can be catastrophic. The management of a patient on ECLS is the same as for any critically ill patient with the added need for anticoagulation to maintain patency of the extracorporeal circuit without causing bleeding within the patient and thrombosis within the circuitry or the patient. This is the precarious balance of hemostasis during ECLS.
C1 Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada.
RP Annich, GM (reprint author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM gail.annich@sickkids.ca
CR Amoako KA, 2012, ASAIO J, V58, P238, DOI 10.1097/MAT.0b013e31824abed5
   Annich G, 2013, PEDIATR CRIT CARE ME, V14, pS37, DOI 10.1097/PCC.0b013e318292dfa7
   Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Annich GM, 2012, ECMO EXTRACORPOREAL, P91
   Barstad RM, 1996, BRIT J HAEMATOL, V94, P517, DOI 10.1111/j.1365-2141.1996.tb08989.x
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Bembea MM, 2013, PEDIATR CRIT CARE ME, V14, pE77, DOI 10.1097/PCC.0b013e31827127e4
   Fortenberry JD, 1996, J PEDIATR-US, V128, P670, DOI 10.1016/S0022-3476(96)80133-8
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HATTERSLEY PG, 1966, J AMER MED ASSOC, V196, P436, DOI 10.1001/jama.196.5.436
   Hoffman M, 2003, BLOOD REV, V17, pS1, DOI 10.1016/S0268-960X(03)90000-2
   HUMMEL M, 1994, CLIN TRANSPLANT, V8, P59
   Lequier L, 2014, ELSO ANTICOAGULATION, P3
   Lequier L, 2012, ECMO EXTRACORPOREAL, P137
   Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X
   Major TC, 2011, BIOMATERIALS, V32, P5957, DOI 10.1016/j.biomaterials.2011.03.036
   MARCOLIN R, 1995, INT J ARTIF ORGANS, V18, P624
   MCMANUS ML, 1995, J PEDIATR-US, V126, P900, DOI 10.1016/S0022-3476(95)70205-9
   Nagle EL, 2013, PEDIATR CRIT CARE ME, V14, pE182, DOI 10.1097/PCC.0b013e31827200b6
   Palatianos GM, 2003, ANN THORAC SURG, V76, P129, DOI 10.1016/S0003-4975(03)00338-2
   Peek GJ, 1999, ASAIO J, V45, P250, DOI 10.1097/00002480-199907000-00003
   Ranucci M, 2011, CRIT CARE, V15, DOI 10.1186/cc10556
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Tayama E, 2000, ARTIF ORGANS, V24, P618, DOI 10.1046/j.1525-1594.2000.06615.x
   Urlesberger B, 1996, J PEDIATR-US, V129, P264, DOI 10.1016/S0022-3476(96)70252-4
   Valhonart H, 1999, ASAIO J, V45, P113
   VANE JR, 1990, NEW ENGL J MED, V323, P27
   Volk HD, 2000, CHEM IMMUNOL, V74, P162
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   WOODMAN RC, 1990, BLOOD, V76, P1680
NR 30
TC 28
Z9 28
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD JUN
PY 2015
VL 13
SU 1
SI SI
BP S336
EP S342
DI 10.1111/jth.12963
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CL1BN
UT WOS:000356677500045
PM 26149045
OA Bronze
DA 2018-10-19
ER

PT J
AU Jaffer, IH
   Fredenburgh, JC
   Hirsh, J
   Weitz, JI
AF Jaffer, I. H.
   Fredenburgh, J. C.
   Hirsh, J.
   Weitz, J. I.
TI Medical device-induced thrombosis: what causes it and how can we prevent
   it?
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Review
DE catheters; factor XI; factor XII; medical devices; thrombosis
ID ELASTIN-LIKE POLYPEPTIDES; ACUTE CORONARY SYNDROMES; MECHANICAL
   HEART-VALVES; STAINLESS-STEEL STENT; IN-VIVO ASSESSMENT;
   PLATELET-ADHESION; FACTOR-XI; COMPLEMENT ACTIVATION; CATHETER
   THROMBOSIS; CELL-ADHESION
AB Blood-contacting medical devices, such as vascular grafts, stents, heart valves, and catheters, are often used to treat cardiovascular diseases. Thrombus formation is a common cause of failure of these devices. This study (i) examines the interface between devices and blood, (ii) reviews the pathogenesis of clotting on blood-contacting medical devices, (iii) describes contemporary methods to prevent thrombosis on blood-contacting medical devices, (iv) explains why some anticoagulants are better than others for prevention of thrombosis on medical devices, and (v) identifies future directions in biomaterial research for prevention of thrombosis on blood-contacting medical devices.
C1 [Jaffer, I. H.; Fredenburgh, J. C.; Hirsh, J.; Weitz, J. I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada.
   [Jaffer, I. H.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.
   [Fredenburgh, J. C.; Hirsh, J.; Weitz, J. I.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Weitz, J. I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.
RP Weitz, JI (reprint author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.
EM weitzj@taari.ca
CR Alibeik S, 2012, J BIOMAT SCI-POLYM E, V23, P1981, DOI 10.1163/092050611X603250
   Alibeik S, 2012, J BIOMED MATER RES A, V100A, P856, DOI 10.1002/jbm.a.34022
   Alibeik S, 2011, ACTA BIOMATER, V7, P4177, DOI 10.1016/j.actbio.2011.07.022
   AlKhaffaf H, 1996, J VASC SURG, V23, P686, DOI 10.1016/S0741-5214(96)80050-4
   Amara U, 2008, CURRENT TOPICS COMPL, VII, P68
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bane CE, 2014, DRUG DISCOV TODAY, V19, P1454, DOI 10.1016/j.drudis.2014.05.018
   Bluestein D, 2013, J BIOMECH, V46, P338, DOI 10.1016/j.jbiomech.2012.11.033
   BOWERS VM, 1989, J BIOMED MATER RES, V23, P1453, DOI 10.1002/jbm.820231208
   Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760
   Chan WS, 2000, ARCH INTERN MED, V160, P191, DOI 10.1001/archinte.160.2.191
   Chung YC, 2005, BIOMATERIALS, V26, P2313, DOI 10.1016/j.biomaterials.2004.06.043
   Crosby JR, 2013, ARTERIOSCL THROM VAS, V33, P1670, DOI 10.1161/ATVBAHA.113.301282
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   Deng J, 2014, ACS APPL MATER INTER, V6, P21603, DOI 10.1021/am506249r
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   Edmunds LH, 2006, ANN THORAC SURG, V82, P2315, DOI 10.1016/j.athoracsur.2006.06.072
   Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Galli M, 2000, J INVASIVE CARDIOL, V12, P452
   Gao WQ, 2013, INT J CLIN EXP MED, V6, P259
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Jordan SW, 2006, BIOMATERIALS, V27, P3473, DOI 10.1016/j.biomaterials.2006.01.009
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KAZATCHKINE MD, 1989, ADV EXP MED BIOL, V260, P19
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   Kim YH, 2005, AM HEART J, V149, P336, DOI 10.1016/j.ahj.2004.02.018
   Klement P, 2006, BIOMATERIALS, V27, P5107, DOI 10.1016/j.biomaterials.2006.05.005
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Krisinger MJ, 2012, BLOOD, V120, P1717, DOI 10.1182/blood-2012-02-412080
   Kudo FA, 2002, INT ANGIOL, V21, P214
   Kuiper KKJ, 1998, SCAND CARDIOVASC J, V32, P261
   Larsson M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006804
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Leyh RG, 2002, EUR J CARDIO-THORAC, V21, P577, DOI 10.1016/S1010-7940(01)01154-X
   Li JM, 2002, J SURG RES, V105, P200, DOI 10.1006/jsre.2002.6381
   Liu T, 2014, ACTA BIOMATER, V10, P1940, DOI 10.1016/j.actbio.2013.12.013
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   Lu L, 2012, J BIOMED MATER RES A, V100A, P2421, DOI 10.1002/jbm.a.34143
   MacEwan SR, 2014, J CONTROL RELEASE, V190, P314, DOI 10.1016/j.jconrel.2014.06.028
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111
   MCPHERSON DT, 1992, BIOTECHNOL PROGR, V8, P347, DOI 10.1021/bp00016a012
   Mehta SR, 2008, CIRCULATION, V118, P2038, DOI 10.1161/CIRCULATIONAHA.108.789479
   Mehta SR, 2007, J AM COLL CARDIOL, V50, P1742, DOI 10.1016/j.jacc.2007.07.042
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199
   Nakayama Y, 2011, J BIOMED MATER RES B, V99B, P420, DOI 10.1002/jbm.b.31914
   Nelson KD, 1996, ASAIO J, V42, pM884, DOI 10.1097/00002480-199609000-00119
   Ortega-Vinuesa JL, 1998, BIOMATERIALS, V19, P251, DOI 10.1016/S0142-9612(97)00206-8
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   Sick PB, 2005, AM HEART J, V149, P681, DOI 10.1016/j.ahj.2004.07.011
   Sick PB, 2004, AM J CARDIOL, V93, P1351, DOI 10.1016/j.amjcard.2004.02.029
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   Vrolix MCM, 2000, AM J CARDIOL, V86, P385, DOI 10.1016/S0002-9149(00)00951-6
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wohrle J, 2001, EUR HEART J, V22, P1808, DOI 10.1053/euhj.2001.2608
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734
   Wyers MC, 1999, CARDIOVASC PATHOL, V8, P153, DOI 10.1016/S1054-8807(99)00005-8
   Yau JW, 2014, THROMB HAEMOSTASIS, V112, P79, DOI 10.1160/TH13-12-1047
   Yau JW, 2014, BLOOD, V123, P2102, DOI 10.1182/blood-2013-12-540872
   Yau JW, 2012, ACTA BIOMATER, V8, P4092, DOI 10.1016/j.actbio.2012.07.019
   Yau JW, 2011, BLOOD, V118, P6667, DOI 10.1182/blood-2011-07-364141
   Yayapour N, 1999, COLLOID SURFACE B, V15, P127, DOI 10.1016/S0927-7765(99)00049-1
   Yeh HY, 2009, J BIOMAT SCI-POLYM E, V20, P807, DOI 10.1163/156856209X426952
NR 79
TC 63
Z9 63
U1 8
U2 54
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD JUN
PY 2015
VL 13
SU 1
SI SI
BP S72
EP S81
DI 10.1111/jth.12961
PG 10
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CL1BN
UT WOS:000356677500011
PM 26149053
OA Bronze
DA 2018-10-19
ER

PT J
AU Gao, Y
   Wang, YL
   Kong, D
   Qu, B
   Su, XJ
   Li, H
   Pi, HY
AF Gao, Yuan
   Wang, Yu-ling
   Kong, Dan
   Qu, Bo
   Su, Xiao-jing
   Li, Huan
   Pi, Hong-ying
TI Nerve autografts and tissue-engineered materials for the repair of
   peripheral nerve injuries: a 5-year bibliometric analysis
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; peripheral nerve; nerve autograft; nerve
   transplantation; biomaterial; tissue engineering; neural regeneration
ID REGENERATION; CONDUITS; GRAFT; TRANSPLANTATION; BIOMATERIALS; DEFECTS;
   GUIDE; CELLS
AB With advances in biomedical methods, tissue-engineered materials have developed rapidly as an alternative to nerve autografts for the repair of peripheral nerve injuries. However, the materials selected for use in the repair of peripheral nerve injuries, in particular multiple injuries and large-gap defects, must be chosen carefully. Various methods and materials for protecting the healthy tissue and repairing peripheral nerve injuries have been described, and each method or material has advantages and disadvantages. Recently, a large amount of research has been focused on tissue-engineered materials for the repair of peripheral nerve injuries. Using the keywords "peripheral nerve injury", "autotransplant", "nerve graft", and "biomaterial", we retrieved publications using tissue-engineered materials for the repair of peripheral nerve injuries appearing in the Web of Science from 2010 to 2014. The country with the most total publications was the USA. The institutions that were the most productive in this field include Hannover Medical School (Germany), Washington University (USA), and Nantong University (China). The total number of publications using tissue-engineered materials for the repair of peripheral nerve injuries gradually increased over time, as did the number of Chinese publications, suggesting that China has made many scientific contributions to this field of research.
C1 [Gao, Yuan; Kong, Dan; Su, Xiao-jing; Li, Huan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing 100853, Peoples R China.
   [Wang, Yu-ling; Pi, Hong-ying] Chinese Peoples Liberat Army Gen Hosp, Dept Nursing, Beijing 100853, Peoples R China.
   [Qu, Bo] Chinese Peoples Liberat Army Gen Hosp, Dept Surg, Clin Div, Beijing 100853, Peoples R China.
RP Pi, HY (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Nursing, Beijing 100853, Peoples R China.
EM phy301@sina.com
CR Alluin O, 2006, J NEUROTRAUM, V23, P1883, DOI 10.1089/neu.2006.23.1883
   Badoiu S C, 2014, Chirurgia (Bucur), V109, P584
   Beigi MH, 2014, J BIOMED MATER RES A, V102, P4554, DOI 10.1002/jbm.a.35119
   Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018
   Chang CJ, 2009, TISSUE ENG PT A, V15, P547, DOI 10.1089/ten.tea.2007.0342
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Hernandez-Cortes P, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046024
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Koudehi MF, 2014, J MATER SCI-MATER M, V25, P363, DOI 10.1007/s10856-013-5076-1
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Leuzzi S, 2014, G CHIR, V35, P101, DOI 10.11138/gchir/2014.35.3.101
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   Matsumoto K, 2000, ASAIO J, V46, P415, DOI 10.1097/00002480-200007000-00009
   Mukhatyar V, 2014, ANN BIOMED ENG, V42, P1436, DOI 10.1007/s10439-013-0960-x
   Nagao RJ, 2011, NEUROL RES, V33, P600, DOI 10.1179/1743132810Y.0000000023
   Pateman CJ, 2015, BIOMATERIALS, V49, P77, DOI 10.1016/j.biomaterials.2015.01.055
   Peters KM, 2010, J UROLOGY, V183, P1438, DOI 10.1016/j.juro.2009.12.036
   Radtke C, 2014, CELLS TISSUES ORGANS, V200, P48, DOI 10.1159/000369006
   Ramburrun P, 2014, BIOMED RES INT, DOI 10.1155/2014/132350
   Rinker B, 2014, CLIN PLAST SURG, V41, P533, DOI 10.1016/j.cps.2014.03.006
   Rochkind S, 2014, BIOMED RES INT, V2014
   Sivak WN, 2014, METHODS MOL BIOL, V1162, P139, DOI 10.1007/978-1-4939-0777-9_11
   Tom VJ, 2011, EXP NEUROL, V211, P315
   Yue HJ, 2008, KEYAN GUANLI, V5, P43
NR 28
TC 9
Z9 11
U1 2
U2 31
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD JUN
PY 2015
VL 10
IS 6
BP 1003
EP 1008
DI 10.4103/1673-5374.158369
PG 6
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CL9KW
UT WOS:000357298200035
PM 26199621
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Campitiello, F
   Della Corte, A
   Guerniero, R
   Pellino, G
   Canonico, S
AF Campitiello, Ferdinand
   Della Corte, Angela
   Guerniero, Raffaella
   Pellino, Gianluca
   Canonico, Silvestro
TI Efficacy of a New Flowable Wound Matrix in Tunneled and Cavity Ulcers: A
   Preliminary Report
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Article
DE tunneling lesions; biomaterials; flowable matrix
ID VENOUS ULCERS; SENESCENCE
AB Introduction. In chronic wounds the healing is stagnant, and regenerative surgery is often needed. Many engineered tissues with a conventional bidimensional sheet are ineffective for tunneling wounds, because adherence to the: wound bed is not Complete: An advanced wound Matrix for treating wounds with irregular geometries has been developed (Integra Flowable Wound Matrix, Integra LifeScienee Corp, Plainsboro, NJ). Methods and Materials. Between March 2013 and December 2013 the authors treated 18 patients (11 female) with tunneled or cavity ulcers with the advanced wound matrix at the Unit of General and Geriatric Surgery of the Second University of Naples, Naples, Italy. Two patients (11.1%) had postsurgical Wounds, two (11.1%) had post-traumatic wounds, and 14 (77.8%) had neuropathic ulcers. After debridement and antibiotic therapy, the lesions were filled; with the wound matrix product. Surgical wound edges were either approximated with stitches or left to heal by secondary intention and covered with wet gauze. During the first week, follow-up visits were carried out every 3 days, then once a week until complete healing was achieved. All patients underwent preoperative and postoperative ultrasonography scans and plain radiograph controls. Results. Twenty-one applications were performed. Engraftment was complete in all but 1 patient who bad diabetes and graft failure.. Three patients needed repeated applications to complete the filling of the lesions. Median (range) pain Visual Analog Scores on a scale of 0 to 10, where 0 = no pain, and 10 = intolerable pain were 6.3 (range 3-8) preoperatively and 0.5 (range 0-2) at first follow-up (P <= 0.001). All but 2 patients showed a progressive remodeling of the tissue gap at scheduled radiographic controls. Conclusions. To the author's knowledge, the advanced wound matrix used in this study is the only available biomaterial for the treatment of tunneled lesions. It stimulates tissue regeneration by filling surfaces which cannot be repaired spontaneously or by using conventional biomaterials in the form of sheets. Its application is atraumatic, painless, and safe.
C1 [Campitiello, Ferdinand; Della Corte, Angela; Guerniero, Raffaella; Pellino, Gianluca; Canonico, Silvestro] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, I-80138 Naples, Italy.
RP Canonico, S (reprint author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Unit Gen & Geriatr Surg, Piazza Miraglia 2, I-80138 Naples, Italy.
EM silvestro.canonico@unina2.it
OI Pellino, Gianluca/0000-0002-8322-6421
CR Campitiello E, 2005, Acta Biomed, V76 Suppl 1, P69
   Canonico S, 2013, SKIN GRAFTS, DOI [10.5772/51852, DOI 10.5772/51852]
   Canonico S, 2009, DERMATOL SURG, V35, P195, DOI 10.1111/j.1524-4725.2008.34409.x
   Edwards JS, 2010, KNOWL MAN RES PRACT, V8, P1, DOI 10.1057/kmrp.2009.39
   Gottlieb M, 2004, J BURNS SURG WOUND C, V3, P4
   Iorio ML, 2012, PLAST RECONSTR SURG, V130, p232S, DOI 10.1097/PRS.0b013e3182615703
   Le X., 2013, INT J BIOMATER, V2013
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3
   Moiemen N, 2011, PLAST RECONSTR SURG, V127, P1149, DOI 10.1097/PRS.0b013e31820436e3
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Stanley A, 2001, J VASC SURG, V33, P1206, DOI 10.1067/mva.2001.115379
   Yang Fan, 2008, P3
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
NR 14
TC 7
Z9 7
U1 0
U2 1
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
EI 1943-2704
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD JUN
PY 2015
VL 27
IS 6
BP 152
EP 157
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA CL8NL
UT WOS:000357231300004
PM 26061490
DA 2018-10-19
ER

PT J
AU Ohta, S
   Nishiyama, T
   Sakoda, M
   Machioka, K
   Fuke, M
   Ichimura, S
   Inagaki, F
   Shimizu, A
   Hasegawa, K
   Kokudo, N
   Kaneko, M
   Yatomi, Y
   Ito, T
AF Ohta, Seiichi
   Nishiyama, Toru
   Sakoda, Megumu
   Machioka, Kyoko
   Fuke, Masaya
   Ichimura, Shigetoshi
   Inagaki, Fuyuki
   Shimizu, Atsushi
   Hasegawa, Kiyoshi
   Kokudo, Norihiro
   Kaneko, Makoto
   Yatomi, Yutaka
   Ito, Taichi
TI Development of carboxymethyl cellulose nonwoven sheet as a novel
   hemostatic agent
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Carboxymethyl cellulose; Nonwoven sheet; Hemostasis; Blood clotting;
   Bandage; Biomaterial
ID BLEEDING-TIME; COLLAGEN; MECHANISM
AB Carboxymethyl cellulose (CMC) is a plant-derived material that has high biocompatibility and water solubility. We developed a CMC nonwoven sheet as a hemostatic agent by carboxymethylating a continuous filament cellulose nonwoven sheet. The CMC nonwoven sheet was able to absorb water and dissolve in it. The rates of absorption and dissolution depended on the degree of carboxymethylation. After dissolving in blood, CMC accelerated clot development (possibly owing to the incorporation of CMC into fibrin fibers) and increased the viscosity of the blood, both of which would contribute to the improved blood clotting of an injured surface. In vivo experiments using a rat tail cutting method showed that a CMC nonwoven sheet shortened the bleeding time of the tail when applied to the cut surface. The hemostatic effect of the CMC nonwoven sheet was almost at the same level as a commercial hemostatic bandage. These results suggest that a CMC nonwoven sheet could be used as a novel sheet-type hemostatic agent. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.
C1 [Ohta, Seiichi; Nishiyama, Toru; Ito, Taichi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan.
   [Sakoda, Megumu; Ichimura, Shigetoshi] Kanagawa Inst Technol, Dept Appl Biosci, Atsugi, Kanagawa 2430292, Japan.
   [Machioka, Kyoko; Fuke, Masaya] Asahi Kasei Fibers Corp, Nobeoka, Miyazaki 8820847, Japan.
   [Inagaki, Fuyuki; Shimizu, Atsushi; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Bunkyo Ku, Tokyo 1130033, Japan.
   [Kaneko, Makoto; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Bunkyo Ku, Tokyo 1130033, Japan.
RP Ito, T (reprint author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
EM taichi@m.u-tokyo.ac.jp
FU (PD) from the Japan Society for the Promotion of Science (JSPS) [5621]
FX We thank M. Aoshima for the useful discussion. We also acknowledge Q.
   Pan for her help in conducting ATR-IR measurements. S. Ohta is grateful
   to the Research Fellowship (PD, no. 5621) from the Japan Society for the
   Promotion of Science (JSPS).
CR ABBOTT WM, 1975, SURGERY, V78, P723
   Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca
   Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Aoshima M., 2012, JPN J THROMB HEMOSTA, V23, P387
   BJORENSON JE, 1986, J ENDODONT, V12, P289, DOI 10.1016/S0099-2399(86)80110-8
   Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028
   DEJANA E, 1982, THROMB HAEMOSTASIS, V48, P108
   Dowling MB, 2011, BIOMATERIALS, V32, P3351, DOI 10.1016/j.biomaterials.2010.12.033
   EYLER RW, 1947, ANAL CHEM, V19, P24, DOI 10.1021/ac60001a007
   Frantz VK, 1944, ANN SURG, V120, P181
   Funahashi M., 2002, NEPHROL DIAL TRANSPL, V17, P1457
   Gu HB, 2013, FIBER POLYM, V14, P1266, DOI 10.1007/s12221-013-1266-1
   Heinze T, 2005, MACROMOL SYMP, V223, P13, DOI 10.1002/masy.200550502
   HETT DA, 1995, BRIT J ANAESTH, V75, P771, DOI 10.1093/bja/75.6.771
   Hori H, 2002, J ALLERGY CLIN IMMUN, V110, P652, DOI 10.1067/mai.2002.127862
   IBARROLA JL, 1985, J ENDODONT, V11, P75, DOI 10.1016/S0099-2399(85)80123-0
   Kihara H, 2001, EUR J PHARMACOL, V433, P157, DOI 10.1016/S0014-2999(01)01432-7
   Low R K, 1993, J Laparoendosc Surg, V3, P415, DOI 10.1089/lps.1993.3.415
   Ogushi Y, 2007, J BIOSCI BIOENG, V104, P30, DOI 10.1263/jbb.104.30
   Rajasekaran A., 2010, INT J BIOL MED RES, V1, P85
   Roy SC, 2007, BIOMATERIALS, V28, P4667, DOI 10.1016/j.biomaterials.2007.07.045
   Shilo S, 2013, TISSUE ENG PT A, V19, P1519, DOI [10.1089/ten.tea.2012.0345, 10.1089/ten.TEA.2012.0345]
   Shulda A., 2012, ADV MATER, V24, P492
   Taniguchi R., 2007, WEB J, V86, P29
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   Varma AJ, 2001, CARBOHYD POLYM, V45, P101, DOI 10.1016/S0144-8617(00)00278-2
   Wang HM, 2007, BLOOD COAGUL FIBRIN, V18, P555, DOI 10.1097/MBC.0b013e3281eec966
   Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44
   Yan L, 2014, ADV HEALTHC MATER, V3, P555, DOI 10.1002/adhm.201300312
   You KE, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025002
   ZUCKER WH, 1976, AM J PATHOL, V82, P129
NR 31
TC 10
Z9 10
U1 4
U2 57
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUN
PY 2015
VL 119
IS 6
BP 718
EP 723
DI 10.1016/j.jbiosc.2014.10.026
PG 6
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA CL1ZR
UT WOS:000356743900018
PM 25488042
DA 2018-10-19
ER

PT J
AU Russmueller, G
   Moser, D
   Spassova, E
   Plasenzotti, R
   Poeschl, PW
   Seemann, R
   Becker, S
   Pirklbauer, K
   Eder-Czembirek, C
   Czembirek, C
   Perisanidis, C
   Ewers, R
   Schopper, C
AF Russmueller, G.
   Moser, D.
   Spassova, E.
   Plasenzotti, R.
   Poeschl, P. W.
   Seemann, R.
   Becker, S.
   Pirklbauer, K.
   Eder-Czembirek, C.
   Czembirek, C.
   Perisanidis, C.
   Ewers, R.
   Schopper, C.
TI Tricalcium phosphate-based biocomposites for mandibular bone
   regeneration-A histological study in sheep
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Bone regeneration; Mandibular defect; Tricalcium phosphate; Autologous
   bone marrow; Coagulation factor XIII; Polylactide scaffold
ID MARROW STROMAL CELLS; STEM-CELLS; RECONSTRUCTION; DEFECTS;
   OSTEOPROMOTION; SCAFFOLD; SURGERY; TISSUES; GROWTH; REPAIR
AB The present study investigated the suitability of three different absorbable biocomposites for the repair of critical sized bone defects created at the mandibular angle of adult sheep.
   Each biocomposite was composed of a three-dimensional individualized polylactide scaffold, containing a tricalcium phosphate biomaterial (chronOS (R)). Either autologous bone marrow (chOS/Bone-Marrow) or coagulation factor XIII (chOS/FactorXIII) was added to the biomaterial for osteopromotion. Venous whole blood (chOS/Blood) added to the biomaterial served as a control. A total of 18 adult sheep were used for implantation studies, subdivided into three groups of six animals each.
   After 12 weeks of observation, the animals were sacrificed and the mandibles were retrieved for qualitative and quantitative histologic assessment within three regions of interest (transitional zone, center, and periphery) throughout the biocomposites. Successful bone regeneration was defined by the absence of scaffold deformation and the presence of new bone formation within the biocomposites.
   In histomorphometry, only chOS/BoneMarrow showed elevated area fractions of newly formed bone in all regions of interest (transitional zone 50.7 +/- 7.5, center 31.9 +/- 9.3, periphery 23.1 +/- 13.5). This led to preservation of the macroscopic scaffold structure in all specimens. Zero hurdle regression confirmed this by validating the factor biocomposite as significant (p < 0.001) for regeneration success. In our experiment, chOS/BoneMarrow was the only biocomposite passing the hurdle of regeneration in all three regions of interest.
   In contrast, bone formation was less pronounced and uniform in chOS/FactorXIII and chOS/blood-containing specimens. In these groups, scaffolds showed obvious to significant deformation.
   Overall, autologous bone marrow showed the most promising results in our experimental setting. As opposed to reports in the literature, we could not confirm the suitability of coagulation factor XIII to promote bone formation, since bone formation rates were comparable only to those of the control venous blood. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Russmueller, G.; Moser, D.; Poeschl, P. W.; Seemann, R.; Pirklbauer, K.; Eder-Czembirek, C.; Czembirek, C.; Perisanidis, C.; Ewers, R.; Schopper, C.] Med Univ Vienna, Dept Cranio Maxillofacial & Oral Surg, A-1090 Vienna, Austria.
   [Plasenzotti, R.] Med Univ Vienna, Inst Biomed Res, A-1090 Vienna, Austria.
   [Spassova, E.] Biotechnologies GmbH, AlgOss, Vienna, Austria.
   [Becker, S.] Austrian Cluster Tissue Regenerat, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.
RP Russmueller, G (reprint author), Med Univ Vienna, Dept Cranio Maxillofacial & Oral Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM guenter.russmueller@meduniwien.ac.at
OI Plasenzotti, Roberto/0000-0001-7652-1249
CR Al-Jallad HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015893
   Ashammakhi N, 2001, PLAST RECONSTR SURG, V108, P167, DOI 10.1097/00006534-200107000-00027
   Becker S, 2006, SPINE, V31, P11, DOI 10.1097/01.brs.0000192762.40274.57
   Becker S, 2008, J MATER SCI-MATER M, V19, P659, DOI 10.1007/s10856-007-3223-2
   Becker SWJ, 2001, SPINAL CORD, V39, P114, DOI 10.1038/sj.sc.3101092
   Bertele G, 2005, Minerva Stomatol, V54, P179
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Chanchareonsook N, 2014, TISSUE ENG PART B-RE, V20, P147, DOI [10.1089/ten.TEB.2013.0131, 10.1089/ten.teb.2013.0131]
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Eichner A, 2002, EXP CELL RES, V275, P132, DOI 10.1006/excr.2002.5488
   Gronthos S, 2004, LANCET, V364, P735, DOI 10.1016/S0140-6736(04)16948-1
   He Y, 2007, J CRANIOFAC SURG, V18, P800, DOI 10.1097/scs.0b013e31806901f5
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ilizarov G A, 1989, Clin Orthop Relat Res, P249
   Kilian O, 2005, BIOMATERIALS, V26, P1819, DOI 10.1016/j.biomaterials.2004.06.015
   Kinoshita Y, 1996, Tissue Eng, V2, P327, DOI 10.1089/ten.1996.2.327
   Kinoshita Yukihiko, 2005, Nihon Hotetsu Shika Gakkai Zasshi, V49, P569
   Kuznetsov SA, 2008, BIOMATERIALS, V29, P4211, DOI 10.1016/j.biomaterials.2008.07.013
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Louis P, 2004, J ORAL MAXIL SURG, V62, P719, DOI 10.1016/j.joms.2003.12.012
   Lucarelli E, 2005, CLIN ORTHOP RELAT R, P62, DOI 10.1097/01.blo.0000165736.87628.12
   Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567
   Matsuo A, 2012, J CRANIO MAXILL SURG, V40, pE453, DOI 10.1016/j.jcms.2012.03.004
   Muszbek L, 2001, PHYSIOL REV, V91, P931
   Nakano Y, 2007, J HISTOCHEM CYTOCHEM, V55, P675, DOI 10.1369/jhc.6A7091.2007
   Nolff MC, 2009, VET COMP ORTHOPAED, V22, P96, DOI 10.3415/VCOT-08-04-0038
   Pieri F, 2008, J CLIN PERIODONTOL, V35, P539, DOI 10.1111/j.1600-051X.2008.01220.x
   Schliephake H, 2000, J ORAL MAXIL SURG, V58, P1212, DOI 10.1053/joms.2000.16616
   Schliephake H, 2001, INT J ORAL MAX SURG, V30, P531, DOI 10.1054/ijom.2001.0164
   Strong EB, 2003, OTOLARYNG HEAD NECK, V129, P417, DOI 10.1016/S0194-5998(03)01315-9
   Sverzut CE, 2008, J ORAL MAXIL SURG, V66, P647, DOI 10.1016/j.joms.2007.06.664
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Zhou LB, 2008, BRIT J ORAL MAX SURG, V46, P445, DOI 10.1016/j.bjoms.2008.01.006
NR 35
TC 7
Z9 7
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD JUN
PY 2015
VL 43
IS 5
BP 696
EP 704
DI 10.1016/j.jcms.2015.03.022
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA CK9GN
UT WOS:000356548700018
PM 25937475
DA 2018-10-19
ER

PT J
AU Mangano, C
   Barboni, B
   Valbonetti, L
   Berardinelli, P
   Manelli, A
   Muttini, A
   Bedini, R
   Tete, S
   Piattelli, A
   Mattioli, M
AF Mangano, Carlo
   Barboni, Barbara
   Valbonetti, Luca
   Berardinelli, Paolo
   Manelli, Alessandra
   Muttini, Aurelio
   Bedini, Rossella
   Tete, Stefano
   Piattelli, Adriano
   Mattioli, Mauro
TI In Vivo Behavior of a Custom-Made 3D Synthetic Bone Substitute in Sinus
   Augmentation Procedures in Sheep
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE bone grafting; hydroxyapatites; tricalcium phosphate; X-ray
   microtomography; scaffolds; sinus floor augmentation
ID BMP-INDUCED OSTEOGENESIS; RAPID PROTOTYPING TECHNIQUE; PIG
   OVARIAN-FOLLICLES; POROUS HYDROXYAPATITE; PORE-SIZE;
   MECHANICAL-PROPERTIES; PERIOVULATORY PERIOD; SCAFFOLDS; FABRICATION;
   EXPRESSION
AB In this study, the in vivo behavior of a custom-made three-dimensional (3D) synthetic bone substitute was evaluated when used as scaffold for sinus augmentation procedures in an animal model. The scaffold was a calcium phosphate ceramic fabricated by the direct rapid prototyping technique, dispense-plotting. The geometrical and chemical properties of the scaffold were first analyzed through light and electron scanning microscopes, helium picnometer, and semi-quantitative X-ray diffraction measurements. Then, 6 sheep underwent monolateral sinus augmentation with the fabricated scaffolds. The animals were euthanized after healing periods of 45 and 90 days, and block sections including the grafted area were obtained. Bone samples were subjected to micro computerized tomography, morphological and histomorphometric analyses. A complete integration of the scaffold was reported, with abundant deposition of newly formed bone tissue within the biomaterial pores,. Moreover, initial foci of bone remodeling were mainly localized at the periphery of the implanted area after 45 days, while continuous bridges of mature lamellar bone were recorded in 90-day specimens. This evidence supports the hypothesis that bone regeneration proceeds from the periphery to the center of the sinus cavity. These results showed how a technique allowing control of porosity, pore design, and external shape of a ceramic bone substitute may be valuable for producing synthetic bone grafts with good clinical performances.
C1 [Mangano, Carlo] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
   [Barboni, Barbara; Valbonetti, Luca] Stem TeCh Grp, Chieti, Italy.
   [Barboni, Barbara; Valbonetti, Luca; Berardinelli, Paolo; Manelli, Alessandra; Muttini, Aurelio; Mattioli, Mauro] Univ Teramo, Dept Comparat Biomed Sci, Teramo, TE, Italy.
   [Bedini, Rossella] ISS, Dept Technol & Hlth, Rome, Italy.
   [Tete, Stefano; Piattelli, Adriano] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
RP Mangano, C (reprint author), Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
EM francescoguidomangano@gmail.com
RI Bedini, Rossella/B-2465-2013; Valbonetti, Luca/F-4078-2012
OI Valbonetti, Luca/0000-0001-5914-615X; Bedini,
   Rossella/0000-0002-0830-6632
FU Tercas Foundation; Ministry of Education, University and Research
   (M.I.U.R.), Rome, Italy
FX This work was supported by Tercas Foundation and, partially, by the
   Ministry of Education, University and Research (M.I.U.R.), Rome, Italy.
   The authors gratefully acknowledge the help of Sabine Hamisch,
   UweHamhaber, BioCerEntwicklungs-GmbH, Ludwig-Thoma-Str. 36c, 95447
   Bayreuth, Germany, in providing the materials and of Maura Turriani,
   Delia Nardinocchi, and Oriana Di Giacinto for their precious technical
   support in cell cultures and histological analysis.
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Barbara B, 2004, THERIOGENOLOGY, V62, P943, DOI 10.1016/j.theriogenology.2003.12.010
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Crespi R, 2009, J PERIODONTOL, V80, P586, DOI 10.1902/jop.2009.080466
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Diaz-Flores L, 2011, J CUTAN PATHOL, V38, P857, DOI 10.1111/j.1600-0560.2011.01778.x
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Fierz FC, 2008, BIOMATERIALS, V29, P3799, DOI 10.1016/j.biomaterials.2008.06.012
   Froum S J, 1998, Int J Periodontics Restorative Dent, V18, P528
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Killingsworth MC, 2011, PATHOBIOLOGY, V78, P24, DOI 10.1159/000322739
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Martelli A, 2006, J MOL ENDOCRINOL, V36, P107, DOI 10.1677/jme.1.01921
   Martelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-72
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3119, DOI 10.1007/s10856-010-4166-6
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3039, DOI 10.1007/s10856-010-4153-y
   Stevens B, 2008, J BIOMED MATER RES B, V85B, P573, DOI 10.1002/jbm.b.30962
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Zecha PJ, 2011, INT J ORAL MAX SURG, V40, P533, DOI 10.1016/j.ijom.2011.01.007
NR 43
TC 5
Z9 5
U1 1
U2 8
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD JUN
PY 2015
VL 41
IS 3
BP 241
EP 251
DI 10.1563/AAID-JOI-D-13-00053
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CL0PS
UT WOS:000356645200003
PM 23829685
DA 2018-10-19
ER

PT J
AU He, T
   Wang, JN
   Huang, PL
   Zeng, BZ
   Li, HH
   Cao, QY
   Zhang, SY
   Luo, ZO
   Deng, DYB
   Zhang, HW
   Zhou, WY
AF He, Ting
   Wang, Jingnan
   Huang, Peilin
   Zeng, Baozhen
   Li, Haihong
   Cao, Qingyun
   Zhang, Shiying
   Luo, Zhuo
   Deng, David Y. B.
   Zhang, Hongwu
   Zhou, Wuyi
TI Electrospinning polyvinylidene fluoride fibrous membranes containing
   anti-bacterial drugs used as wound dressing
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Electrospinning; Enro/PVDF fibrous membranes; Drug release; Wound
   dressing
ID POLY(VINYLIDENE FLUORIDE); POLYMER NANOFIBERS; CONTROLLED-RELEASE; PVDF;
   BIOMATERIAL; DELIVERY; GELATIN
AB The aim of this study was to synthesis drug-loaded fibrous membrane scaffolds for potential applications as wound dressing. Polyvinylidene fluoride (PVDF) fibrous membranes were loaded with enrofloxacin (Enro) drugs by using an electrospinning process, and their mechanical strength, drug release profile and anti-bacterial properties were evaluated. Enro drug-loaded PVDF membranes exhibited good elasticity, flexibility and excellent mechanical strength. The electrospinning Enro/PVDF membranes showed a burst drug release in the initial 12 h, followed by sustained release for the next 3 days, which was an essential property for antibiotic drugs applied for wound healing. The drug-loaded PVDF fibrous membranes displayed excellent anti-bacterial activity toward Escherichia coli and Staphylococcus aureus. The results suggest that electrospinning PVDF membrane scaffolds loaded with drugs can be used as wound dressing. (C) 2015 Elsevier B.V. All rights reserved.
C1 [He, Ting; Huang, Peilin; Li, Haihong; Zhou, Wuyi] South China Agr Univ, Coll Sci, Dept Appl Chem, Inst Biomat, Guangzhou 510642, Guangdong, Peoples R China.
   [Wang, Jingnan; Deng, David Y. B.] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China.
   [Cao, Qingyun] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.
   [Zhang, Shiying; Luo, Zhuo] Changsha Univ, Key Lab Applicat Technol Environm Photocatalysis, Changsha 410022, Hunan, Peoples R China.
   [Zeng, Baozhen; Zhang, Hongwu] Southern Med Univ, Guangdong Prov Key Lab Construct & Detect Tissue, Dept Anat, Guangzhou 510515, Guangdong, Peoples R China.
RP Deng, DYB (reprint author), South China Agr Univ, Dept Appl Chem, Inst Biomat, Wushan Rd 493, Guangzhou 510642, Guangdong, Peoples R China.
EM dengyub@mail.sysu.edu.cn; zhanghwu@mail2.sysu.edu.cn;
   zhouwuyi@scau.edu.cn
FU National Natural Science Foundation of China [31101854]; Key Academic
   Program of 211 Project of South China Agricultural University
   [2009B010100001]; Opening Project of the Key Laboratory of Application
   Technology of Environmental Photocatalysis of Hunan Province
   [ccsu-KF-1402]
FX The work was supported by the National Natural Science Foundation of
   China (no. 31101854), the Key Academic Program of 211 Project of South
   China Agricultural University (2009B010100001) and the Opening Project
   of the Key Laboratory of Application Technology of Environmental
   Photocatalysis of Hunan Province (ccsu-KF-1402).
CR Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Aoyagi S, 2007, INT J PHARM, V330, P138, DOI 10.1016/j.ijpharm.2006.09.016
   Bormashenko Y, 2004, POLYM TEST, V23, P791, DOI 10.1016/j.polymertesting.2004.04.001
   Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   Charernsriwilaiwat N, 2013, INT J PHARMACEUT, V452, P333, DOI 10.1016/j.ijpharm.2013.05.012
   Chen HM, 2010, J MATER PROCESS TECH, V210, P1551, DOI 10.1016/j.jmatprotec.2010.05.001
   Chen ZG, 2008, CARBOHYD POLYM, V72, P410, DOI 10.1016/j.carbpol.2007.09.018
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Donini C., 2008, INT J PHARMACEUT, V245, P87
   Dorna E., 2013, J CONTROL RELEASE, V169, P313
   Hattori T, 1996, POLYMER, V37, P85, DOI 10.1016/0032-3861(96)81602-8
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kanokpanont S, 2012, INT J PHARMACEUT, V436, P141, DOI 10.1016/j.ijpharm.2012.06.046
   Kim TG, 2007, INT J PHARM, V338, P276, DOI 10.1016/j.ijpharm.2007.01.040
   Konstantinos N. K., 2011, INT J PHARMACEUT, V409, P216
   Lai ST, 2013, J NANOSCI NANOTECHNO, V13, P91, DOI 10.1166/jnn.2013.7086
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Natthan C., 2012, INT J PHARMACEUT, V427, P379
   Ong S. Y., 2010, BIOMATERIALS, V322, P4323
   Paola L., 2013, ACTA BIOMATER, V9, P7814
   Puppi D, 2010, ACTA BIOMATER, V6, P1258, DOI 10.1016/j.actbio.2009.08.015
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Salimi A, 2003, POLYM TEST, V22, P699, DOI 10.1016/S0142-9418(03)00003-5
   Shen XX, 2011, INT J PHARMACEUT, V408, P200, DOI 10.1016/j.ijpharm.2011.01.058
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sun XM, 2014, COLLOID SURFACE B, V115, P61, DOI 10.1016/j.colsurfb.2013.11.030
   Torres V. E. A., 2010, ACTA BIOMATER, V6, P1069
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
NR 33
TC 26
Z9 27
U1 11
U2 94
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2015
VL 130
BP 278
EP 286
DI 10.1016/j.colsurfb.2015.04.026
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CL1WJ
UT WOS:000356735300036
PM 25936562
DA 2018-10-19
ER

PT J
AU Barros, J
   Grenho, L
   Fernandes, MH
   Manuel, CM
   Melo, LF
   Nunes, OC
   Monteiro, FJ
   Ferraz, MP
AF Barros, J.
   Grenho, L.
   Fernandes, M. H.
   Manuel, C. M.
   Melo, L. F.
   Nunes, O. C.
   Monteiro, F. J.
   Ferraz, M. P.
TI Anti-sessile bacterial and cytocompatibility properties of CHX-loaded
   nanohydroxyapatite
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Nanohydroxyapatite; Chlorhexidine digluconate; Anti-sessile;
   Cytocompatibility
ID IMPLANT-ASSOCIATED INFECTIONS; EPIDERMIDIS BIOFILM FORMATION; IN VIVO
   CHARACTERIZATION; DELIVERY-SYSTEM; CIPROFLOXACIN IMPLANTS; ANTIMICROBIAL
   PEPTIDES; COATED TITANIUM; BASIC DYE; CHLORHEXIDINE; ADSORPTION
AB Nanohydroxyapatite possesses exceptional biocompatibility and bioactivity regarding bone cells and tissues, justifying its use as a coating material or as a bone substitute. Unfortunately, this feature may also encourage bacterial adhesion and biofilm formation. Surface functionalization with antimicrobials is a promising strategy to reduce the likelihood of bacterial infestation and colonization on medical devices. Chlorhexidine digluconate is a common and effective antimicrobial agent used for a wide range of medical applications. The purpose of this work was the development of a nanoHA biomaterial loaded with CHX to prevent surface bacterial accumulation and, simultaneously, with good cytocompatibility, for application in the medical field. CHX (5-1500 mg/L) was loaded onto nanoHA discs and the materials were evaluated for CHX adsorption and release profile, physic-chemical features, antibacterial activity against Escherichia coli, Staphylococcus aureus and Staphylococcus epidermidis, and cytocompatibility toward L929 fibroblasts. Results showed that the adsorption of CHX on nanoHA surface occurred by electrostatic interactions between the cationic group of CHX and the phosphate group of nanoHA. The release of CHX from CHX-loaded nanoHA showed a fast initial rate followed by a slower kinetics release, due to constraints caused by dilution and diffusion-limiting processes. NanoHA.50 to nanoHA.1500 showed strong anti-sessile activity, inhibiting bacterial adhesion and the biofilm formation. CHX-nanoHA caused a dose- and time-dependent inhibitory effect on the proliferation of fibroblasts for nanoHA.100 to nanoHA.1500. Cellular behavior on nanoHA.5 and nanoHA.50 was similar to control. Therefore, CHX-loaded nanoHA surfaces appear as a promising alternative to prevention of devices-related infections. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Barros, J.; Grenho, L.; Monteiro, F. J.] Univ Porto, I3S, P-4100 Oporto, Portugal.
   [Barros, J.; Grenho, L.; Monteiro, F. J.] INEB Inst Engn Biomed, Oporto, Portugal.
   [Barros, J.; Grenho, L.; Monteiro, F. J.] Univ Porto, Dept Engn Met & Mat, FEUP Fac Engn, P-4100 Oporto, Portugal.
   [Barros, J.; Manuel, C. M.; Melo, L. F.; Nunes, O. C.] Univ Porto, Dept Chem Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, P-4100 Oporto, Portugal.
   [Fernandes, M. H.] Univ Porto, Fac Med Dent, P-4100 Oporto, Portugal.
   [Manuel, C. M.] Univ Lusofona Porto, Oporto, Portugal.
   [Ferraz, M. P.] Univ Fernando Pessoa, CEBIMED Ctr Estudos Biomed, Oporto, Portugal.
RP Barros, J (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM joanabarros@fe.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Barros, Joana/0000-0002-8205-5675; Monteiro,
   Fernando/0000-0002-1361-4605; Nunes, Olga/0000-0003-4742-2537; Duarte
   Manuel, Candida Maria/0000-0002-7030-1525; Melo,
   Luis/0000-0002-8469-4462
FU FEDER through Programa Operacional Factores de Competitividade-COMPETE;
   national (Portuguese) funds through FCT-Fundacao para a Ciencia e a
   Tecnologia within project NanoBiofilm [PTDC/SAU-BMA/111233/2009]
FX This work was co-financed by FEDER funding through Programa Operacional
   Factores de Competitividade-COMPETE and by national (Portuguese) funds
   through FCT-Fundacao para a Ciencia e a Tecnologia within project
   NanoBiofilm (PTDC/SAU-BMA/111233/2009).
CR Alcaide M, 2009, J BIOMED MATER RES A, V89A, P539, DOI 10.1002/jbm.a.31985
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   Alvarez H, 2008, J BIOMED MATER RES B, V85B, P93, DOI 10.1002/jbm.b.30921
   Barbour ME, 2007, COLLOID SURFACE A, V307, P116, DOI 10.1016/j.colsurfa.2007.05.010
   Baro M, 2002, J CONTROL RELEASE, V83, P353, DOI 10.1016/S0168-3659(02)00179-7
   Barros J, 2014, J BIOMATER APPL, V28, P1325, DOI 10.1177/0885328213507300
   Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Castro C, 2003, J CONTROL RELEASE, V93, P341, DOI 10.1016/j.jconrel.2003.09.004
   Cheung H. Y., 2012, PLOS ONE, V7
   Chibowski E, 1998, LANGMUIR, V14, P5237, DOI 10.1021/la971107b
   Cortizo MC, 2012, J DENT, V40, P329, DOI 10.1016/j.jdent.2012.01.008
   Desta M.B., 2013, J THERMODYN
   Dou XC, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025002
   Family R, 2012, CASP J INTERN MED, V3, P460
   Ferraz MP, 2007, J BIOMED MATER RES A, V81A, P994, DOI 10.1002/jbm.a.31151
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fong N, 2010, ACTA BIOMATER, V6, P2554, DOI 10.1016/j.actbio.2010.01.005
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Franco CF, 2003, ARTIF ORGANS, V27, P486, DOI 10.1046/j.1525-1594.2003.07245.x
   Gimenez-Martin E, 2009, CELLULOSE, V16, P467, DOI 10.1007/s10570-009-9281-5
   Grenho L., 2013, J BIOMED MAT RES A
   Hameed BH, 2008, J HAZARD MATER, V158, P499, DOI 10.1016/j.jhazmat.2008.01.098
   Hauman CHJ, 2003, INT ENDOD J, V36, P75, DOI 10.1046/j.1365-2591.2003.00631.x
   Hiraishi N, 2010, J BIOMED MATER RES B, V94B, P134, DOI 10.1002/jbm.b.31633
   Hook ER, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-3
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kim J, 2010, DENT MATER, V26, P771, DOI 10.1016/j.dental.2010.04.001
   Kolska Z., 2013, POLYM SCI, P203
   Mittal A, 2007, J HAZARD MATER, V146, P243, DOI 10.1016/j.jhazmat.2006.12.012
   Morra M, 2004, BIOMED PHARMACOTHER, V58, P418, DOI 10.1016/j.biopha.2004.08.002
   Neut D, 2005, J BIOMED MATER RES A, V73A, P165, DOI 10.1002/jbm.a.30253
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   RUSSEL AD, 1986, PHARM INT, V7, P305
   Seil JT, 2011, ACTA BIOMATER, V7, P2579, DOI 10.1016/j.actbio.2011.03.018
   Shi PJ, 2010, J BIOMED MATER RES A, V93A, P1020, DOI 10.1002/jbm.a.32598
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   SODHI RNS, 1992, J DENT RES, V71, P1493, DOI 10.1177/00220345920710080601
   de Souza CAS, 2011, COLLOID SURFACE B, V87, P310, DOI 10.1016/j.colsurfb.2011.05.035
   Tank K. P., 2013, J NANOPART RES, V15
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Yue IC, 2004, BIOMATERIALS, V25, P3743, DOI 10.1016/j.biomaterials.2003.09.113
   Zamanian A, 2010, ADV APPL CERAM, V109, P440, DOI 10.1179/174367610X12804792635107
NR 47
TC 7
Z9 7
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2015
VL 130
BP 305
EP 314
DI 10.1016/j.colsurfb.2015.04.034
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CL1WJ
UT WOS:000356735300040
PM 25936560
DA 2018-10-19
ER

PT J
AU Wegrzyn, J
   Kaufman, KR
   Hanssen, AD
   Lewallen, DG
AF Wegrzyn, Julien
   Kaufman, Kenton R.
   Hanssen, Arlen D.
   Lewallen, David G.
TI Performance of Porous Tantalum vs. Titanium Cup in Total Hip
   Arthroplasty: Randomized Trial with Minimum 10-Year Follow-Up
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE total hip arthroplasty; porous tantalum monoblock cup; cementless
   fixation; osseointegration; aseptic loosening
ID MONOBLOCK ACETABULAR COMPONENT; BONE INGROWTH; COMPUTED-TOMOGRAPHY;
   POLYETHYLENE WEAR; OSTEOLYSIS; REPLACEMENTS; MULTICENTER; BIOMATERIAL;
   DISLOCATION; INTERFACE
AB Porous tantalum monoblock cups have been proposed to improve survivorship of cementless primary THA. However, there are few direct comparative trials to established implants such as porous-coated titanium cups. 113 patients were randomized into two groups according to the cup: a porous tantalum monoblock cup (TM) or a porous-coated titanium monoblock cup (control). At a mean of 12 years after THA, no implants migrated in both groups. Two TM patients (4%) and 13 control patients (33%) presented with radiolucency around the cup (P > 0.001). In the control group, 1 cup (2%) was revised for aseptic loosening. At 12 years post-implantation, porous tantalum monoblock cups demonstrated 100% survivorship, and significantly less radiolucency as compared to porous-coated titanium monoblock cups. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wegrzyn, Julien; Kaufman, Kenton R.; Hanssen, Arlen D.; Lewallen, David G.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
RP Lewallen, DG (reprint author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.
OI Kaufman, Kenton/0000-0002-7311-3781
CR Beaule PE, 2004, J BONE JOINT SURG AM, V86A, P929, DOI 10.2106/00004623-200405000-00007
   Beck RT, 2012, J ORTHOP RES, V30, P541, DOI 10.1002/jor.21554
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hanzlik JA, 2013, J ARTHROPLASTY, V28, P922, DOI 10.1016/j.arth.2013.01.035
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Howard JL, 2011, J BONE JOINT SURG AM, V93A, P1597, DOI 10.2106/JBJS.J.00195
   HUK OL, 1994, J BONE JOINT SURG BR, V76B, P568
   Kitamura N, 2005, CLIN ORTHOP RELAT R, P291, DOI 10.1097/01.blo.0000192359.12573.15
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kostakos AT, 2010, J ARTHROPLASTY, V25, P35, DOI 10.1016/j.arth.2008.09.027
   Leung S, 2005, J BONE JOINT SURG AM, V87A, P592, DOI 10.2106/JBJS.D.02116
   Levi ADO, 1998, SPINE, V23, P1245, DOI 10.1097/00007632-199806010-00014
   Macheras GA, 2010, J BONE JOINT SURG BR, V92B, P624, DOI 10.1302/0301-620X.92B5.23256
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Macheras G, 2009, J ARTHROPLASTY, V24, P705, DOI 10.1016/j.arth.2008.06.020
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Martell JM, 1997, J BONE JOINT SURG AM, V79A, P1635, DOI 10.2106/00004623-199711000-00004
   Martell JM, 2003, J BONE JOINT SURG AM, V85A, P1111, DOI 10.2106/00004623-200306000-00020
   Massin P, 1989, J Arthroplasty, V4, P245, DOI 10.1016/S0883-5403(89)80020-8
   Mayman DJ, 2007, J ARTHROPLASTY, V22, P130, DOI 10.1016/j.arth.2007.04.016
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Moen TC, 2011, CLIN ORTHOP RELAT R, V469, P382, DOI 10.1007/s11999-010-1500-8
   Mulier Michiel, 2006, Acta Orthop Belg, V72, P326
   Noiseux NO, 2014, J ARTHROPLASTY, V29, P617, DOI 10.1016/j.arth.2013.07.037
   NUNN D, 1989, J BONE JOINT SURG BR, V71, P629
   Poggie RA, 1999, T ORTHOP RES SOC, V24, P747
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P1130, DOI 10.2106/00004623-199274080-00002
   Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004
   Sculco TP, 2002, J ARTHROPLASTY, V17, P118, DOI 10.1054/arth.2002.32690
   Xenakis TA, 2009, INT ORTHOP, V33, P911, DOI 10.1007/s00264-008-0581-4
NR 36
TC 19
Z9 21
U1 3
U2 15
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JUN
PY 2015
VL 30
IS 6
BP 1008
EP 1013
DI 10.1016/j.arth.2015.01.013
PG 6
WC Orthopedics
SC Orthopedics
GA CK4GY
UT WOS:000356183500021
PM 25765132
DA 2018-10-19
ER

PT J
AU Isa, ILM
   Srivastava, A
   Tiernan, D
   Owens, P
   Rooney, P
   Dockery, P
   Pandit, A
AF Isa, Isma Liza Mohd
   Srivastava, Akshay
   Tiernan, David
   Owens, Peter
   Rooney, Peadar
   Dockery, Peter
   Pandit, Abhay
TI Hyaluronic Acid Based Hydrogels Attenuate Inflammatory Receptors and
   Neurotrophins in Interleukin-1 beta Induced Inflammation Model of
   Nucleus Pulposus Cells
SO BIOMACROMOLECULES
LA English
DT Article
ID INTERVERTEBRAL DISC DEGENERATION; NERVE GROWTH-FACTOR;
   SMOOTH-MUSCLE-CELLS; LOW-BACK-PAIN; MESENCHYMAL STEM-CELLS; ROOT
   GANGLION NEURONS; LUNG INJURY; IN-VITRO; REGENERATION; INHIBITION
AB Inflammation plays an important role in symptomatic intervertebral disc degeneration and is associated with the production of neurotrophins in sensitizing innervation into the disc. The use of high molecular weight (HMw) hyaluronic acid (HA) hydrogels offers a potential therapeutic biomaterial for nucleus pulposus (NP) regeneration as it exerts an anti-inflammatory effect and provides a microenvironment that is more suitable for NP. Therefore, it was hypothesized that cross-linked HMw HA hydrogels modulate the inflammatory receptor of IL-1R1, MyD88 and neurotrophin expression of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in an in vitro inflammation model of NP. HA cross-linking was optimized using various concentrations of 4-arm PEG-amine by determination of free carboxyl groups of HA and unreacted free amine groups of PEG-amine. The optimally cross-linked HA hydrogels were characterized for hydrolytic stability, enzymatic degradation and cytotoxicity on NP cells. The therapeutic effect of HA hydrogels was further investigated in IL-1 beta induced inflammation on NP cell cultures and the mechanism of HA by examining the expression of cell surface receptor of CD44. Hydrogel was optimally cross-linked at 75 mM PEG, stable in phosphate buffered saline, and showed greater than 40% resistance to enzymatic degradation. No cytotoxic effect of NP cells was observed in the presence of hydrogels for 1, 3, and 7 days. IL-1R1 and MyD88 were significantly suppressed. Additionally, NGF and BDNF mRNA were down-regulated after treatment with cross-linked HA hydrogel. Possible protective mechanism of HA is shown by high expression of CD44 receptor of NP cells after HA treatment in which suggest the binding of HA to CD44 receptor and prevent NP cells from further undergoing inflammation. These results indicate that optimally stabilized cross-linked HMw HA hydrogel has a therapeutic effect in response to inflammation-associated pain and becomes an ideal matrices hydrogel for NP regeneration.
C1 [Isa, Isma Liza Mohd; Srivastava, Akshay; Tiernan, David; Rooney, Peadar; Pandit, Abhay] Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland.
   [Owens, Peter; Dockery, Peter] Natl Univ Ireland, Ctr Microscopy & Imaging, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Rooney, Peadar/0000-0003-3119-3928
FU Majlis Amanah Rakyat (MARA), Malaysia [ROG1112]; DiscMat Collaborative
   Research Center AO Foundation
FX The authors would like to thank Majlis Amanah Rakyat (MARA), Malaysia
   (Grant No.: ROG1112) and the DiscMat Collaborative Research Center AO
   Foundation for providing financial support to this project. The authors
   would like to acknowledge Dr. Oliver Carroll for his technical support,
   Mr. Anthony Sloan for editorial assistance with this manuscript, and Mr.
   Maciej Doczyk for his help with diagrams.
CR Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53
   Aoki Y, 2004, LIFE SCI, V74, P2627, DOI 10.1016/j.lfs.2004.01.008
   Aoki Y, 2007, SPINE, V32, P857, DOI 10.1097/01.brs.0000259810.48681.90
   Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009
   de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X
   Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8
   DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596
   Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X
   Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631
   Fontana G., 2014, BIOCONJUGATE CHEM
   FORRESTER JV, 1980, IMMUNOLOGY, V40, P435
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108
   Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072
   Gingras M, 2003, FASEB J, V17, P2124, DOI 10.1096/fj.02-1180fje
   Gruber HE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2456
   Halloran DO, 2008, BIOMATERIALS, V29, P438, DOI 10.1016/j.biomaterials.2007.10.009
   Hellard D, 2004, DEV BIOL, V275, P34, DOI 10.1016/j.ydbio.2004.07.021
   Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056
   Ishida O, 1997, J BONE MINER RES, V12, P1657, DOI 10.1359/jbmr.1997.12.10.1657
   Karna E, 2006, PHARMACOL RES, V54, P275, DOI 10.1016/j.phrs.2006.06.002
   Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003
   KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210
   Krock E, 2014, J CELL MOL MED, V18, P1213, DOI 10.1111/jcmm.12268
   Le Maitre Christine Lyn, 2007, Arthritis Res Ther, V9, pR77
   Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732
   Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Levin DA, 2007, BULL HOSP JT DIS, V65, P29
   Li CQ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-27
   Liu YY, 2008, CRIT CARE, V12, DOI 10.1186/cc6982
   Luo XM, 2004, SPINE, V29, pE531, DOI 10.1097/01.brs.0000146453.76528.7c
   Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016
   Majid K., 2008, SEMIN SPINE SURG, V20, P87
   Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004
   Peng BG, 2006, SPINE, V31, P560, DOI 10.1097/01.brs.0000201324.45537.46
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Prehm P, 2004, BIOCHEM PHARMACOL, V68, P1401, DOI 10.1016/j.bcp.2004.06.017
   PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597
   Purmessur D., 2015, SPINE J
   Renn CL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-61
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764
   Schimizzi Aimee L, 2006, Spine J, V6, P550, DOI 10.1016/j.spinee.2005.12.005
   Shankar H, 2009, TECH REG ANESTH PAIN, V13, P67, DOI [10.1053/j.trap.2009.05.001, DOI 10.1053/J.TRAP.2009.05.001]
   Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970
   Takahashi K, 2008, EUR SPINE J, V17, pS428, DOI 10.1007/s00586-008-0752-4
   Tan H., 2011, J BIOMED MATER RES A, V92, P979
   Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77
   Wieland J. A., 2009, J CONTROL RELEASE, V120, P233
   Woolf CJ, 1996, J NEUROSCI, V16, P2716
   Wuertz K, 2013, GLOB SPINE J, V3, P175, DOI 10.1055/s-0033-1347299
   Wuertz K, 2012, EUR CELLS MATER, V23, P103
   Zavan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055510
NR 60
TC 22
Z9 22
U1 1
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2015
VL 16
IS 6
BP 1714
EP 1725
DI 10.1021/acs.biomac.5b00168
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA V39IY
UT WOS:000209405900005
PM 25871410
DA 2018-10-19
ER

PT J
AU Lang, N
   Merkel, E
   Fuchs, F
   Schumann, D
   Klemm, D
   Kramer, F
   Mayer-Wagner, S
   Schroeder, C
   Freudenthal, F
   Netz, H
   Kozlik-Feldmann, R
   Sigler, M
AF Lang, Nora
   Merkel, Elena
   Fuchs, Franziska
   Schumann, Dieter
   Klemm, Dieter
   Kramer, Friederike
   Mayer-Wagner, Susanne
   Schroeder, Christian
   Freudenthal, Franz
   Netz, Heinrich
   Kozlik-Feldmann, Rainer
   Sigler, Matthias
TI Bacterial nanocellulose as a new patch material for closure of
   ventricular septal defects in a pig model
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE Ventricular septal defects; Patch material; Biomaterial;
   Biocompatibility
ID BOVINE PERICARDIUM; BIOCOMPATIBILITY; CELLULOSE; CELLS; IMPLANTS;
   MATRICES
AB Current materials for closure of cardiac defects such as ventricular septal defects (VSDs) are associated with compliance mismatch and a chronic inflammatory response. Bacterial nanocellulose (BNC) is a non-degradable biomaterial with promising properties such as high mechanical strength, favourable elasticity and a negligible inflammatory reaction. The aim of this study was the evaluation of a BNC patch for VSD closure and the investigation of its in vivo biocompatibility in a chronic pig model.
   Young's modulus and tensile strength of BNC patches were determined before and after blood exposure. Muscular VSDs were created and closed with a BNC patch on the beating heart in an in vivo pig model. Hearts were explanted after 7, 30 or 90 days. Macropathology, histology and immunohistochemistry were performed.
   Young's modulus and tensile strength of the BNC patch decreased after blood contact from 6.3 +/- 1.9 to 3.86 +/- 2.2 MPa (P < 0.01) and 0.33 +/- 0.06 to 0.26 +/- 0.06 MPa (P < 0.01), respectively, indicating the development of higher elasticity. Muscular VSDs were closed with a BNC patch without residual shunting. After 90 days, a mild chronic inflammatory reaction was present. Moreover, there was reduced tissue overgrowth in comparison with polyester. Proceeding cellular organization characterized by fibromuscular cells, production of extracellular matrix, neoangiogenesis and complete neoendothelialization were found. There were no signs of thrombogenicity.
   BNC patches can close VSDs with good mid-term results and its biocompatibility can be considered as satisfactory. Its elasticity increases in the presence of blood, which might be advantageous. Therefore, it has potential to be used as an alternative patch material in congenital heart disease.
C1 [Lang, Nora; Merkel, Elena; Fuchs, Franziska; Netz, Heinrich; Kozlik-Feldmann, Rainer] Univ Munich, Dept Pediat Cardiol & Intens Care Med, Munich, Germany.
   [Lang, Nora] Univ Freiburg, Dept Congenital Heart Defects & Pediat Cardiol, Ctr Heart, D-79106 Freiburg, Germany.
   [Schumann, Dieter; Klemm, Dieter; Kramer, Friederike] Transfer Grp Polymet eV, Jena, Germany.
   [Mayer-Wagner, Susanne; Schroeder, Christian] Univ Munich, Dept Orthoped Surg, Munich, Germany.
   [Freudenthal, Franz] Kardiozentrum, La Paz, Bolivia.
   [Sigler, Matthias] Univ Gottingen, Dept Pediat Cardiol & Intens Care Med, D-37073 Gottingen, Germany.
RP Lang, N (reprint author), Univ Freiburg, Dept Congenital Heart Defects & Pediat Cardiol, Ctr Heart, Mathildenstr 1, D-79106 Freiburg, Germany.
EM nora.lang@universitaets-herzzentrum.de
RI Schroder, Christian/I-2920-2016
OI Schroder, Christian/0000-0003-2003-565X
FU German Society of Pediatric Cardiology; Elterninitiative Grosshadern
   e.V.; Heart for Heart Foundation; FoeFoLe Programme of the LMU of Munich
FX The work was awarded by a poster price of the German Society of
   Pediatric Cardiology. The work was supported by the Elterninitiative
   Grosshadern e.V., the Heart for Heart Foundation and the FoeFoLe
   Programme of the LMU of Munich.
CR Santibanez-Salgado JA, 2010, EUR CELLS MATER, V19, P158, DOI 10.22203/eCM.v019a16
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Barros D'Sa AA, 1980, ANN SURG, V192, P645
   Cho SW, 2005, BIOMATERIALS, V26, P1915, DOI 10.1016/j.biomaterials.2004.06.018
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   Foth R, 2009, CIRC-CARDIOVASC INTE, V2, P90, DOI 10.1161/CIRCINTERVENTIONS.108.810507
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Jux Christian, 2003, J Interv Cardiol, V16, P149, DOI 10.1046/j.1540-8183.2003.08027.x
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kozlik-Feldmann R, 2008, J AM COLL CARDIOL, V51, P1597, DOI 10.1016/j.jacc.2007.10.068
   Kozlik-Feldmann R, 2009, J THORAC CARDIOV SUR, V138, P365, DOI 10.1016/j.jtcvs.2009.02.014
   Lang N, 2010, HEART SURG FORUM, V13, pE299, DOI 10.1532/HSF98.20091181
   Matsuhisa H, 2013, ANN THORAC SURG, V96, P891, DOI 10.1016/j.athoracsur.2013.05.013
   Mirensky TL, 2008, PEDIATR RES, V63, P559, DOI 10.1203/01.pdr.0000305938.92695.b9
   Moons P, 2009, ACTA PAEDIATR, V98, P472, DOI 10.1111/j.1651-2227.2008.01152.x
   Pok S, 2011, J CARDIOVASC TRANSL, V4, P646, DOI 10.1007/s12265-011-9289-8
   Quentin T, 2009, ACTA HISTOCHEM, V111, P538, DOI 10.1016/j.acthis.2008.04.001
   Schmidt D, 2005, EUR J CARDIO-THORAC, V27, P795, DOI 10.1016/j.ejcts.2005.01.064
   SHRIVASTAVA S, 1989, INT J CARDIOL, V25, P27, DOI 10.1016/0167-5273(89)90158-7
   Sigler M, 2005, Z KARDIOL, V94, P383, DOI 10.1007/s00392-005-0231-4
   Sigler M, 2007, HEART, V93, P444, DOI 10.1136/hrt.2006.098103
   Vasilyev NV, 2008, J THORAC CARDIOV SUR, V135, P603, DOI 10.1016/j.jtcvs.2007.09.045
   Weber B, 2011, BIOMATERIALS, V32, P9630, DOI 10.1016/j.biomaterials.2011.07.070
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
NR 25
TC 6
Z9 6
U1 0
U2 21
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1010-7940
EI 1873-734X
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD JUN
PY 2015
VL 47
IS 6
BP 1013
EP 1021
DI 10.1093/ejcts/ezu292
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA CJ7IJ
UT WOS:000355668000011
PM 25064053
OA Bronze
DA 2018-10-19
ER

PT J
AU Maia, LP
   Reino, DM
   Muglia, VA
   Almeida, ALG
   Nanci, A
   Wazen, RM
   de Oliveira, PT
   Palioto, DB
   Novaes, AB
AF Maia, Luciana P.
   Reino, Danilo M.
   Muglia, Valdir A.
   Almeida, Adriana L. G.
   Nanci, Antonio
   Wazen, Rima M.
   de Oliveira, Paulo T.
   Palioto, Daniela B.
   Novaes, Arthur B., Jr.
TI Influence of periodontal tissue thickness on buccal plate remodelling on
   immediate implants with xenograft
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE biomaterials; bone substitutes; bone-implant interactions; immediate
   implant placement; xenograft
ID FRESH EXTRACTION SOCKETS; GUIDED BONE REGENERATION; RIDGE ALTERATIONS;
   FLAPLESS SURGERY; BIO-OSS(R) COLLAGEN; TOOTH EXTRACTION; BEAGLE DOGS;
   PLACEMENT; PRESERVATION; BIOTYPE
AB AimTo evaluate the influence of gingival thickness and bone grafting on buccal bone plate remodelling after immediate implant placement in sockets with thin buccal bone, using a flapless approach.
   Materials and MethodsThe gingiva of eight dogs was thinned at one side of the mandible, mandibular premolars were extracted without flaps, and four implants were installed on each side at 1.5mm from the buccal bone. The sites were randomly assigned into: TG (test group)=thin gingiva; TG+GM (TG with grafting material); CG (control group)=normal gingiva; and CG+GM (CG with grafting material). After 12weeks the dogs were sacrificed and the samples were processed for histological analysis.
   ResultsAll animals exhibited a thin buccal bone initially. In all the experimental groups the buccal gap was filled with newly formed bone and the buccal bone level was slightly apical to the implant shoulder. There were no statistically significant differences among the groups for the histomorphometric parameters.
   ConclusionsThe thickness of the buccal bone was a fundamental factor in buccal bone plate resorption, even with flapless implantation. The gingival thickness or the addition of a biomaterial in the gap did not influence the results.
C1 [Maia, Luciana P.; Reino, Danilo M.; Almeida, Adriana L. G.; Palioto, Daniela B.; Novaes, Arthur B., Jr.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Buccomaxilofacial Surg & Traumatol & Periodo, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Muglia, Valdir A.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Dent Mat Prosthet, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Nanci, Antonio; Wazen, Rima M.] Univ Montreal, Fac Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ, Canada.
   [de Oliveira, Paulo T.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Stomatol & Basic Pathol, BR-14040904 Ribeirao Preto, SP, Brazil.
RP Novaes, AB (reprint author), Univ Sao Paulo, Fac Odontol Ribeirao Preto, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM novaesjr@forp.usp.br
RI novaes, arthur/O-2945-2013; Tambasco de Oliveira, Paulo/F-9749-2010;
   Palioto, Daniela/H-3054-2016
OI Tambasco de Oliveira, Paulo/0000-0002-6662-0486; Maia,
   Luciana/0000-0001-5697-2587
FU State of Sao Paulo Research Foundation (FAPESP) [11/00674-6]; Geistlich
   Pharma AG
FX This study was financially supported by the State of Sao Paulo Research
   Foundation (FAPESP; process number 11/00674-6) and the graft material
   used was provided by Geistlich Pharma AG.
CR Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Barone A, 2011, CLIN ORAL IMPLAN RES, V22, P1131, DOI 10.1111/j.1600-0501.2010.02084.x
   Bashara H, 2012, CLIN ORAL IMPLAN RES, V23, P911, DOI 10.1111/j.1600-0501.2011.02240.x
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Berglundh T, 2012, J CLIN PERIODONTOL, V39, P1, DOI 10.1111/j.1600-051X.2011.01827.x
   Blanco J, 2008, J CLIN PERIODONTOL, V35, P640, DOI 10.1111/j.1600-051X.2008.01237.x
   Blanco J, 2010, CLIN ORAL IMPLAN RES, V21, P624, DOI 10.1111/j.1600-0501.2009.01885.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Bragger U, 1996, CLIN ORAL IMPLAN RES, V7, P268, DOI 10.1034/j.1600-0501.1996.070309.x
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P891, DOI 10.1111/j.1600-0501.2010.01946.x
   De Rouck T, 2009, J CLIN PERIODONTOL, V36, P428, DOI 10.1111/j.1600-051X.2009.01398.x
   Denissen H W, 1993, Int J Oral Maxillofac Implants, V8, P191
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P898, DOI 10.1111/j.1600-051X.2009.01463.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P442, DOI 10.1111/j.1600-051X.2009.01381.x
   Gelb D A, 1993, Int J Oral Maxillofac Implants, V8, P388
   GHER ME, 1994, J PERIODONTOL, V65, P881, DOI 10.1902/jop.1994.65.9.881
   Heberer S, 2008, CLIN ORAL IMPLAN RES, V19, P1219, DOI 10.1111/j.1600-0501.2008.01617.x
   Kim BS, 2009, ORAL SURG ORAL MED O, V107, pE24, DOI 10.1016/j.tripleo.2008.12.010
   Kim JI, 2009, ORAL SURG ORAL MED O, V107, P508, DOI 10.1016/j.tripleo.2008.08.003
   Kohal RJ, 1998, J PERIODONTOL, V69, P927, DOI 10.1902/jop.1998.69.8.927
   Lee A, 2011, IMPLANT DENT, V20, pE38, DOI 10.1097/ID.0b013e3182181d3d
   Linkevicius T, 2015, CLIN IMPLANT DENT R, V17, P497, DOI 10.1111/cid.12155
   Linkevicius T, 2010, J ORAL MAXIL SURG, V68, P2272, DOI 10.1016/j.joms.2009.08.018
   Linkevicius T, 2009, INT J ORAL MAX IMPL, V24, P712
   Maia LP, 2015, CLIN ORAL IMPLAN RES, V26, P35, DOI 10.1111/clr.12298
   Muller HP, 1997, J CLIN PERIODONTOL, V24, P65, DOI 10.1111/j.1600-051X.1997.tb01186.x
   Novaes AB, 2012, J ORAL IMPLANTOL, V38, P687, DOI 10.1563/AAID-JOI-D-10-00176
   Novaes AB, 2011, J PERIODONTOL, V82, P872, DOI 10.1902/jop.2010.100244
   Novaes AB, 2011, J OSSEOINTEGRATION, V3, P45
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Qahash M, 2008, CLIN ORAL IMPLAN RES, V19, P166, DOI 10.1111/j.1600-0501.2007.01428.x
   Rungcharassaeng K, 2012, INT J PERIODONT REST, V32, P657
   Sclar AG, 2007, J ORAL MAXIL SURG, V65, P20, DOI 10.1016/j.joms.2007.03.017
   Spinato S, 2014, CLIN ORAL IMPLAN RES, V25, pE120, DOI 10.1111/clr.12073
   Suaid FA, 2014, CLIN ORAL IMPLAN RES, V25, pE10, DOI 10.1111/clr.12036
   Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x
   Vignoletti F, 2009, J CLIN PERIODONTOL, V36, P688, DOI 10.1111/j.1600-051X.2009.01439.x
   Watzek G, 1995, Int J Oral Maxillofac Implants, V10, P561
NR 46
TC 2
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JUN
PY 2015
VL 42
IS 6
BP 590
EP 598
DI 10.1111/jcpe.12405
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CK6VS
UT WOS:000356367300012
PM 25875308
DA 2018-10-19
ER

PT J
AU Chen, YC
   Huang, HY
   Lin, HM
   Hsu, FY
   Su, YP
   Hwang, DF
AF Chen, Yu-Chun
   Huang, Hsiao-Ya
   Lin, Hsiu-Mei
   Hsu, Fu-Yin
   Su, Yu-Ping
   Hwang, Deng-Fwu
TI Biomaterial availability of magnesium substituted beta-tricalcium
   phosphate converted from sea urchin Tripneustes gratilla shell
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Tripneustes gratilla; Magnesium substituted beta-tricalcium phosphate;
   Hydrothermal reaction; Biomaterial
ID RIETVELD REFINEMENT; BONE; HYDROXYAPATITE; CERAMICS; SCAFFOLDS;
   TRANSFORMATION; OSTEOBLASTS; POROSITY; DEFECTS; GLASS
AB Sea urchin Tripneustes gratilla is one of the valuable fishery products in Taiwan. The edible part of sea urchin is about 10% and the rest is regarded as waste. In this study, sea urchin shell was used here as an ingredient to synthesize magnesium substituted beta-tricalcium phosphate (beta-TCMP). Shell powder of the echinoid Tripneustes gratilla was converted by hydrothermal reaction at 180 degrees C for 24 h (referred as SU-180-24 product), and calcinated into tablet at 800 degrees C for 4 h to form the target ingredient (SU-800-4 product). Then these products were tested for chemical composition analysis and bioassays. These products are confirmed to be rich in magnesium and constitute as beta-TCMP. Results from bioassays showed that SU-180-24 and SU-800-4 products increased cell viability in human osteosarcoma cell (MG-63). Alkaline phosphatase (ALP) activity of MG-63 cell cultured with SU-800-4 tablet also showed significant increase when compared to commercial beta-TCMP. It indicated that sea urchin's beta-TCMP materials including SU-180-24 and SU-800-4 products exhibited the potential for applying as the bone graft material. (C) 2015 The Ceramic Society of Japan. All rights reserved.
C1 [Chen, Yu-Chun; Huang, Hsiao-Ya; Hwang, Deng-Fwu] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung 202, Taiwan.
   [Chen, Yu-Chun; Huang, Hsiao-Ya; Hwang, Deng-Fwu] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung 202, Taiwan.
   [Lin, Hsiu-Mei; Hsu, Fu-Yin] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung 202, Taiwan.
   [Su, Yu-Ping] Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan.
   [Su, Yu-Ping] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan.
RP Hwang, DF (reprint author), Natl Taiwan Ocean Univ, Dept Food Sci, 2 Beining Rd, Keelung 202, Taiwan.
EM dfhwang@mail.ntou.edu.tw
FU Center of Excellence for Marine Science, National Taiwan Ocean
   University
FX The study was supported by funding from the Center of Excellence for
   Marine Science, National Taiwan Ocean University.
CR Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   Cunningham E, 2010, J MATER SCI-MATER M, V21, P2255, DOI 10.1007/s10856-009-3961-4
   Damien E, 2004, J Appl Biomater Biomech, V2, P65
   Diba M, 2014, CURR OPIN SOLID ST M, V18, P147, DOI 10.1016/j.cossms.2014.02.004
   Dickson JAD, 2001, GEOCHIM COSMOCHIM AC, V65, P443, DOI 10.1016/S0016-7037(00)00547-0
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Enderle R, 2005, BIOMATERIALS, V26, P3379, DOI 10.1016/j.biomaterials.2004.09.017
   Guha AK, 2009, COLLOID SURFACE B, V73, P146, DOI 10.1016/j.colsurfb.2009.05.009
   Habibovic P., 2008, J ORTHOP RES, V10, P1363
   Hammel EC, 2014, CERAM INT, V40, P15351, DOI 10.1016/j.ceramint.2014.06.095
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kang YQ, 2015, ACTA BIOMATER, V11, P449, DOI 10.1016/j.actbio.2014.09.035
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Le BT, 2014, J CRANIO MAXILL SURG, V42, P552, DOI 10.1016/j.jcms.2013.07.026
   LIN FH, 1994, BIOMATERIALS, V15, P1087
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Nasiri-Tabrizi B, 2013, CERAM INT, V39, P8657, DOI 10.1016/j.ceramint.2013.04.045
   Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Sader MS, 2009, KEY ENG MATER, V396-398, P277, DOI 10.4028/www.scientific.net/KEM.396-398.277
   Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Stipniece Liga, 2015, Key Engineering Materials, V631, P61, DOI 10.4028/www.scientific.net/KEM.631.61
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Teixeira S., 2009, MAT SCI ENG C, V5, P1510
   Tejero R., 2014, PROG POLYM SCI, P1406
   Truumees E, 1999, U PENN ORTHOP J, V12, P77
   Vecchio KS, 2007, ACTA BIOMATER, V3, P785, DOI 10.1016/j.actbio.2007.03.009
   Walsh W. R., 2007, BIOMATERIALS, V29, P266
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Zhang X, 2013, FRONT MATER SCI, V7, P103, DOI 10.1007/s11706-013-0204-x
   Zhang X, 2009, MAT SCI ENG C-MATER, V29, P2003, DOI 10.1016/j.msec.2009.03.012
NR 35
TC 0
Z9 0
U1 1
U2 13
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JUN
PY 2015
VL 123
IS 1438
BP 469
EP 475
DI 10.2109/jcersj2.123.469
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA CJ9UW
UT WOS:000355849700003
OA Bronze
DA 2018-10-19
ER

PT J
AU Valdes-Sanchez, T
   Rodriguez-Jimenez, FJ
   Garcia-Cruz, DM
   Escobar-Ivirico, JL
   Alastrue-Agudo, A
   Erceg, S
   Monleon, M
   Moreno-Manzano, V
AF Valdes-Sanchez, Teresa
   Javier Rodriguez-Jimenez, Francisco
   Garcia-Cruz, Dunia M.
   Escobar-Ivirico, Jorge L.
   Alastrue-Agudo, Ana
   Erceg, Slaven
   Monleon, Manuel
   Moreno-Manzano, Victoria
TI Methacrylate-endcapped caprolactone and FM19G11 provide a proper niche
   for spinal cord-derived neural cells
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterials; ependymal stem cells; pharmacology; spinal cord injury
ID STEM-CELLS; INJURY REGENERATION; SCAFFOLDS; NEURONS
AB Spinal cord injury (SCI) is a cause of paralysis. Although some strategies have been proposed to palliate the severity of this condition, so far no effective therapies have been found to reverse it. Recently, we have shown that acute transplantation of ependymal stem/progenitor cells (epSPCs), which are spinal cord-derived neural precursors, rescue lost neurological function after SCI in rodents. However, in a chronic scenario with axon repulsive reactive scar, cell transplantation alone is not sufficient to bridge a spinal cord lesion, therefore a combinatorial approach is necessary to fill cavities in the damaged tissue with biomaterial that supports stem cells and ensures that better neural integration and survival occur. Caprolactone 2-(methacryloyloxy) ethyl ester (CLMA) is a monomer [obtained as a result of epsilon-caprolactone and 2-hydroxyethyl methacrylate (HEMA) ring opening/esterification reaction], which can be processed to obtain a porous non-toxic 3D scaffold that shows good biocompatibility with epSPC cultures. epSPCs adhere to the scaffolds and maintain the ability to expand the culture through the biomaterial. However, a significant reduction of cell viability of epSPCs after 6days in vitro was detected. FM19G11, which has been shown to enhance self-renewal properties, rescues cell viability at 6days. Moreover, addition of FM19G11 enhances the survival rates of mature neurons from the dorsal root ganglia when cultured with epSPCs on 3D CLMA scaffolds. Overall, CLMA porous scaffolds constitute a good niche to support neural cells for cell transplantation approaches that, in combination with FM19G11, offer a new framework for further trials in spinal cord regeneration. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Valdes-Sanchez, Teresa; Javier Rodriguez-Jimenez, Francisco; Alastrue-Agudo, Ana; Moreno-Manzano, Victoria] Ctr Invest Principe Felipe, Neuronal Regenerat Lab, E-46012 Valencia, Spain.
   [Garcia-Cruz, Dunia M.; Escobar-Ivirico, Jorge L.; Monleon, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.
   [Erceg, Slaven] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain.
RP Moreno-Manzano, V (reprint author), Ctr Invest Principe Felipe, Neuronal Regenerat Lab, E-46012 Valencia, Spain.
EM vmorenom@cipf.es
RI Moreno, Victoria/B-4175-2014; Escobar ivirico, Jorge/J-1203-2016
OI Moreno, Victoria/0000-0002-6035-9491; Escobar ivirico,
   Jorge/0000-0002-1077-2333
FU Instituto de Salud Carlos III; FEDER [FISS PI10/01683]; Ministerio de
   Ciencia e Innovacion (MICINN; Spanish Consolider Ion Channel Initiative)
   [CSD 2008-00005]
FX We are especially grateful to Richard Griffeth for his English-language
   editing. We also thank the Confocal Microscopy and the Electron
   Microscopy services of the Centro de Investigacion Principe Felipe
   (Valencia, Spain). This work was supported by the Instituto de Salud
   Carlos III (cofinanciacion FEDER; Grant No. FISS PI10/01683) and
   Ministerio de Ciencia e Innovacion (MICINN; Spanish Consolider Ion
   Channel Initiative No. CSD 2008-00005).
CR Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165
   Rodriguez-Jimenez FJ, 2012, STEM CELLS, V30, P2221, DOI 10.1002/stem.1189
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326
   Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24
   Oliveira AL, 2012, J MATER SCI-MATER M, V23, P2821, DOI 10.1007/s10856-012-4741-0
   Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064
   Rodriguez-Jimenez Francisco Javier, 2012, J Funct Biomater, V3, P556, DOI 10.3390/jfb3030556
   Rodriguez-Jimenezs FJ, 2011, CELL CYCLE, V9, P2803
   Scuteri A, 2011, NEUROSCIENCE, V172, P12, DOI 10.1016/j.neuroscience.2010.10.065
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Thouas GA, 2008, IEEE ENG MED BIO, P1825, DOI 10.1109/IEMBS.2008.4649534
   Valdes-Sanchez T, 2010, DEV BIOL, V339, P465, DOI 10.1016/j.ydbio.2010.01.001
   Wilcox JT, 2012, NEUROSCI LETT, V519, P93, DOI 10.1016/j.neulet.2012.02.028
   Yang JS, 2008, NEUROSCI LETT, V445, P246, DOI 10.1016/j.neulet.2008.09.015
NR 18
TC 2
Z9 2
U1 4
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2015
VL 9
IS 6
BP 734
EP 739
DI 10.1002/term.1735
PG 6
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CK6KB
UT WOS:000356335900008
PM 23533014
DA 2018-10-19
ER

PT J
AU Barua, S
   Gogoi, B
   Aidew, L
   Buragohain, AK
   Chattopadhyay, P
   Karak, N
AF Barua, Shaswat
   Gogoi, Bhaskarjyoti
   Aidew, Lipika
   Buragohain, Alak K.
   Chattopadhyay, Pronobesh
   Karak, Niranjan
TI Sustainable Resource based Hyperbranched Epoxy Nanocomposite as an
   Infection Resistant, Biodegradable, Implantable Muscle Scaffold
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Sustainable; Hyperbranched epoxy; Nanofibrillar cellulose; Scaffold;
   Antimicrobial
ID IN-VITRO; CELLULOSE; COMPOSITES; NANOPARTICLES; DESIGN; CELLS
AB Use of sustainable resources in the realm of materials science has opened newer possibilities for fabricating biodegradable biomaterials. Cellulose is an abundantly available bioresource that proved excellent potential in composite science and the biomaterials domain. Hence, in this report the potentiality of a "green" CuO-nanofibrillar cellulose/glycerol based hyperbranched epoxy nanocomposite was presented as an implantable muscle tissue scaffold. Muscles reconstruction has been a longstanding problem in medical science. However, with the evolution of polymeric scaffolds, repairing of damaged or lost tissues becomes possible with the aid of tissue engineering. The prepared material possessed high mechanical properties (tensile strength 55 MPa) to support cell growth. In vitro studies revealed that the material could support the growth and proliferation of L6 muscle cells, without causing any detriment to their cellular morphology. Further, both in vitro and in vivo toxicity assessments established the profound biocompatibility of the material. Moreover, the nanocomposite exhibited inhibitory effect against Staphylococcus aureus, Escherichia coli and Candida albicans, the microorganisms responsible for various surgical site infections. In vivo investigation revealed the biodegradability of the prepared material which overrules the need of repeated surgery for any implantable biomaterial. Thus, the overall work endorses the sustainable resource based nanocomposite as a high performance, biodegradable, antimicrobial scaffold material for reconstruction of muscles tissues.
C1 [Barua, Shaswat; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Ctr Polymer Sci & Technol, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
   [Gogoi, Bhaskarjyoti; Aidew, Lipika; Buragohain, Alak K.] Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur 784028, Assam, India.
   [Chattopadhyay, Pronobesh] Def Res Lab, Tezpur 784001, Assam, India.
RP Karak, N (reprint author), Tezpur Univ, Dept Chem Sci, Ctr Polymer Sci & Technol, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
EM karakniranjan@gmail.com
RI Karak, Niranjan/A-1030-2014
OI Karak, Niranjan/0000-0002-3402-9536; Barua, Shaswat/0000-0003-0050-3698
FU NRB [DNRD/05/4003/NRB/251]
FX The authors express their gratitude to NRB for financial assistance
   through Grant no. DNRD/05/4003/NRB/251, dated 29.02.12. SAIF, NEHU,
   Shillong is acknowledged for the TEM imaging.
CR Anyaogu KC, 2008, LANGMUIR, V24, P4340, DOI 10.1021/la800102f
   Arnaoutoglou E, 2011, INTERACT CARDIOV TH, V12, P609, DOI 10.1510/icvts.2010.256784
   Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347
   Barua S., 2014, BIOMED MATER, V9
   Barua S, 2015, POLYM INT, V64, P303, DOI 10.1002/pi.4790
   Barua S, 2013, RSC ADV, V3, P14997, DOI 10.1039/c3ra42209g
   Barua S, 2013, CHEM ENG SCI, V95, P138, DOI 10.1016/j.ces.2013.03.026
   Barua S, 2013, COLLOID SURFACE B, V105, P37, DOI 10.1016/j.colsurfb.2012.12.015
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   Braunegg G, 2004, POLYM-PLAST TECHNOL, V43, P1779, DOI 10.1081/PPT-200040130
   CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5
   Carlsson DO, 2012, J MATER CHEM, V22, P19014, DOI 10.1039/c2jm33975g
   Chaturvedi V., 2011, AUST BIOCH, V42, P8
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Danielsson C, 2006, BIOMATERIALS, V27, P1410, DOI 10.1016/j.biomaterials.2005.08.026
   Das B, 2013, J MATER CHEM B, V1, P4115, DOI 10.1039/c3tb20693a
   Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dugan JM, 2013, NANOMEDICINE-UK, V8, P287, DOI [10.2217/NNM.12.211, 10.2217/nnm.12.211]
   Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Kondo T, 1997, J POLYM SCI POL PHYS, V35, P717, DOI 10.1002/(SICI)1099-0488(199703)35:4<717::AID-POLB18>3.0.CO;2-J
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mattoussi H, 2012, ADV DRUG DELIVER REV, V64, P138, DOI 10.1016/j.addr.2011.09.011
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Novotna K, 2013, CELLULOSE, V20, P2263, DOI 10.1007/s10570-013-0006-4
   Oliver Cassell CS, 2002, BR J PLAST SURG, V55, P603
   Orts WJ, 2005, J POLYM ENVIRON, V13, P301, DOI 10.1007/s10924-005-5514-3
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x
   Shaswat Barua, 2013, Advanced Science, Engineering and Medicine (ASEM), V5, P291, DOI 10.1166/asem.2013.1286
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
NR 37
TC 5
Z9 5
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD JUN
PY 2015
VL 3
IS 6
BP 1136
EP 1144
DI 10.1021/acssuschemeng.5b00069
PG 9
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA CJ6ZZ
UT WOS:000355645000013
DA 2018-10-19
ER

PT J
AU Calvo-Guirado, JL
   Aguilar-Salvatierra, A
   Delgado-Ruiz, RA
   Negri, B
   Fernandez, MPR
   de Val, JEMS
   Gomez-Moreno, G
   Romanos, GE
AF Luis Calvo-Guirado, Jose
   Aguilar-Salvatierra, Antonio
   Delgado-Ruiz, Rafael Arcesio
   Negri, Bruno
   Piedad Ramirez Fernandez, Maria
   Mate Sanchez de Val, Jose Eduardo
   Gomez-Moreno, Gerardo
   Romanos, Georgios E.
TI Histological and Histomorphometric Evaluation of Zirconia Dental
   Implants Modified by Femtosecond Laser versus Titanium Implants: An
   Experimental Study in Fox Hound Dogs
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE BIC; crestal bone loss; zirconia implants
ID FOLLOW-UP; SINGLE IMPLANTS; OSSEOINTEGRATION; BONE; BIOMATERIAL;
   SURVIVAL
AB PurposeThis study applied femtosecond laser technology to zirconia dental implants (Bredent GmbH & Co.KG, Senden, Germany) to generate a surface texture of microgrooves over the entire intraosseous surface, analyzing its behavior in an in vivo model in comparison with titanium implants with sandblasted and acid-etched surfaces.
   Materials and MethodsThe study used six American Fox Hound dogs. Each received four implants per hemi-mandible, making a total of eight implants per animal. The 48 immediate loaded implants were divided into two groups of 24 titanium implants (control group) and 24 zirconia implants (study/test group), distributed randomly. Bone-to-implant contact (BIC) values and crestal resorption were determined at 1 and 3 months, also measuring calcium, phosphorous, and carbon concentrations by means of energy dispersive x-ray.
   ResultsBIC percentages after 30 days were 51.36% for titanium implants and 44.68% for zirconia implants. After 90 days, values increased to 61.73% in titanium and 47.94% in zirconia implants. After 30 days, there was more crestal bone lost in the titanium group (0.77mm) compared with the zirconia group (0.01mm). After 90 days, zirconia implants showed greater marginal bone resorption (1.25mm) compared with the titanium group (0.37mm).
   ConclusionsThe present study shows that zirconia implants with modified surfaces can produce good osseointegration values when compared with titanium implants in terms of BIC and crestal bone resorption at 1 and 3 months.
C1 [Luis Calvo-Guirado, Jose; Aguilar-Salvatierra, Antonio; Negri, Bruno; Piedad Ramirez Fernandez, Maria; Mate Sanchez de Val, Jose Eduardo] Univ Murcia, Fac Med & Dent, Dept Gen & Implant Dent, Murcia 30007, Spain.
   [Delgado-Ruiz, Rafael Arcesio] SUNY Stony Brook, Sch Dent Med, Dept Prosthodont & Digital Technol, Stony Brook, NY 11794 USA.
   [Negri, Bruno; Mate Sanchez de Val, Jose Eduardo] Univ Murcia, Fac Med & Dent, Restorat Dent, Murcia 30007, Spain.
   [Gomez-Moreno, Gerardo] Univ Granada, Fac Dentristry, Dept Pharmacol Interact, Granada, Spain.
   [Romanos, Georgios E.] SUNY Stony Brook, Sch Dent Med, Clin Affairs, Stony Brook, NY 11794 USA.
RP Calvo-Guirado, JL (reprint author), Univ Murcia, Fac Med & Dent, Hosp Morales Meseguer, 2 Planta Clin Odontol Calle Marques de los Velez, Murcia 30007, Spain.
EM joseluis.calvo@um.es
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; calvo guirado,
   jose luis/0000-0002-4067-2253; Gomez-Moreno,
   Gerardo/0000-0001-9094-4985; Delgado-Ruiz, Rafael/0000-0003-1721-0509;
   RAMIREZ FERNANDEZ, MARIA PIEDAD/0000-0003-1913-9902
CR Al-Hamdan K, 2011, CLIN ORAL IMPLAN RES, V22, P399, DOI 10.1111/j.1600-0501.2010.02106.x
   Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x
   Andreiotelli M, 2009, CLIN IMPLANT DENT R, V11, P158, DOI 10.1111/j.1708-8208.2008.00105.x
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Calvo-Guirado JL, 2011, J CLIN EXPT DENT, V4, P8
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P826, DOI 10.1111/clr.12145
   Cannizzaro G, 2010, EUR J ORAL IMPLANTOL, V3, P111
   Delgado-Ruiz RA, 2011, J BIOMED MATER RES B, V96B, P91, DOI 10.1002/jbm.b.31743
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Dierens M, 2012, CLIN ORAL IMPLAN RES, V23, P197, DOI 10.1111/j.1600-0501.2011.02212.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Jacobs R, 2010, J CLIN PERIODONTOL, V37, P1119, DOI 10.1111/j.1600-051X.2010.01626.x
   Javed F, 2013, CLIN IMPLANT DENT R, V15, P47, DOI 10.1111/j.1708-8208.2010.00330.x
   Kan JYK, 2011, INT J ORAL MAX IMPL, V26, P179
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Malo P, 2011, J AM DENT ASSOC, V142, P310, DOI 10.14219/jada.archive.2011.0170
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Nickenig HJ, 2009, CLIN ORAL IMPLAN RES, V20, P550, DOI 10.1111/j.1600-0501.2008.01684.x
   Nisapakultorn K, 2010, CLIN ORAL IMPLAN RES, V21, P662, DOI 10.1111/j.1600-0501.2009.01887.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Romanos G, 2010, J ORAL IMPLANTOL, V36, P315, DOI 10.1563/AAID-JOI-D-09-00060
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   SCHENK EA, 1983, STAIN TECHNOL, V58, P377, DOI 10.3109/10520298309066818
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P13
   Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x
   Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x
   Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015
   tersBrugge PJ, 2002, BIOMATERIALS, V23, P3269
   Verdugo F, 2009, J PERIODONTOL, V80, P816, DOI 10.1902/jop.2009.080572
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
NR 35
TC 8
Z9 8
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD JUN
PY 2015
VL 17
IS 3
BP 525
EP 532
DI 10.1111/cid.12162
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CJ7DX
UT WOS:000355655500013
PM 24138572
DA 2018-10-19
ER

PT J
AU Mangano, C
   Sinjari, B
   Shibli, JA
   Mangano, F
   Hamisch, S
   Piattelli, A
   Perrotti, V
   Iezzi, G
AF Mangano, Carlo
   Sinjari, Bruna
   Shibli, Jamil A.
   Mangano, Francesco
   Hamisch, Sabine
   Piattelli, Adriano
   Perrotti, Vittoria
   Iezzi, Giovanna
TI A Human Clinical, Histological, Histomorphometrical, and Radiographical
   Study on Biphasic HA-Beta-TCP 30/70 in Maxillary Sinus Augmentation
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE biphasic calcium phosphate; bone regeneration; histology;
   hydroxyapatite; sinus augmentation
ID CALCIUM-PHOSPHATE CERAMICS; DEPROTEINIZED BOVINE BONE; TRICALCIUM
   PHOSPHATE; HYDROXYAPATITE SCAFFOLDS; GRAFT MATERIALS; SULFATE;
   DEGRADATION; OSTEOINDUCTION; COMBINATION; FABRICATION
AB BackgroundBy mixing hydroxyapatite (HA) and tricalcium phosphate (TCP), biphasic calcium phosphate ceramics can be obtained, and by varying their ratio it is possible to tailor the characteristics of the biomaterial.
   PurposeThe aim of the present human study was to evaluate the histological and radiographical aspects of bone formation in maxillary sinus augmentation using a 30/70 HA-beta-TCP with a reticular structure.
   Materials and MethodsA total of 12 patients, undergoing two-stage sinus augmentation procedure using HA-beta-TCP at a ratio of 30/70, were included in the present study. After a 6-month healing period, during implant insertion, radiographical analysis was performed, and then the bone core biopsies were harvested and processed for histology.
   ResultsAt radiographic evaluation, the bone gain was on average 6.850.60mm. HA-beta-TCP 30/70 appeared to be lined by newly formed bone, with no gaps at the interface. The histomorphometric analysis revealed 26 +/- 2% of residual grafted biomaterial, 29 +/- 3% of newly formed bone, and 45 +/- 2% of marrow spaces.
   ConclusionsThe present results indicate histologically the high biocompatibility and osteoconductivity of HA-beta-TCP 30/70, and clinically its successful use for sinus augmentation procedures.
C1 [Mangano, Carlo; Mangano, Francesco] Univ Insubria, Dept Morphol & Surg Sci, Varese, Italy.
   [Sinjari, Bruna; Piattelli, Adriano; Perrotti, Vittoria; Iezzi, Giovanna] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy.
   [Shibli, Jamil A.] Univ Guarulhos, Oral Surg Dent Res Div, Guarulhos, SP, Brazil.
   [Hamisch, Sabine] BioCer Entwicklungs GmbH, Bayreuth, Germany.
RP Iezzi, G (reprint author), Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66100 Chieti, Italy.
EM gio.iezzi@unich.it
OI Sinjari, Bruna/0000-0002-4444-3343; Mangano,
   Francesco/0000-0001-5488-4268
FU PRIN - Ministry of Education, University and Research (M.I.U.R.), Rome,
   Italy [PRIN 20102ZLNJ5]
FX This work was supported by PRIN 2010-2011 (PRIN 20102ZLNJ5), financed by
   the Ministry of Education, University and Research (M.I.U.R.), Rome,
   Italy. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Becker W, 1995, Int J Oral Maxillofac Implants, V10, P143
   Cheng LJ, 2010, ACTA BIOMATER, V6, P1569, DOI 10.1016/j.actbio.2009.10.050
   Daculsi G, 1989, BIOCERAMICS, V2, P3
   De Leonardis D, 2000, J PERIODONTOL, V71, P940
   Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915
   Deisinger U, 2006, CYTOTHERAPY, V8, P15
   Detsch R, 2011, J BIOMATER APPL, V26, P359, DOI 10.1177/0885328210373285
   EDBERG E, 1930, ACTA CHIR SCAND, V67, P313
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Hattori Hiroyuki, 2010, J Orthop Surg (Hong Kong), V18, P63
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim CK, 1998, J PERIODONTOL, V69, P1317, DOI 10.1902/jop.1998.69.12.1317
   Lindgren C, 2012, CLIN IMPLANT DENT R, V14, P41, DOI 10.1111/j.1708-8208.2010.00224.x
   Lindgren C, 2010, CLIN ORAL IMPLAN RES, V21, P924, DOI 10.1111/j.1600-0501.2010.01933.x
   Lindgren C, 2009, INT J ORAL MAX IMPL, V24, P1093
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Mangano C, 2013, INT J ORAL MAX IMPL, V28, P51, DOI 10.11607/jomi.2667
   Mayr H, 2008, KEY ENG MATER, V361-363, P1043, DOI 10.4028/www.scientific.net/KEM.361-363.1043
   Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040
   Nystrom C, 1928, ACTA CHIR SCAND, V63, P296
   Pecora GE, 1998, INT J ORAL MAX IMPL, V13, P866
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli A, 1996, BIOMATERIALS, V17, P1127, DOI 10.1016/0142-9612(96)85915-1
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 2008, J CELL MOL MED, V12, P2609, DOI 10.1111/j.1582-4934.2008.00312.x
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Sanzana ES, 2014, J BIOMED MATER RES A, V102, P1767, DOI 10.1002/jbm.a.34845
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3119, DOI 10.1007/s10856-010-4166-6
   Simon JL, 2007, J BIOMED MATER RES A, V83A, P747, DOI 10.1002/jbm.a.31329
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Sottosanti J, 1992, Compendium, V13, P226
   Sottosanti J., 1992, COMPENDIUM, V13, P232
   Sottosanti J., 1992, COMPENDIUM, V13, P230
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   van den Bergh JPA, 1998, CLIN ORAL IMPLAN RES, V9, P429, DOI 10.1034/j.1600-0501.1996.090608.x
   Vorndran E, 2009, ADV ENG MATER, V10, pB67
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
NR 49
TC 19
Z9 20
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD JUN
PY 2015
VL 17
IS 3
BP 610
EP 618
DI 10.1111/cid.12145
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CJ7DX
UT WOS:000355655500022
PM 24004190
DA 2018-10-19
ER

PT J
AU Rnjak-Kovacina, J
   DesRochers, TM
   Burke, KA
   Kaplan, DL
AF Rnjak-Kovacina, Jelena
   DesRochers, Teresa M.
   Burke, Kelly A.
   Kaplan, David L.
TI The Effect of Sterilization on Silk Fibroin Biomaterial Properties
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterial; scaffolds; silk fibroin; sterilization; tissue engineering
ID SIZED TISSUE CONSTRUCTS; SPIDER SILK; IN-VITRO; GAMMA-IRRADIATION;
   KIDNEY-DISEASE; BLEND FILMS; STEM-CELLS; SCAFFOLDS; BONE; VIVO
AB The effects of common sterilization techniques on the physical and biological properties of lyophilized silk fibroin sponges are described. Sterile silk fibroin sponges were cast using a pre-sterilized silk fibroin solution under aseptic conditions or post-sterilized via autoclaving, radiation, dry heat, exposure to ethylene oxide, or hydrogen peroxide gas plasma. Low average molecular weight and low concentration silk fibroin solutions could be sterilized via autoclaving or filtration without significant loses of protein. However, autoclaving reduced the molecular weight distribution of the silk fibroin protein solution, and silk fibroin sponges cast from autoclaved silk fibroin were significantly stiffer compared to sponges cast from unsterilized or filtered silk fibroin. When silk fibroin sponges were sterilized post-casting, autoclaving increased scaffold stiffness, while decreasing scaffold degradation rate in vitro. In contrast, irradiation accelerated scaffold degradation rate. Exposure to ethylene oxide significantly decreased cell proliferation rate on silk fibroin sponges, which was rescued by leaching ethylene oxide into PBS prior to cell seeding.
C1 [Rnjak-Kovacina, Jelena; DesRochers, Teresa M.; Burke, Kelly A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Rnjak-Kovacina, Jelena] UNSW Australia, Grad Sch Biomed Engn, Sydney, NSW, Australia.
   [DesRochers, Teresa M.] KIYATEC Inc, Greenville, SC USA.
   [Burke, Kelly A.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [NIH P41 EB002520, EY020856, F32-DK093194]; Air Force Office of
   Scientific Research
FX We thank the NIH (NIH P41 EB002520; EY020856; F32-DK093194 awarded to
   KAB) and the Air Force Office of Scientific Research for support. We
   thank Hannah Baker and Dr. George Christ (WFIRM) for their assistance
   with gamma sterilization, Dr. Michael House and staff at Tufts Medical
   for their assistance with plasma sterilization, Dr. Chiara Ghezzi for
   her advice on mechanical testing, and Carmen Preda for technical
   assistance.
CR Bellas E, 2013, BIOMATERIALS, V34, P2960, DOI 10.1016/j.biomaterials.2013.01.058
   Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Choi JH, 2011, METHODS MOL BIOL, V702, P319, DOI 10.1007/978-1-61737-960-4_23
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   De Moraes M.A., 2013, J BIOMED MATER RES B, V102, P869
   DesRochers TM, 2012, J TISSUE ENG REGEN M, V6, P126
   DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002
   DesRochers TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059219
   Faraj KA, 2011, TISSUE ENG REGEN MED, V8, P460
   George KA, 2013, MAT SCI ENG C-MATER, V33, P668, DOI 10.1016/j.msec.2012.10.016
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hattori S, 2012, BIOINSPIR BIOMIM NAN, V1, P195, DOI 10.1680/bbn.11.00006
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hofmann S, 2014, ACTA BIOMATER, V10, P308, DOI 10.1016/j.actbio.2013.08.035
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Kempner ES, 2001, J PHARM SCI, V90, P1637, DOI 10.1002/jps.1114
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Liu Y, 2004, POLYMER, V45, P7705, DOI 10.1016/j.polymer.2004.09.005
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lucke M, 2015, INT J PHARMACEUT, V481, P125, DOI 10.1016/j.ijpharm.2015.01.024
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Marsano E, 2008, INT J BIOL MACROMOL, V43, P106, DOI 10.1016/j.ijbiomac.2008.03.009
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Rnjak-Kovacina J, 2014, ADV FUNCT MATER, V24, P2188, DOI 10.1002/adfm.201302901
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rogers W., 2012, STERILISATION BIOMAT
   Seib FP, 2014, BIOMATERIALS, V35, P83, DOI 10.1016/j.biomaterials.2013.09.053
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
   Vollrath F, 2000, J Biotechnol, V74, P67
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhao Y., 2011, J BIOMED SCI ENG, V4, P397, DOI [10.4236/jbise.2011.45050, DOI 10.4236/JBISE.2011.45050]
NR 61
TC 11
Z9 11
U1 6
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN
PY 2015
VL 15
IS 6
BP 861
EP 874
DI 10.1002/mabi.201500013
PG 14
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CJ8MA
UT WOS:000355754300012
PM 25761231
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Liaqat, F
   Tahir, MN
   Schechtel, E
   Kappl, M
   Auernhammer, GK
   Char, K
   Zentel, R
   Butt, HJ
   Tremel, W
AF Liaqat, Faroha
   Tahir, Muhammad Nawaz
   Schechtel, Eugen
   Kappl, Michael
   Auernhammer, Guenter K.
   Char, Kookheon
   Zentel, Rudolf
   Butt, Hans-Juergen
   Tremel, Wolfgang
TI High-Performance TiO2 Nanoparticle/DOPA-Polymer Composites
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE catechol polymers; fracture toughness; inorganic-organic nanocomposites;
   metal-coordination bonding; TiO2 nanoparticles
ID NANOTUBE SHEET/BISMALEIMIDE NANOCOMPOSITES; LINKED GRAPHENE OXIDE;
   ARTIFICIAL NACRE; MULTIFUNCTIONAL MATERIALS; MECHANICAL PERFORMANCE;
   LAYERED NANOCOMPOSITES; ABRASION RESISTANCE; ORGANIC MATRIX;
   HIGH-STRENGTH; FILMS
AB Many natural materials are complex composites whose mechanical properties are often outstanding considering the weak constituents from which they are assembled. Nacre, made of inorganic (CaCO3) and organic constituents, is a textbook example because of its strength and toughness, which are related to its hierarchical structure and its well-defined organic-inorganic interface. Emulating the construction principles of nacre using simple inorganic materials and polymers is essential for understanding how chemical composition and structure determine biomaterial functions. A hard multilayered nanocomposite is assembled based on alternating layers of TiO2 nanoparticles and a 3-hydroxy-tyramine (DOPA) substituted polymer (DOPA-polymer), strongly cemented together by chelation through infiltration of the polymer into the TiO2 mesocrystal. With a Young's modulus of 17.5 +/- 2.5 GPa and a hardness of 1.1 +/- 0.3 GPa the resulting material exhibits high resistance against elastic as well as plastic deformation. A key feature leading to the high strength is the strong adhesion of the DOPA-polymer to the TiO2 nanoparticles.
C1 [Liaqat, Faroha; Tahir, Muhammad Nawaz; Schechtel, Eugen; Tremel, Wolfgang] Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55099 Mainz, Germany.
   [Kappl, Michael; Auernhammer, Guenter K.; Butt, Hans-Juergen] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Char, Kookheon] Seoul Natl Univ, WCU Program Chem Convergence Energy & Environm, Natl Creat Res Initiat Ctr Intelligent Hybrids, Sch Chem & Biol Engn, Seoul 151744, South Korea.
   [Zentel, Rudolf] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany.
RP Tahir, MN (reprint author), Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55099 Mainz, Germany.
EM tahir@uni-mainz.de; tremel@uni-mainz.de
RI Tremel, Wolfgang/D-8125-2011; Tahir, Muhammad Nawaz/B-2001-2016; Mainz,
   EMZ-M/E-3619-2016; Auernhammer, Gunter/J-1640-2012; Butt,
   Hans-Jurgen/C-4811-2011; Kappl, Michael/A-5697-2009; Tahir,
   Muhammad/B-4681-2016; MPIP, AK Butt/B-8805-2009; Zentel,
   Rudolf/D-4542-2011
OI Tremel, Wolfgang/0000-0002-4536-994X; Tahir, Muhammad
   Nawaz/0000-0002-9031-5537; Auernhammer, Gunter/0000-0003-1515-0143;
   Tahir, Muhammad/0000-0002-9031-5537; 
FU IRTG [1404]
FX F.L. thanks the IRTG 1404 for financial support.
CR Akemi Ooka A, 2000, Biopolymers, V57, P92
   An Z, 2011, ADV MATER, V23, P3842, DOI 10.1002/adma.201101544
   Andersen N. H., 2009, LANGMUIR, V25, P3323
   Barrett DG, 2013, ADV FUNCT MATER, V23, P1111, DOI 10.1002/adfm.201201922
   Barthelat F, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/035001
   Bhushan B., 1999, PRINCIPLES APPL TRIB
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Bouville F, 2014, NAT MATER, V13, P508, DOI [10.1038/NMAT3915, 10.1038/nmat3915]
   Brau M., 2014, WO Patent, Patent No. [2014095717 A1, 2014095717]
   Burghard Z, 2007, ADV MATER, V19, P970, DOI 10.1002/adma.200601068
   Burghard Z, 2009, NANO LETT, V9, P4103, DOI 10.1021/nl902324x
   Cheng QF, 2010, CARBON, V48, P260, DOI 10.1016/j.carbon.2009.09.014
   Cheng QF, 2014, ACCOUNTS CHEM RES, V47, P1256, DOI 10.1021/ar400279t
   Cheng QF, 2013, ANGEW CHEM INT EDIT, V52, P3750, DOI 10.1002/anie.201210166
   Cheng QF, 2012, ADV MATER, V24, P1838, DOI 10.1002/adma.201200179
   Cheng QF, 2010, SMALL, V6, P763, DOI 10.1002/smll.200901957
   Cheng QF, 2009, ADV FUNCT MATER, V19, P3219, DOI 10.1002/adfm.200900663
   Colfen H., 2008, MESOCRYSTALS NONCLAS
   Cui W, 2014, ACS NANO, V8, P9511, DOI 10.1021/nn503755c
   Dinh CT, 2009, ACS NANO, V3, P3737, DOI 10.1021/nn900940p
   Eberhardt M, 2005, EUR POLYM J, V41, P1569, DOI 10.1016/j.europolymj.2005.01.025
   Espinosa HD, 2009, PROG MATER SCI, V54, P1059, DOI 10.1016/j.pmatsci.2009.05.001
   Finnemore A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1970
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gomopoulos N, 2010, NANO LETT, V10, P980, DOI 10.1021/nl903959r
   Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044
   Hu KS, 2013, ADV MATER, V25, P2301, DOI 10.1002/adma.201300179
   Hwang DS, 2012, J MATER CHEM, V22, P15530, DOI 10.1039/c2jm32439c
   Jander G., 1970, LEHRBUCH PRAPARATIVE, P393
   Jang K., 2002, NATURE, V419, P801
   Kickelbick G., 2007, HYBRID MAT SYNTHESIS
   Launspach M, 2012, MICRON, V43, P1351, DOI 10.1016/j.micron.2012.03.014
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Li YQ, 2012, ADV MATER, V24, P3426, DOI 10.1002/adma.201200452
   Lichtenegger HC, 2002, SCIENCE, V298, P389, DOI 10.1126/science.1075433
   Malisova B., 2010, THESIS VSCHT PRAGUA
   Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54
   Michaud-Soret I., 1995, BIOCHEMISTRY-US, V34, P5501
   Moses DN, 2006, J BIOL CHEM, V281, P34826, DOI 10.1074/jbc.M603429200
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Natalio F., 2011, J MATER CHEM, V21, P11123
   Natalio F, 2013, SCIENCE, V339, P1298, DOI 10.1126/science.1216260
   Natalio F, 2012, NAT NANOTECHNOL, V7, P530, DOI [10.1038/nnano.2012.91, 10.1038/NNANO.2012.91]
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Ou JF, 2011, SURF INTERFACE ANAL, V43, P803, DOI 10.1002/sia.3631
   Pierpont C. G., 1994, PROG INORG CHEM, V41, P381
   Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176
   Podsiadlo P, 2007, ADV MATER, V19, P949, DOI 10.1002/adma.200602706
   Pomogailo A. D., 2000, RUSS CHEM REV, V69, P53
   Rabatic BM, 2006, ADV MATER, V18, P1033, DOI 10.1002/adma.200500988
   Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/NMAT3115, 10.1038/nmat3115]
   Ruiz-Hitzky E., 2008, BIOINORGANIC HYBRID, P1, DOI DOI 10.1002/0471238961.BI0NRUIZ.A01/ABSTRACT
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Schneider D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.164301
   Schneider D, 2012, NANO LETT, V12, P3101, DOI 10.1021/nl300982d
   Schottner G, 2001, CHEM MATER, V13, P3422, DOI 10.1021/cm011060m
   Shukoor MI, 2008, ANGEW CHEM INT EDIT, V47, P4748, DOI 10.1002/anie.200704735
   Shukoor MI, 2007, CHEM COMMUN, P4677, DOI 10.1039/b707978h
   Tahir MN, 2006, ANGEW CHEM INT EDIT, V45, P908, DOI 10.1002/anie.200502517
   Tang W, 2014, J AM CHEM SOC, V136, P16357, DOI 10.1021/ja508946h
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s
   Tian Y, 2013, ADV MATER, V25, P2980, DOI 10.1002/adma.201300118
   Umland F., 1975, CHARAKTERISTISCHE RE
   Villarreal TL, 2005, J AM CHEM SOC, V127, P12601
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   Walther A, 2010, ANGEW CHEM INT EDIT, V49, P6448, DOI 10.1002/anie.201001577
   Walther A, 2010, NANO LETT, V10, P2742, DOI 10.1021/nl1003224
   Wang JF, 2014, ACS NANO, V8, P2739, DOI 10.1021/nn406428n
   Wang JF, 2013, NANOSCALE, V5, P6356, DOI 10.1039/c3nr00801k
   Wang JF, 2012, ANGEW CHEM INT EDIT, V51, P4676, DOI 10.1002/anie.201200267
   Wang JF, 2012, CHEM SOC REV, V41, P1111, DOI 10.1039/c1cs15106a
   Wang JH, 2008, CHEM MATER, V20, P20, DOI 10.1021/cm702375e
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/nmat4089, 10.1038/NMAT4089]
   Wu MX, 2014, ANGEW CHEM INT EDIT, V53, P3358, DOI 10.1002/anie.201310656
   Yao HB, 2010, ANGEW CHEM INT EDIT, V49, P10127, DOI 10.1002/anie.201004748
   Yao HB, 2012, J MATER CHEM, V22, P13005, DOI 10.1039/c2jm31492d
   Yu J, 2013, BIOMACROMOLECULES, V14, P1072, DOI 10.1021/bm301908y
   Zhu J, 2013, ACS NANO, V7, P4818, DOI 10.1021/nn400972t
   Zok FW, 2007, ACTA MATER, V55, P6365, DOI 10.1016/j.actamat.2007.07.042
   Zvarec O, 2013, LANGMUIR, V29, P10899, DOI 10.1021/la401858s
NR 83
TC 6
Z9 6
U1 6
U2 104
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD JUN
PY 2015
VL 36
IS 11
SI SI
BP 1129
EP 1137
DI 10.1002/marc.201400706
PG 9
WC Polymer Science
SC Polymer Science
GA CJ8IO
UT WOS:000355743700019
PM 25929974
DA 2018-10-19
ER

PT J
AU Colaco, M
   Mettu, J
   Badlani, G
AF Colaco, Marc
   Mettu, Jayadev
   Badlani, Gopal
TI The scientific basis for the use of biomaterials in stress urinary
   incontinence (SUI) and pelvic organ prolapse (POP)
SO BJU INTERNATIONAL
LA English
DT Review
DE mesh; stress urinary incontinence; pelvic organ prolapse; genetics;
   collagen; elastin
ID STEM-CELL THERAPY; 1-YEAR FOLLOW-UP; QUALITY-OF-LIFE; FLOOR DISORDERS;
   UTEROSACRAL LIGAMENTS; POSTMENOPAUSAL WOMEN; GENITAL PROLAPSE; UTERINE
   PROLAPSE; SYNTHETIC MESH; SURGICAL MESH
AB ObjectivesTo review the scientific and clinical literature to assess the basis for the use of biomaterials in stress urinary incontinence (SUI) and pelvic organ prolapse (POP). Pelvic floor diseases (PFDS), such as SUI and POP, are common and vexing disorders. While synthetic mesh-based repairs have long been considered an option for PFD treatment, and their efficacy established in randomised clinical trials, safety of its use has recently been called into question.
   Materials and MethodsUsing the PubMed, MEDLINE and Medical Subject Headings (MeSH) databases, we performed a critical review of English-language publications that contained the following keywords: pelvic organ prolapse', stress urinary incontinence', mesh', biomaterial', collagen', elastin' and extracellular matrix'. After reviewing for relevance for mesh use in the pelvis by two independent reviewers with a third available in the case of disagreement, a total of 60 articles were included in the present review.
   ResultsWe found that many of the potential causes of PFDs are due to altered metabolism of patient extracellular matrix (specifically collagen, elastin, and their respective enzymes) and as such, repairs using native tissue may suffer from the same abnormalities leading to a subsequent lack of repair integrity. However, mesh use is not without its unique risks. Several publications have suggested that biomaterials may undergo alteration after implantation, but these findings have not been demonstrated in the normal milieu.
   ConclusionWhile the decision for the use of synthetic mesh is scientifically sound, its benefits and risks must be discussed with the patient in an informed decision-making process.
C1 [Colaco, Marc; Mettu, Jayadev; Badlani, Gopal] Wake Forest Sch Med, Dept Urol, Winston Salem, NC 27157 USA.
RP Colaco, M (reprint author), Wake Forest Sch Med, Dept Urol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM mcolaco@wakehealth.edu
CR Aboushwareb T, 2011, NEUROUROL URODYNAM, V30, P775, DOI 10.1002/nau.21101
   Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870
   Alarab M, 2010, INT UROGYNECOL J, V21, P1397, DOI 10.1007/s00192-010-1199-9
   Allen-Brady K, 2009, AM J HUM GENET, V84, P678, DOI 10.1016/j.ajhg.2009.04.002
   Altman D, 2008, EUR UROL, V54, P918, DOI 10.1016/j.eururo.2007.12.004
   Barber MD, 2013, INT UROGYNECOL J, V24, P1783, DOI 10.1007/s00192-013-2169-9
   Blaganje M, 2012, INT J GYNECOL OBSTET, V117, P164, DOI 10.1016/j.ijgo.2011.11.029
   Blanchard KT, 1999, TOXICOL PATHOL, V27, P519, DOI 10.1177/019262339902700505
   Campeau L, 2011, BJU INT, V108, P1240, DOI 10.1111/j.1464-410X.2011.10385.x
   Cannon TW, 2005, BJU INT, V96, P664, DOI 10.1111/j.1464-410X.2005.05702.x
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Chen B, 2003, AM J OBSTET GYNECOL, V189, P59, DOI 10.1067/mob.2003.378
   Chen BH, 2002, INT UROGYNECOL J PEL, V13, P80, DOI 10.1007/s001920200020
   Chen Y, 2004, NEUROUROL URODYNAM, V23, P367, DOI 10.1002/nau.20006
   Cho HJ, 2009, YONSEI MED J, V50, P564, DOI [10.3349/ymj.2009.50.4.554, 10.3349/ymj.2009.50.4.564]
   Clave A, 2010, INT UROGYNECOL J, V21, P261, DOI 10.1007/s00192-009-1021-8
   Connell KA, 2008, J CLIN INVEST, V118, P1050, DOI 10.1172/JCI34193
   Cosson M, 2004, EUR J OBSTET GYN R B, V112, P201, DOI 10.1016/S0301-2115(03)00333-6
   Costantini E, 2011, UROL INT, V86, P419, DOI 10.1159/000324243
   Culligan P, 2005, OBSTET GYNECOL, V106, P29, DOI 10.1097/01.AOG.0000165824.62167.c1
   Dietz HP, 2003, INT UROGYNECOL J PEL, V14, P239, DOI 10.1007/s00192-003-1041-8
   Fenner DE, 2000, CLIN OBSTET GYNECOL, V43, P650, DOI 10.1097/00003081-200009000-00024
   FROSTLING H, 1984, SCAND J WORK ENV HEA, V10, P163, DOI 10.5271/sjweh.2347
   Gil KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-8
   Goepel C, 2008, ACTA HISTOCHEM, V110, P204, DOI 10.1016/j.acthis.2007.10.014
   Hahnestad YS, 2004, BRIT MED J, V329, P889, DOI 10.1136/bmj.329.7471.889
   Hamer MA, 2013, EUR J OBSTET GYN R B, V170, P559, DOI 10.1016/j.ejogrb.2013.07.025
   Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0
   Karam JA, 2007, BJU INT, V100, P346, DOI 10.1111/j.1464-410X.2007.06998.x
   Kerkhof MH, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.881
   Keys T, 2012, UROLOGY, V80, P237, DOI 10.1016/j.urology.2012.04.008
   Keys Tristan, 2011, Curr Urol Rep, V12, P393, DOI 10.1007/s11934-011-0213-1
   Klutke J, 2008, ACTA OBSTET GYN SCAN, V87, P111, DOI 10.1080/00016340701819247
   Kocak I, 2005, EUR UROL, V48, P634, DOI 10.1016/j.eururo.2005.04.017
   Lee CN, 2010, J KOREAN MED SCI, V25, P813, DOI 10.3346/jkms.2010.25.6.813
   Lin SY, 2007, INT UROGYNECOL J, V18, P43, DOI 10.1007/s00192-006-0090-1
   Maher C, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004014.PUB5
   Maher CM, 2011, INT UROGYNECOL J, V22, P1445, DOI 10.1007/s00192-011-1542-9
   Mangera A, 2013, BJU INT, V112, P674, DOI 10.1111/bju.12186
   Mei SS, 2013, FEMALE PELVIC MED RE, V19, P254, DOI 10.1097/SPV.0b013e31829ff74d
   Mitterberger M, 2008, EUR UROL, V53, P169, DOI 10.1016/j.eururo.2007.07.026
   Mitterberger M, 2008, J UROLOGY, V179, P226, DOI 10.1016/j.juro.2007.08.154
   Myers E, 2013, SOUTH MED J, V106, P684, DOI 10.1097/SMJ.0000000000000031
   Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Pelvic Mesh-Bard Caselist, 2013, PELV MESH LIT BARD G
   Pelvic Mesh-Gynecare Caselist, 2013, PELV MESH LIT BARD G
   Pott PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046978
   Rodrigues AM, 2008, INT UROGYNECOL J, V19, P1471, DOI 10.1007/s00192-008-0662-3
   Roman S, 2014, NEUROUROL URODYNAM, V33, P531, DOI 10.1002/nau.22443
   Salman MC, 2010, INT UROGYNECOL J, V21, P235, DOI 10.1007/s00192-009-1006-7
   Schaffer JI, 2005, CLIN OBSTET GYNECOL, V48, P639, DOI 10.1097/01.grf.0000170428.45819.4e
   Schimpf MO, 2014, AM J OBSTET GYNECOL, V211
   Shah HN, 2012, INDIAN J UROL, V28, P129, DOI 10.4103/0970-1591.98453
   Surcel C, 2012, ROM J MORPHOL EMBRYO, V53, P151
   Ulrich D, 2014, TISSUE ENG PT A, V20, P785, DOI 10.1089/ten.TEA.2013.0170
   VOLLMAR J, 1961, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V298, P729, DOI 10.1007/BF02435362
   Witherspoon P, 2004, BRIT J SURG, V91, P368, DOI 10.1002/bjs.4462
   Wu JM, 2014, OBSTET GYNECOL, V123, P141, DOI 10.1097/AOG.0000000000000057
   Zhou L, 2012, J UROLOGY, V188, P875, DOI 10.1016/j.juro.2012.05.017
   Zong WJ, 2010, OBSTET GYNECOL, V115, P953, DOI 10.1097/AOG.0b013e3181da7946
   Zou XH, 2010, BIOMATERIALS, V31, P4872
NR 62
TC 6
Z9 8
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD JUN
PY 2015
VL 115
IS 6
BP 859
EP 866
DI 10.1111/bju.12819
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA CJ1WL
UT WOS:000355275600010
PM 24889349
OA Bronze
DA 2018-10-19
ER

PT J
AU Harhaus, L
   Huang, JJ
   Kao, SW
   Wu, YL
   Mackert, GA
   Honer, B
   Cheng, MH
   Kneser, U
   Cheng, CM
AF Harhaus, Leila
   Huang, Jung-Ju
   Kao, Shu-Wei
   Wu, Yen-Lin
   Mackert, Gina Alicia
   Hoener, Bernd
   Cheng, Ming-Huei
   Kneser, Ulrich
   Cheng, Chao-Min
TI The vascularized periosteum flap as novel tissue engineering model for
   repair of cartilage defects
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE cartilage repair; tissue engineering; vascularized periosteum flap;
   translational research; osteoarthritis; cartilage defects
ID CONTINUOUS PASSIVE MOTION; DYNAMIC FLUID PRESSURE; FULL-THICKNESS
   DEFECTS; IN-VITRO; JOINT SURFACES; FIBRIN GLUE; GRAFTS; CHONDROGENESIS;
   CULTURE; RABBITS
AB Periosteum is a promising tissue engineering scaffold in research of cartilage repair; so far however, periosteum transfers have not been realized successfully because of insufficient nourishment of the graft. In a translational approach we, for the first time, designed a vascularized periosteum flap as independent' biomaterial with its own blood supply to address this problem and to reconstruct circumscript cartilage defects. In six 3-month-old New Zealand rabbits, a critical size cartilage defect of the medial femur condyle was created and covered by a vascularized periosteum flap pedicled on the saphenous vessels. After 28days, formation of newly built cartilage was assessed macroscopically, histologically and qualitatively via biomechanical compression testing, as well as on molecular biological level via immunohistochemistry. All wounds healed completely, all joints were stable and had full range of motion. All flaps survived and were perfused through their pulsating pedicles. They showed a stable attachment to the bone, although partially incomplete adherence. Hyaline cartilage with typical columnar cell distribution and positive Collagen II staining was formed in the transferred flaps. Biomechanical testing revealed a significantly higher maximum load than the positive control, but a low elasticity. This study proved that vascularization of the periosteum flap is the essential step for flap survival and enables the flap to transform into cartilage. Reconstruction of circumscript cartilage defects seems to be possible. Although these are the first results out of a pilot project, this technique, we believe, can have a wide range of potential applications and high relevance in the clinical field.
C1 [Harhaus, Leila; Mackert, Gina Alicia; Kneser, Ulrich] Heidelberg Univ, Dept Plast Surg, Dept Hand Plast & Reconstruct Surg, Burn Care Ctr,BG Trauma Ctr Ludwigshafen, D-67071 Ludwigshafen, Germany.
   [Harhaus, Leila; Huang, Jung-Ju; Kao, Shu-Wei; Cheng, Ming-Huei] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Coll Med, Taoyuan, Taiwan.
   [Wu, Yen-Lin; Cheng, Chao-Min] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan.
   [Hoener, Bernd] SRH Univ, Dept Social & Legal Sci, Heidelberg, Germany.
RP Harhaus, L (reprint author), Heidelberg Univ, Dept Plast Surg, Dept Hand Plast & Reconstruct Surg, Burn Care Ctr,BG Trauma Ctr Ludwigshafen, Ludwig Guttmann Str 13, D-67071 Ludwigshafen, Germany.
EM leila.harhaus@bgu-ludwigshafen.de
FU Chang Gung Tsing Hua Foundation [CMRPG3C0211]
FX The work was supported by a grant from Chang Gung Tsing Hua Foundation
   (CMRPG3C0211). Thanks to Shu-Rui Yang, PhD, for his valuable
   contributions to the study design and his help and to Ching-Yu Yang for
   her support in many regards.
CR Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P232, DOI 10.1007/s001670050154
   Aroen A, 2006, J ORTHOP RES, V24, P1069, DOI 10.1002/jor.20104
   Chen ACY, 2009, J TRAUMA, V67, P165, DOI 10.1097/TA.0b013e3181881338
   Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/bjm.a.31186
   DELANEY JP, 1989, CLIN ORTHOP RELAT R, P278
   Deponti D, 2014, TISSUE ENG PT A, V20, P1113, DOI [10.1089/ten.tea.2013.0171, 10.1089/ten.TEA.2013.0171]
   GALLAY SH, 1994, J ORTHOPAED RES, V12, P515, DOI 10.1002/jor.1100120408
   Ito Y, 2001, OSTEOARTHR CARTILAGE, V9, P215, DOI 10.1053/joca.2000.0378
   Ivkovic A, 2010, GENE THER, V17, P779, DOI 10.1038/gt.2010.16
   IWASAKI M, 1995, J BONE JOINT SURG AM, V77A, P543, DOI 10.2106/00004623-199504000-00007
   Miura Y, 1994, ORTHOP T, V18, P686
   Mukherjee N, 2001, J ORTHOPAED RES, V19, P524, DOI 10.1016/S0736-0266(00)00045-0
   NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   ODRISCOLL SW, 2001, CLIN ORTHOP S, V391, P190
   Ortak T, 2005, J CRANIOFAC SURG, V16, P594, DOI 10.1097/01.scs.0000168773.71356.62
   RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P181, DOI 10.3109/17453678208992198
   Rutgers M, 2010, OSTEOARTHR CARTILAGE, V18, P12, DOI 10.1016/j.joca.2009.08.009
   Saris DBF, 1999, J ORTHOPAED RES, V17, P668, DOI 10.1002/jor.1100170508
   Shah NV, 2013, ORTHOPEDICS, V36, P945, DOI 10.3928/01477447-20131120-09
   Tarng YW, 2012, INT ORTHOP, V36, P863, DOI 10.1007/s00264-011-1291-x
   Tarng YW, 2010, J BIOMED MATER RES A, V95A, P156, DOI 10.1002/jbm.a.32830
   TONNA EA, 1960, P SOC EXP BIOL MED, V107, P720
NR 24
TC 4
Z9 4
U1 1
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD JUN
PY 2015
VL 19
IS 6
BP 1273
EP 1283
DI 10.1111/jcmm.12485
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA CJ2RP
UT WOS:000355332500012
PM 25754287
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Kulaga, E
   Ploux, L
   Roucoules, V
AF Kulaga, Emilia
   Ploux, Lydie
   Roucoules, Vincent
TI Effect of ageing and sterilization on plasma multilayer system
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Polymer coatings for biomaterial; Plasma polymer; Ageing Sterilization
ID SILVER NANOPARTICLES; SURFACE MODIFICATION; FILMS; POLYMERIZATION;
   POLYPROPYLENE; COATINGS; SPECTROSCOPY; INCREASES; TOXICITY; CULTURE
AB Single and coupled effects of sterilization (autoclaving and electron beam) and ageing of plasma polymer multilayer coating on polypropylene mesh are studied. The multilayer system consists in silver nano-particles entrapped between two maleic anhydride plasma polymer layers and acts as a mechanosensitive antibacterial reservoir. Tensile strength generates cracks within the plasma polymer over-layer which might be used as diffusive channels for Ag+ species. Changes in surface and bulk properties are followed by SEM, TEM, XPS and antibacterial assays. Whilst autoclave treatment influences surface structure unfavorably, electron beam irradiation with dose of 25 kGy does not induce surface physical or topographical changes. However, electron beam sterilization induces changes in chemistry of the surface causing a decrease in O/C elemental concentration ratio. The surface shows better antibacterial efficiency towards planktonic bacteria after electron beam sterilization and more surprisingly, the combination of electron beam sterilization and ageing has beneficial effect on final properties of the material under stretching. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Kulaga, Emilia; Ploux, Lydie; Roucoules, Vincent] Univ Haute Alsace, Univ Strasbourg, UMR CNRS 7361, IS2M, F-68057 Mulhouse, France.
RP Roucoules, V (reprint author), UMR CNRS 7361, Inst Sci Mat Mulhouse, 15 Rue Jean Starcky,BP2488, F-68057 Mulhouse, France.
EM vincent.roucoules@uha.fr
OI Kulaga, Emilia/0000-0003-3770-0177
FU Region Alsace in France
FX The authors gratefully acknowledge the financial support from Region
   Alsace in France. The authors would like to thank Cousin Biotech for
   providing polypropylene mesh substrates. Florent Kuntz and Ludovic
   Frechard from Aerial are kindly acknowledged for their expertise and
   assistance in the electron beam sterilization process.
CR Acar N, 2002, RADIAT PHYS CHEM, V63, P185, DOI 10.1016/S0969-806X(01)00231-6
   Ademovic Z, 2005, PLASMA PROCESS POLYM, V2, P53, DOI 10.1002/ppap.200400038
   Airoudj A, 2011, ADV ENG MATER, V13, pB360, DOI 10.1002/adem.201080075
   Alissawi N, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0928-z
   Assumpcao TAA, 2011, APPL PHYS B, V103, P165, DOI DOI 10.1007/S00340-010-4258-5
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bretagnol F, 2008, ACTA BIOMATER, V4, P1745, DOI 10.1016/j.actbio.2008.06.013
   Brito-Silva AM, 2010, POLYM ENG SCI, V50, P2350, DOI 10.1002/pen.21771
   Calderon JG, 1998, J BIOMED MATER RES, V42, P597, DOI 10.1002/(SICI)1097-4636(19981215)42:4<597::AID-JBM16>3.0.CO;2-R
   CHARLESBY A, 1953, PROC R SOC LON SER-A, V218, P245, DOI 10.1098/rspa.1953.0102
   Chu LQ, 2006, LANGMUIR, V22, P2822, DOI 10.1021/la0530283
   Ding ZL, 2013, J APPL POLYM SCI, V130, P1659, DOI 10.1002/app.39351
   Forch R, 2005, PLASMA PROCESS POLYM, V2, P351, DOI 10.1002/ppap.200400083
   Friedrich M., 2010, Research Journal of Medical Sciences, V4, P330, DOI 10.3923/rjmsci.2010.330.333
   Gahleitner MW, 2003, P 9 EUR PLAC C ROM 3
   Geissler A, 2010, PLASMA PROCESS POLYM, V7, P64, DOI 10.1002/ppap.200900098
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P271, DOI 10.1002/(SICI)1096-9918(199604)24:4<271::AID-SIA116>3.3.CO;2-A
   Gibson RF, 2011, PRINCIPLES COMPOSITE, V219
   Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356
   Hegemann D, 2007, PLASMA PROCESS POLYM, V4, P229, DOI 10.1002/ppap.200600169
   Jiang XC, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9780-1
   Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p
   Korbekandi H, 2012, DELIVERY OF NANOPARTICLES, P3
   Kulaga E, 2014, PLASMA PROCESS POLYM, V11, P63, DOI 10.1002/ppap.201300091
   Levine H., 1988, WATER SCI REV, V3
   MARTAKIS N, 1994, J APPL POLYM SCI, V51, P313, DOI 10.1002/app.1994.070510214
   Nitschke M, 2012, COLLOID SURFACE B, V90, P41, DOI 10.1016/j.colsurfb.2011.09.034
   OLEARY RK, 1968, J PHARM SCI, V57, P12, DOI 10.1002/jps.2600570102
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Roucoules V, 2007, LANGMUIR, V23, P13136, DOI 10.1021/la701460f
   Schneider K, 2012, POLYPROPYLENE, P459
   Serbetci K, 2007, AM J SURG, V194, P375, DOI 10.1016/j.amjsurg.2005.11.018
   Siffer F, 2005, ANAL CHIM ACTA, V539, P289, DOI 10.1016/j.aca.2005.02.072
   Tamirisa PA, 2006, MACROMOLECULES, V39, P7092, DOI 10.1021/ma060944u
   Thomas M, 2007, PLASMA PROCESS POLYM, V4, pS475, DOI 10.1002/ppap.200731210
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vidal O, 1998, J BACTERIOL, V180, P2442
   Yamamoto M, 2006, LANGMUIR, V22, P8581, DOI 10.1021/la0600245
NR 38
TC 3
Z9 3
U1 3
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JUN
PY 2015
VL 116
BP 1
EP 13
DI 10.1016/j.polymdegradstab.2015.02.011
PG 13
WC Polymer Science
SC Polymer Science
GA CJ2XU
UT WOS:000355348800001
DA 2018-10-19
ER

PT J
AU Segev-Zarko, L
   Saar-Dover, R
   Brumfeld, V
   Mangoni, ML
   Shai, Y
AF Segev-Zarko, L.
   Saar-Dover, Ron
   Brumfeld, Vlad
   Mangoni, Maria Luisa
   Shai, Yechiel
TI Mechanisms of biofilm inhibition and degradation by antimicrobial
   peptides
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE antibiotic resistance; anti-biofilm activity; antimicrobial peptides;
   biofilm; biophysics; Pseudomonas aeruginosa
ID GENERATION VIBRATIONAL SPECTROSCOPY; PSEUDOMONAS-AERUGINOSA BIOFILMS;
   QUARTZ-CRYSTAL MICROBALANCE; BACTERIAL BIOFILMS; SEQUENCE ALTERATION;
   CATIONIC PEPTIDE; HOST-DEFENSE; SURFACES; ADHESION; MICROORGANISMS
AB Many bacteria live as biofilms to cope with unfavourable surroundings. Biofilms start from (i) a planktonic stage, (ii) initial adhesion to surfaces and (iii) formation of sessile micro-colonies that secrete extracellular polymeric substance (EPS), leading to bacterial resistance to antibiotics. Antimicrobial peptides (AMPs) are extensively studied with regard to planktonic bacteria but much less so with regard to biofilm formation. In the present study, we investigated how the above three steps are affected by the properties of the AMPs using a series of peptides composed of six lysines and nine leucines, which differ in their sequences and hence their biophysical properties. Treatment with bactericidal peptides at non-inhibitory concentrations resulted in reduced biofilm growth, for some starting from 25 nM which is 0.2 and 0.4% of their minimum inhibitory concentration (MIC 6.3 and 12.5 mu M, respectively), continuing in a dose-dependent manner. We suggest that reduced bacterial adhesion to surfaces and decreased biofilm growth are due to the peptide's ability to coat either the biomaterial surface or the bacterium itself. Degradation of established biofilms by bactericidal and non-bactericidal peptides, within 1 h of incubation, occurs by either killing of embedded bacteria or detachment of live ones. In addition to shedding light on the mechanism of biofilm inhibition and degradation, these data may assist in the design of anti-biofilm AMPs.
C1 [Segev-Zarko, L.; Saar-Dover, Ron; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
   [Brumfeld, Vlad] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel.
   [Mangoni, Maria Luisa] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.
RP Shai, Y (reprint author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
EM Yechiel.Shai@weizmann.ac.il
FU Italian Foundation for Cystic Fibrosis [14/2011]; Delegazione FFC di
   Foggia; Gruppo di Sostegno FFC di Seregno; European Community's Seventh
   Framework Programme [278998]
FX This work was partially supported by grants from the Italian Foundation
   for Cystic Fibrosis [Project FFC#14/2011], Delegazione FFC di Foggia,
   Gruppo di Sostegno FFC di Seregno, and the European Community's Seventh
   Framework Programme (FP7/2007-2013) under grant agreement [278998]. Y.S.
   is the incumbent of the Harold S. and Harriet B. Brady Professorial
   Chair in Cancer Research.
CR Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Chennupati SK, 2009, AMJ RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x
   de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Fernebro J, 2011, DRUG RESIST UPDATE, V14, P125, DOI 10.1016/j.drup.2011.02.001
   Fogaca AC, 2010, FEMS MICROBIOL LETT, V306, P152, DOI 10.1111/j.1574-6968.2010.01950.x
   Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004
   Hara T, 2001, BIOPOLYMERS, V58, P437, DOI 10.1002/1097-0282(20010405)58:4<437::AID-BIP1019>3.0.CO;2-I
   Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6
   Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100
   Jorge P, 2012, BIOFOULING, V28, P1033, DOI 10.1080/08927014.2012.728210
   Kapoor R, 2011, ANTIMICROB AGENTS CH, V55, P3054, DOI 10.1128/AAC.01516-10
   Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383
   KETCHEM RR, 1993, SCIENCE, V261, P1457, DOI 10.1126/science.7690158
   Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3
   Liu LH, 2009, NAT NANOTECHNOL, V4, P457, DOI [10.1038/NNANO.2009.153, 10.1038/nnano.2009.153]
   Luca V, 2013, CELL MOL LIFE SCI, V70, P2773, DOI 10.1007/s00018-013-1291-7
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006
   Mermut O, 2006, J AM CHEM SOC, V128, P3598, DOI 10.1021/ja056031h
   Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12
   O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Otvos L, 2000, PROTEIN SCI, V9, P742
   Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08
   Papo N, 2004, BIOCHEMISTRY-US, V43, P6393, DOI 10.1021/bi049944h
   Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720
   Phillips DC, 2007, J PHYS CHEM C, V111, P255, DOI 10.1021/jp0645263
   Pimentel ND, 2014, INT J FOOD MICROBIOL, V190, P1, DOI 10.1016/j.ijfoodmicro.2014.08.004
   POWELL MF, 1992, J PHARM SCI, V81, P731, DOI 10.1002/jps.2600810802
   Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776
   Rossi LM, 2008, J PHARM SCI-US, V97, P1060, DOI 10.1002/jps.21053
   Saar-Dover R, 2013, METHODS MOL BIOL, V1033, P173, DOI 10.1007/978-1-62703-487-6_12
   Saar-Dover R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002891
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627
   Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023
   Trafny EA, 2013, WORLD J MICROB BIOT, V29, P1635, DOI 10.1007/s11274-013-1326-0
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461
   Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021
NR 50
TC 33
Z9 34
U1 3
U2 50
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JUN 1
PY 2015
VL 468
BP 259
EP 270
DI 10.1042/BJ20141251
PN 2
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CI7KS
UT WOS:000354942800006
PM 25761937
DA 2018-10-19
ER

PT J
AU Mohan, G
   Gallant, ND
AF Mohan, Greeshma
   Gallant, Nathan D.
TI Surface chemistry gradients on silicone elastomers for high-throughput
   modulation of cell-adhesive interfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PDMS; hydrophobicity; fibronectin; combinatorial methods;
   mechanotransduction
ID POLYMER SURFACES; INTEGRIN BINDING; FIBRONECTIN CONFORMATION;
   WETTABILITY GRADIENT; SUBSTRATE MECHANICS; FOCAL ADHESIONS; STEM-CELLS;
   DIFFERENTIATION; PROLIFERATION; ADSORPTION
AB Combinatorial and high-throughput approaches to screening cell responses to material properties accelerate the speed of discovery and facilitate the identification of cell instructive cues or trends that may be missed by discrete sampling. However, these technologies have not yet been widely applied to materials with tissue-like stiffness. The fabrication of monotonically varying surface chemistry gradients on polydimethylsiloxane, an elastic biomaterial, and the influence of these engineered surfaces on protein adsorption and adherent cell morphology were explored in this study. Crosslinked networks of polydimethylsiloxane were functionalized with a hydrophobic self-assembled monolayer and then modified by spatiotemporally regulated ultraviolet ozonolysis to obtain gradients of oxygenated species ranging from approximate to 10 degrees to approximate to 100 degrees in water contact angle. Automated microscopy and image analysis of fibroblast cell morphology revealed a strong correlation between cell spreading and hydrophobicity. However, structural and functional analysis of the fibronectin interface indicated a proportional increase in cell spreading with adsorption, but a biphasic relationship with fibronectin conformation, underscoring the complexity of the adhesive interface. This work demonstrates the development of an elastomer surface modification platform that can be extended to future combinatorial studies of biological responses to chemical and mechanical material properties. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2066-2076, 2015.
C1 [Mohan, Greeshma] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL 33620 USA.
   [Gallant, Nathan D.] Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
RP Gallant, ND (reprint author), Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
EM ngallant@usf.edu
OI Gallant, Nathan/0000-0001-6454-7660
FU National Science Foundation [CAREER DMR-1056475]
FX Contract grant sponsor: National Science Foundation; contract grant
   number: CAREER DMR-1056475
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Hernandez JCR, 2007, BIOPHYS J, V93, P202, DOI 10.1529/biophysj.106.102491
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104
   Efimenko K, 2005, POLYMER, V46, P9329, DOI 10.1016/j.polymer.2005.07.046
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evaraert EP, 1996, J ADHES SCI TECHNOL, V10, P351
   EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263
   Llopis-Hernandez V, 2011, PLOS ONE, V6, P1
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2
   Mei Y, 2007, CURR OPIN CHEM BIOL, V11, P388, DOI 10.1016/j.cbpa.2007.07.006
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Moore NM, 2010, BIOMATERIALS, V31, P1604, DOI [10.1016/j.biomatetials.2009.11.011, 10.1016/j.biomaterials.2009.11.011]
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   MOSHER DF, 1981, J INVEST DERMATOL, V77, P175, DOI 10.1111/1523-1747.ep12479791
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044
   Roberson SV, 2002, APPL SURF SCI, V200, P150, DOI 10.1016/S0169-4332(02)00887-5
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Williams C, 2011, BIOMATERIALS, V32, P5625, DOI 10.1016/j.biomaterials.2011.04.050
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
NR 60
TC 5
Z9 5
U1 4
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2015
VL 103
IS 6
BP 2066
EP 2076
DI 10.1002/jbm.a.35349
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH4SV
UT WOS:000354024100018
PM 25294744
DA 2018-10-19
ER

PT J
AU Choudhary, R
   Koppala, S
   Srivastava, A
   Sasikumar, S
AF Choudhary, Rajan
   Koppala, Sivasankar
   Srivastava, Aviral
   Sasikumar, Swamiappan
TI In-vitro bioactivity of nanocrystalline and bulk larnite/chitosan
   composites: comparative study
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Eggshell; Sol-gel chemistry; X-ray diffraction; Composites; Bioactivity;
   Surface properties
ID TISSUE ENGINEERING SCAFFOLDS; SUBSTITUTED HYDROXYAPATITE; COMBUSTION
   SYNTHESIS; POLYLACTIDE FOAMS; GLASS COMPOSITES; DRUG-DELIVERY; HENS
   EGGSHELL; BONE; CHITOSAN; CALCIUM
AB A major problem in the field of hard tissue engineering is to develop a biomaterial which could allow the organ to regenerate itself completely by biological fixation. Silicate bioceramics are new hope in this field. Nanocrystalline larnite (Ca2SiO4) was prepared by sol-gel combustion method by using calcium nitrate/eggshell waste. XRD analysis of the synthesized product shows the formation of single phasic larnite and FT-IR spectrum confirms the presence of characteristic functional groups of larnite. In vitro bioactivity of different compositional ratio of larnite/chitosan has been investigated to study the influence of the ratio of constituents of composite on bioactivity. XRD pattern of the composite surface after bioactivity study reveals that the composite which mimics the ratio of bioceramic to biopolymer in natural bone shows good bioactivity and remarkable hydroxyapatite layer deposition. SEM images shows the hydroxyapatite particles deposited on the surface of eggshell derived larnite composite is highly agglomerated with the average particle size of 3-5 nm.
C1 [Choudhary, Rajan; Koppala, Sivasankar; Srivastava, Aviral; Sasikumar, Swamiappan] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
RP Sasikumar, S (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
EM vitsasi@yahoo.co.in
RI Swamiappan, Sasikumar/M-9921-2016; Choudhary, Rajan/R-7998-2018
OI Swamiappan, Sasikumar/0000-0003-2533-4923; Koppala,
   Sivasankar/0000-0002-4086-030X
FU VIT University
FX Authors are thankful to VIT University for providing necessary
   facilities and financial support.
CR Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Anjaneyulu U, 2014, B MATER SCI, V37, P207, DOI 10.1007/s12034-014-0646-5
   Bhatkar VB, 2011, B MATER SCI, V34, P1281, DOI 10.1007/s12034-011-0166-5
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chen QZ, 2012, PROG BIOMATER, V1, DOI 10.1186/2194-0517-1-2
   Cheng W, 2005, MATER LETT, V59, P2214, DOI 10.1016/j.matlet.2005.02.069
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Goloshchapov DL, 2013, CERAM INT, V39, P4539, DOI 10.1016/j.ceramint.2012.11.050
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   Gou ZR, 2005, J EUR CERAM SOC, V25, P1507, DOI 10.1016/j.jeurceramsoc.2004.05.029
   Han B, 1999, POLYPEPTIDE GROWTH F
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Holme HK, 2008, CARBOHYD POLYM, V73, P656, DOI 10.1016/j.carbpol.2008.01.007
   Huang D, 2011, J BIOMAT SCI-POLYM E, V22, P931, DOI 10.1163/092050610X496576
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iler R, 1979, CHEM SILICA
   Kalinkin AM, 2003, GLASS PHYS CHEM+, V29, P410, DOI 10.1023/A:1025185229274
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Kikuchi M, 1999, J BIOMED MATER RES, V48, P108, DOI 10.1002/(SICI)1097-4636(1999)48:2<108::AID-JBM2>3.3.CO;2-6
   Klug H. P., 1962, XRAY DIFFRACTION PRO
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Krithiga G, 2011, B MATER SCI, V34, P177, DOI 10.1007/s12034-011-0044-1
   Lakshmi R., 2013, Combustion Science and Technology, V185, P1777, DOI 10.1080/00102202.2013.835308
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   Lin KL, 2006, J INORG MATER, V21, P1429
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Nalwa H. S., 2003, HDB ORGANIC INORGANI, V1
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Pighinelli L, 2013, CARBOHYD POLYM, V93, P256, DOI 10.1016/j.carbpol.2012.06.004
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Prabakaran K, 2005, B MATER SCI, V28, P115, DOI 10.1007/BF02704229
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Salernitano E, 2003, J Appl Biomater Biomech, V1, P3
   Salinas AJ, 2001, J SOL-GEL SCI TECHN, V21, P13, DOI 10.1023/A:1011249330581
   Samal S.S., 2008, J MINER MAT CHARACT, V7, P355
   Sasikumar S., 2006, TRENDS BIOMATER ARTI, V19, P70
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Shogren RL, 1999, ACS S SERIES, V723
   Sprio S, 2009, J MECH BEHAV BIOMED, V2, P147, DOI 10.1016/j.jmbbm.2008.05.006
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tilekar Ganesh, 2011, Frontiers of Chemical Science and Engineering, V5, P477, DOI 10.1007/s11705-011-1107-y
   Udduttula A, 2013, T INDIAN CERAM SOC, V72, P257, DOI 10.1080/0371750X.2013.867641
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   van Wyk JPH, 2001, TRENDS BIOTECHNOL, V19, P172, DOI 10.1016/S0167-7799(01)01601-8
   Verma N, 2012, POL J ENVIRON STUD, V21, P491
   Wu C, 2007, J BIOMED MATER RES B, V83B, P153, DOI 10.1002/jbm.b.30779
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
   Yunos DM, 2008, J MATER SCI, V43, P4433, DOI 10.1007/s10853-008-2552-y
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhao YK, 2009, J SOL-GEL SCI TECHN, V52, P69, DOI 10.1007/s10971-009-2006-2
   Zhong HB, 2011, CERAM INT, V37, P2459, DOI 10.1016/j.ceramint.2011.03.037
NR 66
TC 7
Z9 7
U1 2
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JUN
PY 2015
VL 74
IS 3
BP 631
EP 640
DI 10.1007/s10971-015-3642-3
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA CH9UN
UT WOS:000354382000007
DA 2018-10-19
ER

PT J
AU Tzur-Balter, A
   Shtenberg, G
   Segal, E
AF Tzur-Balter, Adi
   Shtenberg, Giorgi
   Segal, Ester
TI Porous silicon for cancer therapy: from fundamental research to the
   clinic
SO REVIEWS IN CHEMICAL ENGINEERING
LA English
DT Review
DE cancer; drug delivery; porous silicon
ID MULTISTAGE DELIVERY-SYSTEM; MESOPOROUS SILICON; DRUG-DELIVERY;
   PHOTODYNAMIC THERAPY; BREAST-CANCER; TUMORITROPIC ACCUMULATION;
   GEOMETRICAL CONFINEMENT; BIOMEDICAL APPLICATIONS; CELLULAR-ASSOCIATION;
   PHOTONIC CRYSTALS
AB Porous silicon (PSi) has emerged over the past decade as a promising biomaterial for nanomedicine in general and cancer nanomedicine in particular. PSi offers a unique combination of properties, including large surface area and porous volume, biocompatibility, degradability in vivo into non-toxic silicic acid species, as well as its wealth of intrinsic optical properties (e.g., luminescence, photonic). This arsenal of properties together with the ability to tailor the PSi nanostructure and surface characteristics have led to an immense research effort directed at the development of PSi-based platforms for biomedical applications. After a brief introduction of the biology of cancer and currently practiced therapies, we provide an updated review of the progress of PSi-based platforms for cancer therapy and imaging.
C1 [Shtenberg, Giorgi; Segal, Ester] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.
   [Segal, Ester] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel.
   [Tzur-Balter, Adi] Technion Israel Inst Technol, Interdept Program Biotechnol, IL-32000 Haifa, Israel.
RP Segal, E (reprint author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.
EM esegal@tx.technion.ac.il
OI Segal, Ester/0000-0001-9472-754X
FU Russell Berrie Nanotechnology Institute (RBNI); Lorry I. Lokey
   Interdisciplinary Center for Life Sciences and Engineering (LSE)
FX This work is partially supported by the Russell Berrie Nanotechnology
   Institute (RBNI) and the Lorry I. Lokey Interdisciplinary Center for
   Life Sciences and Engineering (LS&E). ATB gratefully acknowledges the
   RBNI Scholarship for Outstanding Graduate Students.
CR Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Baldo BA, 2013, CANCER METAST REV, V32, P723, DOI 10.1007/s10555-013-9447-3
   Bayliss SC, 1997, J MATER SCI LETT, V16, P737, DOI 10.1023/A:1018581014416
   Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009
   Bimbo LM, 2011, BIOMATERIALS, V32, P2625, DOI 10.1016/j.biomaterials.2010.12.011
   Bimbo LM, 2010, ACS NANO, V4, P3023, DOI 10.1021/nn901657w
   Bonanno LM, 2011, NANOMEDICINE-UK, V6, P1755, DOI [10.2217/NNM.11.153, 10.2217/nnm.11.153]
   BOUCHER Y, 1990, CANCER RES, V50, P4478
   Bracci L, 2014, CELL DEATH DIFFER, V21, P15, DOI 10.1038/cdd.2013.67
   Canham L., 1997, PROPERTIES POROUS SI
   Canham L., 2014, HDB POROUS SILICON
   Canham LT, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/18/185704
   Canham L, 2013, NANOMEDICINE-UK, V8, P1573, DOI [10.2217/NNM.13.134, 10.2217/nnm.13.134]
   Canham LT, 1996, ADV MATER, V8, P850, DOI 10.1002/adma.19960081020
   Canham LT, 1996, ADV MATER, V8, P847, DOI 10.1002/adma.19960081019
   Canham LT, 1997, THIN SOLID FILMS, V297, P304, DOI 10.1016/S0040-6090(96)09534-X
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587
   Chiappini C, 2010, CHEMPHYSCHEM, V11, P1029, DOI 10.1002/cphc.200900914
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001
   Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014
   Doherty GJ, 2009, PALO ALTO ANN REV
   Ferlay JS, 2012, GLOBOCAN 2012 CANC I
   Ferrari M, 2010, NAT REV CLIN ONCOL, V7, P485, DOI 10.1038/nrclinonc.2010.131
   Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6
   Gizzatov A, 2014, CANCER LETT, V352, P97, DOI 10.1016/j.canlet.2014.06.001
   Glatstein E, 2008, J CLIN ONCOL, V26, P2438, DOI 10.1200/JCO.2008.17.1843
   Godin B, 2012, ADV FUNCT MATER, V22, P4225, DOI 10.1002/adfm.201200869
   Godin B, 2011, ACCOUNTS CHEM RES, V44, P979, DOI 10.1021/ar200077p
   Godin B, 2010, J BIOMED MATER RES A, V94A, P1236, DOI 10.1002/jbm.a.32807
   Goh ASW, 2007, INT J RADIAT ONCOL, V67, P786, DOI 10.1016/j.ijrobp.2006.09.011
   Gorustovich AA, 2007, J BIOMATER APPL, V21, P431, DOI 10.1177/0885328206068061
   Gu L, 2012, ADV MATER, V24, P4025
   Gu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3326
   Gu L, 2010, SMALL, V6, P2546, DOI 10.1002/smll.201000841
   Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704
   Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177
   Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2
   Hong C, 2011, ANTI-CANCER DRUG, V22, P971, DOI 10.1097/CAD.0b013e32834b859c
   Hong C, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-321
   Hua MY, 2010, BIOMATERIALS, V31, P7355, DOI 10.1016/j.biomaterials.2010.05.061
   Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003
   Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102
   JAIN RK, 1988, CANCER RES, V48, P2641
   Jane A, 2009, TRENDS BIOTECHNOL, V27, P230, DOI 10.1016/j.tibtech.2008.12.004
   Juarranz A, 2008, CLIN TRANSL ONCOL, V10, P148, DOI 10.1007/s12094-008-0172-2
   Kallinen AM, 2014, MOL PHARMACEUT, V11, P2876, DOI 10.1021/mp500225b
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kilian KA, 2009, CHEM COMMUN, P630, DOI 10.1039/b815449j
   Kinnari PJ, 2013, BIOMATERIALS, V34, P9134, DOI 10.1016/j.biomaterials.2013.08.034
   Kinsella JM, 2011, ADV MATER, V23, pH248, DOI 10.1002/adma.201101877
   Koukourakis G, 2009, ADV UROL, V2009
   Kovalainen M, 2013, MOL PHARMACEUT, V10, P353, DOI 10.1021/mp300494p
   Kumar R, 2014, ANTI-CANCER AGENT ME, V14, P713, DOI 10.2174/18715206113136660364
   Lee C, 2008, J MATER CHEM, V18, P4790, DOI 10.1039/b808500e
   Lee C, 2007, J MATER CHEM, V17, P2648, DOI 10.1039/b700892a
   Lee C, 2010, PHOTOCHEM PHOTOBIOL, V86, P981, DOI 10.1111/j.1751-1097.2010.00731.x
   Levin WP, 2005, BRIT J CANCER, V93, P849, DOI 10.1038/sj.bjc.6602754
   Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041
   Li X, 2000, BIOMED MICRODEVICES, V2, P265, DOI 10.1023/A:1009951121205
   Li YY, 2003, SCIENCE, V299, P2045, DOI 10.1126/science.1081298
   Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147
   Liu DF, 2013, ADV FUNCT MATER, V23, P1893, DOI 10.1002/adfm.201202491
   Loo C, 2004, TECHNOL CANCER RES T, V3, P33, DOI 10.1177/153303460400300104
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328
   Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1
   Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010
   Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004
   Mann AP, 2011, ONCOTARGET, V2, P298
   Martinez JO, 2013, BIOMATERIALS, V34, P8469, DOI 10.1016/j.biomaterials.2013.07.049
   Martinez JO, 2013, SMALL, V9, P1722, DOI 10.1002/smll.201201939
   Massad-Ivanir N, 2012, ADV EXP MED BIOL, V733, P37, DOI 10.1007/978-94-007-2555-3_4
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Nieto A, 2013, EXP EYE RES, V116, P161, DOI 10.1016/j.exer.2013.09.001
   Park JH, 2008, PROG POLYM SCI, V33, P113, DOI 10.1016/j.progpolymsci.2007.09.003
   Park JS, 2011, SMALL, V7, P2061, DOI 10.1002/smll.201100438
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212
   Perelman LA, 2008, NANOMEDICINE-UK, V3, P31, DOI 10.2217/17435889.3.1.31
   Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5
   Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897
   Russo L, 2011, MATERIALS, V4, P1023, DOI 10.3390/ma4061023
   Salonen J, 2008, CHEM ENG J, V137, P162, DOI 10.1016/j.cej.2007.09.001
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   Santos HA., 2014, POROUS SILICON BIOME
   Sarparanta M, 2012, MOL PHARMACEUT, V9, P654, DOI 10.1021/mp200611d
   Sarparanta MP, 2012, BIOMATERIALS, V33, P3353, DOI 10.1016/j.biomaterials.2012.01.029
   Schott AF, 2012, J CLIN ONCOL, V30, P1747, DOI 10.1200/JCO.2011.41.3161
   Secret E, 2014, ADV MATER, V26, P7643, DOI 10.1002/adma.201403415
   Secret E, 2013, ADV HEALTHC MATER, V2, P718, DOI 10.1002/adhm.201200335
   Secret E, 2013, CHEM COMMUN, V49, P4202, DOI 10.1039/c3cc38837a
   Segal E, 2007, ADV FUNCT MATER, V17, P1153, DOI 10.1002/adfm.200601077
   Serda RE, 2010, SMALL, V6, P2691, DOI 10.1002/smll.201000727
   Serda RE, 2010, SMALL, V6, P1329, DOI 10.1002/smll.201000126
   Shahbazi MA, 2013, BIOMATERIALS, V34, P7776, DOI 10.1016/j.biomaterials.2013.06.052
   Shen HF, 2013, CLIN CANCER RES, V19, P1806, DOI 10.1158/1078-0432.CCR-12-2764
   Shen HF, 2012, ADV HEALTHC MATER, V1, P84, DOI 10.1002/adhm.201100005
   Shen JL, 2014, THERANOSTICS, V4, P487, DOI 10.7150/thno.8263
   Shen JL, 2013, ACS NANO, V7, P9867, DOI 10.1021/nn4035316
   Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007
   Sun W, 2007, PHYS STATUS SOLIDI A, V204, P1429, DOI 10.1002/pssa.200674377
   Sun W, 2007, ADV MATER, V19, P921, DOI 10.1002/adma.200600319
   Tamarov KP, 2014, SCI REP-UK, V4, DOI 10.1038/srep07034
   Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931
   Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34
   Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324
   Tolli MA, 2014, BIOMATERIALS, V35, P8394, DOI 10.1016/j.biomaterials.2014.05.078
   Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4
   Tzur-Balter A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7208
   Tzur-Balter A, 2013, ACTA BIOMATER, V9, P6208, DOI 10.1016/j.actbio.2012.12.010
   van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021
   VAUPEL P, 1989, CANCER RES, V49, P6449
   Veiseh O, 2011, BIOMATERIALS, V32, P5717, DOI 10.1016/j.biomaterials.2011.04.039
   Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544
   Wu EC, 2011, BIOMATERIALS, V32, P1957, DOI 10.1016/j.biomaterials.2010.11.013
   Xiao L, 2011, ACS NANO, V5, P3651, DOI 10.1021/nn1035262
   Xu R, 2013, SMALL, V9, P1799, DOI 10.1002/smll.201201510
   Yokoi K, 2013, CANCER LETT, V334, P319, DOI 10.1016/j.canlet.2012.09.001
   Zhang MZ, 2014, BIOMATERIALS, V35, P423, DOI 10.1016/j.biomaterials.2013.09.033
NR 129
TC 3
Z9 3
U1 5
U2 47
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0167-8299
EI 2191-0235
J9 REV CHEM ENG
JI Rev. Chem. Eng.
PD JUN
PY 2015
VL 31
IS 3
BP 193
EP 207
DI 10.1515/revce-2015-0001
PG 15
WC Engineering, Chemical
SC Engineering
GA CI6UJ
UT WOS:000354897900001
DA 2018-10-19
ER

PT J
AU Tallawi, M
   Zebrowski, DC
   Rai, R
   Roether, JA
   Schubert, DW
   El Fray, M
   Engel, FB
   Aifantis, KE
   Boccaccini, AR
AF Tallawi, Marwa
   Zebrowski, David C.
   Rai, Ranjana
   Roether, Judith A.
   Schubert, Dirk W.
   El Fray, Miroslawa
   Engel, Felix B.
   Aifantis, Katerina E.
   Boccaccini, Aldo R.
TI Poly(Glycerol Sebacate)/Poly(Butylene Succinate-Butylene Dilinoleate)
   Fibrous Scaffolds for Cardiac Tissue Engineering
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID MYOCARDIAL-INFARCTION; MECHANICAL-PROPERTIES; HEART-DISEASE;
   BIOMATERIALS; CARDIOMYOCYTES; REGENERATION; ELASTOMER; SYSTEM
AB The present article investigates the use of a novel electrospun fibrous blend of poly(glycerol sebacate) (PGS) and poly(butylene succinate-butylene dilinoleate) (PBS-DLA) as a candidate for cardiac tissue engineering. Random electrospun fibers with various PGS/PBS-DLA compositions (70/30, 60/40, 50/50, and 0/100) were fabricated. To examine the suitability of these fiber blends for heart patches, their morphology, as well as their physical, chemical, and mechanical properties were measured before examining their biocompatibility through cell adhesion. The fabricated fibers were bead-free and exhibited a relatively narrow diameter distribution. The addition of PBS-DLA to PGS resulted in an increase of the average fiber diameter, whereas increasing the amount of PBS-DLA decreased the hydrophilicity and the water uptake of the nanofibrous scaffolds to values that approached those of neat PBS-DLA nanofibers. Moreover, the addition of PBS-DLA significantly increased the elastic modulus. Initial toxicity studies with C2C12 myoblast cells up to 72 h confirmed nontoxic behavior of the blends. Immunofluorescence analyses and scanning electron microscopy analyses confirmed that C2C12 cells showed better cell attachment and proliferation on electrospun mats with higher PBS-DLA content. However, immunofluorescence analyses of the 3-day-old rat cardiomyocytes cultured for 2 and 5 days demonstrated better attachment on the 70/30 fibers containing well-aligned sarcomeres and expressing high amounts of connexin 43 in cellular junctions indicating efficient cell-to-cell communication. It can be concluded, therefore, that fibrous PGS/PBS-DLA scaffolds exhibit promising characteristics as a biomaterial for cardiac patch applications.
C1 [Tallawi, Marwa; Rai, Ranjana; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91054 Erlangen, Germany.
   [Zebrowski, David C.; Engel, Felix B.] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Expt Renal & Cardiovasc Res, D-91054 Erlangen, Germany.
   [Roether, Judith A.; Schubert, Dirk W.] Univ Erlangen Nurnberg, Inst Polymer Mat, Dept Mat Sci & Engn, D-91054 Erlangen, Germany.
   [El Fray, Miroslawa] West Pomeranian Univ Technol, Inst Polymer, Div Biomat & Microbiol Technol, Szczecin, Poland.
   [Aifantis, Katerina E.] Aristotle Univ Thessaloniki, Sch Engn, Lab Mech & Mat, GR-54006 Thessaloniki, Greece.
   [Aifantis, Katerina E.] Univ Arizona, Dept Civil Engn Engn Mech, Tucson, AZ USA.
RP Engel, FB (reprint author), Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Expt Renal & Cardiovasc Res, Schwabachanlage 12 TRC, D-91054 Erlangen, Germany.
EM felix.engel@uk-erlangen.de; aldo.boccaccini@ww.uni-erlangen.de
RI El Fray, Miroslawa/J-4128-2016; Engel, Felix/A-1767-2008; Boccaccini,
   Aldo/C-7905-2013
OI Engel, Felix/0000-0003-2605-3429; El Fray, Miroslawa/0000-0002-2474-3517
FU ERC [MINATRAN 211166]; ELAN-Programm Grant by the
   Friedrich-Alexander-Universitat Erlangen-Nurnberg
FX The authors acknowledge partial financial support from the ERC Starting
   Grant MINATRAN 211166. Aga Kozlowska is acknowledged for experimental
   assistance, Alina Grunewald for her technical support and Prof. Ben
   Fabry for providing access to his laboratory. This work was also
   supported by an ELAN-Programm Grant by the
   Friedrich-Alexander-Universitat Erlangen-Nurnberg (to F.B.E.).
CR Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Boccaccini A. R., 2011, MYOCARDIAL TISSUE EN
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Curtis MW, 2009, J CARDIOVASC NURS, V24, P87, DOI 10.1097/01.JCN.0000343562.06614.49
   Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294
   Gibson C. C., 2009, BIOL INTERACTIONS MA
   Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367
   Jager A, 2012, SOFT MATTER, V8, P4343, DOI 10.1039/c2sm07247e
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Liu GY, 1996, J BIOL CHEM, V271, P25338, DOI 10.1074/jbc.271.41.25338
   MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V664, P349, DOI 10.1016/0005-2760(81)90057-6
   Patra C, 2012, BIOMATERIALS, V33, P4327, DOI 10.1016/j.biomaterials.2012.03.021
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rickne A, 2009, SWEDISH POSSIBILITIE
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Supaphol P, 2008, J APPL POLYM SCI, V108, P969, DOI 10.1002/app.27664
   Tallawi M, 2013, MACROMOL SYMP, V334, P57, DOI 10.1002/masy.201300114
   van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   Zdebiak P, 2008, FIBRES TEXT EAST EUR, V16, P77
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 32
TC 14
Z9 14
U1 1
U2 47
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUN 1
PY 2015
VL 21
IS 6
BP 585
EP 596
DI 10.1089/ten.tec.2014.0445
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CI6LF
UT WOS:000354870000008
PM 25439964
OA Green Published
DA 2018-10-19
ER

PT J
AU Muhamed, J
   Revi, D
   Rajan, A
   Geetha, S
   Anilkumar, TV
AF Muhamed, Jaseer
   Revi, Deepa
   Rajan, Akhila
   Geetha, Surendran
   Anilkumar, Thapasimuthu V.
TI Biocompatibility and Immunophenotypic Characterization of a Porcine
   Cholecyst-derived Scaffold Implanted in Rats
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE safety assessment; biocompatibility; xenograft; cholecyst-derived
   scaffold; immunohistochemistry; medical devices; animal model
ID EXTRACELLULAR-MATRIX; MACROPHAGE PHENOTYPE; IMMUNE-RESPONSE; REJECTION;
   PATHOLOGY; SYSTEM
AB Comparative histomorphological assessment of local response to implanted reference biomaterial, also called biocompatibility testing/evaluation, in an appropriate animal model is a widely practiced safety evaluation procedure performed on biomaterials before clinical use. Standardized protocols and procedures, originally designed for testing synthetic materials, available for the testing/evaluation do not account for the immunogenic potential of a candidate biomaterial. Therefore, it is appropriate to supplement the routine biocompatibility test reports with adjunct data that may provide insight into the immunogenic potential of candidate biomaterials, especially when testing biomaterials that are derived from mammalian sources. This article presents expanded safety evaluation data of a porcine cholecyst-derived scaffold (CDS) intended as a xenogeneic graft. The biocompatibility was tested in rat subcutaneous model in comparison with a reference material and the CDS was found biocompatible. However, when studied by immunohistochemistry and real-time reverse transcription polymerase chain reaction for the number and/or polarization of M1 macrophage, M2 macrophage, cytotoxic T-cell, helper T cell, TH1 cell, and TH2 cell, the CDS appeared to induce a differential local immunopathological tissue reaction despite the similarity in biocompatibility with the reference material. The adjunct data collected were useful for objectively assessing the safety of CDS as a xenograft.
C1 [Muhamed, Jaseer; Revi, Deepa; Rajan, Akhila; Geetha, Surendran; Anilkumar, Thapasimuthu V.] Sree Chitra Tirunal Inst Med Sci & Technol, Div Expt Pathol, Trivandrum 695012, Kerala, India.
RP Anilkumar, TV (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Satelmond Palace Campus, Trivandrum 695012, Kerala, India.
EM tvanilkumar@sctimst.ac.in
OI Rajan, Akhila/0000-0002-9624-4696; Muhamed, Jaseer/0000-0001-5046-9438
FU Department of Biotechnology, Government of India
   [BT/PR15461/MED/32/167/2011]
FX The authors thank the Department of Biotechnology, Government of India
   for financial support (BT/PR15461/MED/32/167/2011).
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anilkumar TV, 2014, J BIOMED MATER RES B, V102, P1506, DOI 10.1002/jbm.b.33131
   [Anonymous], 2010, F2210 ASTM INT
   [Anonymous], 2006, 1099320 ISOTS
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burugapalli K, 2008, OBES SURG, V18, P1418, DOI 10.1007/s11695-008-9518-7
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P928, DOI 10.1021/bm061088x
   Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x
   Dahe GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025236
   Elmore SA, 2012, TOXICOL PATHOL, V40, P148, DOI 10.1177/0192623311427571
   Ettlin RA, 2013, TOXICOL PATHOL, V41, P689, DOI 10.1177/0192623312466192
   Fishman JA, 2012, XENOTRANSPLANTATION, V19, P72, DOI 10.1111/j.1399-3089.2012.00693.x
   Haley P, 2005, TOXICOL PATHOL, V33, P404, DOI 10.1080/01926230590934304
   Hautz T, 2010, AM J TRANSPLANT, V10, P1200, DOI 10.1111/j.1600-6143.2010.03075.x
   Hautz T, 2012, TRANSPL INT, V25, P56, DOI 10.1111/j.1432-2277.2011.01369.x
   Ho KLV, 2004, J UROLOGY, V171, P268, DOI 10.1097/01.ju.0000098680.60020.32
   International Organization for Standardization(ISO), 2007, 109936 ISO
   John TT, 2008, UROLOGY, V72, P1036, DOI 10.1016/j.urology.2008.07.043
   Kajbafzadeh AM, 2014, PEDIATR SURG INT, V30, P371, DOI 10.1007/s00383-014-3474-1
   Kalota SJ, 2004, J UROLOGY, V172, P1349, DOI 10.1097/01.ju.0000137867.04413.38
   Li RD, 2013, CLIN TRANSPLANT, V27, P666, DOI 10.1111/ctr.12187
   Maronpot RR, 2012, TOXICOL PATHOL, V40, P1082, DOI 10.1177/0192623312446528
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Muhamed J, 2013, TOXICOL PATHOL, V41, P497, DOI 10.1177/0192623312460922
   Petter-Puchner A, 2007, SURG ENDOSC, V21, P830, DOI 10.1007/s00464-006-9158-8
   Revi D., 2013, J TISSUE ENG, V4
   Schuh JCL, 2008, TOXICOL PATHOL, V36, P63, DOI 10.1177/0192623307309926
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Umashankar P R, 2012, Toxicol Int, V19, P51, DOI 10.4103/0971-6580.94513
   Vivo, 2011, 34NF29 USP, P83
   Wang CL, 2009, INT UROGYNECOL J, V20, P1149, DOI 10.1007/s00192-009-0845-6
NR 37
TC 9
Z9 9
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
EI 1533-1601
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD JUN
PY 2015
VL 43
IS 4
BP 536
EP 545
DI 10.1177/0192623314550722
PG 10
WC Pathology; Toxicology
SC Pathology; Toxicology
GA CI5YJ
UT WOS:000354835400009
PM 25318959
OA Bronze
DA 2018-10-19
ER

PT J
AU Shinonaga, T
   Tsukamoto, M
   Kawa, T
   Chen, P
   Nagai, A
   Hanawa, T
AF Shinonaga, T.
   Tsukamoto, M.
   Kawa, T.
   Chen, P.
   Nagai, A.
   Hanawa, T.
TI Formation of periodic nanostructures using a femtosecond laser to
   control cell spreading on titanium
SO APPLIED PHYSICS B-LASERS AND OPTICS
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Photo-Excited Processes and Applications
   (ICPEPA)
CY SEP 29-OCT 02, 2014
CL Matsue, JAPAN
ID SURFACES; PROLIFERATION; POLYSTYRENE; MORPHOLOGY; ALIGNMENT; ABLATION;
   ADHESION; BEHAVIOR; PLATE
AB Although titanium (Ti) is a common biomaterial, controlling cell spreading by forming periodic structures using a femtosecond laser should improve its biocompatibility. Herein we investigate the influence of periodic nanostructures formed on the surface of a Ti plate on cell spreading. Nanostructures with a periodicity of 590 nm are formed using a femtosecond laser with a wavelength of 775 nm. Cell spreading on the plate without period structures lacks a definite direction, whereas cell spreading on the Ti plate with periodic structures occurs along the grooves, suggesting that forming periodic structures via a femtosecond laser can control cell spreading.
C1 [Shinonaga, T.; Tsukamoto, M.] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan.
   [Kawa, T.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan.
   [Chen, P.; Nagai, A.; Hanawa, T.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Shinonaga, T (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Osaka 5670047, Japan.
EM togo@jwri.osaka-u.ac.jp
CR Das SK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117509
   Dufft D, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074106
   Dumas V, 2012, J BIOMED MATER RES A, V100A, P3108, DOI 10.1002/jbm.a.34239
   Fujita S, 2008, BIOMATERIALS, V29, P4494, DOI 10.1016/j.biomaterials.2008.08.027
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Hanawa T, 2010, JPN DENT SCI REV, V46, P93, DOI 10.1016/j.jdsr.2009.11.001
   Hashida M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803940
   Huang PJ, 1997, THERMOCHIM ACTA, V297, P85, DOI 10.1016/S0040-6031(97)00168-8
   Jia TQ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125429
   Landis EC, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752276
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Miyaji G, 2008, OPT EXPRESS, V16, P16265, DOI 10.1364/OE.16.016265
   Miyaji G, 2012, OPT EXPRESS, V20, P14848, DOI 10.1364/OE.20.014848
   Miyazaki K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4826078
   Okamuro K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165417
   Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039
   Reif J, 2002, APPL SURF SCI, V197, P891, DOI 10.1016/S0169-4332(02)00450-6
   Sakabe S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.033409
   Shimotsuma Y, 2003, PHYS REV LETT, V91, DOI [10.1103/PhysRevLett.91.107001, 10.1103/PhysRevLett.91.247405]
   Shinonaga T, 2014, OPT EXPRESS, V22, P14696, DOI 10.1364/OE.22.014696
   Shinonaga T, 2014, APPL SURF SCI, V288, P649, DOI 10.1016/j.apsusc.2013.10.090
   Tsukamoto M, 2007, J PHYS CONF SER, V59, P666, DOI 10.1088/1742-6596/59/1/140
   Tsukamoto M, 2014, PROC SPIE, V8969, DOI 10.1117/12.2040957
   Tsukamoto M, 2006, VACUUM, V80, P1346, DOI 10.1016/j.vacuum.2006.01.016
   Wang XF, 2006, J BIOMED MATER RES A, V78A, P746, DOI 10.1002/jbm.a.30764
NR 28
TC 16
Z9 16
U1 4
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2171
EI 1432-0649
J9 APPL PHYS B-LASERS O
JI Appl. Phys. B-Lasers Opt.
PD JUN
PY 2015
VL 119
IS 3
SI SI
BP 493
EP 496
DI 10.1007/s00340-015-6082-4
PG 4
WC Optics; Physics, Applied
SC Optics; Physics
GA CI2ZV
UT WOS:000354618000014
DA 2018-10-19
ER

PT J
AU Jacob, RS
   Ghosh, D
   Singh, PK
   Basu, SK
   Jha, NN
   Das, S
   Sukul, PK
   Patil, S
   Sathaye, S
   Kumar, A
   Chowdhury, A
   Malik, S
   Sen, S
   Maji, SK
AF Jacob, Reeba S.
   Ghosh, Dhiman
   Singh, Pradeep K.
   Basu, Santanu K.
   Jha, Narendra Nath
   Das, Subhadeep
   Sukul, Pradip K.
   Patil, Sachin
   Sathaye, Sadhana
   Kumar, Ashutosh
   Chowdhury, Arindam
   Malik, Sudip
   Sen, Shamik
   Maji, Samir K.
TI Self healing hydrogels composed of amyloid nano fibrils for cell culture
   and stem cell differentiation
SO BIOMATERIALS
LA English
DT Article
DE Amyloid hydrogel; Nanofibrils; Self-assembly; Stem cell; Tissue
   engineering
ID ASSEMBLED PEPTIDE NANOTUBES; BETA-PROTEIN; ALZHEIMERS-DISEASE;
   FMOC-DIPHENYLALANINE; ALPHA-SYNUCLEIN; BIOSENSOR APPLICATIONS; NANOFIBER
   SCAFFOLD; DESIGN; TISSUE; AGGREGATION
AB Amyloids are highly ordered protein/peptide aggregates associated with human diseases as well as various native biological functions. Given the diverse range of physiochemical properties of amyloids, we hypothesized that higher order amyloid self-assembly could be used for fabricating novel hydrogels for biomaterial applications. For proof of concept, we designed a series of peptides based on the high aggregation prone C-terminus of A beta 42, which is associated with Alzheimer's disease. These Fmoc protected peptides self assemble to beta sheet rich nanofibrils, forming hydrogels that are thermoreversible, non-toxic and thixotropic. Mechanistic studies indicate that while hydrophobic, pi-pi interactions and hydrogen bonding drive amyloid network formation to form supramolecular gel structure, the exposed hydrophobic surface of amyloid fibrils may render thixotropicity to these gels. We have demonstrated the utility of these hydrogels in supporting cell attachment and spreading across a diverse range of cell types. Finally, by tuning the stiffness of these gels through modulation of peptide concentration and salt concentration these hydrogels could be used as scaffolds that can drive differentiation of mesenchymal stem cells. Taken together, our results indicate that small size, ease of custom synthesis, thixotropic nature makes these amyloid-based hydrogels ideally suited for biomaterial/nanotechnology applications. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Jacob, Reeba S.; Ghosh, Dhiman; Singh, Pradeep K.; Basu, Santanu K.; Jha, Narendra Nath; Das, Subhadeep; Kumar, Ashutosh; Sen, Shamik; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
   [Sukul, Pradip K.; Malik, Sudip] Indian Assoc Cultivat Sci, Polymer Sci Unit, Kolkata 700032, India.
   [Patil, Sachin; Sathaye, Sadhana] Inst Chem Technol, Bombay 400031, Maharashtra, India.
   [Chowdhury, Arindam] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India.
   [Das, Subhadeep] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India.
RP Maji, SK (reprint author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
EM samirmaji@iitb.ac.in
RI Malik, Sudip/B-3340-2008; Das, Subhadeep/J-4038-2016
OI Malik, Sudip/0000-0001-5358-5653; Sen, Shamik/0000-0002-8639-8659; Das,
   Subhadeep/0000-0003-1870-8456
FU IRCC (IIT Bombay); CSIR [37(1404)/10/EMR-II]; DST, Government of India
   [SR/FT/LS-032/2009]; UGC (Govt. of India)
FX Authors wish to acknowledge IRCC (IIT Bombay), CSIR (37(1404)/10/EMR-II)
   and DST (SR/FT/LS-032/2009), Government of India for financial support
   and cell biology lab (BSBE, IIT Bombay) for fluorescence imaging,
   CRNTS/IRCC central facilities for FEG SEM, FTIR, AFM and TIFR Mumbai for
   NMR facility. R.S.J and D.G acknowledge UGC (Govt. of India) for their
   fellowship, Srivastav Ranganathan and Saikat Ghosh for schematics and
   Dr. Shimul Salot and Roshni Ramachandran for giving critical comments
   during manuscript preparation. Authors also acknowledge Prof. D. Teplow,
   UCLA, Prof. R. Riek, ETH Zurich, Prof Rein Ulijn, University of
   Strathclyde Glasgow for their valuable suggestions.
CR Adams DJ, 2010, SOFT MATTER, V6, P1971, DOI 10.1039/b921863g
   Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Bhak G, 2010, BIOMATERIALS, V31, P5986, DOI 10.1016/j.biomaterials.2010.03.080
   Bolisetty S, 2012, BIOMACROMOLECULES, V13, P3241, DOI 10.1021/bm301005w
   Bolisetty S, 2012, ADV FUNCT MATER, V22, P3424, DOI 10.1002/adfm.201103054
   Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203
   Bongiovanni MN, 2011, BIOMATERIALS, V32, P6099, DOI 10.1016/j.biomaterials.2011.05.021
   Carrotta R, 2005, J BIOL CHEM, V280, P30001, DOI 10.1074/jbc.M500052200
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484
   Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fast JL, 2009, BIOCHEMISTRY-US, V48, P11724, DOI 10.1021/bi900853v
   Fichman G, 2014, ACTA BIOMATER, V10, P1671, DOI 10.1016/j.actbio.2013.08.013
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Fukuhara S, 2012, BIOCHEMISTRY-US, V51, P5394, DOI 10.1021/bi3004236
   Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Gras SL, 2009, ADV CHEM ENG, V35, P161, DOI 10.1016/S0065-2377(08)00206-8
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hamedi M, 2008, NANO LETT, V8, P1736, DOI 10.1021/nl0808233
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Herland A, 2005, ADV MATER, V17, P1466, DOI 10.1002/adma.200500183
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001
   Klunk WE, 1999, METHOD ENZYMOL, V309, P285
   Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/NNANO.2010.26, 10.1038/nnano.2010.26]
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a
   LeVine H, 1999, METHOD ENZYMOL, V309, P274
   Li CX, 2014, ADV MATER, V26, P3207, DOI 10.1002/adma.201306198
   Li CX, 2013, ADV MATER, V25, P1010, DOI 10.1002/adma.201203382
   Li CX, 2012, NAT NANOTECHNOL, V7, P421, DOI [10.1038/NNANO.2012.62, 10.1038/nnano.2012.62]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017
   Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155
   Mankar S., 2011, NANO REV, V2
   Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Owczarz M, 2015, J COLLOID INTERF SCI, V437, P244, DOI 10.1016/j.jcis.2014.09.022
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Pek YS, 2008, NAT NANOTECHNOL, V3, P671, DOI 10.1038/nnano.2008.270
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Raeburn J, 2015, SOFT MATTER, V11, P927, DOI 10.1039/c4sm02256d
   Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139
   Reynolds NP, 2014, BIOMACROMOLECULES, V15, P599, DOI 10.1021/bm401646x
   Reynolds NP, 2013, BIOMACROMOLECULES, V14, P2305, DOI 10.1021/bm400430t
   Ryan DM, 2012, POLYM CHEM-UK, V3, P18, DOI 10.1039/c1py00335f
   Sasso L, 2014, NANOSCALE, V6, P1629, DOI 10.1039/c3nr05752f
   Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cellbio.10.1.373
   Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203
   Singh PK, 2012, CELL BIOCHEM BIOPHYS, V64, P29, DOI 10.1007/s12013-012-9364-z
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Stupp SI, 2013, FARADAY DISCUSS, V166, P9, DOI 10.1039/c3fd00120b
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Tang C, 2011, LANGMUIR, V27, P14438, DOI 10.1021/la202113j
   Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869
   Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075727
   Westermark GT, 1999, METHOD ENZYMOL, V309, P3
   WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170
   Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108
   Yan H, 2008, FARADAY DISCUSS, V139, P71, DOI 10.1039/b717748h
   Yemini M, 2005, ANAL CHEM, V77, P5155, DOI 10.1021/ac050414g
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
NR 83
TC 45
Z9 46
U1 16
U2 290
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 54
BP 97
EP 105
DI 10.1016/j.biomaterials.2015.03.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI2QD
UT WOS:000354591200010
PM 25907043
DA 2018-10-19
ER

PT J
AU Parmar, PA
   Chow, LW
   St-Pierre, JP
   Horejs, CM
   Peng, YY
   Werkmeister, JA
   Ramshaw, JAM
   Stevens, MM
AF Parmar, Paresh A.
   Chow, Lesley W.
   St-Pierre, Jean-Philippe
   Horejs, Christine-Maria
   Peng, Yong Y.
   Werkmeister, Jerome A.
   Ramshaw, John A. M.
   Stevens, Molly M.
TI Collagen-mimetic peptide-modifiable hydrogels for articular cartilage
   regeneration
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Mesenchymal stem cell; Biodegradation; Bioactivity; Biomimetic
   material; Cartilage tissue engineering
ID MATRIX METALLOPROTEINASE-7 MATRILYSIN; TISSUE ENGINEERING APPLICATIONS;
   STREPTOCOCCUS-PYOGENES; ENCAPSULATING CHONDROCYTES; POLY(ETHYLENE
   GLYCOL); CELL ENCAPSULATION; PEG HYDROGELS; PROTEIN; BIOMATERIALS;
   DEGRADATION
AB Regenerative medicine strategies for restoring articular cartilage face significant challenges to recreate the complex and dynamic biochemical and biomechanical functions of native tissues. As an approach to recapitulate the complexity of the extracellular matrix, collagen-mimetic proteins offer a modular template to incorporate bioactive and biodegradable moieties into a single construct. We modified a Streptococcal collagen-like 2 protein with hyaluronic acid (HA) or chondroitin sulfate (CS)-binding peptides and then cross-linked with a matrix metalloproteinase 7 (MMP7)-sensitive peptide to form biodegradable hydrogels. Human mesenchymal stem cells (hMSCs) encapsulated in these hydrogels exhibited improved viability and significantly enhanced chondrogenic differentiation compared to controls that were not functionalized with glycosaminoglycan-binding peptides. Hydrogels functionalized with CS-binding peptides also led to significantly higher MMP7 gene expression and activity while the HA-binding peptides significantly increased chondrogenic differentiation of the hMSCs. Our results highlight the potential of this novel biomaterial to modulate cell-mediated processes and create functional tissue engineered constructs for regenerative medicine applications. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Parmar, Paresh A.; Chow, Lesley W.; St-Pierre, Jean-Philippe; Horejs, Christine-Maria; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Parmar, Paresh A.; Chow, Lesley W.; St-Pierre, Jean-Philippe; Horejs, Christine-Maria; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England.
   [Parmar, Paresh A.; Chow, Lesley W.; St-Pierre, Jean-Philippe; Horejs, Christine-Maria; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
   [Parmar, Paresh A.; Peng, Yong Y.; Werkmeister, Jerome A.; Ramshaw, John A. M.] CSIRO Mfg Flagship, Clayton, Vic 3169, Australia.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Exhibit Rd, London SW7 2AZ, England.
EM m.stevens@imperial.ac.uk
OI Horejs, Christine-Maria/0000-0002-8614-7737
FU Australian Commonwealth Scientific and Industrial Research Organisation
   (CSIRO) in the Manufacturing Flagship; Medical Engineering Solutions in
   Osteoarthritis Centre of Excellence - Wellcome Trust [088844]; UK
   Regenerative Medicine Platform Hub "Acellular Approaches for Therapeutic
   Delivery" - Medical Research Council [MR/K026682/1]; Engineering and
   Physical Sciences Research Council; Biotechnology and Biological
   Sciences Research Council; ERC; Wellcome Trust Senior Investigator Award
   [098411/Z/12/Z]; Medical Research Council [MR/K026682/1]
FX Our work was supported and funded by the Australian Commonwealth
   Scientific and Industrial Research Organisation (CSIRO) in the
   Manufacturing Flagship and the Medical Engineering Solutions in
   Osteoarthritis Centre of Excellence funded by the Wellcome Trust
   (088844). Prof. M.M. Stevens and Dr. C.-M. Horejs are supported by the
   UK Regenerative Medicine Platform Hub "Acellular Approaches for
   Therapeutic Delivery" (MR/K026682/1), which is funded by the Medical
   Research Council, the Engineering and Physical Sciences Research Council
   and the Biotechnology and Biological Sciences Research Council. Prof. M.
   M. Stevens thanks the ERC consolidator grant "Naturale-CG" and a
   Wellcome Trust Senior Investigator Award (098411/Z/12/Z) for funding.
   The authors would also like to acknowledge the Chemistry Mass
   Spectrometry, NMR and CD Facilities, Harvey Flower Microstructural
   Characterization Suite, Dr. R. V. Law for help with NMR analysis, J. A.
   M. Steele for help with histology and immunohistochemistry, and Dr. E.
   T. Pashuck for help with the cyclic RGDS peptide synthesis.
CR Appelman TP, 2011, BIOMATERIALS, V32, P1508, DOI 10.1016/j.biomaterials.2010.10.017
   Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514
   Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Butterfield Karen Chao, 2011, Biomatter, V1, P174, DOI 10.4161/biom.18791
   Centers for Disease Control and Prevention (CDC), 2005, MMWR-MORBID MORTAL W, V2009, P421
   Chow LW, 2014, ADV HEALTHC MATER, V3, P1381, DOI 10.1002/adhm.201400032
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Cremer KA, 1998, J MOL MED, V76, P275
   Feng Q, 2014, PLOS ONE, V9
   Flannery AV, PROTEOLYTIC ENZYMES
   Guo Y, 2012, J MATER SCI-MATER M, V23, P2267, DOI 10.1007/s10856-012-4684-5
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Ii M, 2006, EXP BIOL MED, V231, P20
   IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691
   Khire VS, 2007, MACROMOLECULES, V40, P5669, DOI 10.1021/ma070146j
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEFEBVRE V, 1995, J CELL BIOL, V128, P239, DOI 10.1083/jcb.128.1.239
   Levesque SG, 2007, BIOCONJUGATE CHEM, V18, P874, DOI 10.1021/bc0602127
   Liu SQ, 2010, BIOMATERIALS, V31, P631
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   McCullen SD, 2011, CURR OPIN BIOTECH, V22, P715, DOI 10.1016/j.copbio.2011.05.001
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898
   Peng YY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-146
   Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040
   Perez CMR, 2011, MACROMOL BIOSCI, V11, P1426, DOI 10.1002/mabi.201100230
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Place ES, 2012, ADV HEALTHC MATER, V1, P480, DOI 10.1002/adhm.201200038
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984
   Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Rice MA, 2004, J BIOMED MATER RES A, V70A, P560, DOI 10.1002/jbm.a.30106
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Roberts JJ, 2014, BIOMACROMOLECULES, V15, P1132, DOI 10.1021/bm401524h
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01
   St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Wang QG, 2010, EUR CELLS MATER, V19, P86, DOI 10.22203/eCM.v019a09
   Werkmeister JA, 2012, BIOMED MATER, V7, P1
   Wilkinson JM, PRACTICAL PROTEIN CH
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Zhen EY, 2008, ARTHRITIS RHEUM, V58, P2420, DOI 10.1002/art.23654
NR 54
TC 47
Z9 49
U1 5
U2 142
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 54
BP 213
EP 225
DI 10.1016/j.biomaterials.2015.02.079
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI2QD
UT WOS:000354591200021
PM 25907054
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Wang, QN
   Jin, Y
   Deng, XY
   Liu, HP
   Pang, HW
   Shi, PP
   Zhan, ZG
AF Wang, Qiannan
   Jin, Ying
   Deng, Xiaoyuan
   Liu, Hanping
   Pang, Hongwen
   Shi, Panpan
   Zhan, Zhigang
TI Second-harmonic generation microscopy for assessment of mesenchymal
   stern cell-seeded acellular dermal matrix in wound-healing
SO BIOMATERIALS
LA English
DT Article
DE Wound healing; Acellular dermal matrix (ADM); Mesenchymal stem cells
   (MSCs); Two-photon fluorescence (TPF) microscopy; Second-harmonic
   generation (SHG) microscopy
ID IN-VIVO; HUMAN SKIN; IMAGING MICROSCOPY; ANGIOGENESIS; REGENERATION;
   DIFFERENTIATION; EQUIVALENTS; TOMOGRAPHY; RESOLUTION; DELIVERY
AB Direct intra-skin injection of mesenchymal stem cells (MSCs) and the use of biomaterial scaffolds for grafts are both promising approaches of skin wound repair, however they still cannot generate skin that completely resembles the natural skin structures. In this study, we combined these two approaches by using acellular dermal matrix (ADM) recellularized with MSCs to repair cutaneous wounds in a murine model and two-photon fluorescence (TPF) microscopy and second-harmonic generation (SHG) microscopy to assess the effects of this therapy on wound healing. Bone marrow-derived mesenchymal stem cells (BM-MSCs) were tagged with GFP and seeded into ADM (ADM-MSC) via MSC and ADM co-culture. ADM-MSC, ADM or saline was applied to murine excisional skin wounds and wound-healing was evaluated by histological examination on days 7, 14, 21 and TFP microscopy on days 1, 3, 5 and 21 post-treatment. ADM-MSC promoted healing significantly more than treatment with ADM or saline alone, as it led to substantial neovascularization and complete skin appendage regeneration. Furthermore, the SHG microscopic imaging technique proved to be a useful tool for monitoring changes in the collagen network at the wound site during the healing process and assessing the effects of different therapies. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Wang, Qiannan; Jin, Ying; Deng, Xiaoyuan; Liu, Hanping; Shi, Panpan; Zhan, Zhigang] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.
   [Deng, Xiaoyuan] S China Normal Univ, Res Resources Ctr, Guangzhou, Guangdong, Peoples R China.
   [Pang, Hongwen] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.
RP Jin, Y (reprint author), S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.
EM jinying@scnu.edu.cn; xydeng12@126.com
FU National Natural Science Foundation of China [81171379]; CAS [yg2012048]
FX This work was supported by the National Natural Science Foundation of
   China (No.81171379) and Instrument functional development and
   technological innovation projects of CAS (No.yg2012048).
CR ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J
   Boyd NL, 2013, TISSUE ENG PT A, V19, P211, DOI 10.1089/ten.tea.2011.0408
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Campagnola PJ, 2001, J BIOMED OPT, V6, P277, DOI 10.1117/1.1383294
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008
   Chun JL, 2013, STEM CELL TRANSL MED, V2, P68, DOI 10.5966/sctm.2012-0107
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Cubison TCS, 2006, BURNS, V32, P992, DOI 10.1016/j.burns.2006.02.007
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Feng YP, 2014, NEURAL REGEN RES, V9, P1968, DOI 10.4103/1673-5374.145378
   FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818
   Huang SP, 2012, ANN PLAS SURG, V69, P656, DOI 10.1097/SAP.0b013e318273f909
   Koehler MJ, 2006, OPT LETT, V31, P2879, DOI 10.1364/OL.31.002879
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349
   Ma AL, 2013, INT IMMUNOPHARMACOL, V16, P399, DOI 10.1016/j.intimp.2013.02.005
   Masters BR, 2001, OPT EXPRESS, V8, P2, DOI 10.1364/OE.8.000002
   Mathieu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051991
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122
   Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033
   Palero JA, 2006, OPT EXPRESS, V14, P4395, DOI 10.1364/OE.14.004395
   Portmann-Lanz CB, 2007, PLACENTA, V28, P6, DOI 10.1016/j.placenta.2006.01.004
   Rennert R. C., 2013, INT J BIOMATER, V2013
   Schneider RK, 2010, DIFFERENTIATION, V79, P182, DOI 10.1016/j.diff.2010.01.005
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Schneider RKM, 2008, DIFFERENTIATION, V76, P156, DOI 10.1111/j.1432-0436.2007.00204.x
   Sharma RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031504
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108
   Vishnubalaji R, 2012, CELL TISSUE RES, V350, P1, DOI 10.1007/s00441-012-1471-z
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Zhang XJ, 2009, BIOMATERIALS, V30, P2666, DOI 10.1016/j.biomaterials.2009.01.018
   Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
NR 40
TC 14
Z9 14
U1 2
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 659
EP 668
DI 10.1016/j.biomaterials.2015.03.011
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800061
PM 25890761
DA 2018-10-19
ER

PT J
AU Rooney, P
   Srivastava, A
   Watson, L
   Quinlan, LR
   Pandit, A
AF Rooney, Peadar
   Srivastava, Akshay
   Watson, Luke
   Quinlan, Leo R.
   Pandit, Abhay
TI Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an
   inflammatory model of interstitial cystitis
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hyaluronan; Interstitial cystitis; Inflammation; Permeability; Cytokine
ID BLADDER SYNDROME; GLYCOSAMINOGLYCAN EXCRETION; SULFATED
   GLYCOSAMINOGLYCANS; ANTIPROLIFERATIVE FACTOR; NONBACTERIAL CYSTITIS;
   CHONDROITIN SULFATE; TIGHT JUNCTIONS; URINE MARKERS; INTERLEUKIN-6;
   DERIVATIVES
AB Hyaluronic acid (HA) has received a lot of attention recently as a biomaterial with applications in wound healing, drug delivery, vascular repair and cell and/or gene delivery. Interstitial cystitis (IC) is characterised by an increase in the permeability of the bladder wall urothelium due to loss of the glycosaminoglycan (GAG) layer. The degradation of the urothelium leads to chronic pain and urinary dysfunction. The aetiology of the degradation of the GAG layer in this instance is currently unknown. At a clinical level, GAG replacement therapy using a HA solution is currently utilised as a treatment for IC. However, there is a significant lack of data on the mechanism of action of HA in IC. The current study investigates the mechanistic effect of clinically relevant HA treatment on an in vitro model of IC using urothelial cells, examining cytokine secretion, GAG secretion and trans-epithelial permeability. This study demonstrates that HA can significantly decrease induced cytokine secretion (4-5 fold increase), increase sulphated GAG production (2-fold increase) and without altering tight junction expression, decrease trans-epithelial permeability, suggesting that the HA pathway is a clinical target and potential treatment vector. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rooney, Peadar; Srivastava, Akshay; Watson, Luke; Pandit, Abhay] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Quinlan, Leo R.] Natl Univ Ireland, Physiol Sch Med, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
EM Abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Rooney, Peadar/0000-0003-3119-3928;
   Quinlan, Leo/0000-0002-4011-6732
FU Enterprise Ireland [IP/2011/0096]
FX This work was funded with Enterprise Ireland Grant IP/2011/0096.
CR Akcay T., 1999, International Urology and Nephrology, V31, P431, DOI 10.1023/A:1007198708404
   Bresnihan B, 2007, ANN RHEUM DIS, V66, P1656, DOI 10.1136/ard.2006.061143
   Buffington CAT, 1996, J UROLOGY, V155, P1801, DOI 10.1016/S0022-5347(01)66201-3
   Chancellor Michael B, 2007, Rev Urol, V9, P81
   Cheng C, 2012, INT UROGYNECOL J, V23, P1361, DOI 10.1007/s00192-012-1711-5
   Erickson DR, 2008, J UROLOGY, V179, P1850, DOI 10.1016/j.juro.2008.01.047
   Erickson DR, 1997, J UROLOGY, V157, P61, DOI 10.1016/S0022-5347(01)65280-7
   Erickson DR, 1998, J UROLOGY, V160, P1282, DOI 10.1016/S0022-5347(01)62516-3
   Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7
   Fasano A, 2000, ANN NY ACAD SCI, V915, P214
   Frank J, 2003, EUR J TRAUMA, V29, P208
   Garcia Y, 2007, BIOMATERIALS, V28, P175, DOI 10.1016/j.biomaterials.2006.08.037
   Ghazi K., 2012, PLOS ONE, V7, P48351
   Gibson PR, 2004, GUT, V53, P1724, DOI 10.1136/gut.2004.047092
   Green M, 2004, UROLOGY, V63, P688, DOI 10.1016/j.urology.2003.11.022
   Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064
   Held P, 1990, INTERSTITIAL CYSTITI, P29
   HURST RE, 1993, J UROLOGY, V149, P31, DOI 10.1016/S0022-5347(17)35990-6
   Hurst RE, 1996, J UROLOGY, V4295, P817
   Janssen DAW, 2013, J UROLOGY, V189, P336, DOI 10.1016/j.juro.2012.09.022
   Kallestrup EB, 2005, SCAND J UROL NEPHROL, V39, P143, DOI 10.1080/00365590410015876
   Keay S, 1999, J UROLOGY, V162, P1487, DOI 10.1016/S0022-5347(05)68345-0
   Keay S, 2011, CHEM BIOL DRUG DES, V77, P421, DOI 10.1111/j.1747-0285.2011.01108.x
   Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390
   Koskela LR, 2008, J UROLOGY, V180, P737, DOI 10.1016/j.juro.2008.03.184
   Kuo H-C, 2012, PLOS ONE, V7
   Lamale LM, 2006, UROLOGY, V68, P702, DOI 10.1016/j.urology.2006.04.033
   Lokeshwar VB, 2005, J UROLOGY, V174, P344, DOI 10.1097/01.ju.0000161599.69942.2e
   LOTZ M, 1994, J UROLOGY, V152, P869, DOI 10.1016/S0022-5347(17)32594-6
   Lv YS, 2013, INT J UROL, V20, P1017, DOI 10.1111/iju.12090
   Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003
   Markham T, 2006, J AM ACAD DERMATOL, V54, P1003, DOI 10.1016/j.jaad.2006.01.038
   MARTINS SM, 1994, J UROLOGY, V151, P1198, DOI 10.1016/S0022-5347(17)35212-6
   Moldwin RM, 2007, UROLOGY, V69, P73, DOI 10.1016/j.urology.2006.08.1105
   Nickel JC, 2010, UROLOGY, V76, P804, DOI 10.1016/j.urology.2010.03.016
   Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10
   PARSONS CL, 1991, J UROLOGY, V145, P732, DOI 10.1016/S0022-5347(17)38437-9
   Peters KM, 1999, UROLOGY, V54, P450, DOI 10.1016/S0090-4295(99)00162-4
   Rosenberg MT, 2005, J UROLOGY, V174, P2231, DOI 10.1097/01.ju.0000181203.82693.95
   Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x
   Slobodov G, 2007, J UROLOGY, V171, P945
   Smaldone MC, 2009, UROLOGY, V73, P2
   Soler R, 2008, INT BRAZ J UROL, V34, P503, DOI 10.1590/S1677-55382008000400013
   Tseng-Rogenski S, 2009, AM J PHYSIOL-RENAL, V297, pF816, DOI 10.1152/ajprenal.90733.2008
   Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034
   Valent P, 1995, Exp Dermatol, V4, P255, DOI 10.1111/j.1600-0625.1995.tb00254.x
   Voigt J, 2012, WOUND REPAIR REGEN, V20, P317, DOI 10.1111/j.1524-475X.2012.00777.x
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Wang WL, 2000, J CELL SCI, V113, P4435
   Wei DC, 2000, J UROLOGY, V163, P1577, DOI 10.1016/S0022-5347(05)67682-3
   Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99
NR 51
TC 18
Z9 18
U1 2
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2015
VL 19
BP 66
EP 75
DI 10.1016/j.actbio.2015.02.030
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH6NA
UT WOS:000354152100008
PM 25818949
DA 2018-10-19
ER

PT J
AU Kasetty, G
   Kalle, M
   Morgelin, M
   Brune, JC
   Schmidtchen, A
AF Kasetty, Gopinath
   Kalle, Martina
   Morgelin, Matthias
   Brune, Jan C.
   Schmidtchen, Artur
TI Anti-endotoxic and antibacterial effects of a dermal substitute coated
   with host defense peptides
SO BIOMATERIALS
LA English
DT Article
DE Host defense peptides; Epiflex; Human acellular dermis; Antimicrobial;
   Inflammation
ID ACUTE INFLAMMATORY RESPONSES; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY;
   INFECTIOUS COMPLICATIONS; BREAST RECONSTRUCTION; BIOMATERIAL SURFACES;
   EXTRACELLULAR-MATRIX; IN-VITRO; ACTIVATION; POLYPEPTIDES
AB Biomaterials used during surgery and wound treatment are of increasing importance in modern medical care. In the present study we set out to evaluate the addition of thrombin-derived host defense peptides to human acellular dermis (hAD, i.e. epiflex (R)). Antimicrobial activity of the functionalized hAD was demonstrated using radial diffusion and viable count assays against Gram-negative Escherichia coil, Pseudornonas aeruginosa and Gram-positive Staphylococcus aureus bacteria. Electron microscopy analyses showed that peptide-mediated bacterial killing led to reduced hAD degradation. Furthermore, peptide-functionalized hAD displayed endotoxin-binding activity in vitro, as evidenced by inhibition of NF-kappa B activation in human monocytic cells (THP-1 cells) and a reduction of pro-inflammatory cytokine production in whole blood in response to lipopolysaccharide stimulation. The dermal substitute retained its anti-endotoxic activity after washing, compatible with results showing that the MD bound a significant amount of peptide. Furthermore, bacteria-induced contact activation was inhibited by peptide addition to the hAD. E. coli infected MD, alone, or after treatment with the antiseptic substance poly-hexamethylenebiguanide (PHMB), yielded NF-kappa B activation in THP-1 cells. The activation was abrogated by peptide addition. Thus, thrombin-derived HDPs should be of interest in the further development of new biomaterials with combined antimicrobial and anti-endotoxic functions for use in surgery and wound treatment. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Kasetty, Gopinath; Kalle, Martina; Schmidtchen, Artur] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, SE-22184 Lund, Sweden.
   [Kasetty, Gopinath] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Resp Med & Allergol, SE-22184 Lund, Sweden.
   [Morgelin, Matthias] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden.
   [Brune, Jan C.] Deutsch Inst Zell & Gewebeersatz gGmbH, Berlin, Germany.
   [Schmidtchen, Artur] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore.
RP Kasetty, G (reprint author), Tornavagen 10, SE-22184 Lund, Sweden.
EM gopinath.kasetty@med.lu.se
RI Schmidtchen, Artur/F-9507-2015
FU Swedish Research Council [2012-1883]; Vinnova; Torsten Soderberg;
   Welander-Finsen; Knut and Alice Wallenberg; Crafoord; Osterlund; Kock
   Foundations; Swedish Government Funds for Clinical Research (ALF)
FX We thank Dr. Mark D. Smith from the German Institute for Cell and Tissue
   Replacement (DIZG) for support, stimulating discussions, and valuable
   input and comments on the final manuscript. This work was supported by
   grants from the Swedish Research Council (project 2012-1883), Vinnova,
   Torsten Soderberg, the Welander-Finsen, Knut and Alice Wallenberg,
   Crafoord, Osterlund, Kock Foundations, and The Swedish Government Funds
   for Clinical Research (ALF).
CR Alessandro Bistolfi GM, 2011, ISRN ORTHOP, V2011, P8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Dobbins BM, 2002, J CLIN PATHOL, V55, P824, DOI 10.1136/jcp.55.11.824
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hill JL, 2012, ANN PLAS SURG, V68, P432, DOI 10.1097/SAP.0b013e31823b6ac6
   Kalle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051313
   Kasetty G, 2011, J INNATE IMMUN, V3, P471, DOI 10.1159/000327016
   Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10
   LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7
   Lindman JP, 2006, ARCH FACIAL PLAST S, V8, P208, DOI 10.1001/archfaci.8.3.208
   Liu DZ, 2014, ANN PLAS SURG, V72, P503, DOI 10.1097/SAP.0b013e318268a87c
   Lundqvist K, 2004, THROMB HAEMOSTASIS, V92, P281, DOI 10.1160/TH03-12-0732
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101
   Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200
   Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y
   Orenstein S, 2010, J SURG RES, V158, P10, DOI 10.1016/j.jss.2009.05.033
   Orenstein SB, 2010, SURG ENDOSC, V24, P805, DOI 10.1007/s00464-009-0664-3
   Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019
   Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857
   Rossner E, 2011, CELL TISSUE BANK, V12, P209, DOI 10.1007/s10561-010-9187-3
   Roessner ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045991
   Schommer NN, 2013, TRENDS MICROBIOL, V21, P660, DOI 10.1016/j.tim.2013.10.001
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Tang L, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thierry B, 2008, LANGMUIR, V24, P11834, DOI 10.1021/la801359w
   Tossi A, 2000, BIOPOLYMERS, V55, P4
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580
   Weichman KE, 2013, PLAST RECONSTR SURG, V132, P725, DOI 10.1097/PRS.0b013e31829fe35b
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yeaman MR, 2002, ANTIMICROB AGENTS CH, V46, P3883
   Yu K, 2014, COLLOID SURFACE B, V124, P69, DOI 10.1016/j.colsurfb.2014.08.009
   Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147
NR 49
TC 6
Z9 6
U1 0
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 415
EP 425
DI 10.1016/j.biomaterials.2015.02.111
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800039
PM 25890739
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Zhu, Y
   Jiang, H
   Ye, SH
   Yoshizumi, T
   Wagner, WR
AF Zhu, Yang
   Jiang, Hongbin
   Ye, Sang-Ho
   Yoshizumi, Tomo
   Wagner, William R.
TI Tailoring the degradation rates of thermally responsive hydrogels
   designed for soft tissue injection by varying the autocatalytic
   potential
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Thermally responsive material; Degradation; Heart
ID BLOCK-COPOLYMER HYDROGELS; IN-VITRO DEGRADATION; HYDROLYTIC DEGRADATION;
   N-ISOPROPYLACRYLAMIDE; DRUG-DELIVERY; BIODEGRADABLE POLYMERS;
   POLY(ETHYLENE GLYCOL); PLGA MICROSPHERES; ACID) HYDROGELS; TEMPERATURE
AB The ability to modulate the degradation properties of biomaterials such as thermally responsive hydrogels is desirable when exploring new therapeutic strategies that rely on the temporary presence of a placed scaffold or gel. Here we report a method of manipulating the absorption rate of a poly(N-isopropylacrylamide) ((poly(NIPAAm)) based hydrogel across a wide range (from 1 d to 5 mo) by small alterations in the composition. Relying upon the autocatalytic effect, the degradation of poly(NIPAAm-co-HEMA-co-MAPLA), (HEMA = 2-hydroxyethyl methacrylate; MAPLA = methacrylate-polylactide) was greatly accelerated by adding a fourth monomer methacrylic acid (MAA) at no more than 2 mol% to obtain poly(NIPAAm-co-HEMA-co-MAPLA-co-MAA) (pNHMMj) where j reflects the MM molar % in the reactant mixture. MAA residue introduction decreased the pH inside the hydrogels and in surrounding buffered solutions. Accelerated degradation positively, correlated with MM content in pNHMMj polymers, putatively by the accelerated cleavage of MAPLA residues to raise the transition temperature of the polymer above body temperature. Physical properties including thermal transition behavior and initial mechanical strength did not vary significantly with MM content. A rat hindlimb injection model generally reflected the in vitro observation that higher MAA content resulted in more rapid degradation and cellular infiltration. The strategy of tuning the degradation of thermally responsive hydrogels where degradation or solubilization is determined by their polyester components might be applied to other tissue engineering and regenerative medicine applications where designed biomaterial degradation behavior is needed. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Zhu, Yang; Jiang, Hongbin; Ye, Sang-Ho; Yoshizumi, Tomo; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Zhu, Yang; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Ye, Sang-Ho; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI Ye, Sang-Ho/H-5294-2011
OI Ye, Sang-Ho/0000-0002-4760-9812; Zhu, Yang/0000-0002-7384-607X
FU US National Institutes of Health [R01 HL105911]
FX The financial support for this work by the US National Institutes of
   Health (grant R01 HL105911) is gratefully acknowledged.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Cui ZW, 2010, J BIOMAT SCI-POLYM E, V21, P913, DOI 10.1163/156856209X451323
   Druecke D, 2004, WOUND REPAIR REGEN, V12, P518, DOI 10.1111/j.1067-1927.2004.012504.x
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Holloway JL, 2014, J CONTROL RELEASE, V191, P63, DOI 10.1016/j.jconrel.2014.05.053
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kumashiro Y, 2004, MACROMOL RAPID COMM, V25, P867, DOI 10.1002/marc.200300279
   Lee BH, 2005, MACROMOL BIOSCI, V5, P629, DOI 10.1002/mabi.200500029
   Lee BH, 2005, POLYM INT, V54, P418, DOI 10.1002/pi.1709
   Li Z, 2009, BIOMACROMOLECULES, V10, P3306, DOI 10.1021/bm900900e
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nikouei NS, 2011, ACTA BIOMATER, V7, P3708, DOI 10.1016/j.actbio.2011.05.035
   Nishio S, 2014, CIRCULATION, V129, P534, DOI 10.1161/CIRCULATIONAHA.113.003769
   Overstreet DJ, 2010, BIOMACROMOLECULES, V11, P1154, DOI 10.1021/bm100035f
   Park M. H., 2011, ACCOUNTS CHEM RES, V45, P424, DOI DOI 10.1021/AR200162J
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Potta T, 2011, POLYM DEGRAD STABIL, V96, P1261, DOI 10.1016/j.polymdegradstab.2011.04.010
   Qiu YZ, 2011, ACTA BIOMATER, V7, P959, DOI 10.1016/j.actbio.2010.11.002
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111
   Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k
   Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673
   SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Vakkalanka SK, 1996, POLYM BULL, V36, P221, DOI 10.1007/BF00294910
   Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
   Zhang Y, 1997, J BIOMED MATER RES, V34, P531, DOI 10.1002/(SICI)1097-4636(19970315)34:4<531::AID-JBM13>3.0.CO;2-F
   Zolnik BS, 2007, J CONTROL RELEASE, V122, P338, DOI 10.1016/j.jconrel.2007.05.034
NR 56
TC 11
Z9 12
U1 2
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 484
EP 493
DI 10.1016/j.biomaterials.2015.02.100
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800045
PM 25890745
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Qazi, TH
   Mooney, DJ
   Pumberger, M
   Geissler, S
   Duda, GN
AF Qazi, Taimoor H.
   Mooney, David J.
   Pumberger, Matthias
   Geissler, Sven
   Duda, Georg N.
TI Biomaterials based strategies for skeletal muscle tissue engineering:
   Existing technologies and future trends
SO BIOMATERIALS
LA English
DT Review
DE Progenitor cells; Hydrogels; Patterned scaffolds; In situ regeneration;
   Vascularization; Innervation
ID MESENCHYMAL STEM-CELLS; CHRONIC ELECTRICAL-STIMULATION; MYOBLAST
   TRANSFER THERAPY; HINDLIMB ISCHEMIA MODEL; HYBRID MUSCULAR TISSUES;
   FAST-TWITCH MUSCLE; RAT ANIMAL-MODEL; IN-VITRO MODEL; SATELLITE CELLS;
   EXTRACELLULAR-MATRIX
AB Skeletal muscles have a robust capacity to regenerate, but under compromised conditions, such as severe trauma, the loss of muscle functionality is inevitable. Research carried out in the field of skeletal muscle tissue engineering has elucidated multiple intrinsic mechanisms of skeletal muscle repair, and has thus sought to identify various types of cells and bioactive factors which play an important role during regeneration. In order to maximize the potential therapeutic effects of cells and growth factors, several biomaterial based strategies have been developed and successfully implemented in animal muscle injury models. A suitable biomaterial can be utilized as a template to guide tissue reorganization, as a matrix that provides optimum micro-environmental conditions to cells, as a delivery vehicle to carry bioactive factors which can be released in a controlled manner, and as local niches to orchestrate in situ tissue regeneration. A myriad of biomaterials, varying in geometrical structure, physical form, chemical properties, and biofunctionality have been investigated for skeletal muscle tissue engineering applications. In the current review, we present a detailed summary of studies where the use of biomaterials favorably influenced muscle repair. Biomaterials in the form of porous three-dimensional scaffolds, hydrogels, fibrous meshes, and patterned substrates with defined topographies, have each displayed unique benefits, and are discussed herein. Additionally, several biomaterial based approaches aimed specifically at stimulating vascularization, innervation, and inducing contractility in regenerating muscle tissues are also discussed. Finally, we outline promising future trends in the field of muscle regeneration involving a deeper understanding of the endogenous healing cascades and utilization of this knowledge for the development of multifunctional, hybrid, biomaterials which support and enable muscle regeneration under compromised conditions. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Qazi, Taimoor H.; Geissler, Sven; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Qazi, Taimoor H.; Pumberger, Matthias; Geissler, Sven; Duda, Georg N.] Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany.
   [Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Pumberger, Matthias] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
   [Geissler, Sven; Duda, Georg N.] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
RP Duda, GN (reprint author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
EM taimoor.qazi@charite.de; mooneyd@seas.harvard.edu;
   Matthias.Pumberger@charite.de; sven.geissler@charite.de;
   Georg.Duda@charite.de
RI Duda, Georg/H-2085-2016; Qazi, Taimoor Hasan/I-7675-2015
OI Duda, Georg/0000-0001-7605-3908; Qazi, Taimoor
   Hasan/0000-0002-3132-9170; Geissler, Sven/0000-0002-8750-6324
FU Einstein Foundation Berlin through the Charite-Universitatsmedizin
   Berlin; Berlin-Brandenburg School for Regenerative Therapies [GSC 203];
   Friede Springer Stiftung; Federal Ministry of Education and Research
   through the BCRT; German Research Foundation (DFG) [FOR2165, GE2512/2-1]
FX The authors gratefully acknowledge the award of an Einstein Visiting
   Fellowship to D.J.M by the Einstein Foundation Berlin through the
   Charite-Universitatsmedizin Berlin, and the Berlin-Brandenburg School
   for Regenerative Therapies GSC 203. T.H.Q. wishes to acknowledge the
   Friede Springer Stiftung for financial support. This work was partially
   supported by the Federal Ministry of Education and Research by funding
   through the BCRT, and by the German Research Foundation (DFG) by funding
   through the FOR2165 (grant GE2512/2-1). The funders had no role in the
   review design, data collection, decision to publish, or preparation of
   the manuscript.
CR Ahadian S, 2012, LAB CHIP, V12, P3491, DOI 10.1039/c2lc40479f
   Ashley Z, 2007, J MUSCLE RES CELL M, V28, P203, DOI 10.1007/s10974-007-9119-4
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Auluck A, 2005, EUR J ORAL SCI, V113, P218, DOI 10.1111/j.1600-0722.2005.00215.x
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Bach AD, 2006, J CELL MOL MED, V10, P716, DOI 10.2755/jcmm010.003.14
   Bach AD, 2003, CELL TISSUE RES, V314, P263, DOI 10.1007/s00441-003-0757-6
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Balint R, 2013, TISSUE ENG PART B-RE, V19, P48, DOI [10.1089/ten.TEB.2012.0183, 10.1089/ten.teb.2012.0183]
   Bandyopadhyay B, 2013, BIOTECHNOL PROGR, V29, P197, DOI 10.1002/btpr.1665
   Baylor SM, 2012, J GEN PHYSIOL, V139, P261, DOI 10.1085/jgp.201210773
   Beier JP, 2006, PLAST RECONSTR SURG, V118, P1113, DOI 10.1097/01.prs.0000221007.97115.1d
   Beier JP, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-34
   Bian WN, 2008, IEEE ENG MED BIOL, V27, P109, DOI 10.1109/MEMB.2008.928460
   Bian WN, 2012, FASEB J, V26, P955, DOI 10.1096/fj.11-187575
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028
   BOLDRIN L, 2010, HEALTH TECHNOL ASSES, V14, P941, DOI DOI 10.1369/JHC.2010.956201
   Boldrin L, 2008, CELL TRANSPLANT, V17, P577, DOI 10.3727/096368908785095980
   Boldrin L, 2007, TISSUE ENG, V13, P253, DOI 10.1089/ten.2006.0093
   Borschel GH, 2006, PLAST RECONSTR SURG, V117, P2235, DOI 10.1097/01.prs.0000224295.54073.49
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7
   Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001
   Brady MA, 2008, J TISSUE ENG REGEN M, V2, P408, DOI 10.1002/term.112
   Breukers RD, 2010, J BIOMED MATER RES A, V95A, P256, DOI 10.1002/jbm.a.32822
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Cheema U, 2003, CELL MOTIL CYTOSKEL, V54, P226, DOI 10.1002/cm.10095
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035
   Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761
   Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Cronin EM, 2004, J BIOMED MATER RES A, V69A, P373, DOI 10.1002/jbm.a.30009
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   Darabi R, 2011, STEM CELL REV REP, V7, P948, DOI 10.1007/s12015-011-9258-2
   De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327
   DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31
   Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364
   Dhawan V, 2007, TISSUE ENG, V13, P2813, DOI 10.1089/ten.2007.0003
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Donnelly K, 2010, TISSUE ENG PART C-ME, V16, P711, DOI 10.1089/ten.TEC.2009.0125
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dugan JM, 2013, ACTA BIOMATER, V9, P4707, DOI 10.1016/j.actbio.2012.08.050
   DUSTERHOFT S, 1990, DIFFERENTIATION, V44, P178, DOI 10.1111/j.1432-0436.1990.tb00616.x
   Egusa H, 2013, TISSUE ENG PT A, V19, P770, DOI [10.1089/ten.tea.2012.0164, 10.1089/ten.TEA.2012.0164]
   Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fishman JM, 2013, TISSUE ENG PART B-RE, V19, P503, DOI [10.1089/ten.teb.2013.0120, 10.1089/ten.TEB.2013.0120]
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002
   Fuoco C, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-24
   Geissler S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.501
   Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Glaeser JD, 2010, TISSUE ENG PT A, V16, P3139, DOI [10.1089/ten.tea.2009.0508, 10.1089/ten.TEA.2009.0508]
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   GOLDSPINK DF, 1995, AM J PHYSIOL-ENDOC M, V268, pE288
   GOLDSPINK G, 1992, AM J PHYSIOL, V262, pR356
   Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67
   Grefte S, 2010, REGEN MED, V5, P737, DOI 10.2217/RME.10.69
   Guerette B, 1997, CELL TRANSPLANT, V6, P101, DOI 10.1016/S0963-6897(96)00230-8
   GUERETTE B, 1995, MUSCLE NERVE, V18, P39
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hong Y, 2012, TISSUE ENG PART C-ME, V18, P122, DOI [10.1089/ten.TEC.2011.0295, 10.1089/ten.tec.2011.0295]
   Hosseini V, 2012, TISSUE ENG PT A, V18, P2453, DOI [10.1089/ten.tea.2012.0181, 10.1089/ten.TEA.2012.0181]
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Huang NF, 2010, AM J TRANSL RES, V2, P43
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Huri PY, 2013, BIOCHEM BIOPH RES CO, V438, P180, DOI 10.1016/j.bbrc.2013.07.049
   Jana S, 2013, ADV HEALTHC MATER, V2, P557, DOI 10.1002/adhm.201200177
   JARVINEN MJ, 1993, SPORTS MED, V15, P78
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Kaji H, 2010, BIOMATERIALS, V31, P6981, DOI 10.1016/j.biomaterials.2010.05.071
   Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kharraz Y, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/491497
   Kim Jennifer, 2003, Arch Facial Plast Surg, V5, P403, DOI 10.1001/archfaci.5.5.403
   Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063
   Kim MH, 2010, BIOMATERIALS, V31, P1213, DOI 10.1016/j.biomaterials.2009.10.057
   Kim MS, 2010, MACROMOL BIOSCI, V10, P91, DOI 10.1002/mabi.200900168
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Koponen JK, 2007, MOL THER, V15, P2172, DOI 10.1038/sj.mt.6300302
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Ku SH, 2012, BIOMATERIALS, V33, P6098, DOI 10.1016/j.biomaterials.2012.05.018
   Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Ladd MR, 2011, BIOMATERIALS, V32, P1549, DOI 10.1016/j.biomaterials.2010.10.038
   Langelaan MLP, 2011, J TISSUE ENG REGEN M, V5, P529, DOI 10.1002/term.345
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Larkin LM, 2006, IN VITRO CELL DEV-AN, V42, P75
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liao IC, 2008, CELL MOL BIOENG, V1, P133, DOI 10.1007/s12195-008-0021-y
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu GH, 2013, BIOMATERIALS, V34, P8617, DOI 10.1016/j.biomaterials.2013.07.077
   Liu J, 2012, TISSUE ENG PT A, V18, P2303, DOI [10.1089/ten.tea.2011.0658, 10.1089/ten.TEA.2011.0658]
   Liu J, 2013, ACTA BIOMATER, V9, P4688, DOI 10.1016/j.actbio.2012.08.009
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Ma JQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/812135
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.TEA.2010.0682, 10.1089/ten.tea.2010.0682]
   Malerba A, 2010, NEUROL RES, V32, P55, DOI 10.1179/174313209X380865
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211
   Matziolis G, 2006, TISSUE ENG, V12, P361, DOI 10.1089/ten.2006.12.361
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   McCullen SD, 2011, CURR OPIN BIOTECH, V22, P715, DOI 10.1016/j.copbio.2011.05.001
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Mertens JP, 2014, REGEN MED, V9, P89, DOI [10.2217/RME.13.81, 10.2217/rme.13.81]
   Messina A, 2005, FASEB J, V19, P1570, DOI 10.1096/fj.04-3241fje
   Monge C, 2012, TISSUE ENG PT A, V18, P1664, DOI [10.1089/ten.tea.2012.0079, 10.1089/ten.TEA.2012.0079]
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104
   Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010
   Musina RA, 2006, B EXP BIOL MED+, V141, P147, DOI 10.1007/s10517-006-0115-2
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/ten.2004.10.1093
   NAUMANN K, 1994, DIFFERENTIATION, V55, P203, DOI 10.1046/j.1432-0436.1994.5530203.x
   Neumann T, 2003, TISSUE ENG, V9, P995, DOI 10.1089/107632703322495637
   Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301
   Okano T, 1998, CELL TRANSPLANT, V7, P71, DOI 10.1016/S0963-6897(97)00067-5
   Okano T, 1998, CELL TRANSPLANT, V7, P435, DOI 10.1016/S0963-6897(98)00030-X
   Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.teb.2013.0534, 10.1089/ten.TEB.2013.0534]
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Patz TM, 2005, MAT SCI ENG B-SOLID, V123, P242, DOI 10.1016/j.mseb.2005.08.088
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   Perniconi B, 2011, BIOMATERIALS, V32, P7870, DOI 10.1016/j.biomaterials.2011.07.016
   Pette D, 2002, J MUSCLE RES CELL M, V23, P215, DOI 10.1023/A:1020974710389
   Philippou A, 2012, ADV CLIN CHEM, V58, P49, DOI 10.1016/B978-0-12-394383-5.00010-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001
   Qazi TH, 2014, ACTA BIOMATER, V10, P2434, DOI 10.1016/j.actbio.2014.02.023
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rakus D, 2015, J PROTEOME RES, V14, P1400, DOI 10.1021/pr5010357
   Rangarajan S, 2013, ANN BIOMED ENG, V24, P24
   Reinke S, 2013, SCI TRANSL MED, V5
   Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088
   Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0
   Rhim C, 2007, MUSCLE NERVE, V36, P71, DOI 10.1002/mus.20788
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Salimath AS, 2014, J TISSUE ENG REGEN M
   SANDOW A, 1952, YALE J BIOL MED, V25, P176
   Sassoli Chiara, 2012, Cells, V1, P832, DOI 10.3390/cells1040832
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   Saxena AK, 2001, BIO-MED MATER ENG, V11, P275
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Sempf K, 2013, EUR J PHARM BIOPHARM, V85, P53, DOI 10.1016/j.ejpb.2012.11.030
   Serena E, 2008, NEUROL RES, V30, P207, DOI 10.1179/174313208X281109
   Shadrach JL, 2011, PHILOS T R SOC B, V366, P2297, DOI 10.1098/rstb.2011.0027
   Shah R, 2005, BIOMATERIALS, V26, P1497, DOI 10.1016/j.biomaterials.2004.04.049
   Shah R, 2013, J TISSUE ENG REGEN M
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Shvartsman D, 2014, MOL THER, V22, P1243, DOI 10.1038/mt.2014.76
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Simons M, 2000, CIRCULATION, V102, pE73, DOI 10.1161/01.CIR.102.11.e73
   Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023
   Smith AST, 2012, J CELL BIOCHEM, V113, P1044, DOI 10.1002/jcb.23437
   Smythe GM, 2000, MOL THER, V1, P304, DOI 10.1006/mthe.2000.0049
   Stern-Straeter J, 2005, J CELL MOL MED, V9, P883, DOI 10.1111/j.1582-4934.2005.tb00386.x
   Stern-Straeter J, 2007, IN VIVO, V21, P435
   Takahashi H, 2013, BIOMATERIALS, V34, P7372, DOI 10.1016/j.biomaterials.2013.06.033
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Thorrez L, 2008, BIOMATERIALS, V29, P75, DOI 10.1016/j.biomaterials.2007.09.014
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011
   Toumi H, 2003, BRIT J SPORT MED, V37, P284, DOI 10.1136/bjsm.37.4.284
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7
   Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964
   VANDENBURGH H, 1979, SCIENCE, V203, P265, DOI 10.1126/science.569901
   Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931
   VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P166
   VANDENBURGH HH, 1989, IN VITRO CELL DEV B, V25, P607
   vanWachem PB, 1996, J BIOMED MATER RES, V30, P353, DOI 10.1002/(SICI)1097-4636(199603)30:3<353::AID-JBM9>3.0.CO;2-P
   von Roth Philipp, 2012, Open Orthop J, V6, P352, DOI 10.2174/1874325001206010352
   Wang L, 2014, MOL THER, V22, P1441, DOI 10.1038/mt.2014.78
   Wang L, 2013, MOL NEUROBIOL, V48, P397, DOI 10.1007/s12035-013-8412-z
   Wang W, 2009, BIOMED MATER, V4, P1748, DOI DOI 10.1088/1748-6041/4/2/
   Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265
   WEHRLE U, 1994, DIFFERENTIATION, V58, P37, DOI 10.1046/j.1432-0436.1994.5810037.x
   Weir MR, 1999, AM J KIDNEY DIS, V34, P1, DOI 10.1016/S0272-6386(99)70101-0
   Williams ML, 2013, J TISSUE ENG REGEN M, V7, P434, DOI 10.1002/term.537
   Wilschut KJ, 2010, EXP CELL RES, V316, P341, DOI 10.1016/j.yexcr.2009.10.014
   Winkler T, 2012, J TISSUE ENG REGEN M, V6, ps60, DOI 10.1002/term.1542
   Winkler T, 2009, TISSUE ENG PT A, V15, P487, DOI 10.1089/ten.tea.2007.0426
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Yang HS, 2014, BIOMATERIALS, V35, P1478, DOI 10.1016/j.biomaterials.2013.10.067
   Yuan CC, 2013, MICRO NANO LETT, V8, P440, DOI 10.1049/mnl.2013.0153
   Zhao Y, 2009, BIOTECHNOL BIOENG, V102, P624, DOI 10.1002/bit.22080
   Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080
NR 227
TC 100
Z9 100
U1 12
U2 179
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 502
EP 521
DI 10.1016/j.biomaterials.2015.02.110
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800047
PM 25890747
DA 2018-10-19
ER

PT J
AU Vasconcelos, DP
   Costa, M
   Amaral, IF
   Barbosa, MA
   Aguas, AP
   Barbosa, JN
AF Vasconcelos, Daniela P.
   Costa, Madalena
   Amaral, Isabel F.
   Barbosa, Mario A.
   Aguas, Artur P.
   Barbosa, Judite N.
TI Development of an immunomodulatory biomaterial: Using resolvin D1 to
   modulate inflammation
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Immune response; Chitosan; Immunomodulation; Resolvin
ID MACROPHAGE POLARIZATION; AIR POUCH; IN-VIVO; RESOLUTION; PHENOTYPE;
   MEDIATORS; CHITOSAN; LYOPHILIZATION; IMPLANTATION; SCAFFOLDS
AB In our search for immunomodulatory biomaterials capable of modulating the inflammatory response through M2 macrophage polarization, we report here on a new strategy that resulted from the incorporation of resolvin D1 (RvD1), a pro-resolution lipid mediator in porous 3D chitosan (Ch) scaffolds, followed by its lyophilisation. We have investigated the inflammatory response caused by this biomaterial in vivo using a mouse air-pouch model of inflammation. We found that this developed material caused a decrease in inflammatory cells recruited to the implant site, together with higher numbers of F4/80(+)/CD206(+) cells (M2 macrophages) and lower numbers of F4/80(+)/CCR7(+) cells (M1 macrophages). It also induced a general decrease in pro-inflammatory cytokines, and caused a decrease in the inflammatory cells observed around and within the implanted scaffolds, when compared with Ch alone or Ch not submitted to lyophilisation after RvD1 incorporation. Our results demonstrate that we were able to develop an immunomodulating biomaterial that triggers a shift in the macrophage response towards a M2 reparative response that will be advantageous for the host. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Vasconcelos, Daniela P.; Costa, Madalena; Barbosa, Mario A.; Aguas, Artur P.; Barbosa, Judite N.] Univ Porto, ICBAS, P-4050313 Oporto, Portugal.
   [Vasconcelos, Daniela P.; Amaral, Isabel F.; Barbosa, Mario A.; Barbosa, Judite N.] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal.
   [Vasconcelos, Daniela P.; Amaral, Isabel F.; Barbosa, Mario A.; Barbosa, Judite N.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Costa, Madalena; Aguas, Artur P.] Univ Porto, ICBAS, UMIB Unit Multidisciplinary Biomed Res, P-4050313 Oporto, Portugal.
RP Barbosa, JN (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM judite@ineb.up.pt
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Santos,
   Madalena/0000-0002-1101-3515; Vasconcelos, Daniela/0000-0002-9242-2336;
   Novais Barbosa, Judite/0000-0003-1852-2790; Amaral,
   Isabel/0000-0003-2921-3627; Aguas, Artur P/0000-0002-1487-9517
FU FEDER Funds through the Programa Operacional Factores de Competitividade
   - COMPETE; FCT - Fundacao para a Ciencia e Tecnologia
   [PTDC/SAU-BMA/113030/2009]; QREN through program ON.2 - "Project on
   Biomedical Engineering for Regenerative Therapies and Cancer"
   [NORTE-07-0124-FEDER-000005]
FX This work was financed by FEDER Funds through the Programa Operacional
   Factores de Competitividade - COMPETE and Portuguese funds through FCT -
   Fundacao para a Ciencia e Tecnologia in the framework of project
   PTDC/SAU-BMA/113030/2009. I.F. Amaral is funded by QREN through program
   ON.2, in the framework of Project "NORTE-07-0124-FEDER-000005 - Project
   on Biomedical Engineering for Regenerative Therapies and Cancer".
CR Abdelmoaty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075543
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   CASTRO AG, 1991, INFECT IMMUN, V59, P3009
   Couto DS, 2012, ADV DRUG DELIVER REV, V64, P69, DOI 10.1016/j.addr.2011.10.008
   Di Tommaso C, 2010, EUR J PHARM SCI, V40, P38, DOI 10.1016/j.ejps.2010.02.006
   Domb AJ, 2014, FOCAL CONTROLLED DRU
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Franz S, 2011, BIOMATERIALS, V32, P6692
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034
   Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036
   Hooper KA, 2000, J BIOMED MATER RES, V50, P365, DOI 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X
   Howard MD, 2012, DRUG DEV IND PHARM, V38, P1270, DOI 10.3109/03639045.2011.645835
   Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lewis A, 2009, DRUG DEVICE COMBINATION PRODUCTS, pXVII
   Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011
   Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x
   Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Sedwick AD, 1983, J PATHOL, V141, P483
   Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197
   Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225
   Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2
   Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035
   Vasconcelos DP, 2013, BIOMATERIALS, V34, P9952, DOI 10.1016/j.biomaterials.2013.09.012
   Widgerow AD, 2012, WOUND REPAIR REGEN, V20, P2, DOI 10.1111/j.1524-475X.2011.00754.x
   Winyard PG, 2003, METHODS MOL BIOL INF
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Zilberman M, 2011, STUD MECHANOBIOL TIS, V8, P1, DOI 10.1007/978-3-642-18065-1
NR 35
TC 24
Z9 24
U1 4
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 566
EP 573
DI 10.1016/j.biomaterials.2015.02.120
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800052
PM 25890752
DA 2018-10-19
ER

PT J
AU Moore, MA
   Samsell, B
   Wallis, G
   Triplett, S
   Chen, S
   Jones, AL
   Qin, XF
AF Moore, Mark A.
   Samsell, Brian
   Wallis, Glenna
   Triplett, Sherry
   Chen, Silvia
   Jones, Alyce Linthurst
   Qin, Xiaofei
TI Decellularization of human dermis using non-denaturing anionic detergent
   and endonuclease: a review
SO CELL AND TISSUE BANKING
LA English
DT Review
DE Allograft; Homograft; Dermis; Decellularized; Acellular dermal matrix;
   MatrACELL
ID REGENERATIVE TISSUE MATRIX; HEART-VALVES; ARTHROSCOPIC REPLACEMENT;
   GRAFTJACKET ALLOGRAFT; ACELLULAR DERMIS; FAILURE LOADS; RECONSTRUCTION;
   REPAIR; TENDON; SYNERGRAFT(TM)
AB Decellularized human dermis has been used for a number of clinical applications including wound healing, soft tissue reconstruction, and sports medicine procedures. A variety of methods exist to prepare this useful class of biomaterial. Here, we describe a decellularization technology (MatrACELL(A (R))) utilizing a non-denaturing anionic detergent, N-Lauroyl sarcosinate, and endonuclease, which was developed to remove potentially immunogenic material while retaining biomechanical properties. Effective decellularization was demonstrated by a residual DNA content of a parts per thousand currency sign4 ng/mg of wet weight which represented > 97 % DNA removal compared to unprocessed dermis. Two millimeter thick MatrACELL processed human acellular dermal matrix (MH-ADM) exhibited average ultimate tensile load to failure of 635.4 +/- A 199.9 N and average suture retention strength of 134.9 +/- A 55.1 N. Using an in vivo mouse skin excisional model, MH-ADM was shown to be biocompatible and capable of supporting cellular and vascular in-growth. Finally, clinical studies of MH-ADM in variety of applications suggest it can be an appropriate scaffold for wound healing, soft tissue reconstruction, and soft tissue augmentation.
C1 [Moore, Mark A.; Samsell, Brian; Wallis, Glenna; Triplett, Sherry; Chen, Silvia; Jones, Alyce Linthurst; Qin, Xiaofei] LifeNet Hlth, Inst Regenerat Med, Virginia Beach, VA 23453 USA.
RP Moore, MA (reprint author), LifeNet Hlth, Inst Regenerat Med, 1864 Concert Dr, Virginia Beach, VA 23453 USA.
EM mark_moore@lifenethealth.org
CR Al-Hamdan KS, 2011, SAUDI DENT J, V23, P205, DOI 10.1016/j.sdentj.2011.05.002
   Albo Daniel, 2006, Am J Surg, V192, pe12, DOI 10.1016/j.amjsurg.2006.08.029
   [Anonymous], 2001, US Patent, Patent No. [6,293,970, 6293970]
   [Anonymous], 2003, US Patent, Patent No. [6,544,289, 6544289]
   [Anonymous], 2003, US Patent, Patent No. [6,569,200, 6569200]
   [Anonymous], 2006, US Patent, Patent No. [7,063,726, 7063726]
   [Anonymous], 2004, US Patent, Patent No. [6,743,574, 6746574]
   Barber FA, 2008, ARTHROSCOPY, V24, P20, DOI 10.1016/j.arthro.2007.07.013
   Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012
   Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021
   Bechtel JFM, 2005, EUR J CARDIO-THORAC, V27, P410, DOI 10.1016/j.ejcts.2004.12.017
   Bechtel JFM, 2003, J HEART VALVE DIS, V12, P734
   Beitzel K, 2012, AM J SPORT MED, V40, P1148, DOI 10.1177/0363546512437835
   Bond JL, 2008, ARTHROSCOPY, V24, P403, DOI 10.1016/j.arthro.2007.07.033
   Brigido SA, 2004, ORTHOPEDICS, V27, pS145
   Burkhead WZ, 2007, SEMIN ARTHROPLASTY, V18, P11, DOI DOI 10.1053/J.SART.2006.11.017
   Candage R, 2008, SURGERY, V144, P703, DOI 10.1016/j.surg.2008.06.018
   Capito AE, 2012, ANN PLAS SURG, V68, P495, DOI 10.1097/SAP.0b013e31823b6b01
   Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85
   Chen SG, 2012, INT J BURNS TRAUMA, V2, P105
   Choe JM, 2001, J UROLOGY, V166, P122, DOI 10.1016/S0022-5347(05)66090-9
   Daniel Lee, 2007, J FOOT ANKLE SURG, V46, P451
   Daniel Lee, 2008, J FOOT ANKLE SURG, V47, P8
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Dopirak R, 2007, INT J SHOULDER SURG, V1, P7, DOI 10.4103/0973-6042.30673
   Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P87
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Eshan A, 2012, J HAND SURG-AM, V37, P1538
   Hawkins JA, 2003, J THORAC CARDIOV SUR, V126, P247, DOI 10.1016/S0022-5223(03)00116-8
   Hopkins RA, 2009, J THORAC CARDIOV SUR, V137, P907, DOI 10.1016/j.jtcvs.2008.12.009
   Kapfer SA, 2006, J PEDIATR SURG, V41, P216, DOI 10.1016/j.jpedsurg.2005.10.093
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athorascur.2004.09.033
   Ketchedjian A, 2005, J THORAC SURG, V129, P155
   Levenda A, 2012, ANN M ARTHR ASS N AM
   Lofland GK, 2012, ANN THORAC SURG, V93, P968, DOI 10.1016/j.athoracsur.2011.09.039
   Mitchell CR, 2011, UROLOGY, V77, P746, DOI 10.1016/j.urology.2010.05.003
   Moore MA, 2004, AM ASS TISS BANKS AN
   Moore MA, 2012, CELL TISSUE BANK, V13, P401, DOI 10.1007/s10561-011-9266-0
   Mulder, 2012, WOUNDS, V24, P185
   Nahabedian MY, 2009, PLAST RECONSTR SURG, V124, P1743, DOI 10.1097/PRS.0b013e3181bf8087
   Norton L.W., 2009, FUNDAMENTALS TISSUE, P721, DOI 10.1007/978-3-540-77755-7_50
   Ortiz Juan A, 2014, Mil Med, V179, pe249, DOI 10.7205/MILMED-D-13-00276
   Pellegata AF, 2013, BIOMED RES INT, V13, P1
   Qin X, 2008, SOC AM WOUND CAR 21
   Randall KL, 2008, J FOOT ANKLE SURG, V47, P430, DOI 10.1053/j.jfas.2008.04.012
   Salzberg A, 2006, ANN PLAST SURG, V57, P1
   Sbitany H, 2009, PLAST RECONSTR SURG, V124, P1735, DOI 10.1097/PRS.0b013e3181bf803d
   Sievers HH, 2003, Z KARDIOL, V92, P53, DOI 10.1007/s00392-003-0883-x
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Snyder SJ, 2007, OPER TECHN SPORT MED, V15, P86, DOI 10.1053/j.otsm.2006.07.006
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Steinmetz M, 1986, CLIN IMMUN NEWS, V7, P134
   Vashi C, 2014, PLAST SURG INT, V2014, P1
   Wallace SC, 2013, J ORAL IMPLANTOL, V39, P503, DOI 10.1563/AAID-JOI-D-13-00001
   Wilkins RM, 2010, CURR ORTHOP PRACT, V21, P315, DOI 10.1097/BCO.0b013e3181c7ea2e
   Winters Christopher L, 2008, Adv Skin Wound Care, V21, P375, DOI 10.1097/01.ASW.0000323532.98003.26
   Wolfinbarger LJ, 2008, Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced United States Patent US, Patent No. [7338757 B2, 7338757]
   Wolfinbarger LJ, 2004, Patent No. [United States Patent US, 6734018 B2, 6734018]
   Wong Ivan, 2010, J Shoulder Elbow Surg, V19, P104, DOI 10.1016/j.jse.2009.12.017
   Yonehiro L, 2013, WOUNDS, V25, P340
NR 62
TC 26
Z9 27
U1 1
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD JUN
PY 2015
VL 16
IS 2
BP 249
EP 259
DI 10.1007/s10561-014-9467-4
PG 11
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA CH7CC
UT WOS:000354192200009
PM 25163609
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Shen, LR
   Tian, ZH
   Liu, WT
   Li, GY
AF Shen, Lirui
   Tian, Zhenhua
   Liu, Wentao
   Li, Guoying
TI Influence on the physicochemical properties of fish collagen gels using
   self-assembly and simultaneous cross-linking with the
   N-hydroxysuccinimide adipic acid derivative
SO CONNECTIVE TISSUE RESEARCH
LA English
DT Article
DE Collagen gel; cross-linking; N-hydroxysuccinimide adipic acid derivative
   Southern catfish; properties; self-assembly
ID DYNAMIC VISCOELASTIC PROPERTIES; RHEOLOGICAL PROPERTIES; GELATIN FILMS;
   GLUTARALDEHYDE; STABILITY; ORGANIZATION; BIOMATERIAL; TEMPERATURE;
   SCAFFOLDS; DELIVERY
AB Collagen gels from Southern catfish (Silurus meridionalis Chen) skins were prepared via the self-assembly of collagen molecules and simultaneous cross-linking with the N-hydroxysuccinimide adipic acid derivative (NHS-AA). The doses of NHS-AA were converted to [NHS-AA]/[NH2] ratios (0.025-1.6, calculated by the [active ester group] of NHS-AA and [epsilon-NH2] of lysine and hydroxylysine residues of collagen). When the ratio<0.05, collagen gels were formed by collagen molecule self-assembly, resulting in the opalescent appearance of collagen gels and the characteristic D-periodicity of partial collagen fibrils, the collagen gel ([NHS-AA]/ [NH2] = 0.05) displayed a small increase in denaturation temperature (T-d, 42.8 degrees C), remaining weight (12.59%), specific water content (SWC 233.7) and elastic modulus (G' 128.4 Pa) compared with uncross-linked collagen gel (39.1 degrees C, 9.12%, 222.4 and 85.4 Pa, respectively). As the ratio>0.05, disappearance of D-periodicity and a gradual change in appearance from opalescent to transparent suggested that the inhibition of NHS-AA in the self-assembly of collagen molecules was more obvious. As a result, the collagen gel ([NHS-AA]/[NH2] = 0.2) had the lowest T-d (35.8 degrees C), remaining weight (7.96%), SWC (130.9) and G' (31.9 Pa). When the ratio was 1.6, the collagen molecule self-assembly was markedly suppressed and the formation of collagen gel was predominantly via the covalent cross-linking bonds which led to the transparent appearance, and the maximum values of T-d (47.0 degrees C), remaining weight (45.92%) and G' (420.7 Pa) of collagen gel. These results indicated that collagen gels with different properties can be prepared using different NHS-AA doses.
C1 [Shen, Lirui; Li, Guoying] Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
   [Tian, Zhenhua; Liu, Wentao] Sichuan Univ, Natl Engn Lab Clean Technol Leather Manufacture, Chengdu 610065, Peoples R China.
RP Li, GY (reprint author), Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
EM liguoyings@163.com
FU National Natural Science Foundation of China [21276167, 21476147]
FX This work was funded by the National Natural Science Foundation of China
   (Nos. 21276167 and 21476147).
CR Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Chen YH, 2011, KOREA-AUST RHEOL J, V23, P41, DOI 10.1007/s13367-011-0006-6
   CHEUNG DT, 1990, CONNECT TISSUE RES, V25, P27, DOI 10.3109/03008209009009810
   Duan L, 2014, INT J BIOL MACROMOL, V69, P482, DOI 10.1016/j.ijbiomac.2014.06.005
   Dupont-Gillain CC, 2005, COLLOID SURFACE B, V43, P179, DOI 10.1016/j.colsurfb.2004.12.022
   Fang M, 2013, LANGMUIR, V29, P2330, DOI 10.1021/la3048104
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gasperlin M, 1998, INT J PHARMACEUT, V168, P243, DOI 10.1016/S0378-5173(98)00099-4
   Kasapis S, 2001, INT J BIOL MACROMOL, V29, P315, DOI 10.1016/S0141-8130(01)00180-5
   Korhonen M, 2001, INT J PHARM, V221, P187, DOI 10.1016/S0378-5173(01)00675-5
   Krishnamoorthy G, 2013, J BIOMED MATER RES A, V101, P1173, DOI 10.1002/jbm.a.34411
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3
   Mori H, 2013, MAT SCI ENG C-MATER, V33, P3230, DOI 10.1016/j.msec.2013.03.047
   Mori H, 2012, MAT SCI ENG C-MATER, V32, P2007, DOI 10.1016/j.msec.2012.05.022
   Nomura Y, 2000, J AGR FOOD CHEM, V48, P2028, DOI 10.1021/jf990773a
   Nomura Y, 1995, J FOOD SCI, V60, P1233, DOI 10.1111/j.1365-2621.1995.tb04563.x
   Pietrucha K, 2005, INT J BIOL MACROMOL, V36, P299, DOI 10.1016/j.ijbiomac.2005.07.004
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Saito H, 2004, MAT SCI ENG C-BIO S, V24, P781, DOI 10.1016/j.msec.2004.08.039
   Saito H, 2007, ACTA BIOMATER, V3, P89, DOI 10.1016/j.actbio.2006.08.003
   Sawhney RK, 2002, J CELL BIOL, V157, P1083, DOI 10.1083/jcb.200203069
   Tian ZH, 2014, CONNECT TISSUE RES, V55, P239, DOI 10.3109/03008207.2014.898066
   Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Watanabe K, 1997, POLYMER, V38, P5155, DOI 10.1016/S0032-3861(97)00046-3
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang M, 2011, INT J BIOL MACROMOL, V49, P847, DOI 10.1016/j.ijbiomac.2011.08.007
   Zhang M, 2009, FOOD CHEM, V115, P826, DOI 10.1016/j.foodchem.2009.01.006
NR 33
TC 4
Z9 4
U1 1
U2 33
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0300-8207
EI 1607-8438
J9 CONNECT TISSUE RES
JI Connect. Tissue Res.
PD JUN
PY 2015
VL 56
IS 3
BP 244
EP 252
DI 10.3109/03008207.2015.1020941
PG 9
WC Cell Biology; Orthopedics
SC Cell Biology; Orthopedics
GA CH8VT
UT WOS:000354314900008
PM 25689166
DA 2018-10-19
ER

PT J
AU Cicchetto, A
   Kumar, V
   Chapman, J
AF Cicchetto, A.
   Kumar, V.
   Chapman, J.
TI FIBRIN ADIPOSE TISSUE (FAT) AS SURGICAL BIOMATERIAL
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 [Cicchetto, A.; Kumar, V.; Chapman, J.] Calif State Univ Sacramento, Sacramento, CA 95819 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1465-3249
EI 1477-2566
J9 CYTOTHERAPY
JI Cytotherapy
PD JUN
PY 2015
VL 17
IS 6
SU S
MA 231
BP S68
EP S68
DI 10.1016/j.jcyt.2015.03.540
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA CH6JK
UT WOS:000354142700212
DA 2018-10-19
ER

PT J
AU Khanlou, HM
   Ang, BC
   Talebian, S
   Barzani, MM
   Silakhori, M
   Fauzi, H
AF Khanlou, Hossein Mohammad
   Ang, Bee Chin
   Talebian, Sepehr
   Barzani, Mohsen Marani
   Silakhori, Mahyar
   Fauzi, Hadi
TI A systematic study of maghemite/PMMA nano-fibrous composite via an
   electrospinning process: Synthesis and characterization
SO MEASUREMENT
LA English
DT Article
DE Electrospinning; Maghemite; Polymethyl Methacrylate (PMMA); Nano-fibres;
   Composite; Magnetic particle; Fabrication and characterization
ID MAGNETIC NANOPARTICLES; SILVER NANOPARTICLES; POLY(METHYL METHACRYLATE);
   DRUG-DELIVERY; NANOFIBERS; NANOCOMPOSITES; MICROEMULSION; ENVIRONMENTS;
   NANOCRYSTALS; BIOMATERIAL
AB In this study, maghemite/PMMA nano-fibrous composites have been successfully fabricated by using the electrospinning process. PMMA nano-fibres have been selected to be used as the matrix; the PMMA was dissolved in three diverse solvents (Acetone, THF and DMF) in order to obtain fine PMMA nano-fibres. As a result, the PMMA-DMF proved to be the most appropriate polymer solution among the three solvents, with its impressive defect-free surface morphology results. The production of maghemite using Massart's procedure resulted in nano-particles with an average diameter of 4.98 +/- 0.13 nm (using transmission electron microscopy (TEM)). Maghemite nano-particle were then mixed with a prepared polymer solution in order to fabricate maghemite/PMMA nano-fibrous composite. Furthermore, the investigation of the morphology and structure of the composite was carried out using field emission scanning electron microscopy (FESEM), Energy-dispersion X-ray spectroscopy (EDX), Alternating Gradient Magnetometer (AGM), Fourier transform infrared spectrometer (FTIR), X-ray diffraction (XRD) and tensile strength measurement devices. The results indicated that there was a great amount of maghemite, both in and on the composite's surface, which can be utilized in the purpose of magnetic applications. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Khanlou, Hossein Mohammad; Ang, Bee Chin; Talebian, Sepehr] Univ Malaya, Dept Mech, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia.
   [Barzani, Mohsen Marani; Silakhori, Mahyar; Fauzi, Hadi] Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
RP Khanlou, HM (reprint author), Univ Malaya, Dept Mech, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia.
EM khanlou4@um.edu.my
RI Engineering, Faculty/I-7935-2015; Ang, Bee Chin/B-8227-2010
OI Engineering, Faculty/0000-0002-4848-7052; Fauzi,
   Hadi/0000-0001-6867-8000; Mohammad Khanlou, Hossein/0000-0003-0896-1714;
   Silakhori, Mahyar/0000-0001-6713-1425
FU University of Malaya; University of Malaya [UMRG RP022C-13AET, PPP
   PG007-2013A]
FX The authors would like to acknowledge the University of Malaya for
   financial support. This research was carried under the University of
   Malaya research grant No. UMRG RP022C-13AET and PPP PG007-2013A.
CR Agarwal S, 2013, PROG POLYM SCI, V38, P963, DOI 10.1016/j.progpolymsci.2013.02.001
   Ambashta RD, 2010, J HAZARD MATER, V180, P38, DOI 10.1016/j.jhazmat.2010.04.105
   Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1
   Auffan M, 2008, ENVIRON SCI TECHNOL, V42, P6730, DOI 10.1021/es800086f
   Baji A, 2010, COMPOS SCI TECHNOL, V70, P703, DOI 10.1016/j.compscitech.2010.01.010
   Bao Y, 2013, RSC ADV, V3, P8998, DOI 10.1039/c3ra41322e
   Barrera C, 2005, MATER DIV ASME, V100, P467
   Batlle X, 2002, J PHYS D APPL PHYS, V35, pR15, DOI 10.1088/0022-3727/35/6/201
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Brar SK, 2010, WASTE MANAGE, V30, P504, DOI 10.1016/j.wasman.2009.10.012
   Chigome S, 2011, ANAL CHIM ACTA, V706, P25, DOI 10.1016/j.aca.2011.08.021
   Chin AB, 2007, J MATER PROCESS TECH, V191, P235, DOI 10.1016/j.jmatprotec.2007.03.011
   Clark SM, 2005, NANOTECHNOLOGY, V16, P2813, DOI 10.1088/0957-4484/16/12/013
   Galland S, 2013, J MATER CHEM C, V1, P7963, DOI 10.1039/c3tc31748j
   Gopal R, 2006, J MEMBRANE SCI, V281, P581, DOI 10.1016/j.memsci.2006.04.026
   Gubin SP, 2005, USP KHIM+, V74, P539, DOI 10.1070/RC2005V074N06ABEH000897
   HALPERIN WP, 1986, REV MOD PHYS, V58, P533, DOI 10.1103/RevModPhys.58.533
   Han X, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/20/205302
   Hirt AM, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863543
   Hou YW, 2000, J PHYS CHEM B, V104, P212, DOI 10.1021/jp992312y
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155
   Kaufner L, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/11/115710
   Khanlou H., 2015, NEURAL COMPUT APPL, P1
   Khanlou H.M., 2014, TEXT RES J
   Khanlou H.M., 2015, SCI ENG COMPOS MAT
   Khanlou HM, 2014, NEURAL COMPUT APPL, P1
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P307
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P125
   Khanlou HM, 2015, MEASUREMENT, V65, P193, DOI 10.1016/j.measurement.2015.01.014
   Kodama RH, 1999, J MAGN MAGN MATER, V200, P359, DOI 10.1016/S0304-8853(99)00347-9
   Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e
   Lee KJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/46/465201
   Macossay J, 2007, POLYM ADVAN TECHNOL, V18, P180, DOI 10.1002/pat.844
   McCullagh C, 2011, J CHEM TECHNOL BIOT, V86, P1002, DOI 10.1002/jctb.2650
   Nath J.K., 2014, CRYST GROWTH DES
   Ortega D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/47/475706
   Pablico-Lansigan MH, 2013, NANOSCALE, V5, P4040, DOI 10.1039/c3nr00544e
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   De Berti IOP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175601
   Petosa AR, 2010, ENVIRON SCI TECHNOL, V44, P6532, DOI 10.1021/es100598h
   Piperno S, 2006, APPL SURF SCI, V252, P5583, DOI 10.1016/j.apsusc.2005.12.142
   Santhosh P, 2011, ANALYST, V136, P1557, DOI 10.1039/c0an00616e
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   Shim Il-Wun, 2001, B KOREAN CHEM SOC, V22, P3
   Shukla N, 2009, IONICS, V15, P357, DOI 10.1007/s11581-008-0275-3
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Singh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091584
   Talebian S., 2014, MATER RES INNOV, V18
   Talebian S., 2014, MATER RES INNOV, V18
   Talebian S, 2014, RSC ADV, V4, P49144, DOI 10.1039/c4ra06761d
   Tang SCN, 2013, WATER RES, V47, P2613, DOI 10.1016/j.watres.2013.02.039
   Thakur M, 2006, J PHYS-CONDENS MAT, V18, P9093, DOI 10.1088/0953-8984/18/39/035
   Tong XZ, 2013, COMPOS SCI TECHNOL, V88, P33, DOI 10.1016/j.compscitech.2013.08.028
   Tsang S.C., 2004, ANGEW CHEM, V116
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Vidal-Vidal J, 2006, COLLOID SURFACE A, V288, P44, DOI 10.1016/j.colsurfa.2006.04.027
   Wang HG, 2010, J MATER SCI, V45, P1032, DOI 10.1007/s10853-009-4035-1
   Yu D.-G., 2014, J NANOMATER
   Yu DG, 2013, RSC ADV, V3, P4652, DOI 10.1039/c3ra40334c
   Yu DG, 2012, INT J NANOMED, V7, P5725, DOI [10.2147/IJN.S37455, 10.2147/IJN.S29961]
   Yu DG, 2012, CARBOHYD POLYM, V90, P1016, DOI 10.1016/j.carbpol.2012.06.036
   Zhang CC, 2009, APPL PHYS A-MATER, V97, P281, DOI [10.1007/s00339-009-53789, 10.1007/s00339-009-5378-9]
   Zhao X, 2011, CHEM ENG J, V170, P381, DOI 10.1016/j.cej.2011.02.071
NR 64
TC 11
Z9 11
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0263-2241
EI 1873-412X
J9 MEASUREMENT
JI Measurement
PD JUN
PY 2015
VL 70
BP 179
EP 187
DI 10.1016/j.measurement.2015.04.004
PG 9
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA CI0BZ
UT WOS:000354402000019
DA 2018-10-19
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Lukes, J
   Sepitka, J
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Lukes, Jaroslav
   Sepitka, Josef
TI Nanoindentation studies and modeling of surface layers on austenitic
   stainless steels by extreme electrochemical treatments
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE AISI 304L and 316L SS; electropolishing EP50 and EP1000; nanoindentation
   results; surface layer modeling
ID AISI 316L SS; XPS MEASUREMENTS; BIOMATERIAL
AB The nanoindentation studies were performed on two austenitic stainless steels, AISI 304L and 316L. The steel samples have undergone two different electrochemical treatments, standard (EP50) and a high-current density electropolishing (EP1000). Firstly, the observations of the steels' surfaces were done with the optic images of the AISI 304L and 316L SS after these two treatments displayed. Presented in the paper results have shown clearly that the high-current density close to 1000A/dm(2) allows for obtaining the passive nanolayers with other mechanical properties than those obtained after a standard electropolishing (EP50). The prediction of these results has been confirmed by the preliminary XPS studies allowing for modeling of the steels' surface layers. The main finding of the study is revealing a new method of electrochemical treatment (EP1000) allowing to obtain the reduced Young's modulus of the stainless steels lower than that obtained after EP50. This feature is of high importance regarding the use of these steels as biomaterials. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, PL-75620 Koszalin, Poland.
   [Lukes, Jaroslav; Sepitka, Josef] Czech Tech Univ, Fac Mech Engn, Dept Mech Biomech & Mechatron, Tech 4, Prague 16007 6, Czech Republic.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
CR Aronniemi M, 2005, SURF SCI, V578, P108, DOI 10.1016/j.susc.2005.01.019
   ASM International Handbook Committee, 1990, PROP SEL IR STEELS H, V1, P944
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T., 2014, SURF COATING TECHN C
   Hryniewicz T., 2014, INT LETT CHEM PHYS A, V4, P98, DOI DOI 10.18052/WWW.SCIPRESS.COM/ILCPA.23.98
   Hryniewicz T, 2014, FRONT MATER, DOI 10.3389/fmats.2014.00003
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Lai JKL, 2012, STAINLESS STEELS: AN INTRODUCTION AND THEIR RECENT DEVELOPMENTS, P1
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P460
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P799
   Rokosz K, 2014, TEH VJESN, V21, P533
   Rokosz K, 2013, INT J MATER RES, V104, P1223, DOI 10.3139/146.110984
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Sedriks AJ., 1996, CORROSION STAINLESS
   Shuman D., 2005, COMPUTERIZED IMAGE A, P21
NR 19
TC 5
Z9 5
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUN
PY 2015
VL 47
IS 6
BP 643
EP 647
DI 10.1002/sia.5758
PG 5
WC Chemistry, Physical
SC Chemistry
GA CH6YX
UT WOS:000354183700001
DA 2018-10-19
ER

PT J
AU Bou-Francis, A
   Soyka, RPW
   Ferguson, SJ
   Hall, RM
   Kapur, N
AF Bou-Francis, Antony
   Soyka, Rene P. Widmer
   Ferguson, Stephen J.
   Hall, Richard M.
   Kapur, Nikil
TI Novel methodology for assessing biomaterial-biofluid interaction in
   cancellous bone
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Bone surrogates; Bone cement; Cement injection behavior; Cement leakage;
   Vertebral augmentation; Experimental computational cross-validation
ID PERCUTANEOUS VERTEBROPLASTY; POLYMETHYLMETHACRYLATE CEMENT; VERTEBRAL
   AUGMENTATION; REGIONAL-VARIATIONS; PULMONARY-EMBOLISM;
   EXPERIMENTAL-MODEL; METASTATIC SPINE; FLOW; EXTRAVASATION; PERMEABILITY
AB Understanding the cement flow behaviour and accurately predicting the cement placement within the vertebral body is extremely challenging. Vertebral cancellous bone displays highly complex geometrical structures and architectural inhomogeneities over a range of length scales, thus making the scientific understanding of the cement injection behaviour difficult in clinical or cadaveric studies. Previous experimental studies on cement flow have used open-porous aluminum foam to represent osteoporotic bone. Although the porosity was well controlled, the geometrical structure of each of the foams was inherently unique. This paper presents novel methodology using customized, reproducible and pathologically representative three-dimensional bone surrogates to help study biomaterial-biofluid interaction. The aim was to provide a robust tool for comprehensive assessment of biomaterial injection behaviour through controlling the bone surrogate morphology and the injection parameters (i.e. needle gauge, needle placement, flow rate and injected volume), measuring the injection pressure, and allowing the visualization and quantitative analysis of the spreading distribution. This methodology provides a clinically relevant representation of cement flow patterns and a tool for validating computational simulations. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Bou-Francis, Antony; Hall, Richard M.] Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
   [Bou-Francis, Antony; Kapur, Nikil] Univ Leeds, Sch Mech Engn, Inst Thermofluids, Leeds LS2 9JT, W Yorkshire, England.
   [Soyka, Rene P. Widmer; Ferguson, Stephen J.] ETH, Inst Biomech, CH-8093 Zurich, Switzerland.
RP Bou-Francis, A (reprint author), Univ Leeds, Sch Mech Engn, Room X101, Leeds LS2 9JT, W Yorkshire, England.
EM a.boufrancis@leeds.ac.uk
RI Ferguson, Stephen/A-4118-2012
OI Ferguson, Stephen/0000-0003-0650-5889; Hall, Richard/0000-0001-5504-6717
FU European Union under the FP7 Marie Curie Action
   [PITN-GA-2009-238690-SPINEFX]; Engineering and Physical Sciences
   Research Council [EP/H013385/1]
FX This work was funded by the European Union under the FP7 Marie Curie
   Action, grant agreement no. PITN-GA-2009-238690-SPINEFX.
CR Ahn H, 2007, EUR SPINE J, V16, P1171, DOI 10.1007/s00586-007-0375-1
   Baroud G, 2005, SPINE, V30, P68, DOI 10.1097/01.brs.0000149188.51154.5b
   Baroud G, 2004, J BIOMECH, V37, P189, DOI 10.1016/S0021-9290(03)00246-X
   Baroud G, 2006, SPINE, V31, P2562, DOI 10.1097/01.brs.0000240695.58651.62
   Bohner M, 2003, BIOMATERIALS, V24, P2721, DOI 10.1016/S0142-9612(03)00086-3
   Bou-Francis A, 2014, J BIOMATER APPL, V29, P582, DOI 10.1177/0885328214537858
   Bouxsein ML, 2003, OSTEOPOROSIS INT, V14, pS118, DOI 10.1007/s00198-003-1489-x
   Bryant J D, 1989, Proc Inst Mech Eng H, V203, P71
   Chen H, 2008, OSTEOPOROSIS INT, V19, P1473, DOI 10.1007/s00198-008-0593-3
   Currey JD, 2001, CALCIFIED TISSUE INT, V68, P205, DOI 10.1007/s002230020040
   Gong H, 2006, SPINE, V31, P24, DOI 10.1097/01.brs.0000193939.99618.ee
   Gosev I, 2013, CIRCULATION, V127, P1251, DOI 10.1161/CIRCULATIONAHA.112.144535
   Habib M, 2010, INT SOC ADV SPINE SU, V4, P26
   Habib N, 2012, HEART LUNG, V41, P509, DOI 10.1016/j.hrtlng.2012.02.008
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hughes S.W., 2005, PHYS EDUC, V40, P5
   Krebs J., 2005, SPINE, V30, pE118
   Lador R, 2010, SPINE J, V10, P1118, DOI 10.1016/j.spinee.2010.09.020
   Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009
   Lin CL, 2005, POWDER TECHNOL, V154, P61, DOI 10.1016/j.powtec.2005.04.031
   Lochmuller EM, 2008, OSTEOPOROSIS INT, V19, P537, DOI 10.1007/s00198-007-0478-x
   Loeffel M, 2008, SPINE, V33, P1352, DOI 10.1097/BRS.0b013e3181732aa9
   Mathis JM, 2003, J VASC INTERV RADIOL, V14, P953
   Mohamed R, 2010, SPINE, V35, P353, DOI 10.1097/BRS.0b013e3181b63673
   Myers ER, 1997, SPINE, V22, p25S, DOI 10.1097/00007632-199712151-00005
   Nauman EA, 1999, ANN BIOMED ENG, V27, P517, DOI 10.1114/1.195
   Ortiz O, 2010, NEUROIMAG CLIN N AM, V20, P145, DOI 10.1016/j.nic.2010.02.001
   Pinder G. F., 2008, ESSENTIALS MULTIPHAS
   Reidy D, 2003, SPINE, V28, P1534, DOI 10.1097/00007632-200307150-00011
   RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sidhu GS, 2013, J NEUROSURG-SPINE, V19, P61, DOI 10.3171/2013.4.SPINE12978
   Soyka RPW, 2013, J MECH BEHAV BIOMED, V27, P43, DOI 10.1016/j.jmbbm.2013.06.007
   Tourtier JP, 2012, NEW ENGL J MED, V366, P258, DOI 10.1056/NEJMicm1010341
   Tschirhart CE, 2005, J BIOMECH, V38, P1582, DOI 10.1016/j.jbiomech.2004.07.023
   Widmer RP, 2013, COMPUT METHOD BIOMEC, V16, P908, DOI 10.1080/10255842.2011.643787
   Widmer RP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003735
   Widmer Soyka R.P., 2013, J MECH BEHAV BIOMED, V6161
NR 38
TC 1
Z9 1
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUN
PY 2015
VL 46
BP 158
EP 167
DI 10.1016/j.jmbbm.2015.02.027
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH0ZY
UT WOS:000353752100016
PM 25792413
OA Green Published
DA 2018-10-19
ER

PT J
AU Pangdaeng, S
   Sata, V
   Aguiar, JB
   Pacheco-Torgal, F
   Chindaprasirt, P
AF Pangdaeng, S.
   Sata, V.
   Aguiar, J. B.
   Pacheco-Torgal, F.
   Chindaprasirt, P.
TI Apatite formation on calcined kaolin-white Portland cement geopolymer
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Geopolymer; Apatite; Simulated body fluid; Kaolin; White Portland cement
ID IN-VITRO BIOACTIVITY; SIMULATED BODY-FLUID; FLY-ASH GEOPOLYMER; FORMING
   ABILITY; SURFACE; GEL; BIOMATERIALS; TEMPERATURE; INTERFACE; STRENGTH
AB In this study, calcined kaolin-white Portland cement geopolymer was investigated for use as biomaterial. Sodium hydroxide and sodium silicate were used as activators. In vitro test was performed with simulated body fluid (SBF) for bioactivity characterization. The formation of hydroxyapatite bio-layer on the 28-day soaked samples surface was tested using SEM, EDS and XRD analyses. The results showed that the morphology of hydroxyapatite was affected by the source material composition, alkali concentration and curing temperature. The calcined kaolin-white Portland cement geopolymer with relatively high compressive strength, could be fabricated for use as biomaterial. The mix with 50% white Portland cement and 50% calcined kaolin had 28-day compressive strength of 59.0 MPa and the hydroxyapatite bio-layer on the 28-day soaked sample surface was clearly evident. (C) 2015 Elsevier B.V. All rights reserved,
C1 [Pangdaeng, S.; Sata, V.; Chindaprasirt, P.] Khon Kaen Univ, Fac Engn, Dept Civil Engn, Sustainable Infrastruct Res & Dev Ctr, Khon Kaen 40002, Thailand.
   [Aguiar, J. B.; Pacheco-Torgal, F.] Univ Minho, C TAC Res Ctr, Dept Civil Engn, P-4800058 Guimaraes, Portugal.
RP Chindaprasirt, P (reprint author), Khon Kaen Univ, Fac Engn, Dept Civil Engn, Sustainable Infrastruct Res & Dev Ctr, Khon Kaen 40002, Thailand.
EM prinya@kku.ac.th
RI chindaprasirt, prinya/F-6768-2010; Pacheco-Torgal, F./C-5710-2012;
   Aguiar, Jose/B-6597-2009
OI chindaprasirt, prinya/0000-0003-1062-3626; Pacheco-Torgal,
   F./0000-0001-7767-6787; Aguiar, Jose/0000-0003-3954-5721
FU Thailand Research Fund (TRF); Khon Kaen University [PHD/0143/2554,
   RTA5780004]
FX This work was financially supported by the Thailand Research Fund (TRF)
   and Khon Kaen University under the TRF-Royal Golden Jubilee Ph.D.
   program (Grant No. PHD/0143/2554) and TRF-Senior Research Scholar (Grant
   No. RTA5780004).
CR [Anonymous], 2005, C109 ASTM, P76
   [Anonymous], 2005, C191 ASTM, P179
   Buchwald A, 2011, J NON-CRYST SOLIDS, V357, P1376, DOI 10.1016/j.jnoncrysol.2010.12.036
   Cabanas MV, 2002, CHEM MATER, V14, P3550, DOI 10.1021/cm021121w
   Catauro M., 2011, MECH BIOL CHARACTERI
   Chaipanich A, 2011, APPL SURF SCI, V257, P8385, DOI 10.1016/j.apsusc.2011.04.046
   Chindaprasirt P, 2012, J MATER SCI, V47, P4876, DOI 10.1007/s10853-012-6353-y
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Derrien AC, 2004, J THERM ANAL CALORIM, V75, P937, DOI 10.1023/B:JTAN.0000027187.14921.86
   Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z
   Gallego D, 2008, MAT SCI ENG C-BIO S, V28, P347, DOI 10.1016/j.msec.2007.04.020
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Greenspan D. C., 1994, EFFECT SURFACE AREA
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Huan Z, 2007, ACTA BIOMATER, V3, P952, DOI 10.1016/j.actbio.2007.05.003
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee WKW, 2002, COLLOID SURFACE A, V211, P115, DOI 10.1016/S0927-7757(02)00239-X
   Leivo J, 2006, ACTA BIOMATER, V2, P659, DOI 10.1016/j.actbio.2006.06.001
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Liew YM, 2012, CONSTR BUILD MATER, V30, P794, DOI 10.1016/j.conbuildmat.2011.12.079
   MacKenzie KJD, 2010, J MATER SCI, V45, P999, DOI 10.1007/s10853-009-4031-5
   Maltais Y, 1997, CEMENT CONCRETE RES, V27, P1009, DOI 10.1016/S0008-8846(97)00098-7
   Mami M, 2008, APPL SURF SCI, V254, P7386, DOI 10.1016/j.apsusc.2008.05.340
   Martin S., 2005, EUR CELLS MATER, V9, P71
   Nilsson M, 2002, J BIOMED MATER RES, V61, P600, DOI 10.1002/jbm.10268
   Oudadesse H, 2008, APPL SURF SCI, V255, P593, DOI 10.1016/j.apsusc.2008.06.086
   Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7
   Pacheco-Torgal F, 2008, CONSTR BUILD MATER, V22, P1939, DOI 10.1016/j.conbuildmat.2007.07.015
   Pangdaeng S, 2014, MATER DESIGN, V53, P269, DOI 10.1016/j.matdes.2013.07.018
   Rovnanik P, 2010, CONSTR BUILD MATER, V24, P1176, DOI 10.1016/j.conbuildmat.2009.12.023
   Sata V, 2012, CEMENT CONCRETE COMP, V34, P94, DOI 10.1016/j.cemconcomp.2011.09.003
   Somna K, 2011, FUEL, V90, P2118, DOI 10.1016/j.fuel.2011.01.018
   Sotya Astutiningsih H. W. A, 2010, J CIV ENG ARCHIT, V4, P11
   Tailby J, 2010, CEMENT CONCRETE RES, V40, P787, DOI 10.1016/j.cemconres.2009.12.003
   Takadama H, 2002, J AM CERAM SOC, V85, P1933, DOI 10.1111/j.1151-2916.2002.tb00383.x
   Temuujin J, 2009, J HAZARD MATER, V167, P82, DOI 10.1016/j.jhazmat.2008.12.121
   Todea M, 2012, CORROS SCI, V54, P299, DOI 10.1016/j.corsci.2011.09.032
   Torldttikul P., 2009, SCIENCEASIA, V35, P358
   Veiga KK, 2012, CONSTR BUILD MATER, V34, P494, DOI 10.1016/j.conbuildmat.2012.02.090
   Wang XJ, 2008, ACTA BIOMATER, V4, P1530, DOI 10.1016/j.actbio.2008.04.005
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   Yao X, 2009, THERMOCHIM ACTA, V493, P49, DOI 10.1016/j.tca.2009.04.002
   Zhang J, 2013, APPL SURF SCI, V280, P256, DOI 10.1016/j.apsusc.2013.04.144
NR 45
TC 10
Z9 10
U1 2
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 1
EP 6
DI 10.1016/j.msec.2015.02.039
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400001
PM 25842101
DA 2018-10-19
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Carbodiimide cross-linking of amniotic membranes in the presence of
   amino acid bridges
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Carbodiimide; Chemical modification; Amniotic membrane; Cross-linking
   bridge; Amino acid type
ID LINKED HYALURONIC-ACID; COMPRISING 2-HYDROXYETHYL METHACRYLATE; PIGMENT
   EPITHELIAL-CELLS; SHEET DELIVERY; CHEMICAL-COMPOSITION; CHITOSAN
   MATERIALS; ENDOTHELIAL-CELLS; GELATIN MEMBRANES; ANTERIOR-CHAMBER;
   ACRYLIC-ACID
AB The purpose of this study was to investigate the carbodiimide cross-linking of amniotic membrane (AM) in the presence of amino acid bridges. The biological tissues were treated with glycine, lysine, or glutamic acid and chemically cross-linked to examine the role of amino acid types in collagenous biomaterial processing. Results of zeta potential measurements showed that the use of uncharged, positively and negatively charged amino acids dictates the charge state of membrane surface. Tensile strength and water content measurements demonstrated that the addition of lysine molecules to the cross-linking system can increase the cross-linking efficiency and dehydration degree while the introduction of glutamic acid in the AM samples decreases the number of cross-links per unit mass of chemically modified tissue collagen. The differences in the cross-linking density further determined the thermal and biological stability by differential scanning calorimetry and in vitro degradation tests. As demonstrated in matrix permeability studies, the improved formation of covalent cross-linkages imposed by lysine facilitated construction of stronger cross-linking structures. In contrast, the added glycine molecules were insufficient to enhance the resistances of the proteinaceous matrices to thermal denaturation and enzymatic degradation. The cytocompatibility of these biological tissue membranes was evaluated by using human corneal epithelial cell cultures. Results of cell viability, metabolic activity, and pro-inflammatory gene expression level showed that the AM materials cross-linked with carbodiimide in the presence of different types of amino acids are well tolerated without evidence of detrimental effect on cell growth. In addition, the amino acid treated and carbodiimide cross-linked AM implants had good biocompatibility in the anterior chamber of the rabbit eye model. Our findings suggest that amino acid type is a very important engineering parameter to mediate carbodiimide cross-linking of AM collagen. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Taoyuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC100-2628-E-182-004-MY3]
FX This work was supported by grant NSC100-2628-E-182-004-MY3 from the
   National Science Council of Republic of China. The author is grateful to
   Dr. David Hui-Kang Ma (Department of Ophthalmology, Chang Gung Memorial
   Hospital) and Miss Hsiao-Yun Cheng (Molecular Medicine Research Center,
   Chang Gung University) for technical assistance.
CR Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Burugapalli K, 2009, J BIOMAT SCI-POLYM E, V20, P1049, DOI [10.1163/156856209X444411, 10.1163/156856209X4444111]
   CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Highberger J. H., 1939, J AM CHEM SOC, V61, P2302
   Hu M, 1999, J BIOMED MATER RES, V47, P79, DOI 10.1002/(SICI)1097-4636(199910)47:1<79::AID-JBM11>3.0.CO;2-J
   Kim YH, 2011, J NEUROSCI METH, V202, P38, DOI 10.1016/j.jneumeth.2011.08.036
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2014, COLLOID SURFACE B, V122, P277, DOI 10.1016/j.colsurfb.2014.07.009
   Lai JY, 2014, RSC ADV, V4, P18871, DOI 10.1039/c4ra01930j
   Lai JY, 2014, CARBOHYD POLYM, V101, P203, DOI 10.1016/j.carbpol.2013.09.060
   Lai JY, 2014, MAT SCI ENG C-MATER, V34, P334, DOI 10.1016/j.msec.2013.09.026
   Lai JY, 2013, INT J NANOMED, V8, P4157, DOI 10.2147/IJN.S52731
   Lai JY, 2013, DRUG DES DEV THER, V7, P1273, DOI 10.2147/DDDT.S53759
   Lai JY, 2013, J BIOMED NANOTECHNOL, V9, P2048, DOI 10.1166/jbn.2013.1734
   Lai JY, 2013, J MATER SCI-MATER M, V24, P2201, DOI 10.1007/s10856-013-4961-y
   Lai JY, 2013, MAT SCI ENG C-MATER, V33, P3704, DOI 10.1016/j.msec.2013.04.059
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lai JY, 2013, INT J MOL SCI, V14, P2036, DOI 10.3390/ijms14012036
   Lai JY, 2012, INT J MOL SCI, V13, P10970, DOI 10.3390/ijms130910970
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Ma DHK, 2009, OCUL SURF, V7, P128
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Spoerl E, 2004, OPHTHAL RES, V36, P71, DOI 10.1159/000076884
   Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002
   Wang GX, 2006, ARTIF CELL BLOOD SUB, V34, P11, DOI 10.1080/10731190500428283
NR 45
TC 3
Z9 3
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 28
EP 36
DI 10.1016/j.msec.2015.02.021
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400004
PM 25842104
DA 2018-10-19
ER

PT J
AU Bartneck, M
   Topuz, F
   Tag, CG
   Sauer-Lehnen, S
   Warzecha, KT
   Trautwein, C
   Weiskirchen, R
   Tacke, F
AF Bartneck, Matthias
   Topuz, Fuat
   Tag, Carmen Gabriele
   Sauer-Lehnen, Sibille
   Warzecha, Klaudia Theresa
   Trautwein, Christian
   Weiskirchen, Ralf
   Tacke, Frank
TI Molecular response of liver sinusoidal endothelial cells on hydrogels
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Liver sinusoidal endothelial cells; Cell sorting; FACS; MACS; ICAM; VCAM
ID HEPATIC STELLATE CELLS; ISOLATED KUPFFER CELLS; PORTAL-HYPERTENSION;
   ADHESION MOLECULES; E-SELECTIN; FIBROSIS; ULTRASTRUCTURE; ANGIOGENESIS;
   PURIFICATION; HEPATOCYTES
AB There is a high demand for the isolation of primary endothelial cells for biomaterial endotheliazation studies, tissue engineering, and artificial organ development. Further, biomarkers for monitoring the response of endothelial cells in biomaterials science are required. We systematically compared two strategies for isolating liver sinusoidal endothelial cells (LSEC) from mouse liver. We demonstrate that fluorescence-activated cell sorting results in a considerably higher purity (similar to 97%) compared to magnetic-assisted cell sorting (similar to 80%), but is associated with a lower yield and recovery rate. Cell repellent polyethylene glycol (PEG) substrates affected the morphology of primary LSEC in culture and significantly downregulated the intracellular adhesion molecule (ICAM) and upregulated the vascular cell adhesion molecule (VCAM). This molecular response could partially be reverted by further modification with arginylglycylaspartic acid (RGD). Thus, usage of PEGylated materials may reduce, while applying RGD may support endotheliazation of materials, and we could relate LSEC attachment to their expression of ICAM and VCAM mRNA, suggesting their usage as biomarkers for endothelialization. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Bartneck, Matthias; Tag, Carmen Gabriele; Sauer-Lehnen, Sibille; Warzecha, Klaudia Theresa; Trautwein, Christian; Tacke, Frank] RWTH Univ Hosp Aachen, Dept Med 3, D-52074 Aachen, Germany.
   [Topuz, Fuat] Rhein Westfal TH Aachen, DWI eV, D-52056 Aachen, Germany.
   [Topuz, Fuat] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52056 Aachen, Germany.
   [Tag, Carmen Gabriele; Sauer-Lehnen, Sibille; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, D-52074 Aachen, Germany.
RP Tacke, F (reprint author), RWTH Univ Hosp Aachen, Dept Med 3, Pauwelsstr 30, D-52074 Aachen, Germany.
EM frank.tacke@gmx.net
OI Weiskirchen, Ralf/0000-0003-3888-0931
CR Bartneck M, 2014, MACROMOL BIOSCI, V14, P411, DOI 10.1002/mabi.201300362
   Bartneck M, 2012, ACS NANO, V6, P8767, DOI 10.1021/nn302502u
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Beer MV, 2012, ANAL BIOANAL CHEM, V403, P517, DOI 10.1007/s00216-012-5850-9
   BRAET F, 1994, LAB INVEST, V70, P944
   Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522
   DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006.
   DROCHMANS P, 1975, J CELL BIOL, V66, P1, DOI 10.1083/jcb.66.1.1
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   Ehling J, 2013, HEPATOLOGY, V58, P1517, DOI 10.1002/hep.26326
   Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Gulubova MV, 2002, HISTOCHEM J, V34, P67
   Harrington EO, 2006, LUNG, V184, P259, DOI 10.1007/s00408-005-2589-5
   Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x
   KATANO M, 1981, MICROBIOL IMMUNOL, V25, P1059, DOI 10.1111/j.1348-0421.1981.tb00112.x
   Liberek T, 2004, PERITON DIALYSIS INT, V24, P139
   Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550
   Matsumoto K, 2000, BIOCHEM J, V352, P233, DOI 10.1042/0264-6021:3520233
   POLLIACK A, 1978, BLOOD CELLS, V4, P301
   Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3
   Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x
   Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270
   SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509
   Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/egh.11.92, 10.1586/EGH.11.92]
   Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909
   YAN HC, 1994, J IMMUNOL, V152, P3053
   Yokomori H, 2012, MICRON, V43, P129, DOI 10.1016/j.micron.2011.08.002
   You Q, 2013, BIOCHEM PHARMACOL, V86, P836, DOI 10.1016/j.bcp.2013.07.006
   ZAHLTEN RN, 1981, FED PROC, V40, P2460
   Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670
NR 33
TC 4
Z9 4
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 64
EP 72
DI 10.1016/j.msec.2015.02.045
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400009
PM 25842109
DA 2018-10-19
ER

PT J
AU Bernardes, FR
   Rodrigues, SF
   Silva, ES
   Reis, GS
   Silva, MBR
   Junior, AMJ
   Balancin, O
AF Bernardes, Fabiano R.
   Rodrigues, Samuel F.
   Silva, Eden S.
   Reis, Gedeon S.
   Silva, Mariana B. R.
   Junior, Alberto M. J.
   Balancin, Oscar
TI Analytical modeling of the thermomechanical behavior of ASTM F-1586 high
   nitrogen austenitic stainless steel used as a biomaterial under
   multipass deformation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Recrystallization; Precipitates; Z-phase
ID STRAIN-INDUCED PRECIPITATION; NB-BEARING; STATIC RECRYSTALLIZATION; HOT;
   NIOBIUM
AB Precipitation-recrystallization interactions in ASTM F-1586 austenitic stainless steel were studied by means of hot torsion tests with multipass deformation under continuous cooling, simulating an industrial laminating process. Samples were deformed at 0.2 and 03 at a strain rate of 1.0 s(-1), in a temperature range of 900 to 1200 degrees C and interpass times varying from 5 to 80 s. The tests indicate that the stress level depends on deformation temperature and the slope of the equivalent mean stress (EMS) vs. 1/F presents two distinct behaviors, with a transition at around 1100 degrees C, the non-recrystallization temperature (T-nr). Below the T-nr, strain-induced precipitation of Z-phase (NbCrN) occurs in short interpass times (t(pass) < 30 s), inhibiting recrystallization and promoting stepwise stress build-up with strong recovery, which is responsible for increasing the T-nr. At interpass times longer than 30s, the coalescence and dissolution of precipitates promote a decrease in the T-nr and favor the formation of recrystallized grains. Based on this evidence, the physical simulation of controlled processing allows for a domain refined grain with better mechanical properties. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Bernardes, Fabiano R.; Rodrigues, Samuel F.; Silva, Eden S.; Reis, Gedeon S.] Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mat & Mech, BR-65030005 Sao Luis, MA, Brazil.
   [Silva, Mariana B. R.; Junior, Alberto M. J.; Balancin, Oscar] Fed Univ Sao Carlos UFSCar, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Rodrigues, SF (reprint author), Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mat & Mech, Av Getulio Vargas 4, BR-65030005 Sao Luis, MA, Brazil.
EM samuel.filgueiras@ifma.edu.br
RI Silva, Mariana/G-5147-2015; Rodrigues, Samuel/I-2873-2017
OI Silva, Mariana/0000-0001-5044-5436; Rodrigues,
   Samuel/0000-0003-0002-4566
FU CAPES (Federal Agency for the Support and Improvement of Higher
   Education); CNPq (National Council for Scientific and Technological
   Development); FAPEMA (Maranhao Foundation for Scientific Research and
   Development)
FX The authors thank the Brazilian research funding agencies CAPES (Federal
   Agency for the Support and Improvement of Higher Education), CNPq
   (National Council for Scientific and Technological Development) and
   FAPEMA (Maranhao Foundation for Scientific Research and Development) for
   their financial support of this work.
CR ANDERSEN I, 1995, ACTA METALL MATER, V43, P2673, DOI 10.1016/0956-7151(94)00488-4
   BAI DQ, 1993, METALL TRANS A, V24, P2151, DOI 10.1007/BF02648589
   Boratto F., 1988, ISIJ INT TOKYO, P383
   Cuddy L.J., 1982, THERMOMECHANICAL PRO, P129
   Ernrman J., 2004, ACTA MAT, V52, P4337
   Giordani EJ, 2006, SCRIPTA MATER, V55, P743, DOI 10.1016/j.scriptamat.2006.05.015
   Giordani E.J., 2001, MAT SCI ENG C
   Giordani EJ, 2005, MATER SCI FORUM, V500-501, P179, DOI 10.4028/www.scientific.net/MSF.500-501.179
   Gomez M, 2009, MAT SCI ENG A-STRUCT, V501, P188, DOI 10.1016/j.msea.2008.09.074
   HANSEN SS, 1980, METALL TRANS A, V11, P387, DOI 10.1007/BF02654563
   JACK DH, 1973, MATER SCI ENG, V11, P1, DOI 10.1016/0025-5416(73)90055-4
   MEDINA SF, 1995, SCRIPTA METALL MATER, V32, P43, DOI 10.1016/S0956-716X(99)80009-0
   Mousavi Anijdan SH, 2011, MAT SCI ENG A-STRUCT, V528, P803
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Pollak E.l., 1996, ACTA MAT, V44
   Rodrigues SF, 2014, MATER RES-IBERO-AM J, V17, P436, DOI [10.1590/S1516-14392014005000001, 10.1590/S1516-14392014000200023]
   Sakai T, 2014, PROG MATER SCI, V60, P130, DOI 10.1016/j.pmatsci.2013.09.002
   Silva ES, 2012, MAT SCI ENG A-STRUCT, V543, P69, DOI 10.1016/j.msea.2012.02.048
   Sousa R.C., 2012, MAT SCI ENG A-STRUCT, V582, P96
NR 20
TC 1
Z9 1
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 87
EP 98
DI 10.1016/j.msec.2015.02.040
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400012
PM 25842112
DA 2018-10-19
ER

PT J
AU Linan, LZ
   Lima, NMN
   Maciel, R
   Sabino, MA
   Kozlowski, MT
   Manenti, F
AF Linan, Lamia Zuniga
   Nascimento Lima, Nadson M.
   Maciel Filho, Rubens
   Sabino, Marcos A.
   Kozlowski, Mark T.
   Manenti, Flavio
TI Pilot-scale synthesis and rheological assessment of poly(methyl
   methacrylate) polymers: Perspectives for medical application
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; PMMA; Synthesis; Viscoelastic properties; Molecular weight
ID BATCH POLYMERIZATION REACTOR; MOLECULAR-WEIGHT CONTROL; POROUS
   POLYMETHYLMETHACRYLATE; VISCOELASTIC PROPERTIES; PREDICTIVE CONTROL;
   BONE-CEMENT; PMMA; ENTANGLEMENT; SPECTROSCOPY; IMPLANTS
AB This work presents the rheological assessment of poly(methyl methacrylate) (PMMA) polymers synthesized in a dedicated pilot-scale plant. This material is to be used for the construction of scaffolds via Rapid Prototyping (RP). The polymers were prepared to match the physical and biological properties required for medical applications. Differential Scanning Calorimetry (DSC) and Size Exclusion Chromatography (SEC) measurements verified that the synthesized polymers were atactic, amorphous and linear in chains. Rheological properties such as viscosity, storage and loss modulus, beyond the loss factor, and creep and recovery were measured in a plate-plate sensor within the viscoelastic linear region. The results showed the relevant influence of the molecular weight on the viscosity and elasticity of the material, and how, as the molecular weight increases, the viscoelastic properties are getting closer to those of human bone. This article demonstrates that by using the implemented methodology it is possible to synthesize a polymer, with properties comparable to commercially-available PMMA. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Linan, Lamia Zuniga; Nascimento Lima, Nadson M.; Maciel Filho, Rubens] Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
   [Sabino, Marcos A.] Univ Simon Bolivar, Dept Quim, Grp B5IDA, Caracas 1080A, Venezuela.
   [Kozlowski, Mark T.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
   [Manenti, Flavio] Politecn Milan, Dipartamento Chim Mat & Ingn Chim, I-20133 Milan, Italy.
RP Linan, LZ (reprint author), Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
EM lazuli@feq.unicamp.br; nadson@feq.unicamp.br; maciel@feq.unicamp.br;
   msabino@usb.ve; kozthought@gmail.com; flavio.manenti@polimi.it
RI Lima, Nadson/E-8572-2014; FAPESP, BIOEN/H-6149-2012
OI Manenti, Flavio/0000-0002-3305-8044
FU Sao Paulo State Research Support Foundation/Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57860-3, 2009/09092-0,
   2011/09631-8, 2010/16952-2]; National Counsel of Technological and
   Scientific Development (CNPq)/INCT-BIOFABRIS/FEQ/UNICAMP [573661/2008-1]
FX This work was supported by the Sao Paulo State Research Support
   Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP), Grant numbers 2008/57860-3, 2009/09092-0, 2011/09631-8, and
   2010/16952-2 and by the National Counsel of Technological and Scientific
   Development (CNPq)/INCT-BIOFABRIS/FEQ/UNICAMP, Grant number
   573661/2008-1.
CR Ahn SM, 1998, J APPL POLYM SCI, V69, P59, DOI 10.1002/(SICI)1097-4628(19980705)69:1<59::AID-APP8>3.0.CO;2-L
   Antunes AJB, 2005, COMPUT CHEM ENG, V30, P268, DOI 10.1016/j.compchemeng.2005.09.002
   Bruens ML, 2003, J CRANIOFAC SURG, V14, P63, DOI 10.1097/00001665-200301000-00011
   Buechner PM, 2001, ANN BIOMED ENG, V29, P719, DOI 10.1114/1.1385813
   CHANG JS, 1992, IND ENG CHEM RES, V31, P861, DOI 10.1021/ie00003a031
   Chang JS, 1999, IND ENG CHEM RES, V38, P144, DOI 10.1021/ie980403w
   CONGALIDIS JP, 1989, AICHE J, V35, P891, DOI 10.1002/aic.690350603
   Dalosto V.J., 2005, THESIS U FEDERAL RIO
   De Almeida S.G., BIOMATERIAIS
   Eckstein A, 1998, MACROMOLECULES, V31, P1335, DOI 10.1021/ma971270d
   Espalin D, 2010, RAPID PROTOTYPING J, V16, P164, DOI 10.1108/13552541011034825
   Fetters LJ, 1999, MACROMOLECULES, V32, P6847, DOI 10.1021/ma990620o
   Frazer Robert Q, 2005, J Long Term Eff Med Implants, V15, P629
   Fuchs K, 1996, MACROMOLECULES, V29, P5893, DOI 10.1021/ma951385m
   Kim BJ, 2012, J KOREAN NEUROSURG S, V52, P541, DOI 10.3340/jkns.2012.52.6.541
   Kretlow JD, 2010, TISSUE ENG PART C-ME, V16, P1427, DOI 10.1089/ten.tec.2010.0046
   Lima NMN, 2013, COMPUT-AIDED CHEM EN, V32, P163
   Lima NMN, 2010, AICHE J, V56, P965, DOI 10.1002/aic.12030
   Liulan L, 2007, J RARE EARTH, V25, P379
   Mano JF, 2005, MAT SCI ENG C-BIO S, V25, P145, DOI 10.1016/j.msec.2005.01.017
   Mendes R., THESIS
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Muenstedt H, 2008, MACROMOLECULES, V41, P9777, DOI 10.1021/ma800237x
   Pahija E, 2013, COMPUT-AIDED CHEM EN, V32, P805
   Rho HJ, 1998, CHEM ENG SCI, V53, P3729, DOI 10.1016/S0009-2509(98)00166-3
   Salmoria GV, 2008, PROC MONOGR ENG WATE, P305
   Santos JGF, 2006, MACROMOL SYMP, V243, P1, DOI 10.1002/masy.200651101
   Simon PFW, 2001, MACROMOLECULES, V34, P1677, DOI 10.1021/ma0014766
   Stanczyk M, 2005, J BIOMECH, V38, P1397, DOI 10.1016/j.jbiomech.2004.06.021
   TUMINELLO WH, 1986, POLYM ENG SCI, V26, P1339, DOI 10.1002/pen.760261909
   Zuniga L., 2012, COMPUTER AIDED CHEM, V30, P1352
NR 31
TC 2
Z9 2
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 107
EP 116
DI 10.1016/j.msec.2015.02.038
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400014
PM 25842114
DA 2018-10-19
ER

PT J
AU Shao, Y
   Sang, JM
   Fu, JP
AF Shao, Yue
   Sang, Jianming
   Fu, Jianping
TI On human pluripotent stem cell control: The rise of 3D bioengineering
   and mechanobiology
SO BIOMATERIALS
LA English
DT Review
DE Human pluripotent stem cells; Mechanobiology; Bioengineering;
   Regenerative medicine; Development; Human disease modeling
ID SELF-RENEWAL; HIPPO PATHWAY; TUMOR-SUPPRESSOR; IN-VITRO; CARDIOMYOCYTE
   PROLIFERATION; FUNCTIONAL MATURATION; CYTOSKELETAL TENSION;
   ALZHEIMERS-DISEASE; MECHANICAL STRAIN; MEDIATED CONTROL
AB Human pluripotent stem cells (hPSCs) provide promising resources for regenerating tissues and organs and modeling development and diseases in vitro. To fulfill their promise, the fate, function, and organization of hPSCs need to be precisely regulated in a three-dimensional (3D) environment to mimic cellular structures and functions of native tissues and organs. In the past decade, innovations in 3D culture systems with functional biomaterials have enabled efficient and versatile control of hPSC fate at the cellular level. However, we are just at the beginning of bringing hPSC-based regeneration and development and disease modeling to the tissue and organ levels. In this review, we summarize existing bioengineered culture platforms for controlling hPSC fate and function by regulating inductive mechanical and biochemical cues coexisting in the synthetic cell microenvironment. We highlight recent excitements in developing 3D hPSC-based in vitro tissue and organ models with in vivolike cellular structures, interactions, and functions. We further discuss an emerging multifaceted mechanotransductive signaling network with transcriptional coactivators YAP and TAZ at the center stage that regulate fates and behaviors of mammalian cells, including hPSCs. Future development of 3D biomaterial systems should incorporate dynamically modulated mechanical and chemical properties targeting specific intracellular signaling events leading to desirable hPSC fate patterning and functional tissue formation in 3D. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Shao, Yue; Sang, Jianming; Fu, Jianping] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Fu, Jianping] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Fu, JP (reprint author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
EM jpfu@umich.edu
RI Shao, Yue/M-4183-2016; Fu, Jianping/C-9605-2009
OI Shao, Yue/0000-0001-7548-3551; Fu, Jianping/0000-0001-9629-6739
FU National Science Foundation [CMMI 1129611, CBET 1149401, ECCS 1231826,
   CBET 1263889]; National Institutes of Health [R21 HL114011, R21
   EB017078, R01 HL119542]; American Heart Association [12SDG12180025];
   Department of Mechanical Engineering at the University of Michigan, Ann
   Arbor
FX We acknowledge valuable comments and suggestions on the manuscript from
   members of the Integrated Biosystems and Biomechanics Laboratory.
   Research in Dr. Fu's laboratory is supported by the National Science
   Foundation (CMMI 1129611, CBET 1149401, ECCS 1231826, and CBET 1263889),
   the National Institutes of Health (R21 HL114011, R21 EB017078, and R01
   HL119542), the American Heart Association (12SDG12180025), and the
   Department of Mechanical Engineering at the University of Michigan, Ann
   Arbor. Finally, we extend our apologies to all our colleagues in the
   field whose work we are unable to discuss formally because of space
   constraints.
CR Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013
   Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027
   Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693
   Bauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050491
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027
   Blauwkamp TA, 2012, NAT COMMUN, P3
   Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007
   Bratt-Leal AM, 2013, BIOMATERIALS, V34, P7227, DOI 10.1016/j.biomaterials.2013.05.079
   Bratt-Leal AM, 2011, INTEGR BIOL-UK, V3, P1224, DOI 10.1039/c1ib00064k
   Bratt-Leal AM, 2011, BIOMATERIALS, V32, P48, DOI 10.1016/j.biomaterials.2010.08.113
   Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445
   Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Codelia VA, 2014, CURR BIOL, V24, P2012, DOI 10.1016/j.cub.2014.07.034
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cvetkovic C, 2014, P NATL ACAD SCI USA, V111, P10125, DOI 10.1073/pnas.1401577111
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dave PC, 2014, NAT MATER, V13, P532, DOI 10.1038/nmat3997
   Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dixon JE, 2014, P NATL ACAD SCI USA, V111, P5580, DOI 10.1073/pnas.1319685111
   Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019
   Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540
   Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Fung WT, 2009, LAB CHIP, V9, P2591, DOI [10.1039/b903753e, 10.1039/b903753c]
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039
   Hazeltine LB, 2013, BIOTECHNOL ADV, V31, P1002, DOI 10.1016/j.biotechadv.2013.03.002
   Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010
   Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Hoist J, 2010, NAT BIOTECHNOL, V28, P1123
   Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Irwin EE, 2011, BIOMATERIALS, V32, P6912, DOI 10.1016/j.biomaterials.2011.05.058
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778
   Keung AJ, 2012, INTEGR BIOL-UK, V4, P1049, DOI 10.1039/c2ib20083j
   Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim JA, 2013, BIOMATERIALS, V34, P8555, DOI 10.1016/j.biomaterials.2013.07.056
   Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102
   Kim S, 2007, STEM CELLS, V25, P2601, DOI 10.1634/stemcells.2006-0814
   Kinney M, 2013, ANN BIOMED ENG, V42, P352
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832
   Kusuma S, 2013, P NATL ACAD SCI USA, V110, P12601, DOI 10.1073/pnas.1306562110
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee CY, 2013, P NATL ACAD SCI USA, V110, P5022, DOI 10.1073/pnas.1218407110
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811
   Li YQ, 2014, P NATL ACAD SCI USA, V111, P13511, DOI 10.1073/pnas.1411295111
   Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070
   Lim HL, 2011, ADV FUNCT MATER, V21, P55, DOI 10.1002/adfm.201001519
   Ma Z, 2013, BIOMATERIALS, V35, P1367
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Mahlstedt MM, 2010, BIOTECHNOL BIOENG, V105, P130, DOI 10.1002/bit.22520
   Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Meregalli M, 2011, STEM CELL CLIN RES, P17
   Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513
   Mitalipov S, 2009, ADV BIOCHEM ENG BIOT, V114, P185, DOI 10.1007/10_2008_45
   Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638
   Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012
   Musah S, 2014, P NATL ACAD SCI USA, V111, P13805, DOI 10.1073/pnas.1415330111
   Musah S, 2012, ACS NANO, V6, P10168, DOI 10.1021/nn3039148
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nawroth JC, 2013, BIOTECHNOL ADV, V31, P632, DOI 10.1016/j.biotechadv.2012.12.005
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018
   Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014
   Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Reddy BVVG, 2013, DEV CELL, V24, P459, DOI [10.1016/j.devce1.2013.01.020, 10.1016/j.devcel.2013.01.020]
   Remue E, 2010, FEBS LETT, V584, P4175, DOI 10.1016/j.febslet.2010.09.020
   Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891
   Samuel R, 2013, P NATL ACAD SCI USA, V110, P12774, DOI 10.1073/pnas.1310675110
   Sara SN, 2013, NAT METHODS, V10, P781
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873
   Shao Y, 2014, ADV MATER, V26, P1494, DOI 10.1002/adma.201304431
   Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014
   Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Stenberg J, 2011, CYTOTECHNOLOGY, V63, P227, DOI 10.1007/s10616-011-9344-y
   SUDOL M, 1994, ONCOGENE, V9, P2145
   Sun GP, 2013, SCI SIGNAL, V6
   Sun YB, 2014, ACS CHEM NEUROSCI, V5, P621, DOI 10.1021/cn5001155
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Sun YB, 2013, INTEGR BIOL-UK, V5, P450, DOI 10.1039/c2ib20256e
   Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003
   Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110
   Thaxton C, 2007, MOL CELL NEUROSCI, V34, P231, DOI 10.1016/j.mcn.2006.11.003
   Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748
   Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007
   Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Visser-Grieve S, 2011, CELL RES, V21, P1513, DOI 10.1038/cr.2011.122
   Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987
   Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]
   Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107
   Yang Kisuk, 2012, Int J Stem Cells, V5, P1
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025
   Young HE, 2004, ANAT REC PART A, V276A, P75, DOI 10.1002/ar.a.10134
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113
   Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037
   Zhang DW, 2014, BIOMATERIALS, V35, P1420, DOI 10.1016/j.biomaterials.2013.11.028
   Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026
   Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111
   Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810
   Zhou JA, 2010, DEVELOPMENT, V137, P2785, DOI 10.1242/dev.045997
   Zweigerdt R, 2009, ADV BIOCHEM ENG BIOT, V114, P201, DOI 10.1007/10_2008_27
NR 170
TC 39
Z9 40
U1 4
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 52
BP 26
EP 43
DI 10.1016/j.biomaterials.2015.01.078
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG2FT
UT WOS:000353091000003
PM 25818411
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Andreasen, CM
   Ding, M
   Overgaard, S
   Bollen, P
   Andersen, TL
AF Andreasen, Christina M.
   Ding, Ming
   Overgaard, Soren
   Bollen, Peter
   Andersen, Thomas L.
TI A reversal phase arrest uncoupling the bone formation and resorption
   contributes to the bone loss in glucocorticoid treated ovariectomised
   aged sheep
SO BONE
LA English
DT Article
DE Glucocorticoid-induced osteoporosis; Bone remodelling; Reversal phase;
   Coupling; Bone markers; Sheep model
ID LARGE ANIMAL-MODEL; REMODELING COMPARTMENT CANOPIES; CANCELLOUS BONE;
   TRABECULAR BONE; POSTMENOPAUSAL OSTEOPOROSIS; MECHANICAL-PROPERTIES;
   MICROARCHITECTURE; CELLS; VALIDATION; INCREASE
AB Large animals as sheep are often used as models for human osteoporosis. Our aim was therefore to determine how glucocorticoid treatment of ovariectomised sheep affects the cancellous bone, determining the cellular events within the bone remodelling process that contributes to their bone loss. Twenty female sheep were assigned for two groups; an untreated control group and an ovariectomised group treated with glucocorticoids (0.6 mg/kg/day, 5 times weekly) for 7 months.
   At 7 months the glucocorticoid-treated ovariectomised sheep showed a significant change in the bone microstructure revealed by a decreased trabecular bone volume and thickness compared to the control sheep. The treatment led to a temporary elevation of the bone resorption marker CTX (c-terminal collagen telopeptide), while the bode formation marker osteocalcin remained suppressed all 7 months. Histomorphometrically, the treated sheep had a complete absence of osteoid surfaces, and a 5-fold increase in the extent of eroded/reversal surfaces after 7 months. Most of these reversal surfaces were actually arrested reversal surfaces, defined as reversal surfaces without the presence of neighbouring osteoid surfaces or osteoclasts, which is classically observed next to active reversal surfaces. As in humans, these arrested reversal surfaces had compared to active reversal surfaces a reduced canopy coverage, a significantly decreased cell density, and a decreased immunoreactivity for the osteoblastic markers osterix, runx2 and smooth muscle actin in the mononutlear reversal cells colonising the surfaces.
   In conclusion, glucocorticoid treatment of ovariectomised sheep induced a significant bone loss, caused by an arrest of the reversal phase, resulting in an uncoupling of the bone formation and resorption during the reversal phase, as recently demonstrated in postmenopausal women with glucocorticoid-induced osteoporosis. This supports the relevance of the sheep model to the pathophysiology of glucocorticoid-induced osteoporosis in postmenopausal women, making it a relevant preclinical model for orthopaedic implant and biomaterial research. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Andreasen, Christina M.; Ding, Ming; Overgaard, Soren] Univ Southern Denmark, Odense Univ Hosp, Dept Orthopaed & Traumatol O, Orthopaed Res Lab,Inst Clin Res, DK-5000 Odense C, Denmark.
   [Bollen, Peter] Univ Southern Denmark, Biomed Lab, DK-5000 Odense C, Denmark.
   [Andersen, Thomas L.] Univ Southern Denmark, Inst Reg Hlth Res, Dept Clin Cell Biol KCB, Vejle Hosp,Lillebaelt Hosp, DK-7100 Vejle, Denmark.
RP Andreasen, CM (reprint author), Odense Univ Hosp, Orthopaed Res Lab, Dept Orthopaed Surg & Traumatol O, JB Winslowsvej 15, DK-5000 Odense C, Denmark.
EM cmandreasen@health.sdu.dk; ming.ding@rsyd.dk; Soeren.overgaard@rsyd.dk;
   PBollen@health.sdu.dk; thomas.levin.andersen@rsyd.dk
OI Andreasen, Christina M./0000-0002-2624-5677; Ding,
   Ming/0000-0002-6610-8079; Levin Andersen, Thomas/0000-0002-6981-7276;
   Overgaard, Soren/0000-0001-6829-4787
FU Region of Southern Denmark Research Fund [10-5110, 10-15629]; University
   of Southern Denmark [2010-11202]
FX We are thankful to: Gitte Hojlund Reinberg, Birgit MacDonald, Kaja Rau
   Laursen for their excellent technical assistance, Karen Bentsen for the
   preparation of drug solutions and blood samples, and the staff of the
   Biomedical Laboratory for taking good care of the animals. This study is
   supported by the Region of Southern Denmark Research Fund (MD, J nr.
   10-5110 and 10-15629), and the University of Southern Denmark for 1 year
   PhD fellowship to CMA (November 2010-11202).
CR Andersen TL, 2014, AM J PATHOL, V184, P1142, DOI 10.1016/j.ajpath.2013.12.005
   Andersen TL, 2013, AM J PATHOL, V183, P235, DOI 10.1016/j.ajpath.2013.03.006
   Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627
   Arlot M E, 1990, Osteoporos Int, V1, P41, DOI 10.1007/BF01880415
   Augat P, 2003, J BIOMED MATER RES A, V66A, P457, DOI 10.1002/jbm.a.10601
   Baron R, 1983, CLIN DISORDERS BONE, P191
   Baron R, 1980, REVERSAL PHASE OSTEO, P311
   Canalis Ernesto, 2005, Curr Osteoporos Rep, V3, P98, DOI 10.1007/s11914-005-0017-7
   Carbonare LD, 2001, J BONE MINER RES, V16, P97, DOI 10.1359/jbmr.2001.16.1.97
   CHAVASSIEUX P, 1993, OSTEOPOROSIS INT, V3, P97, DOI 10.1007/BF01623380
   Chavassieux P, 1997, BONE, V20, P451, DOI 10.1016/S8756-3282(97)00016-1
   Delaisse Jean-Marie, 2014, Bonekey Rep, V3, P561, DOI 10.1038/bonekey.2014.56
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Ding M, 2002, J ORTHOPAED RES, V20, P615, DOI 10.1016/S0736-0266(01)00132-2
   Ding M, 2012, J TISSUE ENG REGEN M, V6, P443, DOI 10.1002/term.448
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   Dovio A, 2006, EUR J ENDOCRINOL, V154, P745, DOI 10.1530/eje.1.02147
   Dovio A, 2004, J CLIN ENDOCR METAB, V89, P4923, DOI 10.1210/jc.2004-0164
   ERIKSEN EF, 1990, J BONE MINER RES, V5, P311, DOI 10.1002/jbmr.5650050402
   ERIKSEN EF, 1986, ENDOCR REV, V7, P379, DOI 10.1210/edrv-7-4-379
   Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77
   Goldhahn J, 2005, J ORTHOP TRAUMA, V19, P23, DOI 10.1097/00005131-200501000-00005
   Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Jensen PA, 2011, J BONE MINER RES  S1, V26, P57
   Jensen PR, 2014, BIOCHEM BIOPH RES CO, V443, P694, DOI 10.1016/j.bbrc.2013.12.036
   Jensen PR, 2012, J BONE MINER RES, V27, P770, DOI 10.1002/jbmr.1490
   Kristensen HB, 2014, AM J PATHOL, V184, P778, DOI 10.1016/j.ajpath.2013.11.022
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047
   Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2
   Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0
   Oheim R, 2012, EUR CELLS MATER, V24, P372, DOI 10.22203/eCM.v024a27
   Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583
   RIGGS BL, 1991, WESTERN J MED, V154, P63
   Rothberg DL, 2015, CURR OSTEOPOROS REP, V13, P16, DOI 10.1007/s11914-014-0245-9
   Saag KG, 2012, BULL HOSP JT DIS, V70, pS21
   Schorlemmer S, 2003, J BONE MINER RES, V18, P2010, DOI 10.1359/jbmr.2003.18.11.2010
   Soe K, 2013, BONE, V56, P191, DOI 10.1016/j.bone.2013.06.007
   Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113
   Turner AS, 2002, VET J, V163, P232, DOI 10.1053/tvjl.2001.0642
   Veigel E, 2011, OSTEOPOROSIS INT, V22, P1115, DOI 10.1007/s00198-010-1289-z
   Weinstein R S, 2001, Rev Endocr Metab Disord, V2, P65, DOI 10.1023/A:1010007108155
   Wu ZX, 2008, MED ENG PHYS, V30, P1112, DOI 10.1016/j.medengphy.2008.01.007
   Zarrinkalam MR, 2009, EUR SPINE J, V18, P244, DOI 10.1007/s00586-008-0813-8
NR 45
TC 12
Z9 13
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD JUN
PY 2015
VL 75
BP 32
EP 39
DI 10.1016/j.bone.2015.02.014
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CG1ZQ
UT WOS:000353075100005
PM 25689083
DA 2018-10-19
ER

PT J
AU Iqbal, N
   Kadir, MRA
   Bin Mahmood, NH
   Iqbal, S
   Almasi, D
   Naghizadeh, F
   Balaji, HR
   Kamarul, T
AF Iqbal, Nida
   Kadir, Mohammed Rafiq Abdul
   Bin Mahmood, Nasrul Humaimi
   Iqbal, Saman
   Almasi, D.
   Naghizadeh, Farnaz
   Balaji, H. R.
   Kamarul, Tunku
TI Characterization and biological evaluation of silver containing
   fluoroapatite nanoparticles prepared through microwave synthesis
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomaterial; Bioactivity; Antibacterial; Metal ions; Microwave; Cell
   culture
ID FLUORIDATED HYDROXYAPATITE COATINGS; ANTIBACTERIAL PROPERTIES;
   SUBSTITUTED HYDROXYAPATITE; CALCIUM HYDROXYAPATITE; BONE; BIOCERAMICS;
   BIOACTIVITY; PHOSPHATES; DEPOSITION; COMPOSITE
AB Nanosized hydroxyapatite is a material that is commonly used as a matrix for bone tissue engineering. Although its chemical property is similar to that of natural bone, its limited antibacterial property has made it less desirable for use in present-day clinical applications. In the present study, we have investigated the possibility of improving the antibacterial and bioactivity of hydroxyapatite, by producing nanosized silver-containing fluorapatite, using the microwave technique.
   Nanosized silver-fluorapatite particles were synthesized using 0.5 and 1=x fluoride through co-precipitation and the microwave refluxing treatment at 800 W, for 8 min. The crystalline phase, chemical composition, and morphology of the prepared samples were characterized using X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), energy dispersive X-ray analysis (EDX), and transmission electron microscopy (TEM). The chemical analysis indicated the presence of a nanosized silver-fluorapatite phase. Transmission electron microscopy analysis showed a spheroid-like morphology, with an approximate diameter of +/- 76-92 nm. The bioactivity of the prepared samples, which was evaluated using simulated body fluid (SBF) immersion for 28 days, demonstrated good apatite layer formation. The antibacterial activity was evaluated using the disk diffusion method and showed good growth inhibition, while the osteoblast culture studies indicated that the presence of silver and fluoride provided superior cell attachment and growth. The antibacterial and cell culture results indicated that this new nanosized silver-fluorapatite bioceramic material had good antibacterial qualities, but remained biocompatible with osteoblasts. These findings suggested that nanosized silver-fluorapatite could potentially be used for bone regeneration applications. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Iqbal, Nida; Kadir, Mohammed Rafiq Abdul; Bin Mahmood, Nasrul Humaimi; Naghizadeh, Farnaz] Univ Teknol Malaysia UTM, Fac Biosci & Med Engn, Med Devices & Technol Grp MEDITEG, Johor Baharu 81310, Johor, Malaysia.
   [Iqbal, Saman] Univ Engn & Technol, Dept Phys, Lahore, Pakistan.
   [Almasi, D.] Univ Teknol Malaysia, Fac Mech Engn, Dept Mfg & Ind Engn, Skudai 81310, Johor, Malaysia.
   [Balaji, H. R.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Kuala Lumpur, Malaysia.
RP Kadir, MRA (reprint author), Univ Teknol Malaysia UTM, Fac Biosci & Med Engn, Med Devices & Technol Grp MEDITEG, Johor Baharu 81310, Johor, Malaysia.
EM rafiq@biomedical.utm.my
RI Abdul Kadir, Mohammed/D-1117-2010; balaji raghavendran, hanumantha
   rao/B-8507-2012; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011
OI Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313
FU UTM [45027]; HIR-Ministry of Education University of Malaya
   [UM.C/625/1/HIR/MOHE/CHAN/o3-A000003-50001]
FX The authors would like to acknowledge the Institute of Medical Molecular
   Biotechnology (IMMB), Faculty of Medicine UiTM for providing cell
   culture facilities. The authors would also like to acknowledge the
   financial support provided by UTM research grant science funding (Vote:
   45027) and HIR-Ministry of Education
   (UM.C/625/1/HIR/MOHE/CHAN/o3-A000003-50001) University of Malaya.
CR Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016
   Ann L.C., 2014, J ENV CHEM ENG
   Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Fathi MH, 2006, SURF ENG, V22, P353, DOI 10.1179/174329406X126708
   Fleet ME, 2000, J SOLID STATE CHEM, V149, P391, DOI 10.1006/jssc.1999.8563
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hristoffersen J., 1984, J CRYST GROWTH, V67, P102
   Hund W, 1998, CFI-CERAM FORUM INT, V75, P13
   Iconaru SL, 2012, DIG J NANOMATER BIOS, V7, P399
   Iqbal N, 2014, CERAM INT, V40, P16091, DOI 10.1016/j.ceramint.2014.07.038
   Iqbal N, 2013, ADV MATER RES-SWITZ, V795, P692, DOI 10.4028/www.scientific.net/AMR.795.692
   Iqbal N, 2014, CERAM INT, V40, P4507, DOI 10.1016/j.ceramint.2013.08.125
   Iqbal N, 2013, MATER RES BULL, V48, P3172, DOI 10.1016/j.materresbull.2013.04.068
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kolmas J, 2014, BIOMED RES INT, DOI 10.1155/2014/178123
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Lin JHC, 2001, J MATER SCI-MATER M, V12, P731, DOI 10.1023/A:1011280828663
   MARQUIS RE, 1995, CAN J MICROBIOL, V41, P955, DOI 10.1139/m95-133
   Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1016/S0168-6445(02)00143-2
   Nie YL, 2012, J HAZARD MATER, V233, P194, DOI 10.1016/j.jhazmat.2012.07.020
   Pripatnanont P, 2007, J ORAL MAXIL SURG, V65, P2418, DOI 10.1016/j.joms.2007.06.619
   Qu HB, 2006, ACTA BIOMATER, V2, P113, DOI 10.1016/j.actbio.2005.09.003
   Rameshbabu N, 2006, B MATER SCI, V29, P611, DOI 10.1007/s12034-006-0012-3
   Solignac M, 1998, PRESSE MED, V27, P27
   Spivak JM, 2001, EUR SPINE J, V10, pS197, DOI 10.1007/s005860100286
   Sun F, 2013, J BIOMED NANOTECHNOL, V9, P1914, DOI 10.1166/jbn.2013.1687
   Tredwin CJ, 2013, DENT MATER, V29, P166, DOI 10.1016/j.dental.2012.11.008
   Turkoz M, 2013, CERAM INT, V39, P8925, DOI 10.1016/j.ceramint.2013.04.088
   Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Victoria E. Caroline, 2002, TRENDS BIOMATER ARTI, V16, P12
   Wang J, 2009, ACTA BIOMATER, V5, P1798, DOI 10.1016/j.actbio.2009.01.005
   Wang YS, 2007, ACTA BIOMATER, V3, P191, DOI 10.1016/j.actbio.2006.10.002
   Zhang HG, 2006, J MATER SCI-MATER M, V17, P691, DOI 10.1007/s10856-006-9679-7
   Zhu HL, 2013, ASIAN J CHEM, V25, P8444, DOI 10.14233/ajchem.2013.14779
NR 41
TC 12
Z9 12
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN
PY 2015
VL 41
IS 5
BP 6470
EP 6477
DI 10.1016/j.ceramint.2015.01.086
PN A
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA CG3JK
UT WOS:000353176300046
DA 2018-10-19
ER

PT J
AU Agyemang, FO
   Sheikh, FA
   Appiah-Ntiamoah, R
   Chandradass, J
   Kim, H
AF Agyemang, Frank Ofori
   Sheikh, Faheem A.
   Appiah-Ntiamoah, Richard
   Chandradass, Jeyaseelan
   Kim, Hern
TI Synthesis and characterization of poly (vinylidene fluoride)-calcium
   phosphate composite for potential tissue engineering applications
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Poly (vinylidene fluoride); Calcium phosphate; Scaffolds; Bio-composite;
   Tensile strength
ID POLY(VINYLIDENE FLUORIDE); POLYVINYLIDENE FLUORIDE; PVDF MEMBRANES;
   BOVINE BONES; HYDROXYAPATITE; BIOMATERIALS; EXTRACTION; MORPHOLOGY;
   BEHAVIOR; MINERALIZATION
AB Tricalcium phosphate is the most commonly used biomaterial because of its good biocompatibility. However, its poor mechanical strength under complex stress and powder-like appearance hinder its application. The use of a composite biomaterial which maintains a fine balance between excellent mechanical properties and biocompatibility can be a solution to this problem. In the present study, we aimed to fabricate porous composite scaffolds via phase-inversion technique without using any additional toxic chemicals which can interfere with their biocompatibility. The composite materials fabricated of poly (vinylidene fluoride) and tricalcium phosphates were prepared, using polyvinyl pyrrolidone as a dispersant. The resulting scaffolds were characterized by using attenuated total reflection infrared spectroscopy (FTIR-ATR), scanning electron microscopy (SEM), therm gravimetric analysis (TGA), differential scanning calorimetry (DSC), X-ray diffraction (XRD) and universal tensile strength (UTM) analysis. The composites showed well blend of materials and internal porous structures. The XRD results indicated a mixture of alpha and beta-phases due to successful incorporation of tricalcium phosphate in polymer blends, thereby, exhibiting a crystalline structure. The fabricated composites showed an efficient thermal stability at around 400 degrees C. The tensile strength of scaffolds increased from 140 +/- 1.6 to 148 +/- 2.2 g/mm(2), which makes the composite scaffold potential candidate for hard tissue applications. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Agyemang, Frank Ofori; Sheikh, Faheem A.; Appiah-Ntiamoah, Richard; Chandradass, Jeyaseelan; Kim, Hern] Myongji Univ, Environm Fus Technol Ctr, Dept Energy & Biotechnol, Yongin 449728, Gyeonggi Do, South Korea.
RP Kim, H (reprint author), Myongji Univ, Environm Fus Technol Ctr, Dept Energy & Biotechnol, Yongin 449728, Gyeonggi Do, South Korea.
EM faheem99in@yahoo.com; hernkim@mju.ac.kr
RI Sheikh, Faheem/Q-9166-2018
OI Sheikh, Faheem/0000-0003-0942-4398
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT
   and Future Planning [2014R1A2A2A01004352]; Ministry of Education,
   Republic of Korea [2009-0093816]
FX This study was supported by National Research Foundation of Korea (NRF)
   - Grants funded by the Ministry of Science, ICT and Future Planning
   (2014R1A2A2A01004352) and the Ministry of Education, Republic of Korea
   (2009-0093816).
CR AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Aoki N, 1997, BBA-GEN SUBJECTS, V1334, P207, DOI 10.1016/S0304-4165(96)00094-3
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BALLINTYN NJ, 1979, BIOMATER ARTIF CELL, V7, P23, DOI 10.3109/10731197909119369
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Barakat NAM, 2008, MAT SCI ENG C-BIO S, V28, P1381, DOI 10.1016/j.msec.2008.03.003
   Boccaccio T, 2002, J MEMBRANE SCI, V210, P315, DOI 10.1016/S0376-7388(02)00407-6
   Bottino A, 2001, SEP PURIF TECHNOL, V22-3, P269, DOI 10.1016/S1383-5866(00)00127-1
   Coles LG, 2014, P I MECH ENG H, V228, P1217, DOI 10.1177/0954411914560835
   Dey A, 2011, CERAM INT, V37, P1377, DOI 10.1016/j.ceramint.2011.01.005
   Dillon DR, 2006, POLYMER, V47, P1678, DOI 10.1016/j.polymer.2006.01.015
   Fang LM, 2005, BIOMATERIALS, V26, P3471, DOI 10.1016/j.biomaterials.2004.09.022
   GALLANTREE HR, 1983, IEE PROC-I, V130, P219, DOI 10.1049/ip-i-1.1983.0040
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Geringer J, 2011, WEAR, V271, P2793, DOI 10.1016/j.wear.2011.05.034
   GUENARD V, 1991, BIOMATERIALS, V12, P259, DOI 10.1016/0142-9612(91)90210-2
   Huang X., 2014, CHIN MED J, V127, P3171
   Kang GD, 2014, J MEMBRANE SCI, V463, P145, DOI 10.1016/j.memsci.2014.03.055
   Laroche G, 1998, J BIOMED MATER RES, V39, P184, DOI 10.1002/(SICI)1097-4636(199802)39:2<184::AID-JBM3>3.0.CO;2-L
   Lemes HD, 2015, INT J ORAL MAX SURG, V44, P389, DOI 10.1016/j.ijom.2014.11.009
   Lin DJ, 2006, EUR POLYM J, V42, P1581, DOI 10.1016/j.eurpolymj.2006.01.027
   Liu F, 2011, J MEMBRANE SCI, V375, P1, DOI 10.1016/j.memsci.2011.03.014
   Liu ZH, 1998, POLYMER, V39, P1779, DOI 10.1016/S0032-3861(97)00222-X
   Lu HF, 2003, BIOMATERIALS, V24, P4893, DOI 10.1016/S0142-9612(03)00404-6
   Ma R, 2014, INT J MOL SCI, V15, P5426, DOI 10.3390/ijms15045426
   Mano JF, 2003, POLYMER, V44, P4293, DOI 10.1016/S0032-3861(03)00361-6
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Niklason LE, 2001, JAMA-J AM MED ASSOC, V285, P573, DOI 10.1001/jama.285.5.573
   Pant HR, 2013, COLLOID SURFACE B, V102, P152, DOI 10.1016/j.colsurfb.2012.08.032
   Rekik H, 2013, COMPOS PART B-ENG, V45, P1199, DOI 10.1016/j.compositesb.2012.08.002
   Rodriguez K, 2011, ACS APPL MATER INTER, V3, P681, DOI 10.1021/am100972r
   Salimi A, 2003, POLYM TEST, V22, P699, DOI 10.1016/S0142-9418(03)00003-5
   Sheikh FA, 2011, J BIOMATER TISS ENG, V1, P194, DOI 10.1166/jbt.2011.1017
   Slosarczyk A, 2010, CERAM INT, V36, P577, DOI 10.1016/j.ceramint.2009.09.032
   Takauti Carlos Alberto Yoshihiro, 2014, Braz. Dent. J., V25, P379, DOI 10.1590/0103-6440201302383
   Tazaki M, 1997, J APPL POLYM SCI, V65, P1517
   Thein-Han W, 2011, TISSUE ENG PT A, V17, P2943, DOI 10.1089/ten.tea.2010.0674
   Wang W, 2011, ANN ACAD MED SINGAP, V40, P237
   Xu ZH, 2005, J MEMBRANE SCI, V255, P125, DOI 10.1016/j.memsci.2005.02.001
   Yeow ML, 2004, J APPL POLYM SCI, V92, P1782, DOI 10.1002/app.20141
   ZULFIQAR S, 1994, POLYM DEGRAD STABIL, V43, P423, DOI 10.1016/0141-3910(94)90015-9
NR 41
TC 10
Z9 10
U1 2
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN
PY 2015
VL 41
IS 5
BP 7066
EP 7072
DI 10.1016/j.ceramint.2015.02.014
PN B
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA CG3JL
UT WOS:000353176400054
DA 2018-10-19
ER

PT J
AU Lee, SJ
   Betensky, RA
   Gianneschi, GE
   Gallucci, GO
AF Lee, Sang J.
   Betensky, Rebecca A.
   Gianneschi, Grace E.
   Gallucci, German O.
TI Accuracy of digital versus conventional implant impressions
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; conventional impression; digital impression; implant
   restoration
ID DENTAL CAD/CAM TECHNOLOGY; COMPUTER-AIDED ANALYSIS; IN-VITRO; MODELS
AB ObjectiveThe accuracy of digital impressions greatly influences their clinical viability in implant restorations. The aim of this study was to compare the accuracy of gypsum models acquired from the conventional implant impression to digitally milled models created from direct digitalization by three-dimensional analysis.
   Materials and MethodsThirty gypsum and 30 digitally milled models, impressed directly from a reference model, were prepared. The models and reference model were scanned by a laboratory scanner, and 30 surface tessellation language datasets from each group were imported to an inspection software program. The datasets were aligned to the reference dataset by a repeated best-fit algorithm, and 10 specified contact locations of interest were measured in mean volumetric deviations. The areas were pooled by cusps, fossae, interproximal contacts, horizontal and vertical axes of implant position and angulation. The pooled areas were statistically analysed by comparing each group to the reference model to investigate the mean volumetric deviations accounting for accuracy and standard deviations for precision.
   ResultsMilled models from digital impressions had comparable accuracy to gypsum models from conventional impressions. However, differences in fossae and vertical displacement of the implant position from the gypsum and digitally milled models compared to the reference model exhibited statistical significance (P<0.001, P=0.020, respectively).
   ConclusionMilled models from digital impression are comparable to gypsum models from conventional impression.
C1 [Lee, Sang J.; Gianneschi, Grace E.; Gallucci, German O.] Harvard Univ, Sch Dent Med, Dept Restorat Dent & Biomat Sci, Boston, MA 02115 USA.
   [Betensky, Rebecca A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
RP Lee, SJ (reprint author), Harvard Univ, Sch Dent Med, Dept Restorat Dent & Biomat Sci, 188 Longwood Ave, Boston, MA 02115 USA.
EM sang_lee@hsdm.harvard.edu
RI Gallucci, German/H-4505-2011
FU ITI Foundation (Basel, Switzerland) [733-2010]
FX This study was funded by the ITI Foundation (Basel, Switzerland)
   Research Grant No. 733-2010. The author(s) would like to gratefully
   acknowledge the statistical assistance and collaboration through Harvard
   Catalyst. The author(s) declare no potential conflict of interests with
   respect to the research, authorship and/or publication of this article.
CR Brosky ME, 2003, J PROSTHET DENT, V90, P434, DOI 10.1016/j.prosdent.2003.08.021
   Chandran DT, 2010, BIO-MED MATER ENG, V20, P243, DOI 10.3233/BME-2010-0638
   Christensen GJ, 2008, J AM DENT ASSOC, V139, P761, DOI 10.14219/jada.archive.2008.0258
   Christensen GJ, 2009, J AM DENT ASSOC, V140, P1301, DOI 10.14219/jada.archive.2009.0054
   DeLong R, 2001, J Prosthodont, V10, P78, DOI 10.1111/j.1532-849X.2001.00078.x
   DeLong R, 2003, J DENT RES, V82, P438, DOI 10.1177/154405910308200607
   Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1
   Guth JF, 2013, CLIN ORAL INVEST, V17, P1389, DOI 10.1007/s00784-012-0812-3
   Guth JF, 2013, CLIN ORAL INVEST, V17, P1201, DOI 10.1007/s00784-012-0795-0
   Karl M, 2004, INT J ORAL MAX IMPL, V19, P30
   Larson TD, 2002, J PROSTHET DENT, V87, P625, DOI 10.1067/mpr.2002.125180
   Lee H, 2008, J PROSTHET DENT, V99, P107, DOI 10.1016/S0022-3913(08)60026-8
   Lee SJ, 2013, CLIN ORAL IMPLAN RES, V24, P111, DOI 10.1111/j.1600-0501.2012.02430.x
   Ma T, 1997, INT J ORAL MAX IMPL, V12, P371
   Persson ASK, 2008, DENT MATER, V24, P1123, DOI 10.1016/j.dental.2008.01.008
   Persson ASK, 2009, DENT MATER, V25, P929, DOI 10.1016/j.dental.2009.01.100
   Quaas S, 2007, J DENT, V35, P903, DOI 10.1016/j.jdent.2007.08.008
   Rudolph H, 2007, COMPUT BIOL MED, V37, P579, DOI 10.1016/j.compbiomed.2006.05.006
   Sorrentino Roberto, 2010, Clin Implant Dent Relat Res, V12 Suppl 1, pe63, DOI 10.1111/j.1708-8208.2009.00167.x
   SPECTOR MR, 1990, J PROSTHET DENT, V63, P444, DOI 10.1016/0022-3913(90)90235-5
   Stimmelmayr M., 2012, CLIN ORAL INVEST, V17, P1929
   Stimmelmayr M, 2012, CLIN ORAL INVEST, V16, P1137, DOI 10.1007/s00784-011-0622-z
   Stimmelmayr M, 2012, CLIN ORAL INVEST, V16, P851, DOI 10.1007/s00784-011-0564-5
NR 23
TC 28
Z9 30
U1 0
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2015
VL 26
IS 6
BP 715
EP 719
DI 10.1111/clr.12375
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CG6JQ
UT WOS:000353407000014
PM 24720423
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Afonso, MLCD
   Jaimes, RFVV
   Nascente, PAP
   Rogero, SO
   Agostinho, SML
AF Chaves de Andrade Afonso, Monica Luisa
   Vera Villamil Jaimes, Ruth Flavia
   Nascente, Pedro A. P.
   Rogero, Sizue Ota
   Leite Agostinho, Silvia Maria
TI Surface characterization, electrochemical behaviour and cytotoxicity of
   UNS S31254 stainless steel for orthopaedic applications
SO MATERIALS LETTERS
LA English
DT Article
DE 254 stainless steel; Sodium chloride; Orthopaedic implants
ID CORROSION; IMPLANTS; PASSIVATION; ALBUMIN
AB The surface characterization and electrochemical behaviour of UNS S31254 (254 SS) have been performed in 0.15 mol L-1 NaCl medium in order to evaluate its application as orthopaedic implants. Polarization curves, chronoamperometry, electrochemical impedance spectroscopy and X-ray photoelectron spectroscopy were used for characterizing the samples. A cytotoxicity test was also performed to study the biocompatibility of the proposed steel as biomaterial. The electrochemical behaviour of 254 SS was compared to that observed for ISO 5832-9 and ASTM F138 stainless steels, used in orthopaedic implants. 254 SS is similar to ISO 5832-9 SS: it is passivated on the potential range between the corrosion and the transpassivation potential. Mo (VI) forms an outer layer which blocks Cr (VI) dissolution. Cytotoxicity test showed no cytotoxic character of 254 SS. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Chaves de Andrade Afonso, Monica Luisa] Inst Super Tecn, Inst Telecomun, P-1049001 Lisbon, Portugal.
   [Vera Villamil Jaimes, Ruth Flavia; Leite Agostinho, Silvia Maria] Univ Sao Paulo, Inst Quim, BR-05508900 Sao Paulo, SP, Brazil.
   [Nascente, Pedro A. P.] Univ Fed Sao Carlos, Dept Engn Mat, BR-13565905 Sao Carlos, SP, Brazil.
   [Rogero, Sizue Ota] Inst Pesquisas Energet & Nucl, BR-05508000 Sao Paulo, SP, Brazil.
RP Agostinho, SML (reprint author), Univ Sao Paulo, Inst Quim, Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, SP, Brazil.
EM smlagost@iq.usp.br
RI Afonso, Monica/H-9088-2013
OI Afonso, Monica/0000-0003-3100-1906
FU FAPESP [01\10051-4]; CNPq [200989\2011-1]
FX The authors thank FAPESP (Grant no. 01\10051-4), CNPq (Grant no.
   200989\2011-1) and Adolfo Lutz Instiitute by cytotoxicity analysis, ASTM
   International, West Conshohocken, PA.
CR Afonso MLCA, 2008, COLLOID SURFACE A, V317, P760, DOI 10.1016/j.colsurfa.2007.11.014
   Bisquert J, 1998, J ELECTROANAL CHEM, V452, P229, DOI 10.1016/S0022-0728(98)00115-6
   Boukamp B, 1998, EQUIVCRT COMPUTER SO, V4, P51
   Disegi J., 2000, INJURY, V31, pD2
   Doh SJ, 2003, NUCL INSTRUM METH B, V199, P211, DOI 10.1016/S0168-583X(02)01548-3
   Frateur I, 2006, ELECTROCHIM ACTA, V51, P1550, DOI 10.1016/j.electacta.2005.02.116
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Ilevbare GO, 2003, CORROS SCI, V45, P1545, DOI 10.1016/S0010-938X(02)00229-9
   International Organization for Standardization, 2009, 10993 ISO
   Li R, 1997, SURF COAT TECH, V88, P90, DOI 10.1016/S0257-8972(96)02865-4
   Macdonald JR, 1996, IMPEDANCE SPECTROSCO
   Micheli L. D., 1999, British Corrosion Journal, V34, P67
   Padilha AF, 2005, J MATER PROCESS TECH, V170, P89, DOI 10.1016/j.jmatprotec.2005.05.002
   QVARFORT R, 1989, CORROS SCI, V29, P987
   Rodrigues SF, 2014, MATER RES-IBERO-AM J, V17, P436, DOI [10.1590/S1516-14392014005000001, 10.1590/S1516-14392014000200023]
   Rogero Sizue Ota, 2003, Mat. Res., V6, P317, DOI 10.1590/S1516-14392003000300003
   Salahinejad E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061633
   Jaimes RFVV, 2010, MATER LETT, V64, P1476, DOI 10.1016/j.matlet.2010.03.066
   Villamil R. F. V., 2002, REV BRAS ORTOP, V37, P471
   Villamil RFV, 2003, ASTM STP, V1438, pP168
   Walczak J, 1998, BIOMATERIALS, V19, P229, DOI 10.1016/S0142-9612(97)00208-1
NR 21
TC 2
Z9 2
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUN 1
PY 2015
VL 148
BP 71
EP 75
DI 10.1016/j.matlet.2015.01.157
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CG2IC
UT WOS:000353097100018
DA 2018-10-19
ER

PT J
AU Filli, L
   Luechinger, R
   Frauenfelder, T
   Beck, S
   Guggenberger, R
   Farshad-Amacker, N
   Andreisek, G
AF Filli, Lukas
   Luechinger, Roger
   Frauenfelder, Thomas
   Beck, Stefan
   Guggenberger, Roman
   Farshad-Amacker, Nadja
   Andreisek, Gustav
TI Metal-induced artifacts in computed tomography and magnetic resonance
   imaging: comparison of a biodegradable magnesium alloy versus titanium
   and stainless steel controls
SO SKELETAL RADIOLOGY
LA English
DT Article
DE Biodegradable implants; Magnesium; Artifacts; Magnetic resonance
   imaging; Multidetector computed tomography
ID IN-VITRO; VIVO EVALUATION; REDUCTION; CT; IMPLANTS; ALGORITHM; STRENGTH
AB To evaluate metal artifacts induced by biodegradable magnesium-a new class of degradable biomaterial that is beginning to enter the orthopedic routine-on CT and MRI compared to standard titanium and steel controls.
   Different pins made of titanium, stainless steel, and biodegradable magnesium alloys were scanned using a second-generation dual-energy multidetector CT and a 1.5-T MR scanner. In CT, quantitative assessment of artifacts was performed by two independent readers by measuring the noise in standardized regions of interest close to the pins. In MRI, the artifact diameter was measured. Interobserver agreement was evaluated using intraclass correlation coefficients. Artifacts were compared using Mann Whitney U tests.
   In comparison to stainless steel, biodegradable magnesium alloys induced significantly fewer artifacts in both 1.5-T MRI (p = 0.019-0.021) and CT (p = 0.003-0.006). Compared to titanium, magnesium induced significantly less artifact-related noise in CT (p = 0.003-0.008). Although artifacts were less on MRI for biodegradable magnesium compared to titanium, this result was not statistically significant.
   Biodegradable magnesium alloys induce substantially fewer artifacts in CT compared to standard titanium and stainless steel, and fewer artifacts in MRI for the comparison with stainless steel.
C1 [Filli, Lukas; Frauenfelder, Thomas; Guggenberger, Roman; Farshad-Amacker, Nadja; Andreisek, Gustav] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland.
   [Luechinger, Roger] Univ Zurich, Inst Biomed Engn, CH-8091 Zurich, Switzerland.
   [Luechinger, Roger] Swiss Fed Inst Technol, CH-8091 Zurich, Switzerland.
   [Beck, Stefan] Synthes GmbH, CH-4528 Zuchwil, Switzerland.
   [Filli, Lukas] Univ Zurich Hosp, Dept Radiol, CH-8091 Zurich, Switzerland.
RP Filli, L (reprint author), Univ Zurich Hosp, Dept Radiol, Ramistr 100, CH-8091 Zurich, Switzerland.
EM lukas.filli@usz.ch; roman.guggenberger@usz.ch;
   thomas.frauenfelder@usz.ch; Beck.Stefan@synthes.com;
   roman.guggenberger@usz.ch; nadja.farshad@usz.ch; gustav@andreisek.de
RI Frauenfelder, Thomas/O-1734-2016
OI Frauenfelder, Thomas/0000-0002-3295-6619; Luechinger,
   Roger/0000-0002-7365-0421
CR [Anonymous], 2007, F211907 ASTM
   Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065
   Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020
   Ernstberger T, 2007, SPINE J, V7, P353, DOI 10.1016/j.spinee.2006.03.016
   Ernstberger T, 2009, NEURORADIOLOGY, V51, P525, DOI 10.1007/s00234-009-0537-4
   Guggenberger R, 2012, EUR RADIOL, V22, P2357, DOI 10.1007/s00330-012-2501-7
   Harris CA, 2006, ORTHOP CLIN N AM, V37, P349, DOI 10.1016/j.ocl.2006.04.001
   Koch KM, 2011, MAGN RESON MED, V65, P71, DOI 10.1002/mrm.22523
   Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860
   Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087
   Liu PT, 2009, SKELETAL RADIOL, V38, P797, DOI 10.1007/s00256-008-0630-5
   Mahnken AH, 2003, INVEST RADIOL, V38, P769, DOI 10.1097/01.rli.0000086495.96457.54
   Moon SG, 2008, J COMPUT ASSIST TOMO, V32, P630, DOI 10.1097/RCT.0b013e3181568b27
   Morsbach F, 2013, RADIOLOGY, V268, P237, DOI 10.1148/radiol.13122089
   Ostrowski N, 2013, ACTA BIOMATER, V9, P8704, DOI 10.1016/j.actbio.2013.05.010
   Prell D, 2010, INVEST RADIOL, V45, P747, DOI 10.1097/RLI.0b013e3181e94384
   Prell D, 2009, PHYS MED BIOL, V54, P6575, DOI 10.1088/0031-9155/54/21/009
   Shinohara Y, 2013, ACTA RADIOL
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5
   Sutter R, 2012, RADIOLOGY, V265, P204, DOI 10.1148/radiol.12112408
   Tello R, 2003, RADIOLOGY, V227, P1, DOI 10.1148/radio1.2271020085
   Ulbrich EJ, 2012, AM J ROENTGENOL, V199, pW735, DOI 10.2214/AJR.11.8233
   Waizy H, 2013, J BIOMATER APPL
   Wang J, 2013, ACTA BIOMATER, V9, P8678, DOI 10.1016/j.actbio.2013.02.041
   White Lawrence M, 2002, Semin Musculoskelet Radiol, V6, P5, DOI 10.1055/s-2002-23160
   Windhagen H, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-62
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Zomorodian A, 2013, ACTA BIOMATER, V9, P8660, DOI 10.1016/j.actbio.2013.02.036
NR 30
TC 10
Z9 10
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2348
EI 1432-2161
J9 SKELETAL RADIOL
JI Skeletal Radiol.
PD JUN
PY 2015
VL 44
IS 6
BP 849
EP 856
DI 10.1007/s00256-014-2057-5
PG 8
WC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
SC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
GA CG4ED
UT WOS:000353235100009
PM 25417003
DA 2018-10-19
ER

PT J
AU Zhai, MM
   Cui, RJ
   Gu, N
   Zhang, GH
   Lin, W
   Yu, LJ
AF Zhai, Mumu
   Cui, Rongjing
   Gu, Ning
   Zhang, Genhua
   Lin, Wang
   Yu, Lingjun
TI Nanocomposite of Au Nanoparticles/Helical Carbon Nanofibers and
   Application in Hydrogen Peroxide Biosensor
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Helical Carbon Nanofibers; Hemoglobin; Biosensor; Hydrogen Peroxide
ID DIRECT ELECTROCHEMISTRY; HEMOGLOBIN; ELECTRODE; NANOTUBES;
   ELECTROCATALYSIS; ARRAY; FILM
AB A combined sol-gel/hydrogen reduction method has been developed for the mass production of helical carbon nanofibers (HCNFs) by the pyrolysis of acetylene at 425 degrees C in the presence of NiO nanoparticles. The synthesized HCNFs were characterized with scanning electron microscopy (SEM), X-ray diffraction (XRD) and high resolution transmission electron microscopy (HRTEM). The helical-structured carbon nanofibers have a large specific surface area and excellent biocompatibility. A novel enzymatic hydrogen peroxide sensor was then successfully fabricated based on the nanocomposites containing HCNFs and gold nanoparticles (AuNPs). The results indicated that the Au/HCNFs nanoconnposites exhibited excellent electrocatalytic activity to the reduction of H2O2, offering a wide linear range from 1.0 mu M to 3157 mu M with a detection limit as low as 0.46 AM. The apparent Michaelis-Menten constant of the biosensor was 0.61 mM. The as-fabricated biosensor showed a rapid and sensitive amperometric response to hydrogen peroxide with acceptable preparation reproducibility and excellent stability. Because of their low cost and high stability, these novel HCNFs represent seem to be a kind of promising biomaterial and may find wide new applications in scopes such as biocatalysis, immunoassay, environmental monitoring and so on.
C1 [Cui, Rongjing; Zhang, Genhua; Yu, Lingjun] Changshu Inst Technol, Changshu 215500, Peoples R China.
   [Zhai, Mumu; Gu, Ning; Lin, Wang] Hebei Normal Univ, Dept Chem & Mat, Shijiazhuang 050024, Peoples R China.
RP Cui, RJ (reprint author), Changshu Inst Technol, Changshu 215500, Peoples R China.
FU National Natural Science Foundation of China [20905010, 21005034];
   Jiangsu Provincial Natural Science Foundation [BK 20131191]; Suzhou
   Science and technology project [SYN201302]; Hebei Provincial Natural
   Science Foundation [B2011205079]; Hebei Province Department of Education
   Fund [20052022]
FX We greatly appreciate the support of the National Natural Science
   Foundation of China (20905010 and 21005034), Jiangsu Provincial Natural
   Science Foundation (No. BK 20131191) and Suzhou Science and technology
   project (SYN201302). The work is also supported by Hebei Provincial
   Natural Science Foundation (B2011205079) and Hebei Province Department
   of Education Fund (20052022).
CR Bahshi L, 2008, ANAL CHEM, V80, P8253, DOI 10.1021/ac801398m
   Banks CE, 2005, ANALYST, V130, P1232, DOI 10.1039/b508702c
   Cai CX, 2004, ANAL BIOCHEM, V325, P285, DOI 10.1016/j.ab.2003.10.040
   Chen X, 2009, NANO RES, V2, P210, DOI [10.1007/s12274-009-9019-6, 10.1007/S12274-009-9019-6]
   Dequaire M, 2000, ANAL CHEM, V72, P5521, DOI 10.1021/ac000781m
   Hernadi K, 2001, J PHYS CHEM B, V105, P12464, DOI 10.1021/jp0111208p
   Hu GZ, 2012, J MATER CHEM, V22, P8541, DOI 10.1039/c2jm16075g
   Jia NQ, 2009, SENSOR ACTUAT B-CHEM, V137, P230, DOI 10.1016/j.snb.2008.10.011
   Jiang HR, 2013, J BIOMED NANOTECHNOL, V9, P674, DOI 10.1166/jbn.2013.1575
   KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010
   Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004
   Khan A. J., 2013, J BIONANOSCI, V7, P530
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Li JZ, 2000, ANAL CHEM, V72, P5338, DOI 10.1021/ac000611+
   Li S, 2012, THERANOSTICS, V2, P967, DOI 10.7150/thno.5032
   Liu MC, 2009, ELECTROCHEM COMMUN, V11, P1397, DOI 10.1016/j.elecom.2009.05.015
   Mao CJ, 2012, BIOSENS BIOELECTRON, V31, P544, DOI 10.1016/j.bios.2011.10.001
   Mathur A., 2013, J BIONANOSCI, V7, P140
   MATSUBARA C, 1992, ANALYST, V117, P1781, DOI 10.1039/an9921701781
   Mewada A., 2013, J BIONANOSCI, V7, P174, DOI DOI 10.1166/JBNS.2013.1107
   Nitze F, 2012, ELECTROCHIM ACTA, V63, P323, DOI 10.1016/j.electacta.2011.12.104
   Ren ML, 2005, BIOSENS BIOELECTRON, V21, P433, DOI 10.1016/j.bios.2004.08.052
   Shan CS, 2010, BIOSENS BIOELECTRON, V25, P1504, DOI 10.1016/j.bios.2009.11.009
   Shan D, 2009, SENSOR ACTUAT B-CHEM, V137, P259, DOI 10.1016/j.snb.2008.11.029
   Singh V. M., 2013, J BIONANOSCI, V7, P420
   Sotiropoulou S, 2003, ANAL BIOANAL CHEM, V375, P103, DOI 10.1007/s00216-002-1617-z
   Sun JY, 2011, BIOELECTROCHEMISTRY, V82, P125, DOI 10.1016/j.bioelechem.2011.06.007
   Sun W, 2009, BIOELECTROCHEMISTRY, V74, P295, DOI 10.1016/j.bioelechem.2008.11.001
   Tang NJ, 2008, J PHYS CHEM C, V112, P10061, DOI 10.1021/jp8017293
   Varma M. M., 2013, J BIONANOSCI, V7, P360
   Wang Y, 2009, ANAL CHEM, V81, P9710, DOI 10.1021/ac901935a
   Xu HF, 2010, TALANTA, V81, P334, DOI 10.1016/j.talanta.2009.12.006
NR 32
TC 4
Z9 4
U1 1
U2 136
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2015
VL 15
IS 6
BP 4682
EP 4687
DI 10.1166/jnn.2015.9700
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AY2QW
UT WOS:000347435300091
PM 26369097
DA 2018-10-19
ER

PT J
AU Leszczak, V
   Baskett, DA
   Popat, KC
AF Leszczak, Victoria
   Baskett, Dominique A.
   Popat, Ketul C.
TI Endothelial Cell Growth and Differentiation on Collagen-Immobilized
   Polycaprolactone Nanowire Surfaces
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Endothelial Cells; Polycaprolactone Nanowire Surfaces; VE-Cadherin; von
   Willebrand Factor; Collagen
ID IN-VITRO; INTEGRIN ALPHA-2-BETA-1; SHEAR-STRESS; SCAFFOLDS; ADHESION;
   PROLIFERATION; FIBROBLASTS; CULTURE; MATRIX; REGENERATION
AB The success of cardiovascular implants is associated with the development of an endothelium on material surface, critical to the prevention of intimal hyperplasia, calcification and thrombosis. A thorough understanding of the interaction between vascular endothelial cells and the biomaterial involved is essential in order to have a successful application which promotes healing and regeneration through integration with native tissue. In this study, we have developed collagen immobilized nanostructured surfaces with controlled arrays of high aspect ratio nanowires for the growth and maintenance of human microvascular endothelial cells (HMVECs). The nanowire surfaces were fabricated from polycaprolactone using a novel nanotemplating technique, and were immobilized with collagen utilizing an aminolysis method. The collagen immobilized nanowire surfaces were characterized using contact angle measurements, scanning electron microscopy and X-ray photoelectron spectroscopy. Human microvascular endothelial cells were used to evaluate the efficacy of the collagen immobilized nanowire surfaces to promote cell adhesion, proliferation, viability and differentiation. The results presented here indicate significantly higher cellular adhesion, proliferation and viability on nanowire and collagen immobilized surfaces as compared to the control surface. Further, HMVECs have a more elongated body and low shape factor on nanostructured surfaces. The differentiation potential of collagen immobilized nanowire surfaces was also evaluated by immunostaining and western blotting for key endothelial cell markers that are expressed when human microvascular endothelial cells are differentiated. Results indicate that expression of VE-cadherin is increased on collagen immobilized surfaces while the expression of von Willebrand factor is statistically similar on all surfaces.
C1 [Leszczak, Victoria; Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Baskett, Dominique A.] Colorado State Univ, Dept Biomed Engn, Ft Collins, CO 80523 USA.
   [Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Popat, KC (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM ketul.popat@colostate.edu
OI Popat, Ketul C./0000-0002-2417-7789
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [5-R21-AR057341-02]
FX Research reported in this publication was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Number 5-R21-AR057341-02. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Arnoult O., 2010, NOVEL BENIGN SOLUTIO
   Baek J. -Y., 2012, J NANOMATER, V2012, DOI DOI 10.1155/2012/171804
   Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009
   Bechara SL, 2010, BIOMATERIALS, V31, P3492, DOI 10.1016/j.biomaterials.2010.01.084
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   Chew SY, 2011, J BIOMED MATER RES A, V97A, P355, DOI 10.1002/jbm.a.33064
   CLYMAN RI, 1990, CIRC RES, V67, P175, DOI 10.1161/01.RES.67.1.175
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Farhadi M, 2012, J BIOMED MATER RES A, V100A, P549, DOI 10.1002/jbm.a.33293
   GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Hong Y, 2008, J BIOMED MATER RES A, V85A, P628, DOI 10.1002/jbm.a.31603
   Joseph C., 2008, NANOTECHNOLOGY, V19
   Kim JH, 2002, J BIOMED MATER RES, V62, P613, DOI 10.1002/jbm.10340
   Krithica N, 2012, ADV ENG MATER, V14, pB149, DOI 10.1002/adem.201180035
   Leszczak V., 2013, J BIOMATER SCI POLYM, V1
   Leszczak V, 2013, J BIOMAT SCI-POLYM E, V24, P1529, DOI 10.1080/09205063.2013.777228
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   MANTOVANI A, 1992, FASEB J, V6, P2591
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   PALMER RMJ, 1992, BRIT J PHARMACOL, V105, P11, DOI 10.1111/j.1476-5381.1992.tb14202.x
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Popat KC, 2003, J VAC SCI TECHNOL B, V21, P645, DOI 10.1116/1.1545733
   Porter JR, 2009, TISSUE ENG PT A, V15, P2547, DOI 10.1089/ten.tea.2008.0476
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Pozzi Ambra, 1998, Journal of Cell Biology, V142, P587, DOI 10.1083/jcb.142.2.587
   RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548
   Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001
   Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Tuckwell D, 1996, SEMIN CELL DEV BIOL, V7, P649, DOI 10.1006/scdb.1996.0079
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhu YB, 2009, MAT SCI ENG C-BIO S, V29, P1046, DOI 10.1016/j.msec.2008.09.004
NR 53
TC 5
Z9 5
U1 0
U2 87
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUN
PY 2015
VL 11
IS 6
BP 1080
EP 1092
DI 10.1166/jbn.2015.2021
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AT5FP
UT WOS:000344969900014
PM 26353596
DA 2018-10-19
ER

PT J
AU Babur, BK
   Kabiri, M
   Klein, TJ
   Lott, WB
   Doran, MR
AF Babur, Betul Kul
   Kabiri, Mahboubeh
   Klein, Travis Jacob
   Lott, William B.
   Doran, Michael Robert
TI The Rapid Manufacture of Uniform Composite Multicellular-Biomaterial
   Micropellets, Their Assembly into Macroscopic Organized Tissues, and
   Potential Applications in Cartilage Tissue Engineering
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   ARTICULAR-CARTILAGE; REPAIR; MATRIX; SCAFFOLD; KNEE
AB We and others have published on the rapid manufacture of micropellet tissues, typically formed from 100-500 cells each. The micropellet geometry enhances cellular biological properties, and in many cases the micropellets can subsequently be utilized as building blocks to assemble complex macrotissues. Generally, micropellets are formed from cells alone, however when replicating matrix-rich tissues such as cartilage it would be ideal if matrix or biomaterials supplements could be incorporated directly into the micropellet during the manufacturing process. Herein we describe a method to efficiently incorporate donor cartilage matrix into tissue engineered cartilage micropellets. We lyophilized bovine cartilage matrix, and then shattered it into microscopic pieces having average dimensions < 10 mu m diameter; we termed this microscopic donor matrix "cartilage dust (CD)". Using a microwell platform, we show that similar to 0.83 mu g CD can be rapidly and efficiently incorporated into single multicellular aggregates formed from 180 bone marrow mesenchymal stem/stromal cells (MSC) each. The microwell platform enabled the rapid manufacture of thousands of replica composite micropellets, with each micropellet having a material/CD core and a cellular surface. This micropellet organization enabled the rapid bulking up of the micropellet core matrix content, and left an adhesive cellular outer surface. This morphological organization enabled the ready assembly of the composite micropellets into macroscopic tissues. Generically, this is a versatile method that enables the rapid and uniform integration of biomaterials into multicellular micropellets that can then be used as tissue building blocks. In this study, the addition of CD resulted in an approximate 8-fold volume increase in the micropellets, with the donor matrix functioning to contribute to an increase in total cartilage matrix content. Composite micropellets were readily assembled into macroscopic cartilage tissues; the incorporation of CD enhanced tissue size and matrix content, but did not enhance chondrogenic gene expression.
C1 [Babur, Betul Kul; Kabiri, Mahboubeh; Lott, William B.; Doran, Michael Robert] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.
   [Kabiri, Mahboubeh] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran.
   [Klein, Travis Jacob] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Cartilage Regenerat Lab, Brisbane, Qld 4001, Australia.
   [Doran, Michael Robert] Univ Queensland, Mater Med Res, Brisbane, Qld, Australia.
RP Doran, MR (reprint author), Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.
EM michael.doran@qut.edu.au
RI Doran, Michael/F-6059-2014; Lott, William/J-1062-2012
OI Lott, William/0000-0001-7118-7560; Doran, Michael/0000-0001-5876-4757;
   Klein, Travis/0000-0002-6669-7766
FU Australian National Health and Medical Research Council (NHMRC) [631629]
FX This study was funded by the Australian National Health and Medical
   Research Council (NHMRC), grant number 631629
   (https://www.nhmrc.gov.au/), MRD received the funding. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865
   Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869
   Behrens P, 1999, MMW Fortschr Med, V141, P49
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   Brand CA, 2013, ARTHRITIS CARE RES H
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de
   Chen A, 2012, ARTHRITIS, V2012, DOI [10.1155/2012/698709, DOI 10.1155/2012/698709]
   Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541
   Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002
   Ebert JR, 2008, OSTEOARTHR CARTILAGE, V16, P1131, DOI 10.1016/j.joca.2008.03.010
   Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560
   Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206
   Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367
   POTTENGER LA, 1982, J BIOL CHEM, V257, P1479
   Robertson WB, 2004, STANDARD PRACTICE EX
   Schuurman W., 2013, J TISSUE ENG REGENER
   Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014
   Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0
NR 27
TC 6
Z9 6
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 28
PY 2015
VL 10
IS 5
AR e0122250
DI 10.1371/journal.pone.0122250
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ0SC
UT WOS:000355187300003
PM 26020956
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Dai, MZ
   Sun, LG
   Chao, L
   Tan, YM
   Fu, YC
   Chen, C
   Xie, QJ
AF Dai, Mengzhen
   Sun, Lingen
   Chao, Long
   Tan, Yueming
   Fu, Yingchun
   Chen, Chao
   Xie, Qingji
TI Immobilization of Enzymes by Electrochemical and Chemical Oxidative
   Polymerization of L-DOPA to Fabricate Amperometric Biosensors and
   Biofuel Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE electrochemical/chemical oxidative polymerization of L-DOPA; polymeric
   bionanocomposite; enzyme electrode; glucose biosensing; biofuel cell
ID MULTIWALLED CARBON NANOTUBES; QUARTZ-CRYSTAL MICROBALANCE; CAST
   THIN-FILMS; GLUCOSE-OXIDASE; GOLD NANOPARTICLES; GRAPHENE OXIDE; AU
   ELECTRODE; PERFORMANCE; ELECTROPOLYMERIZATION; BIONANOCOMPOSITES
AB Electrochemical/chemical oxidative synthesis and biosensing/biofuel cell applications of poly(L-DOPA) (PD) are studied versus polydopamine (PDA) as a recent hotspot biomaterial. The enzyme electrode developed by coelectrodeposition of PD and glucose oxidase (GOx), uricase, or tyrosinase shows biosensing performance superior to that of the corresponding PDA-based enzyme electrode. The chemical oxidative polymerization of L-DOPA (PDC) by NaAuCl4 in GOx-containing neutral aqueous solution is used to immobilize GOx and gold nanoparticles (AuNPs). The thus-prepared chitosan (CS)/GOx-PDC-AuNPs/Auplate/Au electrode working in the first-generation biosensing mode responds linearly to glucose concentration with a sensitivity of 152 mu A mM(-1) cm(-2), which is larger than those of the CS/GOx-PDA(C)-AuNPs/Au-plate/Au electrode, the CS/GOx-poly(3-anilineboronic acid) (PABA)-AuNPs/Au-plate/Au electrode, and the most reported GOx-based enzyme electrodes. This PDC-based enzyme electrode also works well in the second-generation biosensing mode and as an excellent bioanode in biofuel cell construction, probably because PD as an amino acid polymer has the higher biocompatibility and the more favorable affinity to the enzyme than PDA. The PD material of great convenience in synthesis, outstanding biocompatibility for preparing high-performance bionanocomposites, and strong capability of multifunctional coatings on many surfaces may find wide applications in diversified fields including biotechnology and surface-coating.
C1 [Dai, Mengzhen; Sun, Lingen; Chao, Long; Tan, Yueming; Fu, Yingchun; Chen, Chao; Xie, Qingji] Hunan Normal Univ, Natl & Local Joint Engn Lab New Petrochem Mat & F, Key Lab Chem Biol & Tradit Chinese Med Res, Minist Educ,Coll Chem & Chem Engn, Changsha 410081, Hunan, Peoples R China.
RP Xie, QJ (reprint author), Hunan Normal Univ, Natl & Local Joint Engn Lab New Petrochem Mat & F, Key Lab Chem Biol & Tradit Chinese Med Res, Minist Educ,Coll Chem & Chem Engn, Changsha 410081, Hunan, Peoples R China.
EM xieqj@hunnu.edu.cn
OI Fu, Yingchun/0000-0003-0550-9052; Tan, Yueming/0000-0003-3356-9079
FU National Natural Science Foundation of China [21475041, 21175042,
   21305041, 21105026, 21405042]; Hunan Lotus Scholars Program; Foundations
   of Hunan Provincial Education and Science/Technology Department
   [2014SK3096]; Program for Science and Technology Innovative Research
   Team in Higher Educational Institutions of Hunan Province
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 21475041, 21175042, 21305041, 21105026, and 21405042),
   Hunan Lotus Scholars Program, Foundations of Hunan Provincial Education
   and Science/Technology Department (2014SK3096), and Program for Science
   and Technology Innovative Research Team in Higher Educational
   Institutions of Hunan Province.
CR Arnow LE, 1937, J BIOL CHEM, V118, P531
   Ball V., 2012, J BIONANOSCI, V2, P16
   Baron R, 2005, ANAL CHEM, V77, P1566, DOI 10.1021/ac048691v
   Chen C, 2013, RSC ADV, V3, P4473, DOI 10.1039/c2ra22351a
   Chen C, 2011, BIOSENS BIOELECTRON, V26, P2311, DOI 10.1016/j.bios.2010.09.058
   Chen C, 2009, BIOSENS BIOELECTRON, V24, P2726, DOI 10.1016/j.bios.2008.12.016
   Chen SM, 2003, J ELECTROANAL CHEM, V547, P179, DOI 10.1016/S0022-0728(03)00220-1
   Dey RS, 2013, ACS APPL MATER INTER, V5, P4791, DOI 10.1021/am400280u
   FITZPATRICK TB, 1950, SCIENCE, V112, P223, DOI 10.1126/science.112.2904.223
   Fu YC, 2008, ANAL CHEM, V80, P5829, DOI 10.1021/ac800178p
   Fu YC, 2013, ACS APPL MATER INTER, V5, P934, DOI 10.1021/am302602s
   Fu YC, 2011, ANAL CHEM, V83, P6511, DOI 10.1021/ac200471v
   Fu YC, 2010, J PHYS CHEM C, V114, P1472, DOI 10.1021/jp9092767
   Fu YC, 2009, ADV FUNCT MATER, V19, P1784, DOI 10.1002/adfm.200801576
   Herz W., 2007, PROGR CHEM ORGANIC N, P131
   Huang Y, 2012, BIOSENS BIOELECTRON, V31, P357, DOI 10.1016/j.bios.2011.10.045
   JIMBOW K, 1976, J INVEST DERMATOL, V67, P72, DOI 10.1111/1523-1747.ep12512500
   Kohli N, 2007, MACROMOL BIOSCI, V7, P789, DOI 10.1002/mabi.200700006
   Korani A, 2013, BIOSENS BIOELECTRON, V50, P186, DOI 10.1016/j.bios.2013.05.047
   Lakshmi D, 2009, ANAL CHEM, V81, P3576, DOI 10.1021/ac802536p
   Lang QL, 2014, BIOSENS BIOELECTRON, V51, P158, DOI 10.1016/j.bios.2013.07.021
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Levis Joel T, 2011, J Emerg Med, V40, pe107, DOI 10.1016/j.jemermed.2008.01.008
   Li YL, 2006, THIN SOLID FILMS, V497, P270, DOI 10.1016/j.tsf.2005.10.048
   Li YY, 2012, SENSOR ACTUAT B-CHEM, V168, P46, DOI 10.1016/j.snb.2012.01.013
   Li YY, 2010, SENSOR ACTUAT B-CHEM, V151, P30, DOI 10.1016/j.snb.2010.09.061
   Lu CC, 2011, ELECTROANAL, V23, P2421, DOI 10.1002/elan.201100291
   Luo XL, 2004, ANAL BIOCHEM, V334, P284, DOI 10.1016/j.ab.2004.07.005
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   MASON HS, 1948, J BIOL CHEM, V172, P83
   Matsumoto A, 2009, J AM CHEM SOC, V131, P12022, DOI 10.1021/ja902964m
   MCDOWELL F, 1970, ANN INTERN MED, V72, P29, DOI 10.7326/0003-4819-72-1-29
   Mercuri NB, 2005, TRENDS PHARMACOL SCI, V26, P341, DOI 10.1016/j.tips.2005.05.002
   Palanisamy S, 2014, COLLOID SURFACE B, V114, P164, DOI 10.1016/j.colsurfb.2013.10.006
   Porta G. D., 1966, STRUCTURE CONTROL ED, P155
   Rakhi RB, 2009, J PHYS CHEM B, V113, P3190, DOI 10.1021/jp810235v
   Raper HS, 1928, PHYSIOL REV, V8, P245
   Scherbahn V, 2014, BIOSENS BIOELECTRON, V61, P631, DOI 10.1016/j.bios.2014.05.027
   Shan CS, 2010, BIOSENS BIOELECTRON, V25, P1070, DOI 10.1016/j.bios.2009.09.024
   Smith K., 1978, PHOTOCH PHOTOBIO SCI, P115
   Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271
   Su YH, 2008, BIOTECHNOL PROGR, V24, P262, DOI 10.1021/bp070256+
   Tan YM, 2008, ELECTROANAL, V20, P1599, DOI 10.1002/elan.200804220
   Tan YM, 2010, J PHYS CHEM B, V114, P5016, DOI 10.1021/jp100922t
   Tan YM, 2009, BIOSENS BIOELECTRON, V24, P2225, DOI 10.1016/j.bios.2008.11.026
   Thibault S, 2008, MICROCHIM ACTA, V163, P211, DOI 10.1007/s00604-008-0028-z
   WAITE JH, 1980, BIOCHEM BIOPH RES CO, V96, P1554, DOI 10.1016/0006-291X(80)91351-0
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a
   Wang YX, 2013, J CHROMATOGR A, V1283, P20, DOI 10.1016/j.chroma.2013.01.110
   Xiao Y, 2007, NAT PROTOC, V2, P2875, DOI 10.1038/nprot.2007.413
   Xie QJ, 2003, J COLLOID INTERF SCI, V262, P107, DOI 10.1016/S0021-9797(03)00196-6
   Yang ZP, 2014, BIOSENS BIOELECTRON, V51, P268, DOI 10.1016/j.bios.2013.07.054
   Yehezkeli O, 2011, ACS NANO, V5, P2385, DOI 10.1021/nn200313t
   Zayats M, 2002, J AM CHEM SOC, V124, P2120, DOI 10.1021/ja025503e
   Zhang J, 2007, NAT PROTOC, V2, P2888, DOI 10.1038/nprot.2007.419
   Zhang SX, 2005, BIOELECTROCHEMISTRY, V67, P15, DOI 10.1016/j.bioelechem.2004.12.002
   Zhang ZJ, 2011, J ELECTROANAL CHEM, V650, P241, DOI 10.1016/j.jelechem.2010.10.016
NR 58
TC 13
Z9 13
U1 11
U2 123
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 27
PY 2015
VL 7
IS 20
BP 10843
EP 10852
DI 10.1021/acsami.5b01865
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CJ3KQ
UT WOS:000355382800026
PM 25938891
DA 2018-10-19
ER

PT J
AU Jeffords, ME
   Wu, JL
   Shah, M
   Hong, Y
   Zhang, G
AF Jeffords, Megan E.
   Wu, Jinglei
   Shah, Mickey
   Hong, Yi
   Zhang, Ge
TI Tailoring Material Properties of Cardiac Matrix Hydrogels To Induce
   Endothelial Differentiation of Human Mesenchymal Stem Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE cardiac extracellular matrix; injectable hydrogel; genipin; human
   mesenchymal stem cells; stem cell differentiation
ID EXTRACELLULAR-MATRIX; POSTMYOCARDIAL INFARCTION; HEART-DISEASE;
   CROSS-LINKING; IN-VITRO; GENIPIN; TISSUE; THERAPY; DELIVERY; REPAIR
AB Cardiac matrix hydrogel has shown great promise as an injectable biomaterial due to the possession of cardiac-specific extracellular matrix composition. A cardiac matrix hydrogel facilitating neovascularization will further improve its therapeutic outcomes in cardiac repair. In this study, we explored the feasibility Of tailoring material properties of cardiac matrix hydrogels using a natural compound, genipin, to promote endothelial differentiation of stem cells. Our results demonstrated that the genipin cross-linking could increase the mechanical properties of the cardiac matrix hydrogel to a stiffness range promoting endothelial differentiation of human mesenchymal stem cells (hMSCs). It also decreased. the swelling ratio and prolonged degradation without altering gelation time. Human mesenchymal stem cells cultured on the genipin cross-linked cardiac matrix hydrogels showed great viability. After 1 day culture, hMSCs demonstrated down-regulation of early endothelial marker expression and up-regulation of mature endothelial marker expression. Especially for 1 mM genipin cross-linked cardiac matrix hydrogels, hMSCs showed particularly significant expression of mature endothelial cell marker vWF. These attractive results indicate the potential of using genipin cross-linked cardiac matrix hydrogels to promote rapid vascularization for cardiac infarction treatment through minimally invasive therapy.
C1 [Jeffords, Megan E.; Shah, Mickey; Zhang, Ge] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Wu, Jinglei; Hong, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Wu, Jinglei; Hong, Yi] Univ Texas SW Med Ctr Dallas, Joint Biomed Engn Program, Dallas, TX 75390 USA.
RP Hong, Y (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM yihong@uta.edu; gezhang@uakron.edu
FU National Institutes of Health [1R15HL122949]; American Heart Association
   [14BGIA20510066]; University of Akron
FX We greatly appreciate the financial support from the National Institutes
   of Health (Grant No. 1R15HL122949 to G.Z.) and the American Heart
   Association (Grant No. 14BGIA20510066 to Y.H.). M.E.J. thanks the
   University of Akron for a graduate fellowship.
CR Cashman TJ, 2013, STEM CELL REV REP, V9, P254, DOI 10.1007/s12015-012-9375-6
   Chou SH, 2014, CELL TRANSPLANT, V23, P513, DOI 10.3727/096368914X678436
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   George JC, 2010, TRANSL RES, V155, P10, DOI 10.1016/j.trsl.2009.06.009
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011
   Hoganson DM, 2010, BIOMATERIALS, V31, P6934, DOI 10.1016/j.biomaterials.2010.05.026
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031
   Lalit PA, 2014, CIRC RES, V114, P1328, DOI 10.1161/CIRCRESAHA.114.300556
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Macaya D, 2011, ADV FUNCT MATER, V21, P4788, DOI 10.1002/adfm.201101720
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Ni NC, 2014, SEMIN THORAC CARDIOV, V26, P44, DOI 10.1053/j.semtcvs.2014.03.001
   Ong SR, 2006, BIOMATERIALS, V27, P1930, DOI 10.1016/j.biomaterials.2005.10.018
   Patel DM, 2013, STEM CELLS INT, DOI 10.1155/2013/496218
   Przybyt E, 2013, CURR STEM CELL RES T, V8, P270, DOI 10.2174/1574888X11308040002
   Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   TSENG TH, 1995, CANCER LETT, V97, P61, DOI 10.1016/0304-3835(95)03964-X
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Williams C, 2015, ACTA BIOMATER, V14, P84, DOI 10.1016/j.actbio.2014.11.035
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wu JL, 2015, ACTA BIOMATER, V16, P49, DOI 10.1016/j.actbio.2015.01.027
   Yamazaki M, 2009, BIOL PHARM BULL, V32, P1043, DOI 10.1248/bpb.32.1043
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
NR 43
TC 17
Z9 18
U1 2
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 27
PY 2015
VL 7
IS 20
BP 11053
EP 11061
DI 10.1021/acsami.5b03195
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CJ3KQ
UT WOS:000355382800052
PM 25946697
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mueller, V
   Laakmann, E
   Fehm, TN
   Moebus, V
   Von Minckwitz, G
   Loibl, S
   Witzel, I
AF Mueller, Volkmar
   Laakmann, Elena
   Fehm, Tanja N.
   Moebus, Volker
   Von Minckwitz, Gunter
   Loibl, Sibylle
   Witzel, Isabell
TI Brain Metastases in Breast Cancer Network Germany (BMBC; GBG 79):
   Multicentric, retro- and prospective collection of patient data and
   biomaterial from patients with brain metastases.
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) /
   Clinical Science Symposium on Predicting and Improving Adverse Outcomes
   in Older Adults with Cancer
CY MAY 29-JUN 02, 2015
CL Chicago, IL
SP Amer Soc Clin Oncol
C1 Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.
   Univ Duesseldorf, Dusseldorf, Germany.
   Klinikum Frankfurt Hoechst, Frankfurt, Germany.
   German Breast Grp, Neu Isenburg, Germany.
NR 0
TC 2
Z9 2
U1 0
U2 1
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
EI 1527-7755
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD MAY 20
PY 2015
VL 33
IS 15
SU S
MA TPS639
PG 1
WC Oncology
SC Oncology
GA CM9OA
UT WOS:000358036904831
DA 2018-10-19
ER

PT J
AU Lu, J
   Zou, X
   Zhao, Z
   Mu, ZD
   Zhao, YJ
   Gu, ZZ
AF Lu, Jie
   Zou, Xin
   Zhao, Ze
   Mu, Zhongde
   Zhao, Yuanjin
   Gu, Zhongze
TI Cell Orientation Gradients on an Inverse Opal Substrate
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE cell gradient; inverse opal; colloidal crystal; cell orientation;
   biomaterial
ID NANOFIBER SCAFFOLDS; BARCODE PARTICLES; BIOMATERIALS; ALIGNMENT; REPAIR
AB The generation of cell gradients is critical for understanding many biological systems and realizing the unique functionality of many implanted biomaterials. However, most previous work can only control the gradient of cell density and this has no effect on the gradient of cell orientation, which has an important role in regulating the functions of many connecting tissues. Here, we report on a simple stretched inverse opal substrate for establishing desired cell orientation gradients. It was demonstrated that tendon fibroblasts on the stretched inverse opal gradient showed a corresponding alignment along with the elongation gradient of the substrate. This "random-to-aligned" cell gradient reproduces the insertion part of many connecting tissues, and thus, will have important applications in tissue engineering.
C1 [Lu, Jie; Zou, Xin; Zhao, Ze; Mu, Zhongde; Zhao, Yuanjin; Gu, Zhongze] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Zhao, Yuanjin; Gu, Zhongze] Southeast Univ, Lab Environm & Biosafety, Res Inst, Suzhou 215123, Peoples R China.
RP Zhao, YJ (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM yjzhao@seu.edu.cn; gu@seu.edu.cn
RI Zhao, Yuanjin/I-1861-2013
FU National Science Foundation of China [21473029, 91227124, 21327902];
   National Science Foundation of Jiangsu [BK20140028, BK20131293];
   research Fund for the Doctoral Program of Higher Education of China
   [20120092130006]; Science and Technology Development Program of Suzhou
   [ZXG2012021]; Program for Changjiang Scholars and Innovative Research
   Team in University [IRT1222]; Technology Invocation Team of Qinglan
   Project of Jiangsu Province; Program for New Century Excellent Talents
   in University
FX This work was supported by the National Science Foundation of China
   (Grants 21473029, 91227124, and 21327902), the National Science
   Foundation of Jiangsu (Grants BK20140028 and BK20131293), the research
   Fund for the Doctoral Program of Higher Education of China
   (20120092130006), the Science and Technology Development Program of
   Suzhou (Grant ZXG2012021), the Program for Changjiang Scholars and
   Innovative Research Team in University (IRT1222), the Technology
   Invocation Team of Qinglan Project of Jiangsu Province, and the Program
   for New Century Excellent Talents in University.
CR Brendon M. B., 2008, BIOMATERIALS, V29, P2348
   Cheng Y, 2014, ADV MATER, V26, P5184, DOI 10.1002/adma.201400798
   Christopher J. B., 2009, ANGEW CHEM INT EDIT, V48, P5406
   Ding B, 2012, J PHYS CHEM B, V116, P2545, DOI 10.1021/jp209604m
   Feng LH, 2013, CHEM SOC REV, V42, P6620, DOI 10.1039/c3cs60036j
   Fujie T, 2013, NANO LETT, V13, P3185, DOI 10.1021/nl401237s
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Gurkan UA, 2014, MOL PHARMACEUT, V11, P2151, DOI 10.1021/mp400573g
   Katarina W., 2003, BLOOD, V102, P3262
   Li H., 2011, J MATER CHEM, V21, P14113
   Li HL, 2008, ADV FUNCT MATER, V18, P3258, DOI 10.1002/adfm.200800507
   Li Y, 2015, BIOMACROMOLECULES, V16, P780, DOI 10.1021/bm501680s
   Lipner J, 2014, J MECH BEHAV BIOMED, V40, P59, DOI 10.1016/j.jmbbm.2014.08.002
   Liu W, 2014, SMALL, V10, P88, DOI 10.1002/smll.201301253
   Liu WY, 2013, ANGEW CHEM INT EDIT, V52, P429, DOI 10.1002/anie.201206060
   Lu J, 2014, NANOSCALE, V6, P10650, DOI 10.1039/c4nr02626h
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Saha S, 2012, LANGMUIR, V28, P2028, DOI 10.1021/la203846w
   Wang DY, 2003, ADV MATER, V15, P205, DOI 10.1002/adma.200390046
   Wang YM, 2014, ACS APPL MATER INTER, V6, P2958, DOI 10.1021/am405556x
   Xie JW, 2010, NANOSCALE, V2, P923, DOI 10.1039/c0nr00192a
   Yang G., 2014, ANGEW CHEM, V126, P2959
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   Zhao YJ, 2015, SMALL, V11, P151, DOI 10.1002/smll.201401600
   Zheng FY, 2014, ADV MATER, V26, P7333, DOI 10.1002/adma.201403530
   Zheng WF, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4898209
   Zhou XT, 2012, ACS APPL MATER INTER, V4, P3888, DOI 10.1021/am301237j
NR 29
TC 12
Z9 12
U1 6
U2 104
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 20
PY 2015
VL 7
IS 19
BP 10091
EP 10095
DI 10.1021/acsami.5b02835
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CI8XM
UT WOS:000355055000005
PM 25942047
DA 2018-10-19
ER

PT J
AU Chou, YN
   Chang, Y
   Wen, TC
AF Chou, Ying-Nien
   Chang, Yung
   Wen, Ten-Chin
TI Applying Thermosettable Zwitterionic Copolymers as General
   Fouling-Resistant and Thermal-Tolerant Biomaterial Interfaces
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE zwitterionic copolymer; temperature tolerance; fouling-resistant;
   thermosetting; charge neutrality; sulfobetaine methacrylate
ID FOREIGN-BODY REACTION; BLOOD COMPATIBILITY; BIOMEDICAL APPLICATIONS;
   PROTEIN ADSORPTION; WHOLE-BLOOD; HYDROGEL; POLYMERS; SURFACES;
   POLYSULFOBETAINE; MEMBRANES
AB We introduced a thermosettable zwitterionic copolymer to design a high temperature tolerance biomaterial as a general antifouling polymer interface: The original synthetic fouling-resistant copolymer, poly(vinylpyrrolidone)co-poly(sulfobetaine methacrylate) (poly(VP-co-SBMA)), is both thermal-tolerant and fouling-resistant, and the antifouling stability of copolymer coated interfaces can be effectively controlled by regulating the VP/SBMA composition ratio. We studied poly(VP-co-SBIVIA) copolymer gels and networks with a focus on their general resistance to protein, tell, and bacterial bioadhesion, as influenced by the thermosetting process. Interestingly, we found that the shape of the poly(VP-co-SBMA) copolymer material can be set at a high annealing temperature of 200 C while maintaining good antifouling properties. However, while the zwitterionic PSBMA. polymer gels were bioinert as expected, control of the fouling resistance of the PSBMA polymer networks was lost in the high temperature annealing process. A poly(VP-co-SBMA) copolymer network composed of PSBMA segments at 32 mol % showed reduced fibrinogen adsorption, tissue Cell adhesion, and bacterial attachment, but a relatively higher PSBMA content of 61 mol % was required to optimize resistance to platelet adhesion and erythrocyte attachment to confer hemocompatibility to human blood. We suggest that poly(VP-co-SBMA) copolymers capable of retaining stable, fouling resistance after high temperature shaping have a potential application as thermosettable materials in a bioinert interface for medical devices, such as the thermosettable coating on a stainless steel blood-compatible metal stent investigated in this study.
C1 [Chou, Ying-Nien; Wen, Ten-Chin] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
RP Chang, Y (reprint author), Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
EM ychang@cycu.edu.tw; tcwen@mail.ncku.edu.tw
FU project of Outstanding Professor Research Program in the Chung Yuan
   Christian University, Taiwan [CYCU-00RD-RA002-11757]; Ministry of
   Science and Technology [100-2221-E-006-165-MY2, 102-2221-E-033-009-MY3,
   103-2221-E-033-078-MY3]
FX The authors would like to acknowledge the project of Outstanding
   Professor Research Program in the Chung Yuan Christian University,
   Taiwan (CYCU-00RD-RA002-11757), and the Ministry of Science and
   Technology (100-2221-E-006-165-MY2, 102-2221-E-033-009-MY3 and
   103-2221-E-033-078-MY3) for their financial support.
CR Ananthanarayan R, 2006, TXB MICROBIOLOGY
   Bai T, 2014, ANGEW CHEM INT EDIT, V53, P12729, DOI 10.1002/anie.201405930
   Bai T, 2014, BIOMATERIALS, V35, P3926, DOI 10.1016/j.biomaterials.2014.01.077
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Cao Z., 2010, ANGEW CHEM, V122, P3859, DOI DOI 10.1002/ANGE.V122:22
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Chang Y, 2013, ADV FUNCT MATER, V23, P1100, DOI 10.1002/adfm.201201386
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Ekblad T, 2008, BIOMACROMOLECULES, V9, P2775, DOI 10.1021/bm800547m
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hoffman AS, 1982, ADV CHEM SER, V199, P3
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kostina NY, 2012, BIOMACROMOLECULES, V13, P4164, DOI 10.1021/bm301441x
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Liu LY, 2008, J BIOMAT SCI-POLYM E, V19, P821, DOI 10.1163/156856208784522083
   Liu XL, 2012, LANGMUIR, V28, P9451, DOI 10.1021/la300728j
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Shih YJ, 2010, LANGMUIR, V26, P17286, DOI 10.1021/la103186y
   Sin MC, 2014, POLYM J, V46, P436, DOI 10.1038/pj.2014.46
   Telford AM, 2010, ACS APPL MATER INTER, V2, P2399, DOI 10.1021/am100406j
   Xu FJ, 2009, PROG POLYM SCI, V34, P719, DOI 10.1016/j.progpolymsci.2009.04.005
   Yang W, 2012, BIOMATERIALS, V33, P7945, DOI 10.1016/j.biomaterials.2012.07.035
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
   Zhang Z, 2009, LANGMUIR, V25, P13516, DOI 10.1021/la901957k
NR 36
TC 17
Z9 18
U1 14
U2 132
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 20
PY 2015
VL 7
IS 19
BP 10096
EP 10107
DI 10.1021/acsami.5b01756
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CI8XM
UT WOS:000355055000006
PM 25912841
DA 2018-10-19
ER

PT J
AU Vitacolonna, M
   Belharazem, D
   Maier, P
   Hohenberger, P
   Roessner, ED
AF Vitacolonna, Mario
   Belharazem, Djeda
   Maier, Patrick
   Hohenberger, Peter
   Roessner, Eric Dominic
TI In vivo Quantification of the Effects of Radiation and Presence of Hair
   Follicle Pores on the Proliferation of Fibroblasts in an Acellular Human
   Dermis in a Dorsal Skinfold Chamber: Relevance for Tissue Reconstruction
   following Neoadjuvant Therapy
SO PLOS ONE
LA English
DT Article
ID LENTIVIRAL VECTOR; EXTRACELLULAR-MATRIX; CLINICAL-EXPERIENCE; LASER
   PERFORATION; STEM-CELLS; SCAFFOLD; SUBSTITUTES; IMPLANTATION;
   BIOMATERIAL; PROSTHESES
AB Introduction
   In neoadjuvant therapy, irradiation has a deleterious effect on neoangiogenesis. The aim of this study was to examine the post-implantation effects of neoadjuvant irradiation on the survival and proliferation of autologous cells seeded onto an acellular human dermis (hAD; Epiflex). Additionally, we examined the influence of dermal hair follicle pores on viability and proliferation. We used dorsal skinfold chambers implanted in rats and in-situ microscopy to quantify cell numbers over 9 days.
   Methods
   24 rats received a skinfold chamber and were divided into 2 main groups; irradiated and un-irradiated. In the irradiated groups 20Gy were applied epicutaneously at the dorsum. Epiflex pieces were cut to size 5x5mm such that each piece had either one or more visible hair follicle pores, or no such visible pores. Fibroblasts were transduced lentiviral with a fluorescent protein for cell tracking. Matrices were seeded statically with 2.5x10(4) fluorescent fibroblasts and implanted into the chambers. In each of the two main groups, half of the rats received Epiflex with hair follicle pores and half received Epiflex without pores. Scaffolds were examined in-situ at 0, 3, 6 and 9 days after transplantation. Visible cells on the surface were quantified using ImageJ.
   Results
   In all groups cell numbers were decreased on day 3. A treatment-dependent increase in cell numbers was observed at subsequent time points. Irradiation had an adverse effect on cell survival and proliferation. The number of cells detected in both irradiated and non-irradiated subjects was increased in those subjects that received transplants with hair follicle pores.
   Discussion
   This in-vivo study confirms that radiation negatively affects the survival and proliferation of fibroblasts seeded onto a human dermis transplant. The presence of hair follicle pores in the dermis transplants is shown to have a positive effect on cell survival and proliferation even in irradiated subjects.
C1 [Vitacolonna, Mario; Hohenberger, Peter; Roessner, Eric Dominic] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, D-69115 Heidelberg, Germany.
   [Belharazem, Djeda] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, D-69115 Heidelberg, Germany.
   [Maier, Patrick] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiat Oncol, D-69115 Heidelberg, Germany.
RP Roessner, ED (reprint author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, Bergheimer Str 58, D-69115 Heidelberg, Germany.
EM eric.roessner@medma.uni-heidelberg.de
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   Bergmeister H, 2005, J BIOMED MATER RES B, V74B, P495, DOI 10.1002/jbm.b.30228
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Brown JM, 2013, SEMIN RADIAT ONCOL, V23, P281, DOI 10.1016/j.semradonc.2013.05.002
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018
   Dai WD, 2009, BIOSCI TRENDS, V3, P216
   Dellgren G, 1999, SCAND CARDIOVASC J, V33, P259
   Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984
   Grabenwoger M, 1998, ANN THORAC SURG, V66, pS110, DOI 10.1016/S0003-4975(98)00982-5
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Hasegawa T, 2010, J DENT RES, V89, P854, DOI 10.1177/0022034510370022
   Jhaveri HM, 2010, J PERIODONTOL, V81, P616, DOI 10.1902/jop.2009.090530
   Kasyanov VA, 2009, J MATER SCI-MATER M, V20, P329, DOI 10.1007/s10856-008-3590-3
   Kesler CT, 2014, ANGIOGENESIS, V17, P419, DOI 10.1007/s10456-013-9400-7
   Kolker AR, 2005, ANN PLAS SURG, V55, P36, DOI 10.1097/01.sap.0000168248.83197.d4
   Lamme EN, 1998, J INVEST DERMATOL, V111, P989, DOI 10.1046/j.1523-1747.1998.00459.x
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lee MS, 2004, ORTHOPEDICS, V27, pS151
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   Maier P, 2012, CANCER GENE THER, V19, P802, DOI 10.1038/cgt.2012.67
   Maier P, 2010, RADIAT RES, V173, P612, DOI 10.1667/RR1952.1
   Mandoli C, 2010, MACROMOL BIOSCI, V10, P127, DOI 10.1002/mabi.200900323
   Mao XW, 2006, TECHNOL CANCER RES T, V5, P127, DOI 10.1177/153303460600500206
   Morimoto N, 2005, J SURG RES, V125, P56, DOI 10.1016/j.jss.2004.11.012
   Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033
   Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805
   Novaes AB, 2007, J PERIODONTOL, V78, P296, DOI 10.1902/jop.2007.060060
   Orbay H, 2011, AESTHET PLAST SURG, V35, P756, DOI 10.1007/s00266-011-9683-2
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K
   Rodrigues Annelissa Zorzeto, 2010, Braz. Dent. J., V21, P179, DOI 10.1590/S0103-64402010000300001
   Rossner E, 2011, CELL TISSUE BANK, V12, P209, DOI 10.1007/s10561-010-9187-3
   Roessner E, 2013, ANN SURG ONCOL, V20, pS709, DOI 10.1245/s10434-013-3209-x
   Roessner ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045991
   Roessner ED, 2011, J BIOMATER APPL, V25, P413, DOI 10.1177/0885328209347961
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426
   Vitacolonna M, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-7
   Vitacolonna M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-55
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
   Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871
NR 46
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 8
PY 2015
VL 10
IS 5
AR UNSP e0125689
DI 10.1371/journal.pone.0125689
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL2IX
UT WOS:000356768100067
PM 25955842
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Yang, ZY
   Chen, W
   Xia, ZD
   Liu, YJ
   Peggrem, S
   Geng, T
   Yang, ZX
   Li, H
   Xu, B
   Zhang, C
   Triffitt, JT
   Zhang, YZ
AF Yang, Zongyou
   Chen, Wei
   Xia, Zhidao
   Liu, Yueju
   Peggrem, Shaun
   Geng, Tao
   Yang, Zhaoxu
   Li, Han
   Xu, Bin
   Zhang, Chi
   Triffitt, James T.
   Zhang, Yingze
TI Local Application of Ibandronate/Gelatin Sponge Improves Osteotomy
   Healing in Rabbits
SO PLOS ONE
LA English
DT Article
ID TIBIAL SHAFT FRACTURES; ZOLEDRONIC ACID; CATABOLIC RESPONSES; SKELETAL
   COMPLICATIONS; MULTIPLE-MYELOMA; BONE-RESORPTION; IN-VITRO;
   BISPHOSPHONATE; ALENDRONATE; PAMIDRONATE
AB Delayed healing or non-union of skeletal fractures are common clinical complications. Ibandronate is a highly potent anti-catabolic reagent used for treatment of osteopenia and fracture prevention. We hypothesized that local application of ibandronate after fracture fixation may improve and sustain callus formation and therefore prevent delayed healing or nonunion. This study tested the effect of local application of an ibandronate/gelatin sponge composite on osteotomy healing. A right-side distal-femoral osteotomy was created surgically, with fixation using a k-wire, in forty adult male rabbits. The animals were divided into four groups of ten animals and treated by: (i) intravenous injection of normal saline (Control); (ii) local implantation of absorbable gelatin sponge (GS); (iii) local implantation of absorbable GS containing ibandronate (IB+ GS), and (iv) intravenous injection of ibandronate (IB i. v.). At two and four weeks the affected femora were harvested for X-ray photography, computed tomography (CT), biomechanical testing and histopathology. At both time-points the results showed that the calluses in both the ibandronate-treated groups, but especially in the IB+ GS group, were significantly larger than in the control and GS groups. At four weeks the cross sectional area (CSA) and mechanical test results of ultimate load and energy in the IB+ GS group were significantly higher than in other groups. Histological procedures showed a significant reduction in osteoclast numbers in the IB+ GS and IB i. v. groups at day 14. The results indicate that local application of an ibandronate/gelatin sponge biomaterial improved early osteotomy healing after surgical fixation and suggest that such treatment may be a valuable local therapy to enhance fracture repair and potentially prevent delayed or non-union.
C1 [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China.
   [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Key Lab Orthopaed Biomech Hebei Prov, Shijiazhuang 050051, Peoples R China.
   [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Orthopaed Res Inst Hebei Prov, Shijiazhuang, Hebei, Peoples R China.
   [Xia, Zhidao; Peggrem, Shaun] Swansea Univ, Ctr Nanohlth, Coll Med, Swansea SA2 8PP, W Glam, Wales.
   [Yang, Zhaoxu] Hebei Gen Hosp, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China.
   [Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.
RP Zhang, YZ (reprint author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China.
EM yzling_liu@163.com
OI Xia, Zhidao/0000-0002-2047-7282
CR Amanat N, 2005, J ORTHOP RES, V23, P1029, DOI 10.1016/j.orthres.2005.03.004
   Amanat N, 2007, J BONE MINER RES, V22, P867, DOI 10.1359/JBMR.070318
   Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74
   AZUMA Y, 1995, BONE, V16, P235, DOI 10.1016/8756-3282(94)00035-X
   Bergner R, 2007, J CLIN PHARMACOL, V47, P942, DOI 10.1177/0091270007301801
   Bobba RS, 2006, DRUG SAFETY, V29, P1133, DOI 10.2165/00002018-200629120-00005
   Chennuru S, 2008, INTERN MED J, V38, P635, DOI 10.1111/j.1445-5994.2007.01580.x
   Copuroglu C, 2013, INJURY, V44, P1379, DOI 10.1016/j.injury.2013.08.003
   Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132
   Diel IJ, 2009, SUPPORT CARE CANCER, V17, P719, DOI 10.1007/s00520-008-0553-7
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, piii
   Goodship A E, 1994, Ann Oncol, V5 Suppl 7, pS53
   Grazio S, 2008, CLIN RHEUMATOL, V27, P651, DOI 10.1007/s10067-007-0827-3
   Guyver P, 2012, INJURY, V43, P1187, DOI 10.1016/j.injury.2012.03.035
   Hardeman F, 2012, INJURY, V43, P153, DOI 10.1016/j.injury.2011.04.003
   Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252
   Lipton A, 2002, CANCER INVEST, V20, P45, DOI 10.1081/CNV-120014886
   Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301
   Little DG, 2005, J BONE MINER RES, V20, P2044, DOI 10.1359/JBMR.050712
   Maalouf Naim M, 2006, Endocr Pract, V12, P48
   Manabe T, 2012, CALCIFIED TISSUE INT, V90, P193, DOI 10.1007/s00223-011-9563-4
   Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1
   Mills LA, 2013, BMJ OPEN, P3
   Miura N, 2009, CLIN EXP NEPHROL, V13, P85, DOI 10.1007/s10157-008-0078-x
   Olson Karin, 2007, J Oncol Pharm Pract, V13, P223, DOI 10.1177/1078155207080806
   Peter CP, 1996, J ORTHOP RES, V14, P74, DOI 10.1002/jor.1100140113
   Ralston SH, 2004, CALCIFIED TISSUE INT, V74, P1, DOI 10.1007/s00223-001-1135-6
   Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807
   Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843
   Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281
   Rosen LS, 2003, CANCER, V98, P1735, DOI 10.1002/cncr.11701
   Rozental TD, 2009, J HAND SURG-AM, V34A, P595, DOI 10.1016/j.jhsa.2008.12.011
   Ruggiero SL, 2006, ORAL SURG ORAL MED O, V102, P433, DOI 10.1016/j.tripleo.2006.06.004
   Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004
   Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022
   SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Stakkestad JA, 2008, CLIN RHEUMATOL, V27, P955, DOI 10.1007/s10067-007-0824-6
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   VANBEEK E, 1994, J BONE MINER RES, V9, P1875, DOI 10.1002/jbmr.5650091206
   Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P110, DOI 10.1007/s00223-009-9323-x
   Yu NYC, 2013, EUR CELLS MATER, V25, P190, DOI 10.22203/eCM.v025a14
   Yu Nicole Y C, 2012, Front Biosci (Elite Ed), V4, P2647
NR 44
TC 3
Z9 3
U1 5
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2015
VL 10
IS 5
AR UNSP e0125807
DI 10.1371/journal.pone.0125807
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH7KF
UT WOS:000354214400050
PM 25951178
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Peters, GM
   Skala, LP
   Plank, TN
   Oh, H
   Reddy, GNM
   Marsh, A
   Brown, SP
   Raghavan, SR
   Davis, JT
AF Peters, Gretchen Marie
   Skala, Luke P.
   Plank, Taylor N.
   Oh, Hyuntaek
   Reddy, G. N. Manjunatha
   Marsh, Andrew
   Brown, Steven P.
   Raghavan, Srinivasa R.
   Davis, Jeffery T.
TI G4-Quartet center dot M+ Borate Hydrogels
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID HIGH-RESOLUTION H-1; SOLID-STATE NMR; SUPRAMOLECULAR HYDROGELS; GEL
   FORMATION; GELATION; RECOGNITION; POLYMERS; MOLECULES; GELATORS; ACID
AB The ability to modulate the physical properties of a supramolecular hydrogel may be beneficial for biomaterial and biomedical applications. We find that guanosine (G 1), when combined with 0.5 equiv of potassium borate, forms a strong, self-supporting hydrogel with elastic moduli >10 kPa. The countercation in the borate salt (MB(OH)(4)) significantly alters the physical properties of the hydrogel. The gelator combination of G 1 and KB(OH)(4) formed the strongest hydrogel, while the weakest system was obtained with LiB(OH)(4), as judged by H-1 NMR and rheology. Data from powder XRD, H-1 double-quantum solid-state magic-angle spinning (MAS) NMR and small-angle neutron scattering (SANS) were consistent with a structural model that involves formation of borate dimers and G4 center dot K+ quartets by G 1 and KB(OH)(4). Stacking of these G4 center dot M+ quartets into G4-nanowires gives a hydrogel. We found that the M+ cation helps stabilize the anionic guanosine-borate (GB) diesters, as well as the G4-quartets. Supplementing the standard gelator mixture of G 1 and 0.5 equiv of KB(OH)(4) with additional KCl or KNO3 increased the strength of the hydrogel. We found that thioflavin T fluoresces in the presence of G4 center dot M+ precursor structures. This fluorescence response for thioflavin T was the greatest for the K+ GB system, presumably due to the enhanced interaction of the dye with the more stable G4 center dot K+ quartets. The fluorescence of thioflavin T increased as a function of gelator concentration with an increase that correlated with the system's gel point, as measured by solution viscosity
C1 [Peters, Gretchen Marie; Skala, Luke P.; Plank, Taylor N.; Davis, Jeffery T.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
   [Oh, Hyuntaek; Raghavan, Srinivasa R.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Reddy, G. N. Manjunatha; Brown, Steven P.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.
   [Marsh, Andrew] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
RP Davis, JT (reprint author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
EM jdavis@umd.edu
RI Brown, Steven/F-8765-2014
OI Brown, Steven/0000-0003-2069-8496; Raghavan,
   Srinivasa/0000-0003-0710-9845; G N, Manjunatha
   Reddy/0000-0002-8283-2462; Peters, Gretchen Marie/0000-0002-3634-3182
FU US DOE [DE-FG01-98ER14888]; EPSRC [EP/K003674/1]; US Dept. of Education;
   Engineering and Physical Sciences Research Council [EP/K003674/1,
   EP/L027100/1]
FX This work was supported by the US DOE [DE-FG01-98ER14888] and EPSRC
   (EP/K003674/1). G.P. thanks the US Dept. of Education for a GAANN
   fellowship. We thank Wonseok Hwang and Prof. Lawrence Sita for their
   help with the rheology, and we thank TA Instruments (New Castle, DE) for
   providing the rheometer.
CR Adhikari B, 2014, J MATER CHEM B, V2, P4802, DOI 10.1039/c4tb00702f
   Araki K, 2005, TOP CURR CHEM, V256, P133, DOI 10.1007/b107173
   Arnal-Herault C, 2007, ANGEW CHEM INT EDIT, V46, P8409, DOI 10.1002/anie.200702605
   Arnal-Herault C, 2007, ANGEW CHEM INT EDIT, V46, P4268, DOI 10.1002/anie.200700787
   Babu SS, 2014, CHEM REV, V114, P1973, DOI 10.1021/cr400195e
   Bang I, 1910, BIOCHEM Z, V26, P293
   Benner K, 2000, CARBOHYD RES, V327, P287, DOI 10.1016/S0008-6215(00)00054-9
   Bhasikuttan A. C., 2015, J CHEM SOC CHEM COMM, DOI [10.1039/C4CC10030A, DOI 10.1039/C4CC10030A]
   Brown SP, 2007, PROG NUCL MAG RES SP, V50, P199, DOI 10.1016/j.pnmrs.2006.10.002
   Brown SP, 2012, SOLID STATE NUCL MAG, V41, P1, DOI 10.1016/j.ssnmr.2011.11.006
   Buchs B, 2011, ORG BIOMOL CHEM, V9, P2906, DOI 10.1039/c0ob01139h
   Buerkle L. E., 2012, CHEM SOC REV, V41, P6089, DOI DOI 10.1039/C2CS35106D
   Buerkle LE, 2009, LANGMUIR, V25, P8833, DOI 10.1021/la900746w
   Buerlde L. E., 2012, J CHEM SCI, V3, P564, DOI DOI 10.1039/C1SC00729G
   Cafferty BJ, 2013, J AM CHEM SOC, V135, P2447, DOI 10.1021/ja312155v
   Caran KL, 2013, SOFT FIBRILLAR MATERIALS: FABRICATION AND APPLICATIONS, P3
   Case WS, 2007, ELECTROPHORESIS, V28, P3008, DOI 10.1002/elps.200700287
   CHANTOT JF, 1969, FEBS LETT, V4, P173, DOI 10.1016/0014-5793(69)80227-9
   Ciesielski A, 2010, ANGEW CHEM INT EDIT, V49, P1963, DOI 10.1002/anie.200905827
   Cornwell DJ, 2015, MATER HORIZ, V2, P279, DOI 10.1039/c4mh00245h
   Das RN, 2012, CHEM-EUR J, V18, P6008, DOI 10.1002/chem.201103814
   Dash J, 2011, SOFT MATTER, V7, P8120, DOI 10.1039/c1sm05839h
   Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589
   de la Faverie AR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku111
   Dowling VA, 2004, ANAL CHEM, V76, P4558, DOI 10.1021/ac0400010
   Du XW, 2014, CHEM-ASIAN J, V9, P1446, DOI 10.1002/asia.201301693
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Gabel SA, 2008, J BIOL INORG CHEM, V13, P207, DOI 10.1007/s00775-007-0311-1
   Garcia-Arriaga M, 2008, J AM CHEM SOC, V130, P10492, DOI 10.1021/ja8039019
   GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013
   Ghoussoub A, 2005, CHEM COMMUN, P5763, DOI 10.1039/b512527h
   Guo MY, 2014, J AM CHEM SOC, V136, P6969, DOI 10.1021/ja500205v
   Guo WW, 2014, ANGEW CHEM INT EDIT, V53, P10134, DOI 10.1002/anie.201405692
   Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022
   Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/nchem.1937, 10.1038/NCHEM.1937]
   Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z
   Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f
   Kuang Y, 2014, ANGEW CHEM INT EDIT, V53, P8104, DOI 10.1002/anie.201402216
   Kwan ICM, 2011, CHEM COMMUN, V47, P3882, DOI 10.1039/c0cc05654e
   Lau HK, 2015, BIOMACROMOLECULES, V16, P28, DOI 10.1021/bm501361c
   Li Z, 2010, LANGMUIR, V26, P10093, DOI 10.1021/la100211y
   Liu GF, 2014, ANGEW CHEM INT EDIT, V53, P7789, DOI 10.1002/anie.201403249
   Meng LY, 2013, ORG BIOMOL CHEM, V11, P1525, DOI 10.1039/c3ob27204d
   Mihai S, 2010, J MATER CHEM, V20, P9443, DOI 10.1039/c0jm01248c
   Mihai S, 2009, NEW J CHEM, V33, P2335, DOI 10.1039/b908641m
   Mohanty J, 2013, J AM CHEM SOC, V135, P367, DOI 10.1021/ja309588h
   Okano T, 1970, Yakugaku Zasshi, V90, P1542
   Peters GM, 2014, J AM CHEM SOC, V136, P12596, DOI 10.1021/ja507506c
   Peters GM, 2014, SUPRAMOL CHEM, V26, P286, DOI 10.1080/10610278.2013.872782
   Raeburn J, 2015, CHEM COMMUN, V51, P5170, DOI 10.1039/c4cc08626k
   Raghavan SR, 2012, SOFT MATTER, V8, P8539, DOI 10.1039/c2sm25107h
   Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464
   Sangeetha NM, 2005, CHEM SOC REV, V34, P821, DOI 10.1039/b417081b
   SCHOTT H, 1972, ANGEW CHEM INT EDIT, V11, P824, DOI 10.1002/anie.197208241
   Sessler JL, 2007, CHEM SOC REV, V36, P314, DOI 10.1039/b604119c
   Shapiro YE, 2011, PROG POLYM SCI, V36, P1184, DOI 10.1016/j.progpolymsci.2011.04.002
   Simeone L, 2011, CHEM-EUR J, V17, P13854, DOI 10.1002/chem.201101827
   Skilling KJ, 2014, SOFT MATTER, V10, P237, DOI 10.1039/c3sm52244j
   Sreenivasachary N, 2005, P NATL ACAD SCI USA, V102, P5938, DOI 10.1073/pnas.0501663102
   Sreenivasachary N, 2008, CHEM-ASIAN J, V3, P134, DOI 10.1002/asia.200700041
   Steed JW, 2011, CHEM COMMUN, V47, P1379, DOI 10.1039/c0cc03293j
   Wada T, 2004, BIOPOLYMERS, V76, P15, DOI 10.1002/bip.10563
   Wada T, 2000, J AM CHEM SOC, V122, P6900, DOI 10.1021/ja9935456
   Way AE, 2014, MACROMOLECULES, V47, P1810, DOI 10.1021/ma402618z
   Webber AL, 2011, J AM CHEM SOC, V133, P19777, DOI 10.1021/ja206516u
   Weiss R. G., 2006, MOL GELS MAT SELF AS
   Weiss RG, 2014, J AM CHEM SOC, V136, P7519, DOI 10.1021/ja503363v
   Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914
   Yoshii T, 2015, J AM CHEM SOC, V137, P3360, DOI 10.1021/ja5131534
   Yoshii T, 2014, ANGEW CHEM INT EDIT, V53, P7264, DOI 10.1002/anie.201404158
   Yoshikawa I, 2007, TETRAHEDRON, V63, P7474, DOI 10.1016/j.tet.2007.02.010
   Yu GC, 2013, CHEM SOC REV, V42, P6697, DOI 10.1039/c3cs60080g
   Yu Y, 2008, J PHYS CHEM B, V112, P1130, DOI 10.1021/jp709613p
   Zhang XR, 2013, ELECTROPHORESIS, V34, P1778, DOI 10.1002/elps.201200683
   Zhao D, 2014, NUCLEIC ACIDS RES, V42, P11612, DOI 10.1093/nar/gku833
NR 75
TC 43
Z9 43
U1 11
U2 167
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 6
PY 2015
VL 137
IS 17
BP 5819
EP 5827
DI 10.1021/jacs.5b02753
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CH9EJ
UT WOS:000354338500026
PM 25871426
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Pasquini, L
   Molinari, A
   Fantazzini, P
   Dauphen, Y
   Cuif, JP
   Levy, O
   Dubinsky, Z
   Caroselli, E
   Prada, F
   Goffredo, S
   Di Giosia, M
   Reggi, M
   Falini, G
AF Pasquini, Luca
   Molinari, Alan
   Fantazzini, Paola
   Dauphen, Yannicke
   Cuif, Jean-Pierre
   Levy, Oren
   Dubinsky, Zvy
   Caroselli, Erik
   Prada, Fiorella
   Goffredo, Stefano
   Di Giosia, Matteo
   Reggi, Michela
   Falini, Giuseppe
TI Isotropic microscale mechanical properties of coral skeletons
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE corals; mechanical properties; microstructure; biomaterial
ID SINGLE-CRYSTAL ARAGONITE; BONE; BIOMINERALIZATION; INDENTATION;
   ANISOTROPY; FRACTURE; NACRE
AB Scleractinian corals are a major source of biogenic calcium carbonate, yet the relationship between their skeletal microstructure and mechanical properties has been scarcely studied. In this work, the skeletons of two coral species: solitary Balanophyllia europaea and colonial Stylophora pistillata, were investigated by nanoindentation. The hardness HIT and Young's modulus E-IT were determined from the analysis of several load-depth data on two perpendicular sections of the skeletons: longitudinal (parallel to the main growth axis) and transverse. Within the experimental and statistical uncertainty, the average values of the mechanical parameters are independent on the section's orientation. The hydration state of the skeletons did not affect the mechanical properties. The measured values, E-IT in the 76-77 GPa range, and H-IT in the 4.9-5.1 GPa range, are close to the ones expected for polycrystal-line pure aragonite. Notably, a small difference in HIT is observed between the species. Different from corals, single-crystal aragonite and the nacreous layer of the seashell Atrina rigida exhibit clearly orientation-dependent mechanical properties. The homogeneous and isotropic mechanical behaviour of the coral skeletons at the microscale is correlated with the microstructure, observed by electron microscopy and atomic force microscopy, and with the X-ray diffraction patterns of the longitudinal and transverse sections.
C1 [Pasquini, Luca; Molinari, Alan; Fantazzini, Paola] Alma Mater Studiorum Univ Bologna, Dept Phys & Astron, I-40127 Bologna, Italy.
   [Dauphen, Yannicke; Cuif, Jean-Pierre] Univ Paris 11, UMR IDES, F-91405 Orsay, France.
   [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.
   [Caroselli, Erik; Prada, Fiorella; Goffredo, Stefano] Alma Mater Studiorum Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy.
   [Di Giosia, Matteo; Reggi, Michela; Falini, Giuseppe] Alma Mater Studiorum Univ Bologna, Dept Chem Giacomo Ciamician, I-40126 Bologna, Italy.
RP Pasquini, L (reprint author), Alma Mater Studiorum Univ Bologna, Dept Phys & Astron, Viale Berti Pichat 6-2, I-40127 Bologna, Italy.
EM luca.pasquini@unibo.it; giuseppe.falini@unibo.it
RI Pasquini, Luca/U-1826-2017
OI Pasquini, Luca/0000-0001-8939-2204; Di Giosia,
   Matteo/0000-0003-3494-298X; CAROSELLI, ERIK/0000-0001-6434-5663; Prada,
   Fiorella/0000-0003-2499-8074; FANTAZZINI, PAOLA/0000-0002-4203-540X
FU European Research Council under the European Union [249930]
FX The research leading to these results has received funding from the
   European Research Council under the European Union's Seventh Framework
   Programme (FP7/2007-2013)/ERC grant agreement no. (249930-CoralWarm:
   Corals and global warming: the Mediterranean versus the Red Sea).
CR Bull SJ, 2005, J PHYS D APPL PHYS, V38, pR393, DOI 10.1088/0022-3727/38/24/R01
   CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419
   Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151
   Constantz BR., 1986, PALAIOS, V1, P52, DOI [10.2307/3514508, DOI 10.2307/3514508]
   Cuif JP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000783
   Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x
   Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4
   Falini G, 2013, J STRUCT BIOL, V183, P226, DOI 10.1016/j.jsb.2013.05.001
   Fantazzini P, 2013, ENVIRON SCI TECHNOL, V47, P12679, DOI 10.1021/es402521b
   Fleischli FD, 2008, ACTA BIOMATER, V4, P1694, DOI 10.1016/j.actbio.2008.05.029
   Fratzl P, 2008, NAT MATER, V7, P610, DOI 10.1038/nmat2240
   Goldstein SA, 1987, BIOMECHANICS, V20, P1055, DOI DOI 10.1016/0021-9290(87)90023-6
   Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HAN YH, 1991, J AM CERAM SOC, V74, P3129, DOI 10.1111/j.1151-2916.1991.tb04311.x
   Hobatho MC, 1997, ST HEAL T, V40, P157
   Kaandorp JA, 2001, J THEOR BIOL, V209, P257, DOI 10.1006/jtbi.2001.2261
   Kearney C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255505
   Kunitake ME, 2013, ACTA BIOMATER, V9, P5353, DOI 10.1016/j.actbio.2012.09.030
   Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k
   Liu LG, 2005, PHYS CHEM MINER, V32, P97, DOI 10.1007/s00269-005-0454-y
   Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y
   Meroz E, 2002, P ROY SOC B-BIOL SCI, V269, P717, DOI 10.1098/rspb.2001.1924
   Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9
   Nowick A. S., 1995, CRYSTAL PROPERTIES V
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Presser V, 2010, J MATER SCI, V45, P2408, DOI 10.1007/s10853-010-4208-y
   Seto J, 2008, ADV FUNCT MATER, V18, P1905, DOI 10.1002/adfm.200800214
   Spalding M., 2001, WORLD ATLAS CORAL RE
   Stambler N, 2005, CORAL REEFS, V24, P1, DOI 10.1007/s00338-004-0452-4
   Stempfle P, 2010, MAT SCI ENG C-MATER, V30, P715, DOI 10.1016/j.msec.2010.03.003
   Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026
   Ungureanu CG, 2010, EUR J MINERAL, V22, P693, DOI 10.1127/0935-1221/2010/0022-2054
   Wang RZ, 2011, ANNU REV MATER RES, V41, P41, DOI 10.1146/annurev-matsci-062910-095806
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WILFERT M, 1969, Zeitschrift fuer Morphologie der Tiere, V64, P77, DOI 10.1007/BF00300386
   Wu YC, 2009, J MATER SCI-MATER M, V20, P1273, DOI 10.1007/s10856-009-3695-3
NR 37
TC 2
Z9 2
U1 2
U2 33
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD MAY 6
PY 2015
VL 12
IS 106
AR 20150168
DI 10.1098/rsif.2015.0168
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG5TX
UT WOS:000353359900034
PM 25977958
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Lee, SW
   Lee, HJ
   Hwang, HS
   Ko, K
   Han, DW
   Ko, K
AF Lee, Seung-Won
   Lee, Hye Jeong
   Hwang, Han Sung
   Ko, Kisung
   Han, Dong Wook
   Ko, Kinarm
TI Optimization of Matrigel-based culture for expansion of neural stem
   cells
SO ANIMAL CELLS AND SYSTEMS
LA English
DT Article
DE Matrigel; neural stem cells; expansion; neural differentiation
ID PRECURSOR CELLS; IN-VITRO; DIFFERENTIATION; NEUROSPHERES; GROWTH;
   TISSUE; PROLIFERATION; SPECIFICATION; CNS
AB Neural stem cells (NSCs) are capable of self-renewal and can differentiate into neurons and two types of glial cells. NSCs have great potential for basic studies of neurogenesis and neurodegenerative diseases, and for therapeutic transplantation applications. NSCs can be derived from the fetal or adult brain. In vitro expansion of NSCs may help to elucidate their properties involved in neurogenesis and is crucial to obtain on-demand the large numbers of these cells needed for clinical transplantation trials. Laminin is an extracellular matrix molecule commonly used to culture NSCs as an attached monolayer. However, laminin is costly if NSCs need to be cultured in large quantities. Matrigel is a soluble basement membrane biomaterial, which has been widely used for feeder-free cultures of human embryonic stem cells. In the present study, we evaluated the ability of Matrigel to support the attachment and long-term proliferation of NSCs. We investigated the growth and adherence of NSCs derived from the fetal mouse brain on Matrigel at various concentrations (0.01-1%). We found that 0.02% Matrigel is sufficient for NSCs to be expanded in vitro in long-term culture. The NSCs cultured on Matrigel-coated plates showed typical cellular and molecular characteristics and had multipotency to be differentiated into neurons and glial cells. The Matrigel-based monolayer culture system established in this study provides a cost-effective approach to maintain NSCs in vitro in long-term cultures.
C1 [Lee, Seung-Won; Lee, Hye Jeong; Han, Dong Wook; Ko, Kinarm] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea.
   [Lee, Seung-Won; Lee, Hye Jeong; Ko, Kinarm] Konkuk Univ, Inst Adv Biomed Sci, Ctr Stem Cell Res, Seoul 143701, South Korea.
   [Hwang, Han Sung] Konkuk Univ, Sch Med, Dept Obstet & Gynecol, Seoul 143729, South Korea.
   [Ko, Kisung] Chung Ang Univ, Med Res Inst, Dept Med, Coll Med, Seoul 156756, South Korea.
   [Ko, Kinarm] Konkuk Univ, Open Innovat Ctr, Seoul 143701, South Korea.
RP Ko, K (reprint author), Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea.
EM knko@kku.ac.kr
OI Hwang, Han Sung/0000-0003-0622-0701
FU National Research Foundation of Korea (NRF) - Korean Government (MEST)
   [2014R1A2A01007212]; Korean Health Technology RAMP;D Project, Ministry
   of Health and Welfare, Korea [HI12C0337]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korean Government (MEST) (grant number
   2014R1A2A01007212); the Korean Health Technology R&D Project, Ministry
   of Health and Welfare, Korea (No. HI12C0337).
CR ALBINI A, 1992, INT J CANCER, V52, P234, DOI 10.1002/ijc.2910520214
   Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147
   Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061
   Choi NY, 2014, MOL CELLS, V37, P473, DOI 10.14348/molcells.2014.0080
   Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283
   Eriksson C, 2003, EXP NEUROL, V184, P1058, DOI 10.1016/j.expneurol.2003.08.014
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111
   Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012
   Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117
   Isaji M, 1997, BRIT J PHARMACOL, V122, P1061, DOI 10.1038/sj.bjp.0701493
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Lee HJ, 2013, ANIM CELLS SYST, V17, P429, DOI 10.1080/19768354.2013.865675
   Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Malik N, 2014, NEUROTOXICOLOGY, V45, P192, DOI 10.1016/j.neuro.2014.10.007
   Marshall Gregory P. II, 2008, V438, P135, DOI 10.1007/978-1-59745-133-8_12
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Okano Hideyuki, 2002, Keio Journal of Medicine, V51, P115
   Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427
   Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204
   Ramos-Hryb AB, 2013, INT J DEV BIOL, V57, P885, DOI 10.1387/ijdb.130206gw
   Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
NR 29
TC 5
Z9 5
U1 1
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1976-8354
EI 2151-2485
J9 ANIM CELLS SYST
JI Anim. Cells Syst.
PD MAY 4
PY 2015
VL 19
IS 3
BP 175
EP 180
DI 10.1080/19768354.2015.1035750
PG 6
WC Cell Biology; Zoology
SC Cell Biology; Zoology
GA CL6NV
UT WOS:000357084700003
OA Bronze
DA 2018-10-19
ER

PT J
AU Iijima, K
   Hashizume, M
AF Iijima, Kazutoshi
   Hashizume, Mineo
TI Application of Polysaccharides as Structural Materials
SO TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY
LA English
DT Review
DE polysaccharide; structural material; biomaterial; porous scaffold; film;
   fiber
ID POLYION COMPLEX FIBER; SOLUTION INTERFACES; CRYSTALLINE CELLULOSE;
   COMPOSITE SCAFFOLDS; CHITOSAN MEMBRANES; ULTRATHIN FILMS; ALGINATE
   FIBERS; ALPHA-CHITIN; DELIVERY; SURFACE
AB The preparation of materials from polysaccharides is important from both a functional and industrial aspect. In this review, after a brief explanation on the chemical structures and properties of the representative polysaccharides used in material chemistry, we described the preparation of structural materials, such as porous scaffolds, films, and fibers, from polysaccharides for biomedical applications, with a focus on polysaccharide species and fabrication methods and also discussed our own findings.
C1 [Iijima, Kazutoshi; Hashizume, Mineo] Tokyo Univ Sci, Dept Ind Chem, Shinjuku Ku, Tokyo 1620826, Japan.
RP Iijima, K (reprint author), Tokyo Univ Sci, Dept Ind Chem, Shinjuku Ku, Tokyo 1620826, Japan.
EM mhashizu@ci.kagu.tus.ac.jp
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Amaike M, 1998, MACROMOL RAPID COMM, V19, P287, DOI 10.1002/(SICI)1521-3927(19980601)19:6<287::AID-MARC287>3.0.CO;2-X
   Ariga K, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.30
   Caridade SG, 2013, BIOMACROMOLECULES, V14, P1653, DOI 10.1021/bm400314s
   Chow KS, 2000, BIOMACROMOLECULES, V1, P61, DOI 10.1021/bm005503b
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Desai K, 2008, BIOMACROMOLECULES, V9, P1000, DOI 10.1021/bm701017z
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fujie T, 2007, ADV MATER, V19, P3549, DOI 10.1002/adma.200700661
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hagisawa K, 2013, J VASC SURG-VENOUS L, V1, P289, DOI 10.1016/j.jvsv.2013.04.001
   Hashizume M, 2003, LANGMUIR, V19, P10172, DOI 10.1021/la035079a
   Hashizume M, 2011, COLLOID SURFACE B, V88, P534, DOI 10.1016/j.colsurfb.2011.07.031
   Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994
   Iijima K, 2014, KOBUNSHI RONBUNSHU, V71, P11, DOI 10.1295/koron.71.11
   Iwatake A, 2008, COMPOS SCI TECHNOL, V68, P2103, DOI 10.1016/j.compscitech.2008.03.006
   Karakecili A, 2012, POLYM COMPOSITE, V33, P1215, DOI 10.1002/pc.22253
   Karbowiak T, 2006, J COLLOID INTERF SCI, V294, P400, DOI 10.1016/j.jcis.2005.07.030
   Kittle JD, 2012, BIOMACROMOLECULES, V13, P714, DOI 10.1021/bm201631r
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
   Kokubo T, 2004, J CERAM SOC JPN, V112, P363, DOI 10.2109/jcersj.112.363
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Li L, 2012, J MATER CHEM, V22, P8585, DOI 10.1039/c2jm30555k
   Li Y, 2013, J APPL POLYM SCI, V130, P1539, DOI [10.1002/APP.39339, 10.1002/app.39339]
   Liang WH, 2010, J BIOMED MATER RES A, V94A, P1050, DOI 10.1002/jbm.a.32774
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mamedov AA, 2000, LANGMUIR, V16, P5530, DOI 10.1021/1a000560b
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Mikhailov GM, 2001, RUSS J APPL CHEM+, V74, P1573, DOI 10.1023/A:1013734008473
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Morimoto N, 2013, BIOMACROMOLECULES, V14, P56, DOI 10.1021/bm301286h
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/nmat2784, 10.1038/NMAT2784]
   Ohkawa K, 2001, MACROMOL MATER ENG, V286, P168, DOI 10.1002/1439-2054(20010301)286:3<168::AID-MAME168>3.3.CO;2-Z
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Park SY, 2001, MATER RES BULL, V36, P511, DOI 10.1016/S0025-5408(01)00545-1
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Qi XN, 2014, J BIOMED MATER RES A, V102, P366, DOI 10.1002/jbm.a.34710
   REES DA, 1981, PURE APPL CHEM, V53, P1, DOI 10.1351/pac198153010001
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Sasaki Y, 2012, CHEM LETT, V41, P202, DOI 10.1246/cl.2012.202
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Sawada S, 2011, COLLOID POLYM SCI, V289, P685, DOI 10.1007/s00396-010-2361-0
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Serizawa T, 2000, BIOMACROMOLECULES, V1, P306, DOI 10.1021/bm000006g
   Serizawa T, 2013, BIOMACROMOLECULES, V14, P613, DOI 10.1021/bm4000822
   Shin S, 2007, LANGMUIR, V23, P9104, DOI 10.1021/la700818q
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   Silva RM, 2004, J MATER SCI-MATER M, V15, P1105, DOI 10.1023/B:JMSM.0000046392.44911.46
   Sturcova A, 2004, BIOMACROMOLECULES, V5, P1333, DOI 10.1021/bm034517p
   Tamura H, 2004, CARBOHYD POLYM, V56, P205, DOI 10.1016/j.carbpol.2004.02.003
   Tan HP, 2007, J MATER SCI-MATER M, V18, P1961, DOI 10.1007/s10856-007-3095-5
   Tang CY, 2008, COMPOS PART A-APPL S, V39, P1638, DOI 10.1016/j.compositesa.2008.07.005
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   TOKURA S, 1979, POLYM J, V11, P781, DOI 10.1295/polymj.11.781
   URAGAMI T, 1994, J MEMBRANE SCI, V88, P243, DOI 10.1016/0376-7388(94)87010-1
   Voet D., 2012, FUNDAMENTAL BIOCH LI
   Watanabe H, 2007, B CHEM SOC JPN, V80, P433, DOI 10.1246/bcsj.80.433
   Wong T. W., 2009, RECENT PAT DRUG DELI, V3, P5
   Yamamoto H, 2003, B CHEM SOC JPN, V76, P2053, DOI 10.1246/bcsj.76.2053
   Yamamoto H, 2000, MACROMOL CHEM PHYSIC, V201, P84, DOI 10.1002/(SICI)1521-3935(20000101)201:1<84::AID-MACP84>3.0.CO;2-Y
   Yusof NLBM, 2004, CARBOHYD RES, V339, P2701, DOI 10.1016/j.carres.2004.09.008
   Zhong C, 2012, J MATER CHEM, V22, P6080, DOI 10.1039/c2jm15610e
NR 69
TC 5
Z9 5
U1 6
U2 41
PU GAKUSHIN PUBL CO
PI TOKYO
PA YUSHOKAIN7F, 1-38-12 NIHONBASHIKAKIGARACHO, CHUO-KU, TOKYO, 103-0014,
   JAPAN
SN 0915-7352
J9 TRENDS GLYCOSCI GLYC
JI Trends Glycosci. Glycotechnol.
PD MAY
PY 2015
VL 27
IS 155
BP 67
EP 79
DI 10.4052/tigg.1419.1
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CU1HW
UT WOS:000363272500001
DA 2018-10-19
ER

PT J
AU Prabhu, R
   Whittington, WR
   Patnaik, SS
   Mao, YX
   Begonia, MT
   Williams, LN
   Liao, J
   Horstemeyer, MF
AF Prabhu, Rajkumar
   Whittington, Wilburn R.
   Patnaik, Sourav S.
   Mao, Yuxiong
   Begonia, Mark T.
   Williams, Lakiesha N.
   Liao, Jun
   Horstemeyer, M. F.
TI A Coupled Experiment-finite Element Modeling Methodology for Assessing
   High Strain Rate Mechanical Response of Soft Biomaterials
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 99; Split-Hopkinson Pressure Bar; High Strain
   Rate; Finite Element Modeling; Soft Biomaterials; Dynamic Experiments;
   Internal State Variable Modeling; Brain; Liver; Tendon; Fat
ID TISSUE; MUSCLE; BRAIN; BAR
AB This study offers a combined experimental and finite element (FE) simulation approach for examining the mechanical behavior of soft biomaterials (e.g. brain, liver, tendon, fat, etc.) when exposed to high strain rates. This study utilized a Split-Hopkinson Pressure Bar (SHPB) to generate strain rates of 100-1,500 sec(-1). The SHPB employed a striker bar consisting of a viscoelastic material (polycarbonate). A sample of the biomaterial was obtained shortly postmortem and prepared for SHPB testing. The specimen was interposed between the incident and transmitted bars, and the pneumatic components of the SHPB were activated to drive the striker bar toward the incident bar. The resulting impact generated a compressive stress wave (i.e. incident wave) that traveled through the incident bar. When the compressive stress wave reached the end of the incident bar, a portion continued forward through the sample and transmitted bar (i.e. transmitted wave) while another portion reversed through the incident bar as a tensile wave (i.e. reflected wave). These waves were measured using strain gages mounted on the incident and transmitted bars. The true stress-strain behavior of the sample was determined from equations based on wave propagation and dynamic force equilibrium. The experimental stress-strain response was three dimensional in nature because the specimen bulged. As such, the hydrostatic stress (first invariant) was used to generate the stress-strain response. In order to extract the uniaxial (one-dimensional) mechanical response of the tissue, an iterative coupled optimization was performed using experimental results and Finite Element Analysis (FEA), which contained an Internal State Variable (ISV) material model used for the tissue. The ISV material model used in the FE simulations of the experimental setup was iteratively calibrated (i.e. optimized) to the experimental data such that the experiment and FEA strain gage values and first invariant of stresses were in good agreement.
C1 [Prabhu, Rajkumar; Patnaik, Sourav S.; Begonia, Mark T.; Williams, Lakiesha N.; Liao, Jun] Mississippi State Univ, Dept Agr & Biol Engn, Holly Springs, MS 38635 USA.
   [Whittington, Wilburn R.; Mao, Yuxiong; Horstemeyer, M. F.] Mississippi State Univ, Ctr Adv Vehicular Syst, Holly Springs, MS USA.
RP Prabhu, R (reprint author), Mississippi State Univ, Dept Agr & Biol Engn, Holly Springs, MS 38635 USA.
EM praj@cavs.msstate.edu
RI Patnaik, Sourav/E-4595-2010
OI Patnaik, Sourav/0000-0001-7457-8604; Whittington,
   Wilburn/0000-0002-1635-9830; Horstemeyer, Mark/0000-0003-4230-0063
FU Center for Advanced Vehicular Systems (CAVS); Agricultural and
   Biological Engineering Department at Mississippi State University; U.S.
   Army TACOM Life Cycle Command through Mississippi State University
   [W56HZV-08-C-0236]; National Nuclear Security Administration,
   (Department of Energy) [DE-FC26-06NT42755]
FX The authors would like to recognize the Center for Advanced Vehicular
   Systems (CAVS) and the Agricultural and Biological Engineering
   Department at Mississippi State University for supporting this work.
   This material is based upon work supported by the U.S. Army TACOM Life
   Cycle Command under Contract No. W56HZV-08-C-0236, through a subcontract
   with Mississippi State University, and was performed for the Simulation
   Based Reliability and Safety (SimBRS) research program. Also, this
   material is based upon work supported by the National Nuclear Security
   Administration, (Department of Energy) under award number
   [DE-FC26-06NT42755]. Finally, the authors would like to thank Mr. David
   Adams, Mr. Michael McCollum and Ms. Erin Colebeck for their effort in
   this research.
CR Aubry M, 2002, Br J Sports Med, V36, P6, DOI 10.1136/bjsm.36.1.6
   Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406
   Bouvard J. L, 2010, ACTA MECH, V213, P1
   Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f
   Chen J., 2009, P ASME 2009 SUMM BIO
   Cullis I G, 2001, J R Army Med Corps, V147, P16
   DHARAN CKH, 1970, EXP MECH, V10, P370, DOI 10.1007/BF02320419
   Finkelstein E., 2006, INCIDENCE EC BURDEN
   Gray G. T., 2000, ASM HDB, V8, P488
   Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549
   Horstemeyer M. F., 2012, INTEGRATED COMPUTATI
   KENNER VH, 1973, J BIOMECH, V6, P1, DOI 10.1016/0021-9290(73)90032-8
   KHALIL TB, 1979, J SOUND VIB, V63, P351, DOI 10.1016/0022-460X(79)90679-5
   Ngo T, 2007, ELECT J STRUCT ENG, V7, P76
   Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023
   Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015
   Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035
   Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021
   Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001
   Usmani Z, 2010, WEB INTELLIGENCE INT
   Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015
   Zhao H, 1996, INT J SOLIDS STRUCT, V33, P3363, DOI 10.1016/0020-7683(95)00186-7
   Zhao H, 1997, INT J IMPACT ENG, V19, P319, DOI 10.1016/S0734-743X(96)00038-3
NR 23
TC 0
Z9 0
U1 0
U2 9
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2015
IS 99
AR e51545
DI 10.3791/51545
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7MV
UT WOS:000361535300002
PM 26067742
OA Green Published
DA 2018-10-19
ER

PT J
AU Alimperti, S
   Andreadis, ST
AF Alimperti, Stella
   Andreadis, Stelios T.
TI CDH2 and CDH11 act as regulators of stem cell fate decisions
SO STEM CELL RESEARCH
LA English
DT Review
ID N-CADHERIN EXPRESSION; LIMB MESENCHYMAL CHONDROGENESIS; GROWTH-FACTOR
   RECEPTOR; SMOOTH-MUSCLE-CELLS; RHO-FAMILY GTPASES; ADHERENS JUNCTIONS;
   BONE-MARROW; SCAFFOLD-FREE; P120 CATENIN; BETA-CATENIN
AB Accumulating evidence suggests that the mechanical and biochemical signals originating from cell-cell adhesion are critical for stem cell lineage specification. In this review, we focus on the role of cadherin mediated signaling in development and stem cell differentiation, with emphasis on two well-known cadherins, cadherin-2 (CDH2) (N-cadherin) and cadherin-11 (CDH11) (OB-cadherin). We summarize the existing knowledge regarding the role of CDH2 and CDH11 during development and differentiation in vivo and in vitro. We also discuss engineering strategies to control stem cell fate decisions by fine-tuning the extent of cell-cell adhesion through surface chemistry and microtopology. These studies may be greatly facilitated by novel strategies that enable monitoring of stem cell specification in real time. We expect that better understanding of how intercellular adhesion signaling affects lineage specification may impact biomaterial and scaffold design to control stem cell fate decisions in three-dimensional context with potential implications for tissue engineering and regenerative medicine. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Alimperti, Stella; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA.
   [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall, Amherst, NY 14260 USA.
EM sandread@buffalo.edu
FU National Science Foundation [CBET-1403086]
FX This work was supported in part by a grant from the National Science
   Foundation (CBET-1403086) to S.T.A.
CR Agarwal SK, 2006, CURR OPIN RHEUMATOL, V18, P268, DOI 10.1097/01.bor.0000218948.42730.39
   Alimperti S, 2012, GENE THER, V19, P1123, DOI 10.1038/gt.2011.208
   Alimperti S, 2014, BIOTECHNOL PROGR, V30, P974, DOI 10.1002/btpr.1904
   Alimperti S, 2014, J CELL SCI, V127, P2627, DOI 10.1242/jcs.134833
   Anastasiadis PZ, 2000, J CELL SCI, V113, P1319
   Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637
   Augello A, 2007, ARTHRITIS RHEUM, V56, P1175, DOI 10.1002/art.22511
   Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Becker SFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085717
   BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Borghi N, 2009, CURR TOP DEV BIOL, V89, P1, DOI 10.1016/S0070-2153(09)89001-7
   Boscher C, 2008, CELL SIGNAL, V20, P1061, DOI 10.1016/j.cellsig.2008.01.008
   Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955067402003733
   Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004
   Brieva TA, 2004, TISSUE ENG, V10, P553, DOI 10.1089/107632704323061915
   Brieva TA, 2004, BIOTECHNOL BIOENG, V85, P283, DOI 10.1002/bit.10855
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068
   Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108
   Charest JL, 2009, J INVEST DERMATOL, V129, P564, DOI 10.1038/jid.2008.265
   Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254
   Chopra A, 2011, AM J PHYSIOL-HEART C, V300, pH1252, DOI 10.1152/ajpheart.00515.2010
   Dander E, 2012, LEUKEMIA, V26, P1681, DOI 10.1038/leu.2011.384
   Debiais F, 2001, J CELL BIOCHEM, V81, P68, DOI 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S
   Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld
   Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777
   Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Evans SF, 2013, BIOMATERIALS, V34, P1878, DOI 10.1016/j.biomaterials.2012.09.024
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047
   Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Gray DS, 2008, EXP CELL RES, V314, P2846, DOI 10.1016/j.yexcr.2008.06.023
   Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496
   Grosheva I, 2001, J CELL SCI, V114, P695
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855
   Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806
   Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927
   Hatanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037600
   HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386
   Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006
   Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375
   Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857
   Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013
   Jia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051549
   Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014
   Kawaguchi J, 2001, J BONE MINER RES, V16, P1265, DOI 10.1359/jbmr.2001.16.7.1265
   Kawaguchi J, 2001, J BONE MINER RES, V16, P260, DOI 10.1359/jbmr.2001.16.2.260
   Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005
   Kii I, 2004, J BONE MINER RES, V19, P1840, DOI 10.1359/JBMR.040812
   KIMURA Y, 1995, DEV BIOL, V169, P347, DOI 10.1006/dbio.1995.1149
   Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9
   Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200
   Kuijpers KAJ, 2007, EUR UROL, V52, P1213, DOI 10.1016/j.eururo.2007.01.052
   Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044
   Lambert M, 2000, J CELL SCI, V113, P2207
   Lecanda F, 2000, J CELL BIOCHEM, V77, P499, DOI 10.1002/(SICI)1097-4644(20000601)77:3<499::AID-JCB14>3.0.CO;2-0
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583
   Lira CBB, 2008, PROTEIN EXPRES PURIF, V61, P220, DOI 10.1016/j.pep.2008.06.007
   Luegmayr E, 2000, HISTOCHEM CELL BIOL, V113, P467
   Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241
   Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   Marthiens V, 2002, MOL CELL NEUROSCI, V20, P458, DOI 10.1006/mcne.2002.1130
   Marthiens W, 2002, BIOL CELL, V94, P315, DOI 10.1016/S0248-4900(02)00005-9
   Martin TA, 2001, CLIN CANCER RES, V7, P734
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mertsching H, 2005, BIOMATERIALS, V26, P6610, DOI 10.1016/j.biomaterials.2005.04.048
   Moharil J., 2015, LENTIVIRAL MIC UNPUB
   Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016
   Myers TJ, 2010, EXPERT OPIN BIOL TH, V10, P1663, DOI 10.1517/14712598.2010.531257
   Nakazora S, 2010, BIOCHEM BIOPH RES CO, V400, P493, DOI 10.1016/j.bbrc.2010.08.070
   Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591
   Nelson Celeste M, 2007, Methods Mol Biol, V370, P1
   Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148
   Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040
   Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200
   Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216
   Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104
   Ouyang MX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2560
   Padilla F, 1998, MOL CELL NEUROSCI, V11, P217, DOI 10.1006/mcne.1998.0681
   Padmashali RM, 2014, MOL THER, V22, P1971, DOI 10.1038/mt.2014.103
   Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035
   Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200
   Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985
   Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329
   Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443
   Raut SD, 2010, J CONTROL RELEASE, V144, P213, DOI 10.1016/j.jconrel.2010.02.009
   Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2
   Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88
   Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003
   Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0
   Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178
   Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014
   Schiele NR, 2013, TISSUE ENG PT A, V19, P1223, DOI 10.1089/ten.tea.2012.0321
   Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098
   Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053
   Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299
   Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1
   Shih WT, 2012, CELL ADHES MIGR, V6, P513, DOI 10.4161/cam.21766
   Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861
   Shin CS, 2000, J CELL BIOCHEM, V78, P566, DOI 10.1002/1097-4644(20000915)78:4<566::AID-JCB6>3.0.CO;2-K
   SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281
   Smutny M, 2010, J CELL BIOL, V189, P1075, DOI 10.1083/jcb.201005151
   Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   SUVA LJ, 1994, MOL ENDOCRINOL, V8, P1507, DOI 10.1210/me.8.11.1507
   Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626
   TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960
   Thompson SA, 2014, J MOL CELL CARDIOL, V68, P29, DOI 10.1016/j.yjmcc.2013.12.025
   Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46
   Tian J, 2010, LAB CHIP, V10, P1967, DOI 10.1039/c003153d
   Tomita K, 2000, CANCER RES, V60, P3650
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Tuan RS, 2003, J BONE JOINT SURG AM, V85A, P137, DOI 10.2106/00004623-200300002-00019
   Tufan AC, 2002, EXP CELL RES, V273, P197, DOI 10.1006/excr.2001.5448
   Tufan AC, 2002, DEV DYNAM, V223, P241, DOI 10.1002/dvdy.10046
   Tufan AC, 2001, FASEB J, V15, P1436, DOI 10.1096/fj.00-0784fje
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   Wang Lei, 2002, Hematology, V7, P113
   Wang XL, 2013, J BIOMED MATER RES A, V101, P3388, DOI 10.1002/jbm.a.34645
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377
   WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2
   Williams G, 2002, J BIOL CHEM, V277, P4361, DOI 10.1074/jbc.M109185200
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
   Xu L., 2012, MOL BIOL REP
   Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416
   Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156
   Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126
   Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001
   You H, 2013, J CELL SCI, V126, P2718, DOI 10.1242/jcs.122903
   Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183
   Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187
NR 164
TC 22
Z9 22
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1873-5061
EI 1876-7753
J9 STEM CELL RES
JI Stem Cell Res.
PD MAY
PY 2015
VL 14
IS 3
BP 270
EP 282
DI 10.1016/j.scr.2015.02.002
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP6JR
UT WOS:000359993400003
PM 25771201
OA DOAJ Gold, Green Accepted
DA 2018-10-19
ER

PT J
AU Opondo, SO
AF Opondo, Sam Okoth
TI Biocolonial and Racial Entanglements: Immunity, Community, and
   Superfluity in the Name of Humanity
SO ALTERNATIVES
LA English
DT Article
DE superfluity; immunity; humanity; biocolonialism
AB Through a reading of Neill Blomkamp's 2009 science fiction/mock documentary District 9 and John le Carre's novel The Constant Gardener, this article illustrates how the acceptance that we are all human has an identity-constituting function that enables bodies and lives to be valued differently with far-reaching implications for both biomedical experiments and experiments with the ethics of cohabitation. More specifically, this article examines biocolonial regimes, imagined immunities, and limited sympathies that transform racialized, class-mediated, and transnational vulnerable bodies into experimental labor or biomaterial (hearts, kidneys, and corneas) to be consumed or disposed of as part of life-sustaining and life-administering apparatuses.
C1 [Opondo, Sam Okoth] Vassar Coll, Comparat Polit Africana Studies, Poughkeepsie, NY 12601 USA.
RP Opondo, SO (reprint author), Vassar Coll, Poughkeepsie, NY 12601 USA.
EM saopondo@vassar.edu
CR Allain J, 2011, MED LAW REV, V19, P117, DOI 10.1093/medlaw/fwr001
   [Anonymous], 1968, EBONY, P118
   Bauman Zygmunt, 1989, MODERNITY HOLOCAUST, p[18, 144]
   Bertani Mauro, 2003, SOC MUST BE DEFENDED, P247
   Carney Scott, 2011, RED MARKET TRAIL WOR, P2
   Cesaire A., 1972, DISCOURSE COLONIALIS
   Colebrook Claire, 2005, DELEUZE AND SPACE, P204
   Comaroff Jean, 2001, SOCIAL IDENTITIES, V7, P252
   Comaroff Jean, 2002, S ATLANTIC Q, V101, P783
   Cooper M, 2008, EAST ASIAN SCI TECHN, V2, P73, DOI 10.1007/s12280-008-9040-y
   Deleuze Gilles, 1988, SPINOZA PRACTICAL PH
   DERRIDA J, 1980, CRIT INQUIRY, V7, P55, DOI 10.1086/448088
   Deustch Albert, 1942, BALTIMORE AFROAMERIA, P9
   Epstein Steven, 2007, INCLUSION POLITICS D, P43
   Esposito Roberto, 2011, IMMUNITAS PROTECTIN
   Esposito Roberto, 2008, BIOS BIOPOLITICS PHI, P111
   Esposito Roberto, 2012, TERMS POLITICAL COMM, P49
   FANON F, 1967, BLACK SKIN WHITE MAS, P109
   Fanon Franz, 1988, AFRICAN REVOLUTION P, P10
   Feldman Ilana, 2010, NAME HUMANITY GOVT T, P4
   Gilroy Paul, 2001, CAMPS NATIONS CULTUR, P14
   Grove, 2014, BLOOD
   Grove Jairus, 2015, MAKING THINGS INT, P184
   Heller-Nicholas Alexandra, 2011, SCREEN ED, V61, P137
   Johnson KerenAmi, 1997, CONSUMP MARK CULT, V1, P255
   Le Carre John, 2001, CONSTANT GARDENER, P417
   Lederer Susan E., 2008, FLESH BLOOD ORGAN TR, P118
   Loeb Elizabeth, 2008, WOMENS STUDIES Q, V36, P45
   Mbembe A, 2003, PUBLIC CULTURE, V15, P11, DOI 10.1215/08992363-15-1-11
   Mbembe Achille, 2004, PUBLIC CULTURE, V16, P380
   Meerpol Abel, 2000, STRANGE FRUIT BILLIE, P15
   Niewijk Alexandria, 1999, HASTINGS CTR REPORT, V29
   Osamu Nishitani, 2006, TRANSLATION BIOPOLIT, P259
   Peterson Bhekizizwe, 2012, NEW VIOLENT CARTOGRA, P222
   Petryna Adriana, 2010, NAME HUMANITY GOVT T, P278
   Rabinow Paul, 2006, BIOSOCIETIES, V1, P211
   Ramose M. B, 1999, AFRICAN PHILOS UBUNT
   Rendall Steven, 2012, MANHUNT PHILOS HIST
   Rieder J, 2011, SCI FICT FILM TELEV, V4, P41, DOI 10.3828/sfftv.2011.3
   Roberts Dorothy, 2011, FATAL INVENTION SCI, P156
   Rose Nikolas, 2001, THEOR CULT SOC, V18, p[1, 21]
   Scheper-Hughes N., 2002, SAIS REV, V22, P61, DOI DOI 10.1353/SAIS.2002.0022
   ScheperHughes N., 2005, GLOBAL ASSEMBLAGES T, P145
   Sharp LA, 2006, STRANGE HARVEST: ORGAN TRANSPLANTS, DENATURED BODIES, AND THE TRANSFORMED SELF, P1
   Sharp LA, 2000, ANNU REV ANTHROPOL, V29, P287, DOI 10.1146/annurev.anthro.29.1.287
   Silverman Kaja, 1996, THRESHOLD VISIBLE WO, P24
   Stein R, 2010, UNDER SIGN NAT, P101
   Stobie Cheryl, 2012, IMAGE TEXT J DESIGN, V20, P128
   Wald Priscilla, 2000, CULTURAL STUDIES POL, P196
NR 49
TC 0
Z9 0
U1 1
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0304-3754
EI 2163-3150
J9 ALTERNATIVES
JI Alternatives
PD MAY
PY 2015
VL 40
IS 2
SI SI
BP 115
EP 132
DI 10.1177/0304375415589432
PG 18
WC International Relations
SC International Relations
GA CN0AX
UT WOS:000358075200004
DA 2018-10-19
ER

PT J
AU Rotaru, I
   Olaru, D
AF Rotaru, I.
   Olaru, D.
TI Theoretical pressure and friction in total disc prosthesis for lumbar
   spine. Influence of ball radius and biomaterial combination
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Ball-and-Socket; Biomaterial; Friction; Pressure; Disc Prosthesis
ID METAL-ON-METAL; INTERVERTEBRAL DISC; ARTHROPLASTY; REPLACEMENT; FUSION;
   DEVICE
AB Total disc prosthesis for lumbar spine is a medical device used to completely replace the damaged intervertebral lumbar disc. The main advantages of prosthesis implantation are that this conserves the intervertebral mobility and prevents the adjacent discs degeneration. The purpose of this work was to study the theoretical effect of ball radius on the maximum pressure and on the frictional torque which occurs within lumbar total disc prostheses made of different biomaterial combination. The design of total disc prosthesis investigated was ball-and-socket and the biomaterial couple was metal-on-metal, polymer-on-metal and ceramic-on-ceramic. The results of this study indicated that the maximum pressure in disc prosthesis decrease with ball radius, while the frictional torque has a linear increase with ball radius. This study suggested designing of total disc prostheses for lumbar spine with small ball radius and with ceramic-on-ceramic material combination.
C1 [Rotaru, I.; Olaru, D.] Gheorghe Asachi Tech Univ Iasi, Dept Mech Engn Mechatron & Robot, Fac Mech Engn, Iasi 700050, Romania.
   [Rotaru, I.] Gr T Popa Univ Med & Pharm Iasi, Dept Biomed Sci, Fac Med Bioengn, Iasi 700454, Romania.
RP Rotaru, I (reprint author), Gheorghe Asachi Tech Univ Iasi, Dept Mech Engn Mechatron & Robot, Fac Mech Engn, 61-63 Bd Dimitrie Mangeron, Iasi 700050, Romania.
EM rotaruiuliana2000@gmail.com
FU POSDRU CUANTUMDOC "DOCTORAL STUDIES FOR EUROPEAN PERFORMANCES IN
   RESEARCH AND INNOVATION" - European Social Fund [ID79407]; Romanian
   Government
FX This paper was realised with the support of POSDRU CUANTUMDOC "DOCTORAL
   STUDIES FOR EUROPEAN PERFORMANCES IN RESEARCH AND INNOVATION" ID79407
   project funded by the European Social Fund and Romanian Government.
CR Bishop NE, 2008, MED ENG PHYS, V30, P1057, DOI 10.1016/j.medengphy.2008.01.001
   Bushelow M, 2008, 23 ANN M N AM SPIN S
   Chen SH, 2009, MED ENG PHYS, V31, P244, DOI 10.1016/j.medengphy.2008.07.007
   Denoziere G, 2006, J BIOMECH, V39, P766, DOI 10.1016/j.jbiomech.2004.07.039
   Fekete TF, 2010, ACTA NEUROCHIR, V152, P393, DOI 10.1007/s00701-009-0529-5
   Gloria A, 2008, J APPL BIOMATER BIOM, V6, P163
   Gloria A, 2011, J BIOMATER APPL, V25, P795, DOI 10.1177/0885328209360933
   GRAVIUS S, 2007, DTSCH ARZTEBL, V104, pA2592
   Grupp TM, 2009, EUR SPINE J, V18, P98, DOI 10.1007/s00586-008-0840-5
   Houpert L., 1999, C ROUL TOUL MAY 5 7
   Kopeliovich D., MAT JOINT PROSTHESES
   Matei L., 2011, TRIBOL INT, V44, P532
   Moghadas P, 2012, J BIOMECH, V45, P504, DOI 10.1016/j.jbiomech.2011.11.045
   Nechtow W., 2008, 54 ANN M ORTH RES SO, P1928
   Pop G., 2004, BIOMATERIALE SI COMP
   Pylos T., 2004, J BIOMECH, V37, P405
   Ray CD, 1997, SPINE, V22, P667, DOI 10.1097/00007632-199703150-00019
   Reitmaier S, 2012, J MECH BEHAV BIOMED, V14, P67, DOI 10.1016/j.jmbbm.2012.05.010
   Rotaru D. Olaru, 2012, B POLYTECHNIC I IASI, VLVIII, P2
   Rotaru I., 2012, B POLYTECHNIC I IASI, VLVIII, P2
   Rotaru I., 2011, SROMECA, V1, P9
   Rotaru I., 2011, P 3 IEEE INT C EHB, P211
   Rotaru I., 2013, TEHNOMUS, V112
   Sakalkale Durgadas P, 2003, Pain Physician, V6, P195
   Serhan Hassan, 2011, SAS J, V5, P75, DOI 10.1016/j.esas.2011.05.001
   Shaheen A., 2007, J ENG MED, V221, pH 621
   Streicher R M, 1996, Proc Inst Mech Eng H, V210, P223, DOI 10.1243/PIME_PROC_1996_210_416_02
   Tipper JL, 2001, WEAR, V250, P120, DOI 10.1016/S0043-1648(01)00653-6
   van den Eerenbeemt KD, 2010, EUR SPINE J, V19, P1262, DOI 10.1007/s00586-010-1445-3
   Wang WH, 2013, MED ENG PHYS, V35, P357, DOI 10.1016/j.medengphy.2012.05.013
   Zander T, 2009, CLIN BIOMECH, V24, P135, DOI 10.1016/j.clinbiomech.2008.11.008
NR 31
TC 0
Z9 0
U1 1
U2 6
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAY-JUN
PY 2015
VL 17
IS 5-6
BP 727
EP 733
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA CM5ZD
UT WOS:000357766600034
DA 2018-10-19
ER

PT J
AU Witzel, I
   Laakmann, E
   Fehm, T
   Mobus, V
   vonMinckwitz, G
   Kaiser, J
   Loibl, S
   Muller, V
AF Witzel, Isabell
   Laakmann, Elena
   Fehm, Tanja
   Moebus, Volker
   vonMinckwitz, Gunter
   Kaiser, Julia
   Loibl, Sibylle
   Mueller, Volkmar
TI Brain metastases in breast cancer network Germany (BMBC, GBG 79):
   Multicentric, retro- and prospective collection of patient data and
   biomaterial from breast cancer patients with brain metastases
SO CANCER RESEARCH
LA English
DT Meeting Abstract
CT 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium
CY DEC 09-13, 2014
CL San Antonio, TX
SP Canc Therapy Res Ctr, Amer Assoc Canc Res
C1 [Witzel, Isabell; Laakmann, Elena; Mueller, Volkmar] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.
   [Fehm, Tanja] Arbeitsgemeinschaft Gynakol Onkol AGO Trafo, Translat Res Board, Hamburg, Germany.
   [Moebus, Volker] Arbeitsgemeinschaft Gynakol Onkol AGO B, Breast Study Grp, Hamburg, Germany.
   [vonMinckwitz, Gunter; Kaiser, Julia; Loibl, Sibylle] German Breast Grp, Berlin, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD MAY 1
PY 2015
VL 75
SU 9
MA OT2-5-01
DI 10.1158/1538-7445.SABCS14-OT2-5-01
PG 2
WC Oncology
SC Oncology
GA CL1UK
UT WOS:000356730200116
DA 2018-10-19
ER

PT J
AU Hussein, MA
   Mohammed, AS
   Al-Aqeeli, N
AF Hussein, Mohamed A.
   Mohammed, Abdul Samad
   Al-Aqeeli, Naser
TI Wear Characteristics of Metallic Biomaterials: A Review
SO MATERIALS
LA English
DT Review
DE metallic biomaterial; tribology; wear; friction
ID CO-CR ALLOY; BIOMEDICAL APPLICATIONS; POWDER-METALLURGY; SURGICAL
   IMPLANTS; TITANIUM-ALLOYS; COCRMO-ALLOYS; BEHAVIOR; OSSEOINTEGRATION;
   INDENTATION; COEFFICIENT
AB Metals are extensively used in a variety of applications in the medical field for internal support and biological tissue replacements, such as joint replacements, dental roots, orthopedic fixation, and stents. The metals and alloys that are primarily used in biomedical applications are stainless steels, Co alloys, and Ti alloys. The service period of a metallic biomaterial is determined by its abrasion and wear resistance. A reduction in the wear resistance of the implant results in the release of incompatible metal ions into the body that loosen the implant. In addition, several reactions may occur because of the deposition of wear debris in tissue. Therefore, developing biomaterials with high wear resistance is critical to ensuring a long life for the biomaterial. The aim of this work is to review the current state of knowledge of the wear of metallic biomaterials and how wear is affected by the material properties and conditions in terms of the type of alloys developed and fabrication processes. We also present a brief evaluation of various experimental test techniques and wear characterization techniques that are used to determine the tribological performance of metallic biomaterials.
C1 [Hussein, Mohamed A.; Mohammed, Abdul Samad; Al-Aqeeli, Naser] King Fahd Univ Petr & Minerals, Dept Mech Engn, Dhahran 31261, Saudi Arabia.
   [Hussein, Mohamed A.] Kafrelsheikh Univ, Dept Mech Engn, Kafrelsheikh 33516, Egypt.
RP Mohammed, AS (reprint author), King Fahd Univ Petr & Minerals, Dept Mech Engn, Dhahran 31261, Saudi Arabia.
EM mahussein@kfupm.edu.sa; samad@kfupm.edu.sa; naqeeli@kfupm.edu.sa
RI Hussein, Mohamed/F-4120-2015
OI Hussein, Mohamed/0000-0002-6720-7618
FU King Abdulaziz City for Science and Technology (KACST) through the
   Science & Technology Unit at King Fahd University of Petroleum &
   Minerals (KFUPM) as part of the National Science, Technology and
   Innovation Plan [12-ADV3036-04]; King Fahd University of Petroleum &
   Minerals (KFUPM) [IN131020]
FX The authors would like to acknowledge the support provided by King
   Abdulaziz City for Science and Technology (KACST) through the Science &
   Technology Unit at King Fahd University of Petroleum & Minerals (KFUPM)
   for funding this work through project No. 12-ADV3036-04 as part of the
   National Science, Technology and Innovation Plan and King Fahd
   University of Petroleum & Minerals (KFUPM) through Project No. IN131020.
CR Alam M.d. Ohidul, 2002, TRIBOL INT, V35, P357, DOI DOI 10.1016/S0301-679X(02)00015-4
   Alvarado J, 2003, APPL ENG MECH MED GE, V6, P22
   Alvarez-Vera M, 2013, WEAR, V301, P175, DOI 10.1016/j.wear.2013.01.085
   Attar H, 2015, MATER LETT, V142, P38, DOI 10.1016/j.matlet.2014.11.156
   Barfeie A, 2015, BRIT DENT J, V218, DOI 10.1038/sj.bdj.2015.171
   Beake BD, 2013, TRIBOL INT, V63, P123, DOI 10.1016/j.triboint.2012.08.007
   Bhushan B., 2013, INTRO TRIBOLOGY, V621, P621
   Bhushan B, 2008, PHILOS T R SOC A, V366, P1351, DOI 10.1098/rsta.2007.2163
   Black J., 1998, HDB BIOMATERIALS PRO
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Chan SMT, 2011, J TRIBOL-T ASME, V133, DOI 10.1115/1.4004760
   Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005
   Choubey A, 2005, TRENDS BIOMATER ARTI, V18, P141, DOI DOI 10.1016/J.MSEA.2004.02.027
   Cvijovic A. I., 2010, TRIBOL LETT, V40, P59, DOI [10.1007/s11249-010-9639-8, DOI 10.1007/S11249-010-9639-8]
   Diaz C, 2009, NUCL INSTRUM METH B, V267, P1630, DOI 10.1016/j.nimb.2009.01.118
   Dowson D., 1995, BIOENGINEERING SKIN, P159
   Fellah M., 2014, TMS, V237, P237
   Fischer A, 2012, J MECH BEHAV BIOMED, V9, P50, DOI 10.1016/j.jmbbm.2012.01.007
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gialanella S, 2008, J MATER SCI, V43, P1701, DOI 10.1007/s10853-007-2358-3
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Henriques VAR, 2010, J MATER SCI, V45, P5844, DOI 10.1007/s10853-010-4660-8
   Hou XD, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/7/074006
   Hou XD, 2012, ACTA MATER, V60, P4128, DOI 10.1016/j.actamat.2012.03.054
   Munoz AI, 2011, J MATER SCI-MATER M, V22, P437, DOI 10.1007/s10856-010-4224-0
   Iwabuchi A, 2007, WEAR, V263, P492, DOI 10.1016/j.wear.2007.01.102
   Karanjai M, 2007, MAT SCI ENG A-STRUCT, V447, P19, DOI 10.1016/j.msea.2006.10.154
   Latysh V, 2006, CURR APPL PHYS, V6, P262, DOI 10.1016/j.cap.2005.07.053
   Lawrence K., 1980, NATURE, V283, P106, DOI DOI 10.1038/283106A07350519
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Li YH, 2014, MATERIALS, V7, P1709, DOI 10.3390/ma7031709
   Liang P. G., 1967, J BIOMED MATER RES, V1, P135, DOI 10.1002/jbm.8200101135605609
   Litonjua LA, 2003, QUINTESSENCE INT, V34, P435
   Luo X, 2013, WEAR, V302, P1615, DOI 10.1016/j.wear.2013.01.023
   Manhabosco TM, 2011, CORROS SCI, V53, P1786, DOI 10.1016/j.corsci.2011.01.057
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Mohan L, 2013, APPL SURF SCI, V282, P281, DOI 10.1016/j.apsusc.2013.05.120
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Niespodziana K, 2008, REV ADV MATER SCI, V18, P236
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Park J., 2007, BIOMATERIALS INTRO
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Pilliar R. M., 2009, METALLIC BIOMATERIAL
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001
   Ratner J. B. B. D., 1996, BIOMATERIALS SCI, V37, P50
   Reul H, 2002, J HEART VALVE DIS, V11, P409
   Ribeiro ALR, 2009, J MATER SCI-MATER M, V20, P1629, DOI 10.1007/s10856-009-3737-x
   Sathish S, 2010, MAT SCI ENG C-MATER, V30, P376, DOI 10.1016/j.msec.2009.12.004
   Shahgaldi BF, 2000, INJURY, V31, P85, DOI 10.1016/S0020-1383(99)00241-7
   Sivamani RK, 2003, SKIN RES TECHNOL, V9, P227, DOI 10.1034/j.1600-0846.2003.02366.x
   Spary IJ, 2006, PHILOS MAG, V86, P5581, DOI 10.1080/14786430600854988
   Stolyarov VV, 2004, MAT SCI ENG A-STRUCT, V371, P313, DOI 10.1016/j.msea.2003.12.026
   Sun D, 2009, WEAR, V267, P1845, DOI 10.1016/j.wear.2009.03.005
   Suresh KS, 2012, MAT SCI ENG C-MATER, V32, P763, DOI 10.1016/j.msec.2012.01.022
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Turssi CP, 2003, J BIOMED MATER RES B, V65B, P280, DOI 10.1002/jbm.b.10563
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Walowit JA, 1997, ASAIO J, V43, pM556
   Wennerberg A., 2015, IMPLANT SURFACES THE, V1st, P168
   Williams D., 1990, CONCISE ENCY MED DEN, pxvii
   Xu LJ, 2013, T NONFERR METAL SOC, V23, P692, DOI 10.1016/S1003-6326(13)62518-2
   YOSHIMITSU O, 2005, BIOMATERIALS, V26, P11, DOI DOI 10.1016/J.BIOMATERIALS.2004.02.005
NR 64
TC 31
Z9 31
U1 7
U2 101
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2015
VL 8
IS 5
BP 2749
EP 2768
DI 10.3390/ma8052749
PG 20
WC Materials Science, Multidisciplinary
SC Materials Science
GA CL3VK
UT WOS:000356879100045
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Choudhary, R
   Raj, R
   Swamiappan, S
AF Choudhary, Rajan
   Raj, Rishabh
   Swamiappan, Sasikumar
TI Synthesis and characterization of diopside by sol-gel combustion method
   by using L-alanine as a fuel for biomedical applications
SO JOURNAL OF THE INDIAN CHEMICAL SOCIETY
LA English
DT Article
DE Bioceramic; bioactivity; diopside; bio-waste; powder-XRD
ID BIOMATERIALS; BIOCERAMICS; BIOACTIVITY; ABILITY
AB Bioceramic calcium silicates have evolved as a potential biomaterial for artificial bone and dental root implants due to its excellent bioactivity and improved mechanical strength hence in the present work we aimed to convert the bio-waste into a useful biomaterial. In this study diopside (CaMgSi2O6) has been successfully prepared by sol-gel combustion method by using L-alanine as a fuel, nitrate ions as an oxidiser and egg shell (chicken) as a calcium source. Optimization of calcination temperature resulted in a well crystalline diopside powders with high phase purity. Synthesized powders were characterized by powder-XRD for phase identification, FT-IR spectroscopy for functional group analysis and scanning electron microscope for the measurement of particle size and surface morphology.
C1 [Choudhary, Rajan; Raj, Rishabh; Swamiappan, Sasikumar] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
RP Swamiappan, S (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
EM ssasikumar@vit.ac.in
RI Swamiappan, Sasikumar/M-9921-2016; Choudhary, Rajan/R-7998-2018
OI Swamiappan, Sasikumar/0000-0003-2533-4923; 
FU VIT University through Research Grants for Engineeiing, Management and
   Science (RGEMS) scheme
FX Authors are greatly thankful to the management of VIT University for
   providing the necessary facility for present study. The authors express
   their sincere gratitude. to Dr. V. Raju, Vice Chancellor, VIT University
   for funding this work through Research Grants for Engineeiing,
   Management and Science (RGEMS) scheme.
CR Bhatkar VB, 2011, B MATER SCI, V34, P1281, DOI 10.1007/s12034-011-0166-5
   Bozadjiev L, 2006, J U CHEM TECHNOLOGY, V41, P125
   Ghorbanian L, 2012, J NANOSTRUCT, V2, P357, DOI 10.7508/jns.2012.03.011
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Iwata NY, 2004, COLLOID SURFACE B, V33, P1, DOI 10.1016/j.colsurfb.2003.07.004
   Kokubo T., 1997, AN QUIM, V93, P49
   Nonami T, 1999, J MATER SCI-MATER M, V10, P475, DOI 10.1023/A:1008996908797
   Padilla S, 2006, ACTA BIOMATER, V2, P331, DOI 10.1016/j.actbio.2006.01.006
   Sainz MA, 2010, ACTA BIOMATER, V6, P2797, DOI 10.1016/j.actbio.2010.01.003
   Yamamoto S, 2012, J AUST CERAM SOC, V48, P180
NR 10
TC 1
Z9 1
U1 0
U2 4
PU SCIENTIFIC PUBL-INDIA
PI JODHPUR
PA 5-A, NEW PALI RD, PO BOX 91, NEAR HOTEL TAJ HARI MAHAL, JODHPUR, 342
   003, INDIA
SN 0019-4522
J9 J INDIAN CHEM SOC
JI J. Indian Chem. Soc.
PD MAY
PY 2015
VL 92
IS 5
BP 773
EP 776
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CK7GA
UT WOS:000356399600041
DA 2018-10-19
ER

PT J
AU Sych, EE
   Pinchuk, ND
   Klimenko, VP
   Uvarova, IV
   Tovstonog, AB
   Tomila, TV
   Evich, YI
AF Sych, E. E.
   Pinchuk, N. D.
   Klimenko, V. P.
   Uvarova, I. V.
   Tovstonog, A. B.
   Tomila, T. V.
   Evich, Ya. I.
TI Synthesis and Properties of Si-Modified Biogenic Hydroxyapatite Ceramics
SO POWDER METALLURGY AND METAL CERAMICS
LA English
DT Article
DE hydroxyapatite; silica; biomaterial; specific surface area; structure
ID IN-VITRO; COMPOSITES; PHOSPHATE; SILICON
AB The paper examines the production of Si-modified biogenic hydroxyapatite ceramics. The introduction of methylsilicic acid hydrogel in amounts converted to 2 and 5 wt.% Si and subsequent sintering at 600A degrees C increase the specific surface area by 10 times, from 6.1 to 59.8 m(2)/g. The porosity of ceramics increases from 43.0 to 62.3% when the modifying addition reaches up to 5 wt.%, the compressive strength being equal to 27-33 MPa. The modifying addition also influences the structure and reduces the minimum grain size of the material from 0.65 to 0.1 mu m.
C1 [Sych, E. E.; Pinchuk, N. D.; Klimenko, V. P.; Uvarova, I. V.; Tovstonog, A. B.; Tomila, T. V.; Evich, Ya. I.] Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
RP Sych, EE (reprint author), Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
EM lena_sych@ukr.net
RI Sych, Olena/T-3111-2017
OI Sych, Olena/0000-0001-9902-7833
CR [Anonymous], [No title captured], Patent No. 61938
   Atta-ur-Rahman, 2008, STUDIES NATURAL PROD, P954
   Emanuel E., 1999, ANNU REV PLANT PHYS, V50, P641
   Exley C, 1998, J INORG BIOCHEM, V69, P139, DOI 10.1016/S0162-0134(97)10010-1
   Goldstein SA, 1987, BIOMECHANICS, V20, P1055, DOI DOI 10.1016/0021-9290(87)90023-6
   Ivanchenko LA, 1999, POWDER METALL MET C+, V38, P448, DOI 10.1007/BF02676058
   Ivchenko D. V., 2006, ORTOPED TRAVMATOL PR, P12
   Li XW, 2006, J MATER SCI-MATER M, V17, P573, DOI 10.1007/s10856-006-8942-2
   Loeper J., 1978, PHYSL ROLE SILICON I, P589
   Luzin V. I., 2011, UKRAIN MORFOL ALMANA, V9, P116
   Luzin V. I., 2009, TRAVMA, V10, P346
   Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021
   Ning CQ, 2005, J MATER SCI-MATER M, V16, P355, DOI 10.1007/s10856-005-0635-8
   Podrushnyak E. P., Ukrainian Patent, Patent No. [61938, 61K3300]
   Podrushnyak E. P., 1998, PROBL OSTEOLOGII, V1, P98
   Podrushnyak E. P., Ukrainian Patent, Patent No. [A61K6/ 02, 61P1900]
   Podrushnyak E. P., Patent No. [Ukrainian Patent, A61K33/ 00, 61K602]
   Sych EE, 2010, POWDER METALL MET C+, V49, P153
   Sych O., 2007, FUNCT MAT, V14, P430
   Zaman QHMS, 2008, J CERAM SOC JPN, V116, P88, DOI 10.2109/jcersj2.116.88
NR 20
TC 3
Z9 3
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-1302
EI 1573-9066
J9 POWDER METALL MET C+
JI Powder Metall. Met. Ceram.
PD MAY
PY 2015
VL 54
IS 1-2
BP 67
EP 73
DI 10.1007/s11106-015-9681-z
PG 7
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CK6RO
UT WOS:000356355600010
DA 2018-10-19
ER

PT J
AU Kokorev, OV
   Khodorenko, VN
   Anikeev, SG
   Gunther, VE
AF Kokorev, O. V.
   Khodorenko, V. N.
   Anikeev, S. G.
   Gunther, V. E.
TI Biocompatibility of Textile Titanium Nickel Implants with Fibroblast
   Culture
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE biomaterial; biocompatibility; fibroblasts; textile implant; titanium
   nickel alloy
AB The parameters of biocompatibility of titanium nickel implants of different design with fibroblast culture are studied. Colonization of textile and mesh implants with fibroblasts and tissue development depend on the size of mesh cells and thread diameter. Titanium nickel implants of different constructions do not inhibit the growth of fibroblast culture.
C1 [Kokorev, O. V.; Khodorenko, V. N.; Anikeev, S. G.; Gunther, V. E.] Tomsk State Univ, Res Inst Med Mat & Shape Memory Implants, Siberian Phys Technol Inst, Tomsk 634050, Russia.
RP Kokorev, OV (reprint author), Tomsk State Univ, Res Inst Med Mat & Shape Memory Implants, Siberian Phys Technol Inst, Tomsk 634050, Russia.
EM kokorevov@yandex.ru
RI Anikeev, Sergey/E-1449-2017; Hodorenko, Valentina/P-2247-2016; Gunther,
   Viktor/O-6678-2014
OI Anikeev, Sergey/0000-0001-9323-5973; Kokorev, Oleg/0000-0003-3690-0177
CR Dambaev G. Ts., 2000, Implant for Surgical Treatment of Visceral Diseases, Patent No. 2143867
   Dambaev G. Ts, 2012, MED MAT SHAPE MEMORY, V11, P19
   Gunter VE, 2011, MED MAT SHAPE MEMORY, V1, P96
   Gunther V. E., 2002, Artificial Visceral Cell Culture Carrier, Patent No. 2191607
   Gunther V. E., 2010, SHAPE MEMORY IMPLANT
   Gunther VE, 2000, DELAY LAW NEW CLASS
   Ivchenko O. A., 2012, MED MAT SHAPE MEMORY, V10, P25
   Kainer K.U., 2006, METAL MATRIX COMPOSI
   Kokorev O. V., 2012, VESTN NOV MEDITS TEK, V19, P32
   Kokorev O. V., 2012, SIB MEDITS ZH, V27, P130
   KOKOREV OV, 2010, KLET TRANSPLANTOL TK, V5, P31
   Schawaller D., 2006, ADV SCI TECHNOL, V50, P1
   Sigmund W, 2006, J AM CERAM SOC, V89, P395, DOI 10.1111/j.1551-2916.2005.00807.x
   Volova T. G., 2003, POLYOXYALKANOATES PO
NR 14
TC 1
Z9 1
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
EI 1573-8221
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD MAY
PY 2015
VL 159
IS 1
BP 87
EP 91
DI 10.1007/s10517-015-2897-6
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CK0VX
UT WOS:000355924500024
PM 26028231
DA 2018-10-19
ER

PT J
AU Paliwal, SR
   Paliwal, R
   Vyas, SP
AF Paliwal, Shivani Rai
   Paliwal, Rishi
   Vyas, Suresh P.
TI A review of mechanistic insight and application of pH-sensitive
   liposomes in drug delivery
SO DRUG DELIVERY
LA English
DT Review
DE Chemotherapy; drug/gene delivery; fusogenicity; intracellular delivery;
   pH-sensitive lipid
ID TUMOR-BEARING MICE; BREAST-CANCER THERAPY; GENE DELIVERY; INTRACELLULAR
   DELIVERY; IN-VIVO; PHOSPHATIDYLETHANOLAMINE LIPOSOMES; PROLONGED
   CIRCULATION; CATIONIC LIPOSOMES; TRIGGERED RELEASE; HYBRID COMPLEXES
AB The pH-sensitive liposomes have been extensively used as an alternative to conventional liposomes in effective intracellular delivery of therapeutics/antigen/DNA/diagnostics to various compartments of the target cell. Such liposomes are destabilized under acidic conditions of the endocytotic pathway as they usually contain pH-sensitive lipid components. Therefore, the encapsulated content is delivered into the intracellular bio-environment through destabilization or its fusion with the endosomal membrane. The therapeutic efficacy of pH-sensitive liposomes enables them as biomaterial with commercial utility especially in cancer treatment. In addition, targeting ligands including antibodies can be anchored on the surface of pH-sensitive liposomes to target specific cell surface receptors/antigen present on tumor cells. These vesicles have also been widely explored for antigen delivery and serve as immunological adjuvant to enhance the immune response to antigens. The present review deals with recent research updates on application of pH-sensitive liposomes in chemotherapy/diagnostics/ antigen/gene delivery etc.
C1 [Paliwal, Shivani Rai] Guru Ghasidas Vishwavidyalaya Bilaspur, SLT Inst Pharmaceut Sci, Dept Pharmaceut, Bilaspur, Chattisgarh, India.
   [Paliwal, Rishi] Columbia Inst Pharm, Dept Pharmaceut, Raipur, Chhattisgarh, India.
   [Vyas, Suresh P.] Dr HS Gour Vishwavidyalaya, Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar, Madhya Pradesh, India.
RP Paliwal, SR (reprint author), Guru Ghasidas Vishwavidyalaya A Cent Univ, SLT Inst Pharmaceut Sci, Bilaspur 495009, Chattisgarh, India.
EM srai2k@gmail.com
CR Abra RM, 2002, J LIPOSOME RES, V12, P1, DOI 10.1081/LPR-120004770
   Andresen TL, 2005, PROG LIPID RES, V44, P68, DOI 10.1016/j.plipres.2004.12.001
   Andrews CD, 2012, MOL PHARMACEUT, V9, P1118, DOI 10.1021/mp2003835
   Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008
   Bertrand N, 2010, METHODS MOL BIOL, V605, P545, DOI 10.1007/978-1-60327-360-2_36
   de Barros ALB, 2011, BIOORG MED CHEM LETT, V21, P7373, DOI 10.1016/j.bmcl.2011.10.016
   Chang JS, 1999, VACCINE, V17, P1540, DOI 10.1016/S0264-410X(98)00353-3
   Chang JS, 2001, VACCINE, V19, P3608, DOI 10.1016/S0264-410X(01)00104-9
   Chen DQ, 2011, INT J NANOMED, V6, P2053, DOI 10.2147/IJN.S24344
   Chen HG, 2012, EUR J MED CHEM, V52, P159, DOI 10.1016/j.ejmech.2012.03.013
   Chen Y, 2013, INT J NANOMED, V8, P1573, DOI 10.2147/IJN.S42800
   Araujo JGC, 2011, EXP BIOL MED, V236, P808, DOI 10.1258/ebm.2011.011038
   COLLINS D, 1995, LIPOSOMES TOOLS BASI, P201
   CONNOR J, 1986, CANCER RES, V46, P3431
   CONNOR J, 1984, P NATL ACAD SCI-BIOL, V81, P1715, DOI 10.1073/pnas.81.6.1715
   de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277
   Di Marzio L, 2008, BBA-BIOMEMBRANES, V1778, P2749, DOI 10.1016/j.bbamem.2008.07.029
   Drummond DC, 2000, PROG LIPID RES, V39, P409, DOI 10.1016/S0163-7827(00)00011-4
   Ducat E, 2011, INT J PHARMACEUT, V420, P319, DOI 10.1016/j.ijpharm.2011.08.034
   DUZGUNES N, 1985, BIOCHEMISTRY-US, V24, P3091, DOI 10.1021/bi00334a004
   Fattal E, 2004, ADV DRUG DELIVER REV, V56, P931, DOI 10.1016/j.addr.2003.10.037
   Soares DCF, 2012, EUR J PHARM SCI, V45, P58, DOI 10.1016/j.ejps.2011.10.018
   Gerasimov OV, 1999, ADV DRUG DELIVER REV, V38, P317, DOI 10.1016/S0169-409X(99)00035-6
   Giuberti CD, 2011, J LIPOSOME RES, V21, P60, DOI 10.3109/08982101003754377
   Guo WJ, 2002, J CONTROL RELEASE, V83, P121, DOI 10.1016/S0168-3659(02)00167-0
   Hong MS, 2002, J PHARM PHARMACOL, V54, P51, DOI 10.1211/0022357021771913
   HUANG A, 1982, BIOCHIM BIOPHYS ACTA, V716, P140, DOI 10.1016/0304-4165(82)90262-8
   Jiang TY, 2012, BIOMATERIALS, V33, P9246, DOI 10.1016/j.biomaterials.2012.09.027
   Junior ADC, 2007, LIFE SCI, V80, P659, DOI 10.1016/j.lfs.2006.10.011
   Kale AA, 2007, J LIPOSOME RES, V17, P197, DOI 10.1080/08982100701525035
   Karanth H, 2007, J PHARM PHARMACOL, V59, P469, DOI 10.1211/jpp.59.4.0001
   Khalil IA, 2011, J CONTROL RELEASE, V156, P374, DOI 10.1016/j.jconrel.2011.08.012
   Kim IY, 2009, J CONTROL RELEASE, V140, P55, DOI 10.1016/j.jconrel.2009.07.005
   Kim MJ, 2008, ARCH PHARM RES, V31, P539, DOI 10.1007/s12272-001-1190-9
   KONO K, 1994, BBA-BIOMEMBRANES, V1193, P1, DOI 10.1016/0005-2736(94)90325-5
   Koren E, 2012, J CONTROL RELEASE, V160, P264, DOI 10.1016/j.jconrel.2011.12.002
   Koynova R, 2006, P NATL ACAD SCI USA, V103, P14373, DOI 10.1073/pnas.0603085103
   LAI MZ, 1985, BIOCHEMISTRY-US, V24, P1646, DOI 10.1021/bi00328a012
   Lee KY, 2002, BIOCHEM BIOPH RES CO, V292, P682, DOI 10.1006/bbrc.2002.6711
   Leite EA, 2009, LIFE SCI, V84, P641, DOI 10.1016/j.lfs.2009.02.002
   Leroux JC, 2001, J CONTROL RELEASE, V72, P71, DOI 10.1016/S0168-3659(01)00263-2
   LESERMAN L, 1990, PROG CLIN BIOL RES, V343, P95
   Li P, 2012, INT J NANOMED, V7, P925, DOI 10.2147/IJN.S26955
   LITZINGER DC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P201, DOI 10.1016/0304-4157(92)90039-D
   Lutwyche P, 1998, ANTIMICROB AGENTS CH, V42, P2511, DOI 10.1128/AAC.42.10.2511
   Ferreira SMZMD, 2012, BIOORG MED CHEM LETT, V22, P4605, DOI 10.1016/j.bmcl.2012.05.105
   Mo R, 2013, BIOMATERIALS, V34, P2773, DOI 10.1016/j.biomaterials.2013.01.030
   Momekova D, 2010, METHODS MOL BIOL, V605, P527, DOI 10.1007/978-1-60327-360-2_35
   Moore NM, 2008, MOL PHARM, V5, P140, DOI 10.1021/mp700072n
   Nakamura K, 2009, BIOL PHARM BULL, V32, P1628, DOI 10.1248/bpb.32.1628
   NAYAR R, 1985, BIOCHEMISTRY-US, V24, P5967, DOI 10.1021/bi00342a042
   Paliwal SR, 2012, MOL PHARMACEUT, V9, P176, DOI 10.1021/mp200439z
   Paliwal SR, 2013, RSC SMART MATER, P80, DOI 10.1039/9781849736800-00080
   Paliwal SR, 2011, NANOMEDICINE-UK, V6, P1085, DOI [10.2217/NNM.11.72, 10.2217/nnm.11.72]
   Pichon Chantal, 2013, Methods Mol Biol, V969, P247, DOI 10.1007/978-1-62703-260-5_16
   Rodrigues PCA, 1999, BIOORGAN MED CHEM, V7, P2517, DOI 10.1016/S0968-0896(99)00209-6
   Rosa M, 2008, MOL MEMBR BIOL, V25, P23, DOI 10.1080/09687680701499451
   Roux E, 2004, J CONTROL RELEASE, V94, P447, DOI 10.1016/j.jconrel.2003.10.024
   Roux E, 2003, BIOMACROMOLECULES, V4, P240, DOI 10.1021/bm025651x
   Roux E, 2002, INT J PHARM, V242, P25, DOI 10.1016/S0378-5173(02)00183-7
   Roux E, 2002, J PHARM SCI, V91, P1795, DOI 10.1002/jps.10172
   Sakaguchi N, 2008, BIOMATERIALS, V29, P4029, DOI 10.1016/j.biomaterials.2008.06.006
   Sakaguchi N, 2008, BIOCONJUGATE CHEM, V19, P1588, DOI 10.1021/bc800126s
   Sakaguchi N, 2008, BIOCONJUGATE CHEM, V19, P1040, DOI 10.1021/bc7004736
   Sawant RM, 2006, BIOCONJUGATE CHEM, V17, P943, DOI 10.1021/bc060080h
   SEDDON JM, 1983, BIOCHEMISTRY-US, V22, P1280, DOI 10.1021/bi00274a045
   Shi GF, 2002, J CONTROL RELEASE, V80, P309, DOI 10.1016/S0168-3659(02)00017-2
   Shigeta K, 2007, J CONTROL RELEASE, V118, P262, DOI 10.1016/j.jconrel.2006.12.019
   Simard P, 2010, MOL PHARMACEUT, V7, P1098, DOI 10.1021/mp900261m
   Simard P, 2009, INT J PHARMACEUT, V381, P86, DOI 10.1016/j.ijpharm.2009.05.013
   Simoes S, 2004, ADV DRUG DELIVER REV, V56, P947, DOI 10.1016/j.addr.2003.10.038
   Simoes S, 2001, BBA-BIOMEMBRANES, V1515, P23, DOI 10.1016/S0005-2736(01)00389-3
   Slepushkin VA, 1997, J BIOL CHEM, V272, P2382
   Soenen SJH, 2009, BIOMATERIALS, V30, P3691, DOI 10.1016/j.biomaterials.2009.03.040
   SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002
   Sudimack JJ, 2002, BBA-BIOMEMBRANES, V1564, P31, DOI 10.1016/S0005-2736(02)00399-1
   Tachibana R, 1998, BIOCHEM BIOPH RES CO, V251, P538, DOI 10.1006/bbrc.1998.9460
   Torchilin V P, 1985, Crit Rev Ther Drug Carrier Syst, V2, P65
   Torchilin V. P., 1993, J LIPOSOME RES, V3, P201, DOI DOI 10.3109/08982109309148213]
   Torres E, 2011, J CONTROL RELEASE, V154, P196, DOI 10.1016/j.jconrel.2011.05.017
   Venugopalan P, 2002, PHARMAZIE, V57, P659
   WANG CY, 1987, P NATL ACAD SCI USA, V84, P7851, DOI 10.1073/pnas.84.22.7851
   Watabe S, 2001, VACCINE, V19, P4434, DOI 10.1016/S0264-410X(01)00194-3
   Watarai S, 2013, SCI WORLD J, V2013, P1
   WEBB MS, 1995, BBA-BIOMEMBRANES, V1238, P147, DOI 10.1016/0005-2736(95)00121-I
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1105, P193, DOI 10.1016/0005-2736(92)90194-Q
   Xia GM, 2013, CHEM PHARM BULL, V61, P390
   YATVIN MB, 1980, BIOPHYS STRUCT MECH, V6, P233, DOI 10.1007/BF00537296
   YATVIN MB, 1980, SCIENCE, V210, P1253, DOI 10.1126/science.7434025
   Yoshikawa T, 2008, BIOCHEM BIOPH RES CO, V366, P408, DOI 10.1016/j.bbre.2007.11.153
   Yu B, 2010, MOL MEMBR BIOL, V27, P286, DOI 10.3109/09687688.2010.521200
   Yuba E, 2013, BIOMATERIALS, V34, P3042, DOI 10.1016/j.biomaterials.2012.12.031
   Yuba E, 2010, BIOMATERIALS, V31, P943, DOI 10.1016/j.biomaterials.2009.10.006
   ZHOU F, 1995, J DRUG TARGET, V3, P91, DOI 10.3109/10611869509059210
   Zignani M, 2000, BBA-BIOMEMBRANES, V1463, P383, DOI 10.1016/S0005-2736(99)00234-5
NR 95
TC 26
Z9 27
U1 4
U2 75
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD MAY
PY 2015
VL 22
IS 3
BP 231
EP 242
DI 10.3109/10717544.2014.882469
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CJ8PH
UT WOS:000355764900001
PM 24524308
OA Bronze
DA 2018-10-19
ER

PT J
AU Tsintou, M
   Dalamagkas, K
   Seifalian, AM
AF Tsintou, Magdalini
   Dalamagkas, Kyriakos
   Seifalian, Alexander Marcus
TI Advances in regenerative therapies for spinal cord injury: a
   biomaterials approach
SO NEURAL REGENERATION RESEARCH
LA English
DT Review
DE tissue engineering; neuroregeneration; repair; central nervous system;
   biomaterial; regenerative medicine; nanotechnology; spinal cord injury
ID NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; TEMPLATED AGAROSE SCAFFOLDS;
   HYALURONAN-BASED HYDROGEL; COLONY-STIMULATING FACTOR; BONE-MARROW;
   AXONAL REGENERATION; FUNCTIONAL RECOVERY; COLLAGEN SCAFFOLDS;
   SCHWANN-CELLS
AB Spinal cord injury results in the permanent loss of function, causing enormous personal, social and economic problems. Even though neural regeneration has been proven to be a natural mechanism, central nervous system repair mechanisms are ineffective due to the imbalance of the inhibitory and excitatory factors implicated in neuroregeneration. Therefore, there is growing research interest on discovering a novel therapeutic strategy for effective spinal cord injury repair. To this direction, cell-based delivery strategies, biomolecule delivery strategies as well as scaffold-based therapeutic strategies have been developed with a tendency to seek for the answer to a combinatorial approach of all the above. Here we review the recent advances on regenerative/neural engineering therapies for spinal cord injury, aiming at providing an insight to the most promising repair strategies, in order to facilitate future research conduction.
C1 [Tsintou, Magdalini; Dalamagkas, Kyriakos; Seifalian, Alexander Marcus] UCL, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London, England.
   [Seifalian, Alexander Marcus] Royal Free London NHS Fdn Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London, England.
EM a.seifalian@gmail.com
FU Program "IKY (Greek State Scholarships Foundation) Scholarships" from
   funds of the Operational Program "Education and Lifelong Learning", of
   the European Social Fund (ESF) of the National Strategic Reference
   Framework (NSRF); A.G. Leventis Foundation; John S. Latsis Public
   Benefit Foundation; Faculty of Medicine of the University of Thessaly
   (Greece)
FX This work was partially funded by the Program "IKY (Greek State
   Scholarships Foundation) Scholarships" from funds of the Operational
   Program "Education and Lifelong Learning", of the European Social Fund
   (ESF) of the National Strategic Reference Framework (NSRF), 2007-2013.
   It was also partially funded by Scholarships from the A.G. Leventis
   Foundation, by a Scholarship from John S. Latsis Public Benefit
   Foundation and by a special Scholarship from the Faculty of Medicine of
   the University of Thessaly (Greece).
CR Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003
   Akdemir HU, 2013, ULUS TRAVMA ACIL CER, V19, P441, DOI 10.5505/tjtes.2013.21456
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004
   Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008
   Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003
   Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5
   Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2006-0393
   Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010
   Caicco MJ, 2013, J BIOMED MATER RES A, V101, P1472, DOI 10.1002/jbm.a.34454
   Callera F, 2006, EXP HEMATOL, V34, P130, DOI 10.1016/j.exphem.2005.11.006
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011
   Chen NC, 2012, BIOMATERIALS, V33, P1353, DOI 10.1016/j.biomaterials.2011.10.062
   Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Crompton KE, 2006, J MATER SCI-MATER M, V17, P633, DOI 10.1007/s10856-006-9226-6
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Donoghue PS, 2013, TISSUE ENG PT A, V19, P497, DOI [10.1089/ten.tea.2012.0382, 10.1089/ten.TEA.2012.0382]
   English D, 2013, J CELL BIOCHEM, V114, P764, DOI 10.1002/jcb.24436
   Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Fan Z., 2013, CELL TRANSPLANT S1, V22, P39
   Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7
   Forgione N, 2013, WORLD NEUROSURG
   Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297
   Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Guest J, 2011, BRAIN RES BULL, V84, P267, DOI 10.1016/j.brainresbull.2010.11.007
   Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hansmann F, 2012, CELL TRANSPLANT, V21, P1161, DOI 10.3727/096368911X627444
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298
   Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596
   Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P432, DOI 10.1089/scd.2011.0242
   Hayashi J, 2006, J CEREBR BLOOD F MET, V26, P906, DOI 10.1038/sj.jcbfm.9600247
   He L, 2013, NEUROSCI BULL, V29, P129, DOI 10.1007/s12264-013-1318-y
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hejcl A, 2013, STEM CELLS DEV, V22, P2794, DOI 10.1089/scd.2012.0616
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Ibarretxe G, 2012, STEM CELLS INT, V2012
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088
   Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72
   Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670
   Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589
   Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367
   Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163
   Kozlowska H, 2007, STEM CELLS DEV, V16, P481, DOI 10.1089/scd.2007.9993
   Kubinova S, 2015, J TISSUE ENG REGEN M, V9, P1298, DOI 10.1002/term.1694
   Kubinova S, 2012, REGEN MED, V7, P207, DOI [10.2217/RME.11.121, 10.2217/rme.11.121]
   Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149
   Lanfer B, 2010, TISSUE ENG PT A, V16, P1103, DOI [10.1089/ten.tea.2009.0282, 10.1089/ten.TEA.2009.0282]
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047
   Li XR, 2013, BIOMATERIALS, V34, P5107, DOI 10.1016/j.biomaterials.2013.03.062
   Lis Anna, 2013, Polim Med, V43, P59
   Liu JB, 2013, CELLS TISSUES ORGANS, V198, P35, DOI 10.1159/000351665
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001
   Lo V, 2013, J NEUROSURG SCI, V57, P281
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   Macaya DJ, 2013, BIOMATERIALS, V34, P3591, DOI 10.1016/j.biomaterials.2012.12.050
   Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008
   Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008
   Mitra T, 2013, MATER RES-IBERO-AM J, V16, P755, DOI [10.1590/S1516-14392013000400009, 10.1590/S1516-14392013005000059]
   Moon LDF, 2006, RESTOR NEUROL NEUROS, V24, P147
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   National Spinal Cord Injury Statistical Center, 2013, FACTS FIG GLANC
   Nomura H, 2008, NEUROSURGERY, P141
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580
   Ovechkin AV, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00174
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   Pan HC, 2008, J CLIN NEUROSCI, V15, P656, DOI 10.1016/j.jocn.2007.03.020
   Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5
   Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126
   Park D, 2011, BIOMATERIALS, V32, P777, DOI 10.1016/j.biomaterials.2010.09.044
   Park JH, 2012, NEUROSURGERY, V70, P1238, DOI 10.1227/NEU.0b013e31824387f9
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Raad M, 2012, ELECTROPHORESIS, V33, P3659, DOI 10.1002/elps.201200470
   Ribeiro-Samy S, 2013, MACROMOL BIOSCI, V13, P1576, DOI 10.1002/mabi.201300178
   Rochkind S, 2006, EUR SPINE J, V15, P234, DOI 10.1007/s00586-005-0981-8
   Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Saracino GAA, 2013, CHEM SOC REV, V42, P225, DOI 10.1039/c2cs35065c
   Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114
   Sebastia-Alcacer V, 2014, SPINAL CORD, V52, P29, DOI 10.1038/sc.2013.128
   Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098
   Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002
   Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381
   Tan A, 2012, J CONTROL RELEASE, V163, P342, DOI 10.1016/j.jconrel.2012.08.009
   Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116
   Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thomas KE, 2011, BRIT MED BULL, V98, P127, DOI 10.1093/bmb/ldr013
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   White RE, 2008, RESTOR NEUROL NEUROS, V26, P197
   Wilcox JT, 2012, NEUROSCI LETT, V519, P93, DOI 10.1016/j.neulet.2012.02.028
   Willerth SM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt58
   Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206
   Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570
   Wu BQ, 2013, CHINESE MED J-PEKING, V126, P3723, DOI 10.3760/cma.j.issn.0366-6999.20111068
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xiong Y, 2012, INT J NANOMED, V7, P1977, DOI 10.2147/IJN.S30706
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
   Yarygin V N, 2006, Neurosci Behav Physiol, V36, P483, DOI 10.1007/s11055-006-0044-6
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807
   Zhang HT, 2012, CYTOTHERAPY, V14, P1203, DOI 10.3109/14653249.2012.711470
   Zhang XB, 2007, J NEUROTRAUM, V24, P1863, DOI 10.1089/neu.2007.0334
   Zhao RR, 2013, EUR J NEUROSCI, V38, P2946, DOI 10.1111/ejn.12276
   Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 150
TC 27
Z9 31
U1 7
U2 94
PU SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
PI SHENYANG
PA PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA
SN 1673-5374
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD MAY
PY 2015
VL 10
IS 5
BP 726
EP 742
DI 10.4103/1673-5374.156966
PG 17
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CK1JU
UT WOS:000355964400018
PM 26109946
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wang, LP
   Ren, J
   Zhang, XY
   Yang, XC
   Yang, W
AF Wang, Liping
   Ren, Jie
   Zhang, Xiaoyan
   Yang, Xiaoci
   Yang, Wu
TI Synthesis and Characterization of pH-sensitive and Self-oscillating IPN
   Hydrogel in a pH Oscillator
SO POLYMER-KOREA
LA English
DT Article
DE PAA/PEG IPN hydrogel; reversibility; self-oscillation; pH-responsiveness
ID BELOUSOV-ZHABOTINSKII REACTION; PERISTALTIC MOTION; GEL; DRIVEN
AB A self-oscillating interpenetrating polymer network (IPN) poly(acrylic acid)/poly(ethylene glycol) (PAA/PEG) hydrogel was prepared by using radical polymerization with a two-step method. The IPN hydrogel was characterized by FUR spectroscopy and morphological analysis. The results indicated that the chains of PEG and PAA twined to form porous structure which is beneficial to water molecules entering inside of the hydrogel. In addition, the pH-responsive behavior, salt sensitivity, swelling/de-swelling oscillatory behaviors and self-oscillation in a closed pH oscillator were also studied. The results showed that the prepared hydrogel exhibited pH-sensitivity, good swelling/de-swelling reversibility and excellent salt sensitivity. The self-oscillating behavior of swelling/de-swelling for the prepared hydrogel was caused by pH alteration coupled with the external media. This study may create a new possibility as biomaterial including new self-walking actuators and other related devices.
C1 [Wang, Liping; Ren, Jie; Zhang, Xiaoyan; Yang, Xiaoci; Yang, Wu] Northwest Normal Univ, Chem & Chem Engn Coll, Key Lab Bioelectrochemtry & Environm Anal Gansu, Lanzhon 730070, Peoples R China.
RP Ren, J (reprint author), Northwest Normal Univ, Chem & Chem Engn Coll, Key Lab Bioelectrochemtry & Environm Anal Gansu, Lanzhon 730070, Peoples R China.
EM jieren@nwnu.edu.cn
FU Basic Project of Science and Research of Colleges and Universities of
   Gansu Province [5001-109]; Natural Science Foundation of Gansu Province
   [1010 RJZA015, 096RJZA120]
FX This work was supported in part by the Basic Project of Science and
   Research of Colleges and Universities of Gansu Province (5001-109), the
   Natural Science Foundation of Gansu Province (1010 RJZA015; 096RJZA120).
CR Alzari V, 2009, BIOMACROMOLECULES, V10, P2672, DOI 10.1021/bm900605y
   Bilici C, 2010, J APPL POLYM SCI, V118, P2981, DOI 10.1002/app.32693
   Dogu Y, 2006, J APPL POLYM SCI, V99, P37, DOI 10.1002/app.22140
   Edblom E. C., 1989, J PHYS CHEM-US, V93, P2122
   FIELD RJ, 1974, J AM CHEM SOC, V96, P2001, DOI 10.1021/ja00814a003
   Gou B. L., 2007, CARBOHYD RES, V342, P2416
   GYORGYI L, 1990, J PHYS CHEM-US, V94, P7162, DOI 10.1021/j100381a039
   Kim SJ, 2003, SENSOR ACTUAT B-CHEM, V88, P286, DOI 10.1016/S0925-4005(02)00371-4
   Liu MM, 2012, CARBOHYD POLYM, V87, P2425, DOI 10.1016/j.carbpol.2011.11.010
   Motornov M, 2010, PROG POLYM SCI, V35, P174, DOI 10.1016/j.progpolymsci.2009.10.004
   Murase Y, 2010, SENSOR ACTUAT B-CHEM, V149, P272, DOI 10.1016/j.snb.2010.06.017
   Murase Y, 2009, LANGMUIR, V25, P483, DOI 10.1021/la8029006
   Okazaki N, 1999, J PHYS CHEM A, V103, P10915, DOI 10.1021/jp992626l
   Rapoport N, 2007, PROG POLYM SCI, V32, P962, DOI 10.1016/j.progpolymsci.2007.05.009
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tamashiro MN, 1998, EUR PHYS J B, V1, P337, DOI 10.1007/s100510050192
   Taniguchi H, 2010, J PHYS CHEM B, V114, P2405, DOI 10.1021/jp911779j
   Tokarev I., 2009, ACS APPL MATER INTER, V3, P532
   Wang J, 2004, MACROMOLECULES, V37, P670, DOI 10.1021/ma035453d
   Yoshida R, 2005, BIOMACROMOLECULES, V6, P2923, DOI 10.1021/bm050398x
   Yoshida R, 1996, J AM CHEM SOC, V118, P5134, DOI 10.1021/ja9602511
   Yoshida R, 2010, ADV MATER, V22, P3463, DOI 10.1002/adma.200904075
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
   Zhang YX, 2005, POLYMER, V46, P7695, DOI 10.1016/j.polymer.2005.05.121
   Zhao SP, 2010, CARBOHYD RES, V345, P425, DOI 10.1016/j.carres.2009.11.014
NR 25
TC 3
Z9 3
U1 5
U2 33
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD MAY
PY 2015
VL 39
IS 3
BP 359
EP 364
DI 10.7317/pk.2015.39.3.359
PG 6
WC Polymer Science
SC Polymer Science
GA CJ7VK
UT WOS:000355708300001
OA Bronze
DA 2018-10-19
ER

PT J
AU Hu, CC
   Chaw, JR
   Chen, YC
   Chen, CF
   Liu, HW
AF Hu, Chao-Chien
   Chaw, Jen-Ray
   Chen, Yu-Chih
   Chen, Chin-Fu
   Liu, Hsia-Wei
TI A Novel Thermo-Responsive Nanogel for Intraocular Drug Delivery
SO JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE
LA English
DT Article
DE Amphiphilic Polymer; Thermo-Responsive; Nanogels; Bevacizumab; Drug
   Delivery
ID POLY(ETHYLENE GLYCOL); MACULAR DEGENERATION; COPOLYMERS; HYDROGELS
AB The novel amphiphilic hydrophilic hydrophobic block copolymers of methoxy-poly(ethylene glycol)block-poly(lactic-co-glycolic acid) (mPEG-PLGA) were synthesized by the ring-opening polymerization, cross-linked with 2,2-bis(2-oxazoline) (BOX) and the chemical structures were characterized by H-1 nuclear magnetic resonance (H-1-NMR). Cross-linked mPEG-PLGA-BOX block copolymers formed a core shell micellar structure with a critical micelle concentration of 9.21 x 10(-4) mg/mL. The mPEG-PLGA-BOX micelles were spherical with a hydrodynamic diameter of between 26.10 nm to 39.70 nm. A solution containing mPEG-PLGA-BOX micelles exhibited a fast and reversible sol gel phase transition behavior that could convert into nanogels at body temperature. The pharmacokinetic release rate of anti-vascular endothelial growth factor (VEGF) entrapped in nanogels were examined in vitro. Release profiles of the anti-VEGF agents (bevacizumab) showed that there was sustained release for approximately 30 days. Released bevacizumab inhibited the RF6A cells growth, which showed drug delivery system may provide localized and sustained release of bevacizumab over an extended period. The mPEG-PLGA-BOX nanogel has been successfully synthesized and determined as thermosensitive and biocompatible. This suggests that the nanogel may be considered as a novel biomaterial with potential as the form of injectable dilute dispersions or as in situ gelling carrier for extended anti-VEGF drug release to treat intraocular neovascular diseases.
C1 [Hu, Chao-Chien] Shin Kong Wu Ho Su Mem Hosp, Dept Ophthalmol, Taipei 111101, Taiwan.
   [Hu, Chao-Chien] Fu Jen Catholic Univ, Sch Med, New Taipei City 24205, Taiwan.
   [Chaw, Jen-Ray] Fu Jen Catholic Univ, Grad Inst Appl Sci & Engn, New Taipei City 24205, Taiwan.
   [Chen, Yu-Chih; Liu, Hsia-Wei] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City 24205, Taiwan.
   [Chen, Chin-Fu] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu 31040, Taiwan.
RP Liu, HW (reprint author), Fu Jen Catholic Univ, Dept Life Sci, New Taipei City 24205, Taiwan.
FU National Science Foundation [101-2221-E-030-002]; Shin Kong Wu Ho-Su
   Memorial Hospital [SKH-8302-101-DR-21]
FX This research was financially supported by the National Science
   Foundation (101-2221-E-030-002) and Shin Kong Wu Ho-Su Memorial Hospital
   (SKH-8302-101-DR-21).
CR ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Bakri SJ, 2006, RETINA-J RET VIT DIS, V26, P519, DOI 10.1097/01.iae.0000225354.92444.7a
   CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5
   Chen JP, 2006, MACROMOL BIOSCI, V6, P1026, DOI 10.1002/mabi.200600142
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Kiss E, 2010, LANGMUIR, V26, P1440, DOI 10.1021/la903373g
   Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053
   Meletis E. I., 2014, QUANTUM MATTER, V3, P287
   Michels S, 2005, OPHTHALMOLOGY, V112, P1035, DOI 10.1016/j.ophtha.2005.02.007
   Nagahama K, 2009, LANGMUIR, V25, P9734, DOI 10.1021/la901092x
   Oh JK, 2009, PROG POLYM SCI, V34, P1261, DOI 10.1016/j.progpolymsci.2009.08.001
   Paolo D. S., 2014, REV THEOR SCI, V2, P146
   Peng KT, 2010, BIOMATERIALS, V31, P5227, DOI 10.1016/j.biomaterials.2010.03.027
   Qiao MX, 2005, INT J PHARM, V294, P103, DOI 10.1016/j.ijpharm.2005.01.017
   Sidorov L. A., 2006, J COMPUT THEOR NANOS, V3, P405
   Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001
NR 17
TC 1
Z9 1
U1 1
U2 33
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1546-1955
EI 1546-1963
J9 J COMPUT THEOR NANOS
JI J. Comput. Theor. Nanosci.
PD MAY
PY 2015
VL 12
IS 5
SI SI
BP 762
EP 768
DI 10.1166/jctn.2015.3799
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CJ6AI
UT WOS:000355575000012
DA 2018-10-19
ER

PT J
AU Muller, V
   Laakmann, E
   Fehm, T
   Mobus, V
   von Minckwitz, G
   Kaiser, J
   Loibl, S
   Witzel, I
AF Mueller, V.
   Laakmann, E.
   Fehm, T.
   Moebus, V.
   von Minckwitz, G.
   Kaiser, J.
   Loibl, S.
   Witzel, I.
TI Brain Metastases in Breast Cancer Network Germany (BMBC, GBG 79):
   Multicentric, retrospective and prospective collection of patient data
   and biomaterial from breast cancer patients as platform for
   translational research
SO ANNALS OF ONCOLOGY
LA English
DT Meeting Abstract
CT IMPAKT Breast Cancer Conference
CY MAY 07-09, 2015
CL Brussels, BELGIUM
SP European Soc Med Oncol
C1 [Mueller, V.; Laakmann, E.; Witzel, I.] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany.
   [Fehm, T.] Univ Klinikum Dusseldorf, Dept Obstet & Gynecol, Dusseldorf, Germany.
   [Moebus, V.] Klinikum Frankfurt Hoechst, Dept Obstet & Gynecol, Frankfurt, Germany.
   [von Minckwitz, G.; Kaiser, J.; Loibl, S.] GBG Forsch GmbH, German Breast Grp, Med & Res, Neu Isenburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0923-7534
EI 1569-8041
J9 ANN ONCOL
JI Ann. Oncol.
PD MAY
PY 2015
VL 26
SU 3
MA 18P
DI 10.1093/annonc/mdv115.6
PG 1
WC Oncology
SC Oncology
GA CI6SE
UT WOS:000354890600010
DA 2018-10-19
ER

PT J
AU Trindade, R
   Albrektsson, T
   Wennerberg, A
AF Trindade, Ricardo
   Albrektsson, Tomas
   Wennerberg, Ann
TI Current Concepts for the Biological Basis of Dental Implants Foreign
   Body Equilibrium and Osseointegration Dynamics
SO ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Implants; Osseointegration; Foreign body reaction
ID MARGINAL BONE LOSS; BIOMATERIAL-INDUCED INFLAMMATION; CELLS IN-VITRO;
   GIANT-CELLS; OSTEOCLAST FORMATION; RECEPTOR ACTIVATOR; LANGERHANS CELLS;
   ORAL IMPLANTS; TITANIUM; SKIN
AB To understand the biological basis of osseointegration, one has to understand the 2 main sides of the implant host interaction: tissue and biomaterial characteristics. This article addresses osseous tissue characteristics and the potential role of soft tissues in the osseointegration of dental implants. Successful integration is driven by an inflammatory process. Protein adsorption is key for tissue integration with biomaterials. Osseointegration dynamics relate to the in vivo lifetime of the implant. Understanding this biology is important; it opens the door to putting aside heuristic methods and replaces them by methods that produce solutions to achieve a specific biological goal.
C1 [Trindade, Ricardo; Albrektsson, Tomas; Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prosthodont, S-21421 Malmo, Sweden.
   [Albrektsson, Tomas] Gothenburg Univ, Dept Biomat, Sahlgrenska Acad, S-41346 Gothenburg, Sweden.
RP Wennerberg, A (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, Carl Gustavsvag 34, S-21421 Malmo, Sweden.
EM ann.wennerberg@mah.se
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365
   Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   Barrett AW, 1996, CRIT REV ORAL BIOL M, V7, P36, DOI 10.1177/10454411960070010301
   Bougas K, 2012, THESIS MALMO U SWEDE
   Boyd AR, 2011, J MATER SCI-MATER M, V22, P71, DOI 10.1007/s10856-010-4180-8
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Buchanan LA, 2010, J BIOMED MATER RES A, V93A, P537, DOI 10.1002/jbm.a.32561
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157
   Crotti TN, 2004, BIOMATERIALS, V25, P565, DOI 10.1016/S0142-9612(03)00556-8
   Cutler CW, 2006, J DENT RES, V85, P678, DOI 10.1177/154405910608500801
   DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804
   Du Z, 2014, CLIN IMPLANT DENT RE
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Frost H M, 1998, J Orthop Sci, V3, P272, DOI 10.1007/s007760050053
   Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001
   Hasseus B, 2004, CLIN EXP IMMUNOL, V136, P483, DOI 10.1111/j.1365-2249.2004.02469.x
   Hasseus B, 2004, EUR J ORAL SCI, V112, P48, DOI 10.1111/j.0909-8836.2004.00097.x
   Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Khan UA, 2014, J CELL BIOCHEM, V115, P1290, DOI 10.1002/jcb.24781
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021
   Lin YH, 2007, J ORAL MAXIL SURG, V65, P2340, DOI 10.1016/j.joms.2007.06.673
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Mozumder MS, 2012, J BIOMED MATER RES A, V100A, P2695, DOI 10.1002/jbm.a.34199
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Rani VVD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195101
   Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Shimpuku H, 2003, CLIN ORAL IMPLAN RES, V14, P423, DOI 10.1034/j.1600-0501.2003.110823.x
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Tamaki Y, 2008, J BIOMED MATER RES B, V84B, P191, DOI 10.1002/jbm.b.30861
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Trindade R., 2014, CLIN IMPLANT DENT RE
   Ujiie Y, 2012, INT J DENT, DOI 10.1155/2012/742439
   Wang TW, 2006, BIOMATERIALS, V27, P5059, DOI 10.1016/j.biomaterials.2006.05.004
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018
   Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47
NR 52
TC 17
Z9 19
U1 4
U2 15
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1042-3699
EI 1558-1365
J9 ORAL MAXIL SURG CLIN
JI Oral Maxillofac. Surg. Clin. N. Am.
PD MAY
PY 2015
VL 27
IS 2
BP 175
EP +
DI 10.1016/j.coms.2015.01.004
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CJ4ZH
UT WOS:000355496700002
PM 25753575
DA 2018-10-19
ER

PT J
AU Booms, P
   Ghanaati, S
   Sader, R
AF Booms, P.
   Ghanaati, S.
   Sader, R.
TI Biomaterial-based tissue-like constructs for assessing effects of
   vismodegib on soft and hard tissue
SO ORAL ONCOLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1368-8375
EI 1879-0593
J9 ORAL ONCOL
JI Oral Oncol.
PD MAY
PY 2015
VL 51
IS 5
MA P24
BP E49
EP E50
DI 10.1016/j.oraloncology.2015.02.072
PG 2
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA CH4TZ
UT WOS:000354027100072
DA 2018-10-19
ER

PT J
AU Zhang, PF
   Li, GQ
AF Zhang, Pengfei
   Li, Guoqiang
TI Healing-on-demand composites based on polymer artificial muscle
SO POLYMER
LA English
DT Article
DE Healing-on-demand; Artificial muscle; Biomaterial
ID SYNTACTIC FOAM; THERMOMECHANICAL CHARACTERIZATION; FIBERS; HYDROGELS;
   GELS; CYCLODEXTRIN; REPTATION; ORGANOGEL; BEHAVIOR; RUBBER
AB In this study, a new polymer artificial muscle based healing-on-demand composite was prepared and characterized. The composite consists of polymer artificial muscle made of commercial fishing line, thermoset host, and thermoplastic particle. Three-point bending damage to the beam sample can be healed even at a constrained boundary condition upon local heating, undergoing a close-then-heal procedure. The fractured beams were heated locally by a heat gun for 10 min. The healing efficiency was investigated at both free boundary condition and fixed boundary condition. The fast contraction of artificial muscle brings the fractured surfaces in spatial proximity; simultaneously, the melting thermoplastic agent fills the crack via capillary action and bonds the two fracture surfaces. With 60% pre-strain of the reinforcing polymer artificial muscles (8% volume fraction), over 60% of healing efficiency was achieved at free boundary condition and 54% at fixed boundary condition after repeated damage-healing events. Due to its low cost, high healing efficiency, good compatibility, and excellent flexibility, we envision that the polymer artificial muscle will be a new device in designing next generation healing-on-demand polymer composite. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Zhang, Pengfei; Li, Guoqiang] Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA.
   [Li, Guoqiang] Southern Univ, Dept Mech Engn, Baton Rouge, LA 70813 USA.
RP Li, GQ (reprint author), Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA.
EM lguoqi1@lsu.edu
FU National Science Foundation [CMMI 1333997]; NASA [NNX11AM17A]; Louisiana
   Board of Regents [NNX11AM17A, NASA/LEQSF(2011-14)-Phase3-05]; Army
   Research Office [W911NF-13-1-0145]
FX This study was financially supported by National Science Foundation
   under grant number CMMI 1333997, the Cooperative Agreement NNX11AM17A
   between NASA and the Louisiana Board of Regents under contract
   NASA/LEQSF(2011-14)-Phase3-05, and Army Research Office under grant
   number W911NF-13-1-0145. Mr. Zhen Zhang at Louisiana State University
   helped run the rheological test of CIA powders. His assistance is
   greatly appreciated.
CR Amamoto Y, 2011, ANGEW CHEM INT EDIT, V50, P1660, DOI 10.1002/anie.201003888
   Bleay SM, 2001, COMPOS PART A-APPL S, V32, P1767, DOI 10.1016/S1359-835X(01)00020-3
   Bousmina M, 1998, MACROMOLECULES, V31, P8273, DOI 10.1021/ma980562r
   Canadell J, 2011, MACROMOLECULES, V44, P2536, DOI 10.1021/ma2001492
   CHOY CL, 1981, J POLYM SCI POL PHYS, V19, P335, DOI 10.1002/pol.1981.180190213
   Chuo TW, 2013, J POLYM SCI POL CHEM, V51, P3395, DOI 10.1002/pola.26736
   Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669
   DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789
   Deng GH, 2010, MACROMOLECULES, V43, P1191, DOI 10.1021/ma9022197
   FOX TG, 1964, J CHEM PHYS, V41, P344, DOI 10.1063/1.1725872
   Froimowicz P, 2011, MACROMOL RAPID COMM, V32, P468, DOI 10.1002/marc.201000643
   Hager MD, 2010, ADV MATER, V22, P5424, DOI 10.1002/adma.201003036
   Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906
   Hamilton AR, 2010, ADV MATER, V22, P5159, DOI 10.1002/adma.201002561
   Harada A, 2014, ACCOUNTS CHEM RES, V47, P2128, DOI 10.1021/ar500109h
   Haraguchi K, 2011, MACROMOL RAPID COMM, V32, P1253, DOI 10.1002/marc.201100248
   He LH, 2011, CHEM COMMUN, V47, P7497, DOI 10.1039/c1cc11928a
   Herbst F, 2013, SELF-HEALING POLYMERS: FROM PRINCIPLES TO APPLICATIONS, P275
   Hu JL, 2012, PROG POLYM SCI, V37, P1720, DOI 10.1016/j.progpolymsci.2012.06.001
   Imato K, 2012, ANGEW CHEM INT EDIT, V51, P1138, DOI 10.1002/anie.201104069
   Ji GF, 2010, INT J SOLIDS STRUCT, V47, P2445, DOI 10.1016/j.ijsolstr.2010.05.006
   Kakuta T, 2013, ADV MATER, V25, P2849, DOI 10.1002/adma.201205321
   Kalista SJ, 2007, MECH ADV MATER STRUC, V14, P391, DOI 10.1080/15376490701298819
   Kirkby EL, 2009, POLYMER, V50, P5533, DOI 10.1016/j.polymer.2009.05.014
   Kirkby EL, 2008, ADV FUNCT MATER, V18, P2253, DOI 10.1002/adfm.200701208
   KLEIN J, 1978, NATURE, V271, P143, DOI 10.1038/271143a0
   KLEIN J, 1978, MACROMOLECULES, V11, P852, DOI 10.1021/ma60065a002
   Kolmakov GV, 2009, ACS NANO, V3, P885, DOI 10.1021/nn900052h
   Li G, 2015, SELF-HEALING COMPOSITES: SHAPE MEMORY POLYMER-BASED STRUCTURES, P1
   Li GG, 2010, COMPOS SCI TECHNOL, V70, P1419, DOI 10.1016/j.compscitech.2010.04.026
   Li GQ, 2013, POLYMER, V54, P5075, DOI 10.1016/j.polymer.2013.07.010
   Li GQ, 2013, POLYMER, V54, P920, DOI 10.1016/j.polymer.2012.12.046
   Li GQ, 2012, P ROY SOC A-MATH PHY, V468, P2319, DOI 10.1098/rspa.2011.0628
   Li GQ, 2010, POLYMER, V51, P755, DOI 10.1016/j.polymer.2009.12.002
   Li GQ, 2008, COMPOS SCI TECHNOL, V68, P3337, DOI 10.1016/j.compscitech.2008.09.009
   Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762
   Love A, 1944, TREATISE MATH THEORY
   Lu J, 2011, J CONTROL RELEASE, V152, pE229, DOI 10.1016/j.jconrel.2011.09.028
   Meng H, 2013, POLYMER, V54, P2199, DOI 10.1016/j.polymer.2013.02.023
   Mukhopadhyay P, 2010, ANGEW CHEM INT EDIT, V49, P6338, DOI 10.1002/anie.201001382
   Park JS, 2008, J COMPOS MATER, V42, P2869, DOI 10.1177/0021998308097280
   Rahman MA, 2013, ACS APPL MATER INTER, V5, P1494, DOI 10.1021/am303015e
   Sottos NR, 2011, NATURE, V472, P299, DOI 10.1038/472299a
   South A. B., 2010, ANGEW CHEM, V122, P779, DOI DOI 10.1002/ANGE.200906040
   Sun L, 2012, MATER DESIGN, V33, P577, DOI 10.1016/j.matdes.2011.04.065
   Terech P, 2013, PHYS CHEM CHEM PHYS, V15, P7338, DOI 10.1039/c3cp50671a
   Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v
   Urban MW, 2014, ANGEW CHEM INT EDIT, V53, P3775
   van Gemert GML, 2012, MACROMOL CHEM PHYS, V213, P234, DOI 10.1002/macp.201100559
   Vidyasagar A, 2011, ANGEW CHEM INT EDIT, V50, P8021, DOI 10.1002/anie.201103584
   Wang X, 2011, ANGEW CHEM INT EDIT, V50, P11378, DOI 10.1002/anie.201105822
   White SR, 2014, SCIENCE, V344, P620, DOI 10.1126/science.1251135
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   Williams KA, 2007, J R SOC INTERFACE, V4, P359, DOI 10.1098/rsif.2006.0202
   Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g
   WOOL RP, 1981, J APPL PHYS, V52, P5953, DOI 10.1063/1.328526
   Yin T, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/7/074001
   Yoon JA, 2012, MACROMOLECULES, V45, P142, DOI 10.1021/ma2015134
   Yu XD, 2012, SOFT MATTER, V8, P3329, DOI 10.1039/c2sm07309a
   Zhang PF, 2013, J POLYM SCI POL PHYS, V51, P966, DOI 10.1002/polb.23295
NR 60
TC 22
Z9 22
U1 3
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD MAY 1
PY 2015
VL 64
BP 29
EP 38
DI 10.1016/j.polymer.2015.03.022
PG 10
WC Polymer Science
SC Polymer Science
GA CJ1KB
UT WOS:000355241400005
DA 2018-10-19
ER

PT J
AU Petreus, T
   Holicov, AM
   Balan, GG
   Mitrica, DE
AF Petreus, Tudor
   Holicov, Ana Maria
   Balan, Gheorghe Gh.
   Mitrica, Dana Elena
TI Comparative Evaluation of Biocompatibility Assays used in Polymer
   Biomaterials Assessment
SO REVISTA DE CHIMIE
LA English
DT Article
DE biocompatibility; biomaterials; metabolic/membrane integrity/DNA
   quantitation assays; chitosan film; normal phenotype cells
ID ENDODONTIC TREATMENT; BACTERIAL VIABILITY; IMPLANTATION; STAIN
AB Most of the biocompatibility assays - metabolic, DNA quantitation and membrane permeability - are commonly used to evaluate biomaterials with medical and dental applications. Comparing the results and efficacy among these various protocols may lead to a faster and more accurate choice for a specific assay according to the evaluated biomaterial and its physical/chemical features. The aim of the present work was to perform a reliability comparison between metabolic, membrane integrity and DNA content assays, with respect to biocompatibility of biomaterials with biomedical use. Using chitosan films as polymer support we have observed a good correlation (0.7<R2<1) between cell proliferation evaluated by MTT assay and the DNA quantitation for both tumor and normal phenotype cell lines. For all investigated cell lines grown on chitosan films, less epithelial phenotype MCF10A, there was a good correlation for the two metabolic assays, MTT and CellTiterBlue. Same good correlation was noticed for SytoxGreen (membrane integrity assay) and CyQuant (DNA quantitation). Correlation study performed for metabolic/membrane integrity/DNA quantitation assays demonstrated the usefulness of a permanent adaptation of the cytotoxicity assay for biomaterial evaluation according to physical/chemical and mechanical sample features. For the polymer films used in the present study (chitosan), metabolic assays and DNA quantitation assays showed well correlated results for both tumor and normal phenotype cells. Both assay types may be used, but the final choice will respect potential interferences of the reagents in the assays with biomaterial compounds.
C1 [Petreus, Tudor; Holicov, Ana Maria] Gr T Popa Univ Med & Pharm, Fac Med, Dept Cell & Mol Biol, Iasi 700115, Romania.
   [Balan, Gheorghe Gh.; Mitrica, Dana Elena] Gr T Popa Univ Med & Pharm, Fac Med, Dept Med Semiol & Gastroenterol, Iasi 700115, Romania.
RP Balan, GG (reprint author), Gr T Popa Univ Med & Pharm, Fac Med, Dept Med Semiol & Gastroenterol, 16 Univ Str, Iasi 700115, Romania.
EM balan.gheo@yahoo.com
CR Aminov L, 2014, MATER PLAST, V51, P417
   Aminov L, 2014, MATER PLAST, V51, P246
   BARILE F.A., 2008, PRINCIPLES TOXICOLOG, P231
   Cardiff RD, 2014, J CLIN INVEST, V124, P478, DOI 10.1172/JCI73910
   Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X
   Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5
   Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697
   Lin GJ, 2013, J BIOL INORG CHEM, V18, P873, DOI 10.1007/s00775-013-1032-2
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421
   Simion D, 2013, MATER PLAST, V50, P323
   Strober W., 2001, CURRENT PROTOCOLS IM
   Voicu G, 2012, REV CHIM-BUCHAREST, V63, P1031
   Zaharia C, 2014, MATER PLAST, V51, P1
   Zuang V, 2001, ATLA-ALTERN LAB ANIM, V29, P575
NR 15
TC 2
Z9 2
U1 0
U2 5
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD MAY
PY 2015
VL 66
IS 5
BP 707
EP 709
PG 3
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CI9YF
UT WOS:000355126000022
DA 2018-10-19
ER

PT J
AU Iyer, KA
   Torkelson, JM
AF Iyer, Krishnan A.
   Torkelson, John M.
TI Sustainable Green Hybrids of Polyolefins and Lignin Yield Major
   Improvements in Mechanical Properties When Prepared via Solid-State
   Shear Pulverization
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Lignin; Composites; Polypropylene; Polyethylene; Extrusion; Antioxidant;
   Tensile properties; Rheology
ID POLYPROPYLENE/WOOD-FLOUR COMPOSITES; POLYMER BLEND COMPATIBILIZATION;
   THERMAL-PROPERTIES; ANTIOXIDANT PROPERTIES; PHYSICAL-PROPERTIES; FLAME
   RETARDANTS; POLYETHYLENE; DISPERSION; NANOCOMPOSITES; POLYSTYRENE
AB Lignin, a byproduct of paper and pulp industries, is a sustainable, inexpensive biomaterial with potential as composite filler. Past research on polyolefin/lignin composites made by melt processing has led to modest increases in Youngs modulus and drastic reductions in tensile strength and elongation at break relative to neat polymer. Here, green hybrids of low density polyethylene (LDPE) and polypropylene (PP) with 5-30 wt % lignin are made by solid-state shear pulverization (SSSP). Microscopy shows that SSSP leads to superior lignin dispersion and suppressed degradation when compared to melt-mixed composites reported in the literature. Composites made by SSSP exhibit major improvements in Youngs modulus (81% and 62% increases for 30 wt % lignin in LDPE and PP, respectively, relative to neat polymer), tensile strength equal to or better than that of neat LDPE and near that of neat PP, and much better strain at break than reported in the literature for polyolefin/lignin composites. The SSSP-produced hybrids exhibit major increases in hardness, with 70/30 wt % PP/lignin hybrids reaching values near that of polycarbonate. Well-dispersed lignin improves LDPE and PP thermo-oxidative stability as shown by thermogravimetric analysis (similar to 35 degrees C increase in 20% mass loss temperature in air with 20 wt % lignin addition) and isothermal shear flow rheology. Lastly, SSSP-processed composites exhibit slightly improved crystallizability and melt viscosities at moderate to high shear rates that differ relatively little from those of neat LDPE and PP.
C1 [Iyer, Krishnan A.; Torkelson, John M.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Torkelson, John M.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Torkelson, JM (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.
EM j-torkelson@northwestern.edu
RI Torkelson, John/B-7616-2009
OI Iyer, krishnan/0000-0002-8302-714X
FU Initiative for Sustainability and Energy at Northwestern University
   (ISEN); Northwestern University; Northwestern University Terminal Year
   Fellowship; NSF-MRSEC program at Northwestern University [DMR-1121262]
FX We thank Total Petrochemicals and ExxonMobil for providing PP and LDPE,
   respectively. We acknowledge support from the Initiative for
   Sustainability and Energy at Northwestern University (ISEN),
   Northwestern University, and a Northwestern University Terminal Year
   Fellowship (to K.A.I.). This study made use of Central Facilities
   supported by the NSF-MRSEC program (Grant Number DMR-1121262) at
   Northwestern University.
CR Alexy P, 2000, POLYMER, V41, P4901, DOI 10.1016/S0032-3861(99)00714-4
   Bahl K, 2014, POLYMER, V55, P3825, DOI 10.1016/j.polymer.2014.06.061
   Barzegari MR, 2012, POLYM COMPOSITE, V33, P353, DOI 10.1002/pc.22154
   Bourmaud A, 2013, IND CROP PROD, V43, P225, DOI 10.1016/j.indcrop.2012.07.030
   Brunner PJ, 2012, POLYM ENG SCI, V52, P1555, DOI 10.1002/pen.23115
   BU HS, 1988, MAKROMOL CHEM-RAPID, V9, P75
   Canetti M, 2006, POLYM DEGRAD STABIL, V91, P494, DOI 10.1016/j.polymdegradstab.2005.01.052
   Canetti M, 2004, J APPL POLYM SCI, V91, P1435, DOI 10.1002/app.13311
   Chen F, 2011, POLYM COMPOSITE, V32, P1019, DOI 10.1002/pc.21087
   Chen Z, 2001, POLYM INT, V50, P966, DOI 10.1002/pi.723
   Chibani N, 2016, J VINYL ADDIT TECHN, V22, P231, DOI 10.1002/vnl.21437
   COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812
   De Chirico A, 2003, POLYM DEGRAD STABIL, V79, P139, DOI 10.1016/S0141-3910(02)00266-5
   de Menezes AJ, 2009, POLYMER, V50, P4552, DOI 10.1016/j.polymer.2009.07.038
   Diop MF, 2015, POLYMER, V60, P77, DOI 10.1016/j.polymer.2015.01.016
   Diop MF, 2014, POLYMER, V55, P4948, DOI 10.1016/j.polymer.2014.07.050
   Diop MF, 2013, MACROMOLECULES, V46, P7834, DOI 10.1021/ma401628u
   Diop MF, 2013, POLYMER, V54, P4143, DOI 10.1016/j.polymer.2013.06.003
   Doan TTL, 2006, COMPOS SCI TECHNOL, V66, P952, DOI 10.1016/j.compscitech.2005.08.009
   Doherty WOS, 2011, IND CROP PROD, V33, P259, DOI 10.1016/j.indcrop.2010.10.022
   Fetecau C., 2011, P ASME 2011 INT MECH, V8, P599
   Furgiuele N, 2000, MACROMOLECULES, V33, P225, DOI 10.1021/ma990434i
   Ganglani M, 2001, J APPL POLYM SCI, V80, P671
   Gregorova A, 2007, J APPL POLYM SCI, V106, P1626, DOI 10.1002/app.26687
   Haque MM, 2009, BIORESOURCE TECHNOL, V100, P4903, DOI 10.1016/j.biortech.2009.04.072
   Hu L, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41484
   Hu L, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41040
   Ichazo MN, 2001, COMPOS STRUCT, V54, P207, DOI 10.1016/S0263-8223(01)00089-7
   Iwamoto S, 2014, CELLULOSE, V21, P1573, DOI 10.1007/s10570-014-0195-5
   Iyer KA, 2015, MACROMOL MATER ENG, V300, P772, DOI 10.1002/mame.201500019
   Iyer KA, 2015, POLYMER, V56, P464, DOI 10.1016/j.polymer.2014.11.017
   Iyer KA, 2014, COMPOS SCI TECHNOL, V102, P152, DOI 10.1016/j.compscitech.2014.07.029
   Iyer KA, 2013, POLYM COMPOSITE, V34, P1211, DOI 10.1002/pc.22534
   Jairam S, 2013, ACS SUSTAIN CHEM ENG, V1, P1630, DOI 10.1021/sc4003196
   Jeencham R, 2014, COMPOS PART B-ENG, V56, P249, DOI 10.1016/j.compositesb.2013.08.012
   Jiang X, 2012, J APPL POLYM SCI, V124, P525, DOI 10.1002/app.34891
   Joseph PV, 1999, COMPOS SCI TECHNOL, V59, P1625, DOI 10.1016/S0266-3538(99)00024-X
   Kadla JF, 2004, COMPOS PART A-APPL S, V35, P395, DOI 10.1016/j.compositesa.2003.09.019
   KOSIKOVA B, 1995, EUR POLYM J, V31, P953, DOI 10.1016/0014-3057(95)00052-6
   La Mantia FP, 2011, COMPOS PART A-APPL S, V42, P579, DOI 10.1016/j.compositesa.2011.01.017
   Lebovitz AH, 2002, MACROMOLECULES, V35, P8672, DOI 10.1021/ma021182f
   Lu H, 2014, ACS SUSTAIN CHEM ENG, V2, P2699, DOI 10.1021/sc500440q
   Maldhure AV, 2011, J THERM ANAL CALORIM, V103, P625, DOI 10.1007/s10973-010-1048-6
   Maldhure AV, 2012, J APPL POLYM SCI, V125, P1701, DOI 10.1002/app.35633
   Masuda J, 2008, MACROMOLECULES, V41, P5974, DOI 10.1021/ma801321j
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   Morandim-Giannetti AA, 2012, CARBOHYD POLYM, V87, P2563, DOI 10.1016/j.carbpol.2011.11.041
   Ndiaye D, 2011, J APPL POLYM SCI, V119, P3321, DOI 10.1002/app.32985
   Pandey JK, 2010, MACROMOL MATER ENG, V295, P975, DOI 10.1002/mame.201000095
   Park JM, 2006, COMPOS SCI TECHNOL, V66, P2686, DOI 10.1016/j.compscitech.2006.03.014
   Peterson JD, 2001, MACROMOL CHEM PHYSIC, V202, P775, DOI 10.1002/1521-3935(20010301)202:6<775::AID-MACP775>3.0.CO;2-G
   Pouteau C, 2003, POLYM DEGRAD STABIL, V81, P9, DOI 10.1016/S0141-3910(03)00057-0
   Pracella M, 2006, COMPOS SCI TECHNOL, V66, P2218, DOI 10.1016/j.compscitech.2005.12.006
   Premalal HGB, 2002, POLYM TEST, V21, P833, DOI 10.1016/S0142-9418(02)00018-1
   Pucciariello R, 2010, J POLYM ENVIRON, V18, P326, DOI 10.1007/s10924-010-0212-1
   Rusu M, 1999, J POLYM ENG, V19, P355
   Sadeghifar H, 2015, ACS SUSTAIN CHEM ENG, V3, P349, DOI 10.1021/sc500756n
   Sahoo S, 2011, COMPOS PART A-APPL S, V42, P1710, DOI 10.1016/j.compositesa.2011.07.025
   Sailaja RRN, 2010, MATER DESIGN, V31, P4369, DOI 10.1016/j.matdes.2010.03.046
   Sailaja RRN, 2005, POLYM INT, V54, P1589, DOI 10.1002/pi.1864
   Samal SK, 2014, J POLYM ENVIRON, V22, P58, DOI 10.1007/s10924-013-0620-0
   Schartel B, 2003, POLYMER, V44, P6241, DOI 10.1016/S0032-3861(03)00692-X
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Tao Y, 2006, POLYMER, V47, P6773, DOI 10.1016/j.polymer.2006.07.041
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z
   Toriz G, 2002, POLYM COMPOSITE, V23, P806, DOI 10.1002/pc.10478
   Wakabayashi K, 2008, MACROMOLECULES, V41, P1905, DOI 10.1021/ma071687b
   Wakabayashi K, 2010, POLYMER, V51, P5525, DOI 10.1016/j.polymer.2010.09.007
   Walker AM, 2007, POLYMER, V48, P1066, DOI 10.1016/j.polymer.2006.12.038
   WUNDERLICH B, 1967, J POLYM SCI A2, V5, P987, DOI 10.1002/pol.1967.160050514
   Xia HS, 2004, J APPL POLYM SCI, V93, P378, DOI 10.1002/app.20435
   Xu X, 2014, MACROMOL RES, V22, P1084, DOI 10.1007/s13233-014-2161-3
NR 72
TC 12
Z9 12
U1 6
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAY
PY 2015
VL 3
IS 5
BP 959
EP 968
DI 10.1021/acssuschemeng.5b00099
PG 10
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA CH5JU
UT WOS:000354072700019
DA 2018-10-19
ER

PT J
AU Li, XD
   Hong, ATL
   Naskar, N
   Chung, HJ
AF Li, Xinda
   Hong, Albert T. -L.
   Naskar, Nilanjon
   Chung, Hyun-Joong
TI Criteria for Quick and Consistent Synthesis of Poly(glycerol sebacate)
   for Tailored Mechanical Properties
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE-ENGINEERING SCAFFOLDS; BIODEGRADABLE ELASTOMER; POLYMER;
   BIOMATERIALS; DEGRADATION
AB Poly(glycerol sebatate) (PGS) and its derivatives make up an attractive class of biomaterial, owing to their tunable,mechanical properties With programmable biodegradability. In practice, however, the application of PGS is often hampered by frequent inconsistency in reproducing process conditions. The inconsistency stems from the volatile nature of glycerol during the esterification process. In this study, we suggest that the degree of esterification (DE). can be used to predict precisely the physical status, the mechanical properties, and the degradation of the PGS materials. Young's modulus is shown to linearly increase with DE, which is in agreement with an entropic spring theory of rubbers. To provide a processing guideline for researchers, we also provide a physical status map as a function of curing temperature and time. The amount of glycerol loss, obtainable by monitoring the evolution of the total mass loss and the DE during synthesis, is shown to make the predictions even more precise. We expect that these strategies cart be applicable to different categories of polymers that involve condensation polymerization with the volatility of the reactants. In addition, we demonstrate that microwave-assisted prepolymerization is a time- and energy-efficient pathway to obtain PGS. For example, 15 min of microwave time is shown to be as efficient as prepolymerization in nitrogen atmosphere for 6 h at 130 degrees C. The quick synthesis method, however, causes a severe evaporation of glycerol, resulting in a large distortion in the monomer ratio between glycerol and sebacic acid. Consequently, more rigid PGS is produced under a similar curing condition compared to the conventional prepolymerizatton method. Finally, we demonstrate that the addition of molecularly rigid cross-linking agents and network-Structured inorganic nanoparticles are also effective in enhancing the mechanical properties of the PGS-derived materials.
C1 [Li, Xinda; Hong, Albert T. -L.; Naskar, Nilanjon; Chung, Hyun-Joong] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
RP Chung, HJ (reprint author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
EM chung.hj13@ualberta.ca
RI Chung, Hyun-Joong/D-5383-2013; Naskar, Nilanjon/C-3891-2018
OI Chung, Hyun-Joong/0000-0003-0569-6951; Naskar,
   Nilanjon/0000-0003-4620-8213
FU NSERC RGPIN [435914]; University of Alberta
FX We thank Mr. T. Ng and Prof. A. Elias for help with mechanical testing
   and Prof. J. Choi (Chungnam National University) and Prof. R. Composto
   (University of Pennsylvania) for electron microscopy of nanoparticles.
   We acknowledge NSERC RGPIN 435914 and a startup grant from University of
   Alberta for financial support. A.T.H. and N.N. thank the URI and
   Globalink programs from University of Alberta and MITACS, respectively,
   for their internship supports.
CR [Anonymous], 1998, D41298A ASTM, DOI [10.1520/D0412-98A, DOI 10.1520/D0412-98A]
   Aydin HM, 2013, BIOMATER SCI-UK, V1, P503, DOI 10.1039/c3bm00157a
   Bettinger CJ, 2011, MACROMOL BIOSCI, V11, P467, DOI 10.1002/mabi.201000397
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Cheng H, 2011, ADV MATER, V23, pH95, DOI 10.1002/adma.201003482
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Jaafar IH, 2010, J MATER SCI, V45, P2525, DOI 10.1007/s10853-010-4259-0
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Kharaziha M, 2013, BIOMATERIALS, V34, P6355, DOI 10.1016/j.biomaterials.2013.04.045
   Li Y, 2013, POLYM INT, V62, P534, DOI 10.1002/pi.4419
   Liang SL, 2012, POLYM INT, V61, P17, DOI 10.1002/pi.3165
   Liu QY, 2012, PROG POLYM SCI, V37, P715, DOI 10.1016/j.progpolymsci.2011.11.001
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Maliger R, 2013, J APPL POLYM SCI, V127, P3980, DOI 10.1002/app.37719
   Pereira MJN, 2013, ADV MATER, V25, P1209, DOI 10.1002/adma.201203824
   Petsonk EL, 2000, CHEST, V118, P1183, DOI 10.1378/chest.118.4.1183
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   RICHARDS RB, 1951, J APPL CHEM, V1, P370, DOI 10.1002/jbt.2570010812
   Sperling L. H., 1992, INTRO PHYS POLYM SCI
   Walls HJ, 2000, J POWER SOURCES, V89, P156, DOI 10.1016/S0378-7753(00)00424-9
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wu Y, 2012, J APPL POLYM SCI, V123, P1612, DOI 10.1002/app.34556
   Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Yuan L., 2013, BIOMED MATER, V8
   Zhang H, 2014, MACROMOL RAPID COMM, V35, P1906, DOI 10.1002/marc.201400389
NR 37
TC 21
Z9 21
U1 5
U2 53
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2015
VL 16
IS 5
BP 1525
EP 1533
DI 10.1021/acs.biomac.5b00018
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CI1KS
UT WOS:000354503700009
PM 25857651
DA 2018-10-19
ER

PT J
AU Fermor, HL
   Russell, SL
   Williams, S
   Fisher, J
   Ingham, E
AF Fermor, Hazel L.
   Russell, Serena L.
   Williams, Sophie
   Fisher, John
   Ingham, Eileen
TI Development and characterisation of a decellularised bovine
   osteochondral biomaterial for cartilage repair
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; FOLLOW-UP;
   MATRIX SCAFFOLD; KNEE; DEFECTS; OSTEOARTHRITIS; COLLAGEN; CELLS;
   REGENERATION
AB It is proposed that an acellular natural osteochondral scaffold will provide a successful repair material for the early intervention treatment of cartilage lesions, to prevent or slow the progression of cartilage deterioration to osteoarthritis. Here, we investigated the efficacy of methods for the decellularisation of bovine osteochondral plugs. The plugs were subject to four freeze/thaw cycles followed by two cycles of washes in hypotonic solution and low concentration (0.1 % w/v) sodium dodecyl sulphate with protease inhibitors. Plugs were treated with nuclease (DNase and RNase) treatment followed by sterilization in peracetic acid. Full tissue decellularisation was achieved as confirmed by histological analysis and DNA quantification, however the resultant acellular matrix had reduced glycosaminoglycan content which led to an increased percent deformation of cartilage. Furthermore, the acellular scaffold was not reproducibly biocompatible. Additional terminal washes were included in the process to improve biocompatibility, however, this led to visible structural damage to the cartilage. This damage was found to be minimised by reducing the cut edge to cartilage area ratio through decellularisation of larger cuts of osteochondral tissue.
C1 [Fermor, Hazel L.; Ingham, Eileen] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England.
   [Russell, Serena L.; Williams, Sophie; Fisher, John] Univ Leeds, Sch Mech Engn, Leeds, W Yorkshire, England.
RP Fermor, HL (reprint author), Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England.
EM h.l.fermor@leeds.ac.uk
FU EPSRC; WELMEC, a Centre of Excellence in Medical Engineering by Wellcome
   Trust; EPSRC [WT 088908/Z/09/Z]; NIHR LMBRU Leeds Musculoskeletal
   Biomedical Research Unit; ERC; Engineering and Physical Sciences
   Research Council [EP/N00941X/1, EP/K029592/1, EP/J017620/1,
   EP/G012172/1]; National Institute for Health Research [NF-SI-0611-10096]
FX This work was funded by EPSRC and partially through WELMEC, a Centre of
   Excellence in Medical Engineering funded by the Wellcome Trust and
   EPSRC, under Grant Number WT 088908/Z/09/Z. J Fisher is an NIHR senior
   investigator. Additionally the principle investigators J Fisher and E
   Ingham are supported in part by the NIHR LMBRU Leeds Musculoskeletal
   Biomedical Research Unit and the ERC. E Ingham and J Fisher are academic
   founders of Tissue Regenix and are shareholders and advisers to Tissue
   Regenix Group PLC.
CR Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Arthritis Research UK, 2013, OST GEN PRACT DAT PE
   Bae DK, 2013, ARTHROSCOPY, V29, P244, DOI 10.1016/j.arthro.2012.09.006
   Bauer S, 2012, KNEE, V19, P431, DOI 10.1016/j.knee.2011.06.005
   Bayrak A, 2013, TISSUE ENG PT A, V19, P1592, DOI [10.1089/ten.tea.2012.0394, 10.1089/ten.TEA.2012.0394]
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Chaing H, 2009, J FORMOS MED ASSOC, V108, P87
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   da Costa FDA, 2010, ANN THORAC SURG, V90, P1854, DOI 10.1016/j.athoracsur.2010.08.022
   Ding CH, 2005, OSTEOARTHR CARTILAGE, V13, P198, DOI 10.1016/j.joca.2004.11.007
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Fermor HL, BIO MED MAT IN PRESS
   Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669
   Greaves NS, 2013, WOUND REPAIR REGEN, V21, P813, DOI 10.1111/wrr.12113
   Hogg P, 2013, CELL TISSUE BANK, V14, P465, DOI 10.1007/s10561-012-9333-1
   JEFFERY AK, 1991, J BONE JOINT SURG BR, V73, P795
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Knight R, 2006, WILEY ENCY BIOMEDICA
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   McGonagle D, 2010, J ANAT, V216, P279, DOI 10.1111/j.1469-7580.2009.01186.x
   Moradi B, 2012, ARTHROSCOPY, V28, P1851, DOI 10.1016/j.arthro.2012.05.883
   MOW VC, 2005, BASIC ORTHOPAEDIC BI, P181
   Oshima Y, 2009, TISSUE ENG PART C-ME, V15, P595, DOI [10.1089/ten.tec.2008.0487, 10.1089/ten.TEC.2008.0487]
   Pawaskar SS, 2010, J BIOMECH ENG, V132, P1
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   SOKAL RR, 1995, BIOMETRY PRINCIPALS
   Solheim E, 2013, KNEE, V20, P287, DOI 10.1016/j.knee.2013.01.001
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Taylor SD, 2012, P I MECH ENG H, V226, P55, DOI 10.1177/0954411911428717
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
NR 39
TC 8
Z9 8
U1 2
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2015
VL 26
IS 5
AR 186
DI 10.1007/s10856-015-5517-0
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI5UO
UT WOS:000354825500011
PM 25893393
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Gabbai-Armelin, PR
   Souza, MT
   Kido, HW
   Tim, CR
   Bossini, PS
   Magri, AMP
   Fernandes, KR
   Pastor, FAC
   Zanotto, ED
   Parizotto, NA
   Peitl, O
   Renno, ACM
AF Gabbai-Armelin, P. R.
   Souza, M. T.
   Kido, H. W.
   Tim, C. R.
   Bossini, P. S.
   Magri, A. M. P.
   Fernandes, K. R.
   Pastor, F. A. C.
   Zanotto, E. D.
   Parizotto, N. A.
   Peitl, O.
   Renno, A. C. M.
TI Effect of a new bioactive fibrous glassy scaffold on bone repair
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENT; IN-VITRO; HUMAN OSTEOBLASTS; IONIC PRODUCTS;
   DEFECT; MODEL; BIOSILICATE(R); PROLIFERATION; MICROSPHERES; REGENERATION
AB Researchers have investigated several therapeutic approaches to treat non-union fractures. Among these, bioactive glasses and glass ceramics have been widely used as grafts. This class of biomaterial has the ability to integrate with living bone. Nevertheless, bioglass and bioactive materials have been used mainly as powder and blocks, compromising the filling of irregular bone defects. Considering this matter, our research group has developed a new bioactive glass composition that can originate malleable fibers, which can offer a more suitable material to be used as bone graft substitutes. Thus, the aim of this study was to assess the morphological structure (via scanning electron microscope) of these fibers upon incubation in phosphate buffered saline (PBS) after 1, 7 and 14 days and, also, evaluate the in vivo tissue response to the new biomaterial using implantation in rat tibial defects. The histopathological, immunohistochemistry and biomechanical analyzes after 15, 30 and 60 days of implantation were performed to investigate the effects of the material on bone repair. The PBS incubation indicated that the fibers of the glassy scaffold degraded over time. The histological analysis revealed a progressive degradation of the material with increasing implantation time and also its substitution by granulation tissue and woven bone. Histomorphometry showed a higher amount of newly formed bone area in the control group (CG) compared to the biomaterial group (BG) 15 days post-surgery. After 30 and 60 days, CG and BG showed a similar amount of newly formed bone. The novel biomaterial enhanced the expression of RUNX-2 and RANK-L, and also improved the mechanical properties of the tibial callus at day 15 after surgery. These results indicated a promising use of the new biomaterial for bone engineering. However, further long-term studies should be carried out to provide additional information concerning the material degradation in the later stages and the bone regeneration induced by the fibrous material.
C1 [Gabbai-Armelin, P. R.; Kido, H. W.; Tim, C. R.] Fed Univ Sao Carlos UFSCar, Sao Carlos, SP, Brazil.
   [Souza, M. T.; Zanotto, E. D.; Peitl, O.] Fed Univ Sao Carlos UFSCar, Vitreous Mat Lab LaMaV, Dept Mat Engn, Sao Carlos, SP, Brazil.
   [Bossini, P. S.; Magri, A. M. P.; Fernandes, K. R.; Renno, A. C. M.] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
   [Pastor, F. A. C.] Fed Univ Sao Carlos UFSCar, Dept Physiol Sci, Sao Carlos, SP, Brazil.
   [Gabbai-Armelin, P. R.; Kido, H. W.; Tim, C. R.; Parizotto, N. A.] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Sao Carlos, SP, Brazil.
RP Gabbai-Armelin, PR (reprint author), Fed Univ Sao Carlos UFSCar, Rodovia Washington Luis SP 310,Km 235, Sao Carlos, SP, Brazil.
EM paulogabbai@gmail.com
RI Zanotto, Edgar/A-7992-2011; CerTEV, CeRTEV/J-6817-2015; Gabbai-Armelin,
   Paulo/L-5984-2016; Bossini, Paulo/G-2333-2014; Kido,
   Hueliton/O-9970-2015
OI Zanotto, Edgar/0000-0003-4931-4505; Kido, Hueliton/0000-0001-8554-432X;
   Tim, Carla/0000-0002-4745-9375
FU CAPES; CNPq; FAPESP; Sao Paulo Research Funding Agency [2013/07793-6];
   PhD students Grant [2011/22937-9]
FX The authors are indebted to CAPES, CNPq and FAPESP, Sao Paulo Research
   Funding Agency, Grant Number 2013/07793-6 (CeRTEV - Center for
   Technology, Research and Education in Glass) for funding this research
   work and PhD students Grant 2011/22937-9.
CR Abiraman S, 2002, B MATER SCI, V25, P419, DOI 10.1007/BF02708021
   Afzal F, 2004, J PATHOL, V202, P503, DOI 10.1002/path.1536
   Anandarajah AP, 2009, TRENDS ENDOCRIN MET, V20, P88, DOI 10.1016/j.tem.2008.10.007
   Axelrad TW, 2007, INJURY, V38, pS49, DOI 10.1016/j.injury.2007.02.010
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Dias AG, 2006, J BIOMATER APPL, V20, P253, DOI 10.1177/0885328206052466
   Dorozhkin S, 2009, P I MECH ENG H, V223, P459, DOI 10.1243/09544119JEIM513
   Drosse I, 2008, INJURY, V39, pS9, DOI 10.1016/S0020-1383(08)70011-1
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Gu Y, 2011, J BIOMED MATER RES A, V97A, P177, DOI 10.1002/jbm.a.33018
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 2002, J INORG MATER, V17, P897
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023
   Lin YN, 2014, J BIOMED MATER RES A, V102, P4491, DOI 10.1002/jbm.a.35120
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Matsumoto MA, 2012, J MATER SCI-MATER M, V23, P1447, DOI 10.1007/s10856-012-4612-8
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Oliveira P, 2010, J MATER SCI-MATER M, V21, P1379, DOI 10.1007/s10856-009-3945-4
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Pedrosa WF, 2009, CLIN ORAL IMPLAN RES, V20, P1254, DOI 10.1111/j.1600-0501.2009.01747.x
   Poologasundarampillai G, 2014, ACTA BIOMATER, V10, P3733, DOI 10.1016/j.actbio.2014.05.020
   Qi XP, 2008, ACTA BIOMATER, V4, P1837, DOI 10.1016/j.actbio.2008.05.009
   Renno ACM, 2013, ACTA BIOMATER, V9, P5728, DOI 10.1016/j.actbio.2012.11.009
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Saino E, 2011, EUR CELLS MATER, V21, P59, DOI 10.22203/eCM.v021a05
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Souza MT, 2013, Patent Application, Patent No. [BR 10 2013 020961 9, 1020130209619]
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   Valimaki VV, 2005, BIOMATERIALS, V26, P6693, DOI 10.1016/j.biomaterials.2005.04.033
   van de Watering FCJ, 2012, CLIN ORAL IMPLAN RES, V23, P151, DOI 10.1111/j.1600-0501.2011.02218.x
   Virk MS, 2013, J BONE JOINT SURG AM, V95A, P694, DOI 10.2106/JBJS.L.00285
   Wu CT, 2010, J BIOMED MATER RES B, V94B, P32, DOI 10.1002/jbm.b.31621
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Pinto KNZ, 2013, PHOTOMED LASER SURG, V31, P252, DOI 10.1089/pho.2012.3435
   Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681
NR 45
TC 10
Z9 10
U1 1
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2015
VL 26
IS 5
AR UNSP 177
DI 10.1007/s10856-015-5516-1
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI5UO
UT WOS:000354825500002
PM 25893392
DA 2018-10-19
ER

PT J
AU Hutmacher, DW
   Little, JP
   Pettet, GJ
   Loessner, D
AF Hutmacher, Dietmar W.
   Little, J. Paige
   Pettet, Graeme J.
   Loessner, Daniela
TI Biomaterial science meets computational biology
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CANCER PROGRESSION; CELL; OVARIAN
AB There is a pressing need for a predictive tool capable of revealing a holistic understanding of fundamental elements in the normal and pathological cell physiology of organoids in order to decipher the mechanoresponse of cells. Therefore, the integration of a systems bioengineering approach into a validated mathematical model is necessary to develop a new simulation tool. This tool can only be innovative by combining biomaterials science with computational biology. Systems-level and multi-scale experimental data are incorporated into a single framework, thus representing both single cells and collective cell behaviour. Such a computational platform needs to be validated in order to discover key mechano-biological factors associated with cell-cell and cell-niche interactions.
C1 [Hutmacher, Dietmar W.; Little, J. Paige; Pettet, Graeme J.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
   [Hutmacher, Dietmar W.; Loessner, Daniela] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia.
   [Hutmacher, Dietmar W.; Little, J. Paige; Pettet, Graeme J.; Loessner, Daniela] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Hutmacher, Dietmar W.] Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany.
   [Pettet, Graeme J.] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia.
   [Loessner, Daniela] Translat Res Inst, Brisbane, Qld, Australia.
RP Hutmacher, DW (reprint author), Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
EM dietmar.hutmacher@qut.edu.au; daniela.lossner@qut.edu.au
RI Loessner, Daniela/L-2265-2017
OI Loessner, Daniela/0000-0001-5891-3441; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Little, J Paige/0000-0001-8377-5343
CR Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Gilbert PM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt44
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Loessner D, 2014, ADV DRUG DELIVER REV, V79-80, P193, DOI 10.1016/j.addr.2014.06.001
   Loessner D, 2013, J CELL SCI, V126, P2761, DOI 10.1242/jcs.123836
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Werner HMJ, 2014, NAT REV CLIN ONCOL, V11, P167, DOI 10.1038/nrclinonc.2014.6
NR 8
TC 0
Z9 0
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2015
VL 26
IS 5
AR 185
DI 10.1007/s10856-015-5518-z
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI5UO
UT WOS:000354825500010
PM 25893394
DA 2018-10-19
ER

PT J
AU Peres, GL
   Leite, DC
   da Silveira, NP
AF Peres, Gisele Louro
   Leite, Daiani Canabarro
   da Silveira, Nadya Pesce
TI Ultrasound effect on molecular weight reduction of amylopectin
SO STARCH-STARKE
LA English
DT Article
DE amylopectin; molecular weight; ultrasound; viscosity
ID POLYMER-SOLUTIONS; LIGHT-SCATTERING; RHEOLOGICAL PROPERTIES;
   HIGH-AMYLOSE; STARCH; DEGRADATION; MACROMOLECULES; TEMPERATURE;
   PURIFICATION; DISPERSIONS
AB Amylopectin is a major polymer found in native starch granules and presents wide applicability as a biomaterial because of its low cost and biocompatibility. However, in many cases, the use of polysaccharides with low molecular weight is needed, mainly due to the possibility to produce functionalized nanomaterials, as well as to increase their diffusion quality. An effective technique for reducing the molecular weight of polysaccharides without chemical structure alteration is the ultrasound technique. In this paper, amylopectin solubilized in DMSO 90% (v/v) was submitted to ultrasound treatment under various conditions. For the evaluation before and after ultrasound treatment, laser light scattering (LLS) techniques, and viscosity measurements accompanied by pH, conductivity and temperature observations were carried out. As a result of the ultrasound treatment a decrease in the size of the polymer chains and solution viscosity were observed in all the conditions analyzed, demonstrating a low-cost method for reducing the molecular weight of amylopectin.
C1 [Peres, Gisele Louro; Leite, Daiani Canabarro; da Silveira, Nadya Pesce] Univ Fed Rio Grande do Sul, Lab Mol Dynam & Instrumentat, Inst Chem, Bio & Macromol, Porto Alegre, RS, Brazil.
RP Peres, GL (reprint author), Inst Chem, E-116,Ave Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM glperes@yahoo.com.br
RI silveira, nadya/G-9970-2016
OI silveira, nadya/0000-0002-1556-7304; LEITE, DAIANI/0000-0003-1197-8437
FU FAPERGS; CAPES; CNPq
FX The authors would like to thank FAPERGS, CAPES, and CNPq for their
   financial support of this study.
CR Albano KM, 2014, FOOD HYDROCOLLOID, V40, P30, DOI 10.1016/j.foodhyd.2014.02.003
   Aliyu M, 2000, ULTRASON SONOCHEM, V7, P265, DOI 10.1016/S1350-4177(00)00052-3
   Bello-Perez LA, 1998, CARBOHYD POLYM, V37, P383, DOI 10.1016/S0144-8617(97)00139-2
   Berry G. C., 1971, J POLYM SCI POLY PHY, V9
   Blomfeldt TOJ, 2012, RSC ADV, V2, P6617, DOI 10.1039/c2ra20946b
   BURCHARD W, 1983, ADV POLYM SCI, V48, P1
   Burgalassi S, 2000, J OCUL PHARMACOL TH, V16, P497, DOI 10.1089/jop.2000.16.497
   Czechowska-Biskup R, 2005, CARBOHYD POLYM, V60, P175, DOI 10.1016/j.carbpol.2004.12.001
   DAVIS H, 1994, J POLYM SCI POL CHEM, V32, P2267, DOI 10.1002/pola.1994.080321208
   Farzi M, 2011, INT J FOOD SCI TECH, V46, P849, DOI 10.1111/j.1365-2621.2011.02558.x
   Freudig B, 2003, ENG LIFE SCI, V3, P266, DOI 10.1002/elsc.200390042
   GALINSKY G, 1995, MACROMOLECULES, V28, P2363, DOI 10.1021/ma00111a033
   HAWORTH WN, 1946, NATURE, V157, P19, DOI 10.1038/157019a0
   Herrero-Martinez JM, 2004, J CHROMATOGR A, V1053, P227, DOI 10.1016/j.chroma.2004.06.048
   Hosseini SMH, 2013, FOOD HYDROCOLLOID, V32, P235, DOI 10.1016/j.foodhyd.2013.01.002
   Hu T, 2014, STARCH-STARKE, V66, P841, DOI 10.1002/star.201400013
   Iida Y, 2008, INNOV FOOD SCI EMERG, V9, P140, DOI 10.1016/j.ifset.2007.03.029
   Karaman S, 2012, ULTRASON SONOCHEM, V19, P928, DOI 10.1016/j.ultsonch.2011.12.009
   Koda S, 2011, ULTRASON SONOCHEM, V18, P276, DOI 10.1016/j.ultsonch.2010.06.007
   Kolawole AO, 2011, PROCESS BIOCHEM, V46, P2178, DOI 10.1016/j.procbio.2011.08.021
   LANGTON NH, 1969, J SOUND VIB, V10, P22, DOI 10.1016/0022-460X(69)90126-6
   Liu HS, 2009, PROG POLYM SCI, V34, P1348, DOI 10.1016/j.progpolymsci.2009.07.001
   Liu S., 2013, ENV HLTH PERSPECT, V121, P6
   Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545
   PECORA R, 1968, J CHEM PHYS, V49, P1032, DOI 10.1063/1.1670188
   Peroni FHG, 2006, FOOD SCI TECHNOL INT, V12, P505, DOI 10.1177/1082013206073045
   PRICE GJ, 1993, EUR POLYM J, V29, P419, DOI 10.1016/0014-3057(93)90114-U
   PRICE GJ, 1993, POLYMER, V34, P4111, DOI 10.1016/0032-3861(93)90675-Z
   Rao A., 1999, RHEOLOGY FLUID SEMIS
   Rolland-Sabate A, 2012, FOOD HYDROCOLLOID, V27, P161, DOI 10.1016/j.foodhyd.2011.07.008
   Steffe J. F., 1996, RHEOLOGICAL METHODS
   Sujka M, 2013, FOOD HYDROCOLLOID, V31, P413, DOI 10.1016/j.foodhyd.2012.11.027
   Sun JP, 2008, J FOOD QUALITY, V31, P250, DOI 10.1111/j.1745-4557.2008.00192.x
   Szymonska J., 2008, 2 NAT C NAN NANO 200
   Tan ZJ, 2012, DESALINATION, V286, P389, DOI 10.1016/j.desal.2011.11.053
   Vendamme R., 2014, J APPL POLYM SCI, V131, P16
   Wang YH, 2012, CARBOHYD POLYM, V90, P696, DOI 10.1016/j.carbpol.2012.05.099
   Wolf M. J., 1970, CEREAL CHEM, V47
   WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S
   Zhang LF, 2013, ULTRASON SONOCHEM, V20, P222, DOI 10.1016/j.ultsonch.2012.07.021
   Zhu J, 2012, FOOD HYDROCOLLOID, V29, P116, DOI 10.1016/j.foodhyd.2012.02.004
NR 41
TC 7
Z9 8
U1 1
U2 30
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0038-9056
EI 1521-379X
J9 STARCH-STARKE
JI Starch-Starke
PD MAY
PY 2015
VL 67
IS 5-6
BP 407
EP 414
DI 10.1002/star.201400230
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA CH7KL
UT WOS:000354215000004
DA 2018-10-19
ER

PT J
AU Hogan, MV
   Kawakami, Y
   Murawski, CD
   Fu, FH
AF Hogan, MaCalus V.
   Kawakami, Yohei
   Murawski, Christopher D.
   Fu, Freddie H.
TI Tissue Engineering of Ligaments for Reconstructive Surgery
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Review
ID ANTERIOR CRUCIATE LIGAMENT; MEDIAL COLLATERAL LIGAMENT; INTENSITY PULSED
   ULTRASOUND; PLATELET-RICH PLASMA; PATELLAR TENDON AUTOGRAFT; BONE
   MORPHOGENETIC PROTEINS; ENDOTHELIAL GROWTH-FACTOR; FOLLOW-UP EVALUATION;
   STEM-CELLS; ARTIFICIAL LIGAMENTS
AB Purpose: The use of musculoskeletal bioengineering and regenerative medicine applications in orthopaedic surgery has continued to evolve. The aim of this systematic review was to address tissue-engineering strategies for knee ligament reconstruction. Methods: A systematic review of PubMed/Medline using the terms "knee AND ligament" AND "tissue engineering" OR "regenerative medicine" was performed. Two authors performed the search, independently assessed the studies for inclusion, and extracted the data for inclusion in the review. Both preclinical and clinical studies were reviewed, and the articles deemed most relevant were included in this article to provide relevant basic science and recent clinical translational knowledge concerning "tissue-engineering" strategies currently used in knee ligament reconstruction. Results: A total of 224 articles were reviewed in our initial PubMed search. Non-nglish-language studies were excluded. Clinical and preclinical studies were identified, and those with a focus on knee ligament tissue-engineering strategies including stem cell-based therapies, growth factor administration, hybrid biomaterial, and scaffold development, as well as mechanical stimulation modalities, were reviewed. Conclusions: The body of knowledge surrounding tissue-engineering strategies for ligament reconstruction continues to expand. Presently, various tissue-engineering techniques have some potential advantages, including faster recovery, better ligamentization, and possibly, a reduction of recurrence. Preclinical research of these novel therapies continues to provide promising results. There remains a need for well-designed, high-powered comparative clinical studies to serve as a foundation for successful translation into the clinical setting going forward.
C1 [Hogan, MaCalus V.; Kawakami, Yohei; Murawski, Christopher D.; Fu, Freddie H.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15213 USA.
RP Fu, FH (reprint author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Kaufmann Med Bldg,Ste 1011,3471 Fifth Ave, Pittsburgh, PA 15213 USA.
EM ffu@upmc.edu
RI Hogan, MaCalus/N-5484-2017
OI Hogan, MaCalus/0000-0002-6598-1095
CR Anderson K, 2001, AM J SPORT MED, V29, P689, DOI 10.1177/03635465010290060301
   ARAGONA J, 1983, AM J SPORT MED, V11, P228, DOI 10.1177/036354658301100409
   Bach BR, 1998, AM J SPORT MED, V26, P30, DOI 10.1177/03635465980260012201
   Bach BR, 1998, AM J SPORT MED, V26, P20, DOI 10.1177/03635465980260012101
   BALLOCK RT, 1989, J ORTHOP RES, V7, P474, DOI 10.1002/jor.1100070404
   Brophy RH, 2011, J BONE JOINT SURG AM, V93A, P381, DOI 10.2106/JBJSJ.00933
   Cervellin M, 2012, KNEE SURG SPORT TR A, V20, P114, DOI 10.1007/s00167-011-1570-5
   Chang Chih-Hsiang, 2012, Biomed J, V35, P473, DOI 10.4103/2319-4170.104412
   Chow DHK, 2014, J ORTHOP RES, V32, P507, DOI 10.1002/jor.22566
   Cook SD, 2001, CLIN ORTHOP RELAT R, pS231
   COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1
   Crawford C, 2005, CLIN INFECT DIS, V41, P195, DOI 10.1086/430911
   Doan N, 1999, J ORAL MAXIL SURG, V57, P409, DOI 10.1016/S0278-2391(99)90281-1
   Doan N, 1999, J ORAL MAXILLOFAC SU, V57, P420
   Eagan MJ, 2012, J TISSUE ENG REGEN M, V6, P702, DOI 10.1002/term.474
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Emond CE, 2011, J BONE JOINT SURG AM, V93A, P572, DOI 10.2106/JBJS.J.00269
   Ersen A, 2014, ARCH ORTHOP TRAUM SU, V134, P405, DOI 10.1007/s00402-013-1914-3
   Farraro KE, 2014, J BIOMECH, V47, P1979, DOI 10.1016/j.jbiomech.2013.12.003
   GRANA WA, 1994, AM J SPORT MED, V22, P344, DOI 10.1177/036354659402200309
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Gulotta LV, 2008, AM J SPORT MED, V36, P1290, DOI 10.1177/0363546508314396
   Hildebrand KA, 1998, AM J SPORT MED, V26, P549, DOI 10.1177/03635465980260041401
   Hoher J, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P231, DOI 10.1007/s001670050105
   Howson KM, 2005, AM J PHYSIOL-CELL PH, V289, pC1396, DOI 10.1152/ajpcell.00168.2005
   Ishibashi Y, 2001, AM J SPORT MED, V29, P473, DOI 10.1177/03635465010290041601
   Jadeja H, 2007, KNEE, V14, P439, DOI 10.1016/j.knee.2007.08.006
   Jarvela T, 2007, KNEE SURG SPORT TR A, V15, P500, DOI 10.1007/s00167-006-0254-z
   Kim HM, 2011, CONNECT TISSUE RES, V52, P87, DOI 10.3109/03008207.2010.483026
   Kohno T, 2007, J ORTHOP SCI, V12, P67, DOI 10.1007/s00776-006-1088-8
   Leung KS, 2004, ULTRASOUND MED BIOL, V30, P389, DOI 10.1016/j.ultrasmedbio.2003.11.008
   Li H, 2012, ACTA BIOMATER, V8, P4007, DOI 10.1016/j.actbio.2012.07.008
   Li H, 2012, ARTHROSCOPY, V28, P583, DOI 10.1016/j.arthro.2011.12.008
   Liang R, 2006, J ORTHOP RES, V24, P811, DOI 10.1002/jor.20080
   Liang R, 2008, J ORTHOP RES, V26, P1098, DOI 10.1002/jor.20616
   Lind M, 2009, ARTHROSCOPY, V25, P1275, DOI 10.1016/j.arthro.2009.06.003
   Liu ZT, 2010, INT ORTHOP, V34, P45, DOI 10.1007/s00264-009-0768-3
   Lovric V, 2013, KNEE SURG SPORT TR A, V21, P466, DOI 10.1007/s00167-012-1972-z
   Lu H, 2008, ULTRASOUND MED BIOL, V34, P1248, DOI 10.1016/j.ultrasmedbio.2008.01.009
   Lui Pauline Po Yee, 2012, Muscles Ligaments Tendons J, V2, P163
   Lui PPY, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-59
   Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312
   Marumo K, 2005, AM J SPORT MED, V33, P1166, DOI 10.1177/0363546504271973
   Matsumoto T, 2012, AM J SPORT MED, V40, P1296, DOI 10.1177/0363546512439026
   Matsumoto T, 2012, STEM CELLS DEV, V21, P859, DOI 10.1089/scd.2010.0528
   Mazzocca AD, 2012, AM J SPORT MED, V40, P1742, DOI 10.1177/0363546512452713
   Mifune Y, 2013, BIOMATERIALS, V34, P5476, DOI 10.1016/j.biomaterials.2013.04.013
   Mifune Y, 2012, CELL TRANSPLANT, V21, P1651, DOI 10.3727/096368912X647234
   Moraes VY, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD010071.PUB2
   Murray AW, 2004, KNEE, V11, P9, DOI 10.1016/S0968-0160(03)00076-0
   Murray MM, 2013, AM J SPORT MED, V41, P1762, DOI 10.1177/0363546513483446
   Murray MM, 2013, J ORTHOP RES, V31, P1501, DOI 10.1002/jor.22420
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Mutsuzaki H, 2004, J BIOMED MATER RES A, V70A, P319, DOI 10.1002/jbm.a.30084
   Mutsuzaki H, 2012, AM J SPORT MED, V40, P1772, DOI 10.1177/0363546512449618
   Nau T, 2002, J BONE JOINT SURG BR, V84B, P356, DOI 10.1302/0301-620X.84B3.12400
   Pereira HMD, 2013, KNEE SURG SPORT TR A, V21, P986, DOI 10.1007/s00167-013-2414-2
   Petersen W, 2000, KNEE SURG SPORT TR A, V8, P26, DOI 10.1007/s001670050006
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf
   Qin L, 2006, ULTRASOUND MED BIOL, V32, P1905, DOI 10.1016/j.ultrasmedbio.2006.06.028
   Ranger P, 2011, INT ORTHOP, V35, P1477, DOI 10.1007/s00264-010-1154-x
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   Salmon L, 2005, ARTHROSCOPY, V21, P948, DOI 10.1016/j.arthro.2005.04.110
   Sasaki K, 2008, AM J SPORT MED, V36, P1519, DOI 10.1177/0363546508316282
   Seijas R, 2015, KNEE SURG SPORT TR A, V23, P991, DOI 10.1007/s00167-013-2787-2
   Shah AA, 2010, ARTHROSCOPY, V26, P667, DOI 10.1016/j.arthro.2010.02.031
   Shen GS, 2012, J SURG RES, V173, P75, DOI 10.1016/j.jss.2010.08.015
   Silva A, 2009, KNEE SURG SPORT TR A, V17, P676, DOI 10.1007/s00167-009-0762-8
   Snow M, 2010, KNEE SURG SPORT TR A, V18, P1374, DOI 10.1007/s00167-009-0997-4
   Spindler KP, 2008, NEW ENGL J MED, V359, P2135, DOI 10.1056/NEJMcp0804745
   Sun JS, 2001, J BIOMED MATER RES, V57, P449, DOI 10.1002/1097-4636(20011205)57:3<449::AID-JBM1188>3.0.CO;2-0
   Suzuki Akito, 2009, J Oral Sci, V51, P29
   Takakura Y, 2002, J ULTRAS MED, V21, P283, DOI 10.7863/jum.2002.21.3.283
   Taylor DW, 2011, CLIN J SPORT MED, V21, P344, DOI 10.1097/JSM.0b013e31821d0f65
   Tomita F, 2001, ARTHROSCOPY, V17, P461, DOI 10.1053/jars.2001.24059
   Tucker B A, 2010, J Stem Cells, V5, P155, DOI jsc.2010.5.4.155
   van Eck CF, 2012, AM J SPORT MED, V40, P800, DOI 10.1177/0363546511432545
   Wadhwa M, 1996, BRIT J HAEMATOL, V93, P225, DOI 10.1046/j.1365-2141.1996.4611002.x
   Walsh WR, 2007, ARTHROSCOPY, V23, P197, DOI 10.1016/j.arthro.2006.09.003
   Widuchowski W, 2012, BMC MUSCULOSKEL DIS, V27, P115, DOI DOI 10.1186/1471-2474-13-115
   Wong MWN, 2004, J BIOMED MATER RES B, V70B, P362, DOI 10.1002/jbm.b.30049
   Woodall James Jr, 2008, Biomed Sci Instrum, V44, P489
   Xie XX, 2013, J SURG RES, V183, P214, DOI 10.1016/j.jss.2013.01.020
   Yoshikawa T, 2006, AM J SPORT MED, V34, P1918, DOI 10.1177/0363546506294469
   Yoshioka T, 2013, KNEE SURG SPORT TR A, V21, P1763, DOI 10.1007/s00167-012-2002-x
   Yu Y, 2007, ARTHROSCOPY, V23, P205, DOI 10.1016/j.arthro.2006.08.023
   Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315
   Zhai WL, 2012, ORTHOPEDICS, V35, pE520, DOI 10.3928/01477447-20120327-22
NR 89
TC 14
Z9 14
U1 3
U2 53
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
EI 1526-3231
J9 ARTHROSCOPY
JI Arthroscopy
PD MAY
PY 2015
VL 31
IS 5
BP 971
EP 979
DI 10.1016/j.arthro.2014.11.026
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA CH2YN
UT WOS:000353891600027
PM 25618491
DA 2018-10-19
ER

PT J
AU Zustiak, SP
AF Zustiak, Silviya Petrova
TI The Role of Matrix Compliance on Cell Responses to Drugs and Toxins:
   Towards Predictive Drug Screening Platforms
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE compliance; drug screening; matrix; substrate stiffness; therapeutics
ID ORGANS-ON-CHIPS; IN-VITRO; HIGH-THROUGHPUT; MOLECULAR-MECHANISMS;
   SUBSTRATE STIFFNESS; TISSUE STIFFNESS; STEM-CELLS; CANCER; RESISTANCE;
   DISCOVERY
AB Since the birth of tissue engineering, it has been redefined to include not only the development of tissues for clinical use, but also in vitro models for the study of tissue physiology and pathology. Great strides have been accomplished in the design of in vitro tissue models, yet one area in which they are underrepresented, but where they can have an immediate impact, is the development of platforms for drug screening. By providing more in vivo-like cell environments, such models could address the growing concerns about drug failures due to lack of efficacy or unexpected side effects. This review aims to address the interface between substrate compliance and cell responsiveness to toxins and drugs since compliance has been established as a major determinate of overall cell fate. Here, results from 2D substrates and 3D matrices are discussed. Additionally, examples of biomaterial-based high-throughput stiffness assays in drug screening are presented.
C1 St Louis Univ, Dept Biomed Engn, Pk Coll Engn Aviat & Technol, St Louis, MO 63103 USA.
RP Zustiak, SP (reprint author), St Louis Univ, Dept Biomed Engn, Pk Coll Engn Aviat & Technol, 3507 Lindell Blvd, St Louis, MO 63103 USA.
EM szustiak@slu.edu
FU Saint Louis University; President's Research Fund (PRF)
FX This work was funded by start-up funds provided to Dr. Silviya Zustiak
   by Saint Louis University, as well as, by the President's Research Fund
   (PRF) and the Stroble Award in the Health Sciences awarded to Dr.
   Silviya Zustiak by Saint Louis University.
CR Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967
   Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Cha C, 2011, ACTA BIOMATER, V7, P3719, DOI 10.1016/j.actbio.2011.06.017
   Chan CY, 2013, LAB CHIP, V13, P4697, DOI 10.1039/c3lc90115g
   Chang RC, 2011, METHODS MOL BIOL, V671, P219, DOI 10.1007/978-1-59745-551-0_13
   Chen WLK, 2011, ADV DRUG DELIVER REV, V63, P269, DOI 10.1016/j.addr.2011.01.004
   Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]
   Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007
   Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esch MB, 2014, ADV DRUG DELIVER REV, V69, P158, DOI 10.1016/j.addr.2013.12.003
   Feng JT, 2013, CLIN HEMORHEOL MICRO, V55, P121, DOI 10.3233/CH-131696
   Fernandez-Fuente G, 2014, MOL CANCER THER, V13, P1664, DOI 10.1158/1535-7163.MCT-13-0854
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029
   Ghassemi S, 2008, J VAC SCI TECHNOL B, V26, P2549, DOI 10.1116/1.3013424
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grimm S, 2010, J MATER CHEM, V20, P3171, DOI 10.1039/b926432a
   Gupta K, 2010, LAB CHIP, V10, P2019, DOI 10.1039/c004689b
   Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054
   Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603
   Herrick WG, 2013, BIOMACROMOLECULES, V14, P2294, DOI 10.1021/bm400418g
   Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599
   Horwitz S., 1993, ANN ONCOL, V5, pS3
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Huh D., 2011, TRENDS CELL BIOL, P745
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x
   Ivanov M, 2014, TRENDS PHARMACOL SCI, V35, P384, DOI 10.1016/j.tips.2014.05.004
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Justin R. T., 2011, PLOS ONE, V6
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201
   Kumachev A, 2011, BIOMATERIALS, V32, P1477, DOI 10.1016/j.biomaterials.2010.10.033
   Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q
   Lam J, 2015, ADV HEALTHC MATER, V4, P534, DOI 10.1002/adhm.201400410
   Lan SF, 2011, TOXICOL APPL PHARM, V256, P62, DOI 10.1016/j.taap.2011.07.013
   Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320
   Lemmon Christopher A, 2005, Mech Chem Biosyst, V2, P1
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045
   Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9
   Liu C, 2015, BIOTECHNOL APPL BIOC, V62, P556, DOI 10.1002/bab.1302
   Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082
   Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706
   Maltman D., 2010, BIOCHEM SOC T, P1072
   Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007
   Mckee CT, 2011, BIOMATERIALS, V32, P2417, DOI 10.1016/j.biomaterials.2010.11.071
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Nguyen TV, 2014, BIOMATERIALS, V35, P5749, DOI 10.1016/j.biomaterials.2014.03.058
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Ozben T, 2006, FEBS LETT, V580, P2903, DOI 10.1016/j.febslet.2006.02.020
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Patel DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036594
   Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Ramamoorthi K., 2014, AICHE ANN M C P ATL, V112b
   Ramamoorthi K, 2014, CELL MOL BIOENG, V7, P278, DOI 10.1007/s12195-014-0326-y
   Rossow T, 2012, J AM CHEM SOC, V134, P4983, DOI 10.1021/ja300460p
   Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108
   Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951
   Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215
   Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084
   SORENSON CM, 1990, J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749
   Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469
   Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347
   Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0
   Syed S., J VIS EXPT IN PRESS
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tokuda EY, 2014, BIOMATERIALS, V35, P4310, DOI 10.1016/j.biomaterials.2014.01.063
   Tse JR, 2010, CURR PROTOC CELL BIO, V47
   Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219
   Wood JA, 2011, INVEST OPHTH VIS SCI, V52, P9298, DOI 10.1167/iovs.11-7857
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Zustiak S. P., 2010, BIOMACROMOLECULES, P1348
   Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097
NR 98
TC 4
Z9 4
U1 2
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY
PY 2015
VL 15
IS 5
BP 589
EP 599
DI 10.1002/mabi.201400507
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CI0AB
UT WOS:000354396800001
PM 25654999
DA 2018-10-19
ER

PT J
AU Cross, D
   Jiang, XZ
   Ji, WH
   Han, WQ
   Wang, C
AF Cross, Daisy
   Jiang, Xiaoze
   Ji, Weihang
   Han, Wenqing
   Wang, Chun
TI Injectable Hybrid Hydrogels of Hyaluronic Acid Crosslinked by
   Well-Defined Synthetic Polycations: Preparation and Characterization In
   Vitro and In Vivo
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE hyaluronic acid; hybrid hydrogel; physical hydrogel; polyelectrolyte
   hydrogel; star block copolymer
ID BLOCK-COPOLYMERS; CELL TRANSPLANTATION; TRIBLOCK COPOLYMER; DENDRITIC
   CELLS; CHAIN-LENGTH; STEM-CELLS; DELIVERY; MICROSPHERES; THERAPY; DESIGN
AB An injectable hybrid hydrogel system was developed consisting of hyaluronic acid (HA) crosslinked by well-defined block copolymers of the cationic poly(2-aminoethyl methacrylate) (PAEM) and polyethylene glycol (PEG). Robust, shear-thinning hybrid hydrogel was produced by mixing HA and 4-arm star PEG-PAEM block copolymer at 1:1 charge ratio. The encapsulation and release of highly viable human mesenchymal stem cells in physiological media was demonstrated. After subcutaneous injection of the hybrid gel in mice, mild but resolvable inflammatory response was observed. This hybrid gel could serve as a model system for studying structure-function relationship of polyelectrolyte hydrogels and as a practical injectable biomaterial for medical applications.
C1 [Cross, Daisy; Jiang, Xiaoze; Ji, Weihang; Han, Wenqing; Wang, Chun] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
RP Wang, C (reprint author), Univ Minnesota, Dept Biomed Engn, 7-105 Hasselmo Hall,312 Church St SE, Minneapolis, MN 55455 USA.
EM wangx504@umn.edu
RI Ji, Weihang/I-7265-2012
OI Ji, Weihang/0000-0002-1054-6280
FU University of Minnesota's Institute for Engineering in Medicine (IEM);
   NSF CAREER grant [BES0547613]; NIH Biotechnology Training Grant [T32
   GM008347]; University of Minnesota Doctoral Dissertation Fellowship
FX This work is supported in part by the University of Minnesota's
   Institute for Engineering in Medicine (IEM), an NSF CAREER grant
   (BES0547613), a NIH Biotechnology Training Grant (Grant Number T32
   GM008347) fellowship (to DC), and a University of Minnesota Doctoral
   Dissertation Fellowship (to DC). Special thanks to Dr. Robert T.
   Tranquillo (Department of Biomedical Engineering, University of
   Minnesota) for kindly providing human MSCs, and to David Giles
   (University of Minnesota Polymer Characterization Facility) for advice
   regarding rheological characterization.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ANDRIANOV AK, 1994, J APPL POLYM SCI, V53, P1573, DOI 10.1002/app.1994.070531203
   Angot B, 2000, MACROMOLECULES, V33, P5418, DOI 10.1021/ma000079s
   Arimura H, 2005, J BIOMAT SCI-POLYM E, V16, P1347, DOI 10.1163/156856205774472353
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Cerritelli S, 2005, MACROMOLECULES, V38, P7845, DOI 10.1021/ma051176u
   CLARK AH, 1987, ADV POLYM SCI, V83, P57
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034
   Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hornof M, 2008, J GENE MED, V10, P70, DOI 10.1002/jgm.1125
   Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Jankova K, 1998, MACROMOLECULES, V31, P538, DOI 10.1021/ma9710186
   Ji WH, 2011, BIOMACROMOLECULES, V12, P4373, DOI 10.1021/bm201360v
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Kim JI, 2012, BIOMATERIALS, V33, P2823, DOI 10.1016/j.biomaterials.2012.01.004
   KOBAYASHI Y, 1994, BIORHEOLOGY, V31, P235
   Kuroda K, 2005, J AM CHEM SOC, V127, P4128, DOI 10.1021/ja044205+
   Liu B, 2009, BIOMACROMOLECULES, V10, P3182, DOI 10.1021/bm900908g
   Liu KL, 2011, SOFT MATTER, V7, P11290, DOI 10.1039/c1sm06340e
   Liu Y, 2011, MACROMOL BIOSCI, V11, P1325, DOI 10.1002/mabi.201100119
   Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Prestwich GD, 2008, CURR PHARM BIOTECHNO, V9, P242, DOI 10.2174/138920108785161523
   Schmalz A, 2012, SOFT MATTER, V8, P9436, DOI 10.1039/c2sm25686j
   Segura T, 2007, BIOCONJUGATE CHEM, V18, P736, DOI 10.1021/bc060284y
   Tang RP, 2010, J CONTROL RELEASE, V142, P229, DOI 10.1016/j.jconrel.2009.10.021
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Wu J, 2007, J BIOMED MATER RES A, V80A, P800, DOI 10.1002/jbm.a.30972
   Xu J, 2006, MACROMOLECULES, V39, P8178, DOI 10.1021/ma061934w
   Yan CQ, 2012, LANGMUIR, V28, P6076, DOI 10.1021/la2041746
   Yannas I. V., 2004, BIOMATERIALS SCI, P728
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang JJ, 2011, ADV MATER, V23, P5098, DOI 10.1002/adma.201103349
NR 45
TC 6
Z9 6
U1 5
U2 46
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY
PY 2015
VL 15
IS 5
BP 668
EP 681
DI 10.1002/mabi.201400491
PG 14
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CI0AB
UT WOS:000354396800008
PM 25630277
DA 2018-10-19
ER

PT J
AU Chlanda, A
   Rebis, J
   Kijenska, E
   Wozniak, MJ
   Rozniatowski, K
   Swieszkowski, W
   Kurzydlowski, KJ
AF Chlanda, Adrian
   Rebis, Janusz
   Kijenska, Ewa
   Wozniak, Michal J.
   Rozniatowski, Krzysztof
   Swieszkowski, Wojciech
   Kurzydlowski, Krzysztof J.
TI Quantitative imaging of electrospun fibers by PeakForce Quantitative
   NanoMechanics atomic force microscopy using etched scanning probes
SO MICRON
LA English
DT Article
DE Atomic force microscopy; PeakForce Quantitative NanoMechanics;
   Electrospun fibers; Focused ion beam; Mechanical properties
ID MECHANICAL-PROPERTIES; FIBRINOGEN FIBERS; NANOFIBERS; CHONDROCYTES;
   FABRICATION; MORPHOLOGY; SCAFFOLDS; SILICON; PROTEIN
AB Electrospun polymeric submicron and nanofibers can be used as tissue engineering scaffolds in regenerative medicine. In physiological conditions fibers are subjected to stresses and strains from the surrounding biological environment. Such stresses can cause permanent deformation or even failure to their structure. Therefore, there is a growing necessity to characterize their mechanical properties, especially at the nanoscale.
   Atomic force microscopy is a powerful tool for the visualization and probing of selected mechanical properties of materials in biomedical sciences. Image resolution of atomic force microscopy techniques depends on the equipment quality and shape of the scanning probe. The probe radius and aspect ratio has huge impact on the quality of measurement.
   In the presented work the nanomechanical properties of four different polymer based electros pun fibers were tested using PeakForce Quantitative NanoMechanics atomic force microscopy, with standard and modified scanning probes. Standard, commercially available probes have been modified by etching using focused ion beam (FIB). Results have shown that modified probes can be used for mechanical properties mapping of biomaterial in the nanoscale, and generate nanomechanical information where conventional tips fail. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Chlanda, Adrian; Rebis, Janusz; Kijenska, Ewa; Wozniak, Michal J.; Rozniatowski, Krzysztof; Swieszkowski, Wojciech; Kurzydlowski, Krzysztof J.] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-02507 Warsaw, Poland.
   [Wozniak, Michal J.] Warsaw Univ Technol, Univ Res Ctr Funct Mat, PL-02507 Warsaw, Poland.
RP Chlanda, A (reprint author), Warsaw Univ Technol, Fac Mat Sci & Engn, 141 Woloska Str, PL-02507 Warsaw, Poland.
EM adrian.chlanda@inmat.pw.edu.pl
OI Kijenska-Gawronska, Ewa/0000-0002-2614-2838; Chlanda,
   Adrian/0000-0002-8795-7563
FU National Science Center of Poland (NCN) [UMO-2011/01/B/ST8/07559,
   DEC-2011/01/M/ST8/07742]; Ministry of Science and Higher Education,
   Republic of Poland (MNiSW) [0616/IP2/2011/71]
FX This study is financially supported by: (1) National Science Center of
   Poland (NCN) under grant: "Three-dimensional composite scaffold based on
   biodegradable polymers and bioceramic with incorporated growth factors
   for bone tissue engineering. Research on the manufacturing process and
   the material influence on living cells function", number:
   UMO-2011/01/B/ST8/07559. (2) Ministry of Science and Higher Education,
   Republic of Poland (MNiSW) under grant: "Polymer-ceramic composite,
   extracellular matrix mimicking biomaterials for tissue engineering
   needs: processes of degradation of the structure and mechanical
   properties", number: 0616/IP2/2011/71. (3) National Science Center of
   Poland (NCN) under grant: "Hybrid growth factors delivery system
   supporting bone tissue regeneration", number DEC-2011/01/M/ST8/07742.
CR Adamcik J, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3589369
   [Anonymous], 2011, PEAKFORCE QNM US GUI
   Baker S, 2012, MAT SCI ENG C-MATER, V32, P215, DOI 10.1016/j.msec.2011.10.021
   Bale M, 2002, J VAC SCI TECHNOL B, V20, P364, DOI 10.1116/1.1447242
   Bosworth LA, 2013, NANOMED-NANOTECHNOL, V9, P322, DOI 10.1016/j.nano.2012.10.008
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006
   Chattopadhyray S, 2006, CRIT REV SOLID STATE, V31, P15, DOI 10.1080/10408430600689299
   Chen Y, 2000, J CRYST GROWTH, V210, P527, DOI 10.1016/S0022-0248(99)00728-9
   Chew SY, 2006, NANOTECHNOLOGY, V17, P3880, DOI 10.1088/0957-4484/17/15/045
   Croisier F, 2012, ACTA BIOMATER, V8, P218, DOI 10.1016/j.actbio.2011.08.015
   Elsabee MZ, 2012, MAT SCI ENG C-MATER, V32, P1711, DOI 10.1016/j.msec.2012.05.009
   Fischer H., 2013, J MICROSC
   Khadka DB, 2012, NANOMED-NANOTECHNOL, V8, P1242, DOI 10.1016/j.nano.2012.02.013
   Kijenska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676
   Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244
   Lee J, 2012, ACTA BIOMATER, V8, P2549, DOI 10.1016/j.actbio.2012.03.030
   Lee JH, 2008, ULTRAMICROSCOPY, V108, P1163, DOI 10.1016/j.ultramic.2008.04.073
   Liu H, 2012, MACROMOLECULES, V45, P8770, DOI 10.1021/ma301961h
   Pittenger B., 2010, QUANTITATIVE MECH PR
   Raghavan P, 2012, REACT FUNCT POLYM, V72, P915, DOI 10.1016/j.reactfunctpolym.2012.08.018
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rozniatowski K., 2013, TOWAROZNAWCZE PROBLE, V34
   Sencadas V, 2012, CARBOHYD POLYM, V87, P1295, DOI 10.1016/j.carbpol.2011.09.017
   Sun B., 2013, PROG POLYM SCI
   Wang Y, 2010, APPL SURF SCI, V256, P6107, DOI 10.1016/j.apsusc.2010.03.127
   Wozniak MJ, 2010, SOFT MATTER, V6, P2462, DOI 10.1039/b926890a
   Wozniak MJ, 2009, MICRON, V40, P870, DOI 10.1016/j.micron.2009.06.002
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Zanden C, 2012, EUR POLYM J, V48, P472, DOI 10.1016/j.eurpolymj.2012.01.004
   Zhang J., 2011, APPL PHYS LETT, V99
NR 31
TC 12
Z9 12
U1 0
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD MAY
PY 2015
VL 72
BP 1
EP 7
DI 10.1016/j.micron.2015.01.005
PG 7
WC Microscopy
SC Microscopy
GA CI1ME
UT WOS:000354507500001
PM 25710786
DA 2018-10-19
ER

PT J
AU Rytlewski, JA
   Aldon, MA
   Lewis, EW
   Suggs, LJ
AF Rytlewski, Julie A.
   Aldon, M. Alejandra
   Lewis, Evan W.
   Suggs, Laura J.
TI Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs
SO MICROVASCULAR RESEARCH
LA English
DT Article
DE Mesenchymal stem cells; Tubulogenesis; Vasculogenic mimicry; Fibrin;
   Hypoxia; Neovascularization
ID MESENCHYMAL STEM-CELLS; 3-DIMENSIONAL EXTRACELLULAR MATRICES;
   HUMAN-MELANOMA CELLS; VASCULOGENIC MIMICRY; IN-VITRO; CAPILLARY LUMEN;
   GROWTH-FACTOR; VE-CADHERIN; MORPHOGENESIS; VIVO
AB Stem cell-based therapies are a promising new avenue for treating ischemic disease and chronic wounds. Mesenchymal stem cells (MSCs) have a proven ability to augment the neovascularization processes necessary for wound healing and are widely popular as an autologous source of progenitor cells. Our lab has previously reported on PEGylated fibrin as a unique hydrogel that promotes spontaneous tubulogenesis of encapsulated MSCs without exogenous factors. However, the mechanisms underlying this process have remained unknown. To better understand the therapeutic value of PEGylated fibrin delivery of MSCs, we sought to clarify the relationship between biomaterial properties and cell behavior. Here we find that fibrin PEGylation does not dramatically alter the macroscopic mechanical properties of the fibrin-based matrix (less than 10% difference). It does, however, dramatically reduce the rate of diffusion through the gel matrix. PEGylated fibrin enhances the tubulogenic growth of encapsulated MSCs demonstrating fluid-filled lumens by interconnected MSCs. Image analysis gave a value of 4320 +/- 1770 pm total network length versus 618 +/- 443 gm for unmodified fibrin. PEGylation promotes the endothelial phenotype of encapsulated MSCs compared to unmodified fibrin as evidenced by higher levels of endothelial markers (von Willebrand factor, 2.2-fold; vascular endothelial cadherin, 1.8-fold) and vascular endothelial growth factor (VEGF, up to 1.8-fold). Prospective analysis of underlying molecular pathways demonstrated that this endothelial-like MSC behavior is sensitively modulated by hypoxic stress, but not VEGF supplementation as evidenced by a significant increase in VEGF and MMP-2 secretion per cell under hypoxia. Further gain-of-function studies under hypoxic stress demonstrated that hypoxia culture of MSCs in unmodified fibrin could increase both vWF and VE-cadherin levels to values that were not significantly different than cells cultured in PEGylated fibrin. This result corroborated our hypothesis that the diffusion-limited environment of PEGylated fibrin is augmenting endothelial differentiation cues provided by unmodified fibrin. However, MSC networks lack platelet endothelial cell adhesion molecule-1 (PECAM-1) expression, which indicates incomplete differentiation towards an endothelial cell type. Collectively, the data here supports a revised understanding of MSC-derived neovascularization that contextualizes their behavior and utility as a hybrid endothelial-stromal cell type, with mixed characteristics of both populations. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rytlewski, Julie A.; Aldon, M. Alejandra; Lewis, Evan W.; Suggs, Laura J.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP Suggs, LJ (reprint author), Univ Texas Austin, Dept Biomed Engn, 107 W Dean Keeton,Stop C0800, Austin, TX 78712 USA.
EM julie.rytlewski@utexas.edu; alejandra.aldon@utexas.edu;
   evan.lewis@utexas.edu; laura.suggs@engr.utexas.edu
FU American Heart Association [11GRNT7080002]; Department of Defense (NDSEG
   fellowship); Cockrell School of Engineering; National Center for
   Research Resources [S10RR027950]
FX We gratefully acknowledge our sources of funding: the American Heart
   Association (11GRNT7080002) for funding this project; the Department of
   Defense (NDSEG fellowship) and Cockrell School of Engineering (Thrust
   2000 fellowship) for funding JR We also would like to thank the ICMB
   Microscopy and Imaging Facility (UT Austin) for access to cryo-SEM and
   confocal microscopes and Award Number S10RR027950 from the National
   Center for Research Resources for providing access to two-photon
   microscopy. The content here is solely the responsibility of the authors
   and does not necessarily represent the official views of the National
   Center for Research Resources or the National Institutes of Health.
CR Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117
   Athanassopoulos A, 2012, BURNS, V38, P691, DOI 10.1016/j.burns.2011.12.019
   Bayless KJ, 2002, J CELL SCI, V115, P1123
   Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159
   Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Folberg R, 2004, APMIS, V112, P508, DOI 10.1111/j.1600-0463.2004.apm11207-0810.x
   Galas RJ, 2014, J CELL PHYSIOL, V229, P90, DOI 10.1002/jcp.24421
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Gibot L, 2010, TISSUE ENG PT A, V16, P3199, DOI 10.1089/ten.TEA.2010.0189
   Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798
   Hess AR, 2003, CANCER RES, V63, P4757
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Karlsson LK, 2009, ANN VASC SURG, V23, P663, DOI 10.1016/j.avsg.2009.03.007
   Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Majumdar D, 2013, PLACENTA, V34, P642, DOI 10.1016/j.placenta.2013.04.021
   Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5
   Nagle RB, 2011, PROSTATE CANCER, DOI 10.1155/2011/249290
   Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1
   Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   Oberringer M, 2007, BIOL CELL, V99, P197, DOI 10.1042/BC20060116
   Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Razban V, 2012, BIORESEARCH OPEN ACC, V1, P174, DOI 10.1089/biores.2012.9905
   Rytlewski JA, 2012, TISSUE ENG PART C-ME, V18, P507, DOI [10.1089/ten.tec.2011.0417, 10.1089/ten.TEC.2011.0417]
   Sahai S, 2012, TISSUE ENG PART C-ME, V18, P557, DOI [10.1089/ten.tec.2011.0518, 10.1089/ten.TEC.2011.0518]
   Simionescu DT, 2012, J HEALTHC ENG, V3, P179, DOI 10.1260/2040-2295.3.2.179
   Vartanian AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1044, DOI 10.1134/S000629791209012X
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
   Zhao N, 2012, MED ONCOL, V29, P3599, DOI 10.1007/s12032-012-0245-5
NR 37
TC 6
Z9 7
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
EI 1095-9319
J9 MICROVASC RES
JI Microvasc. Res.
PD MAY
PY 2015
VL 99
BP 26
EP 35
DI 10.1016/j.mvr.2015.02.005
PG 10
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA CI0IL
UT WOS:000354420200004
PM 25711526
OA Green Accepted
DA 2018-10-19
ER

PT J
AU An, SF
   Gao, Y
   Huang, XY
   Ling, JQ
   Liu, ZH
   Xiao, Y
AF An, Shaofeng
   Gao, Yan
   Huang, Xiangya
   Ling, Junqi
   Liu, Zhaohui
   Xiao, Yin
TI A comparative study of the proliferation and osteogenic differentiation
   of human periodontal ligament cells cultured on beta-TCP ceramics and
   demineralized bone matrix with or without osteogenic inducers in vitro
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE human periodontal ligament cells; osteogenic differentiation; tricalcium
   phosphate; demineralized bone matrix
ID MARROW STROMAL CELLS; TRICALCIUM PHOSPHATE; MORPHOGENETIC PROTEINS;
   GRAFT SUBSTITUTES; CALCIUM; REGENERATION; BIOCERAMICS; REPAIR;
   MINERALIZATION; BIOMATERIAL
AB The repair of bone defects that result from periodontal diseases remains a clinical challenge for periodontal therapy. beta-tricalcium phosphate (beta-TCP) ceramics are biodegradable inorganic bone substitutes with inorganic components that are similar to those of bone. Demineralized bone matrix (DBM) is an acid-extracted organic matrix derived from bone sources that consists of the collagen and matrix proteins of bone. A few studies have documented the effects of DBM on the proliferation and osteogenic differentiation of human periodontal ligament cells (hPDLCs). The aim of the present study was to investigate the effects of inorganic and organic elements of bone on the proliferation and osteogenic differentiation of hPDLCs using three-dimensional porous beta-TCP ceramics and DBM with or without osteogenic inducers. Primary hPDLCs were isolated from human periodontal ligaments. The proliferation of the hPDLCs on the scaffolds in the growth culture medium was examined using a Cell-Counting kit-8 (CCK-8) and scanning electron microscopy (SEM). Alkaline phosphatase (ALP) activity and the osteogenic differentiation of the hPDLCs cultured on the beta-TCP ceramics and DBM were examined in both the growth culture medium and osteogenic culture medium. Specific osteogenic differentiation markers were examined using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). SEM images revealed that the cells on the beta-TCP were spindle-shaped and much more spread out compared with the cells on the DBM surfaces. There were no significant differences observed in cell proliferation between the beta-TCP ceramics and the DBM scaffolds. Compared with the cells that were cultured on beta-TCP ceramics, the ALP activity, as well as the Runx2 and osteocalcin (OCN) mRNA levels in the hPDLCs cultured on DBM were significantly enhanced both in the growth culture medium and the osteogenic culture medium. The organic elements of bone may exhibit greater osteogenic differentiation effects on hPDLCs than the inorganic elements.
C1 [An, Shaofeng; Gao, Yan; Huang, Xiangya; Ling, Junqi; Liu, Zhaohui] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510055, Guangdong, Peoples R China.
   [An, Shaofeng; Gao, Yan; Huang, Xiangya; Ling, Junqi; Liu, Zhaohui] Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Guangdong, Peoples R China.
   [Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Ling, JQ (reprint author), Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, 56 Ling Yuan Xi Rd, Guangzhou 510055, Guangdong, Peoples R China.
EM lingjq@mail.sysu.edu.cn; yin.xiao@qut.edu.au
OI An, Shaofeng/0000-0002-5183-9530; Xiao, Yin/0000-0003-1785-3491
FU Guangdong Natural Science Foundation [S2012040007041]
FX This study was supported by the Guangdong Natural Science Foundation
   (grant no. S2012040007041).
CR An S, 2012, J PERIODONTAL RES, V47, P374, DOI 10.1111/j.1600-0765.2011.01443.x
   Anzai J, 2010, BIOCHEM BIOPH RES CO, V403, P345, DOI 10.1016/j.bbrc.2010.11.032
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Bernstein A, 2008, J BIOMED MATER RES B, V84B, P452, DOI 10.1002/jbm.b.30891
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Dori F, 2005, J PERIODONTOL, V76, P2236, DOI 10.1902/jop.2005.76.12.2236
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Elahi MM, 2004, J CRANIOFAC SURG, V15, P967, DOI 10.1097/00001665-200411000-00015
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   GUIZZARDI S, 1992, SPINE, V17, P701, DOI 10.1097/00007632-199206000-00010
   Hu ZM, 2011, J BIOMED MATER RES A, V98A, P473, DOI 10.1002/jbm.a.33119
   Hughes FJ, 2010, P I MECH ENG H, V224, P1345, DOI 10.1243/09544119JEIM820
   Ishikawa I, 2009, PERIODONTOL 2000, V51, P220, DOI 10.1111/j.1600-0757.2009.00312.x
   Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032
   Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Katz JM, 2009, J BIOMED MATER RES B, V89B, P127, DOI 10.1002/jbm.b.31195
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lin NH, 2009, PERIODONTOL 2000, V51, P239, DOI 10.1111/j.1600-0757.2009.00303.x
   Mahr MA, 2000, OPHTHALMIC PLAST REC, V16, P393, DOI 10.1097/00002341-200009000-00014
   Martin GJ, 1999, SPINE, V24, P637, DOI 10.1097/00007632-199904010-00005
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Miron RJ, 2013, J PERIODONTOL, V84, P1646, DOI 10.1902/jop.2013.120574
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Orimo H, 2008, MOL CELL BIOCHEM, V315, P51, DOI 10.1007/s11010-008-9788-3
   Papadopoulos CE, 2003, J PERIODONTOL, V74, P451, DOI 10.1902/jop.2003.74.4.451
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   Sandhu HS, 2001, EUR SPINE J, V10, pS122, DOI 10.1007/s005860100303
   Shayegan A, 2009, DENT TRAUMATOL, V25, P413, DOI 10.1111/j.1600-9657.2009.00799.x
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   Urist MR, 2002, CLIN ORTHOP RELAT R, P5
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 41
TC 3
Z9 4
U1 1
U2 19
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD MAY
PY 2015
VL 35
IS 5
BP 1341
EP 1346
DI 10.3892/ijmm.2015.2122
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CH2IQ
UT WOS:000353849300021
PM 25738431
OA Bronze
DA 2018-10-19
ER

PT J
AU Jambhekar, S
   Kernen, F
   Bidra, AS
AF Jambhekar, Shantanu
   Kernen, Florian
   Bidra, Avinash S.
TI Clinical and histologic outcomes of socket grafting after flapless tooth
   extraction: A systematic review of randomized controlled clinical trials
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Review
ID ALVEOLAR RIDGE PRESERVATION; DRIED BONE ALLOGRAFT; MAGNESIUM-ENRICHED
   HYDROXYAPATITE; PLATELET-RICH FIBRIN; HISTOMORPHOMETRIC EVALUATION;
   DIMENSIONAL CHANGES; CALCIUM-SULFATE; AESTHETIC ZONE; SINUS
   AUGMENTATION; COLLAGEN SPONGE
AB Statement of problem. Several biomaterials and techniques have been reported for socket grafting and alveolar ridge preservation. However, the evidence for clinical and histologic outcomes for socket grafting with different types of materials in flapless extraction is not clear.
   Purpose. The purpose of this systematic review was to analyze the outcomes of a socket grafting procedure performed with flapless extraction of teeth in order to determine which graft material results in the least loss of socket dimensions, the maximum amount of vital bone, the least remnant graft material, and the least amount of connective tissue after a minimum of 12 weeks of healing. Secondary outcomes, including the predictability of regenerating deficient buccal bone, necessity of barrier membranes, and coverage with autogenous soft tissue graft, were also evaluated.
   Material and methods. An electronic search for articles in the English-language literature was performed independently by multiple investigators using a systematic search process with the PubMed search engine. After applying predetermined inclusion and exclusion criteria, the final list of randomized controlled clinical trials (RCTs) for flapless extraction and socket grafting was analyzed to derive results for the various objectives of the study.
   Results. The initial electronic search resulted in 2898 titles. The systematic application of inclusion and exclusion criteria resulted in 32 RCTs studying 1354 sockets, which addressed the clinical and histologic outcomes of flapless extraction with socket grafting and provided dimensional and histologic information at or beyond the 12-week reentry period. From these RCTs, the mean loss of buccolingual width at the ridge crest was lowest for xenografts (1.3 mm), followed by allografts (1.63 mm), alloplasts (2.13 mm), and sockets without any socket grafting (2.79 mm). Only 3 studies reported on loss of width at 3 mm below the ridge crest. The mean loss of buccal wall height from the ridge crest was lowest for xenografts (0.57 mm) and allografts (0.58 mm), followed by alloplasts (0.77 mm) and sockets without any grafting (1.74 mm). The mean histologic outcomes at or beyond the 12-week reentry period revealed the highest vital bone content for sockets grafted with alloplasts (45.53%), followed by sockets with no graft material (41.07%), xenografts (35.72%), and allografts (29.93%). The amount of remnant graft material was highest for sockets grafted with allografts (21.75%), followed by xenografts (19.3%) and alloplasts (13.67%). The highest connective tissue content at the time of reentry was seen for sockets with no grafting (52.53%), followed by allografts (51.03%), xenografts (44.42%), and alloplast (38.39%). Data for new and emerging biomaterials such as cell therapy and tissue regenerative materials were not amenable to calculations because of biomaterial heterogeneity and small sample sizes.
   Conclusions. After flapless extraction of teeth, and using a minimum healing period of 12 weeks as a temporal measure, xenografts and allografts resulted in the least loss of socket dimensions compared to alloplasts or sockets with no grafting. Histologic outcomes after a minimum of 12 weeks of healing showed that sockets grafted with alloplasts had the maximum amount of vital bone and the least amount of remnant graft material and remnant connective tissue. There is a limited but emerging body of evidence for the predictable regeneration of deficient buccal bone with socket grafting materials, need for barrier membranes, use of tissue engineering, and use of autogenous soft tissue grafts from the palate to cover the socket.
C1 [Jambhekar, Shantanu] Terna Dent Coll Nerul, Bombay, Maharashtra, India.
   [Jambhekar, Shantanu; Kernen, Florian] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06030 USA.
   [Bidra, Avinash S.] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Postgrad Prosthodont, Farmington, CT 06030 USA.
RP Bidra, AS (reprint author), Univ Connecticut, Ctr Hlth, 263 Farmington Ave,L6078, Farmington, CT 06030 USA.
EM avinashbidra@yahoo.com
CR Aimetti M, 2009, INT J ORAL MAX IMPL, V24, P901
   Alkan EA, 2013, INT J ORAL MAX SURG, V42, P1522, DOI 10.1016/j.ijom.2013.06.002
   AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2014, CLIN ORAL IMPLAN RES, P1
   Avila-Ortiz G, 2014, J DENT RES, V93, P950, DOI 10.1177/0022034514541127
   Barone A., 2014, CLIN ORAL IMPLANTS R
   Barone A, 2014, CLIN ORAL IMPLANTS R
   Barone A, 2014, J PERIODONTOL, V85, P14, DOI 10.1902/jop.2013.120711
   Barone A, 2013, CLIN ORAL IMPLAN RES, V24, P1231, DOI 10.1111/j.1600-0501.2012.02535.x
   Bartee B K, 2001, J Oral Implantol, V27, P187, DOI 10.1563/1548-1336(2001)027<0187:ESRFAR>2.3.CO;2
   Bidra Avinash S, 2014, Dent Clin North Am, V58, P1, DOI 10.1016/j.cden.2013.09.001
   Brkovic BMB, 2012, CLIN ORAL INVEST, V16, P581, DOI 10.1007/s00784-011-0531-1
   Brownfield LA, 2012, J PERIODONTOL, V83, P581, DOI 10.1902/jop.2011.110365
   Calasans-Maia M, 2014, CLIN ORAL IMPLAN RES, V25, P1125, DOI 10.1111/clr.12237
   Cardaropoli D, 2008, INT J PERIODONT REST, V28, P469
   Cardaropoli D, 2012, INT J PERIODONT REST, V32, P421
   Chan HL, 2013, INT J ORAL MAX IMPL, V28, P710, DOI 10.11607/jomi.2913
   Chappuis V, 2013, J DENT RES, V92, p195S, DOI 10.1177/0022034513506713
   Checchi V, 2011, INT J ORAL MAX SURG, V40, P526, DOI 10.1016/j.ijom.2010.12.005
   Coomes AM, 2014, J PERIODONTOL, V85, P525, DOI 10.1902/jop.2013.130207
   Crespi R, 2014, INT J ORAL MAX IMPL, V29, P699, DOI 10.11607/jomi.3535
   Crespi R, 2011, INT J ORAL MAX IMPL, V26, P1057
   Crespi R, 2011, INT J ORAL MAX IMPL, V26, P866
   Crespi R, 2009, J PERIODONTOL, V80, P210, DOI [10.1902/jop.2009.080400, 10.1902/jop.2009.080400 ]
   Darby I, 2009, INT J ORAL MAX IMPL, V24, P260
   Engler-Hamm D, 2011, J PERIODONTOL, V82, P377, DOI 10.1902/jop.2010.090342
   Eskow AJ, 2014, J PERIODONTOL, V85, P514, DOI 10.1902/jop.2013.130178
   EVIAN CI, 1982, J PERIODONTOL, V53, P81, DOI 10.1902/jop.1982.53.2.81
   Fernandes PG, 2011, J PERIODONTOL, V82, P72, DOI 10.1902/jop.2010.100241
   Festa VM, 2013, CLIN IMPLANT DENT R, V15, P707, DOI 10.1111/j.1708-8208.2011.00398.x
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P906, DOI 10.1111/j.1600-051X.2008.01305.x
   Fotek PD, 2009, J PERIODONTOL, V80, P776, DOI 10.1902/jop.2009.080514
   Geurs N, 2014, INT J ORAL MAX IMPL, V29, P485, DOI 10.11607/jomi.3408
   Hammerle CHF, 2012, CLIN ORAL IMPLAN RES, V23, P80, DOI 10.1111/j.1600-0501.2011.02370.x
   Hanser T, 2014, INT J PERIODONT REST, V34, P305, DOI 10.11607/prd.1749
   Hauser F, 2013, IMPLANT DENT, V22, P295, DOI 10.1097/ID.0b013e3182906eb3
   Heberer S, 2012, CLIN ORAL IMPLAN RES, V23, P19, DOI 10.1111/j.1600-0501.2010.02148.x
   Heberer S, 2011, INT J ORAL MAX IMPL, V26, P385
   Hoang TN, 2012, J PERIODONTOL, V83, P174, DOI 10.1902/jop.2011.110209
   Horowitz Robert, 2012, J Evid Based Dent Pract, V12, P149, DOI 10.1016/S1532-3382(12)70029-5
   Horvath A, 2013, CLIN ORAL INVEST, V17, P341, DOI 10.1007/s00784-012-0758-5
   Huh JB, 2011, J ADV PROSTHODONT, V3, P161, DOI 10.4047/jap.2011.3.3.161
   Jung RE, 2013, J CLIN PERIODONTOL, V40, P90, DOI 10.1111/jcpe.12027
   Kassim B, 2014, AUST DENT J, V59, P48, DOI 10.1111/adj.12098
   Kim YK, 2011, IMPLANT DENT, V20, P267, DOI 10.1097/ID.0b013e3182166afc
   Kutkut A, 2012, J PERIODONTOL, V83, P401, DOI 10.1902/jop.2011.110237
   Laney WR, 2007, GLOSSARY ORAL MAXILL, p[4, 175]
   Lekovic V, 1998, J PERIODONTOL, V69, P1044, DOI 10.1902/jop.1998.69.9.1044
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Lindhe J, 2014, CLIN ORAL IMPLAN RES, V25, P786, DOI 10.1111/clr.12170
   Mah J, 2004, EUR J ORTHODONT, V26, P475, DOI 10.1093/ejo/26.5.475
   MAHESH L, 2013, J ORAL IMPLANTOL
   Moghaddas Hamid, 2012, Dent Res J (Isfahan), V9, P758
   Morjaria KR, 2014, CLIN IMPLANT DENT R, V16, P1, DOI 10.1111/j.1708-8208.2012.00450.x
   Nahles S, 2013, CLIN ORAL IMPLAN RES, V24, P812, DOI 10.1111/j.1600-0501.2012.02462.x
   Neiva R, 2011, INT J PERIODONT REST, V31, P457
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Oghli AA, 2010, QUINTESSENCE INT, V41, P605
   Orgeas GV, 2013, INT J ORAL MAX IMPL, V28, P1049, DOI 10.11607/jomi.2670
   Pelegrine AA, 2010, CLIN ORAL IMPLAN RES, V21, P535, DOI 10.1111/j.1600-0501.2009.01891.x
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Rasperini G, 2010, INT J PERIODONT REST, V30, P265
   Sbordone L, 2011, CLIN ORAL IMPLAN RES, V22, P485, DOI 10.1111/j.1600-0501.2010.02030.x
   Schneider D, 2014, J CLIN PERIODONTOL, V41, P612, DOI 10.1111/jcpe.12246
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Sclar AG, 2004, J ORAL MAXIL SURG, V62, P90, DOI 10.1016/j.joms.2004.06.041
   Shakibaie B, 2013, INT J PERIODONT REST, V33, P223, DOI 10.11607/prd.0734
   Sisti A, 2012, CLIN ORAL IMPLAN RES, V23, P526, DOI 10.1111/j.1600-0501.2011.02386.x
   Smukler H, 1999, INT J ORAL MAX IMPL, V14, P407
   Suttapreyasri S, 2013, J CRANIOFAC SURG, V24, P1088, DOI 10.1097/SCS.0b013e31828b6dc3
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Tarnow DP, 2014, INT J PERIODONT REST, V34, P323, DOI 10.11607/prd.1821
   Tarnow DP, 1996, PERIODONTOL 2000, V11, P85, DOI 10.1111/j.1600-0757.1996.tb00186.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Thalmair T, 2013, J CLIN PERIODONTOL, V40, P721, DOI 10.1111/jcpe.12111
   Toloue SM, 2012, J PERIODONTOL, V83, P847, DOI 10.1902/jop.2011.110470
   Tomlin Elizabeth M, 2014, Open Dent J, V8, P66, DOI 10.2174/1874210601408010066
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x
   Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Weng D, 2011, EUR J ORAL IMPLANTOL, V4, P59
   Wood RA, 2012, J PERIODONTOL, V83, P329, DOI 10.1902/jop.2011.110270
NR 84
TC 26
Z9 27
U1 0
U2 23
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3913
EI 1097-6841
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD MAY
PY 2015
VL 113
IS 5
BP 371
EP 382
DI 10.1016/j.prosdent.2014.12.009
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CH9GM
UT WOS:000354344000004
PM 25749077
DA 2018-10-19
ER

PT J
AU Wu, QQ
   Gong, P
   Wang, TL
   Gong, T
   Man, Y
AF Wu, Qingqing
   Gong, Ping
   Wang, Tianlu
   Gong, Ting
   Man, Yi
TI Evaluation of the efficacy of keratinized mucosa augmentation techniques
   around dental implants: A systematic review
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Review
ID CONNECTIVE-TISSUE GRAFT; INCREASED ATTACHED GINGIVA; DERMAL MATRIX
   ALLOGRAFTS; IMMEDIATE IMPLANT; MUCOGINGIVAL SURGERY; PERIODONTAL
   APPLICATIONS; LONGITUDINAL EVALUATION; CLINICAL-EVALUATION; SUBMERGED
   IMPLANTS; AESTHETIC OUTCOMES
AB Statement of problem. The absence of periimplant keratinized mucosa is considered risky in patients with a predisposition to periodontitis or recession. Although various soft tissue augmentation techniques exist, dentists are seeking for more efficient approaches to augment periimplant keratinized mucosa.
   Purpose. The purpose of this systematic review was to evaluate the efficacy of the various techniques and biomaterials adopted in periimplant keratinized mucosa augmentation and whether one technique or biomaterial is superior.
   Material and methods. A search in Medline-PubMed and the Cochrane Central Register of controlled trials was conducted. Randomized clinical trials, prospective cohort studies, clinical control studies, and case series from January 1, 1980, to December 31, 2013, with a follow-up of at least 6 months reporting changes on keratinized mucosa width were included. Several Journals were hand-searched for related articles. The bibliographies of all publications selected for inclusion were also scanned.
   Results. The screening of titles and abstracts resulted in 60 relevant publications. Six of them were finally included. Free gingival graft, connective tissue graft, acellular dermal matrix, and collagen matrix were used for keratinized mucosa augmentation. Because of heterogeneity of the studies, only descriptive analysis was performed. Improvements in keratinized mucosa width were reported in all studies.
   Conclusions. A definitive conclusion could not be achieved owing to the lack of well-designed studies and appropriate methods of studying soft tissue. The establishment of universal surgical guidelines and measurement systems is imperative in the future.
C1 [Wu, Qingqing; Wang, Tianlu; Gong, Ting] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Wu, Qingqing; Wang, Tianlu; Gong, Ting] Sichuan Univ, Dept Oral Implantol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Gong, Ping; Man, Yi] Sichuan Univ, Dept Prosthodont, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.
   [Gong, Ping] Sichuan Univ, Dept Oral Implantol, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.
RP Man, Y (reprint author), 14,3rd Sect Renmin Nan Rd, Chengdu 610041, Sichuan, Peoples R China.
EM manyi780203@gmail.com
FU National Key Clinical Speciality on Oral Implantology; National Science
   Foundation [81101347]; ITI small grant [2009660]
FX Supported by National Key Clinical Speciality on Oral Implantology,
   National Science Foundation (81101347) and an ITI small grant (2009660).
CR Allen Edward P, 2006, Dent Today, V25, P50
   Barone R, 1998, INT J PERIODONT REST, V18, P377
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Bianchi AE, 2004, CLIN ORAL IMPLAN RES, V15, P269, DOI 10.1111/j.1600-0501.2004.01020.x
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BRANEMARK PI, 1977, SCAND J PLAST RECONS, P7
   Branemark PI, 1985, INTRO OSSEOINTEGRATI
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P163, DOI 10.1111/j.1600-051X.2008.01266.x
   Camargo PM, 2001, PERIODONTOL 2000, V27, P72, DOI 10.1034/j.1600-0757.2001.027001072.x
   Caneva M, 2013, CLIN ORAL IMPLAN RES, V24, P50, DOI 10.1111/j.1600-0501.2012.02450.x
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P186
   Covani U, 2007, J PERIODONTOL, V78, P1644, DOI 10.1902/jop.2007.060461
   DORFMAN HS, 1980, J CLIN PERIODONTOL, V7, P316, DOI 10.1111/j.1600-051X.1980.tb01974.x
   Edel A, 1974, J Clin Periodontol, V1, P185, DOI 10.1111/j.1600-051X.1974.tb01257.x
   ERICSSON I, 1984, J CLIN PERIODONTOL, V11, P95, DOI 10.1111/j.1600-051X.1984.tb00837.x
   Esposito M, 2001, INT J ORAL MAX IMPL, V16, P783
   Esposito M, 2007, COCHRANE DB SYST REV, V18
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   FRIEDMAN N, 1962, J PERIODONTOL, V33, P328, DOI 10.1902/jop.1962.33.4.328
   Greenstein G, 2011, COMPEND CONTIN ED DE, V32, P32
   Griffin TJ, 2006, J PERIODONTOL, V77, P2070, DOI 10.1092/jop.2006.050296
   HAN TJ, 1995, INT J PERIODONT REST, V15, P405
   Higgins J, 2011, COCHRANE HDB SYSTEMA
   Hoelscher D C, 1996, J Mich Dent Assoc, V78, P56
   KARRING T, 1975, J PERIODONTOL, V46, P577, DOI 10.1902/jop.1975.46.10.577
   Keceli HG, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2007.01181.x
   KENNEDY JE, 1985, J CLIN PERIODONTOL, V12, P667, DOI 10.1111/j.1600-051X.1985.tb00938.x
   Khoury F, 2000, QUINTESSENCE INT, V31, P483
   LANG NP, 1972, J PERIODONTOL, V43, P623, DOI 10.1902/jop.1972.43.10.623
   Lee YM, 2012, INT J PERIODONT REST, V32, P213
   Lindhe J, 1998, PERIODONTOL 2000, V17, P47, DOI 10.1111/j.1600-0757.1998.tb00122.x
   Lorenzo R, 2012, CLIN ORAL IMPLAN RES, V23, P316, DOI 10.1111/j.1600-0501.2011.02260.x
   Maksoud Mohamed A, 2003, J Oral Implantol, V29, P120, DOI 10.1563/1548-1336(2003)029<0120:MOTPIT>2.3.CO;2
   McGuire MK, 2005, J PERIODONTOL, V76, P867, DOI 10.1902/jop.2005.76.6.867
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x
   Nemcovsky CE, 2002, INT J PERIODONT REST, V22, P607
   Nemcovsky CE, 1999, INT J PERIODONT REST, V19, P387
   Orsini M, 2004, J PERIODONTOL, V75, P470, DOI 10.1902/jop.2004.75.3.470
   Park Jun-Beom, 2006, Implant Dent, V15, P275, DOI 10.1097/01.id.0000227078.70869.20
   Prato GP, 1995, PERIODONTOL 2000, V9, P90, DOI 10.1111/j.1600-0757.1995.tb00058.x
   Quirynen M, 1991, CLIN ORAL IMPLAN RES, V2, P186, DOI 10.1034/j.1600-0501.1991.020405.x
   Rapley J W, 1992, Int J Periodontics Restorative Dent, V12, P373
   Rhee PH, 1998, ARCH OTOLARYNGOL, V124, P1201, DOI 10.1001/archotol.124.11.1201
   Roccuzzo M, 2002, J CLIN PERIODONTOL, V29, P178, DOI 10.1034/j.1600-051X.29.s3.11.x
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   Schrott AR, 2009, CLIN ORAL IMPLAN RES, V20, P1170, DOI 10.1111/j.1600-0501.2009.01795.x
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Seibert J S, 1983, Compend Contin Educ Dent, V4, P437
   Silverstein L H, 1994, Implant Dent, V3, P231, DOI 10.1097/00008505-199412000-00003
   Simons A M, 1994, Implant Dent, V3, P235, DOI 10.1097/00008505-199412000-00004
   Simons A M, 1993, Implant Dent, V2, P27, DOI 10.1097/00008505-199304000-00006
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   SULLIVAN HC, 1969, DENT CLIN N AM, V13, P133
   Ten Cate A, 1985, GINGIVAL JUNCTION TI, P145
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   TENBRUGGENKATE CM, 1991, ORAL SURG ORAL MED O, V72, P154, DOI 10.1016/0030-4220(91)90155-6
   von Elm E, 2007, ANN INTERN MED, V147, P573, DOI [10.1016/j.ypmed.2007.08.012, 10.7326/0003-4819-147-8-200710160-00010]
   WARRER K, 1995, CLIN ORAL IMPLAN RES, V6, P131, DOI 10.1034/j.1600-0501.1995.060301.x
   Wei PC, 2002, J PERIODONTOL, V73, P257, DOI 10.1902/jop.2002.73.3.257
   Wei PC, 2000, J PERIODONTOL, V71, P1297, DOI 10.1902/jop.2000.71.8.1297
   Wilson TG, 2005, J PERIODONTOL, V76, P881, DOI 10.1902/jop.2005.76.6.881
   Yan JJ, 2006, INT J PERIODONT REST, V26, P287
   Yilmaz S, 1994, J Marmara Univ Dent Fac, V2, P383
   YUKNA RA, 1978, J PERIODONTAL RES, V13, P177, DOI 10.1111/j.1600-0765.1978.tb00167.x
   Zigdon H, 2008, CLIN ORAL IMPLAN RES, V19, P387, DOI 10.1111/j.1600-0501.2007.01492.x
   Zitzmann NU, 2001, J CLIN PERIODONTOL, V28, P517, DOI 10.1034/j.1600-051x.2001.028006517.x
NR 71
TC 4
Z9 6
U1 4
U2 28
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3913
EI 1097-6841
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD MAY
PY 2015
VL 113
IS 5
BP 383
EP 390
DI 10.1016/j.prosdent.2014.10.001
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CH9GM
UT WOS:000354344000005
PM 25681355
DA 2018-10-19
ER

PT J
AU Shah, SV
   Chakravarthy, D
AF Shah, Shishir V.
   Chakravarthy, Debashish
TI Evaluation of a Bovine 100% Native Collagen for the Treatment of Chronic
   Wounds A Case Series
SO JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING
LA English
DT Article
DE Bovine; Chronic wounds; Collagen; Decubitus ulcers; Diabetic ulcers;
   Microscaffold; Native; Nonhealing wounds; Pressure ulcers; Vasculitis;
   Venous ulcers; Wound closure
ID FIBROBLASTS; MECHANISMS; DISEASE
AB PURPOSE: The roles of debridement, infection control, and moisture balance in wound healing are familiar to wound care clinicians, but these measures may not be sufficient for wound closure in all patients. In these cases, adjuvant therapies such as collagen dressings may be needed. Collagen dressings are thought to encourage wound healing by laying down a provisional biomaterial matrix that captures wound exudates because of its absorbent nature, and thus creates an environment necessary for healing. This case series describes our experience with a bovine-derived, 100% native, type I collagen in patients with chronic and persistent wounds.
   CASES: This case series included 20 patients with 21 chronic wounds ranging from 0.6 to 101.4 cm(2) that had been recalcitrant to prior conservative treatment and/or the use of submucosal intestinal matrix, oxidized regenerated cellulose/collagen matrix, or skin substitute. In addition to the bovine-derived 100% native collagen, standard wound care included the use of any systemic or topical antimicrobial treatments needed to specifically address wound infections. The total duration of treatment with the bovine-derived 100% native collagen was up to 12 weeks. Complete wound healing was achieved for 15 of the patients in this series; wound healing times varied from 13 to 68 days. Two additional patients achieved wound healing, using a combination of the bovine-derived 100% native collagen and other therapies, at 114 days and 107 days, respectively, after starting the wound healing process with solely the bovine-derived 100% native collagen treatment. One patient did not respond to treatment. The collagen treatment was well tolerated by the patients, with 3 incidences of dermatitis that resolved after treatment with corticosteroids.
   CONCLUSION: Following a change in their chronic wound care regimen to include a bovine-derived, 100% native, type I collagen, we achieved an 83.3% (15 out of 18 patients) wound closure rate. Two patients were excluded from the data set analysis because they received additional intervention outside the parameters described in this multiple-case series.
C1 [Shah, Shishir V.] St Josephs Hosp Wound Ctr, Phoenix, AZ USA.
   [Chakravarthy, Debashish] Medline Ind Inc, Mundelein, IL USA.
RP Shah, SV (reprint author), 15029 N Thompson Pk,Ste B111-611, Scottsdale, AZ 85260 USA.
EM woundexpert@gmail.com
FU Medline Industries (Mundelein, Illinois)
FX Medline Industries (Mundelein, Illinois) contributed funding for this
   case series and publication assistance. Editorial assistance in
   preparing this manuscript was provided by Magellan Medical Technology
   Consultants, Inc (Minneapolis, Minnesota). This article was adapted from
   a poster presentation at the Symposium of Advanced Wound Care, April
   2008, San Diego, California. At this conference, the lead author
   received reimbursement of costs associated with the poster presentation
   from Medline Industries.
CR Ayello EA, 2003, WOUND CARE ESSENTIAL, P138
   Baum CL, 2005, DERMATOL SURG, V31, P674
   Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289
   CALLAM M, 1992, PHLEBOLOGY S1, V7, pS6
   Clerici G, 2010, INT WOUND J, V7, P176, DOI 10.1111/j.1742-481X.2010.00670.x
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   FALANGA V, 1993, J INVEST DERMATOL, V100, P721, DOI 10.1111/1523-1747.ep12472373
   Fleischli JG, 2009, J AM PODIAT MED ASSN, V99, P301, DOI 10.7547/0980301
   Fowler E, 1990, CHRONIC WOUND CARE C, P12
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Hansen SL, 2003, WOUND REPAIR REGEN, V11, P474, DOI 10.1046/j.1524-475X.2003.11615.x
   Herrick SE, 1996, J INVEST DERMATOL, V106, P187, DOI 10.1111/1523-1747.ep12329920
   Lazaro-Martinez JL, 2010, OSTOMY WOUND MA S11A, V56, pS4
   Nelzen O, 1996, BRIT J SURG, V83, P255, DOI 10.1002/bjs.1800830235
   Rees RS, 1999, ADV WOUND CARE, V12, P4
   Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Singh Aparajita, 2004, Asian J Surg, V27, P326, DOI 10.1016/S1015-9584(09)60061-0
   Snyder RJ, 2010, OSTOMY WOUND MA S11A, V56, pS9
   Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200
   Walmsley S, 2002, CLIN REPORTS
   Woo K, 2007, ADV SKIN WOUND CARE, V20, P99
   Yager DR, 1999, WOUND REPAIR REGEN, V7, P433, DOI 10.1046/j.1524-475X.1999.00433.x
NR 23
TC 2
Z9 2
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1071-5754
EI 1528-3976
J9 J WOUND OSTOMY CONT
JI J. Wound Ostomy Cont. Nurs.
PD MAY-JUN
PY 2015
VL 42
IS 3
BP 226
EP 234
DI 10.1097/WON.0000000000000124
PG 9
WC Nursing
SC Nursing
GA CH7LK
UT WOS:000354217700003
PM 25945821
DA 2018-10-19
ER

PT J
AU Hashim, N
   Yusoh, K
AF Hashim, Norazlina
   Yusoh, Kamal
TI Supercritical carbon dioxide-assisted process in synthesis of
   polymer/clay melt
SO MACROMOLECULAR RESEARCH
LA English
DT Review
DE supercritical carbon dioxide; melt processing; clay nanocomposites;
   nanofiller dispersion; foaming
ID SOLUTION-ENHANCED DISPERSION; SOLVENT-EXTRACTION SYSTEM; RAPID
   EXPANSION; ANTISOLVENT PRECIPITATION; BIODIESEL PRODUCTION;
   NANOCOMPOSITE FOAMS; SEDS TECHNIQUE; ASES PROCESS; SILICATE
   NANOCOMPOSITES; PARTICLE FORMATION
AB Nanocomposites are currently being used in a number of fields, and new applications are continuously being developed including mechanical and biomaterial devices, as well as various in solar and fuel cells applications. Generally, the synthesis of polymer nanocomposites are done using solution chemistry, and this may raise serious concerns regarding air and water pollutions. Immediately, the 'green' method using supercritical carbon dioxide (scCO(2)) has grabbed the attention of researchers who are responsible to synthesize polymer composites by non-hazardous routes. Extrusion processes would benefit from the use of scCO(2) since the rationale of the extrusion process is to formulate, provide texture and shape molten polymers by forcing them through a die. ScCO2 has been used in several studies as a medium of clay dispersion in polymer matrix by providing a solvent-free fabrication route for nanocomposites. Furthermore, it has more favorable interactions with polymers compared to other inert gases and has the ability to be dissolve in large quantities. It acts as a plasticizer, which modifies viscosity and interfacial properties of the polymer drastically. In this paper, experimental and theoretical studies of solubility and viscosity of several polymer melts in clay are discussed in detail. The assistance of scCO(2) in clay dispersion and as a foaming agent has been reviewed extensively.
C1 [Hashim, Norazlina] TATI Univ Coll, Fac Chem Engn Technol, Kemaman 24000, Terengganu, Malaysia.
   [Yusoh, Kamal] Univ Malaysia Pahang, Fac Chem & Nat Resources Engn, Gambang 26300, Pahang, Malaysia.
RP Hashim, N (reprint author), TATI Univ Coll, Fac Chem Engn Technol, Kemaman 24000, Terengganu, Malaysia.
EM norazlinatatiuc@gmail.com
RI Yusoh, Kamal/L-8761-2018
OI Yusoh, Kamal/0000-0003-2663-344X
CR Adachi H, 2009, J SUPERCRIT FLUID, V49, P265, DOI 10.1016/j.supflu.2008.12.010
   Aguiar AC, 2012, J SUPERCRIT FLUID, V71, P1, DOI 10.1016/j.supflu.2012.07.005
   Amiguet VT, 2012, FOOD CHEM, V130, P853, DOI 10.1016/j.foodchem.2011.07.098
   ARANDA P, 1992, CHEM MATER, V4, P1395, DOI 10.1021/cm00024a048
   Baker KC, 2011, ACTA BIOMATER, V7, P3382, DOI 10.1016/j.actbio.2011.05.014
   Bakhbakhi Y, 2013, EUR J PHARM SCI, V48, P30, DOI 10.1016/j.ejps.2012.10.013
   Baldwin DF, 1996, POLYM ENG SCI, V36, P1437, DOI 10.1002/pen.10538
   Baldwin DF, 1996, POLYM ENG SCI, V36, P1446, DOI 10.1002/pen.10539
   Balsiger C, 2005, CHEMOSPHERE, V61, P361, DOI 10.1016/j.chemosphere.2005.02.087
   Bernardo-Gil MG, 2007, J SUPERCRIT FLUID, V40, P344, DOI 10.1016/j.supflu.2006.07.026
   Bhatti HN, 2008, FUEL, V87, P2961, DOI 10.1016/j.fuel.2008.04.016
   Bilotti E, 2008, J APPL POLYM SCI, V107, P1116, DOI 10.1002/app.25395
   Blasig A, 2002, IND ENG CHEM RES, V41, P4976, DOI 10.1021/ie0201819
   BLEICH J, 1993, INT J PHARM, V97, P111, DOI 10.1016/0378-5173(93)90131-X
   BLEICH J, 1994, INT J PHARM, V106, P77, DOI 10.1016/0378-5173(94)90278-X
   Bordes P, 2009, POLYM DEGRAD STABIL, V94, P789, DOI 10.1016/j.polymdegradstab.2009.01.027
   Boschetto DL, 2013, IND CROP PROD, V50, P352, DOI 10.1016/j.indcrop.2013.07.044
   Brion M, 2009, J SUPERCRIT FLUID, V51, P50, DOI 10.1016/j.supflu.2009.06.021
   Broekaert C, 2007, EUR POLYM J, V43, P4160, DOI 10.1016/j.eurpolymj.2007.08.003
   Byrappa K, 2008, ADV DRUG DELIVER REV, V60, P299, DOI 10.1016/j.addr.2007.09.001
   Cabedo L, 2009, J APPL POLYM SCI, V112, P3669, DOI 10.1002/app.29945
   Cao K, 2010, CHEM ENG SCI, V65, P1621, DOI 10.1016/j.ces.2009.11.004
   Cardoso LC, 2013, MOLECULES, V18, P3137, DOI 10.3390/molecules18033137
   Castro-Vargas HI, 2013, J SUPERCRIT FLUID, V76, P17, DOI 10.1016/j.supflu.2012.10.006
   Chang SC, 2007, J SUPERCRIT FLUID, V40, P420, DOI 10.1016/j.supflu.2006.07.025
   Chen AZ, 2012, J SUPERCRIT FLUID, V67, P7, DOI 10.1016/j.supflu.2012.03.004
   Chen AZ, 2009, J SUPERCRIT FLUID, V49, P394, DOI 10.1016/j.supflu.2009.02.004
   Chen C, 2012, POLYMER, V53, P1373, DOI 10.1016/j.polymer.2012.01.049
   Chen JE, 2013, J SUPERCRIT FLUID, V77, P33, DOI 10.1016/j.supflu.2013.02.007
   Chen KX, 2005, POWDER TECHNOL, V152, P127, DOI 10.1016/j.powtec.2005.01.009
   Chernyak Y, 2001, IND ENG CHEM RES, V40, P6118, DOI 10.1021/ie010267m
   Chong GH, 2011, J SUPERCRIT FLUID, V60, P69, DOI 10.1016/j.supflu.2011.04.020
   COLTON JS, 1987, POLYM ENG SCI, V27, P500, DOI 10.1002/pen.760270704
   da Silva MS, 2012, CHEM ENG SCI, V68, P94, DOI 10.1016/j.ces.2011.09.015
   de Paz E, 2012, J SUPERCRIT FLUID, V72, P125, DOI 10.1016/j.supflu.2012.08.007
   Di YW, 2005, MACROMOL MATER ENG, V290, P1083, DOI 10.1002/mame.200500115
   Dong ZX, 2004, J SUPERCRIT FLUID, V31, P67, DOI 10.1016/j.supflu.2003.09.020
   Doroudiani S, 1996, POLYM ENG SCI, V36, P2645, DOI 10.1002/pen.10664
   Drobek M, 2013, J MEMBRANE SCI, V429, P428, DOI 10.1016/j.memsci.2012.11.058
   Ekinci MS, 2014, J SUPERCRIT FLUID, V92, P319, DOI 10.1016/j.supflu.2014.06.004
   Elizondo E, 2010, J SUPERCRIT FLUID, V53, P108, DOI 10.1016/j.supflu.2010.02.018
   Engwicht A, 1999, INT J PHARM, V185, P61, DOI 10.1016/S0378-5173(99)00127-1
   Farias-Campomanes AM, 2013, J SUPERCRIT FLUID, V77, P70, DOI 10.1016/j.supflu.2013.02.006
   Foster N, 2003, IND ENG CHEM RES, V42, P6476, DOI 10.1021/ie030219x
   Fraile M, 2013, J SUPERCRIT FLUID, V81, P226, DOI 10.1016/j.supflu.2013.06.010
   Franceschi E, 2009, J FOOD ENG, V95, P656, DOI 10.1016/j.jfoodeng.2009.06.034
   Franceschi E, 2008, J SUPERCRIT FLUID, V47, P259, DOI 10.1016/j.supflu.2008.08.002
   Fujimoto Y, 2003, MACROMOL RAPID COMM, V24, P457, DOI 10.1002/marc.200390068
   Ganapathy HS, 2007, EUR POLYM J, V43, P119, DOI 10.1016/j.eurpolymj.2006.10.009
   Garcia-Gonzalez CA, 2009, ACTA BIOMATER, V5, P1094, DOI 10.1016/j.actbio.2008.10.018
   Garcia-Leiner M., 2003, ANTEC C P, V2, P1528
   GOEL SK, 1994, POLYM ENG SCI, V34, P1137, DOI 10.1002/pen.760341407
   Gogolewski S., 1993, POLYM DEGRAD STABIL, V40, P13
   Goren K, 2012, J SUPERCRIT FLUID, V67, P108, DOI 10.1016/j.supflu.2012.03.013
   Hakuta Y, 2003, CURR OPIN SOLID ST M, V7, P341, DOI 10.1016/j.cossms.2003.12.005
   Haldorai Y, 2012, J SUPERCRIT FLUID, V71, P45, DOI 10.1016/j.supflu.2012.07.007
   Han XM, 2003, POLYM ENG SCI, V43, P1261, DOI 10.1002/pen.10107
   Horsch S, 2006, POLYMER, V47, P7485, DOI 10.1016/j.polymer.2006.08.048
   Hu DD, 2012, J FOOD ENG, V109, P545, DOI 10.1016/j.jfoodeng.2011.10.025
   Hwang HS, 2007, J SUPERCRIT FLUID, V39, P409, DOI 10.1016/j.supflu.2006.02.011
   Jarmer DJ, 2003, J SUPERCRIT FLUID, V27, P317, DOI 10.1016/S0896-8446(02)00245-0
   Javadi A, 2012, J MATER RES, V27, P1506, DOI 10.1557/jmr.2012.74
   Jeong HH, 2008, J IND ENG CHEM, V14, P77, DOI 10.1016/j.jiec.2007.08.002
   Jiang XL, 2009, J SUPERCRIT FLUID, V48, P167, DOI 10.1016/j.supflu.2008.10.006
   Jin HY, 2012, POWDER TECHNOL, V227, P17, DOI 10.1016/j.powtec.2012.04.050
   Kang YQ, 2008, J COLLOID INTERF SCI, V322, P87, DOI 10.1016/j.jcis.2008.02.031
   Keshtkar M, 2014, POLYMER, V55, P4077, DOI 10.1016/j.polymer.2014.06.059
   Kikic I, 1998, IND ENG CHEM RES, V37, P1577, DOI 10.1021/ie980838j
   Kikuchi E, 2011, J CLEAN PROD, V19, P414, DOI 10.1016/j.jclepro.2010.05.021
   Kim KH, 2011, ATMOS ENVIRON, V45, P1369, DOI 10.1016/j.atmosenv.2010.12.029
   Kiran E, 2010, J SUPERCRIT FLUID, V54, P308, DOI 10.1016/j.supflu.2010.05.004
   Kongsombut B, 2009, IND ENG CHEM RES, V48, P11230, DOI 10.1021/ie900690v
   Kunastitchai S, 2006, INT J PHARM, V316, P93, DOI 10.1016/j.ijpharm.2006.02.051
   Kusdiana D, 2004, BIORESOURCE TECHNOL, V91, P289, DOI 10.1016/S0960-8524(03)00201-3
   Lay E. N., 2009, J CHEM ENG DATA, V55, P223
   Le Moigne N, 2014, EUR POLYM J, V61, P157, DOI 10.1016/j.eurpolymj.2014.10.008
   Lee KT, 2014, PROG ENERG COMBUST, V45, P54, DOI 10.1016/j.pecs.2014.07.001
   Lee ST, 2008, J CELL PLAST, V44, P293, DOI 10.1177/0021955X08088859
   Lee SM, 2008, MACROMOL RES, V16, P6, DOI 10.1007/BF03218954
   LELE AK, 1994, IND ENG CHEM RES, V33, P1476, DOI 10.1021/ie00030a007
   Lepoittevin B, 2003, POLYMER, V44, P2033, DOI 10.1016/S0032-3861(03)00076-4
   Li DC, 2011, J SUPERCRIT FLUID, V60, P89, DOI 10.1016/j.supflu.2011.07.015
   Li DC, 2011, IND ENG CHEM RES, V50, P1997, DOI 10.1021/ie101723g
   Lin IH, 2010, J SUPERCRIT FLUID, V51, P384, DOI 10.1016/j.supflu.2009.10.008
   Liu GT, 1996, IND ENG CHEM RES, V35, P4626, DOI 10.1021/ie960142v
   Liu T, 2005, IND ENG CHEM RES, V44, P4292, DOI 10.1021/ie0501428
   Liu W, 2013, J CELL PLAST, V49, P535, DOI 10.1177/0021955X13503845
   Liu WW, 2014, APPL SURF SCI, V292, P142, DOI 10.1016/j.apsusc.2013.11.102
   Liu ZM, 2002, CHEM MATER, V14, P4619, DOI 10.1021/cm0203215
   Liu ZM, 2002, POLYMER, V43, P1183, DOI 10.1016/S0032-3861(01)00703-0
   Lu HS, 2013, CHINESE J CHEM ENG, V21, P551, DOI 10.1016/S1004-9541(13)60508-X
   Ma J, 2007, EUR POLYM J, V43, P4931, DOI 10.1016/j.eurpolymj.2007.09.010
   Machado FRS, 2014, IND CROP PROD, V54, P17, DOI 10.1016/j.indcrop.2014.01.007
   Manke C. W., 2002, U. S. Patent, Patent No. [6,469,073, 6469073]
   Martin A, 2008, ADV DRUG DELIVER REV, V60, P339, DOI 10.1016/j.addr.2007.06.019
   Marulanda VF, 2010, J SUPERCRIT FLUID, V54, P53, DOI 10.1016/j.supflu.2010.04.001
   Mauricio MR, 2011, COMPOS PART A-APPL S, V42, P757, DOI 10.1016/j.compositesa.2011.03.002
   Mawson S, 1997, POLYMER, V38, P2957, DOI 10.1016/S0032-3861(96)00852-X
   Meziani MJ, 2005, IND ENG CHEM RES, V44, P4594, DOI 10.1021/ie048796o
   Mezzomo N, 2013, J SUPERCRIT FLUID, V74, P22, DOI 10.1016/j.supflu.2012.11.020
   Mezzomo N, 2012, J SUPERCRIT FLUID, V66, P342, DOI 10.1016/j.supflu.2011.08.006
   Mielewski D. F., 2004, INT GEOPHYS, Patent No. 6,753,360 B2
   Mielewski D.F., 2004, US Patent, Patent No. 6753360
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   Montes A., 2013, IND ENG CHEM RES, V53, P474
   Moribe K, 2009, INT J PHARMACEUT, V380, P201, DOI 10.1016/j.ijpharm.2009.06.030
   Muth O, 2000, J SUPERCRIT FLUID, V17, P65, DOI 10.1016/S0896-8446(99)00042-X
   Nalawade SP, 2006, PROG POLYM SCI, V31, P19, DOI 10.1016/j.progpolymsci.2005.08.002
   Nguyen QT, 2007, POLYMER, V48, P6923, DOI 10.1016/j.polymer.2007.09.015
   Niza NM, 2013, J SUPERCRIT FLUID, V79, P73, DOI 10.1016/j.supflu.2013.02.021
   Nofar M, 2012, J CELL PLAST, V48, P271, DOI 10.1177/0021955X12440271
   O'Connor P, 2012, EUR POLYM J, V48, P1279, DOI 10.1016/j.eurpolymj.2012.04.011
   Oh K. S., 2008, EUR POLYM J, V44, P415
   Okamoto H, 2008, ADV DRUG DELIVER REV, V60, P433, DOI 10.1016/j.addr.2007.02.002
   Omar J, 2013, FOOD ANAL METHOD, V6, P1244, DOI 10.1007/s12161-012-9536-x
   Park CB, 1996, POLYM ENG SCI, V36, P34, DOI 10.1002/pen.10382
   Park EJ, 2011, POLYMER, V52, P5403, DOI 10.1016/j.polymer.2011.09.038
   Park MW, 2012, CHEM ENG RES DES, V90, P2202, DOI 10.1016/j.cherd.2012.05.001
   Park SJ, 2008, J SUPERCRIT FLUID, V47, P85, DOI 10.1016/j.supflu.2008.05.010
   Pasquali I, 2008, INT J PHARMACEUT, V364, P176, DOI 10.1016/j.ijpharm.2008.05.014
   Reategui JLP, 2014, J SUPERCRIT FLUID, V94, P223, DOI 10.1016/j.supflu.2014.07.019
   Pereira VJ, 2013, J SUPERCRIT FLUID, V81, P128, DOI 10.1016/j.supflu.2013.05.010
   Pilla S, 2009, POLYM ENG SCI, V49, P1653, DOI 10.1002/pen.21385
   Plaza M, 2013, J AGR FOOD CHEM, V61, P5500, DOI 10.1021/jf400584f
   Pourmortazavi SM, 2005, IND ENG CHEM RES, V44, P6523, DOI 10.1021/ie0503242
   Prado JM, 2014, J SUPERCRIT FLUID, V86, P15, DOI 10.1016/j.supflu.2013.11.018
   Rajaei H, 2012, J SUPERCRIT FLUID, V67, P1, DOI 10.1016/j.supflu.2012.02.005
   Ramkumar DHS, 1998, POLYM ENG SCI, V38, P1426, DOI 10.1002/pen.10313
   Ratzsch M, 1996, J MACROMOL SCI PURE, VA33, P913, DOI 10.1080/10601329608014641
   Ray SS, 2003, MACROMOLECULES, V36, P2355, DOI 10.1021/ma021728y
   Reverchon E, 1999, J SUPERCRIT FLUID, V15, P1, DOI 10.1016/S0896-8446(98)00129-6
   Rizvi S. S. H., 1995, TRENDS FOOD SCI TECH, V6, P209
   Roseiro LB, 2013, IND CROP PROD, V47, P132, DOI 10.1016/j.indcrop.2013.02.026
   Rossmann M, 2012, J SUPERCRIT FLUID, V66, P350, DOI 10.1016/j.supflu.2011.11.023
   Saka S, 2001, FUEL, V80, P225, DOI 10.1016/S0016-2361(00)00083-1
   Salinas-Hernandez R., 2008, IND ENG CHEM RES, V48, P769
   Sane A, 2005, J PHYS CHEM B, V109, P19688, DOI 10.1021/jp0581072
   Santos DT, 2012, J FOOD ENG, V108, P444, DOI [10.1016/jjfoodeng.2011.08.022, 10.1016/j.jfoodeng.2011.08.022]
   Shariati A, 2003, CURR OPIN SOLID ST M, V7, P371, DOI 10.1016/j.cossms.2003.12.001
   Shekunov BY, 2001, CHEM ENG SCI, V56, P2421
   Shin HY, 2012, J SUPERCRIT FLUID, V61, P134, DOI 10.1016/j.supflu.2011.09.009
   STAHL E, 1980, J AGR FOOD CHEM, V28, P1153, DOI 10.1021/jf60232a023
   Steckel H, 2004, EUR J PHARM BIOPHARM, V57, P507, DOI 10.1016/j.ejph.2004.01.002
   Su FH, 2011, J SUPERCRIT FLUID, V56, P114, DOI 10.1016/j.supflu.2010.12.001
   Sun Y.-P., 1998, CHEM MATER, V11, P7
   Sun YP, 2000, IND ENG CHEM RES, V39, P4663, DOI 10.1021/ie000114j
   Suo QL, 2005, POWDER TECHNOL, V154, P110, DOI 10.1016/j.powtec.2005.05.001
   Suwito Supriyono, 2012, Frontiers of Chemical Science and Engineering, V6, P210, DOI 10.1007/s11705-012-1282-5
   Svoboda P, 2012, POLYM TEST, V31, P444, DOI 10.1016/j.polymertesting.2012.01.004
   Tabernero A, 2012, CHEM ENG PROCESS, V60, P9, DOI 10.1016/j.cep.2012.06.004
   Tabernero A, 2012, POWDER TECHNOL, V217, P177, DOI 10.1016/j.powtec.2011.10.025
   Thakur R, 2005, IND ENG CHEM RES, V44, P7380, DOI 10.1021/ie050417j
   Tomasko DL, 2003, CURR OPIN SOLID ST M, V7, P407, DOI 10.1016/j.cossms.2003.10.005
   Treece MA, 2007, J APPL POLYM SCI, V103, P884, DOI 10.1002/app.25226
   Tsimpliaraki A, 2013, J SUPERCRIT FLUID, V81, P86, DOI 10.1016/j.supflu.2013.05.003
   Tsimpliaraki A, 2011, J SUPERCRIT FLUID, V57, P278, DOI 10.1016/j.supflu.2011.03.010
   Tsivintzelis I, 2007, J SUPERCRIT FLUID, V42, P265, DOI 10.1016/j.supflu.2007.02.009
   Urbanczyk L, 2008, POLYMER, V49, P3979, DOI 10.1016/j.polymer.2008.06.052
   Urbanczyk L, 2009, EUR POLYM J, V45, P643, DOI 10.1016/j.eurpolymj.2008.11.033
   Van Ngo TT, 2010, POLYMER, V51, P3436, DOI 10.1016/j.polymer.2010.05.039
   Vasapollo G, 2004, J SUPERCRIT FLUID, V29, P87, DOI 10.1016/S0896-8446(03)00039-1
   Ventosa N, 2003, J SUPERCRIT FLUID, V26, P33, DOI 10.1016/S0896-8446(02)00189-4
   de Melo SABV, 2014, J SUPERCRIT FLUID, V93, P112, DOI 10.1016/j.supflu.2013.11.019
   Vigano J., 2014, J SUPERCRIT FLUID, V96, P272
   Wang YM, 2008, J SUPERCRIT FLUID, V44, P62, DOI 10.1016/j.supflu.2007.09.018
   Wang YS, 2007, EUR POLYM J, V43, P43, DOI 10.1016/j.eurpolymj.2006.09.007
   Wang Z, 2006, POLYMER, V47, P7670, DOI 10.1016/j.polymer.2006.09.011
   Wijngaard H, 2012, FOOD RES INT, V46, P505, DOI 10.1016/j.foodres.2011.09.027
   Wijngaard H, 2009, J AGR FOOD CHEM, V57, P10625, DOI 10.1021/jf902498y
   Wong A, 2007, IND ENG CHEM RES, V46, P7107, DOI 10.1021/ie070551z
   Wu K, 2008, J SUPERCRIT FLUID, V46, P211, DOI 10.1016/j.supflu.2008.02.007
   Xu LQ, 2014, IND ENG CHEM RES, V53, P2277, DOI 10.1021/ie403594t
   Yang JT, 2013, IND ENG CHEM RES, V52, P14169, DOI 10.1021/ie4018447
   Yang K, 2008, J SUPERCRIT FLUID, V43, P515, DOI 10.1016/j.supflu.2007.07.022
   Yeo SD, 2005, J SUPERCRIT FLUID, V34, P287, DOI 10.1016/j.supflu.2004.10.006
   Yu WL, 2008, CHINESE J CHEM ENG, V16, P956, DOI 10.1016/S1004-9541(09)60023-9
   Yun JH, 2012, APCBEE PROC, V2, P22, DOI 10.1016/j.apcbee.2012.06.005
   Yun JH, 2013, J IND ENG CHEM, V19, P686, DOI 10.1016/j.jiec.2012.10.005
   Yuvaraj H, 2008, EUR POLYM J, V44, P2253, DOI 10.1016/j.eurpolymj.2008.04.040
   Zhai WT, 2006, POLYMER, V47, P7580, DOI 10.1016/j.polymer.2006.08.034
   Zhai WT, 2010, IND ENG CHEM RES, V49, P9834, DOI 10.1021/ie101225f
   Zhang YZ, 2012, POWDER TECHNOL, V221, P343, DOI 10.1016/j.powtec.2012.01.023
   Zhao HB, 2013, COMPOS PART B-ENG, V51, P79, DOI 10.1016/j.compositesb.2013.02.034
   Zhao HB, 2013, IND ENG CHEM RES, V52, P2569, DOI 10.1021/ie301573y
NR 184
TC 2
Z9 2
U1 6
U2 58
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD MAY
PY 2015
VL 23
IS 5
BP 403
EP 417
DI 10.1007/s13233-015-3067-4
PG 15
WC Polymer Science
SC Polymer Science
GA CH9YV
UT WOS:000354393500001
DA 2018-10-19
ER

PT J
AU Domingues, JFD
   Roest, S
   Wang, Y
   van der Mei, HC
   Libera, M
   van Kooten, TG
   Busscher, HJ
AF Domingues, Joana F. da Silva
   Roest, Steven
   Wang, Yi
   van der Mei, Henny C.
   Libera, Matthew
   van Kooten, Theo G.
   Busscher, Henk J.
TI Macrophage phagocytic activity toward adhering staphylococci on cationic
   and patterned hydrogel coatings versus common biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterial-associated infection; Poly(ethylene)glycol coatings;
   Cationic coatings; Water contact angles; Phagocytosis
ID GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; TISSUE INTEGRATION; MICROBIAL
   ADHESION; BIOFILM FORMATION; J774 MACROPHAGES; STAINLESS-STEEL;
   CELL-ADHESION; NITRIC-OXIDE; SURFACES
AB Biomaterial-associated-infection causes failure of biomaterial implants. Many new biomaterials have been evaluated for their ability to inhibit bacterial colonization and stimulate tissue-cell-integration, but neglect the role of immune cells. This paper compares macrophage phagocytosis of adhering Staphylococcus aureus on cationic-coatings and patterned poly(ethylene)glycol-hydrogels versus common biomaterials and stainless steel in order to identify surface conditions that promote clearance of adhering bacteria. Staphylococci were allowed to adhere and grow on the materials in a parallel-plate-flow-chamber, after which murine macrophages were introduced. From the decrease in the number of adhering staphylococci, phagocytosis-rates were calculated, and total macrophage displacements during an experiment determined. Hydrophilic surfaces had the lowest phagocytosis-rates, while common biomaterials had intermediate phagocytosis-rates. Patterning of poly(ethylene)glycol-hydrogel coatings increased phagocytosis-rates to the level of common biomaterials, while on cationic-coatings phagocytosis-rates remained relatively low. Likely, phagocytosis-rates on cationic coatings are hampered relative to common biomaterials through strong electrostatic binding of negatively-charged macrophages and staphylococci. On polymeric biomaterials and glass, phagocytosis-rates increased with macrophage displacement, while both parameters increased with biomaterial surface hydrophobicity. Thus hydrophobicity is a necessary surface condition for effective phagocytosis. Concluding, next-generation biomaterials should account for surface effects on phagocytosis in order to enhance the ability of these materials to resist biomaterial-associated-infection. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Domingues, Joana F. da Silva; Roest, Steven; van der Mei, Henny C.; van Kooten, Theo G.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Wang, Yi; Libera, Matthew] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
RP van der Mei, HC (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1,FB-40, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
OI Wang, Yi/0000-0001-5495-5839
FU UMCG; U.S. Army Research Office [W911NF-12-1-0331]
FX This project was funded by the UMCG and partially supported by the U.S.
   Army Research Office via Grant #W911NF-12-1-0331.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686
   Bieser AM, 2011, MACROMOL BIOSCI, V11, P526, DOI 10.1002/mabi.201000398
   Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/nchembio.264, 10.1038/NCHEMBIO.264]
   Chiang WC, 2009, APPL ENVIRON MICROB, V75, P1674, DOI 10.1128/AEM.02274-08
   Costerton J, 2007, INT J ARTIF ORGANS, V30, P757
   Dai XG, 2014, ANALYST, V139, P5568, DOI 10.1039/c4an01220h
   Dai XG, 2012, SOFT MATTER, V8, P3067, DOI 10.1039/c1sm06702h
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10
   Dinjaski N, 2014, BIOMATERIALS, V35, P14, DOI 10.1016/j.biomaterials.2013.09.059
   Domingues JFD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070046
   Draing C, 2008, IMMUNOBIOLOGY, V213, P285, DOI 10.1016/j.imbio.2007.12.001
   Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hattor Y, 1997, BIOCHEM BIOPH RES CO, V233, P375, DOI 10.1006/bbrc.1997.6462
   Hedberg Y, 2014, COLLOID SURFACE B, V122, P216, DOI 10.1016/j.colsurfb.2014.06.066
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Hucknall A, 2009, BIOINTERPHASES, V4, pFA50, DOI 10.1116/1.3151968
   Jones KJ, 2005, J MED MICROBIOL, V54, P315, DOI 10.1099/jmm.0.45872-0
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x
   Kimbrell MR, 2008, IMMUNOL LETT, V118, P132, DOI 10.1016/j.imlet.2008.03.009
   Krsko P, 2003, LANGMUIR, V19, P5618, DOI 10.1021/la034157r
   Krsko P, 2005, NANOFABRICATION TECH
   Krsko P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)71223-2
   Lee JH, 2012, BIOMATERIALS, V33, P999, DOI 10.1016/j.biomaterials.2011.10.036
   Lichter JA, 2009, LANGMUIR, V25, P7686, DOI 10.1021/la900349c
   Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138
   Magin CM, 2010, BIOFOULING, V26, P719, DOI 10.1080/08927014.2010.511198
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   Mintzer MA, 2012, MOL PHARMACEUT, V9, P342, DOI 10.1021/mp2005033
   Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Nguyen F, 1998, ELECTROCHIM ACTA, V44, P239, DOI 10.1016/S0013-4686(98)00111-X
   Peltroche-Llacsahuanga H, 2000, FEMS MICROBIOL LETT, V191, P151, DOI 10.1016/S0378-1097(00)00384-0
   Rochford ET, 2014, J BIOMED MAT RES A
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Scislowska-Czarnecka A, 2012, J BIOMAT SCI-POLYM E, V23, P715, DOI 10.1163/092050611X559421
   Seral C, 2003, ANTIMICROB AGENTS CH, V47, P2283, DOI 10.1128/AAC.47.7.2283-2292.2003
   Song Z, 2013, ORTHOP REV, V5, P65, DOI 10.4081/or.2013.e14
   Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   SUNDERLAND J, 1995, J BIOLUM CHEMILUM, V10, P291, DOI 10.1002/bio.1170100506
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185
   Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744
   VANOSS CJ, 1978, ANNU REV MICROBIOL, V32, P19, DOI 10.1146/annurev.mi.32.100178.000315
   Vincent ME, 2010, CHEM SOC REV, V39, P974, DOI 10.1039/b917851a
   Wagner VE, 2003, J BIOMED MATER RES A, V66A, P62, DOI 10.1002/jbm.a.10516
   Wang Y, 2014, BIOMATERIALS, V35, P5446, DOI 10.1016/j.biomaterials.2014.03.057
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Wiles JA, 2004, J PHYS CHEM B, V108, P20296, DOI 10.1021/jp0457904
   Yue CX, 2014, BIOMATERIALS, V35, P2580, DOI 10.1016/j.biomaterials.2013.12.036
   Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 68
TC 8
Z9 8
U1 4
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2015
VL 18
BP 1
EP 8
DI 10.1016/j.actbio.2015.02.028
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG8ZX
UT WOS:000353605300001
DA 2018-10-19
ER

PT J
AU Levato, R
   Planell, JA
   Mateos-Timoneda, MA
   Engel, E
AF Levato, Riccardo
   Planell, Josep A.
   Mateos-Timoneda, Miguel A.
   Engel, Elisabeth
TI Role of ECM/peptide coatings on SDF-1 alpha triggered mesenchymal
   stromal cell migration from microcarriers for cell therapy
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Chemotaxis; ECM (extracellular matrix); Mesenchymal stromal cells;
   Surface modification; Cell therapy
ID STEM-CELLS; BONE-MARROW; ENDOTHELIAL-CELLS; ADHESION; CXCR4; CULTURE;
   DIFFERENTIATION; EXPRESSION; CARTILAGE; DELIVERY
AB Many cell therapies rely on the ability of mesenchymal stromal cells (MSCs) to diffuse and localize throughout the target tissue - such as tumoral and ischemic tissues-, in response to specific cytokine signals, rather than being concentrated at the site of implantation. Therefore, it is fundamental to engineer biomaterial carriers as reservoirs, from which cells can migrate, possibly in a controlled manner. In this work, microcarriers (mu Cs) made of polylactic acid are characterized as MSC delivery vehicles capable of modulating key chemotactic pathways. The effect of different functionalization strategies on MSC migratory behavior from the mu Cs is studied in vitro in relation to SDF-1 alpha/CXCR4 axis, - a major actor in MSC recruitment, chemotaxis and homing. Collagen and arginine-glycine-aspartic acid (RGD) peptides were either covalently grafted or physisorbed on mu C surface. While stable covalent modifications promoted better cell adhesion and higher proliferation compared to physisorption, the functionalization method of the mu Cs also affected the cells migratory behavior in response to SDF-1 alpha (CXCL12) stimulation. Less stable coatings (physisorbed) showed sensibly higher number of migrating cells than covalent collagen/RGD coatings. The combination of physic-chemical cues provided by protein/peptide functionalization and stimuli induced by 3D culture on mu Cs improved MSC expression of CXCR4, and exerted a control over cell migration, a condition suitable to promote cell homing after transplantation in vivo. These are key findings to highlight the impact of surface modification approaches on chemokine-triggered cell release, and allow designing biomaterials for efficient and controlled cell delivery to damaged tissues. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Levato, Riccardo; Planell, Josep A.; Mateos-Timoneda, Miguel A.; Engel, Elisabeth] Inst Bioengn Catalonia IBEC, Biomat Regenerat Therapies Grp, Barcelona, Spain.
   [Levato, Riccardo; Mateos-Timoneda, Miguel A.; Engel, Elisabeth] CIBER Biomat Bioingn & Nanomed CIBER BBN, Zaragoza, Spain.
   [Engel, Elisabeth] Tech Univ Catalonia, Dept Mat Sci & Met, Barcelona, Spain.
RP Mateos-Timoneda, MA (reprint author), Inst Bioengn Catalonia IBEC, Biomat Regenerat Therapies Grp, Barcelona, Spain.
EM mamateos@ibecbarcelona.eu
OI Levato, Riccardo/0000-0002-3795-3804
FU Spanish Ministry of Education, Culture and Sport (MECD) [AP2010-4827];
   Spanish Ministry of Economy and Competitiveness [MAT2012-38793]
FX RL acknowledges the Spanish Ministry of Education, Culture and Sport
   (MECD) for its financial support through the FPU programme (Grant
   reference AP2010-4827) and the Spanish Ministry of Economy and
   Competitiveness (Project MAT2012-38793).
CR Alieva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035148
   Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229
   Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013
   Chang J, 2012, CELL PROLIFERAT, V45, P430, DOI 10.1111/j.1365-2184.2012.00836.x
   Chen W, 2013, CELL BIOCHEM BIOPHYS, V67, P1181, DOI 10.1007/s12013-013-9632-6
   Chung HJ, 2009, TISSUE ENG PT A, V15, P1391, DOI 10.1089/ten.tea.2008.0344
   Das Madhurima, 2013, J Stem Cells, V8, P1
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Egea V, 2011, CELL DEATH DIFFER, V18, P853, DOI 10.1038/cdd.2010.154
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Filova E, 2014, J BIOMED MATER RES A, V102, P698, DOI 10.1002/jbm.a.34733
   Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769
   Goncalves RM, 2012, EUR CELLS MATER, V23, P249, DOI 10.22203/eCM.v023a19
   Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004
   Herklotz M, 2009, BIOMATERIALS, V30, P35, DOI 10.1016/j.biomaterials.2008.09.023
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319
   Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024
   Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Levato R, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035020
   Levato R, 2012, MACROMOL BIOSCI, V12, P557, DOI 10.1002/mabi.201100383
   Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Madhavan NK, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI DOI 10.1016/J.BI0RTECH.2010.05.092
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   Pompe T, 2004, TISSUE ENG, V10, P841, DOI 10.1089/1076327041348356
   Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200
   Punet X, 2013, BIOMACROMOLECULES, V14, P2690, DOI 10.1021/bm4005436
   Rafiq QA, 2013, BIOTECHNOL LETT, V35, P1233, DOI 10.1007/s10529-013-1211-9
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Sart S, 2013, J TISSUE ENG REGEN M, V7, P537, DOI 10.1002/term.545
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048
   Wiehe JM, 2013, INT J CARDIOL, V167, P2073, DOI 10.1016/j.ijcard.2012.05.065
   Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526
   Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796
   Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
NR 43
TC 12
Z9 12
U1 3
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2015
VL 18
BP 59
EP 67
DI 10.1016/j.actbio.2015.02.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG8ZX
UT WOS:000353605300007
PM 25702533
DA 2018-10-19
ER

PT J
AU Kasputis, T
   Pieper, A
   Rodenhausen, KB
   Schmidt, D
   Sekora, D
   Rice, C
   Schubert, E
   Schubert, M
   Pannier, AK
AF Kasputis, Tadas
   Pieper, Alex
   Rodenhausen, Keith Brian
   Schmidt, Daniel
   Sekora, Derek
   Rice, Charles
   Schubert, Eva
   Schubert, Mathias
   Pannier, Angela K.
TI Use of precisely sculptured thin film (STF) substrates with generalized
   ellipsometry to determine spatial distribution of adsorbed fibronectin
   to nanostructured columnar topographies and effect on cell adhesion
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanotopography; Surface analysis; Protein adsorption; Biocompatibility;
   Cell adhesion
ID PROTEIN ADSORPTION; SURFACE-CHEMISTRY; NANOSCALE ROUGHNESS; INTEGRIN
   BINDING; STEM-CELLS; TITANIUM; PROLIFERATION; OSTEOBLASTS; ATTACHMENT;
   INTERPLAY
AB Sculptured thin film (STF) substrates consist of nanocolumns with precise orientation, intercolumnar spacing, and optical anisotropy, which can be used as model biomaterial substrates to study the effect of homogenous nanotopogrophies on the three-dimensional distribution of adsorbed proteins. Generalized ellipsometry was used to discriminate between the distributions of adsorbed FN either on top of or within the intercolumnar void spaces of STFs, afforded by the optical properties of these precisely crafted substrates. Generalized ellipsometry indicated that STFs with vertical nanocolumns enhanced total FN adsorption two-fold relative to flat control substrates and the FN adsorption studies demonstrate different STF characteristics influence the degree of FN immobilization both on top and within intercolumnar spaces, with increasing spacing and surface area enhancing total protein adsorption. Mouse fibroblasts or mouse mesenchymal stem cells were subsequently cultured on STFs, to investigate the effect of highly ordered and defined nanotopographies on cell adhesion, spreading, and proliferation. All STF nanotopographies investigated in the absence of adsorbed FN were found to significantly enhance cell adhesion relative to flat substrates; and the addition of FN to STFs was found to have cell-dependent effects on enhancing cell material interactions. Furthermore, the amount of FN adsorbed to the STFs did not correlate with comparative enhancements of cell material interactions, suggesting that nanotopography predominantly contributes to the biocompatibility of homogenous nanocolumnar surfaces. This is the first study to correlate precisely defined nanostructured features with protein distribution and cell nanomaterial interactions. STFs demonstrate immense potential as biomaterial surfaces for applications in tissue engineering, drug delivery, and biosensing. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kasputis, Tadas; Pieper, Alex; Pannier, Angela K.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.
   [Rodenhausen, Keith Brian; Schmidt, Daniel; Sekora, Derek; Rice, Charles; Schubert, Eva; Schubert, Mathias] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
   [Schmidt, Daniel] Natl Univ Singapore, Singapore Synchotron Light Source, Singapore 119077, Singapore.
   [Schubert, Mathias; Pannier, Angela K.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.
   [Kasputis, Tadas; Pieper, Alex; Rodenhausen, Keith Brian; Schmidt, Daniel; Sekora, Derek; Rice, Charles; Schubert, Eva; Schubert, Mathias; Pannier, Angela K.] Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska Med Ctr, Maly & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA.
RP Pannier, AK (reprint author), 231 LW Chase Hall, Lincoln, NE 68583 USA.
EM apannier2@unl.edu
RI Schmidt, Daniel/F-2694-2010; Schubert, Mathias/B-2676-2017
OI Schubert, Mathias/0000-0001-6238-663X
FU National Science Foundation (CAREER) [CBET-1254415]; Center for
   Nanohybrid Functional Materials [NSF EPS-1004094]; American Heart
   Association [10SDG2640217]; University of Nebraska Foundation; J.A.
   Woollam Company; USDA CSREES-Nebraska [NEB-21-146]
FX Support for this research was provided in part by funds from the
   National Science Foundation (CAREER to AKP, CBET-1254415), Center for
   Nanohybrid Functional Materials (NSF EPS-1004094), American Heart
   Association (#10SDG2640217), the University of Nebraska Foundation
   (Layman Funds), the J.A. Woollam Company, and USDA CSREES-Nebraska
   (NEB-21-146).
CR Akasaka T, 2010, MAT SCI ENG C-MATER, V30, P391, DOI 10.1016/j.msec.2009.12.006
   Albuschies J., 2013, SCI REP, V3
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bazaka K, 2011, BIOTECHNOL J, V6, P1103, DOI 10.1002/biot.201100027
   Bittrich E, 2010, BIOINTERPHASES, V5, P1, DOI 10.1116/1.3530841
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Cheng Q, 2009, BIOMATERIALS, V30, P4203, DOI 10.1016/j.biomaterials.2009.04.023
   Depan D, 2013, ACTA BIOMATER, V9, P6084, DOI 10.1016/j.actbio.2012.12.019
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   Dolatshahi-Pirouz A, 2011, COLLOID SURFACE B, V84, P18, DOI 10.1016/j.colsurfb.2010.12.004
   Dolatshahi-Pirouz A, 2009, NANOTECHNOLOGY, P20
   Elias AL, 2005, J MICROMECH MICROENG, V15, P49, DOI 10.1088/0960-1317/15/1/008
   Elter P, 2011, LANGMUIR, V27, P8767, DOI 10.1021/la201358c
   Emohare O, 2013, J MATER SCI-MATER M, V24, P1543, DOI 10.1007/s10856-013-4904-7
   Garcia AJ, 2000, MOL BIOL CELL, V11, p393A
   Gerein NJ, 2010, SOL ENERG MAT SOL C, V94, P2343, DOI 10.1016/j.solmat.2010.08.010
   Gladwin KM, 2013, ADV HEALTHC MATER, V2, P728, DOI 10.1002/adhm.201200233
   Harris KD, 2000, J ELECTROCHEM SOC, V147, P2002, DOI 10.1149/1.1393475
   He YP, 2011, NANOSCALE, V3, P2361, DOI 10.1039/c1nr10103j
   Heydarkhan-Hagvall S, 2007, CELL COMMUN ADHES, V14, P181, DOI 10.1080/15419060701755594
   Joos U, 2006, EUR J CELL BIOL, V85, P225, DOI 10.1016/j.ejcb.2005.08.007
   Kasputis T, 2013, J PHYS CHEM C, V117, P13971, DOI 10.1021/jp402055h
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Koenig M, 2014, ANAL BIOANAL CHEM, V406, P7233, DOI 10.1007/s00216-014-8154-4
   KOTELIANSKY VE, 1981, EUR J BIOCHEM, V119, P619, DOI 10.1111/j.1432-1033.1981.tb05652.x
   Lai M, 2012, COLLOID SURFACE B, V97, P211, DOI 10.1016/j.colsurfb.2012.04.029
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lee BH, 2012, ACTA BIOMATER, V8, P1693, DOI 10.1016/j.actbio.2012.01.012
   Li JA, 2013, NUCL INSTRUM METH B, V307, P575, DOI 10.1016/j.nimb.2012.11.055
   Liang D, 2013, APPL PHYS LETT, P103
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lisfi A, 2001, PHYS REV B, P63
   Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x
   Lopez-Bosque MJ, 2013, NANOTECHNOLOGY, P24
   Lovejoy KS, 2011, MOL CANCER THER, V10, P1709, DOI 10.1158/1535-7163.MCT-11-0250
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Misra RDK, 2013, J BIOMED MATER RES A, V101, P1, DOI 10.1002/jbm.a.34105
   More SS, 2010, J NEUROSCI, V30, P9500, DOI 10.1523/JNEUROSCI.1544-10.2010
   Novin M, 2013, SURF INTERFACE ANAL, V45, P619, DOI 10.1002/sia.5101
   Pareta RA, 2009, BIOTECHNOL BIOENG, V103, P459, DOI 10.1002/bit.22276
   Pennisi C. P., 2009, NANOTECHNOLOGY, V20
   Pennisi CP, 2011, COLLOID SURFACE B, V85, P189, DOI 10.1016/j.colsurfb.2011.02.028
   Pompe T, 2005, EUR BIOPHYS J BIOPHY, V34, P1049, DOI 10.1007/s00249-005-0490-z
   Pompe T, 2005, BIOPHYS J, V88, P527, DOI [10.1529/biophysj.104.048074, 10.1529/biophysj.104.049074]
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   Reich U, 2012, J BIOMED MATER RES B, V100B, P940, DOI 10.1002/jbm.b.32656
   Rider DA, 2011, NANOTECHNOLOGY, P22
   Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601
   Robbie K, 1996, NATURE, V384, P616, DOI 10.1038/384616a0
   Rodenhausen KB, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3653880
   Rodenhausen KB, 2011, THIN SOLID FILMS, V519, P2817, DOI 10.1016/j.tsf.2010.11.081
   Rodenhausen KB, 2012, OPT EXPRESS, V20, P5419, DOI 10.1364/OE.20.005419
   Ryu S, 2013, TISSUE ENG REGEN MED, V10, P39, DOI 10.1007/s13770-013-0384-6
   Sabirianov RF, 2011, PHYS CHEM CHEM PHYS, V13, P6597, DOI 10.1039/c0cp02389b
   Salakhutdinov I, 2008, J NANOMATER
   Schmidt D, 2008, PHYS STATUS SOLIDI A, V205, P748, DOI 10.1002/pssa.200777906
   Schmidt D, 2009, J APPL PHYS, P105
   Schmidt D, 2012, APPL PHYS LETT, P100
   Schmidt D, 2011, THIN SOLID FILMS, V519, P2645, DOI 10.1016/j.tsf.2010.12.111
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Shen Y, 2009, ACTA BIOMATER, V5, P3593, DOI 10.1016/j.actbio.2009.05.021
   Shi HQ, 1999, NATURE, V398, P593
   Steele JJ, 2007, J MATER SCI-MATER EL, V18, P367, DOI 10.1007/s10854-006-9049-8
   Sweetman MJ, 2012, ADV FUNCT MATER, V22, P1158, DOI 10.1002/adfm.201102000
   Tajima S, 2008, J BIOMED MATER RES A, V84A, P828, DOI 10.1002/jbm.a.31539
   Teo BKK, 2011, BIOMATERIALS, V32, P9866, DOI 10.1016/j.biomaterials.2011.08.088
   Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074
   Thomas M, 2011, ACS APPL MATER INTER, V3, P1887, DOI 10.1021/am200076m
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Venkatsurya PKC, 2012, MAT SCI ENG C-MATER, V32, P330, DOI 10.1016/j.msec.2011.10.036
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yonezawa A, 2011, BIOCHEM PHARMACOL, V81, P563, DOI 10.1016/j.bcp.2010.11.016
   Zhang J, 2009, ADV MATER, V21, P790, DOI 10.1002/adma.200801586
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhao YP, 2003, P SOC PHOTO-OPT INS, V5219, P59, DOI 10.1117/12.505253
NR 78
TC 8
Z9 8
U1 1
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2015
VL 18
BP 88
EP 99
DI 10.1016/j.actbio.2015.02.016
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG8ZX
UT WOS:000353605300010
PM 25712389
DA 2018-10-19
ER

PT J
AU Chamberlain, MD
   West, MED
   Lam, GC
   Sefton, MV
AF Chamberlain, M. Dean
   West, Michael E. D.
   Lam, Gabrielle C.
   Sefton, Michael V.
TI In Vivo Remodelling of Vascularizing Engineered Tissues
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Hypoxia; HIF-1 alpha; Angiogenesis; Mesenchymal stromal cells; Myeloid
   cells; Macrophages; M1; M2; Host response
ID ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; HUMAN-MELANOMA
   XENOGRAFTS; BONE-MARROW; MACROPHAGE ACTIVATION; STROMAL CELLS; TUMOR
   ANGIOGENESIS; OXYGEN GRADIENTS; HOST VASCULATURE; MYELOID CELLS
AB A critical aspect of creating vascularized tissues is the remodelling that occurs in vivo, driven in large part by the host response to the tissue construct. Rather than a simple inflammatory response, a beneficial tissue remodelling response results in the formation of vascularised tissue. The characteristics and dynamics of this response are slowly being elucidated, especially as they are modulated by the complex interaction between the biomaterial and cellular components of the tissue constructs and the host. This process has elements that are similar to both wound healing and tumour development, and its features are illustrated by reference to the bottom-up generation of a tissue using modular constructs. These modular constructs consist of mesenchymal stromal cells (MSC) embedded in endothelial cell (EC)-covered collagen gel rods that are a few hundred microns in size. Particular attention is paid to the role of hypoxia and macrophage recruitment, as well as the paracrine effects of the MSC and EC in this host response.
C1 [Chamberlain, M. Dean; West, Michael E. D.; Lam, Gabrielle C.; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Chamberlain, M. Dean; West, Michael E. D.; Lam, Gabrielle C.; Sefton, Michael V.] Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.
   [Chamberlain, M. Dean; Sefton, Michael V.] Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
RI Chamberlain, Michael/A-9107-2016
OI Chamberlain, Michael/0000-0003-1813-8545
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR); Ontario Research
   Excellence Fund; CIHR; NSERC
FX We thank the Natural Sciences and Engineering Research Council of Canada
   (NSERC), Canadian Institutes of Health Research (CIHR) and the Ontario
   Research Excellence Fund for financial support. M. D. C. thanks CIHR for
   a Post-doctoral Fellowship, M. E. D. W. thanks NSERC for a CREATE
   Graduate Scholarship and G. C. L. thanks CIHR for a Frederick Banting
   and Charles Best Canada Graduate Scholarship (CGS) Doctoral Award and a
   Training Program in Regenerative Medicine Award.
CR Aguilera KY, 2014, CELL MOL LIFE SCI, V71, P299, DOI 10.1007/s00018-013-1432-z
   Akman HO, 2001, BLOOD, V98, P3324, DOI 10.1182/blood.V98.12.3324
   Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Awad O, 2006, ARTERIOSCL THROM VAS, V26, P758, DOI 10.1161/01.ATV.0000203513.29227.6f
   Balaji S, 2013, ADV WOUND CARE, V2, P283, DOI 10.1089/wound.2012.0398
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423
   Benelli R, 2001, FASEB J, V15, P267, DOI 10.1096/fj.01-0651fje
   Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Butler MJ, 2012, TISSUE ENG PT A, V18, P1628, DOI [10.1089/ten.tea.2011.0467, 10.1089/ten.TEA.2011.0467]
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]
   Chamberlain MD, 2011, TISSUE ENG PT A, V17, P151, DOI 10.1089/ten.TEA.2010.0293
   Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001
   Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1222, DOI [10.1089/ten.tea.2013.0241, 10.1089/ten.TEA.2013.0241]
   Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1235, DOI [10.1089/ten.tea.2013.0242, 10.1089/ten.TEA.2013.0242]
   Ciucurel EC, 2013, BIOFABRICATION: MICRO- AND NANO-FABRICATION, PRINTING, PATTERNING, AND ASSEMBLIES, P119
   Cooper TP, 2011, ACTA BIOMATER, V7, P1072, DOI 10.1016/j.actbio.2010.11.008
   Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771
   Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877
   Debels H, 2013, TISSUE ENG PT A, V19, P2615, DOI [10.1089/ten.tea.2013.0071, 10.1089/ten.TEA.2013.0071]
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   Fitzpatrick L. E., 2014, SCAFFOLDS TISSUE ENG, P173
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671
   Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31
   Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003
   Gulliksrud K, 2008, RADIAT RES, V170, P638, DOI 10.1667/RR1400.1
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960
   Hu M, 2014, LARYNGOSCOPE, V124, P642, DOI 10.1002/lary.24293
   Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071
   Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686
   Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149
   Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086
   Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Kang KT, 2011, BLOOD, V118, P6718, DOI 10.1182/blood-2011-08-375188
   Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602
   Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183
   Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352
   Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002
   Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004
   Kolaczkowska E, 2012, BLOOD, V120, P4455, DOI 10.1182/blood-2012-09-457226
   Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278
   Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martins-Green M, 2013, ADV WOUND CARE, V2, P327, DOI 10.1089/wound.2012.0380
   Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3
   Mehrad B, 2007, THROMB HAEMOSTASIS, V97, P755, DOI 10.1160/TH07-01-0040
   MEININGER CJ, 1988, AM J PHYSIOL, V255, pH554
   Melero-Martin JM, 2010, TISSUE ENG PT A, V16, P2457, DOI [10.1089/ten.tea.2010.0024, 10.1089/ten.TEA.2010.0024]
   Menon C, 2003, CANCER RES, V63, P7232
   Mikami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067739
   Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109
   Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444
   Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393
   Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn
   Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347
   Peng LH, 2013, CELL TISSUE RES, V352, P573, DOI 10.1007/s00441-013-1609-7
   Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603
   Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528
   Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931
   Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167
   Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009
   Roberts T, 1996, BIOMATERIALS, V17, P267, DOI 10.1016/0142-9612(96)85564-5
   Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012
   Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186
   Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176
   Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001
   Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021
   Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Stockmann C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00069
   Sun CJ, 2014, J RADIAT RES, V55, P183, DOI 10.1093/jrr/rrt092
   Takahashi T, 1999, NAT MED, V5, P434
   Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x
   Tura O, 2013, STEM CELLS, V31, P338, DOI 10.1002/stem.1280
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   Van Belle E, 1998, CIRCULATION, V97, P381
   Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240
   Zhu HT, 2012, ONCOL REP, V28, P1217, DOI 10.3892/or.2012.1944
NR 106
TC 3
Z9 3
U1 1
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2015
VL 43
IS 5
BP 1189
EP 1200
DI 10.1007/s10439-014-1146-x
PG 12
WC Engineering, Biomedical
SC Engineering
GA CH1KM
UT WOS:000353780300012
PM 25297985
DA 2018-10-19
ER

PT J
AU Teimouri, A
   Ebrahimi, R
   Emadi, R
   Beni, BH
   Chermahini, AN
AF Teimouri, Abbas
   Ebrahimi, Raheleh
   Emadi, Rahmatollah
   Beni, Batool Hashemi
   Chermahini, Alireza Najafi
TI Nano-composite of silk fibroin-chitosan/Nano ZrO2 for tissue engineering
   applications: Fabrication and morphology
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Silk fibroin; Chitosan; Tissue engineering; Microporous materials
ID POROUS SCAFFOLDS; PORE-SIZE; HYDROXYAPATITE; BIOMATERIAL; ZIRCONIA;
   PROLIFERATION; MIGRATION; NANOFIBER; MEMBRANE; MATRICES
AB A scaffold possessing certain desired features such as biodegradation, biocompatibility, and porous structure could serve as a template for tissue engineering. In the present study, silk fibroin (SF), chitosan (CS) and zirconia (Nano ZrO2) were all combined using the freeze drying technique to fabricate a bio-composite scaffold. The composite scaffold (SF/CS/Nano ZrO2) was characterized by SEM, XRD, TGA, BET and FT-IR studies. The scaffold was found to possess a porous nature with pore dimensions suitable for cell infiltration and colonization. The presence of zirconia in the SF/CS/Nano ZrO2 scaffold led to an increase in compressive strength and water uptake capacity while at the same time decreasing the porosity. Cytocompatibility of the SF/CS/Nano ZrO2 scaffold, assessed by MU assay, revealed non-toxicity to the Human Gingival Fibroblast (HGF, NCBI: C-131). Thus, we suggest that SF/CS/Nano ZrO2 composite scaffold is a potential candidate to be used for tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Teimouri, Abbas; Ebrahimi, Raheleh] Payame Noor Univ, Dept Chem, Tehran 193953697, Iran.
   [Emadi, Rahmatollah] Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
   [Beni, Batool Hashemi] Isfahan Univ Med Sci, Sch Med, Dept Anat Sci, Esfahan, Iran.
   [Chermahini, Alireza Najafi] Isfahan Univ Technol, Dept Chem, Esfahan 8415683111, Iran.
RP Teimouri, A (reprint author), Payame Noor Univ, Dept Chem, POB 81395-671, Esfahan, Iran.
EM a_teimouri@pnu.ac.ir
RI Najafi Chermahini, Alireza/F-8271-2017
OI Najafi Chermahini, Alireza/0000-0001-9803-7837
FU Payame Noor University in Isfahan Research council [62370]
FX Supports from the Payame Noor University in Isfahan Research council
   (Grant # 62370) and contribution from Isfahan University of Technology
   are gratefully acknowledged. The authors would like to thank Dr. L.
   Ghorbanian for critical reading of the manuscript. We thank Mrs. Hydari
   for providing cell culture facilities.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bahrami SB, 2003, IRAN POLYM J, V12, P139
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bhardwaj N, 2011, INT J BIOL MACROMOL, V49, P260, DOI 10.1016/j.ijbiomac.2011.04.013
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cao H, 2013, J MATER SCI, V48, P150, DOI 10.1007/s10853-012-6722-6
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chi NH, 2013, CARBOHYD POLYM, V92, P591, DOI 10.1016/j.carbpol.2012.09.012
   Chung TW, 2010, J MATER SCI-MATER M, V21, P1343, DOI 10.1007/s10856-009-3876-0
   Eberli D., 2011, REGENERATIVE MED TIS
   Ghorbanian L, 2013, INT J BIOL MACROMOL, V58, P275, DOI 10.1016/j.ijbiomac.2013.04.004
   Gibson L., 1999, CAMBRIDGE SOLID STAT
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gregg S. L., 1982, ADSORPTION SURFACE A
   Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang XJ, 2007, EUR POLYM J, V43, P3710, DOI 10.1016/j.eurpolymj.2007.06.010
   Jao WC, 2012, POLYM ADVAN TECHNOL, V23, P1066, DOI 10.1002/pat.2014
   Jayakumar R, 2011, INT J BIOL MACROMOL, V49, P274, DOI 10.1016/j.ijbiomac.2011.04.020
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li JJ, 2009, MAT SCI ENG C-BIO S, V29, P1207, DOI 10.1016/j.msec.2008.09.038
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mirahmadi F, 2013, MAT SCI ENG C-MATER, V33, P4786, DOI 10.1016/j.msec.2013.07.043
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004
   Pattnaik S, 2011, INT J BIOL MACROMOL, V49, P1167, DOI 10.1016/j.ijbiomac.2011.09.016
   Peon E, 2004, LAT AM APPL RES, V34, P225
   Peter M, 2010, CHEM ENG J, V158, P353, DOI 10.1016/j.cej.2010.02.003
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Silva R. M., 2004, J MATER SCI-MATER M, V15, P1105
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Singh M, 1999, J MATER SCI, V34, P5315, DOI 10.1023/A:1004796921503
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Teimouri A, 2014, CERAM INT, V40, P6405, DOI 10.1016/j.ceramint.2013.12.051
   Thomas J., 1997, PRINCIPLES PRACTICE
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vacanti JP, 2000, PRINCIPLES TISSUE EN, V3, P3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhensheng L., 2006, BIOMATERIALS, V26, P3919
   Zhou YS, 2013, INT J BIOL MACROMOL, V53, P88, DOI 10.1016/j.ijbiomac.2012.11.013
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 60
TC 19
Z9 19
U1 2
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAY
PY 2015
VL 76
BP 292
EP 302
DI 10.1016/j.ijbiomac.2015.02.023
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CG8ZK
UT WOS:000353604000038
PM 25709014
DA 2018-10-19
ER

PT J
AU Vergroesen, PPA
   Bochynska, AI
   Emanuel, KS
   Sharifi, S
   Kingma, I
   Grijpma, DW
   Smit, TH
AF Vergroesen, Pieter-Paul A.
   Bochynska, Agnieszka I.
   Emanuel, Kaj S.
   Sharifi, Shahriar
   Kingma, Idsart
   Grijpma, Dirk W.
   Smit, Theodoor H.
TI A Biodegradable Glue for Annulus Closure Evaluation of Strength and
   Endurance
SO SPINE
LA English
DT Article
DE intervertebral disc; annulus fibrosus repair; nucleus pulposus;
   biomechanics; ex vivo; ultimate strength testing; biodegradable
   polymers; adhesive biomaterial; discectomy; herniation; motion segment
   testing; organ culture; bioreactor
ID BIOMECHANICAL EVALUATION; NUCLEUS REPLACEMENT; DISC DEGENERATION; MODEL;
   PUNCTURE
AB Study Design. A biodegradable glue was biomechanically tested for annulus closure using nondegenerated goat intervertebral discs. Ultimate strength and endurance tests were performed using native and punctured discs as positive and negative controls, respectively.
   Objective. The aim of this study was to investigate the feasibility and biomechanical properties of a biodegradable glue for annulus closure.
   Summary of Background Data. There is an unmet clinical need for annulus closure techniques. Isocyanate-terminated tissue glues show potential because they adhere to annulus tissue, have an elastic modulus similar to the annulus, and show limited cytotoxicity to human annulus fibrosus cells.
   Methods. Three biomechanical tests were performed divided in 2 parts: part 1: ultimate strength tests comparing native, punctured (2.4-mm needle), and glued caprine intervertebral discs (n = 11 per group); part 2: 10 discs per group were subjected to a 10-day ex vivo endurance test of 864,000 load cycles, followed by ultimate strength tests. Outcome parameters include the restoration of strength after puncture, reduction of herniation in the endurance test, and conservation of glue strength after endurance testing.
   Results. Part 1: The glue partially restored subsidence to failure and yield strength/ultimate strength ratio of intervertebral discs. Part 2: During endurance testing, 40% of punctured discs failed compared with none of the glued discs. Endurance testing did not affect glue strength, and pooling of ultimate strength tests showed that the glue restored ultimate strength, work to failure, and yield strength/ultimate strength to 79%, 75%, and 119% of native values, respectively.
   Conclusion. A biodegradable isocyanate-terminated glue increases the force at which nucleus protrusion occurs, and it limits herniations during endurance or ultimate strength tests. Biomechanical tests in a bioreactor provide a low-cost assessment for annulus repair strategies; however, the clinical efficacy needs to be further addressed using long-term in vivo studies.
C1 [Vergroesen, Pieter-Paul A.; Emanuel, Kaj S.; Smit, Theodoor H.] Vrije Univ Amsterdam, Dept Orthoped Surg, Med Ctr, NL-1007 MB Amsterdam, Netherlands.
   [Vergroesen, Pieter-Paul A.; Emanuel, Kaj S.; Kingma, Idsart; Smit, Theodoor H.] MOVE Res Inst Amsterdam, Amsterdam, Netherlands.
   [Bochynska, Agnieszka I.; Grijpma, Dirk W.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Bochynska, Agnieszka I.] Radboud Univ Nijmegen, Med Ctr, Dept Orthoped, Orthoped Res Lab,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.
   [Sharifi, Shahriar; Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, Groningen, Netherlands.
   [Kingma, Idsart] Vrije Univ Amsterdam, Dept Human Movement Sci, NL-1007 MB Amsterdam, Netherlands.
RP Smit, TH (reprint author), Vrije Univ Amsterdam, Dept Orthoped Surg, Med Ctr, De Boelelaan 1117,Room 3F-045,POB 7057, NL-1007 MB Amsterdam, Netherlands.
EM Th.smit@vumc.nl
OI Bochynska, Agnieszka/0000-0001-9423-0023; Emanuel,
   Kaj/0000-0002-4970-4303; Vergroesen, Pieter-Paul/0000-0001-7769-2197
FU government-led consortium for the development of BioMedical Materials,
   BMM [P2.01 IDiDAS]; ZonMW-VICI grant [918.11.635]
FX The government-led consortium for the development of BioMedical
   Materials, BMM (grant number P2.01 IDiDAS), and ZonMW-VICI grant
   918.11.635 funds were received to support this work.
CR ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002
   Akhtar R, 2011, MATER TODAY, V14, P96, DOI 10.1016/S1369-7021(11)70059-1
   Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354
   Bochynska AI, 2013, MACROMOL SYMP, V334, P40, DOI 10.1002/masy.201300101
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468
   Kang JD, 2010, SPINE J, V10, P1106, DOI 10.1016/j.spinee.2010.10.014
   Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03
   Paul CPL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062411
   Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147
   Reitmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069610
   Smit TH, 1997, SPINE, V22, P2823, DOI 10.1097/00007632-199712150-00005
   Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346
   Smit TH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-38
   van Dijk M, 2003, EUR SPINE J, V12, P34, DOI 10.1007/s00586-002-0458-y
   Vergroesen PPA, 2014, EUR SPINE J, V23, P2359, DOI 10.1007/s00586-014-3450-4
   Wilke HJ, 2013, SPINE, V38, pE587, DOI 10.1097/BRS.0b013e31828ca4bc
NR 20
TC 10
Z9 10
U1 1
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD MAY 1
PY 2015
VL 40
IS 9
BP 622
EP 628
DI 10.1097/BRS.0000000000000792
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA CH2CX
UT WOS:000353833700012
PM 25608249
DA 2018-10-19
ER

PT J
AU Simon-Yarza, T
   Rossi, A
   Heffels, KH
   Prosper, F
   Groll, J
   Blanco-Prieto, MJ
AF Simon-Yarza, Teresa
   Rossi, Angela
   Heffels, Karl-Heinz
   Prosper, Felipe
   Groll, Juergen
   Blanco-Prieto, Maria J.
TI Polymeric Electrospun Scaffolds: Neuregulin Encapsulation and
   Biocompatibility Studies in a Model of Myocardial Ischemia
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CARDIAC REGENERATION; MACROPHAGE PHENOTYPE; DRUG-DELIVERY;
   HEART-FAILURE; INFARCTION; BIOMATERIALS; CARRIER; PATCH
AB Cardiovascular disease represents one of the major health challenges in modern times and is the number one cause of death globally. Thus, numerous studies are under way to identify effective cell- and/or growth factor (GF)-based therapies for repairing damaged cardiac tissue. In this regard, improving the engraftment or survival of regenerative cells and prolonging GF exposure have become fundamental goals in advancing these therapeutic approaches. Biomaterials have emerged as innovative scaffolds for the delivery of both cells and proteins in tissue engineering applications. In the present study, electrospinning was used to generate smooth homogenous polymeric fibers, which consisted of a poly(lactic-co-glycolic acid) (PLGA)/NCO-sP(EO-stat-PO) polymer blend encapsulating the cardioactive GF, Neuregulin-1 (Nrg). We evaluated the biocompatibility and degradation of this Nrg-containing biomaterial in a rat model of myocardial ischemia. Histological analysis revealed the presence of an initial acute inflammatory response after implantation, which was followed by a chronic inflammatory phase, characterized by the presence of giant cells. Notably, the scaffold remained in the heart after 3 months. Furthermore, an increase in the M2:M1 macrophage ratio following implantation suggested the induction of constructive tissue remodeling. Taken together, the combination of Nrg-encapsulating scaffolds with cells capable of inducing cardiac regeneration could represent an ambitious and promising therapeutic strategy for repairing diseased or damaged myocardial tissue.
C1 [Simon-Yarza, Teresa; Blanco-Prieto, Maria J.] Univ Navarra, Dept Pharm & Pharmaceut Technol, Sch Pharm, E-31080 Pamplona, Spain.
   [Rossi, Angela; Heffels, Karl-Heinz; Groll, Juergen] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Prosper, Felipe] Univ Navarra, Hematol Serv & Area Cell Therapy, Clin Univ Navarra, Fdn Appl Med Res, E-31080 Pamplona, Spain.
RP Blanco-Prieto, MJ (reprint author), Univ Navarra, Dept Pharm & Pharmaceut Technol, Sch Pharm, Irunlarrea 1, E-31080 Pamplona, Spain.
EM juergen.groll@fmz.uni-wuerzburg.de; mjblanco@unav.es
RI Groll, Jurgen/F-4202-2012; Prosper, Felipe/H-6859-2017
OI Groll, Jurgen/0000-0003-3167-8466; Prosper, Felipe/0000-0001-6115-8790;
   Blanco-prieto, Maria J/0000-0003-0710-899X
FU ISCIII-RETIC [RD12/0019/0031]; MINECO [PLE2009-0116 CARDIOBIO]; Program
   INNPACTO (PROCARDIO); European Union FPVII (INELPY); FUN (University of
   Navarra) Caja de Ahorros de Navarra (Programa Tu Eliges: Tu Decides);
   Spanish Ministerio de Educacion (programa FPU);  [SAF2013-42528-R]
FX This work was partially supported by ISCIII-RETIC RD12/0019/0031, MINECO
   PLE2009-0116 CARDIOBIO, SAF2013-42528-R, Program INNPACTO (PROCARDIO),
   European Union FPVII (INELPY), FUN (University of Navarra) Caja de
   Ahorros de Navarra (Programa Tu Eliges: Tu Decides). T.S.-Y. thanks the
   Spanish Ministerio de Educacion (programa FPU) for the fellowship grant.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arana M, 2013, ACTA BIOMATER, V9, P6075, DOI 10.1016/j.actbio.2012.12.014
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Doppler SA, 2013, J THORAC DIS, V5, P683, DOI 10.3978/j.issn.2072-1439.2013.08.71
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Freytes DO, 2012, CELLS TISSUES ORGANS, V195, P171, DOI 10.1159/000331392
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Grafahrend D, 2011, NAT MATER, V10, P67, DOI [10.1038/nmat2904, 10.1038/NMAT2904]
   Heyes CD, 2007, MOL BIOSYST, V3, P419, DOI 10.1039/b700055n
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304
   Lakshmanan R, 2012, EXPERT OPIN BIOL TH, V12, P1623, DOI 10.1517/14712598.2012.721770
   Lundberg MS, 2013, CIRC RES, V112, P1097, DOI 10.1161/CIRCRESAHA.112.300638
   Martin K, 2014, CURR PHARM DESIGN, V20, P1930, DOI 10.2174/13816128113199990450
   Mendes-Ferreira P, 2013, DRUG DISCOV TODAY, V18, P836, DOI 10.1016/j.drudis.2013.01.010
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Rim N. G., 2013, BIOMED MAT, V8
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Simon-Yarza T, 2013, INT J PHARMACEUT, V454, P784, DOI 10.1016/j.ijpharm.2013.04.015
   SIMONYARZA T, 2012, RSC DRUG DISCOV, P501
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   World Health Organization, 2012, WORLD HLTH STAT
   World Health Organization (WHO), 2013, CARD DIS CVDS FACT S
NR 31
TC 6
Z9 6
U1 5
U2 37
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY 1
PY 2015
VL 21
IS 9-10
BP 1654
EP 1661
DI 10.1089/ten.tea.2014.0523
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CH3TD
UT WOS:000353952300017
PM 25707939
DA 2018-10-19
ER

PT J
AU Omran, AM
   Do Woo, K
   Kang, DS
   Abdel-Gaber, GT
   Fouad, H
   Abdo, HS
   Khalil, KA
AF Omran, A. M.
   Do Woo, Kee
   Kang, Duck Soo
   Abdel-Gaber, G. T.
   Fouad, H.
   Abdo, Hany S.
   Khalil, Abdelrazek Khalil
TI Fabrication and evaluation of porous Ti-HA bio-nanomaterial by leaching
   process
SO ARABIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Ti-HA composite; Biomaterial; Leaching solution; PCAS; Porosity; Powder
   metallurgy
ID HYDROXYAPATITE; TITANIUM; ALLOYS
AB A porous surface of Ti-HA composite was successfully fabricated by pulsed current activated sintering (PCAS), followed by leaching using diluted H3PO4. The Ti and HA powders were mixed at different contents of the HA, Ti-5, 10, 30 and 40 wt% HA powders. The mixed powders were pressed in a coated graphite die using pulsed current activated sintering (PCAS) under pressure of 60 MPa at temperature of 1000 degrees C for 5 min. The sintered Ti-HA specimens were immersed in the eight kinds of leaching solutions at room temperature for 24 h. The leached specimen's surfaces were characterized using XRD, SEM, EDX and Rockwell hardness. The XRD patterns after sintering show that many phases were detected at the sintered specimen surfaces such as; Ti2O, CaO, CaTiO3, TixPy in addition to the remaining Ti and HA. Furthermore, the high concentration H3PO4 leaching solution is more efficient than the low concentration. Also the produced porous surfaces of Ti-HA materials containing more than 30% HA have a low relative density and hardness than the commercial Ti-6Al-4V ELI alloy. In a word, the presence of porous surface coated by HA will promote the nucleation of the biological apatite created with the human tissue and increase the bonding between them. So, the produced porous materials are considered so easy for the muscle cells to permeate after transplanted with high coherence. (C) 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Omran, A. M.] Al Azhar Univ, Fac Engn, Dept Min & Met, Qena 83513, Egypt.
   [Do Woo, Kee; Kang, Duck Soo] Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561756, South Korea.
   [Do Woo, Kee; Kang, Duck Soo] Chonbuk Natl Univ, RCIT, Jeonju 561756, South Korea.
   [Abdel-Gaber, G. T.] South Valley Univ, Fac Engn, Qena, Egypt.
   [Fouad, H.] King Saud Univ, Riyadh Community Coll, Riyadh 11437, Saudi Arabia.
   [Fouad, H.] Helwan Univ, Fac Engn, Dept Biomed Engn, Helwan, Egypt.
   [Khalil, Abdelrazek Khalil] King Saud Univ, Dept Mech Engn, Riyadh 11421, Saudi Arabia.
   [Abdo, Hany S.; Khalil, Abdelrazek Khalil] Aswan Univ, Fac Energy Engn, Aswan, Egypt.
   [Abdo, Hany S.] King Saud Univ, CEREM, Adv Mfg Inst, Riyadh 11421, Saudi Arabia.
RP Khalil, KA (reprint author), King Saud Univ, Dept Mech Engn, POB 800, Riyadh 11421, Saudi Arabia.
EM kabdelmawgoud@ksu.edu.sa
RI Abdo, Hany/D-3646-2014
OI Abdo, Hany/0000-0002-7260-639X; Abdelmawgoud, Khalil/0000-0001-7965-5779
FU Deanship of Scientific Research at king Saud University [RG 1435-001]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at king Saud University for funding this
   Research Group No. (RG 1435-001).
CR Ahmed T., 1995, SCI TECHNOL, V2
   Jakubowicz J, 2009, ELECTROCHEM COMMUN, V11, P461, DOI 10.1016/j.elecom.2008.12.024
   Khor KA, 2003, SURF COAT TECH, V168, P195, DOI 10.1016/S0257-8972(03)00238-X
   Kumar R. R., 2002, BIOMATER, V23, P1679
   Langsberg J. P., 1992, NATURE, V360, P65
   Long Marc, 1998, BIOMATER, V19, P1921
   Ma J, 2003, J MATER SCI-MATER M, V14, P797, DOI 10.1023/A:1025092506583
   Ning CQ, 2004, BIOMATERIALS, V25, P3379, DOI 10.1016/j.biomaterials.2003.10.017
   OKAZAKI Y, 1995, J JPN I MET, V59, P229, DOI 10.2320/jinstmet1952.59.2_229
   Omran AM, 2008, MET MATER-INT, V14, P321, DOI 10.3365/met.mat.2008.06.321
   Sun RX, 2006, MAT SCI ENG C-BIO S, V26, P28, DOI 10.1016/j.msec.2005.05.003
   Thian ES, 2001, BIOMATERIALS, V22, P1225, DOI 10.1016/S0142-9612(00)00272-6
   Turkan U, 2006, SURF COAT TECH, V200, P5020, DOI 10.1016/j.surfcoat.2005.05.005
   Woo K. D., 2009, J KOREAN INST MET MA, V47, P8
   Woo K. D., 2010, CER INT, V36, P1
   Yumoto S., 1992, INT J PIXE, V2, P493, DOI 10.1142/S0129083592000531
NR 16
TC 6
Z9 6
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1878-5352
EI 1878-5379
J9 ARAB J CHEM
JI Arab. J. Chem.
PD MAY
PY 2015
VL 8
IS 3
BP 372
EP 379
DI 10.1016/j.arabjc.2014.11.052
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG4PT
UT WOS:000353269300012
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Paliwal, R
   Uniyal, S
   Rai, JPN
AF Paliwal, Rashmi
   Uniyal, Shivani
   Rai, J. P. N.
TI Evaluating the potential of immobilized bacterial consortium for black
   liquor biodegradation
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Biodegradation; Bacterial consortium; Immobilization; Corncob; GC/MS;
   SEM
ID PAPER-MILL EFFLUENT; KRAFT LIGNIN DEGRADATION; CYANIDE WASTE-WATER;
   PHANEROCHAETE-CHRYSOSPORIUM; MANGANESE PEROXIDASE; CELL IMMOBILIZATION;
   ENHANCED PRODUCTION; GAS-CHROMATOGRAPHY; ETHANOL-PRODUCTION; BLEACH
   PLANT
AB Two indigenous bacterial strains, Bacillus megaterium ETLB-1 (accession no. KC767548) and Pseudomonas plecoglossicida ETLB-3 (accession no. KC767547), isolated from soil contaminated with paper mill effluent, were co-immobilized on corncob cubes to investigate their biodegradation potential against black liquor (BL). Results exhibit conspicuous reduction in color and lignin of BL upto 913.46 Co-Pt and 531.45 mg l(-1), respectively. Reduction in chlorophenols up to 12 mg l(-1) was recorded with highest release of chloride ions, i.e., 1290 mg l(-1). Maximum enzyme activity for lignin peroxidase (LiP), manganese peroxidase (MnP), and laccase (LAC) was recorded as 5.06, 8.13, and 8.23 U ml(-1), respectively, during the treatment. Scanning electron microscopy (SEM) revealed successful immobilization of bacterial strains in porous structures of biomaterial. Gas chromatography/mass spectroscopy (GC/MS) showed formation of certain low molecular weight metabolites such as 4-hydroxy-benzoic acid, 3-hydroxy-4-methoxybenzaldehyde, ferulic acid, and t-cinnamic acid and removal of majority of the compounds (such as teratogenic phthalate derivatives) during the period of treatment. Results demonstrated that the indigenous bacterial consortium possesses excellent decolorization and lignin degradation capability which enables its commercial utilization in effluents treatment system.
C1 [Paliwal, Rashmi; Uniyal, Shivani; Rai, J. P. N.] GB Pant Univ Agr & Technol, Ecotechnol Lab, Dept Environm Sci, Pantnagar 263145, Uttar Pradesh, India.
RP Paliwal, R (reprint author), GB Pant Univ Agr & Technol, Ecotechnol Lab, Dept Environm Sci, Pantnagar 263145, Uttar Pradesh, India.
EM paliwal39561@gmail.com
OI Paliwal, Rashmi/0000-0002-0948-7834
CR Arora DS, 2002, INT BIODETER BIODEGR, V50, P115, DOI 10.1016/S0964-8305(02)00064-1
   BAJPAI P, 1993, PROCESS BIOCHEM, V28, P377, DOI 10.1016/0032-9592(93)80024-B
   Belem A, 2008, GLOBAL NEST J, V10, P426
   BERGMANN JG, 1957, ANAL CHEM, V29, P241, DOI 10.1021/ac60122a018
   Branyik T, 2004, BIOTECHNOL BIOENG, V88, P84, DOI 10.1002/bit.20217
   Brenner D. J., 2005, BERGEYS MANUAL SYSTE, V2
   BUSWELL JA, 1987, CRIT REV BIOTECHNOL, V6, P1, DOI 10.3109/07388558709086984
   Chandra R, 2012, BIOCHEM ENG J, V61, P49, DOI 10.1016/j.bej.2011.12.004
   Chandra R, 2011, BIORESOURCE TECHNOL, V102, P6429, DOI 10.1016/j.biortech.2011.03.048
   Chen CY, 2008, CHEMOSPHERE, V71, P133, DOI 10.1016/j.chemosphere.2007.10.058
   Chen CY, 2007, WATER SCI TECHNOL, V56, P99, DOI 10.2166/wst.2007.699
   Chen YH, 2012, J APPL MICROBIOL, V112, P900, DOI 10.1111/j.1365-2672.2012.05275.x
   Chung E, 2005, BIOTECHNOL LETT, V27, P477, DOI 10.1007/s10529-005-2224-9
   D'Souza DT, 2006, ENZYME MICROB TECH, V38, P504, DOI 10.1016/j.enzmictec.2005.07.005
   Franzetti L, 2007, ANN MICROBIOL, V57, P39, DOI 10.1007/BF03175048
   Genisheva Z, 2013, FOOD CHEM, V138, P1510, DOI 10.1016/j.foodchem.2012.11.058
   Genisheva Z, 2011, IND CROP PROD, V34, P979, DOI 10.1016/j.indcrop.2011.03.006
   Greenberg A., 1995, STANDARD METHODS EXA
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Ko JJ, 2009, BIORESOURCE TECHNOL, V100, P1622, DOI 10.1016/j.biortech.2008.09.029
   KUWAHARA M, 1984, FEBS LETT, V169, P247, DOI 10.1016/0014-5793(84)80327-0
   Lee SE, 2012, J MICROBIOL BIOTECHN, V22, P1673, DOI 10.4014/jmb.1202.02049
   Linger JG, 2014, P NATL ACAD SCI USA, V111, P12013, DOI 10.1073/pnas.1410657111
   LUNDQUIST K, 1971, ACTA CHEM SCAND, V25, P889, DOI 10.3891/acta.chem.scand.25-0889
   Malaviya P, 2007, BIORESOURCE TECHNOL, V98, P3647, DOI 10.1016/j.biortech.2006.11.021
   Mishra M, 2010, BIODEGRADATION, V21, P967, DOI 10.1007/s10532-010-9356-x
   Oliveira LPD, 2009, BRAZ J MICROBIOL, V40, P818
   Pakshirajan K, 2009, APPL BIOCHEM BIOTECH, V157, P159, DOI 10.1007/s12010-008-8283-3
   Paliwal R, 2012, APPL BIOCHEM BIOTECH, V167, P1865, DOI 10.1007/s12010-012-9735-3
   Pang Y, 2011, BIORESOURCE TECHNOL, V102, P10733, DOI 10.1016/j.biortech.2011.08.078
   Pathak C, 2013, ENVIRON MONIT ASSESS, V185, P7343, DOI 10.1007/s10661-013-3104-8
   Pearl A, 1940, PAP TRADE J, V111, P35
   Philp JC, 2003, ANAL CHIM ACTA, V487, P61, DOI 10.1016/S0003-2670(03)00358-1
   Raghukumar C, 2001, APPL MICROBIOL BIOT, V55, P510, DOI 10.1007/s002530000579
   Raj A, 2007, INT BIODETER BIODEGR, V59, P292, DOI 10.1016/j.ibiod.2006.09.006
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   SALTER GJ, 1991, CURR OPIN BIOTECH, V2, P385, DOI 10.1016/S0958-1669(05)80143-0
   Shi K, 2013, BIOTECHNOL BIOFUELS, V6, P1
   Shi Y, 2013, BIOPROC BIOSYST ENG, V36, P1957, DOI 10.1007/s00449-013-0972-9
   Singh A, 2002, J ENVIRON BIOL, V23, P283
   Singhal V, 2005, J ENVIRON BIOL, V26, P525
   Sipsas V, 2009, J FOOD ENG, V90, P495, DOI 10.1016/j.jfoodeng.2008.07.016
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tayal AK, 1999, BIOMED CHROMATOGR, V13, P220, DOI 10.1002/(SICI)1099-0801(199905)13:3<220::AID-BMC823>3.0.CO;2-E
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Vos P, 2009, BERGEYS MANUAL SYSTE, V3
   Xu PA, 2012, CHEM ENG J, V203, P423, DOI 10.1016/j.cej.2012.07.048
   Yang C-F, 2007, J ENV ENG MANAG, V17, P157
   Yu JL, 2010, RENEW ENERG, V35, P1130, DOI 10.1016/j.renene.2009.11.045
NR 49
TC 11
Z9 12
U1 2
U2 27
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD MAY
PY 2015
VL 22
IS 9
BP 6842
EP 6853
DI 10.1007/s11356-014-3872-x
PG 12
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA CG1PX
UT WOS:000353046600042
PM 25433900
DA 2018-10-19
ER

PT J
AU Huang, WW
   Rollett, A
   Kaplan, DL
AF Huang, Wenwen
   Rollett, Alexandra
   Kaplan, David L.
TI Silk-elastin-like protein biomaterials for the controlled delivery of
   therapeutics
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE drug delivery; gene delivery; hydrogel; nanoparticle; protein;
   self-assembly; silk-elastin; stimuli responsive
ID STIMULI-RESPONSIVE NANOCARRIERS; INVERSE TEMPERATURE TRANSITION;
   CONTROLLED DRUG-DELIVERY; ENZYME-PRODRUG THERAPY; GENE DELIVERY;
   CONTROLLED-RELEASE; BLOCK-COPOLYMERS; ESCHERICHIA-COLI; CANCER-THERAPY;
   SOLID TUMORS
AB Introduction: Genetically engineered biomaterials are useful for controlled delivery owing to their rational design, tunable structure-function, biocompatibility, degradability and target specificity. Silk-elastin-like proteins (SELPs), a family of genetically engineered recombinant protein polymers, possess these properties. Additionally, given the benefits of combining semi-crystalline silk-blocks and elastomeric elastin-blocks, SELPs possess multi-stimuli-responsive properties and tunability, thereby becoming promising candidates for targeted cancer therapeutics delivery and controlled gene release.
   Areas covered: An overview of SELP biomaterials for drug delivery and gene release is provided. Biosynthetic strategies used for SELP production, fundamental physicochemical properties and self-assembly mechanisms are discussed. The review focuses on sequence-structure-function relationships, stimuli-responsive features and current and potential drug delivery applications.
   Expert opinion: The tunable material properties allow SELPs to be pursued as promising biomaterials for nanocarriers and injectable drug release systems. Current applications of SELPs have focused on thermally-triggered biomaterial formats for the delivery of therapeutics, based on local hyperthermia in tumors or infections. Other prominent controlled release applications of SELPs as injectable hydrogels for gene release have also been pursued. Further biomedical applications that utilize other stimuli to trigger the reversible material responses of SELPs for targeted delivery, including pH, ionic strength, redox, enzymatic stimuli and electric field, are in progress. Exploiting these additional stimuli-responsive features will provide a broader range of functional biomaterials for controlled therapeutics release and tissue regeneration.
C1 [Huang, Wenwen; Rollett, Alexandra; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083
FU NIH [P41 EB002520]
FX This work is supported by NIH Grant no. P41 EB002520. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript. This includes employment, consultancies, honoraria, stock
   ownership or options, expert testimony, grants or patents received or
   pending or royalties.
CR Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Anderson JP, 1998, BIOPOLYMERS, V45, P307
   ANDERSON JP, 1994, BIOPOLYMERS, V34, P1049, DOI 10.1002/bip.360340808
   Bikram M, 2008, EXPERT OPIN DRUG DEL, V5, P1077, DOI [10.1517/17425247.5.10.1077, 10.1517/17425247.5.10.1077 ]
   Boddy AV, 2005, CLIN CANCER RES, V11, P7834, DOI 10.1158/1078-0432.CCR-05-0803
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Brigger I, 2012, ADV DRUG DELIVER REV, V64, P24, DOI 10.1016/j.addr.2012.09.006
   Calejo MT, 2013, EXPERT OPIN DRUG DEL, V10, P1669, DOI 10.1517/17425247.2013.846906
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Chang J, 2011, J AM CHEM SOC, V133, P1745, DOI 10.1021/ja110191f
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Ciofani G, 2014, MACROMOL BIOSCI, V14, P632, DOI 10.1002/mabi.201300361
   Collins T, 2013, MICROB CELL FACT, V12, P1
   Collins T, 2014, BIOMACROMOLECULES, V15, P2701, DOI 10.1021/bm5005564
   COX BA, 1974, J BIOL CHEM, V249, P997
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dandu R, 2006, ACS SYM SER, V924, P150
   Dandu R, 2008, J BIOACT COMPAT POL, V23, P5, DOI 10.1177/0883911507085278
   Dandu R, 2007, PROG POLYM SCI, V32, P1008, DOI 10.1016/j.progpolymsci.2007.05.015
   Dandu R, 2009, POLYMER, V50, P366, DOI 10.1016/j.polymer.2008.11.047
   Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   DOEL MT, 1980, NUCLEIC ACIDS RES, V8, P4575, DOI 10.1093/nar/8.20.4575
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Ferrari FA, 1986, EP0293443A1, Patent No. 0293443
   Fleige E, 2012, ADV DRUG DELIVER REV, V64, P866, DOI 10.1016/j.addr.2012.01.020
   Florczak A, 2014, BIOMACROMOLECULES, V15, P2971, DOI 10.1021/bm500591p
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Frandsen JL, 2012, CHEM SOC REV, V41, P2696, DOI 10.1039/c2cs15303c
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gao HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02534
   Gaumet M, 2008, EUR J PHARM BIOPHARM, V69, P1, DOI 10.1016/j.ejpb.2007.08.001
   Ge ZS, 2013, CHEM SOC REV, V42, P7289, DOI 10.1039/c3cs60048c
   Ghandehari H, 2002, AM CHEM SOC, V224, P308
   Golinska MD, 2013, BIOMACROMOLECULES, V14, P48, DOI 10.1021/bm3011775
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Greish K, 2010, J GENE MED, V12, P572, DOI 10.1002/jgm.1469
   Gustafson J, 2009, J CONTROL RELEASE, V140, P256, DOI 10.1016/j.jconrel.2009.05.022
   Gustafson JA, 2010, ADV DRUG DELIVER REV, V62, P1509, DOI 10.1016/j.addr.2010.04.006
   Gustafson JA, 2010, MOL PHARMACEUT, V7, P1050, DOI 10.1021/mp100161u
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Hart DS, 2007, J PHARM SCI-US, V96, P484, DOI 10.1002/jps.20755
   Hatefi A, 2007, PHARM RES, V24, P773, DOI 10.1007/s11095-006-9200-5
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Huang J, 2004, AM CHEM SOC, V227, P188
   Huang WW, 2014, MACROMOLECULES, V47, P8107, DOI 10.1021/ma5016227
   Huang WW, 2014, MACROMOLECULES, V47, P8098, DOI 10.1021/ma5016215
   Huang WW, 2011, MACROMOLECULES, V44, P5299, DOI 10.1021/ma200563t
   Hwang D, 2009, INT J PHARM, V368, P215, DOI 10.1016/j.ijpharm.2008.10.021
   Hwang W, 2009, LANGMUIR, V25, P12682, DOI 10.1021/la9015993
   Johnson S, 2012, CHEM COMMUN, V48, P10654, DOI 10.1039/c2cc35384a
   Kim W, 2007, POLYM REV, V47, P93, DOI 10.1080/15583720601109586
   Krishnaji ST, 2011, LANGMUIR, V27, P1000, DOI 10.1021/la102638j
   Krishnaji ST, 2013, ADV FUNCT MATER, V23, P241, DOI 10.1002/adfm.201200510
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Li LQ, 2010, POLYM CHEM-UK, V1, P1160, DOI 10.1039/b9py00346k
   Liu YM, 2014, P NATL ACAD SCI USA, V111, pE2780, DOI 10.1073/pnas.1402909111
   Machado R., 2013, BIOMED MATER, V8, P1
   Machado R, 2013, AMB EXPRESS, V3, P1
   Mackay JA, 2008, INT J HYPERTHER, V24, P483, DOI 10.1080/02656730802149570
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Meyer DE, 2001, CANCER RES, V61, P1548
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/NMAT3776, 10.1038/nmat3776]
   Nagarsekar A, 2003, BIOMACROMOLECULES, V4, P602, DOI 10.1021/bm0201082
   Nakayama M, 2006, J CONTROL RELEASE, V115, P46, DOI 10.1016/j.jconrel.2006.07.007
   Ner Y, 2009, POLYMER, V50, P5828, DOI 10.1016/j.polymer.2009.09.017
   Nerini IF, 2014, CLIN PHARMACOL THER, V96, P224, DOI 10.1038/clpt.2014.105
   Numata K, 2012, MACROMOL BIOSCI, V12, P75, DOI 10.1002/mabi.201100274
   Numata K, 2011, BIOCONJUGATE CHEM, V22, P1605, DOI 10.1021/bc200170u
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m
   Ozaki C, 2014, J BIOMAT SCI-POLYM E, V25, P1266, DOI 10.1080/09205063.2014.926580
   Pei Y, 2004, J BIOMAT SCI-POLYM E, V15, P585, DOI 10.1163/156856204323046852
   Portney NG, 2006, ANAL BIOANAL CHEM, V384, P620, DOI 10.1007/s00216-005-0247-7
   Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561
   Pray L, 2008, NAT ED, V1, P51
   Price R, 2014, J CONTROL RELEASE, V190, P304, DOI 10.1016/j.jconrel.2014.06.016
   Price R, 2012, INT J PHARMACEUT, V427, P97, DOI 10.1016/j.ijpharm.2011.09.037
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Qiu WG, 2009, BIOMACROMOLECULES, V10, P602, DOI 10.1021/bm801296r
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Raucher D, 2008, EXPERT OPIN DRUG DEL, V5, P353, DOI 10.1517/17425247.5.3.353 
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Rincon AC, 2006, J BIOMED MATER RES A, V78A, P343, DOI 10.1002/jbm.a.30702
   Rodriguez-Cabello JC, 2007, J BIOMAT SCI-POLYM E, V18, P269, DOI 10.1163/156856207779996904
   Ryu JS, 2014, EUR J PHARM BIOPHARM, V88, P382, DOI 10.1016/j.ejpb.2014.05.016
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Shen W, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P243, DOI 10.1007/978-3-7091-0385-2_9
   Shi P, 2014, INT J NANOMED, V9, P1617, DOI 10.2147/IJN.S53886
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Somamoto S, 2012, J BIOTECHNOL BIOMATE, V2, P139
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sun ZY, 2013, J AM CHEM SOC, V135, P3675, DOI 10.1021/ja312647n
   Tjin MS, 2014, POLYM J, V46, P444, DOI 10.1038/pj.2014.65
   Urry DW, 2010, ADV DRUG DELIVER REV, V62, P1404, DOI 10.1016/j.addr.2010.07.001
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   URRY DW, 1985, BIOPOLYMERS, V24, P2345, DOI 10.1002/bip.360241212
   URRY DW, 1992, BIOPOLYMERS, V32, P373, DOI 10.1002/bip.360320413
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Wang Q, 2014, ADV FUNCT MATER, V24, P4303, DOI 10.1002/adfm.201304106
   Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002
   Wlodarczyk-Biegun MK, 2014, ACTA BIOMATER, V10, P3620, DOI 10.1016/j.actbio.2014.05.006
   Xia XX, 2014, BIOMACROMOLECULES, V15, P908, DOI 10.1021/bm4017594
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
   You YZ, 2008, CHEM MATER, V20, P3354, DOI 10.1021/cm703363w
   Yuan F, 1998, SEMIN RADIAT ONCOL, V8, P164, DOI 10.1016/S1053-4296(98)80042-8
   Zeng LK, 2014, MACROMOL RAPID COMM, V35, P1273, DOI 10.1002/marc.201400058
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
NR 128
TC 27
Z9 27
U1 8
U2 97
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD MAY
PY 2015
VL 12
IS 5
BP 779
EP 791
DI 10.1517/17425247.2015.989830
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CG3WA
UT WOS:000353209100007
PM 25476201
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Laird, D
   El-Baba, MD
   Charpin-El Hamri, G
   Eberwein, P
   Nelson, K
   Tomakidi, P
   Steinberg, T
AF Laird, Dougal
   El-Baba, Marie Daoud
   Charpin-El Hamri, Ghislaine
   Eberwein, Philipp
   Nelson, Katja
   Tomakidi, Pascal
   Steinberg, Thorsten
TI In vitro and in vivo biocompatibility evaluation of a novobiocin
   stimulus-responsive poly(ethylene glycol)-based hydrogel designed for
   soft tissue regeneration
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Poly(ethylene glycol) (PEG)-based hydrogel; stimulus responsive;
   impedance measurement; cytotoxicity; novobiocin; coumermycin;
   biocompatibility
ID PROTEIN; RGD; BIOMATERIALS; COMBINATION; EXPRESSION; SURFACES; CELLS
AB In vitro and in vivo biocompatibility evaluation of medical devices designed for soft tissue healing and regeneration is mandatory for new biomaterials targeted toward human application. To this end, a novel stimulus-responsive eight-arm poly(ethylene glycol) (PEG)-based hydrogel for soft tissue regeneration was subjected to preclinical safety evaluation. While in vitro safety testing included determination of half-maximal inhibitory concentrations by cell index impedance measurements, an in vivo pilot rat study focused on detectable signs of oral mucosal inflammation. In a hydrogel with a total volume of 40 mu L, the following concentrations of the constituents were released upon hydrogel dissolution in 1mL body fluid: PEG, 19 mu M; gyrase B, 152 mu M; and coumermycin, 76 mu M, while the dissolving agent novobiocin was effective in a range from 50 to 100 mu M. Concerning the components' biological effects, half-maximal inhibitory concentrations of 806 and 95 mu M for human oral mucosal gingival fibroblasts and gingival keratinocytes were calculated for novobiocin, proving gingival keratinocytes more susceptible to substance effects. Furthermore, with respect to coumermycin concentrations, half-maximal inhibitory concentrations of 10 and 3 mu M for gingival fibroblasts and gingival keratinocytes, respectively, were obtained, and thereby revealed coumermycin to be toxic in vitro. In vivo, submucosal hard palatal implantation of standard hydrogels showed no evidence of inflammation at any time point under study, which was supported by immunohistochemistry analysis. In order to realize the potential of such a promising stimulus-responsive hydrogel biomaterial concept for soft tissue wound healing and/or regenerative applications, the crosslinker coumermycin and its competitor novobiocin should be replaced by more innocuous alternative protein-ligand pairs.
C1 [Laird, Dougal; Tomakidi, Pascal; Steinberg, Thorsten] Univ Med Ctr Freiburg, Dept Oral Biotechnol, D-79106 Freiburg, Germany.
   [El-Baba, Marie Daoud; Charpin-El Hamri, Ghislaine] Univ Lyon, Dept Genie Biol, IUT, Lyon, France.
   [Eberwein, Philipp] Univ Eye Hosp Freiburg, Dept Ophthalmol, Freiburg, Germany.
   [Nelson, Katja] Univ Med Ctr Freiburg, Dept Craniomaxillofacial Surg, Freiburg, Germany.
RP Steinberg, T (reprint author), Univ Med Ctr Freiburg, Dept Oral Biotechnol, Hugstetterstr 55, D-79106 Freiburg, Germany.
EM thorsten.steinberg@uniklinik-freiburg.de
FU Deutsche Forschungsgemeinschaft/DFG [EB-478/2-1, TO-198/10-1]; Medical
   Faculty of the University of Freiburg
FX This study was supported by a grant of the Deutsche
   Forschungsgemeinschaft/DFG to Philipp Eberwein (EB-478/2-1) and Pascal
   Tomakidi (TO-198/10-1). Moreover, this work is part of the Research
   Consortium ProTissueMat funded by the Medical Faculty of the University
   of Freiburg.
CR Albandar JM, 1999, J PERIODONTOL, V70, P30, DOI 10.1902/jop.1999.70.1.30
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Buban T, 2004, CANCER GENET CYTOGEN, V149, P81, DOI 10.1016/S0165-4608(03)00297-8
   Chang CW, 2010, SOFT MATTER, V6, P5157, DOI 10.1039/c0sm00067a
   DRUSANO GL, 1986, ANTIMICROB AGENTS CH, V30, P42, DOI 10.1128/AAC.30.1.42
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Eustaquio AS, 2003, ARCH MICROBIOL, V180, P25, DOI 10.1007/s00203-003-0555-2
   FEDORKO J, 1969, APPL MICROBIOL, V18, P869
   Fleischmajer R, 1998, ANN NY ACAD SCI, V857, P212, DOI 10.1111/j.1749-6632.1998.tb10118.x
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474
   Guebeli RJ, 2013, ACTA BIOMATER, V9, P8272, DOI 10.1016/j.actbio.2013.05.008
   KENNEDY MJ, 1995, J CLIN ONCOL, V13, P1136, DOI 10.1200/JCO.1995.13.5.1136
   Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030
   Krishnan S, 2008, J MATER CHEM, V18, P3405, DOI 10.1039/b801491d
   KUTUZOV H, 1952, ANAT REC, V114, P67, DOI 10.1002/ar.1091140106
   Luhrmann A, 1998, ANTIMICROB AGENTS CH, V42, P1911, DOI 10.1128/AAC.42.8.1911
   Luong E, 2009, ADV BIOCHEM ENG BIOT, V114, P129, DOI 10.1007/10_2008_8
   Mahajan A, 2012, E J DENT, V2, P193
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Moodley K, 2011, J NEUROSCI METH, V200, P173, DOI 10.1016/j.jneumeth.2011.07.005
   Mussig E, 2010, EUR J CELL BIOL, V89, P315, DOI 10.1016/j.ejcb.2009.08.004
   NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5
   NORDENBERG J, 1992, BRIT J CANCER, V65, P183, DOI 10.1038/bjc.1992.38
   PALU G, 1984, BIOCHEM PHARMACOL, V33, P147, DOI 10.1016/0006-2952(84)90382-4
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054
   Pivodova V, 2011, BIOMED PAP, V155, P109, DOI 10.5507/bp.2011.021
   Ratliff BB, 2010, AM J PHYSIOL-RENAL, V299, pF178, DOI 10.1152/ajprenal.00102.2010
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SMITH RD, 1990, J AM SOC MASS SPECTR, V1, P53, DOI 10.1016/1044-0305(90)80006-9
   Tomakidi P, 2000, J OROFAC ORTHOP, V61, P2
   Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007
   Venault A, 2013, J NANOSCI NANOTECHNO, V13, P2656, DOI 10.1166/jnn.2013.7359
   Wang TW, 2006, J BIOMED MATER RES B, V79B, P379, DOI 10.1002/jbm.b.30552
   Wu LX, 2008, LEUKEMIA, V22, P1402, DOI 10.1038/leu.2008.89
   Zhang W, 2014, IEJSME, V14, P89
   Zhao HF, 2003, HUM GENE THER, V14, P1619, DOI 10.1089/104303403322542266
NR 37
TC 1
Z9 1
U1 0
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2015
VL 30
IS 3
BP 319
EP 339
DI 10.1177/0883911515570370
PG 21
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA CG6ZC
UT WOS:000353450600006
DA 2018-10-19
ER

PT J
AU Dawlee, S
   Jayabalan, M
AF Dawlee, S.
   Jayabalan, M.
TI Intrinsically radiopaque polyurethanes with chain extender 4,4
   '-isopropylidenebis [2-( 2,6-diiodophenoxy)ethanol] for biomedical
   applications
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Biocompatibility; cytotoxicity; iodinated polyurethanes; radiopacity;
   X-ray
ID METHACRYLATE COPOLYMER; BIOCOMPATIBILITY; ELASTOMERS; POLYMERIZATION;
   POLYMERS; UREA)
AB Radiopaque polyurethanes are used for medical applications as it allows post-operative assessment of the biomaterial devices using X-ray. Inherently, radiopaque polyurethanes based on polytetramethylene glycol (PTMG), polypropylene glycol, 4,4-methylenebis(phenyl isocyanate), and a new iodinated chain extender 4,4-isopropylidenebis[2-(2,6-diiodophenoxy)ethanol] with flexible spacers were synthesized and characterized. The iodinated polyurethanes were clear, optically transparent, and had high molecular weights. The polyurethanes also possessed excellent radiopacity and high thermal stability. The biocompatibility of the most promising iodinated polyurethane was evaluated both in vitro (cytotoxicity evaluation by direct contact and MTT assay, using L929 mouse fibroblast cells) and in vivo (toxicology studies in rabbits and subcutaneous implantation in rats). The material was nontoxic and well tolerated by the animals. Thus, these radiopaque and transparent polyurethanes are expected to have potential for various biomedical applications.
C1 [Dawlee, S.; Jayabalan, M.] Sree Chitra Tirunal Inst Med Sci & Technol, Polymer Sci Div, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
RP Jayabalan, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Polymer Sci Div, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
EM muthujayabalan@rediffmail.com
FU Council for Scientific and Industrial Research, New Delhi; Kerala State
   Council for Science, Technology and Environment, Trivandrum
FX S. D. acknowledges the financial support from Council for Scientific and
   Industrial Research, New Delhi and Kerala State Council for Science,
   Technology and Environment, Trivandrum.
CR Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1
   [Anonymous], 2002, ISO1099310
   Aviv H, 2009, BIOMATERIALS, V30, P5610, DOI 10.1016/j.biomaterials.2009.06.038
   Boelen EJH, 2008, J BIOMED MATER RES A, V86A, P76, DOI 10.1002/jbm.a.31601
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   Dawlee S, 2013, J BIOMATER APPL, V28, P28, DOI 10.1177/0885328211434090
   Dawlee S, 2012, J APPL POLYM SCI, V125, P2252, DOI 10.1002/app.36457
   Dawlee S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055002
   Dawlee S, 2009, J MATER SCI-MATER M, V20, P243, DOI 10.1007/s10856-008-3557-4
   EDGAR KJ, 1990, J ORG CHEM, V55, P5287, DOI 10.1021/jo00305a026
   Gogolewski S., 1996, DESK REFERENCE FUNCT, P657
   Ihova B, 1996, ADV DRUG DELIV REV, V21, P157
   ISO10993-6, 2007, ISO109936
   James NR, 2007, BIOMATERIALS, V28, P3182, DOI 10.1016/j.biomaterials.2007.03.025
   James NR, 2006, BIOMATERIALS, V27, P160, DOI 10.1016/j.biomaterials.2005.05.099
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   Kiran S, 2014, J BIOMED MATER RES A, V102, P3207, DOI 10.1002/jbm.a.34997
   Kiran S, 2012, J BIOMED MATER RES A, V100A, P3472, DOI 10.1002/jbm.a.34295
   Kiran S, 2009, BIOMATERIALS, V30, P5552, DOI 10.1016/j.biomaterials.2009.06.049
   Kwok CS, 2000, BIOMACROMOLECULES, V1, P139, DOI 10.1021/bm000292w
   Lakshmi S, 2003, J APPL POLYM SCI, V88, P2580, DOI 10.1002/app.12187
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Liaw DJ, 1997, J APPL POLYM SCI, V66, P1251, DOI 10.1002/(SICI)1097-4628(19971114)66:7<1251::AID-APP5>3.0.CO;2-F
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Pereira IHL, 2010, ACTA BIOMATER, V6, P3056, DOI 10.1016/j.actbio.2010.02.036
   Qu WQ, 2011, J POLYM SCI POL CHEM, V49, P2191, DOI 10.1002/pola.24649
   Sang L, 2014, J BIOMED MATER RES A, V102, P1121, DOI 10.1002/jbm.a.34777
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Velayudhan S, 2005, ACTA BIOMATER, V1, P201, DOI 10.1016/j.actbio.2004.11.005
   Zaharia C, 2008, ACTA BIOMATER, V4, P1762, DOI 10.1016/j.actbio.2008.06.009
   Zhao Jonathon Z, 2008, Biocompatible polymeric contrast agents and radiopaque materials for medical devices, Patent No. [8,197,796, 8197796]
   Zhao O H, 1992, J Biomed Mater Res, V26, P1019
NR 33
TC 0
Z9 0
U1 0
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2015
VL 29
IS 10
BP 1329
EP 1342
DI 10.1177/0885328214565221
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG3DB
UT WOS:000353156600001
PM 25542732
DA 2018-10-19
ER

PT J
AU Hong, JY
   Yon, J
   Lee, JS
   Lee, IK
   Yang, C
   Kim, MS
   Choi, SH
   Jung, UW
AF Hong, Ji-Youn
   Yon, Jeyoung
   Lee, Jung-Seok
   Lee, In-Kyeong
   Yang, Cheryl
   Kim, Min-Soo
   Choi, Seong-Ho
   Jung, Ui-Won
TI Effects of epigallocatechin-3-gallate on the healing of extraction
   sockets with a periapical lesion: A pilot study in dogs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bio-oss collagen; epigallocatechin gallate; histology; periapical
   periodontitis; tooth extraction
ID POLYPHENOL (-)-EPIGALLOCATECHIN GALLATE; RETROGRADE PERI-IMPLANTITIS;
   RIDGE PRESERVATION; TOOTH EXTRACTION; IMMEDIATE PLACEMENT; BIO-OSS(R)
   COLLAGEN; TISSUE ALTERATIONS; SITES; APICOECTOMY; OSTEOCLASTS
AB The aim of this study was to characterize the healing process of extraction sockets with a periapical lesion following immediate graft with collagenated bovine bone mineral (CBBM) soaked with epigallocatechin-3-gallate (EGCG). Following induction of periapical lesions in premolars in five dogs, treatment of extraction sockets was divided into three groups: control (no treatment) and two test groups, CBBM with or without EGCG. 3D reconstruction and superimposition of the digital images were used to measure the dimensional changes in alveolar ridge. Histologic specimen was evaluated in all groups. The horizontal ridge widths at 4-mm level were wider in both test groups (3.3 +/- 1.7 mm in CBBM; 3.0 +/- 1.7 mm in CBBM+EGCG) than in the control group (1.7 +/- 2.4 mm). Fibrosis and limited new bone formation were observed in the apical regions of test groups; however, the extent of fibrosis was less in the CBBM+EGCG group. Within the limitations of this study, it was conjectured that adjunctive use of EGCG with CBBM can be a candidate biomaterial in grafting of extraction socket with periapical lesion. Bone regeneration at the coronal region of the CBBM grafted socket might not be influenced by the presence of a periapical lesion. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 727-734, 2015.
C1 [Hong, Ji-Youn] Kyung Hee Univ, Dept Periodontol, Sch Dent, Seoul 134727, South Korea.
   [Yon, Jeyoung; Lee, Jung-Seok; Lee, In-Kyeong; Yang, Cheryl; Kim, Min-Soo; Choi, Seong-Ho; Jung, Ui-Won] Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, Seoul 120752, South Korea.
RP Jung, UW (reprint author), Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, Seoul 120752, South Korea.
EM drjew@yuhs.ac
OI Hong, Ji-Youn/0000-0003-1040-7077
FU Korea Health technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A120822]
FX Contract grant sponsor: Korea Health technology R&D Project, Ministry of
   Health & Welfare, Republic of Korea; contract grant number: A120822
CR Akhtar N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3368
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Ayangco L, 2001, INT J ORAL MAX IMPL, V16, P412
   Becker W, 1990, Int J Periodontics Restorative Dent, V10, P376
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Del Fabbro M, 2009, J ORAL MAXIL SURG, V67, P2476, DOI 10.1016/j.joms.2009.04.063
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x
   Hosokawa Y, 2010, MOL NUTR FOOD RES, V54, pS151, DOI 10.1002/mnfr.200900549
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Kamon M, 2010, CELL BIOL INT, V34, P109, DOI 10.1042/CBI20090011
   Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Lin SK, 2002, EUR J ORAL SCI, V110, P246, DOI 10.1034/j.1600-0447.2002.11227.x
   Maruyama T, 2011, ARCH ORAL BIOL, V56, P48, DOI 10.1016/j.archoralbio.2010.08.015
   Quirynen M, 2005, CLIN ORAL IMPLAN RES, V16, P599, DOI 10.1111/j.1600-0501.2005.01147.x
   Quirynen M, 2003, PERIODONTOL 2000, V33, P129, DOI 10.1046/j.0906-6713.2002.03311.x
   Rodd HD, 2007, DENT TRAUMATOL, V23, P328, DOI 10.1111/j.1600-9657.2006.00466.x
   SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915
   Siegenthaler DW, 2007, CLIN ORAL IMPLAN RES, V18, P727, DOI 10.1111/j.1600-0501.2007.01411.x
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Trope M, 1996, ORAL SURG ORAL MED O, V81, P221, DOI 10.1016/S1079-2104(96)80419-7
   Vier FV, 2002, INT ENDOD J, V35, P710, DOI 10.1046/j.1365-2591.2002.00554.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Waasdorp JA, 2010, J PERIODONTOL, V81, P801, DOI 10.1902/jop.2010.090706
   Wang CY, 1997, ORAL MICROBIOL IMMUN, V12, P65, DOI 10.1111/j.1399-302X.1997.tb00619.x
   Yang FJ, 1998, J NUTR, V128, P2334
   Yun JH, 2007, J PERIODONTAL RES, V42, P212, DOI 10.1111/j.1600-0765.2006.00935.x
   Yun JH, 2004, J PERIODONTAL RES, V39, P300, DOI 10.1111/j.1600-0765.2004.00743.x
NR 34
TC 1
Z9 1
U1 1
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2015
VL 103
IS 4
BP 727
EP 734
DI 10.1002/jbm.b.33238
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5MU
UT WOS:000353336800001
PM 25045081
DA 2018-10-19
ER

PT J
AU Lin, WJ
   Zhang, G
   Cao, P
   Zhang, DY
   Zheng, YF
   Wu, RX
   Qin, L
   Wang, GQ
   Wen, TY
AF Lin, Wenjiao
   Zhang, Gui
   Cao, Ping
   Zhang, Deyuan
   Zheng, Yufeng
   Wu, Rangxiu
   Qin, Li
   Wang, Geqi
   Wen, Taoyuan
TI Cytotoxicity and its test methodology for a bioabsorbable nitrided iron
   stent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioabsorbable; nitrided iron stent; cytotoxicity; size effect; test
   methodology
ID IN-VITRO CORROSION; FE-BASED ALLOYS; CORONARY-ARTERIES; PURE IRON;
   BIOCOMPATIBILITY; IMPLANTATION; BIOMATERIAL; DEGRADATION; RESISTANCE;
   MORPHOLOGY
AB Comprehensive assessments of the cytotoxicity of nitrided iron, a promising bioabsorbable metallic material, were conducted using in vitro methods. Extracting and standing experiments were conducted to determine the factors influencing the precipitation of the extract during extraction and incubation. The MTT method, fluorescent staining, and direct contact method were used to explore the in vitro cytotoxicity of nitrided iron stent extracts, nitrided iron foils, and their bulk corrosion products. The extracting and standing experiments confirmed that the extraction medium and available oxygen are crucial for precipitation during the extraction and incubation processes. In the MTT test, the extract of nitrided iron stents with a high iron ion concentration (124.11 +/- 7.55 g/mL) was not cytotoxic to L929 fibroblasts. Thus, the in vitro cytotoxicity of nitrided iron stents was actually caused by the size effect of corrosion particles and not the material itself. Test methodology for in vitro cytotoxicity of biodegradable iron-based materials was analyzed, and the results demonstrate that multiple methods should be combined for comprehensive evaluation of the cytocompatibility of bioabsorbable iron-based materials to get an impartial conclusion. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 764-776, 2015.
C1 [Lin, Wenjiao; Zhang, Gui; Zhang, Deyuan; Wu, Rangxiu; Qin, Li; Wang, Geqi; Wen, Taoyuan] Lifetech Sci Shenzhen Co Ltd, R&D Ctr, Shenzhen 518057, Peoples R China.
   [Cao, Ping] Shenzhen Testing Ctr Med Devices, Shenzhen 518057, Peoples R China.
   [Zheng, Yufeng] Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China.
RP Zhang, DY (reprint author), Lifetech Sci Shenzhen Co Ltd, R&D Ctr, Shenzhen 518057, Peoples R China.
EM zhangdeyuan_2012@163.com
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National 863 Program [2011AA030103]; Provincial Science and Technology
   Plan Program of Guangdong [2008A030102006]; Municipal Key Technologies
   R&D Program of Shenzhen [ZD200904300071A]; Municipal Special Funds for
   Industry-University-Research Institute Collaboration [SY200806270124A];
   Municipal Science and Technology Plan of Shenzhen-General Program
   [JSA201006010138A]
FX Contract grant sponsor: National 863 Program; contract grant number:
   2011AA030103; Contract grant sponsor: Provincial Science and Technology
   Plan Program of Guangdong; contract grant number: 2008A030102006;
   Contract grant sponsor: Municipal Key Technologies R&D Program of
   Shenzhen; contract grant number: ZD200904300071A; Contract grant
   sponsor: Municipal Special Funds for Industry-University-Research
   Institute Collaboration; contract grant number: SY200806270124A;
   Contract grant sponsor: Municipal Science and Technology Plan of
   Shenzhen-General Program; contract grant number: JSA201006010138A
CR ANSI/AAMI, 2007, ISO1099312 ANSIAAMI
   ANSI/AAMI, 2009, 109935 ISO
   Baek HS, 2005, YONSEI MED J, V46, P579, DOI 10.3349/ymj.2005.46.4.579
   Brien BO, 2009, ACTA BIOMATER, V5, P945
   Brown DA, 2009, J VASC INTERV RADIOL, V20, P315, DOI 10.1016/j.jvir.2008.11.007
   Chen CZ, 2010, SURF COAT TECH, V204, P3082, DOI 10.1016/j.surfcoat.2010.03.017
   Ciedlik M, 2011, CORROS SCI, V53, P296
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Feng QM, 2012, J MATER SCI-MATER M, V24, P713
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Gastaldi D, 2011, J MECH BEHAV BIOMED, V4, P352, DOI 10.1016/j.jmbbm.2010.11.003
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   Lei MK, 2001, BIOMATERIALS, V22, P641, DOI 10.1016/S0142-9612(00)00226-X
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Nie FL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065015
   Peuster M, 2006, CARDIOL YOUNG, V16, P107, DOI 10.1017/S1047951106000011
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Pierson D, 2012, J BIOMED MATER RES B, V100B, P58, DOI 10.1002/jbm.b.31922
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P782, DOI 10.1016/j.msec.2012.11.002
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Slottow TLP, 2008, CARDIOVASC REVASCULA, V9, P248, DOI 10.1016/j.carrev.2008.04.001
   Song MM, 2010, BIOMATERIALS, V31, P1509, DOI 10.1016/j.biomaterials.2009.11.034
   Speight JG, 2004, LANGES HDB CHEM, P1335
   Staiger MP, 2011, MATER SCI ENG B-ADV, V176, P1596, DOI 10.1016/j.mseb.2011.09.032
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Tamura K, 2002, MATER TRANS, V43, P3052, DOI 10.2320/matertrans.43.3052
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wang YB, 2012, MAT SCI ENG C-MATER, V32, P599, DOI 10.1016/j.msec.2011.12.018
   Wegener B, 2011, MATER SCI ENG B-ADV, V176, P1789, DOI 10.1016/j.mseb.2011.04.017
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu C, 2013, CHINESE MED J-PEKING, V126, P4752, DOI 10.3760/cma.j.issn.0366-6999.20131120
   Ying EB, 2010, SCI TOTAL ENVIRON, V408, P4475, DOI 10.1016/j.scitotenv.2010.07.025
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zhang X, 2011, ENG FAIL ANAL, V18, P1981, DOI 10.1016/j.engfailanal.2011.03.007
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 45
TC 8
Z9 9
U1 4
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2015
VL 103
IS 4
BP 764
EP 776
DI 10.1002/jbm.b.33246
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5MU
UT WOS:000353336800005
PM 25065998
DA 2018-10-19
ER

PT J
AU Yan, LP
   Oliveira, JM
   Oliveira, AL
   Reis, RL
AF Yan, L-P.
   Oliveira, J. M.
   Oliveira, A. L.
   Reis, R. L.
TI In vitro evaluation of the biological performance of macro/micro-porous
   silk fibroin and silk-nano calcium phosphate scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE silk fibroin; nano calcium phosphate; scaffold; cytocompatibility;
   biomechanical property
ID TISSUE-ENGINEERING APPLICATIONS; OF-THE-ART; BIOMATERIAL SCAFFOLDS;
   COMPOSITE SCAFFOLDS; ARTICULAR-CARTILAGE; BONE-FORMATION; 3-D SCAFFOLDS;
   STEM-CELLS; DELIVERY
AB This study evaluates the biological performance of salt-leached macro/microporous silk scaffolds (S16) and silk-nano calcium phosphate scaffolds (SC16), both deriving from a 16 wt % aqueous SF solution. Enzymatic degradation results showed that the silk-based scaffolds presented desirable biostability, and the incorporation of calcium phosphate further improved the scaffolds' biostability. Human adipose tissue derived stromal cells (hASCs) were cultured onto the scaffolds in vitro. The Alamar blue assay and DNA content revealed that both scaffolds were non-cytotoxic and can support the viability and proliferation of the hASCs. Scanning electron microscopy observation demonstrated that the microporous structure was beneficial for the cell adhesion while the macroporous structure favored the cell migration and proliferation. The histological analysis displayed abundant extracellular matrix formed inside the scaffolds, leading to the significant increase of scaffolds' modulus. These results revealed that S16 and SC16 could be promising alternatives for cartilage and bone tissue engineering scaffolding applications, respectively. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 888-898, 2015.
C1 [Yan, L-P.; Oliveira, J. M.; Oliveira, A. L.; Reis, R. L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Yan, L-P.; Oliveira, J. M.; Oliveira, A. L.; Reis, R. L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Oliveira, A. L.] Portuguese Catholic Univ, Sch Biotechnol, CBQF Ctr Biotechnol & Fine Chem, P-4200072 Oporto, Portugal.
RP Oliveira, JM (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Oliveira, Ana/J-3404-2013; Reis, Rui
   L./A-8938-2008; Oliveira, Joaquim Miguel/H-8636-2012
OI Group, 3Bs/0000-0002-5195-3456; Oliveira, Ana/0000-0001-8012-4203; Reis,
   Rui L./0000-0002-4295-6129; Oliveira, Joaquim
   Miguel/0000-0001-7052-8837; Yan, Leping/0000-0002-4806-5052
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM/105703/2008]; OsteoCart [PTDC/CTM-BPC/115977/2009]; European
   Union's FP7 Programme [REGPOT-CT2012-316331-POLARIS]; FCT
   [SFRH/BD/64717/2009, IF/00423/2012, IF/00411/2013]
FX Contract grant sponsor: Portuguese Foundation for Science and Technology
   (FCT); contract grant number: PTDC/CTM/105703/2008; Contract grant
   sponsor: OsteoCart; contract grant number: PTDC/CTM-BPC/115977/2009;
   Contract grant sponsor: European Union's FP7 Programme; contract grant
   number: REGPOT-CT2012-316331-POLARIS; Contract grant sponsor: FCT;
   contract grant numbers: SFRH/BD/64717/2009, IF/00423/2012, IF/00411/2013
CR Abbah SA, 2009, BIOMATERIALS, V30, P5086, DOI 10.1016/j.biomaterials.2009.05.067
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Collins AM, 2009, ADV MATER, V21, P75, DOI 10.1002/adma.200802239
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Duarte ARC, 2009, INT MATER REV, V54, P214, DOI 10.1179/174328009X411181
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim H. J., 2012, J TISSUE ENG, V3
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Oliveira AL, 2006, 20 EUR C BIOM NANT F
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Oliveira JM, 2009, J BIOMED MATER RES A, V91A, P175, DOI 10.1002/jbm.a.32213
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Yan LP, 2013, J BIOACT COMPAT POL, V28, P439, DOI 10.1177/0883911513503538
   Yan LP, 2013, NANOMEDICINE-UK, V8, P359, DOI [10.2217/NNM.12.118, 10.2217/nnm.12.118]
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
NR 43
TC 9
Z9 9
U1 0
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2015
VL 103
IS 4
BP 888
EP 898
DI 10.1002/jbm.b.33267
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5MU
UT WOS:000353336800019
PM 25164158
DA 2018-10-19
ER

PT J
AU Rokutanda, S
   Yanamoto, S
   Yamada, S
   Naruse, T
   Inokuchi, S
   Umeda, M
AF Rokutanda, Satoshi
   Yanamoto, Souichi
   Yamada, Shin-ichi
   Naruse, Tomofumi
   Inokuchi, Satoshi
   Umeda, Masahiro
TI Application of Polyglycolic Acid Sheets and Fibrin Glue Spray to Bone
   Surfaces During Oral Surgery: A Case Series
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID SKIN-GRAFTS; SEALANT; FELT
AB Purpose: Previous studies have described the use of a combination of polyglycolic acid (PGA) sheets (a resorbable biomaterial) and fibrin glue spray to treat open soft tissue wounds during oral surgery, which have produced good results. However, there have not been any detailed investigations of the use of these materials to treat exposed hard tissue wounds. This study investigated the combination of PGA sheets and fibrin glue spray to treat exposed bone surfaces during oral surgery.
   Materials and Methods: PGA sheets and fibrin glue spray were applied to exposed bone surfaces after lesion resection in 8 patients (10 sites) who had been diagnosed with malignant tumors. The sheets were cut into pieces (width, 5 to 10 mm) and applied to the exposed bone surface.
   Results: PGA adhesion was confirmed for the final time on postoperative days 28 to 56 (mean, 35.8 days), and there were no cases in which the PGA sheets fell off the wound prematurely. Epithelialization of the wound surface occurred gradually and was complete by postoperative weeks 4 to 5, regardless of the size of the wound.
   Conclusion: This method was considered very effective at preventing postoperative bleeding, alleviating postoperative pain, and promoting epithelialization during the reconstruction of bone surfaces after tumor resection in the oral cavity. (c) 2015 American Association of Oral and Maxillofacial Surgeons
C1 [Rokutanda, Satoshi; Yanamoto, Souichi; Yamada, Shin-ichi; Naruse, Tomofumi; Inokuchi, Satoshi; Umeda, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki 8528588, Japan.
RP Rokutanda, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.
EM satoshi6@nagasaki-u.ac.jp
CR Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5
   Doyama N, 2014, DIGEST ENDOSC, V26, P41
   HALL HD, 1970, J ORAL SURG, V28, P565
   Kobayashi S, 2011, SURG ENDOSC, V25, P3590, DOI 10.1007/s00464-011-1764-4
   Maniwa Tomohiro, 2009, Interact Cardiovasc Thorac Surg, V8, P697, DOI 10.1510/icvts.2008.201814
   Ochiai T, 2010, J GASTROINTEST SURG, V14, P884, DOI 10.1007/s11605-009-1149-3
   Qureshi SS, 2005, J SURG ONCOL, V89, P102, DOI 10.1002/jso.20192
   SCHRAMM VL, 1980, ARCH OTOLARYNGOL, V106, P528
   Shinozaki T, 2013, JPN J CLIN ONCOL, V43, P33, DOI 10.1093/jjco/hys186
   Takeuchi J, 2013, J ORAL MAXIL SURG, V71, pE126, DOI 10.1016/j.joms.2012.08.012
   Takimoto K, 2014, DIGEST ENDOSC, V26, P46, DOI 10.1111/den.12280
   Yonezawa H, 2012, BR J ORAL MAXILLOFAC, V50, P43
NR 12
TC 4
Z9 4
U1 0
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD MAY
PY 2015
VL 73
IS 5
BP 1017E1
EP 1017E6
DI 10.1016/j.joms.2015.01.014
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CG3AL
UT WOS:000353148700036
PM 25883005
DA 2018-10-19
ER

PT J
AU Francic, N
   Lyagin, IV
   Efremenko, EN
   Lobnik, A
AF Francic, Nina
   Lyagin, Ilya V.
   Efremenko, Elena N.
   Lobnik, Aleksandra
TI Hybrid sol-gel bio-films: influence of synthetic parameters on behaviour
   and performance of entrapped His(6)-tagged organophosphorus hydrolase
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on Solid State Physics (ICSSP)
CY DEC 01-06, 2013
CL Univ Punjab, Lahore, PAKISTAN
SP Ctr Excellence Solid State Phys, Biotroll Pvt Ltd, Dawn Sci, Sanco, Bana Int, Comp Engn Serv
HO Univ Punjab
DE Sol-gel; Silica thin film; Enzyme encapsulation; His(6)-tagged
   organophosphorus hydrolase; Organophosphate detoxification
ID INFRARED-SPECTROSCOPY; SILICA; IMMOBILIZATION; STABILIZATION;
   ENCAPSULATION; PESTICIDES; STRATEGIES; ENZYMES; SPECTRA; LIPASE
AB The presented work describes the optimising of sol-gel process parameters including the aging time of the sol, the water/silane ratios, type of precursor [tetramethoxysilane (TMOS) or tetraethoxysilane (TEOS)], and the precursor ratios using organically modified silanes [methyltrimethoxysilane (MTMOS) and 3-glycidoxypropyltrimethoxysilane (GPTMS)], for the successful entrapment of hexahistidine-tagged organophosphorus hydrolase (His(6)-OPH) and its applicability during organophosphate detoxification processes. The prepared bio-composite films retained enzyme activity by up to 90 % with expected differences between the starting sols' compositions. The obtained values of K-M and V-max for TMOS/MTMOS and TEOS/GPTMS bio-composites equalled 1.5 +/- A 0.1, 1.4 +/- A 0.3 mM, 0.40 +/- A 0.02 and 1.8 +/- A 0.2 mu M/s for paraoxon, respectively, thus assuming effective application of such biocatalysts during the detoxifications of organophosphorus compounds. Furthermore, the bio-composite films showed enhanced pH and temperature stability with respect to the free enzymes as they can be easily separated from the reactive media, as well as having multiple reusages.
   Bio-composite materials based on hexahistidine-tagged organophosphorus hydrolase were developed by enzyme encapsulation into silica sol-gel matrixes (tetramethoxysilane/methyltrimethoxysilane, tetraethoxysilane/3-glycidoxypropyltrimethoxysilane). The process of biomaterial production was optimised in several pathways and biomaterials were characterised via IR-spectroscopy, SEM-imaging, so as their catalytic efficiency in organophosphate hydrolysis.
C1 [Francic, Nina; Lobnik, Aleksandra] Univ Maribor, Ctr Sensor Technol, Fac Mech Engn, SLO-2000 Maribor, Slovenia.
   [Lyagin, Ilya V.; Efremenko, Elena N.] Moscow MV Lomonosov State Univ, Fac Chem, Chem Enzymol Dept, Moscow 119991, Russia.
RP Lobnik, A (reprint author), Univ Maribor, Ctr Sensor Technol, Fac Mech Engn, Smetanova 17, SLO-2000 Maribor, Slovenia.
EM aleksandra.lobnik@um.si
RI Efremenko, Elena/E-8386-2014; Lyagin, Ilya/E-6774-2014
OI Efremenko, Elena/0000-0002-6992-854X; Lyagin, Ilya/0000-0002-3970-4334
FU Slovenian Research Agency (ARRS) for Young Researchers [1000-08-310045];
   International Slovenia-Russia Cooperation in Science [BI-RU/10-11-017]
FX This work was supported by Grants from the Slovenian Research Agency
   (ARRS) for Young Researchers (1000-08-310045), and International
   Slovenia-Russia Cooperation in Science, 2010-2011, Project No.
   BI-RU/10-11-017.
CR Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004
   BRINKER CJ, 1994, J MEMBRANE SCI, V94, P85, DOI 10.1016/0376-7388(93)E0129-8
   Carlsson N, 2014, ADV COLLOID INTERFAC, V205, P339, DOI 10.1016/j.cis.2013.08.010
   Chen JP, 2003, ENZYME MICROB TECH, V32, P801, DOI 10.1016/S0141-0229(03)00052-8
   Chu L, 1997, MICROPOROUS MATER, V8, P207, DOI 10.1016/S0927-6513(96)00068-5
   Cipolatti EP, 2014, J MOL CATAL B-ENZYM, V99, P56, DOI 10.1016/j.molcatb.2013.10.019
   Ciriminna R, 2013, CHEM REV, V113, P6592, DOI 10.1021/cr300399c
   Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME
   Cumana S, 2013, J MOL CATAL B-ENZYM, V85-86, P220, DOI 10.1016/j.molcatb.2012.09.014
   Efremenko E, 2006, APPL MICROBIOL BIOT, V70, P558, DOI 10.1007/s00253-005-0103-x
   Efremenko EN, 2001, RUSS CHEM B+, V50, P1826, DOI 10.1023/A:1014377912147
   Francic N, 2011, ANAL BIOANAL CHEM, V401, P2631, DOI 10.1007/s00216-011-5336-1
   Gallardo J, 2002, J NON-CRYST SOLIDS, V298, P219, DOI 10.1016/S0022-3093(02)00921-3
   Hwang ET, 2013, ENG LIFE SCI, V13, P49, DOI 10.1002/elsc.201100225
   Innocenzi P, 2003, J NON-CRYST SOLIDS, V316, P309, DOI 10.1016/S0022-3093(02)01637-X
   Koszelewski D, 2010, J MOL CATAL B-ENZYM, V63, P39, DOI 10.1016/j.molcatb.2009.12.001
   Lyagin IV, 2014, MOSC UNIV CHEM BULL, V69, P125, DOI 10.3103/S0027131414030055
   Muroya M, 1999, COLLOID SURFACE A, V157, P147, DOI 10.1016/S0927-7757(99)00054-0
   Reetz MT, 2003, ADV SYNTH CATAL, V345, P717, DOI 10.1002/adsc.200303016
   Sirotkina M, 2012, INT BIODETER BIODEGR, V68, P18, DOI 10.1016/j.ibiod.2011.12.004
   Stepankova V, 2013, ACS CATAL, V3, P2823, DOI 10.1021/cs400684x
   Votchitseva YA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P167, DOI 10.1134/S0006297906020088
   Yang G, 2009, BIORESOURCE TECHNOL, V100, P4311, DOI 10.1016/j.biortech.2009.03.069
NR 23
TC 2
Z9 2
U1 0
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD MAY
PY 2015
VL 74
IS 2
BP 387
EP 397
DI 10.1007/s10971-014-3609-9
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA CG7HF
UT WOS:000353472900015
DA 2018-10-19
ER

PT J
AU Behera, PS
   Vasanthavel, S
   Ponnilavan, V
   Kannan, S
AF Behera, Pallavi Suhasinee
   Vasanthavel, S.
   Ponnilavan, V.
   Kannan, S.
TI Influence of gadolinium content on the tetragonal to cubic phase
   transition in zirconia-silica binary oxides
SO JOURNAL OF SOLID STATE CHEMISTRY
LA English
DT Article
DE Zirconia; Silica; Gadolinium; Cubic; Tetragonal; Magnetic
ID NEPHROGENIC SYSTEMIC FIBROSIS; PARTIALLY STABILIZED ZIRCONIA; MRI
   CONTRAST AGENTS; MAGNETIC-PROPERTIES; CRYSTALLINE PHASES; GRADE
   ZIRCONIA; ZRO2; BIOCERAMICS; BIOMATERIAL; GADODIAMIDE
AB The present study reports the effect of gadolinium (Gd3+) in zirconia-silica (ZrO2-SiO2) binary oxides. The pure ZrO2-SiO2 synthesized at 1100 degrees C was tetragonal. The addition of Gd3+ in the concentration range of 5%-10% resulted in the formation of t-ZrO2, whereas higher contents of Gd3+ led to the formation of cubic ZrO2 (c-ZrO2). The presence of Gd3+ also affected the lattice parameters of both t-ZrO2 and c-ZrO2. Magnetic studies confirmed a steady increase in the paramagnetic behaviour with increasing content of Gd3+. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Behera, Pallavi Suhasinee; Vasanthavel, S.; Ponnilavan, V.; Kannan, S.] Pondicherry Univ, Ctr Nanosci & Technol, Pondicherry 605014, India.
RP Kannan, S (reprint author), Pondicherry Univ, Ctr Nanosci & Technol, Pondicherry 605014, India.
EM skannan.nst@pondiuni.edu.in
RI S, Kannan/Q-4342-2017
OI S, Kannan/0000-0003-2285-4907
FU Council of Scientific and Industrial Research, India (CSIR Scheme)
   [22(612)/12/EMR-II]
FX The authors are thankful to the financial support received from the
   Council of Scientific and Industrial Research, India (CSIR Scheme No.
   22(612)/12/EMR-II). The Instrumentation facility availed from the
   Central Instrumentation Facility (CIF) of Pondicherry University is
   greatly acknowledged.
CR ACOSTA DR, 1995, J MATER RES, V10, P1397, DOI 10.1557/JMR.1995.1397
   Allain J, 1999, J BONE JOINT SURG BR, V81B, P835, DOI 10.1302/0301-620X.81B5.9454
   Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p
   CARLONE C, 1992, PHYS REV B, V45, P2079, DOI 10.1103/PhysRevB.45.2079
   Catledge SA, 2003, J MATER SCI-MATER M, V14, P863, DOI 10.1023/A:1025678525474
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Collidge TA, 2007, RADIOLOGY, V245, P168, DOI 10.1148/radiol.2451070353
   del Monte F, 2000, J AM CERAM SOC, V83, P1506
   del Monte F, 2000, J AM CERAM SOC, V83, P628
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Gremillard L, 2002, J AM CERAM SOC, V85, P401
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   Hayek S.S., 2008, BIOMED SCI ENG, V1, P182
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOWARD CJ, 1988, ACTA CRYSTALLOGR B, V44, P116, DOI 10.1107/S0108768187010279
   Hummer CD, 1995, J ARTHROPLASTY, V10, P848, DOI 10.1016/S0883-5403(05)80085-3
   Iqbal MA, 2013, J ALLOY COMPD, V579, P181, DOI 10.1016/j.jallcom.2013.06.033
   Kobayashi Y., 2013, ISRN NANOTECHNOL, P1
   Larson A. C., 2004, LOS ALAMOS NATL LAB, P86
   Leiner T, 2007, EUR RADIOL, V17, P1921, DOI 10.1007/s00330-007-0663-5
   Lopez EF, 2001, J MATER CHEM, V11, P1891
   Murtaza G, 2014, CURR APPL PHYS, V14, P176, DOI 10.1016/j.cap.2013.11.002
   Peng JH, 2011, J MAGN MAGN MATER, V323, P133, DOI 10.1016/j.jmmm.2010.08.048
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   SMITH DK, 1965, ACTA CRYSTALLOGR, V18, P983, DOI 10.1107/S0365110X65002402
   Telgmann L, 2013, ANAL CHIM ACTA, V764, P1, DOI 10.1016/j.aca.2012.12.007
   Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242
   Vasanthavel S, 2014, J AM CERAM SOC, V97, P635, DOI 10.1111/jace.12672
   Wang YL, 2007, SOLID STATE IONICS, V178, P53, DOI 10.1016/j.ssi.2006.11.003
   WYCKOFF RWG, 1963, CRYSTAL STRUCTURES, V0001
   Xu HT, 2008, J MATER SCI-MATER EL, V19, P589, DOI 10.1007/s10854-007-9394-2
NR 38
TC 13
Z9 13
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4596
EI 1095-726X
J9 J SOLID STATE CHEM
JI J. Solid State Chem.
PD MAY
PY 2015
VL 225
BP 305
EP 309
DI 10.1016/j.jssc.2014.12.029
PG 5
WC Chemistry, Inorganic & Nuclear; Chemistry, Physical
SC Chemistry
GA CF8QW
UT WOS:000352828000043
DA 2018-10-19
ER

PT J
AU Saied, A
   David, J
   Labarbera, K
   Katz, SC
   Somasundar, P
AF Saied, Abdul
   David, Jenny
   Labarbera, Kim
   Katz, Steven C.
   Somasundar, Ponnandai
TI Chemotherapy Does Not Adversely Impact Outcome Following Post-Incisional
   Hernia Repair With Biomaterial Mesh
SO JOURNAL OF SURGICAL ONCOLOGY
LA English
DT Article
DE chemotherapy; post-incisional hernia repair; biological mesh
ID LIVER-TRANSPLANTATION; SURGICAL-TREATMENT; MATRIX
AB BackgroundPatients receiving chemotherapy are at increased risk for developing recurrent or post-incisional hernias (PIH). Biological materials are an alternative to synthetic mesh in contaminated fields. The impact of chemotherapy on biomaterial tissue ingrowth and integration has not been well studied.
   MethodsFrom 2008 to 2011 patients who underwent PIH repair with biomaterial mesh (Biodesign (R)) were selected. Patients were divided into two groups: those receiving chemotherapy (CT) and those not receiving chemotherapy (NCT).
   ResultsForty-five patients were identified, 28 (62%) in the NCT group and 17 (38%) in the CT group. Median follow up for NCT and CT groups were 27 and 17 months, respectively. A total of 9/45 (20%) surgical site infections (SSI) were diagnosed, with 6/28 (21%) in the NCT and 3/17 (18%) in the CT group (P=0.53). Seroma formation was seen in 5/28 (18%) of NCT patients and 4/17 (23%) in CT group (P=0.46). Overall hernia recurrence rate was 22%, and the rates of recurrence were similar among the CT 3/17 (18%) and NCT 7/28 (25%) groups (P=0.42).
   ConclusionThe use of perioperative chemotherapy did not increase the rate of wound complications following PIH repair with biologic mesh in this group of patients. J. Surg. Oncol. 2015 111:725-728. (c) 2015 Wiley Periodicals, Inc.
C1 [Saied, Abdul; David, Jenny; Labarbera, Kim; Katz, Steven C.; Somasundar, Ponnandai] Roger Williams Med Ctr, Dept Surg, Providence, RI 02908 USA.
   [Katz, Steven C.; Somasundar, Ponnandai] Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA.
RP Somasundar, P (reprint author), Roger Williams Med Ctr, Dept Surg, 825 Chalkstone Ave, Providence, RI 02908 USA.
EM psomasun@chartercare.org
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Boutros C, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-72
   Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008
   Brewer MB, 2011, HERNIA, V15, P141, DOI 10.1007/s10029-010-0748-y
   Burger JWA, 2005, WORLD J SURG, V29, P1608, DOI 10.1007/s00268-005-7929-3
   Cheng H, 2007, Hernia, V11, P129, DOI 10.1007/s10029-006-0176-1
   Cordon CR, 2009, ANN PLAS SURG, V62, P707, DOI 10.1097/SAP.0b013e3181828141
   De Ugarte DA, 2003, J SURG RES, V112, P65, DOI 10.1016/S0022-4804(03)00107-0
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Hirsch EF, 2004, J AM COLL SURGEONS, V198, P324, DOI 10.1016/j.jamcollsurg.2003.09.016
   Hodde J, 2007, ACTA CHIR BELG, V107, P641, DOI 10.1080/00015458.2007.11680139
   Holton Luther H 3rd, 2005, J Long Term Eff Med Implants, V15, P547
   Itani KMF, 2012, SURGERY, V152, P498, DOI 10.1016/j.surg.2012.04.008
   Janssen H, 2002, BRIT J SURG, V89, P1049, DOI 10.1046/j.1365-2168.2002.02165.x
   Krpata DM, 2013, SURGERY, V153, P120, DOI 10.1016/j.surg.2012.06.003
   Nho RLH, 2012, J VISC SURG, V149, pE3, DOI 10.1016/j.jviscsurg.2012.05.004
   Ong ES, 2006, J GASTROINTEST SURG, V10, P202, DOI 10.1016/j.gassur.2005.07.004
   Piazzese E, 2004, TRANSPLANT P, V36, P3097, DOI 10.1016/j.transproceed.2004.10.047
   Rettenmaier MA, 2009, J GYNECOL ONCOL, V20, P246, DOI 10.3802/jgo.2009.20.4.246
   SUGARBAKER PH, 1985, ANN SURG, V201, P344, DOI 10.1097/00000658-198503000-00015
NR 20
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-4790
EI 1096-9098
J9 J SURG ONCOL
JI J. Surg. Oncol.
PD MAY 1
PY 2015
VL 111
IS 6
BP 725
EP 728
DI 10.1002/jso.23869
PG 4
WC Oncology; Surgery
SC Oncology; Surgery
GA CG6ND
UT WOS:000353417700011
PM 25580588
OA Other Gold
DA 2018-10-19
ER

PT J
AU McMurray, RJ
   Dalby, MJ
   Tsimbouri, PM
AF McMurray, Rebecca J.
   Dalby, Matthew J.
   Tsimbouri, P. Monica
TI Using biomaterials to study stem cell mechanotransduction, growth and
   differentiation
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Review
DE stem cell; self-renewal; differentiation; mechanotransduction; cell
   adhesion; integrins; topography; biomaterials
ID SELF-ASSEMBLED MONOLAYERS; ACTIVATED PROTEIN-KINASE; PRIMARY CILIUM;
   IN-VITRO; SIGNALING PATHWAYS; EXTRACELLULAR-MATRIX; SPINDLE ORIENTATION;
   LINEAGE COMMITMENT; MAMMALIAN-CELLS; CYCLE CONTROL
AB Self-renewal and differentiation are two fundamental characteristics of stem cells. Stem cell self-renewal is critical for replenishing the stem cell population, while differentiation is necessary for maintaining tissue homeostasis. Over the last two decades a great deal of effort has been applied to discovering the processes that control these opposing stem cell fates. One way of examining the role of the physical environment is the use of biomaterial strategies that have the ability to manipulate cells without any requirement for chemical factors. The mechanism whereby cells have been found to respond to a mechanical stimulus is termed mechanotransduction, the process by which a mechanical cue (or alteration in cell spreading changing internal cellular mechanics, i.e. intracellular tension) is transduced into a chemical signal inside the cell, eliciting changes in gene expression. This can occur either directly, as a result of changes in the cell cytoskeleton, or indirectly through a series of biochemical signalling cascades. The main focus of this review is to examine the role of mechanotransduction in the differentiation and self-renewal of stem cells. In particular, we will focus on the use of biomaterials as a tool for examining mechanotrandsuctive effects on self-renewal and differentiation. (c) 2014 The Authors. Journal of Tissue Engineering and Regenerative Medicine published by John Wiley & Sons, Ltd.
C1 [McMurray, Rebecca J.] Northwestern Univ, Dept Biomed Engn, Mrksich Res Grp, Evanston, IL 60208 USA.
   [Dalby, Matthew J.; Tsimbouri, P. Monica] Univ Glasgow, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Dalby, MJ (reprint author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM matthew.dalby@glasgow.ac.uk
OI Dalby, Matthew/0000-0002-0528-3359; Tsimbouri,
   Penelope/0000-0001-5124-7458
FU BBSRC [BB/G008868/1]; Wellcome Trust ISSF fellowship; Biotechnology and
   Biological Sciences Research Council [BB/G008868/1]; Engineering and
   Physical Sciences Research Council [EP/K034898/1]
FX This study was supported by grants from BBSRC (grant number
   BB/G008868/1) and a Wellcome Trust ISSF fellowship awarded to M.P.T.
CR Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069
   Biggs MJP, 2010, P I MECH ENG H, V224, P1441, DOI 10.1243/09544119JEIM775
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Caplan AI, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, P243, DOI 10.1016/B978-0-12-374729-7.00029-9
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120
   Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7
   Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676
   Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426
   Connelly JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027259
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Curran JM, 2010, LAB CHIP, V10, P1662, DOI 10.1039/c004149a
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   CURTIS ASG, 1978, NATURE, V274, P52, DOI 10.1038/274052a0
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby Matthew J, 2007, Methods Mol Biol, V370, P121
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Ebara M, 2012, ADV MATER, V24, P273, DOI 10.1002/adma.201102181
   Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132
   Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989
   Fus J, 2010, NAT METHODS, V7, P733
   Georges GE, 2007, BIOL BLOOD MARROW TR, V13, P423, DOI 10.1016/j.bbmt.2006.11.011
   Ghule PN, 2011, J CELL PHYSIOL, V226, P1149, DOI 10.1002/jcp.22440
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Hes S, 2009, ANNU REV CELL DEV BI, V25, P377
   Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235
   HUMPHRIES MJ, 1990, J CELL SCI, V97, P585
   Ingber D E, 1997, Gravit Space Biol Bull, V10, P49
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingmar Schoens BLP, 2013, ANN REV MATER RES, V43, P589
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Kanamori T, 2008, EMBO J, V27, P1647, DOI 10.1038/emboj.2008.102
   Kawakami K, 2001, J CELL SCI, V114, P3125
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kims S, 2011, NAT CELL BIOL, V13, P351
   Kingham E, 2013, SMALL, V9, P2140, DOI 10.1002/smll.201202340
   Kingham E, 2013, ACS NANO, V7, P1867, DOI 10.1021/nn3037094
   Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028
   KORNBERG L, 1992, J BIOL CHEM, V267, P23439
   Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223
   Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608
   Les DM, 2011, ADV MATER, V23, P3278
   Lims SH, 2010, BIOMATERIALS, V31, P9031
   Lis A, 2011, NAT CELL BIOL, V13, P402
   Lis L, 2005, ANNU REV CELL DEV BI, V21, P605
   Maniotis AJ, 1997, J CELL BIOCHEM, V65, P114
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312
   Mbalaviele G, 2000, J BIOL CHEM, V275, P14388, DOI 10.1074/jbc.275.19.14388
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Muraglia A, 2000, J CELL SCI, V113, P1161
   Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0
   Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075
   Ohs S, 2009, P NATL ACAD SCI USA, V106, P2130
   Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269
   Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x
   Paszek P, 2005, J THEOR BIOL, V233, P423, DOI 10.1016/j.jtbi.2004.10.023
   Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qis L, 2013, PLOS ONE, V8
   Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498
   SAVATIER P, 1994, ONCOGENE, V9, P809
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571
   Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Sherley JL, 2002, STEM CELLS, V20, P561, DOI 10.1634/stemcells.20-6-561
   Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402
   Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365
   Simmonss PJ, 2009, FASEB J, V23, P303
   STEIN GS, 1990, FASEB J, V4, P3111
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001
   Todd SJ, 2007, SOFT MATTER, V3, P547, DOI 10.1039/b618256a
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   Toledanos H, 2009, MECH REGULATING STEM
   Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599
   Trappmann B, 2013, CURR OPIN BIOTECH, V24, P948, DOI 10.1016/j.copbio.2013.03.020
   Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m
   Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436
   Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x
   Ullah M, 2013, DIFFERENTIATION, V85, P78, DOI 10.1016/j.diff.2013.02.001
   Vincente-Manzanaress M, 2005, J CELL SCI, V118, P4917, DOI [10.1242/jcs.02662, DOI 10.1242/JCS.02662]
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214
   Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84
   Wang YS, 2011, BIOMATERIALS, V32, P6737, DOI 10.1016/j.biomaterials.2011.05.075
   Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649
   WEISS P, 1952, P NATL ACAD SCI USA, V38, P264, DOI 10.1073/pnas.38.3.264
   White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.E04-12-1056
   White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Wirkner M, 2011, CHEMBIOCHEM, V12, P2623, DOI 10.1002/cbic.201100437
   Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Xies T, 2000, SCIENCE, V290, P328
   Yadlapalli S, 2013, NATURE, V498, P251, DOI 10.1038/nature12106
   Yamashita YM, 2010, CURR OPIN CELL BIOL, V22, P605, DOI 10.1016/j.ceb.2010.07.009
   Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313
   Yamashita YM, 2009, FRONT BIOSCI-LANDMRK, V14, P3003, DOI 10.2741/3430
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yeos WS, 2001, CHEM BIOCH, V2, P590
   Yeos WS, 2006, LANGMUIR, V22, P10816
   Yims EK, 2010, BIOMATERIALS, V31, P1299
   Yims EK, 2007, EXP CELL RES, V313, P1820
   Yoshikawa HY, 2011, J AM CHEM SOC, V133, P1367, DOI 10.1021/ja1060615
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105
   Zhus X, 1995, MOL BIOL CELL, V6, P273
NR 153
TC 22
Z9 23
U1 3
U2 67
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAY
PY 2015
VL 9
IS 5
BP 528
EP 539
DI 10.1002/term.1957
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CG6HI
UT WOS:000353399400005
PM 25370612
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Guerriero, G
   Hausman, JF
   Strauss, J
   Ertan, H
   Siddiqui, KS
AF Guerriero, Gea
   Hausman, Jean-Francois
   Strauss, Joseph
   Ertan, Haluk
   Siddiqui, Khawar Sohail
TI Destructuring plant biomass: Focus on fungal and extremophilic cell wall
   hydrolases
SO PLANT SCIENCE
LA English
DT Review
DE Lignocellulosic biomass; Saccharification; Carbohydrate-active enzymes;
   Fungal secretome; Extremozymes; Synergistic activation
ID ISOTHERMAL TITRATION CALORIMETRY; NEOCALLIMASTIX-PATRICIARUM J11;
   CROSS-PATHWAY CONTROL; LIGNOCELLULOSIC BIOMASS; BETA-GLUCOSIDASE;
   CELLOBIOSE DEHYDROGENASE; ENZYMATIC-HYDROLYSIS; BIOFUEL PRODUCTION;
   NEUROSPORA-CRASSA; CALDICELLULOSIRUPTOR-BESCII
AB The use of plant biomass as feedstock for biomaterial and biofuel production is relevant in the current bio-based economy scenario of valorizing renewable resources. Fungi, which degrade complex and recalcitrant plant polymers, secrete different enzymes that hydrolyze plant cell wall polysaccharides. The present review discusses the current research trends on fungal, as well as extremophilic cell wall hydrolases that can withstand extreme physico-chemical conditions required in efficient industrial processes. Secretomes of fungi from the phyla Ascomycota, Basidiomycota, Zygomycota and Neocallimastigomycota are presented along with metabolic cues (nutrient sensing, coordination of carbon and nitrogen metabolism) affecting their composition. We conclude the review by suggesting further research avenues focused on the one hand on a comprehensive analysis of the physiology and epigenetics underlying cell wall degrading enzyme production in fungi and on the other hand on the analysis of proteins with unknown function and metagenomics of extremophilic consortia. The current advances in consolidated bioprocessing, altered secretory pathways and creation of designer plants are also examined. Furthermore, recent developments in enhancing the activity, stability and reusability of enzymes based on synergistic, proximity and entropic effects, fusion enzymes, structure-guided recombination between homologous enzymes and magnetic enzymes are considered with a view to improving saccharification. (C) 2015 Published by Elsevier Ireland Ltd.
C1 [Guerriero, Gea; Hausman, Jean-Francois] Luxembourg Inst Sci & Technol, Environm Res & Innovat ERIN, Esch Sur Alzette, Luxembourg.
   [Strauss, Joseph] Univ Nat Resources & Life Sci Vienna BOKU, Fungal Genet & Genom Unit, Dept Appl Genet & Cell Biol, Tulln Donau, Austria.
   [Strauss, Joseph] Austrian Inst Technol GmbH AIT, Hlth & Environm Dept, Tulln Donau, Austria.
   [Ertan, Haluk] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
   [Ertan, Haluk] Istanbul Univ, Dept Mol Biol & Genet, Istanbul, Turkey.
   [Siddiqui, Khawar Sohail] King Fand Univ Petr & Minerals, Dept Biol, Dhahran, Saudi Arabia.
RP Guerriero, G (reprint author), Luxembourg Inst Sci & Technol, Environm Res & Innovat ERIN, Esch Sur Alzette, Luxembourg.
EM gea.guerriero@list.lu; ksiddiqui@kfupm.edu.sa
RI Guerriero, Gea/B-4883-2013
OI Guerriero, Gea/0000-0001-6586-6997; Strauss, Joseph/0000-0003-0474-6267
FU Austrian Science Fund (FWF) [M1315]; Fonds National de la Recherche,
   Luxembourg [CANCAN C13/SR/5774202, CAD-WALL INTER/FWO/12/14]; Lower
   Austria Science Fund NFB [LS12-009]
FX GG gratefully acknowledges the Austrian Science Fund (FWF;
   http://www.fwf.ac.at/en/) Grant No. M1315. GG and JFH wish to thank the
   support by the Fonds National de la Recherche, Luxembourg, (Project
   CANCAN C13/SR/5774202 and project CAD-WALL INTER/FWO/12/14). JS
   acknowledges the support by the Lower Austria Science Fund NFB grant
   LS12-009. Personal assistance of KSS by KFUPM is acknowledged. Dr Lucia
   Silvestrini is thanked for providing the scanning electron microscope
   picture of A. nidulans appearing in the Graphical Abstract. The funde'rs
   had no role in the preparation of the manuscript.
CR Adav SS, 2012, J PROTEOMICS, V75, P1493, DOI 10.1016/j.jprot.2011.11.020
   Adlakha N, 2012, APPL ENVIRON MICROB, V78, P7447, DOI 10.1128/AEM.01386-12
   Alfaro M, 2014, J PROTEOMICS, V102, P28, DOI 10.1016/j.jprot.2014.03.001
   Alftren J, 2014, BIOMASS BIOENERG, V65, P72, DOI 10.1016/j.biombioe.2014.03.009
   Alftren J, 2013, APPL BIOCHEM BIOTECH, V169, P2076, DOI 10.1007/s12010-013-0122-5
   Anand A, 2013, EXTREMOPHILES, V17, P357, DOI 10.1007/s00792-013-0524-x
   Aono E, 2010, MOL BIOSYST, V6, P1216, DOI 10.1039/c000396d
   Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4
   Arfi Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2850
   Bae J, 2015, APPL ENVIRON MICROB, V81, P59, DOI 10.1128/AEM.02864-14
   Banerjee S, 2010, BIOFUEL BIOPROD BIOR, V4, P77, DOI 10.1002/bbb.188
   Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38
   Baumann MJ, 2011, ANAL BIOCHEM, V410, P19, DOI 10.1016/j.ab.2010.11.001
   Biver S, 2014, J IND MICROBIOL BIOT, V41, P479, DOI 10.1007/s10295-014-1400-0
   Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007
   Blumer-Schuette SE, 2014, FEMS MICROBIOL REV, V38, P393, DOI 10.1111/1574-6976.12044
   Bommarius AS, 2014, CURR OPIN BIOTECH, V29, P139, DOI 10.1016/j.copbio.2014.04.007
   Boussaid A, 1999, BIOTECHNOL BIOENG, V64, P284, DOI 10.1002/(SICI)1097-0290(19990805)64:3<284::AID-BIT4>3.0.CO;2-C
   Braus GH, 2006, MED MYCOL, V44, pS91, DOI 10.1080/13693780600898029
   Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731
   Brown NA, 2014, MOL MICROBIOL, V94, P1103, DOI 10.1111/mmi.12820
   Brown NA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-91
   Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182
   Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273
   Burguener German F, 2014, Genome Announc, V2, DOI 10.1128/genomeA.01096-13
   Cavicchioli R, 2011, ENVIRON MICROBIOL, V13, P1903, DOI 10.1111/j.1462-2920.2011.02512.x
   Chandra RP, 2007, ADV BIOCHEM ENG BIOT, V108, P67, DOI 10.1007/10_2007_064
   Chen YC, 2014, BIORESOURCE TECHNOL, V170, P513, DOI 10.1016/j.biortech.2014.08.016
   Cheng YS, 2012, APPL MICROBIOL BIOT, V95, P661, DOI 10.1007/s00253-011-3791-4
   Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111
   Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109
   Cortazar AR, 2014, AMINO ACIDS, V46, P471, DOI 10.1007/s00726-013-1649-z
   Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578
   de Souza WR, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-40
   de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001
   DEKKER RFH, 1990, APPL BIOCHEM BIOTECH, V23, P25, DOI 10.1007/BF02942050
   Delmas S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002875
   Elleuche S, 2015, APPL MICROBIOL BIOT, V99, P1545, DOI 10.1007/s00253-014-6315-1
   Elliott CE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-169
   Ertan H, 2012, BIOCHIMIE, V94, P1221, DOI 10.1016/j.biochi.2012.02.012
   Foreman P.K., 2003, J BIOL CHEM, V278, P31988
   Gacek A, 2012, APPL MICROBIOL BIOT, V95, P1389, DOI 10.1007/s00253-012-4208-8
   Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044
   Gong ZW, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-36
   Gourlay K, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-51
   Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373
   Grum-Grzhimaylo AA, 2013, PERSOONIA, V31, P147, DOI 10.3767/003158513X673080
   GUSAKOV AV, 1992, BIOTECHNOL BIOENG, V40, P663, DOI 10.1002/bit.260400604
   Haitjema CH, 2014, BIOTECHNOL BIOENG, V111, P1471, DOI 10.1002/bit.25264
   Hess M, 2008, TRENDS MICROBIOL, V16, P414, DOI 10.1016/j.tim.2008.06.001
   Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45
   Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624
   Ji L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0130-x
   Jung S, 2013, PLANT MOL BIOL, V83, P317, DOI 10.1007/s11103-013-0088-2
   Kang Y.M., 2015, J MOL CATAL B-ENZYM, V114, P29
   Karnaouri A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00281
   KENGEN SWM, 1993, EUR J BIOCHEM, V213, P305, DOI 10.1111/j.1432-1033.1993.tb17763.x
   Klose H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-63
   Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058
   Kong C, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-346
   Kubicek C.P., 2012, TOOLSPART 2 ENZYMOLO
   Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020
   Kumar GN, 2011, BIOMED CHROMATOGR, V25, P707, DOI 10.1002/bmc.1506
   Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g
   Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11
   Lanver D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004272
   Lee HL, 2011, BIORESOURCE TECHNOL, V102, P3973, DOI 10.1016/j.biortech.2010.11.114
   Levasseur A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-486
   Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41
   Lin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108442
   Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549
   Mabee WE, 2006, APPL BIOCHEM BIOTECH, V129, P55, DOI 10.1385/ABAB:129:1:55
   Maehara T, 2013, FUNGAL BIOL-UK, V117, P220, DOI 10.1016/j.funbio.2013.02.002
   Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000
   Makela MR, 2014, FUNGAL GENET BIOL, V72, P2, DOI 10.1016/j.fgb.2014.08.010
   Mardanov AV, 2009, APPL ENVIRON MICROB, V75, P4580, DOI 10.1128/AEM.00718-09
   Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106
   Martins I, 2014, J PROTEOMICS, V98, P175, DOI 10.1016/j.jprot.2013.11.023
   Milstein O., 1983, ARCH MICROBIAL, V135, P147
   Mir BA, 2014, TRENDS BIOTECHNOL, V32, P281, DOI 10.1016/j.tibtech.2014.03.003
   Mitsuzawa S, 2009, J BIOTECHNOL, V143, P139, DOI 10.1016/j.jbiotec.2009.06.019
   Murphy L, 2010, ANAL BIOCHEM, V404, P140, DOI 10.1016/j.ab.2010.04.020
   Nevalainen H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00075
   Oggerin M, 2013, ENVIRON MICROBIOL, V15, P2228, DOI 10.1111/1462-2920.12094
   Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184
   Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y
   Piao HL, 2014, BIOTECHNOL BIOENG, V111, P1550, DOI 10.1002/bit.25250
   Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]
   Ratto M, 1997, APPL MICROBIOL BIOT, V48, P53, DOI 10.1007/s002530051014
   Ravalason H, 2012, BIORESOURCE TECHNOL, V114, P589, DOI 10.1016/j.biortech.2012.03.009
   Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111
   Rizk M, 2015, BIOTECHNOL LETT, V37, P139, DOI 10.1007/s10529-014-1654-7
   Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200
   Ryu JS, 2011, APPL ENVIRON MICROB, V77, P7933, DOI 10.1128/AEM.05496-11
   Sagt CMJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-48
   Seckbach J., 2013, HELGA POLYEXTERMOPHI
   Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x
   Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0
   Sharma A, 2012, EXTREMOPHILES, V16, P1, DOI 10.1007/s00792-011-0402-3
   Sharma RK, 2015, CRIT REV MICROBIOL, V41, P52, DOI 10.3109/1040841X.2013.791247
   Shen BZ, 2012, NAT BIOTECHNOL, V30, P1131, DOI 10.1038/nbt.2402
   Siddiqui K.S., 2008, PROTEIN ADAPTATIONS
   Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514
   Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723
   Siddiqui KS, 2014, J BIOTECHNOL, V178, P1, DOI 10.1016/j.jbiotec.2014.03.002
   Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012
   Smith MA, 2012, FEBS J, V279, P4453, DOI 10.1111/febs.12032
   Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514
   Srikrishnan S, 2012, BIOTECHNOL BIOENG, V109, P1595, DOI 10.1002/bit.24414
   Trudeau DL, 2014, BIOTECHNOL BIOENG, V111, P2390, DOI 10.1002/bit.25308
   USDA, 2010, USDA BIOF STRAT PROD, P1
   Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001
   Wang HC, 2014, BIOCHEM BIOPH RES CO, V451, P190, DOI 10.1016/j.bbrc.2014.07.088
   Wang HC, 2013, PROTEIN EXPRES PURIF, V90, P153, DOI 10.1016/j.pep.2013.06.004
   Xie SX, 2014, CURR OPIN BIOTECH, V27, P195, DOI 10.1016/j.copbio.2014.02.007
   Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005
   Xiong Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004500
   Youssef NH, 2013, APPL ENVIRON MICROB, V79, P4620, DOI 10.1128/AEM.00821-13
   Zajc J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00708
   Zamocky M, 2006, CURR PROTEIN PEPT SC, V7, P255, DOI 10.2174/138920306777452367
   Zhang SB, 2012, BIORESOURCE TECHNOL, V117, P140, DOI 10.1016/j.biortech.2012.04.042
   Zhao YP, 2014, APPL BIOCHEM BIOTECH, V174, P1246, DOI 10.1007/s12010-014-1102-0
   Zhou P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-294
   Znameroski EA, 2014, J BIOL CHEM, V289, P2610, DOI 10.1074/jbc.M113.533273
   Znameroski EA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-6
NR 125
TC 23
Z9 26
U1 1
U2 99
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-9452
J9 PLANT SCI
JI Plant Sci.
PD MAY
PY 2015
VL 234
BP 180
EP 193
DI 10.1016/j.plantsci.2015.02.010
PG 14
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA CG2HZ
UT WOS:000353096800018
PM 25804821
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Patel, JJ
   Flanagan, CL
   Hollister, SJ
AF Patel, Janki J.
   Flanagan, Colleen L.
   Hollister, Scott J.
TI Bone Morphogenetic Protein-2 Adsorption onto Poly-e-caprolactone Better
   Preserves Bioactivity In Vitro and Produces More Bone In Vivo than
   Conjugation Under Clinically Relevant Loading Scenarios
SO Tissue Engineering Part C-Methods
LA English
DT Article
ID HUMAN OSTEOGENIC PROTEIN-1; CONTROLLED-RELEASE; MANDIBULAR
   RECONSTRUCTION; DELIVERY-SYSTEMS; SCAFFOLDS; REGENERATION; GRAFTS;
   GROWTH; CELLS; BMP-2
AB Background: One strategy to reconstruct large bone defects is to prefabricate a vascularized flap by implanting a biomaterial scaffold with associated biologics into the latissimus dorsi and then transplanting this construct to the defect site after a maturation period. This strategy, similar to all clinically and regulatory feasible biologic approaches to surgical reconstruction, requires the ability to quickly (<1 h within an operating room) and efficiently bind biologics to scaffolds. It also requires the ability to localize biologic delivery. In this study, we investigated the efficacy of binding bone morphogenetic protein-2 (BMP2) to poly-e-caprolactone (PCL) using adsorption and conjugation as a function of time.
   Methods: BMP2 was adsorbed (Ads) or conjugated (Conj) to PCL scaffolds with the same three-dimensional printed architecture while altering exposure time (0.5, 1, 5, and 16 h), temperature (4 degrees C, 23 degrees C), and BMP2 concentration (1.4, 5, 20, and 65 mu g/mL). The in vitro release was quantified, and C2C12 cell alkaline phosphatase (ALP) expression was used to confirm bioactivity. Scaffolds with either 65 or 20 mu g/mL Ads or Conj BMP2 for 1 h at 23 degrees C were implanted subcutaneously in mice to evaluate in vivo bone regeneration. Micro-computed tomography, compression testing, and histology were performed to characterize bone regeneration.
   Results: After 1 h exposure to 65 mu g/mL BMP2 at 23 degrees C, Conj and Ads resulted in 12.83 +/- 1.78 and 10.78 +/- 1.49 mu g BMP2 attached, respectively. Adsorption resulted in a positive ALP response and had a small burst release; whereas conjugation provided a sustained release with negligible ALP production, indicating that the conjugated BMP2 may not be bioavailable. Adsorbed 65 mu g/mL BMP2 solution resulted in the greatest regenerated bone volume (15.0 +/- 3.0 mm(3)), elastic modulus (20.1 +/- 3.0 MPa), and %bone ingrowth in the scaffold interior (17.2%+/- 5.4%) when compared with conjugation.
   Conclusion: Adsorption may be optimal for the clinical application of prefabricating bone flaps due to BMP2 binding in a short exposure time, retained BMP2 bioactivity, and bone growth adhering to scaffold geometry and into pores with healthy marrow development.
C1 [Patel, Janki J.; Flanagan, Colleen L.; Hollister, Scott J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn, Lurie Biomed Engn 2214, 1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
FU NIH/NIDCR Tissue Engineering at Michigan trainee grant [DE 007057]; NIH
   [R21 DE 022439, R01 AR 060892]
FX This research was funded by the NIH/NIDCR Tissue Engineering at Michigan
   trainee grant (DE 007057), NIH R21 DE 022439, and NIH R01 AR 060892.
CR Alam M I, 2003, Int J Oral Maxillofac Surg, V32, P508
   [Anonymous], 2005, P SING MIT ALL S SIN
   Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Bae SE, 2012, J CONTROL RELEASE, V160, P676, DOI 10.1016/j.jconrel.2012.04.021
   Becker ST, 2009, ORAL ONCOL, V45, pE181, DOI 10.1016/j.oraloncology.2009.07.004
   Bhumiratana S, 2012, STEM CELL TRANSL MED, V1, P64, DOI 10.5966/sctm.2011-0020
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Dias MR, 2014, MED ENG PHYS, V36, P448, DOI 10.1016/j.medengphy.2014.02.010
   Fitzsimmons J, 2014, 510 K PREMARKET NOTI
   Gharibjanian NA, 2009, PLAST RECONSTR SURG, V123, P1169, DOI 10.1097/PRS.0b013e31819f2987
   Han JA, 2011, J BIOMED MATER RES A, V96A, P705, DOI 10.1002/jbm.a.33023
   Heliotis M, 2006, INT J ORAL MAX SURG, V35, P265, DOI 10.1016/j.ijom.2005.07.013
   Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kim TH, 2012, J BIOMED MATER RES A, V100A, P1512, DOI 10.1002/jbm.a.34086
   Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571
   Kontogiorgos E, 2011, CALCIFIED TISSUE INT, V89, P43, DOI 10.1007/s00223-011-9492-2
   Kumagai T., 2007, KEY ENG MATER, V361, P1025
   Liu HW, 2006, BONE, V39, P825, DOI 10.1016/j.bone.2006.04.027
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mitsak AG, 2011, TISSUE ENG PT A, V17, P1831, DOI [10.1089/ten.TEA.2010.0560, 10.1089/ten.tea.2010.0560]
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Partee B, 2006, J MANUF SCI E-T ASME, V128, P531, DOI 10.1115/1.2162589
   Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Schantz J-T, 2006, NEUROSURGERY, V58, pONS
   Smith MH, 2007, INT J MED ROBOT COMP, V3, P207, DOI 10.1002/rcs.143
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Terheyden H, 2004, INT J ORAL MAX SURG, V33, P164, DOI 10.1016/j.ijom.2003.08.009
   Terheyden H, 1999, INT J ORAL MAX SURG, V28, P461, DOI 10.1016/S0901-5027(99)80063-0
   van de Watering FCJ, 2012, J CONTROL RELEASE, V159, P69, DOI 10.1016/j.jconrel.2011.12.041
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2006, BIOMATERIALS, V27, P1081, DOI 10.1016/j.biomaterials.2005.07.042
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Yeo A, 2014, 510 K PREMARKET NOTI
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zhang Q, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045002
   Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 46
TC 14
Z9 14
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAY 1
PY 2015
VL 21
IS 5
BP 489
EP 498
DI 10.1089/ten.tec.2014.0377
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CG7SH
UT WOS:000353504800007
PM 25345571
OA Green Published
DA 2018-10-19
ER

PT J
AU Galera, PD
   Ribeiro, CR
   Sapp, HL
   Coleman, J
   Fontes, W
   Brooks, DE
AF Galera, Paula D.
   Ribeiro, Cassio R.
   Sapp, Harold L.
   Coleman, James
   Fontes, Wagner
   Brooks, Dennis E.
TI Proteomic analysis of equine amniotic membrane: characterization of
   proteins
SO VETERINARY OPHTHALMOLOGY
LA English
DT Article
DE amniotic membrane; dermatopontin; horse; lumican; protein; proteome
ID OCULAR SURFACE RECONSTRUCTION; EXTRACELLULAR-MATRIX; DERMATOPONTIN
   EXPRESSION; COLLAGEN FIBRILLOGENESIS; CELL-ADHESION; TRANSPLANTATION;
   LUMICAN; DECORIN; IDENTIFICATION; SKIN
AB IntroductionHuman amniotic membrane (AM) has been used as a biomaterial for surgical wound skin and ocular surface reconstruction for several years. Currently, equine AM has been used for corneal reconstruction in several animal species, and appears to have the same properties as human AM. Despite the observed positive healing abilities of this tissue in horses with ulcerative keratitis the proteins of equine AM have not been described.
   ObjectiveTo identify proteins known to be associated with corneal healing from frozen equine AM.
   ProceduresPlacentas were acquired from healthy live foal births from a local Thoroughbred breeding farm. The amnion was removed from the chorion by blunt dissection, washed with phosphate-buffered saline (PBS), and treated with 0.05% trypsin and 0.02% ethylene diaminetetraacetic acid in PBS. Amnion was attached to nitrocellulose paper (epithelial side up), and cut into 4x4cm pieces. The sheets were frozen at -80 degrees C. The protein samples were solubilized, and analyzed by 2D gel electrophoresis and shotgun proteomics.
   ResultsA reference identification map of the equine AM proteins was produced and 149 different proteins were identified. From gel-based proteomics, 49 spots were excised and 43 proteins identified by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Shotgun proteomics identified 116 proteins with an overlap of 10 proteins in both analyses.
   ConclusionsWe have described a reference map for equine AM proteins that may provide a background to explain the positive results found in horses with ulcerative keratopathies using this biomaterial.
C1 [Galera, Paula D.; Ribeiro, Cassio R.] Univ Brasilia, Coll Vet Med, Dept Vet Med, Brasilia, DF, Brazil.
   [Sapp, Harold L.; Coleman, James; Brooks, Dennis E.] Univ Florida, Coll Vet Med, Dept Small & Large Anim Clin Sci, Gainesville, FL USA.
   [Fontes, Wagner] Univ Brasilia, Inst Biol Sci, Dept Cell Biol, Brasilia, DF, Brazil.
RP Galera, PD (reprint author), Univ Brasilia, Coll Vet Med, Dept Vet Med, Brasilia, DF, Brazil.
EM dra.paulagalera@gmail.com
RI Fontes, Wagner/A-1771-2008
OI Fontes, Wagner/0000-0001-5140-8573
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) -
   Brazil [479526/2011-7]; Veterinary College - University of Florida
FX Supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior) - Brazil (process no. 479526/2011-7) and Veterinary College -
   University of Florida.
CR Arcelli R, 2009, VET RES COMMUN, V33, pS169, DOI 10.1007/s11259-009-9284-6
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Barachetti L, 2010, VET OPHTHALMOL, V13, P326, DOI 10.1111/j.1463-5224.2010.00821.x
   Barros Paulo S. M., 1998, Veterinary Ophthalmology, V1, P119, DOI 10.1046/j.1463-5224.1998.00026.x
   Barros PSM, 2005, VET OPHTHALMOL, V8, P189, DOI 10.1111/j.1463-5224.2005.00391.x
   Baum J, 2002, CORNEA, V21, P339, DOI 10.1097/00003226-200205000-00001
   Brooks DE, 2008, VET OPHTHALMOL, V11, P123, DOI 10.1111/j.1463-5224.2008.00611.x
   Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035
   Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277
   Choi US, 2010, VET OPHTHALMOL, V13, P122, DOI 10.1111/j.1463-5224.2010.00765.x
   Cooper LJ, 2006, INVEST OPHTH VIS SCI, V47, P3303, DOI 10.1167/iovs.05-1426
   CRONSHAW AD, 1993, MATRIX, V13, P255, DOI 10.1016/S0934-8832(11)80009-0
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Dyrlund TF, 2012, J PROTEOME RES, V11, P4231, DOI 10.1021/pr300358k
   GELATT K.N, 2011, VET OPHTHALMIC SURG, P191
   Goodrich LR, 2000, AM J VET RES, V61, P326, DOI 10.2460/ajvr.2000.61.326
   Guo Q, 2011, ACTA OPHTHALMOL, V89, P315
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Hopkinson A, 2005, PROTEOMICS, V5, P1967, DOI 10.1002/pmic.200401073
   Hopkinson A, 2006, J PROTEOME RES, V5, P2226, DOI 10.1021/pr050425q
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843
   Kalpravidh M, 2009, VET RES COMMUN, V33, P1003, DOI 10.1007/s11259-009-9319-z
   Kato A, 2011, J BIOL CHEM, V286, P14861, DOI 10.1074/jbc.M110.179762
   KIM JC, 1995, CORNEA, V14, P473
   Kim JY, 2009, VET OPHTHALMOL, V12, P36, DOI 10.1111/j.1463-5224.2009.00671.x
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   Kruse FE, 1999, OPHTHALMOLOGY, V106, P1504, DOI 10.1016/S0161-6420(99)90444-X
   Kuroda K, 1999, J INVEST DERMATOL, V112, P706, DOI 10.1046/j.1523-1747.1999.00563.x
   Lange-Consiglio A, 2011, J TISSUE ENG REGEN M, V6, P622
   Lassaline ME, 2005, VET OPHTHALMOL, V8, P311, DOI 10.1111/j.1463-5224.2005.00405.x
   Leygue E, 2000, J PATHOL, V192, P313
   Liu T, 2012, MOL VIS, V18, P2137
   Long CG, 2006, 52 ANN CONV AM ASS E, V52, P501
   Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006
   Mandal N, 2010, BIOL PROCED ONLINE, V12, P56, DOI 10.1007/s12575-009-9019-7
   Meek Keith M, 2009, Biophys Rev, V1, P83, DOI 10.1007/s12551-009-0011-x
   Mienaltowski MJ, 2009, BMC MED GENOMICS, V2, P1
   Milani JF, 2008, PESQUISA VET BRASIL, V28, P379, DOI 10.1590/S0100-736X2008000800006
   Miragliotta V, 2009, VET DERMATOL, V20, P243, DOI 10.1111/j.1365-3164.2009.00748.x
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Okamoto O, 1999, BIOCHEM J, V337, P537, DOI 10.1042/0264-6021:3370537
   Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564
   Ollivier FJ, 2006, VET OPHTHALMOL, V9, P404, DOI 10.1111/j.1463-5224.2006.00480.x
   OXLUND H, 1990, EUR J OBSTET GYN R B, V34, P247, DOI 10.1016/0028-2243(90)90078-F
   Plummer CE, 2009, VET OPHTHALMOL, V12, P17, DOI 10.1111/j.1463-5224.2009.00741.x
   RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Russo A, 2012, CELL TISSUE BANK, V13, P353, DOI 10.1007/s10561-011-9261-5
   Saika S, 2003, INVEST OPHTH VIS SCI, V44, P2094, DOI 10.1167/iovs.02-1059
   Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607
   Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t
   SUPERTIFURGA A, 1993, GENOMICS, V17, P463, DOI 10.1006/geno.1993.1348
   Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4
   Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x
   Takemoto S, 2002, BASIC RES CARDIOL, V97, P461, DOI 10.1007/s00395-002-0371-x
   Takeuchi T, 2006, J ENDOCRINOL, V190, P351, DOI 10.1677/joe.1.06619
   Tzen CY, 2004, EXP CELL RES, V294, P30, DOI 10.1016/j.yexer.2003.10.026
   Yamatoji M, 2001, INT J CANCER, V130, P2903
   Yeah LK, 2005, INVEST OPHTHALMOL, V46, P479
NR 60
TC 1
Z9 1
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1463-5216
EI 1463-5224
J9 VET OPHTHALMOL
JI Vet. Ophthalmol.
PD MAY
PY 2015
VL 18
IS 3
BP 198
EP 209
DI 10.1111/vop.12190
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA CG7SE
UT WOS:000353504400004
PM 24981051
DA 2018-10-19
ER

PT J
AU Liu, XD
   Zhang, FB
   Shan, H
   Chen, PY
AF Liu, Xiao-Dong
   Zhang, Fu-Bo
   Shan, Hu
   Chen, Pu-Yan
TI The potential mechanism of bursal-derived BP8 on B cell developments
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Bursa of Fabricus; B cell development; Bursal peptide (BP8); Gene
   microarray; Immunomodulatory peptide; Retinol uptake
ID VITAMIN-A; INTERLEUKIN-6 SYNTHESIS; DEHYDROGENASE; METABOLISM;
   FABRICIUS; CHICKEN; SYSTEM
AB The bursa of Fabricius, the key humoral immune organ unique to birds, is critical for B cell differentiation and antibody production. BP8 (AGHTKKAP) is a novel immunomodulatory peptide that regulates B-cell development. Gene microarray was used to investigate the mechanism of BP8 on B cell development. BP8 regulated expressions of 1,570 genes that were involved in retinol metabolism, the Wnt signaling pathway, MAPK pathway, Jak-Stat pathway, Notch signaling pathway, cytokine-cytokine receptor interaction, and Ca2+ signals. Finally, BP8 triggered ADH7 and RDH10 expression, interacted with retinol binding protein, and regulated retinol uptake in vitro and vivo. These data reveal a bursal-derived multifunctional factor, BP8, as a novel biomaterial which is essential for the development of the immune system and represents an important linker between the B cell development and retinol metabolism. This study elucidates the mechanisms involved in humoral immune system and has implications in treating human diseases.
C1 [Liu, Xiao-Dong; Zhang, Fu-Bo; Shan, Hu] Qingdao Agr Univ, Coll Anim Sci & Vet Med, Qingdao 266109, Peoples R China.
   [Chen, Pu-Yan] Nanjing Agr Univ, Div Key Lab Anim Dis Diag & Immunol, Chinas Dept Agr, Nanjing 210095, Jiangsu, Peoples R China.
RP Chen, PY (reprint author), Nanjing Agr Univ, Div Key Lab Anim Dis Diag & Immunol, Chinas Dept Agr, Nanjing 210095, Jiangsu, Peoples R China.
EM shanhu67@163.com; puyanchen@aliyun.com
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD); National Special Research Programs for Non-profit
   Trades, Ministry of Agriculture [201203082]; international S&T
   Cooperation Program of China (ISTCP) [2014DFR30980]
FX This work was supported by the Project funded by the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD), the
   National Special Research Programs for Non-profit Trades, Ministry of
   Agriculture (No. 201203082) and international S&T Cooperation Program of
   China (ISTCP) (No. 2014DFR30980). The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600
   Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103
   COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75
   Davison F, 2011, AVIAN IMMUNOLOGY, P1
   Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011
   Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152
   FINE JS, 1994, EXP HEMATOL, V22, P1188
   Fritzenwanger M, 2007, CYTOKINE, V38, P137, DOI 10.1016/j.cyto.2007.05.015
   Fritzenwanger M, 2006, CYTOKINE, V36, P101, DOI 10.1016/j.cyto.2006.10.015
   GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224
   Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244
   Liu XD, 2014, AMINO ACIDS, V46, P2705, DOI 10.1007/s00726-014-1824-x
   LYDYARD PM, 1976, J EXP MED, V144, P79, DOI 10.1084/jem.144.1.79
   Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378
   Nie L, 2008, MOL CELL BIOL, V28, P2078, DOI 10.1128/MCB.00844-07
   Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334
   Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7
   van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832
   ZGOMBICKNIGHT M, 1995, J BIOL CHEM, V270, P4305, DOI 10.1074/jbc.270.9.4305
NR 20
TC 1
Z9 2
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
EI 1573-6776
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAY
PY 2015
VL 37
IS 5
BP 1013
EP 1020
DI 10.1007/s10529-015-1772-x
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CF6BP
UT WOS:000352641700007
PM 25650343
DA 2018-10-19
ER

PT J
AU Knoll, LD
AF Knoll, L. D.
TI BIOMATERIAL GRAFTING WITH PENILE PROSTHETIC INSERTION IN THE MANAGEMENT
   OF PEYRONIE'S DISEASE: EFFICACY AND SAFETY
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD MAY
PY 2015
VL 12
SU 2
SI SI
MA 071
BP 126
EP 126
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA CF8EQ
UT WOS:000352789100072
DA 2018-10-19
ER

PT J
AU Tszydel, M
   Zablotni, A
   Wojciechowska, D
   Michalak, M
   Krucinska, I
   Szustakiewicz, K
   Maj, M
   Jaruszewska, A
   Strzelecki, J
AF Tszydel, M.
   Zablotni, A.
   Wojciechowska, D.
   Michalak, M.
   Krucinska, I.
   Szustakiewicz, K.
   Maj, M.
   Jaruszewska, A.
   Strzelecki, J.
TI Research on possible medical use of silk produced by caddisfly larvae of
   Hydropsyche angustipennis (Trichoptera, Insecta)
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Silk; Cytotoxicity; Sterilization; Mechanical properties; Caddisfly
AB Silk products are used in medicine as biomaterials, and are particularly promising as scaffolds in tissue engineering. To date only silkworm and spider silk medical potential has been evaluated, whereas the possible application of the material spun by caddisflies in wet environment has not been examined. Biomedical application of every natural material requires biocompatibility testing and evaluation of unique microbiological and mechanical properties. This article focuses on silk fibers formed in caddisflies cocoons of Hydropsyche angustipennis (Insecta, Trichoptera) larvae. Preliminary biological evaluation shows that trichopteran silk is not cytotoxic to human cells. Caddistly silk itself does not possess antiseptic properties and thus sterilization is indispensable for its application in medicine. Among tested methods of sterilization and disinfection only thermal methods (tyndallization and autoclaving) enabled complete eradication of bacteria and gave fully sterile material. Caddisfiy silk appeared to be resistant to high temperature. Fully sterile fibers can be stored without a loss of breaking force and tensile strength. Our work shows that trichopteran silk has a significant potential to be used as a biomaterial. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Tszydel, M.] Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, PL-90237 Lodz, Poland.
   [Zablotni, A.] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Microbiol, PL-90237 Lodz, Poland.
   [Wojciechowska, D.; Michalak, M.; Krucinska, I.] Lodz Univ Technol, Fac Mat Technol & Text Design, Dept Mat & Commod Sci & Text Metrol, PL-90543 Lodz, Poland.
   [Szustakiewicz, K.] Wroclaw Univ Technol, Polymer Engn & Technol Div, PL-50370 Wroclaw, Poland.
   [Maj, M.] Nicolaus Copernicus Univ Torun, L Rydygier Coll Med Bydgoszcz, Tissue Engn Dept, PL-85092 Bydgoszcz, Poland.
   [Jaruszewska, A.; Strzelecki, J.] Nicholas Copernicus Univ, Inst Phys, PL-87100 Torun, Poland.
RP Tszydel, M (reprint author), Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, 12-16 Banacha Str, PL-90237 Lodz, Poland.
EM mtszydel@biol.uni.lodz.pl; agzab@biol.uni.lodz.pl; dorowoj@gmail.com;
   marina.michalak@p.lodz.pl; konrad.szustakiewicz@pwr.edu.pl;
   m.uzarska@wp.pl; agatabrazkiewicz@gmail.com; jast@fizyka.umk.pl
RI Maj, Malgorzata/D-4366-2014
OI Maj, Malgorzata/0000-0003-2433-8578; Zablotni,
   Agnieszka/0000-0001-7982-9767; Tszydel, Mariusz/0000-0002-0254-7451
FU Polish Ministry of Science and Higher Education [0438/T02/2010/70];
   Institute of Physics, Nicolaus Copernicus University [414-F]
FX M. Tszydel acknowledges the Research Grant 0438/T02/2010/70 from the
   Polish Ministry of Science and Higher Education "Iuventus Plus":
   Structure and properties of trichopteran (Insecta, Trichoptera) fibers
   in view of the possibilities of their applicational using.r J.
   Strzelecki acknowledges the research grant for young scientists 414-F
   from Institute of Physics, Nicolaus Copernicus University.
CR Ashton N.N., 2013, SELF TENSIONING AQUA
   Austin P.R., 1981, SCIENCE, V212, P44
   BASCOMBE AD, 1990, WATER SCI TECHNOL, V22, P173
   Brown SA, 2004, J N AM BENTHOL SOC, V23, P771, DOI 10.1899/0887-3593(2004)023<0771:PPOHST>2.0.CO;2
   Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x
   Cianficconi F., 1992, P 7 INT S TRICH, P33
   Craig L.C., 2003, SPIDERWEBS SILK TRAC, P230
   De Moraes M.A., 2013, J BIOMED MATER RES B, V102, P869
   ELLIOTT JM, 1968, J ANIM ECOL, V37, P615, DOI 10.2307/3078
   ELLIOTT JM, 1969, OIKOS, V20, P110, DOI 10.2307/3543750
   Elliott JM, 1977, FRESHWATER BIOL ASS, V25, P1
   Erman N.A., 1987, P 5 INT S TRICH HAG, P275
   Font R, 2011, J ANAL APPL PYROL, V91, P89, DOI 10.1016/j.jaap.2011.01.007
   Gellynck K., 2006, THESIS U GENT
   Hegazy K.E.S., 2006, P 14 ANN C MISR SOC, P741
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Michalak M, 2005, FIBRES TEXT EAST EUR, V13, P28
   Moretti G P., 1983, TRICOTTERI TRICHOPTE
   Petersen L. B. -M., 1985, VERHANDLUNGEN INT VE, V22, P3270
   PHILIPSON GN, 1974, FRESHWATER BIOL, V4, P525, DOI 10.1111/j.1365-2427.1974.tb00112.x
   Rengasamy RS, 2005, AUTEX RES J, V5, P30
   Saravanan D., 2006, J TEXT APPAREL TECHN, V5, P1
   Sionkowska A., 2001, POLYM DEGRAD STABIL, V96, P523
   SOKAL RR, 1969, BIOMETRY PRINCIPLES
   Statzner B, 2005, LIMNOL OCEANOGR, V50, P713, DOI 10.4319/lo.2005.50.2.0713
   Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d
   Strzelecki J, 2012, ACTA PHYS POL A, V122, P329, DOI 10.12693/APhysPolA.122.329
   Strzelecki JW, 2011, CENT EUR J PHYS, V9, P482, DOI 10.2478/s11534-010-0105-x
   Tsukada M, 2010, INT J BIOL MACROMOL, V46, P54, DOI 10.1016/j.ijbiomac.2009.10.003
   Tszydel M, 2009, FIBRES TEXT EAST EUR, V17, P7
   Urbanczyk G.W., 1985, SCI FIBERS
   Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007
   Van Nimmen E., 2002, P SEM ANN C EXP APPL, P246
   Wichard W., 1992, P 7 INT S TRICH, P25
   Wissman A., 2001, THERMOCHIM ACTA, V525, P129
   Xi Y, 2005, J THERM ANAL CALORIM, V81, P91, DOI 10.1007/s10973-005-0750-2
   Yonemura N, 2009, J MOL EVOL, V68, P641, DOI 10.1007/s00239-009-9234-5
   Yonemura N, 2006, BIOMACROMOLECULES, V7, P3370, DOI 10.1021/bm060663u
   Zhang Y., 2006, J SILK, V7, P22
   Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004
NR 41
TC 3
Z9 3
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAY
PY 2015
VL 45
BP 142
EP 153
DI 10.1016/j.jmbbm.2015.02.003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CF6KH
UT WOS:000352665100014
PM 25723346
DA 2018-10-19
ER

PT J
AU Rising, A
   Johansson, J
AF Rising, Anna
   Johansson, Jan
TI Toward spinning artificial spider silk
SO NATURE CHEMICAL BIOLOGY
LA English
DT Article
ID SOLID-STATE NMR; AMYLOID FIBRIL FORMATION; MAJOR AMPULLATE GLAND;
   DRAGLINE SILK; SECONDARY STRUCTURE; NEPHILA-CLAVIPES;
   PHYSICAL-PROPERTIES; TERMINAL DOMAINS; MESSENGER-RNA; PROTEINS
AB Spider silk is strong and extensible but still biodegradable and well tolerated when implanted, making it the ultimate biomaterial. Shortcomings that arise in replicating spider silk are due to the use of recombinant spider silk proteins (spidroins) that lack native domains, the use of denaturing conditions under purification and spinning and the fact that the understanding of how spiders control silk formation is incomplete. Recent progress has unraveled the molecular mechanisms of the spidroin N- and C-terminal nonrepetitive domains (NTs and CTs) and revealed the pH and ion gradients in spiders' silk glands, clarifying how spidroin solubility is maintained and how silk is formed in a fraction of a second. Protons and CO2, generated by carbonic anhydrase, affect the stability and structures of the NT and CT in different ways. These insights should allow the design of conditions and devices for the spinning of recombinant spidroins into native-like silk.
C1 [Rising, Anna; Johansson, Jan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.
   [Rising, Anna; Johansson, Jan] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.
RP Rising, A (reprint author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.
EM anna.rising@ki.se; janne.johansson@ki.se
OI Rising, Anna/0000-0002-1872-1207
FU Swedish Research Council
FX We are grateful to S. Knight for valuable discussions and helpful
   comments on this manuscript. The Swedish Research Council supported work
   in the authors' laboratory.
CR Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921
   Andersson M, 2013, BIOMACROMOLECULES, V14, P2945, DOI 10.1021/bm400898t
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   CANDELAS GC, 1981, J EXP ZOOL, V216, P1, DOI 10.1002/jez.1402160102
   CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U
   Chen GF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052293
   Chen X, 2002, BIOMACROMOLECULES, V3, P644, DOI 10.1021/bm0156126
   Clarke TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-365
   COHEN AC, 1980, COMP BIOCHEM PHYS A, V66, P715, DOI 10.1016/0300-9629(80)90025-0
   DENNY M, 1976, J EXP BIOL, V65, P483
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121
   Gao ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056142
   Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hagn F, 2011, ANGEW CHEM INT EDIT, V50, P310, DOI 10.1002/anie.201003795
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Holland GP, 2008, CHEM COMMUN, P5568, DOI 10.1039/b812928b
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Hronska M, 2004, BIOMACROMOLECULES, V5, P834, DOI 10.1021/bm0343904
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008
   Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004
   Jenkins JE, 2010, CHEM COMMUN, V46, P6714, DOI 10.1039/c0cc00829j
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200
   Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   Kovoor J., 1987, P160
   Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Landreh M, 2010, J MOL BIOL, V404, P328, DOI 10.1016/j.jmb.2010.09.054
   Lane AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-846
   Lang G, 2013, JOVE-J VIS EXP, DOI 10.3791/50492
   Lefevre T, 2007, BIOMACROMOLECULES, V8, P2342, DOI 10.1021/bm7005517
   Lefevre T, 2012, BIOPOLYMERS, V97, P322, DOI 10.1002/bip.21712
   Lin Z, 2013, ADV MATER, V25, P1216, DOI 10.1002/adma.201204357
   Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2
   Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102
   MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Ries J, 2014, J AM CHEM SOC, V136, P17136, DOI 10.1021/ja508760a
   Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765
   Schwarze S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3815
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   STAUFFER SL, 1994, J ARACHNOL, V22, P5
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0
   Wang SJ, 2012, J BIOMOL NMR, V54, P415, DOI 10.1007/s10858-012-9679-5
   Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
NR 69
TC 72
Z9 75
U1 7
U2 140
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1552-4450
EI 1552-4469
J9 NAT CHEM BIOL
JI Nat. Chem. Biol.
PD MAY
PY 2015
VL 11
IS 5
BP 309
EP 315
DI 10.1038/NCHEMBIO.1789
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CG3FD
UT WOS:000353162600005
PM 25885958
DA 2018-10-19
ER

PT J
AU Kassem, M
AF Kassem, M.
TI Synthesis, physicochemical characterizations, and photocatalytic
   behaviors of Ni (x) K2Mo4O13 systems
SO RESEARCH ON CHEMICAL INTERMEDIATES
LA English
DT Article
DE Potassium tetramolybdate; Nickel; Characterizations; Photocatalytic
   behaviors
ID FERRITE COMPOSITE NANOPARTICLES; BIOMATERIAL SYSTEM; HYDROTHERMAL
   SYNTHESIS; ANTIMICROBIAL ACTIVITY; TITANIUM-DIOXIDE; MAGNETIC CORE;
   PHOTODEGRADATION; CATALYSTS; CU; DEGRADATION
AB Different samples of Ni (x) K2Mo4O13 have been prepared by mixing appropriate amounts, in solid state, of Ni and K2Mo4O13 (PDF ICDD 27-416) according to the molar ratio Ni/K2Mo4O13 = 0, 0.05, 0.1, 0.2, 0.5, and 1. The prepared samples were characterized using X-ray powder diffraction (XRD), Fourier transform infrared (FT-IR), differential thermal analysis (DTA), nitrogen adsorption apparatus, and UV spectrophotometer. XRD results indicate that the phase composition of the Ni/K2Mo4O13 samples has been significantly changed with the change in molar ratio of Ni/K2Mo4O13. The presence of Ni gave rise to the formation of other new phases identified as K2Mo3O10 (PDF ICDD 37-1467) and alpha-NiMoO4 (PDF ICDD 32-692). The results of FT-IR and DTA also allowed us to track the formation of the above-mentioned substances. The nitrogen adsorption-desorption isotherms and the pore size distribution reveal that the texture of the prepared samples has also been affected by the nickel content. The photocatalytic behaviors of pure K2Mo4O13 and Ni (x) K2Mo4O13 were studied by means of monitoring the ability of these materials to enhance the degradation under UV irradiation of the methyl red in liquid media. It was found that the phase composition is the most influential parameter in the photocatalytic behavior of the studied samples.
C1 Atom Energy Commiss Syria, Dept Chem, Damascus, Syria.
RP Kassem, M (reprint author), Atom Energy Commiss Syria, Dept Chem, POB 6091, Damascus, Syria.
EM cscientific@aec.org.sy
CR [Anonymous], 2008, WINXPOW 32
   Armatas NG, 2008, INORG CHEM, V47, P832, DOI 10.1021/ic701573r
   Bansal P, 2009, DESALIN WATER TREAT, V12, P108, DOI 10.5004/dwt.2009.944
   Cai L.Z., 2003, INORG CHIM ACTA, V344, P6
   Cheng MM, 2008, APPL CATAL B-ENVIRON, V77, P355, DOI 10.1016/j.apcatb.2007.08.006
   Choy JH, 2002, CHEM MATER, V14, P2486, DOI 10.1021/cm010815m
   Deyk C., 2008, E-J CHEM, V5, P1021
   Eda K, 2004, J SOLID STATE CHEM, V177, P916, DOI 10.1016/j.jssc.2003.09.029
   Eda K, 2009, J SOLID STATE CHEM, V182, P55, DOI 10.1016/j.jssc.2008.10.001
   Gnaser H., 2004, ENCY NANOSCIENCE NAN, V6, P505
   Griboval A, 2001, APPL CATAL A-GEN, V217, P173, DOI 10.1016/S0926-860X(01)00588-9
   Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1
   Hegde MS, 2005, PRAMANA-J PHYS, V65, P641, DOI 10.1007/BF03010452
   Kim HG, 1999, CHEM COMMUN, P1077, DOI 10.1039/a902892g
   Korosi L, 2006, COLLOID SURFACE A, V280, P146, DOI 10.1016/j.colsurfa.2006.01.052
   Kubelka P., 1931, Zeitschrift fur Technische Physik, V12, P593
   Lee H.C., 2002, B KOREAN CHEM SOC, V33, P477
   Li D.M., 2007, J MOL STRUCT, V832, P173
   Li HB, 2008, MATER RES BULL, V43, P1971, DOI 10.1016/j.materresbull.2007.10.005
   Li SJ, 2008, SCI CHINA SER B, V51, P179, DOI 10.1007/s11426-007-0100-2
   Madeira LM, 2004, CATAL REV, V46, P53, DOI 10.1081/CR-120030053
   Mitchell S., 2010, J SOLID STATE CHEM, V41, P34
   Mohan Ram R. A., 1986, Proceedings of the Indian Academy of Sciences, Chemical Sciences, V96, P291
   Qu WW, 2010, J PHYS CHEM SOLIDS, V71, P35, DOI 10.1016/j.jpcs.2009.10.005
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, MAT SCI ENG C, VC119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Reddy BM, 2002, APPL CATAL A-GEN, V228, P269, DOI 10.1016/S0926-860X(01)00982-6
   Rupa AV, 2007, J HAZARD MATER, V147, P906, DOI 10.1016/j.jhazmat.2007.01.107
   Shaban YA, 2010, INT J NANOTECHNOL, V7, P69, DOI 10.1504/IJNT.2010.029549
   Sing K, 2001, COLLOID SURFACE A, V187, P3, DOI 10.1016/S0927-7757(01)00612-4
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Slamet H.W., 2009, WORLD APPL SCI J, V6, P112
   Storck S, 1998, APPL CATAL A-GEN, V174, P137, DOI 10.1016/S0926-860X(98)00164-1
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   TAKATA T, 2000, STUD SURF SCI CATA B, V130, P1943
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wu CD, 2001, CHIN J STRUCT CHEM, V20, P266
   Wu XY, 2006, B KOR CHEM SOC, V27, P1206
   Xia HL, 2007, J ENVIRON SCI-CHINA, V19, P1141, DOI 10.1016/S1001-0742(07)60186-7
   Xie SB, 2000, J PHYS CHEM B, V104, P10059, DOI 10.1021/jp002419h
   Zaleska A., 2008, RECENT PAT ENG, V2, P157, DOI DOI 10.2174/187221208786306289
   Zhang GK, 2006, J MOL CATAL A-CHEM, V255, P109, DOI 10.1016/j.molcata.2006.03.073
   Zhang XM, 2005, J PHYS CHEM B, V109, P19156, DOI 10.1021/jp052858m
   Zhao G., 2008, J SOLID STATE CHEM, V181, P2133
NR 48
TC 1
Z9 1
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0922-6168
EI 1568-5675
J9 RES CHEM INTERMEDIAT
JI Res. Chem. Intermed.
PD MAY
PY 2015
VL 41
IS 5
BP 2891
EP 2900
DI 10.1007/s11164-013-1397-4
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CF3XV
UT WOS:000352483300021
DA 2018-10-19
ER

PT J
AU Mardones, R
   Jofre, CM
   Minguell, JJ
AF Mardones, Rodrigo
   Jofre, Claudio M.
   Minguell, Jose J.
TI Cell Therapy and Tissue Engineering Approaches for Cartilage Repair
   and/or Regeneration
SO INTERNATIONAL JOURNAL OF STEM CELLS
LA English
DT Review
AB Articular cartilage injuries caused by traumatic, mechanical and/or by progressive degeneration result in pain, swelling, subsequent loss of joint function and finally osteoarthritis. Due to the peculiar structure of the tissue (no blood supply), chondrocytes, the unique cellular phenotype in cartilage, receive their nutrition through diffusion from the synovial fluid and this limits their intrinsic capacity for healing. The first cellular avenue explored for cartilage repair involved the in situ transplantation of isolated chondrocytes. Latterly, an improved alternative for the above reparative strategy involved the infusion of mesenchymal stem cells (MSC), which in addition to a self-renewal capacity exhibit a differentiation potential to chondrocytes, as well as a capability to produce a vast array of growth factors, cytokines and extracellular matrix compounds involved in cartilage development. In addition to the above and foremost reparative options up till now in use, other therapeutic options have been developed, comprising the design of biomaterial substrates (scaffolds) capable of sustaining MSC attachment, proliferation and differentiation. The implantation of these engineered platforms, closely to the site of cartilage damage, may well facilitate the initiation of an in situ' cartilage reparation process. In this mini-review, we examined the timely and conceptual development of several cell-based methods, designed to repair/regenerate a damaged cartilage. In addition to the above described cartilage reparative options, other therapeutic alternatives still in progress are portrayed.
C1 [Mardones, Rodrigo] Clin Las Condes, Lab Ingn Tejidos, Ctr Traumatol & Ortopedia, Santiago 7550000, Chile.
   [Mardones, Rodrigo; Jofre, Claudio M.; Minguell, Jose J.] Clin Las Condes, Lab Ingn Tejidos, Ctr Terapia Regenerat Celular, Santiago 7550000, Chile.
RP Minguell, JJ (reprint author), Clin Las Condes, Ctr Terapia Regenerat Celular, Av Las Condes 10373,Of 75, Santiago 7550000, Chile.
EM jminguell@clinicalascondes.cl
CR Allers C, 2014, CYTOTHERAPY, V16, P454, DOI 10.1016/j.jcyt.2013.08.006
   [Anonymous], 2005, NICE UPD GUID US AUT
   Athanasiou KA, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028825
   Bhardwaj N, 2015, MACROMOL BIOSCI, V15, P153, DOI 10.1002/mabi.201400335
   Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395
   Cole Brian J, 2010, Instr Course Lect, V59, P181
   Dvir-Ginzberg M, 2014, BIOMARKERS, P1, DOI DOI 10.3109/1354750X.2014.955884
   Emadedin M, 2012, ARCH IRAN MED, V15, P422, DOI 012157/AIM.0010
   Freymann U, 2013, OA ORTHOPAEDICS, V1, P6
   Frisch J, 2014, HUM GENE THER, V25, P1050, DOI 10.1089/hum.2014.091
   Giannini S, 2013, AM J SPORT MED, V41, P511, DOI 10.1177/0363546512467622
   Harvey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079283
   Hoch AI, 2014, STEM CELL TRANSL MED, V3, P643, DOI 10.5966/sctm.2013-0196
   Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534
   Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kon E, 2011, ARTHROSCOPY, V27, P1490, DOI 10.1016/j.arthro.2011.05.011
   Lee CSD, 2013, TISSUE ENG PT A, V19, P1451, DOI [10.1089/ten.TEA.2012.0233, 10.1089/ten.tea.2012.0233]
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Minas T, 2010, CLIN ORTHOP RELAT R, V468, P147, DOI 10.1007/s11999-009-0998-0
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Minguell JJ, 2013, STEM CELLS DEV, V22, P193, DOI 10.1089/scd.2012.0417
   Muthuswamy Vasantha, 2013, Perspect Clin Res, V4, P9, DOI 10.4103/2229-3485.106369
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Responte Donald J., 2007, Critical Reviews in Biomedical Engineering, V35, P363
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Rodriguez-Merchan E Carlos, 2012, Am J Orthop (Belle Mead NJ), V41, P236
   Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11
   Schminke B, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0461-4
   Skowronski Jan, 2013, Ortop Traumatol Rehabil, V15, P69, DOI 10.5604/15093492.1012405
   Somoza RA, 2014, TISSUE ENG PART B-RE, V20, P596, DOI [10.1089/ten.teb.2013.0771, 10.1089/ten.TEB.2013.0771]
   Steinert AF, 2008, INJURY, V39, pS97, DOI 10.1016/j.injury.2008.01.034
   Vasiliadis HS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003323.pub3
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971
   Zhang Z, 2014, TISSUE ENG B
   Zwolanek D, 2015, BIORESEARCH
NR 38
TC 36
Z9 40
U1 1
U2 16
PU KOREAN SOC STEM CELL RESEARCH
PI BANPO-DONG
PA CATHOLIC UNIV KOREA 505, INST BIOMEDICAL INDUSTRY, BANPO-DONG, SEOCHO-GU
   00000, SOUTH KOREA
SN 2005-3606
EI 2005-5447
J9 INT J STEM CELLS
JI Int J. Stem Cells
PD MAY
PY 2015
VL 8
IS 1
BP 48
EP 53
DI 10.15283/ijsc.2015.8.1.48
PG 6
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA CJ6XP
UT WOS:000355638800006
PM 26019754
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU De Santis, E
   Lang, NP
   Favero, G
   Beolchini, M
   Morelli, F
   Botticelli, D
AF De Santis, Enzo
   Lang, Niklaus P.
   Favero, Giovanni
   Beolchini, Marco
   Morelli, Fabrizio
   Botticelli, Daniele
TI Healing at mandibular block-grafted sites. An experimental study in dogs
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal study; bone defects; bone graft; bone healing; bone regeneration;
   deproteinized bovine bone mineral; histology
ID LATERAL RIDGE AUGMENTATION; PARTIALLY EDENTULOUS PATIENTS; AUTOGENOUS
   BONE-GRAFTS; BOVINE BONE; IMPLANTS; MEMBRANES; REGENERATION; DEFECTS;
   MAXILLA; MODEL
AB AimThe aim of this study was to evaluate the healing of autologous bone block grafts or deproteinized bovine bone mineral (DBBM) block grafts applied concomitantly with collagen membranes for horizontal alveolar ridge augmentation.
   Material and methodsIn six Labrador dogs, molars were extracted bilaterally, the buccal bony wall was removed, and a buccal box-shaped defect created. After 3months, a bony block graft was harvested from the right ascending ramus of the mandible and reduced to a standardized size. A DBBM block was tailored to similar dimensions. The two blocks were secured with screws onto the buccal wall of the defects in the right and left sides of the mandible, respectively. Resorbable membranes were applied at both sides, and the flaps sutured. After 3months, one implant was installed in each side of the mandible, in the interface between grafts and parent bone. After 3months, biopsies were harvested and ground sections prepared to reveal a 6-month healing period of the grafts.
   Results776.2% and 5.9 +/- 7.5% of vital mineralized bone were found at the autologous bone and DBBM block graft sites, respectively. Moreover, at the DBBM site, 63 +/- 11.7% of connective tissue and 31 +/- 15.5% of DBBM occupied the area analyzed. Only 0.2 +/- 0.4% of DBBM was found in contact with newly formed bone. The horizontal loss was in a mean range of 0.9-1.8mm, and 0.3-0.8mm, at the autologous bone and DBBM block graft sites, respectively.
   ConclusionsAutologous bone grafts were vital and integrated to the parent bone after 6months of healing. In contrast, DBBM grafts were embedded into connective tissue, and only a limited amount of bone was found inside the scaffold of the biomaterial.
C1 [De Santis, Enzo; Botticelli, Daniele] ARDEC, Ariminum Odontol, Rimini, Italy.
   [Lang, Niklaus P.; Botticelli, Daniele] Univ Hong Kong, Prince Philip Dent Hosp, Hong Kong, Hong Kong, Peoples R China.
   [Lang, Niklaus P.] Univ Zurich, Zurich, Switzerland.
   [Favero, Giovanni; Beolchini, Marco; Morelli, Fabrizio; Botticelli, Daniele] Univ Med Sci, Fac Dent, Havana, Cuba.
   [Botticelli, Daniele] UNESP Univ Estadual Paulista, Fac Dent Aracatuba, Sao Paulo, Brazil.
RP Botticelli, D (reprint author), Ave Salvador Allende & G Vedado, Havana, Cuba.
EM daniele.botticelli@gmail.com
OI favero, gian antonio/0000-0002-9126-2393; Botticelli,
   Daniele/0000-0003-2804-1632
FU Sweden & Martina SRL, Due Carrare, Padova, Italy; ARDEC, Ariminum
   Odontologica SRL, Rimini, Italy; Clinical Research Foundation (CRF) for
   the Promotion of Oral Health, Brienz, Switzerland
FX This study has been supported by a grant from Sweden & Martina SRL, Due
   Carrare, Padova, Italy and by ARDEC, Ariminum Odontologica SRL, Rimini,
   Italy and the Clinical Research Foundation (CRF) for the Promotion of
   Oral Health, Brienz, Switzerland. The material for the regenerative
   procedures was kindly provided by Geistlich Biomaterials AG, Wolhusen,
   LU, Switzerland. The competent contributions of Prof. Luiz A. Salata and
   of Mr Sebastiao Bianco (USP - Faculty of Dentistry of Ribeirao Preto -
   University of Sao Paulo, Sao Paulo, Brazil) in the histological
   processing are highly acknowledged.
CR Acocella A, 2010, J CRANIO MAXILL SURG, V38, P222, DOI 10.1016/j.jcms.2009.07.004
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Buser D, 1996, J ORAL MAXIL SURG, V54, P420, DOI 10.1016/S0278-2391(96)90113-5
   Chiapasco M, 1999, CLIN ORAL IMPLAN RES, V10, P278, DOI 10.1034/j.1600-0501.1999.100404.x
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   Clementini M, 2012, INT J ORAL MAX SURG, V41, P847, DOI 10.1016/j.ijom.2012.03.016
   Cordaro L, 2002, CLIN ORAL IMPLAN RES, V13, P103, DOI 10.1034/j.1600-0501.2002.130113.x
   Cordaro L, 2011, CLIN ORAL IMPLAN RES, V22, P1145, DOI 10.1111/j.1600-0501.2010.02093.x
   de Carvalho PSP, 2000, INT J ORAL MAX IMPL, V15, P565
   Neto PJD, 2012, CLIN IMPLANT DENT R, V14, P861, DOI 10.1111/j.1708-8208.2010.00321.x
   De Santis E, 2012, CLIN ORAL IMPLAN RES, V23, P340, DOI 10.1111/j.1600-0501.2011.02326.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P203, DOI 10.1034/j.1600-0501.2002.130211.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P175, DOI 10.1034/j.1600-0501.2002.130208.x
   Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P167
   Faria PEP, 2008, CLIN ORAL IMPLAN RES, V19, P393, DOI 10.1111/j.1600-0501.2007.01485.x
   Felice P., 2013, CLIN IMPLANT DENT R, V24, DOI [10.1111/cid.12115, DOI 10.1111/CID.12115]
   Hammerle CHF, 2008, CLIN ORAL IMPLAN RES, V19, P19, DOI 10.1111/j.1600-0501.2007.01407.x
   Maiorana C, 2005, INT J PERIODONT REST, V25, P19
   Nystrom E, 1993, Int J Oral Maxillofac Implants, V8, P45
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Raghoebar GM, 1996, J ORAL MAXIL SURG, V54, P1180, DOI 10.1016/S0278-2391(96)90346-8
   Rossi F, 2014, CLIN ORAL IMPLAN RES, V25, P124, DOI 10.1111/clr.12097
   Schmitt C, 2013, CLIN ORAL IMPLAN RES, V24, P450, DOI 10.1111/j.1600-0501.2011.02351.x
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P642, DOI 10.1111/j.1600-0501.2008.01537.x
   Schwarz F, 2010, CLIN ORAL IMPLAN RES, V21, P904, DOI 10.1111/j.1600-0501.2010.01951.x
   Simion M, 2006, INT J PERIODONT REST, V26, P415
   Neto RS, 2014, CLIN ORAL IMPLAN RES, V25, P226, DOI 10.1111/clr.12107
   von Arx T, 2001, INT J ORAL MAX IMPL, V16, P343
   von Arx T, 2006, CLIN ORAL IMPLAN RES, V17, P359, DOI 10.1111/j.1600-0501.2005.01234.x
   Widmark G, 1997, INT J ORAL MAX SURG, V26, P106, DOI 10.1016/S0901-5027(05)80827-6
   Yeo A, 2012, CLIN ORAL IMPLAN RES, V23, P1322, DOI 10.1111/j.1600-0501.2011.02366.x
   Zakhary IE, 2012, OR SURG OR MED OR PA, V114, pS179, DOI 10.1016/j.oooo.2011.09.031
   Zerbo IR, 2003, CLIN ORAL IMPLAN RES, V14, P759, DOI 10.1046/j.0905-7161.2003.00967.x
NR 33
TC 14
Z9 14
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2015
VL 26
IS 5
BP 516
EP 522
DI 10.1111/clr.12434
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CF4ZB
UT WOS:000352562200005
PM 24921198
DA 2018-10-19
ER

PT J
AU Moorhoff, C
   Li, Y
   Cook, WD
   Braybrook, C
   Chen, QZ
AF Moorhoff, Cornelis
   Li, Yuan
   Cook, Wayne D.
   Braybrook, Carl
   Chen, Qi-Zhi
TI Characterization of the prepolymer and gel of biocompatible poly(xylitol
   sebacate) in comparison with poly(glycerol sebacate) using a combination
   of mass spectrometry and nuclear magnetic resonance
SO POLYMER INTERNATIONAL
LA English
DT Article
DE poly(polyol sebacate)s; biomaterial; NMR; MS; structural
   characterization
ID ENZYMATIC DEGRADATION; GLYCEROL ESTERS; DIVINYL SEBACATE; C-13-NMR
   SPECTRA; XYLITOL; POLYMERS; ELASTOMERS; ALDITOLS; NETWORK;
   POLYMERIZATION
AB Atmospheric pressure chemical ionization (negative ion) and electrospray ionization (positive and negative ion) mass spectrometry and nuclear magnetic resonance (H-1 NMR and C-13 NMR) were used to characterize the prepolymer (i.e. uncrosslinked) poly(xylitol sebacate) (PXS), prepared by condensation of xylitol [X] and sebacic acid [S], and this was compared with poly(glycerol sebacate) (PGS), prepared by condensation of glycerol [G] and [S]. The PXS prepolymer, prepared at 118 degrees C/24 h, gave predominantly 1-acyl-[XS] and 1,5-diacyl-[SXS] species and smaller amounts of 2-acyl substitutions. At 130 degrees C/24 h an increase of the amount of the 1-acyl and 1,5-diacyl substitutions in the [(SX)(n)], [S(XS)(n)] and [(XS)(n)X] series was identified, as was found for the analogous PGS prepolymer ([(SG)(n)], [S(GS)(n)] and [(GS)(n)G] series). Novel tetrahydrofuranyl species were found in the PXS prepolymer. Further polymerization of the PXS prepolymer gave a gel which when analysed using C-13 NMR was shown to mainly contain 1-acyl and 1,5-diacyl substitutions. (c) 2014 Society of Chemical Industry
C1 [Moorhoff, Cornelis; Li, Yuan; Cook, Wayne D.; Chen, Qi-Zhi] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Braybrook, Carl] CSIRO, Mfg Flagship, Mat Sci & Engn, Clayton, Vic 3169, Australia.
RP Moorhoff, C (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM cor-nelis.moorhoff@monash.edu; wayne.cook@monash.edu
RI Braybrook, Carl/L-3093-2017
FU Australian Research Council [DP130101384]
FX The authors thank Dr Peter Nichols of the Monash School of Chemistry for
   conducting the 2D NMR experiment. Q-ZC thanks the Australian Research
   Council for a Discovery Project grant (DP130101384).
CR Adnani A, 2011, CARBOHYD RES, V346, P472, DOI 10.1016/j.carres.2010.12.023
   ANGYAL SJ, 1980, CARBOHYD RES, V84, P201, DOI 10.1016/S0008-6215(00)85551-2
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Chen Q., 2013, PROG POLYM SCI, V38, P581
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Cramer JF, 2007, ENZYME MICROB TECH, V41, P346, DOI 10.1016/j.enzmictec.2007.03.001
   Crombez-Robert C, 1998, CARBOHYD RES, V307, P355, DOI 10.1016/S0008-6215(98)00006-8
   GERWIG GJ, 1984, CARBOHYD RES, V129, P149, DOI 10.1016/0008-6215(84)85307-0
   Goodby JW, 1997, LIQ CRYST, V22, P367, DOI 10.1080/026782997209441
   Gross JH, 2004, MASS SPECTROMETRY TX
   GUNSTONE FD, 1991, CHEM PHYS LIPIDS, V58, P219
   GUNSTONE FD, 1990, CHEM PHYS LIPIDS, V56, P195, DOI 10.1016/0009-3084(90)90102-W
   GUNSTONE FD, 1993, CHEM PHYS LIPIDS, V66, P189, DOI 10.1016/0009-3084(93)90004-M
   HORNING EC, 1973, ANAL CHEM, V45, P936, DOI 10.1021/ac60328a035
   Jung ME, 1999, ORG LETT, V1, P1517, DOI 10.1021/ol990838v
   Kafouris D, 2013, MACROMOLECULES, V46, P622, DOI 10.1021/ma3016882
   Li Y, 2012, POLYM INT, V62, P534
   Li Y, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035006
   Li Y, 2012, RSC ADV, V2, P8229, DOI 10.1039/c2ra20736b
   Liang SL, 2011, BIOMATERIALS, V32, P8486, DOI 10.1016/j.biomaterials.2011.07.080
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Liu QY, 2007, J APPL POLYM SCI, V103, P1412, DOI 10.1002/app.24394
   Lloyd JA, 2009, ANAL CHEM, V81, P9158, DOI 10.1021/ac901324j
   MACOSKO CW, 1976, MACROMOLECULES, V9, P199, DOI 10.1021/ma60050a003
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   Nagata M, 1999, J POLYM SCI POL CHEM, V37, P2005, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2005::AID-POLA14>3.3.CO;2-8
   Nagata M, 1996, REACT FUNCT POLYM, V30, P165, DOI 10.1016/1381-5148(95)00107-7
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Pinner S., 1961, PRACTICAL COURSE POL
   Pouillart P, 1999, EUR J PHARM SCI, V7, P93, DOI 10.1016/S0928-0987(98)00011-6
   Pretsch E., 2009, STRUCTURE DETERMINAT
   Rai R, 2012, PROG POLYM SCI, V37, P1051, DOI 10.1016/j.progpolymsci.2012.02.001
   Rowland SP, 1967, CARBOHYD RES, V3, P361
   Rufino AR, 2009, J CHEM TECHNOL BIOT, V84, P957, DOI 10.1002/jctb.2117
   SCHNARR GW, 1979, J CHEM SOC PERK T 1, P496, DOI 10.1039/p19790000496
   Stochmayer WH, 1945, ADV FRONTS CHEM
   Terrier P, 2011, MASS SPECTROM REV, V30, P854, DOI 10.1002/mas.20302
   Uyama H, 2001, MACROMOL BIOSCI, V1, P40, DOI 10.1002/1616-5195(200101)1:1<40::AID-MABI40>3.3.CO;2-K
   Uyama H, 1999, MACROMOL RAPID COMM, V20, P171, DOI 10.1002/(SICI)1521-3927(19990401)20:4<171::AID-MARC171>3.3.CO;2-U
   WANG N, 1995, CARBOHYD RES, V274, P45, DOI 10.1016/0008-6215(95)00063-Y
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WHITEHOUSE CM, 1985, ANAL CHEM, V57, P675, DOI 10.1021/ac00280a023
   You ZW, 2010, BIOMATERIALS, V31, P3129, DOI 10.1016/j.biomaterials.2010.01.023
NR 45
TC 1
Z9 1
U1 1
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD MAY
PY 2015
VL 64
IS 5
SI SI
BP 668
EP 688
DI 10.1002/pi.4831
PG 21
WC Polymer Science
SC Polymer Science
GA CF0NC
UT WOS:000352239900012
DA 2018-10-19
ER

PT J
AU Stankova, NE
   Atanasov, PA
   Nedyalkov, NN
   Stoyanchov, TR
   Kolev, KN
   Valova, EI
   Georgieva, JS
   Armyanov, SA
   Amoruso, S
   Wang, X
   Bruzzese, R
   Grochowska, K
   Sliwinski, G
   Baert, K
   Hubin, A
   Delplancke, MP
   Dille, J
AF Stankova, N. E.
   Atanasov, P. A.
   Nedyalkov, N. N.
   Stoyanchov, T. R.
   Kolev, K. N.
   Valova, E. I.
   Georgieva, J. S.
   Armyanov, St. A.
   Amoruso, S.
   Wang, X.
   Bruzzese, R.
   Grochowska, K.
   Sliwinski, G.
   Baert, K.
   Hubin, A.
   Delplancke, M. P.
   Dille, J.
TI fs- and ns-laser processing of polydimethylsiloxane (PDMS) elastomer:
   Comparative study
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium on Laser Interaction with Advaned Materials: Fundamentals and
   Applications
CY 2014
CL Lille, FRANCE
DE PDMS-elastomer; fs and ns laser processing; UV and vis ns- and fs-laser
   treatment; mu-Raman spectrometry; Metallization; Electroless platinga
ID SILICONE-RUBBER; RAMAN-SPECTROSCOPY; ABLATION; POLY(DIMETHYLSILOXANE);
   IRRADIATION; FABRICATION; POLYMERS; MICROSTRUCTURES; DECOMPOSITION;
   INCUBATION
AB Medical grade polydimethylsiloxane (PDMS) elastomer is a widely used biomaterial as encapsulation and/or as substrate insulator carrier for long term neural implants because of its remarkable properties. Femtosecond (lambda = 263 and 527 nm) and nanosecond (266 and 532 nm) laser processing of PDMS-elastomer surface, in air, is investigated. The influence of different processing parameters, including laser wavelength, pulse duration, fluence, scanning speed and overlapping of the subsequent pulses, on the surface activation and the surface morphology are studied. High definition tracks and electrodes are produced. Remarkable alterations of the chemical composition and structural morphology of the ablated traces are observed in comparison with the native material. Raman spectra illustrate well-defined dependence of the chemical composition on the laser fluence, pulse duration, number of pulses and wavelength. An extra peak about similar to 512-518 cm(-1), assigned to crystalline silicon, is observed after ns- or visible fs-laser processing of the surface. In all cases, the intensities of Si-O-Si symmetric stretching at 488 cm(-1), Si-CH3 symmetric rocking at 685 cm(-1), Si-C symmetric stretching at 709 cm(-1), CH3 asymmetric rocking + Si-C asymmetric stretching at 787 cm(-1), and CH3 symmetric rocking at 859 cm(-1), modes strongly decrease. The laser processed areas are also analyzed by SEM and optical microscopy. Selective Pt or Ni metallization of the laser processed traces is produced successfully via electroless plating. The metallization process is not sensitive with respect to the time interval after the laser treatment. DC resistance is measured to be as low as 0.5 Omega mm(-1). Our results show promising prospects with respect to use such a laser-based method for micro-or nano-fabrication of PDMS devices for MEMS and NEMS. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Stankova, N. E.; Atanasov, P. A.; Nedyalkov, N. N.; Stoyanchov, T. R.] Bulgarian Acad Sci, Inst Elect, BU-1784 Sofia, Bulgaria.
   [Kolev, K. N.; Valova, E. I.; Georgieva, J. S.; Armyanov, St. A.] Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, BU-1113 Sofia, Bulgaria.
   [Amoruso, S.; Wang, X.; Bruzzese, R.] Univ Naples Federico II, Dipartimento Sci Fis, CNR SPIN, I-80126 Naples, Italy.
   [Grochowska, K.; Sliwinski, G.] Polish Acad Sci, Szewalski Inst, Photophys Dept, PL-80231 Gdansk, Poland.
   [Baert, K.; Hubin, A.] Vrije Univ Brussel, Fac Engn, Res Grp, SURF Electrochem & Surface Engn, Brussels, Belgium.
   [Delplancke, M. P.; Dille, J.] Univ Libre Bruxelles, Mat Engn Characterizat Synth & Recycling, Serv 4MAT, Fac Sci Appl, B-1050 Brussels, Belgium.
RP Stankova, NE (reprint author), Bulgarian Acad Sci, Inst Elect, 72 Tsarigradsko Shosse, BU-1784 Sofia, Bulgaria.
EM nestankova@yahoo.com
RI WANG, Xuan/F-1243-2011; amoruso, salvatore/E-3941-2012
OI WANG, Xuan/0000-0002-0830-0898; amoruso, salvatore/0000-0002-1011-3215;
   Grochowska, Katarzyna/0000-0001-7577-3399
FU between Bulgarian Academy of Sciences (BAS); foreign research
   institution: BAS/CNR (Italy) - project "Femtosecond and nanosecond laser
   ablation-assisted fabrication of metal and metal-oxides nanostructures";
   foreign research institution: BAS/Polish Academy of Sciences (Poland) -
   project "Fabrication and characterization of noble metal nanoparticles
   arrays"; foreign research institution: BAS/Fonds Wetenschappelijk
   Onderzoek (Belgium) - project "Electrochemical preparation, modification
   and characterization of nanostructured materials"; foreign research
   institution: BAS/Wallonie-Bruxelles International - project "New methods
   for polymer pretreatment for the deposition of nanostructured coatings";
   BNSF
FX The authors would like to acknowledge the support of the following
   bilateral joint projects between Bulgarian Academy of Sciences (BAS) and
   foreign research institutions: BAS/CNR (Italy) - project "Femtosecond
   and nanosecond laser ablation-assisted fabrication of metal and
   metal-oxides nanostructures"; BAS/Polish Academy of Sciences (Poland) -
   project "Fabrication and characterization of noble metal nanoparticles
   arrays"; BAS/Fonds Wetenschappelijk Onderzoek (Belgium) - project
   "Electrochemical preparation, modification and characterization of
   nanostructured materials"; and BAS/Wallonie-Bruxelles International -
   project "New methods for polymer pretreatment for the deposition of
   nanostructured coatings". Financial support of the BNSF under the
   project entitled "New advanced method for processing nanocomposite
   materials for creation of microsystems for medical and high-tech
   applications" is acknowledged.
CR Asgar A., 2007, LAB CHIP, V7, P1192
   Atanasov PA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4887812
   Bae SC, 2005, LANGMUIR, V21, P5685, DOI 10.1021/la050233+
   Blanchet GB, 2000, J APPL PHYS, V88, P2975, DOI 10.1063/1.1288501
   CAIN SR, 1992, J APPL PHYS, V71, P4107, DOI 10.1063/1.350840
   Colas A., 2004, BIOMATERIALS SCI INT, V7.19, p[80, 697]
   Colas ACJ, 2004, BIOMATER SCI, P80
   Darvishi S, 2012, OPT LASER ENG, V50, P210, DOI 10.1016/j.optlaseng.2011.09.003
   Deepak KLN, 2010, PRAMANA-J PHYS, V75, P1221, DOI 10.1007/s12043-010-0210-9
   Dicara C, 2003, P SOC PHOTO-OPT INS, V5147, P255, DOI 10.1117/12.537694
   Dupas-Bruzek C, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236509
   Dupas-Bruzek C, 2009, APPL SURF SCI, V255, P8715, DOI 10.1016/j.apsusc.2009.06.025
   Ferrari AC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121405
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Gao KL, 2014, SMALL, V10, P1015, DOI 10.1002/smll.201300116
   Graubner VM, 2006, APPL SURF SCI, V252, P4781, DOI 10.1016/j.apsusc.2005.07.123
   HajjHassan M, 2008, SENSORS-BASEL, V8, P6704, DOI 10.3390/s8106704
   Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169
   Huang H., 2012, NAN C EXP 2012 JUN 1
   Huang H, 2010, LASER MED SCI, V25, P517, DOI 10.1007/s10103-009-0741-9
   Lacour SP, 2010, MED BIOL ENG COMPUT, V48, P945, DOI 10.1007/s11517-010-0644-8
   Laude L.D., 1995, [No title captured], Patent No. [EP 1995/0693138 A1, 19950693138]
   Laude L.D., 2008, [No title captured], Patent No. [US 2008/0305320 A1, 20080305320]
   Laude L.D., 1997, [No title captured], Patent No. [US 1997/5599592 A, 19975599592]
   Laude LD, 2003, P SOC PHOTO-OPT INS, V4977, P578, DOI 10.1117/12.483853
   Laude LD, 2003, NUCL INSTRUM METH B, V208, P314, DOI 10.1016/S0168-583X(03)01183-2
   Lippert T, 2004, ADV POLYM SCI, V168, P51, DOI 10.1007/b12682
   Liu KW, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/1/015012
   Narayana L., 2012, OPT ENG, V51
   Palma C, 1999, APPL SURF SCI, V138, P24, DOI 10.1016/S0169-4332(98)00382-1
   Rosset S, 2013, APPL PHYS A-MATER, V110, P281, DOI 10.1007/s00339-012-7402-8
   Rubahn K, 2004, APPL PHYS A-MATER, V79, P1715, DOI 10.1007/s00339-004-2888-3
   Schuettler M, 2005, J NEURAL ENG, V2, pS121, DOI 10.1088/1741-2560/2/1/013
   Sones CL, 2014, APPL SURF SCI, V298, P125, DOI 10.1016/j.apsusc.2014.01.138
   SRINIVASAN R, 1990, J APPL PHYS, V68, P1842, DOI 10.1063/1.346620
   SRINIVASAN V, 1986, J APPL PHYS, V59, P3861, DOI 10.1063/1.336728
   SUTCLIFFE E, 1986, J APPL PHYS, V60, P3315, DOI 10.1063/1.337698
   Tuthill T.R., 2013, IEEE T BIOMED CIRC S, V7, P1
   van Pelt S, 2014, APPL SURF SCI, V303, P456, DOI 10.1016/j.apsusc.2014.03.025
   Ward Y, 2004, J MATER SCI, V39, P6781, DOI 10.1023/B:JMSC.0000045606.60263.27
   ZWEIG AD, 1993, J APPL PHYS, V74, P4181, DOI 10.1063/1.354422
NR 41
TC 15
Z9 15
U1 2
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 1
PY 2015
VL 336
BP 321
EP 328
DI 10.1016/j.apsusc.2014.12.121
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CE2BL
UT WOS:000351617600055
DA 2018-10-19
ER

PT J
AU Mabry, KM
   Lawrence, RL
   Anseth, KS
AF Mabry, Kelly M.
   Lawrence, Rosa L.
   Anseth, Kristi S.
TI Dynamic stiffening of poly(ethylene glycol)-based hydrogels to direct
   valvular interstitial cell phenotype in a three-dimensional environment
SO BIOMATERIALS
LA English
DT Article
DE Heart valve; Valvular interstitial cells; Hydrogel; Elasticity;
   Three-dimensional cell culture; ECM
ID EXTRACELLULAR-MATRIX; IN-VITRO; CULTURE; HEART; MECHANOTRANSDUCTION;
   FIBROBLASTS; ACTIVATION; STIFFNESS; CUES; DEPOSITION
AB Valvular interstitial cells (VICs) are active regulators of valve homeostasis and disease, responsible for secreting and remodeling the valve tissue matrix. As a result of VIC activity, the valve modulus can substantially change during development, injury and repair, and disease progression. While twodimensional biomaterial substrates have been used to study mechanosensing and its influence on VIC phenotype, less is known about how these cells respond to matrix modulus in a three-dimensional environment. Here, we synthesized MMP-degradable poly(ethylene glycol) (PEG) hydrogels with elastic moduli ranging from 0.24 kPa to 12 kPa and observed that cell morphology was constrained in stiffer gels. To vary gel stiffness without substantially changing cell morphology, cell-laden hydrogels were cultured in the 0.24 kPa gels for 3 days to allow VIC spreading, and then stiffened in situ via a second, photoinitiated thiol-ene polymerization such that the gel modulus increased from 0.24 kPa to 1.2 kPa or 13 kPa. VICs encapsulated within soft gels exhibited alpha SMA stress fibers (similar to 40%), a hallmark of the myofibroblast phenotype. Interestingly, in stiffened gels, VICs became deactivated to a quiescent fibroblast phenotype, suggesting that matrix stiffness directs VIC phenotype independent of morphology, but in a manner that depends on the dimensionality of the culture platform. Collectively, these studies present a versatile method for dynamic stiffening of hydrogels and demonstrate the significant effects of matrix modulus on VIC myofibroblast properties in three-dimensional environments. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Mabry, Kelly M.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Lawrence, Rosa L.] Fairview High Sch, Boulder, CO 80305 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
EM Kristi.Anseth@colorado.edu
FU NIH Pharmaceutical Biotechnology; NIH [R01 HL089260]; HHMI
FX The authors would like to thank Samuel Payne for help with VIC cultures
   and Dr. Huan Wang for PCR primers. The authors would also like to
   acknowledge support to KMM from an NIH Pharmaceutical Biotechnology
   Training Grant, funding from an NIH grant (R01 HL089260) and HHMI.
CR Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795
   Bryant SJ, 2006, SCAFFOLDING TISSUE E, P1
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Duan B, 2013, ACTA BIOMATER, V9, P7640, DOI 10.1016/j.actbio.2013.04.050
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Durbin AD, 2002, CARDIOVASC PATHOL, V11, P69, DOI 10.1016/S1054-8807(01)00109-0
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fayet C, 2007, CARDIOVASC PATHOL, V16, P203, DOI 10.1016/j.carpath.2007.02.008
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kural MH, 2014, BIOMATERIALS, V35, P1128, DOI 10.1016/j.biomaterials.2013.10.047
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Liu AC, 2007, HISTOL HISTOPATHOL, V22, P873, DOI 10.14670/HH-22.873
   Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   Quinlan AMT, 2012, J BIOMED MATER RES A, V100A, P2474, DOI 10.1002/jbm.a.34162
   Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841
   Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767
   Rodriguez KJ, 2011, MATRIX BIOL, V30, P70, DOI 10.1016/j.matbio.2010.09.001
   Ryan DG, 2003, INVEST OPHTH VIS SCI, V44, P4255, DOI 10.1167/iovs.03-0578
   Wang H, 2013, P NATL ACAD SCI USA, V110, P19336, DOI 10.1073/pnas.1306369110
   Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069667
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969
   Witt W, 2014, J MOL CELL CARDIOL, V74, P127, DOI 10.1016/j.yjmcc.2014.05.008
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394
NR 43
TC 65
Z9 65
U1 8
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 49
BP 47
EP 56
DI 10.1016/j.biomaterials.2015.01.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE2LO
UT WOS:000351647300006
PM 25725554
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Liu, H
   Xu, GW
   Wang, YF
   Zhao, HS
   Xiong, S
   Wu, Y
   Heng, BC
   An, CR
   Zhu, GH
   Xie, DH
AF Liu, Hua
   Xu, Guo Wei
   Wang, Ya Fei
   Zhao, Hong Shi
   Xiong, Si
   Wu, Yan
   Heng, Boon Chin
   An, Cheng Rui
   Zhu, Gang Hua
   Xie, Ding Hua
TI Composite scaffolds of nano-hydroxyapatite and silk fibroin enhance
   mesenchymal stem cell-based bone regeneration via the interleukin 1
   alpha autocrine/paracrine signaling loop
SO BIOMATERIALS
LA English
DT Article
DE Bone regeneration; Hydroxyapatite; Stem cell; Silk; Interleukin;
   Osteogenesis
ID IN-VITRO; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; STROMAL CELLS;
   PPAR-GAMMA; ADIPOGENESIS; OSTEOINDUCTIVITY; FABRICATION; ACTIVATION;
   PARTICLES
AB Composite scaffolds of nano-hydroxyapatite (nHAp) and silk fibroin (SF) have been reported to promote bone regeneration mainly through signaling pathways associated with cell biomaterial interaction. However, it is unclear whether soluble factors also play a role in osteoinduction with nHAp-SF. In this study, we confirmed the biocompatibility and superior osteoinductivity of nHAp-SF scaffolds versus SF scaffolds both in vitro and on a calvarial defect model in vivo. This was followed by further analysis with microarray assay. The cDNA microarray results identified 247 differentially expressed genes in bone marrow mesenchymal stem cells (BMSCs) cultured on SF-nHAp scaffolds versus SF scaffolds. The greatest disparity in gene expression levels were observed with Ilia and Ilr2. Real-time PCR assay validated the results. The addition of IL-1 alpha into cultures of BMSCs with SF significantly increased both Bmp2 and Ilr2 expression. However, with BMSCs alone, the Ilr2 expression increased substantially, whereas Bmp2 expression exhibited a decrease rather than increase. These data suggested that nHAp may exert osteoinductive effects on BMSCs via the secretion of IL-1 alpha in an autocrine/paracrine fashion, and IL-1 alpha activity could be regulated through the synthesis of IL1R2 by BMSCs upon interaction with nHAp. These results complemented our understanding of the underlying mechanisms of biomaterial osteoinductivity. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Zhu, Gang Hua; Xie, Ding Hua] Cent S Univ, Xiangya Hosp 2, Dept Otolaryngol Head & Neck Surg, Inst Otol, Changsha 410011, Hunan, Peoples R China.
   [Liu, Hua; Xu, Guo Wei; Wang, Ya Fei; Zhao, Hong Shi; Xiong, Si; Wu, Yan; An, Cheng Rui] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Liu, Hua; Xu, Guo Wei; Wang, Ya Fei; Zhao, Hong Shi; Xiong, Si; Wu, Yan; An, Cheng Rui] Zhejiang Prov Key Lab Tissue Engn & Regenerat Med, Hangzhou 310058, Zhejiang, Peoples R China.
   [Heng, Boon Chin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
RP Zhu, GH (reprint author), Cent S Univ, Xiangya Hosp 2, Dept Otolaryngol Head & Neck Surg, Inst Otol, Changsha 410011, Hunan, Peoples R China.
EM z1g2h3@hotmail.com; dhuaxie@163.com
RI Heng, Boon Chin/E-5462-2016
OI Heng, Boon Chin/0000-0003-2541-3699
FU National Basic Research Program of China (973 Program) [2012CB967904,
   2012CB967900]; National Natural Science Foundation of China [31200739,
   31470948]; Doctoral Fund of Ministry of Education of China
   [20120101120003]; Science and Technology Department Program of Zhejiang
   Province [201303156]; International Science & Technology Cooperation
   Program of China [2011DFA32190]; Regenerative Medicine in Innovative
   Medical Subjects of Zhejiang Province; Zhejiang Provincial Program for
   the Cultivation of High-level Innovative Health talents
FX This work was supported by the National Basic Research Program of China
   (973 Program, 2012CB967904, 2012CB967900), the National Natural Science
   Foundation of China (31200739 and 31470948), the Doctoral Fund of
   Ministry of Education of China (20120101120003), the Science and
   Technology Department Program of Zhejiang Province (201303156), the
   International Science & Technology Cooperation Program of China
   (2011DFA32190), as well as sponsored by Regenerative Medicine in
   Innovative Medical Subjects of Zhejiang Province and Zhejiang Provincial
   Program for the Cultivation of High-level Innovative Health talents.
CR Ali IHA, 2014, BRIT J PHARMACOL, V171, P3620, DOI 10.1111/bph.12724
   Aronsson L, 2010, PLOS ONE, P5
   Bodo M., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P679
   Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023
   Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   Graneli C, 2014, CONNECT TISSUE RES, V55, P262, DOI 10.3109/03008207.2014.910198
   Huh JE, 2014, INT J MOL SCI, V15, P13010, DOI 10.3390/ijms150713010
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   JIN CH, 1990, MOL CELL ENDOCRINOL, V74, P221
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kweon H, 2011, J ORAL MAXIL SURG, V69, P1578, DOI 10.1016/j.joms.2010.07.062
   Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431
   Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002
   Lin KL, 2014, ACTA BIOMATER, V10, P4071, DOI 10.1016/j.actbio.2014.06.017
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Liu H, 2006, J IMMUNOL, V176, P2864, DOI 10.4049/jimmunol.176.5.2864
   Liu H, 2009, J CELL MOL MED, V13, P2436, DOI 10.1111/j.1582-4934.2009.00793.x
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lu XY, 2014, J BIOMED MATER RES A, V102, P2833, DOI 10.1002/jbm.a.34951
   McNamara SL, 2014, BIOMATERIALS, V35, P6941, DOI 10.1016/j.biomaterials.2014.05.013
   Nyman LR, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.11
   Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219
   Panda N, 2014, J BIOMAT SCI-POLYM E, V25, P1440, DOI 10.1080/09205063.2014.943548
   Pillai HK, 2014, ENVIRON HEALTH PERSP, V122, P1225, DOI 10.1289/ehp.1408111
   Qian JM, 2014, J BIOMED MATER RES A, V102, P2961, DOI 10.1002/jbm.a.34964
   Sheikh FA, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-303
   Song JH, 2008, J BONE MINER METAB, V26, P138, DOI 10.1007/s00774-007-0804-6
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Thorfve A, 2014, ACTA BIOMATER, V10, P1451, DOI 10.1016/j.actbio.2013.12.012
   Wei K, 2011, J BIOMED MATER RES A, V97A, P272, DOI 10.1002/jbm.a.33054
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Zambuzzi WF, 2011, J BIOMED MATER RES A, V97A, P193, DOI 10.1002/jbm.a.32933
   Zhao HS, 2011, TISSUE ENG PT A, V17, P765, DOI [10.1089/ten.tea.2010.0196, 10.1089/ten.TEA.2010.0196]
   Zhao Y, 2009, J BIOMED MATER RES A, V91A, P1140, DOI 10.1002/jbm.a.32272
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zong C, 2010, EUR CELLS MATER, V20, P109
NR 38
TC 56
Z9 59
U1 3
U2 142
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 49
BP 103
EP 112
DI 10.1016/j.biomaterials.2015.01.017
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE2LO
UT WOS:000351647300011
PM 25725559
DA 2018-10-19
ER

PT J
AU Ensari, N
   Tutar, H
   Ekinci, O
   Ugur, MB
   Bayazit, YA
   Gokdogan, C
   Goksu, N
AF Ensari, Nuray
   Tutar, Hakan
   Ekinci, Ozgur
   Ugur, Mehmet Birol
   Bayazit, Yildirim A.
   Gokdogan, Cagil
   Goksu, Nebil
TI Effects of polylactic acid film on middle ear mucosa and cochlear
   function in Guinea pigs
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Article
DE Polylactic acid; Ototoxicity; Middle ear effects; Inner ear effects;
   Adhesive otitis media; Biomaterial
ID EUSTACHIAN-TUBE; OTITIS-MEDIA; TYMPANOPLASTY; REGENERATION; ADHESIONS;
   SURGERY
AB Our aim was to assess the effects of polylactic acid (PLA) on middle ear mucosa and cochlea, to be used as a film barrier for postoperative adhesion prevention in the middle ear. Twenty-one albino Guinea pigs were included in the study. A window was opened on both tympanic bulla and on one side PLA material was placed in the middle ear and on the other side only fenestration was performed and used as a control. All Guinea pigs underwent evaluation of tympanic membranes microscopically; functional hearing was analyzed by auditory brainstem responses preoperatively, in the first and the sixth month. All Guinea pigs were killed on the sixth month for histopathologic evaluation of their temporal bones. There was no statistical difference between both groups regarding hearing thresholds, interpeak wave latencies preoperatively and on first and the sixth months postoperatively. Histopathological evaluation revealed no specific changes. There was a mild local inflammation both in the PLA implanted and control ears. PLA film barrier most likely has no toxic effects on Guinea pig middle ear and does not show any ototoxic side effects.
C1 [Ensari, Nuray] Antalya Ataturk Educ & Res Hosp, Dept Otolaryngol, Antalya, Turkey.
   [Tutar, Hakan; Ugur, Mehmet Birol; Bayazit, Yildirim A.; Goksu, Nebil] Gazi Univ, Dept Otolaryngol, Fac Med, Ankara, Turkey.
   [Ekinci, Ozgur] Gazi Univ, Dept Pathol, Fac Med, Ankara, Turkey.
   [Gokdogan, Cagil] Gazi Univ, Audiol Unit, Fac Med, Ankara, Turkey.
RP Tutar, H (reprint author), Gazi Univ, Dept Otolaryngol, Fac Med, Ankara, Turkey.
EM drhakantutar@yahoo.com
CR Avital S, 2005, DIS COLON RECTUM, V48, P153, DOI 10.1007/s10350-004-0748-z
   BLUESTONE CD, 1988, J ALLERGY CLIN IMMUN, V81, P997, DOI 10.1016/0091-6749(88)90168-6
   Ceylan A, 2007, OTOL NEUROTOL, V28, P341, DOI 10.1097/01.mao.0000253286.48619.1c
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   Hashimoto S, 2000, Auris Nasus Larynx, V27, P39, DOI 10.1016/S0385-8146(99)00033-4
   Lipan MJ, 2011, OTOLARYNG HEAD NECK, V144, P763, DOI 10.1177/0194599810395115
   MAGNUSON B, 1981, INT J PEDIATR OTORHI, V3, P25, DOI 10.1016/0165-5876(81)90016-1
   McGhee MA, 1999, AM J OTOL, V20, P712
   Nankivell PC, 2010, COCHRANE DB SYST REV, V7, P1
   NG M, 1992, LARYNGOSCOPE, V102, P1097, DOI 10.1288/00005537-199210000-00002
   Peltonen LI, 2007, OTOL NEUROTOL, V28, P850, DOI 10.1097/MAO.0b013e318064f199
   Pinilla M, 2003, OTOLARYNG HEAD NECK, V128, P124, DOI 10.1067/mhn.2003.55
   Qin YY, 2006, J BIOMED MATER RES B, V79B, P312, DOI 10.1002/jbm.b.30544
   SADE J, 1986, AM J OTOL, V7, P439
   SHEA MC, 1981, CLIN OTOLARYNGOL, V6, P125, DOI 10.1111/j.1365-2273.1981.tb01797.x
   Shen Y, 2011, LARYNGOSCOPE, V121, P1040, DOI 10.1002/lary.21470
   Vicente J, 2006, ACTA OTO-LARYNGOL, V126, P144, DOI 10.1080/00016480500312570
   WULLSTEIN SR, 1985, AM J OTOL, V6, P31
   Yaguchi Y, 2007, ACTA OTO-LARYNGOL, V127, P1038, DOI 10.1080/00016480701200285
NR 20
TC 2
Z9 2
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0937-4477
EI 1434-4726
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD MAY
PY 2015
VL 272
IS 5
BP 1091
EP 1097
DI 10.1007/s00405-014-2904-y
PG 7
WC Otorhinolaryngology
SC Otorhinolaryngology
GA CE3BE
UT WOS:000351698300006
PM 24504490
DA 2018-10-19
ER

PT J
AU Zeng, DM
   Pan, JJ
   Wang, Q
   Liu, XF
   Wang, H
   Zhang, KQ
AF Zeng, Dong-Mei
   Pan, Jue-Jing
   Wang, Qun
   Liu, Xin-Fang
   Wang, Hui
   Zhang, Ke-Qin
TI Controlling silk fibroin microspheres via molecular weight distribution
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk fibroin; Molecular weight; Salting out; Microspheres; Ionic
   strength
ID DRUG-DELIVERY; NANOPARTICLES; BIOMATERIAL; SCAFFOLDS; FEATURES
AB Silk fibroin (SF) microspheres were produced by salting out SF solution via the addition of potassium phosphate buffer solution (K2HPO4-KH2PO4). The morphology, size and polydispersity of SF microspheres were adjusted by changing the molecular weight (MW) distribution and concentration of SF, as well as the ionic strength and pH of the buffer solution. Changing the conditions under which the SF fiber dissolved in the Lithium Boride (LiBr) solution resulted in altering the MW distribution of SF solution. Under optimal salting-out conditions (ionic strength > 0.7 M and pH > 7) and using a smaller and narrower SF MW distribution, SF microspheres with smoother shapes and more uniform sizes were produced. Meanwhile, the size and polydispersity of the microspheres increased when the SF concentration was increased from 0.25 mg/mL to 20 mg/mL. The improved SF microspheres, obtained by altering the distribution of molecular weight, have potential in drug and gene delivery applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zeng, Dong-Mei; Pan, Jue-Jing; Wang, Qun; Liu, Xin-Fang; Wang, Hui; Zhang, Ke-Qin] Soochow Univ, Coll Textile & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Jiangsu, Peoples R China.
   [Zhang, Ke-Qin] Soochow Univ, Res Ctr Cooperat Innovat Funct Organ Polymer Mat, Suzhou 215123, Jiangsu, Peoples R China.
RP Zhang, KQ (reprint author), Soochow Univ, Coll Textile & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Jiangsu, Peoples R China.
EM kqzhang@suda.edu.cn
FU National Natural Science Foundation of China [91027039, 51373110,
   51203108]; Natural Science Foundation of Jiangsu Province of China
   [BK2011355]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China [11KJB430011, 10KJA540046]; Nanotechnology
   Foundation of Suzhou [ZXG2013037]; China Postdoctoral Science Foundation
   [2013M531403]; Priority Academic Program Development ofJiangsu Higher
   Education Institutions (PAPD); Qing Lan Project for Excellent Scientific
   and Technological Innovation Team ofJiangsu Province; Jiangsu Scientific
   and Technological Innovation Team
FX We gratefully acknowledge the financial support from the National
   Natural Science Foundation of China under grants 91027039, 51373110 and
   51203108, the Natural Science Foundation of Jiangsu Province of China
   under Grant BK2011355, the Natural Science Foundation of the Jiangsu
   Higher Education Institutions of China under Grants 11KJB430011 and
   10KJA540046, the Nanotechnology Foundation of Suzhou under Grant
   ZXG2013037 and the China Postdoctoral Science Foundation under Grant
   2013M531403. We also acknowledge the fund from the project of the
   Priority Academic Program Development ofJiangsu Higher Education
   Institutions (PAPD), Qing Lan Project for Excellent Scientific and
   Technological Innovation Team ofJiangsu Province (2012) and Project for
   Jiangsu Scientific and Technological Innovation Team (2013).
CR Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Germershaus O, 2014, BIOMATERIALS, V35, P3427, DOI 10.1016/j.biomaterials.2013.12.083
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li GH, 2012, MAT SCI ENG C-MATER, V32, P627, DOI 10.1016/j.msec.2011.12.013
   Liu L, 2011, POLYM ADVAN TECHNOL, V22, P909, DOI 10.1002/pat.1595
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Masuhiro T., 1994, J POLYM SCI B, V32, P1407
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Nitta SK, 2013, INT J MOL SCI, V14, P1629, DOI 10.3390/ijms14011629
   Panday A, 2009, MACROMOLECULES, V42, P4632, DOI 10.1021/ma900451e
   RAO PU, 1994, J AGR FOOD CHEM, V42, P2201, DOI 10.1021/jf00046a023
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Srihanam P, 2011, KOREAN J CHEM ENG, V28, P293, DOI 10.1007/s11814-010-0322-4
   Srisuwan Y, 2009, J MACROMOL SCI A, V46, P521, DOI 10.1080/10601320902797780
   Tang B, 2014, DYES PIGMENTS, V103, P183, DOI 10.1016/j.dyepig.2013.12.008
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wu PY, 2013, ACS APPL MATER INTER, V5, P12638, DOI 10.1021/am403992b
   Yang HC, 2009, MICROCHEM J, V92, P87, DOI 10.1016/j.microc.2009.02.001
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   You XQ, 2011, MAT SCI ENG C-MATER, V31, P1632, DOI 10.1016/j.msec.2011.06.010
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zhang YQ, 2011, SOFT MATTER, V7, P9728, DOI 10.1039/c0sm01332c
NR 34
TC 8
Z9 8
U1 6
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2015
VL 50
BP 226
EP 233
DI 10.1016/j.msec.2015.02.005
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CE4MG
UT WOS:000351804100028
PM 25746265
DA 2018-10-19
ER

PT J
AU Gonzalez-Sanchez, MI
   Perni, S
   Tommasi, G
   Morris, NG
   Hawkins, K
   Lopez-Cabarcos, E
   Prokopovich, P
AF Isabel Gonzalez-Sanchez, M.
   Perni, Stefano
   Tommasi, Giacomo
   Glyn Morris, Nathanael
   Hawkins, Karl
   Lopez-Cabarcos, Enrique
   Prokopovich, Polina
TI Silver nanoparticle based antibacterial methacrylate hydrogels potential
   for bone graft applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydrogels; Silver; Nanoparticles; Infections; Staphylococcus
   epidermidis; Methicillin-resistant Staphylococcus aureus (MRSA)
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; DIFFUSION;
   MINERALIZATION; BIOMATERIALS; GENTAMICIN; STABILITY; IMPLANT; CEMENT;
   PEG
AB Infections are frequent and very undesired occurrences after orthopedic procedures; furthermore, the growing concern caused by the rise in antibiotic resistance is progressively dwindling the efficacy of such drugs. Artificial bone graft materials could solve some of the problems associated with the gold standard use of natural bone graft such as limited bone material, pain at the donor site and rejections if donor tissue is used. We have previously described new acrylate base nanocomposite hydrogels as bone graft materials. In the present paper, we describe the integration of silver nanoparticles in the polymeric mineralized biomaterial to provide non-antibiotic antibacterial activity against Staphylococcus epidermidis and Methicillin-resistant Staphylococcus aureus. Two different crosslinking degrees were tested and the silver nanoparticles were integrated into the composite matrix by means of three different methods; entrapment in the polymeric hydrogel before the mineralization; diffusion during the process of calcium phosphate crystallization and adsorption post-mineralization. The latter being generally the most effective method of encapsulation; however, the adsorption of silver nanoparticles inside the pores of the biomaterial led to a decreasing antibacterial activity for adsorption time longer than 2 days. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
C1 [Isabel Gonzalez-Sanchez, M.] Univ Castilla La Mancha, Sch Ind Engn, Dept Phys Chem, Albacete, Spain.
   [Isabel Gonzalez-Sanchez, M.; Lopez-Cabarcos, Enrique] Univ Complutense Madrid, Dept Phys Chem 2, Madrid, Spain.
   [Isabel Gonzalez-Sanchez, M.; Perni, Stefano; Tommasi, Giacomo; Glyn Morris, Nathanael; Prokopovich, Polina] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3NB, S Glam, Wales.
   [Perni, Stefano; Prokopovich, Polina] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Hawkins, Karl] Univ Coll Swansea, Inst Life Sci, Ctr Nanohlth, Swansea, W Glam, Wales.
RP Prokopovich, P (reprint author), Cardiff Univ, Sch Pharm & Pharmaceut Sci, Redwood Bldg,King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales.
EM prokopovichp@cardiff.ac.uk
RI Perni, Stefano/B-8158-2009; GONZALEZ SANCHEZ, MARIA ISABEL/M-4223-2015
OI Perni, Stefano/0000-0002-3101-0098; GONZALEZ SANCHEZ, MARIA
   ISABEL/0000-0002-7390-5420; Prokopovich, Polina/0000-0002-5700-9570;
   Hawkins, Karl/0000-0003-0174-4151
FU COST [CM1101]; Arthritis Research UK [ARUK:18461]
FX The studies were performed in the frame of COST CM1101 project
   "Colloidal Aspects of Nanoscience for Innovative Processes and
   Materials". PP also would like to thank Arthritis Research UK
   (ARUK:18461) for funding this study.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Bardajee GR, 2012, J INORG BIOCHEM, V117, P367, DOI 10.1016/j.jinorgbio.2012.06.012
   Bechert T, 2000, NAT MED, V6, P1053, DOI 10.1038/79568
   Bondarenko O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064060
   Bormann N, 2014, BONE, V59, P162, DOI 10.1016/j.bone.2013.11.005
   Coraca-Huber D, 2014, ORTHOPEDICS, V37, DOI 10.3928/01477447-20140728-50
   Dutta S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39873
   Fleiter N, 2014, BONE JOINT RES, V3, P223, DOI 10.1302/2046-3758.37.2000301
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Grosso MJ, 2012, J SHOULDER ELB SURG, V21, P754, DOI 10.1016/j.jse.2011.08.052
   Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008
   Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007
   Haynes William M., 2007, CRC HDB CHEM PHYS
   Hervas-Perez J.P., 2006, BIOMOL ENG, V23, P233
   Huang JJ, 2012, CHEM MATER, V24, P1331, DOI 10.1021/cm203764f
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kaner D., 2010, J CLIN PERIODONTOL, V38, P95
   KARPATISMIDROCZKI E, 1995, COLLOID POLYM SCI, V273, P857, DOI 10.1007/BF00657635
   Killion JA, 2014, INT J POLYM MATER PO, V63, P641, DOI 10.1080/00914037.2013.854238
   Konig DP, 2001, LANGENBECK ARCH SURG, V386, P328, DOI 10.1007/s004230100229
   Krstic J, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40321
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Le T.T., 2010, MAT SCI ENG C, V30, P910
   Li GY, 2013, J APPL POLYM SCI, V127, P2690, DOI 10.1002/app.37609
   Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Lowenstam HA, 1989, BIOMINERALIZATION
   Martin BD, 1998, BIOMATERIALS, V19, P69, DOI 10.1016/S0142-9612(97)00184-1
   McCrory R, 2003, J PHARM PHARMACOL, V55, P411, DOI 10.1211/0022357021035
   Mohamed RR, 2014, INT J BIOL MACROMOL, V69, P95, DOI 10.1016/j.ijbiomac.2014.05.025
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Morris K, 2007, LANCET INFECT DIS, V7, P509, DOI 10.1016/S1473-3099(07)70173-1
   Nadworny PL, 2008, NANOMED-NANOTECHNOL, V4, P241, DOI 10.1016/j.nano.2008.04.006
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   Nuryastuti T, 2009, APPL ENVIRON MICROB, V75, P6850, DOI 10.1128/AEM.00875-09
   Penalba Arias P., 2014, INJURY
   Perni S, 2014, COLLOID SURFACE A, V460, P219, DOI 10.1016/j.colsurfa.2013.09.034
   Perni S, 2014, ADV COLLOID INTERFAC, V206, P265, DOI 10.1016/j.cis.2013.11.008
   Prokopovich P., 2005, J BIOMED MATER RES B, V103, P273
   Prokopovich P, 2013, INT J NANOMED, V8, P2227, DOI 10.2147/IJN.S42822
   Ramadan Y, 2014, MAT SCI ENG C-MATER, V42, P696, DOI 10.1016/j.msec.2014.06.017
   Roberts JJ, 2013, BIOMATERIALS, V34, P9969, DOI 10.1016/j.biomaterials.2013.09.020
   Sallam KI, 2007, FOOD CONTROL, V18, P566, DOI 10.1016/j.foodcont.2006.02.002
   Sander C.G., 2010, BIOMACROMOLECULES, V11, P154
   Selby A, 2014, J MECH BEHAV BIOMED, V35, P144, DOI 10.1016/j.jmbbm.2013.11.023
   Sharma VK, 2014, ADV COLLOID INTERFAC, V204, P15, DOI 10.1016/j.cis.2013.12.002
   Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y
   Sintubin L, 2009, APPL MICROBIOL BIOT, V84, P741, DOI 10.1007/s00253-009-2032-6
   Sophier J., 2010, ACTA BIOMATER, V6, P2932
   Sorli L, 2012, J BONE JOINT SURG BR, V94B, P249, DOI 10.1302/0301-620X.94B2.27779
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vlierberghe S. V., 2011, BIOMACROMOLECULES, V12, P1387
   Wang JJ, 2012, J APPL POLYM SCI, V125, P548, DOI 10.1002/app.35687
   Wichterle O., 1960, HYDROPHILIC GELS BIO
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w
   Yokoi T, 2010, MAT SCI ENG C-MATER, V30, P154, DOI 10.1016/j.msec.2009.09.012
   Zhou CC, 2011, BIOMATERIALS, V32, P2704, DOI 10.1016/j.biomaterials.2010.12.040
NR 59
TC 30
Z9 30
U1 2
U2 80
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2015
VL 50
BP 332
EP 340
DI 10.1016/j.msec.2015.02.002
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CE4MG
UT WOS:000351804100041
PM 25746278
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Ekstrand-Hammarstrom, B
   Hong, J
   Davoodpour, P
   Sandholm, K
   Ekdahl, KN
   Bucht, A
   Nilsson, B
AF Ekstrand-Hammarstrom, Barbro
   Hong, Jaan
   Davoodpour, Padideh
   Sandholm, Kerstin
   Ekdahl, Kristina N.
   Bucht, Anders
   Nilsson, Bo
TI TiO2 nanoparticles tested in a novel screening whole human blood model
   of toxicity trigger adverse activation of the kallikrein system at low
   concentrations
SO BIOMATERIALS
LA English
DT Article
DE Contact system; P25; Platelets; Nanoparticles; Complement
ID AIR-POLLUTION; HEMOCOMPATIBILITY EVALUATION; SURFACE-PROPERTIES;
   COMPLEMENT; TITANIUM; PARTICLES; INFLAMMATION; COAGULATION; BIOMATERIAL;
   THROMBOSIS
AB There is a compelling need to understand and assess the toxicity of industrially produced nanoparticles (NPs). In order to appreciate the long-term effects of NPs, sensitive human-based screening tests that comprehensively map the NP properties are needed to detect possible toxic mechanisms. Animal models can only be used in a limited number of test applications and are subject to ethical concerns, and the interpretation of experiments in animals is also distorted by the species differences.
   Here, we present a novel easy-to-perform highly sensitive whole-blood model using fresh non-anticoagulated human blood, which most justly reflects complex biological cross talks in a human system. As a demonstrator of the tests versatility, we evaluated the toxicity of TiO2 NPs that are widely used in various applications and otherwise considered to have relatively low toxic properties. We show that TiO2 NPs at very low concentrations (50 ng/mL) induce strong activation of the contact system, which in this model elicits thromboinflammation. These data are in line with the finding of components of the contact system in the protein corona of the TiO2 NPs after exposure to blood.
   The contact system activation may lead to both thrombotic reactions and generation of bradykinin, thereby representing fuel for chronic inflammation in vivo and potentially long-term risk of autoimmunity, arteriosclerosis and cancer. These results support the notion that this novel whole-blood model represents an important contribution to testing of NP toxicity. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ekstrand-Hammarstrom, Barbro] Swedish Def Res Agcy, Div CBRN Def & Secur, Linkoping, Sweden.
   [Hong, Jaan; Davoodpour, Padideh; Ekdahl, Kristina N.; Nilsson, Bo] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.
   [Sandholm, Kerstin; Ekdahl, Kristina N.] Linnaeus Univ, Linnaeus Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
   [Bucht, Anders] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
RP Nilsson, B (reprint author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.
EM bo.nilsson@igp.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
FU Swedish Research Council (VR) [2013-65X-05647-34-4]; FORMAS; European
   Community [602699]; AFA Insurance
FX We thank Lillemor Stenbeck-Funke and Susanne Lindblom for their
   excellent technical assistance, Linnea Ahlinder for performing PCCS
   measurements, and Dr. Deborah McClellan for excellent editorial
   assistance. This work was supported by grant 2013-65X-05647-34-4 from
   the Swedish Research Council (VR), FORMAS, the European Community's
   Seventh Framework Programme under the grant agreement no 602699 (DIREKT)
   in the project Biodesign, and from the AFA Insurance. AFA is a nonprofit
   insurance company that is jointly owned by the Swedish Labor
   Organization and the Swedish Employers Organization.
CR Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson PO, 2011, SMALL, V7, P514, DOI 10.1002/smll.201001832
   Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920
   Back J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4399
   Bleeker EAJ, 2013, REGUL TOXICOL PHARM, V65, P119, DOI 10.1016/j.yrtph.2012.11.007
   Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690
   Chen Y, 2011, INT J NANOMED, V6, P2321, DOI 10.2147/IJN.S25460
   COOL DE, 1985, J BIOL CHEM, V260, P3666
   Costa-Neto CM, 2008, INT IMMUNOPHARMACOL, V8, P135, DOI 10.1016/j.intimp.2007.08.003
   da Costa PLN, 2014, CANCER LETT, V345, P27, DOI 10.1016/j.canlet.2013.12.009
   Dales RE, 2010, J THROMB HAEMOST, V8, P669, DOI 10.1111/j.1538-7836.2010.03760.x
   De Falco L, 2013, Reumatismo, V65, P97, DOI 10.4081/reumatismo.2013.97
   Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Ekdahl RN, 2013, EXP BIOL MED, V734, P257
   Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003
   European Commission, 2011, O J L, V54, P38
   Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2
   Gobel K, 2011, J AUTOIMMUN, V36, P106, DOI 10.1016/j.jaut.2010.11.004
   Gustafsson A, 2011, J IMMUNOTOXICOL, V8, P111, DOI 10.3109/1547691X.2010.546382
   Hoek G, 2001, EPIDEMIOLOGY, V12, P355, DOI 10.1097/00001648-200105000-00017
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hulander M, 2009, ACS APPL MATER INTER, V1, P1053, DOI 10.1021/am900028e
   Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005
   Kaida Takahiro, 2004, J Cosmet Sci, V55, P219
   Kaur IP, 2014, J CONTROL RELEASE
   KILCHHERR E, 1985, J MOL BIOL, V186, P403, DOI 10.1016/0022-2836(85)90114-7
   Krajewski S, 2013, ACTA BIOMATER, V9, P7460, DOI 10.1016/j.actbio.2013.03.016
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028
   Liu YQ, 2014, INT J CLIN EXP MED, V7, P1233
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118
   Newman MD, 2009, J AM ACAD DERMATOL, V61, P685, DOI 10.1016/j.jaad.2009.02.051
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650
   Qui J., 2012, NATURE, V489, P350
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   RATNOFF OD, 1964, J LAB CLIN MED, V63, P359
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   Shannahan JH, 2012, INHAL TOXICOL, V24, P320, DOI 10.3109/08958378.2012.668229
   Sul YT, 2010, INT J NANOMED, V5, P87
   Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001
   Wolf Ronni, 2003, Acta Dermatovenerol Croat, V11, P158
   Yuan YL, 2010, J NANOSCI NANOTECHNO, V10, P4868, DOI 10.1166/jnn.2010.2225
NR 51
TC 12
Z9 12
U1 2
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 51
BP 58
EP 68
DI 10.1016/j.biomaterials.2015.01.031
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE4JK
UT WOS:000351796700007
PM 25770998
DA 2018-10-19
ER

PT J
AU Cohen, HC
   Frost, DC
   Lieberthal, TJ
   Li, LJ
   Kao, WJ
AF Cohen, Hannah Caitlin
   Frost, Dustin C.
   Lieberthal, Tyler Jacob
   Li, Lingjun
   Kao, W. John
TI Biomaterials differentially regulate Src kinases and phosphoinositide
   3-kinase-gamma in polymorphonuclear leukocyte primary and tertiary
   granule release
SO BIOMATERIALS
LA English
DT Article
DE Neutrophil; Acute inflammation; Degranulation; Poly(ethylene glycol);
   Gelatin; Protein adsorption
ID OXYGEN SPECIES GENERATION; HUMAN NEUTROPHIL GRANULES; FAMILY KINASES;
   RESPIRATORY BURST; ADHESION; MONOCYTES; DEGRANULATION; ACTIVATION;
   HYDROGELS; PROTEINS
AB In the foreign body response, infiltrating PMNs exocytose granule subsets to influence subsequent downstream inflammatory and wound healing events. In previous studies, we found that PMNs cultured on poly(ethylene glycol) (PEG)-containing hydrogels (i.e., PEG and gelatin + PEG hydrogels) had enhanced primary granule release, yet similar tertiary granule release compared with PMNs cultured on polydimethylsiloxane or tissue culture polystyrene. PMN primary granules contain microbicidal proteins and proteases, which can potentially injure bystander cells, degrade the extracellular matrix, and promote inflammation. Here, we sought to understand the mechanism of the enhanced primary granule release from PMNs on PEG hydrogels. We found that primary granule release from PMNs on PEG hydrogels was adhesion mediated and involved Src family kinases and PI3K-gamma. The addition of gelatin to PEG hydrogels did not further enhance PMN primary granule release. Using stable-isotope dimethyl labeling-based shotgun proteomics, we identified many serum proteins including Ig gamma constant chain region proteins and alpha-1-acid glycoprotein 1 - that were absorbed/adsorbed in higher quantities on PEG hydrogels than on TCPS, and may be involved in mediating PMN primary granule release. Ultimately, this mechanistic knowledge can be used to direct inflammation and wound healing following biomaterial implantation to promote a more favorable healing response. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Cohen, Hannah Caitlin; Frost, Dustin C.; Li, Lingjun; Kao, W. John] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA.
   [Lieberthal, Tyler Jacob; Kao, W. John] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA.
   [Li, Lingjun] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA.
   [Kao, W. John] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@wisc.edu
FU NIH [HL115482, R01 DK071801]; NIH EUREKA grant [NIH R01NS071513];
   Innovation & Economic Development Research program research grant;
   Wisconsin Alumni Research Foundation technology transfer grant; National
   Defense Science and Engineering Graduate fellowship; NIH shared
   instrument grant [NIH-NCRR S10RR029531]
FX This research was supported in part by NIH HL115482, NIH R01 DK071801,
   NIH EUREKA grant (NIH R01NS071513), an Innovation & Economic Development
   Research program research grant, a Wisconsin Alumni Research Foundation
   technology transfer grant, and a National Defense Science and
   Engineering Graduate fellowship awarded to H.C. Cohen. The Orbitrap
   Elite instrument was purchased through the support of an NIH shared
   instrument grant (NIH-NCRR S10RR029531). We thank David A. Cantu for his
   help with phlebotomy procedures and the University of Wisconsin Carbone
   Comprehensive Cancer Center for use of the Bio-Plex (R) suspension array
   system to complete this research.
CR Abdel-Latif D, 2005, CAN J PHYSIOL PHARM, V83, P69, DOI 10.1139/Y04-123
   Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624
   Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897
   Andrews Simon, 2007, Sci STKE, V2007, pcm3, DOI 10.1126/stke.4072007cm3
   BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8
   Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21
   BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187
   Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257
   Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739
   Cohen HC, 2013, AM J PATHOL, V182, P2180, DOI 10.1016/j.ajpath.2013.02.022
   Cohen HC, 2014, J BIOMED MATER RES A, V102, P4252, DOI 10.1002/jbm.a.35101
   Faulk DM, 2014, SOC BIOM ANN M EXP
   Fumagalli L, 2010, EUR J CLIN INVEST, V40, P38
   Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874
   Fumagalli L, 2013, J IMMUNOL, V190, P3648, DOI 10.4049/jimmunol.1201951
   Gerasimov I G, 2013, Tsitologiia, V55, P75
   Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com
   Heinzelmann M, 1998, J IMMUNOL, V160, P5530
   HUIZINGA TWJ, 1990, J IMMUNOL, V144, P1432
   Jethwaney D, 2007, PROTEOME SCI, P5
   Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093
   Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223
   Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738
   Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200
   Lundahl J, 1996, SCAND J IMMUNOL, V44, P143, DOI 10.1046/j.1365-3083.1996.d01-296.x
   Lynn AD, 2011, J BIOMED MATER RES A, V96A, P621, DOI 10.1002/jbm.a.33015
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06
   Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008
   Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321
   Mocsai A, 1999, J IMMUNOL, V162, P1120
   Nijhuis E, 2002, J LEUKOCYTE BIOL, V71, P115
   Rasmussen PB, 1996, FEBS LETT, V390, P109, DOI 10.1016/0014-5793(96)00639-4
   Rauniyar N, 2013, J PROTEOME RES, V12, P1031, DOI 10.1021/pr3008896
   Sicari BM, 2014, SOC BIOM ANN M EXP
   Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740
   Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634
   Soehnlein O, 2009, J MOL MED-JMM, V87, P1157, DOI 10.1007/s00109-009-0508-6
   Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630
   Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006
   Soehnlein O, 2009, THROMB HAEMOSTASIS, V102, P198, DOI 10.1160/TH08-11-0720
   Soehnlein O, 2009, J LEUKOCYTE BIOL, V85, P344, DOI 10.1189/jlb.0808495
   Sopko R, 2014, DEV CELL, V31, P114, DOI 10.1016/j.devcel.2014.07.027
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Takafuji S, 2003, J INVEST ALLERG CLIN, V13, P50
   Takami M, 2001, AM J PHYSIOL-CELL PH, V280, pC1045
   TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394
   Tou J, 2002, BIOCHEM BIOPH RES CO, V292, P951, DOI 10.1006/bbrc.2002.6765
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Wang XT, 2011, J BIOMAT SCI-POLYM E, V22, P1343, DOI 10.1163/092050610X508400
   Wolf MT, 2014, J BIOMED MATER RES A, V102, P234, DOI 10.1002/jbm.a.34671
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
   Xu X, 2002, SCAND J IMMUNOL, V55, P178, DOI 10.1046/j.1365-3083.2002.01041.x
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   Zhao TM, 2003, J CLIN INVEST, V112, P1732, DOI 10.1172/JCI200319108
NR 55
TC 5
Z9 5
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 50
BP 47
EP 55
DI 10.1016/j.biomaterials.2015.01.050
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE2OX
UT WOS:000351656000006
PM 25736495
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, C
   Di, LZ
   Ding, CH
   Lu, LX
   Zhai, T
   Yang, DA
AF Zhang, C.
   Di, L. Z.
   Ding, C. H.
   Lu, L. X.
   Zhai, T.
   Yang, D. A.
TI Sol-gel synthesis and characterisation of La doped (1-x)
   BaTiO3-x(Bi0.5K0.5) TiO3 PTCR ceramics
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE BT-BKT; Lead free ceramics; Sol-gel; PTCR
ID POSITIVE TEMPERATURE-COEFFICIENT; BARIUM-TITANATE CERAMICS; FERRITE
   COMPOSITE NANOPARTICLES; ELECTRICAL-PROPERTIES; NICKEL FERRITE;
   BIOMATERIAL SYSTEM; ANTIMICROBIAL ACTIVITY; PHOTOCATALYTIC SHELL;
   DRUG-DELIVERY; MAGNETIC CORE
AB As a promising material for lead free positive temperature coefficient of resistivity (PTCR) ceramics, La doped (1-x) BaTiO3-x(Bi0.5K0.5) TiO3 [(12x) BT-xBKT] samples with 0 <= x <= 0.04 were prepared by a citrate-nitrate sol-gel method. The corresponding gels were heated at different temperatures (500, 600 and 800 degrees C) to study the conditions necessary for the formation of the pure BT-BKT. Single phased perovskite powders with average particles size of 70 nm were obtained by heating the precursor gels at 800 degrees C for 1 h in air. The crystal structure, microstructure and the electrical properties of La doped BT-BKT samples were studied. When the content of La was 0.2 mol.-%, the 0.99BT-0.01BKT ceramic showed the lowest rho(RT). With increasing addition of BKT, the Curie temperature (T-c) and the room temperature resistivity (rho(RT)) increased. When the content of BKT was 4 mol.-%, the sample sintered in air atmosphere still showed good PTCR behaviours with T-c = 143 degrees C, RT=1.1 x 10(4) Omega cm and I-g (rho(max)/rho(min))=3.76.
C1 [Zhang, C.; Ding, C. H.; Lu, L. X.; Zhai, T.; Yang, D. A.] Tianjin Univ, Key Lab Adv Ceram & Machining Technol, Minist Educ, Tianjin 300072, Peoples R China.
   [Di, L. Z.] Tianjin Med Coll, Tianjin 300222, Peoples R China.
RP Yang, DA (reprint author), Tianjin Univ, Key Lab Adv Ceram & Machining Technol, Minist Educ, Tianjin 300072, Peoples R China.
EM dayang@tju.edu.cn
CR Brutchey RL, 2008, ADV MATER, V20, P1029, DOI 10.1002/adma.200701804
   Cernea M, 2010, J ALLOY COMPD, V490, P690, DOI 10.1016/j.jallcom.2009.10.140
   Chaouchi A, 2011, J ALLOY COMPD, V509, P9138, DOI 10.1016/j.jallcom.2011.06.085
   Ding SW, 2008, CERAM INT, V34, P2007, DOI 10.1016/j.ceramint.2007.07.023
   Gao P, 2014, CERAM INT, V40, P637, DOI 10.1016/j.ceramint.2013.06.047
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   He ZM, 2009, MATER SCI ENG B-ADV, V164, P116, DOI 10.1016/j.mseb.2009.08.003
   HEYWANG W, 1964, J AM CERAM SOC, V47, P484, DOI 10.1111/j.1151-2916.1964.tb13795.x
   Huo WR, 2006, SENSOR ACTUAT A-PHYS, V128, P265, DOI 10.1016/j.sna.2006.01.022
   JONKER GH, 1964, SOLID STATE ELECTRON, V7, P895, DOI 10.1016/0038-1101(64)90068-1
   Langhammer HT, 2006, J EUR CERAM SOC, V26, P2899, DOI 10.1016/j.jeurceramsoc.2006.02.006
   LEE JH, 1995, J AM CERAM SOC, V78, P2845, DOI 10.1111/j.1151-2916.1995.tb08065.x
   Leng SL, 2009, J AM CERAM SOC, V92, P2772, DOI 10.1111/j.1551-2916.2009.03251.x
   Li HL, 2013, CERAM INT, V39, P7589, DOI 10.1016/j.ceramint.2013.03.013
   Li ZC, 2005, J EUR CERAM SOC, V25, P441, DOI 10.1016/j.jeurceramsoc.2004.03.012
   Liu ML, 2010, J ALLOY COMPD, V508, P559, DOI 10.1016/j.jallcom.2010.08.121
   Mahani RM, 2010, J ALLOY COMPD, V508, P354, DOI 10.1016/j.jallcom.2010.05.060
   Misra RDK, 2010, MATER TECHNOL, V25, P118, DOI 10.1179/175355510X12723642365241
   Morrison FD, 1999, J APPL PHYS, V86, P6355, DOI 10.1063/1.371698
   Morrison FD, 2001, J AM CERAM SOC, V84, P531, DOI 10.1111/j.1151-2916.2001.tb00694.x
   Park K, 2008, CERAM INT, V34, P1573, DOI 10.1016/j.ceramint.2006.04.007
   Petrovic MMV, 2013, MATER RES BULL, V48, P3766, DOI 10.1016/j.materresbull.2013.05.103
   Pu YP, 2011, J MATER SCI-MATER EL, V22, P1479, DOI 10.1007/s10854-011-0333-x
   Pu YP, 2010, J ALLOY COMPD, V498, pL5, DOI 10.1016/j.jallcom.2010.03.149
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Wei JF, 2011, J MATER SCI-MATER EL, V22, P551, DOI 10.1007/s10854-010-0176-x
   Xing XR, 2004, J ALLOY COMPD, V384, P312, DOI 10.1016/j.jallcom.2004.06.062
NR 32
TC 0
Z9 0
U1 3
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAY
PY 2015
VL 30
IS 3
BP 138
EP 143
DI 10.1179/1753555714Y.0000000224
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5LP
UT WOS:000351129500003
DA 2018-10-19
ER

PT J
AU Rahman, A
   Charoo, MS
   Jayaganthan, R
AF Rahman, A.
   Charoo, M. S.
   Jayaganthan, R.
TI Structural, optical and photocatalytic properties of zinc aluminate
   spinel nanoparticles
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE FTI; XRD; Spectrophotometer; Photocatalyst
ID FERRITE COMPOSITE NANOPARTICLES; NICKEL FERRITE; BIOMATERIAL SYSTEM;
   ANTIMICROBIAL ACTIVITY; OXIDE NANOPARTICLES; DRUG-DELIVERY; MAGNETIC
   CORE; TITANIA; KINETICS; TEMPERATURE
AB Zinc aluminate spinel nanoparticles with different concentrations of alumina ( x=0.000, 0.005, 0.010, 0.015 and 0.020) are synthesised by solid state reaction method. The synthesised products are characterised by powder X-ray diffraction, Raman spectroscopy, Fourier transform infrared, UV-visible spectroscopy. The prepared nanoparticles exhibit a cubic structure with average crystallite size 68.3, 48.1, 58.3, 45.2 and 51.4 nm respectively. Optical measurements indicated a slight shift in the absorption band edge by increasing the alumina doping concentration. The band gap values of zinc aluminate spinel nanoparticles are found to increase with increase in alumina concentration ( x=0.000, 0.005, 0.010, 0.015 and 0.020). The photocatalytic activity of zinc aluminate spinel nanoparticles is studied by performing the decomposition of methylene blue dye under UV light irradiation. The dye considerably photocatalytically degraded by 90.0% under UV light irradiation within 5 h with pseudo first order rate constant of 0.3067 min(-1).
C1 [Rahman, A.] Natl Inst Technol Srinagar, Dept Met & Mat Engn, Srinagar 190006, Jammu & Kashmir, India.
   [Charoo, M. S.] Natl Inst Technol Srinagar, Dept Mech Engn, Srinagar 190006, Jammu & Kashmir, India.
   [Jayaganthan, R.] Indian Inst Technol, Dept Met & Mat Engn, Roorkee 247667, Uttar Pradesh, India.
   [Jayaganthan, R.] Indian Inst Technol, Ctr Nanotechnol, Roorkee 247667, Uttar Pradesh, India.
RP Rahman, A (reprint author), Natl Inst Technol Srinagar, Dept Met & Mat Engn, Srinagar 190006, Jammu & Kashmir, India.
EM atikurrhmn@gmail.com
OI RENGASWAMY, JAYAGANTHAN/0000-0002-3634-9306
CR Angelo P. C., 2012, POWDER METALLURGY SC, P1
   Arshad M, 2011, J ALLOY COMPD, V509, P8378, DOI 10.1016/j.jallcom.2011.05.047
   Azam A, 2010, J ALLOY COMPD, V506, P237, DOI 10.1016/j.jallcom.2010.06.184
   Behnajady MA, 2006, J HAZARD MATER, V136, P816, DOI 10.1016/j.jhazmat.2006.01.017
   BRANSON DL, 1965, J AM CERAM SOC, V48, P591, DOI 10.1111/j.1151-2916.1965.tb14679.x
   Chen XY, 2008, MATER SCI ENG B-ADV, V151, P224, DOI 10.1016/j.mseb.2008.09.023
   Dutta M, 2008, APPL SURF SCI, V254, P2743, DOI 10.1016/j.apsusc.2007.10.009
   Elilarassi R, 2010, J MATER SCI-MATER EL, V21, P1168, DOI 10.1007/s10854-009-0041-y
   Escardino A, 2000, J AM CERAM SOC, V83, P2938, DOI 10.1111/j.1151-2916.2000.tb01664.x
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Hu Z.-S., 2013, FUNCT MATER LETT, V6
   Mathur S, 2001, J AM CERAM SOC, V84, P1921
   MAZZA D, 1992, J AM CERAM SOC, V75, P1929, DOI 10.1111/j.1151-2916.1992.tb07219.x
   MCMILLAN P, 1982, J NON-CRYST SOLIDS, V53, P279, DOI 10.1016/0022-3093(82)90086-2
   Mimani T, 2001, J ALLOY COMPD, V315, P123, DOI 10.1016/S0925-8388(00)01262-7
   Misra RDK, 2008, MATER SCI TECH-LOND, V24, P1011, DOI 10.1179/174328408X341690
   Nakamoto K., 2009, INFRARED RAMAN SPECT
   Pandey R, 1999, J AM CERAM SOC, V82, P3337
   Pant HR, 2011, J HAZARD MATER, V189, P465, DOI 10.1016/j.jhazmat.2011.02.062
   Rahman A, 2012, SURF ENG, V28, P620, DOI 10.1179/1743294412Y.0000000041
   Rahman A, 2012, SURF ENG, V28, P249, DOI 10.1179/1743294411Y.0000000030
   Rahman A, 2012, SURF ENG, V28, P285, DOI 10.1179/1743294411Y.0000000039
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, SYNTHESIS CHARACTERI, V119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Samanta K, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245213
   Sampath SK, 1999, J PHYS-CONDENS MAT, V11, P3635, DOI 10.1088/0953-8984/11/18/301
   Strek M, 2000, J ALLOY COMPD, V300, P456, DOI 10.1016/S0925-8388(99)00696-9
   Sultan K., 2014, ADV MAT LETT, V5, P9, DOI DOI 10.5185/amlett.2013.6496
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Suwanboon S, 2008, J ALLOY COMPD, V462, P335, DOI 10.1016/j.jallcom.2007.08.048
   Suwanboon S., 2007, J SCI TECHNOL, V4, P111
   TAKAGAHARA T, 1992, PHYS REV B, V46, P15578, DOI 10.1103/PhysRevB.46.15578
   TSUBOI M, 1964, J CHEM PHYS, V40, P1326, DOI 10.1063/1.1725316
   Valenzuela MA, 1997, APPL CATAL A-GEN, V148, P315, DOI 10.1016/S0926-860X(96)00235-9
   van der Laag NJ, 2004, J EUR CERAM SOC, V24, P2417, DOI 10.1016/j.jeurceramsoc.2003.06.001
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wagner C, 1933, Z PHYS CHEM B-CHEM E, V22, P181
   Wang JB, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208564
   Wu X, 2014, MATER TECHNOL, V29, pA20, DOI 10.1179/1753555714Y.0000000145
   Zeng B., 2013, FUNCT MATER LETT, V6
   Zhang LL, 2014, MATER TECHNOL, V29, pA9, DOI 10.1179/1753555713Y.0000000124
   Zhao Z, 2014, MATER TECHNOL, V29, pA3, DOI 10.1179/1753555714Y.0000000148
   Zhu XQ, 2011, APPL CATAL B-ENVIRON, V102, P316, DOI 10.1016/j.apcatb.2010.12.019
   Zou CW, 2009, CHEM PHYS LETT, V476, P84, DOI 10.1016/j.cplett.2009.06.024
   Zou DL, 2008, SURF COAT TECH, V202, P1928, DOI 10.1016/j.surfcoat.2007.08.022
NR 49
TC 1
Z9 1
U1 1
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAY
PY 2015
VL 30
IS 3
BP 168
EP 176
DI 10.1179/1753555714Y.0000000211
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5LP
UT WOS:000351129500009
DA 2018-10-19
ER

PT J
AU Jiang, YY
   Zhu, YJ
   Chen, F
   Wu, J
AF Jiang, Ying-Ying
   Zhu, Ying-Jie
   Chen, Feng
   Wu, Jin
TI Solvothermal synthesis of submillimeter ultralong hydroxyapatite
   nanowires using a calcium oleate precursor in a series of monohydroxy
   alcohols
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Powders: chemical preparation; Fibers; Apatite; Nanowires
ID PHOSPHORUS SOURCE; HYDROTHERMAL SYNTHESIS; DRUG-DELIVERY; PROTEIN
   ADSORPTION; RAPID SYNTHESIS; GROWTH; PHOSPHATE; PROLIFERATION; NANORODS;
   ARRAYS
AB Hydroxyapatite (Ca-10(OH)(2)(PO4)(6), HAP), as the major inorganic component of bones and teeth in vertebrates, is a very important biomaterial with high biocompatibility, nontoxicity and high thermal stability, thus, it has wide applications in various biomedical fields. Among various morphologies of HAP, HAP nanowires are very promising for various applications; however, the synthesis of ultralong HAP nanowires with lengths larger than 100 pm is highly challengeable and has been rarely reported. In this paper, we report, for the first time, the solvothermal synthesis of submillimeter-sized ultralong hydroxyapatite nanowires using calcium oleate as the precursor and NaH2PO4 as the phosphorus source in a series of monohydroxy alcohols. The products are characterized by scanning electron microscopy, X-ray powder diffraction, and Fourier transform infrared (FTIR) spectroscopy. The as-prepared ultralong hydroxyapatite nanowires have diameters of tens of nanometers and lengths from several hundred micrometers up to nearly one millimeter. This method is simple, surfactant-free, environment friendly, and generally applicable in a series of monohydroxy alcohols including methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol and 1-hexanol. Moreover, this method may be scaled up for large-scale production of ultralong hydroxyapatite nanowires. The as-prepared ultralong hydroxyapatite nanowires are promising for applications in various fields such as bone tissue engineering, drug delivery, adsorbent for organic pollutants and heavy metal ions, and nonflammable inorganic paper. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Jiang, Ying-Ying; Zhu, Ying-Jie; Chen, Feng; Wu, Jin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI CHEN, Feng/E-4310-2016; Chen, Feng/D-6406-2012
OI CHEN, Feng/0000-0002-1162-1684; Chen, Feng/0000-0002-1162-1684
FU National Natural Science Foundation of China [51172260]
FX Financial support from the National Natural Science Foundation of China
   (51172260) is gratefully acknowledged.
CR Cao MH, 2004, LANGMUIR, V20, P4784, DOI 10.1021/la0498197
   Chen F, 2014, CURR NANOSCI, V10, P465, DOI 10.2174/1573413710666140319233658
   Chen F, 2013, BIOMATER SCI-UK, V1, P1074, DOI 10.1039/c3bm60086f
   Chen F, 2011, BIOMATERIALS, V32, P9031, DOI 10.1016/j.biomaterials.2011.08.032
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   Costa DO, 2012, ACS APPL MATER INTER, V4, P1490, DOI 10.1021/am201735k
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Guiseppi-Elie A, 2012, J MATER CHEM, V22, P19529, DOI 10.1039/c2jm32516k
   Hui JF, 2011, CHEM-EUR J, V17, P6926, DOI 10.1002/chem.201100680
   Kotanen CN, 2013, BIOMATERIALS, V34, P6318, DOI 10.1016/j.biomaterials.2013.05.022
   Lu BQ, 2014, CHEM-EUR J, V20, P7116, DOI 10.1002/chem.201400252
   Lu BQ, 2014, CHEM-EUR J, V20, P1242, DOI 10.1002/chem.201304439
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   Qi C, 2012, MATER LETT, V85, P71, DOI 10.1016/j.matlet.2012.06.106
   Reardon PJT, 2013, J MATER CHEM B, V1, P6170, DOI 10.1039/c3tb21073a
   Yang Z, 2005, J MATER SCI, V40, P1121, DOI 10.1007/s10853-005-6927-z
   Zhao XY, 2013, CRYSTENGCOMM, V15, P7926, DOI 10.1039/c3ce41255e
   Zhao XY, 2013, CHEM-ASIAN J, V8, P1313, DOI 10.1002/asia.201300142
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 21
TC 24
Z9 24
U1 16
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAY
PY 2015
VL 41
IS 4
BP 6098
EP 6102
DI 10.1016/j.ceramint.2014.12.122
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA CC6YA
UT WOS:000350513700112
DA 2018-10-19
ER

PT J
AU Wang, YM
   Wang, WJ
   Wo, Y
   Gui, T
   Zhu, H
   Mo, XM
   Chen, CC
   Li, QF
   Ding, WL
AF Wang, Yueming
   Wang, Wenjin
   Wo, Yan
   Gui, Ting
   Zhu, Hao
   Mo, Xiumei
   Chen, Chien-Chung
   Li, Qingfeng
   Ding, Wenlong
TI Orientated Guidance of Peripheral Nerve Regeneration Using Conduits with
   a Microtube Array Sheet (MTAS)
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nerve regeneration; nerve guide; surface topography; biomaterial;
   orientated nerve growth
ID SCHWANN-CELLS; FUNCTIONAL RECOVERY; GROWTH-FACTOR; STEM-CELLS; GRAFT;
   RAT; DIFFERENTIATION; DENERVATION; MEMBRANES; SCAFFOLD
AB Material surface topography has been shown to affect the biological behavior of cells in vitro; however, the in vivo effect on peripheral nerve regeneration has not been explored. Here, we studied the potential of a. microtube array sheet (MTAS) with a unique longitudinal surface topography to promote peripheral nerve regeneration efficiency, both in vivo and in vitro. Schwann cells, spinal cord motor neurons, and dorsal root ganglion neurons were Seeded on the MTAS to study the effect of the construct on the biological properties and behaviors of neural cells. The MTAS guided the oriented migration of Schwann cells without affecting other critical biological properties, such as proliferation and neurotrophin expression. In addition, the MTAS guided the directed extension of neurites from both types of neurons. Next, we tested the capability of the MTAS to facilitate peripheral nerve regeneration by bridging a 10 mm sciatic nerve defect in rats with a nerve conduit equipped with an MTAS lining. The MTAS significantly promoted peripheral nerve regeneration, as suggested by the greater fiber caliber in the midconduit and the greater abundance of fibers in nerve segment distal to the conduit. Moreover, scanning electron microscopy (SEM) analysis suggested the orientated guidance of nerve regeneration by the MTAS, as indicated by the smaller eccentricity of the nerve fibers and the concordant arrangement of the collagen fiber in both the fibers and the matrix in the MTAS group. Our results collectively suggest that the conduits with the MTAS developed in this study have significant potential for facilitating peripheral nerve regeneration by modifying critical biological behaviors and guiding orientated nerve growth.
C1 [Wang, Yueming; Wang, Wenjin; Wo, Yan; Gui, Ting; Zhu, Hao; Ding, Wenlong] Shanghai Jiao Tong Univ, Dept Anat Histol & Embryol, Sch Med, Shanghai 200025, Peoples R China.
   [Wang, Wenjin; Li, Qingfeng] Shanghai Ninth Hosp, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China.
   [Mo, Xiumei] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
   [Chen, Chien-Chung] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Taipei 11031, Taiwan.
RP Li, QF (reprint author), Shanghai Ninth Hosp, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China.
EM Dingw1500@sina.com; drliqingfeng@yahoo.cn
RI mo, xiumei/C-9340-2013
FU National Natural Science Funds of China [31100782, 81271380, 81201505];
   Natural Science Fund - Shanghai Committee of Science and Technology
   [11ZR1419400, 1052 nm04200]
FX This work is supported by the National Natural Science Funds of China
   (Project Nos. 31100782, 81271380, 81201505) and by the Natural Science
   Fund, supported by the Shanghai Committee of Science and Technology
   (Project Nos. 11ZR1419400 and 1052 nm04200).
CR Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073
   BEST TJ, 1993, PLAST RECONSTR SURG, V92, P516, DOI 10.1097/00006534-199309000-00022
   Biazar E, 2013, ASAIO J, V59, P651, DOI 10.1097/MAT.0b013e3182a79151
   BROCKES JP, 1981, J EXP BIOL, V95, P215
   Chan KM, 2014, EXP NEUROL, V261, P826, DOI 10.1016/j.expneurol.2014.09.006
   Day CS, 2002, MICROSURG, V22, P144, DOI 10.1002/micr.21742
   Firat C, 2014, ANN PLAS SURG, V73, P54, DOI 10.1097/SAP.0b013e31829fd2be
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   Fukuda Y, 2014, J BIOMED MATER RES B, V102, P674, DOI 10.1002/jbm.b.33046
   Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9
   Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316
   Lago N, 2007, J NEUROSCI RES, V85, P2800, DOI 10.1002/jnr.21286
   Li GC, 2014, BIOMATERIALS, V35, P8503, DOI 10.1016/j.biomaterials.2014.05.093
   Lin LC, 2014, CURR NANOSCI, V10, P227, DOI 10.2174/1573413709999131209124001
   Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mohammadi R, 2014, J CRANIO MAXILL SURG, V42, P1389, DOI 10.1016/j.jcms.2014.03.031
   Ou KL, 2011, EUR POLYM J, V47, P882, DOI 10.1016/j.eurpolymj.2011.02.001
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253
   Shih YH, 2012, TEXT RES J, V82, P602, DOI 10.1177/0040517511420756
   Song M, 2007, ANN BIOMED ENG, V35, P1812, DOI 10.1007/s10439-007-9348-0
   Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63
   Tang X, 2012, BIOMATERIALS, V33, P3860, DOI 10.1016/j.biomaterials.2012.02.008
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tong WY, 2012, BIOMATERIALS, V33, P7686, DOI 10.1016/j.biomaterials.2012.07.002
   Xiao JH, 2009, NEUROSIGNALS, V17, P265, DOI 10.1159/000231893
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   Yamanaka T., 2014, PLOS ONE, V9
   Yang JC, 2012, MACROMOL MATER ENG, V297, P115, DOI 10.1002/mame.201100045
   Yang XN, 2013, BIOMATERIALS, V34, P5606, DOI 10.1016/j.biomaterials.2013.04.018
   Yu WW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/16/165102
NR 35
TC 15
Z9 15
U1 3
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 29
PY 2015
VL 7
IS 16
BP 8437
EP 8450
DI 10.1021/acsami.5b00215
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CH3LD
UT WOS:000353931300010
PM 25853547
DA 2018-10-19
ER

PT J
AU Pal, RK
   Kurland, NE
   Wang, CZ
   Kundu, SC
   Yadavalli, VK
AF Pal, Ramendra K.
   Kurland, Nicholas E.
   Wang, Congzhou
   Kundu, Subhas C.
   Yadavalli, Vamsi K.
TI Biopatterning of Silk Proteins for Soft Micro-optics
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silk protein; photolithography; iridescence; soft optics;
   microfabrication; Fresnel lens
ID FRESNEL ZONE-PLATE; STRUCTURAL COLOR; FIBROIN FIBERS; LITHOGRAPHY;
   SERICIN; FILMS; BIODEGRADATION; BIOMATERIALS; IRIDESCENCE; BIOMIMETICS
AB Silk proteins from spiders and silkworms have been proposed as outstanding candidates for soft micro-optic and photonic applications because of their optical transparency, unique biological properties, and mechanical robustness. Here, we present a Method to font microstructures of the two constituent silk proteins, fibroin and sericin for use as an optical biomaterial. Using photolithography, chemically modified silk protein photoresists are patterned in 2D arrays of periodic patterns and Fresnel zone plates. Angle-dependent iridescent colors are produced in these periodic micropatterns because of the Bragg diffraction. Silk protein photolithography can used to form patterns on different substrates including flexible sheets with features of any shape with high fidelity and resolution over large areas. Finally, we show that these Mechanically stable and transparent iridescent architectures are Also completely biodegradable. This versatile and scalable technique can therefore be used to develop biocompatible, soft micro-optic devices that can be degraded in a controlled manner.
C1 [Pal, Ramendra K.; Kurland, Nicholas E.; Wang, Congzhou; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
   [Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Yadavalli, VK (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
EM vyadavalli@vcu.edu
OI Kundu, Subhas C./0000-0002-7170-2291; Yadavalli,
   Vamsi/0000-0002-8879-1948
CR Ainslie KM, 2008, LAB CHIP, V8, P1864, DOI 10.1039/b806446f
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Aramwit P, 2013, NAT PROD COMMUN, V8, P501
   Azofeifa DE, 2012, OPT MATER, V35, P175, DOI 10.1016/j.optmat.2012.07.024
   BAEZ AV, 1961, J OPT SOC AM, V51, P405, DOI 10.1364/JOSA.51.000405
   Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chien CC, 2013, BIOTECHNOL ADV, V31, P375, DOI 10.1016/j.biotechadv.2012.04.005
   Der A, 2010, SENSOR ACTUAT B-CHEM, V151, P26, DOI 10.1016/j.snb.2010.09.064
   Domachuk P., 2009, APPL PHYS LETT, V95
   Fan YH, 2003, OPT EXPRESS, V11, P3080, DOI 10.1364/OE.11.003080
   Galeotti F, 2012, SOFT MATTER, V8, P4815, DOI 10.1039/c2sm25089f
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Glover BJ, 2010, ANN BOT-LONDON, V105, P505, DOI 10.1093/aob/mcq007
   He Y, 2014, J BIOMED NANOTECHNOL, V10, P767, DOI 10.1166/jbn.2014.1769
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Kanellos GT, 2010, OPT EXPRESS, V18, P179, DOI 10.1364/OE.18.000179
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim DH, 2012, SMALL, V8, P3263, DOI 10.1002/smll.201200933
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]
   Kurland NE, 2014, ADV MATER, V26, P4431, DOI 10.1002/adma.201400777
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Masuda Y, 2005, LANGMUIR, V21, P4478, DOI 10.1021/la050075m
   Morgan B, 2004, J MICROELECTROMECH S, V13, P113, DOI 10.1109/JMEMS.2003.823220
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Pang S, 2011, LAB CHIP, V11, P3698, DOI 10.1039/c1lc20654k
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Prum RO, 1998, NATURE, V396, P28, DOI 10.1038/23838
   Qin GK, 2013, J POLYM SCI POL PHYS, V51, P254, DOI 10.1002/polb.23204
   Rajasekharan R, 2012, ADV MATER, V24, pOP170, DOI 10.1002/adma.201200296
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sakdinawat A, 2010, NAT PHOTONICS, V4, P840, DOI 10.1038/nphoton.2010.267
   Sarrat B, 2011, LANGMUIR, V27, P3174, DOI 10.1021/la104364n
   Seago A.E., 2009, J ROYAL SOC INTERFAC, V6, P165, DOI DOI 10.1098/RSIF.2008.0354.FOCUS
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Tao H, 2012, P NATL ACAD SCI USA, V109, P19584, DOI 10.1073/pnas.1209056109
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   Wang JN, 2012, CHEM-ASIAN J, V7, P301, DOI 10.1002/asia.201100882
   White R.D., 2011, J MICROMECH MICROENG, V21, P11
   Wu D, 2010, SOFT MATTER, V6, P263, DOI 10.1039/b910605g
   Wu SR, 2012, MATERIALS, V5, P1752, DOI 10.3390/ma5101752
   Xia Y., 1999, ANGEW CHEM INT EDIT, V37, P551
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 57
TC 18
Z9 18
U1 2
U2 75
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 29
PY 2015
VL 7
IS 16
BP 8809
EP 8816
DI 10.1021/acsami.5b01380
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CH3LD
UT WOS:000353931300052
PM 25853731
DA 2018-10-19
ER

PT J
AU Jay, L
   Bourget, JM
   Goyer, B
   Singh, K
   Brunette, I
   Ozaki, T
   Proulx, S
AF Jay, Louis
   Bourget, Jean-Michel
   Goyer, Benjamin
   Singh, Kanwarpal
   Brunette, Isabelle
   Ozaki, Tsuneyuki
   Proulx, Stephanie
TI Characterization of Tissue-Engineered Posterior Corneas Using Second-
   and Third-Harmonic Generation Microscopy
SO PLOS ONE
LA English
DT Article
ID 3RD HARMONIC-GENERATION; SELF-ASSEMBLY APPROACH; 2ND-HARMONIC
   GENERATION; IMAGING MICROSCOPY; COLLAGEN LAMELLAE; CELLS; REGENERATION;
   ENDOTHELIUM; ORIENTATION; EQUIVALENT
AB Three-dimensional tissues, such as the cornea, are now being engineered as substitutes for the rehabilitation of vision in patients with blinding corneal diseases. Engineering of tissues for translational purposes requires a non-invasive monitoring to control the quality of the resulting biomaterial. Unfortunately, most current methods still imply invasive steps, such as fixation and staining, to clearly observe the tissue-engineered cornea, a transparent tissue with weak natural contrast. Second-and third-harmonic generation imaging are well known to provide high-contrast, high spatial resolution images of such tissues, by taking advantage of the endogenous contrast agents of the tissue itself. In this article, we imaged tissue-engineered corneal substitutes using both harmonic microscopy and classic histopathology techniques. We demonstrate that second-and third-harmonic imaging can non-invasively provide important information regarding the quality and the integrity of these partial-thickness posterior corneal substitutes (observation of collagen network, fibroblasts and endothelial cells). These two nonlinear imaging modalities offer the new opportunity of monitoring the engineered corneas during the entire process of production.
C1 [Jay, Louis; Singh, Kanwarpal; Ozaki, Tsuneyuki] Inst Natl Rech Sci, Ctr Energie Mat Telecommun, Varennes, PQ, Canada.
   [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada.
   [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada.
   [Goyer, Benjamin; Proulx, Stephanie] CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada.
   [Goyer, Benjamin; Proulx, Stephanie] Univ Laval, LOEX, Ctr Rech Organogenese Exprt, Quebec City, PQ, Canada.
   [Proulx, Stephanie] Univ Laval, Fac Med, Dept Ophtalmol & Otorhinolaryngol, Quebec City, PQ, Canada.
RP Proulx, S (reprint author), CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada.
EM stephanie.proulx@fmed.ulaval.ca
OI Ozaki, Tsuneyuki/0000-0001-8857-3900
FU Canadian Institutes for Health Research (CIHR) [CPG121034]; Natural
   Sciences and Engineering Research Council of Canada (NSERC)
   [414484-2012]; FRQS Vision Health Research Network;  [CHRPJ 313019-05]
FX This work was supported by the Canadian Institutes for Health Research
   (CIHR grant #CPG121034) in partnership with the Natural Sciences and
   Engineering Research Council of Canada (NSERC grant #414484-2012) (SP,
   IB) and grant #CHRPJ 313019-05 (TO). The Eye Bank Banque d'yeux du
   Centre Universitaire d'Ophtalmologie" is partly supported by the FRQS
   Vision Health Research Network (SP, IB). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586
   Auxenfans C, 2009, EUR J DERMATOL, V19, P107, DOI 10.1684/ejd.2008.0573
   Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442
   Barzda V, 2005, OPT EXPRESS, V13, P8263, DOI 10.1364/OPEX.13.008263
   Buhrmann R., 2007, FDN CANADIAN HLTH ST
   Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813
   EBAA, 2013, 2013 EYE BANK STAT R, P1
   Gauvin R, 2010, TISSUE ENG PT A, V16, P1737, DOI [10.1089/ten.tea.2009.0313, 10.1089/ten.TEA.2009.0313]
   Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7
   Germain L, 2004, TISSUE ENG CORNEA EN, P1533
   Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Howat WJ, 2014, METHODS, V70, P12, DOI 10.1016/j.ymeth.2014.01.022
   Hsueh CM, 2009, BIOPHYS J, V97, P1198, DOI 10.1016/j.bpj.2009.05.040
   Jay L, 2008, OPT EXPRESS, V16, P16284, DOI 10.1364/OE.16.016284
   L'Heureux N, 1998, FASEB J, V12, P47
   Larouche Danielle, 2009, V482, P233, DOI 10.1007/978-1-59745-060-7_15
   Lee GG, 2013, IEEE T BIOMED CIRC S, V7, P158, DOI 10.1109/TBCAS.2013.2253463
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Mega Y, 2012, OPT LETT, V37, P3312, DOI 10.1364/OL.37.003312
   Mimura T, 2013, PROG RETIN EYE RES, V35, P1, DOI 10.1016/j.preteyeres.2013.01.003
   Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657
   Morishige N, 2009, CORNEA, V28, pS46, DOI 10.1097/ICO.0b013e3181ae9f37
   Muller M, 1998, J MICROSC-OXFORD, V191, P266
   Pankert MB, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14720
   PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S
   Proulx S, 2012, EXP EYE RES, V95, P68, DOI 10.1016/j.exer.2011.06.013
   Proulx S, 2010, MOL VIS, V16, P2192
   Su PJ, 2010, BIOMATERIALS, V31, P9415, DOI 10.1016/j.biomaterials.2010.08.055
   TAYLOR MJ, 1981, BRIT J OPHTHALMOL, V65, P815, DOI 10.1136/bjo.65.12.815
   Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520
   Tserevelakis GJ, 2010, MICRON, V41, P444, DOI 10.1016/j.micron.2010.02.006
   VIELREICHER M, 2013, J R SOC INTERFACE, V10
   Yelin D, 1999, OPT EXPRESS, V5, P169, DOI 10.1364/OE.5.000169
   Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs-030814
NR 41
TC 3
Z9 3
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2015
VL 10
IS 4
AR e0125564
DI 10.1371/journal.pone.0125564
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG9SE
UT WOS:000353659400086
PM 25918849
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Amemiya, T
   Nakamura, T
   Yamamoto, T
   Kinoshita, S
   Kanamura, N
AF Amemiya, Takeshi
   Nakamura, Takahiro
   Yamamoto, Toshiro
   Kinoshita, Shigeru
   Kanamura, Narisato
TI Autologous Transplantation of Oral Mucosal Epithelial Cell Sheets
   Cultured on an Amniotic Membrane Substrate for Intraoral Mucosal Defects
SO PLOS ONE
LA English
DT Article
ID SURFACE RECONSTRUCTION; BASEMENT-MEMBRANE; KERATIN PROTEINS;
   LOCALIZATION; EQUIVALENT; CORNEAL; SERUM; IV
AB The human amniotic membrane (AM) is a thin intrauterine placental membrane that is highly biocompatible and possesses anti-inflammatory and anti-scarring properties. Using AM, we developed a novel method for cultivating oral mucosal epithelial cell sheets. We investigated the autologous transplantation of oral mucosal epithelial cells cultured on AM in patients undergoing oral surgeries. We obtained specimens of AM from women undergoing cesarean sections. This study included five patients without any history of a medical disorder who underwent autologous cultured oral epithelial transplantation following oral surgical procedures. Using oral mucosal biopsy specimens obtained from these patients, we cultured oral epithelial cells on an AM carrier. We transplanted the resultant cell sheets onto the oral mucosal defects. Patients were followed-up for at least 12 months after transplantation. After 2-3 weeks of being cultured on AM, epithelial cells were well differentiated and had stratified into five to seven layers. Immunohistochemistry revealed that the cultured cells expressed highly specific mucosal epithelial cell markers and basement membrane proteins. After the surgical procedures, no infection, bleeding, rejection, or sheet detachment occurred at the reconstructed sites, at which new oral mucous membranes were evident. No recurrence was observed in the long-term follow-up, and the postoperative course was excellent. Our results suggest that AM-cultured oral mucosal epithelial cell sheets represent a useful biomaterial and feasible method for oral mucosal reconstruction. However, our primary clinical study only evaluated their effects on a limited number of small oral mucosal defects.
C1 [Amemiya, Takeshi; Yamamoto, Toshiro; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan.
   [Nakamura, Takahiro; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Ophthalmol, Kyoto, Japan.
   [Nakamura, Takahiro] Doshisha Univ, Fac Life & Med Sci, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan.
RP Amemiya, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan.
EM amemiya@koto.kpu-m.ac.jp
FU Japan Society for the Promotion of Science [21592535]; Kyoto Prefectural
   University of Medicine
FX This work supported by a Grant-in-Aid for Scientific Research (No.
   21592535) from the Japan Society for the Promotion of Science (NK), and
   a Grant for Advanced Medical Treatment in Kyoto Prefectural University
   of Medicine (NK). The funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adachi K, 2014, ORAL DIS, V20, P582, DOI 10.1111/odi.12176
   Amemiya T, 2004, J ORAL TISSUE ENG, V1, P89
   Amemiya T, 2010, JPN J CONSERV DENT, V53, P214
   Amemiya T, 2010, INFLAM REGENER, V30, P176
   Amemiya T, 2008, J ORAL TISSUE ENG, V6, P106
   Amemiya T, 2003, J JPN ASS REGENERATI, V1, P25
   Amemiya T, 2010, BIO-MED MATER ENG, V20, P37, DOI 10.3233/BME-2010-0613
   Black AF, 2005, TISSUE ENG, V11, P723, DOI 10.1089/ten.2005.11.723
   CLAUSEN H, 1986, J ORAL PATHOL MED, V15, P36, DOI 10.1111/j.1600-0714.1986.tb00561.x
   COLOCHO G, 1974, ARCH SURG-CHICAGO, V109, P370
   COOPER D, 1986, J BIOL CHEM, V261, P4646
   Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29
   Feghali-Assaly M, 1997, EUR J ORAL SCI, V105, P599, DOI 10.1111/j.1600-0722.1997.tb00224.x
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Izumi K, 2003, INT J ORAL MAX SURG, V32, P188, DOI 10.1054/ijom.2002.0365
   JUHL M, 1989, SCAND J DENT RES, V97, P159
   Kesting MR, 2014, ORAL MAXILLOFAC SURG, V18, P153, DOI 10.1007/s10006-012-0382-1
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6
   Maragou P, 1999, ORAL DIS, V5, P20
   Modesti A, 1989, Prog Clin Biol Res, V296, P459
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Nakamura T, 2006, INVEST OPHTH VIS SCI, V47, P909, DOI 10.1167/iovs.05-1188
   Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195
   Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497
   Nakamura T, 2011, BRIT J OPHTHALMOL, V95, P942, DOI 10.1136/bjo.2010.188714
   NANAEV AK, 1991, PLACENTA, V12, P573, DOI 10.1016/0143-4004(91)90493-Y
   Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0
   ROSDY M, 1990, J INVEST DERMATOL, V95, P409, DOI 10.1111/1523-1747.ep12555510
   ROSDY M, 1993, BRIT J DERMATOL, V129, P227, DOI 10.1111/j.1365-2133.1993.tb11839.x
   Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031
   SHABANA AHM, 1991, ARCH ORAL BIOL, V36, P747, DOI 10.1016/0003-9969(91)90041-R
   STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Yamamoto T, 2007, J ORAL TISSUE ENG, V5, P54
NR 37
TC 5
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2015
VL 10
IS 4
AR e0125391
DI 10.1371/journal.pone.0125391
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG9SB
UT WOS:000353659100126
PM 25915046
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Jin, SH
   Kang, SK
   Cho, IT
   Han, SY
   Chung, HU
   Lee, DJ
   Shin, J
   Baek, GW
   Kim, TI
   Lee, JH
   Rogers, JA
AF Jin, Sung Hun
   Kang, Seung-Kyun
   Cho, In-Tak
   Han, Sang Youn
   Chung, Ha Uk
   Lee, Dong Joon
   Shin, Jongmin
   Baek, Geun Woo
   Kim, Tae-il
   Lee, Jong-Ho
   Rogers, John A.
TI Water-Soluble Thin Film Transistors and Circuits Based on Amorphous
   Indium-Gallium-Zinc Oxide
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE a-IGZO; transient electronics; dissolution; PVA; inverter; ring
   oscillators
ID TRANSIENT ELECTRONICS; FABRICATION; BIOCOMPATIBILITY; CYTOTOXICITY;
   BIOMATERIAL; TOXICITY; POLYMERS; ZNO
AB This paper presents device designs, circuit demonstrations, and dissolution kinetics for amorphous indium-gallium-zinc oxide (a-IGZO) thin film transistors (TFTs) comprised completely of water-soluble materials, including SiNx, SiOx, molybdenum, and poly(vinyl alcohol) (PVA). Collections of these types of physically transient a-IGZO TFTs and 5-stage ring oscillators (ROs), constructed 0 with them, show field effect mobilities (similar to 10 cm(2)/Vs), on/off ratios (similar to 2 x 10(6)), subthreshold slopes (similar to 220 mV/dec), Ohmic contact properties, and oscillation frequency of 5:67 kHz at supply voltages of 19 V, all comparable to otherwise similar devices constructed in conventional ways with standard, nontransient materials. Studies of dissolution kinetics for a-IGZO films in deionized water, bovine serum, and phosphate buffer saline solution provide data of relevance for the potential use of these materials and this technology in temporary biomedical implants.
C1 [Jin, Sung Hun; Baek, Geun Woo] Incheon Natl Univ, Dept Elect Engn, Inchon 406772, South Korea.
   [Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn Chem Mech Sci & Engn Elect &, Urbana, IL 61801 USA.
   [Kang, Seung-Kyun; Han, Sang Youn; Chung, Ha Uk; Lee, Dong Joon; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.
   [Kang, Seung-Kyun; Han, Sang Youn; Chung, Ha Uk; Lee, Dong Joon] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Cho, In-Tak; Shin, Jongmin; Lee, Jong-Ho] Seoul Natl Univ, Dept Elect Engn, Seoul 151600, South Korea.
   [Kim, Tae-il] Sungkyunkwan Univ SKKU, Sch Chem Engn, Inst Basic Sci, CNIR, Suwon 440746, Gyeonggi Do, South Korea.
   [Han, Sang Youn] Samsung Display Co, Display R&D Ctr, Yongin 446711, Gyeongki Do, South Korea.
RP Jin, SH (reprint author), Incheon Natl Univ, Dept Elect Engn, Inchon 406772, South Korea.
EM shjin@inu.ac.kr; jhl@snu.ac.kr; jrogers@illinois.edu
RI Rogers, John/L-2798-2016; Kang, Seung-Kyun/L-3053-2017; Jin, Sung
   Hun/O-2092-2018
OI Kim, Tae-il/0000-0002-6667-5356
FU NSF-INSPIRE Grant [DMR-1242240]; National Research Foundation of Korea
   (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2014R1A1A1038274]
FX This research was supported by NSF-INSPIRE Grant (DMR-1242240) and Basic
   Science Research Program through the National Research Foundation of
   Korea (NRF) funded by the Ministry of Science, ICT & Future Planning
   (NRF-2014R1A1A1038274).
CR Badding MA, 2014, J TOXICOL ENV HEAL A, V77, P1193, DOI 10.1080/15287394.2014.920757
   BARIC A, 1969, LIMNOL OCEANOGR, V14, P796, DOI 10.4319/lo.1969.14.5.0796
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Brumbach M., 2007, ENCY ELECTROCHEMISTR, P18, DOI 10.1002/9783527610426.bard100101
   Chen Y., 2013, SOC INF DISP INT S, V46.3, P640
   Chiu CJ, 2011, IEEE SENS J, V11, P2902, DOI 10.1109/JSEN.2011.2146770
   Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146
   DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2
   Horasawa N, 1997, Dent Mater J, V16, P200
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hwang SW, 2014, ACS NANO, V8, P5843, DOI 10.1021/nn500847g
   Hwang SW, 2014, ADV MATER, V26, P3905, DOI 10.1002/adma.201306050
   Hwang SW, 2014, ADV MATER, V26, P1992, DOI 10.1002/adma.201304821
   Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   irimia-Viadu M., 2013, CHEM SOC REV, V43, P588, DOI DOI 10.HTTP://DX.D0I.0RG/10.1039/C3CS60235D
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Jin S. H., 2014, APPL PHYS LETT, V105
   Kang S.-M., 1996, DIGITAL INTEGRATED C
   Kang SK, 2014, ADV FUNCT MATER, V24, P4427, DOI 10.1002/adfm.201304293
   KIM CJ, 2006, IEDM, P307
   Kim MW, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713859
   KREBS HA, 1950, ANNU REV BIOCHEM, V19, P409, DOI 10.1146/annurev.bi.19.070150.002205
   Lam C. X. F., 2008, BIOMED MATER, V3
   Lee CH, 2011, NANO LETT, V11, P3435, DOI 10.1021/nl201901z
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Park JY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430921
   Ponnusamy Thiruselvam, 2012, Biomatter, V2, P77, DOI 10.4161/biom.20390
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Salvator G. A., 2014, NATURE COMMUN, V5, P1
   Sedra A. S., 2010, MICROELECTRONIC CIRC, P1075
   WATAHA JC, 1994, DENT MATER, V10, P298, DOI 10.1016/0109-5641(94)90037-X
   WEBB DR, 1986, TOXICOL APPL PHARM, V82, P405, DOI 10.1016/0041-008X(86)90276-0
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Yan DH, 2009, INORG CHEM, V48, P6471, DOI 10.1021/ic900420m
   Yang DJ, 2012, SENSOR ACTUAT B-CHEM, V171, P1166, DOI 10.1016/j.snb.2012.06.057
   Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847
NR 42
TC 31
Z9 32
U1 10
U2 77
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 22
PY 2015
VL 7
IS 15
BP 8268
EP 8274
DI 10.1021/acsami.5b00086
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CG9AP
UT WOS:000353607100053
PM 25805699
DA 2018-10-19
ER

PT J
AU Costa, PF
   Hutmacher, DW
   Theodoropoulos, C
   Gomes, ME
   Reis, RL
   Vaquette, C
AF Costa, Pedro F.
   Hutmacher, Dietmar W.
   Theodoropoulos, Christina
   Gomes, Manuela E.
   Reis, Rui L.
   Vaquette, Cedryck
TI Additively Manufactured Device for Dynamic Culture of Large Arrays of 3D
   Tissue Engineered Constructs
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID MINERALIZED MATRIX DEPOSITION; MARROW STROMAL OSTEOBLASTS; PERFUSION
   BIOREACTOR; STEM-CELLS; SCAFFOLD DESIGN; IN-VITRO; BONE-FORMATION; FLOW;
   BIOMATERIALS; 3RD-DIMENSION
AB The ability to test large arrays of cell and biomaterial combinations in 3D environments is still rather limited in the context of tissue engineering and regenerative medicine. This limitation can be generally addressed by employing highly automated and reproducible methodologies. This study reports on the development of a highly versatile and upscalable method based on additive manufacturing for the fabrication of arrays of scaffolds, which are enclosed into individualized perfusion chambers. Devices containing eight scaffolds and their corresponding bioreactor chambers are simultaneously fabricated utilizing a dual extrusion additive manufacturing system. To demonstrate the versatility of the concept, the scaffolds, while enclosed into the device, are subsequently surface-coated with a biomimetic calcium phosphate layer by perfusion with simulated body fluid solution. 96 scaffolds are simultaneously seeded and cultured with human osteoblasts under highly controlled bidirectional perfusion dynamic conditions over 4 weeks. Both coated and noncoated resulting scaffolds show homogeneous cell distribution and high cell viability throughout the 4 weeks culture period and CaP-coated scaffolds result in a significantly increased cell number. The methodology developed in this work exemplifies the applicability of additive manufacturing as a tool for further automation of studies in the field of tissue engineering and regenerative medicine.
C1 [Costa, Pedro F.; Gomes, Manuela E.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-480609 Caldas Das Taipas, Guimaraes, Portugal.
   [Costa, Pedro F.; Gomes, Manuela E.; Reis, Rui L.] ICVS, PT Govt Associate Lab 3Bs, Braga, Guimaraes, Portugal.
   [Hutmacher, Dietmar W.; Theodoropoulos, Christina; Vaquette, Cedryck] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
RP Hutmacher, DW (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM dietmar.hutmacher@qut.edu.au
RI Group, 3Bs/E-4374-2012; Gomes, Manuela/B-6282-2009; Reis, Rui
   L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Gomes, Manuela/0000-0002-2036-6291;
   Reis, Rui L./0000-0002-4295-6129; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Costa, Pedro/0000-0003-3114-9417; Vaquette,
   Cedryck/0000-0001-7937-4432
FU Australian Research Council; Portuguese Foundation for Science and
   Technology [SFRH/BD/62452/2009]
FX P.F.C. and D.W.H. contributed equally to this work. This work was
   supported by the Australian Research Council. P.F.C. acknowledges the
   Portuguese Foundation for Science and Technology for his PhD grant
   (SFRH/BD/62452/2009).
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Alvarez-Barreto JF, 2007, ANN BIOMED ENG, V35, P429, DOI 10.1007/s10439-006-9244-z
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Arafat MT, 2011, ACTA BIOMATER, V7, P809, DOI 10.1016/j.actbio.2010.09.010
   Araujo JV, 2008, J BIOMAT SCI-POLYM E, V19, P1261, DOI 10.1163/156856208786052335
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Costa PF, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035006
   Costa PF, 2014, J CLIN PERIODONTOL, V41, P283, DOI 10.1111/jcpe.12214
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI 10.1089/ten.TEA.2009.0164
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Goncalves A., 2011, ACTA BIOMATER, V7, P1644
   Gottwald E, 2007, LAB CHIP, V7, P777, DOI 10.1039/b618488j
   Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255
   Grylls R., 2003, Machine Design International, V75, P56
   Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101
   Hidalgo-Bastida LA, 2012, BIOTECHNOL BIOENG, V109, P1095, DOI 10.1002/bit.24368
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2007, J CELL MOL MED, V11, P654, DOI 10.1111/j.1582-4934.2007.00078.x
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jaasma MJ, 2008, J BIOTECHNOL, V133, P490, DOI 10.1016/j.jbiotec.2007.11.010
   Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002
   Mei Y, 2012, MATER TODAY, V15, P444, DOI 10.1016/S1369-7021(12)70196-7
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Oliveira AL, 2009, ACTA BIOMATER, V5, P1626, DOI 10.1016/j.actbio.2008.12.009
   Pereira DA, 2007, BRIT J PHARMACOL, V152, P53, DOI 10.1038/sj.bjp.0707373
   Rotenberg MY, 2012, LAB CHIP, V12, P2696, DOI [10.1039/c2lc40144d, 10.1039/c21c40144d]
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2006.12.021
   Tian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042804
   Tsuji H, 2003, POLYM INT, V52, P843, DOI 10.1002/pi.1199
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   Vaquette C, 2013, BIOMATERIALS, V34, P5538, DOI 10.1016/j.biomaterials.2013.03.088
   Yang F, 2008, CHEM ENG J, V137, P154, DOI 10.1016/j.cej.2007.07.076
   Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
NR 53
TC 6
Z9 6
U1 3
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD APR 22
PY 2015
VL 4
IS 6
BP 864
EP 873
DI 10.1002/adhm.201400591
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CG5SD
UT WOS:000353353500007
PM 25721231
DA 2018-10-19
ER

PT J
AU Monn, MA
   Weaver, JC
   Zhang, TY
   Aizenberg, J
   Kesari, H
AF Monn, Michael A.
   Weaver, James C.
   Zhang, Tianyang
   Aizenberg, Joanna
   Kesari, Haneesh
TI New functional insights into the internal architecture of the laminated
   anchor spicules of Euplectella aspergillum
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE structure-property relationship; structural biomaterial; biocomposite;
   variational analysis
ID MECHANICAL-PROPERTIES; FRACTURE-RESISTANCE; COMPOSITES; SPONGE; BONE;
   DEMOSPONGE; NANOSCALE; BIOSILICA; COLLAGEN; SYSTEMS
AB To adapt to a wide range of physically demanding environmental conditions, biological systems have evolved a diverse variety of robust skeletal architectures. One such example, Euplectella aspergillum, is a sediment-dwelling marine sponge that is anchored into the sea floor by a flexible holdfast apparatus consisting of thousands of anchor spicules (long, hair-like glassy fibers). Each spicule is covered with recurved barbs and has an internal architecture consisting of a solid core of silica surrounded by an assembly of coaxial silica cylinders, each of which is separated by a thin organic layer. The thickness of each silica cylinder progressively decreases from the spicule's core to its periphery, which we hypothesize is an adaptation for redistributing internal stresses, thus increasing the overall strength of each spicule. To evaluate this hypothesis, we created a spicule structural mechanics model, in which we fixed the radii of the silica cylinders such that the force transmitted from the surface barbs to the remainder of the skeletal system was maximized. Compared with measurements of these parameters in the native sponge spicules, our modeling results correlate remarkably well, highlighting the beneficial nature of this elastically heterogeneous lamellar design strategy. The structural principles obtained from this study thus provide potential design insights for the fabrication of high-strength beams for load-bearing applications through the modification of their internal architecture, rather than their external geometry.
C1 [Monn, Michael A.; Zhang, Tianyang; Kesari, Haneesh] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   [Weaver, James C.; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
RP Kesari, H (reprint author), Brown Univ, Sch Engn, Providence, RI 02912 USA.
EM haneesh_kesari@brown.edu
OI Monn, Michael/0000-0002-9966-5891
FU National Science Foundation [DMR-0520651, DMR-1420570]; Korean Institute
   of Machinery and Materials-Brown Nano and Micromechanics for Disaster
   Mitigation and Technological Reliability project
FX We thank Prof. Huajian Gao for helpful discussions. This work was
   supported by the National Science Foundation through Materials Research
   Science and Engineering Centers Program DMR-0520651 at Brown University,
   Materials Research Science and Engineering Centers Program DMR-1420570
   at Harvard University, and the Korean Institute of Machinery and
   Materials-Brown Nano and Micromechanics for Disaster Mitigation and
   Technological Reliability project.
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Bazant ZP, 2005, SCALING STRUCTURAL S, P3
   Browning A, 2013, J MECH BEHAV BIOMED, V19, P75, DOI 10.1016/j.jmbbm.2012.11.003
   CattaneoVietti R, 1996, NATURE, V383, P397, DOI 10.1038/383397b0
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Currey JD, 2003, J BONE MINER RES, V18, P591, DOI 10.1359/jbmr.2003.18.4.591
   Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Gere JM, 1997, MECH MATER, P220
   Green DJ, 1998, CAMBRIDGE SOLID STAT, P210
   Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221, P163
   Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Launey ME, 2009, ACTA MATER, V57, P2919, DOI 10.1016/j.actamat.2009.03.003
   Lawn B., 1993, FRACTURE BRITTLE SOL, P1
   Leys SP, 2003, MICROSC RES TECHNIQ, V62, P300, DOI 10.1002/jemt.10397
   Marsden JE, 1993, ELEMENTARY CLASSICAL, P19
   Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994
   Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135
   Nalla RK, 2003, J BIOMED MATER RES A, V67A, P484, DOI 10.1002/jbm.a.10079
   Porter MM, 2013, JOM-US, V65, P720, DOI 10.1007/s11837-013-0606-3
   Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/NMAT3115, 10.1038/nmat3115]
   Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a
   Thompson DW, 1942, GROWTH FORM NEW EDIT, P665
   Tomisa A.P., 2011, INT J ORAL MAXILLOF, V26, P45
   Vincent JFV, 1990, STRUCTURAL BIOMATERI, P204
   Vincent JFV, 1990, STRUCTURAL BIOMATERI, P126
   Wang XH, 2009, FRONTIERS MAT SCI CH, V3, P226
   Weaver JC, 2007, J STRUCT BIOL, V158, P93, DOI 10.1016/j.jsb.2006.10.027
   Weaver JC, 2010, J ADHESION, V86, P72, DOI 10.1080/00218460903417917
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yang W, 2013, ACTA BIOMATER, V9, P5876, DOI 10.1016/j.actbio.2012.12.026
   Zlotnikov I, 2013, RSC ADV, V3, P5798, DOI 10.1039/c3ra40574e
NR 35
TC 13
Z9 13
U1 6
U2 47
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 21
PY 2015
VL 112
IS 16
BP 4976
EP 4981
DI 10.1073/pnas.1415502112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG4FJ
UT WOS:000353239100049
PM 25848003
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Berdichevski, A
   Yameen, HS
   Dafni, H
   Neeman, M
   Seliktar, D
AF Berdichevski, Alexandra
   Yameen, Haneen Simaan
   Dafni, Hagit
   Neeman, Michal
   Seliktar, Dror
TI Using bimodal MRI/fluorescence imaging to identify host angiogenic
   response to implants
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial scaffold; angiogenesis; hydrogel; contrast agents; tissue
   regeneration
ID ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; FOREIGN-BODY
   REACTION; IN-VIVO; FACTOR DELIVERY; FIBRINOGEN HYDROGEL; SYNTHETIC
   MATRIX; SOFT-TISSUE; VEGF; SCAFFOLDS
AB Therapies that promote angiogenesis have been successfully applied using various combinations of proangiogenic factors together with a biodegradable delivery vehicle. In this study we used bimodal noninvasive monitoring to show that the host response to a proangiogenic biomaterial can be drastically affected by the mode of implantation and the surface area-to-volume ratio of the implant material. Fluorescence/MRI probes were covalently conjugated to VEGF-bearing biodegradable PEG-fibrinogen hydrogel implants and used to document the in vivo degradation and liberation of bioactive constituents in an s.c. rat implantation model. The hydrogel biodegradation and angiogenic host response with three types of VEGF-bearing implant configurations were compared: preformed cylindrical plugs, preformed injectable microbeads, and hydrogel precursor, injected and polymerized in situ. Although all three were made with identical amounts of precursor constituents, the MRI data revealed that in situ polymerized hydrogels were fully degraded within 2 wk; microbead degradation was more moderate, and plugs degraded significantly more slowly than the other configurations. The presence of hydrogel degradation products containing the fluorescent label in the surrounding tissues revealed a distinct biphasic release profile for each type of implant configuration. The purported in vivo VEGF release profile from the microbeads resulted in highly vascularized s.c. tissue containing up to 16-fold more capillaries in comparison with controls. These findings demonstrate that the configuration of an implant can play an important role not only in the degradation and resorption properties of the materials, but also in consequent host angiogenic response.
C1 [Berdichevski, Alexandra; Yameen, Haneen Simaan; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Dafni, Hagit] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel.
   [Neeman, Michal] Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
RI Neeman, Michal/A-8264-2008
OI Neeman, Michal/0000-0002-6296-816X; Seliktar, Dror/0000-0001-6964-8567
FU Singapore National Research Foundation; Lorry I. Lokey Interdisciplinary
   Center for Life Sciences and Engineering; Russell Berrie Nanotechnology
   Institute; EC-IP FP7 Grants Angioscaff and Biodesign; 7th Framework
   European Research Council Advanced Grant [232640-IMAGO]
FX We wish to thank the Preclinical Research Authority and the Imaging and
   Microscopy Center at the Bruce Rappaport Faculty of Medicine for their
   help and technical support. This work was supported by the Singapore
   National Research Foundation (D.S. and A.B.), the Lorry I. Lokey
   Interdisciplinary Center for Life Sciences and Engineering (D.S.),
   Russell Berrie Nanotechnology Institute (D.S.), EC-IP FP7 Grants
   Angioscaff and Biodesign (to D.S.), and in part by the 7th Framework
   European Research Council Advanced Grant 232640-IMAGO (to M.N.). M.N. is
   incumbent of the Helen and Morris Mauerberger Chair.
CR Aghion E, 2012, J MATER SCI-MATER M, V23, P805, DOI 10.1007/s10856-011-4536-8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Bland E, 2013, J TISSUE ENG REGEN M, V7, P505, DOI 10.1002/term.540
   Chwalek K, 2011, BIOMATERIALS, V32, P9649, DOI 10.1016/j.biomaterials.2011.08.078
   Cunha-Reis C, 2013, J TISSUE ENG REGEN M, V7, P39, DOI 10.1002/term.494
   Dafni H, 2002, NMR BIOMED, V15, P120, DOI 10.1002/nbm.724
   Dafni H, 2002, CANCER RES, V62, P6731
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Ge YB, 2011, YAKUGAKU ZASSHI, V131, P1807, DOI 10.1248/yakushi.131.1807
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055
   Griffith CK, 2009, TISSUE ENG PT A, V15, P2423, DOI 10.1089/ten.tea.2008.0267
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499
   Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018
   Jiang HL, 2001, J BIOMAT SCI-POLYM E, V12, P1281, DOI 10.1163/156856202753419222
   Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352
   Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726
   Kotkova Z, 2010, CHEM-EUR J, V16, P10094, DOI 10.1002/chem.200903519
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Maurer B, 2014, ANN RHEUM DIS, V73, P1880, DOI 10.1136/annrheumdis-2013-203535
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   RAPPOLEE DA, 1988, CURR OPIN IMMUNOL, V1, P47, DOI 10.1016/0952-7915(88)90050-7
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rufaihah AJ, 2013, BIOMATERIALS, V34, P8195, DOI 10.1016/j.biomaterials.2013.07.031
   Sahni A, 2000, BLOOD, V96, P3772
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Wang YT, 2011, NANOMED-NANOTECHNOL, V7, P1009, DOI 10.1016/j.nano.2011.03.006
   Weir C, 2008, HEART LUNG CIRC, V17, P395, DOI 10.1016/j.hlc.2008.01.006
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang Y, 2005, ANALYST, V130, P1502, DOI 10.1039/b506911d
   Yang Z, 2012, J DIGEST DIS, V13, P168, DOI 10.1111/j.1751-2980.2011.00566.x
   Yilgor P, 2013, J TISSUE ENG REGEN M, V7, P687, DOI 10.1002/term.1456
   Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347
   Zheng J, 2004, PEGYLATED LIPOSOME C
NR 54
TC 20
Z9 20
U1 3
U2 44
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 21
PY 2015
VL 112
IS 16
BP 5147
EP 5152
DI 10.1073/pnas.1502232112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG4FJ
UT WOS:000353239100078
PM 25825771
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Moshaverinia, A
   Chen, C
   Xu, XT
   Ansari, S
   Zadeh, HH
   Schricker, SR
   Paine, ML
   Moradian-Oldak, J
   Khademhosseini, A
   Snead, ML
   Shi, ST
AF Moshaverinia, Alireza
   Chen, Chider
   Xu, Xingtian
   Ansari, Sahar
   Zadeh, Homayoun H.
   Schricker, Scott R.
   Paine, Michael L.
   Moradian-Oldak, Janet
   Khademhosseini, Ali
   Snead, Malcolm L.
   Shi, Songtao
TI Regulation of the Stem Cell-Host Immune System Interplay Using Hydrogel
   Coencapsulation System with an Anti-Inflammatory Drug
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID NF-KAPPA-B; TNF-ALPHA; TISSUE REGENERATION; ALGINATE HYDROGELS;
   CO-ENCAPSULATION; UP-REGULATION; IFN-GAMMA; RELEASE; DIFFERENTIATION;
   BONE
AB The host immune system is known to influence mesenchymal stem cell (MSC)-mediated bone tissue regeneration. However, the therapeutic capacity of hydrogel biomaterial to modulate the interplay between MSCs and T-lymphocytes is unknown. Here it is shown that encapsulating hydrogel affects this interplay when used to encapsulate MSCs for implantation by hindering the penetration of pro-inflammatory cells and/or cytokines, leading to improved viability of the encapsulated MSCs. This combats the effects of the host pro-inflammatory T-lymphocyte-induced nuclear factor kappaB pathway, which can reduce MSC viability through the CASPASE-3 and CASPASE-8 associated proapoptotic cascade, resulting in the apoptosis of MSCs. To corroborate rescue of engrafted MSCs from the insult of the host immune system, the incorporation of the anti-inflammatory drug indomethacin into the encapsulating alginate hydrogel further regulates the local microenvironment and prevents pro-inflammatory cytokine-induced apoptosis. These findings suggest that the encapsulating hydrogel can regulate the MSC-host immune cell interplay and direct the fate of the implanted MSCs, leading to enhanced tissue regeneration.
C1 [Moshaverinia, Alireza; Xu, Xingtian; Ansari, Sahar; Zadeh, Homayoun H.; Paine, Michael L.; Moradian-Oldak, Janet; Snead, Malcolm L.] Univ So Calif, Ostrow Sch Dent, CCMB, Los Angeles, CA 90033 USA.
   [Schricker, Scott R.] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA.
   [Khademhosseini, Ali] Harvard Univ, Sch Med, Biomat Innovat Res Ctr, Cambridge, MA 02139 USA.
   [Chen, Chider; Shi, Songtao] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA.
RP Moshaverinia, A (reprint author), Univ So Calif, Ostrow Sch Dent, CCMB, 2250 Alcazar St, Los Angeles, CA 90033 USA.
EM moshaver@usc.edu; songtaos@dental.upenn.edu
RI Schricker, Scott/A-3957-2008; Chen, Chider/L-9880-2016
OI Schricker, Scott/0000-0003-1982-1282; Chen, Chider/0000-0003-2899-1208;
   Khademhosseini, Ali/0000-0001-6322-8852
FU National Institute of Dental and Craniofacial Research, National
   Institutes of Health, Department of Health and Human Services
   [K08DE023825, R01DE017449, R01 DE019932]; California Institute for
   Regenerative Medicine [RN1-00572]
FX A.M. and C.C. contributed equally to this work. This work was supported
   by grants from the National Institute of Dental and Craniofacial
   Research, National Institutes of Health, Department of Health and Human
   Services (K08DE023825 to A.M., R01DE017449 and R01 DE019932 to S.S.);
   and a grant from the California Institute for Regenerative Medicine
   (RN1-00572 for S.S.).
CR Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Ansari S, 2013, BIOMATERIALS, V34, P10191, DOI 10.1016/j.biomaterials.2013.08.069
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110
   Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c
   Fichtner-Feigl S, 2005, J CLIN INVEST, V115, P3057, DOI 10.1172/JCI24792
   Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Hatch A, 2011, LANGMUIR, V27, P4257, DOI 10.1021/la105016a
   Higashi T, 2004, J BIOSCI BIOENG, V97, P191, DOI 10.1016/S1389-1723(04)70189-9
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje
   Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim H. K., 2014, BIOMATERIALS, V35, P214
   Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106
   Lin CC, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-8
   Liu Y, 2012, INT J BIOCHEM CELL B, V44, P2044, DOI 10.1016/j.biocel.2012.08.003
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020
   Moshaverinia A, 2014, TISSUE ENG PT A, V20, P611, DOI 10.1089/ten.TEA.2013.0229
   Moshaverinia A, 2013, J BIOMED MATER RES A, V101, P3285, DOI 10.1002/jbm.a.34546
   Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048
   Nakao S, 2002, MOL CELL BIOCHEM, V238, P11, DOI 10.1023/A:1019927616000
   Nalbant S, 2006, CLIN EXP RHEUMATOL, V24, P361
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z
   Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Seo BM, 2008, ORAL DIS, V14, P428, DOI 10.1111/j.1601-0825.2007.01396.x
   Shi J, 2008, J BIOMED MATER RES B, V84B, P595, DOI 10.1002/jbm.b.30907
   SIMON LS, 1999, AM J MED, V106, P37
   Sirota L, 2000, ACTA PAEDIATR, V89, P331
   Suleyman H, 2008, J PHYSIOL PHARMACOL, V59, P661
   Taki H., 1998, CLIN EXP IMMUNOL, V11, P133
   Tasso R, 2010, BIOMATERIALS, V31, P2121, DOI 10.1016/j.biomaterials.2009.11.064
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133
   Xin JY, 2010, INT J PHARMACEUT, V386, P221, DOI 10.1016/j.ijpharm.2009.11.024
NR 54
TC 24
Z9 24
U1 3
U2 69
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD APR 15
PY 2015
VL 25
IS 15
BP 2296
EP 2307
DI 10.1002/adfm.201500055
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CG1TP
UT WOS:000353057600011
PM 26120294
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhong, Y
   Leung, V
   Wan, LY
   Dutz, S
   Ko, FK
   Hafeli, UO
AF Zhong, Yi
   Leung, Victor
   Wan, Lynn Yuqin
   Dutz, Silvio
   Ko, Frank K.
   Haefeli, Urs O.
TI Electrospun magnetic nanofibre mats - A new bondable biomaterial using
   remotely activated magnetic heating
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on the Scientific and Clinical
   Applications of Magnetic Carriers
CY JUN 10-14, 2014
CL Dresden, GERMANY
DE Solvothermal; Hydrophilic Fe3O4; Magnetic nanofibre; Hyperthermia;
   Electrospinning; Polymer bonding; Heat sealing
ID IRON-OXIDE NANOPARTICLES; FLUID HYPERTHERMIA; DRUG-DELIVERY; IN-VIVO;
   DIAGNOSTICS; THERAPY
AB A solvothermal process was adopted to produce hydrophilic magnetite (Fe3O4) nanoparticles which were subsequently emulsified with a chloroform/methanol (70/30 v/v) solution of poly(caprolactone) (PCL) and then electrospun into a 0.2 mm thick PCL maL. The magnetic heating of the mats at a field amplitude of 25 kA/m and frequency of 400 kHz exhibited promising efficiency for magnetic hyperthermia, with a specific absorption rate of about 40 W/g for the magnetic mat. The produced heat was used to melt the magnetic mat onto the surrounding non-magnetic polymer mat from within, without destroying the nanostructure of the non-magnetic polymer more than 0.5 mm away. Magnetic nanolibre mats might thus be useful for internal heat sealing applications, and potentially also for thermotherapy. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhong, Yi; Leung, Victor; Wan, Lynn Yuqin; Ko, Frank K.] Univ British Columbia, Dept Mat Engn, Vancouver, BC V5Z 1M9, Canada.
   [Haefeli, Urs O.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada.
   [Dutz, Silvio] Tech Univ Ilmenau, Inst Biomed Techn & Informat, D-98684 Ilmenau, Germany.
   [Dutz, Silvio] Leibniz Inst Photon Technol, Dept Nano Biophoton, Jena, Germany.
   [Zhong, Yi] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Key Lab Sci & Technol Ecotext, Minist Educ, Shanghai, Peoples R China.
RP Hafeli, UO (reprint author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada.
EM frank.ko@ubc.ca; urs.hafeli@ubc.ca
RI Dutz, Silvio/E-3865-2010
OI Hafeli, Urs/0000-0003-0671-4509
FU Discovery Grant; Natural Sciences and Engineering Research Council of
   Canada (NSERC) in Canada; Central Universities of China Ministry of
   Education [2013D110525]
FX The authors gratefully acknowledge the support of Discovery Grant and
   CFI by the Natural Sciences and Engineering Research Council of Canada
   (NSERC) in Canada and the Central Universities of China Ministry of
   Education (Item no. 2013D110525) for their financial support to complete
   this work.
CR Amarjargal A, 2013, EUR POLYM J, V49, P3796, DOI 10.1016/j.eurpolymj.2013.08.026
   Andra W, 2007, HDB MAGNETISM ADV MA, V4
   Deng H, 2005, ANGEW CHEM INT EDIT, V44, P2782, DOI 10.1002/anie.200462551
   Dennis CL, 2013, INT J HYPERTHER, V29, P715, DOI 10.3109/02656736.2013.836758
   Dutz S, 2013, INT J HYPERTHER, V29, P790, DOI 10.3109/02656736.2013.822993
   Dutz S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265102
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hilger I, 2001, RADIOLOGY, V218, P570, DOI 10.1148/radiology.218.2.r01fe19570
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   Kallrot M, 2006, BIOMATERIALS, V27, P1788, DOI 10.1016/j.biomaterials.2005.10.010
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011
   Ko F, 2003, ADV MATER, V15, P1161, DOI 10.1002/adma.200304955
   Ko K.F., 2013, J FIBER BIOENG INFOR, V6, P129
   Kozissnik B, 2013, INT J HYPERTHER, V29, P706, DOI 10.3109/02656736.2013.837200
   Krishnan KM, 2010, IEEE T MAGN, V46, P2523, DOI 10.1109/TMAG.2010.2046907
   Muller R, 2006, J PHYS-CONDENS MAT, V18, pS2527, DOI 10.1088/0953-8984/18/38/S01
   Ortega D, 2013, NANOSCI-SPEC PER REP, V1, P60, DOI 10.1039/9781849734844-00060
   Rumenapp C, 2012, PHARM RES-DORDR, V29, P1165, DOI 10.1007/s11095-012-0711-y
   Salunkhe AB, 2014, CURR TOP MED CHEM, V14, P572, DOI 10.2174/1568026614666140118203550
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Tomitaka A, 2011, J MAGN MAGN MATER, V323, P1398, DOI 10.1016/j.jmmm.2010.11.054
   Tran N, 2010, J MATER CHEM, V20, P8760, DOI 10.1039/c0jm00994f
NR 23
TC 6
Z9 6
U1 3
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR 15
PY 2015
VL 380
BP 330
EP 334
DI 10.1016/j.jmmm.2014.09.069
PG 5
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA CB1BG
UT WOS:000349360800058
DA 2018-10-19
ER

PT J
AU Lysenko, O
   Dubok, O
   Borysenko, A
   Shinkaruk, O
AF Lysenko, Oleksandr
   Dubok, Oleksii
   Borysenko, Anatolii
   Shinkaruk, Oleksandr
TI The biological properties of the silver- and copper-doped ceramic
   biomaterial
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Bioactive ceramics; Nanocrystallinity; Silver and copper; Antimicrobial;
   Cytotoxicity; Osteogenesis; Bioinspired nanomaterials
ID CALCIUM-PHOSPHATE SCAFFOLDS; SUBSTITUTED HYDROXYAPATITE; IN-VITRO;
   ANTIBACTERIAL; BONE; BIOCERAMICS; CELLS; ANGIOGENESIS; CAPACITY;
   SURFACES
AB The biological properties of nanostructured bioactive ceramic composite (BCC) granules doped with 0.1-10 at.% silver and 0.05-5 at.% copper have been investigated both in vitro and in vivo to develop effective alloplastic material for infected bone defect substitute. It is assumed that the granules consisting of biphasic calcium phosphate and bioactive glass ceramics due to their nanoscale (15-40 nm) and multiphase structure, bioelement placement in different ceramic phases as well as antimicrobial effect should improve osteogenic properties and biocompatibility. Tests in vitro have been conducted with multipotent mesenchymal stromal cells (MSCs) and test strains of microorganisms. The same biocomposite has been used in vivo to study the repair of bone defects in animal model. The findings indicate that doped BCC leads to antimicrobial activity. Inhibition of MSCs growth has been observed for granules doped with ions of more than 1 at.% silver and 0.5 at.% copper. The results of the in vivo study reveal that BCC implantation significantly improves bone reparation. Differences between bone repair with undoped and doped, with 1 at.% silver and 0.5 at.% copper, ceramic samples were not observed. The BCC doped within 0.5-1 at.% silver and 0.25-0.5 at.% copper stimulates bone tissue repair and has satisfactory biocompatibility and antimicrobial properties.
C1 [Lysenko, Oleksandr; Borysenko, Anatolii] Bogomolets Natl Med Univ, Dept Therapeut Stomatol, UA-01601 Kiev, Ukraine.
   [Dubok, Oleksii; Shinkaruk, Oleksandr] NASU, Inst Problems Mat Sci, Dept Analyt Chem & Funct Ceram, UA-03142 Kiev, Ukraine.
   [Dubok, Oleksii] Natl Taras Shevchenko Univ Kyiv, Fac Chem, Dept Inorgan Chem, UA-01601 Kiev, Ukraine.
RP Lysenko, O (reprint author), Bogomolets Natl Med Univ, Dept Therapeut Stomatol, 34 Peremohy Ave, UA-01601 Kiev, Ukraine.
EM dr.alex.lysenko@gmail.com
FU Branch target preparation Kyiv National Taras Shevchenko University,
   NAMS of Ukraine [0114U003876]
FX The authors gratefully acknowledge the support of Dr. Olena Voloshuk
   from Bogomolets National Medical University (Ukraine), the Department of
   Microbiology, Virology, and Immunology. Dmytro Zubov, leading researcher
   and Roman Vasyliev, researcher from State Institute of Genetic and
   Regenerative Medicine of NAMS (Ukraine), in the implementation phases of
   the study. We express profound gratitude to Prof. Anatolii Levitskyi for
   the access to biochemical laboratory and vivarium facilities at State
   Institute of Stomatology of NAMS (Odesa, Ukraine). This project is
   financially supported by Branch target preparation Kyiv National Taras
   Shevchenko University, NAMS of Ukraine (Grant No. 0114U003876).
CR [Anonymous], 2009, 109935 ISO
   Balagna C, 2011, J BIOMATER APPL, V25, P595, DOI 10.1177/0885328209356603
   Balamurugan A, 2008, DENT MATER, V24, P1343, DOI 10.1016/j.dental.2008.02.015
   Bancroft JD, 1990, THEORY PRACTICE HIST
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Chen JD, 2011, MATER LETT, V65, P1923, DOI 10.1016/j.matlet.2011.03.076
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Dodwad V, 2012, INT J PHARM PHARM SC, V4, P30
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03
   Ewald A, 2012, J BIOMED MATER RES A, V100A, P2392, DOI 10.1002/jbm.a.34184
   Fan J, 2007, MATER CHEM PHYS, V103, P489, DOI 10.1016/j.matchemphys.2007.02.069
   Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009
   Gupta A, 2001, MICROBIOL-SGM, V147, P3393, DOI 10.1099/00221287-147-12-3393
   HAMMOND JS, 1975, ANAL CHEM, V47, P2193, DOI 10.1021/ac60363a019
   Heitz-Mayfield L, 2006, J CLIN PERIODONTOL, V33, P62, DOI 10.1111/j.1600-051X.2005.00872.x
   Hsu YH, 2007, J MATER SCI-MATER M, V18, P2251, DOI 10.1007/s10856-007-3126-2
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Luthen F, 2010, MATER SCI FORUM, V638-642, P600, DOI 10.4028/www.scientific.net/MSF.638-642.600
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Munch E, 2008, JOM-US, V60, P54, DOI 10.1007/s11837-008-0072-5
   O'Donnell MD, 2008, ACTA BIOMATER, V4, P1455, DOI 10.1016/j.actbio.2008.04.018
   PARMIGIANI F, 1992, J ELECTRON SPECTROSC, V59, P255, DOI 10.1016/0368-2048(92)87005-7
   Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Rodriguez JP, 2002, J CELL BIOCHEM, V85, P92, DOI 10.1002/jcb.10111
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   SCHON G, 1973, ACTA CHEM SCAND, V27, P2623, DOI 10.3891/acta.chem.scand.27-2623
   Shanmugam S, 2014, CERAM INT, V40, P15655, DOI 10.1016/j.ceramint.2014.07.086
   Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2
   Sogo Y, 2004, MATER SCI TECH-LOND, V20, P1079, DOI 10.1179/026708304225019704
   Spence G, 2009, J BIOMED MATER RES A, V90A, P217, DOI 10.1002/jbm.a.32083
   STOSCHECK CM, 1990, METHODS ENZYMOL, V182, P50
   Thanyaphoo S, 2012, J PHARM SCI-US, V101, P2870, DOI 10.1002/jps.23230
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Xing ZC, 2010, BIOMACROMOLECULES, V11, P1248, DOI 10.1021/bm1000372
NR 39
TC 3
Z9 3
U1 3
U2 44
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD APR 10
PY 2015
VL 17
IS 4
AR 178
DI 10.1007/s11051-015-2971-z
PG 15
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CI9ZR
UT WOS:000355130900001
DA 2018-10-19
ER

PT J
AU Pascual-Gil, S
   Garbayo, E
   Diaz-Herraez, P
   Prosper, F
   Blanco-Prieto, MJ
AF Pascual-Gil, S.
   Garbayo, E.
   Diaz-Herraez, P.
   Prosper, F.
   Blanco-Prieto, M. J.
TI Heart regeneration after myocardial infarction using synthetic
   biomaterials
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Myocardial infarction; Cell therapy; Protein therapy; Clinical trials;
   Synthetic biomaterials; Delivery systems; Tissue engineering
ID STEM-CELL TRANSPLANTATION; IMPROVES CARDIAC-FUNCTION; ASSEMBLING PEPTIDE
   NANOFIBERS; FIBROBLAST-GROWTH-FACTOR; DRUG-DELIVERY; THERMOSENSITIVE
   HYDROGEL; INTRAMYOCARDIAL DELIVERY; CARDIOVASCULAR-DISEASES; INJECTABLE
   HYDROGEL; SUSTAINED-RELEASE
AB Myocardial infarction causes almost 7.3 million deaths each year worldwide. However, current treatments are more palliative than curative. Presently, cell and protein therapies are considered the most promising alternative treatments. Clinical trials performed until now have demonstrated that these therapies are limited by protein short half-life and by low transplanted cell survival rate, prompting the development of novel cell and protein delivery systems able to overcome such limitations. In this review we discuss the advances made in the last 10 years in the emerging field of cardiac repair using biomaterial-based delivery systems with focus on the progress made on preclinical in vivo studies. Then, we focus in cardiac tissue engineering approaches, and how the incorporation of both cells and proteins together into biomaterials has opened new horizons in the myocardial infarction treatment. Finally, the ongoing challenges and the perspectives for future work in cardiac tissue engineering will also be discussed. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Pascual-Gil, S.; Garbayo, E.; Diaz-Herraez, P.; Blanco-Prieto, M. J.] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain.
   [Prosper, F.] Univ Navarra, Univ Navarra Clin, Hematol Cardiol & Cell Therapy, E-31080 Pamplona, Spain.
   [Prosper, F.] Univ Navarra, Fdn Appl Med Res, E-31080 Pamplona, Spain.
RP Blanco-Prieto, MJ (reprint author), Univ Navarra, C Irunlarrea 1, E-31080 Pamplona, Spain.
EM mjblanco@unav.es
RI Prosper, Felipe/H-6859-2017; Garbayo, Elisa/V-1740-2017
OI Prosper, Felipe/0000-0001-6115-8790; Garbayo, Elisa/0000-0003-2049-4143;
   Pascual-Gil, Simon/0000-0003-0560-456X; Blanco-prieto, Maria
   J/0000-0003-0710-899X
FU Spanish Ministry of Economy and Competitiveness [SAF2013-42528-R];
   Fundacion Empresa Universidad de Navarra; Ibercaja; Spanish Ministry of
   Sciences and Innovations [JCI-2011-10737]; "Asociacion de Amigos de la
   Universidad de Navarra"
FX We gratefully acknowledge support from the Spanish Ministry of Economy
   and Competitiveness (SAF2013-42528-R), the Fundacion Empresa Universidad
   de Navarra, Ibercaja, the Spanish Ministry of Sciences and Innovations
   (JCI-2011-10737) and the "Asociacion de Amigos de la Universidad de
   Navarra".
CR ABRA RM, 1981, BIOCHIM BIOPHYS ACTA, V666, P493, DOI 10.1016/0005-2760(81)90311-8
   Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102
   AMBROSIO G, 1986, CIRCULATION, V74, P1424, DOI 10.1161/01.CIR.74.6.1424
   Anselmo A.C., 2014, J CONTROL RELEASE
   Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068
   Armstead VE, 1997, FASEB J, V11, P1271
   Aso SI, 2007, J CONTROL RELEASE, V122, P189, DOI 10.1016/j.jconrel.2007.07.003
   Bearzi C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.12
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bernal A, 2013, STEM CELL REV REP, V9, P814, DOI 10.1007/s12015-013-9461-4
   Blumenthal B, 2010, ARTIF ORGANS, V34, pE46, DOI 10.1111/j.1525-1594.2009.00937.x
   Braunschweig F, 2011, EUROPACE, V13, pII13, DOI 10.1093/europace/eur081
   Castellano D, 2014, STEM CELLS DEV, V23, P1479, DOI 10.1089/scd.2013.0578
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Charoenphol P, 2010, BIOMATERIALS, V31, P1392, DOI 10.1016/j.biomaterials.2009.11.007
   Cheng AY, 2013, CURR OPIN BIOTECH, V24, P864, DOI 10.1016/j.copbio.2013.04.005
   Cochain C, 2013, ANTIOXID REDOX SIGN, V18, P1100, DOI 10.1089/ars.2012.4849
   Cui XJ, 2010, TOHOKU J EXP MED, V222, P281, DOI 10.1620/tjem.222.281
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Diaz-Herraez P, 2013, EUR J PHARM BIOPHARM, V85, P143, DOI 10.1016/j.ejpb.2013.03.022
   Diaz-Herraez P., 2014, DRUG DELIV INTEGR CL
   Doppler SA, 2013, J THORAC DIS, V5, P683, DOI 10.3978/j.issn.2072-1439.2013.08.71
   Du J, 2013, ENVIRON TOXICOL PHAR, V36, P451, DOI 10.1016/j.etap.2013.05.007
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Fathi E, 2013, J TISSUE ENG REGEN M, V7, P697, DOI 10.1002/term.1460
   Formiga FR, 2013, EUR J PHARM BIOPHARM, V85, P665, DOI 10.1016/j.ejpb.2013.02.017
   Formiga FR, 2012, HEART FAIL REV, V17, P449, DOI 10.1007/s10741-011-9285-8
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Fornasini M, 2010, AM J MED, V123, P166, DOI 10.1016/j.amjmed.2009.06.031
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2007, ANN THORAC SURG, V83, P648, DOI 10.1016/j.athoracsur.2006.06.085
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fukuhara S, 2005, CIRC J, V69, P850, DOI 10.1253/circj.69.850
   Garbayo E., CONTROLLED INT UNPUB
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Garg T, 2011, INT J PHARM SCI RES, V2, P1600, DOI 10.13040/IJPSR.0975-8232.2(6).1600-02
   Gho JMIH, 2013, J CARD FAIL, V19, P494, DOI 10.1016/j.cardfail.2013.05.006
   Giraud MN, 2010, ARTIF ORGANS, V34, pE184, DOI 10.1111/j.1525-1594.2009.00979.x
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gray WD, 2011, J CARDIOVASC TRANSL, V4, P631, DOI 10.1007/s12265-011-9292-0
   Grimaldi V, 2013, J CARDIOL, V62, P267, DOI 10.1016/j.jjcc.2013.05.017
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Guo HD, 2010, BIOCHEM BIOPH RES CO, V399, P42, DOI 10.1016/j.bbrc.2010.07.031
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108
   Hastings C.L., 2014, ADV DRUG DELIV REV
   He YY, 2013, J CARDIOVASC PHARM, V61, P283, DOI 10.1097/FJC.0b013e31827ecd50
   Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024
   Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Immordino ML, 2006, INT J NANOMED, V1, P297
   Jay SM, 2013, CIRC RES, V113, P933, DOI 10.1161/CIRCRESAHA.113.300215
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kaila N, 2002, MED RES REV, V22, P566, DOI 10.1002/med.10018
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kanashiro-Takeuchi RM, 2011, J MOL CELL CARDIOL, V51, P619, DOI 10.1016/j.yjmcc.2011.05.015
   Ke Qingen, 2005, Shengli Xuebao, V57, P673
   Kiani MF, 2002, PHARM RES-DORDR, V19, P1317, DOI 10.1023/A:1020350708672
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Koudstaal S, 2014, J CARDIOVASC TRANSL, V7, P232, DOI 10.1007/s12265-013-9518-4
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kumar D, 2013, EXPERT OPIN DRUG DEL, V10, P397, DOI 10.1517/17425247.2013.749854
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304
   Lakshmanan R, 2013, MACROMOL BIOSCI, V13, P1119, DOI 10.1002/mabi.201300223
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   Lammers T, 2010, MOL PHARMACEUT, V7, P1899, DOI 10.1021/mp100228v
   LAURENT TC, 1992, FASEB J, V6, P2397
   Levchenko TS, 2012, THER DELIV, V3, P501, DOI 10.4155/TDE.12.18
   Li X, 2014, BIOMATERIALS, V35, P5679, DOI 10.1016/j.biomaterials.2014.03.067
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Littarru GP, 2011, BIOFACTORS, V37, P366, DOI 10.1002/biof.154
   MacArthur JW, 2013, CIRCULATION, V128, pS79, DOI 10.1161/CIRCULATIONAHA.112.000343
   Mathaes R, 2014, INT J PHARMACEUT, V465, P159, DOI 10.1016/j.ijpharm.2014.02.037
   Mayfield AE, 2014, BIOMATERIALS, V35, P133, DOI 10.1016/j.biomaterials.2013.09.085
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Mendis S, 2011, GLOBAL ATLAS CARDIOV
   Meng E, 2012, THER DELIV, V3, P1457, DOI [10.4155/tde.12.132, 10.4155/TDE.12.132]
   Meng J, 2012, CURR DRUG METAB, V13, P1123, DOI 10.2174/138920012802850056
   Miyagi Y, 2010, BIOMATERIALS, V31, P7684, DOI 10.1016/j.biomaterials.2010.06.048
   MOGHIMI SM, 1991, BIOCHEM BIOPH RES CO, V177, P861, DOI 10.1016/0006-291X(91)91869-E
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Mufamadi M. S., 2011, J DRUG DELIV, V2011, DOI DOI 10.1155/2011/939851
   Oh KS, 2010, J CONTROL RELEASE, V146, P207, DOI 10.1016/j.jconrel.2010.04.014
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Poppe A, 2012, ARTIF ORGANS, V36, P238, DOI 10.1111/j.1525-1594.2011.01328.x
   Projahn D, 2014, J CELL MOL MED, V18, P790, DOI 10.1111/jcmm.12225
   Ravichandran R, 2012, INT J NANOMED, V7, P5969, DOI 10.2147/IJN.S37575
   Ren S, 2012, J INT MED RES, V40, P2167, DOI 10.1177/030006051204000615
   Ruiz-Esparza GU, 2013, INT J NANOMED, V8, P629, DOI 10.2147/IJN.S30599
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219
   Schulman IH, 2012, REGEN MED, V7, P17, DOI 10.2217/RME.12.80
   Scott RC, 2007, BIOTECHNOL BIOENG, V96, P795, DOI 10.1002/bit.21233
   Scott RC, 2009, FASEB J, V23, P3361, DOI 10.1096/fj.08-127373
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Seshadri G, 2010, BIOMATERIALS, V31, P1372, DOI 10.1016/j.biomaterials.2009.10.045
   Sheng C.C., 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/547902
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Simon-Yarza T., 2015, TISSUE ENG IN PRESS
   Simon-Yarza T, 2013, INT J PHARMACEUT, V454, P784, DOI 10.1016/j.ijpharm.2013.04.015
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Smits AM, 2005, J CELL MOL MED, V9, P25, DOI 10.1111/j.1582-4934.2005.tb00334.x
   Srivastava D, 2012, ANN NY ACAD SCI, V1270, P66, DOI 10.1111/j.1749-6632.2012.06696.x
   Sun Xiaolun, 2012, J Cardiovasc Dis Res, V3, P251, DOI 10.4103/0975-3583.102688
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Sy JC, 2010, J CARDIOVASC TRANSL, V3, P461, DOI 10.1007/s12265-010-9210-x
   Takehara Naofumi, 2013, Ann Vasc Dis, V6, P137, DOI 10.3400/avd.ra.13.00019
   Tang CK, 2009, INT J MOL SCI, V10, P2136, DOI 10.3390/ijms10052136
   Tokunaga M, 2010, J MOL CELL CARDIOL, V49, P972, DOI 10.1016/j.yjmcc.2010.09.015
   Torchilin V.P., 2010, HDB EXP PHARM
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Toyoda Y, 2013, CIRC J, V77, P1097, DOI 10.1253/circj.CJ-13-0296
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   van der Laan AM, 2009, NAT REV CARDIOL, V6, P515, DOI 10.1038/nrcardio.2009.103
   von Wattenwyl R, 2012, ASAIO J, V58, P268, DOI 10.1097/MAT.0b013e3182523237
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang B, 2013, ADV EXP MED BIOL, V765, P307, DOI 10.1007/978-1-4614-4989-8_43
   Wang HB, 2012, J CELL MOL MED, V16, P1310, DOI 10.1111/j.1582-4934.2011.01409.x
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wang Y, 2009, TEX HEART I J, V36, P89
   Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350
   Webber MJ, 2010, J TISSUE ENG REGEN M, V4, P600, DOI 10.1002/term.273
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Xia LW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3226
   Yamada Y, 2013, AM J PHYSIOL-HEART C, V304, pH1124, DOI 10.1152/ajpheart.00707.2012
   Yasuda S, 2000, J AM COLL CARDIOL, V36, P115, DOI 10.1016/S0735-1097(00)00675-6
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 155
TC 42
Z9 43
U1 5
U2 125
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD APR 10
PY 2015
VL 203
BP 23
EP 38
DI 10.1016/j.jconrel.2015.02.009
PG 16
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CE3AP
UT WOS:000351696600003
PM 25665866
DA 2018-10-19
ER

PT J
AU Chapman, CAR
   Chen, H
   Stamou, M
   Biener, J
   Biener, MM
   Lein, PJ
   Seker, E
AF Chapman, Christopher A. R.
   Chen, Hao
   Stamou, Marianna
   Biener, Juergen
   Biener, Monika M.
   Lein, Pamela J.
   Seker, Erkin
TI Nanoporous Gold as a Neural Interface Coating: Effects of Topography,
   Surface Chemistry, and Feature Size
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE neural electrode; nanostructure; cell-material interaction; nanoporous
   gold; neuron-astrocyte co-culture; nanotopography; multifunctional
   biomaterial; gliosis
ID MECHANICAL-PROPERTIES; CATALYTIC-ACTIVITY; MOLECULAR RELEASE;
   GENE-EXPRESSION; ELECTRODES; BIOMATERIALS; ACTIVATION; NEURONS;
   MICROFABRICATION; HIPPOCAMPAL
AB Designing neural interfaces that maintain close physical coupling of neurons to an electrode surface remains a major challenge for both implantable and in vitro neural recording electrode arrays. Typically, low-impedance nanostructured electrode coatings rely on chemical cues from pharmaceuticals or surface-immobilized peptides to suppress glial scar tissue formation over the electrode surface (astrogliosis), which is an obstacle to reliable neuron-electrode coupling. Nanoporous gold (np-Au), produced by an alloy corrosion process, is a promising candidate to reduce astrogliosis solely through topography by taking advantage of its tunable length scale. In the present in vitro study on np-Aus interaction with cortical neuron-glia co-cultures, we demonstrate that the nanostructure of np-Au achieves close physical coupling of neurons by maintaining a high neuron-to-astrocyte surface coverage ratio. Atomic layer deposition-based surface modification was employed to decouple the effect of morphology from surface chemistry. Additionally, length scale effects were systematically studied by controlling the characteristic feature size of np-Au through variations in the dealloying conditions. Our results show that np-Au nanotopography, not surface chemistry, reduces astrocyte surface coverage while maintaining high neuronal coverage and may enhance neuron-electrode coupling through nanostructure-mediated suppression of scar tissue formation.
C1 [Chapman, Christopher A. R.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Chen, Hao; Stamou, Marianna; Lein, Pamela J.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.
   [Seker, Erkin] Univ Calif Davis, Dept Elect & Comp Engn, Davis, CA 95616 USA.
   [Biener, Juergen; Biener, Monika M.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Seker, E (reprint author), Univ Calif Davis, Dept Elect & Comp Engn, 3177 Kemper Hall, Davis, CA 95616 USA.
EM eseker@ucdavis.edu
OI Seker, Erkin/0000-0003-2401-3562; Chapman, Christopher Abbott
   Reece/0000-0002-9009-0139; Lein, Pamela/0000-0001-7665-7584
FU UC Lab Fees Research Program Award [12-LR-237197]; Research Investments
   in the Sciences & Engineering (RISE) Award; UC Davis College of
   Engineering; National Science Foundation [DGE-1148897]; National
   Institute of Health [T32-GM008799]; CounterACT Program; National
   Institutes of Health Office of the Director; National Institute of
   Neurological Disorders and Stroke [U54 NS079202]; National Institute of
   Environmental Health Sciences [T32 ES007059]; Superfund Basic Research
   Program [P42 ES04699]; U.S. DOE [DE-AC52-07NA27344]
FX We gratefully acknowledge support from UC Lab Fees Research Program
   Award [12-LR-237197], Research Investments in the Sciences & Engineering
   (RISE) Award, and UC Davis College of Engineering start-up funds.
   C.A.R.C. was supported by a National Science Foundation Graduate
   Research Fellowship [DGE-1148897] and a predoctoral fellowship from the
   National Institute of Health [T32-GM008799]. Support was also provided
   by the CounterACT Program, National Institutes of Health Office of the
   Director, and the National Institute of Neurological Disorders and
   Stroke [U54 NS079202]. H.C. was supported by a predoctoral fellowship
   from the National Institute of Environmental Health Sciences [T32
   ES007059]; H.C. and M.S. received predoctoral fellowships from the
   Superfund Basic Research Program [P42 ES04699]. Any opinion, findings,
   and conclusions or recommendations expressed in this material are those
   of the authors(s) and do not necessarily reflect the views of the
   National Science Foundation or the National Institutes of Health. Work
   at LLNL was performed under the auspices of the U.S. DOE by LLNL
   [Contract DE-AC52-07NA27344].
CR ARENDS MJ, 1990, AM J PATHOL, V136, P593
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Biener MM, 2011, NANO LETT, V11, P3085, DOI 10.1021/nl200993g
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   BILLINGSLEY ML, 1982, J PHARMACOL EXP THER, V222, P765
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   Bruggemann Dorothea, 2012, International Journal of Nano and Biomaterials, V4, P108
   Bruggemann D., 2013, J NANOMATER, V2013
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Daggumati P, 2013, JOVE-J VIS EXP, DOI 10.3791/50678
   Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340
   Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709
   Ereifej ES, 2011, J BIOMED MATER RES A, V99A, P141, DOI 10.1002/jbm.a.33170
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496
   Feng JD, 2011, BIOSENS BIOELECTRON, V30, P21, DOI 10.1016/j.bios.2011.08.021
   Fujita T, 2012, NAT MATER, V11, P775, DOI [10.1038/nmat3391, 10.1038/NMAT3391]
   George SM, 2010, CHEM REV, V110, P111, DOI 10.1021/cr900056b
   Gittard SD, 2010, BIOTECHNOL J, V5, P192, DOI 10.1002/biot.200900250
   Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970
   Hodge AM, 2006, ADV ENG MATER, V8, P853, DOI 10.1002/adem.200600079
   Howard AS, 2003, TOXICOL APPL PHARM, V190, P72, DOI 10.1016/S0041-008X(03)00156-X
   Huang CL, 2015, ENVIRON RES, V136, P253, DOI 10.1016/j.envres.2014.11.006
   Ilic B, 2000, J MATER SCI, V35, P3447, DOI 10.1023/A:1004884723515
   Jin HJ, 2011, SCIENCE, V332, P1179, DOI 10.1126/science.1202190
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kurtulus O, 2014, NANOSCALE, V6, P7062, DOI 10.1039/c4nr01288g
   Lee D, 2007, SCRIPTA MATER, V56, P437, DOI 10.1016/j.scriptamat.2006.08.069
   Li K, 2011, ANAL LETT, V44, P2559, DOI 10.1080/00032719.2011.553004
   Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Morgan JT, 2013, EXP EYE RES, V115, P1, DOI 10.1016/j.exer.2013.06.012
   Patel J, 2013, ANAL CHEM, V85, P11610, DOI 10.1021/ac403013r
   Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Santos GM, 2014, NANOSCALE, V6, P5718, DOI 10.1039/c4nr01266f
   Schade L, 2014, LANGMUIR, V30, P7190, DOI 10.1021/la5011192
   Seker E., 2010, NANOTECHNOLOGY, V21, P1
   Seker E, 2012, ADV HEALTHC MATER, V1, P172, DOI 10.1002/adhm.201200002
   Seker E, 2009, MATERIALS, V2, P2188, DOI 10.3390/ma2042188
   Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037
   Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/NNANO.2012.265, 10.1038/nnano.2012.265]
   Squire L. R., 2008, FUNDAMENTAL NEUROSCI, V4
   Tan YH, 2014, BIOMATER SCI-UK, V2, P110, DOI 10.1039/c3bm60096c
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Wessling B., 2007, J ELECTROCHEM SOC, V154, P83
   Woolley A. J., 2013, J NEURAL ENG, V10, P1
   Zalups R. K., 2000, MOL BIOL TOXICOLOGY, V1, P609
NR 52
TC 36
Z9 36
U1 3
U2 74
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 8
PY 2015
VL 7
IS 13
BP 7093
EP 7100
DI 10.1021/acsami.5b00410
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF7QQ
UT WOS:000352751800008
PM 25706691
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mullen, CA
   Vaughan, TJ
   Billiar, KL
   McNamara, LM
AF Mullen, Conleth A.
   Vaughan, Ted J.
   Billiar, Kristen L.
   McNamara, Laoise M.
TI The Effect of Substrate Stiffness, Thickness, and Cross-Linking Density
   on Osteogenic Cell Behavior
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; AVERAGING THEORY;
   MC3T3-E1 CELLS; FAR CELLS; COLLAGEN; DIFFERENTIATION; PROLIFERATION;
   SCAFFOLDS; OSTEOCYTE
AB Osteogenic cells respond to mechanical changes in their environment by altering their spread area, morphology, and gene expression profile. In particular, the bulk modulus of the substrate, as well as its microstructure and thickness, can substantially alter the local stiffness experienced by the cell. Although bone tissue regeneration strategies involve culture of bone cells on various biomaterial scaffolds, which are often cross-linked to enhance their physical integrity, it is difficult to ascertain and compare the local stiffness experienced by cells cultured on different biomaterials. In this study, we seek to characterize the local stiffness at the cellular level for MC3T3-E1 cells plated on biomaterial substrates of varying modulus, thickness, and cross-linking concentration. Cells were cultured on flat and wedge-shaped gels made from polyacrylamide or cross-linked collagen. The cross-linking density of the collagen gels was varied to investigate the effect of fiber cross-linking in conjunction with substrate thickness. Cell spread area was used as a measure of osteogenic differentiation. Finite element simulations were used to examine the effects of fiber cross-linking and substrate thickness on the resistance of the gel to cellular forces, corresponding to the equivalent shear stiffness for the gel structure in the region directly surrounding the cell. The results of this study show that MC3T3 cells cultured on a soft fibrous substrate attain the same spread cell area as those cultured on a much higher modulus, but nonfibrous substrate. Finite element simulations predict that a dramatic increase in the equivalent shear stiffness of fibrous collagen gels occurs as cross-linking density is increased, with equivalent stiffness also increasing as gel thickness is decreased. These results provide an insight into the response of osteogenic cells to individual substrate parameters and have the potential to inform future bone tissue regeneration strategies that can optimize the equivalent stiffness experienced by a cell.
C1 [Mullen, Conleth A.; Vaughan, Ted J.; McNamara, Laoise M.] NUI Galway, Dept Biomed Engn, Ctr Biomech Res BMEC, Galway, Ireland.
   [Mullen, Conleth A.; McNamara, Laoise M.] NUI Galway, NCBES, Galway, Ireland.
   [Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
RP McNamara, LM (reprint author), NUI Galway, Dept Biomed Engn, Ctr Biomech Res BMEC, Galway, Ireland.
EM laoise.mcnamara@nuigalway.ie
OI McNamara, Laoise/0000-0002-5050-9230
CR Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02
   Bitar M, 2007, J MATER SCI-MATER M, V18, P237, DOI 10.1007/s10856-006-0685-1
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Driessen NJB, 2003, J BIOMECH, V36, P1151, DOI 10.1016/S0021-9290(03)00082-4
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Feng CH, 2013, ACTA BIOMATER, V9, P5502, DOI 10.1016/j.actbio.2012.11.024
   Fischer RS, 2012, NAT PROTOC, V7, P2056, DOI 10.1038/nprot.2012.127
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Huang CJ, 2013, NANO LETT, V13, P1611, DOI 10.1021/nl400033h
   Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Khatiwala C. B., 2006, AM I CHEM ENG ANN M
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim HW, 2005, J MATER SCI-MATER M, V16, P189, DOI 10.1007/s10856-005-6679-y
   Lahiri D, 2011, J BIOMED MATER RES A, V96A, P1, DOI 10.1002/jbm.a.32952
   Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052
   Ma XY, 2013, BIOPHYS J, V104, P1410, DOI 10.1016/j.bpj.2013.02.017
   Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923
   Mante F, 1999, BIOMATERIALS, V20, P1051, DOI 10.1016/S0142-9612(98)00257-9
   McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003
   Mullen CA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0885
   Mullen CA, 2013, J MECH BEHAV BIOMED, V28, P183, DOI 10.1016/j.jmbbm.2013.06.013
   Papachroni KK, 2009, TRENDS MOL MED, V15, P208, DOI 10.1016/j.molmed.2009.03.001
   Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Rudnicki MS, 2013, BIOPHYS J, V105, P11, DOI 10.1016/j.bpj.2013.05.032
   SAIDI IS, 1995, APPL OPTICS, V34, P7410, DOI 10.1364/AO.34.007410
   Santos A, 2009, OSTEOPOROSIS INT, V20, P1027, DOI 10.1007/s00198-009-0858-5
   Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z
   Song W., 2011, J NANOMATER
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200
   Tse J.R., 2001, CURRENT PROTOCOLS CE
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Weyts FAA, 2003, CALCIFIED TISSUE INT, V72, P505, DOI 10.1007/s00223-002-2027-0
   You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047
NR 48
TC 19
Z9 19
U1 2
U2 33
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD APR 7
PY 2015
VL 108
IS 7
BP 1604
EP 1612
DI 10.1016/j.bpj.2015.02.022
PG 9
WC Biophysics
SC Biophysics
GA CF4DF
UT WOS:000352498100008
PM 25863052
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Autefage, H
   Gentleman, E
   Littmann, E
   Hedegaard, MAB
   Von Erlach, T
   O'Donnell, M
   Burden, FR
   Winkler, DA
   Stevens, MM
AF Autefage, Helene
   Gentleman, Eileen
   Littmann, Elena
   Hedegaard, Martin A. B.
   Von Erlach, Thomas
   O'Donnell, Matthew
   Burden, Frank R.
   Winkler, David A.
   Stevens, Molly M.
TI Sparse feature selection methods identify unexpected global cellular
   response to strontium-containing materials
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE strontium-releasing biomaterials; human mesenchymal stem cells;
   microarray analysis; sparse feature selection analysis; mevalonate
   pathway
ID MESENCHYMAL STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; OSTEOBLAST
   DIFFERENTIATION; MOLECULAR-MECHANISMS; DESCRIPTOR SELECTION; SQUALENE
   SYNTHASE; LIPID RAFTS; RANELATE; OSTEOPOROSIS; CHOLESTEROL
AB Despite the increasing sophistication of biomaterials design and functional characterization studies, little is known regarding cells' global response to biomaterials. Here, we combined nontargeted holistic biological and physical science techniques to evaluate how simple strontium ion incorporation within the well-described biomaterial 45S5 bioactive glass (BG) influences the global response of human mesenchymal stem cells. Our objective analyses of whole gene-expression profiles, confirmed by standard molecular biology techniques, revealed that strontium-substituted BG up-regulated the isoprenoid pathway, suggesting an influence on both sterol metabolite synthesis and protein prenylation processes. This up-regulation was accompanied by increases in cellular and membrane cholesterol and lipid raft contents as determined by Raman spectroscopy mapping and total internal reflection fluorescence microscopy analyses and by an increase in cellular content of phosphorylated myosin II light chain. Our unexpected findings of this strong metabolic pathway regulation as a response to biomaterial composition highlight the benefits of discovery-driven nonreductionist approaches to gain a deeper understanding of global cell-material interactions and suggest alternative research routes for evaluating biomaterials to improve their design.
C1 [Autefage, Helene; Gentleman, Eileen; Littmann, Elena; Hedegaard, Martin A. B.; Von Erlach, Thomas; O'Donnell, Matthew; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Autefage, Helene; Gentleman, Eileen; Littmann, Elena; Hedegaard, Martin A. B.; Von Erlach, Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England.
   [Autefage, Helene; Gentleman, Eileen; Littmann, Elena; Hedegaard, Martin A. B.; Von Erlach, Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
   [Gentleman, Eileen] Kings Coll London, Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England.
   [Hedegaard, Martin A. B.] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, DK-5230 Odense, Denmark.
   [Burden, Frank R.; Winkler, David A.] CSIRO, Mfg Flagship, Biomed Mfg Program, Cell Biol Grp, Clayton, Vic 3168, Australia.
   [Winkler, David A.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.
   [Winkler, David A.] La Trobe Univ, Latrobe Inst Mol Sci, Bundoora, Vic 3086, Australia.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM stevens@imperial.ac.uk
OI Winkler, Dave/0000-0002-7301-6076; Winkler, David
   Alan/0000-0003-2423-674X; Hedegaard, Martin A.B./0000-0003-2972-0899;
   Gentleman, Eileen/0000-0003-0447-5137
FU Medical Engineering Solutions in Osteoarthritis Centre of Excellence -
   Wellcome Trust; Engineering and Physical Sciences Research Council;
   Technology Strategy Board, United Kingdom; Rosetrees Trust; Wellcome
   Trust; European Commission [289958]; Danish Council for Independent
   Research (Technology and Production Sciences) [0602-02350B]; Newton
   Turner Fellowship
FX We thank Ms. S. Skeete for laboratory assistance; Dr. S. Sampson and
   Prof. T. Cass for providing equipment access and training; Dr. L. Game
   and Ms. N. Lambie, from the Genomics Laboratory of the Clinical Science
   Center, Imperial College London, for advice regarding the design of the
   microarray experiment and for the ChIP hybridization and scanning,
   respectively; and Dr. G. R. Barton from the Bioinformatics Support
   Service, Imperial College London, for statistical analysis and
   assistance in the analysis of the microarray dataset and the study
   design. M.M.S. and H.A. were supported by the Medical Engineering
   Solutions in Osteoarthritis Centre of Excellence funded by the Wellcome
   Trust and the Engineering and Physical Sciences Research Council. M.M.S.
   was also supported by the Technology Strategy Board, United Kingdom, and
   the Rosetrees Trust. H.A. was partially supported by the VIP award from
   the Wellcome Trust. E.L. was supported by European Commission funding
   under the 7th Framework Programme Marie Curie Initial Training Networks
   Grant 289958, bioceramics for bone repair. E.G. is supported by a
   Research Career Development Fellowship from the Wellcome Trust. M.A.B.H.
   was partially supported by The Danish Council for Independent Research
   (Technology and Production Sciences contract 0602-02350B). D.A.W. is the
   recipient of a Newton Turner Fellowship for Exceptional Senior
   Scientists.
CR Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   Brancolini C, 1999, MOL BIOL CELL, V10, P2441, DOI 10.1091/mbc.10.7.2441
   Brusselmans K, 2007, J BIOL CHEM, V282, P18777, DOI 10.1074/jbc.M611763200
   Burden FR, 2009, QSAR COMB SCI, V28, P645, DOI 10.1002/qsar.200810173
   Burden FR, 2009, QSAR COMB SCI, V28, P1092, DOI 10.1002/qsar.200810202
   Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6
   del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571
   Do R, 2009, CLIN GENET, V75, P19, DOI 10.1111/j.1399-0004.2008.01099.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Figueiredo MAT, 2003, IEEE T PATTERN ANAL, V25, P1150, DOI 10.1109/TPAMI.2003.1227989
   Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gentleman MM, 2014, INT MATER REV, V59, P417, DOI 10.1179/1743280414Y.0000000038
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Hasse B, 2002, J NEUROSCI RES, V69, P227, DOI 10.1002/jnr.10287
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]
   Lo T, 2012, J PROTEOME RES, V11, P586, DOI 10.1021/pr200868p
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200
   Newman SD, 2014, TISSUE ENG PT A, V20, P1850, DOI [10.1089/ten.tea.2013.0304, 10.1089/ten.TEA.2013.0304]
   O'Donnell MD, 2010, J MATER CHEM, V20, P8934, DOI 10.1039/c0jm01139h
   Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   Reyes JMG, 2006, STEM CELLS, V24, P1213, DOI 10.1634/stemcells.2004-0324
   Rosemond E, 2011, MOL PHARMACOL, V79, P251, DOI 10.1124/mol.110.067363
   Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Stepan JJ, 2013, J BONE MINER METAB, V31, P606, DOI 10.1007/s00774-013-0494-1
   Swain RJ, 2007, BIOCHEM SOC T, V35, P544, DOI 10.1042/BST0350544
   Swain RJ, 2008, J CELL BIOCHEM, V104, P1427, DOI 10.1002/jcb.21720
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m
   Wustner D, 2007, CHEM PHYS LIPIDS, V146, P1, DOI 10.1016/j.chemphyslip.2006.12.004
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zoltewicz SJ, 2012, ASN NEURO, V4, DOI 10.1042/AN20120045
NR 48
TC 27
Z9 27
U1 2
U2 22
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 7
PY 2015
VL 112
IS 14
BP 4280
EP 4285
DI 10.1073/pnas.1419799112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CF1EZ
UT WOS:000352287800040
PM 25831522
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Di Buduo, CA
   Wray, LS
   Tozzi, L
   Malara, A
   Chen, Y
   Ghezzi, CE
   Smoot, D
   Sfara, C
   Antonelli, A
   Spedden, E
   Bruni, G
   Staii, C
   De Marco, L
   Magnani, M
   Kaplan, DL
   Balduini, A
AF Di Buduo, Christian A.
   Wray, Lindsay S.
   Tozzi, Lorenzo
   Malara, Alessandro
   Chen, Ying
   Ghezzi, Chiara E.
   Smoot, Daniel
   Sfara, Carla
   Antonelli, Antonella
   Spedden, Elise
   Bruni, Giovanna
   Staii, Cristian
   De Marco, Luigi
   Magnani, Mauro
   Kaplan, David L.
   Balduini, Alessandra
TI Programmable 3D silk bone marrow niche for platelet generation ex vivo
   and modeling of megakaryopoiesis pathologies
SO BLOOD
LA English
DT Article
ID HEMATOPOIETIC STEM-CELLS; IN-VITRO; VASCULAR NICHE; 3-DIMENSIONAL
   SCAFFOLDS; HUMAN MEGAKARYOCYTES; ENDOTHELIAL-CELLS; CORD BLOOD; FLOW;
   DIFFERENTIATION; THROMBOPOIESIS
AB We present a programmable bioengineered 3-dimensional silk-based bone marrow niche tissue system that successfully mimics the physiology of human bone marrow environment allowing us to manufacture functional human platelets ex vivo. Using stem/progenitor cells, megakaryocyte function and platelet generation were recorded in response to variations in extracellular matrix components, surface topography, stiffness, coculture with endothelial cells, and shear forces. Millions of human platelets were produced and showed to be functional based on multiple activation tests. Using adult hematopoietic progenitor cells our system demonstrated the ability to reproduce key steps of thrombopoiesis, including alterations observed in diseased states. A critical feature of the system is the use of natural silk protein biomaterial allowing us to leverage its biocompatibility, nonthrombogenic features, programmable mechanical properties, and surface binding of cytokines, extracellular matrix components, and endothelial-derived proteins. This in turn offers new opportunities for the study of blood component production ex vivo and provides a superior tissue system for the study of pathologic mechanisms of human platelet production.
C1 [Di Buduo, Christian A.; Wray, Lindsay S.; Tozzi, Lorenzo; Malara, Alessandro; Balduini, Alessandra] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [Di Buduo, Christian A.; Wray, Lindsay S.; Tozzi, Lorenzo; Malara, Alessandro; Balduini, Alessandra] San Matteo Fdn, Ist Ricovero & Cura Carattere Sci, Biotechnol Res Labs, Pavia, Italy.
   [Wray, Lindsay S.; Tozzi, Lorenzo; Chen, Ying; Ghezzi, Chiara E.; Smoot, Daniel; Kaplan, David L.; Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Sfara, Carla; Antonelli, Antonella; Magnani, Mauro] Univ Urbino Carlo Bo, Biochem & Mol Biol Sect, Dept Biomol Sci, Urbino, Italy.
   [Spedden, Elise; Staii, Cristian] Tufts Univ, Dept Phys, Medford, MA 02155 USA.
   [Bruni, Giovanna] Univ Pavia, Chem Phys Sect, Dept Chem, I-27100 Pavia, Italy.
   [De Marco, Luigi] Ctr Riferimento Oncol, Ist Ricovero & Cura Carattere Sci, Stem Cells Unit, Dept Translat Res, I-33081 Aviano, Italy.
   [De Marco, Luigi] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.
RP Balduini, A (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; alessandra.balduini@tufts.edu
RI Balduini, Alessandra/K-6802-2016; Di Buduo, Christian/G-4771-2018;
   malara, alessandro/K-4027-2016
OI Balduini, Alessandra/0000-0003-3145-1245; Di Buduo,
   Christian/0000-0002-6472-2008; malara, alessandro/0000-0002-3396-3693;
   Tozzi, Lorenzo/0000-0002-0679-5030; Bruni, Giovanna/0000-0003-1958-2998
FU Cariplo Foundation [2010-0807]; National Institutes of Health, National
   Institute of Biomedical Imaging and Bioengeneering [EB016041-01];
   Italian Ministry of Health [RF-2009-1550218, RF-2010-2316198]; Italian
   Ministry of University and Research; Fondo per gli Investimenti della
   Ricerca di Base [RBFR1299KO]; Associazione Italiana per la Ricerca sul
   Cancro (AIRC, Milano)
FX This work was supported by the Cariplo Foundation (2010-0807), National
   Institutes of Health, National Institute of Biomedical Imaging and
   Bioengeneering (grant EB016041-01), the Italian Ministry of Health
   (grants RF-2009-1550218 and RF-2010-2316198), the Italian Ministry of
   University and Research, Fondo per gli Investimenti della Ricerca di
   Base (RBFR1299KO), and by a grant from the Associazione Italiana per la
   Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical
   Oncology 5x1000" to AIRC-Gruppo Italiano Malattie Mieloproliferative
   (AGIMM).
CR Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973
   AVRAHAM H, 1993, J CLIN INVEST, V91, P2378, DOI 10.1172/JCI116470
   Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x
   Balduini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021015
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Cabrales P, 2008, AM J RESP CELL MOL, V38, P354, DOI 10.1165/rcmb.2007-0292OC
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Cramer EM, 1997, BLOOD, V89, P2336
   De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723
   Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010
   DeZern AE, 2014, ONCOLOGIST, V19, P735, DOI 10.1634/theoncologist.2014-0056
   Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829
   Feng Q, 2014, STEM CELL REP, V3, P817, DOI 10.1016/j.stemcr.2014.09.010
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Inoue S, 2001, ANAT RECORD, V264, P294, DOI 10.1002/ar.1166
   Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2
   Jiang JL, 2014, BLOOD, V124, P2094, DOI 10.1182/blood-2014-01-547927
   Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304
   KAUFMAN RM, 1965, BLOOD-J HEMATOL, V26, P720
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Lambert MP, 2013, BLOOD, V121, P3319, DOI 10.1182/blood-2012-09-455428
   Lasky LC, 2011, TISSUE ENG PART C-ME, V17, P1081, DOI 10.1089/ten.tec.2011.0108
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   MAGNANI M, 1989, BIOTECHNOL APPL BIOC, V11, P439
   Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626
   Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876
   Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795
   Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25
   Mazzucato M, 2004, BLOOD, V104, P3221, DOI 10.1182/blood-2004-03-1145
   Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Nakagawa Y, 2013, EXP HEMATOL, V41, P742, DOI 10.1016/j.exphem.2013.04.007
   Nakamura S, 2014, CELL STEM CELL, V14, P535, DOI 10.1016/j.stem.2014.01.011
   Ohta M, 1998, BLOOD, V91, P4074
   Pallotta I, 2011, TISSUE ENG PART C-ME, V17, P1223, DOI 10.1089/ten.tec.2011.0134
   Pitchford SC, 2012, BLOOD, V120, P2787, DOI 10.1182/blood-2011-09-378174
   RAFII S, 1995, BLOOD, V86, P3353
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553
   Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab
   Schlinker AC, 2015, BIOTECHNOL BIOENG, V112, P788, DOI 10.1002/bit.25477
   Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108
   Sullenbarger B, 2009, EXP HEMATOL, V37, P101, DOI 10.1016/j.exphem.2008.09.009
   Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622
   Thiele W, 2012, BLOOD, V120, P1899, DOI 10.1182/blood-2011-09-376657
   Thon JN, 2014, BLOOD, V124, P1857, DOI 10.1182/blood-2014-05-574913
   Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]
   TUSZYNSKI GP, 1984, J BIOL CHEM, V259, P5247
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
NR 60
TC 55
Z9 56
U1 3
U2 27
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD APR 2
PY 2015
VL 125
IS 14
BP 2254
EP 2264
DI 10.1182/blood-2014-08-595561
PG 11
WC Hematology
SC Hematology
GA CI3DD
UT WOS:000354626900013
PM 25575540
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Muller, EA
   Pollard, B
   Raschke, MB
AF Muller, Eric A.
   Pollard, Benjamin
   Raschke, Markus B.
TI Infrared Chemical Nano-Imaging: Accessing Structure, Coupling, and
   Dynamics on Molecular Length Scales
SO JOURNAL OF PHYSICAL CHEMISTRY LETTERS
LA English
DT Article
ID NEAR-FIELD MICROSCOPY; OPTICAL MICROSCOPY; SPATIAL-RESOLUTION;
   ANALYTICAL-MODEL; IR SPECTROSCOPY; SCATTERING; TIP; NANOSPECTROSCOPY;
   ABSORPTION; SURFACE
AB This Perspective highlights recent advances in infrared vibrational chemical nano-imaging. In its implementations of scattering scanning near-field optical microscopy (s-SNOM) and phototherrnal-induced resonance (PTIR), IR nanospectroscopy provides few-nanometer spatial resolution for the investigation of polymer, biomaterial, and related soft-matter surfaces and nanostructures. Broad-band IR s-SNOM with coherent laser and synchrotron sources allows for chemical recognition with small ensemble sensitivity and the potential for sensitivity reaching the single molecule limit Probing selected vibrational marker resonances, it gives access to nanoscale chemical imaging of composition, domain morphologies, order/disorder, molecular orientation, or crystallographic phases. Local intra- and intermolecular coupling can be measured through frequency shifts of a vibrational marker in heterogeneous environments and associated inhomogeneities in vibrational dephasing. In combination with ultrafast spectroscopy, the vibrational coherent evolution of homogeneous sub-ensembles coupled to their environment can be observed. Outstanding challenges are discussed in terms of extensions to coherent and multidimensional spectroscopies, implementation in liquid and in situ environments, general sample limitations, and engineering s-SNOM scanning probes to better control the nano localized optical excitation and to increase sensitivity.
C1 [Raschke, Markus B.] Univ Colorado, Dept Chem, Dept Phys, Boulder, CO 80309 USA.
   Univ Colorado, JILA, Boulder, CO 80309 USA.
RP Raschke, MB (reprint author), Univ Colorado, Dept Chem, Dept Phys, Boulder, CO 80309 USA.
EM markus.raschke@colorado.edu
RI Muller, Eric/J-2161-2012; Raschke, Markus/F-8023-2013
OI Muller, Eric/0000-0002-9629-1767; Pollard, Benjamin/0000-0002-5109-6415
FU U.S. DOE [DEAC06-76RL01830]; Advanced Light Source; Office of Science,
   Office of Basic Energy Sciences of the U.S. Department of Energy
   [DE-AC02-05CH11231]; National Science Foundation (NSF) [CHE 1306398]
FX The authors thank Joanna Atkin, Hans Bechtel, Omar Khatib, Mike Martin,
   Scott Lea, and Tom Perkins for stimulating collaborations and
   discussions. M.B.R acknowledges support through a partner proposal with
   the Environmental Molecular Sciences Laboratory (EMSL), a national
   scientific user facility from the DOE Office of Biological and
   Environmental Research at Pacific Northwest National Laboratory (PNNL).
   PNNL is operated by Battelle for the U.S. DOE under Contract
   DEAC06-76RL01830. E.A.M. and M.B.R. thank the Advanced Light Source for
   support, which is supported by the Director, Office of Science, Office
   of Basic Energy Sciences, of the U.S. Department of Energy under
   Contract No. DE-AC02-05CH11231. Funding from the National Science
   Foundation (NSF Grant CHE 1306398) is gratefully acknowledged.
CR Ade H, 2009, NAT MATER, V8, P281, DOI [10.1038/NMAT2399, 10.1038/nmat2399]
   Akhremitchev BB, 2001, LANGMUIR, V17, P2774, DOI 10.1021/la001401v
   Amarie S, 2012, BEILSTEIN J NANOTECH, V3, P312, DOI 10.3762/bjnano.3.35
   Amenabar I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3890
   Atkin JM, 2012, ADV PHYS, V61, P745, DOI 10.1080/00018732.2012.737982
   Baiz CR, 2014, OPT EXPRESS, V22, P18724, DOI 10.1364/OE.22.018724
   Bechtel HA, 2014, P NATL ACAD SCI USA, V111, P7191, DOI 10.1073/pnas.1400502111
   Bensmann S, 2014, OPT EXPRESS, V22, P22369, DOI 10.1364/OE.22.022369
   Berweger S, 2013, J AM CHEM SOC, V135, P18292, DOI 10.1021/ja409815g
   Berweger S, 2011, NANO LETT, V11, P4309, DOI 10.1021/nl2023299
   BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468
   Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344
   Bloem R, 2010, OPT EXPRESS, V18, P27067, DOI 10.1364/OE.18.027067
   Brehm M, 2006, NANO LETT, V6, P1307, DOI 10.1021/nl0610836
   Calhoun TR, 2012, CHEM PHYS LETT, V523, P1, DOI 10.1016/j.cplett.2011.10.051
   Cvitkovic A, 2007, OPT EXPRESS, V15, P8550, DOI 10.1364/OE.15.008550
   Danckwerts M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026104
   Dazzi A, 2005, OPT LETT, V30, P2388, DOI 10.1364/OL.30.002388
   Donaldson PM, 2013, ANGEW CHEM INT EDIT, V52, P634, DOI 10.1002/anie.201204973
   Eisele M, 2014, NAT PHOTONICS, V8, P841, DOI [10.1038/NPHOTON.2014.225, 10.1038/nphoton.2014.225]
   Filimon M, 2011, PHYS CHEM CHEM PHYS, V13, P11620, DOI 10.1039/c0cp02756a
   Gomez L, 2006, J OPT SOC AM B, V23, P823, DOI 10.1364/JOSAB.23.000823
   Govyadinov AA, 2013, J PHYS CHEM LETT, V4, P1526, DOI 10.1021/jz400453r
   Hauer B, 2012, OPT EXPRESS, V20, P13173, DOI 10.1364/OE.20.013173
   Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395
   Hermann P, 2014, OPT EXPRESS, V22, P17948, DOI 10.1364/OE.22.017948
   Hitchcock AP, 2008, MICRON, V39, P311, DOI 10.1016/j.micron.2007.09.008
   Hoffmann JM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766178
   Huth F, 2011, NAT MATER, V10, P352, DOI [10.1038/nmat3006, 10.1038/NMAT3006]
   Huth F, 2013, NANO LETT, V13, P1065, DOI 10.1021/nl304289g
   Huth F, 2012, NANO LETT, V12, P3973, DOI 10.1021/nl301159v
   Ichimura T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220801
   INOUYE Y, 1994, OPT LETT, V19, P159, DOI 10.1364/OL.19.000159
   Katzenmeyer AM, 2013, ANAL CHEM, V85, P1972, DOI 10.1021/ac303620y
   Keilmann F, 2009, ART HSE NANO SCI ENG, P235
   Kjoller K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/18/185705
   Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154
   Kohlgraf-Owens DC, 2014, NANOPHOTONICS-BERLIN, V3, P105, DOI 10.1515/nanoph-2013-0056
   Lai ZZ, 2013, J PHYS CHEM B, V117, P4661, DOI 10.1021/jp309122b
   Lu F, 2014, NAT PHOTONICS, V8, P307, DOI [10.1038/nphoton.2013.373, 10.1038/NPHOTON.2013.373]
   Marcott C, 2011, APPL SPECTROSC, V65, P1145, DOI [10.1366/11&hyphen06341, 10.1366/11-06341]
   Mastel S, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905507
   McLeod AS, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085136
   Moody G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.097401
   Neacsu CC, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201402
   Ocelic N, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2348781
   Pakoulev AV, 2008, J PHYS CHEM A, V112, P6320, DOI 10.1021/jp711014h
   POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865
   Pollard B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4587
   Rajapaksa I, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3480608
   Raschke MB, 2003, APPL PHYS LETT, V83, P5089, DOI 10.1063/1.1632023
   Schnell M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4499
   Shim SH, 2009, PHYS CHEM CHEM PHYS, V11, P748, DOI 10.1039/b813817f
   Taubner T, 2004, APPL PHYS LETT, V85, P5064, DOI 10.1063/1.1827334
   Taubner T, 2003, J MICROSC-OXFORD, V210, P311, DOI 10.1046/j.1365-2818.2003.01164.x
   Wagner M, 2014, NANO LETT, V14, P4529, DOI 10.1021/nl501558t
   WESSEL J, 1985, J OPT SOC AM B, V2, P1538, DOI 10.1364/JOSAB.2.001538
   Westermeier C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5101
   Xu XJG, 2013, NANO LETT, V13, P1588, DOI 10.1021/nl304804p
   Xu XJG, 2012, J PHYS CHEM LETT, V3, P1836, DOI 10.1021/jz300463d
   Yampolsky S, 2014, NAT PHOTONICS, V8, P650, DOI [10.1038/nphoton.2014.143, 10.1038/NPHOTON.2014.143]
   Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998
   ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083
NR 63
TC 39
Z9 39
U1 5
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-7185
J9 J PHYS CHEM LETT
JI J. Phys. Chem. Lett.
PD APR 2
PY 2015
VL 6
IS 7
BP 1275
EP 1284
DI 10.1021/acs.jpclett.5b00108
PG 10
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Atomic, Molecular & Chemical
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CF1TS
UT WOS:000352331400032
PM 26262987
DA 2018-10-19
ER

PT J
AU Mestres, G
   Espanol, M
   Xia, W
   Persson, C
   Ginebra, MP
   Ott, MK
AF Mestres, Gemma
   Espanol, Montserrat
   Xia, Wei
   Persson, Cecilia
   Ginebra, Maria-Pau
   Ott, Marjam Karlsson
TI Inflammatory Response to Nano- and Microstructured Hydroxyapatite
SO PLOS ONE
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENT; IN-VITRO; CELL RESPONSE; TRICALCIUM PHOSPHATE;
   PARTICLE-SIZE; BONE-MARROW; MACROPHAGES; BIOMATERIALS; TOPOGRAPHY;
   ACTIVATION
AB The proliferation and activation of leukocytes upon contact with a biomaterial play a crucial role in the degree of inflammatory response, which may then determine the clinical failure or success of an implanted biomaterial. The aim of this study was to evaluate whether nano-and microstructured biomimetic hydroxyapatite substrates can influence the growth and activation of macrophage-like cells. Hydroxyapatite substrates with different crystal morphologies consisting of an entangled network of plate-like and needle-like crystals were evaluated. Macrophage proliferation was evaluated on the material surface (direct contact) and also in extracts i.e. media modified by the material (indirect contact). Additionally, the effect of supplementing the extracts with calcium ions and/or proteins was investigated. Macrophage activation on the substrates was evaluated by quantifying the release of reactive oxygen species and by morphological observations. The results showed that differences in the substrate's microstructure play a major role in the activation of macrophages as there was a higher release of reactive oxygen species after culturing the macrophages on plate-like crystals substrates compared to the almost non-existent release on needle-like substrates. However, the difference in macrophage proliferation was ascribed to different ionic exchanges and protein adsorption/retention from the substrates rather than to the texture of materials.
C1 [Mestres, Gemma; Xia, Wei; Persson, Cecilia; Ott, Marjam Karlsson] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden.
   [Espanol, Montserrat; Ginebra, Maria-Pau] Tech Univ Catalonia, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn, Barcelona, Spain.
RP Ott, MK (reprint author), Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden.
EM marjam.ott@angstrom.uu.se
RI Ginebra, Maria-Pau/J-8149-2017; Espanol, Montserrat/J-8293-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Espanol,
   Montserrat/0000-0001-7510-0602; Mestres, Gemma/0000-0001-7462-4236
FU Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility
   for Growth [GROWTH 291795]; Lars Hiertas Minne Foundation [FO2013-0337];
   STINT [IG2011-2047]; Ollie och Elof Ericssons Stifelse for Vetenskaplig
   Forskning; Spanish Government [MAT2012-38438-003-01]; EU through
   European Regional Development Funds; prize "ICREA Academia'' for
   excellence in research - Generalitat de Catalunya
FX This work was funded by Marie Curie Actions FP7-PEOPLE-2011-COFUND
   (GROWTH 291795) via the VINNOVA programme Mobility for Growth, Lars
   Hiertas Minne Foundation (FO2013-0337 project), STINT (IG2011-2047
   project), and Ollie och Elof Ericssons Stifelse for Vetenskaplig
   Forskning. The authors acknowledge the Spanish Government for financial
   support through project MAT2012-38438-003-01, co-funded by the EU
   through European Regional Development Funds. Support for the research of
   MPG was received through the prize "ICREA Academia'' for excellence in
   research, funded by the Generalitat de Catalunya. Part of this work was
   performed at the BioMat facility/Science for Life Laboratory at Uppsala
   University. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Albrecht C, 2009, TOXICOL IN VITRO, V23, P520, DOI 10.1016/j.tiv.2009.01.005
   Ambrozova G, 2010, EUR J NUTR, V49, P133, DOI 10.1007/s00394-009-0057-3
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139
   BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227
   Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287
   Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011
   Espanol M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0037-7
   FARLEY JR, 1994, J BONE MINER RES, V9, P497
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Gustavsson J, 2012, J MATER SCI-MATER M, V23, P2509, DOI 10.1007/s10856-012-4705-4
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Muller KH, 2014, BIOMATERIALS, V35, P1074, DOI 10.1016/j.biomaterials.2013.10.041
   Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005
   Omar OM, 2011, BIOMATERIALS, V32, P8190, DOI 10.1016/j.biomaterials.2011.07.055
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Xing SM, 2002, MICROSC RES TECHNIQ, V57, P523, DOI 10.1002/jemt.10106
   Yamaguchi T, 1998, J BONE MINER RES, V13, P1390, DOI 10.1359/jbmr.1998.13.9.1390
NR 47
TC 9
Z9 9
U1 3
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 2
PY 2015
VL 10
IS 4
AR e0120381
DI 10.1371/journal.pone.0120381
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9BS
UT WOS:000352139000020
PM 25837264
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Banerjee, A
   Chatterjee, K
   Madras, G
AF Banerjee, Aditi
   Chatterjee, Kaushik
   Madras, Giridhar
TI Enzymatic degradation of polycaprolactone-gelatin blend
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE polymer blend; degradation; enzyme kinetics
ID POLY-EPSILON-CAPROLACTONE; BIODEGRADATION; HYDROLYSIS; POLYESTERS;
   MIGRATION; LIPASES; FIBERS; GROWTH; RATIO
AB Blends of polycaprolactone (PCL), a synthetic polymer and gelatin, natural polymer offer a optimal combination of strength, water wettability and cytocompatibility for use as a resorbable biomaterial. The enzymatic degradation of PCL, gelatin and PCL-gelatin blended films was studied in the presence of lipase (Novozym 435, immobilized) and lysozyme. Novozym 435 degraded the PCL films whereas lysozyme degraded the gelatin. Though Novozym 435 and lysozyme individually could degrade PCL-gelatin blended films, the combination of these enzymes showed the highest degradation of these blended films. Moreover, the enzymatic degradation was much faster when fresh enzymes were added at regular intervals. The changes in physico-chemical properties of polymer films due to degradation were studied by scanning electron microscopy, Fourier transform infrared spectroscopy and differential scanning calorimetry. These results have important implications for designing resorbable biomedical implants.
C1 [Banerjee, Aditi; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
   [Madras, Giridhar] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.
RP Banerjee, A (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
RI Madras, Giridhar/A-1257-2007; Madras, Giridhar/K-8468-2015
OI Madras, Giridhar/0000-0003-2211-5055; Madras,
   Giridhar/0000-0003-2211-5055; Chatterjee, Kaushik/0000-0002-7204-2926
FU Department of Science and Technology, India (DST); DST
FX The authors thank the Department of Science and Technology, India (DST)
   for financial support. KC acknowledges the Ramanujan Fellowship from
   DST.
CR Banerjee A, 2014, MATER SCI TECH-LOND, V30, P567, DOI 10.1179/1743284713Y.0000000503
   BENEDICT CV, 1983, J APPL POLYM SCI, V28, P327, DOI 10.1002/app.1983.070280128
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   Cheng Y, 2000, BIOMACROMOLECULES, V1, P782, DOI 10.1021/bm005616v
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chung TW, 2006, ARTIF ORGANS, V30, P35, DOI 10.1111/j.1525-1594.2006.00178.x
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   COOK WJ, 1981, J POLYM SCI POL LETT, V19, P159, DOI 10.1002/pol.1981.130190402
   Cortazar I C, 2012, POLYM DEGRAD STABIL, V97, P1241
   Falconi M, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035011
   FIELDS RD, 1974, J APPL POLYM SCI, V18, P3571, DOI 10.1002/app.1974.070181207
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Hoglund A, 2007, BIOMACROMOLECULES, V8, P2025, DOI 10.1021/bm070292x
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563
   Mobarakeh L. G., 2008, BIOMATERIALS, V29, P4532
   MOCHIZUKI M, 1995, J APPL POLYM SCI, V55, P289, DOI 10.1002/app.1995.070550212
   OLIVER CN, 1983, P NATL ACAD SCI-BIOL, V80, P2156, DOI 10.1073/pnas.80.8.2156
   Reis RL, 2004, BIODEGRADABLE SYSTEM
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Sivalingam G, 2003, CHEM ENG SCI, V58, P2911, DOI 10.1016/S0009-2509(03)00155-6
   Sivalingam G, 2003, POLYM DEGRAD STABIL, V79, P413, DOI 10.1016/S0141-3910(02)00357-9
   TOKIWA Y, 1977, NATURE, V270, P76, DOI 10.1038/270076a0
   Waldeck H, 2007, J BIOMED MATER RES A, V82A, P861, DOI 10.1002/jbm.a.31054
   Woei K, 2001, TISSUE ENG, V7, P441, DOI 10.1089/10763270152436490
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zheng R, 2014, BIOMATERIALS, V35, P152, DOI 10.1016/j.biomaterials.2013.09.082
NR 31
TC 5
Z9 5
U1 2
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD APR
PY 2015
VL 2
IS 4
AR 045303
DI 10.1088/2053-1591/2/4/045303
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA DD6AY
UT WOS:000370007300020
DA 2018-10-19
ER

PT J
AU Dorsey, SM
   Haris, M
   Singh, A
   Witschey, WRT
   Rodell, CB
   Kogan, F
   Reddy, R
   Burdick, JA
AF Dorsey, Shauna M.
   Haris, Mohammad
   Singh, Anup
   Witschey, Walter R. T.
   Rodell, Christopher B.
   Kogan, Feliks
   Reddy, Ravinder
   Burdick, Jason A.
TI Visualization of Injectable Hydrogels Using Chemical Exchange Saturation
   Transfer MRI
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE hyaluronic acid; hydrogel; magnetic resonance imaging; chemical exchange
   saturation transfer
ID HYALURONIC-ACID HYDROGEL; IN-VIVO; CONTRAST AGENTS; TRANSFER CEST;
   WATER; DEGRADATION; BIOMATERIALS; METABOLITES; INFARCTION; CREATINE
AB Injectable biomaterials are being developed for a wide range of biomedical applications; however, characterization of materials (e.g., distribution, chemical composition) after injection is often difficult and relies on invasive and destructive procedures. To address this problem, this study utilizes a new magnetic resonance imaging (MRI) acquisition technique based on chemical exchange saturation transfer (CEST), where the signal relies on the exchange of protons in specific molecules with bulk water protons. Such a signal can be generated from specific functional groups endogenous to or engineered into a desired material. Here, CEST MRI was used to visualize injectable hyaluronic acid (HA) hydrogels either alone or after injection into tissue. The CEST effect was shown to track with changes in material properties-as hydrogel macromer concentration was increased, the CEST contrast increased linearly. Furthermore, CEST MRI was used to detect hydrogels injected into cardiac explants with an increase in signal at the hydrogel site relative to the surrounding myocardial signal. Unlike conventional MRI, CEST can simultaneously visualize and discriminate between different injectable materials based on their unique chemistry. To illustrate this, we tuned the CEST signal to detect differences in two hydrogel systems based on their dominant functional groups. The covalent addition of an arginine-based peptide to HA hydrogels led to a 2-fold increase in signal when the exchangeable amine (-NH2) protons in the peptide were targeted. Thus, CEST MRI could become a valuable tool for studying injectable hydrogel properties and enable further optimization of biomaterial therapies aimed at clinical translation.
C1 [Dorsey, Shauna M.; Rodell, Christopher B.; Burdick, Jason A.] Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.
   [Haris, Mohammad; Singh, Anup; Witschey, Walter R. T.; Kogan, Feliks; Reddy, Ravinder] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
OI Reddy, Ravinder/0000-0003-4580-2392
FU National Institutes of Health [R00 HL108157, R01 HL111090, T32 HL007954,
   P41 EB015893, P41 EB015893S1]; Established Investigator Award from
   American Heart Association
FX The authors acknowledge the assistance of S. Wehrli from the Children's
   Hospital of Pennsylvania for assistance with the high-resolution,
   temperature-controlled spectroscopy. This work was financially supported
   by the National Institutes of Health (R00 HL108157, R01 HL111090, T32
   HL007954, P41 EB015893, P41 EB015893S1) and a predoctoral fellowship
   (C.B.R) and Established Investigator Award (J.A.B.) from the American
   Heart Association.
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Blakely B, 2010, J BIOMED MATER RES B, V93B, P9, DOI 10.1002/jbm.b.31539
   Bryant RG, 1996, ANNU REV BIOPH BIOM, V25, P29, DOI 10.1146/annurev.bb.25.060196.000333
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615
   Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459
   Guivel-Scharen V, 1998, J MAGN RESON, V133, P36, DOI 10.1006/jmre.1998.1440
   Haris M, 2014, NAT MED, V20, P209, DOI 10.1038/nm.3436
   Haris M, 2012, NMR BIOMED, V25, P1305, DOI 10.1002/nbm.2792
   Hoffman RE, 2006, MAGN RESON CHEM, V44, P606, DOI 10.1002/mrc.1801
   Karfeld-Sulzer LS, 2011, MAGN RESON MED, V65, P220, DOI 10.1002/mrm.22587
   Kichula ET, 2014, ANN BIOMED ENG, V42, P1546, DOI 10.1007/s10439-013-0937-9
   Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873
   Kogan Feliks, 2013, Curr Radiol Rep, V1, P102
   Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011
   Leon CM, 2009, POLYM INT, V58, P847, DOI 10.1002/pi.2616
   Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106
   Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105
   Liu GS, 2013, NMR BIOMED, V26, P810, DOI 10.1002/nbm.2899
   Liu GS, 2012, MAGN RESON MED, V67, P1106, DOI 10.1002/mrm.23100
   Liu GS, 2010, CONTRAST MEDIA MOL I, V5, P162, DOI 10.1002/cmmi.383
   MacArthur JW, 2013, CIRCULATION, V128, pS79, DOI 10.1161/CIRCULATIONAHA.112.000343
   McMahon MT, 2008, MAGN RESON MED, V60, P803, DOI 10.1002/mrm.21683
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Purcell BP, 2014, BIOMATER SCI-UK, V2, P693, DOI 10.1039/c3bm60227c
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Singh A, 2013, MAGN RESON MED, V69, P818, DOI 10.1002/mrm.24290
   Singh A, 2012, MAGN RESON MED, V68, P588, DOI 10.1002/mrm.23250
   Soesbe TC, 2013, NMR BIOMED, V26, P829, DOI 10.1002/nbm.2874
   Soranno DE, 2014, J BIOMED MATER RES A, V102, P2173, DOI 10.1002/jbm.a.34902
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sun PZ, 2005, J MAGN RESON, V175, P193, DOI 10.1016/j.jmr.2005.04.005
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761
   Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Woessner DE, 2005, MAGNET RESON MED, V53, P790, DOI 10.1002/mrm.20408
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu SB, 1999, CHEM REV, V99, P2353, DOI 10.1021/cr980441p
   Yuan ZJ, 2010, TISSUE ENG PART C-ME, V16, P237, DOI [10.1089/ten.tec.2009.0152, 10.1089/ten.TEC.2009.0152]
   Zhang Y, 2014, MACROMOL BIOSCI, V14, P1249, DOI 10.1002/mabi.201400117
NR 47
TC 10
Z9 10
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2015
VL 1
IS 4
BP 227
EP 237
DI 10.1021/ab500097d
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RM
UT WOS:000369347300004
DA 2018-10-19
ER

PT J
AU Muller-Herrmann, S
   Scheibel, T
AF Mueller-Herrmann, Susanne
   Scheibel, Thomas
TI Enzymatic Degradation of Films, Particles, and Nonwoven Meshes Made of a
   Recombinant Spider Silk Protein
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE recombinant silk proteins; cross-linking; biodegradation; MMPs; protease
   XIV; collagenase IA; scaffolds for biomedical applications
ID LEUKOCYTE ELASTASE LEVELS; IN-VITRO DEGRADATION; HIGH SERUM-LEVELS;
   MATRIX-METALLOPROTEINASES; PMN-ELASTASE; INFRARED-SPECTROSCOPY;
   STREPTOMYCES-GRISEUS; CHRONIC WOUNDS; FIBROIN; INHIBITORS
AB The performance of biomaterials in vivo is largely influenced by their stability and the rate and extent to which they degrade. Materials for tissue engineering applications, for example, have to be mechanically stable to support cell adhesion and proliferation without collapsing. On the other hand they need to be replaced gradually by native extracellular matrix and have to be (slowly) biodegradable. Therefore, it is of critical importance to be able to tune the 15 degradation behavior of a biomaterial. Recombinantly produced spider silk proteins have been shown to be versatile biopolymers for medical applications. They can be processed into a variety of morphologies, and by chemical or genetic modification the properties can be adjusted to specific demands. Furthermore, in vivo experiments confirmed the lack of immunological reactions toward certain spider silks. In this study the degradation behavior of the recombinant spider silk protein eADF4(C16) in solution as well as processed into particles, films and nonwoven meshes was analyzed, and the impact of cross linking of the scaffolds was assessed thereon. In addition to two bacterial proteolytic model enzymes, protease type XIV from Streptomyces griseus (PXIV) and collagenase type IA from Clostridium histolyticum (CHC) used in all experiments, several recombinant human matrix metalloproteinases (MMPs) and one elastase were used in studying degradation of soluble eADF4(C16). For soluble eADF4(C16) all degradation kinetics were similar. In case of eADF4(C16) scaffolds significant differences were observable between PXIV and CHC. All scaffolds were more stable toward proteolytic degradation in the presence of CHC than in the presence of PXIV. Further, particles were degraded significantly faster than films, and nonwoven meshes showed the highest proteolytic stability. Chemical cross-linking of the scaffolds led to a decrease in both degradation rate and extent.
C1 [Mueller-Herrmann, Susanne; Scheibel, Thomas] Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
RP Scheibel, T (reprint author), Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
EM thomas.scheibel@bm.uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
FU Deutsche Forschungsgemeinschaft [SFB840 TP A8]
FX The authors thank Hendrik Bargel for assistance with SEM analyses and
   Martin Humenik for assistance with MALDI-TOF MS measurements. This work
   was supported by the Deutsche Forschungsgemeinschaft (SFB840 TP A8).
CR Akyol N, 1997, ACTA OPHTHALMOL SCAN, V75, P287
   Alexander JS, 2010, MULT SCLER J, V16, P801, DOI 10.1177/1352458510370791
   Amalinei Cornelia, 2007, Rom J Morphol Embryol, V48, P323
   ANDUS T, 1993, DIGEST DIS SCI, V38, P1638, DOI 10.1007/BF01303172
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12
   Asano Y, 2006, RHEUMATOLOGY, V45, P303, DOI 10.1093/rheumatology/kei143
   BAUER CA, 1974, EUR J BIOCHEM, V41, P45, DOI 10.1111/j.1432-1033.1974.tb03242.x
   BAUER CA, 1974, EUR J BIOCHEM, V45, P469, DOI 10.1111/j.1432-1033.1974.tb03571.x
   Blum C, 2014, ADV FUNCT MATER, V24, P763, DOI 10.1002/adfm.201302100
   Blum C., 2012, BIONANOSCIENCE, V2
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   BULLEN EC, 1995, J INVEST DERMATOL, V104, P236, DOI 10.1111/1523-1747.ep12612786
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Decock J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-77
   DEGER O, 1995, CLIN CHIM ACTA, V236, P129, DOI 10.1016/0009-8981(95)06033-A
   Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720
   Edkins TJ, 2012, CLIN VACCINE IMMUNOL, V19, P562, DOI 10.1128/CVI.00018-12
   Eglin D, 2009, SOFT MATTER, V5, P938, DOI 10.1039/b803718n
   Enoch S, 2007, SURGERY, V26, P31
   Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024
   Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080
   Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   HOFER HP, 1995, INJURY, V26, P103, DOI 10.1016/0020-1383(95)92186-E
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu YP, 2012, ADV MATER SCI ENG, DOI 10.1155/2012/185905
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Imamoto Y, 2001, BIOCHEMISTRY-US, V40, P8997, DOI 10.1021/bi010021l
   Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340
   Jung K, 2008, CLIN CHEM, V54, P772, DOI 10.1373/clinchem.2007.099937
   Karapanagiotidis GT, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-59
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Kim JH, 2012, J BIOMED MATER RES A, V100A, P3287, DOI 10.1002/jbm.a.34274
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lauhio A, 2011, PHARMACOL RES, V64, P590, DOI 10.1016/j.phrs.2011.06.019
   Leal-Egana A, 2012, ADV ENG MATER, V14, pB67, DOI 10.1002/adem.201180072
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   McCarty SM, 2013, ADV WOUND CARE, V2, P438, DOI 10.1089/wound.2012.0370
   McLennan SV, 2009, WOUND PRACT RES, V16, P116
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Metzmacher I., 2005, THESIS LMU MUNCHEN M
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512
   Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Neubauer MP, 2013, BIOMATER SCI-UK, V1, P1160, DOI 10.1039/c3bm60108k
   Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Orem A, 1997, CLIN CHIM ACTA, V264, P49, DOI 10.1016/S0009-8981(97)00072-7
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI 10.1093/nar/gkr987
   Rego-Perez I, 2011, ANN RHEUM DIS, V70, P646, DOI 10.1136/ard.2010.133637
   Riley KN, 2005, J BURNS WOUNDS, V4, P112
   Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358
   Schacht K, 2011, BIOMACROMOLECULES, V12, P2488, DOI 10.1021/bm200154k
   Schultz GS, 1998, WOUNDS, V10, p1F
   Shang K, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.3.2
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, SOFT MATTER, V6, P4168, DOI 10.1039/b927267d
   Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596
   Ulrich D, 2003, PLAST RECONSTR SURG, V112, P1279, DOI 10.1097/01.PRS.0000081462.40448.49
   Ulrich D, 2003, PLAST RECONSTR SURG, V111, P1423, DOI 10.1097/01.PRS.0000049450.95669.07
   Ulrich Dietmar, 2004, Plast Reconstr Surg, V114, P229, DOI 10.1097/01.PRS.0000129079.19089.6C
   Utz ER, 2010, J SURG RES, V159, P633, DOI 10.1016/j.jss.2009.08.021
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011
   Wiegand C, 2010, ARCH DERMATOL RES, V302, P419, DOI 10.1007/s00403-009-1011-1
   Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wittmer CR, 2011, ACTA BIOMATER, V7, P3789, DOI 10.1016/j.actbio.2011.06.001
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   WOLTERS GHJ, 1995, DIABETES, V44, P227, DOI 10.2337/diabetes.44.2.227
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
   Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41
   Zeplin PH, 2014, ADV FUNCT MATER, V24, P2658, DOI 10.1002/adfm.201302813
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
   Zhou JA, 2010, POLYM DEGRAD STABIL, V95, P1679, DOI 10.1016/j.polymdegradstab.2010.05.025
NR 88
TC 14
Z9 15
U1 5
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2015
VL 1
IS 4
BP 247
EP 259
DI 10.1021/ab500147u
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RM
UT WOS:000369347300006
DA 2018-10-19
ER

PT J
AU Rnjak-Kovacina, J
   Wray, LS
   Burke, KA
   Torregrosa, T
   Golinski, JM
   Huang, WW
   Kaplan, DL
AF Rnjak-Kovacina, Jelena
   Wray, Lindsay S.
   Burke, Kelly A.
   Torregrosa, Tess
   Golinski, Julianne M.
   Huang, Wenwen
   Kaplan, David L.
TI Lyophilized Silk Sponges: A Versatile Biomaterial Platform for Soft
   Tissue Engineering
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE silk; scaffold; soft tissue engineering; lyophilized sponge; biomaterial
ID SCAFFOLDS; FIBROIN; BONE; STIFFNESS; IMPACT; SUBSTRATE; CELLS
AB We present a silk biomaterial platform with highly tunable mechanical and degradation properties for engineering and regeneration of soft tissues such as, skin, adipose, and neural tissue, with elasticity properties in the kilopascal range. Lyophilized silk sponges were prepared under different process conditions and the effect of silk molecular weight, concentration and crystallinity on 3D scaffold formation, structural integrity, morphology, mechanical and degradation properties, and cell interactions in vitro and in vivo were studied. Tuning the molecular weight distribution (via degumming time) of silk allowed the formation of stable, highly porous, 3D scaffolds that held form with silk concentrations as low as 0.5% wt/v. Mechanical properties were a function of silk concentration and scaffold degradation was driven by beta-sheet content. Lyophilized silk sponges supported the adhesion of mesenchymal stem cells throughout 3D scaffolds, cell proliferation in vitro, and cell infiltration and scaffold remodeling when implanted subcutaneously in vivo.
C1 [Rnjak-Kovacina, Jelena; Wray, Lindsay S.; Burke, Kelly A.; Torregrosa, Tess; Golinski, Julianne M.; Huang, Wenwen; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Rnjak-Kovacina, Jelena] UNSW Australia, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   [Burke, Kelly A.] Univ Connecticut, Chem & Biomol Engn Dept, Storrs, CT 06269 USA.
RP Rnjak-Kovacina, J (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM j.rnjak-kovacina@unsw.edu.au
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083
FU NIH [NIH P41 EB002520, EY020856]; National Science Foundation Graduate
   Research Fellowship Program [NSF DGE 0806676]; Air Force Office of
   Scientific Research
FX We thank the NIH (NIH P41 EB002520; EY020856), the National Science
   Foundation Graduate Research Fellowship Program (NSF DGE 0806676), and
   the Air Force Office of Scientific Research for support. We thank Rachel
   Stern for her contribution to sponge integrity and degradation studies.
   As Rachel has completed her studies at Tufts University, we were unable
   to find her contact details to seek permission to include her as a
   coauthor on the manuscript. We thank Dr. Chiara E. Ghezzi for her
   assistance in analyzing the mechanical properties of silk scaffolds.
CR Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang WW, 2011, MACROMOLECULES, V44, P5299, DOI 10.1021/ma200563t
   Inoue SI, 2000, J POLYM SCI POL PHYS, V38, P1436, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1436::AID-POLB30>3.0.CO;2-8
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sasithorn N, 2014, J NANOMATER, DOI 10.1155/2014/947315
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Williams D, 2014, CAMB TEXT BIOMED ENG, P1
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yuksel E., 2005, SEMIN PLAST SURG, P261
NR 30
TC 32
Z9 33
U1 4
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2015
VL 1
IS 4
BP 260
EP 270
DI 10.1021/ab500149p
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RM
UT WOS:000369347300007
PM 25984573
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Ochyl, LJ
   Moon, JJ
AF Ochyl, Lukasz J.
   Moon, James J.
TI Whole-animal Imaging and Flow Cytometric Techniques for Analysis of
   Antigen-specific CD8+T Cell Responses after Nanoparticle Vaccination
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology; Issue 98; nanoparticle; vaccine; biomaterial; subunit
   antigen; adjuvant; cytotoxic CD8+T lymphocyte; whole animal imaging;
   tetramer staining; and lymph node
ID CHRONIC VIRAL-INFECTION; T-CELLS; SYNTHETIC VACCINES; IMMUNE-RESPONSES;
   IN-VITRO; MEMORY; TRAFFICKING; SELECTION; PEPTIDE; ASSAY
AB Traditional vaccine adjuvants, such as alum, elicit suboptimal CD8+ T cell responses. To address this major challenge in vaccine development, various nanoparticle systems have been engineered to mimic features of pathogens to improve antigen delivery to draining lymph nodes and increase antigen uptake by antigen-presenting cells, leading to new vaccine formulations optimized for induction of antigen-specific CD8+ T cell responses. In this article, we describe the synthesis of a "pathogen-mimicking" nanoparticle system, termed interbilayer-crosslinked multilamellar vesicles (ICMVs) that can serve as an effective vaccine carrier for co-delivery of subunit antigens and immunostimulatory agents and elicitation of potent cytotoxic CD8+ T lymphocyte (CTL) responses. We describe methods for characterizing hydrodynamic size and surface charge of vaccine nanoparticles with dynamic light scattering and zeta potential analyzer and present a confocal microscopy-based procedure to analyze nanoparticle-mediated antigen delivery to draining lymph nodes. Furthermore, we show a new bioluminescence whole-animal imaging technique utilizing adoptive transfer of luciferase-expressing, antigen-specific CD8+ T cells into recipient mice, followed by nanoparticle vaccination, which permits non-invasive interrogation of expansion and trafficking patterns of CTLs in real time. We also describe tetramer staining and flow cytometric analysis of peripheral blood mononuclear cells for longitudinal quantification of endogenous T cell responses in mice vaccinated with nanoparticles.
C1 [Ochyl, Lukasz J.; Moon, James J.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.
   [Ochyl, Lukasz J.; Moon, James J.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.
   [Moon, James J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Moon, JJ (reprint author), Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.
EM moonjj@med.umich.edu
FU National Institute of Health [1K22AI097291-01]; National Center for
   Advancing Translational Sciences of the National Institutes of Health
   [UL1TR000433]
FX This study was supported by the National Institute of Health grant
   1K22AI097291-01 and by the National Center for Advancing Translational
   Sciences of the National Institutes of Health under Award Number
   UL1TR000433. We also acknowledge Prof. Darrell Irvine at MIT and Prof.
   Matthias Stephan at Fred Hutchinson Cancer Center for their contribution
   on the initial work on the vaccine nanoparticles and OT-I/Luc transgenic
   mice.
CR Ahlers JD, 2010, BLOOD, V115, P1678, DOI 10.1182/blood-2009-06-227546
   Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94
   Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155
   Azadniv M, 2007, INT IMMUNOL, V19, P1165, DOI 10.1093/intimm/dxm086
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Bedoya SK, 2013, JOVE-J VIS EXP, DOI 10.3791/50765
   Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5
   Bilati U, 2005, AAPS PHARMSCITECH, V6
   Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596
   BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
   Chen Y, 2011, JOVE-J VIS EXP, DOI 10.3791/2802
   Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288
   Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287
   CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78
   Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39
   Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105
   HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   Kaur R, 2012, J CONTROL RELEASE, V164, P331, DOI 10.1016/j.jconrel.2012.07.012
   Kim D, 2007, HUM GENE THER, V18, P575, DOI 10.1089/hum.2007.038
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Machholz E, 2012, JOVE-J VIS EXP, DOI 10.3791/2771
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240
   Noto A, 2013, JOVE-J VIS EXP, DOI 10.3791/51105
   Quah BJC, 2014, JOVE-J VIS EXP, DOI 10.3791/51627
   Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Sahdev P., 2014, PHARM RES
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Scheffold A., 2009, CELLULAR DIAGNOSTICS, P476
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   Slingluff CL, 2001, CLIN CANCER RES, V7, P3012
   Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Stivaktakis N, 2004, J BIOMED MATER RES A, V70A, P139, DOI 10.1002/jbm.a.30085
   TILNEY NL, 1971, J ANAT, V109, P369
   van Riet E, 2014, ADV DRUG DELIVER REV, V74, P28, DOI 10.1016/j.addr.2014.05.011
   VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6
   Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006
   WILSON K, 2008, JOVE-J VIS EXP, V14, P740
   Wonderlich J., 2006, CURR PROTOC IMMUNOL
   Xu ZH, 2013, J CONTROL RELEASE, V172, P259, DOI 10.1016/j.jconrel.2013.08.021
   Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069
   Zhuang Y, 2012, J CONTROL RELEASE, V159, P135, DOI 10.1016/j.jconrel.2011.12.017
NR 57
TC 4
Z9 4
U1 2
U2 15
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2015
IS 98
AR e52771
DI 10.3791/52771
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7MR
UT WOS:000361534800068
PM 25992469
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Liu, B
   Li, L
   Zhao, JH
   Wang, ZF
   Tan, XY
   Xu, HY
   An, R
   Liu, YP
AF Liu, Bin
   Li, Long
   Zhao, Jian-Hui
   Wang, Zhi-Fa
   Tan, Xin-Ying
   Xu, Hai-Yan
   An, Ran
   Liu, Yan-Pu
TI Platelet-Rich Fibrin and Adipose-Derived Stem Cells Improve the Efficacy
   of Fat Transplantation and Soft Tissue Repair
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Soft Tissue Repair; Fat Transplantation; Platelet-Rich Fibrin;
   Adipose-Derived Stem Cells; Tissue Engineering
ID REGENERATION; SURVIVAL; PLASMA; AUGMENTATION; LIPOTRANSFER;
   BIOMATERIALS; COMBINATION; THERAPY; MODEL; GRAFT
AB Soft tissue defect restoration remains a challenge for clinical practice. Adipose tissue appears to be a promising filler due to its abundance and easy access but its use has been limited by atrophy, liquefaction, and necrosis. This study focuses on producing a novel fat composite biomaterial for fat transplantation. Autologous adipose derived stem cells (ASCs), platelet-rich fibrin (PRF), and adipose granules (AG) were prepared and mixed to make the fat composite for implanting. The ASCs were characterized by cell surface markers CD29 and CD31 as well as their ability to differentiate into multiple types of cells. PRF induced the differentiation of ASCs into adipocytes and osteoblasts and increased the proliferation of ASCs in a dose-dependent fashion. The fat transplantation in rabbits' ears showed that ASCs and PRF were able to individually or synergistically reduce fat absorption, increase fat survival, angiogensis, and remodeling, improving the efficacy and success rate of fat transplantation. This novel fat composite containing ASCs, PRF, and adipose granules is a promising biomaterial for soft tissue defect repair and cosmetic tissue augmentation.
C1 [Liu, Bin] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Liu, Bin; Xu, Hai-Yan; An, Ran] Fourth Mil Med Univ, Lab Anim Ctr, Xian 710032, Shaanxi, Peoples R China.
   [Li, Long; Wang, Zhi-Fa; Tan, Xin-Ying; Liu, Yan-Pu] Fourth Mil Med Univ, Sch Stomatol, Oral Maxillofacial Surg, Xian 710032, Shaanxi, Peoples R China.
   [Zhao, Jian-Hui] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.
RP Liu, B (reprint author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China.
FU National Natural Science Foundation of China [31170942, 81070820]
FX The authors would like to thank Dr. Shi Lei (Puhe Biomed) for critical
   reading. This work was supported by the National Natural Science
   Foundation of China (Nos. 31170942, 81070820).
CR Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI [10.1016/j.yexcr.2003.10.020, 10.1016/j.yexer.2003.10.020]
   Alexander RW, 2013, CLIN COSMET INVESTI, V6, P91, DOI 10.2147/CCID.S40575
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135
   COLEMAN SR, 1995, AESTHET PLAST SURG, V19, P421, DOI 10.1007/BF00453875
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gimble Jeffrey M, 2011, Front Biosci (Schol Ed), V3, P69, DOI 10.2741/s133
   Hiraoka Y, 2006, TISSUE ENG, V12, P1475, DOI 10.1089/ten.2006.12.1475
   Huang Y, 2015, MATER EXPRESS, V5, P56, DOI 10.1166/mex.2015.1208
   Keyhan SO, 2013, J ORAL MAXIL SURG, V71, P610, DOI 10.1016/j.joms.2012.06.176
   Kurita M, 2008, PLAST RECONSTR SURG, V121, P1033, DOI 10.1097/01.prs.0000299384.53131.87
   Liao HT, 2014, TISSUE ENG PART B-RE, V20, P267, DOI [10.1089/ten.teb.2013.0317, 10.1089/ten.TEB.2013.0317]
   Liu B, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.tec.2012.0126, 10.1089/ten.TEC.2012.0126]
   Luo S, 2013, TOHOKU J EXP MED, V231, P101, DOI 10.1620/tjem.231.101
   Ma XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076103
   Marino G, 2013, J SURG RES, V185, P36, DOI 10.1016/j.jss.2013.05.024
   Marra KG, 2012, BIRTH DEFECTS RES C, V96, P95, DOI 10.1002/bdrc.21001
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Masuda T, 2004, TISSUE ENG, V10, P1672, DOI 10.1089/ten.2004.10.1672
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Padma Rajan, 2013, J Indian Soc Periodontol, V17, P631, DOI 10.4103/0972-124X.119281
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Philips BJ, 2013, PLAST RECONSTR SURG, V132, P845, DOI 10.1097/PRS.0b013e31829fe5b1
   Shiffman MA, 2001, DERMATOL SURG, V27, P819, DOI 10.1046/j.1524-4725.2001.01062.x
   Singh Smita, 2013, Natl J Maxillofac Surg, V4, P94, DOI 10.4103/0975-5950.117825
   Tatullo M, 2012, INT J MED SCI, V9, P872, DOI 10.7150/ijms.5119
   Xu JL, 2012, BIOMATERIALS, V33, P6965, DOI 10.1016/j.biomaterials.2012.06.010
   Yi CG, 2007, J PLAST RECONSTR AES, V60, P272, DOI 10.1016/j.bjps.2006.01.052
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
   Young DA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024104
   Zhang Y, 2012, J CRANIO MAXILL SURG, V40, P321, DOI 10.1016/j.jcms.2011.04.020
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 33
TC 2
Z9 2
U1 0
U2 10
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD APR
PY 2015
VL 5
IS 4
BP 275
EP 282
DI 10.1166/jbt.2015.1311
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA CO8BZ
UT WOS:000359391300003
DA 2018-10-19
ER

PT J
AU Gumus, S
   Polat, S
   Lackner, JM
   Waldhauser, W
AF Gumus, S.
   Polat, S.
   Lackner, J. M.
   Waldhauser, W.
TI The Correlation Between Elastic Properties and AFM Images of
   Nanocoatings on Polymers
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
ID TEMPERATURE VACUUM DEPOSITION; TOPOGRAPHY FORMATION; BIOMATERIALS;
   MECHANISMS; SURFACES
AB In a biomimetic approach for designing implants, both the physical properties (such as topography, elasticity, roughness, hydrophilicity, charges etc.) and the chemical structure of the artificial biomaterial should be considered, since they affect the adhesion of proteins in the nanometer-scale and of the cells in micro-scale at the interface. In this case, surface modification of biomaterials plays a major role because of the expectations from the material surface. These may be realized by changing the surface chemistry, physically or chemically, or by coating it with a material having a certain chemical composition. In this study, surface properties like topography and roughness, and mechanical properties like elastic modulus and hardness are determined for nanocoated materials.
C1 [Gumus, S.; Polat, S.] Kocaeli Univ, Fac Engn, Dept Met & Mat Engn, TR-41380 Kocaeli, Turkey.
   [Lackner, J. M.; Waldhauser, W.] Joanneum Res Forsch Ges mBH, Inst Surface Technol & Photon, Funct Surfaces, A-8712 Niklasdorf, Austria.
RP Gumus, S (reprint author), Kocaeli Univ, Fac Engn, Dept Met & Mat Engn, Umuttepe Campus, TR-41380 Kocaeli, Turkey.
EM sgumus@kocaeli.edu.tr
CR Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Franco Jr. Adonias Ribeiro, 2004, Mat. Res., V7, P483, DOI 10.1590/S1516-14392004000300018
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Karimi A, 2002, THIN SOLID FILMS, V420, P275, DOI 10.1016/S0040-6090(02)00944-6
   Lackner JM, 2012, THIN SOLID FILMS, V520, P2833, DOI 10.1016/j.tsf.2011.10.149
   Lackner JM, 2010, B POL ACAD SCI-TECH, V58, P281
   Li XD, 2002, MATER CHARACT, V48, P11
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Pharr GM, 1998, MAT SCI ENG A-STRUCT, V253, P151, DOI 10.1016/S0921-5093(98)00724-2
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
NR 10
TC 0
Z9 0
U1 0
U2 13
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD APR
PY 2015
VL 127
IS 4
BP 1142
EP 1144
PG 3
WC Physics, Multidisciplinary
SC Physics
GA CM8GQ
UT WOS:000357937100080
OA Bronze
DA 2018-10-19
ER

PT J
AU Karacali, O
AF Karacali, O.
TI Material Fatigue Research for Zirconia Ceramic Dental Implant: a
   Comparative Laboratory and Simulation Study in Dentistry
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
AB This research focuses on the biocompatible zirconia, ceramic (ZrO2) material and load behavior causing fatigue on the surface of the dental implant in dentistry. Fatigue fracture and wear have been identified as some of the major problems associated with implant loosening, stress-shielding and ultimate implant failure. A static and cyclic fatigue testing of ceramic dental implant in laboratory conditions for this investigation were carried out according to the ISO protocol 14801 under worst-case conditions. A finite element analysis (PEA) of dental implant with accurate geometry and material properties were developed to make realistic investigations on biocompatibility of the implant biomaterial properties and mechanical fatigue behavior of new dental implant comparing Von-Mises criteria and maximum stress levels. The comparison of calculated fatigue life simulation data of and experimental data for the biocompatible zinconia, ceramic dental implants is presented. As a conclusion zirconium. implant exceeded the established values for maximum incisal bite forces reported in the literature and and also shows better performance than titanium implant material. The results of fatigue of biocompatible zirconia analysis are helpful for implant biomaterial selection and design for clinical interest: in dentistry.
C1 Istanbul Univ, Fac Engn, Dept Mech Engn, Istanbul, Turkey.
RP Karacali, O (reprint author), Istanbul Univ, Fac Engn, Dept Mech Engn, Istanbul, Turkey.
EM ozdogank@istanbul.edu.tr
FU Istanbul University, Turkey [46540]; Istanbul University
FX This research was supported by Scientific Research Projects (BAP) of
   Istanbul University, Turkey, Project No: 46540. The support of Istanbul
   University is greatly appreciated.
CR Coelho PG, 2009, DENT MATER, V25, P1122, DOI 10.1016/j.dental.2009.03.009
   Merdji A., 2010, COMP MATER SCI, V49, P126
   Mick E., 2013, J MAT, V6, P4001
   Prithviraj D.R., J CLIN EXP DENT, V3, P240
NR 4
TC 0
Z9 0
U1 1
U2 11
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD APR
PY 2015
VL 127
IS 4
BP 1195
EP 1198
DI 10.12693/APhysPolA.127.1195
PG 4
WC Physics, Multidisciplinary
SC Physics
GA CM8GQ
UT WOS:000357937100094
OA Bronze
DA 2018-10-19
ER

PT J
AU Popa, CL
   Bartha, CM
   Albu, M
   Guegan, R
   Motelica-Heino, M
   Chifiriuc, MC
   Bleotu, C
   Badea, ML
   Antohe, S
AF Popa, C. L.
   Bartha, C. M.
   Albu, M.
   Guegan, R.
   Motelica-Heino, M.
   Chifiriuc, M. C.
   Bleotu, C.
   Badea, M. L.
   Antohe, S.
TI SYNTHESIS, CHARACTERIZATION AND CYTOTOXICITY EVALUATION ON ZINC DOPED
   HYDROXYAPATITE IN COLLAGEN MATRIX
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE Zinc; Hydroxyapatite; Collagen; Bio-composite
ID CALCIUM-PHOSPHATE; BONE-FORMATION; EUROPIUM; NANOPARTICLES; TISSUE;
   BIOCOMPATIBILITY; COMPOSITES; SCAFFOLDS; DEXTRIN
AB The goal of this study was to obtain at low temperature a functional nano-composite with characteristics similar to the natural bone by using a cost effective method. The structure and morphology of collagen coated zinc doped hydroxyapatite bio-composites (Zn:HAp-CBc) were examined by X-Ray diffraction (XRD) and Scanning Electron Microscopy (SEM). XRD analysis revealed that the unique hexagonal Ca-10(PO4)(6)(OH)(2) in P-63m space group was observed in the obtained nanocomposites Zn: HAp-CBc. The cytotoxicity of the Zn: HAp-CBc was studied on HeLa cell lines. Cell cycle distribution after treatment was examined by flow cytometry analysis. Our preliminary in vitro studies revealed that the obtained composites based on Zn doped HAp embedded in collagen matrix have excellent biocompatibility and support their further characterization by in vivo approaches and development as a biomaterial used in bone regeneration.
C1 [Popa, C. L.; Bartha, C. M.] Natl Inst Mat Phys, Magurele, Romania.
   [Popa, C. L.; Antohe, S.] Univ Bucharest, Fac Phys, Magurele 077125, Romania.
   [Bartha, C. M.] West Univ Timisoara, Fac Phys, Timisoara 300223, Romania.
   [Albu, M.] Leather & Footwear Res Inst, Natl Res & Dev Inst Text & Leather INCDTP Div, Collagen Dept, Bucharest 031215, Romania.
   [Guegan, R.; Motelica-Heino, M.] Univ Orleans, CNRS, Inst Earth Sci, UMR 7327, F-45071 Orleans 02, France.
   [Chifiriuc, M. C.; Bleotu, C.] Univ Bucharest, Fac Biol, Dept Microbiol Immunol, Bucharest 77206, Romania.
   [Bleotu, C.] Stefan S Nicolau Inst Virol, Bucharest 030304, Romania.
   [Badea, M. L.] Univ Agron Sci & Vet Med, Bucharest 011464, Romania.
   [Antohe, S.] Acad Romanian Scientists, Bucharest 050094, Romania.
RP Antohe, S (reprint author), Univ Bucharest, Fac Phys, 405 Atomistilor St,POB MG1, Magurele 077125, Romania.
EM santohe@solid.fizica.unibuc.ro
RI Chifiriuc, Mariana Carmen/F-9136-2016; ANTOHE, Stefan/C-4954-2011;
   Coralia, Bleotu/B-5976-2011
OI Chifiriuc, Mariana Carmen/0000-0001-6098-1857; Coralia,
   Bleotu/0000-0002-9031-338X; Albu, Madalina Georgiana/0000-0001-9960-2244
FU European Social Found within the Sectorial Operational Program Human
   Resources Development;  [IFA-CEA C4-05/2014];  [PN II 221/2014]; 
   [POSDRU/159/1.5/S/137750]
FX This work was supported by projects IFA-CEA C4-05/2014 and PN II
   221/2014. Also this work was supported by the strategic grant
   POSDRU/159/1.5/S/137750, "Project Doctoral and Postdoctoral programs
   support for increased competitiveness in Exact Sciences research"
   cofinanced by the European Social Found within the Sectorial Operational
   Program Human Resources Development 2007 - 2013.
CR Agrawal K., 2011, J MINER MAT CHARACT, V8, P727, DOI DOI 10.4236/JMMCE.2011.108057
   Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Albu M.G., 2011, COLLAGEN GELS MATRIC
   Buchwald T, 2012, SPECTROSC-INT J, V27, P107, DOI 10.1155/2012/261487
   Carcamo JJ, 2012, SPECTROCHIM ACTA A, V86, P360, DOI 10.1016/j.saa.2011.10.049
   Carlson GA, 2004, BIOCHEM BIOPH RES CO, V321, P472, DOI 10.1016/j.bbrc.2004.06.165
   Chai CS, 1998, BIOMATERIALS, V19, P2291, DOI 10.1016/S0142-9612(98)90138-7
   Chang MC, 2002, J MATER SCI-MATER M, V13, P993, DOI 10.1023/A:1019825132610
   Ciobanu CS, 2011, DIG J NANOMATER BIOS, V6, P1639
   Ciobanu CS, 2011, DIG J NANOMATER BIOS, V6, P1239
   Ciobanu CS, 2010, OPTOELECTRON ADV MAT, V4, P1515
   Ciobanu C. S., 2012, J NANOMATER, V2012, P1
   Ciobanu C. S., 2014, J NANOMATER, V2014, P1
   Ciobanu CS, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-324
   Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613
   Ciobanu CS, 2013, J SPECTROS
   David G, 2011, DIG J NANOMATER BIOS, V6, P1575
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   Falguni Pati, 2010, Bioresource Technology, V101, P3737
   Geiger M, 2003, ADV DRUG DELIV REV, V55, P613
   Ito A, 2005, CURR APPL PHYS, V5, P402, DOI 10.1016/j.cap.2004.10.006
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   JORIS SJ, 1971, J PHYS CHEM-US, V75, P3172, DOI 10.1021/j100689a025
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lungu A, 2011, DIG J NANOMATER BIOS, V6, P1867
   Martin R. B, 1998, SKELETAL TISSUE MECH
   Matsunaga K, 2010, ACTA BIOMATER, V6, P2289, DOI 10.1016/j.actbio.2009.11.029
   Popa CL, 2014, CENT EUR J CHEM, V12, P1032, DOI 10.2478/s11532-014-0554-y
   Predoi D, 2007, DIG J NANOMATER BIOS, V2, P169
   Predoi D, 2008, J OPTOELECTRON ADV M, V10, P152
   Predoi D, 2010, DIG J NANOMATER BIOS, V5, P373
   Ren FZ, 2009, ACTA BIOMATER, V5, P3141, DOI 10.1016/j.actbio.2009.04.014
   Roman-Lopez J, 2014, SPECTROCHIM ACTA A, V120, P610, DOI 10.1016/j.saa.2013.10.027
   Rusu LC, 2014, DIG J NANOMATER BIOS, V9, P317
   Samar K, 2010, MAT SCI ENG C, V30, P295
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Tegza M., 2012, CHEM TECHNOL, V59, P40
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Voicu G, 2014, DIG J NANOMATER BIOS, V9, P99
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
NR 43
TC 3
Z9 3
U1 0
U2 12
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD APR-JUN
PY 2015
VL 10
IS 2
BP 681
EP 691
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CL8YV
UT WOS:000357261800014
DA 2018-10-19
ER

PT J
AU Hastings, CL
   Roche, ET
   Ruiz-Hernandez, E
   Schenke-Layland, K
   Walsh, CJ
   Duffy, GP
AF Hastings, Conn L.
   Roche, Ellen T.
   Ruiz-Hernandez, Eduardo
   Schenke-Layland, Katja
   Walsh, Conor J.
   Duffy, Garry P.
TI Drug and cell delivery for cardiac regeneration
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Myocardial infarction; Heart failure; Cell therapy; Growth factor;
   Biomaterials; Medical device; Drug delivery; Regenerative medicine
ID ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION;
   BONE-MARROW-CELLS; MESENCHYMAL STEM-CELLS; CHRONIC HEART-FAILURE;
   GROWTH-FACTOR-I; SKELETAL MYOBLAST TRANSPLANTATION; TISSUE-ENGINEERING
   APPROACH; RANDOMIZED CONTROLLED-TRIAL; MODIFIED MESSENGER-RNA
AB The spectrum of ischaemic cardiomyopathy, encompassing acute myocardial infarction to congestive heart failure is a significant clinical issue in the modem era. This group of diseases is an enormous source of morbidity and mortality and underlies significant healthcare costs worldwide. Cardiac regenerative therapy, whereby pro-regenerative cells, drugs or growth factors are administered to damaged and ischaemic myocardium has demonstrated significant potential, especially preclinically. While some of these strategies have demonstrated a measure of success in clinical trials, tangible clinical translation has been slow. To date, the majority of clinical studies and a significant number of preclinical studies have utilised relatively simple delivery methods for regenerative therapeutics, such as simple systemic administration or local injection in saline carrier vehicles. Here, we review cardiac regenerative strategies with a particular focus on advanced delivery concepts as a potential means to enhance treatment efficacy and tolerability and ultimately, clinical translation. These include (i) delivery of therapeutic agents in biomaterial carriers, (ii) nanoparticulate encapsulation, (iii) multimodal therapeutic strategies and (iv) localised, minimally invasive delivery via percutaneous transcatheter systems. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] RCSI, Dept Anat, Tissue Engn Res Grp, Dublin 2, Ireland.
   [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] Univ Dublin Trinity Coll, Coll Green, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] RCSI, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.
   [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] TCD, Dublin 2, Ireland.
   [Roche, Ellen T.; Walsh, Conor J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Roche, Ellen T.; Walsh, Conor J.] Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA.
   [Schenke-Layland, Katja] Univ Tubingen, Univ Womens Hosp, Dept Womens Hlth, D-72076 Tubingen, Germany.
   [Schenke-Layland, Katja] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Dept Cell & Tissue Engn, D-70569 Stuttgart, Germany.
   [Schenke-Layland, Katja] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Med Cardiol, Los Angeles, CA 90095 USA.
RP Duffy, GP (reprint author), RCSI, Dept Anat, 123 St Stephens Green, Dublin 2, Ireland.
EM garryduffy@rcsi.ie
RI Schenke-Layland, Katja/E-5940-2013
OI Schenke-Layland, Katja/0000-0001-8066-5157; Roche,
   Ellen/0000-0002-8952-2993; Duffy, Garry/0000-0002-4994-9511
FU European Union [NMP3-SME-2013-604531]; Fulbright International Science
   and Technology Fund
FX We acknowledge the funding derived from the European Union's Seventh
   Framework Programme for research, technological development and
   demonstration under grant agreement no NMP3-SME-2013-604531 from
   November 2013 to October 2017, entitled AMCARE, and the Fulbright
   International Science and Technology Fund.
CR Abdel-Latif A, 2008, AM HEART J, V156, P216, DOI 10.1016/j.ahj.2008.03.024
   Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   Anastasiadis K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-12
   Angion Biomedica Corp, 2012, ATUD EV SAF ACT BB3
   Armeanu S, 2000, MOL THER, V1, P366, DOI 10.1006/mthe.2000.0053
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Assmus B, 2013, JAMA-J AM MED ASSOC, V309, P1622, DOI 10.1001/jama.2013.3527
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071
   Bastings MMC, 2014, ADV HEALTHC MATER, V3, P70, DOI 10.1002/adhm.201300076
   Batista RJV, 1997, ANN THORAC SURG, V64, P634, DOI 10.1016/S0003-4975(97)00779-0
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916
   Behfar A, 2013, CIRC-CARDIOVASC INTE, V6, P710, DOI 10.1161/CIRCINTERVENTIONS.112.000422
   Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066
   Behfar Atta, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS78, DOI 10.1038/ncpcardio0429
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381
   Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036
   Chachques J.C., 2010, CARDIOL RES PRACT, V2011
   Chachques Juan C, 2007, J Interv Cardiol, V20, P188, DOI 10.1111/j.1540-8183.2007.00255.x
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Chaudhry PA, 2000, ANN THORAC SURG, V70, P1275, DOI 10.1016/S0003-4975(00)01755-0
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Chistiakov DA, 2012, DRUG DELIV, V19, P392, DOI 10.3109/10717544.2012.738436
   CHIU RCJ, 1995, ANN THORAC SURG, V60, P12
   Choi Y., 2011, THORAC CARDIOVASC SU, V59, pV143
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Doppler SA, 2013, J THORAC DIS, V5, P683, DOI 10.3978/j.issn.2072-1439.2013.08.71
   Dor V, 2001, Semin Thorac Cardiovasc Surg, V13, P435
   Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Ebelt H, 2013, SHOCK, V39, P353, DOI 10.1097/SHK.0b013e318289728a
   Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Eschenhagen T, 2002, TRANSPL IMMUNOL, V9, P315, DOI 10.1016/S0966-3274(02)00011-4
   Eschenhagen T., 2002, BASIC RES CARDIOL S1, V97, pI146
   Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739
   Fiedler J, 2013, ARTERIOSCL THROM VAS, V33, P201, DOI 10.1161/ATVBAHA.112.300137
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011
   Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1
   Gill S.L., 2014, TECHNOL HLTH CARE
   Giugliano RP, 2003, CIRCULATION, V108, P2828, DOI 10.1161/01.CIR.0000106684.71725.98
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Gojo S, 2007, ANN THORAC SURG, V83, P661, DOI 10.1016/j.athoracsur.2006.06.074
   Gorman RC, 2004, SURG CLIN N AM, V84, P45, DOI 10.1016/S0039-6109(03)00216-0
   Griffith LG, 1998, BIOMATERIALS, V19, P979, DOI 10.1016/S0142-9612(97)00185-3
   Grossi EA, 2010, J AM COLL CARDIOL, V56, P1984, DOI 10.1016/j.jacc.2010.06.051
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Haider HK, 2008, CURR OPIN MOL THER, V10, P611
   Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074
   Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Hesse M, 2014, STEM CELLS, V32, P1701, DOI 10.1002/stem.1696
   Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Houtgraaf JH, 2012, J AM COLL CARDIOL, V59, P539, DOI 10.1016/j.jacc.2011.09.065
   Hsueh YC, 2014, EMBO MOL MED, V6, P496, DOI 10.1002/emmm.201303687
   Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ince H, 2004, J ENDOVASC THER, V11, P695, DOI 10.1583/04-1386R.1
   Ishimaru K, 2013, J THORAC CARDIOV SUR, V146, P1516, DOI 10.1016/j.jtcvs.2013.02.045
   Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152
   Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6
   Jain M, 2001, CIRCULATION, V103, P1920
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035
   Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Johnson NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063075
   Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559
   Jung DW, 2012, ACS CHEM BIOL, V7, P1773, DOI 10.1021/cb3003368
   Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC
   Kai D., 2014, ACTA BIOMATER
   Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60
   Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817
   Kawachi K, 2012, HEART VESSELS, V27, P79, DOI 10.1007/s00380-011-0197-2
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2003, EUR J CARDIO-THORAC, V24, P906, DOI 10.1016/S1010-7940(03)00577-3
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456
   Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733
   Kubota Y, 2014, J THORAC CARDIOV SUR, V147, P1081, DOI 10.1016/j.jtcvs.2013.05.035
   Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6
   Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee LC, 2013, INT J CARDIOL, V168, P2022, DOI 10.1016/j.ijcard.2013.01.003
   Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376
   Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Magovern JA, 2005, SEMIN THORAC CARDIOV, V17, P364, DOI 10.1053/j.semtcvs.2005.09.006
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Mann DL, 2007, ANN THORAC SURG, V84, P1226, DOI 10.1016/j.athoracsur.2007.03.095
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   Mazhari R, 2007, PROG CARDIOVASC DIS, V49, P387, DOI 10.1016/j.pcad.2007.03.004
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Miyagawa S, 2009, SURG TODAY, V39, P133, DOI 10.1007/s00595-008-3803-x
   Monaghan M, 2014, MOL THER, V22, P786, DOI 10.1038/mt.2013.288
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Mukherjee S, 2010, J MATER CHEM, V20, P8819, DOI 10.1039/c0jm00805b
   Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68
   Murakoshi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079374
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   Muthiah M, 2013, EXPERT OPIN DRUG DEL, V10, P1259, DOI 10.1517/17425247.2013.798640
   Nakamura K, 2007, CLIN SCI, V112, P607, DOI 10.1042/CS20060301
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Nasseri BA, 2007, CELL TRANSPLANT, V16, P941, DOI 10.3727/096368907783338235
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/nmeth.2524, 10.1038/NMETH.2524]
   O'Cearbhaill ED, 2014, MAYO CLIN PROC, V89, P259, DOI 10.1016/j.mayocp.2013.10.020
   O'Sullivan JF, 2011, CIRC-CARDIOVASC INTE, V4, P327, DOI 10.1161/CIRCINTERVENTIONS.110.960765
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.04.686
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Parelkar SS, 2014, BIOMACROMOLECULES, V15, P1328, DOI 10.1021/bm401878p
   Pavo N, 2014, BIOMATERIALS, V35, P3541, DOI 10.1016/j.biomaterials.2013.12.071
   Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440
   Perin E.C., 2010, CIRCULATION
   Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418
   Plowright AT, 2014, ANGEW CHEM INT EDIT, V53, P4056, DOI 10.1002/anie.201307034
   Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083
   Pouzet B, 2001, CIRCULATION, V104, pI223
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Projahn D, 2014, J CELL MOL MED, V18, P790, DOI 10.1111/jcmm.12225
   Qayyum AA, 2012, REGEN MED, V7, P421, DOI [10.2217/RME.12.17, 10.2217/rme.12.17]
   Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044
   Qian L, 2012, TISSUE ENG PT A, V18, P1652, DOI [10.1089/ten.tea.2011.0591, 10.1089/ten.TEA.2011.0591]
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rajnoch C, 2001, J THORAC CARDIOV SUR, V121, P871, DOI 10.1067/mtc.2001.112937
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507
   Reinecke H, 2000, CARDIOVASC PATHOL, V9, P337, DOI 10.1016/S1054-8807(00)00055-7
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Roncalli J, 2011, EUR HEART J, V32, P1748, DOI 10.1093/eurheartj/ehq455
   Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104
   Roubille F, 2013, CARDIOVASC DRUG THER, V27, P315, DOI 10.1007/s10557-013-6461-1
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Russo V, 2014, BIOMATERIALS, V35, P3956, DOI 10.1016/j.biomaterials.2014.01.075
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   Sanada F, 2014, CIRC RES, V114, P41, DOI 10.1161/CIRCRESAHA.114.302500
   Sanchis-Gomar F, 2014, INT J CARDIOL, V171, P116, DOI 10.1016/j.ijcard.2013.12.011
   Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Shafy A, 2013, EUR J CARDIO-THORAC, V43, P1211, DOI 10.1093/ejcts/ezs480
   Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Simpson DL, 2012, BIOTECHNOL BIOENG, V109, P274, DOI 10.1002/bit.23301
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Smith R.R., 2013, BIOMATTER, V3
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Smits Pieter C, 2006, EuroIntervention, V1, P417
   Soler-Botija C, 2012, ANN NY ACAD SCI, V1254, P57, DOI 10.1111/j.1749-6632.2012.06519.x
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Song M, 2014, BIOMATERIALS, V35, P2436, DOI 10.1016/j.biomaterials.2013.12.011
   Steendijk Paul, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS94, DOI 10.1038/ncpcardio0416
   Sullivan KMA, 2014, SOUTHERN HUMAN REV, V48, P14
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070
   Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Templin C, 2011, INT J DEV BIOL, V55, P407, DOI 10.1387/ijdb.103219ct
   Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003
   Theiss HD, 2010, INT J CARDIOL, V145, P282, DOI 10.1016/j.ijcard.2009.09.555
   Thornton AJ, 2004, J UROLOGY, V172, P763, DOI 10.1097/01.ju.0000130466.84214.f7
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Tomita S, 1999, CIRCULATION, V100, P247
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726
   Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426
   van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309
   van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Vrtovec B, 2013, CIRCULATION, V128, pS42, DOI 10.1161/CIRCULATIONAHA.112.000230
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Wang HB, 2012, J CELL MOL MED, V16, P1310, DOI 10.1111/j.1582-4934.2011.01409.x
   Wang HX, 2014, CELL REP, V6, P951, DOI 10.1016/j.celrep.2014.01.038
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yacoub Magdi H, 2013, Glob Cardiol Sci Pract, V2013, P5, DOI 10.5339/gcsp.2013.3
   Yi BA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014050
   Yoon J, 2005, ACTA CARDIOL, V60, P277, DOI 10.2143/AC.60.3.2005005
   YOON PD, 1995, TEX HEART I J, V22, P119
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JC1200522326
   Yost MJ, 2004, TISSUE ENG, V10, P273, DOI 10.1089/107632704322791916
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682
   Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013
   Zhang DZ, 2007, CHINESE MED J-PEKING, V120, P300
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang SH, 2004, LIFE SCI, V74, P2853, DOI 10.1016/j.lfs.2003.10.035
   Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015
   Ziegler M, 2012, CIRCULATION, V125, P685, DOI 10.1161/CIRCULATIONAHA.111.070508
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
NR 261
TC 66
Z9 66
U1 13
U2 92
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR
PY 2015
VL 84
BP 85
EP 106
DI 10.1016/j.addr.2014.08.006
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CJ7WC
UT WOS:000355710100006
PM 25172834
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Cezar, CA
   Mooney, DJ
AF Cezar, Christine A.
   Mooney, David J.
TI Biomaterial-based delivery for skeletal muscle repair
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Muscle regeneration; Satellite cell; Synthetic niche; Microenvironmental
   cue; Tissue engineered muscle; Cell therapy; Drug delivery
ID SATELLITE CELL ACTIVATION; HEPATOCYTE GROWTH-FACTOR; STEM-CELLS;
   SELF-RENEWAL; IN-VITRO; ENGINEERED MUSCLE; MYOBLAST TRANSPLANTATION;
   BIOARTIFICIAL MUSCLE; EXTRACELLULAR-MATRIX; POSTNATAL MYOGENESIS
AB Skeletal muscle possesses a remarkable capacity for regeneration in response to minor damage, but severe injury resulting in a volumetric muscle loss can lead to extensive and irreversible fibrosis, scarring, and loss of muscle function. In early clinical trials, the intramuscular injection of cultured myoblasts was proven to be a safe but ineffective cell therapy, likely due to rapid death, poor migration, and immune rejection of the injected cells. In recent years, appropriate therapeutic cell types and culturing techniques have improved progenitor cell engraftment upon transplantation. Importantly, the identification of several key biophysical and biochemical cues that synergistically regulate satellite cell fate has paved the way for the development of cell-instructive biomaterials that serve as delivery vehicles for cells to promote in vivo regeneration. Material carriers designed to spatially and temporally mimic the satellite cell niche may be of particular importance for the complete regeneration of severely damaged skeletal muscle. (C) 2014 Elsevier B.V. All rights reserved.
C1 Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA.
RP Mooney, DJ (reprint author), 29 Oxford St,Room 319, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
FU NIDCR NIH HHS [R01 DE013349]
CR Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Bencze M, 2012, MOL THER, V20, P2168, DOI 10.1038/mt.2012.189
   Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003
   Boonen KJM, 2008, TISSUE ENG PART B-RE, V14, P419, DOI 10.1089/ten.teb.2008.0045
   Boontheekul T, 2008, FARADAY DISCUSS, V139, P53, DOI 10.1039/b719928g
   Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356
   Borisov AB, 2001, ANAT REC, V264, P203, DOI 10.1002/ar.1155
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Bouchentouf M, 2007, AM J TRANSPLANT, V7, P1491, DOI 10.1111/j.1600-6143.2007.01830.x
   Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Cezar C.A., 2014, ADV HEALTHC IN PRESS
   Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb
   Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cossu G, 2007, CELL, V129, P859, DOI 10.1016/j.cell.2007.05.029
   Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903
   Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327
   Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X
   Gates C, 2005, OPER TECHN SPORT MED, V13, P247, DOI 10.1053/j.otsm.2006.01.012
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hall J, 2010, NATION, V291, P2
   Hammers DW, 2012, BIOTECHNOL BIOENG, V109, P1051, DOI 10.1002/bit.24382
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Huang NF, 2010, AM J TRANSL RES, V2, P43
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Juhas M, 2013, CURR OPIN BIOTECH, V24, P880, DOI 10.1016/j.copbio.2013.04.013
   Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kin S, 2007, ASAIO J, V53, P506, DOI 10.1097/MAT.0b013e3180d09d81
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013
   Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595
   Lesault PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046698
   Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111
   Li RK, 2001, ANN THORAC SURG, V72, P1957, DOI 10.1016/S0003-4975(01)03216-7
   Lin S, 2013, MUSCLE NERVE, V47, P194, DOI 10.1002/mus.23447
   Lu YX, 2001, CIRCULATION, V104, P594, DOI 10.1161/hc3101.092215
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   McCullagh K.J., 2014, ADV DRUG DE IN PRESS
   Mendler L, 2008, J HISTOCHEM CYTOCHEM, V56, P111, DOI 10.1369/jhc.7A7322.20071
   Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174
   Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Neal D, 2014, LAB CHIP, V14, P1907, DOI 10.1039/c4lc00023d
   Nguyen HX, 2005, J PHYSIOL-LONDON, V565, P403, DOI 10.1113/jphysiol.2005.085506
   Ota S, 2011, AM J SPORT MED, V39, P1912, DOI 10.1177/0363546511415239
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Palmieri B, 2010, PEDIATR TRANSPLANT, V14, P813, DOI 10.1111/j.1399-3046.2010.01377.x
   Parker MH, 2012, STEM CELLS, V30, P2212, DOI 10.1002/stem.1181
   Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690comd
   Powell C, 1999, HUM GENE THER, V10, P565, DOI 10.1089/10430349950018643
   Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044
   Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049
   Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288
   Salimath A.S., 2014, J TISSUE EN IN PRESS
   Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035
   Shandalov Y, 2014, P NATL ACAD SCI USA, V111, P6010, DOI 10.1073/pnas.1402679111
   Shansky J, 1997, IN VITRO CELL DEV-AN, V33, P659, DOI 10.1007/s11626-997-0118-y
   Shansky J, 2006, TISSUE ENG, V12, P1833, DOI 10.1089/ten.2006.12.1833
   Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1
   Shvartsman D, 2014, MOL THER, V22, P1243, DOI 10.1038/mt.2014.76
   Sicari BM, 2014, SCI TRANSL MED, V6, P234, DOI DOI 10.1126/SCITRANSLMED.3008085
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Sisson TH, 2009, BLOOD, V114, P5052, DOI 10.1182/blood-2008-12-196212
   Slater Clarke R., 2008, V3, P303
   Smythe GM, 2001, J CELL MOL MED, V5, P33, DOI 10.1111/j.1582-4934.2001.tb00136.x
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Tedesco FS, 2012, CURR OPIN NEUROL, V25, P597, DOI 10.1097/WCO.0b013e328357f288
   Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7
   Urciuolo A., 2013, NAT COMMUN, V4
   Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931
   von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110
   Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021
   Wang L, 2014, MOL THER, V22, P1441, DOI 10.1038/mt.2014.78
   Wang L, 2013, MOL NEUROBIOL, V48, P397, DOI 10.1007/s12035-013-8412-z
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   Webster M.T., 2013, PLOS ONE, V8
   Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011
   Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
NR 116
TC 40
Z9 41
U1 7
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR
PY 2015
VL 84
BP 188
EP 197
DI 10.1016/j.addr.2014.09.008
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CJ7WC
UT WOS:000355710100013
PM 25271446
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Manfrini, M
   Mazzoni, E
   Barbanti-Brodano, G
   Nocini, P
   D'agostino, A
   Trombelli, L
   Tognon, M
AF Manfrini, Marco
   Mazzoni, Elisa
   Barbanti-Brodano, Giovanni
   Nocini, Pierfrancesco
   D'agostino, Antonio
   Trombelli, Leonardo
   Tognon, Mauro
TI Osteoconductivity of Complex Biomaterials Assayed by
   Fluorescent-Engineered Osteoblast-like Cells
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Osteoconductivity; Osteointegration; Biomaterial; Bone; Osteoblast
ID GUIDED BONE REGENERATION; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION;
   IN-VITRO; GRAFT SUBSTITUTES; HYDROXYAPATITE; PROLIFERATION; COLLAGEN;
   SCAFFOLDS; ADHESION
AB Biomaterials employed for the bone regeneration can be assayed for specific features such as osteoconductivity and gene expression. In this study, the composite HA/collagen/chondroitin-sulfate biomaterial was investigated using an engineered human cell line, named Saos-eGFP. This cell line, a green fluorescent engineered human osteoblast-like cell, was employed as a cellular model for the in vitro study of biomaterial characteristics. The cytotoxicity was indirectly evaluated by fluorescence detection, osteoconductivity was assayed both by fluorescence and electron microscope analysis as well as cell morphology, whereas the RT-PCR technique was employed to assay gene expression. Saos-eGFP cells viability detection after 24 and 96 h of incubation showed that biomaterial enables the adhesion and proliferation of seeded cells as well as that of the plastic surface, the control. Fluorescence and scanning electron microscopy (SEM) analyses indicated that Saos-eGFP cells were homogeneously distributed on the HA granule surfaces, exhibiting cytoplasmic bridges, and were localized on the collagen-chondroitin sulfate extra-cellular matrix. An expression analysis of specific genes encoding for differentiation markers, showed that biomaterial assayed did not alter the osteogenic pathway of the Saos-eGFP cell line. Our assays confirm the cytocompatibility of this biomaterial, suggesting an osteoconductive capacity mediated by its chemical contents. We showed that the Saos-eGFP cellular model is suitable for in vitro biomaterial assays, and more specifically for assessing osteoconductivity. This result suggests that the cytocompatibility and osteoconductive features of the biomaterial assayed as bone substitute, could have a positive downstream effect on implant osteo-integration.
C1 [Manfrini, Marco; Mazzoni, Elisa; Tognon, Mauro] Univ Ferrara, Sch Med, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.
   [Barbanti-Brodano, Giovanni] Rizzoli Orthopaed Inst, Spine Surg Unit, Bologna, Italy.
   [Nocini, Pierfrancesco; D'agostino, Antonio] Univ Verona, Sch Med, Dept Surg, I-37100 Verona, Italy.
   [Trombelli, Leonardo] Univ Ferrara, Res Ctr Study Periodontal & Peri Implant Dis, I-44100 Ferrara, Italy.
RP Tognon, M (reprint author), Univ Ferrara, Sch Med, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.
EM tgm@unife.it
RI Trombelli, Leonardo/I-4671-2015
OI Trombelli, Leonardo/0000-0002-1147-2199
FU Regione Emilia Romagna; Research Project Region/University "Regenerative
   Medicine in Osteo-articular Diseases; Regenerative medicine for bone
   repair"; AOSpine International, Dubendorf, Switzerland; Fondazione Cassa
   di Risparmio di Bologna, Bologna; Fondazione Cassa di Risparmio di
   Cento, Cento; University of Verona. Italy; University of Ferrara. Italy
FX Dr. Rita Bovolenta's technical assistance is gratefully acknowledged for
   her SEM analysis performed at the Center of Electron Microscopy,
   University of Ferrara, Ferrara, Italy. This study was supported, in
   part, by grants from Regione Emilia Romagna, the Research Project
   Region/University "Regenerative Medicine in Osteo-articular Diseases;
   Regenerative medicine for bone repair"; AOSpine International,
   Dubendorf, Switzerland, project "Gene therapy for bone regeneration";
   Fondazione Cassa di Risparmio di Bologna, Bologna; Fondazione Cassa di
   Risparmio di Cento, Cento; and The Universities of Verona and Ferrara.
   Italy.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Benque E, 1999, INT J ORAL MAX IMPL, V14, P258
   Brunel G, 2001, J PERIODONTOL, V72, P257, DOI 10.1902/jop.2001.72.2.257
   Campioni K., 2010, J BIOMATER NANOBIOTE, V1, P1
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jenis L. G., 2006, US MUSCULOSKELETAL R, V2, P48
   Jones GL, 2010, J BIOMED MATER RES A, V94A, P1244, DOI 10.1002/jbm.a.32805
   Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Locci P, 1997, CELL BIOCHEM FUNCT, V15, P163
   Manfrini M, 2013, J CELL PHYSIOL, V228, P1229, DOI 10.1002/jcp.24276
   Manfrini M., 2011, EUROPEAN MUSCULOSKEL, V6, P96
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Morelli C, 2007, J BIOMED MATER RES A, V83A, P178, DOI 10.1002/jbm.a.31262
   Ogiso M, 1998, J LONG-TERM EFF MED, V8, P193
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Rebaudi A, 2003, INT J PERIODONT REST, V23, P371
   Reichardt L. F., 1999, GUIDEBOOK EXTRACELLU, P335
   RODAN SB, 1987, CANCER RES, V47, P4961
   SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292
   Scabbia A, 2004, J CLIN PERIODONTOL, V31, P348, DOI 10.1111/j.1600-051X.2004.00483.x
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Teixeira S, 2008, J MATER SCI-MATER M, V19, P855, DOI 10.1007/s10856-007-3005-x
   Tognon M., 2008, TOPICS TISSUE ENG, V4, P1
   Trombelli L, 2010, Minerva Stomatol, V59, P103
   Trombelli L, 2010, J PERIODONTOL, V81, P1256, DOI 10.1902/jop.2010.100113
   Trombelli L, 2010, J PERIODONTOL, V81, P158, DOI 10.1902/jop.2009.090275
   Villarreal D R, 1998, J Oral Implantol, V24, P67, DOI 10.1563/1548-1336(1998)024<0067:PAAORT>2.3.CO;2
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 39
TC 2
Z9 2
U1 1
U2 8
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD APR
PY 2015
VL 71
IS 3
BP 1509
EP 1515
DI 10.1007/s12013-014-0374-x
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA CJ2VN
UT WOS:000355342900030
PM 25388843
OA Green Published
DA 2018-10-19
ER

PT J
AU Grenho, L
   Barros, J
   Ferreira, C
   Santos, VR
   Monteiro, FJ
   Ferraz, MP
   Cortes, ME
AF Grenho, L.
   Barros, J.
   Ferreira, C.
   Santos, V. R.
   Monteiro, F. J.
   Ferraz, M. P.
   Cortes, M. E.
TI In vitro antimicrobial activity and biocompatibility of propolis
   containing nanohydroxyapatite
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE nanohydroxyapatite; propolis; antibacterial activity; cytocompatibility
ID BRAZILIAN RED PROPOLIS; CHEMICAL-COMPOSITION; BOTANICAL ORIGIN;
   ANTIBACTERIAL ACTIVITY; PERIODONTAL-LIGAMENT; BIOLOGICAL-ACTIVITY;
   DIFFERENT REGIONS; SALMONELLA-TYPHI; FIBROBLASTS; CONSTITUENTS
AB The high number of biomaterial associated infections demands new strategies to prevent this problem. In this study the suitability of nanohydroxyapatite (nanoHA)-based surfaces containing two Brazilian extracts of propolis (green and red ones) to prevent bacterial growth and biofilm formation, as well as its non-cytotoxic nature, was investigated. Optical density, colony forming units and MTT reduction assay were used to assess the materials' antibacterial activity against planktonic and sessile growth of Staphylococcus aureus. NanoHA matrix was able to absorb both types of propolis and the obtained results revealed the antibacterial effectiveness of the novel materials expressed as the reduction of bacterial growth and biofilm formation ability. Additionally, cell culture tests showed the growth of fibroblasts with high metabolic activity and without membrane damage. Therefore, these nanoHA-based surfaces containing natural products deriving from bees may be a promising bioactive biomaterial to be further studied with the aim of application to orthopaedic or dental devices.
C1 [Grenho, L.; Barros, J.; Monteiro, F. J.; Ferraz, M. P.] Univ Porto, Inst Biomed Engn, INEB, P-4100 Oporto, Portugal.
   [Grenho, L.; Barros, J.; Monteiro, F. J.; Ferraz, M. P.] Univ Porto, Inst Invest & Inovacao Saude I3S, P-4100 Oporto, Portugal.
   [Grenho, L.; Barros, J.; Monteiro, F. J.] Univ Porto, DEMM, Fac Engn, P-4100 Oporto, Portugal.
   [Barros, J.; Ferreira, C.] Univ Porto, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Fac Engn, DEQ, P-4100 Oporto, Portugal.
   [Santos, V. R.; Cortes, M. E.] Univ Fed Minas Gerais, Fac Odontol, Belo Horizonte, MG, Brazil.
   [Ferraz, M. P.] Univ Fernando Pessoa, FP ENAS CEBIMED, Oporto, Portugal.
RP Grenho, L (reprint author), Univ Porto, Inst Biomed Engn, INEB, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
EM liliana.grenho@ineb.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Monteiro, Fernando/0000-0002-1361-4605; Barros,
   Joana/0000-0002-8205-5675
FU INCT/Nanobiofarm; CNPq; FEDER funds through the Programa Operacional
   Factores de Competitividade-COMPETE; Portuguese funds through
   FCT-Fundacao para a Ciencia e a Tecnologia in the framework of the
   NaNOBiofilm project [PTDC/SAU-BMA/111233/2009];  [SFRH/BD/72866/2010]
FX This work was financed by INCT/Nanobiofarm; CNPq; FEDER funds through
   the Programa Operacional Factores de Competitividade-COMPETE; Portuguese
   funds through FCT-Fundacao para a Ciencia e a Tecnologia in the
   framework of the NaNOBiofilm project (PTDC/SAU-BMA/111233/2009); and the
   PhD grant (SFRH/BD/72866/2010). This support is gratefully acknowledged.
   The authors are also grateful to Fluidinova S A for the supply of
   NanoXIM.
CR Al-Shaher A, 2004, J ENDODONT, V30, P359, DOI 10.1097/00004770-200405000-00012
   Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Bankova V, 2005, EVID-BASED COMPL ALT, V2, P29, DOI 10.1093/ecam/neh059
   Barros J, 2014, J BIOMATER APPL, V28, P1325, DOI 10.1177/0885328213507300
   Barud HD, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/703024
   Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007
   Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057
   de Almeida EB, 2013, J ETHNOPHARMACOL, V147, P419, DOI 10.1016/j.jep.2013.03.031
   De Luca MP, 2014, BIOMED RES INT, DOI 10.1155/2014/348647
   Fernandes A, 2005, MEM I OSWALDO CRUZ, V100, P563, DOI 10.1590/S0074-02762005000500018
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Gao JH, 2011, J MATER SCI-MATER M, V22, P1681, DOI 10.1007/s10856-011-4349-9
   Gatto MT, 2002, BIOORGAN MED CHEM, V10, P269, DOI 10.1016/S0968-0896(01)00275-9
   Gjertsen AW, 2011, ORAL SURG ORAL MED O, V112, P843, DOI 10.1016/j.tripleo.2011.08.004
   Gonsales GZ, 2006, J VENOM ANIM TOXINS, V12, P276, DOI 10.1590/S1678-91992006000200009
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hatunoglu E, 2014, ANGLE ORTHOD, V84, P368, DOI 10.2319/020413-101.1
   Isla MI, 2005, J AGR FOOD CHEM, V53, P1166, DOI 10.1021/jf040130h
   Kumar PS, 2012, J CLIN PERIODONTOL, V39, P425, DOI 10.1111/j.1600-051X.2012.01856.x
   Mirzoeva OK, 1997, MICROBIOL RES, V152, P239
   Orsi RO, 2012, NAT PROD RES, V26, P430, DOI 10.1080/14786419.2010.498776
   Orsi RD, 2006, BRAZ J MICROBIOL, V37, P108, DOI 10.1590/S1517-83822006000200002
   Ozan Fatih, 2007, Eur J Dent, V1, P195
   Park YK, 2004, J AGR FOOD CHEM, V52, P1100, DOI 10.1021/jf021060m
   Park YK, 1998, CURR MICROBIOL, V36, P24, DOI 10.1007/s002849900274
   Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b
   Popova M, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-158
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Righi AA, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/267878
   Righi AA, 2011, J SCI FOOD AGR, V91, P2363, DOI 10.1002/jsfa.4468
   Salomao K, 2008, EVID-BASED COMPL ALT, V5, P317, DOI 10.1093/ecam/nem058
   Santana HF, 2012, WORLD J MICROB BIOT, V28, P485, DOI 10.1007/s11274-011-0839-7
   Santos VR, 2008, PHYTOTHER RES, V22, P1544, DOI 10.1002/ptr.2541
   Santos VR, 2005, PHYTOTHER RES, V19, P652, DOI 10.1002/ptr.1715
   Sawaya ACHF, 2004, BRAZ J MICROBIOL, V35, P104, DOI 10.1590/S1517-83822004000100017
   Scazzocchio F, 2006, MICROBIOL RES, V161, P327, DOI 10.1016/j.micres.2005.12.003
   Bonvehi JS, 2012, WORLD J MICROB BIOT, V28, P1351, DOI 10.1007/s11274-011-0932-y
   Sforcin JM, 2007, J ETHNOPHARMACOL, V113, P1, DOI 10.1016/j.jep.2007.05.012
   Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032
   Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059
   Sonmez S, 2005, J ETHNOPHARMACOL, V102, P371, DOI 10.1016/j.jep.2005.06.035
   Szliszka E, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/976415
   TAKAISIKIKUNI NB, 1994, PLANTA MED, V60, P222, DOI 10.1055/s-2006-959463
   Topcuoglu Nursen, 2012, Eur J Dent, V6, P428
   Torlak E, 2013, INT J BIOL MACROMOL, V60, P52, DOI 10.1016/j.ijbiomac.2013.05.013
   Trusheva B, 2006, EVID-BASED COMPL ALT, V3, P249, DOI 10.1093/ecam/ne1006
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
NR 51
TC 13
Z9 15
U1 1
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2015
VL 10
IS 2
AR 025004
DI 10.1088/1748-6041/10/2/025004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ0BK
UT WOS:000355136900004
PM 25784672
DA 2018-10-19
ER

PT J
AU Uklejewski, R
   Winiecki, M
   Musielak, G
   Tokowicz, R
AF Uklejewski, Ryszard
   Winiecki, Mariusz
   Musielak, Grzegorz
   Tokowicz, Renata
TI Effectiveness of various deproteinization processes of bovine cancellous
   bone evaluated via mechano-biostructural properties of produced
   osteoconductive biomaterials
SO BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
LA English
DT Article
DE deproteinized xenogenic osteoconductive biomaterials; processes of bone
   deproteinization; mechano-biostructural properties; bone tissue
   regeneration
ID HYDROGEN-PEROXIDE; CORTICAL BONE; SUBSTITUTE; XENOGRAFT; PROTEIN; ANTLER
AB The purpose of this work was to characterize the results of five different processes of bovine tissue deproteinization, resulting in the fabrication of deproteinized xenogenic osteoconductive biomaterials for bone tissue regeneration as an alternative to autogenic bone grafts. The studies on deproteinization processes of bovine cancellous bone specimens, excised from fresh femoral bovine heads, included the following five processes: thermal deproteinization and four chemical deproteinization processes using the solutions 2.6 wt% sodium hypochlorite, 7 wt% hydrogen peroxide, 1 N potassium hydroxide and 1 N sodium hydroxide. The optimal parameters of the thermal deproteinization were designed on the basis of thermogravimetric analysis (TGA) of bovine bone specimens during a pilot study of the process. Periodical evaluation of all the processes of chemical deproteinization was performed via the assessment of protein concentration in bone specimens by the Lowry method. The mechanical properties of deproteinized bone specimens were evaluated by compression testing in the air-dry condition. The compressive strength of the completely deproteinized bone specimens after the thermal deproteinization process was remarkably lower compared with those after the chemical deproteinization processes: 6.5 times lower compared with those deproteinized with 7 wt% hydrogen peroxide solution and 3 times lower compared with those deproteinized with 2.6 wt% sodium hypochlorite solution. The SEM examination of deproteinized bone specimens showed microcracks on the trabecular surfaces generated by thermal deproteinization stresses. The presence of microcracks in the biomaterial resulted in a decrease in its ultimate compressive strength.
C1 [Uklejewski, Ryszard; Winiecki, Mariusz; Musielak, Grzegorz; Tokowicz, Renata] Poznan Univ Tech, Lab Biomat & Periimplant Bioproc Engn, Dept Proc Engn, Inst Technol & Chem Engn, PL-60965 Poznan, Poland.
   [Uklejewski, Ryszard; Winiecki, Mariusz] Casimir Great Univ, Dept Med Bioengn Fundamentals, Inst Technol, PL-85064 Bydgoszcz, Poland.
RP Uklejewski, R (reprint author), Poznan Univ Tech, Lab Biomat & Periimplant Bioproc Engn, Dept Proc Engn, Inst Technol & Chem Engn, Pl Marii Sklodowskiej Curie 2, PL-60965 Poznan, Poland.
EM uklejew@ukw.edu.pl
RI Musielak, Grzegorz/N-9872-2013; Winiecki, Mariusz/J-4565-2013
OI Winiecki, Mariusz/0000-0002-3568-2473
FU Polish Ministry of Science [NN518412638]
FX This research was supported by the Polish Ministry of Science research
   project No. NN518412638: The thermochemical surface modification of
   preprototypes of the minimally invasive RHA endoprostheses and porous
   intraosseous implants (Head: R. Uklejewski).
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389
   Bertazzo S, 2008, J INORG BIOCHEM, V102, P137, DOI 10.1016/j.jinorgbio.2007.07.031
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   Castro-Cesena A. B., 2011, MRS P, V1301, DOI [10.1557/opl.2011.194, DOI 10.1557/OPL.2011.194]
   Castro-Cesena AB, 2013, MAT SCI ENG C-MATER, V33, P4958, DOI 10.1016/j.msec.2013.08.022
   Chen PY, 2009, ACTA BIOMATER, V5, P693, DOI 10.1016/j.actbio.2008.09.011
   Chen PY, 2011, J MECH BEHAV BIOMED, V4, P961, DOI 10.1016/j.jmbbm.2011.02.006
   Chen PY, 2011, CALCIFIED TISSUE INT, V88, P351, DOI 10.1007/s00223-011-9462-8
   Cho JS, 2013, J BIOMED MATER RES B, V101B, P855, DOI 10.1002/jbm.b.32890
   Figueiredo MM, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P315
   Hui-fen X., 2011, J CLIN REHAB TISS EN, V15, P8749
   Jankovic B, 2011, THERMOCHIM ACTA, V521, P130, DOI 10.1016/j.tca.2011.02.044
   Jian YK, 2008, CHIN J TRAUMATOL, V11, P152, DOI 10.1016/S1008-1275(08)60032-2
   Liu Lei, 2007, Chin J Traumatol, V10, P59
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manilay Z, 2013, ACTA BIOMATER, V9, P5280, DOI 10.1016/j.actbio.2012.08.040
   Murugan R, 2003, B MATER SCI, V26, P523, DOI 10.1007/BF02707351
   Sciadini MF, 1997, J ORTHOPAED RES, V15, P844, DOI 10.1002/jor.1100150609
   Stavropoulos Andreas, 2008, P119, DOI 10.1007/978-1-59745-239-7_7
   Wynnyckyj C, 2011, BBA-GEN SUBJECTS, V1810, P192, DOI 10.1016/j.bbagen.2010.10.003
   Wynnyckyj C, 2009, BONE, V44, P840, DOI 10.1016/j.bone.2008.12.014
   Zhang XH, 2013, BIOMATERIALS, V34, P9103, DOI 10.1016/j.biomaterials.2013.08.024
NR 24
TC 2
Z9 2
U1 0
U2 11
PU KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
PI SEOUL
PA KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL
   135-703, SOUTH KOREA
SN 1226-8372
EI 1976-3816
J9 BIOTECHNOL BIOPROC E
JI Biotechnol. Bioprocess Eng.
PD APR
PY 2015
VL 20
IS 2
BP 259
EP 266
DI 10.1007/s12257-013-0510-2
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CI4IK
UT WOS:000354711700008
DA 2018-10-19
ER

PT J
AU Kim, DG
   Woo, KD
   Kang, DS
   Lee, T
   Lee, MH
AF Kim, D. G.
   Woo, K. D.
   Kang, D. S.
   Lee, T.
   Lee, M. H.
TI Fabrication and biocompatibility evaluation of porous Ti-Nb-based
   biomaterials with space holder by rapid sintering
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Biomaterial; Ti alloy; Space holder; Spark plasma sintering; High-energy
   mechanical milling; Biocompatibility
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; MICROSTRUCTURE
AB Biomaterials of titanium and its alloys are useful as implant materials in orthopaedic surgery. In this study, porous Ti-13wt% Nb-13wt% Zr biomaterials were successfully fabricated using powder metallurgy by adding 10-30 wt-% NH4HCO3 as a space holder and TiH2 as a foaming agent to mixed and milled Ti-Nb-Zr powders. The alloy powders were consolidated by spark plasma sintering process at 1123 K under 30 MPa conditions. The effect of space holder content on the pore size and distribution of the Ti-13wt% Nb-13wt% Zr (TNZ) alloys was observed by optical microscopy and scanning electron microscopy. These microstructure observations revealed that the volume fraction of the pores increased with increasing space holder content. The pore size of the TNZ alloy changed from the 100 mu m scale to the 10 mu m scale with increasing milling time and space holder content in the TNZ powders. The porous TNZ alloys exhibited good biocompatibility.
C1 [Kim, D. G.; Woo, K. D.; Kang, D. S.; Lee, T.] Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561756, South Korea.
   [Kim, D. G.; Woo, K. D.; Kang, D. S.; Lee, T.] Chonbuk Natl Univ, RCAMD, Jeonju 561756, South Korea.
   [Lee, M. H.] Chonbuk Natl Univ, Sch Dent, Dept Dent Biomat, Jeonju 561756, South Korea.
RP Woo, KD (reprint author), Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561756, South Korea.
EM kdwoo@jbnu.ac.kr
FU National Research Foundation (NRF) of Korea [2013R1A1A4A01005459];
   Chonbuk National University
FX This research was conducted with financial support from the National
   Research Foundation (NRF) (No. 2013R1A1A4A01005459) of Korea and was
   partially supported by research funds of Chonbuk National University in
   2014.
CR Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Kim HS, 2006, SCRIPTA MATER, V54, P887, DOI 10.1016/j.scriptamat.2005.11.001
   Lee B, 2014, MATER DESIGN, V57, P712, DOI 10.1016/j.matdes.2013.12.078
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nouri A, 2010, BIOMIMETICS, LEARNING FROM NATURE, P415
   OKAZAKI Y, 1995, J JPN I MET, V59, P108, DOI 10.2320/jinstmet1952.59.1_108
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Woo K. D., 2014, P 16 INT S MAT SCI E
NR 10
TC 2
Z9 2
U1 0
U2 32
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD APR
PY 2015
VL 19
SU 1
BP S301
EP S304
DI 10.1179/1432891715Z.0000000001491
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA CI7QA
UT WOS:000354957900066
DA 2018-10-19
ER

PT J
AU Lee, HC
   Wo, KD
   Kang, DS
   Lee, T
   Oh, ST
   Kang, WJ
AF Lee, H. C.
   Wo, K. D.
   Kang, D. S.
   Lee, T.
   Oh, S. T.
   Kang, W. J.
TI Effect of cobalt-aluminate addition on microstructure and mechanical
   property of Co-Cr-Mo alloy
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Co-Cr-Mo alloy; Inoculant; Lamellar structure; gamma Co-phase; Carbide;
   sigma-phase; Grain refinement; Cobalt-aluminate
ID IMPROVEMENT; SUPERALLOY
AB The as-cast Co-Cr-Mo alloy (ASTM F75) has been widely used as biomaterial in orthopaedic implant because of its excellent mechanical properties, good corrosion resistance and biocompatibility. However, some defects such as porosity and pinhole in an as-cast make some problems for application. Therefore in this study, the cobalt-aluminate (CoAl2O4) used as an inoculant during coating plays to refine the grain size and to reduce the porosity and pinhole content in an as-cast. Therefore, the effect of an inoculant addition on defect content, microstructure and mechanical properties of as-cast Co-Cr-Mo alloy has been investigated. The mechanical properties of the Co-Cr-Mo alloy were improved by addition of an inoculant.
C1 [Lee, H. C.; Wo, K. D.; Kang, D. S.; Lee, T.; Oh, S. T.] Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561765, South Korea.
   [Lee, H. C.; Wo, K. D.; Kang, D. S.; Lee, T.; Oh, S. T.] Chonbuk Natl Univ, RCAMD, Jeonju 561765, South Korea.
   [Kang, W. J.] NIB Mat Co Ltd, Jeonbuk 561330, South Korea.
RP Wo, KD (reprint author), Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561765, South Korea.
EM kdwoo@jbnu.ac.kr
FU Small and Medium Business Administration (SMBA) of Korea [1301000619]
FX This research was conducted with financial support from the Small and
   Medium Business Administration (SMBA) (No. 1301000619) of Korea.
CR Binczyk F., 2011, KOMPOZYTY, V11, P49
   Giacchi JV, 2011, MATER CHARACT, V62, P53, DOI 10.1016/j.matchar.2010.10.011
   Jin WZ, 2008, MATER LETT, V62, P1585, DOI 10.1016/j.matlet.2007.09.028
   Jurosu S., 2010, MATER LETT, V64, P49
   Kaiser R, 2013, J MECH BEHAV BIOMED, V24, P53, DOI 10.1016/j.jmbbm.2013.04.013
   Krauss G., 2005, STEELS PROCESSING ST, P97
   Lee SH, 2008, MATER TRANS, V49, P260, DOI 10.2320/matertrans.MRA2007220
   Ocampo C.M., 1999, METALL MATER TRANS A, V30, P611
   Szala J, 2006, MATER CHARACT, V56, P325, DOI 10.1016/j.matchar.2005.11.015
   Wang DL, 2006, RARE METAL MAT ENG, V35, P1294
NR 10
TC 0
Z9 0
U1 1
U2 8
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD APR
PY 2015
VL 19
SU 1
BP S66
EP S69
DI 10.1179/1432891715Z.0000000001370
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA CI7QA
UT WOS:000354957900014
DA 2018-10-19
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Rzadkiewicz, S
   Raaen, S
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Rzadkiewicz, Slawomir
   Raaen, Steiner
TI HIGH-CURRENT-DENSITY ELECTROPOLISHING (HDEP) OF AISI 316L (EN 1.4404)
   STAINLESS STEEL
SO TEHNICKI VJESNIK-TECHNICAL GAZETTE
LA English
DT Article
DE biomaterials; corrosion; electropolishing; electrochemical techniques;
   surface properties; X-ray photo-emission spectroscopy (XPS)
ID MAGNETIC-FIELD; XPS; SURFACE; SPECTROSCOPY; BEHAVIOR; SPECTRA; STENTS;
   RANGE; SS
AB The paper presents new XPS results of surface layers formed after electrochemical polishing of AISI 316L stainless steel at high current density (HDEP) of 1000 A/dm(2) (EP1000) versus a standard electropolishing (EP50) process used in the industry, i.e. at 50 A/dm(2). For the investigation, different compositions of electrolytes, based on orthophosphoric and sulfuric acids in proportions 4:6, 6:4, 1:0, respectively, were used. The obtained results have clearly shown that both the solution composition and current density highly influence the structure and compositions of passive layers formed after electrochemical treatments. For the steel used as a biomaterial, the surface films with a minimum amount of carcinogenic nickel was found; here also a maximum (Cr+ 3.3.Mo)/Fe coefficient was noticed. On the basis of the obtained results it can be concluded that for 316L SS used as a biomaterial, the electrochemical treatments EP50 and EP1000 in 40 vol% H3PO4 and 60 vol% H2SO4 solution as well as EP50 in 60 vol% H3PO4 and 40 vol% H2SO4 solution, should be used. In case of 316L SS not to be used for implants in the human body, EP1000 in pure concentrated orthophosphoric acid, is advised. EP1000 treatment of the 316L SS in 60 vol% H3PO4 and 40 vol% H2SO4 electrolyte may be used in case of applying the biomaterial for a non-Ni-allergic patient.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz; Rzadkiewicz, Slawomir] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Engn, PL-75620 Koszalin, Poland.
   [Raaen, Steiner] Norwegian Univ Sci & Technol NTNU, Dept Phys, NO-7491 Trondheim, Norway.
RP Rokosz, K (reprint author), Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Engn, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl;
   steinar.raaen@ntnu.no
CR Biesinger MC, 2004, SURF INTERFACE ANAL, V36, P1550, DOI 10.1002/sia.1983
   Chen SC, 2005, SURF COAT TECH, V200, P2065, DOI 10.1016/j.surfcoat.2005.06.008
   Crist B.V., 2000, HDB MONOCHROMATIC XP
   Daulton TL, 2006, ULTRAMICROSCOPY, V106, P561, DOI 10.1016/j.ultramic.2006.02.005
   Faust C. L., 1982, MET FINISH, V80, P89
   Faust C. L., 1982, MET FINISH, V80, P21
   FAUST CL, 1983, MET FINISH, V81, P47
   FAUST CL, 1983, MET FINISH, V81, P53
   Flori M., 2007, ANN FACULTY ENG HUNE, V5, P165
   Geller ZE, 2008, MATER SCI FORUM, V589, P367, DOI 10.4028/www.scientific.net/MSF.589.367
   Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984
   Hensel K. B., 2000, MET FINISH, V98, P440, DOI [DOI 10.1016/S0026-0576(00)80353-0, 10.1016/S0026-0576(00)80353-0]
   HOCHENG H, 2001, Patent No. 6315885
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T., 1997, P 1 INT C MACH MEAS, P331
   Hryniewicz T., 1997, P INT SCI C CHALL CI, V2, P515
   Hryniewicz T., 1989, PHYSICOCHEMICAL TECH
   Hryniewicz T., 2004, SURFACE COATINGS TEC
   Hryniewicz T, 1978, THESIS
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Kao PS, 2003, J MATER PROCESS TECH, V140, P255, DOI 10.1016/S0924-0136(03)00747-7
   Kish JR, 2003, CORROS SCI, V45, P1571, DOI 10.1016/S0010-938X(02)00232-9
   Mazumder M. K., 2001, ELECT SURFACE STRUCT
   Nesbitt HW, 1998, AM MINERAL, V83, P305
   Raval A, 2004, MAT SCI ENG A-STRUCT, V386, P331, DOI 10.1016/j.msea.2004.07.051
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P545
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P460
   Rokosz Krzysztof, 2011, Pomiary Automatyka Kontrola, V57, P563
   Rokosz K., 2011, AUTOBUSY TECHNIKA EK, V5, P1
   Rokosz K., 2012, AUTOBUSY TECHNIKA EK, V5, P421
   Rokosz K, 2012, ELECTROMECHANICAL PO
   Rokosz K., 2010, CORROSION J SCI ENG, V66
   Rokosz K, 2013, INT J MATER RES, V104, P1223, DOI 10.3139/146.110984
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Santonen T., 2010, REV TOXICITY STAINLE
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Srinivasan K., 2002, 202 M SALT LAK CIT U, P355
   Tauson V. L., 2010, GEOCHEM INT, V48, P565
   Toma Y., 2009, Electrochemical polishing method and polishing method, Patent No. [US 2009/0095637 A1, 20090095637]
   Tomassi P., 2002, PORADNIK GALWANOTECH, P125
   Wang Y., 2002, SURF SCI SPECTRA, V9, P91
   Wang Y., 2002, SURFACE SCI SPECTRA, V9, P99
   Zhao H., 2003, PROGR BIOMED RES, V8, P70
NR 46
TC 8
Z9 8
U1 1
U2 10
PU UNIV OSIJEK, TECH FAC
PI SLAVONSKI BROD
PA TRG IVANE BRLIC-MAZURANIC 2, SLAVONSKI BROD, HR-35000, CROATIA
SN 1330-3651
EI 1848-6339
J9 TEH VJESN
JI Teh. Vjesn.
PD APR
PY 2015
VL 22
IS 2
BP 415
EP 424
DI 10.17559/TV-20140722110711
PG 10
WC Engineering, Multidisciplinary
SC Engineering
GA CG9JK
UT WOS:000353630900021
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Jang, HL
   Lee, K
   Kang, CS
   Lee, HK
   Ahn, HY
   Jeong, HY
   Park, S
   Kim, SC
   Jin, K
   Park, J
   Yang, TY
   Kim, JH
   Shin, SA
   Han, HN
   Oh, KH
   Lee, HY
   Lim, J
   Hong, KS
   Snead, ML
   Xu, J
   Nam, KT
AF Jang, Hae Lin
   Lee, Keunho
   Kang, Chan Soon
   Lee, Hye Kyoung
   Ahn, Hyo-Yong
   Jeong, Hui-Yun
   Park, Sunghak
   Kim, Seul Cham
   Jin, Kyoungsuk
   Park, Jimin
   Yang, Tae-Youl
   Kim, Jin Hong
   Shin, Seon Ae
   Han, Heung Nam
   Oh, Kyu Hwan
   Lee, Ho-Young
   Lim, Jun
   Hong, Kug Sun
   Snead, Malcolm L.
   Xu, Jimmy
   Nam, Ki Tae
TI Biofunctionalized Ceramic with Self-Assembled Networks of Nanochannels
SO ACS NANO
LA English
DT Article
DE nanochannels; hierarchical structures; bioinspired; fluid transports;
   ceramics; pressure gradient sintering; polymer agglomeration
ID POROUS CERAMICS; CAPILLARY-FLOW; MICROSTRUCTURE; BONE; THERMODYNAMICS;
   PRINCIPLES; MECHANISM; TRANSPORT; BINDING; SYSTEMS
AB Nature designs circulatory systems with hierarchically organized networks of gradually tapered channels ranging from micrometer to nanometer in diameter. In most hard tissues in biological systems, fluid, gases, nutrients and wastes are constantly exchanged through such networks. Here, we developed a biologically inspired, hierarchically organized structure in ceramic to achieve effective permeation with minimum void region, using fabrication methods that create a long-range, highly interconnected nanochannel system in a ceramic biomaterial. This design of a synthetic model-material was implemented through a novel pressurized sintering process formulated to induce a gradual tapering in channel diameter based on pressure-dependent polymer agglomeration. The resulting system allows long-range, efficient transport of fluid and nutrients into sites and interfaces that conventional fluid conduction cannot reach without external force. We demonstrate the ability of mammalian bone-forming cells placed at the distal transport termination of the nanochannel system to proliferate in a manner dependent solely upon the supply of media by the self-powering nanochannels. This approach mimics the significant contribution that nanochannel transport plays in maintaining living hard tissues by providing nutrient supply that facilitates cell growth and differentiation, and thereby makes the ceramic composite "alive".
C1 [Jang, Hae Lin; Lee, Keunho; Kang, Chan Soon; Lee, Hye Kyoung; Ahn, Hyo-Yong; Jeong, Hui-Yun; Park, Sunghak; Kim, Seul Cham; Jin, Kyoungsuk; Park, Jimin; Yang, Tae-Youl; Kim, Jin Hong; Shin, Seon Ae; Han, Heung Nam; Oh, Kyu Hwan; Hong, Kug Sun; Nam, Ki Tae] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea.
   [Lee, Ho-Young] Seoul Natl Univ, Bundang Hosp, Dept Nucl Med, Seoul 463707, South Korea.
   [Lim, Jun] POSTECH, Pohang Accelerator Lab, Pohang 790784, South Korea.
   [Snead, Malcolm L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA.
   [Xu, Jimmy] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   [Xu, Jimmy] Brown Univ, Dept Phys, Providence, RI 02912 USA.
RP Snead, ML (reprint author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.
EM mlsnead@usc.edu; jimmy_xu@brown.edu; nkitae@snu.ac.kr
RI Han, Heung Nam/D-6461-2013; oh, kyuhwan/H-5265-2018; Han, Heung
   Nam/I-7675-2016
OI Han, Heung Nam/0000-0001-5271-9023; Jin, Kyoungsuk/0000-0003-3009-6691;
   Nam, Ki Tae/0000-0001-6353-8877
FU Basic Science Research Program, through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT Future [2011-0011225]; Global
   Frontier R&D Program on Center for Multiscale Energy System - National
   Research Foundation under the Ministry of Science, ICT Future, Korea
   [0420-20130104]; International Research & Development Program of the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning [2013K1A3A1A32035536]; Brown University by an Air Force
   Office of Scientific Research (AFOSR); Brown's Institute of Brain
   Sciences; National Institute for Dental and Craniofacial Research Grant
   from the National Institutes of Health; U.S. Public Health Service;
   Basic Science Research Program through the National Research Foundation
   in Korea funded by the Ministry of Science, ICT, and Future Planning
   [NRF-2013R1A2A2A01008806]
FX This research was supported by the Basic Science Research Program,
   through the National Research Foundation of Korea (NRF), funded by the
   Ministry of Science, ICT & Future (No. Grant Number: 2011-0011225); the
   Global Frontier R&D Program on Center for Multiscale Energy System
   funded by the National Research Foundation under the Ministry of
   Science, ICT & Future, Korea (0420-20130104); the International Research
   & Development Program of the National Research Foundation of Korea
   (NRF), funded by the Ministry of Science, ICT & Future Planning (No.
   2013K1A3A1A32035536); and at Brown University by an Air Force Office of
   Scientific Research (AFOSR) grant for functional composite materials and
   seed funding from Brown's Institute of Brain Sciences. MLS was supported
   by National Institute for Dental and Craniofacial Research Grant R37
   DE13045 from the National Institutes of Health, U.S. Public Health
   Service. KL and HNH were supported by the Basic Science Research Program
   through the National Research Foundation in Korea funded by the Ministry
   of Science, ICT, and Future Planning (NRF-2013R1A2A2A01008806).
CR Bal K, 2011, INT J HEAT MASS TRAN, V54, P3096, DOI 10.1016/j.ijheatmasstransfer.2011.02.048
   Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557
   Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144
   Barber RW, 2008, MICROFLUID NANOFLUID, V4, P179, DOI 10.1007/s10404-007-0163-6
   Bejan A, 2006, J APPL PHYS, V100, DOI 10.1063/1.2221896
   BROOKES M, 1961, LANCET, V1, P1078
   CHAKLADE.AC, 1965, NATURE, V206, P392, DOI 10.1038/206392c0
   Cho JS, 2013, J EUR CERAM SOC, V33, P233, DOI 10.1016/j.jeurceramsoc.2012.08.029
   Chung S, 2009, SMALL, V5, P609, DOI 10.1002/smll.200800748
   Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270
   Dickson KM, 2001, CALCIFIED TISSUE INT, V68, P304, DOI 10.1007/BF02390838
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Driessens FCM, 1990, BIOMINERALS
   Eijkel JCT, 2007, LAB CHIP, V7, P1630, DOI 10.1039/b716545p
   Fan JT, 2007, MATER LETT, V61, P561, DOI 10.1016/j.matlet.2006.05.009
   Feldman KE, 2010, MACROMOLECULES, V43, P5121, DOI 10.1021/ma1003776
   Gupta S, 2006, NAT MATER, V5, P229, DOI 10.1038/nmat1582
   Gupta S, 2006, NANO LETT, V6, P2066, DOI 10.1021/nl061336v
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jang H. L., 2013, ACS NANO, V8, P634
   McNamee CE, 2007, BIOPHYS J, V93, P324, DOI 10.1529/biophysj.106.102251
   Nogueiras-Nieto L, 2011, J CONTROL RELEASE, V156, P337, DOI 10.1016/j.jconrel.2011.08.021
   Ozdemir C, 2006, J APPL POLYM SCI, V101, P203, DOI 10.1002/app.23191
   Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108
   Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023
   Ramesh S, 2012, MATER DESIGN, V34, P148, DOI 10.1016/j.matdes.2011.08.011
   Renvoise P, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/64003
   Reyssat M, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/56002
   RONCA G, 1985, MACROMOLECULES, V18, P665, DOI 10.1021/ma00146a015
   RUBEGA MA, 1993, AUK, V110, P169
   SAKELLARIOU P, 1986, INT J PHARM, V31, P55, DOI 10.1016/0378-5173(86)90212-7
   Seidl B, 2011, J STRUCT BIOL, V174, P512, DOI 10.1016/j.jsb.2011.03.005
   Shou D., 2013, LANGMUIR, V30, P149
   Shou DH, 2014, LANGMUIR, V30, P5448, DOI 10.1021/la500479e
   Singh R., 2011, ADV MAT RES, V264, P1856
   Sparreboom W, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/015004
   Sparreboom W, 2009, NAT NANOTECHNOL, V4, P713, DOI [10.1038/nnano.2009.332, 10.1038/NNANO.2009.332]
   TRIMM DL, 1986, APPL CATAL, V21, P215, DOI 10.1016/S0166-9834(00)81356-1
   Weibel A, 2007, J EUR CERAM SOC, V27, P2641, DOI 10.1016/j.jeurceramsoc.2006.11.073
   Yang JF, 2001, J MATER RES, V16, P1916, DOI 10.1557/JMR.2001.0262
   Zheng YM, 2010, NATURE, V463, P640, DOI 10.1038/nature08729
   Zhou J, 2011, NANO RES, V4, P171, DOI 10.1007/s12274-010-0067-8
NR 42
TC 5
Z9 5
U1 0
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD APR
PY 2015
VL 9
IS 4
BP 4447
EP 4457
DI 10.1021/acsnano.5b01052
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CH2PL
UT WOS:000353867000114
PM 25827409
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kratz, F
   Grass, S
   Umanskaya, N
   Scheibe, C
   Muller-Renno, C
   Davoudi, N
   Hannig, M
   Ziegler, C
AF Kratz, Fabian
   Grass, Simone
   Umanskaya, Natalia
   Scheibe, Christian
   Mueller-Renno, Christine
   Davoudi, Neda
   Hannig, Matthias
   Ziegler, Christiane
TI Cleaning of biomaterial surfaces: Protein removal by different solvents
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biomaterials; Cleaning; BCA-assay; TEM; Protein removal
ID BOVINE SERUM-ALBUMIN; DENTAL MATERIALS; ADSORPTION; HYDROXYAPATITE;
   WETTABILITY; MICROSCOPY; FIBRINOGEN; PELLICLE; FILMS; PH
AB The removal of biofilms or protein films from biomaterials is still a challenging task. In particular, for research investigations on real (applied) surfaces the reuse of samples is of high importance, because reuse allows the comparison of the same sample in different experiments.
   The aim of the present study was to evaluate the cleaning efficiency of different solvents (SOS, water, acetone, isopropanol, RIPA-buffer and Tween-20) on five different biomaterials (titanium, gold, PMMA (no acetone used), ceramic, and PTFE) with different wettability which were covered by layers of two different adsorbed proteins (BSA and lysozyme). The presence of a protein film after adsorption was confirmed by transmission electron microscopy (TEM).
   After treatment of the surfaces with the different solvents, the residual proteins on the surface were determined by BCA-assay (bicinchoninic acid assay). Data of the present study indicate that SDS is an effective solvent, but for several protein substrate combinations it does not show the cleaning efficiency often mentioned in literature. RIPA-buffer and Tween-20 were more effective. They showed very low residual protein amounts after cleaning on all examined material surfaces and for both proteins, however, with small differences for the respective substrate protein combinations. RIPA-buffer in combination with ultrasonication completely removed the protein layer as confirmed by TEM. (c) 2015 Elsevier B.V. All rights reserved.
C1 [Kratz, Fabian; Scheibe, Christian; Mueller-Renno, Christine; Davoudi, Neda; Ziegler, Christiane] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.
   [Kratz, Fabian; Scheibe, Christian; Mueller-Renno, Christine; Davoudi, Neda; Ziegler, Christiane] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany.
   [Grass, Simone; Umanskaya, Natalia; Hannig, Matthias] Univ Saarland, Clin Operat Dent Periodontol & Prevent Dent, D-66421 Homburg, Germany.
RP Ziegler, C (reprint author), Erwin Schrodinger Str 56, D-67663 Kaiserslautern, Germany.
EM cz@physik.uni-kl.de
OI Ziegler, Christiane/0000-0002-7963-3729
FU German Research Foundation (DFG) as part of the collaborative research
   center [(SFB) 926];  [Zi 487/12-3];  [Ha 2718/7-3]
FX We acknowledge the financial support by the German Research Foundation
   (DFG) within the project B06 as part of the collaborative research
   center (SFB) 926 and the projects Zi 487/12-3 and Ha 2718/7-3. The
   helping hands of Jeanne-Carla Sprenger and Marie-Christine Angermann
   were highly appreciated during the lab work.
CR BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Can B.M.C., 1981, J COLLOID INTERF SCI, V82, P217
   Cheng K.C., 2010, APPL MICROBIOL BIOT, V86, P445
   Ercan D., 2013, CRIT REV BI IN PRESS
   FENG MH, 1995, J BIOMAT SCI-POLYM E, V7, P415
   GORBUNOFF MJ, 1984, ANAL BIOCHEM, V136, P440, DOI 10.1016/0003-2697(84)90241-0
   Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3
   Hannig M, 2005, CLIN ORAL INVEST, V9, P30, DOI 10.1007/s00784-004-0284-1
   Hannig M, 1997, EUR J ORAL SCI, V105, P422, DOI 10.1111/j.1600-0722.1997.tb02139.x
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   KONDO A, 1991, J COLLOID INTERF SCI, V143, P214, DOI 10.1016/0021-9797(91)90454-G
   Kratz F, 2013, PHYS STATUS SOLIDI A, V210, P964, DOI 10.1002/pssa.201200642
   Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528
   Li J., 2004, J APPL MICROBIOL, V46, P293
   Luan YF, 2014, LANGMUIR, V30, P1029, DOI 10.1021/la403498w
   MATTILASANDHOLM T, 1992, FOOD REV INT, V8, P573, DOI 10.1080/87559129209540953
   Muller C, 2010, LANGMUIR, V26, P4136, DOI 10.1021/la903299y
   Muller-Renno C., 2013, ADV BIOCH ENG BIOTEC
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   SEEBER SJ, 1991, VACCINE, V9, P201, DOI 10.1016/0264-410X(91)90154-X
   Sharpe JR, 1997, BIOMATERIALS, V18, P471, DOI 10.1016/S0142-9612(96)00157-3
   Sotres J, 2011, LANGMUIR, V27, P13692, DOI 10.1021/la202870c
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
NR 26
TC 5
Z9 5
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 28
EP 35
DI 10.1016/j.colsurfb.2015.02.016
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000005
PM 25725311
DA 2018-10-19
ER

PT J
AU Kandiah, K
   Venkatachalam, R
   Wang, CY
   Valiyaveettil, S
   Ganesan, K
AF Kandiah, Kavitha
   Venkatachalam, Rajendran
   Wang, Chunyan
   Valiyaveettil, Suresh
   Ganesan, Kumaresan
TI In vitro and preliminary in vivo toxicity screening of high-surface-area
   TiO2-chondroitin-4-sulfate nanocomposites for bone regeneration
   application
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Titania-chondroitin-4 sulfate; Biocompatibility; In vitro bioactivity;
   Osteoblast cell line; Gene expression; Zebra fish
ID TISSUE ENGINEERING APPLICATIONS; OSTEOBLAST-LIKE CELLS; CHONDROITIN
   SULFATE; ANTIBACTERIAL ACTIVITY; SILVER NANOPARTICLES; ZEBRAFISH
   EMBRYOS; OXIDATIVE STRESS; CHITOSAN; SCAFFOLDS; GROWTH
AB The goal of this study was to prepare nontoxic, biomimetic TiO2/chondroitin-4-sulfate nanocomposites with osteointegration ability for biomedical applications. Nanocomposites with higher surface area were subjected to bioactivity study and obtained bone-like layer with stoichiometric Ca/P ratio of 1.64 and 1.66. The susceptibility of nanocomposites against Staphylococcus aureus (similar to 16 mm) and Escherichia coli (similar to 12 mm) is favorable in preventing the risk of bone diseases and postoperative infections. Adequate swelling and degradations properties were favorably achieved to reduce the risk of nanoparticle accumulation in cell organelles. Moreover, the toxicity in AGS cell line and biocompatibility in osteoblast-like MG-63 cell line showed no significant mitochondrial damage. In addition, the in vitro expression of osteoblast inducing genes (OCN, OPN, ALP and COL 1) and their up-regulation, and 20% of increased hatching rate in preliminary in vivo (zebrafish) analysis were favorable for the nanocomposite at the ratio of 2:0.50 than pure TiO2. Hence, it can be concluded that among the prepared nanocomposites TCs.5 is a promising biomimetic biomaterial that can be used for advanced orthopedic research and other applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kandiah, Kavitha; Venkatachalam, Rajendran] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
   [Wang, Chunyan; Valiyaveettil, Suresh] Natl Univ Singapore, Dept Chem, Fac Sci, Singapore 117543, Singapore.
   [Ganesan, Kumaresan] Madurai Kamaraj Univ, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India.
RP Venkatachalam, R (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM veerajendran@gmail.com
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
FU UGC-DAE Consortium [CSR/Acctts/2010-11/1136]; Metal Physics Section,
   Indira Gandhi Centre for Atomic Research, Kalpakkam node
FX The authors acknowledge the UGC-DAE Consortium for research funding
   (CSR/Acctts/2010-11/1136 dt.06.01.2011) and Dr. G. Amarendra, Head,
   Metal Physics Section, Indira Gandhi Centre for Atomic Research,
   Kalpakkam node, for the financial support and valuable suggestions to
   carry out the research.
CR Asharani PV, 2011, NANOTOXICOLOGY, V5, P43, DOI 10.3109/17435390.2010.489207
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bobe K, 2013, ACTA BIOMATER, V9, P8611, DOI [10.1016/j.actbio.2013.03.035, 10.1016/j.actbio2013.03.035]
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Chung YC, 2004, ACTA PHARMACOL SIN, V25, P932
   DREW WL, 1972, APPL MICROBIOL, V24, P240
   Falini G, 2008, J BIOMED MATER RES A, V87A, P470, DOI 10.1002/jbm.a.31771
   Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009
   Han J, 2012, CARBOHYD POLYM, V90, P122, DOI 10.1016/j.carbpol.2012.04.068
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Heinemann S, 2011, ACS APPL MATER INTER, V3, P4323, DOI 10.1021/am200993q
   Hou YP, 2012, J BIOMED MATER RES A, V100A, P939, DOI 10.1002/jbm.a.34031
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kavitha K, 2014, RSC ADV, V4, P43951, DOI 10.1039/c4ra03964e
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Kavitha K, 2014, MAT SCI ENG C, V48, P252
   Kavya KC, 2012, J BIOMED NANOTECHNOL, V8, P149, DOI 10.1166/jbn.2012.1363
   Kim H. C., 2012, APPL PHYS A, V107, P715
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948
   Kroll A, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-9
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Mathew TV, 2013, COLLOID SURFACE B, V101, P14, DOI 10.1016/j.colsurfb.2012.05.017
   Muller G, 2000, CHEM-BIOL INTERACT, V124, P77, DOI 10.1016/S0009-2797(99)00142-8
   Nakayama N, 2007, POLYM DEGRAD STABIL, V92, P1255, DOI 10.1016/j.polymdegradstab.2007.03.026
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Rani VVD, 2011, CARBOHYD POLYM, V83, P858, DOI 10.1016/j.carbpol.2010.08.065
   Santo VE, 2010, J SUPERCRIT FLUID, V54, P320, DOI 10.1016/j.supflu.2010.05.021
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Sikong L., 2010, ENERGY RES J, V1, P120, DOI DOI 10.3844/ERJSP.2010.120.125
   Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001
   Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200
   Vandrovcova M, 2011, PHYSIOL RES, V60, P797
   VanLandingham MR, 2001, MACROMOL SYMP, V167, P15, DOI 10.1002/1521-3900(200103)167:1<15::AID-MASY15>3.0.CO;2-T
   Wu ZY, 2014, COLLOID SURFACE B, V120, P38, DOI 10.1016/j.colsurfb.2014.04.010
   Yeh MK, 2011, ACTA BIOMATER, V7, P3804, DOI 10.1016/j.actbio.2011.06.026
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
   Yuan Y, 2008, J BIOMED MATER RES B, V86B, P245, DOI 10.1002/jbm.b.31012
   Zhang Y, 2004, J MATER SCI-MATER M, V15, P255, DOI 10.1023/B:JMSM.0000015485.94665.25
NR 44
TC 8
Z9 8
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 347
EP 356
DI 10.1016/j.colsurfb.2015.02.027
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000044
PM 25752961
DA 2018-10-19
ER

PT J
AU Fagali, NS
   Grillo, CA
   Puntarulo, S
   de Mele, MAFL
AF Fagali, Natalia S.
   Grillo, Claudia A.
   Puntarulo, Susana
   Fernandez Lorenzo de Mele, Monica A.
TI Cytotoxicity of corrosion products of degradable Fe-based stents:
   Relevance of pH and insoluble products
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biomaterials; Iron; Degradable; Cytotoxicity; Biocompatibility
ID IN-VITRO DEGRADATION; SILVER NANOPARTICLES; BIOCOMPATIBILITY; CELLS;
   IRON; ALLOYS; METAL; IMPLANTATION; VIVO; CADMIUM
AB Fe-based biodegradable metallic materials (Fe-BMMs) have been proposed for cardiovascular applications and are expected to disappear via corrosion after an appropriate period. However, in vivo studies showed that Fe ions release leads to accumulation of orange and brownish insoluble products at the biomaterial/cell interface. As an additional consequence, sharp changes in pH may affect the biocompatibility of these materials. In the present work, the experimental protocols were designed with the aim of evaluating the relative importance that these factors have on biocompatibility evaluation of BMMs. Mitochondrial activity (MU assay) and thiobarbituric acid reactive substances (TBARS) assay on mammalian cells, exposed to 1-5 mM of added Fe3+ salt, were assessed and compared with results linked exclusively to pH effects. Soluble Fe concentration in culture medium and intracellular Fe content were also determined. The results showed that: (i) mitochondrial activity was affected by pH changes over the entire range of concentrations of added Fe3+ assayed, (ii) at the highest added Fe3+ concentrations (>= 3 mM), precipitation was detected and the cells were able to incorporate the precipitate, that seems to be linked to cell damage, (iii) the extent of precipitation depends on the Fe/protein concentration ratio; and (iv) lipid peroxidation products were detected over the entire range of concentrations of added Fe3+. Hence, a new approach opens in the biocompatibility evaluation of Fe-based BMMs, since the cytotoxicity would not be solely a function of released (and soluble) ions but of the insoluble degradation product amount and the pH falling at the biomaterial/cell interface. The concentration of Fe-containing products at the interface depends on diffusional conditions in a very complex way that should be carefully analyzed in the future. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Fagali, Natalia S.; Grillo, Claudia A.; Fernandez Lorenzo de Mele, Monica A.] Univ Nacl La Plata, Inst Res Theoret & Appl Phys Chem INIFTA, CONICET, Dept Chem,Fac Pure Sci, RA-1900 La Plata, Buenos Aires, Argentina.
   [Puntarulo, Susana] UBA CONICET, Sch Pharm & Biochem, Phys Chem Inst Biochem & Mol Med IBIMOL, Buenos Aires, DF, Argentina.
   [Fernandez Lorenzo de Mele, Monica A.] Univ Nacl La Plata, Fac Engn, RA-1900 La Plata, Buenos Aires, Argentina.
RP de Mele, MAFL (reprint author), Univ Nacl La Plata, Inst Res Theoret & Appl Phys Chem INIFTA, CONICET, Dept Chem,Fac Pure Sci, CC 16,Suc 4, RA-1900 La Plata, Buenos Aires, Argentina.
EM mmele@inifta.unlp.edu.ar
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551; Fagali, Natalia
   Soledad/0000-0001-5489-137X
FU University of La Plata (UNLP) [11/I163]; University of Buenos Aires
   (UBA) [UBACyT 555]; ANPCyT [PICT 2012-1795 BID, PICT 00845, PPL 2011
   0003]; CONICET [PIP 00697]
FX The authors would want to acknowledge to Dr. Angel Catala for his
   helpful assistance and collaboration. This study was supported by grants
   from the University of La Plata (UNLP, 11/I163), University of Buenos
   Aires (UBA, UBACyT 555), ANPCyT (PICT 2012-1795 BID, PICT 00845, PPL
   2011 0003) and CONICET (PIP 00697)
CR Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7
   Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brumby PE, 1967, METHOD ENZYMOL, V10, P463
   Buege J A, 1978, Methods Enzymol, V52, P302
   Di Virgilio AL, 2010, J HAZARD MATER, V177, P711, DOI 10.1016/j.jhazmat.2009.12.089
   Di Virgilio AL, 2011, J BIOMED MATER RES B, V99B, P111, DOI 10.1002/jbm.b.31877
   Di Virgilio AL, 2010, J BIOMED MATER RES A, V92A, P80, DOI 10.1002/jbm.a.32339
   Garcia-Fernandez AJ, 2002, COMP BIOCHEM PHYS C, V132, P365, DOI 10.1016/S1532-0456(02)00079-0
   Grillo CA, 2014, COLLOID SURFACE B, V117, P312, DOI 10.1016/j.colsurfb.2014.02.030
   Grillo CA, 2013, J BIOMED MATER RES A, V101, P2129, DOI 10.1002/jbm.a.34503
   Grillo CA, 2010, CONTRACEPTION, V81, P343, DOI 10.1016/j.contraception.2009.12.003
   Han DW, 2012, J NANOSCI NANOTECHNO, V12, P5205, DOI 10.1166/jnn.2012.6367
   Huang T, 2014, MAT SCI ENG C-MATER, V35, P43, DOI 10.1016/j.msec.2013.10.023
   Jiang X, 2014, NANOTOXICOLOGY
   Jiang XM, 2013, TOXICOL LETT, V222, P55, DOI 10.1016/j.toxlet.2013.07.011
   Kraus T, 2014, ACTA BIOMATER, V10, P3346, DOI 10.1016/j.actbio.2014.04.007
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pereda MD, 2008, BIOELECTROCHEMISTRY, V72, P94, DOI 10.1016/j.bioelechem.2007.11.008
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Pierson D, 2012, J BIOMED MATER RES B, V100B, P58, DOI 10.1002/jbm.b.31922
   Pivokonsky M, 2012, WATER RES, V46, P5583, DOI 10.1016/j.watres.2012.07.040
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P782, DOI 10.1016/j.msec.2012.11.002
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P1882, DOI 10.1016/j.msec.2012.10.013
   Schranz D, 2006, CATHETER CARDIO INTE, V67, P671, DOI 10.1002/ccd.20756
   Soodvilai S, 2011, TOXICOL LETT, V204, P38, DOI 10.1016/j.toxlet.2011.04.005
   Thompson CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042720
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Yang JL, 1996, CHEM RES TOXICOL, V9, P1360, DOI 10.1021/tx960122y
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang M., 2014, P 2014 S AG DIR SIM, P1
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
NR 36
TC 10
Z9 10
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 480
EP 488
DI 10.1016/j.colsurfb.2015.02.047
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000060
PM 25797480
DA 2018-10-19
ER

PT J
AU Raja, IS
   Fathima, NN
AF Raja, I. Selestin
   Fathima, Nishter Nishad
TI A gelatin based antioxidant enriched biomaterial by grafting and
   saturation: Towards sustained drug delivery from antioxidant matrix
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Gelatin; Glutathione; Catechin; Differential scanning calorimetry;
   Circular dichroism
ID HYDROGEN-PEROXIDE; CATECHIN; GLUTATHIONE; NANOPARTICLES; DISEASE;
   SYSTEM; AMPLIFICATION; NANOCRYSTALS; INTERFACE; PEPTIDES
AB Proteins grafted with antioxidant molecules have drawn much attention due to their increased life time and biocompatibility. When protein macromolecules are cross linked chemically and physically with antioxidant molecules, they can act as antioxidant biomaterials as well as scaffolds to release the antioxidant molecules by diffusion. In our work, we have attempted to release catechin molecules from the matrix of glutathione grafted gelatin. Conjugation of glutathione and cross linkage was done by carbodiimide method to achieve smaller pores in the gelatin matrix and the characterization was performed by means of FTIR-ATR and calorimetric analyses. The glutathione grafted gelatin (GGSH) has been shown to have more thermal stability and pores with lesser radii than blank gelatin (bGEL). Free radical scavenging activity of GGSH was also found to be more than that of bGEL. Catechin was added to GGSH and bGEL by physical blending in order to achieve short term release of antioxidant molecules. CD spectra revealed that significant conformational changes occurred in secondary structure of gelatin upon interaction with catechin. Slower rate of catechin release from GGSH reflected the influence of cross linkage and physical interactive forces on the drug release properties. We conclude that the mixture of catechin with GGSH can be a potent antioxidant biomaterial releasing catechin at slower rate than the mixture of catechin with bGEL. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Raja, I. Selestin; Fathima, Nishter Nishad] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM nishad.naveed@gmail.com
FU Department of Science and Technology, Govt. of India Fast Track Project
FX The authors thank Department of Science and Technology, Govt. of India
   Fast Track Project for the financial support.
CR Aravindan L, 2013, MACROMOL BIOSCI, V13, P1163, DOI 10.1002/mabi.201300103
   Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066
   Baron M, 2013, INT J ELECTROCHEM SC, V8, P11072
   Basu S, 2006, NEW J CHEM, V30, P1333, DOI 10.1039/b607399a
   Bernkop-Schnurch A, 1999, PHARMACEUT RES, V16, P876, DOI 10.1023/A:1018830204170
   Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m
   CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102
   COLLIER HB, 1973, ANAL BIOCHEM, V56, P310, DOI 10.1016/0003-2697(73)90196-6
   Conforti F, 2006, BIOL PHARM BULL, V29, P2056, DOI 10.1248/bpb.29.2056
   Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1
   Di Colo G, 2008, J PHARM SCI-US, V97, P1652, DOI 10.1002/jps.21043
   Diaz AN, 1996, ANAL CHIM ACTA, V327, P161, DOI 10.1016/0003-2670(96)00077-3
   Fathima NN, 2010, THERMOCHIM ACTA, V501, P98, DOI 10.1016/j.tca.2010.01.016
   Fathima NN, 2009, INT J BIOL MACROMOL, V45, P274, DOI 10.1016/j.ijbiomac.2009.06.003
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   Hornof MD, 2002, J PHARM SCI, V91, P2588, DOI 10.1002/jps.10258
   Ihara N, 2004, BIOMACROMOLECULES, V5, P1633, DOI 10.1021/bm049823x
   Kanungo I, 2011, INT J BIOL MACROMOL, V49, P289, DOI 10.1016/j.ijbiomac.2011.05.003
   Kim SK, 2001, J AGR FOOD CHEM, V49, P1984, DOI 10.1021/jf000494j
   Kommareddy S, 2005, BIOCONJUGATE CHEM, V16, P1423, DOI 10.1021/bc050146t
   Kurisawa M, 2003, BIOMACROMOLECULES, V4, P1394, DOI 10.1021/bm034136b
   La Penna G, 2013, J PHYS CHEM B, V117, P16455, DOI 10.1021/jp410046w
   Lee SS, 2013, ACS NANO, V7, P9693, DOI 10.1021/nn4026806
   Li WB, 2005, POLYMER, V46, P12026, DOI 10.1016/j.polymer.2005.09.016
   Lin ZQ, 2014, J CONTROL RELEASE, V174, P161, DOI 10.1016/j.jconrel.2013.10.026
   Lynch SM, 2000, BBA-MOL CELL BIOL L, V1485, P11, DOI 10.1016/S1388-1981(00)00030-5
   Mohan T, 2012, ACS APPL MATER INTER, V4, P2743, DOI 10.1021/am300375m
   Mondal K, 2014, ACS APPL MATER INTER, V6, P2516, DOI 10.1021/am404931f
   Morgan PE, 2008, FREE RADICAL BIO MED, V45, P1279, DOI 10.1016/j.freeradbiomed.2008.08.004
   Mudunkotuwa IA, 2014, ANALYST, V139, P870, DOI 10.1039/c3an01684f
   Neilson AP, 2007, J AGR FOOD CHEM, V55, P8941, DOI 10.1021/jf071645m
   PaImberger TF, 2007, EUR J PHARM BIOPHARM, V66, P405, DOI 10.1016/j.ejpb.2006.11.017
   Picquart M, 1999, BIOSPECTROSCOPY, V5, P328, DOI 10.1002/(SICI)1520-6343(1999)5:6<328::AID-BSPY2>3.0.CO;2-J
   Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720
   Raab T, 2010, J AGR FOOD CHEM, V58, P2138, DOI 10.1021/jf9034095
   Ramirez A. R., 2014, CLIN SCI, V126, P19
   Scott MD, 2006, FREE RADICAL BIO MED, V40, P1264, DOI 10.1016/j.freeradbiomed.2005.11.017
   Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191
   Sonni F, 2011, J AGR FOOD CHEM, V59, P3940, DOI 10.1021/jf104575w
   Spizzirri UG, 2009, BIOMACROMOLECULES, V10, P1923, DOI 10.1021/bm900325t
   Stenekes RJH, 2000, BIOMACROMOLECULES, V1, P696, DOI 10.1021/bm005574a
   Tsai JC, 2011, AFR J PHARM PHARMACO, V5, P468, DOI 10.5897/AJPP11.059
   Varghese JS, 2014, COLLOID SURFACE B, V113, P346, DOI 10.1016/j.colsurfb.2013.08.049
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
NR 44
TC 7
Z9 7
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 537
EP 543
DI 10.1016/j.colsurfb.2015.03.005
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000067
PM 25794444
DA 2018-10-19
ER

PT J
AU McNeill, B
   Vulesevic, B
   Ostojic, A
   Ruel, M
   Suuronen, EJ
AF McNeill, Brian
   Vulesevic, Branka
   Ostojic, Aleksandra
   Ruel, Marc
   Suuronen, Erik J.
TI Collagen matrix-induced expression of integrin alpha V beta 3 in
   circulating angiogenic cells can be targeted by matricellular protein
   CCN1 to enhance their function
SO FASEB JOURNAL
LA English
DT Article
DE biomaterial; cardiovascular disease; cell preconditioning; ischemia;
   neovascularization
ID ENDOTHELIAL PROGENITOR CELLS; HUMAN SKIN FIBROBLASTS; CYR61; MIGRATION;
   THERAPY; ALPHA(V)BETA(3); IDENTIFICATION; PROLIFERATION; FIBRONECTIN;
   MYOCARDIUM
AB Circulating angiogenic cells (CACs) play an important role in vascular homeostasis and hold therapeutic promise for treating a variety of cardiovascular diseases. However, further improvements are needed because the effects of CAC therapy remain minimal or transient. The regenerative potential of these cells can be improved by culture on a collagen-based matrix through the up-regulation of key integrin proteins. We found that human CAC function was enhanced by using the matricellular protein CCN1 (CYR61/CTGF/NOV family member 1) to target integrin alpha V and beta 3, which are up-regulated on matrix. Compared tomatrix-cultured CACs, CCN1-matrix CACs exhibited a 2.2-fold increase in cell proliferation, 1.8-fold greater migration toward VEGF, and 1.7-fold more incorporation into capillary-like structures in an angiogenesis assay. In vivo, intramuscular injection of CCN1-matrix-cultured CACs into ischemic hind limbs of CD-1 nude mice resulted in blood flow recovery to 80% of baseline, which was greater than matrix-cultured CACs (66%) and PBS (35%) treatment groups. Furthermore, transplanted CCN1-matrix CACs exhibited greater engraftment (11-fold) and stimulated the up-regulation of survival and angiogenic genes (>3-fold). These findings reveal the importance of cell-matrix interactions in regulating CAC function and also reveal a mechanism by which these may be exploited to enhance cell therapies for ischemic disease.
C1 [McNeill, Brian; Vulesevic, Branka; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Vulesevic, Branka; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4W7, Canada.
RP Suuronen, EJ (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St,H5227, Ottawa, ON K1Y 4W7, Canada.
EM esuuronen@ottawaheart.ca
OI RUEL, MARC/0000-0002-0487-1319
FU Canadian Institutes of Health Research (CIHR) [MOP-77536]; Ottawa Heart
   Institute Cardiac Surgery Endowed Chair; Ottawa Heart Institute Lawrence
   Soloway Research Fellowship; Research Fellowship from the Heart & Stroke
   Foundation of Canada; CIHR Canadian Graduate Scholarship
FX This work was supported from the Canadian Institutes of Health Research
   (CIHR; grant MOP-77536 to M.R. and E.J.S.), and the Ottawa Heart
   Institute Cardiac Surgery Endowed Chair (to M.R.). B.M. was the
   recipient of the Ottawa Heart Institute Lawrence Soloway Research
   Fellowship and a Research Fellowship from the Heart & Stroke Foundation
   of Canada, and B.V. of a CIHR Canadian Graduate Scholarship.
CR Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028
   Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4
   Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745
   Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599
   Brenes RA, 2012, VASCULAR, V20, P360, DOI 10.1258/vasc.2011.201205
   CAMPBELL ID, 2011, COLD SPRING HARB PER, V1, P3, DOI DOI 10.1101/CSHPERSPECT
   Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200
   Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200
   Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200
   Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671
   Colombo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066734
   Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054
   Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733
   Emre Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3842
   Espinoza I, 2014, J CELL COMMUN SIGNAL, V8, P23, DOI 10.1007/s12079-013-0214-6
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Fan D, 2014, CIRC RES, V114, P889, DOI 10.1161/CIRCRESAHA.114.302335
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200
   Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807
   Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC
   Jin YJ, 2011, CELL SIGNAL, V23, P125, DOI 10.1016/j.cellsig.2010.08.012
   Karl E, 2007, CELL DEATH DIFFER, V14, P1657, DOI 10.1038/sj.cdd.4402174
   Kireeva ML, 1996, MOL CELL BIOL, V16, P1326
   Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456
   Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mackie AR, 2011, TEX HEART I J, V38, P474
   Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   Resch T, 2012, STEM CELL REV REP, V8, P926, DOI 10.1007/s12015-011-9332-9
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Schmidt MR, 2012, J CARDIOVASC MED, V13, P667, DOI 10.2459/JCM.0b013e328357bff2
   Silvestre JS, 2013, PHYSIOL REV, V93, P1743, DOI 10.1152/physrev.00006.2013
   Sun GM, 2012, MACROMOL BIOSCI, V12, P21, DOI 10.1002/mabi.201100258
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   You JJ, 2014, CELL SIGNAL, V26, P133, DOI 10.1016/j.cellsig.2013.08.026
   Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049
   Yu Y, 2008, EXP CELL RES, V314, P3198, DOI 10.1016/j.yexcr.2008.08.001
   Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044
NR 45
TC 3
Z9 3
U1 1
U2 4
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2015
VL 29
IS 4
BP 1198
EP 1207
DI 10.1096/fj.14-261586
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CH5ZN
UT WOS:000354115000009
PM 25466895
OA Bronze
DA 2018-10-19
ER

PT J
AU Warning, AD
   Arquiza, JMR
   Datta, AK
AF Warning, Alexander D.
   Arquiza, J. M. R.
   Datta, Ashim K.
TI A multiphase porous medium transport model with distributed sublimation
   front to simulate vacuum freeze drying
SO FOOD AND BIOPRODUCTS PROCESSING
LA English
DT Article
DE Biomaterial; Food; Transport phenomena; Sublimation; Vacuum; Microwave;
   Non-equilibrium phase change; Porous Media
ID MASS-TRANSFER; THERMOPHYSICAL PROPERTIES; OPERATIONAL POLICIES; WATER;
   PERMEABILITY; TEMPERATURE; EVAPORATION; PRESSURES; PRODUCTS; ICE
AB A porous medium transport model with a distributed sublimation front is developed for low pressure freeze drying of beef by radiant surface heating and volumetric microwave heating. The model incorporates the importance of Knudsen flow in porous materials during low pressure freeze drying. This effort is part of fundamental physics-based framework building for simulating food and biomaterial processes involving rapid evaporation/sublimation. Temperature, pressure and ice saturation histories were computed. Drying rates and spatial temperature profiles showed excellent agreement with literature experimental data. Sublimation front width, a novel result, is seen to increase as ice saturation decreases, justifying the importance of this distributed sublimation formulation in contrast with the sharp sublimation front commonly employed in literature. The insulation effect of the gas fraction in the pores is observed by the slow movement of the sublimation front in 'thick' samples. Effects of porosity, initial ice saturation and microwave heating are illustrated. (C) 2014 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Warning, Alexander D.; Arquiza, J. M. R.; Datta, Ashim K.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA.
RP Warning, AD (reprint author), Cornell Univ, Dept Biol & Environm Engn, 175 Riley Robb, Ithaca, NY 14853 USA.
EM adw88@cornell.edu
RI Datta, Ashim/K-2294-2012
OI Datta, Ashim/0000-0002-1397-6892
CR Atkins P W, 1991, PHYS CHEM
   AYAPPA KG, 1991, CHEM ENG SCI, V46, P1005, DOI 10.1016/0009-2509(91)85093-D
   Bear J., 1972, DYNAMICS FLUIDS PORO
   Bixler N. E., 1985, NORIA FINITE ELEMENT
   Bralsford R., 1967, INT J FOOD SCI TECH, V2, P353
   Cho SY, 2012, J NANOSCI NANOTECHNO, V12, P806, DOI 10.1166/jnn.2012.5364
   Choi Y, 1986, PHYS CHEM PROPERTIES
   Chung NO, 2012, INT J PHARMACEUT, V437, P42, DOI 10.1016/j.ijpharm.2012.07.068
   Dhall A, 2011, CHEM ENG SCI, V66, P6482, DOI 10.1016/j.ces.2011.09.001
   Dibben D, 2001, ELECTROMAGNETICS FUN, V31
   Electric G., 1982, FLUID FLOW DAT
   Fellows PJ, 2000, FOOD PROCESSING TECH
   FUKUSAKO S, 1990, INT J THERMOPHYS, V11, P353, DOI 10.1007/BF01133567
   Hahn DW, 2012, HEAT CONDUCTION
   Haider A., 2007, FOOD BIOPROD PROCESS, V85, P209, DOI DOI 10.1205/FBP0703
   Halder A., 2011, J HEAT TRANSF, V133
   Halder A, 2012, FOOD BIOPROD PROCESS, V90, P475, DOI 10.1016/j.fbp.2011.10.005
   HARPER JC, 1962, AICHE J, V8, P298, DOI 10.1002/aic.690080308
   Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298
   Hui Y. H., 2004, HDB FROZEN FOODS
   Jiao K, 2009, ELECTROCHIM ACTA, V54, P6876, DOI 10.1016/j.electacta.2009.06.072
   Lewis MJ, 1987, PHYS PROPERTIES FOOD
   Liapis A. I., 1987, HDB IND DRYING
   MA YH, 1975, AICHE J, V21, P335, DOI 10.1002/aic.690210215
   McDonald K, 2002, J FOOD ENG, V52, P167, DOI 10.1016/S0260-8774(01)00100-5
   MILLINGTON R, 1961, T FARADAY SOC, V57, P1200, DOI 10.1039/tf9615701200
   MILLMAN MJ, 1985, AICHE J, V31, P1594, DOI 10.1002/aic.690311003
   Murphy DM, 2005, Q J ROY METEOR SOC, V131, P1539, DOI 10.1256/qj.04.94
   Nam JH, 2005, DRY TECHNOL, V23, P2491, DOI 10.1080/07373930500341757
   Nam JH, 2007, INT J HEAT MASS TRAN, V50, P4891, DOI 10.1016/j.ijheatmasstransfer.2007.08.004
   Ni H, 1999, INT J HEAT MASS TRAN, V42, P1501, DOI 10.1016/S0017-9310(98)00123-9
   Oroszvari BK, 2006, J FOOD ENG, V74, P1, DOI 10.1016/j.jfoodeng.2005.02.024
   Painter SL, 2011, COMPUTAT GEOSCI, V15, P69, DOI 10.1007/s10596-010-9197-z
   Pojanavaraphan T, 2010, APPL CLAY SCI, V50, P271, DOI 10.1016/j.clay.2010.08.020
   Rakesh V, 2013, AICHE J, V59, P33, DOI 10.1002/aic.13793
   Ratti C, 2001, J FOOD ENG, V49, P311, DOI 10.1016/S0260-8774(00)00228-4
   SANDALL OC, 1967, AICHE J, V13, P428, DOI 10.1002/aic.690130309
   Sheehan P, 1998, BIOTECHNOL BIOENG, V60, P712, DOI 10.1002/(SICI)1097-0290(19981220)60:6<712::AID-BIT8>3.0.CO;2-4
   Singh P., 2001, SNOW GLACIER HYDROLO
   Smith PG, 2011, FOOD SCI TEXT SER, P1, DOI 10.1007/978-1-4419-7662-8
   Tanikawa W, 2009, INT J ROCK MECH MIN, V46, P229, DOI 10.1016/j.ijrmms.2008.03.004
   Vargaftik N. B., 1975, TABLES THERMOPHYSICA
   WAGNER W, 1994, J PHYS CHEM REF DATA, V23, P515, DOI 10.1063/1.555947
   Wang W, 2007, AICHE J, V53, P3077, DOI 10.1002/aic.11336
   Wang Y, 2013, COMPOS PART B-ENG, V45, P625, DOI 10.1016/j.compositesb.2012.05.017
   Wang Z.H., 1999, DRY TECHNOL, V17, P434
   Wang ZH, 1997, DRY TECHNOL, V15, P1475, DOI 10.1080/07373939708917304
   Ward CA, 1999, PHYS REV E, V59, P429, DOI 10.1103/PhysRevE.59.429
   Warning A, 2012, J FOOD ENG, V110, P428, DOI 10.1016/j.jfoodeng.2011.12.024
   Webb S.W, 1996, GAS PHASE DIFFUSION
   Webb SW, 2003, TRANSPORT POROUS MED, V51, P327, DOI 10.1023/A:1022379016613
   Weerts AH, 2003, AICHE J, V49, P1334, DOI 10.1002/aic.690490524
   Yamsaengsung R, 2002, J FOOD ENG, V53, P1, DOI 10.1016/S0260-8774(01)00134-0
   Zhang J, 2005, AICHE J, V51, P2569, DOI 10.1002/aic.10518
NR 54
TC 6
Z9 7
U1 3
U2 42
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0960-3085
EI 1744-3571
J9 FOOD BIOPROD PROCESS
JI Food Bioprod. Process.
PD APR
PY 2015
VL 94
BP 637
EP 648
DI 10.1016/j.fbp.2014.08.011
PG 12
WC Biotechnology & Applied Microbiology; Engineering, Chemical; Food
   Science & Technology
SC Biotechnology & Applied Microbiology; Engineering; Food Science &
   Technology
GA CH6IO
UT WOS:000354140500069
DA 2018-10-19
ER

PT J
AU Kamada, T
   Mashima, N
   Nakashima, Y
   Lmai, H
   Takeba, J
   Miura, H
AF Kamada, Tomomi
   Mashima, Naohiko
   Nakashima, Yasuharu
   Lmai, Hiroshi
   Takeba, Jun
   Miura, Hiromasa
TI Mid-Term Clinical and Radiographic Outcomes of Porous Tantalum Modular
   Acetabular Components for Hip Dysplasia
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE total hip arthroplasty; trabecular metal cup of modular type;
   developmental dysplasia of the hip; cementless; bone ingrowth
ID RADIOLOGICAL EVALUATION; SUPERIOR PLACEMENT; FOLLOW-UP; ARTHROPLASTY;
   RECONSTRUCTION; 10-YEAR; REPLACEMENT; BIOMATERIAL; INTERFACE; FIXATION
AB It is still challenging to perform successful cementless cup fixation during total hip arthroplasty for hip dysplasia. In this multicenter study we evaluated the clinical results of porous tantalum modular acetabular cups (TM cups) in 45 dysplastic hips with a mean follow-up period of 9.8 years. The mean Japanese Orthopaedic Association hip score improved from 48.2 preoperatively to 92.1 at the most recent follow-up. All of the cups were radiographically stable with no evidence of progressive radiolucencies or osteolysis regardless of bone grafting. Sixteen hips with bone grafts showed the integration of grafted bone without any radiolucencies. There were no revisions of TM cups. The use of TM cups for dysplastic hips provided satisfactory 10-year clinical and radiographic results. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kamada, Tomomi; Mashima, Naohiko; Lmai, Hiroshi; Takeba, Jun; Miura, Hiromasa] Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan.
   [Nakashima, Yasuharu] Kyushu Univ, Sch Med, Dept Orthopaed Surg, Higashi Ku, Fukuoka 812, Japan.
RP Kamada, T (reprint author), Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan.
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   CALLAGHAN JJ, 1988, J BONE JOINT SURG AM, V70A, P337, DOI 10.2106/00004623-198870030-00004
   Cameron HU, 1996, J ARTHROPLASTY, V11, P582, DOI 10.1016/S0883-5403(96)80113-6
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Delp SL, 1996, CLIN ORTHOP RELAT R, P137
   Doehring TC, 1996, J ARTHROPLASTY, V11, P693, DOI 10.1016/S0883-5403(96)80008-8
   Engesaeter LB, 2008, J ARTHROPLASTY, V23, P235, DOI 10.1016/j.arth.2007.03.023
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hartofilakidis G, 2008, J BONE JOINT SURG BR, V90B, P724, DOI 10.1302/0301-620X.90B6.20490
   Hartofilakidis G, 1996, J BONE JOINT SURG AM, V78A, P683, DOI 10.2106/00004623-199605000-00007
   HASEGAWA Y, 1992, ARCH ORTHOP TRAUM SU, V111, P187, DOI 10.1007/BF00571474
   Hendrich C, 2006, J BONE JOINT SURG AM, V88A, P387, DOI 10.2106/JBJS.D.02373
   Kim M, 2010, CLIN ORTHOP RELAT R, V468, P1611, DOI 10.1007/s11999-010-1288-6
   Kiyama T, 2009, J ARTHROPLASTY, V24, P240, DOI 10.1016/j.arth.2008.08.012
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Macheras G, 2009, J ARTHROPLASTY, V24, P705, DOI 10.1016/j.arth.2008.06.020
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Montgomery AA, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-8
   Mulier Michiel, 2006, Acta Orthop Belg, V72, P326
   Mulroy RD, 1986, J BONE JOINT SURG AM, V72, P1241
   Nakashima Y, 2013, MOD RHEUMATOL, V23, P112, DOI 10.1007/s10165-012-0618-9
   Ogawa H, 2010, J ARTHROPLASTY, V25, P375, DOI 10.1016/j.arth.2009.01.012
   Pagnano MW, 1996, J BONE JOINT SURG AM, V78A, P1004, DOI 10.2106/00004623-199607000-00004
   Sanchez-Sotelo Joaquin, 2002, J Am Acad Orthop Surg, V10, P334
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P1130, DOI 10.2106/00004623-199274080-00002
   Simon JP, 2009, ACTA ORTHOP BELG, V75, P623
   SUGANO N, 1995, J BONE JOINT SURG BR, V77B, P548
   Takao M, 2011, J ARTHROPLASTY, V26, P562, DOI 10.1016/j.arth.2010.05.025
NR 31
TC 12
Z9 13
U1 0
U2 2
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD APR
PY 2015
VL 30
IS 4
BP 607
EP 610
DI 10.1016/j.arth.2014.11.007
PG 4
WC Orthopedics
SC Orthopedics
GA CG7SV
UT WOS:000353506300022
PM 25443360
DA 2018-10-19
ER

PT J
AU Sheikh, Z
   Javaid, MA
   Hamdan, N
   Hashmi, R
AF Sheikh, Zeeshan
   Javaid, Mohammad Ahmad
   Hamdan, Nader
   Hashmi, Raheel
TI Bone Regeneration Using Bone Morphogenetic Proteins and Various
   Biomaterial Carriers
SO MATERIALS
LA English
DT Review
ID HUMAN OSTEOGENIC PROTEIN-1; BETA-TRICALCIUM PHOSPHATE; MARROW STROMAL
   CELLS; ALVEOLAR RIDGE DEFECTS; SYNTHETIC BIODEGRADABLE POLYMERS; COATED
   ALBUMIN NANOPARTICLES; ABSORBABLE COLLAGEN SPONGE; HEPARIN-CONJUGATED
   FIBRIN; MEDIATED GENE DELIVERY; RAT CALVARIAL DEFECTS
AB Trauma and disease frequently result in fractures or critical sized bone defects and their management at times necessitates bone grafting. The process of bone healing or regeneration involves intricate network of molecules including bone morphogenetic proteins (BMPs). BMPs belong to a larger superfamily of proteins and are very promising and intensively studied for in the enhancement of bone healing. More than 20 types of BMPs have been identified but only a subset of BMPs can induce de novo bone formation. Many research groups have shown that BMPs can induce differentiation of mesenchymal stem cells and stem cells into osteogenic cells which are capable of producing bone. This review introduces BMPs and discusses current advances in preclinical and clinical application of utilizing various biomaterial carriers for local delivery of BMPs to enhance bone regeneration.
C1 [Sheikh, Zeeshan] Univ Toronto, Fac Dent, Toronto, ON M5S 3E2, Canada.
   [Javaid, Mohammad Ahmad] Univ British Columbia, Div Periodont, Fac Dent, Nobel Biocare Oral Hlth Ctr, Vancouver, BC V6T IZ3, Canada.
   [Hamdan, Nader] Univ Manitoba, Div Periodont Dent Diagnost & Surg Sci, Fac Dent, Winnipeg, MB R3E 0W2, Canada.
   [Hashmi, Raheel] South City Hosp, Dept Emergency & Trauma, Clifton Karachi 75400, Pakistan.
RP Sheikh, Z (reprint author), Univ Toronto, Fac Dent, 150 Coll St, Toronto, ON M5S 3E2, Canada.
EM zeeshan.sheikh@utoronto.ca; mohammad.javaid2@mail.mcgill.ca;
   naderful@gmail.com; rhashme@hotmail.com
CR Abarrategi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034117
   Aebli N, 2005, J BIOMED MATER RES A, V73A, P295, DOI 10.1002/jbm.a.30299
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Ansari S, 2014, BIOMED RES INT, DOI 10.1155/2014/940860
   Argintar E, 2011, INJURY, V42, P730, DOI 10.1016/j.injury.2010.11.016
   Arnander C, 2006, J CRANIOFAC SURG, V17, P275, DOI 10.1097/00001665-200603000-00013
   Arosarena O, 2005, Orthod Craniofac Res, V8, P267, DOI 10.1111/j.1601-6343.2005.00349.x
   Arosarena OA, 2005, OTOLARYNG HEAD NECK, V132, P592, DOI 10.1016/j.otohns.2004.09.137
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Bae SE, 2012, J CONTROL RELEASE, V160, P676, DOI 10.1016/j.jconrel.2012.04.021
   Bahamonde ME, 2001, J BONE JOINT SURG AM, V83A, pS56
   Baran ET, 2004, J MATER SCI-MATER M, V15, P759, DOI 10.1023/B:JMSM.0000032815.86972.5e
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   Bax BE, 1999, CALCIFIED TISSUE INT, V65, P83, DOI 10.1007/s002239900662
   Becker J, 2006, CLIN ORAL INVEST, V10, P217, DOI 10.1007/s00784-006-0049-0
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Bibbo C, 2015, CLIN PODIATR MED SUR, V32, P35, DOI 10.1016/j.cpm.2014.09.005
   Bibbo C, 2009, FOOT ANKLE INT, V30, P597, DOI 10.3113/FAI.2009.0597
   Bilic R, 2006, INT ORTHOP, V30, P128, DOI 10.1007/s00264-005-0045-z
   Blunk T, 2003, GROWTH FACTORS, V21, P71, DOI 10.1080/0897719031000148822
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 2005, ORTHOP NURS, V24, P49
   Bong MR, 2005, BULL HOSP JT DIS, V63, P20
   BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309
   Bostrom MPG, 1999, ORTHOP CLIN N AM, V30, P647, DOI 10.1016/S0030-5898(05)70117-6
   Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS116, DOI 10.1097/00003086-199810001-00013
   Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   [曹雪华 CAO Xuehua], 2006, [中国修复重建外科杂志, Chinese Journal of Reparative and Reconstructive Surgery], V20, P916
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carreira AC, 2014, J DENT RES, V93, P335, DOI 10.1177/0022034513518561
   Carreira AC, 2014, ARCH BIOCHEM BIOPHYS, V561, P64, DOI 10.1016/j.abb.2014.07.011
   Carter S, 2012, THER ADV MUSCULOSKEL, V4, P293, DOI 10.1177/1759720X12444175
   Celeste A.J., 2002, U.S. Patent, Patent No. [6027917 A, 6027917]
   Cha JK, 2014, J CLIN PERIODONTOL, V41, P86, DOI 10.1111/jcpe.12174
   Chang PC, 2007, J BIOMED MATER RES A, V81A, P771, DOI 10.1002/jbm.a.31031
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen Fa-ming, 2005, Shanghai Kou Qiang Yi Xue, V14, P485
   Chen FM, 2007, J CONTROL RELEASE, V121, P81, DOI 10.1016/j.jconrel.2007.05.023
   Chen FM, 2007, J CONTROL RELEASE, V118, P65, DOI 10.1016/j.jconrel.2006.11.016
   Chen FM, 2006, INT J PHARMACEUT, V307, P23, DOI 10.1016/j.ijpharm.2005.09.024
   Chen FM, 2005, PHARMACOLOGY, V75, P133, DOI 10.1159/000088212
   CHEN TL, 1991, J BONE MINER RES, V6, P1387
   Chen Wei, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P989
   Chenard KE, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601549
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139
   Cook S D, 1995, J Oral Implantol, V21, P281
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   Cui Geng, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P70
   CUNNINGHAM NS, 1995, GROWTH FACTORS, V12, P99, DOI 10.3109/08977199509028956
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124
   David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001
   Degat MC, 2005, PATHOL BIOL, V53, P131, DOI 10.1016/j.patbio.2004.03.004
   den Boer FC, 2002, BONE, V31, P158, DOI 10.1016/S8756-3282(02)00816-5
   Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650
   Dohin B, 2009, CLIN ORTHOP RELAT R, V467, P3230, DOI 10.1007/s11999-009-0967-7
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795
   Eckardt H, 2005, INJURY, V36, P489, DOI 10.1016/j.injury.2004.10.019
   Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010
   Fan Zhongkai, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P903
   Feiner N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-277
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Furuya K, 1999, J CELL BIOCHEM, V72, P177, DOI 10.1002/(SICI)1097-4644(19990201)72:2<177::AID-JCB2>3.0.CO;2-#
   Gao TJ, 2002, TISSUE ENG, V8, P429, DOI 10.1089/107632702760184691
   Gao TJ, 2001, J BIOMED MATER RES, V57, P92, DOI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gomes Manuela E, 2004, Methods Mol Biol, V238, P65
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Gruber RM, 2014, J CLIN PERIODONTOL, V41, P820, DOI 10.1111/jcpe.12264
   Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200
   Hagi TT, 2010, BONE, V46, P1322, DOI 10.1016/j.bone.2010.02.010
   HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8
   Han DK, 2005, J PERIODONTOL, V76, P2216, DOI 10.1902/jop.2005.76.12.2216
   Han FX, 2015, J BIOMED MATER RES B, V103, P1344, DOI 10.1002/jbm.b.33314
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   Hao W, 2010, INT ORTHOP, V34, P1341, DOI 10.1007/s00264-009-0946-3
   Hattori T, 1990, Nihon Seikeigeka Gakkai Zasshi, V64, P824
   He Xiao-bing, 2003, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V17, P185
   Heary RF, 2002, NEUROSURGERY, V50, P510, DOI 10.1097/00006123-200203000-00015
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Herford AS, 2008, J ORAL MAXIL SURG, V66, P616, DOI 10.1016/j.joms.2007.11.021
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hong JY, 2014, CYTOTHERAPY, V16, P1441, DOI 10.1016/j.jcyt.2014.04.005
   Hong L, 1998, J BIOMAT SCI-POLYM E, V9, P1001
   Hong SJ, 2006, BIOMATERIALS, V27, P3810, DOI 10.1016/j.biomaterials.2006.02.045
   Horasawa N, 2015, MAT SCI ENG C-MATER, V46, P86, DOI 10.1016/j.msec.2014.10.025
   Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012
   Hu Ji-jie, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1369
   Hu WH, 2013, ARTIF CELL NANOMED B, V41, P249, DOI 10.3109/10731199.2012.731412
   Hu Yun-Yu, 2003, Chin J Traumatol, V6, P67
   Hubbell JA, 2006, SWISS MED WKLY, V136, P387
   Hubble Matthew J W, 2002, Surg Technol Int, V10, P261
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   Hulsart-Billstrom G, 2013, BIOMACROMOLECULES, V14, P3055, DOI 10.1021/bm400639e
   Hulsart-Billstrom G, 2011, ACTA BIOMATER, V7, P3042, DOI 10.1016/j.actbio.2011.04.021
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   Huse K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046117
   Hustedt Joshua W., 2014, Yale Journal of Biology and Medicine, V87, P549
   Ishibe T, 2009, ORAL SURG ORAL MED O, V108, P867, DOI 10.1016/j.tripleo.2009.06.039
   Issa JPM, 2008, ANAT HISTOL EMBRYOL, V37, P181, DOI 10.1111/j.1439-0264.2007.00824.x
   Itoh S, 2001, J MATER SCI-MATER M, V12, P575, DOI 10.1023/A:1011277207574
   Javaid M.A., 2013, INT DENT J STUD RES, V1, P24
   Jensen OT, 2014, INT J ORAL MAX IMPL, V29, pE103, DOI 10.11607/jomi.te48
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Ji Y, 2009, J INT MED RES, V37, P1075, DOI 10.1177/147323000903700412
   Ji Y, 2010, ANN BIOMED ENG, V38, P632, DOI 10.1007/s10439-009-9888-6
   Jones AA, 2006, J PERIODONTOL, V77, P1184, DOI 10.1902/jop.2006.050337
   Jovanovic SA, 2007, CLIN ORAL IMPLAN RES, V18, P224, DOI 10.1111/j.1600-0501.2006.01324.x
   Jun SH, 2013, J MATER SCI-MATER M, V24, P773, DOI 10.1007/s10856-012-4822-0
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   KAMATH KR, 1993, ADV DRUG DELIVER REV, V11, P59, DOI 10.1016/0169-409X(93)90027-2
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Katanec Davor, 2014, Coll Antropol, V38, P325
   Kato M, 2006, BIOMATERIALS, V27, P3927, DOI 10.1016/j.biomaterials.2006.03.013
   Kawamoto T, 2003, CLEFT PALATE-CRAN J, V40, P538, DOI 10.1597/1545-1569(2003)040<0538:ETMIBI>2.0.CO;2
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360
   Kim CS, 2005, BIOMATERIALS, V26, P2501, DOI 10.1016/j.biomaterials.2004.07.015
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818
   Kim SE, 2014, CARBOHYD POLYM, V114, P123, DOI 10.1016/j.carbpol.2014.08.005
   Kim SE, 2015, J TISSUE ENG REGEN M, V9, pE219, DOI 10.1002/term.1668
   Kim SE, 2011, BIOMATERIALS, V32, P366, DOI 10.1016/j.biomaterials.2010.09.008
   Kim SH, 2013, INT J ARTIF ORGANS, V36, P506, DOI 10.5301/ijao.5000215
   Kim TH, 2013, J BIOMED MATER RES A, V101, P1651, DOI 10.1002/jbm.a.34466
   Kinard LA, 2013, PHARM RES-DORDR, V30, P2332, DOI 10.1007/s11095-013-1077-5
   KING JA, 1994, DEV BIOL, V166, P112, DOI 10.1006/dbio.1994.1300
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   KIRKERHEAD CA, 1995, CLIN ORTHOP RELAT R, P222
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x
   Kraiwattanapong C, 2005, SPINE, V30, P1001, DOI 10.1097/01.brs.0000160997.91502.3b
   Laurencin CT, 2013, CURR PHARM DESIGN, V19, P3353
   LEE SC, 1994, J BIOMED MATER RES, V28, P1149, DOI 10.1002/jbm.820281005
   Lee SY, 2013, CARBOHYD POLYM, V98, P546, DOI 10.1016/j.carbpol.2013.05.095
   LeGeros R.Z., 1997, BONE SUBSTITUTE MAT, P12
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li JH, 2010, J BIOMED MATER RES A, V95A, P973, DOI 10.1002/jbm.a.32926
   Liang Dongchun, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P721
   Lippman Caleb R, 2004, Neurosurg Focus, V16, pE4
   Lomelino RD, 2012, J MATER SCI-MATER M, V23, P781, DOI 10.1007/s10856-011-4530-1
   Lopez-Lacomba JL, 2006, BIOMACROMOLECULES, V7, P792, DOI 10.1021/bm050859e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7
   Maire M, 2005, BIOMATERIALS, V26, P5085, DOI 10.1016/j.biomaterials.2005.01.020
   Malafaya PB, 2003, ADV EXP MED BIOL, V534, P201
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   Martinez-Sanz E, 2012, J CRANIOFAC SURG, V23, P594, DOI 10.1097/SCS.0b013e31824cd6c7
   Matsushita N, 2004, J BIOMED MATER RES A, V70A, P450, DOI 10.1002/jbm.a.30102
   Matsushita N, 2006, J ORTHOP SCI, V11, P505, DOI 10.1007/s00776-006-1048-3
   Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249
   Mayer M, 1996, PLAST RECONSTR SURG, V98, P247, DOI 10.1097/00006534-199608000-00006
   McKee M., 2002, P 18 ANN M ORTH TRAU, P11
   McKee M., 2004, P AM AC ORTH SURG 71, P10
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Miranda DAO, 2005, J PERIODONTOL, V76, P210, DOI 10.1902/jop.2005.76.2.210
   Mitri F, 2012, ARTIF ORGANS, V36, P535, DOI 10.1111/j.1525-1594.2011.01409.x
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   Mizumoto Y, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300003-00019
   Moghaddam A, 2010, ARCH ORTHOP TRAUM SU, V130, P71, DOI 10.1007/s00402-009-0982-x
   Moghaddam-Alvandi A, 2012, UNFALLCHIRURG, V115, P518, DOI 10.1007/s00113-011-2100-0
   Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41, DOI 10.2106/00004623-200412002-00008
   Murakami M, 2002, J DENT RES, V81, P845, DOI 10.1177/154405910208101210
   Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Myllyla RM, 2014, CELL TISSUE RES, V355, P463, DOI 10.1007/s00441-013-1745-0
   Nakase T, 2006, J BONE MINER METAB, V24, P425, DOI 10.1007/s00774-006-0718-8
   Nakashima M, 2003, HUM GENE THER, V14, P591, DOI 10.1089/104303403764539369
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Nicodemo Alberto, 2011, Musculoskelet Surg, V95, P157, DOI 10.1007/s12306-011-0131-x
   Nochi H, 2004, J BONE MINER RES, V19, P111, DOI 10.1359/jbmr.2004.19.1.111
   Nonner D, 2001, J NEUROCHEM, V77, P691, DOI 10.1046/j.1471-4159.2001.00273.x
   Noshi T, 2001, ARTIF ORGANS, V25, P201, DOI 10.1046/j.1525-1594.2001.025003201.x
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Ong JL, 1997, INT J ORAL MAX IMPL, V12, P649
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Osidak EO, 2014, B EXP BIOL MED+, V158, P104, DOI 10.1007/s10517-014-2702-y
   Pan ZX, 2014, ASIAN PAC J TROP MED, V7, P895, DOI 10.1016/S1995-7645(14)60156-5
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Patel VV, 2006, SPINE, V31, P1201, DOI 10.1097/01.brs.0000217650.90861.99
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   Piskounova S, 2009, J BIOMED MATER RES B, V91B, P780, DOI 10.1002/jbm.b.31456
   Polimeni G, 2008, CLIN IMPLANT DENT R, V10, P99, DOI 10.1111/j.1708-8208.2007.00067.x
   Poth N, 2015, BIOMOLECULES, V5, P3, DOI 10.3390/biom5010003
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Qiao CY, 2013, INT J NANOMED, V8, P2985, DOI 10.2147/IJN.S45184
   Qin Yu, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1021
   Rao Subramaniam M, 2013, N Am J Med Sci, V5, P161, DOI 10.4103/1947-2714.109175
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Ren W., 2000, CHIN J STOMATOL, V35, P18
   RENGACHARY SS, 2002, NEUROSURG FOCUS, V13, P1
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   Ristiniemi J, 2007, J BONE JOINT SURG BR, V89B, P265, DOI 10.1302/0301-620X.89B2.18230
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386
   Robertson PA, 2001, SPINE, V26, P1473, DOI 10.1097/00007632-200107010-00018
   Rohanizadeh R, 2011, J ORAL IMPLANTOL, V37, P659, DOI 10.1563/AAID-JOI-D-10-00005
   Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   SAILER HF, 1989, J CRANIO MAXILL SURG, V17, P299, DOI 10.1016/S1010-5182(89)80057-5
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Saito A, 2004, J BIOMED MATER RES A, V70A, P115, DOI 10.1002/jbm.a.30071
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Saito E, 2003, J PERIODONTOL, V74, P1808, DOI 10.1902/jop.2003.74.12.1808
   Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
   SAITOH H, 1994, J ORAL REHABIL, V21, P431, DOI 10.1111/j.1365-2842.1994.tb01157.x
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schmoekel HG, 2005, J SMALL ANIM PRACT, V46, P17, DOI 10.1111/j.1748-5827.2005.tb00269.x
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Schopper C, 2008, J BIOMED MATER RES A, V85A, P954, DOI 10.1002/jbm.a.31525
   Schrier J A, 2001, AAPS PharmSciTech, V2, pE18
   Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Sheikh ZA, 2013, DENT BIOMATERIALS PR
   Shimazu C, 2006, J ORAL REHABIL, V33, P609, DOI 10.1111/j.1365-2842.2005.01593.x
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Skogh ACD, 2009, PLAST RECONSTR SURG, V123, p192E, DOI 10.1097/PRS.0b013e3181a66f52
   Sohier J, 2010, J BIOMED MATER RES A, V92A, P1105, DOI 10.1002/jbm.a.32467
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Stenport VF, 2003, J MATER SCI-MATER M, V14, P247, DOI 10.1023/A:1022884724059
   Sumner DR, 2006, J BONE JOINT SURG AM, V88A, P806, DOI 10.2106/JBJS.E.00846
   Sun SX, 2014, BRAZ J MED BIOL RES, V47, P461, DOI 10.1590/1414-431X20132966
   Sun XJ, 2010, ARCH ORAL BIOL, V55, P195, DOI 10.1016/j.archoralbio.2010.01.006
   Suzuki A, 2006, J ORTHOP RES, V24, P327, DOI 10.1002/jor.20049
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Sweeny L, 2012, J ORAL MAXIL SURG, V70, P1991, DOI 10.1016/j.joms.2011.08.037
   Takahashi Y, 2007, TISSUE ENG, V13, P293, DOI 10.1089/ten.2006.0088
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Taylor PM, 2002, J HEART VALVE DIS, V11, P298
   TENDIJKE P, 1994, J BIOL CHEM, V269, P16985
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Tevlin R, 2014, J DENT RES, V93, P1187, DOI 10.1177/0022034514547271
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   Tian Weidong, 2004, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V21, P844
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   Tressler MA, 2011, ORTHOPEDICS, V34, P955, DOI 10.3928/01477447-20111021-09
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Turgeman G, 2002, J CELL BIOCHEM, V86, P461, DOI 10.1002/jcb.10231
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1972, CLIN ORTHOP RELAT R, P275
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang YJ, 2003, ARTIF ORGANS, V27, P162, DOI 10.1046/j.1525-1594.2003.06953.x
   Wang YF, 2013, J SURG RES, V183, P8, DOI 10.1016/j.jss.2012.11.061
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x
   Wikesjo UME, 2004, J CLIN PERIODONTOL, V31, P662, DOI 10.1111/j.1600-051X.2004.00541.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   WINET H, 1993, J BIOMED MATER RES, V27, P667, DOI 10.1002/jbm.820270514
   WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105
   Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Wordinger R, 2002, MOL VIS, V8, P241
   Xiao W, 2013, ACTA BIOMATER, V9, P8374, DOI 10.1016/j.actbio.2013.05.029
   Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0
   Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536
   Xu XJ, 2015, CELL BIOCHEM BIOPHYS, V71, P215, DOI 10.1007/s12013-014-0187-y
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yang DH, 2015, J TISSUE ENG REGEN M, V9, P1067, DOI 10.1002/term.1973
   Yang HS, 2012, EXP MOL MED, V44, P350, DOI 10.3858/emm.2012.44.5.039
   Yang KN, 2013, NANOSCALE, V5, P1205, DOI 10.1039/c2nr33575a
   Yang X, 2012, J BIOMED MATER RES A, DOI [10.1002/jbm.a.34064, DOI 10.1002/JBM.A.34064]
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Yonemori K, 1997, AM J PATHOL, V150, P1335
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
   Zambuzzi Willian F., 2012, Braz. Dent. J., V23, P315, DOI 10.1590/S0103-64402012000400002
   Zhang Chao, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P100
   Zhang HB, 1996, DEVELOPMENT, V122, P2977
   Zhang SF, 2008, BIOTECHNOL PROGR, V24, P945, DOI 10.1002/btpr.12
   Zhang SF, 2010, BIOMATERIALS, V31, P952, DOI 10.1016/j.biomaterials.2009.10.011
   Zhang SF, 2009, BIOMATERIALS, V30, P5143, DOI 10.1016/j.biomaterials.2009.05.060
   Zhang X, 2014, TISSUE ENG PART B-RE, V20, P84, DOI 10.1089/ten.TEB.2013.0204
   Zhang Y, 2006, J BIOL CHEM, V281, P39096, DOI 10.1074/jbc.M601362200
   Zhao GQ, 1996, MECH DEVELOP, V57, P159, DOI 10.1016/0925-4773(96)00543-6
   [郑永欣 ZHENG Yongxin], 2006, [中华眼科杂志, Chinese Journal of Ophthalmology], V42, P535
   Zhu SJ, 2006, ORAL SURG ORAL MED O, V102, P175, DOI 10.1016/j.tripleo.2005.08.034
   Zhu SJ, 2006, ORAL SURG ORAL MED O, V101, P166, DOI 10.1016/j.tripleo.2005.04.006
NR 331
TC 14
Z9 14
U1 1
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2015
VL 8
IS 4
BP 1778
EP 1816
DI 10.3390/ma8041778
PG 39
WC Materials Science, Multidisciplinary
SC Materials Science
GA CH5RD
UT WOS:000354092100029
PM 28788032
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wu, ZK
   Li, N
   Yan, JZ
   Zhao, WQ
AF Wu Zhikai
   Li Ning
   Yan Jiazhen
   Zhao Wanqian
TI Effect of Al2O3 Coating on Densification and Aging Sensibility of 3Y-TZP
   Ceramics
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article
DE 3Y-TZP; Al2O3 coating; densification; aging sensibility
ID PHASE-TRANSFORMATION; Y-TZP; STABILIZED ZIRCONIA; SINTERING BEHAVIOR;
   ALUMINA; DEGRADATION; YTTRIA; ZRO2; BIOMATERIAL; POWDERS
AB Al2O3 dopants in amount up to 1.5 wt% were coated on 3-mol-yttria-stabilized zirconia nanopowders adopting heterogeneous precipitation method. The influences of Al2O3 coating on the densification and the aging sensibility of 3Y-TZP were investigated. The process of densification was measured using a dilatometer. The density, the mean grain size and the mechanical properties of the densified 3Y-TZP were tested. X-ray diffraction (XRD) and scanning electron microscopy (SEM) were used to characterize the microstructures of specimens. The results show that the densification of Al203-coated zirconia compacts was greatly enhanced by the coating process compared with the conventional co-precipitation process. Dense 3Y-TZP (>6.0 g/cm(3)) can be obtained using the Al2O3-coated starting powders by pressureless sintering at 1350 similar to 1400 degrees C. In addition, the aging sensibility of 3Y-TZP is substantially decreased by adding Al2O3. This is probably attributed to the segregation of Al3+ at the grain boundaries of Al2O3-coated 3Y-TZP.
C1 [Wu Zhikai; Li Ning; Yan Jiazhen; Zhao Wanqian] Sichuan Univ, Chengdu 610065, Peoples R China.
RP Li, N (reprint author), Sichuan Univ, Sch Mfg Sci & Engn, Chengdu 610065, Peoples R China.
EM wuzhikai@163.com; lining@scu.edu.cn
CR Chen CC, 2008, J CERAM PROCESS RES, V9, P131
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Elshazly ES, 2008, J MATER SCI TECHNOL, V24, P873
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Goncalves RF, 2007, J MATER SCI, V42, P2222, DOI 10.1007/s10853-006-1021-8
   Hodgson S N B, 1999, MAT PROCESSING TECHN, V92, P85
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Li JF, 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Matsui K, 2008, J MATER SCI, V43, P2745, DOI 10.1007/s10853-008-2493-5
   Matsui K, 2006, J MATER RES, V21, P2278, DOI 10.1557/JMR.2006.0274
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   Srdic VV, 2001, J AM CERAM SOC, V84, P2771, DOI 10.1111/j.1151-2916.2001.tb01093.x
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   TSUKAMA K, 1985, J MATER SCI LETT, V4, P857, DOI 10.1007/BF00720523
   Wu ZK, 2013, J MATER SCI, V48, P1256, DOI 10.1007/s10853-012-6867-3
   Xie QF, 2011, RARE METAL MAT ENG, V40, P48
   Yang SY, 2004, SOLID STATE IONICS, V172, P413, DOI 10.1016/j.ssi.2004.03.026
   Yi YF, 2009, RARE METAL MAT ENG, V38, P870
NR 24
TC 1
Z9 1
U1 0
U2 11
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD APR
PY 2015
VL 44
IS 4
BP 808
EP 812
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CH6JN
UT WOS:000354143000007
DA 2018-10-19
ER

PT J
AU Kakinoki, S
   Yamaoka, T
AF Kakinoki, Sachiro
   Yamaoka, Tetsuji
TI Single-Step Immobilization of Cell Adhesive Peptides on a Variety of
   Biomaterial Substrates via Tyrosine Oxidation with Copper Catalyst and
   Hydrogen Peroxide
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID PLASMA FIBRONECTIN; MYTILUS-EDULIS; SURFACE; MUSSEL; PROTEINS; DOPA;
   3,4-DIHYDROXYPHENYLALANINE; POLYMERIZATION; MECHANISMS
AB Immobilization of biologically active peptides which were isolated from extracellular matrix proteins is a powerful strategy for the design and functionalization of biomaterial substrates. However, the method of peptide immobilization was restricted, that is, peptide is often immobilized through the reactive groups inherent in substrates with multistep reactions. Here, we report a single-step immobilization of fibronectin-derived cell adhesive peptide (Arg-Glu-Asp-Val; REDV) onto polymer materials by use of tyrosine oxidation with copper catalyst and hydrogen peroxide. REDV peptide was successfully immobilized on tissue culture polystyrene, poly(ethylene terephthalate), poly(vinyl chloride), expanded-poly(tetrafluoroethylene), and poly(l-lactic acid), resulting in enhanced adhesion of human umbilical vein endothelial cells. This method is a single-step reaction under very mild conditions and is available for the biological functionalization of various medical devices.
C1 [Kakinoki, Sachiro; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan.
RP Kakinoki, S (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
EM sachiro@ncvc.go.jp; yamtet@ncvc.go.jp
FU Intramural Research Fund of National Cerebral and Cardiovascular Center
   [25-6-18]; S-Innovation Project of JST
FX This work was supported by the Intramural Research Fund of National
   Cerebral and Cardiovascular Center (25-6-18) and the S-Innovation
   Project of JST.
CR Ali FE, 2004, J INORG BIOCHEM, V98, P173, DOI 10.1016/j.jinorgbio.2003.10.002
   ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   FRYE AH, 1959, J POLYM SCI, V40, P419, DOI 10.1002/pol.1959.1204013712
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hu BH, 2000, TETRAHEDRON LETT, V41, P5795, DOI 10.1016/S0040-4039(00)00957-6
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   Kakinoki S, 2010, ACTA BIOMATER, V6, P1925, DOI 10.1016/j.actbio.2009.12.001
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kobayashi S, 2003, PROG POLYM SCI, V28, P1015, DOI 10.1016/S0079-6700(03)00014-5
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Ooka AA, 2000, BIOPOLYMERS, V57, P92
   Park KM, 2011, J MATER CHEM, V21, P15906, DOI 10.1039/c1jm13869c
   Seth R, 2004, TOXICOL IN VITRO, V18, P501, DOI 10.1016/j.tiv.2004.01.006
   Sever MJ, 2001, TETRAHEDRON, V57, P6139, DOI 10.1016/S0040-4020(01)00601-9
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Vert M, 2007, PROG POLYM SCI, V32, P755, DOI 10.1016/j.progpolymsci.2007.05.006
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   WAITE JH, 1990, INT J BIOL MACROMOL, V12, P139, DOI 10.1016/0141-8130(90)90065-I
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 26
TC 9
Z9 10
U1 2
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD APR
PY 2015
VL 26
IS 4
BP 639
EP 644
DI 10.1021/acs.bioconjchem.5b00032
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CG3JU
UT WOS:000353177300004
PM 25742028
DA 2018-10-19
ER

PT J
AU Singh, B
   Kumar, S
   Saha, N
   Basu, B
   Gupta, R
AF Singh, Brajendra
   Kumar, Samayendra
   Saha, Naresh
   Basu, Bikramjit
   Gupta, Rajeev
TI Phase stability of silver particles embedded calcium phosphate
   bioceramics
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Biomaterial; hydroxyapatite; Raman spectroscopy
ID NANOPHASE CERAMICS; CRYSTAL-STRUCTURE; HYDROXYAPATITE; BIOCOMPATIBILITY;
   DIFFRACTION; FILM
AB In this paper, we report the compositional variation-dependent phase stability of hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) on doping with silver. The transformation of hydroxyapatite to (beta/alpha) tricalcium phosphate phases during sintering has been explored using Raman spectroscopy and X-ray diffraction techniques. The optical absorption spectroscopy analysis reveals the presence of Ag+ ions at low doping levels. As the doping increases, abundance of Ag particles is enhanced.
C1 [Singh, Brajendra] Univ Allahabad, Ctr Mat Sci, Allahabad 211002, Uttar Pradesh, India.
   [Singh, Brajendra; Gupta, Rajeev] Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India.
   [Kumar, Samayendra; Gupta, Rajeev] Indian Inst Technol, Mat Sci Program, Kanpur 208016, Uttar Pradesh, India.
   [Saha, Naresh; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
RP Singh, B (reprint author), Univ Allahabad, Ctr Mat Sci, Allahabad 211002, Uttar Pradesh, India.
EM brajendr@gmail.com
RI Gupta, Rajeev/C-8262-2012
OI Gupta, Rajeev/0000-0002-8328-9780; Singh, Brajendra/0000-0001-9587-8817
FU CSIR; DST, India
FX We acknowledge the financial support from the CSIR and DST, India. BS
   thanks Dr N P Lalla, IUC-DAEF, Indore, for assistance in TEM analysis.
CR Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Costa AM, 2004, KEY ENG MAT, V254-2, P119, DOI 10.4028/www.scientific.net/KEM.254-256.119
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Geoffrey I N, 2001, PHYS CHEM CHEM PHYS, V17, P3838
   Han IH, 2007, BIOMED MATER, V2, pS91, DOI 10.1088/1748-6041/2/3/S01
   HANSEN WN, 1968, PHYS REV, V174, P500, DOI 10.1103/PhysRev.174.500
   Jimenez JA, 2008, J APPL PHYS, V104, DOI 10.1063/1.2976171
   Kannan S, 2005, SCRIPTA MATER, V53, P1259, DOI 10.1016/j.scriptamat.2005.07.037
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Lee IS, 2006, NUCL INSTRUM METH B, V242, P45, DOI 10.1016/j.nimb.2005.08.010
   Lee IS, 2002, BIOMATERIALS, V23, P609, DOI 10.1016/S0142-9612(01)00147-8
   LeGeros R.Z., 1980, P 2 INT C PHOSPH COM, P89
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nath S, 2008, SCRIPTA MATER, V58, P1054, DOI 10.1016/j.scriptamat.2008.01.045
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   PETTINGER B, 1994, ANGEW CHEM INT EDIT, V33, P85, DOI 10.1002/anie.199400851
   PNde Aza, 1997, CHEM MATER, V9, P916
   Singh B, 2015, INT J APPL CERAM TEC, V12, P319, DOI 10.1111/ijac.12167
   Singh B, 2013, MATER LETT, V95, P100, DOI 10.1016/j.matlet.2012.12.074
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Wang D. S., 1990, APPL OPTICS, V19, P2135
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   Yashima M, 2003, J SOLID STATE CHEM, V175, P272, DOI 10.1016/S0022-4596(03)00279-2
NR 26
TC 2
Z9 2
U1 3
U2 11
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
EI 0973-7669
J9 B MATER SCI
JI Bull. Mat. Sci.
PD APR
PY 2015
VL 38
IS 2
BP 525
EP 529
DI 10.1007/s12034-014-0839-y
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA CH2CD
UT WOS:000353831200031
DA 2018-10-19
ER

PT J
AU Jeong, ED
   Whang, JY
   Lee, JW
AF Jeong, Euh-Duck
   Whang, Jae Young
   Lee, Joo-Woon
TI Conducting Cell Scaffold-Poly(3 '-aminomethyl-2,2 ':5 ',2
   ''-terthiophene)
SO BULLETIN OF THE KOREAN CHEMICAL SOCIETY
LA English
DT Article
DE Conductive polymer; Polyterthiophene; Scaffold; Cell adhesion
ID NEURAL INTERFACES; POLYMERS; POLYPYRROLE; ATTACHMENT; SCAFFOLDS; GROWTH;
   ACID; ELECTRODES; PLATFORM; CULTURE
AB Electroactive biomaterials such as polythiophene (PT) are highly attractive scaffolds for tissue engineering applications. The introduction of reactive functionalities into the PT backbone structure is desired to enhance the biomaterial-tissue interface for desired tissue responses. Here, we present amino-functionalized conductive polyterthiophene, poly(3'-aminomethyl-2,2':5',2"-terthiophene) (PTTh-NH2), which successfully demonstrates the potential to influence cellular activity. The chemical structure of monomeric 3'-aminomethyl-2,2':5',2"-terthiophene was confirmed by MS and the polymer characteristics of PTTh-NH2 were determined by AFM, XPS, profilometer and four-point probe. In vitro cell viability study with human umbilical vascular endothelial cells (HUVECs) indicates that the primary amine functionality grafted into polythiophene (PT) backbone improve the cell adhesion and proliferation compared to negative (-) control conventional PT. Thus, PTTh-NH2 could be useful in developing PT composites for various biomedical applications.
C1 [Jeong, Euh-Duck] Korea Basic Sci Inst, Div High Technol Mat Res, Busan 618230, South Korea.
   [Whang, Jae Young] Gyeongsang Natl Univ, Res Inst Green Energy Convergence Technol RIGET, Jinju 660701, South Korea.
   [Lee, Joo-Woon] Korea Natl Univ Transportat, Sch Liberal Arts & Sci, Chem, Chungju 380702, South Korea.
RP Lee, JW (reprint author), Korea Natl Univ Transportat, Sch Liberal Arts & Sci, Chem, Chungju 380702, South Korea.
EM jwoonlee@ut.ac.kr
FU Academic Research Program of the Korea National University of
   Transportation
FX This work was supported by a grant from the Academic Research Program of
   the Korea National University of Transportation in 2014.
CR Alberts B, 2002, MOL BIOL CELL
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Bullett NA, 2004, APPL SURF SCI, V235, P395, DOI 10.1016/j.apsusc.2004.02.058
   Cho YN, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/20/205102
   Collis GE, 2003, J ORG CHEM, V68, P8974, DOI 10.1021/jo034855g
   Dawson RA, 1996, BURNS, V22, P93, DOI 10.1016/0305-4179(95)00092-5
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Higgins TB, 1998, CHEM MATER, V10, P1589, DOI 10.1021/cm970765e
   Janorkar AV, 2007, J BIOMED MATER RES B, V81B, P142, DOI 10.1002/jbm.b.30647
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Kim HJ, 2008, LANGMUIR, V24, P1087, DOI 10.1021/la701689f
   Kim J, 2010, IEEE INT CON MULTI, P7, DOI 10.1109/ICME.2010.5583856
   Lee J. Y., 2009, J R SOC INTERFACE, V6, P735
   Lee JY, 2013, SYNTHETIC MET, V185, P66, DOI 10.1016/j.synthmet.2013.09.044
   Lee JW, 2006, LANGMUIR, V22, P9816, DOI 10.1021/la062129d
   Lee JW, 2014, B KOREAN CHEM SOC, V35, P293, DOI 10.5012/bkcs.2014.35.1.293
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Lee TY, 2002, SYNTHETIC MET, V126, P105, DOI 10.1016/S0379-6779(01)00556-2
   Li GT, 1998, MACROMOL CHEM PHYSIC, V199, P2255, DOI 10.1002/macp.1998.021991025
   Liu X, 2011, BIOMATERIALS, V32, P7309, DOI 10.1016/j.biomaterials.2011.06.047
   McTiernan CD, 2012, NEW J CHEM, V36, P2106, DOI 10.1039/c2nj40366h
   Poole-Warren L, 2010, EXPERT REV MED DEVIC, V7, P35, DOI 10.1586/ERD.09.58
   Seol H, 2006, SYNTHETIC MET, V156, P65, DOI 10.1016/j.synthmet.2005.10.008
   SMITS FM, 1958, AT&T TECH J, V37, P711, DOI 10.1002/j.1538-7305.1958.tb03883.x
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Sun Y, 2007, MACROMOL SYMP, V256, P137, DOI [10.1002/masy.200751016, 10.1002/masy.20751016]
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Yoon JH, 2011, J POWER SOURCES, V196, P8874, DOI 10.1016/j.jpowsour.2011.05.077
NR 32
TC 1
Z9 1
U1 1
U2 16
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0253-2964
EI 1229-5949
J9 B KOREAN CHEM SOC
JI Bull. Korean Chem. Soc.
PD APR
PY 2015
VL 36
IS 4
BP 1114
EP 1119
DI 10.1002/bkcs.10206
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG8RJ
UT WOS:000353577900009
DA 2018-10-19
ER

PT J
AU Nishimura, T
   Mukai, S
   Sawada, S
   Akiyoshi, K
AF Nishimura, Tomoki
   Mukai, Sada-atsu
   Sawada, Shin-ichi
   Akiyoshi, Kazunari
TI Glyco Star Polymers as Helical Multivalent Host and Biofunctional
   Nano-Platform
SO ACS Macro Letters
LA English
DT Article
ID COIL BLOCK-COPOLYMERS; DNA STRAND EXCHANGE; ENZYMATIC-SYNTHESIS;
   AMYLOSE-PRIMER; CATALYZED POLYMERIZATION; INCLUSION COMPLEXES; IODINE;
   ACID; CHAPERONE; KINETICS
AB A series of amylose-based star polymers (1, 2, 4, and 8 arms) as a new glyco biomaterial was synthesized by a click reaction and enzymatic polymerization of specific primers with phosphorylase. The molecular weights were controlled by the enzymatic reaction. Further polymerization resulted in a viscous solution and, especially, for the 8-arm primer, a hydrogel was obtained due to effective cross-linking between the multiarmed structures. The star polymers with a degree of polymerization of about 60 per arm acted as an allosteric multivalent host for hydrophobic molecules by helical formation. A cationic 8-arm star polymer catalyzed DNA strand exchange as a nucleic acid chaperone. Amylose-based star polymers are promising building blocks for producing advanced hybrid glyco biomaterials.
C1 [Nishimura, Tomoki; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158150, Japan.
   [Nishimura, Tomoki; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari] JST, ERATO Akiyoshi Bionanotransporter Project, Kyoto 6158150, Japan.
RP Akiyoshi, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158150, Japan.
EM akiyoshi@bio.polym.kyoto-u.ac.jp
RI Nishimura, Tomoki/E-5189-2010
OI Nishimura, Tomoki/0000-0002-9034-3626
FU JST ERATO program
FX This work was financially supported by the JST ERATO program.
CR Akiyoshi K, 2002, BIOMACROMOLECULES, V3, P280, DOI 10.1021/bm010144l
   Akiyoshi K, 1999, MACROMOL RAPID COMM, V20, P112, DOI 10.1002/(SICI)1521-3927(19990301)20:3<112::AID-MARC112>3.0.CO;2-Q
   BANKS W, 1971, CARBOHYD RES, V17, P25, DOI 10.1016/S0008-6215(00)81539-6
   Bernard J, 2005, MACROMOLECULES, V38, P5475, DOI 10.1021/ma050050u
   Braunmuehl V. v., 1995, MACROMOLECULES, V28, P17
   Cori GT, 1940, J BIOL CHEM, V135, P733
   Frykholm K, 2009, LANGMUIR, V25, P1606, DOI 10.1021/la8032513
   Gelders GG, 2005, BIOMACROMOLECULES, V6, P2622, DOI 10.1021/bm0502011
   GIDLEY MJ, 1989, MACROMOLECULES, V22, P341, DOI 10.1021/ma00191a062
   HANDA T, 1981, BIOPOLYMERS, V20, P2051, DOI 10.1002/bip.1981.360201003
   Hsien-Chih HW, 1978, CARBOHYD RES, V61, P27
   Inoue K, 2000, PROG POLYM SCI, V25, P453, DOI 10.1016/S0079-6700(00)00011-3
   Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001
   Kadokawa J, 2001, CHEM COMMUN, P449, DOI 10.1039/b008180i
   Kadokawa J, 2011, CHEM REV, V111, P4308, DOI 10.1021/cr100285v
   Kamiya S, 1998, MACROMOL CHEM PHYS, V199, P1589, DOI 10.1002/(SICI)1521-3935(19980801)199:8<1589::AID-MACP1589>3.0.CO;2-V
   Kaneko Y, 2007, BIOMACROMOLECULES, V8, P3959, DOI 10.1021/bm701000t
   Kim WJ, 2002, J AM CHEM SOC, V124, P12676, DOI 10.1021/ja0272080
   Kim WJ, 2001, CHEM-EUR J, V7, P176, DOI 10.1002/1521-3765(20010105)7:1<176::AID-CHEM176>3.0.CO;2-M
   Kobayashi K, 1996, MACROMOLECULES, V29, P8670, DOI 10.1021/ma9603443
   Lapienis G, 2009, PROG POLYM SCI, V34, P852, DOI 10.1016/j.progpolymsci.2009.04.006
   Loos K, 2002, BIOMACROMOLECULES, V3, P368, DOI 10.1021/bm0156330
   Loos K, 1997, MACROMOLECULES, V30, P7641, DOI 10.1021/ma971022h
   MILES MJ, 1985, CARBOHYD RES, V135, P257, DOI 10.1016/S0008-6215(00)90777-8
   Milojevic S, 1996, J CONTROL RELEASE, V38, P75, DOI 10.1016/0168-3659(95)00112-3
   Morimoto N, 2007, J AM CHEM SOC, V129, P458, DOI 10.1021/ja065966a
   Morimoto N, 2013, LANGMUIR, V29, P7509, DOI 10.1021/la3047774
   Morimoto N, 2009, CHEM LETT, V38, P496, DOI 10.1246/cl.2009.496
   Morimoto N, 2009, J BIOTECHNOL, V140, P246, DOI 10.1016/j.jbiotec.2009.01.013
   Narumi A, 2003, POLYM BULL, V49, P405, DOI 10.1007/s00289-003-0126-3
   OKAMOTO Y, 1994, J CHROMATOGR A, V666, P403, DOI 10.1016/0021-9673(94)80400-1
   Otsuka I., 2009, LANGMUIR, V26, P2325
   Putseys JA, 2010, J CEREAL SCI, V51, P238, DOI 10.1016/j.jcs.2010.01.011
   Roger P, 2000, MACROMOLECULES, V33, P2446, DOI 10.1021/ma991302s
   SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5
   Sanji T, 2005, ANGEW CHEM INT EDIT, V44, P7301, DOI 10.1002/anie.200502073
   Schatz C, 2010, MACROMOL RAPID COMM, V31, P1664, DOI 10.1002/marc.201000267
   Shimada N, 2008, J POLYM SCI POL CHEM, V46, P1440, DOI 10.1002/pola.22483
   Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A
   Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l
   Tanaka T, 2013, MACROMOL CHEM PHYS, V214, P2829, DOI 10.1002/macp.201300525
   Vlassopoulos D, 2004, J POLYM SCI POL PHYS, V42, P2931, DOI 10.1002/polb.20152
   Vlist J. v. d., 2012, POLYMERS, V4, P674
   ZIEGAST G, 1987, CARBOHYD RES, V160, P185, DOI 10.1016/0008-6215(87)80311-7
NR 44
TC 9
Z9 9
U1 6
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD APR
PY 2015
VL 4
IS 4
BP 367
EP 371
DI 10.1021/acsmacrolett.5b00049
PG 5
WC Polymer Science
SC Polymer Science
GA CG6UD
UT WOS:000353437000007
DA 2018-10-19
ER

PT J
AU Jebahi, S
   Saoudi, M
   Farhat, L
   Oudadesse, H
   Rebai, T
   Kabir, A
   El Feki, A
   Keskes, H
AF Jebahi, S.
   Saoudi, M.
   Farhat, L.
   Oudadesse, H.
   Rebai, T.
   Kabir, A.
   El Feki, A.
   Keskes, H.
TI Effect of novel curcumin-encapsulated chitosan-bioglass drug on bone and
   skin repair after gamma radiation: experimental study on a Wistar rat
   model
SO CELL BIOCHEMISTRY AND FUNCTION
LA English
DT Article
DE curcumin; bioglass; chitosan; bone; skin; osteoporosis; irradiation
ID ANTIOXIDANT ACTIVITY; GLASS; MICE; IRRADIATION
AB Radiation therapy contributes to a significant increase in bone osteoporosis and skin loss. Various natural health products might be beneficial to reduce bone and skin alterations. Curcumin (CUR) medicines derived from natural plants have played an important role in health care. This study aims at synthesizing and evaluating the performance therapy of CUR-encapsulated bioglass-chitosan (CUR-BG-CH). In vitro, the antioxidant assay was evaluated by using 1,1-diphenyl-2-picrylhydrazyl free-radical (DPPH) scavenging and the nitroblue tetrazolium reduction. The CUR-BG-CH antimicrobial effects were tested in liquid media. In vivo, after rat Co-60 -radiation, the tissue wound-healing process was studied by grafting CUR and CUR-BG-CH in femoral condyle and dorsal skin rat tissue. The antioxidant studies indicated that CUR-BG-CH quenches free radicals more efficiently than unmodified CUR and had effective DPPH (91%) and superoxide anion (51%) radical scavenging activities. The CUR-BG-CH biomaterial exhibited an important antimicrobial activity against Staphylococcus aureus. The histomorphometric parameters showed amelioration in CUR-BG-CH-treated rats. An improved mechanical property was noticed (33.16 +/- 5.0HV) when compared with that of unmodified CUR group (23.15 +/- 4.9 HV). A significant decrease in tumour necrosis factor- cytokine production was noted in the CUR-BG-CH rats (90pg/ml) as compared with that of unmodified CUR group (240pg/ml). The total amount of hydroxyproline was significantly enhanced (33.5%) in CUR-BG-CH group as compared with that of control. Our findings suggested that CUR-BG-CH might have promising potential applications for wound healing. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Jebahi, S.; Oudadesse, H.] Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, Rennes, France.
   [Jebahi, S.; Saoudi, M.; El Feki, A.; Keskes, H.] Sfax Fac Sci, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [Farhat, L.] CHU Habib Bourguiba, Med Oncol Serv, Sfax, Tunisia.
   [Rebai, T.; Kabir, A.] Sfax Fac Med, Histol Orthopaed & Traumatol Lab, Sfax, Tunisia.
RP Jebahi, S (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, Rennes, France.
EM jbahisamira@yahoo.fr
CR Antuness LM, 2000, MUTAT RES, V2, P131
   Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t
   Bls N, 2011, PHYTOMEDICINE, V18, P756
   Bonnet N, 2010, IBMS BONEKEY, V7, P235, DOI DOI 10.1138/20100454
   Buis XV, 2012, KOREAN J CHEM ENG, V29, P215
   Camils CB, 1994, MATURITAS, V18, P199
   Caos X, 2011, P NATL ACAD SCI USA, V108, P1609
   Chos JW, 2007, INT J MOL MED, V19, P469
   Chung MJ, 2012, INT IMMUNOPHARMACOL, V12, P453, DOI 10.1016/j.intimp.2011.12.027
   Cordina-Duverger E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078016
   Jaques JAD, 2011, CELL BIOCHEM FUNCT, V29, P703, DOI 10.1002/cbf.1804
   El-Sweedys M, 2007, J APPL BIOMED, V5, P131
   Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849
   GRANT RA, 1973, J ANAT, V115, P29
   Jagetia GC, 2005, PLAST RECONSTR SURG, V115, P515, DOI 10.1097/01.PRS.0000148372.75342.D9
   Jagetia GC, 2004, J SURG RES, V120, P127, DOI 10.1016/j.jss.2003.12.003
   Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140
   Jebahi S, 2012, J APPL BIOMED, V10, P195, DOI 10.2478/v10136-012-0009-8
   Kents LJ, 2006, BIOMATERIALS, V27, P3249
   Koleva II, 2002, PHYTOCHEM ANALYSIS, V13, P8, DOI 10.1002/pca.611
   Kumagai Yoshito, 2002, Environ Health Prev Med, V7, P141, DOI 10.1007/BF02897942
   Lins C, 2012, BIOMED MATER, V7
   Mamalis A, 2014, J DRUGS DERMATOL, V13, P574
   MERYON SD, 1984, CELL BIOCHEM FUNCT, V2, P43, DOI 10.1002/cbf.290020112
   Moon DO, 2010, INT IMMUNOPHARMACOL, V10, P605, DOI 10.1016/j.intimp.2010.02.011
   Muns SH, 2013, PHYTOMEDICINE, V20, P714
   Nair SP, 1996, INFECT IMMUN, V64, P2371
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   Oudadesse H, 2013, KOREAN J CHEM ENG, V30, P1775, DOI 10.1007/s11814-013-0104-x
   Pezeshki-Modaresss M, 2013, J BIOMED MATER RES A, DOI [10.1002/jbm.a.35054, DOI 10.1002/JBM.A.35054]
   Pierangelos B, 2014, PHYTOMEDICINE, V21, P430
   Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3
   Rais D, 2008, J BIOCH, V410, P147
   Ranas T, 2012, FREE RADIC BIOL MED, V15, P2298
   SCHENK RK, 1969, ACTA ANAT, V74, P44
   Steafans IL, 1995, BIOCH BIOPHYS, V318, P408
   Supper S, 2014, EXPERT OPIN DRUG DEL, V11, P249, DOI 10.1517/17425247.2014.867326
   Tais BJ, 2006, J CLIN PERIODONTOL, V33, P86
   Victoria Delpinos M, 2009, INFECT IMMUN, V77, P984
   Wus SJ, 2013, INT J BIOL MACROMOL, V62, P348
NR 40
TC 8
Z9 9
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0263-6484
EI 1099-0844
J9 CELL BIOCHEM FUNCT
JI Cell Biochem. Funct.
PD APR
PY 2015
VL 33
IS 3
BP 150
EP 159
DI 10.1002/cbf.3098
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CG4GN
UT WOS:000353243700007
PM 25809966
DA 2018-10-19
ER

PT J
AU Gellynck, K
   Kodeck, V
   Van De Walle, E
   Kersemans, K
   De Vos, F
   Declercq, H
   Dubruel, P
   Vlaminck, L
   Cornelissen, M
AF Gellynck, Karolien
   Kodeck, Valerie
   Van De Walle, Elke
   Kersemans, Ken
   De Vos, Filip
   Declercq, Heidi
   Dubruel, Peter
   Vlaminck, Lieven
   Cornelissen, Maria
TI First step toward near-infrared continuous glucose monitoring: in vivo
   evaluation of antibody coupled biomaterials
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE In vivo; continuous glucose monitoring; antibody-coupled; vascular
   endothelial-cadherin; enhanced vascularization
ID VASCULAR ENDOTHELIAL-CADHERIN; BLOOD-VESSEL FORMATION; NEOINTIMAL
   FORMATION; DIABETES-MELLITUS; GROWTH-FACTOR; TISSUE; SPECTROSCOPY;
   DIFFUSION; IMPLANTS; SILICON
AB Continuous glucose monitoring (CGM) is crucial in diabetic care. Long-term CGM systems however require an accurate sensor as well as a suitable measuring environment. Since large intravenous sensors are not feasible, measuring inside the interstitial fluid is considered the best alternative. This option, unfortunately, has the drawback of a lag time with blood glucose values. A good strategy to circumvent this is to enhance tissue integration and enrich the peri-implant vasculature. Implants of different optically transparent biomaterials (poly(methyl-methacrylate) [PMMA] and poly(dimethylsiloxane) [PDMS]) - enabling glucose monitoring in the near-infrared (NIR) spectrum - were surface-treated and subsequently implanted in goats at various implantation sites for up to 3 months. The overall in vivo biocompatibility, tissue integration, and vascularization at close proximity of the surfaces of these materials were assessed. Histological screening showed similar tissue reactions independent of the implantation site. No significant inflammation reaction was observed. Tissue integration and vascularization correlated, to some extent, with the biomaterial composition. A modification strategy, in which a vascular endothelial-cadherin antibody was coupled to the biomaterials surface through a dopamine layer, showed significantly enhanced vascularization 3 months after subcutaneous implantation. Our results suggest that the developed strategy enables the creation of tissue interactive NIR transparent packaging materials, opening the possibility of continuous glucose monitoring.
C1 [Gellynck, Karolien; Declercq, Heidi; Cornelissen, Maria] Univ Ghent, Tissue Engn Grp, B-9000 Ghent, Belgium.
   [Kodeck, Valerie; Van De Walle, Elke; Dubruel, Peter] Univ Ghent, PBM, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   [Kersemans, Ken; De Vos, Filip] Univ Ghent, Lab Radiopharm, B-9000 Ghent, Belgium.
   [Vlaminck, Lieven] Univ Ghent, Dept Surg & Anaesthesiol Domest Anim, B-9820 Merelbeke, Belgium.
RP Cornelissen, M (reprint author), Univ Ghent, Tissue Engn Grp, Pintelaan 185 6B3, B-9000 Ghent, Belgium.
EM Ria.Cornelissen@UGent.be
FU Ghent University; Agency for Innovation by Science and Technology (IWT)
   [SBO] [GlucoSens 090053]
FX The authors would like to thank Leen Pieters and Thoke Thiron for their
   technical assistance, while Ghent University is acknowledged for
   supporting the Multidisciplinary Research Partnership Nano- and
   Biophotonics (2010-2014). This work was supported by the Agency for
   Innovation by Science and Technology (IWT) [SBO project GlucoSens
   090053].
CR Abbasi F, 2006, J BIOMAT SCI-POLYM E, V17, P341, DOI 10.1163/156856206775997287
   Ainslie KM, 2005, NANO LETT, V5, P1852, DOI 10.1021/nl051117u
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13
   Berneel E, 2012, J BIOMED MATER RES A, V100A, P1783, DOI 10.1002/jbm.a.34125
   Block SS, 2001, DISINFECTION STERILI, P1481
   Burmeister JJ, 1999, CLIN CHEM, V45, P1621
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24
   Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323
   Haghdoost I, 2007, COMPAR CLIN PATHOL, V16, P53
   Hazen KH, 1998, APPL SPECTROSC, V52, P1597, DOI 10.1366/0003702981943103
   JONGEBLOED WL, 1994, BIOMATERIALS, V15, P766, DOI 10.1016/0142-9612(94)90030-2
   Klueh U, 2005, BIOMATERIALS, V26, P1155, DOI 10.1016/j.biomaterials.2004.04.017
   Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee JM, 2012, BIOMATERIALS, V33, P8917, DOI 10.1016/j.biomaterials.2012.08.066
   Li AG, 2007, J BIOMED MATER RES A, V82A, P498, DOI 10.1002/jbm.a.31168
   Lim WH, 2011, ARTERIOSCL THROM VAS, V31, P2798, DOI 10.1161/ATVBAHA.111.226134
   Lugowski SJ, 2000, J TRACE ELEM MED BIO, V14, P31, DOI 10.1016/S0946-672X(00)80021-8
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Olesberg JT, 2006, ANAL CHEM, V78, P215, DOI 10.1021/ac051036i
   Oliver NS, 2009, DIABETIC MED, V26, P197, DOI 10.1111/j.1464-5491.2008.02642.x
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Race A, 2007, J BIOMECH, V40, P1002, DOI 10.1016/j.jbiomech.2006.04.003
   Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x
   Roelkens G, 2012, IEEE J QUANTUM ELECT, V48, P292, DOI 10.1109/JQE.2011.2178090
   Ryckeboer E, 2013, OPT EXPRESS, V21, P6101, DOI 10.1364/OE.21.006101
   Ryckeboer E, 2013, LAB CHIP, V13, P4392, DOI 10.1039/c3lc50752a
   Schneider F, 2009, SENSOR ACTUAT A-PHYS, V151, P95, DOI 10.1016/j.sna.2009.01.026
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Shastri V. Prasad, 2003, Current Pharmaceutical Biotechnology, V4, P331, DOI 10.2174/1389201033489694
   Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159
   Trabelsi A, 2010, INT C MICROELECTRON, P176, DOI 10.1109/ICM.2010.5696108
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001
   Wan Y, 2011, BIOSENS BIOELECTRON, V26, P2595, DOI 10.1016/j.bios.2010.11.013
   WOOD RC, 1995, BIOMATERIALS, V16, P957, DOI 10.1016/0142-9612(95)93122-T
   Zhu HG, 2005, BIOCONJUGATE CHEM, V16, P1451, DOI 10.1021/bc050171z
NR 41
TC 2
Z9 2
U1 0
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD APR
PY 2015
VL 240
IS 4
BP 446
EP 457
DI 10.1177/1535370214554878
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CG1SP
UT WOS:000353054600005
PM 25304314
OA Green Published
DA 2018-10-19
ER

PT J
AU Lee, KM
   Kim, H
   Nemeno, JG
   Yang, W
   Yoon, J
   Lee, S
   Lee, JI
AF Lee, K. M.
   Kim, H.
   Nemeno, J. G.
   Yang, W.
   Yoon, J.
   Lee, S.
   Lee, J. I.
TI Natural Cardiac Extracellular Matrix Sheet as a Biomaterial for
   Cardiomyocyte Transplantation
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID MYOCARDIAL-INFARCTION; TISSUE RECONSTRUCTION; SCAFFOLDS; CELLS
AB Cardiovascular diseases associated with myocardial infarction are among the major causes of death worldwide due to the limited regenerative capacity of cardiac tissues. Although various approaches, such as biosynthetic biomaterials, have been developed to promote postinfarction cardiac regeneration, a number of limitations, including the immune complications caused by biodegradation of these scaffolds and insufficient cell migration, need to be overcome prior to their clinical application. Hence, the development of natural biomaterials to support myocardial regeneration is crucial. Here, we investigated the effects of a natural biomaterial, cardiac extracellular matrix (ECM) on the proliferation and maintenance of cardiomyocytes in order to assess its suitability for cardiomyocyte expansion. The ECM components not only provide mechanical support, but also induce and preserve the required phenotypic and functional characteristics of the cells. We prepared ECM sheets from decellularized cardiac sections. Cardiomyocytes were then cultured with and without these cardiac ECM sheets. We compared the proliferation rates and phenotypes, and cardiac gene and protein expression, of the cultured cardiomyocytes by automatic cell counting and the MTT assay, microscopy, and RT-PCR and western blotting, respectively. The cardiomyocytes cultured with the natural cardiac ECM sheets exhibited higher proliferation rates and cardiac gene and protein expression than those cultured without the ECM sheets. Our results demonstrate that the ECM sheets are suitable for use in cardiomyocyte transplantation and can provide a novel in vitro model for investigating cell and ECM interactions. We hypothesize that these ECM sheets can be used in the future to improve cardiac transplantation strategies.
C1 [Lee, K. M.; Kim, H.; Nemeno, J. G.; Yang, W.; Lee, S.; Lee, J. I.] Konkuk Univ, IBST, Dept Biomed Sci & Technol, Regenerat Med Lab,Ctr Stem Cell Res, Seoul 143729, South Korea.
   [Yoon, J.] Seoul Natl Univ Sci & Technol, Grad Sch NID Fus Technol, IT Design Fus Program, Seoul, South Korea.
   [Lee, J. I.] Konkuk Univ, Coll Vet Med, Dept Vet Med, Seoul 143729, South Korea.
RP Lee, JI (reprint author), Konkuk Univ, 120 Neungdong Ro, Seoul 143729, South Korea.
EM jeongik@konkuk.ac.kr
RI Lee, Jeong Ik/D-8312-2011
OI Lee, Jeong Ik/0000-0003-2740-2432
FU Korean Health Technology R&D Project, Ministry of Health Welfare
   [A120275]
FX This study was supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare (A120275).
CR Alshammary S, 2013, SURG TODAY, V43, P970, DOI 10.1007/s00595-013-0528-2
   Braunwald E, 2000, CIRCULATION, V102, P14
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Takezawa T, 2002, FASEB J, V16, P1847, DOI 10.1096/fj.00-0405fje
   Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011
   Vacanti JP, 1999, LANCET, V354, pSI32
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yang W, 2014, TRANSPL P, V46, P1247, DOI 10.1016/j.transproceed.2013.11.082
NR 17
TC 4
Z9 4
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD APR
PY 2015
VL 47
IS 3
BP 751
EP 756
DI 10.1016/j.transproceed.2014.12.030
PG 6
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA CG6PT
UT WOS:000353424900040
PM 25891725
DA 2018-10-19
ER

PT J
AU Zhu, TM
   Tang, QS
   Shen, YW
   Tang, HL
   Chen, LP
   Zhu, JH
AF Zhu, Tongming
   Tang, Qisheng
   Shen, Yiwen
   Tang, Hailiang
   Chen, Luping
   Zhu, Jianhong
TI An acellular cerebellar biological scaffold: Preparation,
   characterization, biocompatibility and effects on neural stem cells
SO BRAIN RESEARCH BULLETIN
LA English
DT Article
DE Extracellular matrix; Cerebellum; Central nervous system;
   Decellularization; Regenerative medicine; Tissue engineering
ID SYSTEM EXTRACELLULAR-MATRIX; REGENERATIVE MEDICINE; IN-VIVO; AORTIC
   MATRIX; SPINAL-CORD; BRAIN; DIFFERENTIATION; PROLIFERATION; SUBMUCOSA;
   NEUROGENESIS
AB Biomaterial and regenerative medical research has diversified and developed rapidly. A biological scaffold consisting of an extracellular matrix (ECM) functions not only as a supportive material but also as a regulator of cellular functions. Although decellularized scaffolds have been widely applied for the repair of non-central nervous system (CNS) tissues, their efficacy in the CNS has not been extensively investigated. In this report, we describe a dynamic decellularization protocol that combined intracardial perfusion and a series of treatments to effectively remove the cellular components from the cerebellum, which is a unique and relatively simple CNS structure. The resulting cerebellar scaffold retained neurosupportive proteins and growth factors and, when tested with neural stem cells (NSCs) in vitro, was found to be cytocompatible and to stimulate the proliferation and migration of these cells. NSCs that were cultured in vitro on the scaffold differentiated into neurons and astrocytes, as indicated by their expression of beta III-tubulin and glial fibrillary acidic protein (GFAP). Through subcutaneous and intracranial implantation experiments, this preliminary study demonstrated the in vivo biocompatibility of the cerebellar scaffold and indicated its potential for future applications. Thus, our study demonstrated that the cerebellar ECM scaffold provided tissue-specific advantages for regenerative medical applications. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhu, Tongming; Tang, Qisheng; Shen, Yiwen; Tang, Hailiang; Chen, Luping; Zhu, Jianhong] Fudan Univ, Fudan Univ Huashan Hosp, Natl Key Lab Med Neurobiol, Dept Neurosurg,Inst Brain Sci,Shanghai Med Coll, Shanghai 200040, Peoples R China.
RP Zhu, JH (reprint author), 12 Wulumuqizhonglu, Shanghai 200040, Peoples R China.
EM fdzhujh@163.com
FU National Natural Science Foundation of China [2012CB966300, 81271003]
FX The study was supported by National Natural Science Foundation of China
   (2012CB966300, 81271003).
CR Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5
   Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002
   Arenas-Herrera JE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014106
   Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Bolland BJRF, 2007, J BONE JOINT SURG BR, V89B, P686, DOI 10.1302/0301-620X.89B5.18695
   Butler CE, 2005, PLAST RECONSTR SURG, V116, P1263, DOI 10.1097/01.prs.0000181692.71901.bd
   Butler CE, 2005, PLAST RECONSTR SURG, V116, P1276
   Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Conconi MT, 2004, ANAT REC PART A, V281A, P1303, DOI 10.1002/ar.a.20137
   Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Erceg S, 2011, STEM CELLS, V29, P564, DOI 10.1002/stem.619
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Guo SZ, 2010, SPINAL CORD, V48, P576, DOI 10.1038/sc.2009.170
   Hoshino M, 2012, DEV GROWTH DIFFER, V54, P317, DOI 10.1111/j.1440-169X.2012.01330.x
   Ito M, 1999, BRAIN RES BULL, V50, P331, DOI 10.1016/S0361-9230(99)00147-1
   Kauer-Sant'Anna M, 2007, PEPTIDES, V28, P1447, DOI 10.1016/j.peptides.2007.06.010
   Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970
   KOOCHEKPOUR S, 1995, EUR J CANCER, V31A, P375, DOI 10.1016/0959-8049(94)00476-L
   Massirer KB, 2011, WIRES SYST BIOL MED, V3, P107, DOI 10.1002/wsbm.100
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   O'Connor RC, 2002, UROLOGY, V60, P906, DOI 10.1016/S0090-4295(02)01965-9
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016
   Parnigotto PP, 2000, UROL RES, V28, P46, DOI 10.1007/s002400050009
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   Prestwich GD, 2015, EXPERT OPIN BIOL TH, V15, P3, DOI 10.1517/14712598.2015.975200
   Quarti A, 2011, INTERACT CARDIOV TH, V13, P569, DOI 10.1510/icvts.2011.280016
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6
   Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237
   SIMONASSMANN P, 1995, EXPERIENTIA, V51, P883, DOI 10.1007/BF01921739
   Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498
   ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9
   Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673
   Yang XT, 2011, BRAIN RES BULL, V84, P1, DOI 10.1016/j.brainresbull.2010.09.008
NR 50
TC 10
Z9 11
U1 3
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD APR
PY 2015
VL 113
BP 48
EP 57
DI 10.1016/j.brainresbull.2015.03.003
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA CG2CQ
UT WOS:000353082900007
PM 25791359
DA 2018-10-19
ER

PT J
AU Kobtan, H
AF Kobtan, H.
TI Use of autologous fascia lata as a natural biomaterial for tectonic
   support in surgically induced necrotizing scleritis
SO EYE
LA English
DT Article
ID CATARACT-SURGERY; AMNIOTIC MEMBRANE; REPAIR; ULCERATION; PATIENT; TISSUE
AB Background Surgically induced scleral necrosis (SINS) is a severe form of scleritis threatening both vision and integrity of the eye. SINS is a rare sequel of ocular surgery and has been described after cataract extraction, trabeculectomy, strabismus, retinal detachment surgery including parsplana vitrectomy, penetrating keratoplasty, pterygium excision, and diode cyclophotocoagulation.
   Materials and methods To report on the application of autologous fascia lata as a readily available natural biomaterial for ocular tectonic support in SINS, we performed this retrospective chart review including two eyes of two patients; one case following both repaired rupture globe, parsplana vitrectomy, and diode laser transscleral cyclophotocoagulation and one case following pterygium surgical excision.
   Results Successful coverage of the area of scleral thinning with autologous fascia lata was achieved in both cases with overlying healthy vascularized conjunctiva and resolution of the ocular inflammation.
   Conclusion The fascia lata transplant combined with systemic immunosuppression was successful in providing adequate tectonic support and controlling the progression of scleral melt for two cases with SINS.
C1 [Kobtan, H.] Cairo Univ, Dept Ophthalmol, Cairo, Egypt.
RP Kobtan, H (reprint author), Eye Care Clin, 16 El Saleh Ayoub St, Cairo 11211, Egypt.
EM H_k1970@hotmail.com
CR Alsagoff Z, 2000, BRIT J OPHTHALMOL, V84, P1050, DOI 10.1136/bjo.84.9.1050
   ARENTSEN JJ, 1976, AM J OPHTHALMOL, V81, P194, DOI 10.1016/0002-9394(76)90730-3
   BLOOMFIELD SE, 1980, BRIT J OPHTHALMOL, V64, P170, DOI 10.1136/bjo.64.3.170
   DELAMAZA MS, 1994, OPHTHALMOLOGY, V101, P389
   Grindle C F, 1979, Mod Probl Ophthalmol, V20, P219
   Kachmaryk M, 1996, OPHTHALMIC SURG LAS, V27, P397
   Kaufman L M, 1989, J Pediatr Ophthalmol Strabismus, V26, P236
   Lazzaro DR, 2010, EYE CONTACT LENS, V36, P60, DOI 10.1097/ICL.0b013e3181c6deb0
   Lin CP, 1996, OPHTHALMIC SURG LAS, V27, P995
   LYNE AJ, 1979, T OPHTHAL SOC UK, V99, P146
   Morley AMS, 2008, EYE, V22, P162, DOI 10.1038/sj.eye.6702708
   ODONOGHUE E, 1992, BRIT J OPHTHALMOL, V76, P17, DOI 10.1136/bjo.76.1.17
   Okhravi N, 2005, SURV OPHTHALMOL, V50, P351, DOI 10.1016/j.survophthal.2005.04.001
   Rodriguez-Ares MT, 1999, OPHTHALMIC SURG LAS, V30, P485
   SALAMON SM, 1982, AM J OPHTHALMOL, V93, P334, DOI 10.1016/0002-9394(82)90535-9
   Schein OD, 1998, AM J OPHTHALMOL, V125, P549, DOI 10.1016/S0002-9394(99)80197-4
   SCOTT JA, 1994, EYE, V8, P292, DOI 10.1038/eye.1994.60
   Sevel D., 1966, THESIS U LONDON LOND
   Shen SY, 2004, OPHTHAL SURG LAS IM, V35, P251
   TUFT SJ, 1991, OPHTHALMOLOGY, V98, P467
   Vagefi MR, 2005, BRIT J OPHTHALMOL, V89, P124, DOI 10.1136/bjo.2004.051359
   Watson PG, 1976, SCLERA SYSTEMIC DISO, P171
NR 22
TC 4
Z9 4
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-222X
EI 1476-5454
J9 EYE
JI Eye
PD APR
PY 2015
VL 29
IS 4
BP 580
EP 584
DI 10.1038/eye.2014.327
PG 5
WC Ophthalmology
SC Ophthalmology
GA CF5WG
UT WOS:000352627400021
PM 25633880
OA Green Published
DA 2018-10-19
ER

PT J
AU Vega, SL
   Dhaliwal, A
   Arvind, V
   Patel, PJ
   Beijer, NRM
   de Boer, J
   Murthy, NS
   Kohn, J
   Moghe, PV
AF Vega, Sebastian L.
   Dhaliwal, Anandika
   Arvind, Varun
   Patel, Parth J.
   Beijer, Nick R. M.
   de Boer, Jan
   Murthy, N. Sanjeeva
   Kohn, Joachim
   Moghe, Prabhas V.
TI Organizational metrics of interchromatin speckle factor domains:
   integrative classifier for stem cell adhesion & lineage signaling
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID OSTEOGENIC DIFFERENTIATION; IN-VITRO; MESENCHYMAL CELLS; SUBSTRATE;
   BIOMATERIALS; TOPOGRAPHY; NUCLEUS; PATHWAY; SHAPE; FATE
AB Stem cell fates on biomaterials are influenced by the complex confluence of microenvironmental cues emanating from soluble growth factors, cell-to-cell contacts, and biomaterial properties. Cell-microenvironment interactions influence the cell fate by initiating a series of outside-in signaling events that traverse from the focal adhesions to the nucleus via the cytoskeleton and modulate the sub-nuclear protein organization and gene expression. Here, we report a novel imaging-based framework that highlights the spatial organization of sub-nuclear proteins, specifically the splicing factor SC-35 in the nucleoplasm, as an integrative marker to distinguish between minute differences of stem cell lineage pathways in response to stimulatory soluble factors, surface topologies, and microscale topographies. This framework involves the high resolution image acquisition of SC-35 domains and imaging-based feature extraction to obtain quantitative nuclear metrics in tandem with machine learning approaches to generate a predictive cell state classification model. The acquired SC-35 metrics led to 490% correct classification of emergent human mesenchymal stem cell (hMSC) phenotypes in populations of hMSCs exposed for merely 3 days to basal, adipogenic, or osteogenic soluble cues, as well as varying levels of dexamethasone-induced alkaline phosphatase (ALP) expression. Early osteogenic cellular responses across a series of surface patterns, fibrous scaffolds, and micropillars were also detected and classified using this imaging-based methodology. Complex cell states resulting from inhibition of RhoGTPase, beta-catenin, and FAK could be classified with 490% sensitivity on the basis of differences in the SC-35 organizational metrics. This indicates that SC-35 organization is sensitively impacted by adhesion-related signaling molecules that regulate osteogenic differentiation. Our results show that diverse microenvironment cues affect different attributes of the SC-35 organizational metrics and lead to distinct emergent organizational patterns. Taken together, these studies demonstrate that the early organization of SC-35 domains could serve as a "fingerprint'' of the intracellular mechanotransductive signaling that governs growth factor-and topography-responsive stem cell states.
C1 [Vega, Sebastian L.; Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
   [Dhaliwal, Anandika; Arvind, Varun; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Patel, Parth J.] Rutgers State Univ, New Jersey Med Sch, Piscataway, NJ 08854 USA.
   [Beijer, Nick R. M.; de Boer, Jan] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [de Boer, Jan] Maastricht Univ, cBITE Lab, Merln Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
   [Murthy, N. Sanjeeva; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM moghe@rutgers.edu
FU NIH [EB001046]; NSF DGE [0801620]
FX This study was supported by funding from NIH EB001046 (RESBIO,
   Integrated Resources for Polymeric Biomaterials) and NSF DGE 0801620
   (IGERT on Integrated Science and Engineering of Stem Cells).
CR Akter R, 2009, J BONE MINER RES, V24, P283, DOI 10.1359/JBMR.081010
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Bai B, 2013, BIOMED RES INT, DOI 10.1155/2013/361906
   Boltau M, 1998, NATURE, V391, P877
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Carlson AL, 2012, FASEB J, V26, P3240, DOI 10.1096/fj.11-192732
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016
   de Peppo GM, 2014, INT J NANOMED, V9, P2499, DOI 10.2147/IJN.S58805
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0
   Galli C, 2010, J BIOMED MATER RES A, V95A, P682, DOI 10.1002/jbm.a.32887
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hwang NS, 2013, TISSUE ENG PT A, V19, P1723, DOI [10.1089/ten.tea.2013.0064, 10.1089/ten.TEA.2013.0064]
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   JIMENEZGARCIA LF, 1993, CELL, V73, P47, DOI 10.1016/0092-8674(93)90159-N
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim J., 2015, UNPUB
   Kim J. J., 2013, METHOD MOL BIOL, V1052, P1
   Krause U, 2011, METHODS MOL BIOL, V698, P215, DOI 10.1007/978-1-60761-999-4_17
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072233
   Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136
   Liu E, 2010, CELL CYCLE, V9, P2108, DOI 10.4161/cc.9.11.11864
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03545
   Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497
   Moe AAK, 2012, SMALL, V8, P3050, DOI 10.1002/smll.201200490
   Moen PT, 2004, MOL BIOL CELL, V15, P197
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189
   Ozdemir T, 2013, INTEGR BIOL-UK, V5, P1407, DOI 10.1039/c3ib40068a
   Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Romero-Prado M, 2006, J CELL BIOCHEM, V98, P1457, DOI 10.1002/jcb.20778
   Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074
   Scuteri Arianna, 2014, International Journal of Stem Cells, V7, P127, DOI 10.15283/ijsc.2014.7.2.127
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646
   SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Szczerbal I, 2010, CHROMOSOME RES, V18, P887, DOI 10.1007/s10577-010-9176-1
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   THIRY M, 1995, HISTOL HISTOPATHOL, V10, P1035
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vega SL, 2012, J BIOMOL SCREEN, V17, P1151, DOI 10.1177/1087057112453853
   Wang WC, 2012, J CELL BIOCHEM, V113, P3567, DOI 10.1002/jcb.24235
   Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139
   Xing H., 2014, J PERIODONTOL, P1
   Xu B., 2013, J BIOSCI BIOENG, P624
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Yang Z, 2011, METHODS MOL BIOL, V698, P353, DOI 10.1007/978-1-60761-999-4_26
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
NR 64
TC 4
Z9 4
U1 1
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PD APR
PY 2015
VL 7
IS 4
BP 435
EP 446
DI 10.1039/c4ib00281d
PG 12
WC Cell Biology
SC Cell Biology
GA CF8CX
UT WOS:000352784200006
PM 25765854
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Srivatsan, KV
   Duraipandy, N
   Begum, S
   Lakra, R
   Ramamurthy, U
   Korrapati, PS
   Kiran, MS
AF Srivatsan, Kunnavakkam Vinjimur
   Duraipandy, N.
   Begum, Shajitha
   Lakra, Rachita
   Ramamurthy, Usha
   Korrapati, Puma Sai
   Kiran, Manikantan Syamala
TI Effect of curcumin caged silver nanoparticle on collagen stabilization
   for biomedical applications
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Curcumin; Silver nanoparticles; Collagen; Stabilization; Anti-microbial;
   Biocompatible
ID CROSS-LINKED COLLAGEN; RAT TAIL TENDON; IN-VITRO; ANTIBACTERIAL
   PROPERTIES; MECHANICAL-PROPERTIES; LINKING; CYTOTOXICITY; SCAFFOLD;
   SKIN; BIOMATERIAL
AB The current study aims at understanding the influence of curcumin caged silver nanoparticle (CCSNP) on stability of collagen. The results indicated that curcumin caged silver nanoparticles efficiently stabilize collagen, indicated by enhanced tensile strength, fibril formation and viscosity. The tensile strength of curcumin caged silver nanoparticle cross-linked collagen and elongation at break was also found to be higher than glutaraldehyde cross-linked collagen. The physicochemical characteristics of curcumin caged nanoparticle cross-linked collagen exhibited enhanced strength. The thermal properties were also good with both thermal degradation temperature and hydrothermal stability higher than native collagen. CD analysis showed no structural disparity in spite of superior physicochemical properties suggesting the significance of curcumin caged nanoparticle mediated cross-linking. The additional enhancement in the stabilization of collagen could be attributed to multiple sites for interaction with collagen molecule provided by curcumin caged silver nanoparticles. The results of cell proliferation and anti-microbial activity assays indicated that curcumin caged silver nanoparticles promoted cell proliferation and inhibited microbial growth making it an excellent biomaterial for wound dressing application. The study opens scope for nano-biotechnological strategies for the development of alternate non-toxic cross-linking agents facilitating multiple site interaction thereby improving therapeutic values to the collagen for biomedical application. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Srivatsan, Kunnavakkam Vinjimur; Duraipandy, N.; Lakra, Rachita; Ramamurthy, Usha; Korrapati, Puma Sai; Kiran, Manikantan Syamala] CSIR, Cent Leather Res Inst, Chennai 600020, Tamil Nadu, India.
   [Duraipandy, N.; Korrapati, Puma Sai; Kiran, Manikantan Syamala] Acad Sci & Innovat Res, New Delhi, India.
   [Begum, Shajitha] Univ Madras, Chennai, Tamil Nadu, India.
RP Kiran, MS (reprint author), CSIR, CLRI, Chennai 600020, Tamil Nadu, India.
EM kiranmsk112@gmail.com
RI Natarajan, Duraipandy/O-2473-2013
OI Natarajan, Duraipandy/0000-0001-5705-3101
FU DBT [GAP 1062]; CSIR, Govt. of India [CSC0201, BSC0112]
FX We would like to thank The Director, CSIR-CLRI, Chennai, India for
   providing the facilities to carry out the experiments. Financial
   assistance from DBT for the project RGYI (GAP 1062) and CSIR, Govt. of
   India for the supra-institutional project-STARIT (CSC0201) and NanoSHE
   (BSC0112) under XII five year plan is greatly acknowledged.
CR Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Amsterdam D., 1996, ANTIBIOTICS LAB MED, P52
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BAILEY AJ, 1974, NATURE, V251, P105, DOI 10.1038/251105a0
   Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104
   BAILEY AJ, 1969, GERONTOLOGY, V15, P65, DOI 10.1159/000211677
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Brower V, 1998, NAT BIOTECHNOL, V16, P728, DOI 10.1038/nbt0898-728
   Cao N, 2007, FOOD HYDROCOLLOID, V21, P575, DOI 10.1016/j.foodhyd.2006.07.001
   Castaneda L, 2008, BIOMACROMOLECULES, V9, P3383, DOI 10.1021/bm800793z
   DANIELSEN CC, 1987, MECH AGEING DEV, V40, P9, DOI 10.1016/0047-6374(87)90030-3
   Danilov NA, 2008, BBA-GEN SUBJECTS, V1780, P764, DOI 10.1016/j.bbagen.2008.01.014
   Di Y, 2009, POLYM DEGRAD STABIL, V94, P1684, DOI 10.1016/j.polymdegradstab.2009.06.019
   Duraipandy N, 2015, J MATER CHEM B, V3, P1415, DOI 10.1039/c4tb01791a
   Duraipandy N, 2014, METALLOMICS, V6, P2025, DOI 10.1039/c4mt00165f
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gaidau C., 2010, J OPTOELECTRON ADV M, V12, P2157
   GRANT ME, 1972, NEW ENGL J MED, V286, P242, DOI 10.1056/NEJM197202032860505
   Griffiths PR, 2007, FOURIER TRANSFORM IN
   Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Jayakumar GC, 2012, CARBOHYD POLYM, V87, P1482, DOI 10.1016/j.carbpol.2011.09.042
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Jurenka JS, 2009, ALTERN MED REV, V14, P141
   Jus S, 2011, MAT SCI ENG C-MATER, V31, P1068, DOI 10.1016/j.msec.2011.03.007
   Kandamchira A, 2013, MAT SCI ENG C-MATER, V33, P4985, DOI 10.1016/j.msec.2013.08.018
   Kielty C.M., 2002, CONNECTIVE TISSUE IT
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   LABOUT JJM, 1972, INT J RADIAT BIOL RE, V21, P483, DOI 10.1080/09553007214550561
   Li YP, 2009, MAT SCI ENG C-BIO S, V29, P1643, DOI 10.1016/j.msec.2009.01.001
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   McKusick V.A., 1972, MCKUSICKS HERITABLE
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nimni ME, 1988, MOL STRUCTURE FUNCTI
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Prasad S, 2014, BIOTECHNOL ADV, V32, P1053, DOI 10.1016/j.biotechadv.2014.04.004
   Rajaram A., 1989, J BIOMAT SCI-POLYM E, V1, P167
   Ramachandran G. N., 1976, BIOCH COLLAGEN
   Royce P.M., 1993, JPN J HUM GENET, V38, P445
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   Sajithlal GB, 1998, BIOCHEM PHARMACOL, V56, P1607, DOI 10.1016/S0006-2952(98)00237-8
   Shanmugasundaram N, 2004, J BIOMATER APPL, V18, P247, DOI 10.1177/0885328204040945
   SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silverstein R.M., 1981, SPECTROMETRIC IDENTI
   Singh S, 2013, COLLOID SURFACE B, V102, P83, DOI 10.1016/j.colsurfb.2012.08.012
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   TANZER ML, 1973, SCIENCE, V180, P561, DOI 10.1126/science.180.4086.561
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Usha R, 2013, COLLOID SURFACE B, V109, P121, DOI 10.1016/j.colsurfb.2013.03.034
   WALLACE DG, 1986, BIOPOLYMERS, V25, P1875, DOI 10.1002/bip.360251006
   WOHLLEBE M, 1978, EUR J BIOCHEM, V92, P183, DOI 10.1111/j.1432-1033.1978.tb12736.x
   Wood G., 1960, BIOCHEM J, P598
   Xu B., 2013, BIOMATTER, V3, P1
   Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126
   Zeugolis DI, 2010, MAT SCI ENG C-MATER, V30, P190, DOI 10.1016/j.msec.2009.09.017
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
NR 63
TC 10
Z9 10
U1 1
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2015
VL 75
BP 306
EP 315
DI 10.1016/j.ijbiomac.2015.01.050
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CF1UF
UT WOS:000352332700041
PM 25661876
DA 2018-10-19
ER

PT J
AU Manna, PJ
   Mitra, T
   Pramanik, N
   Kavitha, V
   Gnanamani, A
   Kundu, PP
AF Manna, Piyali Jana
   Mitra, Tapas
   Pramanik, Nilkamal
   Kavitha, V.
   Gnanamani, A.
   Kundu, P. P.
TI Potential use of curcumin loaded carboxymethylated guar gum grafted
   gelatin film for biomedical applications
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Gelatin; Guar gum; Curcumin
ID CROSS-LINKED GELATIN; IN-VITRO; CONTROLLED-RELEASE; ALGINATE SPONGE;
   HYDROGEL FILMS; VIVO; ANTIBACTERIAL; CHITOSAN; IDENTIFICATION;
   IRRADIATION
AB Present study describes the synthesis of carboxylmethyl guar gum (CMGG) from the native guar gum (GG). Further, the prepared CMGG is grafted with gelatin to form CMGG-g-gelatin and then mixed with curcumin to prepare a biomaterial. The resultant biomaterial is subjected to the analysis of H-1 NMR, ATR-FTIR, TGA, SEM and XRD ensure the carboxymethylation and grafting. The results reveal that 45% of the amine groups of gelatin have been reacted with the -COOH group of CMGG and 90-95% of curcumin is released from CMGG-g-gelatin after 96 h of incubation in the phosphate buffer at physiological pH. In vitro cell line studies reveal the biocompatibility of the biomaterial and the antimicrobial studies display the growth inhibition against gram +ve and gram -ve organisms at a considerable level. Overall, the study indicates that the incorporation of curcumin Into CMGG-g-gelatin can improve the functional property of guar gum as well as gelatin. (C) 2015 Published by Elsevier B.V.
C1 [Manna, Piyali Jana; Mitra, Tapas; Pramanik, Nilkamal; Kundu, P. P.] Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, Kolkata 700009, W Bengal, India.
   [Kavitha, V.; Gnanamani, A.] CSIR, Div Microbiol, Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Kundu, PP (reprint author), Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, 92,APC Rd, Kolkata 700009, W Bengal, India.
EM tapasbiochem1@gmail.com; ppk923@yahoo.com
OI Mitra, Tapas/0000-0003-0813-7389
FU UGC, New Delhi
FX One of the authors Dr. Tapas Mitra acknowledges UGC, New Delhi for
   financial assistance provided in the form of Dr. D.S. Kothari Post
   Doctoral Fellowship.
CR Ahuja M, 2012, INT J BIOL MACROMOL, V51, P1086, DOI 10.1016/j.ijbiomac.2012.08.023
   Aravindhan R., 2014, COMPLEX MET, V1, P69, DOI DOI 10.1080/2164232X.2014.886963
   Aydin M, 2010, BRAZ J PHYS, V40, P306, DOI 10.1590/S0103-97332010000300008
   Basniwal R.K., 2011, J AGR FOOD CHEM, V59, P2056
   Bhagavathula N, 2009, WOUND REPAIR REGEN, V17, P360, DOI 10.1111/j.1524-475X.2009.00483.x
   Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Cortesi R, 1998, BIOMATERIALS, V19, P1641, DOI 10.1016/S0142-9612(98)00034-9
   Cunha PLR, 2007, INT J BIOL MACROMOL, V41, P324, DOI 10.1016/j.ijbiomac.2007.04.003
   Dai M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/595126
   Dawlee S, 2005, BIOMACROMOLECULES, V6, P2040, DOI 10.1021/bm050013a
   de Carvalho RA, 2004, FOOD HYDROCOLLOID, V18, P717, DOI 10.1016/j.foodhyd.2003.10.005
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dodi G, 2011, CELL CHEM TECHNOL, V45, P171
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Gong HH, 2012, CARBOHYD POLYM, V88, P1015, DOI 10.1016/j.carbpol.2012.01.057
   GUIDOIN R, 1987, BIOMATERIALS, V8, P433, DOI 10.1016/0142-9612(87)90079-2
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   Haynes C. A., 2001, GOOGLE PATENTS
   Huang YH, 2006, CARBOHYD POLYM, V66, P500, DOI 10.1016/j.carbpol.2006.04.001
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Kuijpers AJ, 2000, BIOMATERIALS, V21, P1763, DOI 10.1016/S0142-9612(00)00064-8
   Liu WG, 2000, POLYMER, V41, P7589, DOI 10.1016/S0032-3861(00)00015-X
   Lv HX, 2011, MOLECULES, V16, P6778, DOI 10.3390/molecules16086778
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Mitra T, 2012, J APPL POLYM SCI, V125, pE490, DOI 10.1002/app.36957
   Mu C., 2010, MACROMOL MATER ENG, V295, P100
   Naveen N, 2010, ADV ENG MATER, V12, pB380, DOI 10.1002/adem.200980067
   Nguyen T.-H., 2010, J BIOMED SCI ENG, V3, P1117, DOI DOI 10.4236/JBISE.2010.312145
   Nguyen V. C., 2013, INT J POLYM SET, V2013, P1
   Pal S, 2007, J APPL POLYM SCI, V105, P3240, DOI 10.1002/app.26440
   Panariello G, 2008, MACROMOL SYMP, V266, P68, DOI 10.1002/masy.200850613
   Qiu X, 2010, J MED CHEM, V53, P8260, DOI 10.1021/jm1004545
   Singh RK, 2010, EUR J MED CHEM, V45, P1078, DOI 10.1016/j.ejmech.2009.12.002
   Stojanovic Z, 2005, STARCH-STARKE, V57, P79, DOI 10.1002/star.200400342
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Verma A, 2013, INT J PHARM SCI RES, V4, P2907, DOI 10.13040/IJPSR.0975-8232.4(8).2907-15
   Wangtueai S, 2009, LWT-FOOD SCI TECHNOL, V42, P825, DOI 10.1016/j.lwt.2008.11.014
   Zhai ML, 2004, CARBOHYD POLYM, V57, P83, DOI 10.1016/j.carbpol.2004.04.003
NR 45
TC 15
Z9 15
U1 4
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2015
VL 75
BP 437
EP 446
DI 10.1016/j.ijbiomac.2015.01.047
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CF1UF
UT WOS:000352332700057
PM 25661877
DA 2018-10-19
ER

PT J
AU Rong, JJ
   Liang, M
   Xuan, FQ
   Sun, JY
   Zhao, LJ
   Zhen, HZ
   Tian, XX
   Liu, D
   Zhang, QY
   Peng, CF
   Yao, TM
   Li, F
   Wang, XZ
   Han, YL
   Yu, WT
AF Rong, Jing-jing
   Liang, Ming
   Xuan, Feng-qi
   Sun, Jing-yang
   Zhao, Li-jun
   Zhen, Hui-zhen
   Tian, Xiao-xiang
   Liu, Dan
   Zhang, Quan-yu
   Peng, Cheng-fei
   Yao, Tian-ming
   Li, Fei
   Wang, Xiao-zeng
   Han, Ya-ling
   Yu, Wei-ting
TI Alginate-calcium microsphere loaded with thrombin: A new composite
   biomaterial for hemostatic embolization
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Alginate; Thrombin; Microsphere; Trauma; Arterial embolization;
   Hemostasis
ID SPLENIC ARTERY EMBOLIZATION; CONTROLLED-RELEASE; POSTPARTUM HEMORRHAGE;
   DELIVERY-SYSTEM; IN-VIVO; INJURY; CHITOSAN; TRAUMA; BIOCOMPATIBILITY;
   COMPLICATIONS
AB To date, transcatheter arterial embolization (TAE) has become a standard treatment to control intracavitary bleeding as an alternative to surgery. Due to excellent biocompatibility and no residual in vivo, biodegradable materials are preferred in TAE. However, gelfoam is the only commercially available biodegradable embolic material used to treat blunt trauma of solid abdominal viscera until now, and controversial on its stability and reliability never stopped in the past five decades. In this study, a new biodegradable macromolecule material (thrombin-loaded alginate-calcium microspheres, TACMs) was prepared using electrostatic droplet techniques and a special method was developed for hemostatic embolization. Thrombin was successfully loaded into microspheres with high encapsulation efficiency and drug loading capacity. A burst release of TACMs was observed at early stage and sustained release later on, with the activity of thrombin preserved well. The strength of TACMs mixed thrombus, which was used as embolic agent, increased in a dose-dependent manner after TACMs were added. In addition, the TACMs were verified to be of no cytotoxicity and systemic toxicity, and biodegradable in vivo. Finally, the results of preliminary applications revealed that the TACMs could serve as an effective and promising embolic material for blunt trauma and hemorrhage of solid abdominal viscera. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Rong, Jing-jing; Liu, Dan; Zhang, Quan-yu] Third Mil Med Univ, Chongqing 400038, Peoples R China.
   [Liang, Ming; Xuan, Feng-qi; Sun, Jing-yang; Zhao, Li-jun; Tian, Xiao-xiang; Liu, Dan; Zhang, Quan-yu; Peng, Cheng-fei; Yao, Tian-ming; Li, Fei; Wang, Xiao-zeng; Han, Ya-ling] Shenyang Mil Reg, Dept Cardiol, Gen Hosp, Shenyang 110016, Peoples R China.
   [Zhen, Hui-zhen; Yu, Wei-ting] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China.
RP Rong, JJ (reprint author), Shenyang Mil Reg, Dept Cardiol, Gen Hosp, Shenyang 110016, Peoples R China.
EM rjaipx@163.com; lming000919@sina.com; xuanfengqi1988@126.com;
   sjy2003413002@sina.com; symc_zlj@126.com; zhenghz@dicp.ac.cn;
   tian_xx@163.com; liudan1014@qq.com; qyzhang1983@gmail.com;
   1059427125@qq.com; yaotianming2003@sina.com; feili_666@163.com;
   wxiaozeng@163.com; hanyl@medmail.com.cn; yuwt@dicp.ac.cn
FU Key Project of "the Twelfth Five-Year Plan" for Medical Science and
   Technology Research of People's Liberation Army [BWS12J006]; Doctor
   Startup Fund of Liaoning Province [20131135]; Youth Foundation of
   Medical Science and Technology Research of People's Liberation Army
   [13QNP003]
FX This work was supported by grant from the Key Project of "the Twelfth
   Five-Year Plan" for Medical Science and Technology Research of People's
   Liberation Army (No. BWS12J006), Doctor Startup Fund of Liaoning
   Province (No. 20131135) and Youth Foundation of Medical Science and
   Technology Research of People's Liberation Army (No. 13QNP003).
CR Abada HT, 2007, TECH VASC INTERV RAD, V10, P257, DOI 10.1053/j.tvir.2008.03.002
   Abdekhodaie M., 2014, CHEM ENG SCI, V124, P4
   Banerjee A, 2013, J TRAUMA ACUTE CARE, V75, P69, DOI 10.1097/TA.0b013e3182988b3b
   Becker TA, 2007, NEUROSURGERY, V60, P1119, DOI 10.1227/01.NEU.0000255447.90106.12
   Cao XL, 2010, J MATER SCI-MATER M, V21, P2861, DOI 10.1007/s10856-010-4133-2
   Cottier JP, 2002, OBSTET GYNECOL, V100, P1074, DOI 10.1016/S0029-7844(02)02050-1
   Cui D., 2012, INT J PHARMACEUT, V463, P527
   De la Riva B, 2009, EUR J PHARM BIOPHARM, V73, P50, DOI 10.1016/j.ejpb.2009.04.014
   Dutta S, 2012, ACS APPL MATER INTER, V4, P1560, DOI 10.1021/am201759w
   Ekeh AP, 2013, AM J SURG, V205, P250, DOI 10.1016/j.amjsurg.2013.01.003
   Forster REJ, 2010, J MATER SCI-MATER M, V21, P2243, DOI 10.1007/s10856-010-4080-y
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Golzarian J., 2006, VASCULAR EMBOLOTHERA
   Gombotz WR, 2012, ADV DRUG DELIVER REV, V64, P194, DOI 10.1016/j.addr.2012.09.007
   Grizzi I, 1998, J BIOMAT SCI-POLYM E, V9, P189, DOI 10.1163/156856298X00514
   Hu CH, 2012, COLLOID SURFACE B, V95, P162, DOI 10.1016/j.colsurfb.2012.02.030
   Katz MD, 2012, RADIOGRAPHICS, V32, P1713, DOI 10.1148/rg.326125524
   Kheirabadi BS, 2009, J TRAUMA, V66, P316, DOI [10.1097/TA.0b013e31819634a1, 10.1097/TA.0b0l3e31819634a1]
   Konya A, 2010, J VASC INTERV RADIOL, V21, P1091, DOI 10.1016/j.jvir.2010.02.037
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Leyon JJ, 2014, CURR PROBL DIAGN RAD, V43, P35, DOI 10.1067/j.cpradiol.2013.10.003
   Li S., 2014, POLYM COMPOS
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Liu B, 2013, J BIOMAT SCI-POLYM E, V24, P589, DOI 10.1080/09205063.2012.701160
   Loffroy RF, 2011, WORLD J GASTRO SURG, V3, P89, DOI 10.4240/wjgs.v3.i7.89
   Lv FQ, 2012, CLIN IMAG, V36, P191, DOI 10.1016/j.clinimag.2011.09.013
   Meng J, 2013, J NANOSCI NANOTECHNO, V13, P1467, DOI 10.1166/jnn.2013.6083
   Moreira PL, 2003, CARDIOVASC INTER RAD, V26, P100, DOI 10.1007/s00270-003-2632-y
   Oerlemans C, 2013, ACTA BIOMATER, V9, P4681, DOI 10.1016/j.actbio.2012.08.038
   Ohta S, 2006, J VASC INTERV RADIOL, V17, P533, DOI 10.1097/01.RVI.0000196356.17770.19
   Owen RJ, 2012, CARDIOVASC INTER RAD, V35, P636, DOI 10.1007/s00270-011-0218-7
   Pandey R, 2004, J ANTIMICROB CHEMOTH, V53, P635, DOI 10.1093/jac/dkh139
   Porcu G, 2005, BJOG-INT J OBSTET GY, V112, P122, DOI 10.1111/j.1471-0528.2005.00306.x
   Requarth JA, 2011, J TRAUMA, V71, P898, DOI 10.1097/TA.0b013e318227ea50
   Sambu N, 2012, HEART, V98, P706, DOI 10.1136/heartjnl-2011-301164
   Skattum J, 2012, INJURY, V43, P62, DOI 10.1016/j.injury.2010.06.028
   Sohn VY, 2009, J SURG RES, V154, P258, DOI 10.1016/j.jss.2008.07.040
   Tang J, 2008, J ULTRAS MED, V27, P925, DOI 10.7863/jum.2008.27.6.925
   Weng LH, 2013, ACTA BIOMATER, V9, P6823, DOI 10.1016/j.actbio.2013.02.017
   Wu H, 2012, REACT FUNCT POLYM, V72, P427, DOI 10.1016/j.reactfunctpolym.2012.04.007
   Wu SC, 2008, WORLD J SURG, V32, P476, DOI 10.1007/s00268-007-9322-x
   Xu RF, 2013, J BIOMAT SCI-POLYM E, V24, P1, DOI 10.1163/156856211X619630
   Zheng CH, 2004, BIOCHEM BIOPH RES CO, V323, P1321, DOI 10.1016/j.bbrc.2004.09.007
NR 43
TC 15
Z9 17
U1 4
U2 85
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2015
VL 75
BP 479
EP 488
DI 10.1016/j.ijbiomac.2014.12.043
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CF1UF
UT WOS:000352332700063
PM 25583022
DA 2018-10-19
ER

PT J
AU Hegewald, AA
   Medved, F
   Feng, DX
   Tsagogiorgas, C
   Beierfuss, A
   Schindler, GAK
   Trunk, M
   Kaps, C
   Mern, DS
   Thome, C
AF Hegewald, Aldemar Andres
   Medved, Fabian
   Feng, Daxiong
   Tsagogiorgas, Charalambos
   Beierfuss, Anja
   Schindler, Genevieve Ama Kyremaa
   Trunk, Marcus
   Kaps, Christian
   Mern, Demissew Shenegelegn
   Thome, Claudius
TI Enhancing tissue repair in annulus fibrosus defects of the
   intervertebral disc: analysis of a bio-integrative annulus implant in an
   in-vivo ovine model
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE annulus fibrosus; biomaterial; disc herniation; intervertebral disc;
   regeneration; spine surgery
ID BONE MORPHOGENETIC PROTEIN-2; NUCLEUS PULPOSUS CELLS; ANULUS FIBROSUS;
   SHEEP MODEL; DEGENERATION; RESPONSIVENESS; REPLACEMENT; COMPETENCE;
   STRENGTH
AB Annulus fibrosus repair techniques for the intervertebral disc (IVD) address the unsolved problem of reherniation after IVD herniation and might facilitate the development of nucleus pulposus replacement techniques for IVD diseases. This study investigates the suitability of a bio-integrative annulus implant.Standardized box defects were applied to the annulus L3/4 and L4/5 of 16 sheep, followed by randomized insertion of the textile polyglycolic acid/polyvinylidene fluoride annulus implant in one of the defects. Explantation was conducted after 2, 6 and 12 weeks, followed by provocative pressure testing and histological analysis. At 2 weeks' follow-up, all specimens of the control defect group demonstrated uncontained herniated nucleus pulposus tissue in the annulus defects. For the treated specimens, the annulus implant consistently provided an effective barrier for herniating nucleus pulposus tissue, with no implant dislocation at all time-points. After 2 weeks, a homogeneous cell infiltration of the annulus implant was observed, leading to a progressive directional matrix build-up. Repair tissue thickness was significantly stronger with the annulus implant at all follow-ups (p < 0.01). No pronounced foreign body reaction and no difference in the amount of supra-annular scar tissue over the defect sites were observed. The implantation procedure inflicted annulus damage adjacent to the defect. At later time-points, however, no difference in comparison with the control defect group was evident. The investigated biointegrative annulus implant showed promising results with regard to biointegration, enhancement of repair tissue and function as a mechanical barrier in an ovine model. (c) 2013 The Authors. Journal of Tissue Engineering and Regenerative Medicine published by John Wiley & Sons, Ltd.
C1 [Hegewald, Aldemar Andres; Medved, Fabian; Feng, Daxiong; Schindler, Genevieve Ama Kyremaa; Mern, Demissew Shenegelegn] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany.
   [Hegewald, Aldemar Andres; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.
   [Feng, Daxiong] Luzhou Med Coll, Affiliated Hosp, Spinal Surg Dept, Luzhou, Sichuan Provinc, Peoples R China.
   [Tsagogiorgas, Charalambos] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Anaesthesiol & Crit Care Med, D-68167 Mannheim, Germany.
   [Beierfuss, Anja] Univ Munich, Dept Small Anim Surg & Ophthalmol, Munich, Germany.
   [Trunk, Marcus] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, D-68167 Mannheim, Germany.
   [Kaps, Christian] TransTissue Technol GmbH, Berlin, Germany.
RP Hegewald, AA (reprint author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.
EM aldemar.hegewald@medma.uni-heidelberg.de
OI Hegewald, Aldemar Andres/0000-0002-2022-2060
FU Federal Ministry of Education and Research [BioInside 13N9831, 13N9830,
   13N9827]
FX This study was supported by the Federal Ministry of Education and
   Research (BioInside 13N9831, 13N9830 and 13N9827). The authors are very
   grateful to Prof. Lothar Schilling for his technical advice, to Marijas
   Jurisic and Michaela Endres for their technical assistance, to Thorsten
   Deichmann and Annahit Arshi from the Institut fur Textiltechnik, Faculty
   for Mechanical Engineering, RWTH Aachen University, for providing the
   annulus implant, to Prof. Kirsten Schmieder for her organizational
   support and to Dr James Melrose for sharing some of his excellent
   histological insights.
CR AHLGREN BD, 1994, SPINE, V19, P948, DOI 10.1097/00007632-199404150-00014
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Barth M, 2008, SPINE, V33, P265, DOI 10.1097/BRS.0b013e318162018c
   Brands B, 2003, THESIS U ZURICH
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chiang CJ, 2011, SPINE, V36, P761, DOI 10.1097/BRS.0b013e3181e08f01
   ETHIER DB, 1994, SPINE, V19, P2071, DOI 10.1097/00007632-199409150-00012
   Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Guder E, 2009, Z ORTHOP UNFALLCHIR, V147, P52, DOI 10.1055/s-2008-1039139
   HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009
   Hegewald Aldemar A, 2009, J Orthop Surg Res, V4, P25, DOI 10.1186/1749-799X-4-25
   Hegewalds AA, 2011, SPINE, V37, P101
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Imai Y, 2007, SPINE, V32, P1303, DOI 10.1097/BRS.0b013e3180593238
   Johnson WEB, 2001, CONNECT TISSUE RES, V42, P197, DOI 10.3109/03008200109005650
   KEY JA, 1948, J BONE JOINT SURG AM, V30-A, P621, DOI 10.2106/00004623-194830030-00009
   Kim H, 2009, SPINE, V34, P1834, DOI 10.1097/BRS.0b013e3181ae18ba
   Koepsell L, 2011, MACROMOL BIOSCI, V11, P391, DOI 10.1002/mabi.201000352
   Kuh SU, 2009, JOINT BONE SPINE, V76, P70, DOI 10.1016/j.jbspin.2008.02.021
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184
   Melrose J, 2004, METH MOLEC MED, V101, P39
   Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z
   Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Saads LC, 2007, THESIS MIT CAMBRIDGE
   Sherman J, 2010, SPINE J, V10, P108, DOI 10.1016/j.spinee.2009.08.453
   SMITH JW, 1951, J BONE JOINT SURG BR, V33, P612
   Vadala G, 2012, EUR SPINE J, V21, pS20, DOI 10.1007/s00586-012-2235-x
   Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09
NR 33
TC 16
Z9 18
U1 2
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2015
VL 9
IS 4
BP 405
EP 414
DI 10.1002/term.1831
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CG1LM
UT WOS:000353034100008
PM 24227682
OA Other Gold
DA 2018-10-19
ER

PT J
AU Taylor, AC
   Edgington, R
   Jackman, RB
AF Taylor, Alice C.
   Edgington, Robert
   Jackman, Richard B.
TI Patterning of Nanodiamond Tracks and Nanocrystalline Diamond Films Using
   a Micropipette for Additive Direct-Write Processing
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE diamond; nanodiamond; patterning; direct-write; microwave
   plasma-enhanced CVD
ID THIN-FILMS; MICROELECTRODE ARRAYS; LITHOGRAPHY; MEMS; SURFACE; GROWTH;
   FABRICATION; CARBON
AB The ability to pattern the seeding of nanodiamonds (NDs), and thus selectively control areas of diamond growth, is a useful capability for many applications, including photonics, microelectromechanical systems (MEMS) prototyping, and biomaterial design. A microprinting technique using a computer-driven micropipette has been developed to deposit patterns of ND monolayers from an unreactive water/glycerol ND ink to 5-mu m resolution. The concentration and composition of the ND solution were optimized to realize high-density monolayers of NDs and consistent ND printing. Subsequent nanocrystalline diamond (NCD) patterns grown using chemical vapor deposition showed a high level of compliance with the printed ND pattern. This "direct-write", bottom-up, and additive process offers a versatile and simple alternative to pattern diamond. The process has the particular advantage that it does not require lithography or destructive processing such as reactive-ion etching (RIE) and, pertinently, does not involve reactive chemicals that could alter the surface chemistry of NDs. Furthermore, given that this process obviates the use of conventional lithography, substrates that are not suitable for lithographic processing (e.g., excessively small or three-dimensional structured substrates) can be inscribed with ND patterns. The technique also allows for the growth of discrete, localized, single-crystal nanodiamonds with applications in quantum technology.
C1 [Jackman, Richard B.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England.
   UCL, Dept Elect & Elect Engn, London WC1H 0AH, England.
RP Jackman, RB (reprint author), UCL, London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England.
EM r.jackman@ucl.ac.uk
FU EU F7 Project "NEUROCARE" [280433-2]; U.K. Engineering and Physical
   Sciences Research Council (EPSRC) [EP/F026110/1]; Engineering and
   Physical Sciences Research Council [EP/F026110/1, EP/N004159/1]
FX This work was performed as part of EU F7 Project "NEUROCARE" (no.
   280433-2) and was partially supported by the U.K. Engineering and
   Physical Sciences Research Council (EPSRC, EP/F026110/1).
CR Ando Y, 2004, DIAM RELAT MATER, V13, P1975, DOI 10.1016/j.diamond.2004.06.025
   ASCARELLI P, 1993, APPL SURF SCI, V64, P307, DOI 10.1016/0169-4332(93)90201-L
   Avigal Y, 1999, DIAM RELAT MATER, V8, P127, DOI 10.1016/S0925-9635(98)00383-5
   Bergonzo P, 2011, IRBM, V32, P91, DOI 10.1016/j.irbm.2011.01.032
   Bongrain A, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/074015
   Bonnauron A, 2008, DIAM RELAT MATER, V17, P1399, DOI 10.1016/j.diamond.2007.12.065
   Chen YC, 2009, DIAM RELAT MATER, V18, P146, DOI 10.1016/j.diamond.2008.10.004
   Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z
   Cottance M., 2013, 2013 S DES TEST INT
   Ding GF, 2000, P SOC PHOTO-OPT INS, V4174, P451, DOI 10.1117/12.396465
   Domonkos M, 2014, PHYS STATUS SOLIDI B, V251, P2587, DOI 10.1002/pssb.201451172
   Edgington RJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056022
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Fox NA, 2000, J APPL PHYS, V87, P8187, DOI 10.1063/1.373516
   Fries MD, 2004, DIAM RELAT MATER, V13, P1740, DOI 10.1016/j.diamond.2004.02.014
   Hebert C, 2014, FARADAY DISCUSS, V172, P47, DOI 10.1039/c4fd00040d
   Hees J, 2012, NANOTECHNOLOGY, V24
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Krueger A, 2011, J MATER CHEM, V21, P12571, DOI 10.1039/c1jm11674f
   Kulakova II, 2004, PHYS SOLID STATE+, V46, P636, DOI 10.1134/1.1711440
   Lee SK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/50/505302
   LU J, 2008, 2008 3 IEEE INT C, P873
   Luo JK, 2007, J MICROMECH MICROENG, V17, pS147, DOI 10.1088/0960-1317/17/7/S12
   Malave A, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194478
   May PW, 2012, DIAM RELAT MATER, V23, P100, DOI 10.1016/j.diamond.2012.01.023
   May PW, 2000, PHILOS T ROY SOC A, V358, P473, DOI 10.1098/rsta.2000.0542
   Maybeck V, 2014, ADV HEALTHC MATER, V3, P283, DOI 10.1002/adhm.201300062
   Mortet V, 2008, PHYS STATUS SOLIDI A, V205, P1009, DOI 10.1002/pssa.200777502
   NARAYAN J, 1992, J APPL PHYS, V71, P3795, DOI 10.1063/1.350892
   Nebel CE, 2007, J R SOC INTERFACE, V4, P439, DOI 10.1098/rsif.2006.0196
   Ondic L, 2011, ACS NANO, V5, P346, DOI 10.1021/nn1021555
   Osswald S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075419
   Pedrosa VA, 2006, ELECTROANAL, V18, P1590, DOI 10.1002/elan.200603561
   Philip J, 2003, J APPL PHYS, V93, P2164, DOI 10.1063/1.1537465
   RALCHENKO VG, 1995, DIAM RELAT MATER, V4, P893, DOI 10.1016/0925-9635(94)00247-9
   Ramanathan M, 2010, J VAC SCI TECHNOL A, V28, P979, DOI 10.1116/1.3299260
   Regan EM, 2011, IEEE J EM SEL TOP C, V1, P557, DOI 10.1109/JETCAS.2011.2174469
   Shimoni O, 2014, ACS APPL MATER INTER, V6, P8894, DOI 10.1021/am5016556
   Sun KW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912029
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Taniguchi J, 2002, NANOTECHNOLOGY, V13, P592, DOI 10.1088/0957-4484/13/5/309
   Wang XD, 2002, J MATER PROCESS TECH, V127, P230, DOI 10.1016/S0924-0136(02)00147-4
   Williams JA, 2006, J PHYS D APPL PHYS, V39, pR201, DOI 10.1088/0022-3727/39/12/R01
   Williams OA, 2011, DIAM RELAT MATER, V20, P621, DOI 10.1016/j.diamond.2011.02.015
   Williams OA, 2006, PHYS STATUS SOLIDI A, V203, P3375, DOI 10.1002/pssa.200671406
   Zhuang H, 2011, LANGMUIR, V27, P11981, DOI 10.1021/la2024428
NR 46
TC 2
Z9 2
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 1
PY 2015
VL 7
IS 12
BP 6490
EP 6495
DI 10.1021/am507900a
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF0PM
UT WOS:000352246700018
PM 25669757
DA 2018-10-19
ER

PT J
AU Cao, FY
   Yin, WN
   Fan, JX
   Tao, L
   Qin, SY
   Zhuo, RX
   Zhang, XZ
AF Cao, Feng-Yi
   Yin, Wei-Na
   Fan, Jin-Xuan
   Tao, Li
   Qin, Si-Yong
   Zhuo, Ren-Xi
   Zhang, Xian-Zheng
TI Evaluating the Effects of Charged Oligopeptide Motifs Coupled with RGD
   on Osteogenic Differentiation of Mesenchymal Stem Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE charged oligopeptide; RGD; cBMHP1; stem cell; osteogenic differentiation
ID POLY(ACRYLIC ACID); BONE-MARROW; ADHESION; FATE; PROLIFERATION;
   BIOMATERIALS; INTERFACE; PEPTIDES; PROTEINS; CULTURE
AB Mesenchymal stem cells, due to their multilineage differentiation potential, have emerged as a promising cell candidate for cell-based therapy. In recent years, biomaterials were artificially synthesized to control the differentiation of mesenchymal stem cells. In this study, a series of charged or neutral oligopeptide motifs coupled with RGD were synthesized and used for surface modification using quartz substrates as model. Cell behaviors on the modified surfaces with different charged oligopeptide motifs were studied. It was found that these different charged oligopeptide motifs coupled with RGD were biocompatible for cell proliferation and adhesion. Moreover, it was demonstrated that the positively charged oligopeptide motif could inhibit osteogenic differentiation, while the negatively charged and neutral oligopeptide motifs could enhance osteogenic differentiation in the presence of RGD. This work may bring us enlightenment that different charged oligopeptide motifs coupled with RGD may be used for biomaterial surface modification for different stem cell-based therapies.
C1 [Zhang, Xian-Zheng] Wuhan Univ, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
   Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
RP Zhang, XZ (reprint author), Wuhan Univ, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
EM xz-zhang@whu.edu.cn
FU National Natural Science Foundation of China [51125014, 51233003];
   Ministry of Science and Technology of China [2011CB606202]; Natural
   Science Foundation of Hubei Province of China [2013CFA003]
FX This work was supported by the financial support from the National
   Natural Science Foundation of China (51125014 and 51233003), the
   Ministry of Science and Technology of China (2011CB606202), and the
   Natural Science Foundation of Hubei Province of China (2013CFA003).
CR Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Calabrese R, 2012, BIOMATERIALS, V33, P7375, DOI 10.1016/j.biomaterials.2012.06.043
   Cao FY, 2015, BIOMATER SCI-UK, V3, P345, DOI 10.1039/c4bm00300d
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Kwon HJ, 2010, ACTA BIOMATER, V6, P494, DOI 10.1016/j.actbio.2009.07.033
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   Lee IC, 2014, ACS APPL MATER INTER, V6, P20654, DOI 10.1021/am503928u
   Lu HX, 2009, J BIOMAT SCI-POLYM E, V20, P577, DOI 10.1163/156856209X426402
   Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   McNichols C, 2014, J BIOMED MATER RES A, V102, P532, DOI 10.1002/jbm.a.34700
   Momin EN, 2010, CURR STEM CELL RES T, V5, P326
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qin SY, 2014, SOFT MATTER, V10, P947, DOI 10.1039/c3sm52730a
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Shi XT, 2014, ACS APPL MATER INTER, V6, P11915, DOI 10.1021/am5029236
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   Song W, 2012, SOFT MATTER, V8, P8429, DOI 10.1039/c2sm25718a
   Sun HL, 2010, BIOMATERIALS, V31, P1133, DOI 10.1016/j.biomaterials.2009.10.030
   Tatavarty R, 2014, CHEM COMMUN, V50, P8484, DOI 10.1039/c4cc02442g
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang Y, 2014, REGEN BIOMATER, V1, P37, DOI 10.1093/rb/rbu012
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
NR 39
TC 14
Z9 14
U1 5
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 1
PY 2015
VL 7
IS 12
BP 6698
EP 6705
DI 10.1021/acsami.5b00064
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF0PM
UT WOS:000352246700042
PM 25748883
DA 2018-10-19
ER

PT J
AU Podlipec, R
   Strancar, J
AF Podlipec, Rok
   Strancar, Janez
TI Cell-Scaffold Adhesion Dynamics Measured in First Seconds Predicts Cell
   Growth on Days Scale - Optical Tweezers Study
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE cell growth; cell adhesion; single cell manipulation; optical tweezers;
   scaffold biocompatibility
ID FORCE SPECTROSCOPY; ADHERENT CELLS; LIVING CELLS; SHEAR-FLOW; IN-VITRO;
   SURFACE; PROLIFERATION; FIBROBLASTS; INTEGRIN; BINDING
AB Understanding the cell-biomaterial interface from the very first contact is of crucial importance for their successful implementation and function in damaged tissues. However, the lack of bio- and mechano-analytical methods to investigate and probe the initial processes on the interface, especially in 3D, raises the need for applying new experimental techniques. In our study, optical tweezers combined with confocal fluorescence microscopy were optimized to investigate the initial cell-scaffold contact and to investigate its correlation with the material-dependent cell growth. By the optical tweezers-induced cell manipulation accompanied by force detection up to 100 pN and position detection by fluorescence microscopy, accurate adhesion dynamics and strength analysis was implemented, where several attachment sites were formed on the interface in the first few seconds. More importantly, we have shown that dynamics of cell adhesion on scaffold surfaces correlates with cell growth on the days scale, which indicates that the first seconds of the contact could markedly direct further cell response. Such a contact dynamics analysis on 3D scaffold surfaces, applied for the first time, can thus serve to predict scaffold biocompatibility.
C1 [Strancar, Janez] Ctr Excellence NAMASTE, SI-1000 Ljubljana, Slovenia.
   Jozef Stefan Inst, Dept Condensed Matter Phys, Biophys Lab, SI-1000 Ljubljana, Slovenia.
RP Strancar, J (reprint author), Ctr Excellence NAMASTE, Jamova Cesta 39, SI-1000 Ljubljana, Slovenia.
EM janez.strancar@ijs.si
FU Centre of Excellence NAMASTE (European Regional Development Fund)
FX This research was financially supported by Centre of Excellence NAMASTE
   (European Regional Development Fund). We gratefully thank S. Pajk
   (Faculty of Pharmacy, University of Ljubljana) for synthesizing membrane
   targeted fluorescent probes.
CR ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0
   Andersson M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2752606
   Arsov Z, 2011, BIOMED OPT EXPRESS, V2, P2083, DOI 10.1364/BOE.2.2083
   Ashkin A., 2006, OPTICAL TRAPPING MAN, P1
   Ayano S, 2006, BIOCHEM BIOPH RES CO, V350, P678, DOI 10.1016/j.bbrc.2006.09.115
   Bausch AR, 2013, NAT MATER, V12, P948, DOI 10.1038/nmat3791
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Bowman RW, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/2/026401
   Capitanio M, 2013, BIOPHYS J, V105, P1293, DOI 10.1016/j.bpj.2013.08.007
   Castelain M, 2012, J APPL PHYS, V111, DOI 10.1063/1.4723566
   Collart-Dutilleul PY, 2014, ACS APPL MATER INTER, V6, P1719, DOI 10.1021/am4046316
   Comstock MJ, 2011, NAT METHODS, V8, P335, DOI 10.1038/NMETH.1574
   Difato F, 2013, INT J MOL SCI, V14, P8963, DOI 10.3390/ijms14058963
   Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143
   Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100
   Gornall JL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.028304
   Gou X, 2013, IEEE T BIO-MED ENG, V60, P2308, DOI 10.1109/TBME.2013.2255287
   Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Hu SY, 2013, J BIOMED NANOTECHNOL, V9, P281, DOI 10.1166/jbn.2013.1528
   Huang WC, 2014, ACTA BIOMATER, V10, P3546, DOI 10.1016/j.actbio.2014.04.025
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jin GZ, 2014, TISSUE ENG REGEN MED, V11, P284, DOI 10.1007/s13770-014-0033-8
   Konig K, 1998, CELL MOL BIOL, V44, P721
   Lee MH, 2010, TISSUE ENG PART B-RE, V16, P41, DOI [10.1089/ten.teb.2009.0449, 10.1089/ten.TEB.2009.0449]
   Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999
   LIU Y, 1995, BIOPHYS J, V68, P2137, DOI 10.1016/S0006-3495(95)80396-6
   Nugiel D J, 1996, Tissue Eng, V2, P127, DOI 10.1089/ten.1996.2.127
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   PAGE B, 1993, INT J ONCOL, V3, P473
   Plieva F. M., 2010, ADV BIOMATER, P499
   Podlipec R, 2014, ACS APPL MATER INTER, V6, P15980, DOI 10.1021/am5037719
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richardson A. C., 2006, P SOC PHOTO-OPT INS, V632628
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289
   Schwarz US, 2013, REV MOD PHYS, V85, P1327, DOI 10.1103/RevModPhys.85.1327
   Schwingel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054850
   Simmons RM, 1996, BIOPHYS J, V70, P1813, DOI 10.1016/S0006-3495(96)79746-1
   Sniadecki NJ, 2007, METHOD CELL BIOL, V83, P313, DOI 10.1016/S0091-679X(07)83013-5
   Spillmann CM, 2004, BIOPHYS J, V87, P4237, DOI 10.1529/biophysj.103.031773
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Thoumine O, 2008, CELL MOL BIOENG, V1, P301, DOI 10.1007/s12195-008-0034-6
   Urbancic I., 2013, THESIS U MARIBOR MAR
   Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu YH, 2011, J BIOMECH, V44, P741, DOI 10.1016/j.jbiomech.2010.10.034
   Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052
   Zhang Y., 2014, NAT COMMUN, V5, P1, DOI DOI 10.HTTPS://D0I.0RG/10.3389/FMICB.2014.00110
NR 57
TC 4
Z9 4
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 1
PY 2015
VL 7
IS 12
BP 6782
EP 6791
DI 10.1021/acsami.5b00235
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF0PM
UT WOS:000352246700051
PM 25764169
DA 2018-10-19
ER

PT J
AU Fernandez-Muinos, T
   Recha-Sancho, L
   Lopez-Chicon, P
   Castells-Sala, C
   Mata, A
   Semino, CE
AF Fernandez-Muinos, Teresa
   Recha-Sancho, Lourdes
   Lopez-Chicon, Patricia
   Castells-Sala, Cristina
   Mata, Alvaro
   Semino, Carlos E.
TI Bimolecular based heparin and self-assembling hydrogel for tissue
   engineering applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell differentiation; Tissue engineering; Biomimetics
ID MOUSE EMBRYONIC FIBROBLASTS; CIRCULAR-DICHROISM SPECTRA; PEPTIDE GELS
   AFFECTS; GROWTH-FACTOR; STEM-CELLS; IN-VITRO; RAPID ANASTOMOSIS; BONE
   REGENERATION; HOST VASCULATURE; CARDIAC-FUNCTION
AB One major goal of tissue engineering is to develop new biomaterials that are similar structurally and functionally to the extracellular matrix (ECM) to mimic natural cell environments. Recently, different types of biomaterials have been developed for tissue engineering applications. Among them, self-assembling peptides are attractive candidates to create artificial cellular niches, because their nanoscale network and biomechanical properties are similar to those of the natural ECM. Here, we describe the development of a new biomaterial for tissue engineering composed by a simple combination of the self-assembling peptide RAD16-I and heparin sodium salt. As a consequence of the presence of heparin moieties the material acquired enhances the capacity of specific binding and release of growth factors (GFs) with heparin binding affinity such as VEGF(165). Promising results were obtained in the vascular tissue engineering area, where the new composite material supported the development of tubular-like structures within a three dimensional (3D) culture model. Moreover, the new scaffold enhances the cell survival and chondrogenic commitment of adipose-derived stem cells (ADSC). Interestingly, the expression of specific markers of mature cartilage tissue including collagen type II was confirmed by western blot and real-time PCR. Furthermore, positive staining for proteoglycans (PGs) indicated the synthesis of cartilage tissue ECM components. Finally, the constructs did not mineralize and exhibited mechanical properties of a tissue undergoing chondrogenesis. Altogether, these results suggest that the new composite is a promising "easy to prepare" material for different reparative and regenerative applications. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Fernandez-Muinos, Teresa; Recha-Sancho, Lourdes; Lopez-Chicon, Patricia; Castells-Sala, Cristina; Semino, Carlos E.] IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Barcelona 08017, Spain.
   [Mata, Alvaro] Univ London, Sch Engn & Mat Sci, London, England.
RP Semino, CE (reprint author), IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Via Augusta 390, Barcelona 08017, Spain.
EM mariafernandezm@iqs.url.edu; lourdesrechas@iqs.url.edu;
   patricia.lopez@iqs.url.edu; cristinacastellss@iqs.url.edu;
   a.mata@qmul.ac.uk; carlos.semino@iqs.url.edu
RI Mata, Alvaro/D-6028-2015
OI Mata, Alvaro/0000-0002-6739-9111
FU European Union [229239]; AO Foundation, Exploratory Research
   Collaborative Research Program Acute Cartilage Injury/lesion/Defect (CRP
   ACI); SUR of DEC of Catalan Government; ESF [2013_FI_B2 00094,
   2014_FI_B1 00202]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under Grant
   Agreement No. 229239, and from the AO Foundation, Exploratory Research
   Collaborative Research Program Acute Cartilage Injury/lesion/Defect (CRP
   ACI) under the project Bioactive and biomimetic scaffolds for cartilage
   regeneration (BIOCART). We thank the SUR of DEC of Catalan Government
   and the ESF for the pre-doctoral fellowship 2013_FI_B2 00094 to T.F.M.
   and 2014_FI_B1 00202 to L.R.S. We also thank the Materials Science
   Laboratory of IQS-School of Engineering for kindly help us with the DMA
   analysis. Finally, we thank M.P.A. from the Genomic Unit of the IGTP for
   her help with the quantitative PCR.
CR Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Borges J, 2007, MINIM INVASIV THER, V16, P141, DOI 10.1080/13645700600935398
   Bussmann B.M., 2013, J TISSUE ENG REGEN M
   Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399
   Castells-sala C, 2013, BIOCHIPS TISSUE CH S, VS2, P004
   Chachques JC, 2013, EXPERT REV CARDIOVAS, V11, P1701, DOI 10.1586/14779072.2013.854165
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Daura X, 2003, EUR BIOPHYS J BIOPHY, V32, P661, DOI 10.1007/s00249-003-0303-1
   Fernandez-Muinos T, 2014, TISSUE ENG PT A, V20, P1145, DOI 10.1089/ten.tea.2013.0369
   Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Genove E, 2009, J CELL MOL MED, V13, P3387, DOI 10.1111/j.1582-4934.2009.00970.x
   Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hubbell Jeffrey A, 2007, Swiss Med Wkly, V137 Suppl 155, p72S
   Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315
   Khan WS, 2010, KNEE, V17, P369, DOI 10.1016/j.knee.2009.12.003
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510
   Kopesky P., 2009, TISSUE ENG A, V16
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Laschke MW, 2012, EUR SURG RES, V48, P85, DOI 10.1159/000336876
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Longo UG, 2012, STEM CELLS INT, V2012
   Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.TEA.2012.0077, 10.1089/ten.tea.2012.0077]
   Mats A, 2010, BIOMATERIALS, V31, P6004
   Miller RE, 2011, CLIN ORTHOP RELAT R, V469, P2716, DOI 10.1007/s11999-011-1891-1
   Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/956345
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Puig-Sanvicens VAC, 2013, DRUG DELIV TRANSL RE, V3, P330, DOI 10.1007/s13346-012-0125-8
   Quinatana L, 2009, TISSUE ENG PT A, V15, P45, DOI 10.1089/ten.tea.2007.0296
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Semino CE, 2004, TISSUE ENG PART, V10
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N
   Terry DE, 2000, ANAL BIOCHEM, V285, P211, DOI 10.1006/abio.2000.4761
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Zhang SG, 2003, ADV EXP MED BIOL, V534, P147
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 52
TC 28
Z9 30
U1 12
U2 139
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 35
EP 48
DI 10.1016/j.actbio.2015.01.008
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600004
PM 25595471
DA 2018-10-19
ER

PT J
AU Klymov, A
   Bronkhorst, EM
   te Riet, J
   Jansen, JA
   Walboomers, XF
AF Klymov, Alexey
   Bronkhorst, Ewald M.
   te Riet, Joost
   Jansen, John A.
   Walboomers, X. Frank
TI Bone marrow-derived mesenchymal cells feature selective migration
   behavior on submicro- and nano-dimensional multi-patterned substrates
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Surface topography; Nanotopography; Cell-surface interactions;
   Migration; Proliferation
ID STEM-CELLS; EXTRACELLULAR-MATRIX; ADHESION FORMATION; SURFACE;
   MECHANOTRANSDUCTION; DIFFERENTIATION; TOPOGRAPHY; IMPLANT
AB This study investigated whether cells have an intrinsic ability to recognize nanopatterns, which could lead to their accumulation or diminution on a biomaterial. A multi-patterned "biochip" was made, containing 36 differently designed surfaces, including squares and grooves varying in feature sizes between 10 and 1000 nm. The grooved patterns could additionally be subdivided into three groups having ridge to groove ratios of 1:1, 1:3 and 3:1. These substrates were used for culture of rat bone marrow derived mesenchymal cells. In time cells should accumulate on patterns of preference, while migrating away from patterns of disfavor. A regression analysis model was designed for the analysis of the obtained data.
   Results showed that strong differences existed between the tested patterns regarding the cellular affinity. All sizes of squares showed strong cell-repelling capacity, with the biggest sized squares displaying up to 40% less cells compared to the smooth surface. Among the nano-grooved patterns cell repelling was seen for the grooves with the ridge to groove ratio of 1:3, while grooves with the ridge to groove ratio of 3:1 partially showed cell attraction. Such effects were shown to be based on selective migration rather than proliferation.
   In conclusion, the use of a multi-patterned biochip setup allows for enhanced evaluation of cell behavior, as compared to uniformly patterned setups. Cells exhibit the ability to actively avoid or migrate to surfaces featuring certain topographies on nanometric scale. Such phenomena may be utilized for the development of biomaterials in regenerative medicine. (C) 2015 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Klymov, Alexey; Bronkhorst, Ewald M.; Jansen, John A.; Walboomers, X. Frank] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [te Riet, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.
RP Walboomers, XF (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM Frank.Walboomers@radboudumc.nl
RI Jansen, John/H-8055-2014; Walboomers, X.Frank/B-3692-2013; Bronkhorst,
   Ewald/L-4230-2015; te Riet, Joost/L-1584-2015
OI te Riet, Joost/0000-0002-9093-010X; Bronkhorst,
   Ewald/0000-0003-0953-8053
FU Dutch Government to the Netherlands Institute for Regenerative Medicine
   (NIRM) [FES0908]; Netherlands Organization for Scientific Research (NWO)
   [680-47-421]; NWO Medium Sized Investment [NWO-ZonMW 91110007]
FX This work was supported by a Grant from the Dutch Government to the
   Netherlands Institute for Regenerative Medicine (NIRM, Grant No.
   FES0908). Joost te Riet is supported by the Netherlands Organization for
   Scientific Research (NWO) (Veni Grant No. 680-47-421). The atomic force
   microscope work was supported by NWO Medium Sized Investment (Grant No.
   NWO-ZonMW 91110007).
CR Anil S, 2011, IMPLANT DENTISTRY - A RAPIDLY EVOLVING PRACTICE, P83
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Harrell FE., 2001, SPRINGER SERIES STAT
   Klymov A, 2013, BIOMATER SCI-UK, V1, P135, DOI 10.1039/c2bm00032f
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lim STS, 2013, MOL CELLS, V36, P1, DOI 10.1007/s10059-013-0139-1
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039
   Svanborg LM, 2010, J BIOMED MATER RES B, V92B, P462, DOI 10.1002/jbm.b.31538
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   van de Sande FH, 2014, J DENT, V42, P1171, DOI 10.1016/j.jdent.2014.07.003
   van Delft FCMJ, 2008, MICROELECTRON ENG, V85, P1362, DOI 10.1016/j.mee.2008.01.028
   van Delft FCMJM, 2000, J VAC SCI TECHNOL B, V18, P3419, DOI 10.1116/1.1319682
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f
NR 23
TC 12
Z9 12
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 117
EP 125
DI 10.1016/j.actbio.2015.01.016
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600011
PM 25644453
DA 2018-10-19
ER

PT J
AU Zhang, F
   Vanmeensel, K
   Batuk, M
   Hadermann, J
   Inokoshi, M
   Van Meerbeek, B
   Naert, I
   Vleugels, J
AF Zhang, Fei
   Vanmeensel, Kim
   Batuk, Maria
   Hadermann, Joke
   Inokoshi, Masanao
   Van Meerbeek, Bart
   Naert, Ignace
   Vleugels, Jef
TI Highly-translucent, strong and aging-resistant 3Y-TZP ceramics for
   dental restoration by grain boundary segregation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Ceramic structure; Dental restorative material; Zirconia; Aging;
   Translucency
ID LOW-TEMPERATURE DEGRADATION; TETRAGONAL ZIRCONIA; Y-TZP; HYDROTHERMAL
   DEGRADATION; FRACTURE; ALUMINA; POLYCRYSTALS; STRENGTH; SYSTEMS;
   BIOMATERIAL
AB Latest trends in dental restorative ceramics involve the development of full-contour 3Y-TZP ceramics which can avoid chipping of veneering porcelains. Among the challenges are the low translucency and the hydrothermal stability of 3Y-TZP ceramics. In this work, different trivalent oxides (Al2O3, Sc2O3, Nd2O3 and La2O3) were selected to dope 3Y-TZP ceramics. Results show that dopant segregation was a key factor to design hydrothermally stable and high-translucent 3Y-TZP ceramics and the cation dopant radius could be used as a controlling parameter. A large trivalent dopant, oversized as compared to Zr4+, exhibiting strong segregation at the ZrO2 grain boundary was preferred. The introduction of 0.2 mol% La2O3 in conventional 0.1-0.25 wt.% Al2O3-doped 3Y-TZP resulted in an excellent combination of high translucency and superior hydrothermal stability, while retaining excellent mechanical properties. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Fei; Vanmeensel, Kim; Vleugels, Jef] Katholieke Univ Leuven, Dept Mat Engn, B-3001 Heverlee, Belgium.
   [Batuk, Maria; Hadermann, Joke] Univ Antwerp, Elect Microscopy Mat Sci, B-2020 Antwerp, Belgium.
   [Inokoshi, Masanao; Van Meerbeek, Bart; Naert, Ignace] Univ Hosp Leuven, KU Leuven BIOMAT, Dept Oral Hlth Sci, KU Leuven & Dent, B-3000 Louvain, Belgium.
RP Zhang, F (reprint author), Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44, B-3001 Heverlee, Belgium.
EM fei.zhang@mtm.kuleuven.be
RI Vanmeensel, Kim/B-7792-2018; Hadermann, Joke/F-4644-2011; Vleugels,
   Jozef/C-8262-2017
OI Vanmeensel, Kim/0000-0001-5189-7055; Hadermann,
   Joke/0000-0002-1756-2566; Vleugels, Jozef/0000-0003-4432-4675
FU KU Leuven [0T/10/052]; Fund for Scientific Research Flanders
   (FWO-Vlaanderen) [G.0431.10N]
FX We acknowledge the Research Fund of KU Leuven under project 0T/10/052
   and the Fund for Scientific Research Flanders (FWO-Vlaanderen) under
   grant G.0431.10N. We thank M. Peumans and P. Pongprueksa for the
   translucency measurement, W. Veulemans for the flexural strength sample
   preparation, and J.W. Seo (MTM), S. Kuypers (JEOL) and Y. Ohnishi (JEOL)
   for the Al element STEM-EDS map (Fig. 1b-3Y-0.25Al).
CR Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   [Anonymous], 2007, COLORIMETRY UNDERSTA
   [Anonymous], 133562008 ISO
   [Anonymous], 68722008 ISO
   Anselmi-Tamburini U, 2007, ADV FUNCT MATER, V17, P3267, DOI 10.1002/adfm.200600959
   ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x
   Apetz R, 2003, J AM CERAM SOC, V86, P480, DOI 10.1111/j.1151-2916.2003.tb03325.x
   Baldissara P, 2010, J PROSTHET DENT, V104, P6, DOI 10.1016/S0022-3913(10)60086-8
   Beuer F, 2012, DENT MATER, V28, P449, DOI 10.1016/j.dental.2011.11.024
   Bona AD, 2014, J DENT, V42, P1202, DOI 10.1016/j.jdent.2014.07.005
   Boulc'h F, 2004, J ELECTROCHEM SOC, V151, pA1210, DOI 10.1149/1.1764711
   Chen YM, 2008, DENT MATER, V24, P1506, DOI 10.1016/j.dental.2008.03.010
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Communications A, 2014, INSIDE DENT TECHNOLO, V5
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Eichler J, 2007, J AM CERAM SOC, V90, P2830, DOI 10.1111/j.1551-2916.2007.01643.x
   Fujisaki K, 2012, J TOSOH RES, V56, P57
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036
   Guo X, 2004, CHEM MATER, V16, P3988, DOI 10.1021/cm040167h
   Guo X, 2003, J AM CERAM SOC, V86, P1867, DOI 10.1111/j.1151-2916.2003.tb03574.x
   Heintze SD, 2010, INT J PROSTHODONT, V23, P493
   HWANG SL, 1990, J AM CERAM SOC, V73, P3269, DOI 10.1111/j.1151-2916.1990.tb06449.x
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Khan MS, 1998, J MATER CHEM, V8, P2299, DOI 10.1039/a803917h
   Klimke J, 2011, J AM CERAM SOC, V94, P1850, DOI 10.1111/j.1551-2916.2010.04322.x
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   LI P, 1994, J AM CERAM SOC, V77, P118, DOI 10.1111/j.1151-2916.1994.tb06964.x
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Matsui K, 2008, ACTA MATER, V56, P1315, DOI 10.1016/j.actamat.2007.11.026
   Matsui K., 2014, SCI REP, V4
   Matsumoto M, 2005, SURF COAT TECH, V194, P31, DOI 10.1016/j.surfcoat.2004.04.078
   Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001
   Nogiwa-Valdez AA, 2013, ACTA BIOMATER, V9, P6226, DOI 10.1016/j.actbio.2012.11.027
   Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Preis V, 2012, J DENT, V40, P921, DOI 10.1016/j.jdent.2012.07.010
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   Samodurova A, 2014, ACTA BIOMATER
   Schechner G, 2014, J DENT RES
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   Studart AR, 2007, BIOMATERIALS, V28, P2695, DOI 10.1016/j.biomaterials.2006.12.033
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   Vichi A, 2014, J ESTHET RESTOR DENT, V26, P224, DOI 10.1111/jerd.12105
   Zacate MO, 2000, SOLID STATE IONICS, V128, P243, DOI 10.1016/S0167-2738(99)00348-3
   Zarone F, 2011, DENT MATER, V27, P83, DOI 10.1016/j.dental.2010.10.024
   Zhang F, 2015, J EUR CERAM SOC, V35, P741, DOI 10.1016/j.jeurceramsoc.2014.09.018
   Zhang H, 2012, J NANOMATER, V2012, P5
   Zhang Y, 2014, DENT MATER, V30, P1195, DOI 10.1016/j.dental.2014.08.375
   Zhang Y, 2013, DENT MATER, V29, P1201, DOI 10.1016/j.dental.2013.09.004
   Zimmermann A, 1998, J AM CERAM SOC, V81, P2527
NR 55
TC 31
Z9 31
U1 4
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 215
EP 222
DI 10.1016/j.actbio.2015.01.037
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600021
PM 25662163
DA 2018-10-19
ER

PT J
AU Lu, J
   Webster, TJ
AF Lu, Jing
   Webster, Thomas J.
TI Reduced immune cell responses on nano and submicron rough titanium
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Monocytes; Macrophages; Immune response; Titanium; Thrombosis formation
ID SURFACE-FEATURES; ADHESION; MACROPHAGES; PROLIFERATION; BIOMATERIAL
AB Current bare metal stents can be improved by nanotechnology to support the simultaneous acceleration of endothelialization and consequent reduction of immune cell responses after implantation. In our prior study, electron beam deposition was utilized to create different scales of roughness on titanium stents including flat (F-Ti), a mixture of nanometer and submicron (S-Ti), and nanometer (N-Ti). Enhanced endothelial responses (adhesion, migration, and nitric acid/endothelin-1 secretion) on nanometer to submicron rough titanium were observed compared to flat titanium. The present study aimed to further investigate the influence of nano and submicron titanium surface features on immune cells. Initial monocyte adhesion was found to be reduced on nano and submicron surface features compared to a flat surface. In a model including both endothelial cells and monocytes, it was proven that the submicron surface gave rise to an endothelial cell monolayer which generated the highest amount of NOx and subsequently led to decreased adhesiveness of endothelial cells to monocytes. The analysis of monocyte morphology gave hints to less differentiated monocytes on a submicron surface. Furthermore, the adhesion of and pro-inflammatory cytokine release from macrophages were all reduced on nano and submicron titanium surface features compared to a flat surface. This study, thus, suggests that nano and submicron titanium surfaces should be further studied for improved vascular stent performance. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lu, Jing] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   [Webster, Thomas J.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
   [Webster, Thomas J.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia.
RP Webster, TJ (reprint author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
EM th.webster@neu.edu
FU Hermann Foundation
FX The authors would like to thank the Hermann Foundation for funding.
CR Auwerx J., 1991, J EXP, V47, P22, DOI DOI 10.1007/BF02041244
   Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115
   Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930
   Choudhary S, 2007, TISSUE ENG, V13, P1421, DOI 10.1089/ten.2006.0376
   Choudhary S, 2006, INT J NANOMED, V1, P41, DOI 10.2147/nano.2006.1.1.41
   Heil TL, 2002, J ORAL REHABIL, V29, P401, DOI 10.1046/j.1365-2842.2002.00893.x
   Khang D, 2009, ACTA BIOMATER, V5, P1425, DOI 10.1016/j.actbio.2009.01.031
   Lambris John D., CURRENT TOPICS INNAT, P64
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Lu J, 2012, TISSUE ENG PT A, V18, P1389, DOI [10.1089/ten.tea.2011.0268, 10.1089/ten.TEA.2011.0268]
   Lu J, 2010, J BIOMED MATER RES A, V94A, P1042, DOI 10.1002/jbm.a.32778
   Niebauer J, 1999, J AM COLL CARDIOL, V34, P1201, DOI 10.1016/S0735-1097(99)00304-6
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Samaroo HD, 2008, INT J NANOMED, V3, P75
   Smith MS, 2004, J VIROL, V78, P4444, DOI 10.1128/JVI.78.9.4444-4453.2004
   Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005
   White RA., 1989, ATHEROSCLEROSIS ARTE
NR 21
TC 17
Z9 17
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 223
EP 231
DI 10.1016/j.actbio.2015.01.036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600022
PM 25660564
DA 2018-10-19
ER

PT J
AU Budrugeac, P
AF Budrugeac, Petru
TI Phase transitions of a parchment manufactured from deer leather A
   calorimetric and kinetic analysis
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Parchment; DSC; Phase transitions; Non-isothermal kinetics
ID MULTIVARIATE NONLINEAR-REGRESSION; DIFFERENTIAL SCANNING CALORIMETRY;
   THERMAL-DENATURATION; THERMOOXIDATIVE DEGRADATION; I COLLAGEN;
   HISTORICAL PARCHMENTS; COMPUTATIONAL ASPECTS; EPOXY-RESIN;
   DETERIORATION; PARAMETERS
AB To further understand the thermal stability of a parchment manufactured from deer skin, DSC measurements carried out on this biomaterial at several heating rates were used for kinetic analysis of the endothermic processes of denaturation in water excess and of the phase transition in dry state. The last process could be attributed to melting of crystalline (rigid) zone of parchment or the denaturation consisting in the evaporation of residual strongly bond water and continued conformational changes of super-helix of collagen that is the main component of parchment. The kinetic analyses of non-isothermal DSC data were performed by isoconversional and "multivariate non-linear regression" (Multivar-NLR) methods. The application of differential isoconversional method suggested by Friedman put in evidence that for both investigated processes, the apparent activation energy depends on the conversion degree. This suggests that the investigated processes exhibit complex mechanisms. The computation of non-isothermal data by Multivar-NLR method shows that these processes are described from kinetic point of view by Lumry-Eyring mechanism (a reversible process followed by an irreversible one). According to the results obtained by kinetic analysis, the process occurring in dry state seems to be rather a denaturation than a melting of crystalline (rigid) zone of parchment.
C1 Natl Inst Res & Dev Elect Engn ICPE CA, Bucharest 030138, Romania.
RP Budrugeac, P (reprint author), Natl Inst Res & Dev Elect Engn ICPE CA, Splaiul Unirii 313, Bucharest 030138, Romania.
EM bp@icpe-ca.ro
FU Romanian National Authority for Scientific Research, CNCS-UEFI-SCDI
   [PN-II-224/2012]
FX This work was supported by a Grant of Romanian National Authority for
   Scientific Research, CNCS-UEFI-SCDI, project number PN-II-224/2012.
CR Anderson HL, 1996, THERMOCHIM ACTA, V271, P23, DOI 10.1016/0040-6031(95)02599-5
   Badea E, 2008, J THERM ANAL CALORIM, V91, P17, DOI 10.1007/s10973-007-8513-x
   Badea E, 2011, J THERM ANAL CALORIM, V104, P495, DOI 10.1007/s10973-011-1495-8
   Bischof JC, 2005, ANN NY ACAD SCI, V1066, P12, DOI 10.1196/annals.1363.003
   Brown ME, 2000, THERMOCHIM ACTA, V355, P125, DOI 10.1016/S0040-6031(00)00443-3
   Budrugeac P, 2008, POLYM DEGRAD STABIL, V93, P1073, DOI 10.1016/j.polymdegradstab.2008.03.017
   Budrugeac P, 2008, J THERM ANAL CALORIM, V92, P291, DOI 10.1007/s10973-007-8770-8
   Budrugeac P, 2005, POLYM DEGRAD STABIL, V89, P265, DOI 10.1016/j.polymdegradstab.2004.09.014
   Budrugeac P, 2011, J THERM ANAL CALORIM, V104, P439, DOI 10.1007/s10973-010-1183-0
   Budrugeac P, 2010, THERMOCHIM ACTA, V500, P30, DOI 10.1016/j.tca.2009.12.007
   Budrugeac P, 2009, J THERM ANAL CALORIM, V97, P443, DOI 10.1007/s10973-009-0081-9
   Budrugeac P, 2008, J CULT HERIT, V9, P146, DOI 10.1016/j.culher.2007.10.001
   Budrugeac P, 2013, REV ROUM CHIM, V58, P371
   Budrugeac P, 2013, THERMOCHIM ACTA, V565, P241, DOI 10.1016/j.tca.2013.05.020
   Burnham AK, 1999, ENERG FUEL, V13, P1, DOI 10.1021/ef9800765
   Chahine C, 2000, THERMOCHIM ACTA, V365, P101, DOI 10.1016/S0040-6031(00)00617-1
   Cucos A, 2013, THERMOCHIM ACTA, V516, P19
   Friedman HA, 1964, J POLYM SCI C, V6, P183, DOI [DOI 10.1002/P0LC.5070060121, 10.1002/polc.5070060121]
   Haines BM, 2006, CONSERVATION LEATHER
   KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045
   Kralova D., 2007, 18 IDAP EUR COMM DIR, P23
   Liu WT, 2014, THERMOCHIM ACTA, V581, P32, DOI 10.1016/j.tca.2014.02.012
   Liu WT, 2010, POLYM DEGRAD STABIL, V95, P2233, DOI 10.1016/j.polymdegradstab.2010.09.012
   LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   NGUYEN AL, 1974, BIOPOLYMERS, V13, P1023, DOI 10.1002/bip.1974.360130516
   OKAMOTO Y, 1964, KOLLOID Z Z POLYM, V194, P124, DOI 10.1007/BF02176215
   Opfermann J, 2000, J THERM ANAL CALORIM, V60, P641, DOI 10.1023/A:1010167626551
   Pietrucha K, 2005, INT J BIOL MACROMOL, V36, P299, DOI 10.1016/j.ijbiomac.2005.07.004
   Popescu C, 2008, POLYM DEGRAD STABIL, V93, P976, DOI 10.1016/j.polymdegradstab.2008.01.031
   Roduit B, 2000, THERMOCHIM ACTA, V355, P171, DOI 10.1016/S0040-6031(00)00447-0
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Tanaka H, 2005, J THERM ANAL CALORIM, V80, P795, DOI 10.1007/s10973-005-0732-4
   Vyazovkin S, 2007, MACROMOL BIOSCI, V7, P1181, DOI 10.1002/mabi.200700162
   Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034
   VYAZOVKIN SV, 1990, THERMOCHIM ACTA, V165, P273, DOI 10.1016/0040-6031(90)80227-P
   WITNAUER LP, 1964, J AM LEATHER CHEM AS, V59, P598
   Wright NT, 2002, ANNU REV BIOMED ENG, V4, P109, DOI 10.1146/annurev.bioeng.4.101001.131546
   Xia ZY, 2012, THERMOCHIM ACTA, V527, P172, DOI 10.1016/j.tca.2011.10.028
NR 39
TC 4
Z9 4
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1572-8943
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD APR
PY 2015
VL 120
IS 1
BP 103
EP 112
DI 10.1007/s10973-014-4252-y
PG 10
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA CE9BZ
UT WOS:000352139800013
DA 2018-10-19
ER

PT J
AU Yan, HD
   Zhang, F
   Wang, CY
   Xia, Z
   Mo, XM
   Fan, CY
AF Yan, Hede
   Zhang, Feng
   Wang, Chunyang
   Xia, Zhen
   Mo, Xiumei
   Fan, Cunyi
TI The Role of an Aligned Nanofiber Conduit in the Management of Painful
   Neuromas in Rat Sciatic Nerves
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE capping technique; traumatic neuroma; neuroma prevention; aligned
   nanofiber nerve conduit; neuropathic pain
ID NEUROPATHIC PAIN; ELECTROSPUN NANOFIBERS; STUMP TRANSPLANTATION; VEIN
   IMPLANTATION; SPINAL-CORD; AUTOTOMY; PATHOBIOLOGY; REGENERATION;
   FABRICATION; ALLODYNIA
AB Background: Capping techniques have been used as a treatment modality for the prevention of neuroma formation and the management of neuropathic pain. However, the results are inconsistent and unpredictable. We hypothesize that this situation may be attributable, in part, to the disparities in the type of materials used to manufacturing of the conduits.
   Methods: In this study, a rat model was used and the sciatic nerve was selected for evaluation. In 1 capping group, a sciatic nerve stump was capped with a nonaligned nanofiber conduit (the nonaligned group), whereas in a second capping group, the conduit was made of aligned nanofibers (the aligned group). In another group, the sciatic nerve stump was not capped as a control (the control group). The results of autotomy behavior, extent of neuroma formation, histological changes in the neuroma, and the expression of c-fos as a pain marker in the fourth lumbar spinal cord were evaluated at 8 weeks postoperatively.
   Results: The control group presented more neuroma-like features in all the observed parameters in comparison with the 2 capping groups; of the 2 capping groups, the aligned group achieved even better outcomes than the nonaligned group.
   Conclusions: Our findings indicate that the aligned nanofiber conduit is a promising biomaterial for the nerve capping technique, and new treatment strategies using aligned nanofiber conduits may be developed for the management of painful amputated neuromas.
C1 [Yan, Hede; Wang, Chunyang; Xia, Zhen; Fan, Cunyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China.
   [Yan, Hede] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China.
   [Yan, Hede] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.
   [Zhang, Feng] Univ Mississippi, Med Ctr, Div Plast Surg, Jackson, MS 39216 USA.
   [Mo, Xiumei] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.
RP Fan, CY (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, 600 Yishan Rd, Shanghai 200233, Peoples R China.
EM fancunyi888@gmail.com
RI mo, xiumei/C-9340-2013
FU National Natural Science Foundation of China [81171477]; Health Bureau
   of Shanghai [2012412]; Department of Education of Zhejiang Province
   [20051185]; Health Department of Zhejiang Province [201338025]
FX This study was supported by funding from the National Natural Science
   Foundation of China (81171477), Key Project of Health Bureau of Shanghai
   (2012412), the Department of Education of Zhejiang Province (20051185),
   and Health Department of Zhejiang Province (201338025).
CR Beilke MC, 2013, ANAL CHIM ACTA, V761, P201, DOI 10.1016/j.aca.2012.11.028
   Bowsher D, 2002, PAIN, V95, P187, DOI 10.1016/S0304-3959(01)00389-X
   CARLTON SM, 1991, NEUROSCI LETT, V131, P88, DOI 10.1016/0304-3940(91)90343-R
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9
   CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0
   COLLINS WF, 1960, ARCH NEUROL-CHICAGO, V3, P381, DOI 10.1001/archneur.1960.00450040031003
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   CRAVIOTO H, 1981, NEUROSURGERY, V8, P181, DOI 10.1227/00006123-198102000-00007
   FARLEY H H, 1965, Minn Med, V48, P347
   Galeano M, 2009, MICROSURG, V29, P568, DOI 10.1002/micr.20652
   Gould JS, 2013, FOOT ANKLE INT, V34, P932, DOI 10.1177/1071100713478927
   Harden RN, 2005, NEUROLOGIST, V11, P111, DOI 10.1097/01.nrl.0000155180.60057.8e
   Herbert TJ, 1998, J HAND SURG-BRIT EUR, V23B, P220, DOI 10.1016/S0266-7681(98)80178-2
   Hirose K, 2010, EUR SPINE J, V19, P1746, DOI 10.1007/s00586-010-1428-4
   Kajander KC, 1996, NEUROSCI LETT, V206, P9, DOI 10.1016/0304-3940(96)12447-2
   Kakinoki R, 2003, INT ORTHOP, V27, P60, DOI 10.1007/s00264-002-0390-0
   KIRVELA O, 1990, PAIN, V41, P161, DOI 10.1016/0304-3959(90)90020-E
   Koch H, 2003, ANN PLAS SURG, V51, P45, DOI 10.1097/01.SAP.0000054187.72439.57
   Koch H, 2003, ANN PLAS SURG, V50, P354, DOI 10.1097/01.SAP.0000041486.24160.8C
   Krishnan Kartik G, 2005, Neurosurgery, V56, P369, DOI 10.1227/01.NEU.0000156881.10388.D8
   MASS DP, 1984, PLAST RECONSTR SURG, V74, P182, DOI 10.1097/00006534-198408000-00002
   MATHEWS GJ, 1972, SURG CLIN N AM, V52, P1313
   MUEHLEMAN C, 1990, Journal of Foot Surgery, V29, P260
   Niederberger E, 2008, EXPERT REV PROTEOMIC, V5, P799, DOI 10.1586/14789450.5.6.799
   Okuda T, 2006, J ORTHOP RES, V24, P1427, DOI 10.1002/jor.20196
   Prabhakaran MP, 2013, BIOTECHNOL BIOENG, V110, P2775, DOI 10.1002/bit.24937
   Sakai Y, 2005, J BIOMED MATER RES B, V73B, P355, DOI 10.1002/jbm.b.30219
   Siddall PJ, 1999, BRAIN RES, V851, P281, DOI 10.1016/S0006-8993(99)02173-3
   Tupper J W, 1976, J Hand Surg Am, V1, P144
   Vernadakis AJ, 2003, CLIN PLAST SURG, V30, P247, DOI 10.1016/S0094-1298(02)00104-9
   WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2
   WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6
   Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   WILLIAMS HB, 1984, CLIN PLAST SURG, V11, P79
   Wu J, 1999, ANN PLAS SURG, V43, P661, DOI 10.1097/00000637-199912000-00016
   Xu Y, 2013, TISSUE ENG PART C-ME, V19, P925, DOI [10.1089/ten.tec.2012.0328, 10.1089/ten.TEC.2012.0328]
   Zeltser R, 2000, PAIN, V89, P19, DOI 10.1016/S0304-3959(00)00342-0
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6
NR 42
TC 2
Z9 2
U1 1
U2 26
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0148-7043
EI 1536-3708
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD APR
PY 2015
VL 74
IS 4
BP 454
EP 461
DI 10.1097/SAP.0000000000000266
PG 8
WC Surgery
SC Surgery
GA CE1SK
UT WOS:000351592000014
PM 25003441
DA 2018-10-19
ER

PT J
AU Bryan, N
   Battersby, C
   Smart, N
   Hunt, J
AF Bryan, N.
   Battersby, C.
   Smart, N.
   Hunt, J.
TI A review of biocompatibility in hernia repair; considerations in vitro
   and in vivo for selecting the most appropriate repair material
SO HERNIA
LA English
DT Review
DE Biocompatibility; Inflammation; Leucocyte; Hernia; In vitro; In vivo
ID ACELLULAR DERMAL MATRIX; BIOLOGIC MESH; RECONSTRUCTION; INFLAMMATION;
   NEUTROPHILS; MECHANISMS; EFFICACY; SURGERY; DECADE; CELLS
AB Repair of hernia typically makes use of a prosthetic material; synthetic or biologic in nature. Any material which enters the body is subject to interrogation by the inflammation and immune system in addition to numerous other cell families, the outcome of which ultimately determines the success of the repair. In this review, we discuss the fundamental biology which occurs in situ when a biomaterial associates with a tissue, compare and contrast the techniques available to predict this in vitro, and review how features of hernia repair materials specifically may manipulate tissue interrogation and integration. Finally, we conclude our article by examining how biocompatibility impacts surgical practise and how a better understanding of the manner by which materials and tissues interact could benefit hernia repair.
   A review of the literature was conducted using appropriate scientific search engines in addition to inclusion of findings from the groups' primary research.
   Using pre-clinical assays to anticipate the biocompatibility of a medical device is critical; however, to maximise the scientific power of in vitro findings, we must carefully consider the in vivo niche of the cells with which we are working. Excessive in vitro culture or contact to non-self materials can add compounding complexity to studies involving leucocytes for instance; therefore, we must ensure careful and stringent assay design when developing techniques for assaying pre-clinical biocompatibility. Furthermore, many of the features associated with hernia repair material design specifically, included to enhance their mechanical or biodegradation characteristics, are inadvertently instructive to cells, and therefore, throughout the prototype stages of a materials development, regular biocompatibility assessment must be performed.
   The biocompatibility of a material is rate limiting in its ability to function as a medical device. The future of hernia repair materials will rely on close cohesion between the surgical and scientific communities to ensure the most robust biocompatibility assessment techniques, and models are utilised to predict the efficacy of a given material in a particular surgical application.
C1 [Bryan, N.; Battersby, C.; Hunt, J.] Inst Ageing & Chron Dis, Clin Engn UKCTE, Liverpool L69 3GA, Merseyside, England.
   [Smart, N.] Royal Devon & Exeter Hosp, Exeter Hlth Sci Res Unit, Exeter EX2 5DW, Devon, England.
RP Bryan, N (reprint author), Inst Ageing & Chron Dis, Clin Engn UKCTE, Duncan Bldg Ground Floor,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM n.bryan@liv.ac.uk
RI Smart, Neil/F-8837-2014
OI Smart, Neil/0000-0002-3043-8324
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Belyansky I, 2012, PLAST RECONSTR SURG, V130, p203S, DOI 10.1097/PRS.0b013e3182638d5b
   Bochicchio GV, 2013, J AM COLL SURGEONS, V217, P606, DOI 10.1016/j.jamcollsurg.2013.04.041
   Bryan N, 2012, CLIN BIOCHEM, V45, P672, DOI 10.1016/j.clinbiochem.2012.02.026
   Bryan N, 2014, J BIOMED MATER RES B, V102, P709, DOI 10.1002/jbm.b.33050
   Bryan N, 2013, J TISSUE ENG REGEN M, V7, P812, DOI 10.1002/term.1474
   Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18
   Bryan N, 2012, BIOMATERIALS, V33, P6380, DOI 10.1016/j.biomaterials.2012.05.058
   Bryan N, 2011, BIOSCIENCE REP, V31, P199, DOI 10.1042/BSR20100064
   Butterfield TA, 2006, J ATHL TRAINING, V41, P457
   Cevasco M, 2012, SURG INFECT, V13, P209, DOI 10.1089/sur.2012.123
   Daubay DA, 2003, SURG CLIN N AM, V83, P463
   Gray SH, 2008, ARCH SURG-CHICAGO, V143, P582, DOI 10.1001/archsurg.143.6.582
   Halm JA, 2007, WORLD J SURG, V31, P423, DOI 10.1007/s00268-006-0317-9
   Hamer-Hodges D W, 1985, J R Coll Surg Edinb, V30, P65
   Hood K, 2013, AM J SURG, V205, P322, DOI 10.1016/j.amjsurg.2012.10.024
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   Itani KMF, 2012, SURGERY, V152, P498, DOI 10.1016/j.surg.2012.04.008
   Kanters AE, 2012, J AM COLL SURGEONS, V215, P787, DOI 10.1016/j.jamcollsurg.2012.08.012
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Kissane NA, 2012, PLAST RECONSTR SURG, V130, p194S, DOI 10.1097/PRS.0b013e318265a5ec
   Le D, 2012, AM J SURG, V205, P602
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   Muysoms F, 2012, HERNIA, V16, P239, DOI 10.1007/s10029-012-0912-7
   Muysoms FE, 2013, HERNIA, V17, P423, DOI 10.1007/s10029-013-1108-5
   Muysoms FE, 2009, HERNIA, V13, P407, DOI 10.1007/s10029-009-0518-x
   Rosen MJ, 2013, ANN SURG, V257, P991, DOI 10.1097/SLA.0b013e3182849871
   Slater NJ, 2013, AM J SURG, V205, P220, DOI 10.1016/j.amjsurg.2012.05.028
   Smart NJ, 2012, COLORECTAL DIS, V14, P1, DOI 10.1111/codi.12042
   ten Raa S, 2006, J SURG RES, V136, P45, DOI 10.1016/j.jss.2006.05.006
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 32
TC 2
Z9 2
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
EI 1248-9204
J9 HERNIA
JI Hernia
PD APR
PY 2015
VL 19
IS 2
BP 169
EP 178
DI 10.1007/s10029-014-1307-8
PG 10
WC Surgery
SC Surgery
GA CE3BS
UT WOS:000351699800001
PM 25216716
DA 2018-10-19
ER

PT J
AU Reslinski, A
   Dabrowiecki, S
   Glowacka, K
AF Reslinski, A.
   Dabrowiecki, S.
   Glowacka, K.
TI The impact of diclofenac and ibuprofen on biofilm formation on the
   surface of polypropylene mesh
SO HERNIA
LA English
DT Article
DE Biofilm; Diclofenac; Ibuprofen; Polypropylene mesh; Hernia
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STAPHYLOCOCCUS-EPIDERMIDIS;
   IN-VITRO; PSEUDOMONAS-AERUGINOSA; LISTERIA-MONOCYTOGENES;
   BACTERIAL-COLONIZATION; CONTACT-LENSES; HERNIA REPAIR; INFECTION;
   ASPIRIN
AB The difficulties related to treatment of deep surgical site infection involve formation of biofilm on the surface of synthetic material. It is considered that in treatment of infections involving formation of biofilm, concomitant therapy shall be applied covering anti-inflammatory drugs. The purpose of the work was to assess the impact of diclofenac and ibuprofen on bacterial biofilm formation on the surface of monofilament polypropylene mesh.
   The study involved 70 strains of Staphylococcus aureus and 70 strains of Escherichia coli isolated from different patients and those which differ with chromosomal DNA pattern within the species. The assessment of the impact of non-steroidal anti-inflammatory drugs (NSAIDs) on biofilm formation was carried out with the use of qualitative method (TTC reduction), quantitative (tenfold serial dilution) and with the use of scanning electron microscope (SEM).
   In the qualitative assessment, after incubation in the medium containing NSAIDs statistically significant growth of S. aureus strain amount and E. coli which poorly make up biofilm was stated. Quantitative examination indicated characteristic decrease of the number of colony forming units in 1 ml of the suspension isolated from bacterial biofilm formed as a result of incubation of isolates in the medium with the addition of examined NSAIDs in comparison to biofilm from control regimen. In the examination with the use of SEM it was stated that the effect of isolates incubation in the medium with NSAIDs was decrease of the number of bacteria adjacent to the biomaterial surface.
   Diclofenac and ibuprofen in the concentration obtained in the serum limit the formation of biofilm by S. aureus and E. coli.
C1 [Reslinski, A.] Nicolaus Copernicus Univ Torun, Dept Gen Surg & Transplantol, Ludwik Rydygier Coll Med Bydgoszcz, PL-85094 Bydgoszcz, Poland.
   [Dabrowiecki, S.] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Nutr & Dietet, Bydgoszcz, Poland.
   [Glowacka, K.] Warmia Mazury Univ Olsztyn, Dept Plant Physiol Genet & Biotechnol, Olsztyn, Poland.
RP Reslinski, A (reprint author), Nicolaus Copernicus Univ Torun, Dept Gen Surg & Transplantol, Ludwik Rydygier Coll Med Bydgoszcz, M Sklodowskiej Curie 9 Str, PL-85094 Bydgoszcz, Poland.
EM bigar@wp.pl
OI Glowacka, Katarzyna/0000-0002-3649-4669
FU European Social Fund; National Budget in terms of Integrated Operational
   Programms of Regional Development; European Union; Nicolaus Copernicus
   University (UMK) [06/2009]
FX The authors would like to thank Professor Eugenia Gospodarek, Head of
   the Department of Microbiology of the Ludwik Rydygier College of
   Medicine of the Nicolaus Copernicus University in Torun for making it
   possible to carry out research. The work is co-financed from the
   resources of the European Social Fund and National Budget in terms of
   Integrated Operational Programms of Regional Development, Measure 2.6.
   'Regional Innovation Strategies and Knowledge Transfer', by the European
   Union in terms of European Social Fund - 'Nicolaus Copernicus University
   College of Medicine development programme' and from the resources of
   Nicolaus Copernicus University (UMK) 06/2009 grant.
CR Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x
   Araujo JC, 2003, J ELECTRON MICROSC, V52, P429, DOI 10.1093/jmicro/52.4.429
   Bandara BMK, 2004, CURR EYE RES, V29, P245, DOI 10.1080/02713680490516729
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022
   del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016
   Demirag MK, 2007, ANN VASC SURG, V21, P464, DOI 10.1016/j.avsg.2006.06.006
   Derry C, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001548.PUB2
   Derry P, 2009, COCHRANE DB SYST REV, V2
   Dutta NK, 2008, EUR J CLIN MICROBIOL, V27, P315, DOI 10.1007/s10096-007-0439-5
   Dutta NK, 2009, LETT APPL MICROBIOL, V48, P783, DOI 10.1111/j.1472-765X.2009.02588.x
   Engelsman AF, 2008, BRIT J SURG, V95, P1051, DOI 10.1002/bjs.6154
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   FARBER BF, 1992, J INFECT DIS, V166, P861, DOI 10.1093/infdis/166.4.861
   GALLIMORE B, 1991, J INFECT DIS, V164, P1220, DOI 10.1093/infdis/164.6.1220
   Grin I, 2011, ADV EXP MED BIOL, V715, P257, DOI 10.1007/978-94-007-0940-9_16
   Hasani A, 2011, HERNIA, V15, P267, DOI 10.1007/s10029-010-0772-y
   Jezupors A, 2006, WORLD J SURG, V30, P2270, DOI 10.1007/s00268-006-0130-5
   Kwiecinska-Pirog Joanna, 2011, Medycyna Doswiadczalna i Mikrobiologia, V63, P131
   Lissy M, 2009, CURR MED RES OPIN, V25, P2423, DOI 10.1185/03007990903158513
   Lotsch J, 2001, BRIT J CLIN PHARMACO, V52, P387, DOI 10.1046/j.1365-2125.2001.01451.x
   Mixter CG, 1998, ARCH SURG-CHICAGO, V133, P432, DOI 10.1001/archsurg.133.4.432
   Muller E, 1998, J INFECT DIS, V177, P501, DOI 10.1086/517386
   Naves P, 2010, J HOSP INFECT, V76, P165, DOI 10.1016/j.jhin.2010.05.011
   Perilli R, 2000, J BIOMED MATER RES, V49, P53, DOI 10.1002/(SICI)1097-4636(200001)49:1<53::AID-JBM7>3.0.CO;2-C
   Rozalska Barbara, 1998, Medycyna Doswiadczalna i Mikrobiologia, V50, P115
   Sanchez VM, 2011, SURG INFECT, V12, P205, DOI 10.1089/sur.2011.033
   Saygun O, 2006, J SURG RES, V131, P73, DOI 10.1016/j.jss.2005.06.020
   Stremitzer S, 2010, WORLD J SURG, V34, P1702, DOI 10.1007/s00268-010-0543-z
   Tolino MJ, 2009, HERNIA, V13, P631, DOI 10.1007/s10029-009-0541-y
   Ulusoy S, 2013, Drug Res (Stuttg), V63, P409, DOI 10.1055/s-0033-1343430
   Wang WH, 2003, GUT, V52, P490, DOI 10.1136/gut.52.4.490
NR 32
TC 7
Z9 8
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
EI 1248-9204
J9 HERNIA
JI Hernia
PD APR
PY 2015
VL 19
IS 2
BP 179
EP 185
DI 10.1007/s10029-013-1200-x
PG 7
WC Surgery
SC Surgery
GA CE3BS
UT WOS:000351699800002
PM 24366755
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ribeiro, S
   Ferreira, V
   Stutz, B
   Casado, P
   Rodrigues, D
   Barboza, EP
AF Ribeiro, Sergio
   Ferreira, Vinicius
   Stutz, Bianca
   Casado, Priscila
   Rodrigues, Diogo
   Barboza, Eliane Porto
TI Evaluation of the Zone of Keratinized Tissue Using Exposed Acellular
   Dermal Matrix Over Tooth Extraction Sites: A Randomized Controlled
   Clinical Trial
SO IMPLANT DENTISTRY
LA English
DT Article
DE acellular dermal matrix; guided bone regeneration; keratinized tissue
ID HISTOLOGIC EVALUATION; GINGIVAL RECESSION; BARRIER MEMBRANES;
   CONNECTIVE-TISSUE; BONE-FORMATION; DEFECTS; AUGMENTATION; SOCKETS;
   HUMANS; GRAFT
AB Background: The presence of an adequate zone of keratinized tissue has been associated with implant health. This study evaluated the zone of keratinized tissue using exposed acellular dermal matrix (ADM) over extraction sites.
   Material and Methods: Fifteen sites received ADM, and fifteen control sites received no biomaterial. All sites were sutured with no attempt to achieve primary closure. Initial measurements of buccal and lingual keratinized tissue were taken from the mucogingival line (MGL) to the most coronal gingival margins. Final measurements were taken from the buccal MGL to the lingual MGL 90 days after surgery. Gingival biopsies were taken before implant placement.
   Results: Test and control groups exhibited a mean value of 4.40 +/- 1.45 mm and 1.40 +/- 1.40 mm, respectively. The newly formed tissue revealed similar histological aspect of normal keratinized tissue.
   Conclusion: Exposed ADM used over tooth extraction sockets can predictably be used to increase the zone of keratinized tissue.
C1 [Ferreira, Vinicius] Univ Estado Rio De Janeiro, Dept Periodontol, Rio De Janeiro, Brazil.
   [Casado, Priscila] Univ Fed Fluminense, Post Graduat Program, Rio De Janeiro, Brazil.
   [Rodrigues, Diogo; Barboza, Eliane Porto] Univ Fed Fluminense, Dept Periodontol, Rio De Janeiro, Brazil.
RP Barboza, EP (reprint author), Ave Presidente Wilson 165-811, BR-20030020 Rio De Janeiro, Brazil.
EM elianeporto.uff@gmail.com
CR Barboza E P, 1999, Implant Dent, V8, P167, DOI 10.1097/00008505-199908020-00010
   Barboza EP, 1999, INT J PERIODONT REST, V19, P601
   Bartee B K, 1995, Implant Dent, V4, P21, DOI 10.1097/00008505-199504000-00004
   Batista EL, 2001, J PERIODONTOL, V72, P265, DOI 10.1902/jop.2001.72.2.265
   Borges GJ, 2009, CLIN ORAL IMPLAN RES, V20, P1105, DOI 10.1111/j.1600-0501.2009.01731.x
   Cardaropoli G, 2006, CLIN ORAL IMPLAN RES, V17, P165, DOI 10.1111/j.1600-0501.2005.01210.x
   Casado PL, 2013, IMPLANT DENT, V22, P143, DOI 10.1097/ID.0b013e3182818792
   Cummings LC, 2005, J PERIODONTOL, V76, P178, DOI 10.1902/jop.2005.76.2.178
   Felipe MEMC, 2007, J PERIODONTOL, V78, P1209, DOI 10.1902/jop.2007.060356
   Fernandes PG, 2011, J PERIODONTOL, V82, P72, DOI 10.1902/jop.2010.100241
   Fotek PD, 2009, J PERIODONTOL, V80, P776, DOI 10.1902/jop.2009.080514
   Harris RJ, 2000, INT J PERIODONT REST, V20, P51
   JOVANOVIC SA, 1995, INT J PERIODONT REST, V15, P57
   Jung RE, 2007, INT J PERIODONT REST, V27, P251
   LEKHOLM U, 1993, CLIN ORAL IMPLAN RES, V4, P121, DOI 10.1034/j.1600-0501.1993.040302.x
   Lin GH, 2013, J PERIODONTOL, V84, P1755, DOI 10.1902/jop.2013.120688
   Luczyszyn Sonia M, 2005, Implant Dent, V14, P176, DOI 10.1097/01.id.0000165082.77499.41
   Moses O, 2005, CLIN ORAL IMPLAN RES, V16, P210, DOI 10.1111/j.1600-0501.2004.01100.x
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Novaes A B Jr, 2001, Implant Dent, V10, P192
   NOVAES AB, 1995, J PERIODONTOL, V66, P864, DOI 10.1902/jop.1995.66.10.864
   Novaes Arthur B Jr, 2002, Implant Dent, V11, P343
   Park Jun-Beom, 2006, Implant Dent, V15, P275, DOI 10.1097/01.id.0000227078.70869.20
   Park JB, 2007, IMPLANT DENT, V16, P246, DOI 10.1097/ID.0b013e3181237926
   Park JB, 2010, IMPLANT DENT, V19, P307, DOI 10.1097/ID.0b013e3181e5abbc
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schulman J, 1996, PRACTICAL PERIODONTI, V8, P201
   Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI 10.1097/AOG.0b013e3181d9d421
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P166
   Tal H, 1999, J PERIODONTOL, V70, P1118, DOI 10.1902/jop.1999.70.9.1118
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P857
NR 31
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2015
VL 24
IS 2
BP 180
EP 184
DI 10.1097/ID.0000000000000225
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CE6AB
UT WOS:000351916700009
PM 25706266
DA 2018-10-19
ER

PT J
AU Revi, D
   Vineetha, VP
   Muhamed, J
   Surendran, GC
   Rajan, A
   Kumary, TV
   Anilkumar, TV
AF Revi, Deepa
   Vineetha, Vadavanath P.
   Muhamed, Jaseer
   Surendran, Geetha C.
   Rajan, Akhila
   Kumary, T. V.
   Anilkumar, Thapasimuthu V.
TI Wound healing potential of scaffolds prepared from porcine jejunum and
   urinary bladder by a non-detergent/enzymatic method
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Extracellular matrix; wound healing; histomorphometry; alpha smooth
   muscle actin; proliferating cell nuclear antigen
ID SMALL-INTESTINAL SUBMUCOSA; EXTRACELLULAR-MATRIX; GROWTH-FACTORS;
   BIOMATERIAL; VIMENTIN; SKIN; DESIGN; REPAIR; MODEL
AB Scaffolds prepared using extracellular matrices of mammalian organs/tissues, when used as grafts, have wound healing potential. This paper evaluated the physical properties and invivo wound healing potential of jejunum-derived scaffold (JDS) and urinary bladder-derived scaffold (UDS) of porcine origin prepared by a non-detergent/enzymatic method. The former had higher flexural rigidity and suture retention strength compared to the latter, but both of them had the essential flexural rigidity and suture retention strength required for skin grafts. Full thickness skin-wounds on rabbit dorsum were treated with these scaffolds and the wound healing ability was compared by studying histomorphology parameters such as re-epithelialisation, collagen deposition, angiogenesis, proliferation of cells, mesenchymal cell infiltration and myofibroblast response. The extent of these reactions was assessed using histomorphometry. The results indicated that both grafts initiated healing faster than those wounds without any graft, as evidenced by the extent of cell proliferation and mesenchymal cell infiltration. The myofibroblast response persisted longer in the non-graft assisted wound healing reaction compared to the healing in the graft assisted wounds. Moreover, the JDS induced higher cell proliferation and greater angiogenesis than UDS probably indicating better healing by the former. The results suggested that JDS and UDS prepared by non-detergent/enzymatic method have potential clinical applications.
C1 [Revi, Deepa; Vineetha, Vadavanath P.; Muhamed, Jaseer; Surendran, Geetha C.; Rajan, Akhila; Anilkumar, Thapasimuthu V.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Expt Pathol, Trivandrum 695012, Kerala, India.
   [Kumary, T. V.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Tissue Culture Lab, Trivandrum 695012, Kerala, India.
RP Anilkumar, TV (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Expt Pathol, Trivandrum 695012, Kerala, India.
EM tvanilkumar@sctimst.ac.in
OI Rajan, Akhila/0000-0002-9624-4696; Muhamed, Jaseer/0000-0001-5046-9438
FU Department of Biotechnology, Government of India
   [BT/PR15461/MED/32/16/7/2011]
FX This research received financial support of the Department of
   Biotechnology, Government of India (BT/PR15461/MED/32/16/7/2011).
CR Anilkumar TV, 2014, J BIOMED MATER RES B, V102, P1506, DOI 10.1002/jbm.b.33131
   Boekema BKHL, 2014, J MATER SCI-MATER M, V25, P423, DOI 10.1007/s10856-013-5075-2
   Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Bryan J, 2004, J Wound Care, V13, P227
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P349, DOI 10.1097/01.ASW.0000418541.31366.a3
   Eckes B, 1998, J CELL SCI, V111, P1897
   Eckes B, 2000, J CELL SCI, V113, P2455
   El Kahi CG, 2009, INT WOUND J, V6, P214, DOI 10.1111/j.1742-481X.2009.00597.x
   Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Kimmel Howard, 2010, J Am Col Certif Wound Spec, V2, P55, DOI 10.1016/j.jcws.2010.11.002
   Lev-Tov H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-8
   Marcal H, 2012, REGEN MED, V7, P159, DOI [10.2217/RME.12.6, 10.2217/rme.12.6]
   Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   O'Leary R, 2003, BRIT J DERMATOL, V149, P665, DOI 10.1046/j.1365-2133.2003.05501.x
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Olczyk P, 2014, BIOMED RES INT, DOI 10.1155/2014/747584
   Peh P, 2011, NANOMEDICINE-UK, V6, P593, DOI 10.2217/nnm.11.54
   QUEEN D, 1987, BIOMATERIALS, V8, P367, DOI 10.1016/0142-9612(87)90007-X
   Revi D, 2014, J BIOMED MATER RES A, V102, P3273, DOI 10.1002/jbm.a.35003
   Revi D, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413518060
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Schultze-Mosgau S, 2007, TISSUE ENG, V13, P921
   Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375
   Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393
   Wong VW, 2012, INT J BIOMATER, V2012
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yonehiro L, 2013, WOUNDS, V25, P340
NR 32
TC 2
Z9 2
U1 0
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD APR
PY 2015
VL 29
IS 9
BP 1218
EP 1229
DI 10.1177/0885328214560218
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3EE
UT WOS:000351707600002
PM 25425562
DA 2018-10-19
ER

PT J
AU Flanagan, KE
   Tien, LW
   Elia, R
   Wu, JL
   Kaplan, D
AF Flanagan, Kelly E.
   Tien, Lee W.
   Elia, Roberto
   Wu, Julian
   Kaplan, David
TI Development of a sutureless dural substitute from Bombyx mori silk
   fibroin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE dural substitute; silk fibroin; electrospinning; biodegradable
   composite; tissue sealant
ID SPECTROSCOPY; FIBROBLASTS; ADHESIVES; SEALANTS; REPAIR
AB Silk solvent casting, electrospinning, and electrogelation techniques were used to create a biodegradable, biocompatible silk fibroin dural substitute. The all-silk system was designed and produced to improve on currently available materials, grafts and tissue sealants used for dural closure in neurosurgery. The silk biomaterial was successfully fabricated as a dual layer adhesive system designed to seal durotomies while also functioning as a dural regeneration scaffold. The mechanical characteristics, biocompatibility, biodegradability, and hydrodynamic sealing capability of the material were evaluated. Results showed that the biomaterial was biocompatible with neural cells and fibroblasts, had mechanical properties mimicking the natural dura, was biodegradable with controllable degradation, and was able to seal against a hydrodynamic pressure of 205 mmHg, which greatly exceeds the maximum cerebrospinal fluid pressure seen in both cranial and spinal dural closures of 50 mmHg. Based on its design and experimental results, the adhesive silk dual layer composite biomaterial shows potential as a sutureless dural repair system that would improve on current dural closure techniques. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 485-494, 2015.
C1 [Flanagan, Kelly E.; Tien, Lee W.; Elia, Roberto; Kaplan, David] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Wu, Julian] Tufts Med Ctr, Dept Neurosurg, Boston, MA USA.
RP Kaplan, D (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
FU NIH [P41 EB002520]
FX Contract grant sponsor: NIH; contract grant number: P41 EB002520 (DLK)
CR [Anonymous], 2010, F239204 ASTM, DOI [10.1520/F2392-04R10, DOI 10.1520/F2392-04R10]
   Campbell PK, 2005, VITRO TESTING, P1
   Cosgrove GR, 2007, J NEUROSURG, V106, P52, DOI 10.3171/jns.2007.106.1.52
   DOLENC VV, 1997, NEUROL MED CHIR TOKY, V37, P889
   Epstein NE, 2010, SPINE J, V10, P1065, DOI 10.1016/j.spinee.2010.09.017
   Fattahi T, 2004, J ORAL MAXIL SURG, V62, P218, DOI 10.1016/j.joms.2003.01.005
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Liu Y, 2009, EXP CELL RES, V36, P333
   Lu Q, 2011, ACTA BIOMATER, V7, P2394, DOI 10.1016/j.actbio.2011.02.032
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   MARCHBANKS R J, 1990, British Journal of Audiology, V24, P179, DOI 10.3109/03005369009076554
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Moskowitz SI, 2009, OPERATIVE NEUROSURG, V1, pons28
   NISHIDA T, 1988, INVEST OPHTH VIS SCI, V29, P1887
   Novitsky YW, 2007, J SURG RES, V140, P6, DOI 10.1016/j.jss.2006.09.015
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Patel N, 1998, FASEB J, V12, P1447
   Rockwood DN, 2010, NAT PROTOC, V6, P1612
   Serban MA, 2011, J BIOMED MATER RES A, V98A, P567, DOI 10.1002/jbm.a.33149
   Thavarajah D, 2009, SPINE J, V35, pE25
   TissueMed Inc, 2012, TISSUEPATCHDURAL BRO
   Vanaclocha V, 1997, ACTA NEUROCHIR, V139, P112, DOI 10.1007/BF02747190
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, J CONTROL RELEASE, V134, P81
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yamada K, 1997, J NEUROSURG, V86, P1012, DOI 10.3171/jns.1997.86.6.1012
NR 31
TC 6
Z9 7
U1 6
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 485
EP 494
DI 10.1002/jbm.b.33217
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000001
PM 24919581
DA 2018-10-19
ER

PT J
AU Hillberg, AL
   Oudshoorn, M
   Lam, JBB
   Kathirgamanathan, K
AF Hillberg, Anna Louise
   Oudshoorn, Matthew
   Lam, Janice B. B.
   Kathirgamanathan, Kalyani
TI Encapsulation of porcine pancreatic islets within an immunoprotective
   capsule comprising methacrylated glycol chitosan and alginate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE diabetes; xenotransplantation; foreign body reactions (response); cell
   therapy; encapsulated cells
ID MICROENCAPSULATED ISLETS; CELL ENCAPSULATION; MICROCAPSULES;
   TRANSPLANTATION; BIOMATERIAL; HYDROGEL; XENOTRANSPLANTATION;
   DEPOLYMERIZATION; OSTEOBLASTS; STABILITY
AB Encapsulation of cells in biocompatible polymer matrices represents a powerful tool for cell-based therapies and therapeutic delivery systems. This technology has successfully been used to deliver pancreatic islets to humans for the treatment of Type 1 diabetes. However, the clinical impact of this technology may be improved by reducing the inflammatory response brought on after implantation of capsules in vivo. Within this study a biocompatible polymeric delivery system combining alginate and photo-crosslinked methacrylated glycol chitosan (MGC) was developed. This approach involved encapsulating cells in calcium-alginate beads, coating with MGC and photo-polymerizing using UVA in the presence of photo-initiator (VA-086), resulting in the formation of capsules approximate to 600 mu m in size. Crosslinking of the MGC outer wall allowed control over capsule swelling and improved the capsules overall properties. Capsule characterization demonstrated the stabilizing influence of polymerization and fluorescence imaging showed that the distribution of glycol chitosan is dependent on molecular weight. Good islet viability and insulin release was demonstrated in vitro over the course of a month, and in vivo transplantation of the capsules demonstrated good biocompatibility, particularly when compared with standard alginate/poly-l-ornithine/alginate capsules. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 503-518, 2015.
C1 [Hillberg, Anna Louise; Oudshoorn, Matthew; Lam, Janice B. B.; Kathirgamanathan, Kalyani] LCT, Auckland, New Zealand.
RP Hillberg, AL (reprint author), LCT, Auckland, New Zealand.
EM annalhillberg@msn.com
CR Amsden BG, 2007, BIOMACROMOLECULES, V8, P3758, DOI 10.1021/bm700691e
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Bae KH, 2006, BIOTECHNOL PROGR, V22, P297, DOI 10.1021/bp050312b
   Beenken-Rothkopf LN, 2012, J BIOMATER APPL, V28, P395
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen HM, 2006, BIOMACROMOLECULES, V7, P2091, DOI 10.1021/bm050862y
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0
   HORCHER A, 1994, TRANSPLANT P, V26, P784
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   Jean O, 2009, BIOMATERIALS, V30, P1
   Kato Y, 2002, CARBOHYD RES, V337, P561, DOI 10.1016/S0008-6215(02)00021-6
   Knight DK, 2007, J BIOMED MATER RES A, V83A, P787, DOI 10.1002/jbm.a.31430
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu N, 2006, CARBOHYD POLYM, V64, P60, DOI 10.1016/j.carbpol.2005.10.028
   Luan NM, 2010, BIOMATERIALS, V31, P8847, DOI 10.1016/j.biomaterials.2010.08.004
   MacKenzie DA, 2003, TRANSPLANTATION, V76, P887, DOI 10.1097/01.TP.0000087114.18315.17
   Nafea EH, 2011, J CONTROL RELEASE, V154, P110, DOI 10.1016/j.jconrel.2011.04.022
   Luan NM, 2012, BIOMATERIALS, V33, P8075, DOI 10.1016/j.biomaterials.2012.07.048
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   Rouillard AD, 2011, TISSUE ENG PART C-ME, V17, P173, DOI [10.1089/ten.tec.2009.0582, 10.1089/ten.TEC.2009.0582]
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Sakai S, 2000, J MICROENCAPSUL, V17, P691
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Skaugrud O, 1999, BIOTECHNOL GENET ENG, V16, P23, DOI 10.1080/02648725.1999.10647970
   Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243
   Sweidan K., 2011, J EXCIP FOOD CHEM, V2, P16
   Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006
   Teramura Y, 2010, ADV DRUG DELIVER REV, V62, P827, DOI 10.1016/j.addr.2010.01.005
   Thanos CG, 2007, J BIOMED MATER RES A, V83A, P216, DOI 10.1002/jbm.a.31472
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tonomura N, 2008, XENOTRANSPLANTATION, V15, P129, DOI 10.1111/j.1399-3089.2008.00450.x
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Vos P, 2014, ADV DRUG DELIV REV, V67-68, P15
   Vos P., 2006, BIOMATERIALS, V27, P5603
   Vos P, 1997, DIABETOLOGIA, V40, P262
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
NR 52
TC 7
Z9 7
U1 3
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 503
EP 518
DI 10.1002/jbm.b.33185
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000003
PM 24915784
DA 2018-10-19
ER

PT J
AU Ketabchi, A
   Weck, A
   Variola, F
AF Ketabchi, Amirhossein
   Weck, Arnaud
   Variola, Fabio
TI Influence of oxidative nanopatterning and anodization on the fatigue
   resistance of commercially pure titanium and Ti-6Al-4V
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE titanium; fatigue; oxidative nanopatterning; anodization; nanotopography
ID CONTROLLED CHEMICAL OXIDATION; ALLOYS; SURFACES; FABRICATION; NANOTUBES;
   CORROSION; STRENGTH; IMPLANTS; BEHAVIOR; TI6AL4V
AB With an increasingly aging population, a significant challenge in implantology is the creation of biomaterials that actively promote tissue integration and offer excellent mechanical properties. Engineered surfaces with micro- and nanoscale topographies have shown great potential to control and direct biomaterial-host tissue interactions. Two simple yet efficient chemical treatments, oxidative nanopatterning and anodization, have demonstrated the ability to confer exciting new bioactive capacities to commercially pure titanium and Ti-6Al-4V alloy. However, the resulting nanoporous and nanotubular surfaces require careful assessment in regard to potential adverse effects on the fatigue resistance, a factor which may ultimately cause premature failure of biomedical implants. In this work, we have investigated the impact of oxidative nanopatterning and anodization on the fatigue resistance of commercially pure titanium and Ti-6Al-4V. Quantitative (e.g., S-N curves) and qualitative analyses were carried out to precisely characterize the fatigue response of treated metals and compare it to that of polished controls. Scanning electron microscopy (SEM) imaging revealed the effects of cyclic loading on the fracture surface and on the structural integrity of chemically grown nanostructured oxides. Results from this study reinforce the importance of mechanical considerations in the development and optimization of micro- and nanoscale surface treatments for metallic biomedical implants. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B:563-571, 2015.
C1 [Ketabchi, Amirhossein; Weck, Arnaud; Variola, Fabio] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
   [Weck, Arnaud; Variola, Fabio] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.
RP Weck, A (reprint author), Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
EM aweck@uottawa.ca
OI Variola, Fabio/0000-0002-5519-6915; Weck, Arnaud/0000-0001-8768-4449
FU University of Ottawa; Faculty of Engineering; Natural Sciences and
   Engineering Research Council of Canada (NSERC)
FX Dr. Variola acknowledges start-up funding from the University of Ottawa
   and Faculty of Engineering. Dr. Weck gratefully acknowledges the support
   of the Natural Sciences and Engineering Research Council of Canada
   (NSERC).
CR ADACHI M, 1990, J DENT RES, V69, P1230, DOI 10.1177/00220345900690060101
   [Anonymous], 2007, E466 ASTM INT, DOI [10.1520/E0466-07, DOI 10.1520/E0466-07]
   [Anonymous], 2013, E112 ASTM INT, DOI [10.1520/E0112-13, DOI 10.1520/E0112-13]
   Apachitei I, 2009, SCRIPTA MATER, V61, P113, DOI 10.1016/j.scriptamat.2009.03.017
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Costa MYP, 2009, MAT SCI ENG A-STRUCT, V507, P29, DOI 10.1016/j.msea.2008.11.068
   Costa Midori Yoshikawa Pitanga, 2006, Mat. Res., V9, P107, DOI 10.1590/S1516-14392006000100020
   Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Demetrescu I, 2010, MOL CRYST LIQ CRYST, V521, P195, DOI 10.1080/15421401003715918
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Fleck C, 2010, INT J FATIGUE, V32, P929, DOI 10.1016/j.ijfatigue.2009.09.009
   He PG, 2013, COMPOS SCI TECHNOL, V82, P15, DOI 10.1016/j.compscitech.2013.04.007
   Hermawan H., 2012, BIODEGRADABLE METALS
   Ketabchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092080
   Laonapakul T, 2012, J MECH BEHAV BIOMED, V8, P123, DOI 10.1016/j.jmbbm.2011.11.011
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leinenbach C, 2006, BIOMATERIALS, V27, P1200, DOI 10.1016/j.biomaterials.2005.08.012
   Leinenbach C, 2009, ACTA BIOMATER, V5, P2810, DOI 10.1016/j.actbio.2009.03.029
   Lutjering G., 2007, TITANIUM
   Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005
   Morrissey RJ, 2005, INT J FATIGUE, V27, P1608, DOI 10.1016/j.ijfatigue.2005.07.009
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Pazos L, 2010, J MECH BEHAV BIOMED, V3, P416, DOI 10.1016/j.jmbbm.2010.03.006
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Richert L, 2008, ADV MATER, V20, P1488, DOI 10.1002/adma.200701428
   Ritchie RO, 1999, FATIGUE FRACT ENG M, V22, P621
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V69B, P46, DOI 10.1002/jbm.b.20021
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23
   VALLITTU PK, 1995, J PROSTHET DENT, V74, P412, DOI 10.1016/S0022-3913(05)80384-1
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Variola F, 2009, ADV ENG MATER, V11, pB227, DOI 10.1002/adem.200900122
   Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186
   Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f
   Yi JH, 2006, SURF SCI, V600, P4613, DOI 10.1016/j.susc.2006.07.053
   Yu WQ, 2010, J BIOMED MATER RES A, V94A, P1012, DOI 10.1002/jbm.a.32687
   Zavanelli RA, 2000, J PROSTHET DENT, V84, P274, DOI 10.1067/mpr.2000.108758
NR 42
TC 7
Z9 8
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 563
EP 571
DI 10.1002/jbm.b.33227
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000009
PM 24953745
DA 2018-10-19
ER

PT J
AU Felgueiras, HP
   Castanheira, L
   Changotade, S
   Poirier, F
   Oughlis, S
   Henriques, M
   Chakar, C
   Naaman, N
   Younes, R
   Migonney, V
   Celis, JP
   Ponthiaux, P
   Rocha, LA
   Lutomski, D
AF Felgueiras, H. P.
   Castanheira, L.
   Changotade, S.
   Poirier, F.
   Oughlis, S.
   Henriques, M.
   Chakar, C.
   Naaman, N.
   Younes, R.
   Migonney, V.
   Celis, J. P.
   Ponthiaux, P.
   Rocha, L. A.
   Lutomski, D.
TI Biotribocorrosion (tribo-electrochemical) characterization of anodized
   titanium biomaterial containing calcium and phosphorus before and after
   osteoblastic cell culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biotribocorrosion; titanium biomaterial; anodization; osteoblastic
   cells; wearing
ID ARTIFICIAL SALIVA; OXIDE-FILMS; IN-VITRO; SURFACES; DIFFERENTIATION;
   CORROSION; IMPLANTS; CA; TRIBOCORROSION; BEHAVIOR
AB The purpose of this study was to investigate the relationship between the osteoblastic cells behavior and biotribocorrosion phenomena on bioactive titanium (Ti). Ti substrates submitted to bioactive anodic oxidation and etching treatments were cultured up to 28 days with MG63 osteoblast-like cells. Important parameters of in vitro bone-like tissue formation were assessed. Although no major differences were observed between the surfaces topography (both rough) and wettability (both hydrophobic), a significant increase in cell attachment and differentiation was detected on the anodized substrates as product of favorable surface morphology and chemical composition. Alkaline phosphatase production has increased (approximate to 20 nmol/min/mg of protein) on the anodized materials, while phosphate concentration has reached the double of the etched material and calcium production increased (over 20 mu g/mL). The mechanical and biological stability of the anodic surfaces were also put to test through biotribocorrosion sliding solicitations, putting in evidence the resistance of the anodic layer and the cells capacity of regeneration after implant degradation. The Ti osteointegration abilities were also confirmed by the development of strong cell-biomaterial bonds at the interface, on both substrates. By combining the biological and mechanical results, the anodized Ti can be considered a viable option for dentistry. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 661-669, 2015.
C1 [Felgueiras, H. P.; Changotade, S.; Poirier, F.; Oughlis, S.; Migonney, V.; Lutomski, D.] Univ Paris 13, Sorbonne Paris Cite, CSPBAT UMR CNRS 7244, LBPS,UFR SMBH, F-93017 Paris, France.
   [Felgueiras, H. P.; Castanheira, L.; Rocha, L. A.] Univ Minho, Ctr Mech & Mat Technol, P-4800058 Guimaraes, Portugal.
   [Castanheira, L.; Ponthiaux, P.] Ecole Cent Paris, LGPM, F-92295 Chatenay Malabry, Paris, France.
   [Henriques, M.] Univ Minho, IBB, Ctr Biol Engn, P-4710057 Braga, Portugal.
   [Chakar, C.; Naaman, N.; Younes, R.] Univ St Joseph, Fac Dent, Beirut, Lebanon.
   [Celis, J. P.] Catholic Univ Louvain, MTM, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
RP Lutomski, D (reprint author), Univ Paris 13, Sorbonne Paris Cite, CSPBAT UMR CNRS 7244, LBPS,UFR SMBH, 74 Rue Marcel Cachin, F-93017 Paris, France.
EM lutomski@smbh.univ-paris13.fr
RI Henriques, Mariana/A-2117-2013; Rocha, Luis/A-8592-2008; Felgueiras,
   Helena/H-4323-2017
OI Henriques, Mariana/0000-0003-0317-4877; Rocha, Luis/0000-0002-7219-1518;
   Felgueiras, Helena/0000-0002-4354-0256; Naaman, Nada/0000-0002-1860-8300
CR Alves SA, 2014, LUBR SCI, V26, P500, DOI 10.1002/ls.1234
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   CARLSSON L, 1986, ACTA ORTHOP SCAND, V57, P285, DOI 10.3109/17453678608994393
   Craig RG, 2002, RESTORATIVE DENT MAT
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Deng HW, 2005, CURRENT TOPICS IN BONE BIOLOGY, P1, DOI 10.1142/9789812701176
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Franco RD, 2009, J BIOMED MATER RES A, V88A, P841, DOI 10.1002/jbm.a.31960
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Gabbi C, 2005, ANN FM VET PARMA, V25, P307
   Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037
   Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785
   Kasemo B, 1985, TISSUE INTEGRATED PR, P99
   Kim KH, 2009, DENT MATER J, V28, P20, DOI 10.4012/dmj.28.20
   Krishna DSR, 2007, TRIBOL INT, V40, P329, DOI 10.1016/j.triboint.2005.08.004
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Kutz M., 2009, BIOMEDICAL ENG DESIG
   Landolt D, 2001, ELECTROCHIM ACTA, V46, P3913, DOI 10.1016/S0013-4686(01)00679-X
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lee JM, 2010, APPL SURF SCI, V256, P3086, DOI 10.1016/j.apsusc.2009.11.078
   LesGuehennec L, 2007, DENT MATER, V23, P844
   Lim YJ, 2001, BIO-MED MATER ENG, V11, P325
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Rodriguez R, 2003, J BIOMED MATER RES A, V65A, P352, DOI 10.1002/jbm.a.10490
   Souza JCM, 2012, WEAR, V292, P82, DOI 10.1016/j.wear.2012.05.030
   Souza JCM, 2010, BIOFOULING, V26, P471, DOI 10.1080/08927011003767985
   Squire MW, 1996, BIOMATERIALS, V17, P725, DOI 10.1016/0142-9612(96)86743-3
   Thirugnanam A, 2009, TRENDS BIOMATER ART, V32, P76
   VansOss CJ, 1989, J COLLOID INTERF SCI, V128, P313
   Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031
   Whitters CJ, 1999, J DENT, V27, P401, DOI 10.1016/S0300-5712(99)00007-X
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhou Z., 2008, J PHYS D, V41, P1
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zhu ZR, 2007, J MED COLL PLA, V22, P303
NR 40
TC 8
Z9 8
U1 0
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 661
EP 669
DI 10.1002/jbm.b.33236
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000019
PM 24989830
DA 2018-10-19
ER

PT J
AU Daculsi, G
AF Daculsi, Guy
TI Smart scaffolds: the future of bioceramic
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; GRAFT SUBSTITUTE BIOMATERIALS; ECTOPIC
   BONE-FORMATION; MICROSTRUCTURE; OSTEOINDUCTION; OSTEOGENICITY;
   REGENERATION; DESIGN
AB The commercial offer for bioceramic bone substitutes is very large, however, the prerequisites for applications in bone reconstruction and tissue engineering, are most often absent. The main criteria being: on the one hand physico-chemical features providing surgeons with an injectable and/or shapeable biomaterial; on the second hand the multi-scale bioactivity leading to osteoconduction and osteoinduction properties. In order to obtain greater suitability according to the nature of the bone defect to be treated, new bone regeneration technologies, "smart scaffolds" must be developed and optimize to support suitable Ortho Biology.
C1 Univ Nantes, Fac Dent, Lab Osteoarticular & Dent Tissue Engn, INSERM,U791, F-44042 Nantes, France.
RP Daculsi, G (reprint author), Univ Nantes, Fac Dent, Lab Osteoarticular & Dent Tissue Engn, INSERM,U791, Pl A Ricordeau, F-44042 Nantes, France.
EM guy.daculsi@univ-nantes.fr
FU European Union [FP7-HEALTH-2009-241879]
FX The research leading to these results has received funding from the
   European Union's 7th Framework Programme under Grant Agreement No.
   FP7-HEALTH-2009-241879 (REBORNE).
CR Campion CR, 2013, J MATER SCI-MATER M, V24, P597, DOI 10.1007/s10856-012-4833-x
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Chan O, 2012, ACTA BIOMATER, V8, P2788, DOI 10.1016/j.actbio.2012.03.038
   Coathup MJ, 2012, J BIOMED MATER RES A, V100A, P1550, DOI 10.1002/jbm.a.34094
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Daculsi G, 2013, IRBM, V34, P346, DOI 10.1016/j.irbm.2013.07.001
   Daculsi G, 2010, J MATER SCI-MATER M, V21, P855, DOI 10.1007/s10856-009-3914-y
   Daculsi G, 2013, KEY ENG MATER, V529-530, P19, DOI 10.4028/www.scientific.net/KEM.529-530.19
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jensen SS, 2014, CLIN ORAL IMPLAN RES, DOI [10.1111/clr.12376, DOI 10.1111/CLR.12376]
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   LeGeros RZ, 2014, SPRING SER BIOMAT S, V2, P1, DOI 10.1007/978-3-642-53980-0_1
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Levengood SKL, 2010, BIOMATERIALS, V31, P3552, DOI 10.1016/j.biomaterials.2010.01.052
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Sanchez-Salcedo S, 2009, ACTA BIOMATER, V5, P2738, DOI 10.1016/j.actbio.2009.03.025
   Vasilescu E, 2011, REV CHIM-BUCHAREST, V62, P212
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Zhang Y, 2013, CERAM INT, V39, P6751, DOI 10.1016/j.ceramint.2013.02.004
NR 26
TC 6
Z9 7
U1 2
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2015
VL 26
IS 4
AR 154
DI 10.1007/s10856-015-5482-7
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PO
UT WOS:000351584300001
PM 25779511
DA 2018-10-19
ER

PT J
AU Grigolo, B
   Cavallo, C
   Desando, G
   Manferdini, C
   Lisignoli, G
   Ferrari, A
   Zini, N
   Facchini, A
AF Grigolo, Brunella
   Cavallo, Carola
   Desando, Giovanna
   Manferdini, Cristina
   Lisignoli, Gina
   Ferrari, Andrea
   Zini, Nicoletta
   Facchini, Andrea
TI Novel nano-composite biomimetic biomaterial allows chondrogenic and
   osteogenic differentiation of bone marrow concentrate derived cells
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOCHONDRAL LESIONS; STROMAL CELLS; SCAFFOLD;
   REPAIR; NICHE; REGENERATION; RATIONALE; DESIGN
AB In clinical orthopedics suitable materials that induce and restore biological functions together with the right mechanical properties are particularly needed for the regeneration of osteochondral lesions. For this purpose, the ideal scaffold should possess the right properties with respect to degradation, cell binding, cellular uptake, non-immunogenicity, mechanical strength, and flexibility. In addition, it should be easy to handle and serve as a template for chondrocyte and bone cells guiding both cartilage and bone formation. The aim of the present study was to estimate the chondrogenic and osteogenic capability of bone marrow concentrated derived cells seeded onto a novel nano-composite biomimetic material. These properties have been evaluated by means of histological, immunohistochemical and electron microscopy analyses. The data obtained demonstrated that freshly harvested cells obtained from bone marrow were able, once seeded onto the biomaterial, to differentiate either down the chondrogenic and osteogenic pathways as evaluated by the expression and production of specific matrix molecules. These findings support the use, for the repair of osteochondral lesions, of this new nano-composite biomimetic material together with bone marrow derived cells in a "one step" transplantation procedure.
C1 [Grigolo, Brunella; Cavallo, Carola; Desando, Giovanna; Manferdini, Cristina; Lisignoli, Gina; Facchini, Andrea] Rizzoli Orthopaed Inst, SSD Lab RAMSES, I-40136 Bologna, Italy.
   [Grigolo, Brunella; Manferdini, Cristina; Lisignoli, Gina; Facchini, Andrea] Rizzoli Orthopaed Inst, SC Lab Immunorheumatol & Tissue Regenerat, I-40136 Bologna, Italy.
   [Ferrari, Andrea; Zini, Nicoletta] Rizzoli Orthopaed Inst, SC Lab Musculoskeletal Cell Biol, I-40136 Bologna, Italy.
   [Zini, Nicoletta] Rizzoli Orthopaed Inst, IGM, CNR Natl Res Council Italy, I-40136 Bologna, Italy.
RP Grigolo, B (reprint author), Rizzoli Orthopaed Inst, SSD Lab RAMSES, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM brunella.grigolo@ior.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745; Cavallo,
   Carola/0000-0002-2913-856X; ZINI, NICOLETTA/0000-0002-4442-7079;
   manferdini, cristina/0000-0002-6648-6061
FU Progetto Regione Emilia-Romagna Universita
FX This work was partially supported by Grants from Progetto Regione
   Emilia-Romagna Universita 2010-2012 "Regenerative medicine of cartilage
   and bone". We thank the II Orthopedic and Traumatologic Clinic of our
   Institute (Director Professor Sandro Giannini) for providing us with
   Bone Marrow Concentrate samples. Bone Sialon Protein, osteopontin and
   Alkaline Phopshatase Hybridoma surnatants were obtained from the
   Developmental Studies Hybridoma Bank. We thank Patrizia Rappini and
   Graziella Salmi for their assistance in the preparation of the
   manuscript and Despina Kiriakidu, Massimo Gamberini and Luciano Pizzi
   for their technical assistance.
CR Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642
   Bluguermann C, 2013, CELL BIOCHEM FUNCT, V31, P271, DOI 10.1002/cbf.2950
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775
   Cavallo C, 2013, J BIOL REG HOMEOS AG, V27, P165
   Cavallo C, 2013, J BIOMED MATER RES A, V101, P1559, DOI 10.1002/jbm.a.34460
   Das Madhurima, 2013, J Stem Cells, V8, P1
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919
   Gangji V, 2011, BONE, V49, P1005, DOI 10.1016/j.bone.2011.07.032
   Giannini S, 2013, AM J SPORT MED, V41, P511, DOI 10.1177/0363546512467622
   Grigolo B, 2009, TISSUE ENG PART C-ME, V15, P647, DOI 10.1089/ten.TEC.2008.0569
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Manferdini C, 2016, J TISSUE ENG REGEN M, V10, P374, DOI 10.1002/term.1723
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Matsumoto T, 2010, J CELL PHYSIOL, V225, P291, DOI 10.1002/jcp.22223
   Murphy MB, 2013, EXP MOL MED, V15, pe54
   Nicoletti A, 2012, J MATER SCI-MATER M, V24, P17
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tonti GA, 2008, INT J DEV BIOL, V52, P1023, DOI 10.1387/ijdb.082725gt
   Velazquez OC, 2007, J VASC SURG, V45, P39
NR 28
TC 4
Z9 4
U1 1
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2015
VL 26
IS 4
AR 173
DI 10.1007/s10856-015-5500-9
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PO
UT WOS:000351584300020
PM 25804305
DA 2018-10-19
ER

PT J
AU Ko, J
   Mohtaram, NK
   Lee, PC
   Willerth, SM
   Jun, MBG
AF Ko, Junghyuk
   Mohtaram, Nima Khadem
   Lee, Patrick C.
   Willerth, Stephanie M.
   Jun, Martin B. G.
TI Mathematical model for predicting topographical properties of poly
   (epsilon-caprolactone) melt electrospun scaffolds including the effects
   of temperature and linear transitional speed
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
DE melt electrospinning; modeling; topography; microfibers and scaffolds
ID FIBER DIAMETER; POLYPROPYLENE; REGENERATION; FABRICATION; PARAMETERS;
   INDEX; FIELD
AB Melt electrospinning can be used to fabricate various fibrous biomaterial scaffolds with a range of mechanical properties and varying topographical properties for different applications such as tissue scaffold and filtration and etc, making it a powerful technique. Engineering the topography of such electrospun microfibers can be easily done by tuning the operational parameters of this process. Recent experimental studies have shown promising results for fabricating various topographies, but there is no body of work that focuses on using mathematical models of this technique to further understand the effect of operational parameters on these properties of microfiber scaffolds. In this study, we developed a novel mathematical model using numerical simulations to demonstrate the effect of temperature, feed rate and flow rate on controlling topographical properties such as fiber diameter of these spun fibrous scaffolds. These promising modelling results are also compared to our previous and current experimental results. Overall, we show that our novel mathematical model can predict the topographical properties affected by key operational parameters such as change in temperature, flow rate and feed rate, and this model could serve as a promising strategy for the controlling of topographical properties of such structures for different applications.
C1 [Ko, Junghyuk; Mohtaram, Nima Khadem; Willerth, Stephanie M.; Jun, Martin B. G.] Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
   [Lee, Patrick C.] Univ Vermont, Sch Engn, Burlington, VT 05405 USA.
   [Willerth, Stephanie M.] Univ Victoria, Div Med Sci, Victoria, BC V8W 3P6, Canada.
   [Willerth, Stephanie M.] Univ Victoria, Dept Biomed Engn, Victoria, BC V8W 3P6, Canada.
RP Ko, J (reprint author), Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
EM mbgjun@uvic.ca
OI Willerth, Stephanie/0000-0002-1665-7723
FU Natural Sciences and Engineering Research Council (NSERC)
FX Funding support from Natural Sciences and Engineering Research Council
   (NSERC) Discovery Grants is acknowledged. The authors would also like to
   acknowledge the Advanced Microscopy Facility at the University of
   Victoria.
CR Brown TD, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0013-7
   Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482
   Chung SW, 2010, ACTA BIOMATER, V6, P1958, DOI 10.1016/j.actbio.2009.12.007
   Dalton Paul D., 2006, Biotechnology Journal, V1, P998, DOI 10.1002/biot.200600064
   Dalton PD, 2007, POLYMER, V48, P6823, DOI 10.1016/j.polymer.2007.09.037
   Dalton PD, 2006, BIOMACROMOLECULES, V7, P686, DOI 10.1021/bm050777q
   Deng RJ, 2009, J APPL POLYM SCI, V114, P166, DOI 10.1002/app.29864
   Farrugia BL, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025001
   Hao MF, 2011, ADV MATER RES-SWITZ, V221, P129, DOI 10.4028/www.scientific.net/AMR.221.129
   Hao MF, 2011, ADV MATER RES-SWITZ, V221, P111, DOI 10.4028/www.scientific.net/AMR.221.111
   Karchin A, 2011, ACTA BIOMATER, V7, P3277, DOI 10.1016/j.actbio.2011.05.017
   Ko J, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/6/065009
   Ko J, 2014, J BIOMAT SCI-POLYM E, V25, P1, DOI 10.1080/09205063.2013.830913
   Kong CS, 2009, POLYM ENG SCI, V49, P391, DOI 10.1002/pen.21303
   Li XY, 2012, POLYMER, V53, P248, DOI 10.1016/j.polymer.2011.11.008
   Liu Y, 2014, J POLYM SCI POL PHYS, V52, P946, DOI 10.1002/polb.23511
   Lyons J, 2004, POLYMER, V45, P7597, DOI 10.1016/j.polymer.2004.08.071
   Mazalevska O, 2013, J APPL POLYM SCI, V129, P779, DOI 10.1002/app.38818
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Mota C, 2013, POLYM INT, V62, P893, DOI 10.1002/pi.4509
   Nagy ZK, 2013, J PHARM SCI-US, V102, P508, DOI 10.1002/jps.23374
   Nayak R, 2013, TEXT RES J, V83, P606, DOI 10.1177/0040517512458347
   Park SH, 2008, ACTA BIOMATER, V4, P1198, DOI 10.1016/j.actbio.2008.03.019
   Raleigh X L, 1884, DUBLIN PHILOS, P184
   Ren JY, 2014, J BIOMED MATER RES A, V102, P3140, DOI 10.1002/jbm.a.34985
   Wang XN, 2011, ADV MATER RES-SWITZ, V332-334, P1550, DOI 10.4028/www.scientific.net/AMR.332-334.1550
   Zhmayev E, 2010, POLYMER, V51, P274, DOI 10.1016/j.polymer.2009.11.025
   Zhou HJ, 2006, POLYMER, V47, P7497, DOI 10.1016/j.polymer.2006.08.042
   Zhrnayev E, 2008, J NON-NEWTON FLUID, V153, P95, DOI 10.1016/j.jnnfm.2007.11.011
NR 29
TC 3
Z9 3
U1 0
U2 30
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
EI 1361-6439
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD APR
PY 2015
VL 25
IS 4
AR 045018
DI 10.1088/0960-1317/25/4/045018
PG 11
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA CE5AF
UT WOS:000351841400019
DA 2018-10-19
ER

PT J
AU Qu, T
   Verma, D
   Shahidi, M
   Pichler, B
   Hellmich, C
   Tomar, V
AF Qu, Tao
   Verma, Devendra
   Shahidi, Mehran
   Pichler, Bernhard
   Hellmich, Christian
   Tomar, Vikas
TI Mechanics of organic-inorganic biointerfaces-Implications for strength
   and creep properties
SO MRS BULLETIN
LA English
DT Article
ID MOLECULAR-DYNAMICS; BIOLOGICAL-MATERIALS; ELECTRON-MICROSCOPY; HARD
   BIOMATERIALS; MINERAL CRYSTALS; BONE; COLLAGEN; HYDROXYAPATITE;
   BEHAVIOR; MICROMECHANICS
AB From the biological/chemical perspective, interface concepts related to the cell surface/synthetic biomaterial interface and the extracellular matrix/biomolecule interface have wide applications in medical and biological technologies. Interfaces also play a significant role in determining structural integrity and mechanical creep and strength properties of biomaterials. Structural arrangement of interfaces combined with interfacial interactions between organic and inorganic phases significantly affects the mechanical properties of biological materials, allowing for a unique combination of seemingly inconsistent properties, such as fracture strength and tensile strength being both high-as opposed to traditional engineering materials, which have high fracture strength linked to low tensile strength and vice versa. While there has been a tremendous amount of work focused on the effects of structural arrangements on biomaterial properties, both experimental and computational studies of the strength, deformation, and viscosity of the interface itself are limited to just a few systems. Even in such studies, the actual interface stress is rarely analyzed, and correlated to the overall material strength or creep properties. This article provides a focused overview of such studies in hard biological materials, followed by a new vision of how the results of interfacial molecular studies could be consistently linked to multiscale, micromechanics-based perceptions of hierarchical biological materials.
C1 [Qu, Tao; Verma, Devendra] Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
   [Shahidi, Mehran] Boku Vienna Univ Nat Resources & Life Sci, Vienna, Austria.
   [Shahidi, Mehran] TU Wien Vienna Univ Technol, Vienna, Austria.
   [Pichler, Bernhard] TU Wien Vienna Univ Technol, Lab Macroscop Mat Testing, Vienna, Austria.
   [Hellmich, Christian] TU Wien Vienna Univ Technol, Inst Mech Mat & Struct, Vienna, Austria.
   [Tomar, Vikas] Purdue Univ, W Lafayette, IN 47907 USA.
RP Qu, T (reprint author), Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
EM qut@purdue.edu; vermad@purdue.edu; mehran.shahidi@boku.ac.at;
   bernhard.pichler@tuwien.ac.at; christian.hellmich@tuwien.ac.at;
   tomar@purdue.edu
OI Pichler, Bernhard/0000-0002-6468-1840
FU US Department of Energy [DE-SC0008619]; National Science Foundation
   [CMMI-1131112]; European Research Council [257023]
FX T.Q. acknowledges support from the US Department of Energy Grant
   DE-SC0008619, D.V. acknowledges support from National Science Foundation
   Grant CMMI-1131112, and M.S. and C.H. acknowledge financial support from
   the European Research Council under grant #257023.
CR Al-Sawalmih A, 2008, ADV FUNCT MATER, V18, P3307, DOI 10.1002/adfm.200800520
   Alexander B, 2012, J R SOC INTERFACE, V9, P1774, DOI 10.1098/rsif.2011.0880
   Almer JD, 2007, J STRUCT BIOL, V157, P365, DOI 10.1016/j.jsb.2006.09.001
   Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9
   BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998
   Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1
   Bhowmik R., 2007, MATER RES SOC S P, V978
   Bhowmik R, 2007, J MATER SCI, V42, P8795, DOI 10.1007/s10853-007-1914-1
   Bhowmik R, 2009, J ENG MECH, V135, P413, DOI 10.1061/(ASCE)0733-9399(2009)135:5(413)
   Bylund G, 2003, DAIRY PROCESSING HDB
   COUSSOT P, 1995, PHYS REV LETT, V74, P3971, DOI 10.1103/PhysRevLett.74.3971
   Dealy J M, 2013, MELT RHEOLOGY ITS AP
   Dubey DK, 2013, J ENG MATER-T ASME, V135, DOI 10.1115/1.4023782
   Dubey DK, 2010, ANN BIOMED ENG, V38, P2040, DOI 10.1007/s10439-010-9988-3
   Dubey DK, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3279158
   Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002
   Dubey DK, 2009, ACTA BIOMATER, V5, P2704, DOI 10.1016/j.actbio.2009.02.035
   Dubey DK, 2009, MAT SCI ENG C-MATER, V29, P2133, DOI 10.1016/j.msec.2009.04.015
   Dubey DK, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/205103
   Eberhardsteiner L, 2014, COMPUT METHOD BIOMEC, V17, P48, DOI 10.1080/10255842.2012.670227
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   Franck A, 2004, UNDERSTANDING RHEOLO
   Frankland SJV, 2003, SURF SCI, V525, pL103, DOI 10.1016/S0039-6028(02)02532-3
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fritsch A, 2007, J MATER SCI, V42, P8824, DOI 10.1007/s10853-007-1859-4
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   Fritsch A, 2009, J THEOR BIOL, V260, P230, DOI 10.1016/j.jtbi.2009.05.021
   Ghosh P, 2007, BIOMACROMOLECULES, V8, P851, DOI 10.1021/bm060942h
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Hellmich C, 2003, BIOMECH MODEL MECHAN, V2, P21, DOI 10.1007/S10237-002-0025-9
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   Ichikawa Y, 2002, INT J NUMER METH ENG, V54, P1717, DOI 10.1002/nme.488
   Iyo T, 2004, J BIOMECH, V37, P1433, DOI 10.1016/j.jbiomech.2003.12.023
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Katti DR, 2010, J BIOMECH, V43, P1723, DOI 10.1016/j.jbiomech.2010.02.027
   Knapp DM, 1997, J RHEOL, V41, P971, DOI 10.1122/1.550817
   Knauss WG, 2003, COMPREHENSIVE STRUCT, V2, P383
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Launey ME, 2009, ADV MATER, V21, P2103, DOI 10.1002/adma.200803322
   LEES S, 1984, INT J BIOL MACROMOL, V6, P321, DOI 10.1016/0141-8130(84)90017-5
   LEES S, 1988, CONNECT TISSUE RES, V18, P41, DOI 10.3109/03008208809019071
   Lelievre F, 1996, J MATER SCI-MATER M, V7, P489, DOI 10.1007/BF00705430
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Morin C, 2014, ULTRASONICS, V54, P1251, DOI 10.1016/j.ultras.2013.12.005
   Newman S, 1997, BIOPOLYMERS, V41, P337, DOI 10.1002/(SICI)1097-0282(199703)41:3<337::AID-BIP9>3.0.CO;2-T
   Nikolov S, 2008, BIOPHYS J, V94, P4220, DOI 10.1529/biophysj.107.125567
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Qu T., 2015, SEM 2015 ANN C EXP E
   Qu T., 2014, P SOC ENG SCI 51 ANN
   Qu T, 2014, MAT SCI ENG C-MATER, V38, P28, DOI 10.1016/j.msec.2014.01.039
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   SALENCON J, 2001, HDB CONTINUUM MECH G
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Shahidi M, 2014, EUR J MECH A-SOLID, V45, P41, DOI 10.1016/j.euromechsol.2013.11.001
   Simone A. D., 2008, BIOCHEM BIOPH RES CO, V372, P121
   Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024
   Vaia RA, 2001, MRS BULL, V26, P394, DOI 10.1557/mrs2001.93
   Wagner NJ, 2009, PHYS TODAY, V62, P27, DOI 10.1063/1.3248476
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   Yoon YJ, 2002, BIOMECH MODEL MECHAN, V1, P83, DOI 10.1007/s10237-002-0008-x
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
NR 66
TC 15
Z9 15
U1 3
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD APR
PY 2015
VL 40
IS 4
BP 349
EP 358
DI 10.1557/mrs.2015.70
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CE9GG
UT WOS:000352151500014
DA 2018-10-19
ER

PT J
AU Spreckelsen, C
   Schmithausen, D
   Roder, P
   Schmidt, R
   Dahl, E
   Geisler, S
   Kabino, K
AF Spreckelsen, C.
   Schmithausen, D.
   Roeder, P.
   Schmidt, R.
   Dahl, E.
   Geisler, S.
   Kabino, K.
TI Model-based approach for optimizing the storage management of
   bio-repositories
SO SIMULATION MODELLING PRACTICE AND THEORY
LA English
DT Article
DE Computer simulation; Optimization; Biological specimen banks; Decision
   support models; Biomedical ontologies; Modelling; Storage management
ID ONTOLOGY
AB Systematically collected samples of human tissue and fluids (e.g. blood, urine) play a key role in biomedical research. Biomaterial banks aim at collecting such biomaterials systematically and providing long-term availability of samples, which have to be kept constantly frozen at low temperatures. Therefore, storage management has to meet critical constraints in order to maintain high quality of the samples. The project aims at supporting the application of optimization and simulation algorithms for storage management. The approach has to provide means for adapting the algorithms flexibly and systematically to different or changing settings of biomaterial management and, therefore, aims at implementing a model-based framework to specify and run the algorithms.
   The process of establishing an optimization/simulation model for a given Biomaterial bank supported by the project starts with acquiring separately a model (1) of biomaterial handling and (2) of the optimization or simulation approach. The models for specific situations are derived from generic ontologies. A subsequent model mapping step assigns components representing aspects of biomaterial handling and storage to roles in a suitable optimization or simulation scheme. The mapping then enables the semi-automatic generation of optimization and simulation code. In the case of offline optimization problems, the framework produces program code that can be processed by an existing generic solver for mixed integer optimization programs (Zuse Institute Mathematical Programming Language code to be processed by the solver Solving Constraint Integer Programs). In the case of online problems, i.e., problems with an ongoing production of new information relevant for the optimization, the approach generates Java code suitable for processing by an existing simulation kernel (SimKit).
   The mapping module has been verified by reproducing a given solution for the Capacitated Facility Problem. Preliminary results of simulation runs show antagonistic effects of sorting bio-specimens by sample type: Sorting decreases the number of freezer opening operations while it increases fragmentation. The project is the first to adopt ontology-based modeling and model mapping for systematically exploring optimization and simulation approaches to biomaterial storage management. The results of simulation runs not only demonstrate the feasibility of the approach, but yield first practical insights (e.g. the effect of sorting samples). (C) 2015 Elsevier B.V. All rights reserved.
C1 [Spreckelsen, C.; Schmithausen, D.; Roeder, P.; Schmidt, R.; Kabino, K.] Rhein Westfal TH Aachen, Dept Med Informat, D-52057 Aachen, Germany.
   [Schmidt, R.; Dahl, E.] Univ Hosp Aachen, Inst Pathol, Aachen, Germany.
   [Geisler, S.] Rhein Westfal TH Aachen, Chair Comp Sci Informat Syst 5, D-52057 Aachen, Germany.
RP Spreckelsen, C (reprint author), Rhein Westfal TH Aachen, Dept Med Informat, Pauwelsstr 30, D-52057 Aachen, Germany.
EM CSpreckelsen@mi.rwth-aachen.de
RI Spreckelsen, Cord/M-7326-2016
OI Spreckelsen, Cord/0000-0002-7301-1566
CR Achterberg T., 2004, 0419 ZIB
   Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7
   de Koster R, 2007, EUR J OPER RES, V182, P481, DOI 10.1016/j.ejor.2006.07.009
   Eminaga O, 2014, METHOD INFORM MED, V53, P29, DOI 10.3414/ME13-01-0035
   Ericsson C, 2006, ACTA ONCOL, V45, P643, DOI 10.1080/02841860600818047
   Fumi A., 2013, INT J ENG BUSINESS M, V5, P1
   GARFINKEL M, 2005, THESIS GEORGIA I TEC
   Grando M.A., 2012, P IEEE 2 INT C HEALT, P51
   GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008
   Gu JX, 2007, EUR J OPER RES, V177, P1, DOI 10.1016/j.ejor.2006.02.025
   Gu JX, 2010, EUR J OPER RES, V203, P539, DOI 10.1016/j.ejor.2009.07.031
   Han J, 2011, WINT SIMUL C PROC, P2909, DOI 10.1109/WSC.2011.6147994
   Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8
   Hoehndorf R, 2013, BRIEF BIOINFORM, V14, P696, DOI 10.1093/bib/bbs053
   Housseman S., 2011, ACM T MODEL COMPUT S, V21, P1
   KOCH T., 2004, THESIS TU BERLIN
   Koch T., 2001, 0120 KONR ZUS ZENTR
   Kofler M., 2011, LOG IND INF LINDI 20, P77
   Kovacs A, 2011, INT J PROD ECON, V133, P312, DOI 10.1016/j.ijpe.2009.10.028
   Macro JG, 2002, PROCEEDINGS OF THE 2002 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1274, DOI 10.1109/WSC.2002.1166388
   McGuinness D.L., 2004, OWL WEB ONTOLOGY LAN
   Noble G.L., 2001, US Patent, Patent No. [US 20010047451 A1, 20010047451]
   Payer H., 2009, 1 WORKSH INT SOL STA, V1, P1
   Rojas Isabel, 2004, In Silico Biol, V4, P89
   Rudolph S, 2011, LECT NOTES COMPUT SC, V6848, P76, DOI 10.1007/978-3-642-23032-5_2
   Segagni D, 2011, STUD HEALTH TECHNOL, V169, P887, DOI 10.3233/978-1-60750-806-9-887
   SHANKAR RD, 2006, P INT WORKSH HEALTHC, P25
   Silver GA, 2011, SIMUL-T SOC MOD SIM, V87, P747, DOI 10.1177/0037549710386843
   Yu AC, 2006, J BIOMED INFORM, V39, P252, DOI 10.1016/j.jbi.2005.11.006
NR 29
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-190X
EI 1878-1462
J9 SIMUL MODEL PRACT TH
JI Simul. Model. Pract. Theory
PD APR
PY 2015
VL 53
BP 74
EP 87
DI 10.1016/j.simpat.2015.01.008
PG 14
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering
SC Computer Science
GA CE5HP
UT WOS:000351862200005
DA 2018-10-19
ER

PT J
AU Anderson, EM
   Kwee, BJ
   Lewin, SA
   Raimondo, T
   Mehta, M
   Mooney, DJ
AF Anderson, Erin M.
   Kwee, Brian J.
   Lewin, Sarah A.
   Raimondo, Theresa
   Mehta, Manav
   Mooney, David J.
TI Local Delivery of VEGF and SDF Enhances Endothelial Progenitor Cell
   Recruitment and Resultant Recovery from Ischemia
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID INTEGRIN-MEDIATED ARREST; GROWTH-FACTOR DELIVERY; HUMAN CD34(+) CELLS;
   BONE-MARROW; IN-VITRO; LIMB ISCHEMIA; CORD BLOOD; ANGIOGENESIS; VIVO;
   TRANSPLANTATION
AB Biomaterials may improve outcomes of endothelial progenitor-based therapies for the treatment of ischemic cardiovascular disease, due to their ability to direct cell behavior. We hypothesized that local, sustained delivery of exogenous vascular endothelial growth factor (VEGF) and stromal cell-derived factor (SDF) from alginate hydrogels could increase recruitment of systemically infused endothelial progenitors to ischemic tissue, and subsequent neovascularization. VEGF and SDF were found to enhance in vitro adhesion and migration of outgrowth endothelial cells (OECs) and circulating angiogenic cells (CACs), two populations of endothelial progenitors, by twofold to sixfold, and nearly doubled recruitment to both ischemic and nonischemic muscle tissue in vivo. Local delivery of VEGF and SDF to ischemic hind-limbs in combination with systemic CAC delivery significantly improved functional perfusion recovery over OEC delivery, or either treatment alone. Compared with OECs, CACs were more responsive to VEGF and SDF treatment, promoted in vitro endothelial sprout formation in a paracrine manner more potently, and demonstrated greater influence on infiltrating inflammatory cells in vivo. These studies demonstrate that accumulation of infused endothelial progenitors can be enriched using biomaterial-based delivery of VEGF and SDF, and emphasize the therapeutic benefit of using CACs for the treatment of ischemia.
C1 [Anderson, Erin M.; Kwee, Brian J.; Raimondo, Theresa; Mehta, Manav; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Anderson, Erin M.; Lewin, Sarah A.; Mehta, Manav; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Mehta, Manav] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St,Pierce Hall 319, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
FU NIH [R01 HL069957]; Wyss Institute for Biologically Inspired Engineering
   at Harvard University
FX Funding was provided by the NIH (R01 HL069957) and Wyss Institute for
   Biologically Inspired Engineering at Harvard University.
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chambers SEJ, 2013, IMMUNOBIOLOGY, V218, P1370, DOI 10.1016/j.imbio.2013.06.010
   Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   Chen RR, 2007, MICROCIRCULATION, V14, P77, DOI 10.1080/10739680601131101
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5
   Hoefer IE, 2005, ATHEROSCLEROSIS, V181, P285, DOI 10.1016/j.atherosclerosis.2005.01.047
   Hristov M, 2007, THROMB HAEMOSTASIS, V98, P274, DOI 10.1160/TH07-03-0181
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019
   Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400
   Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482
   Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994
   Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321
   Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn
   Peled A, 2000, BLOOD, V95, P3289
   Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615
   Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813
   Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017
   Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171
   Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676
   Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565
   Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
   Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194
   Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tongers J, 2010, MICROVASC RES, V79, P200, DOI 10.1016/j.mvr.2010.01.012
   Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044
   Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C
NR 49
TC 18
Z9 20
U1 1
U2 20
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR 1
PY 2015
VL 21
IS 7-8
BP 1217
EP 1227
DI 10.1089/ten.tea.2014.0508
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CF5RC
UT WOS:000352613600004
PM 25434326
OA Green Published
DA 2018-10-19
ER

PT J
AU Simmers, P
   Gishto, A
   Vyavahare, N
   Kothapalli, CR
AF Simmers, Phillip
   Gishto, Arsela
   Vyavahare, Narendra
   Kothapalli, Chandrasekhar R.
TI Nitric Oxide Stimulates Matrix Synthesis and Deposition by Adult Human
   Aortic Smooth Muscle Cells Within Three-Dimensional Cocultures
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID VASCULAR ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; S-NITROSOGLUTATHIONE;
   NEOINTIMA FORMATION; ELASTIN EXPRESSION; RELAXING FACTOR; BLOOD-VESSELS;
   PROTEIN; HYALURONAN; TISSUE
AB Vascular diseases are characterized by the over-proliferation and migration of aortic smooth muscle cells (SMCs), and degradation of extracellular matrix (ECM) within the vessel wall, leading to compromise in cell-cell and cell-matrix signaling pathways. Tissue engineering approaches to regulate SMC over-proliferation and enhance healthy ECM synthesis showed promise, but resulted in low crosslinking efficiency. Here, we report the benefits of exogenous nitric oxide (NO) cues, delivered from S-Nitrosoglutathione (GSNO), to cell proliferation and matrix deposition by adult human aortic SMCs (HA-SMCs) within three-dimensional (3D) biomimetic cocultures. A coculture platform with two adjacent, permeable 3D culture chambers was developed to enable paracrine signaling between vascular cells. HA-SMCs were cultured in these chambers within collagen hydrogels, either alone or in the presence of human aortic endothelial cells (HA-ECs) cocultures, and exogenously supplemented with varying GSNO dosages (0-100 nM) for 21 days. Results showed that EC cocultures stimulated SMC proliferation within GSNO-free cultures. With increasing GSNO concentration, HA-SMC proliferation decreased in the presence or absence of EC cocultures, while HA-EC proliferation increased. GSNO (100 nM) significantly enhanced the protein amounts synthesized by HA-SMCs, in the presence or absence of EC cocultures, while lower dosages (1-10 nM) offered marginal benefits. Multi-fold increases in the synthesis and deposition of elastin, glycosaminoglycans, hyaluronic acid, and lysyl oxidase crosslinking enzyme (LOX) were noted at higher GSNO dosages, and coculturing with ECs significantly furthered these trends. Similar increases in TIMP-1 and MMP-9 levels were noted within cocultures with increasing GSNO dosages. Such increases in matrix synthesis correlated with NO-stimulated increases in endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) expression within EC and SMC cultures, respectively. Results attest to the benefits of delivering NO cues to suppress SMC proliferation and promote robust ECM synthesis and deposition by adult human SMCs, with significant applications in tissue engineering, biomaterial scaffold development, and drug delivery.
C1 [Simmers, Phillip; Gishto, Arsela; Kothapalli, Chandrasekhar R.] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.
   [Vyavahare, Narendra] Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Kothapalli, CR (reprint author), Cleveland State Univ, Dept Chem & Biomed Engn, 2121 Euclid Ave,FH 460, Cleveland, OH 44115 USA.
EM c.kothapalli@csuohio.edu
OI Simmers, Phillip/0000-0002-3761-8328
FU Faculty Research Development Award from the Cleveland State University;
   Provost Undergraduate Research and Creative Achievement Award from the
   Cleveland State University; NSF [1337859]
FX The authors thank the Microfluidics Foundry at Stanford University for
   help with device molds and Mike Sawonik for help with the device design.
   The authors would also like to express their gratitude for the startup
   funds, Faculty Research Development Award (2012-2013), and Provost
   Undergraduate Research and Creative Achievement Award (2012) from the
   Cleveland State University. Partial support from NSF grant (1337859) to
   C.K. is also appreciated.
CR Ahern GP, 1999, J PHYSIOL-LONDON, V520, P165, DOI 10.1111/j.1469-7793.1999.00165.x
   Alonso D, 2003, HEART FAIL REV, V8, P107, DOI 10.1023/A:1022155206928
   Bashur CA, 2012, TISSUE ENG PART B-RE, V18, P203, DOI [10.1089/ten.teb.2011.0521, 10.1089/ten.TEB.2011.0521]
   Behr-Roussel Delphine, 2004, Journal de la Societe de Biologie, V198, P237
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bhattacharyya A, 2014, TISSUE ENG PT A, V20, P1175, DOI [10.1089/ten.TEA.2013.0268, 10.1089/ten.tea.2013.0268]
   Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3
   Bulick AS, 2009, TISSUE ENG PT A, V15, P815, DOI 10.1089/ten.tea.2008.0179
   Buttery LDK, 1996, LAB INVEST, V75, P77
   Carpenter AW, 2012, CHEM SOC REV, V41, P3742, DOI 10.1039/c2cs15273h
   Chen KJ, 2006, FREE RADICAL BIO MED, V41, P668, DOI 10.1016/j.freeradbiomed.2006.05.009
   CURRAN RD, 1991, FASEB J, V5, P2085
   Dey NB, 2012, MOL CELL BIOCHEM, V368, P27, DOI 10.1007/s11010-012-1339-2
   Egashira K, 1997, CIRCULATION, V96, P1048
   Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x
   Faury G, 1998, CIRC RES, V82, P328, DOI 10.1161/01.RES.82.3.328
   FAZIO MJ, 1988, LAB INVEST, V58, P270
   FILLINGER MF, 1993, J VASC SURG, V17, P1058, DOI 10.1016/0741-5214(93)90676-D
   FORNIERI C, 1992, ARTERIOSCLER THROMB, V12, P1008, DOI 10.1161/01.ATV.12.9.1008
   Fukumoto Y, 1997, CIRCULATION, V96, P3104, DOI 10.1161/01.CIR.96.9.3104
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   GARG UC, 1993, EUR J PHARMACOL, V237, P243, DOI 10.1016/0014-2999(93)90275-M
   Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013
   Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002
   IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265
   Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024
   Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6
   Joddar B, 2006, BIOMATERIALS, V27, P2994, DOI 10.1016/j.biomaterials.2006.01.020
   Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020
   JOHNSON DJ, 1995, CIRC RES, V77, P1107, DOI 10.1161/01.RES.77.6.1107
   KEATING M, 1994, TRENDS CARDIOVAS MED, V4, P165, DOI 10.1016/1050-1738(94)90053-1
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim H, 2014, INT J NANOMED, V9, P155, DOI 10.2147/IJN.S48856
   KOLPAKOV V, 1995, CIRC RES, V76, P305, DOI 10.1161/01.RES.76.2.305
   Kothapalli CR, 2008, J TISSUE ENG REGEN M, V2, P106, DOI 10.1002/term.70
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Kothapalli CR, 2009, J TISSUE ENG REGEN M, V3, P655, DOI 10.1002/term.214
   Kothapalli CR, 2009, ACTA BIOMATER, V5, P541, DOI 10.1016/j.actbio.2008.09.004
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P501, DOI 10.1089/ten.tea.2008.0040
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P103, DOI 10.1089/ten.tea.2007.0390
   Kuo YR, 2004, SURGERY, V135, P437, DOI 10.1016/j.surg.2003.07.006
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Lin SG, 2011, TISSUE ENG PT A, V17, P1561, DOI 10.1089/ten.tea.2010.0593
   Lin SG, 2012, BIOMATERIALS, V33, P7047, DOI 10.1016/j.biomaterials.2012.06.044
   Lipke EA, 2005, ACTA BIOMATER, V1, P597, DOI 10.1016/j.actbio.2005.07.010
   LUSCHER TF, 1994, J CARDIOVASC PHARM, V24, pS16
   Mancuso C, 2003, BIOCHEM PHARMACOL, V66, P2355, DOI 10.1016/j.bcp.2003.08.022
   Masters KSB, 2005, J BIOMAT SCI-POLYM E, V16, P659, DOI 10.1163/1568562053783722
   MCMAHON MP, 1985, IN VITRO CELL DEV B, V21, P674
   Mecham RP, 1997, J BIOL CHEM, V272, P18071, DOI 10.1074/jbc.272.29.18071
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mochizuki S, 2003, BIOCHEM BIOPH RES CO, V306, P505, DOI 10.1016/S0006-291X(03)00985-9
   MOURAO PAS, 1986, BIOCHIM BIOPHYS ACTA, V881, P321, DOI 10.1016/0304-4165(86)90022-X
   Naghavi N, 2013, SMALL, V9, P22, DOI 10.1002/smll.201200458
   Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180
   OAKES BW, 1982, EUR J CELL BIOL, V27, P34
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Petersen E, 2000, EUR J VASC ENDOVASC, V20, P457, DOI 10.1053/ejvs.2000.1211
   Pullens RAA, 2009, J TISSUE ENG REGEN M, V3, P11, DOI 10.1002/term.129
   Ricciardolo FLM, 2000, AM J RESP CELL MOL, V22, P97, DOI 10.1165/ajrcmb.22.1.3706
   Robert L, 1995, CIBA F SYMP, V192, P286
   ROSENBLOOM J, 1993, FASEB J, V7, P1208
   ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043
   Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428
   Sivaraman B, 2012, DRUG DELIV TRANSL RE, V2, P323, DOI 10.1007/s13346-012-0070-6
   Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/rccm.2105032
   Suarez ER, 2007, GROWTH FACTORS, V25, P50, DOI 10.1080/08977190701272701
   Sugitani H, 2001, BIOL PHARM BULL, V24, P461, DOI 10.1248/bpb.24.461
   Tsoukias N, 2008, MICROCIRCULATION, V15, P813, DOI 10.1080/10739680802010070
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   Venkataraman L, 2014, TISSUE ENG PT A, V20, P1403, DOI [10.1089/ten.tea.2013.0294, 10.1089/ten.TEA.2013.0294]
   Venkataraman L, 2011, TISSUE ENG PT A, V17, P2879, DOI [10.1089/ten.tea.2010.0749, 10.1089/ten.TEA.2010.0749]
   YANG WD, 1994, BIOCHEM BIOPH RES CO, V203, P1160, DOI 10.1006/bbrc.1994.2304
   Yu H, 2011, CHEM BIOL DRUG DES, V78, P527, DOI 10.1111/j.1747-0285.2011.01174.x
   Zhao HC, 2010, J BIOMED MATER RES A, V93A, P356, DOI 10.1002/jbm.a.32536
   Zhao Q, 2013, BIOMATERIALS, V34, P8450, DOI 10.1016/j.biomaterials.2013.07.045
NR 81
TC 8
Z9 8
U1 1
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR 1
PY 2015
VL 21
IS 7-8
BP 1455
EP 1470
DI 10.1089/ten.tea.2014.0363
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CF5RC
UT WOS:000352613600025
PM 25597545
OA Green Published
DA 2018-10-19
ER

PT J
AU Pfiffner, FK
   Waschkies, C
   Tian, YH
   Woloszyk, A
   Calcagni, M
   Giovanoli, P
   Rudin, M
   Buschmann, J
AF Pfiffner, Fatma Kivrak
   Waschkies, Conny
   Tian, Yinghua
   Woloszyk, Anna
   Calcagni, Maurizio
   Giovanoli, Pietro
   Rudin, Markus
   Buschmann, Johanna
TI A New In Vivo Magnetic Resonance Imaging Method to Noninvasively Monitor
   and Quantify the Perfusion Capacity of Three-Dimensional Biomaterials
   Grown on the Chorioallantoic Membrane of Chick Embryos
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID CONTRAST AGENT; DEGRAPOL-FOAM; TISSUE; MODEL; ANGIOGENESIS; CELLS;
   BIOCOMPATIBILITY; OSTEOBLASTS; MOLECULES; SCAFFOLDS
AB Adequate vascularization in biomaterials is essential for tissue regeneration and repair. Current models do not allow easy analysis of vascularization of implants in vivo, leaving it a highly desirable goal. A tool that allows monitoring of perfusion capacity of such biomaterials noninvasively in a cheap, efficient, and reliable in vivo model would hence add great benefit to research in this field. We established, for the first time, an in vivo magnetic resonance imaging (MRI) method to quantify the perfusion capacity of a model biomaterial, DegraPol((R)) foam scaffold, placed on the embryonic avian chorioallantoic membrane (CAM) in ovo. Perfusion capacity was assessed through changes in the longitudinal relaxation rate before and after injection of a paramagnetic MRI contrast agent, Gd-DOTA (Dotarem((R)); Guerbet S.A.). Relaxation rate changes were compared in three different regions of the scaffold, that is, at the interface to the CAM, in the middle and on the surface of the scaffold (p<0.05). The highest relaxation rate changes, and hence perfusion capacities, were measured in the interface region where the scaffold was attached to the CAM, whereas the surface of the scaffold showed the lowest relaxation rate changes. A strong positive correlation was obtained between relaxation rate changes and histologically determined vessel density (R-2=0.983), which corroborates our MRI findings. As a proof-of-principle, we measured the perfusion capacity in different scaffold materials, silk fibroin either with or without human dental pulp stem cells. For these, three to four times larger perfusion capacities were obtained compared to DegraPol; demonstrating that our method is sensitive to reveal such differences. In summary, we present a novel in vivo method for analyzing the perfusion capacity in three-dimensional-biomaterials grown on the CAM, enabling the determination of the perfusion capacity of a large variety of bioengineered materials.
C1 [Pfiffner, Fatma Kivrak; Calcagni, Maurizio; Giovanoli, Pietro; Buschmann, Johanna] Univ Zurich Hosp, Plast Surg & Hand Surg, CH-8091 Zurich, Switzerland.
   [Waschkies, Conny; Rudin, Markus] ETH, Inst Biomed Engn, Zurich, Switzerland.
   [Waschkies, Conny] Univ Zurich, Zurich, Switzerland.
   [Waschkies, Conny; Tian, Yinghua] Univ Zurich Hosp, Visceral & Transplant Surg, CH-8091 Zurich, Switzerland.
   [Woloszyk, Anna] Univ Zurich, Inst Oral Biol, Zurich, Switzerland.
   [Woloszyk, Anna] Univ Zurich, Mol Life Sci, Zurich, Switzerland.
   [Woloszyk, Anna] Swiss Fed Inst Technol, Zurich, Switzerland.
RP Buschmann, J (reprint author), Univ Zurich Hosp, Plast Surg & Hand Surg, Sternwartstr 14, CH-8091 Zurich, Switzerland.
EM johanna.buschmann@usz.ch
RI Calcagni, Maurizio/C-9769-2012
OI Calcagni, Maurizio/0000-0003-4372-0561
FU Matching Funds of University Hospital Zurich
FX We would like to thank Ms. Pia Fuchs for H&E staining and Dr. Monika
   Hilbe for von Willebrand Factor staining. PD Dr. Andreas Boss is
   acknowledged for providing the contrast agent. Furthermore, Trudel Silk
   Inc., Zurich, Switzerland is highly acknowledged for providing silk
   fibroin and Dr. Sandra Hofmann, Eindhoven University of Technology, for
   manufacturing the scaffolds. We additionally thank PD Dr. Bernd
   Stadlinger of the clinic for dental medicine, for providing the teeth.
   The Matching Funds of University Hospital Zurich are highly acknowledged
   for financial support. We are thankful to ab medica, Italy, for
   providing the DegraPol foams.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baiguera S, 2012, J BIOMED MATER RES B, V100B, P1425, DOI 10.1002/jbm.b.32653
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   Buschmann J, 2011, TISSUE ENG PT A, V17, P291, DOI [10.1089/ten.tea.2010.0278, 10.1089/ten.TEA.2010.0278]
   Buschmann J, 2013, J TISSUE ENG REGEN M, V7, P413, DOI 10.1002/term.538
   Chesnick IE, 2011, MAGN RESON IMAGING, V29, P1244, DOI 10.1016/j.mri.2011.07.022
   Cole R. W., 2010, MICROSCOPY SCI TECHN, V1, P885
   Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4
   Falkner E, 2004, ATLA-ALTERN LAB ANIM, V32, P573
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Klueh U, 2003, J BIOMED MATER RES A, V67A, P838, DOI 10.1002/jbm.a.10059
   Krishnan R, 2014, BIOMATERIALS, V35, P891, DOI 10.1016/j.biomaterials.2013.10.012
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lemon G, 2009, MATH BIOSCI, V221, P101, DOI 10.1016/j.mbs.2009.07.003
   Lokman NA, 2012, INT J MOL SCI, V13, P9959, DOI 10.3390/ijms13089959
   Milleret V, 2009, J BIOMED MATER RES B, V91B, P109, DOI 10.1002/jbm.b.31379
   Mohammad FK, 2012, NEUROTOXICOL TERATOL, V34, P214, DOI 10.1016/j.ntt.2011.09.006
   Mousa SA, 2007, CARCINOGENESIS, V28, P962, DOI 10.1093/carcin/bgl229
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Ribatti D, 1999, HISTOCHEM CELL BIOL, V112, P447, DOI 10.1007/s004180050427
   Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rudin M, 2005, NMR BIOMED, V18, P308, DOI 10.1002/nbm.961
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
   Saad B, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00775
   Sauerbier S, 2009, TISSUE ENG PART C-ME, V15, P455, DOI 10.1089/ten.tec.2008.0626
   Subauste MC, 2009, CLIN EXP METASTAS, V26, P1033, DOI 10.1007/s10585-009-9293-4
   Sukthankar A., 1999, DEGRAPOL BTC BTGC IN
   Tirino V, 2012, SOMATIC STEM CELLS, V879, P443
   Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152
   Wang DX, 2012, INT J NANOMED, V7, P1711, DOI 10.2147/IJN.S29341
   Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001
NR 33
TC 0
Z9 0
U1 0
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2015
VL 21
IS 4
BP 339
EP 346
DI 10.1089/ten.tec.2014.0212
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CF1KE
UT WOS:000352303200001
DA 2018-10-19
ER

PT J
AU Piitulainen, JM
   Posti, JP
   Aitasalo, KMJ
   Vuorinen, V
   Vallittu, PK
   Serlo, W
AF Piitulainen, Jaakko M.
   Posti, Jussi P.
   Aitasalo, Kalle M. J.
   Vuorinen, Ville
   Vallittu, Pekka K.
   Serlo, Willy
TI Paediatric cranial defect reconstruction using bioactive
   fibre-reinforced composite implant: early outcomes
SO ACTA NEUROCHIRURGICA
LA English
DT Article; Proceedings Paper
CT 15th European Congress of Neurosurgery
CY OCT 12-17, 2014
CL Prague, CZECH REPUBLIC
DE Cranioplasty; Craniectomy; Craniofacial bone reconstruction;
   Fibre-reinforced composite; FRC; Bioactive glass; Paediatric; Skull bone
   defect
ID TRAUMATIC BRAIN-INJURY; AUTOGENOUS BONE-GRAFT; DECOMPRESSIVE
   CRANIECTOMY; GLASS S53P4; IN-VITRO; CLINICAL ARTICLE; CHRONIC
   OSTEOMYELITIS; FLAP RESORPTION; RISK-FACTORS; CRANIOPLASTY
AB In children, approximately half of cryopreserved allograft bone flaps fail due to infection and resorption. Synthetic materials offer a solution for allograft bone flap resorption. Fibre-reinforced composite with a bioactive glass particulate filling is a new synthetic material for bone reconstruction. Bioactive glass is capable of chemically bonding with bone and is osteoinductive, osteoconductive and bacteriostatic. Fibre-reinforced composite allows for fabricating thin (0.8 mm) margins for implant, which are designed as onlays on the existing bone. Bioactive glass is dissolved over time, whereas the fibre-reinforced composite serves as a biostable part of the implant, and these have been tested in preclinical and adult clinical trials. In this study, we tested the safety and other required properties of this composite material in large skull bone reconstruction with children.
   Eight cranioplasties were performed on seven patients, aged 2.5-16 years and having large (> 16 cm(2)) skull bone defects. The implant used in this study was a patient-specific, glass-fibre-reinforced composite, which contained a bioactive glass particulate compound, S53P4.
   During follow-up (average 35.1 months), one minor complication was observed and three patients needed revision surgery. Two surgical site infections were observed. After treatment of complications, a good functional and cosmetic outcome was observed in all patients. The implants had an onlay design and fitted the defect well. In clinical and imaging examinations, the implants were in the original position with no signs of implant migration, degradation or mechanical breakage.
   Here, we found that early cranioplasty outcomes with the fibre-reinforced composite implant were promising. However, a longer follow-up time and a larger group of patients are needed to draw firmer conclusions regarding the long-term benefits of the proposed novel biomaterial and implant design. The glass-fibre-reinforced composite implant incorporated by particles of bioactive glass may offer an original, non-metallic and bioactive alternative for reconstruction of large skull bone defects in a paediatric population.
C1 [Piitulainen, Jaakko M.; Aitasalo, Kalle M. J.] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, Turku 20521, Finland.
   [Posti, Jussi P.; Vuorinen, Ville] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku 20521, Finland.
   [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, Dept Biomat Sci, Turku, Finland.
   [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, TCBC, Turku, Finland.
   [Vallittu, Pekka K.] Oral Hlth Care, City Turku Welf Div, Turku, Finland.
   [Serlo, Willy] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland.
RP Piitulainen, JM (reprint author), Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, POB 52, Turku 20521, Finland.
EM jaakko.piitulainen@utu.fi
OI Piitulainen, Jaakko/0000-0001-9788-8904; Posti,
   Jussi/0000-0002-5925-5193
CR Aitasalo KMJ, 2014, HEAD NECK-J SCI SPEC, V36, P722, DOI 10.1002/hed.23370
   Ballo AM, 2009, CLIN ORAL IMPLAN RES, V20, P608, DOI 10.1111/j.1600-0501.2008.01700.x
   Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483
   De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116
   DeLuca L, 1997, PLAST RECONSTR SURG, V99, P1324, DOI 10.1097/00006534-199704001-00019
   Drago L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-584
   Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860
   Engstrand T, 2014, J NEUROSURG, V120, P273, DOI 10.3171/2013.6.JNS1360
   Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312
   Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5
   Goldstein JA, 2013, CURR OPIN OTOLARYNGO, V21, P400, DOI 10.1097/MOO.0b013e328363003e
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Kamdar MR, 2009, PLAST RECONSTR SURG, V124, P2072, DOI 10.1097/PRS.0b013e3181bcefc4
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0
   McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268
   Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178
   Ritter L, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130088
   Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605
   Rogers GF, 2012, J CRANIOFAC SURG, V23, P323, DOI 10.1097/SCS.0b013e318241dcba
   Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901
   Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9
   Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014
   Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Wang DY, 2013, CLIN ORAL INVEST, V17, P1601, DOI 10.1007/s00784-012-0841-y
   Yli-Urpo H, 2003, ACTA ODONTOL SCAND, V61, P241, DOI 10.1080/00016350310004719
   Zehnder M, 2006, ORAL SURG ORAL MED O, V101, P530, DOI 10.1016/j.tripleo.2005.03.014
   Zehnder M, 2004, J ENDODONT, V30, P220, DOI 10.1097/00004770-200404000-00009
   Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564
NR 41
TC 18
Z9 18
U1 0
U2 20
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-6268
EI 0942-0940
J9 ACTA NEUROCHIR
JI Acta Neurochir.
PD APR
PY 2015
VL 157
IS 4
BP 681
EP 687
DI 10.1007/s00701-015-2363-2
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA CE0RD
UT WOS:000351511300024
PM 25663141
DA 2018-10-19
ER

PT J
AU Dias, FG
   Prudente, A
   Siniscalchi, RT
   de Vidal, BC
   Riccetto, CLZ
AF Fernandes Dias, Fernando Goulart
   Prudente, Alessandro
   Siniscalchi, Rodrigo Teixeira
   de Vidal, Benedicto Campos
   Zanettini Riccetto, Cassio Luis
TI Can highly purified collagen coating modulate polypropylene mesh
   immune-inflammatory and fibroblastic reactions? Immunohistochemical
   analysis in a rat model
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Collagen; Coating; Immunohistochemistry; Pelvic floor surgery;
   Polypropylene mesh
ID MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; REPAIR; PROLAPSE;
   SURGERY
AB Collagen has been proposed to be a useful biomaterial, but previous attempts to combine meshes with a collagen membrane have failed. The objective was to verify the effect of high-purified collagen gel coating in the immune-inflammatory response, host collagen metabolism, and angiogenesis around polypropylene mesh.
   In 20 female Wistar rats were implanted, at one side of the abdominal wall, a monofilament polypropylene mesh (PP), and, on the other side, a mesh coated with a new highly purified collagen gel (PPC). The animals were divided into sub-groups and euthanized at 7, 14, 21, and 90 days after implantation. Immunohistochemical analysis was performed using interleukin 1 (IL-1), matrix metalloproteinases (MMP-2, MMP-3), surface antigen CD-31, and tumor necrosis factor (TNF-alpha). Objective analysis (percent reactive area, average density, and vessels concentration) was performed using AxioVision Software.
   Comparative analysis showed: higher vessel density in the PPC group after 14 days (p = 0.002); a decrease in the average density of MMP-2 in the PPC group after 21 and 90 days (p = 0.046); more stability in the behavior of MMP-3 in the PPC group throughout the periods with the percentage reactive area for MMP-3 showing a significant decrease just in the PP group after 14 and 90 days (p = 0.017), and also for MMP-3 average density, in which reduction was significant after 21 days in the PP group, but not until after 90 days in PPC group (p < 0.001).
   Highly purified collagen coating causes significant changes in angiogenesis and in the immune reaction of metalloproteinase around mesh implants in rats. These findings can be useful for improving mesh biocompatibility for pelvic floor surgery if such effects could be properly controlled.
C1 [Fernandes Dias, Fernando Goulart; Prudente, Alessandro; Siniscalchi, Rodrigo Teixeira; Zanettini Riccetto, Cassio Luis] Univ Estadual Campinas, Div Urol, Biomat Res Unit, BR-13083888 Sao Paulo, Brazil.
   [de Vidal, Benedicto Campos] Univ Estadual Campinas, Inst Biol, Dept Anat Cell Biol Physiol & Biophys, BR-13083888 Sao Paulo, Brazil.
RP Dias, FG (reprint author), Univ Estadual Campinas, Div Urol, Biomat Res Unit, R Vital Brazil 250, BR-13083888 Sao Paulo, Brazil.
EM fergfdias@yahoo.com.br
RI Vidal, Benedicto/I-3227-2012
OI Vidal, Benedicto/0000-0003-1629-5619
FU FAPESP (Research Support Foundation of Sao Paulo State) [2013/05,841-3]
FX We thank FAPESP (Research Support Foundation of Sao Paulo State) for the
   financial support for the execution of this research project (process
   number 2013/05,841-3).
CR [Anonymous], 2004, CECIL TEXTBOOK
   BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401
   Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017
   Cervigni M, 2001, Curr Opin Urol, V11, P429, DOI 10.1097/00042307-200107000-00016
   Cervigni M, 2011, EUR J OBSTET GYN R B, V156, P223, DOI 10.1016/j.ejogrb.2011.01.027
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   de Tayrac R, 2007, INT UROGYNECOL J, V18, P513, DOI 10.1007/s00192-006-0176-9
   Gibson D, 2009, MMPS MADE EASY WOUND, V1, P1
   Guerette NL, 2009, OBSTET GYNECOL, V114, P59, DOI 10.1097/AOG.0b013e3181a81b41
   Huffaker RK, 2008, AM J OBSTET GYNECOL, V198, P582, DOI [10.1016/j.ajog.2007.12.029, DOI 10.1016/J.AJOG.2007.12.029]
   KNAPP TR, 1977, J SURG RES, V23, P96, DOI 10.1016/0022-4804(77)90196-2
   Kuiper N, 2008, INT J EXP PATHOL, V89, pA1, DOI 10.1111/j.1365-2613.2007.00572.x
   Lobmann R, 2006, J DIABETES COMPLICAT, V20, P329, DOI 10.1016/j.jdiacomp.2005.08.007
   Maher C, 2008, NEUROUROL URODYNAM, V27, P3, DOI 10.1002/nau.20542
   Maturana LG, 2011, BRAZ J MED BIOL RES, V44, P682, DOI [10.1590/S0100-879X2011007500074, 10.1590/S0100-879X2011000700011]
   National Institute for Health and Clinical Excellence, 2008, SURGICAL REPAIR OF V
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Patel H, 2012, INT UROGYNECOL J, V23, P669, DOI 10.1007/s00192-012-1718-y
   Schonleben F, 2006, INT J COLORECTAL DIS, V21, P840, DOI 10.1007/s00384-006-0091-z
   Siniscalchi RT, 2013, INT UROGYNECOL J, V24, P1747, DOI 10.1007/s00192-013-2109-8
   Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201
   Thiel M, 2005, BJU INT, V95, P833, DOI 10.1111/j.1464-410X.2005.05411.x
   van't Riet M, 2004, SURG ENDOSC, V18, P681, DOI 10.1007/s00464-003-9054-4
   Vidal BC, 2010, BIOTECH HISTOCHEM, V85, P365, DOI 10.3109/10520290903430496
   VIDAL BD, 1995, CR ACAD SCI III-VIE, V318, P831
   Yung S, 2006, PERITON DIALYSIS INT, V26, P162
NR 27
TC 6
Z9 6
U1 0
U2 10
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD APR
PY 2015
VL 26
IS 4
BP 569
EP 576
DI 10.1007/s00192-014-2529-0
PG 8
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA CE1XV
UT WOS:000351607100016
PM 25335748
DA 2018-10-19
ER

PT J
AU Sun, J
   Xiao, Y
   Wang, S
   Slepian, MJ
   Wong, PK
AF Sun, Jian
   Xiao, Yuan
   Wang, Shue
   Slepian, Marvin J.
   Wong, Pak Kin
TI Advances in Techniques for Probing Mechanoregulation of Tissue
   Morphogenesis
SO JALA
LA English
DT Review
DE automated biology; microtechnology; nanotechnology
ID COLLECTIVE CELL-MIGRATION; VASCULAR MESENCHYMAL CELLS; AIRWAY
   SMOOTH-MUSCLE; RAT SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; SHEAR-STRESS;
   MECHANICAL INTERACTIONS; FOCAL ADHESIONS; TRACTION FORCE; IN-VITRO
AB Cells process various mechanical cues in the microenvironment to self-organize into high-order architectures during tissue morphogenesis. Impairment of morphogenic processes is the underlying cause of many diseases; as such, understanding the regulatory mechanisms associated with these processes will form the foundation for the development of innovative approaches in cell therapy and tissue engineering. Nevertheless, little is known about how cells collectively respond to mechanical cues in the microenvironment, such as global geometric guidance, local cell-cell interactions, and other physicochemical factors, for the emergence of the structural hierarchy across multiple length scales. To elucidate the mechanoregulation of tissue morphogenesis, numerous approaches based on biochemical, biomaterial, and biophysical techniques have been developed in the past decades. In this review, we summarize techniques and approaches for probing the mechanoregulation of tissue morphogenesis and illustrate their applications in vasculature development. The potential and limitations of these methods are also discussed with a view toward the investigation of a wide spectrum of tissue morphogenic processes.
C1 [Sun, Jian; Xiao, Yuan; Wang, Shue; Wong, Pak Kin] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.
   [Slepian, Marvin J.; Wong, Pak Kin] Univ Arizona, Biomed Engn & Inst Bio5, Tucson, AZ 85721 USA.
   [Slepian, Marvin J.] Univ Arizona, Dept Med, Tucson, AZ 85721 USA.
RP Wong, PK (reprint author), Univ Arizona, Biomed Engn & Inst Bio5, 11130 Mt Ave, Tucson, AZ 85721 USA.
EM pak@email.arizona.edu
RI Wong, Pak Kin/A-7974-2012
OI Wong, Pak Kin/0000-0001-7388-2110
FU National Institutes of Health Director's New Innovator Award
   [DP2OD007161]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported by National Institutes of Health Director's New Innovator
   Award (DP2OD007161).
CR Alesutan I, 2013, CELL PHYSIOL BIOCHEM, V32, P728, DOI 10.1159/000354475
   An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001
   Anon E, 2012, P NATL ACAD SCI USA, V109, P10891, DOI 10.1073/pnas.1117814109
   Bagni M. A., 1992, Journal of Muscle Research and Cell Motility, V13, P516
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178
   Chen Peter C. Y., 2012, Proceedings of the World Congress on Engineering (WCE 2012), P622
   Chen TH, 2012, BIOMATERIALS, V33, P9019, DOI 10.1016/j.biomaterials.2012.08.067
   Chen TH, 2012, CIRC RES, V110, P551, DOI 10.1161/CIRCRESAHA.111.255927
   Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049
   COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2
   Dai SP, 2010, J BIOL CHEM, V285, P4995, DOI 10.1074/jbc.M109.067454
   Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009
   Di Carlo D, 2012, JALA-J LAB AUTOM, V17, P32, DOI 10.1177/2211068211431630
   Dickinson LE, 2012, J BIOMED MATER RES A, V100A, P1457, DOI 10.1002/jbm.a.34059
   Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540
   Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348
   Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045
   Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annutev.med.57.121304.131306
   Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200
   Francis-Sedlak ME, 2010, MICROVASC RES, V80, P3, DOI 10.1016/j.mvr.2009.12.005
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101
   Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Harris AR, 2012, P NATL ACAD SCI USA, V109, P16449, DOI 10.1073/pnas.1213301109
   Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097
   Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092
   Honarmandi P, 2011, LAB CHIP, V11, P684, DOI 10.1039/c0lc00487a
   Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120
   Hsiai TK, 2004, ANN BIOMED ENG, V32, P189, DOI 10.1023/B:ABME.0000012739.88554.01
   Huang H, 2002, BIOPHYS J, V82, P2211, DOI 10.1016/S0006-3495(02)75567-7
   Huang HJ, 2008, ACS NANO, V2, P203, DOI 10.1021/nn7000867
   Huang SX, 2010, MICROCIRCULATION, V17, P113, DOI 10.1111/j.1549-8719.2009.00011.x
   Ichioka S, 1997, J SURG RES, V72, P29, DOI 10.1006/jsre.1997.5170
   Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010
   Junkin M, 2013, BIOMATERIALS, V34, P2049, DOI 10.1016/j.biomaterials.2012.11.060
   Junkin M, 2011, J CELL SCI, V124, P4213, DOI 10.1242/jcs.088898
   Junkin M, 2011, BIOMATERIALS, V32, P1848, DOI 10.1016/j.biomaterials.2010.11.009
   Junkin M, 2009, ADV MATER, V21, P1247, DOI 10.1002/adma.200802122
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kniazeva E, 2009, AM J PHYSIOL-CELL PH, V297, pC179, DOI 10.1152/ajpcell.00018.2009
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047
   Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044
   Lau DH, 1999, CANCER BIOTHER RADIO, V14, P31, DOI 10.1089/cbr.1999.14.31
   Lei YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041163
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Long JX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002847
   Mabeta P, 2009, ANGIOGENESIS, V12, P81, DOI 10.1007/s10456-009-9134-8
   Magidson V, 2007, METHOD CELL BIOL, V82, P239, DOI 10.1016/S0091-679(06)82007-8
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Manser E., 2006, RHO FAMILY GTPASES
   Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007
   Matsugaki A, 2013, ACTA BIOMATER, V9, P7227, DOI 10.1016/j.actbio.2013.03.015
   Matsumura T, 1997, J IMMUNOL, V158, P3408
   Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6
   Milkiewicz M, 2008, J CELL PHYSIOL, V217, P502, DOI 10.1002/jcp.21526
   Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Mowbray AL, 2008, J BIOL CHEM, V283, P1622, DOI 10.1074/jbc.M707985200
   Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795
   Myers KA, 2011, J CELL BIOL, V192, P321, DOI 10.1083/jcb.201006009
   Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002
   Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181
   Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8
   Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096
   Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988
   Petersen W, 2004, J ORTHOPAED RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009
   Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352
   Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Rape A, 2011, J CELL SCI, V124, P4233, DOI 10.1242/jcs.090563
   Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917
   Riahi R, 2014, INTEGR BIOL-UK, V6, P192, DOI 10.1039/c3ib40095f
   Riahi R, 2013, ANALYST, V138, P4777, DOI 10.1039/c3an00722g
   Riahi R, 2012, JALA-J LAB AUTOM, V17, P59, DOI 10.1177/2211068211426550
   Rimann M, 2014, JALA-J LAB AUTOM, V19, P191, DOI 10.1177/2211068213508651
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109
   Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110
   Rosenthal R, 2005, EXP EYE RES, V80, P837, DOI 10.1016/j.exer.2004.12.013
   Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217
   Sarin V, 2005, J PHYSIOL-LONDON, V564, P603, DOI 10.1113/jphysiol.2005.083238
   Saunders RL, 2010, CELL MOL BIOENG, V3, P60, DOI 10.1007/s12195-010-0112-4
   Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061
   Schoen I, 2013, ANNU REV MATER RES, V43, P589, DOI 10.1146/annurev-matsci-062910-100407
   Shen H, 2014, PHYS CHEM CHEM PHYS, V16, P1914, DOI [10.1039/c3cp51435h, 10.1039/C3CP51435H]
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104
   Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108
   Sun J, 2014, BIOMATERIALS, V35, P3273, DOI 10.1016/j.biomaterials.2013.12.101
   Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107
   Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102
   Tagawa H, 1997, CIRC RES, V80, P281, DOI 10.1161/01.RES.80.2.281
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007
   Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tse Justin R, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1016s47
   Tseng P, 2012, NAT METHODS, V9, P1113, DOI [10.1038/NMETH.2210, 10.1038/nmeth.2210]
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   Turturro MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058897
   Udagawa T, 2000, J PHARMACOL EXP THER, V294, P421
   Ueda A, 2004, AM J PHYSIOL-HEART C, V287, pH994, DOI 10.1152/ajpheart.00400.2003
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van der Meer AD, 2010, AM J PHYSIOL-HEART C, V298, pH719, DOI 10.1152/ajpheart.00933.2009
   Van Gieson EJ, 2001, MICROCIRCULATION, V8, P25
   Wakatsuki T, 2001, J CELL SCI, V114, P1025
   Wang JHC, 2009, METHODS MOL BIOL, V586, P301, DOI 10.1007/978-1-60761-376-3_17
   Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003
   Wang N, 1998, HYPERTENSION, V32, P162, DOI 10.1161/01.HYP.32.1.162
   Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006
   Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006
   Wang TH, 2010, JALA-J ASSOC LAB AUT, V15, pA15, DOI 10.1016/j.jala.2010.03.002
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Wong PK, 2005, J BIOMECH, V38, P529, DOI 10.1016/j.jbiomech.2004.04.008
   Wu X, 2010, AM J PHYSIOL-HEART C, V298, pH2071, DOI 10.1152/ajpheart.01156.2009
   Yang WC, 2010, JALA-J LAB AUTOM, V15, P198, DOI 10.1016/j.jala.2010.01.008
   Zhao RG, 2013, ADV MATER, V25, P1699, DOI 10.1002/adma.201203585
NR 129
TC 3
Z9 3
U1 1
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2211-0682
EI 1540-2452
J9 JALA-J LAB AUTOM
JI JALA
PD APR
PY 2015
VL 20
IS 2
SI SI
BP 127
EP 137
DI 10.1177/2211068214554802
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA CE2FK
UT WOS:000351629600005
PM 25331491
OA Bronze
DA 2018-10-19
ER

PT J
AU Trivedi, P
   Patel, AK
   Maurya, R
   Jayaganthan, R
   Balani, K
AF Trivedi, Pramanshu
   Patel, Anup Kumar
   Maurya, Rita
   Jayaganthan, R.
   Balani, Kantesh
TI Nanomechanical Characterization and Protein Adsorption of Cold-Rolled
   Zirconium Alloy
SO JOM
LA English
DT Article
ID SEVERE PLASTIC-DEFORMATION; IN-VITRO BIOCOMPATIBILITY;
   SURFACE-ROUGHNESS; TITANIUM-ALLOYS; BONE; INTERFACE; METALS;
   WETTABILITY; BIOMATERIAL; ADHESION
AB The success of the implants used for bone regeneration and repair is highly dependent on the cell material interaction, which is further influenced by interaction of body proteins with the implant materials. In this study, a novel nanostructured Zircaloy-2 has been developed using cold rolling (reduction of 25%, 50%. 75%, and 85%), which resulted in the refinement of grains by several orders of magnitude. Phase analysis was done using x-ray diffraction, and the microstructures of room-temperature rolled Zircaloy-2 were obtained using optical microscopy. The adsorption behavior of bovine serum albumin as a function of protein concentration on Zircaloy-2 was performed, and the wettability before and after protein adsorption on Zircaloy-2 samples was estimated by measuring the contact angle of a water droplet on the processed samples. Nanoindentation studies were performed, which indicated higher hardness (of 2.15 GPa) and reduced elastic modulus (47.4 GPa) when compared with that of as-received Zircaloy-2 (hardness of 0.12 GPa and reduced elastic modulus of 5.6 GPa). Also, it was found that protein adsorption increases to 0.59 mg/cm(2) for maximum deformed samples when compared with that of 0.38 mg/cm(2) for as-received samples. Contact angle decreased with increasing reduction from 62A degrees (of the as-received sample) to 44A degrees (at a reduction of 85%). But after protein adsorption, a further decrease in the contact angle from 43A degrees (as received) to 26A degrees (for 85% reduction) was observed. Thus, the engineered cold rolling can allow tailoring the nanomechanical properties of Zircaloy-2 while rendering the required protein adsorption as potential implant material.
C1 [Trivedi, Pramanshu; Patel, Anup Kumar; Maurya, Rita; Balani, Kantesh] Indian Inst Technol, Dept Mat Sci & Engn, Biomat Proc & Characterizat Lab, Kanpur 208016, Uttar Pradesh, India.
   [Jayaganthan, R.] Indian Inst Technol, Dept Met & Mat Engn, Roorkee 247667, Uttar Pradesh, India.
RP Trivedi, P (reprint author), Indian Inst Technol, Dept Mat Sci & Engn, Biomat Proc & Characterizat Lab, Kanpur 208016, Uttar Pradesh, India.
EM kbalani@iitk.ac.in
OI RENGASWAMY, JAYAGANTHAN/0000-0002-3634-9306; Balani,
   Kantesh/0000-0003-0619-9164
CR Amato SF, 2015, REGULATORY AFFAIRS B, P27
   Cabrini R L, 1993, Implant Dent, V2, P264, DOI 10.1097/00008505-199312000-00008
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Gehrke P, 2006, QUINTESSENCE INT, V37, P19
   Goel S, 2014, MATER DESIGN, V55, P612, DOI 10.1016/j.matdes.2013.09.039
   Guglielmotti M B, 1997, Acta Odontol Latinoam, V10, P11
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Hench L.L., 1991, J AM CERAM SOC, V74, P1485
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kulakov O B, 2005, Morfologiia, V127, P52
   Lucas BN, 1997, MATER RES SOC SYMP P, V436, P233
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mordyuk BN, 2012, SURF COAT TECH, V210, P54, DOI 10.1016/j.surfcoat.2012.08.063
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M., 1999, JOM, V4, P32
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Scarborough N., 2015, REGULATORY AFFAIRS B, P11
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sherepo K.M., 1992, MED TEKH, V5, P14
   Sherepo K.M., 2004, MED TEKH, V2, P22
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Trivedi P, 2015, MAT SCI ENG C-MATER, V46, P309, DOI 10.1016/j.msec.2014.10.056
   Trivedi P, 2014, APPL SURF SCI, V293, P143, DOI [10.1016/j.apsusc.2013.12.119, 10.1016/j.apsusc.2013.12.11]
   Valiev R, 2004, NAT MATER, V3, P511, DOI 10.1038/nmat1180
   Valiev RZ, 2006, PROG MATER SCI, V51, P881, DOI 10.1016/j.pmatsci.2006.02.003
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
NR 34
TC 6
Z9 6
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2015
VL 67
IS 4
BP 726
EP 732
DI 10.1007/s11837-015-1324-9
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA CE1QN
UT WOS:000351587000006
DA 2018-10-19
ER

PT J
AU Rokicki, R
   Hryniewicz, T
   Pulletikurthi, C
   Rokosz, K
   Munroe, N
AF Rokicki, Ryszard
   Hryniewicz, Tadeusz
   Pulletikurthi, Chandan
   Rokosz, Krzysztof
   Munroe, Norman
TI Towards a Better Corrosion Resistance and Biocompatibility Improvement
   of Nitinol Medical Devices
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biocompatibility; corrosion resistance; magnetoelectropolishing MEP;
   NaClO surface inclusion detection test; Nitinol biomaterial
ID ALLOY; TITANIUM; SURFACES
AB Haemocompatibility of Nitinol implantable devices and their corrosion resistance as well as resistance to fracture are very important features of advanced medical implants. The authors of the paper present some novel methods capable to improve Nitinol implantable devices to some marked degree beyond currently used electropolishing (EP) processes. Instead, a magnetoelectropolishing process should be advised. The polarization study shows that magnetoelectropolished Nitinol surface is more corrosion resistant than that obtained after a standard EP and has a unique ability to repassivate the surface. Currently used sterilization processes of Nitinol implantable devices can dramatically change physicochemical properties of medical device and by this influence its biocompatibility. The Authors' experimental results clearly show the way to improve biocompatibility of NiTi alloy surface. The final sodium hypochlorite treatment should replace currently used Nitinol implantable devices sterilization methods which rationale was also given in our previous study.
C1 [Rokicki, Ryszard] Electrobright, Macungie, PA 18062 USA.
   [Hryniewicz, Tadeusz; Rokosz, Krzysztof] Koszalin Univ Technol, Surface Electrochem Div, Koszalin, Poland.
   [Pulletikurthi, Chandan; Munroe, Norman] Florida Int Univ, Mech & Mat Engn Dept, Miami, FL 33199 USA.
RP Rokicki, R (reprint author), Electrobright, Macungie, PA 18062 USA.
EM info@electrobright.com; Tadeusz.Hryniewicz@tu.koszalin.pl
OI pulletikurthi, chandan/0000-0002-1804-1164
CR Das KK, 2008, INDIAN J MED RES, V128, P412
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   Galante J., 1999, J ORTHOP RES, V9, P760
   Hryniewicz Tadeusz, 2009, Pomiary Automatyka Kontrola, V55, P247
   Hryniewicz T., 2009, MAT RES SOC S P E, V1244E, P21, DOI DOI 10.1557/PROC-1244-3
   Jain M., 2013, J INVASIVE CARDIOL, V25, P180
   Madamba D.L.L., 2013, 4287 SAN JOS STAT U
   Marks James G Jr, 2003, Am J Contact Dermat, V14, P59
   Norwich DW, 2009, J MATER ENG PERFORM, V18, P558, DOI 10.1007/s11665-009-9415-9
   Rokicki R, 2008, T I MET FINISH, V86, P280, DOI 10.1179/174591908X345040
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   Rokicki R, 2013, U.S. Patent, Patent No. [8,377,237, 8377237]
   Rokicki R., 2010, MAT DEVICE DIAGN IND, V32, P44
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Schuessler A., 2006, P INT C SHAP MEM SUP
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shabalovskaya S, 2009, J MATER ENG PERFORM, V18, P470, DOI 10.1007/s11665-009-9498-3
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Steegmueller R., 2005, P MAT PROC MED DEV C
   Stoeckel D., 1998, NITINOL MAT UNUSUAL
   van Geuns RJ, 2012, JACC-CARDIOVASC INTE, V5, P1209, DOI 10.1016/j.jcin.2012.08.016
   Zhao TT, 2012, J BIOMED MATER RES B, V100B, P646, DOI 10.1002/jbm.b.31989
NR 22
TC 11
Z9 11
U1 0
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD APR
PY 2015
VL 24
IS 4
BP 1634
EP 1640
DI 10.1007/s11665-015-1429-x
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD7SH
UT WOS:000351291200026
DA 2018-10-19
ER

PT J
AU Correia, RC
   Jozala, AF
   Martins, KF
   Penna, TCV
   Duek, EAD
   Rangel-Yagui, CD
   Lopes, AM
AF Correia, Rafaela Coelho
   Jozala, Angela Faustino
   Martins, Kelly Fernanda
   Vessoni Penna, Thereza Christina
   de Rezende Duek, Eliana Aparecida
   Rangel-Yagui, Carlota de Oliveira
   Lopes, Andre Moreni
TI Poly(lactic-co-glycolic acid) matrix incorporated with nisin as a novel
   antimicrobial biomaterial
SO WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
LA English
DT Article
DE PLGA; Polymeric matrix; Nisin; Drug delivery system; Antimicrobial
   peptides
ID DRUG-DELIVERY; LISTERIA-MONOCYTOGENES; NANOPARTICLES; PLGA; RELEASE;
   DEGRADATION; SYSTEM; VITRO
AB The use of poly(lactic-co-glycolic acid) (PLGA) matrix as a biomolecule carrier has been receiving great attention due to its potential therapeutic application. In this context, we investigated the PLGA matrix capacity to incorporate nisin, an antimicrobial peptide capable of inhibiting the growth of Gram-positive bacteria and bacterial spores germination. Nisin-incorporated PLGA matrices were evaluated based on the inhibitory effect against the nisin-bioindicator Lactobacillus sakei. Additionally, the PLGA-nisin matrix stability over an 8-months period was investigated, as well as the nisin release profile. For the incorporation conditions, we observed that a 5 h incorporation time, at 30 A degrees C, with 250 mu g/mL nisin solution in PBS buffer pH 4.5, resulted in the highest inhibitory activity of 2.70 logAU/mL. The PLGA-nisin matrix was found to be relatively stable and showed sustained drug delivery, with continuous release of nisin for 2 weeks. Therefore, PLGA-nisin matrix is could be used as a novel antimicrobial delivery system and an alternative to antibiotics incorporated into PLGA matrices.
C1 [Correia, Rafaela Coelho; Jozala, Angela Faustino; Vessoni Penna, Thereza Christina; Rangel-Yagui, Carlota de Oliveira; Lopes, Andre Moreni] Univ Sao Paulo FCF USP, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, BR-05508000 Sao Paulo, SP, Brazil.
   [Jozala, Angela Faustino] Univ Sorocaba UNISO, Dept Pharm, Sorocaba, Brazil.
   [Martins, Kelly Fernanda] Pontifical Catholic Univ Sao Paulo PUCSP, Biomat Lab, Sorocaba, Brazil.
   [de Rezende Duek, Eliana Aparecida] State Univ Campinas FEM UNICAMP, Dept Mat Engn, Fac Mech Engn, Campinas, SP, Brazil.
RP Lopes, AM (reprint author), Univ Sao Paulo FCF USP, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Av Prof Lineu Prestes 580,B16, BR-05508000 Sao Paulo, SP, Brazil.
EM andreml@usp.br
RI Jozala, Angela/D-2373-2013; Lopes, Andre/E-9058-2013; RANGEL-YAGUI,
   CARLOTA/B-2560-2013
OI Jozala, Angela/0000-0002-3763-5451; Lopes, Andre/0000-0002-3570-2470;
   RANGEL-YAGUI, CARLOTA/0000-0003-4221-9505
FU Coordination for Higher Level Graduate Improvements (CAPES/Brazil);
   National Council for Scientific and Technological Development
   (CNPq/Brazil); State of Sao Paulo Research Foundation (FAPESP/Brazil)
FX This research was supported by grants from the Coordination for Higher
   Level Graduate Improvements (CAPES/Brazil), National Council for
   Scientific and Technological Development (CNPq/Brazil) and State of Sao
   Paulo Research Foundation (FAPESP/Brazil).
CR Amann LC, 2010, PHARM RES-DORDR, V27, P1730, DOI 10.1007/s11095-010-0152-4
   Amjadi I, 2012, APPL BIOCHEM BIOTECH, V168, P1434, DOI 10.1007/s12010-012-9868-4
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   Bernela M, 2014, LWT-FOOD SCI TECHNOL, V59, P1093, DOI 10.1016/j.lwt.2014.05.061
   Chan CF, 2014, CURR ORG CHEM, V18, P204, DOI 10.2174/13852728113176660144
   Chi-Zhang YD, 2004, INT J FOOD MICROBIOL, V90, P15, DOI 10.1016/S0168-1605(03)00168-5
   de Kwaadsteniet M, 2010, PROBIOTICS ANTIMICRO, V2, P61, DOI 10.1007/s12602-009-9017-8
   Delves-Broughton J, 2005, FOOD AUST, V57, P525
   Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   Jozala FA, 2012, FOOD BIOPROCESS TECH, V6, P3456
   Kowalczyk T, 2014, WORLD J MICROB BIOT, V30, P2141, DOI 10.1007/s11274-014-1649-5
   Liu H, 2012, J APPL POLYM SCI, V125, P468
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Malheiros PD, 2010, FOOD MICROBIOL, V27, P175, DOI 10.1016/j.fm.2009.09.013
   Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Pirooznia N., 2012, J NANOBIOTECHNOL, V10, P1
   Prombutara P, 2012, FOOD CONTROL, V24, P184, DOI 10.1016/j.foodcont.2011.09.025
   Ranjan AP, 2012, J NANOBIOTECHNOL, V10, P1
   Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3
   Salmaso S, 2004, INT J PHARM, V287, P163, DOI 10.1016/j.ijpharm.2004.09.003
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Swarbrick J, 2007, ENCY PHARM TECHNOLOG, P1339
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Van De Ven H, 2012, J DRUG TARGET, V20, P142, DOI 10.3109/1061186X.2011.595491
   Van Staden ADP, 2011, THESIS STELLENBOSCH
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   World Health Organization (WHO), 1969, SPEC ID PUR SOM ANT, V69, P53
NR 32
TC 4
Z9 4
U1 0
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0959-3993
EI 1573-0972
J9 WORLD J MICROB BIOT
JI World J. Microbiol. Biotechnol.
PD APR
PY 2015
VL 31
IS 4
BP 649
EP 659
DI 10.1007/s11274-015-1819-0
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CD7TD
UT WOS:000351294200010
PM 25677652
DA 2018-10-19
ER

PT J
AU An, B
   Tang-Schomer, MD
   Huang, WW
   He, JY
   Jones, JA
   Lewis, RV
   Kaplan, DL
AF An, Bo
   Tang-Schomer, Min D.
   Huang, Wenwen
   He, Jiuyang
   Jones, Justin A.
   Lewis, Randolph V.
   Kaplan, David L.
TI Physical and biological regulation of neuron regenerative growth and
   network formation on recombinant dragline silks
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Neural cell; Silk; Recombinant protein; Tissue engineering
ID CELL-ADHESION MOLECULE; PERIPHERAL-NERVE REGENERATION; HOMOPHILIC
   BINDING-SITE; SPIDER SILK; NEURITE OUTGROWTH; TERMINAL DOMAINS;
   FGF-RECEPTOR; PROTEIN; FIBERS; TISSUE
AB Recombinant spider silks produced in transgenic goat milk were studied as cell culture matrices for neuronal growth. Major ampullate spidroin 1 (MaSp1) supported neuronal growth, axon extension and network connectivity, with cell morphology comparable to the gold standard poly-lysine. In addition, neurons growing on MaSp1 films had increased neural cell adhesion molecule (NCAM) expression at both mRNA and protein levels. The results indicate that MaSp1 films present useful surface charge and substrate stiffness to support the growth of primary rat cortical neurons. Moreover, a putative neuron-specific surface binding sequence GRGGL within MaSp1 may contribute to the biological regulation of neuron growth. These findings indicate that MaSp1 could regulate neuron growth through its physical and biological features. This dual regulation mode of MaSp1 could provide an alternative strategy for generating functional silk materials for neural tissue engineering. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [An, Bo; Tang-Schomer, Min D.; Huang, Wenwen; He, Jiuyang; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Jones, Justin A.; Lewis, Randolph V.] Utah State Univ, Dept Biol, Synthet Biomfg Ctr, Logan, UT 84322 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI An, Bo/N-3466-2014; Huang, Wenwen/H-5352-2018
OI An, Bo/0000-0002-1031-3380; Huang, Wenwen/0000-0001-8175-9083
FU NIH [R01 EB014283, P41 EB002520, R01 EY020856]; USTAR, DOE
   [DE-SC0004791]; NSF [IIP-1318194]
FX A. B. and M.D.T contributed equally to this paper; the order was
   determined alphabetically. We thank the NIH (R01 EB014283, P41 EB002520,
   R01 EY020856) to D.L.K and USTAR, DOE (DE-SC0004791), NSF (IIP-1318194)
   to R.V.L for funding support for these studies.
CR Adrianos SL, 2013, BIOMACROMOLECULES, V14, P1751, DOI 10.1021/bm400125w
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   An B, 2014, FRONT CHEM, V2
   An B, 2012, BIOMACROMOLECULES, V13, P3938, DOI 10.1021/bm301110s
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   DAVIS JQ, 1994, J BIOL CHEM, V269, P27163
   Eisoldt L, 2012, BIOPOLYMERS, V97, P355, DOI 10.1002/bip.22006
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2014, BIOL INSPIR SYST, V5, P137, DOI 10.1007/978-94-007-7119-2_8
   Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Huang WW, 2010, J APPL POLYM SCI, V115, P3238, DOI 10.1002/app.31393
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015
   Kiselyov VV, 2010, ADV EXP MED BIOL, V663, P67, DOI 10.1007/978-1-4419-1170-4_4
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KS, 2007, J BIOSCIENCES, V32, P705, DOI 10.1007/s12038-007-0070-8
   Lewicka M, 2012, BIOMATERIALS, V33, P7712, DOI 10.1016/j.biomaterials.2012.07.021
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827
   McKinnon DD, 2014, BIOMACROMOLECULES, V15, P2808, DOI 10.1021/bm500731b
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Paratcha G, CELL, V113, P867
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   RAO Y, 1993, J BIOL CHEM, V268, P20630
   Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685
   SANDIG M, 1994, J BIOL CHEM, V269, P14841
   Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127
   Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357
   Tang-Schomer MD, 2014, ADV FUNCT MATER, V24, P1938, DOI 10.1002/adfm.201303196
   Teule F, 2012, BIOPOLYMERS, V97, P418, DOI 10.1002/bip.21724
   Tucker CL, 2014, BIOMACROMOLECULES, V15, P3158, DOI 10.1021/bm5007823
   Virgintino D, 2009, J CELL MOL MED, V13, P3151, DOI 10.1111/j.1582-4934.2009.00694.x
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 63
TC 11
Z9 11
U1 4
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 48
BP 137
EP 146
DI 10.1016/j.biomaterials.2015.01.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD2SF
UT WOS:000350928600013
PM 25701039
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Jing, W
   Smith, AA
   Liu, B
   Li, JT
   Hunter, DJ
   Dhamdhere, G
   Salmon, B
   Jiang, J
   Cheng, D
   Johnson, CA
   Chen, S
   Lee, K
   Singh, G
   Helms, JA
AF Jing, Wei
   Smith, Andrew A.
   Liu, Bo
   Li, Jingtao
   Hunter, Daniel J.
   Dhamdhere, Girija
   Salmon, Benjamin
   Jiang, Jie
   Cheng, Du
   Johnson, Chelsey A.
   Chen, Serafine
   Lee, Katherine
   Singh, Gurpreet
   Helms, Jill A.
TI Reengineering autologous bone grafts with the stem cell activator WNT3A
SO BIOMATERIALS
LA English
DT Article
DE Age/ageing; Biomimetic material; Bone regeneration; Liposome;
   Osteogenesis; Spinal surgery
ID SPINAL-FUSION SURGERY; AGE-RELATED-CHANGES; ILIAC CREST; STROMAL CELLS;
   OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; TRABECULAR BONE;
   GROWTH-FACTORS; CORTICAL BONE; MARROW
AB Autologous bone grafting represents the standard of care for treating bone defects but this biomaterial is unreliable in older patients. The efficacy of an autograft can be traced back to multipotent stem cells residing within the bone graft. Aging attenuates the viability and function of these stem cells, leading to inconsistent rates of bony union. We show that age-related changes in autograft efficacy are caused by a loss in endogenous Wnt signaling. Blocking this endogenous Wnt signal using Dkk1 abrogates autograft efficacy whereas providing a Wnt signal in the form of liposome-reconstituted WNT3A protein (L-WNT3A) restores bone forming potential to autografts from aged animals. The bioengineered autograft exhibits significantly better survival in the hosting site. Mesenchymal and skeletal stem cell populations in the autograft are activated by L-WNT3A and mitotic activity and osteogenic differentiation are significantly enhanced. In a spinal fusion model, aged autografts treated with L-WNT3A demonstrate superior bone forming capacity compared to the standard of care. Thus, a brief incubation in L-WNT3A reliably improves autologous bone grafting efficacy, which has the potential to significantly improve patient care in the elderly. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jing, Wei; Smith, Andrew A.; Liu, Bo; Li, Jingtao; Hunter, Daniel J.; Dhamdhere, Girija; Cheng, Du; Johnson, Chelsey A.; Chen, Serafine; Lee, Katherine; Singh, Gurpreet; Helms, Jill A.] Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.
   [Salmon, Benjamin] Univ Paris 05, PRES, Sch Dent, Sorbonne Paris Cite,EA 2496, Montrouge, France.
   [Salmon, Benjamin] Hop Univ Paris Nord Val Seine, AP HP, Odontol Dept Bretonneau, Paris, France.
   [Jiang, Jie] Univ Calif Los Angeles, Clin & Translat Sci Inst, Los Angeles, CA USA.
RP Helms, JA (reprint author), Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.
FU California Institute of Regenerative Medicine (CIRM) [TR1-01249]
FX The authors declare that they have no conflict of interest. This
   research project was supported by a grant from the California Institute
   of Regenerative Medicine (CIRM) TR1-01249 (J.A.H., PI).
CR AAMDAL S, 1984, INT J CANCER, V34, P725, DOI 10.1002/ijc.2910340521
   AN HS, 1995, J SPINAL DISORD, V8, P131
   Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005
   [Anonymous], 2011, CLIN POLICY B, V86, P1
   Ardawi MSM, 2011, J BONE MINER RES, V26, P2812, DOI 10.1002/jbmr.479
   Badrinath R, 2014, SPINE J, V14, P990, DOI 10.1016/j.spinee.2013.10.021
   Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074
   Belthur MV, 2008, CLIN ORTHOP RELAT R, V466, P2973, DOI 10.1007/s11999-008-0538-3
   Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Borazjani BH, 2006, J BONE JOINT SURG AM, V88A, P1934, DOI 10.2106/JBJS.E.00992
   Bouxsein ML, 1997, J BONE MINER RES, V12, P839, DOI 10.1359/jbmr.1997.12.5.839
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154
   CEVC G, 1991, BIOCHEMISTRY-US, V30, P7186, DOI 10.1021/bi00243a021
   Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110
   Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547
   Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37
   Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011
   Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388
   Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174
   Dhamdhere GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083650
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215
   Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004
   Fu QA, 2011, ADV FUNCT MATER, V21, P1058, DOI 10.1002/adfm.201002030
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Glassman SD, 2007, SPINE J, V7, P547, DOI 10.1016/j.spinee.2006.11.003
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Gstraunthaler G, 2013, CYTOTECHNOLOGY, V65, P791, DOI 10.1007/s10616-013-9633-8
   Harvey N, 2014, J BONE MINER RES, V29, P1917, DOI 10.1002/jbmr.2286
   Hernigou P, 1997, J BONE JOINT SURG AM, V79A, P1047, DOI 10.2106/00004623-199707000-00011
   Institute NC, AN MOD
   Jain A, 2013, J BONE JOINT SURG AM, V95A, P1265, DOI [10.2106/JBJS.L01118, 10.2106/JBJS.L.01118]
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Kim HT, 2008, CLIN ORTHOP RELAT R, V466, P1819, DOI 10.1007/s11999-008-0304-6
   Kim IC, 2013, J KOREAN NEUROSURG S, V54, P323, DOI 10.3340/jkns.2013.54.4.323
   Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802
   Koerner JD, 2013, SPINE J, V13, P22, DOI 10.1016/j.spinee.2012.11.030
   Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793
   Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100
   Kulisic SM, 2008, ACTA DERMATOVENER CR, V16, P55
   Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298
   Leucht P, 2013, J BONE JOINT SURG AM, V95A, P1278, DOI [10.2106/JBJS.L01502, 10.2106/JBJS.L.01502]
   Li G, 2008, SPINE, V33, P1250, DOI 10.1097/BRS.0b013e3181714a44
   Li H, 2000, Clin Implant Dent Relat Res, V2, P110, DOI 10.1111/j.1708-8208.2000.tb00113.x
   Li J, 2011, CHINESE J CANCER RES, V23, P43, DOI 10.1007/s11670-011-0043-1
   LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227
   Liu B, 2014, J DENT RES, V93, P475, DOI 10.1177/0022034514528211
   Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Miclea RL, 2010, J BONE MINER RES, V25, P2348, DOI 10.1002/jbmr.153
   Minear S, 2010, SCI TRANSL MED, V2, DOI DOI 10.1126/SCITRANSLMED.3000231
   Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Moore ST, 2011, J BIOMATER APPL, V26, P151, DOI 10.1177/0885328210366061
   Morrell NT, 2008, PLOS ONE, V3, pe2930
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311
   Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513
   Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528
   Office AE, 2007, AM ASS TISS BANKS AC
   Pape HC, 2010, J ORTHOP TRAUMA, V24, pS36, DOI 10.1097/BOT.0b013e3181cec4a1
   Piccin D, 2010, DIS MODEL MECH, V3, P421, DOI 10.1242/dmm.003137
   Porter RM, 2009, J ORTHOP RES, V27, P42, DOI 10.1002/jor.20715
   Roforth MM, 2014, BONE, V59, P1, DOI 10.1016/j.bone.2013.10.019
   ROLSTON JLL, 1972, ARCH NEUROL-CHICAGO, V26, P258, DOI 10.1001/archneur.1972.00490090084007
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Sagi HC, 2012, J BONE JOINT SURG AM, V94A, P2128, DOI 10.2106/JBJS.L.00159
   Schmidmaier G, 2006, BONE, V39, P1156, DOI 10.1016/j.bone.2006.05.023
   Sevens MM., 2008, MATER TODAY, V11, P18
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   STRATES BS, 1988, AM J MED SCI, V296, P266, DOI 10.1016/S0002-9629(15)40860-2
   Swenson CL, 2003, J BONE JOINT SURG AM, V85A, P323, DOI 10.2106/00004623-200302000-00021
   SZOT GL, 2007, JOVE-J VIS EXP, V9, P404, DOI DOI 10.3791/404
   van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023
   Whyte JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076883
   Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
   Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x
   Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002
   Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5
   Zwingenberger S, 2012, BIODRUGS, V26, P245, DOI 10.2165/11631680-000000000-00000
NR 86
TC 17
Z9 18
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 47
BP 29
EP 40
DI 10.1016/j.biomaterials.2014.12.014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7DN
UT WOS:000350528000004
PM 25682158
DA 2018-10-19
ER

PT J
AU Zhao, FH
   Vaughan, TJ
   Mcnamara, LM
AF Zhao, Feihu
   Vaughan, Ted J.
   Mcnamara, Laoise M.
TI Multiscale fluid-structure interaction modelling to determine the
   mechanical stimulation of bone cells in a tissue engineered scaffold
SO BIOMECHANICS AND MODELING IN MECHANOBIOLOGY
LA English
DT Article
DE Fluid-structure interaction; Multiscale modelling; Osteoblast; Tissue
   engineered scaffold
ID MARROW STROMAL CELLS; FLOW PERFUSION BIOREACTOR; SHEAR-STRESS;
   OSTEOGENIC DIFFERENTIATION; MATRIX DEPOSITION; IN-VITRO; OSTEOBLASTS;
   OSTEOCYTES; DESIGN; MECHANOTRANSDUCTION
AB Recent studies have shown that mechanical stimulation, by means of flow perfusion and mechanical compression (or stretching), enhances osteogenic differentiation of mesenchymal stem cells and bone cells within biomaterial scaffolds in vitro. However, the precise mechanisms by which such stimulation enhances bone regeneration is not yet fully understood. Previous computational studies have sought to characterise the mechanical stimulation on cells within biomaterial scaffolds using either computational fluid dynamics or finite element (FE) approaches. However, the physical environment within a scaffold under perfusion is extremely complex and requires a multiscale and multiphysics approach to study the mechanical stimulation of cells. In this study, we seek to determine the mechanical stimulation of osteoblasts seeded in a biomaterial scaffold under flow perfusion and mechanical compression using multiscale modelling by two-way fluid-structure interaction and FE approaches. The mechanical stimulation, in terms of wall shear stress (WSS) and strain in osteoblasts, is quantified at different locations within the scaffold for cells of different attachment morphologies (attached, bridged). The results show that 75.4 % of scaffold surface has a WSS of 0.1-10 mPa, which indicates the likelihood of bone cell differentiation at these locations. For attached and bridged osteoblasts, the maximum strains are 397 and 177,200 , respectively. Additionally, the results from mechanical compression show that attached cells are more stimulated ( ) than bridged cells ( ). Such information is important for understanding the biological response of osteoblasts under in vitro stimulation. Finally, a combination of perfusion and compression of a tissue engineering scaffold is suggested for osteogenic differentiation.
C1 [Zhao, Feihu; Vaughan, Ted J.; Mcnamara, Laoise M.] Natl Univ Ireland, Coll Engn & Informat, Biomechan Res Ctr BMEC, Biomed Engn, Galway, Ireland.
RP Mcnamara, LM (reprint author), Natl Univ Ireland, Coll Engn & Informat, Biomechan Res Ctr BMEC, Biomed Engn, Galway, Ireland.
EM laoise.mcnamara@nuigalway.ie
RI Zhao, Feihu/R-9699-2017
OI Zhao, Feihu/0000-0003-0515-6808; McNamara, Laoise/0000-0002-5050-9230
FU European Research Council (ERC) [258992]
FX The authors would like to acknowledge the funding provided by the
   European Research Council (ERC) under Grant Number 258992 (BONEMECHBIO).
   In addition, the first author wishes to express his gratitude to Dr. S.
   W. Verbruggen (Biomedical Engineering, National University of Ireland,
   Galway) for his help with model generation.
CR Adachi T, 2009, J BIOMECH, V42, P1989, DOI 10.1016/j.jbiomech.2009.04.034
   Anderson EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-27
   Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138
   Ban Y, 2011, TISSUE CELL, V43, P311, DOI 10.1016/j.tice.2011.06.003
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Birmingham E, 2013, ANN BIOMED ENG, V41, P814, DOI 10.1007/s10439-012-0714-1
   Blecha LD, 2010, J BIOMECH, V43, P933, DOI 10.1016/j.jbiomech.2009.11.004
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Freyman TM, 2001, EXP CELL RES, V269, P140, DOI 10.1006/excr.2001.5302
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Jaasma MJ, 2008, J BIOTECHNOL, V133, P490, DOI 10.1016/j.jbiotec.2007.11.010
   Juhasz T, 2014, CELL SIGNAL, V26, P468, DOI 10.1016/j.cellsig.2013.12.001
   Jungreuthmayer C, 2009, MED ENG PHYS, V31, P420, DOI 10.1016/j.medengphy.2008.11.003
   Keogh MB, 2011, BIOTECHNOL BIOENG, V108, P1203, DOI 10.1002/bit.23032
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   KLEINNULEND J, 1995, FASEB J, V9, P441
   Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI 10.1089/ten.TEA.2008.0540
   Li MM, 2013, ACS APPL MATER INTER, V5, P5921, DOI 10.1021/am401937m
   Liu LY, 2012, BIOMECH MODEL MECHAN, V11, P391, DOI 10.1007/s10237-011-0319-x
   Haber Y, 2013, BIOMED MICRODEVICES, V15, P1055, DOI 10.1007/s10544-013-9797-1
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   McCoy RJ, 2012, BIOTECHNOL BIOENG, V109, P1583, DOI 10.1002/bit.24424
   Milan JL, 2009, BIOMATERIALS, V30, P4219, DOI 10.1016/j.biomaterials.2009.04.026
   Olivares AL, 2009, BIOMATERIALS, V30, P6142, DOI 10.1016/j.biomaterials.2009.07.041
   Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810
   Park SH, 2012, J MATER SCI-MATER M, V23, P2671, DOI 10.1007/s10856-012-4738-8
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Ryan G, 2009, J BIOMED MATER RES B, V90B, P894, DOI 10.1002/jbm.b.31361
   Samavedi S, 2012, BIOMATERIALS, V33, P7727, DOI 10.1016/j.biomaterials.2012.07.008
   Seliktar D, 2002, Google Patents, Patent No. [EP1019489 A4, 1019489]
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Sittichockechaiwut A, 2009, BONE, V44, P822, DOI 10.1016/j.bone.2008.12.027
   Stops AJF, 2010, J MECH BEHAV BIOMED, V3, P292, DOI 10.1016/j.jmbbm.2009.12.003
   Stops AJF, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979873
   Sugawara Y, 2008, BONE, V43, P19, DOI 10.1016/j.bone.2008.02.020
   Thompson MS, 2010, P I MECH ENG H, V224, P1533, DOI 10.1243/09544119JEIM807
   Vaughan TJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0900
   Verbruggen SW, 2014, BIOMECH MODEL MECHAN, V13, P85, DOI 10.1007/s10237-013-0487-y
   Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286
   Vozzi G, 2014, J BIOMED MATER RES A, V102, P1415, DOI 10.1002/jbm.a.34823
   Westbroek I, 2000, BIOCHEM BIOPH RES CO, V268, P414, DOI 10.1006/bbrc.2000.2154
   Xie L, 2013, STEM CELL REV REP, V9, P858, DOI 10.1007/s12015-013-9456-1
   You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161
   Yourek G, 2010, REGEN MED, V5, P713, DOI [10.2217/rme.10.60, 10.2217/RME.10.60]
NR 45
TC 16
Z9 18
U1 3
U2 36
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1617-7959
EI 1617-7940
J9 BIOMECH MODEL MECHAN
JI Biomech. Model. Mechanobiol.
PD APR
PY 2015
VL 14
IS 2
BP 231
EP 243
DI 10.1007/s10237-014-0599-z
PG 13
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA CD1YQ
UT WOS:000350871000003
PM 24903125
DA 2018-10-19
ER

PT J
AU Araujo, MG
   da Silva, JCC
   de Mendonca, AF
   Lindhe, J
AF Araujo, Mauricio G.
   Costa da Silva, Joao Carlos
   de Mendonca, Arthur Furtado
   Lindhe, Jan
TI Ridge alterations following grafting of fresh extraction sockets in man.
   A randomized clinical trial
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; bone formation; extraction socket; grafting; humans;
   xenograft
ID BEAM COMPUTED-TOMOGRAPHY; COMPLETE DENTURE WEARERS; FACIAL BONE WALL;
   IMPLANT PLACEMENT; TOOTH EXTRACTION; BIO-OSS(R) COLLAGEN; DOG;
   PRESERVATION; MAXILLA; REDUCTION
AB ObjectiveTo evaluate dimensional alterations of the alveolar ridge that occurred following tooth extraction at sites grafted with Bio-Oss((R)) Collagen.
   Material and methodsTwenty-eight subjects with maxillary incisors, canines, and premolars scheduled for extraction were included. The tooth was carefully removed. The patients were randomly assigned to a test or a control group. In the test group patients, Bio-Oss((R)) Collagen was placed in the fresh extraction socket while in the controls no grafting was performed. Radiographic examination (cone beam computed tomograms, CBCT) was performed immediately after tooth extraction and socket treatment. Four months later, a new CBCT was obtained. In the radiographs, (i) the distance (mm) between base of the alveolar process (apex) and the buccal and palatal crests was determined, (ii) the outer profile of alveolar process of the experimental sites was outlined, and the cross section of the area (mm(2)) determined.
   ResultsAfter 4months of healing, the buccal and to a less extent also the palatal bone plate had become markedly reduced in height. The placement of a biomaterial in the socket failed to prevent resorption of the buccal and palatal bone walls. The cross-sectional area of the control ridge was reduced about 25% and of the test ridge with 3%.
   ConclusionThe placement of a xenograft in fresh extraction sockets markedly counteracted the reduction in the hard tissue component of the edentulous sites.
C1 [Araujo, Mauricio G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [de Mendonca, Arthur Furtado] Univ Estado Rio De Janeiro, Dept Prosthodont, Rio De Janeiro, Brazil.
   [Lindhe, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim 15,Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
OI Furtado de Mendonca, Arthur/0000-0002-4855-3435
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   ATWOOD DA, 1971, J PROSTHET DENT, V26, P266, DOI 10.1016/0022-3913(71)90069-2
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   BERGMAN B, 1985, J PROSTHET DENT, V53, P56, DOI 10.1016/0022-3913(85)90066-6
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Braut V, 2011, INT J PERIODONT REST, V31, P125
   CARLSSON GE, 1967, ACTA ODONTOL SCAND, V25, P1
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P186
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   Ghassemian M, 2012, J PERIODONTOL, V83, P187, DOI 10.1902/jop.2011.110172
   Huynh-Ba G, 2010, CLIN ORAL IMPLAN RES, V21, P37, DOI 10.1111/j.1600-0501.2009.01870.x
   Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x
   JOHNSON K, 1969, Australian Dental Journal, V14, P241
   Johnson K, 1963, AUST DENT J, V8, P428
   Jung R. E., 2013, J CLIN PERIODONTOL, V40, P2013
   Lindhe J, 2014, CLIN ORAL IMPLAN RES, V25, P786, DOI 10.1111/clr.12170
   Mardas N, 2010, CLIN ORAL IMPLAN RES, V21, P688, DOI 10.1111/j.1600-0501.2010.01918.x
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Sahlin-Platt A., 2011, SERIES UMEA U, V119
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   Schroeder HE, 1986, THE PERIODONTIUM
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   TALLGREN A, 1972, J PROSTHET DENT, V27, P120, DOI 10.1016/0022-3913(72)90188-6
   TALLGREN A, 1966, Acta Odontologica Scandinavica, V24, P195, DOI 10.3109/00016356609026127
   TALLGREN ANTJE, 1957, ACTA ODONTOL SCAND, V15, P1
   Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x
   Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
NR 36
TC 51
Z9 53
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2015
VL 26
IS 4
BP 407
EP 412
DI 10.1111/clr.12366
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CD0IT
UT WOS:000350755400019
PM 24621203
DA 2018-10-19
ER

PT J
AU Barwacz, CA
   Brogden, KA
   Stanford, CM
   Dawson, DV
   Recker, EN
   Blanchette, D
AF Barwacz, Christopher A.
   Brogden, Kim A.
   Stanford, Clark M.
   Dawson, Deborah V.
   Recker, Erica N.
   Blanchette, Derek
TI Comparison of pro-inflammatory cytokines and bone metabolism mediators
   around titanium and zirconia dental implant abutments following a
   minimum of 6 months of clinical function
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial(s); cytokine(s); dental abutments; oral
   implants/implantology; titanium; zirconium oxide
ID GINGIVAL CREVICULAR FLUID; NECROSIS-FACTOR-ALPHA; PERI-IMPLANTITIS;
   PROINFLAMMATORY CYTOKINES; PERIODONTAL HEALTH; TNF-ALPHA; LEPTIN;
   OSTEOPONTIN; PARAMETERS; IL-1-BETA
AB ObjectivesDental implant abutments are fundamental prosthetic components within dentistry that require optimal biocompatibility. The primary aim of this cross-sectional study was to preliminarily assess differences in the pro-inflammatory cytokine and bone metabolism mediator protein expression in the peri-implant crevicular fluid (PICF) adjacent to transmucosal abutments.
   Material and MethodsAbutments were fabricated from either titanium or zirconia in patients previously receiving single-tooth implant therapy. All subjects sampled in this study had an identical implant system and implant-abutment connection. Participants (n=46) had an average time of clinical function for 22months (6.2-72.8months, SD 17months) and received a clinical and radiographic examination of the implant site at the time of PICF sampling using a paper strip-based sampling technique. Cytokine, chemokine, and bone metabolism mediator quantities (picograms/30s) were determined using a commercial 22-multiplexed fluorescent bead-based immunoassay instrument. A total of 19 pro-inflammatory cytokines and seven bone metabolism mediators were evaluated.
   ResultsMultivariable analyses provided no evidence of a group (titanium or zirconia), gender, or age effect with regard to the expression of pro-inflammatory mediators evaluated. Significant (P=0.022) differences were observed for the bone mediator leptin, with titanium abutments demonstrating significantly elevated levels in comparison with zirconia. Osteopontin demonstrated a significant (P=0.0044) correlation with age of the subjects.
   ConclusionsNo significant differences in pro-inflammatory cytokine or bone metabolism mediator profiles were observed biochemically, with the exception of leptin, for the abutment biomaterials of titanium or zirconia The molecular PICF findings support the observed clinical biocompatibility of both titanium and zirconia abutments.
C1 [Barwacz, Christopher A.] Univ Iowa, Coll Dent, Craniofacial Clin Res Ctr, Iowa City, IA 52242 USA.
   [Brogden, Kim A.; Stanford, Clark M.; Dawson, Deborah V.; Recker, Erica N.; Blanchette, Derek] Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA.
RP Barwacz, CA (reprint author), Univ Iowa, Coll Dent, Craniofacial Clin Res Ctr, W425 Dent Sci Bldg, Iowa City, IA 52242 USA.
EM chris-barwacz@uiowa.edu
OI Blanchette, Derek/0000-0001-8591-2460
FU National Institutes of Health (NIH) [UL1 RR024979]; Astra Tech AB,
   Molndal, Sweden
FX This study was supported by the National Institutes of Health (NIH)
   Grant UL1 RR024979 and Astra Tech AB, Molndal, Sweden. The authors
   declare no potential conflict of interest with respect to the authorship
   and/or publication of this article.
CR Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413
   Andreiotelli M, 2008, QUINTESSENCE INT, V39, P289
   Ataoglu H, 2002, CLIN ORAL IMPLAN RES, V13, P470, DOI 10.1034/j.1600-0501.2002.130505.x
   Boynuegri AD, 2012, CLIN ORAL INVEST, V16, P353, DOI 10.1007/s00784-010-0497-4
   Bozkurt FY, 2006, J PERIODONTOL, V77, P634, DOI 10.1902/jop.2006.050277
   Canullo L, 2007, INT J PROSTHODONT, V20, P489
   Chang IC, 2010, OSTEOPOROSIS INT, V21, P1401, DOI 10.1007/s00198-009-1107-7
   Coen G, 2004, J NEPHROL, V17, P187
   CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   Fiorellini JP, 2000, INT J ORAL MAX IMPL, V15, P500
   HOLM S, 1979, SCAND J STAT, V6, P65
   Javed F, 2011, CYTOKINE, V53, P8, DOI 10.1016/j.cyto.2010.08.013
   Johnson RB, 2001, J PERIODONTOL, V72, P1254, DOI 10.1902/jop.2000.72.9.1254
   Karthikeyan BV, 2007, J CLIN PERIODONTOL, V34, P467, DOI 10.1111/j.1600-051X.2007.01078.x
   Kido J, 2001, J PERIODONTAL RES, V36, P328, DOI 10.1034/j.1600-0765.2001.360509.x
   Lachmann S, 2007, CLIN ORAL IMPLAN RES, V18, P212, DOI 10.1111/j.1600-0501.2006.01322.x
   LOWNEY JJ, 1995, AM J ORTHOD DENTOFAC, V108, P519, DOI 10.1016/S0889-5406(95)70052-8
   Machtei EE, 2006, CLIN ORAL IMPLAN RES, V17, P658, DOI 10.1111/j.1600-0501.2006.01282.x
   Murata M, 2002, CLIN ORAL IMPLAN RES, V13, P637, DOI 10.1034/j.1600-0501.2002.130610.x
   Norton Michael R, 2002, Compend Contin Educ Dent, V23, P21
   Nothdurft F, 2010, CLIN ORAL IMPLAN RES, V21, P857, DOI 10.1111/j.1600-0501.2009.01899.x
   Nowzari H, 2008, CLIN IMPLANT DENT R, V10, P166, DOI 10.1111/j.1708-8208.2007.00076.x
   Nowzari H, 2012, CLIN IMPLANT DENT R, V14, P546, DOI 10.1111/j.1708-8208.2010.00299.x
   Petkovic AB, 2010, INT J ORAL MAX SURG, V39, P478, DOI 10.1016/j.ijom.2010.01.014
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Salvi GE, 2012, CLIN ORAL IMPLAN RES, V23, P182, DOI 10.1111/j.1600-0501.2011.02220.x
   Schierano G, 2008, J CLIN PERIODONTOL, V35, P532, DOI 10.1111/j.1600-051X.2008.01224.x
   Seuerino VO, 2011, ARCH ORAL BIOL, V56, P823, DOI 10.1016/j.archoralbio.2011.01.006
   Shapses SA, 2003, CALCIFIED TISSUE INT, V73, P86, DOI 10.1007/s00223-002-1090-x
   Sharma CG, 2007, J PERIODONTAL RES, V42, P450, DOI 10.1111/j.1600-0765.2007.00968.x
   Stanford CM, 1999, ADV DENT RES, V13, P88
   Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1
   Thomas T, 2003, JOINT BONE SPINE, V70, P18, DOI 10.1016/S1297-319X(02)00005-2
   Zeadin MG, 2012, BIOCHEM BIOPH RES CO, V425, P924, DOI 10.1016/j.bbrc.2012.08.011
   Zembic A, 2013, CLIN ORAL IMPLAN RES, V24, P384, DOI 10.1111/clr.12044
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhou XH, 2005, BIOSTATISTICS, V6, P187, DOI 10.1093/biostatistics/kxi002
NR 38
TC 7
Z9 7
U1 3
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2015
VL 26
IS 4
BP e35
EP e41
DI 10.1111/clr.12326
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CD0IT
UT WOS:000350755400006
PM 24417614
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Charles, LF
   Woodman, JL
   Ueno, D
   Gronowicz, G
   Hurley, MM
   Kuhn, LT
AF Charles, Lyndon F.
   Woodman, Jessica L.
   Ueno, Daisuke
   Gronowicz, Gloria
   Hurley, Marja M.
   Kuhn, Liisa T.
TI Effects of low dose FGF-2 and BMP-2 on healing of calvarial defects in
   old mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL
   STEM-CELLS; COLLOIDAL GELATIN GELS; AGE-RELATED-CHANGES; OSTEOBLASTIC
   DIFFERENTIATION; OSTEOINDUCTIVE ACTIVITY; STROMAL CELLS; UP-REGULATION;
   SPINE FUSION
AB There is an age-associated reduction in the bone healing activity of bone morphogenetic protein-2 (BMP-2) that is currently addressed by administering higher doses of BMP-2 in elderly patients. The unwanted medical complications from high dose BMP-2 motivated this investigation to determine whether the addition of a low dose of fibroblast growth factor 2 (FGF-2) could enhance the ability of a lower dose of BMP-2 to heal calvarial bone defects in old mice (18-20 months old). FGF-2 (5 ng) and BMP-2 (2 mu g) were administered by a controlled release two-phase biomaterial scaffold placed into the bone defect. FGF-2 released more rapidly and completely in vitro than BMP-2 (40% vs 2%). In vivo, both BMP-2 and FGF-2 + BMP-2 groups formed more new bone in calvarial defects than scaffold alone (p < 0.001) or FGF-2 only groups (p < 0.01). The overall total volume of new bone was not statistically increased by the addition of FGF-2 to BMP-2 as measured by microCT, but the pattern of bone deposition was different. In old mice, but not young, there was enhanced bony fill in the central bone defect area when the BMP-2 was supplemented with FGF-2. Histological analysis of the center of the defect revealed an increased bone volume (%BV/TV (p = 0.004)) from the addition of FGF-2. These studies suggest that combining a low dose of FGF-2 with a low dose of BMP-2 has the potential to increase bone healing in old mice relative to BMP-2 alone. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Charles, Lyndon F.; Woodman, Jessica L.; Kuhn, Liisa T.] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06030 USA.
   [Ueno, Daisuke] Tsurumi Univ, Sch Dent Med, Unit Oral & Maxillofacial Implantol, Yokohama, Kanagawa, Japan.
   [Gronowicz, Gloria] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT 06030 USA.
   [Hurley, Marja M.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.
RP Kuhn, LT (reprint author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, MC1615,263 Farmington Ave, Farmington, CT 06030 USA.
EM lkuhn@uchc.edu
OI Gronowicz, Gloria/0000-0001-7158-3598
FU International Team for Implantology (ITI; Basel, Switzerland)
   [348/2004]; National Institute of Dental & Craniofacial Research of the
   National Institutes of Health [R01DE021103]
FX Research reported in this publication was supported by the International
   Team for Implantology (ITI; Basel, Switzerland) grant # 348/2004 and the
   National Institute of Dental & Craniofacial Research of the National
   Institutes of Health under award number R01DE021103. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health. The
   authors would like to thank Dr. Qin Amy Wang, Dr. Jin Pan, and Dr.
   Roberta Kelm for assistance in conducting animal surgeries. We would
   also like to acknowledge Dr. Doug Adams and the MicroCT Imaging Facility
   at the UConn Health Center for the microCT imaging and Dr. James Grady,
   UCONN Health Center for help with the statistical analysis. The
   nonglycosylated human recombinant BMP-2 was kindly provided by Dr. Peter
   Hortschansky from the Hans Knoll Institute, Jena, Germany and the
   PEG-hydrogel was kindly provided by Institut Straumann.
CR Aalami OO, 2004, PLAST RECONSTR SURG, V114, P713, DOI 10.1097/01.PRS.0000131016.12754.30
   Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008
   Bergman RJ, 1996, J BONE MINER RES, V11, P568
   CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Chen WJ, 2004, J BONE MINER METAB, V22, P303, DOI 10.1007/s00774-004-0487-6
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003
   Farhadi J, 2005, PLAST RECONSTR SURG, V116, P1379, DOI 10.1097/01.prs.0000182355.67397.5a
   Fujimura K, 2002, ARCH ORAL BIOL, V47, P577, DOI 10.1016/S0003-9969(02)00046-8
   Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0
   GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Hak DJ, 2006, J ORTHOP RES, V24, P11, DOI 10.1002/jor.20022
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   Heersche JNM, 1998, J PROSTHET DENT, V79, P14, DOI 10.1016/S0022-3913(98)70187-8
   Howell T. H., 1997, INT J PERIODONT REST, V17, P124
   Jeon E, 2009, PROTEIN PEPTIDE LETT, V16, P664, DOI 10.2174/092986609788490267
   Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x
   Kakudo N, 2006, WOUND REPAIR REGEN, V14, P336, DOI 10.1111/j.1743-6109.2006.00129.x
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   King WJ, 2010, J BIOMED MATER RES A, V93A, P1110, DOI 10.1002/jbm.a.32601
   Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017
   Kotev-Emeth S, 2000, BONE, V27, P777, DOI 10.1016/S8756-3282(00)00389-6
   Kuhn LT, 2013, J GERONTOL A-BIOL, V68, P1170, DOI 10.1093/gerona/glt018
   Luong LN, 2012, BIOMATERIALS, V33, P283, DOI 10.1016/j.biomaterials.2011.09.052
   Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41
   Marie PJ, 2012, GROWTH FACTORS, V30, P117, DOI 10.3109/08977194.2012.656761
   Minamide A, 2007, SPINE, V32, P1067, DOI 10.1097/01.brs.0000261626.32999.8a
   Nadon NL, 2006, AGING CELL, V5, P9, DOI 10.1111/j.1474-9726.2006.00185.x
   Naganawa T, 2008, J CELL BIOCHEM, V103, P1975, DOI 10.1002/jcb.21589
   Nakamura Y, 2005, BONE, V36, P399, DOI 10.1016/j.bone.2004.11.010
   Ono I, 1996, J CRANIOFAC SURG, V7, P418, DOI 10.1097/00001665-199611000-00006
   Ou GM, 2010, J GERONTOL A-BIOL, V65, P1051, DOI 10.1093/gerona/glq114
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Singhatanadgit W, 2006, J CELL PHYSIOL, V209, P912, DOI 10.1002/jcp.20799
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   Tanaka E, 2006, ANN BIOMED ENG, V34, P717, DOI 10.1007/s10439-006-9092-x
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   VARKEY M, 2006, CLIN ORTHOP RELA FEB, P113, DOI DOI 10.1097/01.BLO.0000200236.84189.87
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Wang J, 2014, J BIOMED MATER RES A, V102, P4234, DOI 10.1002/jbm.a.35102
   Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8
   Wen B, 2011, J BIOMED MATER RES B, V97B, P315, DOI 10.1002/jbm.b.31817
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   Zhang H, 2004, J ORTHOPAED RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4
NR 50
TC 17
Z9 18
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2015
VL 64
BP 62
EP 69
DI 10.1016/j.exger.2015.02.006
PG 8
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA CD1CZ
UT WOS:000350812800008
PM 25681640
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Munirathinam, B
   Neelakantan, L
AF Munirathinam, Balakrishnan
   Neelakantan, Lakshman
TI Titania nanotubes from weak organic acid electrolyte: Fabrication,
   characterization and oxide film properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titanium; Anodic oxidation; TiO2 nanotubes; Wettability; Impedance; Mott
   Schottky analysis
ID TIO2 NANOTUBES; HYDROPHILIC PROPERTIES; THIN-FILMS; ARRAYS; ANODIZATION;
   ANATASE; GROWTH; SEMICONDUCTOR; BIOMATERIAL; DIMENSIONS
AB In this study, TiO2 nanotubes were fabricated using anodic oxidation in fluoride containing weak organic add for different durations (0.5 h, 1 h, 2 h and 3 h). Scanning electron microscope (SEM) micrographs reveal that the morphology of titanium oxide varies with anodization time. Raman spectroscopy and X-ray diffraction (XRD) results indicate that the as-formed oxide nanotubes were amorphous in nature, yet transform into crystalline phases (anatase and rutile) upon annealing at 600 degrees C. Wettability measurements show that both as-formed and annealed nanotubes exhibited hydrophilic behavior. The electrochemical behavior was ascertained by DC polarization and AC electrochemical impedance spectroscopy (EIS) measurements in 0.9% NaCl solution. The results suggest that the annealed nanotubes showed higher impedance (10(5)-10(6) Omega cm(2)) and lower passive current density (10(-7) A cm(-2)) than the as-formed nanotubes. In addition, we investigated the influence of post heat treatment on the semiconducting properties of the oxides by capacitance measurements. In vitro bioactivity test in simulated body fluid (SBF) showed that precipitation of Ca/P is easier in crystallized nanotubes than the amorphous structure. Our study uses a simple strategy to prepare nano-structured titania films and hints the feasibility of tailoring the oxide properties by thermal treatment, producing surfaces with better bioactivity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Munirathinam, Balakrishnan; Neelakantan, Lakshman] Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
RP Munirathinam, B (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM blkrish88@gmail.com
OI Neelakantan, Lakshman/0000-0001-6837-1228; Munirathinam,
   Balakrishnan/0000-0002-7499-6424
CR Acevedo-Pena P., 2014, ELECTROCHIM ACTA
   Ainouche L, 2014, ELECTROCHIM ACTA, V133, P597, DOI 10.1016/j.electacta.2014.04.086
   Balakrishnan M, 2013, THIN SOLID FILMS, V540, P23, DOI 10.1016/j.tsf.2013.05.122
   Balaur E, 2005, J MATER CHEM, V15, P4488, DOI 10.1039/b509672c
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Caliskan N, 2014, MAT SCI ENG C-MATER, V35, P100, DOI 10.1016/j.msec.2013.10.033
   CHENG HM, 1995, CHEM MATER, V7, P663, DOI 10.1021/cm00052a010
   Hahn R, 2007, ELECTROCHEM COMMUN, V9, P947, DOI 10.1016/j.elecom.2006.11.037
   Jiang ZL, 2011, MATER CHEM PHYS, V126, P859, DOI 10.1016/j.matchemphys.2010.12.028
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEACH JSL, 1988, CORROS SCI, V28, P43, DOI 10.1016/0010-938X(88)90005-4
   Liu QJ, 2002, MATER RES BULL, V37, P2255, DOI 10.1016/S0025-5408(02)00972-8
   Marcus P, 1998, ELECTROCHIM ACTA, V43, P109, DOI 10.1016/S0013-4686(97)00239-9
   Narayanan R, 2009, MATER CHEM PHYS, V117, P460, DOI 10.1016/j.matchemphys.2009.06.023
   Narayanan R., 2005, THESIS IIT MADRAS IN
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Oh S, 2011, MAT SCI ENG C-MATER, V31, P873, DOI 10.1016/j.msec.2011.02.004
   Petersson IU, 2009, BIOMATERIALS, V30, P4471, DOI 10.1016/j.biomaterials.2009.05.042
   Qu DY, 2003, ELECTROCHIM ACTA, V48, P1675, DOI 10.1016/S0013-4686(03)00146-4
   Reclaru L, 2003, BIOMATERIALS, V24, P3027, DOI 10.1016/S0142-9612(03)00145-5
   Regonini D, 2010, SURF INTERFACE ANAL, V42, P139, DOI 10.1002/sia.3183
   Regonini D., 2008, THESIS U BATH UK
   Roman I, 2014, MAT SCI ENG C-MATER, V37, P374, DOI 10.1016/j.msec.2014.01.036
   Schmidt-Stein F, 2010, ACTA MATER, V58, P6317, DOI 10.1016/j.actamat.2010.07.053
   Sikora E, 1996, ELECTROCHIM ACTA, V41, P783, DOI 10.1016/0013-4686(95)00312-6
   SPURR RA, 1957, ANAL CHEM, V29, P760, DOI 10.1021/ac60125a006
   Sulka GD, 2010, ELECTROCHIM ACTA, V55, P4359, DOI 10.1016/j.electacta.2009.12.053
   Sunil BR, 2013, MAT SCI ENG C-MATER, V33, P1607, DOI 10.1016/j.msec.2012.12.095
   TOMKIEWICZ M, 1990, ELECTROCHIM ACTA, V35, P1631, DOI 10.1016/0013-4686(90)80019-K
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Venkateswarlu K, 2013, ELECTROCHIM ACTA, V105, P468, DOI 10.1016/j.electacta.2013.05.032
   Xie ZB, 2010, ELECTROCHIM ACTA, V56, P905, DOI 10.1016/j.electacta.2010.10.004
   Xiong JY, 2012, THIN SOLID FILMS, V526, P116, DOI 10.1016/j.tsf.2012.11.027
   Yahia SAA, 2012, J ELECTROCHEM SOC, V159, pK83, DOI 10.1149/2.077204jes
   Yang B, 2011, MATER CHEM PHYS, V130, P1227, DOI 10.1016/j.matchemphys.2011.08.063
   Yang WH, 2014, MAT SCI ENG C-MATER, V34, P410, DOI 10.1016/j.msec.2013.09.042
   Ye Q, 2007, VACUUM, V81, P627, DOI 10.1016/j.vacuum.2006.09.001
   Zhang XY, 2001, CHEM MATER, V13, P2511, DOI 10.1021/cm0007297
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 40
TC 14
Z9 15
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 567
EP 578
DI 10.1016/j.msec.2015.01.045
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100066
PM 25686985
DA 2018-10-19
ER

PT J
AU Kanungo, I
   Chellappa, N
   Fathima, NN
AF Kanungo, Ivy
   Chellappa, Nisha
   Fathima, Nishter Nishad
TI Microfabrication of gelatin-polycaprolactone composites for customized
   drug delivery
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Gelatin; Polycaprolactone; Biomaterial; Thermoporometry; Drug delivery
ID DIFFERENTIAL SCANNING CALORIMETRY; PORE-SIZE DISTRIBUTION;
   THERMOPOROMETRY
AB Dynamic properties of water molecules present in the vicinity of protein are sensitive to its local conformational motions. Water mobility at the protein surface/interfaces is affected by its polar and charged groups, which are capable of anchoring water molecules through H-bonds. Differential scanning calorimetry, ATR-FTIR spectroscopy and circular dichroic analysis have been employed to substantiate the changes in hydration of gelatin, interacting with polycaprolactone. Enthalpy of denaturation and decrease in melting temperature indicate alteration in water-bridges around gelatin. In vitro drug release studies substantiate the influence of hydration on its release kinetics. These studies would aid in exploration of potential drug carrier. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kanungo, Ivy; Chellappa, Nisha; Fathima, Nishter Nishad] Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Madras 600020, Tamil Nadu, India.
EM nishad@clri.res.in
FU DST Fast Track project [SR/FTP/ETA-0063/2011]
FX The authors thank DST Fast Track project (SR/FTP/ETA-0063/2011) for
   funding this work.
CR AppaRao B., 2010, INT J PHARM BIOMED R, V1, P90
   Chen KY, 2011, BIOMEDICINE-TAIWAN, V1, P29, DOI 10.1016/j.biomed.2011.10.005
   Chiari C, 2006, OSTEOARTHR CARTILAGE, V14, P1056, DOI 10.1016/j.joca.2006.04.007
   Chong SH, 2012, J CHEM THEORY COMPUT, V8, P724, DOI 10.1021/ct200757a
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Huggins DJ, 2011, J CHEM THEORY COMPUT, V7, P3514, DOI 10.1021/ct200465z
   Kanungo I, 2013, MAT SCI ENG C-MATER, V33, P4651, DOI 10.1016/j.msec.2013.07.020
   Kanungo I, 2013, MATER CHEM PHYS, V140, P357, DOI 10.1016/j.matchemphys.2013.03.049
   Kanungo I, 2011, INT J BIOL MACROMOL, V49, P289, DOI 10.1016/j.ijbiomac.2011.05.003
   Lamson D W, 2000, Altern Med Rev, V5, P196
   Landry MR, 2005, THERMOCHIM ACTA, V433, P27, DOI 10.1016/j.tca.2005.02.015
   Manikoth R, 2012, CARBOHYD POLYM, V88, P628, DOI 10.1016/j.carbpol.2012.01.031
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Perez-Mateos M, 2005, J SCI FOOD AGR, V85, P1651, DOI 10.1002/jsfa.2164
   Prouzet E, 2010, J PHYS CHEM B, V114, P8081, DOI 10.1021/jp101176v
   Ramamourthy G., 2012, INT J MOL SCI, V13, P3229
   Rattanaruengsrikul V, 2009, MACROMOL BIOSCI, V9, P1004, DOI 10.1002/mabi.200900131
   Riikonen J, 2009, J PHYS CHEM C, V113, P20349, DOI 10.1021/jp908580w
   Safinia L, 2006, LANGMUIR, V22, P3235, DOI 10.1021/la051762g
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Taguchi T, 2009, J BIOACT COMPAT POL, V24, P546, DOI 10.1177/0883911509349688
   Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t
   Woody R.W., 1996, CIRCULAR DICHROISM C
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Xu W, 2008, J BIOACT COMPAT POL, V23, P409, DOI 10.1177/0883911508095517
   Yamamoto T, 2005, J COLLOID INTERF SCI, V284, P614, DOI 10.1016/j.jcis.2004.10.025
   Zaman HU, 2011, J MECH BEHAV BIOMED, V4, P1369, DOI 10.1016/j.jmbbm.2011.05.007
   ZHADAN GG, 1994, BIOCHEM J, V299, P731, DOI 10.1042/bj2990731
NR 31
TC 2
Z9 2
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 597
EP 603
DI 10.1016/j.msec.2015.01.058
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100069
PM 25686988
DA 2018-10-19
ER

PT J
AU Mohammadkhah, A
   Marquardt, LM
   Sakiyama-Elbert, SE
   Day, DE
   Harkins, AB
AF Mohammadkhah, Ali
   Marquardt, Laura M.
   Sakiyama-Elbert, Shelly E.
   Day, Delbert E.
   Harkins, Amy B.
TI Fabrication and characterization of poly-(epsilon)-caprolactone and
   bioactive glass composites for tissue engineering applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Borate glass; Neurite extension; Mechanical properties; Degradation
   rate; Polymer sheet
ID PERIPHERAL-NERVE REGENERATION; MECHANICAL-PROPERTIES; PHYSICOCHEMICAL
   CHARACTERIZATION; GUIDANCE CONDUITS; SILICATE 45S5; REPAIR; BORATE;
   SCAFFOLDS; GUIDES; CONVERSION
AB Much work has focused on developing synthetic materials that have tailored degradation profiles and physical properties that may prove useful in developing biomaterials for tissue engineering applications. In the present study, three different composite sheets consisting of biodegradable poly-epsilon-caprolactone (PCL) and varying types of bioactive glass were investigated. The three composites were composed of 50 wt.% PCL and (1) 50 wt.% 13-93 B3 borate glass particles, (2) 50 wt.% 45S5 silicate glass particles, or (3) a blend of 25 wt.% 13-93 B3 and 25 wt.% 45S5 glass particles. Degradation profiles determined for each composite showed the composite that contained only 13-93 B3 borate glass had a higher degradation rate compared to the composite containing only 45S5 silicate glass. Uniaxial tensile tests were performed on the composites to determine the effect of adding glass to the polymer on mechanical properties. The peak stress of all of the composites was lower than that of PCL alone, but 100% PCL had a higher stiffness when pre-reacted in cell media for 6 weeks, whereas composite sheets did not. Finally, to determine whether the composite sheets would maintain neuronal growth, dorsal root ganglia isolated from embryonic chicks were cultured on composite sheets, and neurite outgrowth was measured. The bioactive glass particles added to the composites showed no negative effects on neurite extension, and neurite extension increased on PCL:4555 PCL:13-93 B3 when pre-reacted in media for 24 h. This work shows that composite sheets of PCL and bioactive glass particles provide a flexible biomaterial for neural tissue engineering applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mohammadkhah, Ali; Day, Delbert E.] Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA.
   [Mohammadkhah, Ali; Day, Delbert E.] Missouri Univ Sci & Technol, Ctr Biomed Sci & Engn, Rolla, MO 65409 USA.
   [Marquardt, Laura M.; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Harkins, Amy B.] St Louis Univ, Dept Pharmacol & Physiol Sci, Dept Biomed Engn, St Louis, MO 63104 USA.
RP Harkins, AB (reprint author), St Louis Univ, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.
EM harkinsa@slu.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NSF [DGE-1143954]; Saint Louis University Presidential Research Fund;
   Center for Biomedical Science and Engineering at the Missouri University
   of Science and Technology
FX This work was funded in part by NSF DGE-1143954 (LMM) and a Saint Louis
   University Presidential Research Fund (ABH) and a grant from the Center
   for Biomedical Science and Engineering at the Missouri University of
   Science and Technology. The authors acknowledge the assistance of Dr.
   Scott Sell for use of his MTS Machine and critical reading of this
   manuscript. We thank Mr. Jason Papke for his research assistance.
CR Abedalwafa M, 2013, REV ADV MATER SCI, V34, P123
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Bender MD, 2004, BIOMATERIALS, V25, P1269, DOI 10.1016/j.biomaterials.2003.08.046
   Bunting S, 2005, J HAND SURG-BRIT EUR, V30B, P242, DOI 10.1016/j.jhsh.2004.11.003
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Diamanti E, 2012, MACROMOL SYMP, V321, P25, DOI 10.1002/masy.201251104
   Farole A, 2008, J ORAL MAXIL SURG, V66, P2058, DOI 10.1016/j.joms.2008.06.017
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gu YF, 2013, ACTA BIOMATER, V9, P9126, DOI 10.1016/j.actbio.2013.06.039
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Jeans LA, 2007, J PLAST RECONSTR AES, V60, P1302, DOI 10.1016/j.bjps.2006.06.014
   Ji LJ, 2015, MAT SCI ENG C-MATER, V46, P1, DOI 10.1016/j.msec.2014.09.041
   Johnson EO, 2008, INJURY, V39, pS30, DOI 10.1016/j.injury.2008.05.018
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Lee B, 2001, MICROPOR MESOPOR MAT, V50, P77, DOI 10.1016/S1387-1811(01)00437-1
   Lei B, 2013, MAT SCI ENG C-MATER, V33, P1102, DOI 10.1016/j.msec.2012.11.039
   Lei B, 2012, J BIOMED MATER RES B, V100B, P967, DOI 10.1002/jbm.b.32659
   Liang W, 2008, J NON-CRYST SOLIDS, V354, P1690, DOI 10.1016/j.jnoncrysol.2007.10.003
   Lin YN, 2014, J BIOMED MATER RES A, V102, P4491, DOI 10.1002/jbm.a.35120
   Liu X, 2013, J MATER SCI-MATER M, V24, P583, DOI 10.1007/s10856-012-4831-z
   Lloyd Andrew W, 2002, Med Device Technol, V13, P18
   Marquardt LM, 2013, J BIOMED MATER RES A, V102, P2767
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Starritt NE, 2011, LARYNGOSCOPE, V121, P1614, DOI 10.1002/lary.21868
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Takadama H., 2004, PHOS RES B, V17, P119
   Tyner Tim R, 2007, Am J Surg, V193, pe1, DOI 10.1016/j.amjsurg.2006.08.026
   van Neerven S.G.A., 2014, BIOMED RES INT, V2014, P13
   Verreck G, 2005, BIOMATERIALS, V26, P1307, DOI 10.1016/j.biomaterials.2004.04.040
   Wang SF, 2010, INT J POLYM SCI, DOI 10.1155/2010/138686
   Zhang XF, 2011, J MECH BEHAV BIOMED, V4, P1266, DOI 10.1016/j.jmbbm.2011.04.013
NR 36
TC 13
Z9 13
U1 2
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 632
EP 639
DI 10.1016/j.msec.2015.01.060
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100073
PM 25686992
DA 2018-10-19
ER

PT J
AU Gandhimathi, C
   Venugopal, JR
   Tham, AY
   Ramakrishna, S
   Kumar, SD
AF Gandhimathi, Chinnasamy
   Venugopal, Jayarama Reddy
   Tham, Allister Yingwei
   Ramakrishna, Seeram
   Kumar, Srinivasan Dinesh
TI Biomimetic hybrid nanofibrous substrates for mesenchymal stem cells
   differentiation into osteogenic cells
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE PLACL; Silk fibroin; Nanofibrous scaffolds; Nanohydroxyapatite;
   Mineralization
ID SILK FIBROIN SCAFFOLDS; GENE-EXPRESSION; IN-VITRO; COMPOSITE SCAFFOLDS;
   ENDOTHELIAL-CELLS; ASCORBIC-ACID; LIVING CELLS; BONE; GROWTH; COLLAGEN
AB Mimicking native extracellular matrix with electrospun porous bio-composite nanofibrous scaffolds has huge potential in bone tissue regeneration. The aim of this study is to fabricate porous poly(L-lactic acid)-co-poly-(epsilon-caprolactone)/silk fibroin/ascorbic acid/tetracycline hydrochloride (PLACL/SF/AA/TC) and nanohydroxyapatite (n-HA) was deposited by calcium-phosphate dipping method for bone tissue engineering (BTE). Fabricated nanofibrous scaffolds were characterized for fiber morphology, hydrophilicity, porosity, mechanical test and chemical properties by FT-IR and EDX analysis. The results showed that the fiber diameter and pore size of scaffolds observed around 228 +/- 62-320 +/- 22 nm and 1.5-6.9 mu m respectively. Resulting nanofibrous scaffolds are highly porous (87-94%) with ultimate tensile strength observed in the range of 1.51-4.86 MPa and also showed better hydrophilic properties after addition of AA, TC and n-HA. Human mesenchymal stem cells (MSCs) cultured on these bio-composite nanofibrous scaffolds and stimulated to osteogenic differentiation in the presence of AA/TC/n-HA for BTE. The cell proliferation and biomaterial interactions were studied using MTS assay, SEM and CMFDA dye exclusion methods. Osteogenic differentiation of MSCs was proven by using alkaline phosphatase activity, mineralization and double immunofluorescence staining of both CD90 and osteocalcin. The observed results suggested that the fabricated PLACL/SF/AA/TC/n-HA biocomposite hybrid nanofibrous scaffolds have good potential for the differentiation of MSCs into osteogenesis for bone tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Gandhimathi, Chinnasamy; Tham, Allister Yingwei; Kumar, Srinivasan Dinesh] Nanyang Technol Univ, Lee Kong Chian Sch Med, Cellular & Mol Epigenet Lab, Singapore, Singapore.
   [Venugopal, Jayarama Reddy; Ramakrishna, Seeram] Natl Univ Singapore, Ctr Nanofibers & Nanotechnol, Nanosc & Nanotechnol Initiat, Singapore 117548, Singapore.
RP Kumar, SD (reprint author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Cellular & Mol Epigenet Lab, Singapore, Singapore.
EM dineshkumar@ntu.edu.sg
RI Srinivasan, Dinesh Kumar/A-9872-2008
OI Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU Ministry of Education [L0412020]; Lee Kong Chian School of Medicine;
   Nanyang Technological University, Singapore
FX This work was supported by Ministry of Education Start-up Grant
   (L0412020; Srinivasan Dinesh Kumar), Lee Kong Chian School of Medicine,
   and Nanyang Technological University, Singapore.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0
   Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581
   Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043
   Briquet A, 2010, HAEMATOL-HEMATOL J, V95, P47, DOI 10.3324/haematol.2009.008524
   Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657
   Martinez EC, 2007, J MATER SCI-MATER M, V18, P1627, DOI 10.1007/s10856-007-3038-1
   Gandhimathi C, 2013, MACROMOL BIOSCI, V13, P696, DOI 10.1002/mabi.201200435
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Han B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081781
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Lemmouchi Y, 1997, J CONTROL RELEASE, V45, P227, DOI 10.1016/S0168-3659(96)01569-6
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Minoura N., 2005, J BIOMED MATER RES, V29, P1215
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Murugan R, 2006, MATER LETT, V60, P2844, DOI 10.1016/j.matlet.2006.01.104
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Popat KC, 2006, J ORTHOP RES, V24, P619, DOI 10.1002/jor.20105
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Ramesh B.N., 2005, J MATER SCI, V40, P6319
   Ravandi SAH, 2013, CURR NANOSCI, V9, P423
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116
   Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009
   Schwach A.K., 2001, BIOMATERIALS, V22, P1659
   Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676
   Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   ZHANG YZ, 1992, FASEB J, V6, pA1835
   ZHANG YZ, 1991, FASEB J, V5, P3108
NR 50
TC 9
Z9 10
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 776
EP 785
DI 10.1016/j.msec.2015.01.075
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100089
PM 25687008
DA 2018-10-19
ER

PT J
AU Sahiner, N
   Sagbas, S
   Aktas, N
AF Sahiner, Nurettin
   Sagbas, Selin
   Aktas, Nahit
TI Single step natural poly(tannic acid) particle preparation as
   multitalented biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tannic acid; Particles; Microgel; Nanogel antioxidant; Antimicrobial;
   Drug delivery
ID TANNIC-ACID; DRUG-DELIVERY; NANOPARTICLE PREPARATION; ANTIOXIDANT
   ACTIVITY; LIPID OXIDATION; CROSS-LINKING; MICROGELS; HYDROGEL; CHITOSAN;
   RELEASE
AB In this study, we report the preparation of poly(tannic acid) (p(TA)) particles by crosslinking with glycerol diglycidyl ether (GDE) and trimethylolpropane triglycidyl ether (TMPGDE). The p(TA) particles are negatively charged as obtained by the zeta potential measurements, -27 my.P(TA) particles are found to be an effective antioxidant material as 170 mg L-1 of p(TA) particle demonstrated the antioxidant equivalency of 82.5 +/- 7.2 mg L-1 of gallic acid (GA), used as standard in Folin-Ciocalteau (FC) method. Additionally, TA and p(TA) particles have a strong antimicrobial effect against Escherichia coli ATCC 8739, Staphylococcus aureus ATCC 6538, and Bacillus subtilis ATCC 6633. Furthermore, p(TA) particles were used as drug delivery materials by using model drugs such as TA itself, and GA in the release studies in PBS at pH 7.4 at 37.5 degrees C, and found that p(TA) particles can release 80.8 and 87.4% of the loaded TA and GA, respectively. Interestingly, p(TA) maintained its fluorescent property upon crosslinking of TA units. It is further demonstrated that p(TA) particles are as effective as cisplatin (a cancer drug) against A549 cancerous cells that both showed about 36 and 34% cell viability, respectively whereas linear TA showed 66% cell viability at 37.5 mu g mL(-1) concentration. Above this concentration p(TA) and cisplatin showed almost the same toxicity against A549 cancerous cells. Additionally, p(TA) particles are found to be much more biocompatible against L929 Fibroblast cells, about 84% cell viability in comparison to linear TA with about 53% at 75 mu g mL(-1) concentration. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Sahiner, Nurettin; Sagbas, Selin] Canakkale Onsekiz Mart Univ, Dept Chem, Fac Sci & Arts, TR-17100 Canakkale, Turkey.
   [Sahiner, Nurettin] Canakkale Onsekiz Mart Univ, Nanosci & Technol Res & Applicat Ctr NANORAC, TR-17100 Canakkale, Turkey.
   [Aktas, Nahit] Yuzuncu Yil Univ, Dept Chem Engn, TR-65080 Van, Turkey.
RP Sahiner, N (reprint author), Canakkale Onsekiz Mart Univ, Dept Chem, Fac Sci & Arts, Terzioglu Campus, TR-17100 Canakkale, Turkey.
EM sahiner71@gmail.com
OI Sahiner, Nurettin/0000-0003-0120-530X; Sagbas Suner,
   Selin/0000-0002-3524-0675
FU Scientific and Technological Research Council of Turkey [113Z238]
FX This work is supported by the Scientific and Technological Research
   Council of Turkey (113Z238). The authors are grateful to Mustafa Turk
   from Kirikkale University, for the cell studies.
CR Abbas SR, 2014, FOOD CHEM, V147, P10, DOI 10.1016/j.foodchem.2013.09.113
   Aelenei N, 2009, J MATER SCI-MATER M, V20, P1095, DOI 10.1007/s10856-008-3675-z
   Balange AK, 2010, FOOD CHEM, V120, P268, DOI 10.1016/j.foodchem.2009.10.019
   Bouki E, 2013, MAR ENVIRON RES, V85, P13, DOI 10.1016/j.marenvres.2012.12.005
   Bozic M, 2012, CARBOHYD POLYM, V89, P854, DOI 10.1016/j.carbpol.2012.04.021
   Bysell H, 2011, ADV DRUG DELIVER REV, V63, P1172, DOI 10.1016/j.addr.2011.08.005
   Chaudhuri S, 2011, BIOPHYS CHEM, V154, P26, DOI 10.1016/j.bpc.2010.12.003
   Chen Z, 2013, FOOD CHEM, V138, P414, DOI 10.1016/j.foodchem.2012.11.001
   Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273
   Corominas BGT, 2002, TALANTA, V58, P1243, DOI 10.1016/S0039-9140(02)00410-1
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   Gali H.U., 1991, IN VIVO CANC RES, V52, P2820
   Gautrot JE, 2006, J BIOMAT SCI-POLYM E, V17, P1123, DOI 10.1163/156856206778530713
   Grassino SB, 1999, PROG ORG COAT, V37, P39, DOI 10.1016/S0300-9440(99)00050-8
   Gulcin I, 2010, ARAB J CHEM, V3, P43, DOI 10.1016/j.arabjc.2009.12.008
   Heijmen FH, 1997, BIOMATERIALS, V18, P749, DOI 10.1016/S0142-9612(96)00202-5
   Hu ZB, 1998, NATURE, V393, P149, DOI 10.1038/30205
   Jagadeesan D, 2011, MACROMOL BIOSCI, V11, P889, DOI 10.1002/mabi.201100045
   Ji HF, 2006, BIOORG MED CHEM LETT, V16, P4095, DOI 10.1016/j.bmcl.2006.04.096
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Kawaguchi H, 1998, BIOSEPARATION, V7, P253, DOI 10.1023/A:1008055211667
   Kim TJ, 2010, FOOD CHEM, V118, P740, DOI 10.1016/j.foodchem.2009.05.060
   Klinger D, 2012, POLYMER, V53, P5209, DOI 10.1016/j.polymer.2012.08.053
   Kurisawa M, 2003, MACROMOL BIOSCI, V3, P758, DOI 10.1002/mabi.200300038
   Labieniec M, 2003, MUTAT RES-GEN TOX EN, V539, P127, DOI 10.1016/S1383-5718(03)00161-X
   Lin JW, 2011, J HAZARD MATER, V193, P102, DOI 10.1016/j.jhazmat.2011.07.035
   Luo CH, 2014, MAT SCI ENG C-MATER, V36, P301, DOI 10.1016/j.msec.2013.12.021
   Maqsood S, 2012, FOOD CHEM, V130, P408, DOI 10.1016/j.foodchem.2011.07.065
   Naus PJ, 2007, J HEPATOL, V46, P222, DOI 10.1016/j.jhep.2006.08.012
   Nsereko S, 2002, BIOMATERIALS, V23, P2723, DOI 10.1016/S0142-9612(02)00005-4
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Olalde B, 2013, MAT SCI ENG C-MATER, V33, P3760, DOI 10.1016/j.msec.2013.05.002
   Orlowski P, 2013, TOXICOL IN VITRO, V27, P1798, DOI 10.1016/j.tiv.2013.05.010
   Rivero S, 2010, CARBOHYD POLYM, V82, P270, DOI 10.1016/j.carbpol.2010.04.048
   Sagbas S, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1809-5
   Sagbas S, 2012, INT J HYDROGEN ENERG, V37, P18944, DOI 10.1016/j.ijhydene.2012.10.006
   Sagbas S, 2012, CARBOHYD POLYM, V87, P2718, DOI 10.1016/j.carbpol.2011.11.064
   Sahiner N, 2008, TURK J CHEM, V32, P397
   Sahiner N, 2014, COLLOID SURFACE A, V452, P173, DOI 10.1016/j.colsurfa.2014.03.097
   Sahiner N, 2014, J POWER SOURCES, V246, P55, DOI 10.1016/j.jpowsour.2013.07.043
   Sahiner N, 2013, PROG POLYM SCI, V38, P1329, DOI 10.1016/j.progpolymsci.2013.06.004
   Sahiner N, 2012, MICROPOR MESOPOR MAT, V155, P124, DOI 10.1016/j.micromeso.2012.01.027
   Sanchez-Moreno C, 1999, FOOD RES INT, V32, P407, DOI 10.1016/S0963-9969(99)00097-6
   Sanchez-Moreno C, 1998, J SCI FOOD AGR, V76, P270, DOI 10.1002/(SICI)1097-0010(199802)76:2<270::AID-JSFA945>3.3.CO;2-0
   Scarbert A., 1991, PHYTOCHEMISTRY, V30, P3875
   Tan BH, 2010, POLYMER, V51, P3238, DOI 10.1016/j.polymer.2010.04.059
   Tanimura S, 2005, BIOCHEM BIOPH RES CO, V330, P1306, DOI 10.1016/j.bbrc.2005.03.116
   Uyama H, 2007, MACROMOL BIOSCI, V7, P410, DOI 10.1002/mabi.200700005
   Wang JN, 2009, J HAZARD MATER, V169, P794, DOI 10.1016/j.jhazmat.2009.04.013
   Winiarska-Mieczan A, 2013, ENVIRON TOXICOL PHAR, V36, P9, DOI 10.1016/j.etap.2013.02.018
   Xiao CM, 2003, POLYM DEGRAD STABIL, V81, P297, DOI 10.1016/S0141-3910(03)00100-9
   Xie CG, 2003, WATER RES, V37, P233, DOI 10.1016/S0043-1354(02)00247-6
   Zhang JG, 2004, J AM CHEM SOC, V126, P7908, DOI 10.1021/ja031523k
   Zhang Y, 2013, J MEMBRANE SCI, V429, P235, DOI 10.1016/j.memsci.2012.11.059
NR 54
TC 32
Z9 32
U1 7
U2 105
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 824
EP 834
DI 10.1016/j.msec.2015.01.076
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100095
PM 25687014
DA 2018-10-19
ER

PT J
AU Staehlke, S
   Koertge, A
   Nebe, B
AF Staehlke, Susanne
   Koertge, Andreas
   Nebe, Barbara
TI Intracellular calcium dynamics dependent on defined microtopographical
   features of titanium
SO BIOMATERIALS
LA English
DT Article
DE Actin; Calcium; Cell signaling; Image analysis; Microstructure;
   Osteoblast
ID CELL-MATRIX ADHESION; ACTIN CYTOSKELETON; 1,25-DIHYDROXYVITAMIN D-3;
   OSTEOBLAST ADHESION; SIGNAL-TRANSDUCTION; FOCAL ADHESION; CA2+ CHANNELS;
   BONE; MECHANOTRANSDUCTION; TRAFFICKING
AB Detailed insights into the complex cellular behavior at the biomaterial interface are crucial for the improvement of implant surfaces with respect to their acceptance and integration. The cells perceive microtopographical features and, in consequence, rearrange their adhesion structures like the actin cytoskeleton and adaptor proteins. But little is known about whether these altered cellular phenotypes have consequences for intracellular calcium signaling and its dynamics. To elucidate if an artificial, geometrical microtopography influences calcium ion (Ca2+) mobilization in osteoblasts, human MG-63 cells were stained with the calcium dye Fluo 3-acetoxymethyl ester and set on defined silicon titanium (Ti) arrays with regular pillar structures (P5, 5 x 5 x 5 mu m) and compared with planar Ti. To induce an immediate calcium signal, cells were stimulated with adenosine 5'-triphosphate (ATP). Interestingly, osteoblasts on micropillars expressing a shortened actin cytoskeleton were hampered in their calcium mobilization potential in signal height as well duration. Even the basal level of the intracellular Ca2+ concentration was reduced, which was accompanied by a disturbed fibronectin synthesis. The expression of the voltage-sensitive calcium channels Ca(v)1.2, Ca(v)13 (L-type) and Ca(v)3.1, Ca(v)3.2, Ca(v)3.3 (T-type) as well as the signaling proteins phospho-AKT and phospho-GSK3 alpha/beta remained unaffected on pillars. The topography-dependent calcium dynamics observed here provide new insights into how topographical cues alter cell functions - via the intracellular Ca2+ signaling. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Staehlke, Susanne; Nebe, Barbara] Univ Med Ctr Rostock, Dept Cell Biol, D-18057 Rostock, Germany.
   [Koertge, Andreas] Univ Rostock, Inst Elect Appliances & Circuits, Interface Res Grp, D-18059 Rostock, Germany.
RP Nebe, B (reprint author), Univ Med Ctr Rostock, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
FU DFG Graduate School welisa [1505/1]; University Medical Center Rostock
   (FORUN) [889061]
FX We are grateful for the financial support of the DFG Graduate School
   welisa (No. 1505/1) and of the University Medical Center Rostock (FORUN
   889061) for SS and AK. We thank Dipl.-Ing. Norbert Zichner (Center for
   Microtechnologies ZFM, Chemnitz University of Technology) for the
   production of the titanium coated materials.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bergh JJ, 2006, AM J PHYSIOL-CELL PH, V290, pC822, DOI 10.1152/ajpcell.00403.2005
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bershadsky AD, 2011, P NATL ACAD SCI USA, V108, P20275, DOI 10.1073/pnas.1116814108
   Bilbao PS, 2007, ARCH BIOCHEM BIOPHYS, V466, P15, DOI 10.1016/j.abb.2007.07.012
   Bootman MD, 2002, CURR BIOL, V12, P563
   Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5
   Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Furukawa R, 2003, J CELL SCI, V116, P187, DOI 10.1242/jcs.00220
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Jorgensen NR, 2002, J BIOL CHEM, V277, P7574, DOI 10.1074/jbc.M104608200
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709
   Li FP, 2011, J BONE MINER METAB, V29, P515, DOI 10.1007/s00774-010-0252-6
   Li QS, 2014, BIOMATERIALS, V35, P961, DOI 10.1016/j.biomaterials.2013.10.037
   Li W, 2001, BONE, V29, P231, DOI 10.1016/S8756-3282(01)00572-5
   Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214
   Matschegewski C, 2012, MATERIALS, V5, P1176, DOI 10.3390/ma5071176
   Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073
   Mccue HV, 2013, BIOCHEM J, V449, P449, DOI 10.1042/BJ20120898
   McGarth JL., 2007, CURR BIOL, V17, pR357
   Muller P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071283
   NEBE B, 1995, EXP CELL RES, V218, P479, DOI 10.1006/excr.1995.1181
   Nebe J. Barbara, 2014, Materials Science Forum, V783-786, P1320, DOI 10.4028/www.scientific.net/MSF.783-786.1320
   Nebe J. G. B., 2008, METALLIC BIOMATERIAL, P215
   Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591, DOI 10.1152/ajpcell.1998.275.6.C1591
   Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603
   Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795
   Ravenscroft-Chang MS, 2010, BIOMATERIALS, V31, P602, DOI 10.1016/j.biomaterials.2009.09.084
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716
   Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517
   Shao Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1067, DOI 10.1152/ajpcell.00427.2008
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y
   Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x
   Staehlke Susanne, 2013, Advanced Materials Research, V647, P476, DOI 10.4028/www.scientific.net/AMR.647.476
   Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003
   Talavera K, 2006, CELL CALCIUM, V40, P97, DOI 10.1016/j.ceca.2006.04.013
   Teo BKK, 2011, BIOMATERIALS, V32, P9866, DOI 10.1016/j.biomaterials.2011.08.088
   Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076
   Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
   Zink C, 2012, BIOMATERIALS, V33, P8055, DOI 10.1016/j.biomaterials.2012.07.037
NR 53
TC 9
Z9 9
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 46
BP 48
EP 57
DI 10.1016/j.biomaterials.2014.12.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7CF
UT WOS:000350524600005
PM 25678115
DA 2018-10-19
ER

PT J
AU Zuidema, JM
   Desmond, GP
   Rivet, CJ
   Kearns, KR
   Thompson, DM
   Gilbert, RJ
AF Zuidema, Jonathan M.
   Desmond, Gregory P.
   Rivet, Christopher J.
   Kearns, Kathryn R.
   Thompson, Deanna M.
   Gilbert, Ryan J.
TI Nebulized solvent ablation of aligned PLLA fibers for the study of
   neurite response to anisotropic-to-isotropic fiber/film transition
   (AFFT) boundaries in astrocyte-neuron co-cultures
SO BIOMATERIALS
LA English
DT Article
DE Poly-L-lactic acid; Electrospun fibers; Astrocytes; Fibronectin;
   Chondroitin sulfate proteoglycan; Dorsal root ganglion
ID SPINAL-CORD-INJURY; IN-VITRO MODEL; GLIAL SCAR; NERVE REGENERATION;
   MECHANICAL-PROPERTIES; CELL-DIFFERENTIATION; ASTROGLIAL CELLS;
   ELECTROSPUN; GROWTH; SCAFFOLDS
AB Developing robust in vitro models of in vivo environments has the potential to reduce costs and bring new therapies from the bench top to the clinic more efficiently. This study aimed to develop a biomaterial platform capable of modeling isotropic-to-anisotropic cellular transitions observed in vivo, specifically focusing on changes in cellular organization following spinal cord injury. In order to accomplish this goal, nebulized solvent patterning of aligned, electrospun poly-L-lactic acid (PLLA) fiber substrates was developed. This method produced a clear topographic transitional boundary between aligned PLLA fibers and an isotropic PLLA film region. Astrocytes were then seeded on these scaffolds, and a shift between oriented and non-oriented astrocytes was created at the anisotropic-to-isotropic fiber/film transition (AFFT) boundary. Orientation of chondroitin sulfate proteoglycans (CSPGs) and fibronectin produced by these astrocytes was analyzed, and it was found that astrocytes growing on the aligned fibers produced aligned arrays of CSPGs and fibronectin, while astrocytes growing on the isotropic film region produced randomly-oriented CSPG and fibronectin arrays. Neurite extension from rat dissociated dorsal root ganglia (DRG) was studied on astrocytes cultured on anisotropic, aligned fibers, isotropic films, or from fibers to films. It was found that neurite extension was oriented and longer on PLLA fibers compared to PLLA films. When dissociated DRG were cultured on the astrocytes near the AFFT boundary, neurites showed directed orientation that was lost upon growth into the isotropic film region. The AFFT boundary also restricted neurite extension, limiting the extension of neurites once they grew from the fibers and into the isotropic film region. This study reveals the importance of anisotropic-to-isotropic transitions restricting neurite outgrowth by itself. Furthermore, we present this scaffold as an alternative culture system to analyze neurite response to cellular boundaries created following spinal cord injury and suggest its usefulness to study cellular responses to any aligned-to-unorganized cellular boundaries seen in vivo. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zuidema, Jonathan M.; Desmond, Gregory P.; Rivet, Christopher J.; Kearns, Kathryn R.; Thompson, Deanna M.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Zuidema, Jonathan M.; Desmond, Gregory P.; Rivet, Christopher J.; Kearns, Kathryn R.; Thompson, Deanna M.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Rivet, Christopher J.] Univ Los Andes, Ctr Invest Biomed, Santiago 762001, Chile.
RP Gilbert, RJ (reprint author), Rensselaer Polytech Inst, Biomed Engn, 110 8th St, Troy, NY 12180 USA.
EM gilber2@rpi.edu
OI Kearns, Kathryn/0000-0001-9939-4836; Zuidema,
   Jonathan/0000-0003-2258-0045
FU NSF CAREER Award [1105125]; NSF I-Corps Grant [IIP-1358895]; NIH [RO1
   1RO1EB013281]
FX We acknowledge the following grant support: NSF CAREER Award 1105125 and
   NSF I-Corps Grant IIP-1358895 to RJG, and NIH RO1 1RO1EB013281 to DMT.
   We would like to thank Dr. Linxia Zhang and Christopher Bertucci for
   their help isolating neurons, and Dr. Sergey Pryshchep for his help with
   atomic force microscopy.
CR Achyuta AKH, 2010, MACROMOL BIOSCI, V10, P872, DOI 10.1002/mabi.200900451
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bechara SL, 2010, BIOMATERIALS, V31, P3492, DOI 10.1016/j.biomaterials.2010.01.084
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Chao Z, 2011, ADV MATER, V23, P4776
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Chow WN, 2007, NEURON GLIA BIOL, V3, P119, DOI 10.1017/S1740925X07000580
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   de Windt TS, 2015, OSTEOARTHR CARTILAGE, V23, P143, DOI 10.1016/j.joca.2014.09.016
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Hynds DL, 2001, J NEUROSCI RES, V66, P630, DOI 10.1002/jnr.10020
   Kidoaki S, 2006, J BIOMED MATER RES B, V76B, P219, DOI 10.1002/jbm.b.30336
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002
   Koppes AN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046023
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lau CL, 2014, J NEUROCHEM, V130, P215, DOI 10.1111/jnc.12702
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Mattotti M, 2012, BIOMATERIALS, V33, P1759, DOI 10.1016/j.biomaterials.2011.10.086
   Meng FW, 2012, BIOMATERIALS, V33, P1323, DOI 10.1016/j.biomaterials.2011.10.034
   Mongin AA, 2011, AM J PHYSIOL-CELL PH, V301, pC814, DOI 10.1152/ajpcell.00035.2011
   Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114
   Nahmias Y, 2005, TISSUE ENG, V11, P701, DOI 10.1089/ten.2005.11.701
   Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6
   Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   Sandstrom A, 2014, ADV MATER, V26, P4975, DOI 10.1002/adma.201401286
   Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004
   Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Tutak W, 2013, BIOMATERIALS, V34, P2389, DOI 10.1016/j.biomaterials.2012.12.020
   Vahidi B, 2008, J NEUROSCI METH, V170, P188, DOI 10.1016/j.jneumeth.2008.01.019
   Veazey WS, 2005, J BIOMED MATER RES B, V72B, P334, DOI 10.1002/jbm.b.30159
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721
   Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013
   Weightman AP, 2014, BIOMATERIALS, V35, P3756, DOI 10.1016/j.biomaterials.2014.01.022
   Westedt U, 2006, J CONTROL RELEASE, V111, P235, DOI 10.1016/j.jconrel.2005.12.012
   Xie JW, 2014, ACS NANO, V8, P1878, DOI 10.1021/nn406363j
   Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21
   Zuidema J, 2015, EXTRACELLULAR MATRIX, P181
   Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079
NR 56
TC 9
Z9 9
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 46
BP 82
EP 94
DI 10.1016/j.biomaterials.2014.12.046
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7CF
UT WOS:000350524600008
PM 25678118
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ding, M
   Andreasen, CM
   Dencker, ML
   Jensen, AE
   Theilgaard, N
   Overgaard, S
AF Ding, Ming
   Andreasen, Christina M.
   Dencker, Mads L.
   Jensen, Anders E.
   Theilgaard, Naseem
   Overgaard, Soren
TI Efficacy of a small cell-binding peptide coated hydroxyapatite
   substitute on bone formation and implant fixation in sheep
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ABM; P-15; implant fixation; bone formation; microarchitecture;
   histomorphometry
ID HUMAN INFRABONY DEFECTS; CANCELLOUS BONE; P-15 PEPTIDE; COLLAGEN;
   MATRIX; GRAFT; ATTACHMENT; SURFACE; DESIGN; FUSION
AB Cylindrical critical size defects were created at the distal femoral condyles bilaterally of eight female adult sheep. Titanium implants with 2-mm concentric gaps were inserted and the gaps were filled with one of the four materials: allograft; a synthetic 15-amino acid cell-binding peptide coated hydroxyapatite (ABM/P-15); hydroxyapatite+tricalciumphosphate+ Poly-Lactic-Acid (HA/TCP-PDLLA); or ABM/P-15+HA/TCP-PDLLA. After nine weeks, bone-implant blocks were harvested and sectioned for micro-CT scanning, push-out test, and histomorphometry. Significant bone formation and implant fixation could be observed in all four groups. Interestingly, the microarchitecture of the ABM/P-15 group was significantly different from the control group. Tissue volume fraction and thickness were significantly greater in the ABM/P-15 group than in the allograft group. Bone formation and bone ingrowth to porous titanium implant were not significantly different among the four groups. The ABM/P-15 group had similar shear mechanical properties on implant fixation as the allograft group. Adding HA/TCP-PDLLA to ABM/P-15 did not significantly change these parameters. This study revealed that ABM/P-15 had significantly bone formation in concentric gap, and its enhancements on bone formation and implant fixation were at least as good as allograft. It is suggested that ABM/P-15 might be a good alternative biomaterial for bone implant fixation in this well-validated critical-size defect gap model in sheep. Nevertheless, future clinical researches should focus on prospective, randomized, controlled trials in order to fully elucidate whether ABM/P-15 could be a feasible candidate for bone substitute material in orthopedic practices. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1357-1365, 2015.
C1 [Ding, Ming; Andreasen, Christina M.; Dencker, Mads L.; Jensen, Anders E.; Overgaard, Soren] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Orthopaed Res Lab,Dept Orthopaed Surg & Traumatol, DK-5000 Odense C, Denmark.
   [Theilgaard, Naseem] Danish Technol Inst, DK-2630 Taastrup, Denmark.
RP Ding, M (reprint author), Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Orthopaed Res Lab,Dept Orthopaed Surg & Traumatol, DK-5000 Odense C, Denmark.
EM ming.ding@rsyd.dk
OI Jensen, Anders Elkaer/0000-0002-9056-9326; Ding,
   Ming/0000-0002-6610-8079; Overgaard, Soren/0000-0001-6829-4787
FU Ortotech, Denmark; Region of Southern Denmark Research Grant; University
   of Southern Denmark
FX Contract grant sponsors: Ortotech, Denmark, Region of Southern Denmark
   Research Grant, and University of Southern Denmark scholarships
CR Babiker H, 2012, J BIOMED MATER RES B, V100B, P759, DOI 10.1002/jbm.b.32509
   BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Ding M, 2012, J BIOMED MATER RES B, V100B, P1826, DOI 10.1002/jbm.b.32750
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Gomar F, 2007, INT ORTHOP, V31, P93, DOI 10.1007/s00264-006-0087-x
   GUNDERSEN HJG, 1993, BONE, V14, P217, DOI 10.1016/8756-3282(93)90144-Y
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Kasaj A, 2008, CLIN ORAL INVEST, V12, P241, DOI 10.1007/s00784-008-0191-y
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Overgaard S, 2000, J ORTHOP RES, V18, P313, DOI 10.1002/jor.1100180221
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Scarano Antonio, 2003, Implant Dent, V12, P318, DOI 10.1097/01.ID.0000095467.48241.68
   Sherman BP, 2010, EUR SPINE J, V19, P2156, DOI 10.1007/s00586-010-1546-z
   Thorwarth M, 2005, BIOMATERIALS, V26, P5648, DOI 10.1016/j.biomaterials.2005.02.023
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yukna RA, 2002, J PERIODONTOL, V73, P123, DOI 10.1902/jop.2002.73.1.123
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
NR 24
TC 9
Z9 9
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2015
VL 103
IS 4
BP 1357
EP 1365
DI 10.1002/jbm.a.35281
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC5JQ
UT WOS:000350395300008
PM 25045068
DA 2018-10-19
ER

PT J
AU Alexandre, N
   Costa, E
   Coimbra, S
   Silva, A
   Lopes, A
   Rodrigues, M
   Santos, M
   Mauricio, AC
   Santos, JD
   Luis, AL
AF Alexandre, Nuno
   Costa, Elisio
   Coimbra, Susana
   Silva, Alice
   Lopes, Ascensao
   Rodrigues, Miguel
   Santos, Marta
   Mauricio, Ana Colette
   Santos, Jose Domingos
   Luis, Ana Lucia
TI In vitro and in vivo evaluation of blood coagulation activation of
   polyvinyl alcohol hydrogel plus dextran-based vascular grafts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyvinyl alcohol hydrogel; dextran; coagulation; homeostasis; vascular
   graft
ID PLATELET-ADHESION; D-DIMER; FEMOROPOPLITEAL BYPASS; CARDIOPULMONARY
   BYPASS; THROMBIN GENERATION; PLASMA COAGULATION; MOLECULAR-WEIGHT;
   WHOLE-BLOOD; FACTOR-XII; SURFACE
AB Polyvinyl alcohol hydrogel (PVA) is a water-soluble synthetic polymer that is commonly used in biomedical applications including vascular grafting. It was argued that the copolymerization of PVA with dextran (Dx) can result in improvement of blood-biomaterial interactions. The focus of this experimental study was to assess that interaction through an in vivo and in vitro evaluation of the coagulation system activation. The thrombogenicity of the copolymer was determined by quantification of platelet adhesion through the lactate dehydrogenase assay, determination of whole blood clotting time, and by quantification of platelet activation by flow cytometry. The thrombin-antithrombin complex blood levels were also determined. The obtained results for the in vitro assays suggested a non-thrombogenic profile for PVA/Dx. Additionally in vivo coagulation and hematological parameters were determined in an animal model after PVA/Dx vascular graft implantation. For coagulation homeostasis assessment, the intrinsic and extrinsic pathway's activation was determined by measuring prothrombin time (PT) and activated partial thromboplastin time (aPTT). Other markers of coagulation and inflammation activation including d-dimers, interleukin-6, and C-reactive protein were also assessed. The PVA/Dx copolymer tended to inhibit platelet adhesion/activation process and the contact activation process for coagulation. These results were also confirmed with the in vivo experiments where the measurements for APTT, interleukin-6, and C-reactive protein parameters were normal considering the species normal range of values. The response to those events is an indicator of the in vitro and in vivo hemocompatibility of PVA/Dx and it allows us to select this biomaterial for further preclinical trials in vascular reconstruction. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1366-1379, 2015.
C1 [Alexandre, Nuno] Univ Evora, Dept Zootecnia, Polo Mitra, P-7002554 Evora, Portugal.
   [Alexandre, Nuno] ICAAM, Polo Mitra, P-7002554 Evora, Portugal.
   [Costa, Elisio; Silva, Alice] Univ Porto, Dept Ciencias Biol, Lab Bioquim, Fac Farm, P-4050313 Oporto, Portugal.
   [Costa, Elisio; Coimbra, Susana; Silva, Alice] Univ Porto, IBMC, P-4150 Oporto, Portugal.
   [Coimbra, Susana] Cooperat Ensino Super Politecn & Univ CESPU Cent, P-4585116 Gandra, Portugal.
   [Lopes, Ascensao; Rodrigues, Miguel; Santos, Jose Domingos] Univ Porto, Dept Engn Met & Mat, CEMUC, Fac Engn, P-4200465 Oporto, Portugal.
   [Santos, Marta] Tecmaia, Biosckin Mol & Cell Therapies SA, P-4470605 Maia, Portugal.
   [Mauricio, Ana Colette; Luis, Ana Lucia] Inst Ciencias & Tecnol Agr & Agroalimentares ICET, CECA, P-4051401 Oporto, Portugal.
   [Mauricio, Ana Colette; Luis, Ana Lucia] Univ Porto, ICBAS, Dept Clin Vet, P-4050313 Oporto, Portugal.
RP Alexandre, N (reprint author), Univ Evora, Dept Zootecnia, Polo Mitra, Apartado 94, P-7002554 Evora, Portugal.
EM nmla@uevora.pt
RI Costa, Elisio/K-1990-2013
OI Costa, Elisio/0000-0003-1158-1480; Coimbra, Susana/0000-0001-8411-8038;
   Santos-Silva, Alice/0000-0002-2565-3169; Alexandre,
   Nuno/0000-0002-3291-9332; Rodrigues, Miguel/0000-0001-8391-5860; Santos,
   Jose Domingos/0000-0002-6871-9850; Mauricio, Ana
   Colette/0000-0002-0018-9363; Lopes, Maria A./0000-0003-4105-8148
FU QREN I&DT Cluster in Development of Products for Regenerative Medicine
   and Cell Therapies [QREN 2008/1372]; European Community FEDER fund
   through ON2 - O Novo Norte - North Portugal Regional Operational
   Program; Fundacao para a Ciencia e Tecnologia (FCT), Ministerio da
   Educacao e da Ciencia [FCT - ENMED/0002/2010]; program COMPETE -
   Programa Operacional Factores de Competitividade [OE/AGR/UI0211/2011];
   Nuno Alexandre has a Doctoral Grant from Fundacao para a Ciencia e
   Tecnologia (FCT), Ministerio da Educacao e da Ciencia, Portugal
   [SFRH/BD/64838/2009]
FX Contract grant sponsors: QREN I&DT Cluster in Development of Products
   for Regenerative Medicine and Cell Therapies - Projects Biomat & Cell
   QREN 2008/1372, co-financed by the European Community FEDER fund through
   ON2 - O Novo Norte - North Portugal Regional Operational Program
   2007-2013; Contract grant sponsor: FCT - ENMED/0002/2010 from Fundacao
   para a Ciencia e Tecnologia (FCT), Ministerio da Educacao e da Ciencia
   and EuroNanoMed JTC 2010 Program, and by the program COMPETE - Programa
   Operacional Factores de Competitividade, Project Pest; contract grant
   number: OE/AGR/UI0211/2011; Contract grant sponsor: Nuno Alexandre has a
   Doctoral Grant from Fundacao para a Ciencia e Tecnologia (FCT),
   Ministerio da Educacao e da Ciencia, Portugal; contract grant number:
   SFRH/BD/64838/2009
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Abed A, 2011, J BIOMED MATER RES A, V96A, P535, DOI 10.1002/jbm.a.33007
   Abir Farshad, 2004, Vasc Endovascular Surg, V38, P483, DOI 10.1177/153857440403800601
   Adam SS, 2009, BLOOD, V113, P2878, DOI 10.1182/blood-2008-06-165845
   AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Alhosseini SN, 2012, INT J NANOMED, V7, P25, DOI 10.2147/IJN.S25376
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   Besednova NN, 2012, BIOL B REV, V2, P525
   Bhat T, 2012, EXPERT REV CARDIOVAS, V11, P55
   BOISCLAIR MD, 1990, BRIT J HAEMATOL, V74, P471, DOI 10.1111/j.1365-2141.1990.tb06337.x
   BOISCLAIR MD, 1993, BLOOD, V82, P3350
   BURMAN JF, 1994, LANCET, V344, P1192, DOI 10.1016/S0140-6736(94)90509-6
   Chaouat M, 2008, ADV FUNCT MATER, V18, P2855, DOI 10.1002/adfm.200701261
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chiaradia E, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-66
   Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009
   Chiumiento A, 2006, BIOMACROMOLECULES, V8, P523
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P399, DOI 10.1002/jbm.820230403
   Connell JM, 2007, ASAIO J, V53, P229, DOI 10.1097/MAT.0b013e31802e192b
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161
   Dindo D, 2009, BLOOD COAGUL FIBRIN, V20, P347, DOI 10.1097/MBC.0b013e32832a5fe6
   Du Clos TW, 2013, ISRN INFLAMM, V2013, P379
   Fink H, 2011, J BIOMED MATER RES A, V97A, P52, DOI 10.1002/jbm.a.33031
   Gentry PA, 2004, VET J, V168, P238, DOI [10.1016/j.tvjl.2003.09.013, 10.1016/j.tvjl.203.09.013]
   Gentry P, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P287, DOI 10.1016/B978-0-12-370491-7.00010-6
   GEORGE JN, 1972, BLOOD-J HEMATOL, V40, P862
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   Hanson S. R, 2013, BIOMATERIALS SCI, P551
   Harvey JW, 2011, VET HEMATOLOGY DIAGN
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hassan R, 2010, UPSALA J MED SCI, V115, P245
   Heijnen HFG, 1999, BLOOD, V94, P3791
   Hoke M, 2010, J VASC SURG, V52, P383, DOI 10.1016/j.jvs.2010.02.275
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Iba T, 2007, J TRAUMA, V63, P1093, DOI 10.1097/01.ta.0000251420.41427.d3
   Irvine L, 1991, ASAIO Trans, V37, P569
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kawamoto N, 1998, J ARTIF ORGANS, V1, P4
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Leitao AF, 2013, COLLOID SURFACE B, V111, P493, DOI 10.1016/j.colsurfb.2013.06.031
   LIU LS, 1991, BIOMATERIALS, V12, P390, DOI 10.1016/0142-9612(91)90007-W
   Maruoka S, 2006, CURR EYE RES, V31, P599, DOI 10.1080/02713680600813854
   Meinhart J, 1997, ASAIO J, V43, P515
   Minnema MC, 1999, SEMIN THROMB HEMOST, V25, P419, DOI 10.1055/s-2007-994944
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Neu B, 2008, BIOPHYS J, V95, P3059, DOI 10.1529/biophysj.108.130328
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Pelagalli A, 2003, J COMP PATHOL, V128, P127, DOI 10.1016/S0021-9975(02)00121-4
   Polizopoulou ZS, 2010, SMALL RUMINANT RES, V92, P88, DOI 10.1016/j.smallrumres.2010.04.015
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   Robinson BI, 2003, ANZ J SURG, V73, P95, DOI 10.1046/j.1445-2197.2003.02653.x
   SHOENFELD NA, 1987, J VASC SURG, V5, P76, DOI 10.1067/mva.1987.avs0050076
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Spadaccio C, 2013, INT J CARDIOL, V168, P5028, DOI 10.1016/j.ijcard.2013.07.165
   STOTT RAW, 1995, CLIN CHEM, V41, P306
   STRATTON JR, 1982, CIRCULATION, V66, P1287, DOI 10.1161/01.CIR.66.6.1287
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Tennant BC, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P379, DOI 10.1016/B978-0-12-370491-7.00013-1
   Titushkin IA, 2001, ASAIO J, V47, P11, DOI 10.1097/00002480-200101000-00005
   Tze-Man K, 1993, BIOMATERIALS, V14, P657
   vansderKamp K W HJ, 1994, J BIOMED MATER RES, V28, P349
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585
   Weiss DJ, 2011, SCHALMS VET HEMATOLO
   Wilhelmi MH, 2012, ASAIO J, V58, P79, DOI 10.1097/MAT.0b013e31823a5414
   WOLDHUIS B, 1993, PFLUG ARCH EUR J PHY, V425, P191, DOI 10.1007/BF00374166
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Xu M, 2010, COLLOID SURFACE B, V80, P200, DOI 10.1016/j.colsurfb.2010.06.003
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zeerleder S, 2002, THROMB RES, V105, P441, DOI 10.1016/S0049-3848(02)00041-5
   Zhao J, 2011, J MEMBRANE SCI, V369, P5, DOI 10.1016/j.memsci.2010.10.046
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 82
TC 9
Z9 9
U1 5
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2015
VL 103
IS 4
BP 1366
EP 1379
DI 10.1002/jbm.a.35275
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC5JQ
UT WOS:000350395300009
PM 25044790
DA 2018-10-19
ER

PT J
AU Campoccia, D
   Visai, L
   Reno, F
   Cangini, I
   Rizzi, M
   Poggi, A
   Montanaro, L
   Rimondini, L
   Arciola, CR
AF Campoccia, Davide
   Visai, Livia
   Reno, Filippo
   Cangini, Ilaria
   Rizzi, Manuela
   Poggi, Alessandro
   Montanaro, Lucio
   Rimondini, Lia
   Arciola, Carla Renata
TI Bacterial adhesion to poly-(D,L)lactic acid blended with vitamin E:
   Toward gentle anti-infective biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly-(d; l)lactic acid; anti-infective biomaterials; implant-related
   infection; vitamin E; Staphylococcus
ID MOLECULAR-WEIGHT POLYETHYLENE; INFECTION-RESISTANT SURFACES;
   STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; FIBRONECTIN; REPLACEMENT;
   INHIBITION; MECHANISMS; SCAFFOLDS; ADHERENCE
AB Anti-infective properties of biomedical materials are often achieved by loading or coating them with powerful bactericides. Undesirably, these bioactive molecules can damage the host cells at the biomaterial-tissues interface and, sometimes, even determine systemic toxic effects. The search for biomaterials able to actively resist infection while displaying a safe cytocompatibility profile toward eukaryotic cells is being progressively developed. Poly-(d,l)lactic acid (PLA) is a broadly used resorbable material with established biocompatibility properties. The dissolving surfaces of a biodegradable material tend to be per se elusive for bacteria. Here, films of pristine PLA, of PLA blended with vitamin E (VitE) and PLA blended with vitamin E acetate (VitE ac) were challenged in vitro with the biofilm-producers Staphylococcus epidermidis RP62A and Staphylococcus aureus ATCC25923. The bacterial adhesion properties of the different materials were investigated on small film disc specimens by a method based on microtiter plates. Adherent bacteria were quantified by both CFU plating and bioluminescence. Significant decrease in bacterial adhesion and biofilm accumulation was found on the surface of both the enriched polymers. These findings, together with the favorable intrinsic properties of PLA and the desirable bioactivities conferred by VitE, point up the VitE-blended PLA polymers as gentle anti-infective biomaterials. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1447-1458, 2015.
C1 [Campoccia, Davide; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
   [Visai, Livia] Univ Pavia, INSTM UdR Pavia, Dept Mol Med, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Visai, Livia] IRCCS, Salvatore Maugeri Fdn, Nanotechnol Lab, Dept Occupat Med Ergon & Disabil, Pavia, Italy.
   [Reno, Filippo; Rizzi, Manuela] Univ Eastern Piedmont Amedeo Avogadro, Dept Hlth Sci, Innovat Res Lab Wound Healing, Novara, Italy.
   [Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
   [Rizzi, Manuela] Edo & Elvo Tempia Fdn, Biella, Italy.
   [Poggi, Alessandro] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy.
   [Rimondini, Lia] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy.
   [Rimondini, Lia] Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Florence, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
EM lucio.montanaro@unibo.it; carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
FU "5 per mille" financial contribution for Health Research; Edo ed Elvo
   Tempia Foundation; DIMES-University of Bologna
FX The authors thank Dr. Giorgio Gatti and Dr. Davide Aragno (Department of
   Sciences and Technological Innovation, University of Eastern Piedmont
   "Amedeo Avogadro", Alessandria, Italy) for SEM analysis. This work was
   supported by the "5 per mille" financial contribution for Health
   Research to the Rizzoli Orthopaedic Institute of Bologna. Dr. Manuela
   Rizzi is supported by an "Edo ed Elvo Tempia Foundation" senior
   fellowship. Dr. Ilaria Cangini is supported by a "DIMES-University of
   Bologna" senior fellowship.
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   An YH, 1997, J BONE JOINT SURG BR, V79B, P816, DOI 10.1302/0301-620X.79B5.7228
   ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347
   Arciola CR, 2012, INT J ARTIF ORGANS, V35, P713, DOI 10.5301/ijao.5000158
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2010, INT J ARTIF ORGANS, V33, P565
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   Banche G, 2011, J ORTHOP RES, V29, P1662, DOI 10.1002/jor.21432
   Bladen CL, 2013, J BIOMED MATER RES B, V101B, P458, DOI 10.1002/jbm.b.32904
   Braem A, 2014, J BIOMED MATER RES A, V102, P215, DOI 10.1002/jbm.a.34688
   Campoccia D, 2007, INT J ARTIF ORGANS, V30, P842
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Campoccia D, 2012, INT J ARTIF ORGANS, V35, P800, DOI 10.5301/ijao.5000140
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Daghighi S, 2013, BIOMATERIALS, V34, P8013, DOI 10.1016/j.biomaterials.2013.07.044
   El-Ghannam A, 2010, J BIOMED MATER RES A, V94A, P308, DOI 10.1002/jbm.a.32705
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Fundeanu I, 2010, ACTA BIOMATER, V6, P4271, DOI 10.1016/j.actbio.2010.06.010
   Gomez-Barrena E, 2011, J MATER SCI-MATER M, V22, P1701, DOI 10.1007/s10856-011-4340-5
   Lee ALZ, 2013, BIOMATERIALS, V34, P10278, DOI 10.1016/j.biomaterials.2013.09.029
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Miyazaki H, 2012, WOUND REPAIR REGEN, V20, P573, DOI 10.1111/j.1524-475X.2012.00811.x
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Pittarella P, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39970
   Provinciali M, 2011, J MED MICROBIOL, V60, P1806, DOI 10.1099/jmm.0.032516-0
   Ren F., 2007, BIOMOL ENG, V24, P307
   Ren F, 2004, BIOMATERIALS, V25, P995
   Ren F, 2007, J BIOMAT SCI-POLYM E, V18, P785
   Ren F, 2012, J BIOMATER APPL, V27, P165
   Ren F., 2013, J APPL POLYM SCI, V129, P1527
   Ren F., 2005, BIOMATERIALS, V26, P5594
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Taglietti A, 2014, BIOMATERIALS, V35, P1779, DOI 10.1016/j.biomaterials.2013.11.047
   Turner A, 2014, J MECH BEHAV BIOMED, V31, P21, DOI 10.1016/j.jmbbm.2012.12.006
   Uberos J, 2001, LETT APPL MICROBIOL, V32, P303, DOI 10.1046/j.1472-765X.2001.00908.x
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   Wang QS, 2014, J BIOMED MATER RES A, V102, P4098, DOI 10.1002/jbm.a.35083
   Zhao GQ, 2011, CELL BIOCHEM BIOPHYS, V61, P371, DOI 10.1007/s12013-011-9220-6
NR 46
TC 11
Z9 11
U1 0
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2015
VL 103
IS 4
BP 1447
EP 1458
DI 10.1002/jbm.a.35284
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC5JQ
UT WOS:000350395300016
PM 25046271
DA 2018-10-19
ER

PT J
AU Velayudhan, S
   Kumar, PRA
   Nair, PD
AF Velayudhan, Shiny
   Kumar, P. R. Anil
   Nair, Prabha D.
TI A Novel, Single Step, Highly Sensitive In-Vitro Cell-Based Metabolic
   Assay Using Honeycomb Microporous Polymer Membranes
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Breath Figure; Cell Based Assay; Honeycomb Membranes; High Throughput
ID POLYURETHANE MEMBRANES; DRUG DISCOVERY; FILMS; MICROARRAY;
   CARCINOGENESIS; PLATFORM
AB This study describes a novel, simple and versatile system for cell-based assays at the bench-top. The system consists of Polyurethane (PU) based honeycomb membrane with the active compounds/assay reagents dispensed on its pore linings. Membranes with functionalized pores were thus created and used for conducting cell based assays. As proof-ofconcept Flourocein acetate (FDA) and Propidium iodide (PI) were embedded on the pore linings and live/dead assays were performed on L929 and Hacat cell lines. The results proved the sensitivity of the membrane based cell assay. To ensure the capacity of this system for high throughput applications, membrane based live/dead assay was performed on L929 cells with varying levels of viability. The results from this experiment were quantified by microscopic and spectrofluourimetric techniques both of which were found to correlate well. It was concluded that this simple membrane based cell assay is highly versatile and enables multiple compounds to be tested on the same cell/tissue. Furthermore, this method requires low volumes of assay reagents and eliminates many of the wet techniques that are involved in a conventional assay, without compromising on the sensitivity. It is anticipated that this functionalized membrane system could be easily adapted for both manual and automated high content screening experiments including in vitro biomaterial evaluation as well as cytotoxicity of nanomaterials.
C1 [Velayudhan, Shiny; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Dept Tissue Engn & Regenerat Technol, Trivandrum 695012, Kerala, India.
   [Kumar, P. R. Anil] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Implant Biol, Trivandrum 695012, Kerala, India.
RP Nair, PD (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Dept Tissue Engn & Regenerat Technol, Trivandrum 695012, Kerala, India.
EM prabha@sctimst.ac.in
FU Department of Biotechnology, Government of India (Center of Excellence
   program)
FX The authors thank The Director, SCTIMST and Head BMT Wing for the
   facilities to carry out this work. Financial assistance from Department
   of Biotechnology, Government of India (Center of Excellence program) is
   also gratefully acknowledged.
CR Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Castel D, 2006, DRUG DISCOV TODAY, V11, P616, DOI 10.1016/j.drudis.2006.05.015
   Cheng CX, 2005, LANGMUIR, V21, P6576, DOI 10.1021/la050187d
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Connal LA, 2005, J MATER CHEM, V15, P1286, DOI 10.1039/b414421j
   Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056
   Evenou F, 2012, LAB CHIP, V12, P1717, DOI 10.1039/c2lc20696j
   Fernandes TG, 2008, ANAL CHEM, V80, P6633, DOI 10.1021/ac800848j
   Fukuhira Y, 2009, SOFT MATTER, V5, P2037, DOI 10.1039/b821183c
   George S, 1999, J APPL POLYM SCI, V73, P1949
   Gregor Kijanka R. B., 2011, RECENT DEV CELL BASE
   Guliants VV, 2004, J MEMBRANE SCI, V235, P53, DOI 10.1016/j.memsci.2004.01.019
   Karadag M, 2011, MACROMOL BIOSCI, V11, P1235, DOI 10.1002/mabi.201100024
   Ke BB, 2010, LANGMUIR, V26, P8946, DOI 10.1021/la904729b
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105
   Li JH, 2012, APPL SURF SCI, V258, P6398, DOI 10.1016/j.apsusc.2012.03.049
   Mueller D., 2011, J BIOENGN BIOMED SCI, V2, DOI 10.4172/2155-9538.52-002
   O'Brien TJ, 2003, MUTAT RES-FUND MOL M, V533, P3, DOI 10.1016/j.mrfmmm.2003.09.006
   Oh TI, 2007, CYTOM PART A, V71A, P857, DOI 10.1002/cyto.a.20427
   Park MS, 2004, LANGMUIR, V20, P5347, DOI 10.1021/la035915g
   Patlolla AK, 2009, INT J ENV RES PUB HE, V6, P643, DOI 10.3390/ijerph6020643
   Shi XL, 1999, J TOXICOL ENV HEAL B, V2, P87, DOI 10.1080/109374099281241
   Srinivasarao M, 2001, SCIENCE, V292, P79, DOI 10.1126/science.1057887
   Taylor DL, 2001, CURR OPIN BIOTECH, V12, P75, DOI 10.1016/S0958-1669(00)00180-4
   Tian Y, 2007, POLYM INT, V56, P834, DOI 10.1002/pi.2173
   Tsui YK, 2009, J MATER SCI-MATER M, V20, P1729, DOI 10.1007/s10856-009-3722-4
   Wan L. S., 2011, J PHYS CHEM B, V116, P40
   Wan LS, 2012, CHEM COMMUN, V48, P4417, DOI 10.1039/c2cc17451k
   Wu JH, 2011, BIOMATERIALS, V32, P841, DOI 10.1016/j.biomaterials.2010.09.026
   Xiao H., 2001, J CONTROL RELEAS, V73, P121
   Yu BZ, 2006, BIOSENS BIOELECTRON, V21, P2275, DOI 10.1016/j.bios.2005.11.002
   ZANG DLR, 2012, INT J BIOTECH WELL I, V1, P31
NR 33
TC 2
Z9 2
U1 1
U2 73
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2015
VL 11
IS 4
BP 590
EP 599
DI 10.1166/jbn.2015.2066
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AT5FM
UT WOS:000344969600004
PM 26310066
DA 2018-10-19
ER

PT J
AU Joo, JY
   Amin, ML
   Rajangam, T
   An, SSA
AF Joo, Jae Yeon
   Amin, Md. Lutful
   Rajangam, Thanavel
   An, Seong Soo A.
TI Fibrinogen as a promising material for various biomedical applications
SO MOLECULAR & CELLULAR TOXICOLOGY
LA English
DT Review
DE Fibrinogen; Drug carrier; Arginine-glycine-aspartate peptide; Tissue
   engineering; Biocompatible material; Autologous; 3D bio-printing;
   Microspheres; Microtubes
ID DRUG-DELIVERY SYSTEMS; ALBUMIN MICROSPHERES; DROPLET FORMATION;
   CANCER-THERAPY; GROWTH-FACTOR; IN-VIVO; NANOPARTICLES; RGD; PARTICLES;
   INTEGRIN
AB As demands for innovative drug carriers and transplantable organs increase, many researchers have developed diverse drug carriers and scaffolds using various materials. However, several candidate materials have shown systemic toxicity, making them unsuitable for clinical use. Fibrinogen (Fbg), a natural polymer, could be a promising material for applications in biomedical engineering owing to its biocompatibility and biodegradability, as reported in numerous studies. Moreover, autologous Fbg is abundant in blood and can be easily extracted, presenting Fbg as an excellent biomaterial for biomedical applications due to minimal immunological rejection. In addition, the biocompatibility of other materials could be improved by combining them with Fbg. Over the next few years, Fbg could be widely used in various biomedical and clinical fields. Here, we discuss the characteristics of Fbg and fabricating methods for Fbg scaffolds in various biomedical applications. The future prospects of Fbg as an applicable biomaterial, especially in organ fabrication by the cutting-edge 3D bioprinting technology, are also presented.
C1 [Joo, Jae Yeon; Amin, Md. Lutful; Rajangam, Thanavel; An, Seong Soo A.] Gachon Univ, Dept Bionano Technol, Gyeonggi Do, South Korea.
RP An, SSA (reprint author), Gachon Univ, Dept Bionano Technol, Gyeonggi Do, South Korea.
EM seongaan@gachon.ac.kr
FU National Research Foundation of Korea (NRF) - Korean government (MEST)
   [2012R1A2A2A030 46819]
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant funded by the Korean government (MEST) (2012R1A2A2A030 46819:
   Development of biodegradable and biocompatible nano-patterned
   microfibers and microtubes for skin and vascular tissue engineering).
CR Adhirajan N, 2007, J MICROENCAPSUL, V24, P659, DOI 10.1080/02652040701500137
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Arangoa MA, 2001, PHARMACEUT RES, V18, P1521, DOI 10.1023/A:1013018111829
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Beenken-Rothkopf LN, 2013, ANN CLIN LAB SCI, V43, P111
   Bhunchu S, 2014, PHARMAZIE, V69, P563, DOI 10.1691/ph.2014.3165
   Bohmer MR, 2006, COLLOID SURFACE A, V289, P96, DOI 10.1016/j.colsurfa.2006.04.011
   Bohmer MR, 2010, COLLOID SURFACE B, V79, P47, DOI 10.1016/j.colsurfb.2010.03.021
   Borgman MP, 2009, MOL PHARMACEUT, V6, P1836, DOI 10.1021/mp900134c
   Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788
   Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215
   Chan BP, 2010, TISSUE ENG PART C-ME, V16, P225, DOI 10.1089/ten.tec.2008.0709
   Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj/neo/7900224
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   De Jong WH, 2008, INT J NANOMED, V3, P133
   DEJANA E, 1985, J CLIN INVEST, V75, P11, DOI 10.1172/JCI111661
   Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   DROBNIK J, 1979, J POLYM SCI POL SYM, P65
   Erdogan D, 2008, J BIOMED MATER RES B, V85B, P272, DOI 10.1002/jbm.b.30916
   Fang ZD, 2011, APPL SURF SCI, V257, P4133, DOI 10.1016/j.apsusc.2010.12.011
   Fielding G, 2013, ACTA BIOMATER, V9, P9137, DOI 10.1016/j.actbio.2013.07.009
   Fletcher RA, 2008, TALANTA, V76, P949, DOI 10.1016/j.talanta.2008.04.066
   Francavilla C, 2009, SEMIN CANCER BIOL, V19, P298, DOI 10.1016/j.semcancer.2009.05.004
   Gregor A., 2010, INT C MECAHITECH 10
   Grossman JH, 2012, PHYS TODAY, V65, P38, DOI 10.1063/PT.3.1678
   Hallahan D, 2003, CANCER CELL, V3, P63, DOI 10.1016/S1535-6108(02)00238-6
   HAMAGUCHI M, 1993, BLOOD, V81, P2348
   HAWIGER J, 1987, HUM PATHOL, V18, P111, DOI 10.1016/S0046-8177(87)80330-1
   He CL, 2011, J BIOMED MATER RES A, V97A, P339, DOI 10.1002/jbm.a.33067
   Ji SR, 2012, CANCER BIOL THER, V13, DOI 10.4161/cbt.13.4.18692
   Khatiwala C., 2012, GENE THER REGUL, V7, DOI DOI 10.1142/S1568558611000301
   Kim Gyu Man, 2014, [Journal of the Korean Society for Precision Engineering, 한국정밀공학회지], V31, P743, DOI 10.7736/KSPE.2014.31.8.743
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Lazko J, 2004, COLLOID SURFACE B, V37, P1, DOI 10.1016/j.colsurfb.2004.06.004
   Li XB, 2012, CHEM ENG SCI, V69, P340, DOI 10.1016/j.ces.2011.10.048
   Livney YD, 2010, CURR OPIN COLLOID IN, V15, P73, DOI 10.1016/j.cocis.2009.11.002
   Meng SY, 2011, MED ONCOL, V28, P1180, DOI 10.1007/s12032-010-9621-1
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   MIYAZAKI S, 1986, J PHARM PHARMACOL, V38, P618, DOI 10.1111/j.2042-7158.1986.tb03093.x
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P1370
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P3384
   MORETZ WH, 1986, OTOLARYNG HEAD NECK, V95, P122, DOI 10.1177/019459988609500124
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Nakamura M., 2011, S VLSI TECHN KYOT JA
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Nisisako T, 2002, LAB CHIP, V2, P24, DOI 10.1039/b108740c
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Percin G, 2003, REV SCI INSTRUM, V74, P1120, DOI 10.1063/1.1532839
   Radulescu D., 2003, P 11 INT S EXH REC A, P1
   Rajangam T, 2011, BIOCHIP J, V5, P175, DOI 10.1007/s13206-011-5211-3
   Rathod S, 2008, INDIAN J PHARM SCI, V70, P193, DOI 10.4103/0250-474X.41454
   Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506
   Rejinold NS, 2011, INT J BIOL MACROMOL, V48, P98, DOI 10.1016/j.ijbiomac.2010.10.003
   Rejinold NS, 2010, INT J BIOL MACROMOL, V47, P37, DOI 10.1016/j.ijbiomac.2010.03.023
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   SCHEFFEL U, 1972, J NUCL MED, V13, P498
   Sharma A, 2011, INT J DRUG DEL, V3, P149
   Skardal A, 2012, STEM CELL TRANSL MED, V1, P792, DOI 10.5966/sctm.2012-0088
   SKOGEN WF, 1988, BLOOD, V71, P1475
   SPORN LA, 1995, BLOOD, V86, P1802
   Spotnitz WD, 2014, ISRN SURG, V2014, P1
   Stec JJ, 2000, CIRCULATION, V102, P1634, DOI 10.1161/01.CIR.102.14.1634
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Xu WC, 2012, INT J NANOMED, V7, P915, DOI 10.2147/IJN.S28314
   Zhan CY, 2010, J CONTROL RELEASE, V143, P136, DOI 10.1016/j.jconrel.2009.12.020
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393
   Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 73
TC 3
Z9 3
U1 2
U2 62
PU KOREAN SOCIETY TOXICOGENOMICS & TOXICOPROTEOMICS-KSTT
PI GYEONGGI-DO
PA HANYANG UNIV, SCI & TECHNOL BLDG 1, RM 423, SA-DONG, SANGROK-GU, ANSAN,
   GYEONGGI-DO, 426 791, SOUTH KOREA
SN 1738-642X
EI 2092-8467
J9 MOL CELL TOXICOL
JI Mol. Cell. Toxicol.
PD MAR 31
PY 2015
VL 11
IS 1
BP 1
EP 9
DI 10.1007/s13273-015-0001-y
PG 9
WC Biochemistry & Molecular Biology; Toxicology
SC Biochemistry & Molecular Biology; Toxicology
GA CE7QF
UT WOS:000352035700001
DA 2018-10-19
ER

PT J
AU Fisher, LE
   Hook, AL
   Ashraf, W
   Yousef, A
   Barrett, DA
   Scurr, DJ
   Chen, XY
   Smith, EF
   Fay, M
   Parmenter, CDJ
   Parkinson, R
   Bayston, R
AF Fisher, Leanne E.
   Hook, Andrew L.
   Ashraf, Waheed
   Yousef, Anfal
   Barrett, David A.
   Scurr, David J.
   Chen, Xinyong
   Smith, Emily F.
   Fay, Michael
   Parmenter, Christopher D. J.
   Parkinson, Richard
   Bayston, Roger
TI Biomaterial modification of urinary catheters with antimicrobials to
   give long-term broadspectrum antibiofilm activity
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Antimicrobial; Bladder; Catheter infection; Drug release; Silicone;
   Urinary tract
ID RANDOMIZED CONTROLLED-TRIAL; URETHRAL CATHETER; TRACT-INFECTION; REDUCED
   SUSCEPTIBILITY; BACTERIAL ATTACHMENT; PROTEUS-MIRABILIS; HYDROCEPHALUS;
   CARE; IMPREGNATION; PREVENTION
AB Catheter-associated urinary tract infection (CAUTI) is the commonest hospital-acquired infection, accounting for over 100,000 hospital admissions within the USA annually. Biomaterials and processes intended to reduce the risk of bacterial colonization of the catheters for long-term users have not been successful, mainly because of the need for long duration of activity in flow conditions. Here we report the results of impregnation of urinary catheters with a combination of rifampicin, sparfloxacin and triclosan. In flow experiments, the antimicrobial catheters were able to prevent colonization by common uropathogens Proteus mirabilis, Staphylococcus aureus and Escherichia coli for 7 to 12 weeks in vitro compared with 1-3 days for other, commercially available antimicrobial catheters currently used clinically. Resistance development was minimized by careful choice of antimicrobial combinations. Drug release profiles and distribution in the polymer, and surface analysis were also carried out and the process had no deleterious effect on the mechanical performance of the catheter or its balloon. The antimicrobial catheter therefore offers for the first time a means of reducing infection and its complications in long-term urinary catheter users. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Fisher, Leanne E.; Ashraf, Waheed; Yousef, Anfal; Bayston, Roger] Univ Nottingham Hosp, Queens Med Ctr, Sch Med, Biomat Related Infect Grp, Nottingham NG7 2UH, England.
   [Hook, Andrew L.; Scurr, David J.; Chen, Xinyong] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   [Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England.
   [Smith, Emily F.; Fay, Michael; Parmenter, Christopher D. J.] Univ Nottingham, Nottingham Nanotechnol & Nanosci Ctr, Nottingham NG7 2RD, England.
   [Parkinson, Richard] Nottingham Univ Hosp NHS Trust, Nottingham Urol Ctr, Nottingham NG5 1PB, England.
RP Bayston, R (reprint author), Univ Nottingham Hosp, Queens Med Ctr, Sch Med, Biomat Related Infect Grp, C Floor West Block, Nottingham NG7 2UH, England.
EM le.fisher@btinternet.com; Andrew.hook@nottingham.ac.uk;
   waheed.ashraf@nottingham.ac.uk; anfalyousef@gmail.com;
   david.barrett@nottingham.ac.uk; david.scurr@nottingham.ac.uk;
   x.chen@nottingham.ac.uk; Emily.smith@nottingham.ac.uk;
   Michael.fay@nottingham.ac.uk; Christopher.parmenter@nottingham.ac.uk;
   Richard.parkinson@nuh.nhs.uk; roger.bayston@nottingham.ac.uk
RI Scurr, David/E-8441-2012; Barrett, David/C-9922-2011; Hook,
   Andrew/K-6924-2012
OI Scurr, David/0000-0003-0859-3886; Barrett, David/0000-0001-6900-9474;
   Hook, Andrew/0000-0001-7756-8444; Fay, Michael/0000-0003-0017-5196
FU University of Nottingham; Engineering and Physical Sciences Research
   Council [EP/K005138/1]
FX Paul Cooling is gratefully acknowledged for HPLC assistance, Keith
   Dinsdale and Tom Buss for mechanical property testing guidance and Dr
   Ignacio Villar for XPS assistance. LEF received a studentship from the
   University of Nottingham.
CR Aryan HE, 2005, CHILD NERV SYST, V21, P56, DOI 10.1007/s00381-004-1052-x
   ASTM, 2006, F62399 ASTM
   BAYSTON R, 1981, J CLIN PATHOL, V34, P1057, DOI 10.1136/jcp.34.9.1057
   BAYSTON R, 1989, J NEUROL NEUROSUR PS, V52, P605, DOI 10.1136/jnnp.52.5.605
   Bayston R, 2009, BIOMATERIALS, V30, P3167, DOI 10.1016/j.biomaterials.2009.02.028
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   Cho YH, 2001, BJU INT, V87, P104, DOI 10.1046/j.1464-410x.2001.00978.x
   Cho YW, 2003, J BIOMAT SCI-POLYM E, V14, P963, DOI 10.1163/156856203322381447
   Cochran WL, 2000, J APPL MICROBIOL, V88, P22, DOI 10.1046/j.1365-2672.2000.00825.x
   Crabtree JH, 2003, PERITON DIALYSIS INT, V23, P368
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Denstedt D. J., 1998, J ENDOUROL, V12, P493
   Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002
   Govender ST, 2003, J NEUROSURG, V99, P831, DOI 10.3171/jns.2003.99.5.0831
   GRIFFITH DP, 1976, INVEST UROL, V13, P346
   Holmes PF, 2009, J BIOMED MATER RES A, V91A, P824, DOI 10.1002/jbm.a.32285
   Hook AL, 2013, ADV MATER, V25, P2542, DOI 10.1002/adma.201204936
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Moore KN, 2009, J WOUND OSTOMY CONT, V36, P82, DOI 10.1097/01.WON.0000345181.37656.de
   Muder RR, 2006, CLIN INFECT DIS, V42, P46, DOI 10.1086/498518
   Nicolle LE, 2001, INFECT CONT HOSP EP, V22, P316, DOI 10.1086/501908
   Park JH, 2003, J BIOMAT SCI-POLYM E, V14, P951, DOI 10.1163/156856203322381438
   Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4
   Rafienia M., 2012, IRAN POLYM J, V22, P75
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Sciubba DM, 2005, J NEUROSURG, V103, P131, DOI 10.3171/ped.2005.103.2.0131
   Stickler DJ, 2008, J HOSP INFECT, V69, P350, DOI 10.1016/j.jhin.2008.04.031
   Stickler DJ, 2008, ANTIMICROB AGENTS CH, V52, P991, DOI 10.1128/AAC.01094-07
   Yuk SH, 1997, MACROMOLECULES, V30, P6856, DOI 10.1021/ma970725w
   Zhao XL, 2001, CLIN INFECT DIS, V33, pS147, DOI 10.1086/321841
NR 32
TC 34
Z9 36
U1 5
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAR 28
PY 2015
VL 202
BP 57
EP 64
DI 10.1016/j.jconrel.2015.01.037
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CC6BI
UT WOS:000350449100007
PM 25639970
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Luo, Y
   Shen, H
   Fang, YX
   Cao, YH
   Huang, J
   Zhang, MX
   Dai, JW
   Shi, XY
   Zhang, ZJ
AF Luo, Yu
   Shen, He
   Fang, Yongxiang
   Cao, Yuhua
   Huang, Jie
   Zhang, Mengxin
   Dai, Jianwu
   Shi, Xiangyang
   Zhang, Zhijun
TI Enhanced Proliferation and Osteogenic Differentiation of Mesenchymal
   Stem Cells on Graphene Oxide-Incorporated Electrospun
   Poly(lactic-co-glycolic acid) Nanofibrous Mats
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nanofibrous mat; electrospinning; graphene oxide; mesenchymal stem
   cells; osteogenic differentiation; tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; EXTRACELLULAR-MATRIX; PROTEIN ADSORPTION;
   IN-VITRO; DELIVERY; COMPOSITE; PLGA; APOPTOSIS; POLYMER; CULTURE
AB Currently, combining biomaterial scaffolds with living stem cells for tissue regeneration is a main approach for tissue engineering. Mesenchymal stem cells (MSCs) are promising candidates for musculoskeletal tissue repair through differentiating into specific tissues, such as bone, muscle, and cartilage. Thus, successfully directing the fate of MSCs through factors and inducers would improve regeneration efficiency. Here, we report the fabrication of graphene oxide (GO)-doped poly(lactic-co-glycolic acid) (PLGA) nanofiber scaffolds via electrospinning technique for the enhancement of osteogenic differentiation of MSCs. GO-PLGA nanofibrous mats with three-dimensional porous structure and smooth surface can be readily produced via an electrospinning technique. GO plays two roles in the nanofibrous mats: first, it enhances the hydrophilic performance, and protein- and inducer-adsorption ability of the nanofibers. Second, the incorporated GO accelerates the human MSCs (hMSCs) adhesion and proliferation versus pure PLGA nanofiber and induces the osteogenic differentiation. The incorporating GO scaffold materials may find applications in tissue engineering and other fields.
C1 [Luo, Yu; Shen, He; Cao, Yuhua; Huang, Jie; Zhang, Mengxin; Dai, Jianwu; Zhang, Zhijun] Chinese Acad Sci, Key Lab Nano Bio Interface, Div Nanobiomed, Suzhou Inst Nano Tech & Nano Bion, Suzhou 215123, Peoples R China.
   [Luo, Yu; Shi, Xiangyang] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
   [Fang, Yongxiang; Dai, Jianwu] Chinese Acad Sci, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100190, Peoples R China.
   [Fang, Yongxiang] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Publ Hlth Agr Minist, Lanzhou Vet Res Inst, Lanzhou 730046, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Key Lab Nano Bio Interface, Div Nanobiomed, Suzhou Inst Nano Tech & Nano Bion, 398 Ruoshui Rd, Suzhou 215123, Peoples R China.
EM jwdai@genetics.ac.cn; xshi@dhu.edu.cn; zjzhang2007@sinano.ac.cn
RI Shi, Xiangyang/A-1289-2007; Zhang, Zhijun/E-5980-2014
OI Shi, Xiangyang/0000-0001-6785-6645; Zhang, Zhijun/0000-0002-9853-1031
FU National Natural Science Foundation of China [51361130033]; Ministry of
   Science and Technology of China [2014CB965003]
FX We acknowledge financial support of this work from National Natural
   Science Foundation of China (No. 51361130033) and the Ministry of
   Science and Technology of China (No. 2014CB965003). X. Shi thanks the
   Program for Professor of Special Appointment (Eastern Scholar) at
   Shanghai Institutions of Higher Learning. We also thank Professor Wei
   Chen at SINANO for assistance with the electrospinning facility.
CR Abraham S, 2010, ACTA BIOMATER, V6, P4622, DOI 10.1016/j.actbio.2010.07.029
   Alzhavan O, 2013, CARBON, V59, P200, DOI 10.1016/j.carbon.2013.03.010
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Caballero Montserrat, 2013, Ann Plast Surg, V70, P568, DOI 10.1097/SAP.0b013e31827ed6f4
   Cao YH, 2013, J MATER CHEM B, V1, P5602, DOI 10.1039/c3tb20764a
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Ebrahimi-Barough S, 2015, MOL NEUROBIOL, V52, P1704, DOI 10.1007/s12035-014-8931-2
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fang X, 2011, J MATER CHEM, V21, P4493, DOI 10.1039/c0jm03987j
   Haider A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-314
   Han SF, 2012, J GENET GENOMICS, V39, P633, DOI 10.1016/j.jgg.2012.08.006
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang YP, 2012, ACS APPL MATER INTER, V4, P3054, DOI 10.1021/am300417s
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719
   Kotchey GP, 2011, ACS NANO, V5, P2098, DOI 10.1021/nn103265h
   Ku SH, 2013, BIOMATERIALS, V34, P2017, DOI 10.1016/j.biomaterials.2012.11.052
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lee DY, 2011, BIOMACROMOLECULES, V12, P336, DOI 10.1021/bm101031a
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liu FJ, 2010, SOFT MATER, V8, P239, DOI 10.1080/1539445X.2010.495620
   Liu GD, 2013, ACS APPL MATER INTER, V5, P6909, DOI 10.1021/am402128s
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Luo Y, 2013, CARBOHYD POLYM, V91, P419, DOI 10.1016/j.carbpol.2012.08.069
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Meng J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02655
   Meng J, 2010, J BIOMED MATER RES A, V95A, P312, DOI 10.1002/jbm.a.32845
   Meng ZX, 2013, MAT SCI ENG C-MATER, V33, P699, DOI 10.1016/j.msec.2012.10.021
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Qi RL, 2012, ADV MATER RES-SWITZ, V424-425, P1220, DOI 10.4028/www.scientific.net/AMR.424-425.1220
   Qi RL, 2012, J BIOMAT SCI-POLYM E, V23, P299, DOI 10.1163/092050610X550340
   Qi RL, 2010, J MATER CHEM, V20, P10622, DOI 10.1039/c0jm01328e
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Shen H, 2012, ACS APPL MATER INTER, V4, P6317, DOI 10.1021/am3019367
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Soscia DA, 2013, BIOMATERIALS, V34, P6773, DOI 10.1016/j.biomaterials.2013.05.061
   Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002
   Wang JX, 2014, CONNECT TISSUE RES, V55, P292, DOI 10.3109/03008207.2014.918112
   Wang SG, 2012, J MATER CHEM, V22, P23357, DOI 10.1039/c2jm34249a
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   Xiao SL, 2009, J PHYS CHEM C, V113, P18062, DOI 10.1021/jp905542g
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yoon OJ, 2011, COMPOS PART A-APPL S, V42, P1978, DOI 10.1016/j.compositesa.2011.08.023
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang LM, 2013, J MATER CHEM B, V1, P749, DOI 10.1039/c2tb00096b
   Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
NR 57
TC 94
Z9 98
U1 40
U2 281
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 25
PY 2015
VL 7
IS 11
BP 6331
EP 6339
DI 10.1021/acsami.5b00862
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CE6TZ
UT WOS:000351972400041
PM 25741576
DA 2018-10-19
ER

PT J
AU Liu, K
   Shuai, M
   Chen, D
   Tuchband, M
   Gerasimov, JY
   Su, JJ
   Liu, Q
   Zajaczkowski, W
   Pisula, W
   Mullen, K
   Clark, NA
   Herrmann, A
AF Liu, Kai
   Shuai, Min
   Chen, Dong
   Tuchband, Michael
   Gerasimov, Jennifer Y.
   Su, Juanjuan
   Liu, Qing
   Zajaczkowski, Wojciech
   Pisula, Wojciech
   Muellen, Klaus
   Clark, Noel A.
   Herrmann, Andreas
TI Solvent-free Liquid Crystals and Liquids from DNA
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE DNA; liquids; liquid crystals; smectic mesophases; solvent-free
ID CAST FILM; NANOSTRUCTURES; TEMPERATURE; CHEMISTRY; DELIVERY; BEHAVIOR;
   SYSTEMS; PHASE
AB As DNA exhibits persistent structures with dimensions that exceed the range of their intermolecular forces, solid-state DNA undergoes thermal degradation at elevated temperatures. Therefore, the realization of solvent-free DNA fluids, including liquid crystals and liquids, still remains a significant challenge. To address this intriguing issue, we demonstrate that combining DNA with suitable cationic surfactants, followed by dehydration, can be a simple generic scheme for producing these solvent-free DNA fluid systems. In the anhydrous smectic liquid crystalline phase, DNA sublayers are intercalated between aliphatic hydrocarbon sublayers. The lengths of the DNA and surfactant are found to be extremely important in tuning the physical properties of the fluids. Stable liquid-crystalline and liquid phases are obtained in the -20 degrees C to 200 degrees C temperature range without thermal degradation of the DNA. Thus, a new type of DNA-based soft biomaterial has been achieved, which will promote the study and application of DNA in a much broader context.
C1 [Liu, Kai; Gerasimov, Jennifer Y.; Su, Juanjuan; Liu, Qing; Herrmann, Andreas] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
   [Shuai, Min; Chen, Dong; Tuchband, Michael; Clark, Noel A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA.
   [Shuai, Min; Chen, Dong; Tuchband, Michael; Clark, Noel A.] Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA.
   [Zajaczkowski, Wojciech; Pisula, Wojciech; Muellen, Klaus] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Clark, NA (reprint author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.
EM noel.clark@colorado.edu; a.herrmann@rug.nl
RI Zajaczkowski, Wojciech/C-1464-2016; Herrmann, Andreas/F-3189-2016;
   Clark, Noel/E-9011-2010
OI Zajaczkowski, Wojciech/0000-0003-0113-0985; Herrmann,
   Andreas/0000-0002-8886-0894; Tuchband, Michael/0000-0001-6560-1913
FU European Union (European Research Council); Netherlands Organization for
   Scientific Research (NWO-Vici, NWO-ChemTheme); Zernike Institute for
   Advanced Materials; US NSF under BMM [1270606]; MRSEC [DMR-0820579,
   DMR-1420736]
FX This research was supported by the European Union (European Research
   Council Starting Grant NUCLEOPOLY and STREP project MICREAGENTS), the
   Netherlands Organization for Scientific Research (NWO-Vici,
   NWO-ChemTheme) and the Zernike Institute for Advanced Materials, and the
   US NSF under BMM Grant 1270606, and MRSEC Grants DMR-0820579 and
   DMR-1420736.
CR Babu S. S., 2012, ANGEW CHEM, V124, P3447
   Babu SS, 2012, ANGEW CHEM INT EDIT, V51, P3391, DOI 10.1002/anie.201108853
   Bonnet J., 2009, NUCLEIC ACIDS RES, V37, P1531
   Bourlinos AB, 2005, ADV FUNCT MATER, V15, P1285, DOI 10.1002/adfm.200500076
   Broer D. J., 2012, ANGEW CHEM, V124, P7210
   Broer DJ, 2012, ANGEW CHEM INT EDIT, V51, P7102, DOI 10.1002/anie.201200883
   Coleman DA, 2003, SCIENCE, V301, P1204, DOI 10.1126/science.1084956
   de Vries JW, 2013, J CONTROL RELEASE, V172, P467, DOI 10.1016/j.jconrel.2013.05.022
   Dias R., 2008, DNA INTERACTIONS POL
   Faul CFJ, 2014, ACCOUNTS CHEM RES, V47, P3428, DOI 10.1021/ar500162a
   Gajria S, 2011, WIRES NANOMED NANOBI, V3, P479, DOI 10.1002/wnan.148
   Gray G.W, 1984, SMECTIC LIQUID CRYST
   Guo W., 2014, ANGEW CHEM, V126, P10298
   Guo WW, 2014, ANGEW CHEM INT EDIT, V53, P10134, DOI 10.1002/anie.201405692
   He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597
   Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78
   Krivtsov A, 2012, LANGMUIR, V28, P13698, DOI 10.1021/la302720d
   Kwak M., 2010, ANGEW CHEM, V122, P8754
   Kwak M, 2011, CHEM SOC REV, V40, P5745, DOI 10.1039/c1cs15138j
   Kwak M, 2010, ANGEW CHEM INT EDIT, V49, P8574, DOI 10.1002/anie.200906820
   Lee J, 2012, NAT NANOTECHNOL, V7, P816, DOI [10.1038/nnano.2012.211, 10.1038/NNANO.2012.211]
   Lehn JM, 2007, CHEM SOC REV, V36, P151, DOI 10.1039/b616752g
   Lenz O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058104
   Leone AM, 2003, J AM CHEM SOC, V125, P6784, DOI 10.1021/ja0348795
   Liu K, 2014, P NATL ACAD SCI USA, V111, P18596, DOI 10.1073/pnas.1421257111
   Liu K, 2014, J AM CHEM SOC, V136, P14255, DOI 10.1021/ja5080486
   McLaughlin CK, 2011, CHEM SOC REV, V40, P5647, DOI 10.1039/c1cs15253j
   Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206
   Mocanu AS, 2011, CHEM COMMUN, V47, P2056, DOI 10.1039/c0cc05012a
   Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826
   Neumann T, 2010, J AM CHEM SOC, V132, P7025, DOI 10.1021/ja909514j
   Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w
   Perriman A. W., 2009, ANGEW CHEM, V121, P6360
   Perriman AW, 2009, ANGEW CHEM INT EDIT, V48, P6242, DOI 10.1002/anie.200903100
   Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]
   Pluth MD, 2007, CHEM SOC REV, V36, P161, DOI 10.1039/b603168b
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Sato K, 2001, CHEM ENG SCI, V56, P2255, DOI 10.1016/S0009-2509(00)00458-9
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Tschierske C., 2013, ANGEW CHEM, V125, P8992
   Tschierske C, 2013, ANGEW CHEM INT EDIT, V52, P8828, DOI 10.1002/anie.201300872
   Yuan JY, 2013, PROG POLYM SCI, V38, P1009, DOI 10.1016/j.progpolymsci.2013.04.002
   Zhou J, 2006, BIOPHYS J, V90, P544, DOI 10.1529/biophysj.105.071290
   Zhou SQ, 2004, BIOMACROMOLECULES, V5, P1256, DOI 10.1021/bm034524d
NR 45
TC 8
Z9 9
U1 7
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD MAR 23
PY 2015
VL 21
IS 13
BP 4898
EP 4903
DI 10.1002/chem.201500159
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CE9CB
UT WOS:000352140000002
PM 25712569
DA 2018-10-19
ER

PT J
AU Chang, YC
   Wang, YH
AF Chang, Yu-Chi
   Wang, Yeong-Her
TI Solution-processed Al-chelated gelatin for highly transparent
   non-volatile memory applications
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID RANDOM-ACCESS MEMORY; SWITCHING CHARACTERISTICS; DEVICES
AB Using the biomaterial of Al-chelated gelatin (ACG) prepared by sol-gel method in the ITO/ACG/ITO structure, a highly transparent resistive random access memory (RRAM) was obtained. The transmittance of the fabricated device is approximately 83% at 550 nm while that of Al/gelatin/ITO is opaque. As to the ITO/gelatin/ITO RRAM, no resistive switching behavior can be seen. The ITO/ACG/ITO RRAM shows high ON/OFF current ratio (>10(5)), low operation voltage, good uniformity, and retention characteristics at room temperature and 85 degrees C. The mechanism of the ACG-based memory devices is presented. The enhancement of these electrical properties can be attributed to the chelate effect of Al ions with gelatin. Results show that transparent ACG-based memory devices possess the potential for next-generation resistive memories and bio-electronic applications. (C) 2015 AIP Publishing LLC.
C1 [Wang, Yeong-Her] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Inst Microelect, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Dept Elect Engn, Tainan 701, Taiwan.
RP Wang, YH (reprint author), Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Inst Microelect, Tainan 701, Taiwan.
EM yhw@ee.ncku.edu.tw
FU Ministry of Science and Technology of Taiwan [NSC99-2627-E-006-003,
   NSC98-2221-E-006-213-MY3, NSC NSC101-2221-E-006-141-MY3,
   NSC102-222-E-006-182-MY3, 103CE03]
FX This work was supported in part by the Ministry of Science and
   Technology of Taiwan under Contract Nos. NSC99-2627-E-006-003,
   NSC98-2221-E-006-213-MY3, NSC NSC101-2221-E-006-141-MY3,
   NSC102-222-E-006-182-MY3, and103CE03.
CR Ambrico M, 2010, ORG ELECTRON, V11, P1809, DOI 10.1016/j.orgel.2010.08.001
   Cao X, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/25/255104
   Chang YC, 2014, ACS APPL MATER INTER, V6, P5413, DOI 10.1021/am500815n
   Chen MC, 2010, ELECTROCHEM SOLID ST, V13, pII191, DOI 10.1149/1.3360181
   Hazeri N, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/3/035010
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Kim A, 2011, ACS APPL MATER INTER, V3, P4525, DOI 10.1021/am201215e
   Kim HD, 2011, IEEE ELECTR DEVICE L, V32, P1125, DOI 10.1109/LED.2011.2158056
   Ko Y, 2011, ACS NANO, V5, P9918, DOI 10.1021/nn2036939
   LAMPERT MA, 1956, PHYS REV, V103, P1648, DOI 10.1103/PhysRev.103.1648
   Lippard S. J., 1994, PRINCIPLES BIOINORGA
   Liu KC, 2011, MICROELECTRON ENG, V88, P1586, DOI 10.1016/j.mee.2010.11.021
   Matrajt G, 2004, ASTRON ASTROPHYS, V416, P983, DOI 10.1051/0004-6361:20034526
   Misra P, 2010, PHYS STATUS SOLIDI C, V7, P1718, DOI 10.1002/pssc.200983244
   Schmitz N., 1963, INT K FUER REPR GERM, P74
   Sudesh N. Kumar, 2013, SUPERCOND SCI TECH, V26
   Wang ZQ, 2011, IEEE ELECTR DEVICE L, V32, P1442, DOI 10.1109/LED.2011.2162311
   Wang ZS, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529455
   Yang M., 2010, CHINESE PHYS B, V19
NR 19
TC 6
Z9 6
U1 5
U2 32
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD MAR 23
PY 2015
VL 106
IS 12
AR 123302
DI 10.1063/1.4916028
PG 3
WC Physics, Applied
SC Physics
GA CE5LM
UT WOS:000351876700042
OA Bronze
DA 2018-10-19
ER

PT J
AU Li, C
   Faulkner-Jones, A
   Dun, AR
   Jin, J
   Chen, P
   Xing, YZ
   Yang, ZQ
   Li, ZB
   Shu, WM
   Liu, DS
   Duncan, RR
AF Li, Chuang
   Faulkner-Jones, Alan
   Dun, Alison R.
   Jin, Juan
   Chen, Ping
   Xing, Yongzheng
   Yang, Zhongqiang
   Li, Zhibo
   Shu, Wenmiao
   Liu, Dongsheng
   Duncan, Rory R.
TI Rapid Formation of a Supramolecular Polypeptide-DNA Hydrogel for In Situ
   Three-Dimensional Multilayer Bioprinting
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE biodegradability; DNA structures; hydrogels; polypeptides;
   supramolecular chemistry
ID FUNCTIONALIZED HYDROGELS; CELLS; RELEASE; PROTEIN; NANOTECHNOLOGY;
   SCAFFOLD; GEL
AB A rapidly formed supramolecular polypeptide-DNA hydrogel was prepared and used for in situ multilayer three-dimensional bioprinting for the first time. By alternative deposition of two complementary bio-inks, designed structures can be printed. Based on their healing properties and high mechanical strengths, the printed structures are geometrically uniform without boundaries and can keep their shapes up to the millimeter scale without collapse. 3D cell printing was demonstrated to fabricate live-cell-containing structures with normal cellular functions. Together with the unique properties of biocompatibility, permeability, and biodegradability, the hydrogel becomes an ideal biomaterial for 3D bioprinting to produce designable 3D constructs for applications in tissue engineering.
C1 [Li, Chuang; Jin, Juan; Xing, Yongzheng; Yang, Zhongqiang; Liu, Dongsheng] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China.
   [Faulkner-Jones, Alan; Dun, Alison R.; Shu, Wenmiao; Duncan, Rory R.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland.
   [Chen, Ping; Li, Zhibo] Chinese Acad Sci, Inst Chem, BNLMS, Beijing 100190, Peoples R China.
RP Li, C (reprint author), Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China.
EM w.shu@hw.ac.uk; liudongsheng@tsinghua.edu.cn
RI Liu, Dongsheng/E-7384-2011; Xing, Yongzheng/A-2618-2012; Li,
   Zhibo/K-1614-2013
OI Liu, Dongsheng/0000-0002-2583-818X; Xing, Yongzheng/0000-0002-6186-8028;
   Li, Zhibo/0000-0001-9512-1507; Shu, Wenmiao/0000-0002-1220-361X; Duncan,
   Rory/0000-0003-0693-910X
FU National Basic Research Program of China (973 program) [2013CB932803];
   National Natural Science Foundation of China [91427302, 21421064];
   NSFC-DFG joint project [TRR61]; Beijing Municipal Science & Technology
   Commission; Sino-UK Higher Education Research Partnership for PhD
   Studies Scheme - British Council; Ministry of Education in China; EPSRC
   [EP/M506837/1]; MRC [MRC_G0901607]; Wellcome Trust [WT074146];
   Engineering and Physical Sciences Research Council [EP/M506837/1];
   Medical Research Council [MR/K01563X/1, G0901607]
FX We thank the National Basic Research Program of China (973 program,
   2013CB932803), the National Natural Science Foundation of China
   (91427302, 21421064), the NSFC-DFG joint project TRR61, and the Beijing
   Municipal Science & Technology Commission for financial support. This
   project was also partly supported by the Sino-UK Higher Education
   Research Partnership for PhD Studies Scheme funded by the British
   Council and the Ministry of Education in China and EPSRC (EP/M506837/1)
   and MRC awards to R.R.D. (MRC_G0901607) and by the Wellcome Trust
   (WT074146). The MRC (MRC_MR/K01563X/1) Edinburgh Super-Resolution
   Imaging Consortium (ESRIC) provided the microscope platforms, technical
   assistance, tissue culturing facilities, and analysis packages required
   for the acquisition and analysis of fluorescence imaging data summarized
   in this article.
CR Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104
   Calvert P, 2007, SCIENCE, V318, P208, DOI 10.1126/science.1144212
   Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Chaouat M, 2008, ADV FUNCT MATER, V18, P2855, DOI 10.1002/adfm.200701261
   Chen N, 2014, ACCOUNTS CHEM RES, V47, P1720, DOI 10.1021/ar400324n
   Chen P, 2012, MACROMOLECULES, V45, P9579, DOI 10.1021/ma302233m
   Cheng E., 2009, ANGEW CHEM, V121, P7796, DOI DOI 10.1002/ANGE.V121:41
   Cheng EJ, 2011, CHEM COMMUN, V47, P5545, DOI 10.1039/c1cc11028d
   Cheng EJ, 2009, ANGEW CHEM INT EDIT, V48, P7660, DOI 10.1002/anie.200902538
   Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j
   Dave N, 2010, J AM CHEM SOC, V132, P12668, DOI [10.1021/ja106098j, 10.1021/ja106098J]
   Dong YC, 2014, ACCOUNTS CHEM RES, V47, P1853, DOI 10.1021/ar500073a
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Durmus NG, 2013, NAT MATER, V12, P478, DOI 10.1038/nmat3665
   Faulkner-Jones A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015013
   Haruka K., 2013, BIOFABRICATION, V5
   Hemanth G., 2014, BIOFABRICATION, V6
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Jin J, 2013, ADV MATER, V25, P4714, DOI 10.1002/adma.201301175
   Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Li C., 2015, SMALL, DOI [10.1002/smll.201401906, DOI 10.1002/SMLL.201401906;]
   Liu DS, 2011, NPG ASIA MATER, V3, P109, DOI 10.1038/asiamat.2011.147
   Liu JW, 2011, SOFT MATTER, V7, P6757, DOI 10.1039/c1sm05284e
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Modi S, 2009, NAT NANOTECHNOL, V4, P325, DOI [10.1038/NNANO.2009.83, 10.1038/nnano.2009.83]
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110
   Park N, 2009, NAT MATER, V8, P432, DOI [10.1038/nmat2419, 10.1038/NMAT2419]
   Pataky K, 2012, ADV MATER, V24, P391, DOI 10.1002/adma.201102800
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Peng SM, 2012, MATER TODAY, V15, P190, DOI 10.1016/S1369-7021(12)70089-5
   Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]
   Qi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3275
   Reichert JC, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065001
   Riccardo L, 2014, BIOFABRICATION, V6, DOI DOI 10.1088/1758-5082/6/3/035020
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/nchem.1313, 10.1038/NCHEM.1313]
   Tao X., 2013, BIOFABRICATION, V5
   Um SH, 2006, NAT MATER, V5, P797, DOI 10.1038/nmat1741
   Wei B, 2008, ANGEW CHEM, V120, P337, DOI DOI 10.1002/(ISSN)1521-3757
   Wei B, 2008, ANGEW CHEM INT EDIT, V47, P331, DOI 10.1002/anie.200704143
   Wu YZ, 2014, CHEM COMMUN, V50, P14620, DOI 10.1039/c4cc07144a
   Xing YZ, 2011, ADV MATER, V23, P1117, DOI 10.1002/adma.201003343
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049514
   Zhang YL, 2011, BIOMACROMOLECULES, V12, P2894, DOI 10.1021/bm200423f
   Zhu Z., 2010, ANGEW CHEM, V122, P1070, DOI DOI 10.1002/ANIE.200905570
   Zhu Z, 2010, ANGEW CHEM INT EDIT, V49, P1052, DOI 10.1002/anie.200905570
NR 57
TC 97
Z9 104
U1 35
U2 507
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD MAR 23
PY 2015
VL 54
IS 13
BP 3957
EP 3961
DI 10.1002/anie.201411383
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA CD6NA
UT WOS:000351204600017
PM 25656851
DA 2018-10-19
ER

PT J
AU Xiao, X
   Wang, W
   Liu, D
   Zhang, HQ
   Gao, P
   Geng, L
   Yuan, YL
   Lu, JX
   Wang, Z
AF Xiao, Xin
   Wang, Wei
   Liu, Dong
   Zhang, Haoqiang
   Gao, Peng
   Geng, Lei
   Yuan, Yulin
   Lu, Jianxi
   Wang, Zhen
TI The promotion of angiogenesis induced by three-dimensional porous
   beta-tricalcium phosphate scaffold with different interconnection sizes
   via activation of PI3K/Akt pathways
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BMP-INDUCED OSTEOGENESIS; IN-VIVO; BONE REGENERATION; INTERNAL
   STRUCTURE; ENDOTHELIAL-CELLS; TISSUE; GROWTH; VASCULARIZATION;
   BIOCERAMICS; EXPRESSION
AB The porous architectural characteristics of biomaterials play an important role in scaffold revascularization. However, no consensus exists regarding optimal interconnection sizes for vascularization and its scaffold bioperformance with different interconnection sizes. Therefore, a series of disk-type beta-tricalcium phosphates with the same pore sizes and variable interconnections were produced to evaluate how the interconnection size influenced biomaterial vascularization in vitro and in vivo. We incubated human umbilical vein endothelial cells on scaffolds with interconnections of various sizes. Results showed that scaffolds with a 150 mminterconnection size ameliorated endothelial cell function evidenced by promoting cell adhesion and migration, increasing cell proliferation and enhancing expression of platelet-endothelial cell adhesion molecules and vascular endothelial growth factor. In vivo study was performed on rabbit implanted with scaffolds into the bone defect on femoral condyles. Implantation with scaffolds with 150 mm interconnection size significantly improved neovascularization as shown by micro-CT as compared to scaffolds with 100 and 120 mm interconnection sizes. Moreover, the aforementioned positive effects were abolished by blocking PI3K/Akt/eNOS pathway with LY-294002. Our study explicitly demonstrates that the scaffold with 150 mm interconnection size improves neovascularization via the PI3K/Akt pathway and provides a target for biomaterial inner structure modification to attain improved clinical performance in implant vascularization.
C1 [Xiao, Xin; Liu, Dong; Zhang, Haoqiang; Gao, Peng; Geng, Lei; Yuan, Yulin; Wang, Zhen] Forth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China.
   [Wang, Wei] Forth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.
   [Lu, Jianxi] Shanghai Biolu Biomat Co Ltd, Shanghai, Peoples R China.
RP Wang, Z (reprint author), Forth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China.
EM lujianxi888@hotmail.com; wzfmmu@sina.com
FU Natural Science Foundation of China [31170914]
FX This work was supported by grant from the Natural Science Foundation of
   China (NO. 31170914) to Zhen Wang. The authors are grateful to the
   Shanghai Bio-lu Biomaterials Co., Ltd., for providing beta-TCP
   bioceramics. The authors thank all technicians at the Institute of
   Orthopaedic of XiJing Hospital, Fourth Military Medical University in
   China, for their contribution to the experiment.
CR Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Bohner M, 2000, INJURY, V31, pS37
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   Dulak J, 2002, CARDIOVASC RES, V56, P487, DOI 10.1016/S0008-6363(02)00670-3
   Elcin AE, 2006, TISSUE ENG, V12, P959, DOI 10.1089/ten.2006.12.959
   Furumatsu T, 2003, J BIOCHEM, V133, P633, DOI 10.1093/jb/mvg081
   Henry JA, 2009, ACTA BIOMATER, V5, P29, DOI 10.1016/j.actbio.2008.08.020
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Laurance S, 2011, HAEMATOL-HEMATOL J, V96, P534, DOI 10.3324/haematol.2010.026740
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liu X, 2010, BIOMATERIALS, V31, P8198, DOI 10.1016/j.biomaterials.2010.07.069
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72
   O'Brien CD, 2004, AM J PHYSIOL-CELL PH, V287, pC1103, DOI 10.1152/ajpcell.00573.2003
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Rimondini L, 2005, ORAL SURG ORAL MED O, V99, P148, DOI 10.1016/j.tripleo.2004.05.010
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   SCHWARTZ Z, 1993, J BIOMED MATER RES, V27, P1029, DOI 10.1002/jbm.820270808
   Simon AM, 2002, DEV BIOL, V251, P206, DOI 10.1006/dbio.2002.0826
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
NR 46
TC 36
Z9 38
U1 5
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 23
PY 2015
VL 5
AR 9409
DI 10.1038/srep09409
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CD8WF
UT WOS:000351376400002
PM 25797242
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Carmichael, D
   Siletti, C
   Petrides, D
AF Carmichael, Doug
   Siletti, Charles
   Petrides, Dimitrios
TI Biomaterial production process intensification, analysis, and
   optimization with process simulation tools
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Carmichael, Doug] Intelligen Inc, Boulder, CO USA.
   [Petrides, Dimitrios] Intelligen Inc, Scotch Plains, NJ USA.
   [Siletti, Charles] Intelligen Inc, Concord, NH USA.
EM dcarmichael@intelligen.com
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 22
PY 2015
VL 249
MA 313
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VA9RL
UT WOS:000411183301095
DA 2018-10-19
ER

PT J
AU Larsson, P
   Wagberg, L
AF Larsson, Per
   Wagberg, Lars
TI Biomaterial-based barrier materials and composites: A review on how to
   prevent unwanted
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Larsson, Per; Wagberg, Lars] KTH Royal Inst Technol, Fibre & Polymer Technol, Stockholm, Sweden.
   [Larsson, Per] KTH Royal Inst Technol, BiMaC Innovat, Stockholm, Sweden.
   [Wagberg, Lars] KTH Royal Inst Technol, Wallenberg Wood Sci Ctr, Stockholm, Sweden.
EM per.larsson@polymer.kth.se
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 22
PY 2015
VL 249
MA 110
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA VA9RR
UT WOS:000411186504758
DA 2018-10-19
ER

PT J
AU Fitzpatrick, AWP
   Vanacore, GM
   Zewail, AH
AF Fitzpatrick, Anthony W. P.
   Vanacore, Giovanni M.
   Zewail, Ahmed H.
TI Nanomechanics and intermolecular forces of amyloid revealed by
   four-dimensional electron microscopy
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE nanomechanics; proteins; structural dynamics; 4D electron diffraction
ID A-BETA; FIBRILS; PEPTIDE; VISUALIZATION; MECHANICS; DISEASE; BOND; NMR
AB The amyloid state of polypeptides is a stable, highly organized structural form consisting of laterally associated beta-sheet protofilaments that may be adopted as an alternative to the functional, native state. Identifying the balance of forces stabilizing amyloid is fundamental to understanding the wide accessibility of this state to peptides and proteins with unrelated primary sequences, various chain lengths, and widely differing native structures. Here, we use four-dimensional electron microscopy to demonstrate that the forces acting to stabilize amyloid at the atomic level are highly anisotropic, that an optimized interbackbone hydrogen-bonding network within beta-sheets confers 20 times more rigidity on the structure than sequence-specific sidechain interactions between sheets, and that electrostatic attraction of protofilaments is only slightly stronger than these weak amphiphilic interactions. The potential biological relevance of the deposition of such a highly anisotropic biomaterial in vivo is discussed.
C1 [Fitzpatrick, Anthony W. P.; Vanacore, Giovanni M.; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.
RP Zewail, AH (reprint author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.
EM zewail@caltech.edu
OI gaber, sarah/0000-0002-5995-7291
FU National Science Foundation [DMR-0964886]; Air Force Office of
   Scientific Research in the Gordon and Betty Moore Center for Physical
   Biology at the California Institute of Technology [FA9550-11-1-0055];
   Marie Curie International Outgoing Fellowship
FX This work was supported by the National Science Foundation (DMR-0964886)
   and the Air Force Office of Scientific Research (FA9550-11-1-0055) in
   the Gordon and Betty Moore Center for Physical Biology at the California
   Institute of Technology. A.W.P.F. is supported by a Marie Curie
   International Outgoing Fellowship.
CR Ashby M. F., 2012, ENG MAT, V1
   Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Clary DC, 1997, OPTICAL ELCT MAGNETI
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   DELANO WL, 2002, DELANO SCI
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Eisenberg D, 2005, STRUCTURE PROPERTIES
   Fandrich M, 2009, PRION, V3, P89
   Feldblum ES, 2014, P NATL ACAD SCI USA, V111, P4085, DOI 10.1073/pnas.1319827111
   Fitzpatrick AWP, 2013, J AM CHEM SOC, V135, P19123, DOI 10.1021/ja4115055
   Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P10976, DOI 10.1073/pnas.1309690110
   Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110
   Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250
   Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862
   Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080
   Lide D.R., 1988, CRC HDB CHEM PHYS
   Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102
   Lulevich V, 2010, P NATL ACAD SCI USA, V107, P13872, DOI 10.1073/pnas.1008341107
   Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109
   Mohammed OF, 2009, ANGEW CHEM INT EDIT, V48, P5628, DOI 10.1002/anie.200900513
   Newnham R E, 2005, PROPERTIES MAT ANISO
   Pampaloni F, 2006, P NATL ACAD SCI USA, V103, P10248, DOI 10.1073/pnas.0603931103
   Paparcone R, 2011, BIOMATERIALS, V32, P3367, DOI 10.1016/j.biomaterials.2010.11.066
   Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906
   Park ST, 2012, J AM CHEM SOC, V134, P9146, DOI 10.1021/ja304042r
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607
   Usov I, 2014, ACS NANO, V8, P11035, DOI 10.1021/nn503530a
   Xu ZP, 2010, BIOPHYS J, V98, P2053, DOI 10.1016/j.bpj.2009.12.4317
   Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034
   Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809
   Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135
NR 43
TC 18
Z9 19
U1 2
U2 59
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 17
PY 2015
VL 112
IS 11
BP 3380
EP 3385
DI 10.1073/pnas.1502214112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CD4NM
UT WOS:000351060000069
PM 25733888
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Hulsman, M
   Hulshof, F
   Unadkat, H
   Papenburg, BJ
   Stamatialis, DF
   Truckenmuller, R
   van Blitterswijk, C
   de Boer, J
   Reinders, MJT
AF Hulsman, Marc
   Hulshof, Frits
   Unadkat, Hemant
   Papenburg, Bernke J.
   Stamatialis, Dimitrios F.
   Truckenmuller, Roman
   van Blitterswijk, Clemens
   de Boer, Jan
   Reinders, Marcel J. T.
TI Analysis of high-throughput screening reveals the effect of surface
   topographies on cellular morphology
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell morphology; Interface; Surface topography; Modelling; Mesenchymal
   stem cell
ID POROUS SILICON GRADIENTS; EXTRACELLULAR-MATRIX; INTERIOR SURFACES;
   NUCLEAR LAMINA; STEM-CELLS; DIFFERENTIATION; SCAFFOLDS; FATE;
   COMBINATORIAL; ORIENTATION
AB Surface topographies of materials considerably impact cellular behavior as they have been shown to affect cell growth, provide cell guidance, and even induce cell differentiation. Consequently, for successful application in tissue engineering, the contact interface of biomaterials needs to be optimized to induce the required cell behavior. However, a rational design of biomaterial surfaces is severely hampered because knowledge is lacking on the underlying biological mechanisms. Therefore, we previously developed a high-throughput screening device (TopoChip) that measures cell responses to large libraries of parameterized topographical material surfaces. Here, we introduce a computational analysis of high-throughput materiome data to capture the relationship between the surface topographies of materials and cellular morphology. We apply robust statistical techniques to find surface topographies that best promote a certain specified cellular response. By augmenting surface screening with data-driven modeling, we determine which properties of the surface topographies influence the morphological properties of the cells. With this information, we build models that predict the cellular response to surface topographies that have not yet been measured. We analyze cellular morphology on 2176 surfaces, and find that the surface topography significantly affects various cellular properties, including the roundness and size of the nucleus, as well as the perimeter and orientation of the cells. Our learned models capture and accurately predict these relationships and reveal a spectrum of topographies that induce various levels of cellular morphologies. Taken together, this novel approach of high-throughput screening of materials and subsequent analysis opens up possibilities for a rational design of biomaterial surfaces. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hulsman, Marc; Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, NL-2628 CD Delft, Netherlands.
   [Hulshof, Frits; Unadkat, Hemant; Truckenmuller, Roman; van Blitterswijk, Clemens; de Boer, Jan] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Hulshof, Frits; Stamatialis, Dimitrios F.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [de Boer, Jan] Maastricht Univ, Merln Inst, Lab Cell Biol Inspired Tissue Engn, NL-6211 LK Maastricht, Netherlands.
   [Papenburg, Bernke J.] Materiomics BV, NL-3723 MB Bilthoven, Netherlands.
RP Hulsman, M (reprint author), Delft Univ Technol, Delft Bioinformat Lab, Mekelweg 4, NL-2628 CD Delft, Netherlands.
EM m.hulsman@tudelft.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
FU STW program; NanoNext NL program [06C.12]
FX M.H. acknowledges the financial support of the STW program. F.H.
   acknowledges the financial support of the NanoNext NL program, project
   06C.12: High throughput screening of biologically active surface
   nano-topographies.
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Amis EJ, 2004, NAT MATER, V3, P83, DOI 10.1038/nmat1064
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Clements LR, 2012, LAB CHIP, V12, P1480, DOI 10.1039/c2lc20732j
   Cranford S, 2010, NANOTECHNOL SCI APPL, V3, P127, DOI 10.2147/NSA.S9037
   Drucker H, 1997, ADV NEUR IN, V9, P155
   DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hampoelz B, 2011, CURR OPIN CELL BIOL, V23, P668, DOI 10.1016/j.ceb.2011.10.001
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Huber P. J., 1981, ROBUST STAT
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Le T, 2012, CHEM REV, V112, P2889, DOI 10.1021/cr200066h
   Li X, 2011, ACS COMB SCI, V13, P50, DOI 10.1021/co100019d
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meredith JC, 2009, J MATER CHEM, V19, P34, DOI 10.1039/b808649d
   Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042
   Mishra KP, 2008, BIOMED PHARMACOTHER, V62, P94, DOI 10.1016/j.biopha.2007.06.012
   Pan Z, 2013, CHINESE J POLYM SCI, V31, P737, DOI 10.1007/s10118-013-1264-1
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016
   Qu ZH, 2013, J BIOMAT SCI-POLYM E, V24, P447, DOI 10.1080/09205063.2012.690285
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   Settles B., 2009, 1648 U WISC
   Smith JR, 2005, POLYMER, V46, P4296, DOI 10.1016/j.polymer.2005.03.012
   Sun JG, 2009, CHINESE SCI BULL, V54, P3154, DOI 10.1007/s11434-009-0240-1
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Veith M., 2013, OPEN J REGEN MED, V3, P74
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang PY, 2012, ADV FUNCT MATER, V22, P3414, DOI 10.1002/adfm.201200447
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Zhao Y, 2009, BIOTECHNOL BIOENG, V102, P624, DOI 10.1002/bit.22080
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 45
TC 28
Z9 29
U1 4
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 29
EP 38
DI 10.1016/j.actbio.2014.12.019
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800004
PM 25554402
DA 2018-10-19
ER

PT J
AU Wang, K
   Yu, LY
   Jiang, LY
   Wang, HB
   Wang, CY
   Luo, Y
AF Wang, Kai
   Yu, Lin-Yang
   Jiang, Li-Yang
   Wang, Hai-Bin
   Wang, Chang-Yong
   Luo, Ying
TI The paracrine effects of adipose-derived stem cells on
   neovascularization and biocompatibility of a macroencapsulation device
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Adipose-derived stem cell; Macroencapsulation; Foreign body reaction;
   Angiogenesis; Immunomodulation
ID FOREIGN-BODY RESPONSE; STROMAL CELLS; IMMUNOISOLATION DEVICE;
   SUBCUTANEOUS IMPLANTS; REGENERATIVE MEDICINE; BIOMATERIALS;
   INFLAMMATION; MACROPHAGES; ISLETS; ENCAPSULATION
AB The foreign-body response to biomaterials compromises the performance of many biomedical devices by severe fibrosis and limited neovascularization. Mesenchymal stem cells are known to secrete cytokines for treating inflammatory conditions. In this study, we aim to investigate whether the paracrine products of adipose-derived mesenchymal stem cells (ADSCs) can affect the microenvironment of biomaterials and improve tissue responses to biomaterial implants. A model system was built by loading ADSC spheroids into a macroencapsulation device composed of polytetrafluoroethylene (PTFE) filtration membranes. Soluble ADSC factors that diffused out of the device in vitro promoted the angiogenetic activity of endothelial cells and affected the secretion pattern of macrophages. In vivo study was carried out by subcutaneously embedding blank or ADSC-laden devices in rats. Following a 4 week implantation, the ADSC-laden devices were better vascularized and induced significantly less fibrotic tissue formation in comparison to the non-cellular controls. This study may facilitate our understanding of foreign-body responses and suggest new ways to improve the tissue reaction of biomedical devices for cell-based therapy. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Kai; Yu, Lin-Yang; Jiang, Li-Yang; Luo, Ying] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
   [Wang, Hai-Bin; Wang, Chang-Yong] Acad Mil Med Sci, Dept Adv Interdisciplinary Studies, Inst Basic Med Sci, Beijing 100039, Peoples R China.
   [Wang, Hai-Bin; Wang, Chang-Yong] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing 100039, Peoples R China.
   [Luo, Ying] Natl Engn Lab Regenerat & Implantable Med Devices, Guangzhou 510663, Guangdong, Peoples R China.
RP Luo, Y (reprint author), Peking Univ, Coll Engn, Dept Biomed Engn, Room 206,Fangzheng Bldg,298 Chengfu Rd, Beijing 100871, Peoples R China.
EM ying.luo@pku.edu.cn
RI Luo, Ying/A-9920-2012
OI Luo, Ying/0000-0001-9834-9419
FU Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03];
   National Natural Science Foundation of China [31322021]; Projects Grants
   of National Engineering Laboratory for Regenerative and Implantable
   Medical Devices [2012NELRMD003]
FX This research was financially supported by the Key New Drug Creation and
   Manufacturing Program (2011ZX09102-010-03), the National Natural Science
   Foundation of China (Project No. 31322021), and the Projects Grants of
   National Engineering Laboratory for Regenerative and Implantable Medical
   Devices (2012NELRMD003). We thank Dr. Yong-Jian Deng (Department of
   Pathology, Southern Medical University) for his assistance with the
   analysis of histology slides.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816
   Baraniak PR, 2009, REGEN MED, V5, P121
   Barkai U, 2013, CELL TRANSPLANT, V22, P1463, DOI 10.3727/096368912X657341
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
   Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Bruin JE, 2013, DIABETOLOGIA, V56, P1987, DOI 10.1007/s00125-013-2955-4
   Capone SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062032
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015
   Geller RL, 1997, ANN NY ACAD SCI, V831, P438
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018
   Johnson AS, 2009, CHEM ENG SCI, V64, P4470, DOI 10.1016/j.ces.2009.06.028
   Junge K, 2012, LANGENBECK ARCH SURG, V397, P255, DOI 10.1007/s00423-011-0780-0
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Kumagai-Braesch M, 2013, CELL TRANSPLANT, V22, P1137, DOI 10.3727/096368912X657486
   Laschke MW, 2013, ACTA BIOMATER, V9, P6876, DOI 10.1016/j.actbio.2013.02.013
   Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612
   Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Melief SM, 2013, HAEMATOLOGICA, V98, P888, DOI 10.3324/haematol.2012.078055
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nichols SP, 2012, BIOMATERIALS, V33, P6305, DOI 10.1016/j.biomaterials.2012.05.053
   O'Sullivan ES, 2011, ENDOCR REV, V32, P827, DOI 10.1210/er.2010-0026
   Orive G., 2013, ADV DRUG DELIV REV, V67-68, P3
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371
   Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200
   Prichard HL, 2008, STEM CELLS, V26, P2691, DOI 10.1634/stemcells.2008-0140
   Rafael E, 2003, CELL TRANSPLANT, V12, P407, DOI 10.3727/000000003108746957
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Santos E, 2013, J CONTROL RELEASE, V170, P1, DOI 10.1016/j.jconrel.2013.04.015
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Sorenby A, 2004, CELL TRANSPLANT, V13, P713, DOI 10.3727/000000004783983512
   Su J, 2013, CELL DEATH DIFFER, V21, P388
   Swartzlander MD, 2013, BIOMATERIALS, V34, P952, DOI 10.1016/j.biomaterials.2012.10.037
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   Wang K, 2013, BIOMACROMOLECULES, V14, P2373, DOI 10.1021/bm4004942
   Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Xu KD, 2013, ACTA BIOMATER, V9, P8802, DOI 10.1016/j.actbio.2013.06.021
   Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
NR 62
TC 14
Z9 14
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 65
EP 76
DI 10.1016/j.actbio.2014.12.025
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800008
PM 25575852
DA 2018-10-19
ER

PT J
AU Zhou, S
   Huang, WW
   Belton, DJ
   Simmons, LO
   Perry, CC
   Wang, XQ
   Kaplan, DL
AF Zhou, Shun
   Huang, Wenwen
   Belton, David J.
   Simmons, Leo O.
   Perry, Carole C.
   Wang, Xiaoqin
   Kaplan, David L.
TI Control of silicification by genetically engineered fusion proteins:
   Silk-silica binding peptides
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Spider silk; Silica; Silicification; Fusion proteins
ID SPIDER DRAGLINE SILK; BLOCK-COPOLYMERS; CYLINDROTHECA-FUSIFORMIS;
   PRECIPITATING PEPTIDES; NANOPARTICLES; BIOSILICA; DOMAINS
AB In the present study, an artificial spider silk gene, 6mer, derived from the consensus sequence of Nephila clavipes dragline silk gene, was fused with different silica-binding peptides (SiBPs), A1, A3 and R5, to study the impact of the fusion protein sequence chemistry on silica formation and the ability to generate a silk silica composite in two different bioinspired silicification systems: solution solution and solution solid. Condensed silica nanoscale particles (600-800 nm) were formed in the presence of the recombinant silk and chimeras, which were smaller than those formed by 15mer-SiBP chimeras [1], revealing that the molecular weight of the silk domain correlated to the sizes of the condensed silica particles in the solution system. In addition, the chimeras (6mer-A1/A3/R5) produced smaller condensed silica particles than the control (6mer), revealing that the silica particle size formed in the solution system is controlled by the size of protein assemblies in solution. In the solution-solid interface system, silicification reactions were performed on the surface of films fabricated from the recombinant silk proteins and chimeras and then treated to induce beta-sheet formation. A higher density of condensed silica formed on the films containing the lowest beta-sheet content while the films with the highest beta-sheet content precipitated the lowest density of silica, revealing an inverse correlation between the beta-sheet secondary structure and the silica content formed on the films. Intriguingly, the 6mer-A3 showed the highest rate of silica condensation but the lowest density of silica deposition on the films, compared with 6mer-A1 and -R5, revealing antagonistic crosstalk between the silk and the SiBP domains in terms of protein assembly. These findings offer a path forward in the tailoring of biopolymer silica composites for biomaterial related needs. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhou, Shun; Wang, Xiaoqin; Kaplan, David L.] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Zhou, Shun; Huang, Wenwen; Wang, Xiaoqin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Belton, David J.; Perry, Carole C.] Nottingham Trent Univ, Sch Sci & Technol, Interdisciplinary Biomed Res Ctr, Biomol & Mat Interface Res Grp, Nottingham NG11 8NS, England.
   [Simmons, Leo O.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083; Perry, Professor
   Carole/0000-0003-1517-468X
FU NIH [R01 DE017207]; Natural Science Foundation of China (NSFC)
   [51273138]
FX We thank the NIH (R01 DE017207) and Natural Science Foundation of China
   (NSFC, project no. 51273138) for support of this research.
CR Belton DJ, 2008, P NATL ACAD SCI USA, V105, P5963, DOI 10.1073/pnas.0710809105
   Belton DJ, 2012, LANGMUIR, V28, P4373, DOI 10.1021/la205084z
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Canabady-Rochelle LLS, 2012, BIOMACROMOLECULES, V13, P683, DOI 10.1021/bm201555c
   Choi O, 2011, ENZYME MICROB TECH, V49, P441, DOI 10.1016/j.enzmictec.2011.07.005
   Currie HA, 2011, ADV FUNCT MATER, V21, P2889, DOI 10.1002/adfm.201100249
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Gomes S, 2011, SOFT MATTER, V7, P4964, DOI 10.1039/c1sm05024a
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huang WW, 2011, MACROMOLECULES, V44, P5299, DOI 10.1021/ma200563t
   Knecht MR, 2003, CHEM COMMUN, P3038, DOI 10.1039/b309074d
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200
   Kuno T, 2011, LANGMUIR, V27, P13154, DOI 10.1021/la202576v
   Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004
   Marner WD, 2008, BIOMACROMOLECULES, V9, P1, DOI 10.1021/bm701131x
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Mieszawska AJ, 2010, CHEM MATER, V22, P5780, DOI 10.1021/cm101940u
   Naik RR, 2002, J NANOSCI NANOTECHNO, V2, P95, DOI 10.1166/jnn.2002.074
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219
   Rabotyagova OS, 2010, MACROMOL BIOSCI, V10, P49, DOI 10.1002/mabi.200900203
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h
   Tang-Schomer MD, 2014, P NATL ACAD SCI US
   Wray LS, 2013, ADV FUNCT MATER, V23, P3404, DOI 10.1002/adfm.201202926
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Xia X, 2014, BIOMACROMOLECULES
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
NR 33
TC 16
Z9 16
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 173
EP 180
DI 10.1016/j.actbio.2014.10.040
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800017
PM 25462851
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bhuiyan, D
   Jablonsky, MJ
   Kolesov, I
   Middleton, J
   Wick, TM
   Tannenbaum, R
AF Bhuiyan, D.
   Jablonsky, M. J.
   Kolesov, I.
   Middleton, J.
   Wick, T. M.
   Tannenbaum, R.
TI Novel synthesis and characterization of a collagen-based biopolymer
   initiated by hydroxyapatite nanoparticles
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biodegradable polymer; Collagen; PLGA; Hydroxyapatite
ID HYDROXYLAPATITE POLY(L-LACTIDE) COMPOSITES; LACTIDE-CO-GLYCOLIDE; CREST
   BONE-GRAFT; BIORESORBABLE DEVICES; MECHANICAL-PROPERTIES; POLYMER
   COMPOSITES; FORGED COMPOSITES; INTERNAL-FIXATION; BLOCK-COPOLYMERS; HA
   PARTICLES
AB In this study, we developed a novel synthesis method to create a complex collagen-based biopolymer that promises to possess the necessary material properties for a bone graft substitute. The synthesis was carried out in several steps. In the first step, a ring-opening polymerization reaction initiated by hydroxyapatite nanoparticles was used to polymerize D,L-lactide and glycolide monomers to form poly(lactide-co-glycolide) co-polymer. In the second step, the polymerization product was coupled with succinic anhydride, and subsequently was reacted with N-hydroxysuccinimide in the presence of dicyclohexylcarbodiimide as the cross-linking agent, in order to activate the co-polymer for collagen attachment. In the third and final step, the activated co-polymer was attached to calf skin collagen type I, in hydrochloric acid/phosphate buffer solution and the precipitated co-polymer with attached collagen was isolated. The synthesis was monitored by proton nuclear magnetic resonance, infrared and Raman spectroscopies, and the products after each step were characterized by thermal and mechanical analysis. Calculations of the relative amounts of the various components, coupled with initial dynamic mechanical analysis testing of the resulting biopolymer, afforded a preliminary assessment of the structure of the complex biomaterial formed by this novel polymerization process. (C) 2015 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Bhuiyan, D.; Middleton, J.; Wick, T. M.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Jablonsky, M. J.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.
   [Kolesov, I.] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA.
   [Tannenbaum, R.] SUNY Stony Brook, Program Chem & Mol Engn, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
RP Tannenbaum, R (reprint author), SUNY Stony Brook, Program Chem & Mol Engn, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
EM irena.tannenbaum@stonybrook.edu
OI Wick, Timothy/0000-0001-8922-0939
FU School of Engineering at the University of Alabama at Birmingham
FX The authors acknowledge the financial support of the School of
   Engineering at the University of Alabama at Birmingham and the valuable
   discussions with Drs. Hamid Garmestani Georgia Tech, Paul Eleazer and
   Eugenia Kharlampieva of UAB.
CR Albertsson AC, 2002, ADV POLYM SCI, V157, P1
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   Bishop RC, 1996, J NEUROSURG, V85, P206, DOI 10.3171/jns.1996.85.2.0206
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, V174, P28
   Cherry DK, 2009, NATL HLTH STAT REP, V3, P1
   Chung KC, 2001, J HAND SURG-AM, V26A, P908, DOI 10.1053/jhsu.2001.26322
   D'Avila Carvalho Erbetta C, 2012, J BIOMATER NANOBIOTE, V3, P208, DOI DOI 10.4236/JBNB.2012.32027
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Edgecombe BD, 1998, MACROMOLECULES, V31, P1292, DOI 10.1021/ma970832q
   EDWARDS DC, 1990, J MATER SCI, V25, P4175, DOI 10.1007/BF00581070
   Eitan A, 2003, CHEM MATER, V15, P3198, DOI 10.1021/cm020975d
   Flierl MA, 2010, ORTHOPEDICS, V33, P102, DOI 10.3928/01477447-20100104-21
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Guierrez GE, 2008, J BONE MINER RES, V23, P1722
   Guo XE, 1997, FORMA, V12, P185
   Hamley IW, 1999, ADV POLYM SCI, V148, P113
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Hong ZK, 2004, POLYMER, V45, P6699, DOI 10.1016/j.polymer.2004.07.036
   HORISAKA Y, 1994, J BIOMED MATER RES, V28, P97, DOI 10.1002/jbm.820280113
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Izunobi JU, 2011, J CHEM EDUC, V88, P1098, DOI 10.1021/ed100461v
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Lu XY, 1996, J POLYM SCI POL PHYS, V34, P1795, DOI 10.1002/(SICI)1099-0488(19960730)34:10<1795::AID-POLB11>3.0.CO;2-6
   Mayo FR, 1944, J AM CHEM SOC, V66, P1594, DOI 10.1021/ja01237a052
   Melton L.J., 1993, BONE S1, V14, P1
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   Odian G., 2004, PRINCIPLES POLYM, P464
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Porjazoska A, 2006, J BIOMAT SCI-POLYM E, V17, P323, DOI 10.1163/156856206775997296
   Ren TB, 2005, J BIOMED MATER RES A, V74A, P562, DOI 10.1002/jbm.a.30324
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Rovira A, 1996, BIOMATERIALS, V17, P1335
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Tannenbaum R, 2003, J POLYM SCI POL PHYS, V41, P1814, DOI 10.1002/polb.10557
   VANHOORNE P, 1992, MACROMOLECULES, V25, P37, DOI 10.1021/ma00027a008
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhang PB, 2011, BIOMACROMOLECULES, V12, P2667, DOI 10.1021/bm2004725
   Zhang PB, 2009, BIOMATERIALS, V30, P58, DOI 10.1016/j.biomaterials.2008.08.041
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhu J, 2004, ADV FUNCT MATER, V14, P643, DOI 10.1002/adfm.200305162
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 54
TC 18
Z9 18
U1 1
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 181
EP 190
DI 10.1016/j.actbio.2014.11.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800018
PM 25481742
DA 2018-10-19
ER

PT J
AU Ahmed, MH
   Byrne, JA
   McLaughlin, J
AF Ahmed, Mukhtar H.
   Byrne, John A.
   McLaughlin, James
TI Kinetics and thermodynamics of human serum albumin adsorption on silicon
   doped diamond like carbon
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Chemical vapour deposition; Adsorption; Thermodynamic
ID DLC THIN-FILMS; AMORPHOUS-CARBON; PROTEIN ADSORPTION; SURFACE-TENSION;
   HEMOCOMPATIBILITY; ELLIPSOMETRY; GLYCINE; BIOMATERIALS; DEPOSITION;
   COMPONENTS
AB To gain a better understanding of protein adsorption onto biomaterial surfaces is required for the control of biocompatibility and bioactivity. Various samples of diamond like carbon (DLC) and silicon-doped DLC were synthesised using plasma enhanced chemical vapour deposition (PECVD). The effects of surface morphology on the interaction of human serum albumin (HSA) with doped and undoped DLC films was investigated using spectroscopic ellipsometry (SE) and other surface analysis techniques. The results highlighted an increase in both contact angle and hydrophobicity with increasing silicon dopant levels. A reduction on the contact angle values.
   After adsorption of HSA, the films showed a reduction in the contact angle with a significant change in the cosh, and this gap increased with increasing surface coverage of HSA. The adsorption kinetics of HSA were also investigated and revealed that the maximum adsorption occurred at pH 5.0 and the process involved chemisorption. The experimental isotherm data were analysed using the Langmuir and Freundlich models. The amount of HSA adsorbed increased with contact time and reached saturation after 30 min. The adsorption process was found to be pseudo first order with respect to the bulk concentration and was dependent on both the concentration of protein and surface characteristics of the samples. The amount of adsorbed HSA was higher with higher levels of silicon doping of the DLC. Therefore, doping DLC may provide an approach to controlling the protein adsorption. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ahmed, Mukhtar H.; Byrne, John A.; McLaughlin, James] Univ Ulster, Nanotechnol Integrated Bioengn Ctr, Belfast BT37 0QB, Antrim, North Ireland.
RP Ahmed, MH (reprint author), Univ Ulster, Nanotechnol Integrated Bioengn Ctr, Shore Rd, Belfast BT37 0QB, Antrim, North Ireland.
EM ahmed-m@email.ulster.ac.uk
OI McLaughlin, James/0000-0001-6026-8971; Byrne, John/0000-0001-9527-7659
CR Ahmed M, 2012, J MATER SCI, V47, P1729, DOI 10.1007/s10853-011-5952-3
   Ahmed M. H., 2013, J BIOMATER NANOBIOTE, V4, P194
   Ahmed MH, 2013, J PHOTOCH PHOTOBIO A, V254, P1, DOI 10.1016/j.jphotochem.2012.12.019
   Ahmed MH, 2012, SURF COAT TECH, V209, P8, DOI 10.1016/j.surfcoat.2012.07.011
   Ahmed MH, 2012, APPL SURF SCI, V258, P5166, DOI 10.1016/j.apsusc.2012.01.162
   Alves CM, 2010, J R SOC INTERFACE, V7, P1367, DOI 10.1098/rsif.2010.0022
   ARWIN H, 1984, THIN SOLID FILMS, V113, P101, DOI 10.1016/0040-6090(84)90019-1
   Bayramoglu G, 2005, BIOCHEM ENG J, V26, P12, DOI 10.1016/j.bej.2005.06.002
   Bayramoglu G, 2007, COLLOID SURFACE A, V294, P56, DOI 10.1016/j.colsurfa.2006.07.043
   Benesch J, 2002, J COLLOID INTERF SCI, V249, P84, DOI 10.1006/jcis.2002.8247
   BERG JM, 1994, LANGMUIR, V10, P1225, DOI 10.1021/la00016a041
   Chan D, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2435703
   Chen LY, 2003, DIAM RELAT MATER, V12, P968, DOI 10.1016/S0925-9635(02)00351-5
   Choi HW, 2008, DIAM RELAT MATER, V17, P252, DOI 10.1016/j.diamond.2007.12.034
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Damasceno JC, 2000, SURF COAT TECH, V133, P247, DOI 10.1016/S0257-8972(00)00932-4
   Fedosenko G, 2002, THIN SOLID FILMS, V406, P275, DOI 10.1016/S0040-6090(01)01768-0
   Feng WC, 2009, J VAC SCI TECHNOL B, V27, P1559, DOI 10.1116/1.3077271
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P191, DOI 10.1016/0304-3894(95)00156-5
   Golden J.H., 2001, SEMICOND INT, V79
   Goswami S, 2005, WATER SA, V31, P597
   GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D
   Hameed BH, 2008, J HAZARD MATER, V158, P65, DOI 10.1016/j.jhazmat.2008.01.034
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Howland MC, 2007, BIOPHYS J, V92, P1306, DOI 10.1529/biophysj.106.097071
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Ji XL, 2011, J BIOMOL STRUCT DYN, V28, P621, DOI 10.1080/07391102.2011.10508598
   Kassab A, 2000, J CHROMATOGR B, V746, P123, DOI 10.1016/S0378-4347(00)00311-X
   KERKEB ML, 1993, J COLLOID INTERF SCI, V159, P439, DOI 10.1006/jcis.1993.1344
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Liu BL, 2006, APPL SURF SCI, V252, P7830, DOI 10.1016/j.apsusc.2005.09.058
   Liu M., 2012, INT J RES REV APPL S, V11, P67
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   Lousinian S, 2007, BIOMOL ENG, V24, P107, DOI 10.1016/j.bioeng.2006.05.014
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   Mahajan SS, 1997, THIN SOLID FILMS, V302, P250, DOI 10.1016/S0040-6090(96)09519-3
   Martra G, 2002, RES CHEM INTERMEDIAT, V28, P359, DOI 10.1163/15685670260188665
   Mohsen-Nia M, 2012, PROTEIN J, V31, P150, DOI 10.1007/s10930-011-9384-3
   Ogwu AA, 2008, J BIOMED MATER RES B, V85B, P105, DOI 10.1002/jbm.b.30922
   Okpalugo TIT, 2006, J BIOMED MATER RES B, V78B, P222, DOI 10.1002/jbm.b.30459
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   Robert D, 2000, APPL SURF SCI, V167, P51, DOI 10.1016/S0169-4332(00)00496-7
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Schnell S, 2004, BIOPHYS CHEM, V107, P165, DOI 10.1016/j.bpc.2003.09.003
   Tewari BB, 2007, COLLOID SURFACE A, V296, P264, DOI 10.1016/j.colsurfa.2006.10.007
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Yan WJ, 2013, SCI WORLD J, DOI 10.1155/2013/273023
   Zhang DQ, 2008, MATER CHEM PHYS, V112, P353, DOI 10.1016/j.matchemphys.2008.05.060
   Zhang S, 2006, THIN SOLID FILMS, V515, P66, DOI 10.1016/j.tsf.2005.12.037
   Zhang ZG, 2013, ADV MATER SCI ENG, DOI 10.1155/2013/861804
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 55
TC 5
Z9 6
U1 1
U2 35
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAR 15
PY 2015
VL 154
BP 84
EP 93
DI 10.1016/j.matchemphys.2015.01.048
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA CC1BF
UT WOS:000350075500012
DA 2018-10-19
ER

PT J
AU Madeleine-Perdrillat, C
   Karbowiak, T
   Raya, J
   Gougeon, R
   Bodart, PR
   Debeaufort, F
AF Madeleine-Perdrillat, Claire
   Karbowiak, Thomas
   Raya, Jesus
   Gougeon, Regis
   Bodart, Philippe R.
   Debeaufort, Frederic
TI Water-induced local ordering of chitosan polymer chains in thin layer
   films
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Water; Structure; Polymer; Chitosan; NMR
ID SOLID-STATE NMR; RESIDUE CARBONYL CARBONS; ANGLE-SPINNING NMR;
   X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; ALPHA-CHITIN; FOOD APPLICATIONS;
   CHEMICAL-SHIFTS; SPECTROSCOPY; SALTS
AB Carbon-13 NMR (CP-MAS and FSLG H-1-C-13 HETCOR) have been applied to chitosan salt films synthesized in acetic acid and exposed to different relative humidity environments (32% or 75%) at 20 degrees C for 1 month. It gives insight in the relationship between structure and functional properties according to the hydration level of this biomaterial as a film. The acetate ions trapped in the chitosan act as structuring agents between chitosan chains for the low hydration state. But, increasing the moisture content induces spontaneous removal of acetic acid and a subsequent modification in the film structure, with an increase in local ordering. HETCOR experiments also showed a multiplicity of signals for most of the observed carbon atoms and in particular those implied in the glycosidic linkage, which reveals different water-induced conformational states. Changing the water content allows to modify the polymer structure and therefore to modulate the properties such as controlled release of active compounds trapped in chitosan-based coatings, e.g., for medicated dressing or active packaging. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Madeleine-Perdrillat, Claire; Karbowiak, Thomas; Gougeon, Regis; Debeaufort, Frederic] Univ Bourgogne, AgroSup Dijon, Equipe PAPC, UMR A PAM 02 102, F-21078 Dijon, France.
   [Raya, Jesus] Univ Strasbourg, Inst Chim, CNRS, UMR 7177, F-67008 Strasbourg, France.
   [Bodart, Philippe R.] IUT A Univ Sci & Technol Lille, F-59653 Villeneuve Dascq, France.
RP Karbowiak, T (reprint author), Univ Bourgogne, AgroSup Dijon, Equipe PAPC, UMR A PAM 02 102, 1 Esplanade Erasme, F-21078 Dijon, France.
EM thomas.karbowiak@u-bourgogne.fr
RI Gougeon, Regis/T-4069-2017; karbowiak, thomas/Q-2151-2018;
   Madeleine-Perdrillat, Claire/R-4347-2017
OI Gougeon, Regis/0000-0002-5371-5523; karbowiak,
   thomas/0000-0002-4229-3003; Madeleine-Perdrillat,
   Claire/0000-0001-7226-0344; DEBEAUFORT, Frederic/0000-0002-4760-0500
FU Regional Council of Burgundy [2012-9201AAO049S780]
FX This work was supported by the Regional Council of Burgundy through the
   project number 2012-9201AAO049S780.
CR Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647
   Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001
   Cunha RA, 2012, COMPLEX WORLD OF POLYSACCHARIDES, P229, DOI 10.5772/51803
   DEMARGERANDRE S, 1994, CARBOHYD POLYM, V23, P211, DOI 10.1016/0144-8617(94)90104-X
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Domjan A, 2009, MACROMOLECULES, V42, P4667, DOI 10.1021/ma8021234
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   Epure V, 2011, CARBOHYD POLYM, V83, P947, DOI 10.1016/j.carbpol.2010.09.003
   Franca EF, 2011, BIOPOLYMERS, V95, P448, DOI 10.1002/bip.21602
   Franca EF, 2008, J CHEM THEORY COMPUT, V4, P2141, DOI 10.1021/ct8002964
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y
   Kameda T, 1997, J MOL STRUCT, V412, P197, DOI 10.1016/S0022-2860(96)09529-4
   Kameda T, 2004, MACROMOL BIOSCI, V5, P103, DOI 10.1002/mabi.200400142
   Kameda T, 2004, J BIOMOL NMR, V29, P281, DOI 10.1023/B:JNMR.0000032557.71691.a2
   Kameda T, 1996, J MOL STRUCT, V384, P17, DOI 10.1016/S0022-2860(96)09322-2
   Kono H, 2004, BIOPOLYMERS, V75, P255, DOI 10.1002/bip.20124
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567
   Lertworasirikul A, 2003, CARBOHYD RES, V338, P1229, DOI 10.1016/S0008-6215(03)00145-9
   Ferreira ML, 2008, COLLOID SURFACE A, V315, P241, DOI 10.1016/j.colsurfa.2007.08.006
   Murata K, 2003, POLYMER, V44, P4021, DOI 10.1016/S0032-3861(03)00351-3
   Ogawa K, 2004, INT J BIOL MACROMOL, V34, P1, DOI 10.1016/j.ijbiomac.2003.11.002
   Okuyama K, 1997, MACROMOLECULES, V30, P5849, DOI 10.1021/ma970509n
   Okuyama K, 2000, CARBOHYD POLYM, V41, P237, DOI 10.1016/S0144-8617(99)00142-3
   PETER MG, 1995, J MACROMOL SCI PURE, VA32, P629, DOI 10.1080/10601329508010276
   Prashanth KVH, 2002, CARBOHYD POLYM, V50, P27
   Prathab B, 2007, J POLYM SCI POL PHYS, V45, P1260, DOI 10.1002/polb.21109
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   SAITO H, 1987, MACROMOLECULES, V20, P2424, DOI 10.1021/ma00176a017
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   TANNER SF, 1990, MACROMOLECULES, V23, P3576, DOI 10.1021/ma00217a008
   vanRossum BJ, 1997, J MAGN RESON, V124, P516, DOI 10.1006/jmre.1996.1089
   Webster A, 2006, SOLID STATE NUCL MAG, V30, P150, DOI 10.1016/j.ssnmr.2006.07.001
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 38
TC 9
Z9 9
U1 0
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 15
PY 2015
VL 118
BP 107
EP 114
DI 10.1016/j.carbpol.2014.11.001
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AZ5KL
UT WOS:000348259900016
PM 25542114
DA 2018-10-19
ER

PT J
AU Chutipakdeevong, J
   Ruktanonchai, U
   Supaphol, P
AF Chutipakdeevong, Jesada
   Ruktanonchai, Uracha
   Supaphol, Pitt
TI Hybrid biomimetic electrospun fibrous mats derived from
   poly(epsilon-caprolactone) and silk fibroin protein for wound dressing
   application
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; biomedical applications; biomimetic; nanofiber
ID SCAFFOLDS; SURFACE; POLYCAPROLACTONE; PEPTIDE; STRATEGIES; RESPONSES;
   FIBERS; CELLS
AB To achieve excellent biofunctionality of Bombyx mori silk fibroin (SF), we explored a novel hybridization method to combine the unique properties of SF with poly(epsilon-caprolactone) (PCL) electrospun fibers. The hybrid electrospun fibers demonstrate excellent hydrophilicity and biocompatibility that are important to tissue engineering applications. The biomimetic fibrous structure was fabricated by conventional electrospinning of PCL. The individual surfaces of PCL electrospun fibers were coated with silk fibroin protein using a lyophilization technique. The SF coating layers were durable which were further developed by surface modification with fibronectin to improve their biological function. The hybrid electrospun fibers show excellent support for normal human dermal fibroblast (NHDF) cells adhesion and proliferation than neat PCL fibers, while the surface-modified hybrid electrospun fibers show significantly enhanced proliferation of NHDF cells on their surface. This study indicates the new opportunity of fabrication technique that can construct a biomimetic fibrous structure while the original function as a biomaterial remained existing. (c) 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015, 132, 41653.
C1 [Chutipakdeevong, Jesada; Supaphol, Pitt] Chulalongkorn Univ, Petr & Petrochem Coll, Bangkok 10330, Thailand.
   [Ruktanonchai, Uracha] Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr NANOTEC, Pathum Thani 12120, Thailand.
RP Ruktanonchai, U (reprint author), Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr NANOTEC, 111 Thailand Sci Pk,Paholyothin Rd, Pathum Thani 12120, Thailand.
EM uracha@nanotec.or.th
FU National Nanotechnology Center [BR0108]; 90th Anniversary of
   Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund);
   National Center of Excellence for Petroleum, Petrochemicals, and
   Advanced Materials (NCE-PPAM); Petroleum and Petrochemical College,
   Chulalongkorn University, Thailand; Thailand Graduate Institute of
   Science and Technology (TGIST) [TG-55-09-51-035D]
FX The authors acknowledge partial support received from the National
   Nanotechnology Center (grant number: BR0108), the 90th Anniversary of
   Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund),
   the National Center of Excellence for Petroleum, Petrochemicals, and
   Advanced Materials (NCE-PPAM), and the Petroleum and Petrochemical
   College, Chulalongkorn University, Thailand. J. Chutipakdeevong
   acknowledges a doctoral scholarship received from the Thailand Graduate
   Institute of Science and Technology (TGIST) (TG-55-09-51-035D).
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Ahimou F, 2007, J COLLOID INTERF SCI, V309, P49, DOI 10.1016/j.jcis.2007.01.055
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Aznar-Cervantes SD, 2013, MAT SCI ENG C-MATER, V33, P1945, DOI 10.1016/j.msec.2013.01.001
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Bar-Cohen Y, 2006, BIOINSPIR BIOMIM, V1, pP1, DOI 10.1088/1748-3182/1/1/P01
   Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657
   Chutipakdeevong J, 2013, J APPL POLYM SCI, V130, P3634, DOI 10.1002/app.39611
   Croisier F, 2012, ACTA BIOMATER, V8, P218, DOI 10.1016/j.actbio.2011.08.015
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   K-hasuwan PR, 2011, LANGMUIR, V27, P10938, DOI [10.1021/la20255w, 10.1021/la202255w]
   Khadka DB, 2012, NANOMED-NANOTECHNOL, V8, P1242, DOI 10.1016/j.nano.2012.02.013
   Kim M, 2012, CARBOHYD POLYM, V90, P592, DOI 10.1016/j.carbpol.2012.05.082
   Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liao S, 2008, MAT SCI ENG C-BIO S, V28, P1189, DOI 10.1016/j.msec.2008.08.015
   Lim JS, 2012, BIOPOLYMERS, V97, P265, DOI 10.1002/bip.22016
   Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Okhawilai M, 2010, INT J BIOL MACROMOL, V46, P544, DOI 10.1016/j.ijbiomac.2010.02.008
   Ovington LG, 2007, CLIN DERMATOL, V25, P33, DOI 10.1016/j.clindermatol.2006.09.003
   Satriano C, 2010, J COLLOID INTERF SCI, V341, P232, DOI 10.1016/j.jcis.2009.09.046
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wutticharoenmongkol P, 2006, J NANOSCI NANOTECHNO, V6, P514, DOI 10.1166/jnn.2006.090
   Zahedi P., 2009, POLYM ADVAN TECHNOL, V21, P77, DOI DOI 10.1002/PAT.1625
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
NR 30
TC 8
Z9 8
U1 3
U2 137
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 15
PY 2015
VL 132
IS 11
AR 41653
DI 10.1002/app.41653
PG 11
WC Polymer Science
SC Polymer Science
GA AW6DK
UT WOS:000346359400032
DA 2018-10-19
ER

PT J
AU Shin, YC
   Lee, JH
   Jin, LH
   Kim, MJ
   Kim, YJ
   Hyun, JK
   Jung, TG
   Hong, SW
   Han, DW
AF Shin, Yong Cheol
   Lee, Jong Ho
   Jin, Linhua
   Kim, Min Jeong
   Kim, Yong-Joo
   Hyun, Jung Keun
   Jung, Tae-Gon
   Hong, Suck Won
   Han, Dong-Wook
TI Stimulated myoblast differentiation on graphene oxide-impregnated
   PLGA-collagen hybrid fibre matrices
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Electrospun fibre matrix; Poly(lactic-co-glycolic acid); Graphene oxide;
   Collagen; Myoblast differentiation; Skeletal tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE;
   IN-VITRO; BIOMEDICAL APPLICATIONS; NANOFIBER SCAFFOLDS;
   SURFACE-ROUGHNESS; VASCULAR GRAFTS; ELECTROSPUN; COMPOSITE
AB Background: Electrospinning is a simple and effective method for fabricating micro- and nanofiber matrices. Electrospun fibre matrices have numerous advantages for use as tissue engineering scaffolds, such as high surface area-to-volume ratio, mass production capability and structural similarity to the natural extracellular matrix (ECM). Therefore, electrospun matrices, which are composed of biocompatible polymers and various biomaterials, have been developed as biomimetic scaffolds for the tissue engineering applications. In particular, graphene oxide (GO) has recently been considered as a novel biomaterial for skeletal muscle regeneration because it can promote the growth and differentiation of myoblasts. Therefore, the aim of the present study was to fabricate the hybrid fibre matrices that stimulate myoblasts differentiation for skeletal muscle regeneration.
   Results: Hybrid fibre matrices composed of poly(lactic-co-glycolic acid, PLGA) and collagen (Col) impregnated with GO (GO-PLGA-Col) were successfully fabricated using an electrospinning process. Our results indicated that the GO-PLGA-Col hybrid matrices were comprised of randomly-oriented continuous fibres with a three-dimensional non-woven porous structure. Compositional analysis showed that GO was dispersed uniformly throughout the GO-PLGA-Col matrices. In addition, the hydrophilicity of the fabricated matrices was significantly increased by blending with a small amount of Col and GO. The attachment and proliferation of the C2C12 skeletal myoblasts were significantly enhanced on the GO-PLGA-Col hybrid matrices. Furthermore, the GO-PLGA-Col matrices stimulated the myogenic differentiation of C2C12 skeletal myoblasts, which was enhanced further under the culture conditions of the differentiation media.
   Conclusions: Taking our findings into consideration, it is suggested that the GO-PLGA-Col hybrid fibre matrices can be exploited as potential biomimetic scaffolds for skeletal tissue engineering and regeneration because these GO-impregnated hybrid matrices have potent effects on the induction of spontaneous myogenesis and exhibit superior bioactivity and biocompatibility.
C1 [Shin, Yong Cheol; Lee, Jong Ho; Jin, Linhua; Kim, Min Jeong; Hong, Suck Won; Han, Dong-Wook] Pusan Natl Univ, Dept Cogno Mechatron Engn & NanoIntegrat CognoMec, Pusan 609735, South Korea.
   [Kim, Yong-Joo] Chungnam Natl Univ, Dept Biosyst Machinery Engn, Daejeon 305764, South Korea.
   [Hyun, Jung Keun] Dankook Univ, Coll Med, Dept Rehabil Med, Cheonan 330714, South Korea.
   [Hyun, Jung Keun] Dankook Univ, BK21PLUS NBM Global Res Ctr, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Hyun, Jung Keun] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea.
   [Jung, Tae-Gon] Med Device Dev Ctr, Osong Med Innovat Fdn, Cheongju 363951, South Korea.
RP Hong, SW (reprint author), Pusan Natl Univ, Dept Cogno Mechatron Engn & NanoIntegrat CognoMec, Pusan 609735, South Korea.
EM swhong@pusan.ac.kr
OI Hyun, Jung Keun/0000-0001-9254-4424; Hong, Suck Won/0000-0001-7291-1020
FU Korea Health Technology R&D Project through Korea Health Industry
   Development Institute - Ministry of Health & Welfare, Republic of Korea
   [HI14C0522]
FX This research was supported by a grant of the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute,
   funded by the Ministry of Health & Welfare, Republic of Korea (No.
   HI14C0522).
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Beier JP, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-34
   Buckingham M, 2003, BIOESSAYS, V25, P13, DOI 10.1002/bies.10221
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Ciofani G, 2011, BIOMED MICRODEVICES, V13, P255, DOI 10.1007/s10544-010-9490-6
   COSSU G, 1995, P NATL ACAD SCI USA, V92, P2254, DOI 10.1073/pnas.92.6.2254
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   DONOVAN DL, 1990, J VASC SURG, V12, P531, DOI 10.1067/mva.1990.22707
   Grinou A, 2012, MACROMOL RES, V20, P84, DOI 10.1007/s13233-012-0002-9
   Guex AG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/021001
   GURDON JB, 1993, CELL, V75, P831, DOI 10.1016/0092-8674(93)90526-V
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709
   Hovhannisyan V, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046004
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Jung DJ, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-23
   KATO K, 1993, P NATL ACAD SCI USA, V90, P1310, DOI 10.1073/pnas.90.4.1310
   Khalil KA, 2013, INT J ELECTROCHEM SC, V8, P3483
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   Ku SH, 2013, BIOMATERIALS, V34, P2017, DOI 10.1016/j.biomaterials.2012.11.052
   Kumar A, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-10
   Lee EJ, 2014, J NANOSCI NANOTECHNO, V14, P8458, DOI 10.1166/jnn.2014.9922
   Lee JH, 2015, J BIOMED NANOTECHNOL, V11, P1461, DOI 10.1166/jbn.2015.2080
   Lee TJ, 2014, BIOCHEM BIOPH RES CO, V452, P174, DOI 10.1016/j.bbrc.2014.08.062
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Ma K, 2008, BIOMATERIALS, V29, P2096, DOI 10.1016/j.biomaterials.2008.01.024
   Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Milleret V, 2012, ACTA BIOMATER, V8, P4349, DOI 10.1016/j.actbio.2012.07.032
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pirooznia N, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-20
   Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Sabba D, 2013, SCRIPTA MATER, V68, P487, DOI 10.1016/j.scriptamat.2012.11.027
   Shin YC, 2014, INT J NANOMED, V9, P4067, DOI 10.2147/IJN.S68197
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451
   Standley HJ, 2001, DEVELOPMENT, V128, P1347
   Varela JN, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-14
   Veerapandian M, 2012, INT J NANOMED, V7, P6123, DOI 10.2147/IJN.S38402
   Wang H, 2014, INT J NANOMED, V9, P1433, DOI 10.2147/IJN.S58783
   Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008
   Wu N, 2012, J MATER CHEM, V22, P17254, DOI 10.1039/c2jm33114d
   Wu SL, 2014, INT J NANOMED, V9, P1413, DOI 10.2147/IJN.S57946
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yoon OJ, 2012, MACROMOL RES, V20, P789, DOI 10.1007/s13233-012-0116-0
   Yoon OJ, 2011, COMPOS PART A-APPL S, V42, P1978, DOI 10.1016/j.compositesa.2011.08.023
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang NN, 2011, CARBON, V49, P827, DOI 10.1016/j.carbon.2010.10.024
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zuo PP, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-39
NR 61
TC 46
Z9 47
U1 3
U2 146
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD MAR 12
PY 2015
VL 13
AR UNSP 21
DI 10.1186/s12951-015-0081-9
PG 11
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA CE5SK
UT WOS:000351895800001
PM 25886153
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wang, YW
   Mithieux, SM
   Kong, Y
   Wang, XQ
   Chong, C
   Fathi, A
   Dehghani, F
   Panas, E
   Kemnitzer, J
   Daniels, R
   Kimble, RM
   Maitz, PK
   Li, Z
   Weiss, AS
AF Wang, Yiwei
   Mithieux, Suzanne M.
   Kong, Yvonne
   Wang, Xue-Qing
   Chong, Cassandra
   Fathi, Ali
   Dehghani, Fariba
   Panas, Eleni
   Kemnitzer, John
   Daniels, Robert
   Kimble, Roy M.
   Maitz, Peter K.
   Li, Zhe
   Weiss, Anthony S.
TI Tropoelastin Incorporation into a Dermal Regeneration Template Promotes
   Wound Angiogenesis
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE dermal substitute; integra; skin; tropoelastin; wound healing
ID EXTRACELLULAR-MATRIX; COMPOSITE SCAFFOLDS; SKIN SUBSTITUTES; ELASTIN;
   FABRICATION; ENHANCE; CELLS; TRIAL
AB Severe burn injury results in substantial skin loss and cannot be treated by autografts. The Integra Dermal Regeneration Template (IDRT) is the leading synthetic skin substitute because it allows for wound bed regeneration and wound healing. However, all substitutes suffer from slow blood vessel ingrowth and would benefit considerably from enhanced vascularization to nurture tissue repair. It is shown here that by incorporating the human elastic protein tropoelastin into a dermal regeneration template (TDRT) we can promote angiogenesis in wound healing. In small and large animal models comprising mice and pigs, the hybrid TDRT biomaterial and IDRT show similar contraction to autografts and decrease wound contraction compared to open wounds. In mice, TDRT accelerates early stage angiogenesis by 2 weeks, as evidenced by increased angiogenesis fluorescent radiant efficiency in live animal imaging and the expression of endothelial cell adhesion marker CD146. In the pig, a full thickness wound repair model confirms increased numbers of blood vessels in the regenerating areas of the dermis closest to the hypodermis and immediately below the epidermis at 2 weeks post-surgery. It is concluded that including tropoelastin in a dermal regeneration template has the potential to promote wound repair through enhanced vascularization.
C1 [Wang, Yiwei; Chong, Cassandra; Maitz, Peter K.; Li, Zhe] Univ Sydney, ANZAC Res Inst, Burns Res Grp, Concord, NSW 2139, Australia.
   [Mithieux, Suzanne M.; Kong, Yvonne; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Mithieux, Suzanne M.; Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Wang, Xue-Qing; Kimble, Roy M.] Univ Queensland, Queensland Childrens Med Res Inst, Ctr Childrens Burns & Trauma Res, Brisbane, Qld 4072, Australia.
   [Wang, Xue-Qing; Kimble, Roy M.] Royal Childrens Hosp, Stuart Pegg Paediat Burns Ctr, Brisbane, Qld, Australia.
   [Fathi, Ali; Dehghani, Fariba] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia.
   [Panas, Eleni; Kemnitzer, John] Integra Life Sci, Plainsboro, NJ USA.
   [Daniels, Robert] Elastagen Pty Ltd, N Ryde, NSW 2015, Australia.
   [Maitz, Peter K.; Li, Zhe] Concord Repatriat Gen Hosp, Burns & Reconstruct Surg Unit, Concord, NSW 2139, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
OI Dehghani, Fariba/0000-0002-7805-8101; WEISS,
   ANTHONY/0000-0002-8106-4836; Mithieux, Suzanne/0000-0001-6160-9352;
   Kimble, Roy/0000-0002-2449-7707
FU Australian Research Council; National Health and Medical Research
   Council
FX Y.W. and S.M.M. contributed equally to this work. The authors
   acknowledge funding from the Australian Research Council (A.S.W.) and
   the National Health and Medical Research Council (A.S.W. and R.K.). The
   authors acknowledge the facilities and the scientific and technical
   assistance of the Australian Microscopy & Microanalysis Research
   Facility at the Australian Centre for Microscopy & Microanalysis at the
   University of Sydney. A.S.W. is the Scientific Founder of Elastagen Pty
   Ltd.
CR Almine JF, 2013, FASEB J, V27, P3455, DOI 10.1096/fj.13-231787
   Almine JF, 2012, BIRTH DEFECTS RES C, V96, P248, DOI 10.1002/bdrc.21016
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Annabi N, 2011, J SUPERCRIT FLUID, V59, P157, DOI 10.1016/j.supflu.2011.06.010
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Athanassopoulos A, 2012, BURNS, V38, P691, DOI 10.1016/j.burns.2011.12.019
   Bax DV, 2014, BIOMATERIALS, V35, P6797, DOI 10.1016/j.biomaterials.2014.04.082
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Daamen WF, 2006, J CONTROL RELEASE, V116, pE84, DOI 10.1016/j.jconrel.2006.09.062
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   Fathi A, 2013, POLYMER, V54, P5534, DOI 10.1016/j.polymer.2013.08.052
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Kamath NV, 2002, J CUTAN PATHOL, V29, P27, DOI 10.1034/j.1600-0560.2002.290105.x
   Lagus H, 2013, BURNS, V39, P1577, DOI 10.1016/j.burns.2013.04.023
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Rnjak J, 2011, TISSUE ENG PART B-RE, V17, P81, DOI [10.1089/ten.teb.2010.0452, 10.1089/ten.TEB.2010.0452]
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613
   Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x
   Soliman S, 2010, ACTA BIOMATER, V6, P1227, DOI 10.1016/j.actbio.2009.10.051
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   van der Veen VC, 2010, BURNS, V36, P305, DOI 10.1016/j.burns.2009.07.012
   van Zuijlen PPM, 2002, BURNS, V28, P151, DOI 10.1016/S0305-4179(01)00085-7
   Wilson BD, 2011, ANN BIOMED ENG, V39, P337, DOI 10.1007/s10439-010-0142-z
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   ZIMMERMAN TJ, 1982, OPHTHALMOLOGY, V89, P76
NR 28
TC 13
Z9 13
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR 11
PY 2015
VL 4
IS 4
BP 577
EP 584
DI 10.1002/adhm.201400571
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CD6UR
UT WOS:000351225700013
PM 25469903
DA 2018-10-19
ER

EF